#project_accession: PXD014414
#project_title: Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors
#project_description: Metaplastic breast carcinoma (MBC) is the most aggressive form of triple-negative cancer (TNBC), defined by the presence of “metaplastic” components of spindle, squamous, or sarcomatoid histology. The protein profiles underpinning the pathological subtypes and metastatic behavior of MBC are unknown. Using multiplex quantitative tandem mass tag-based proteomics we quantified 5,798 proteins in MBC, TNBC, and normal breast from 27 patients. MBC showed increased epithelial-to-mesenchymal transition and extracellular matrix, and reduced metabolic pathways compared to TNBC. MBC subtypes exhibited distinct upregulated profiles; translation and ribosomal events in spindle, inflammation and apical junctions in squamous, and extracellular matrix in sarcomatoid. Comparison of the proteomes of spindle MBC with MMTV-cre;Ccn6fl/fl spindle MBC tumors revealed a shared spindle-specific signature of 17 upregulated proteins involved in translation (e.g. RPL4,6,18, P3H1, PYCR1) and 19 downregulated proteins with roles in cell metabolism (e.g. ADH1B, ADH1C, LIPE, SOD1, FABP4). These data identify subtype specific MBC protein profiles providing biomarkers and therapeutic targets.
#quantms_version: 1.1.1
#factor_value: disease
#contrast: Normal
#contrast: Triple-negative breast cancer
#contrast: metaplastic breast carcinomas
#fdr_threshold: 0.05
#INFO=<ID=protein, Number=inf, Type=String, Description="Protein Accession">
#INFO=<ID=label,Number=1, Type=String, Description="Label for the Conditions combination">
#INFO=<ID=log2fc, Number=1, Type=Double, Description="Log2 Fold Change">
#INFO=<ID=se, Number=1, Type=Double, Description="Standard error of the log2 fold change">
#INFO=<ID=df, Number=1, Type=Integer, Description="Degree of freedom of the Student test"> 
#INFO=<ID=pvalue, Number=1, Type=Double, Description="Raw p-values">
#INFO=<ID=adj.pvalue, Number=1, Type=Double, Description="P-values adjusted among all the proteins in the specific comparison using the approach by Benjamini and Hochberg">
#INFO=<ID=issue, Number=1, Type=String, Description="Issue column shows if there is any issue for inference in corresponding protein and comparison">
protein	label	log2fc	se	df	pvalue	adj.pvalue	issue
sp|A0A075B6H7|KV37_HUMAN	metaplastic breast carcinomas-Normal	-1.5865813550195	0.82751471306731	6.0	0.103655633161859	0.261023730780318	nan
sp|A0A075B6H7|KV37_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.494369221943191	0.82751471306731	6.0	0.572071683722606	0.935631258424823	nan
sp|A0A075B6H7|KV37_HUMAN	Normal-Triple-negative breast cancer	2.08095057696269	0.98906925970319	6.0	0.0800395846282146	0.210464269316822	nan
sp|A0A075B6H9|LV469_HUMAN	metaplastic breast carcinomas-Normal	-1.61600350171357	0.56188781611957	24.0000000002138	0.0083151731442427	0.0602818106368712	nan
sp|A0A075B6H9|LV469_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.797075745457031	0.56188781611957	24.000000000255	0.16888123994731	0.843662073010871	nan
sp|A0A075B6H9|LV469_HUMAN	Normal-Triple-negative breast cancer	2.4130792471706	0.671584393062533	24.0000000002304	0.0014624363666251	0.0273097667565284	nan
sp|A0A075B6I0|LV861_HUMAN	metaplastic breast carcinomas-Normal	-1.42566719813009	0.539961673949039	23.9999999991906	0.0143327729222131	0.0795361221927149	nan
sp|A0A075B6I0|LV861_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.483526241875119	0.539961673949039	23.9999999992325	0.379423079546069	0.885234295852111	nan
sp|A0A075B6I0|LV861_HUMAN	Normal-Triple-negative breast cancer	1.9091934400052	0.645377640647982	23.9999999992246	0.0068512831570811	0.0524989501286484	nan
sp|A0A075B6I9|LV746_HUMAN;sp|P04211|LV743_HUMAN	metaplastic breast carcinomas-Normal	-1.3416455951921	0.461072653929819	23.9999999993727	0.0076804567510574	0.0584206824725739	nan
sp|A0A075B6I9|LV746_HUMAN;sp|P04211|LV743_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.746836665238472	0.461072653929819	23.9999999993736	0.118346544611594	0.823891816737944	nan
sp|A0A075B6I9|LV746_HUMAN;sp|P04211|LV743_HUMAN	Normal-Triple-negative breast cancer	2.08848226043058	0.551087226958656	23.9999999993444	0.0008947700576709	0.025773942907156	nan
sp|A0A075B6J9|LV218_HUMAN	metaplastic breast carcinomas-Normal	-1.24380633126511	0.483326959486564	23.9999999997445	0.0166747245581652	0.0864692424825917	nan
sp|A0A075B6J9|LV218_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.662606230872171	0.483326959486564	23.9999999997445	0.183082643750529	0.843662073010871	nan
sp|A0A075B6J9|LV218_HUMAN	Normal-Triple-negative breast cancer	1.90641256213728	0.577686209640947	23.9999999996843	0.0030112892300937	0.0367997257383518	nan
sp|A0A075B6K4|LV310_HUMAN	metaplastic breast carcinomas-Normal	0.137831101898936	0.664534478585006	6.0	0.84255008744983	0.915539879268792	nan
sp|A0A075B6K4|LV310_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.851511216065867	0.664534478585006	6.0	0.247356169244788	0.84964799869723	nan
sp|A0A075B6K4|LV310_HUMAN	Normal-Triple-negative breast cancer	0.71368011416693	0.794270620693913	6.0	0.40351553080359	0.593242783972026	nan
sp|A0A075B6R9|KVD24_HUMAN;sp|A0A0C4DH68|KV224_HUMAN	metaplastic breast carcinomas-Normal	-1.48763458643497	0.500729602753089	23.9999999991238	0.0066487547109741	0.0534585445819025	nan
sp|A0A075B6R9|KVD24_HUMAN;sp|A0A0C4DH68|KV224_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.40022899473751	0.500729602753089	23.9999999991222	0.431961186232098	0.896102083258464	nan
sp|A0A075B6R9|KVD24_HUMAN;sp|A0A0C4DH68|KV224_HUMAN	Normal-Triple-negative breast cancer	1.88786358117248	0.598486346751138	23.999999999082	0.0042880648817101	0.0419484078096101	nan
sp|A0A075B6S5|KV127_HUMAN	metaplastic breast carcinomas-Normal	-0.489943827198481	0.571914000857559	15.0000000000134	0.405103771064611	0.607655656596916	nan
sp|A0A075B6S5|KV127_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.357197858095885	0.571914000857559	14.9999999998662	0.541640358714265	0.923837171685362	nan
sp|A0A075B6S5|KV127_HUMAN	Normal-Triple-negative breast cancer	0.847141685294366	0.683567975903849	14.99999999993	0.234277617728517	0.41930614049483	nan
sp|A0A0A0MRZ8|KVD11_HUMAN;sp|P04433|KV311_HUMAN	metaplastic breast carcinomas-Normal	-1.18299193579231	0.462750159386912	24.0000000001784	0.0173240601966666	0.0885925786057228	nan
sp|A0A0A0MRZ8|KVD11_HUMAN;sp|P04433|KV311_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.395032905751173	0.462750159386912	24.0000000001784	0.401731791721125	0.885297496092956	nan
sp|A0A0A0MRZ8|KVD11_HUMAN;sp|P04433|KV311_HUMAN	Normal-Triple-negative breast cancer	1.57802484154349	0.553092229473287	24.0000000001992	0.0087736767615174	0.0588076066258844	nan
sp|A0A0B4J1V0|HV315_HUMAN	metaplastic breast carcinomas-Normal	-1.07700927080486	0.422478919842532	21.9999998753818	0.018282677451081	0.0915235238665563	nan
sp|A0A0B4J1V0|HV315_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.484034128111222	0.422478919842532	21.9999998735139	0.264229542156264	0.864727586288954	nan
sp|A0A0B4J1V0|HV315_HUMAN	Normal-Triple-negative breast cancer	1.56104339891608	0.504958891836487	21.9999998720098	0.0053308564941651	0.0461452265276174	nan
sp|A0A0B4J1X5|HV374_HUMAN	metaplastic breast carcinomas-Normal	-1.41350852574079	0.538089391169172	23.9999999992824	0.0147760616694348	0.0799928810899041	nan
sp|A0A0B4J1X5|HV374_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.19810456929545	0.538089391169172	23.9999999990165	0.715979091374963	0.949812109346858	nan
sp|A0A0B4J1X5|HV374_HUMAN	Normal-Triple-negative breast cancer	1.61161309503624	0.64313983470472	23.9999999991735	0.0193996947637291	0.0907623920695186	nan
sp|A0A0B4J1X8|HV343_HUMAN;sp|P0DP04|HV43D_HUMAN	metaplastic breast carcinomas-Normal	-0.930371337665101	0.534654606755475	14.9999999995737	0.102304673996634	0.258601320429514	nan
sp|A0A0B4J1X8|HV343_HUMAN;sp|P0DP04|HV43D_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.827461319566522	0.534654606755475	14.9999999995737	0.142541357060074	0.827137892189782	nan
sp|A0A0B4J1X8|HV343_HUMAN;sp|P0DP04|HV43D_HUMAN	Normal-Triple-negative breast cancer	1.75783265723162	0.639034482106574	14.9999999995905	0.0148633689371592	0.0779324922305247	nan
sp|A0A0B4J2D5|GAL3B_HUMAN;sp|P0DPI2|GAL3A_HUMAN	metaplastic breast carcinomas-Normal	-0.66096201092601	0.470919463577571	23.9999999992905	0.173258131727571	0.361439499568716	nan
sp|A0A0B4J2D5|GAL3B_HUMAN;sp|P0DPI2|GAL3A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.13834536500666	0.470919463577571	23.9999999992905	0.0235985156574994	0.71450213652955	nan
sp|A0A0B4J2D5|GAL3B_HUMAN;sp|P0DPI2|GAL3A_HUMAN	Normal-Triple-negative breast cancer	-0.477383354080653	0.562856415560319	23.9999999992704	0.404737549531721	0.594248116815048	nan
sp|A0A0C4DH38|HV551_HUMAN;sp|A0A0J9YXX1|HV5X1_HUMAN	metaplastic breast carcinomas-Normal	-0.636139884485385	0.367423925785074	23.9999999999743	0.0962266895120991	0.250751547601932	nan
sp|A0A0C4DH38|HV551_HUMAN;sp|A0A0J9YXX1|HV5X1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.402929002245121	0.367423925785074	23.9999999996906	0.283684165942745	0.867696529950794	nan
sp|A0A0C4DH38|HV551_HUMAN;sp|A0A0J9YXX1|HV5X1_HUMAN	Normal-Triple-negative breast cancer	1.03906888673051	0.439155587852277	23.9999999998251	0.0263946040141862	0.108853180822773	nan
sp|A0A0C4DH41|HV461_HUMAN;sp|P01824|HV439_HUMAN;sp|P01825|HV459_HUMAN;sp|P06331|HV434_HUMAN;sp|P0DP06|HVD34_HUMAN;sp|P0DP08|HVD82_HUMAN	metaplastic breast carcinomas-Normal	-1.08994675377046	0.332039119020812	22.0000000149514	0.0033995723243975	0.04050243156379	nan
sp|A0A0C4DH41|HV461_HUMAN;sp|P01824|HV439_HUMAN;sp|P01825|HV459_HUMAN;sp|P06331|HV434_HUMAN;sp|P0DP06|HVD34_HUMAN;sp|P0DP08|HVD82_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.407013053955643	0.332039119020812	22.0000000154911	0.233234978687028	0.847998869365766	nan
sp|A0A0C4DH41|HV461_HUMAN;sp|P01824|HV439_HUMAN;sp|P01825|HV459_HUMAN;sp|P06331|HV434_HUMAN;sp|P0DP06|HVD34_HUMAN;sp|P0DP08|HVD82_HUMAN	Normal-Triple-negative breast cancer	1.4969598077261	0.396862654471863	22.0000000154983	0.0010500758937189	0.0264764243087785	nan
sp|A0A1B0GUS4|UB2L5_HUMAN;sp|P68036|UB2L3_HUMAN	metaplastic breast carcinomas-Normal	0.235974912485861	0.229707476454751	23.9999999993982	0.314529479228894	0.521444383519623	nan
sp|A0A1B0GUS4|UB2L5_HUMAN;sp|P68036|UB2L3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.346955415228989	0.229707476454751	23.9999999993982	0.143990680485927	0.827647387111815	nan
sp|A0A1B0GUS4|UB2L5_HUMAN;sp|P68036|UB2L3_HUMAN	Normal-Triple-negative breast cancer	-0.582930327714851	0.274552947636725	23.99999999938	0.0442446789447264	0.143063533864077	nan
sp|A0AVT1|UBA6_HUMAN	metaplastic breast carcinomas-Normal	0.181020356070566	0.182282689792584	21.9999999799803	0.331471229497369	0.539838494291648	nan
sp|A0AVT1|UBA6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.278268004378525	0.182282689792584	21.9999999799713	0.141116642931832	0.823891816737944	nan
sp|A0AVT1|UBA6_HUMAN	Normal-Triple-negative breast cancer	-0.459288360449091	0.217869485826522	21.9999999800407	0.0466428114735427	0.148213884710877	nan
sp|A0FGR8|ESYT2_HUMAN	metaplastic breast carcinomas-Normal	-0.041852348605182	0.198030682807051	23.9999999997297	0.834404174549583	0.912407687537956	nan
sp|A0FGR8|ESYT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.159078499829223	0.198030682807051	23.99999999977	0.429684497467746	0.894615500363341	nan
sp|A0FGR8|ESYT2_HUMAN	Normal-Triple-negative breast cancer	-0.117226151224041	0.236691937617012	23.9999999997728	0.624914612548221	0.773622324634365	nan
sp|A0JNW5|UH1BL_HUMAN	metaplastic breast carcinomas-Normal	0.20049020220935	0.215146251795856	14.0000001146677	0.367191993662023	0.576817668682687	nan
sp|A0JNW5|UH1BL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0330740383876616	0.215146251795856	14.0000001146484	0.880018009123911	0.983583849145686	nan
sp|A0JNW5|UH1BL_HUMAN	Normal-Triple-negative breast cancer	-0.167416163821688	0.257148955337468	14.0000001147641	0.52555839596399	0.695444310582923	nan
sp|A0MZ66|SHOT1_HUMAN	metaplastic breast carcinomas-Normal	0.0336581008944066	0.33593984517273	23.999999999598	0.921025058103453	0.95843058885501	nan
sp|A0MZ66|SHOT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.399664098261596	0.33593984517273	23.999999999598	0.245805119998836	0.84964799869723	nan
sp|A0MZ66|SHOT1_HUMAN	Normal-Triple-negative breast cancer	-0.433322199156002	0.401524913965814	23.9999999995641	0.291229388180921	0.484507750907599	nan
sp|A1L0T0|HACL2_HUMAN	metaplastic breast carcinomas-Normal	-0.327490570406122	0.24549436279737	22.0000000040056	0.195848481494692	0.388425031317635	nan
sp|A1L0T0|HACL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.297705152676023	0.24549436279737	22.0000000034893	0.23811546075453	0.84876230490475	nan
sp|A1L0T0|HACL2_HUMAN	Normal-Triple-negative breast cancer	0.0297854177300986	0.293421885845733	22.0000000034677	0.920064684536353	0.953928574984042	nan
sp|A1X283|SPD2B_HUMAN	metaplastic breast carcinomas-Normal	0.745013754194871	0.328146614220688	23.9999999997083	0.0324470363676996	0.12932128163817	nan
sp|A1X283|SPD2B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0447963567449729	0.328146614220688	23.9999999997083	0.892554244528095	0.988218752026376	nan
sp|A1X283|SPD2B_HUMAN	Normal-Triple-negative breast cancer	-0.789810110939844	0.392210221372783	23.9999999996459	0.0553792218775237	0.167455166342693	nan
sp|A2RRP1|NBAS_HUMAN	metaplastic breast carcinomas-Normal	0.406866881842582	0.307897933903783	24.0000000002758	0.198816276544596	0.391943393868757	nan
sp|A2RRP1|NBAS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.254057054778697	0.307897933903783	24.0000000002758	0.417421956172044	0.8860071777014	nan
sp|A2RRP1|NBAS_HUMAN	Normal-Triple-negative breast cancer	-0.152809827063886	0.368008419356751	24.0000000003315	0.681659000387764	0.813486356388654	nan
sp|A4D1P6|WDR91_HUMAN	metaplastic breast carcinomas-Normal	0.264927862995309	0.238834133830115	21.9999998463972	0.279299170251392	0.482280749047078	nan
sp|A4D1P6|WDR91_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.077509425538539	0.238834133830115	21.9999998450284	0.74860058271575	0.954643368861838	nan
sp|A4D1P6|WDR91_HUMAN	Normal-Triple-negative breast cancer	-0.18741843745677	0.285461389639353	21.9999998452584	0.518282286737326	0.691043048983101	nan
sp|A5D8V6|VP37C_HUMAN	metaplastic breast carcinomas-Normal	0.0362007267530944	0.328006604853683	12.1627568815438	0.913919459771062	0.954704049113454	nan
sp|A5D8V6|VP37C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.526890904102565	0.295656794327832	12.0496551066222	0.099927397789468	0.821630939204717	nan
sp|A5D8V6|VP37C_HUMAN	Normal-Triple-negative breast cancer	-0.563091630855659	0.375784496070142	12.2733988230985	0.159291257381779	0.329486085586205	nan
sp|A5YKK6|CNOT1_HUMAN	metaplastic breast carcinomas-Normal	0.42195729814367	0.172845476080555	22.0000000569012	0.0231426917651042	0.105523055455701	nan
sp|A5YKK6|CNOT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.188965662732316	0.172845476080555	22.0000000569921	0.286105059267696	0.867696529950794	nan
sp|A5YKK6|CNOT1_HUMAN	Normal-Triple-negative breast cancer	-0.610922960875987	0.206589858005502	22.000000056766	0.0072812054787767	0.0537838378032308	nan
sp|A6NDG6|PGP_HUMAN	metaplastic breast carcinomas-Normal	0.256808798467756	0.175441099425957	22.0000000631964	0.157394514559118	0.339506402592153	nan
sp|A6NDG6|PGP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.229850412802914	0.175441099425957	22.0000000621999	0.203667493289829	0.843662073010871	nan
sp|A6NDG6|PGP_HUMAN	Normal-Triple-negative breast cancer	-0.48665921127067	0.209692221286983	22.0000000621834	0.0299575927855891	0.116194910640955	nan
sp|A6NHL2|TBAL3_HUMAN	metaplastic breast carcinomas-Normal	-0.892121665826186	0.498060568725598	22.0000057076884	0.0870320419877648	0.236924781788546	nan
sp|A6NHL2|TBAL3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0293261173274738	0.498060568725598	22.0000057075766	0.953578761225582	0.996541950781621	nan
sp|A6NHL2|TBAL3_HUMAN	Normal-Triple-negative breast cancer	0.92144778315366	0.595296240922194	22.0000057075385	0.135916851899389	0.296060036509547	nan
sp|A6NHR9|SMHD1_HUMAN	metaplastic breast carcinomas-Normal	0.290486522792582	0.189523359449121	14.000000211697	0.147626857620338	0.325621549256803	nan
sp|A6NHR9|SMHD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0514695889501805	0.189523359449121	14.0000002115938	0.789913298078398	0.962981271203673	nan
sp|A6NHR9|SMHD1_HUMAN	Normal-Triple-negative breast cancer	-0.341956111742762	0.226523741350755	14.0000002115839	0.153385736693792	0.321066869502622	nan
sp|A6NI72|NCF1B_HUMAN;sp|A8MVU1|NCF1C_HUMAN;sp|P14598|NCF1_HUMAN	metaplastic breast carcinomas-Normal	0.0382225631661446	0.565194114080676	22.0000000224263	0.946693175070161	0.972567428615729	nan
sp|A6NI72|NCF1B_HUMAN;sp|A8MVU1|NCF1C_HUMAN;sp|P14598|NCF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.129397274157396	0.565194114080676	22.0000000221057	0.821028043248642	0.965774701272009	nan
sp|A6NI72|NCF1B_HUMAN;sp|A8MVU1|NCF1C_HUMAN;sp|P14598|NCF1_HUMAN	Normal-Triple-negative breast cancer	0.0911747109912516	0.675536174976631	22.0000000225563	0.893865636189053	0.937881747061999	nan
sp|A6NMZ7|CO6A6_HUMAN	metaplastic breast carcinomas-Normal	-1.54003926608431	0.73816135966614	14.9999999996914	0.0544373336473341	0.178100095515491	nan
sp|A6NMZ7|CO6A6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.418533324799655	0.73816135966614	14.9999999997213	0.579104764393761	0.936538590276875	nan
sp|A6NMZ7|CO6A6_HUMAN	Normal-Triple-negative breast cancer	1.95857259088396	0.882271575378146	14.9999999997226	0.0422559808550013	0.139621153441376	nan
sp|A7E2V4|ZSWM8_HUMAN	metaplastic breast carcinomas-Normal	0.0317008664735866	0.288421830757014	15.9999999997615	0.913846376748787	0.954704049113454	nan
sp|A7E2V4|ZSWM8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.32952579880417	0.22625669895018	15.9999999998204	0.16461890110962	0.843662073010871	nan
sp|A7E2V4|ZSWM8_HUMAN	Normal-Triple-negative breast cancer	0.297824932330583	0.309814744504173	15.9999999997327	0.350704996559998	0.54119935402295	nan
sp|A8K2U0|A2ML1_HUMAN	metaplastic breast carcinomas-Normal	0.116283485888102	0.514956718933613	14.9999999999217	0.824395449247551	0.907569094159468	nan
sp|A8K2U0|A2ML1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.355471310271901	0.514956718933613	14.9999999997402	0.500551804827898	0.913320451076758	nan
sp|A8K2U0|A2ML1_HUMAN	Normal-Triple-negative breast cancer	0.2391878243838	0.615491003038425	14.9999999998536	0.70302278479099	0.826325225122083	nan
sp|A8MWD9|RUXGL_HUMAN;sp|P62308|RUXG_HUMAN	metaplastic breast carcinomas-Normal	0.365872641943417	0.194052614220204	20.9371452431353	0.0733255432353782	0.211185923021356	nan
sp|A8MWD9|RUXGL_HUMAN;sp|P62308|RUXG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0919577367838582	0.194052614220204	20.9371452418928	0.640489459100045	0.941868024951375	nan
sp|A8MWD9|RUXGL_HUMAN;sp|P62308|RUXG_HUMAN	Normal-Triple-negative breast cancer	-0.457830378727275	0.229537544683659	20.8890248124985	0.0593020304820542	0.174751728122649	nan
sp|B0I1T2|MYO1G_HUMAN	metaplastic breast carcinomas-Normal	-0.497545314134352	0.376006491107554	14.9999999996936	0.205573613969692	0.399606253120033	nan
sp|B0I1T2|MYO1G_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0100721124356436	0.376006491107554	14.9999999996927	0.978982697273732	0.99709406933403	nan
sp|B0I1T2|MYO1G_HUMAN	Normal-Triple-negative breast cancer	0.507617426569995	0.449413715467186	14.9999999997144	0.276422407405966	0.468477251931463	nan
sp|B5ME19|EIFCL_HUMAN;sp|Q99613|EIF3C_HUMAN	metaplastic breast carcinomas-Normal	0.54905374033936	0.179342209188001	22.0000000165916	0.0057165543473886	0.05017239027102	nan
sp|B5ME19|EIFCL_HUMAN;sp|Q99613|EIF3C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.207832021281405	0.179342209188001	22.0000000157752	0.258939063970722	0.862813416943474	nan
sp|B5ME19|EIFCL_HUMAN;sp|Q99613|EIF3C_HUMAN	Normal-Triple-negative breast cancer	-0.341221719057955	0.214354939282732	22.0000000159537	0.125685436177767	0.280953860023469	nan
sp|C9JRZ8|AK1BF_HUMAN	metaplastic breast carcinomas-Normal	-0.634494109657108	1.89154428906319	4.0	0.754150397743788	0.865008944824138	nan
sp|C9JRZ8|AK1BF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-2.30931506701626	1.89154428906319	4.0	0.289180465935623	0.867696529950794	nan
sp|C9JRZ8|AK1BF_HUMAN	Normal-Triple-negative breast cancer	-1.67482095735915	2.07208295127996	4.0	0.464258029505993	0.643802123520201	nan
sp|CONTAMINANT_P00441|CONTAMINANT_SODC_HUMAN;sp|P00441|SODC_HUMAN	metaplastic breast carcinomas-Normal	-0.06349750877919	0.316067302622827	23.9999999995451	0.842470634295855	0.915539879268792	nan
sp|CONTAMINANT_P00441|CONTAMINANT_SODC_HUMAN;sp|P00441|SODC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.413007928742314	0.316067302622827	23.9999999995451	0.203695056654141	0.843662073010871	nan
sp|CONTAMINANT_P00441|CONTAMINANT_SODC_HUMAN;sp|P00441|SODC_HUMAN	Normal-Triple-negative breast cancer	-0.349510419963124	0.377772682569954	23.999999999492	0.364078562494447	0.5541195703899	nan
sp|CONTAMINANT_P00711|CONTAMINANT_LALBA_BOVIN	metaplastic breast carcinomas-Normal	1.04210071487988	1.16781379084158	7.99999999998099	0.398250131013336	0.601923998636815	nan
sp|CONTAMINANT_P00711|CONTAMINANT_LALBA_BOVIN	metaplastic breast carcinomas-Triple-negative breast cancer	1.27465273182451	1.95412623446475	7.9999999998986	0.532505749911329	0.921388505638487	nan
sp|CONTAMINANT_P00711|CONTAMINANT_LALBA_BOVIN	Normal-Triple-negative breast cancer	0.232552016944632	2.02271281951723	7.99999999990996	0.911301925827481	0.949284738781118	nan
sp|CONTAMINANT_P00761|CONTAMINANT_trYP_PIG	metaplastic breast carcinomas-Normal	-0.352720528852603	0.168824838109377	22.0000001660531	0.0484634467929255	0.166333034461371	nan
sp|CONTAMINANT_P00761|CONTAMINANT_trYP_PIG	metaplastic breast carcinomas-Triple-negative breast cancer	0.195573543683558	0.168824838109377	22.0000001660484	0.259105397977147	0.862813416943474	nan
sp|CONTAMINANT_P00761|CONTAMINANT_trYP_PIG	Normal-Triple-negative breast cancer	0.548294072536161	0.201784276474575	22.0000001658528	0.0125820822749388	0.0726685666512126	nan
sp|CONTAMINANT_P00915|CONTAMINANT_CAH1_HUMAN;sp|P00915|CAH1_HUMAN	metaplastic breast carcinomas-Normal	-0.566323867842994	0.67603840718285	22.0000000700413	0.411202619050179	0.613481824830698	nan
sp|CONTAMINANT_P00915|CONTAMINANT_CAH1_HUMAN;sp|P00915|CAH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.89184114001669	0.67603840718285	22.0000000701959	0.200663092370441	0.843662073010871	nan
sp|CONTAMINANT_P00915|CONTAMINANT_CAH1_HUMAN;sp|P00915|CAH1_HUMAN	Normal-Triple-negative breast cancer	1.45816500785968	0.808020445273796	22.0000000698517	0.0848433479609745	0.219129206388717	nan
sp|CONTAMINANT_P00918|CONTAMINANT_CAH2_HUMAN;sp|P00918|CAH2_HUMAN	metaplastic breast carcinomas-Normal	-0.452656992852413	0.482724315451037	22.0000000002773	0.358573007308409	0.567965942611573	nan
sp|CONTAMINANT_P00918|CONTAMINANT_CAH2_HUMAN;sp|P00918|CAH2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.792972868725159	0.482724315451037	22.000000000919	0.114662187180148	0.823891816737944	nan
sp|CONTAMINANT_P00918|CONTAMINANT_CAH2_HUMAN;sp|P00918|CAH2_HUMAN	Normal-Triple-negative breast cancer	1.24562986157757	0.57696591224844	22.0000000008507	0.0420282520974952	0.139006875594104	nan
sp|CONTAMINANT_P01008|CONTAMINANT_ANT3_HUMAN;sp|P01008|ANT3_HUMAN	metaplastic breast carcinomas-Normal	-0.817903809315172	0.366563542134812	23.9999999994606	0.0352648122384643	0.135986352529762	nan
sp|CONTAMINANT_P01008|CONTAMINANT_ANT3_HUMAN;sp|P01008|ANT3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.333289481478094	0.366563542134812	23.9999999992211	0.372271142131033	0.885234295852111	nan
sp|CONTAMINANT_P01008|CONTAMINANT_ANT3_HUMAN;sp|P01008|ANT3_HUMAN	Normal-Triple-negative breast cancer	1.15119329079327	0.43812723269848	23.9999999993074	0.0147549793803232	0.0779324922305247	nan
sp|CONTAMINANT_P02533|CONTAMINANT_K1C14_HUMAN;sp|P02533|K1C14_HUMAN	metaplastic breast carcinomas-Normal	0.329369707395183	0.481206173104754	23.9999999996121	0.500237287761322	0.685513879245402	nan
sp|CONTAMINANT_P02533|CONTAMINANT_K1C14_HUMAN;sp|P02533|K1C14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0132418311343467	0.481206173104754	23.9999999996121	0.978274127272997	0.99709406933403	nan
sp|CONTAMINANT_P02533|CONTAMINANT_K1C14_HUMAN;sp|P02533|K1C14_HUMAN	Normal-Triple-negative breast cancer	-0.342611538529529	0.57515138508312	23.9999999996536	0.556959215455151	0.720362814075067	nan
sp|CONTAMINANT_P02662|CONTAMINANT_CASA1_BOVIN	metaplastic breast carcinomas-Normal	0.697591894266573	0.776943030580227	6.0	0.403844191716143	0.606313501926134	nan
sp|CONTAMINANT_P02662|CONTAMINANT_CASA1_BOVIN	metaplastic breast carcinomas-Triple-negative breast cancer	1.49714522799927	0.776943030580227	6.0	0.102273091230214	0.821630939204717	nan
sp|CONTAMINANT_P02662|CONTAMINANT_CASA1_BOVIN	Normal-Triple-negative breast cancer	0.799553333732697	0.928624537972454	6.0	0.422301862447427	0.608466142512028	nan
sp|CONTAMINANT_P02663|CONTAMINANT_CASA2_BOVIN	metaplastic breast carcinomas-Normal	0.920183128600862	1.70736095236196	6.0	0.609320713066601	0.766127999985258	nan
sp|CONTAMINANT_P02663|CONTAMINANT_CASA2_BOVIN	metaplastic breast carcinomas-Triple-negative breast cancer	1.95774002084131	1.70736095236196	6.0	0.295188527667749	0.867696529950794	nan
sp|CONTAMINANT_P02663|CONTAMINANT_CASA2_BOVIN	Normal-Triple-negative breast cancer	1.03755689224045	2.04068665672343	6.0	0.62929608494198	0.777550625101758	nan
sp|CONTAMINANT_P02668|CONTAMINANT_CASK_BOVIN	metaplastic breast carcinomas-Normal	-0.216491938124428	0.900282341459073	22.0000000026621	0.812191722377359	0.900925915386606	nan
sp|CONTAMINANT_P02668|CONTAMINANT_CASK_BOVIN	metaplastic breast carcinomas-Triple-negative breast cancer	0.403706147911776	0.900282341459073	22.0000000025544	0.658234229799714	0.944190045212043	nan
sp|CONTAMINANT_P02668|CONTAMINANT_CASK_BOVIN	Normal-Triple-negative breast cancer	0.620198086036204	1.07604321099044	22.0000000024556	0.570216142676376	0.731250004219129	nan
sp|CONTAMINANT_P02741|CONTAMINANT_CRP_HUMAN;sp|P02741|CRP_HUMAN	metaplastic breast carcinomas-Normal	-1.44651683056842	0.535148856195298	24.0000000002771	0.0124204345016728	0.0733313042336773	nan
sp|CONTAMINANT_P02741|CONTAMINANT_CRP_HUMAN;sp|P02741|CRP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.784601832344307	0.535148856195298	24.0000000002785	0.155591588644262	0.843465960034572	nan
sp|CONTAMINANT_P02741|CONTAMINANT_CRP_HUMAN;sp|P02741|CRP_HUMAN	Normal-Triple-negative breast cancer	2.23111866291273	0.639625223177197	24.0000000002218	0.0018970749872938	0.0300279869417369	nan
sp|CONTAMINANT_P02754|CONTAMINANT_LACB_BOVIN	metaplastic breast carcinomas-Normal	-0.0843463804487388	0.732303701348195	22.0000000835384	0.909347658436867	0.951423234700707	nan
sp|CONTAMINANT_P02754|CONTAMINANT_LACB_BOVIN	metaplastic breast carcinomas-Triple-negative breast cancer	0.35159567253634	0.732303701348195	22.0000000837599	0.635879431686924	0.941868024951375	nan
sp|CONTAMINANT_P02754|CONTAMINANT_LACB_BOVIN	Normal-Triple-negative breast cancer	0.435942052985079	0.875270334572833	22.0000000836797	0.623380260849493	0.772313077548906	nan
sp|CONTAMINANT_P02768-1|CONTAMINANT_ALBU_HUMAN;sp|P02768|ALBU_HUMAN	metaplastic breast carcinomas-Normal	-1.69068965007457	0.466352872697646	23.9999999997234	0.0013497126265221	0.0271905743670284	nan
sp|CONTAMINANT_P02768-1|CONTAMINANT_ALBU_HUMAN;sp|P02768|ALBU_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.145016904557598	0.466352872697646	23.9999999999005	0.758516111868158	0.955228196959647	nan
sp|CONTAMINANT_P02768-1|CONTAMINANT_ALBU_HUMAN;sp|P02768|ALBU_HUMAN	Normal-Triple-negative breast cancer	1.83570655463217	0.557398295493507	23.9999999998256	0.0030611804930309	0.0368672607204164	nan
sp|CONTAMINANT_P02787|trFE_HUMAN	metaplastic breast carcinomas-Normal	-0.941787746800099	0.560488633203411	22.0000000386638	0.107045229371979	0.266930489446705	nan
sp|CONTAMINANT_P02787|trFE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0507214601099847	0.560488633203411	22.000000038476	0.928712687384475	0.995359816653149	nan
sp|CONTAMINANT_P02787|trFE_HUMAN	Normal-Triple-negative breast cancer	0.891066286690115	0.669912049611448	22.0000000382611	0.197102944195189	0.3786926489393	nan
sp|CONTAMINANT_P02788|trFL_HUMAN;sp|P02788|TRFL_HUMAN	metaplastic breast carcinomas-Normal	-0.241941021894522	0.564630440666126	24.0000000000557	0.672112439592206	0.808148806621432	nan
sp|CONTAMINANT_P02788|trFL_HUMAN;sp|P02788|TRFL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.687704535593835	0.564630440666126	23.9999999998155	0.235073436822912	0.84876230490475	nan
sp|CONTAMINANT_P02788|trFL_HUMAN;sp|P02788|TRFL_HUMAN	Normal-Triple-negative breast cancer	0.929645557488357	0.674862456385239	23.9999999999713	0.181058927547326	0.356693755905161	nan
sp|CONTAMINANT_P04040|CONTAMINANT_CATA_HUMAN;sp|P04040|CATA_HUMAN	metaplastic breast carcinomas-Normal	-0.754223577520347	0.360052806385287	22.0000000015206	0.0479259632034055	0.164882962783891	nan
sp|CONTAMINANT_P04040|CONTAMINANT_CATA_HUMAN;sp|P04040|CATA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.278267430616232	0.360052806385287	22.000000000032	0.447834541915569	0.902988618897891	nan
sp|CONTAMINANT_P04040|CONTAMINANT_CATA_HUMAN;sp|P04040|CATA_HUMAN	Normal-Triple-negative breast cancer	1.03249100813658	0.430345415062833	22.0000000004431	0.0253388179364162	0.105546655163719	nan
sp|CONTAMINANT_P04264|CONTAMINANT_K2C1_HUMAN	metaplastic breast carcinomas-Normal	-0.376632165055707	0.457715136341502	22.0000000443925	0.419421934042403	0.620030732879251	nan
sp|CONTAMINANT_P04264|CONTAMINANT_K2C1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.425640849947518	0.457715136341502	22.0000000443193	0.36250211481671	0.883542279876718	nan
sp|CONTAMINANT_P04264|CONTAMINANT_K2C1_HUMAN	Normal-Triple-negative breast cancer	0.802273015003225	0.547074225880756	22.0000000442571	0.156667114063017	0.326087343234483	nan
sp|CONTAMINANT_P05413|CONTAMINANT_FABPH_HUMAN;sp|P05413|FABPH_HUMAN	metaplastic breast carcinomas-Normal	-0.404549397533032	0.288851302401671	23.9999999997059	0.174146793386494	0.361789963260442	nan
sp|CONTAMINANT_P05413|CONTAMINANT_FABPH_HUMAN;sp|P05413|FABPH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0049141386910866	0.288851302401671	23.9999999997437	0.986567132713651	0.99777413090774	nan
sp|CONTAMINANT_P05413|CONTAMINANT_FABPH_HUMAN;sp|P05413|FABPH_HUMAN	Normal-Triple-negative breast cancer	0.409463536224119	0.345243340473978	23.999999999763	0.24722603082321	0.435790750062052	nan
sp|CONTAMINANT_P05784|CONTAMINANT_K1C18_MOUSE	metaplastic breast carcinomas-Normal	-0.426973710390975	0.737419834300893	6.0	0.583649239509753	0.744075510607736	nan
sp|CONTAMINANT_P05784|CONTAMINANT_K1C18_MOUSE	metaplastic breast carcinomas-Triple-negative breast cancer	-2.92352836809908	0.737419834300893	6.0	0.0074131487939191	0.539588996897564	nan
sp|CONTAMINANT_P05784|CONTAMINANT_K1C18_MOUSE	Normal-Triple-negative breast cancer	-2.4965546577081	0.881385283047055	6.0	0.0298581745356241	0.115989833222481	nan
sp|CONTAMINANT_P05787|CONTAMINANT_K2C8_HUMAN;sp|P05787|K2C8_HUMAN	metaplastic breast carcinomas-Normal	0.217788619227122	0.552464200175104	22.0000000243882	0.697219004774911	0.824459612903524	nan
sp|CONTAMINANT_P05787|CONTAMINANT_K2C8_HUMAN;sp|P05787|K2C8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.23337106288061	0.552464200175104	22.0000000253053	0.0360811264145257	0.73123935744099	nan
sp|CONTAMINANT_P05787|CONTAMINANT_K2C8_HUMAN;sp|P05787|K2C8_HUMAN	Normal-Triple-negative breast cancer	-1.45115968210773	0.660321017682327	22.0000000252831	0.038794766614084	0.131848322456358	nan
sp|CONTAMINANT_P06396|CONTAMINANT_GELS_HUMAN;sp|P06396|GELS_HUMAN	metaplastic breast carcinomas-Normal	-0.0965967653628025	0.246521345285188	22.000003438402	0.698946804548939	0.825328304909653	nan
sp|CONTAMINANT_P06396|CONTAMINANT_GELS_HUMAN;sp|P06396|GELS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.107977915355644	0.246521345285188	22.000003438741	0.665652148374356	0.945447839959305	nan
sp|CONTAMINANT_P06396|CONTAMINANT_GELS_HUMAN;sp|P06396|GELS_HUMAN	Normal-Triple-negative breast cancer	0.204574680718447	0.29464936469646	22.0000034386864	0.49476210254766	0.671260909742212	nan
sp|CONTAMINANT_P07339|CONTAMINANT_CATD_HUMAN;sp|P07339|CATD_HUMAN	metaplastic breast carcinomas-Normal	-0.0233152623115771	0.221191980392011	21.9999829061034	0.917007753689082	0.957027872295921	nan
sp|CONTAMINANT_P07339|CONTAMINANT_CATD_HUMAN;sp|P07339|CATD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.374435397823461	0.221191980392011	21.9999829059231	0.104607560822538	0.821630939204717	nan
sp|CONTAMINANT_P07339|CONTAMINANT_CATD_HUMAN;sp|P07339|CATD_HUMAN	Normal-Triple-negative breast cancer	-0.351120135511884	0.264374983119863	21.9999829117008	0.19775532976755	0.3786926489393	nan
sp|CONTAMINANT_P08311|CONTAMINANT_CATG_HUMAN;sp|P08311|CATG_HUMAN	metaplastic breast carcinomas-Normal	-0.537037527291812	0.435536304026792	23.9999999995994	0.229499083040775	0.429293726520842	nan
sp|CONTAMINANT_P08311|CONTAMINANT_CATG_HUMAN;sp|P08311|CATG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.528612355575796	0.435536304026792	23.9999999995994	0.236670040648962	0.84876230490475	nan
sp|CONTAMINANT_P08311|CONTAMINANT_CATG_HUMAN;sp|P08311|CATG_HUMAN	Normal-Triple-negative breast cancer	1.06564988286761	0.520565450976585	23.9999999995974	0.0517473786956659	0.160007708636645	nan
sp|CONTAMINANT_P08727|CONTAMINANT_K1C19_HUMAN	metaplastic breast carcinomas-Normal	-0.0530610825054942	0.588475826936188	21.0110719805588	0.929008561616731	0.962083737631992	nan
sp|CONTAMINANT_P08727|CONTAMINANT_K1C19_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.469877049220868	0.588475826936188	21.0110719818868	0.433534010093955	0.896102083258464	nan
sp|CONTAMINANT_P08727|CONTAMINANT_K1C19_HUMAN	Normal-Triple-negative breast cancer	-0.416815966715374	0.696139015230498	20.9582773083613	0.555753966651627	0.719883328058029	nan
sp|CONTAMINANT_P08758|CONTAMINANT_ANXA5_HUMAN;sp|P08758|ANXA5_HUMAN	metaplastic breast carcinomas-Normal	-0.0410278979143122	0.233298123288013	22.0000000018177	0.862012318328875	0.928249173443943	nan
sp|CONTAMINANT_P08758|CONTAMINANT_ANXA5_HUMAN;sp|P08758|ANXA5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.116279743542933	0.233298123288013	22.0000000010625	0.62313663808095	0.941374262616245	nan
sp|CONTAMINANT_P08758|CONTAMINANT_ANXA5_HUMAN;sp|P08758|ANXA5_HUMAN	Normal-Triple-negative breast cancer	-0.0752518456286211	0.278844591457856	22.0000000010925	0.789775372353901	0.879763182876798	nan
sp|CONTAMINANT_P08779|CONTAMINANT_K1C16_HUMAN;sp|P08779|K1C16_HUMAN	metaplastic breast carcinomas-Normal	1.34793092413435	0.958904363854832	20.2528331937723	0.174969643154999	0.362341903651542	nan
sp|CONTAMINANT_P08779|CONTAMINANT_K1C16_HUMAN;sp|P08779|K1C16_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.23378018214753	0.808066938905797	18.9100424744931	0.143356729823792	0.82761539023963	nan
sp|CONTAMINANT_P08779|CONTAMINANT_K1C16_HUMAN;sp|P08779|K1C16_HUMAN	Normal-Triple-negative breast cancer	-0.114150741986819	1.0839160594309	19.8598995846133	0.917183654264474	0.953341451332584	nan
sp|CONTAMINANT_P09211|CONTAMINANT_GSTP1_HUMAN;sp|P09211|GSTP1_HUMAN	metaplastic breast carcinomas-Normal	-0.417229954116991	0.282054704031043	23.9999999991327	0.152079993952896	0.33191982921827	nan
sp|CONTAMINANT_P09211|CONTAMINANT_GSTP1_HUMAN;sp|P09211|GSTP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0860058380374402	0.282054704031043	23.9999999991315	0.763051136393082	0.955610180228624	nan
sp|CONTAMINANT_P09211|CONTAMINANT_GSTP1_HUMAN;sp|P09211|GSTP1_HUMAN	Normal-Triple-negative breast cancer	0.331224116079551	0.337119851655248	23.9999999991365	0.335649536576625	0.528266600180256	nan
sp|CONTAMINANT_P10599|CONTAMINANT_THIO_HUMAN;sp|P10599|THIO_HUMAN	metaplastic breast carcinomas-Normal	0.148256153988474	0.243298745904076	22.0000000336781	0.548528868491825	0.722102954006663	nan
sp|CONTAMINANT_P10599|CONTAMINANT_THIO_HUMAN;sp|P10599|THIO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.146873337372659	0.243298745904076	22.0000000337622	0.552234056265694	0.931642387063667	nan
sp|CONTAMINANT_P10599|CONTAMINANT_THIO_HUMAN;sp|P10599|THIO_HUMAN	Normal-Triple-negative breast cancer	-0.295129491361133	0.290797621719731	22.0000000334394	0.321187475806164	0.513128887887703	nan
sp|CONTAMINANT_P13647|CONTAMINANT_K2C5_HUMAN;sp|P13647|K2C5_HUMAN	metaplastic breast carcinomas-Normal	0.118507123123761	0.988826387543747	23.99999999986	0.905602565186883	0.949297674765436	nan
sp|CONTAMINANT_P13647|CONTAMINANT_K2C5_HUMAN;sp|P13647|K2C5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.282285350941363	0.988826387543747	23.99999999986	0.777729450428589	0.960962624554091	nan
sp|CONTAMINANT_P13647|CONTAMINANT_K2C5_HUMAN;sp|P13647|K2C5_HUMAN	Normal-Triple-negative breast cancer	0.163778227817602	1.18187358805706	23.9999999999229	0.890942131762933	0.935996095442474	nan
sp|CONTAMINANT_P15559|CONTAMINANT_NQO1_HUMAN;sp|P15559|NQO1_HUMAN	metaplastic breast carcinomas-Normal	-1.22377809899111	0.740869761266083	21.9999979169302	0.112775844451937	0.276043377730663	nan
sp|CONTAMINANT_P15559|CONTAMINANT_NQO1_HUMAN;sp|P15559|NQO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.56641340977074	0.740869761266083	21.999997916063	0.0460566070422064	0.759166737802103	nan
sp|CONTAMINANT_P15559|CONTAMINANT_NQO1_HUMAN;sp|P15559|NQO1_HUMAN	Normal-Triple-negative breast cancer	2.79019150876185	0.885508734455964	21.9999979158584	0.0046373006013907	0.0436121424321106	nan
sp|CONTAMINANT_P16083|CONTAMINANT_NQO2_HUMAN;sp|P16083|NQO2_HUMAN	metaplastic breast carcinomas-Normal	-0.918259614401709	0.317616017709225	23.9999999997448	0.0080262490831992	0.0598189505662654	nan
sp|CONTAMINANT_P16083|CONTAMINANT_NQO2_HUMAN;sp|P16083|NQO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.028390790160672	0.317616017709225	23.9999999997448	0.929516005726747	0.995359816653149	nan
sp|CONTAMINANT_P16083|CONTAMINANT_NQO2_HUMAN;sp|P16083|NQO2_HUMAN	Normal-Triple-negative breast cancer	0.946650404562381	0.379623751148925	23.9999999997195	0.0199336340871399	0.0923910023003994	nan
sp|CONTAMINANT_P19012|CONTAMINANT_K1C15_HUMAN;sp|P19012|K1C15_HUMAN	metaplastic breast carcinomas-Normal	-0.922519339988309	0.590642585992142	24.0000000004087	0.131404634273891	0.303121430943313	nan
sp|CONTAMINANT_P19012|CONTAMINANT_K1C15_HUMAN;sp|P19012|K1C15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.50528570111791	0.590642585992142	24.0000000004076	0.400743104397277	0.885297496092956	nan
sp|CONTAMINANT_P19012|CONTAMINANT_K1C15_HUMAN;sp|P19012|K1C15_HUMAN	Normal-Triple-negative breast cancer	0.4172336388704	0.705952916669058	24.0000000004229	0.560031316017938	0.722916613286098	nan
sp|CONTAMINANT_P20930|CONTAMINANT_FILA_HUMAN;sp|P20930|FILA_HUMAN	metaplastic breast carcinomas-Normal	-2.1242498231244	1.18729977644087	6.0	0.12379958240009	0.294495496123951	nan
sp|CONTAMINANT_P20930|CONTAMINANT_FILA_HUMAN;sp|P20930|FILA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.288653761331649	1.18729977644087	6.0	0.816012393520167	0.965774701272009	nan
sp|CONTAMINANT_P20930|CONTAMINANT_FILA_HUMAN;sp|P20930|FILA_HUMAN	Normal-Triple-negative breast cancer	2.41290358445605	1.41909466065845	6.0	0.139979361413414	0.301744921269454	nan
sp|CONTAMINANT_P61626|CONTAMINANT_LYSC_HUMAN;sp|P61626|LYSC_HUMAN	metaplastic breast carcinomas-Normal	0.195444696757321	0.344189474897289	22.0000000299051	0.575893318986752	0.737960444222037	nan
sp|CONTAMINANT_P61626|CONTAMINANT_LYSC_HUMAN;sp|P61626|LYSC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.883224079605486	0.344189474897289	22.0000000299051	0.0176172110761395	0.669250232341703	nan
sp|CONTAMINANT_P61626|CONTAMINANT_LYSC_HUMAN;sp|P61626|LYSC_HUMAN	Normal-Triple-negative breast cancer	0.687779382848165	0.411385107429022	22.0000000300347	0.108715942329631	0.25556703840431	nan
sp|CONTAMINANT_P61769|CONTAMINANT_B2MG_HUMAN;sp|P61769|B2MG_HUMAN	metaplastic breast carcinomas-Normal	0.0473813620078568	0.388537652796754	21.9999999717101	0.904047329720558	0.949235187913294	nan
sp|CONTAMINANT_P61769|CONTAMINANT_B2MG_HUMAN;sp|P61769|B2MG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.35632593472197	0.388537652796754	21.9999999701949	0.369037676792861	0.883542279876718	nan
sp|CONTAMINANT_P61769|CONTAMINANT_B2MG_HUMAN;sp|P61769|B2MG_HUMAN	Normal-Triple-negative breast cancer	0.308944572714114	0.464391318426314	21.9999999706205	0.512793989539027	0.685926447174135	nan
sp|CONTAMINANT_P62937|CONTAMINANT_PPIA_HUMAN;sp|P62937|PPIA_HUMAN	metaplastic breast carcinomas-Normal	0.420651740288345	0.25888860619621	22.0000000255552	0.118439069628722	0.284048677810875	nan
sp|CONTAMINANT_P62937|CONTAMINANT_PPIA_HUMAN;sp|P62937|PPIA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.074232132750521	0.25888860619621	22.0000000249032	0.776999169834844	0.960657739983943	nan
sp|CONTAMINANT_P62937|CONTAMINANT_PPIA_HUMAN;sp|P62937|PPIA_HUMAN	Normal-Triple-negative breast cancer	-0.494883873038866	0.309431068756416	22.0000000252731	0.124010234425915	0.27776955473837	nan
sp|CONTAMINANT_P62979|CONTAMINANT_RS27A_HUMAN;sp|P62979|RS27A_HUMAN	metaplastic breast carcinomas-Normal	1.06626335462744	0.312319079502142	22.0000018584602	0.0024866748752763	0.0358739474876542	nan
sp|CONTAMINANT_P62979|CONTAMINANT_RS27A_HUMAN;sp|P62979|RS27A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.30964773432354	0.312319079502142	22.0000018587689	0.33224753136305	0.870890600099115	nan
sp|CONTAMINANT_P62979|CONTAMINANT_RS27A_HUMAN;sp|P62979|RS27A_HUMAN	Normal-Triple-negative breast cancer	-1.37591108895098	0.373292699061943	22.0000018586717	0.0012935099710165	0.0266490250684039	nan
sp|CONTAMINANT_P68871|CONTAMINANT_HBB_HUMAN;sp|P68871|HBB_HUMAN	metaplastic breast carcinomas-Normal	-0.676349708160171	0.782689067912465	22.0000000263473	0.396837456989669	0.600951119377521	nan
sp|CONTAMINANT_P68871|CONTAMINANT_HBB_HUMAN;sp|P68871|HBB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.691666170352378	0.782689067912465	22.0000000265754	0.386411052078365	0.885234295852111	nan
sp|CONTAMINANT_P68871|CONTAMINANT_HBB_HUMAN;sp|P68871|HBB_HUMAN	Normal-Triple-negative breast cancer	1.36801587851255	0.935492366182248	22.0000000258256	0.157785228051904	0.328003813661368	nan
sp|CONTAMINANT_P99999|CONTAMINANT_CYC_HUMAN;sp|P99999|CYC_HUMAN	metaplastic breast carcinomas-Normal	0.876929375649169	0.295229114316148	23.9999999996611	0.0066581941807784	0.0534585445819025	nan
sp|CONTAMINANT_P99999|CONTAMINANT_CYC_HUMAN;sp|P99999|CYC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.402550623587333	0.295229114316148	23.9999999996599	0.185373294119816	0.843662073010871	nan
sp|CONTAMINANT_P99999|CONTAMINANT_CYC_HUMAN;sp|P99999|CYC_HUMAN	Normal-Triple-negative breast cancer	-1.2794799992365	0.352866283739114	23.9999999996712	0.0013476345048635	0.0266490250684039	nan
sp|CONTAMINANT_Q04695|CONTAMINANT_K1C17_HUMAN;sp|Q04695|K1C17_HUMAN	metaplastic breast carcinomas-Normal	0.738948979153287	0.68338260672362	23.9999999993286	0.290304894684087	0.494351162873927	nan
sp|CONTAMINANT_Q04695|CONTAMINANT_K1C17_HUMAN;sp|Q04695|K1C17_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.362894703911606	0.68338260672362	23.9999999993286	0.600280362673754	0.940559810632461	nan
sp|CONTAMINANT_Q04695|CONTAMINANT_K1C17_HUMAN;sp|Q04695|K1C17_HUMAN	Normal-Triple-negative breast cancer	-0.376054275241681	0.816798442677585	23.9999999993428	0.649373254633346	0.793024292875055	nan
sp|CONTAMINANT_Q05443|CONTAMINANT_LUM_BOVIN	metaplastic breast carcinomas-Normal	-2.18661935199503	0.522277362423117	14.000000975373	0.0009138744868666	0.0230047449357996	nan
sp|CONTAMINANT_Q05443|CONTAMINANT_LUM_BOVIN	metaplastic breast carcinomas-Triple-negative breast cancer	0.583184526460236	0.522277362423117	14.0000009754358	0.282955690234226	0.867696529950794	nan
sp|CONTAMINANT_Q05443|CONTAMINANT_LUM_BOVIN	Normal-Triple-negative breast cancer	2.76980387845527	0.624240845575817	14.000000975287	0.0005632017042094	0.0237592699893802	nan
sp|CONTAMINANT_Q06830|CONTAMINANT_PRDX1_HUMAN;sp|Q06830|PRDX1_HUMAN	metaplastic breast carcinomas-Normal	0.434115976810447	0.202577515928991	23.9999999998166	0.0424628232110743	0.152502316045985	nan
sp|CONTAMINANT_Q06830|CONTAMINANT_PRDX1_HUMAN;sp|Q06830|PRDX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.275220560431693	0.202577515928991	24.0000000000896	0.186908756329416	0.843662073010871	nan
sp|CONTAMINANT_Q06830|CONTAMINANT_PRDX1_HUMAN;sp|Q06830|PRDX1_HUMAN	Normal-Triple-negative breast cancer	-0.70933653724214	0.242126442646224	23.9999999999534	0.0073308664980839	0.0539538967815321	nan
sp|CONTAMINANT_Q3MHN5|CONTAMINANT_VTDB_BOVIN	metaplastic breast carcinomas-Normal	-0.789260312348323	0.79917183932245	13.0231311559414	0.341344103472363	0.5513254615851	nan
sp|CONTAMINANT_Q3MHN5|CONTAMINANT_VTDB_BOVIN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.691553156031424	0.79917183932245	13.0231311557272	0.40251335272809	0.885297496092956	nan
sp|CONTAMINANT_Q3MHN5|CONTAMINANT_VTDB_BOVIN	Normal-Triple-negative breast cancer	0.0977071563168987	0.939852270291414	13.0000000032618	0.918787739024781	0.953503798850578	nan
sp|CONTAMINANT_Q3SZ57|CONTAMINANT_FETA_BOVIN	metaplastic breast carcinomas-Normal	-0.158963032696676	0.455657041884229	23.9999999999266	0.730232367402254	0.850350473444642	nan
sp|CONTAMINANT_Q3SZ57|CONTAMINANT_FETA_BOVIN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.145352313010001	0.455657041884229	23.9999999999266	0.752490122405335	0.954643368861838	nan
sp|CONTAMINANT_Q3SZ57|CONTAMINANT_FETA_BOVIN	Normal-Triple-negative breast cancer	0.0136107196866746	0.544614332504711	23.9999999999654	0.980268395547652	0.990321607142567	nan
sp|CONTAMINANT_Q5D862|CONTAMINANT_FILA2_HUMAN;sp|Q5D862|FILA2_HUMAN	metaplastic breast carcinomas-Normal	-1.24166648093537	0.585243684377752	14.9999999998784	0.0509367394798538	0.171023961647509	nan
sp|CONTAMINANT_Q5D862|CONTAMINANT_FILA2_HUMAN;sp|Q5D862|FILA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.144050978614725	0.585243684377752	15.0000000000189	0.808911410752246	0.965774701272009	nan
sp|CONTAMINANT_Q5D862|CONTAMINANT_FILA2_HUMAN;sp|Q5D862|FILA2_HUMAN	Normal-Triple-negative breast cancer	1.09761550232065	0.699499995000557	14.9999999999568	0.137465309127465	0.298649994758107	nan
sp|CONTAMINANT_Q86YZ3|CONTAMINANT_HORN_HUMAN;sp|Q86YZ3|HORN_HUMAN	metaplastic breast carcinomas-Normal	-0.814966798740443	0.347699408630643	20.9780121539051	0.0290110201015891	0.121758372244548	nan
sp|CONTAMINANT_Q86YZ3|CONTAMINANT_HORN_HUMAN;sp|Q86YZ3|HORN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.634184338774684	0.347699408630643	20.9780121534966	0.0824400298070139	0.806849600316436	nan
sp|CONTAMINANT_Q86YZ3|CONTAMINANT_HORN_HUMAN;sp|Q86YZ3|HORN_HUMAN	Normal-Triple-negative breast cancer	1.44915113751513	0.411137635230505	20.9598414669514	0.0020159091253638	0.0312748437634516	nan
sp|O00116|ADAS_HUMAN	metaplastic breast carcinomas-Normal	0.338941472017516	0.260616981728579	14.0000000698638	0.214419320893921	0.410795286830775	nan
sp|O00116|ADAS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.534489551317398	0.260616981728579	14.0000000698134	0.059485087254594	0.773787875546141	nan
sp|O00116|ADAS_HUMAN	Normal-Triple-negative breast cancer	0.195548079299883	0.311496872640377	14.0000000701421	0.540260571489758	0.705629131486033	nan
sp|O00139|KIF2A_HUMAN	metaplastic breast carcinomas-Normal	0.290328269429497	0.2390468995417	23.999999999773	0.23636274357088	0.435987210875783	nan
sp|O00139|KIF2A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.107039969198372	0.2390468995417	23.999999999773	0.658329159268487	0.944190045212043	nan
sp|O00139|KIF2A_HUMAN	Normal-Triple-negative breast cancer	-0.39736823862787	0.285715693304925	23.9999999997308	0.177053451199002	0.352199683893167	nan
sp|O00142|KITM_HUMAN	metaplastic breast carcinomas-Normal	-0.983817598264995	0.339664110774129	14.0000022363158	0.0117241743350547	0.0712452568367856	nan
sp|O00142|KITM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.144119350445117	0.339664110774128	14.0000022362806	0.677795041964738	0.946568877415162	nan
sp|O00142|KITM_HUMAN	Normal-Triple-negative breast cancer	1.12793694871011	0.405976262761365	14.0000022363565	0.0147978297486291	0.0779324922305247	nan
sp|O00151|PDLI1_HUMAN	metaplastic breast carcinomas-Normal	-0.353468261400813	0.259893465979143	22.0000000222039	0.187589085375105	0.379516810582379	nan
sp|O00151|PDLI1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.512173915829741	0.259893465979143	22.0000000215391	0.0614686558994803	0.773787875546141	nan
sp|O00151|PDLI1_HUMAN	Normal-Triple-negative breast cancer	-0.158705654428928	0.310632105917347	22.0000000217228	0.614501805868474	0.764161617174263	nan
sp|O00159|MYO1C_HUMAN	metaplastic breast carcinomas-Normal	-1.15190411597547	0.342839745118234	21.9999989313875	0.0028292925741465	0.0379733940896436	nan
sp|O00159|MYO1C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0268974725669165	0.342839745118234	21.9999989313875	0.938175393254567	0.995571782532303	nan
sp|O00159|MYO1C_HUMAN	Normal-Triple-negative breast cancer	1.12500664340855	0.409771871782224	21.9999989281852	0.0118072074820093	0.0698349680293079	nan
sp|O00160|MYO1F_HUMAN	metaplastic breast carcinomas-Normal	-0.479749855584833	0.358734223219219	23.9999999993555	0.193648812029249	0.386832122106504	nan
sp|O00160|MYO1F_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.157877130792046	0.358734223219219	23.9999999994046	0.663806357478958	0.944724271291086	nan
sp|O00160|MYO1F_HUMAN	Normal-Triple-negative breast cancer	0.63762698637688	0.428769406738961	23.9999999994526	0.150006939434727	0.317190245980301	nan
sp|O00161|SNP23_HUMAN	metaplastic breast carcinomas-Normal	-0.0720820698503762	0.215302229597343	23.9999999999379	0.740688329146919	0.857259055043301	nan
sp|O00161|SNP23_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0775483523492047	0.215302229597343	23.9999999999379	0.721860239419768	0.951699165769519	nan
sp|O00161|SNP23_HUMAN	Normal-Triple-negative breast cancer	0.149630422199581	0.257335384468227	23.9999999999155	0.566351654692495	0.727697294239603	nan
sp|O00170|AIP_HUMAN	metaplastic breast carcinomas-Normal	-0.0096160858205177	0.361405607714782	15.0000000001263	0.979123584072445	0.989752057128702	nan
sp|O00170|AIP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0565044642333326	0.361405607714782	15.0000000001254	0.877844805932272	0.98320986943871	nan
sp|O00170|AIP_HUMAN	Normal-Triple-negative breast cancer	-0.0468883784128149	0.43196232191459	15.0000000001441	0.91500022602477	0.95164604233615	nan
sp|O00178|GTPB1_HUMAN	metaplastic breast carcinomas-Normal	0.202558473707254	0.416759448003967	6.0	0.644184452297141	0.789333808965038	nan
sp|O00178|GTPB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.731621149822969	0.416759448003967	6.0	0.129700150577307	0.823891816737944	nan
sp|O00178|GTPB1_HUMAN	Normal-Triple-negative breast cancer	-0.934179623530223	0.498122815464751	6.0	0.10985332637503	0.256708441975905	nan
sp|O00186|STXB3_HUMAN	metaplastic breast carcinomas-Normal	-0.218082868486414	0.31749618545115	6.0	0.517809219304345	0.69968442540586	nan
sp|O00186|STXB3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0705825822209519	0.31749618545115	6.0	0.83144665505802	0.968322286538674	nan
sp|O00186|STXB3_HUMAN	Normal-Triple-negative breast cancer	0.147500286265462	0.379480524205753	6.0	0.710923976884834	0.83091114597932	nan
sp|O00193|SMAP_HUMAN	metaplastic breast carcinomas-Normal	0.493622995873987	0.373915764270319	23.9999999997503	0.199239799838367	0.392341880724367	nan
sp|O00193|SMAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.623637594225973	0.373915764270319	23.9999999997955	0.108341494304201	0.823891816737944	nan
sp|O00193|SMAP_HUMAN	Normal-Triple-negative breast cancer	-1.11726059009996	0.44691481893702	23.9999999998344	0.0196567653395124	0.0913833398441106	nan
sp|O00203|AP3B1_HUMAN	metaplastic breast carcinomas-Normal	0.399377242115478	0.193759054674969	23.9999999998629	0.0502765485272544	0.169912927873181	nan
sp|O00203|AP3B1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0115374699620754	0.193759054674969	23.9999999996065	0.953010720702983	0.996541950781621	nan
sp|O00203|AP3B1_HUMAN	Normal-Triple-negative breast cancer	-0.410914712077554	0.23158636546511	23.9999999996765	0.088693961446309	0.224367372791119	nan
sp|O00231|PSD11_HUMAN	metaplastic breast carcinomas-Normal	0.335833047686397	0.16311853921583	23.999999999655	0.0505218167753748	0.170318984747815	nan
sp|O00231|PSD11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.113326737758565	0.16311853921583	23.9999999996559	0.49388315119612	0.913320451076758	nan
sp|O00231|PSD11_HUMAN	Normal-Triple-negative breast cancer	-0.449159785444962	0.194963944783595	23.999999999674	0.0302010954892338	0.116487768919398	nan
sp|O00232|PSD12_HUMAN	metaplastic breast carcinomas-Normal	0.347517599116805	0.115160351922119	22.0000000637366	0.0063296035482005	0.0524492501891023	nan
sp|O00232|PSD12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0242820170679524	0.115160351922119	22.0000000640423	0.834942051257981	0.968999064723486	nan
sp|O00232|PSD12_HUMAN	Normal-Triple-negative breast cancer	-0.323235582048852	0.137642947278334	22.0000000642362	0.0282533724076378	0.112421067564965	nan
sp|O00233|PSMD9_HUMAN	metaplastic breast carcinomas-Normal	-0.291159459452097	0.281832568781235	19.9451763272527	0.313924964037534	0.520961847459193	nan
sp|O00233|PSMD9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0318102659237627	0.281832568781235	19.9451763317975	0.911262425593157	0.99408739879047	nan
sp|O00233|PSMD9_HUMAN	Normal-Triple-negative breast cancer	0.259349193528334	0.329304167712099	19.6801709470775	0.440332732500589	0.625231099031165	nan
sp|O00264|PGRC1_HUMAN	metaplastic breast carcinomas-Normal	0.119299063819054	0.223910357455417	14.999999616206	0.601977885781279	0.759671409391409	nan
sp|O00264|PGRC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0584092400138811	0.223910357455417	14.9999996162046	0.797747876292752	0.965774701272009	nan
sp|O00264|PGRC1_HUMAN	Normal-Triple-negative breast cancer	-0.060889823805173	0.267624065157005	14.9999996162229	0.823091464365628	0.899689584857398	nan
sp|O00267|SPT5H_HUMAN	metaplastic breast carcinomas-Normal	0.046093382905691	0.206286983318068	22.0000000496603	0.825252514871322	0.90772315004377	nan
sp|O00267|SPT5H_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.269796975380629	0.206286983318068	22.0000000495328	0.204418912274811	0.843662073010871	nan
sp|O00267|SPT5H_HUMAN	Normal-Triple-negative breast cancer	-0.31589035828632	0.246560104195042	22.000000049173	0.213467667075947	0.395742624294729	nan
sp|O00273|DFFA_HUMAN	metaplastic breast carcinomas-Normal	0.089966319196629	0.185863208120962	22.0000000049918	0.633136883202141	0.780144875543456	nan
sp|O00273|DFFA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.141109818367025	0.185863208120962	22.0000000035284	0.455783314580576	0.908567154037048	nan
sp|O00273|DFFA_HUMAN	Normal-Triple-negative breast cancer	-0.231076137563655	0.222149023768846	22.0000000044116	0.309551165610438	0.50192588999468	nan
sp|O00291|HIP1_HUMAN	metaplastic breast carcinomas-Normal	0.130815621514788	0.261182488991026	23.9999999998916	0.621032923943659	0.773440779014133	nan
sp|O00291|HIP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.20882604190279	0.261182488991026	23.9999999999379	0.43181957252885	0.896102083258464	nan
sp|O00291|HIP1_HUMAN	Normal-Triple-negative breast cancer	-0.339641663417578	0.31217278309924	23.9999999999642	0.287404115446679	0.479824851705054	nan
sp|O00299|CLIC1_HUMAN	metaplastic breast carcinomas-Normal	0.574725533992319	0.21560879055873	23.9999999997373	0.0135306826016502	0.0776608745126424	nan
sp|O00299|CLIC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.199134268245033	0.21560879055873	23.9999999999433	0.364892610887373	0.883542279876718	nan
sp|O00299|CLIC1_HUMAN	Normal-Triple-negative breast cancer	-0.375591265747287	0.257701794899782	23.9999999998438	0.157949643187462	0.328015731129349	nan
sp|O00303|EIF3F_HUMAN	metaplastic breast carcinomas-Normal	0.42374141120114	0.180613636129234	23.9999999996556	0.0275631031290602	0.117797191539169	nan
sp|O00303|EIF3F_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0591292415033702	0.180613636129234	23.9999999996072	0.746219212186822	0.954643368861838	nan
sp|O00303|EIF3F_HUMAN	Normal-Triple-negative breast cancer	-0.48287065270451	0.215874585137573	23.9999999996979	0.0348526831140733	0.124838705464633	nan
sp|O00330|ODPX_HUMAN	metaplastic breast carcinomas-Normal	-0.209363377110366	0.274240184191037	23.9999999994996	0.452646445797711	0.64739857425263	nan
sp|O00330|ODPX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.100152144048349	0.274240184191037	23.9999999997975	0.71816186959132	0.949836203815091	nan
sp|O00330|ODPX_HUMAN	Normal-Triple-negative breast cancer	0.109211233062017	0.327779713974261	23.9999999996571	0.741887998458008	0.851557700975204	nan
sp|O00339|MATN2_HUMAN	metaplastic breast carcinomas-Normal	0.22267472533861	0.454335576857448	23.9999999996773	0.62850616864157	0.778360007018459	nan
sp|O00339|MATN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.395509506760603	0.454335576857448	23.9999999996773	0.392638949737657	0.885234295852111	nan
sp|O00339|MATN2_HUMAN	Normal-Triple-negative breast cancer	0.172834781421993	0.543034879698467	23.9999999996837	0.753028927690858	0.858093857556366	nan
sp|O00391|QSOX1_HUMAN	metaplastic breast carcinomas-Normal	-0.0253175563663323	0.342703471045731	23.0000000001262	0.94174781674398	0.970055699676787	nan
sp|O00391|QSOX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0451183584360354	0.342703471045731	23.0000000001262	0.896402691418524	0.989403873476489	nan
sp|O00391|QSOX1_HUMAN	Normal-Triple-negative breast cancer	-0.0198008020697031	0.405492215330343	23.0000000002004	0.96147513292988	0.981692207683993	nan
sp|O00410|IPO5_HUMAN	metaplastic breast carcinomas-Normal	0.739155705502365	0.418407831849804	23.9999999996165	0.0900142539713495	0.242077168447222	nan
sp|O00410|IPO5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.354856953305036	0.418407831849804	23.9999999998725	0.404754751877102	0.885297496092956	nan
sp|O00410|IPO5_HUMAN	Normal-Triple-negative breast cancer	-1.0940126588074	0.50009301099646	23.9999999997317	0.0386722814586597	0.131842731865215	nan
sp|O00422|SAP18_HUMAN	metaplastic breast carcinomas-Normal	0.863037513504769	0.270344067993877	23.9999999994359	0.0039122926772172	0.0416809642918909	nan
sp|O00422|SAP18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0296514908749449	0.270344067993877	23.9999999992157	0.913574675009703	0.99408739879047	nan
sp|O00422|SAP18_HUMAN	Normal-Triple-negative breast cancer	-0.892689004379714	0.323122964430124	23.9999999994182	0.0108257763381373	0.066515490846522	nan
sp|O00425|IF2B3_HUMAN	metaplastic breast carcinomas-Normal	0.843324425122618	0.626133881226984	22.0000061900671	0.191731985252653	0.384853332717282	nan
sp|O00425|IF2B3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.843500047623755	0.626133881226984	22.0000061902481	0.191643041867807	0.843662073010871	nan
sp|O00425|IF2B3_HUMAN	Normal-Triple-negative breast cancer	0.0001756225011368	0.748373128116075	22.0000061904462	0.999814873511951	0.99994943579539	nan
sp|O00429|DNM1L_HUMAN	metaplastic breast carcinomas-Normal	0.653520731729552	0.259525031573133	23.9999999996228	0.0188751761436209	0.0929781777313555	nan
sp|O00429|DNM1L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.210188257875925	0.259525031573133	23.9999999996697	0.425957689904472	0.892690102886249	nan
sp|O00429|DNM1L_HUMAN	Normal-Triple-negative breast cancer	-0.443332473853628	0.31019174257462	23.9999999996394	0.165828812411445	0.336722646582556	nan
sp|O00442|RTCA_HUMAN	metaplastic breast carcinomas-Normal	-0.446624345230158	0.226266753191244	14.9999999997044	0.0671063764286765	0.200192801379822	nan
sp|O00442|RTCA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.286103928321364	0.226266753191244	14.9999999997044	0.225361674046575	0.843662073010871	nan
sp|O00442|RTCA_HUMAN	Normal-Triple-negative breast cancer	0.160520416908794	0.270440496755379	14.9999999997141	0.561656403027929	0.724464836501683	nan
sp|O00461|GOLI4_HUMAN	metaplastic breast carcinomas-Normal	0.0793238285522584	0.394263847238722	14.9999999999898	0.843249104566488	0.916000007705558	nan
sp|O00461|GOLI4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.030796340445983	0.394263847238722	14.9999999999898	0.938772221678021	0.995571782532303	nan
sp|O00461|GOLI4_HUMAN	Normal-Triple-negative breast cancer	-0.0485274881062754	0.471235429845966	14.9999999999796	0.919343559660266	0.953775902718703	nan
sp|O00468|AGRIN_HUMAN	metaplastic breast carcinomas-Normal	0.489690760280026	0.268412386098757	23.9999999997475	0.0805673310506159	0.224816118300932	nan
sp|O00468|AGRIN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.138809650698983	0.268412386098757	23.9999999997927	0.609784594808171	0.940559810632461	nan
sp|O00468|AGRIN_HUMAN	Normal-Triple-negative breast cancer	-0.350881109581043	0.320814162964944	23.9999999997211	0.284933919327666	0.477379207583246	nan
sp|O00469|PLOD2_HUMAN	metaplastic breast carcinomas-Normal	0.864226253474601	0.26277107620206	22.0000000034537	0.0033491221196417	0.0404817524570511	nan
sp|O00469|PLOD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.399021559420817	0.26277107620206	22.0000000025883	0.143125742661978	0.82761539023963	nan
sp|O00469|PLOD2_HUMAN	Normal-Triple-negative breast cancer	-0.465204694053784	0.314071507982291	22.000000002899	0.152732988731141	0.320103691388595	nan
sp|O00479|HMGN4_HUMAN	metaplastic breast carcinomas-Normal	-0.49228849917526	0.455911485754571	23.9999999995982	0.290968189893526	0.494720339235846	nan
sp|O00479|HMGN4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0403714093760873	0.455911485754571	23.9999999995982	0.930173543258352	0.995359816653149	nan
sp|O00479|HMGN4_HUMAN	Normal-Triple-negative breast cancer	0.532659908551347	0.544918451098014	23.9999999996211	0.338070769905756	0.530319603193361	nan
sp|O00483|NDUA4_HUMAN	metaplastic breast carcinomas-Normal	-0.176325701870302	0.349993433499403	22.0000000305422	0.619411677373109	0.771757642090732	nan
sp|O00483|NDUA4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.437767653890873	0.349993433499403	22.0000000305367	0.224151174298438	0.843662073010871	nan
sp|O00483|NDUA4_HUMAN	Normal-Triple-negative breast cancer	-0.261441952020571	0.418322164797661	22.0000000303362	0.538414742171729	0.704602599597963	nan
sp|O00487|PSDE_HUMAN	metaplastic breast carcinomas-Normal	-0.17769222040754	0.25666910470595	22.0000000028519	0.495991376869988	0.683265088490911	nan
sp|O00487|PSDE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.179722671717195	0.25666910470595	22.0000000016623	0.491134376740392	0.913320451076758	nan
sp|O00487|PSDE_HUMAN	Normal-Triple-negative breast cancer	-0.0020304513096552	0.306778257076796	22.0000000022298	0.994778788558074	0.998986312135056	nan
sp|O00499|BIN1_HUMAN	metaplastic breast carcinomas-Normal	-1.07317384682457	0.483312305311402	14.0000000798901	0.0434016502653367	0.154793010173798	nan
sp|O00499|BIN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0788367579826116	0.483312305311402	14.0000000795798	0.872757006087915	0.981704007186169	nan
sp|O00499|BIN1_HUMAN	Normal-Triple-negative breast cancer	0.994337088841954	0.577668694551546	14.0000000796415	0.107209941105291	0.253315936205068	nan
sp|O00505|IMA4_HUMAN	metaplastic breast carcinomas-Normal	0.888030746047511	0.218190219048142	18.9999999996233	0.0006530056485097	0.0214095259097961	nan
sp|O00505|IMA4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.381348739587835	0.188958272552982	18.9999999997295	0.057918327342051	0.773787875546141	nan
sp|O00505|IMA4_HUMAN	Normal-Triple-negative breast cancer	-0.506682006459676	0.243944080908607	18.9999999996233	0.0516033990417147	0.15971107859838	nan
sp|O00515|LAD1_HUMAN	metaplastic breast carcinomas-Normal	0.246997642069113	0.556140563292159	23.9999999993636	0.660928807316746	0.801798304934621	nan
sp|O00515|LAD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.208711196505077	0.55614056329216	23.9999999994032	0.710744831296763	0.94948208919602	nan
sp|O00515|LAD1_HUMAN	Normal-Triple-negative breast cancer	-0.455708838574189	0.664715112058134	23.999999999375	0.499553430821081	0.676135101017241	nan
sp|O00534|VMA5A_HUMAN	metaplastic breast carcinomas-Normal	-0.930220141202545	0.33269110175084	14.0000000005859	0.0142910546452065	0.0795361221927149	nan
sp|O00534|VMA5A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.557506176694269	0.33269110175084	14.0000000004656	0.11596807277343	0.823891816737944	nan
sp|O00534|VMA5A_HUMAN	Normal-Triple-negative breast cancer	0.372713964508275	0.397641922883584	14.0000000007969	0.364487976501696	0.55430722961373	nan
sp|O00541|PESC_HUMAN	metaplastic breast carcinomas-Normal	-0.0540192754950265	0.454709762470581	14.0000000149742	0.907122023867417	0.949991684730717	nan
sp|O00541|PESC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.494415581116014	0.454709762470581	14.0000000150577	0.295260793195793	0.867696529950794	nan
sp|O00541|PESC_HUMAN	Normal-Triple-negative breast cancer	0.54843485661104	0.543482117048485	14.0000000149599	0.330044100333281	0.52266154812188	nan
sp|O00560|SDCB1_HUMAN	metaplastic breast carcinomas-Normal	0.308221543342494	0.222160473470649	21.9999958725243	0.179220144981572	0.368643417028927	nan
sp|O00560|SDCB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.194279076504177	0.222160473470649	21.9999958725243	0.391293617674913	0.885234295852111	nan
sp|O00560|SDCB1_HUMAN	Normal-Triple-negative breast cancer	-0.113942466838317	0.265532553755394	21.9999958731328	0.672016642297063	0.806711202237428	nan
sp|O00567|NOP56_HUMAN	metaplastic breast carcinomas-Normal	0.662395510268286	0.282352513408481	23.9999999995802	0.0275710634829945	0.117797191539169	nan
sp|O00567|NOP56_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.217803519263353	0.282352513408481	23.999999999579	0.448005409861702	0.902988618897891	nan
sp|O00567|NOP56_HUMAN	Normal-Triple-negative breast cancer	-0.880199029531639	0.337475801943289	23.9999999995775	0.0154163847148433	0.0789584942868092	nan
sp|O00571|DDX3X_HUMAN	metaplastic breast carcinomas-Normal	0.60771020730959	0.196424334312815	23.999999999319	0.0049599922466231	0.0470009737236255	nan
sp|O00571|DDX3X_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.19598302276784	0.196424334312815	23.9999999993177	0.328353098037972	0.867975899287892	nan
sp|O00571|DDX3X_HUMAN	Normal-Triple-negative breast cancer	-0.803693230077431	0.23477198394014	23.9999999992788	0.0022263092689695	0.0322131479751828	nan
sp|O00584|RNT2_HUMAN	metaplastic breast carcinomas-Normal	-0.513674231618423	0.42872770100376	23.9999999995845	0.242562471140992	0.443497059445906	nan
sp|O00584|RNT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.579425924722001	0.42872770100376	23.9999999995856	0.189137335888493	0.843662073010871	nan
sp|O00584|RNT2_HUMAN	Normal-Triple-negative breast cancer	-0.0657516931035788	0.512427613853856	23.9999999995833	0.898969579991907	0.941085638149985	nan
sp|O00592|PODXL_HUMAN	metaplastic breast carcinomas-Normal	-0.250419412815572	0.362080746301344	22.0000000246553	0.496415520067855	0.683265088490911	nan
sp|O00592|PODXL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.552593014160483	0.362080746301344	22.0000000253522	0.141219353101847	0.823891816737944	nan
sp|O00592|PODXL_HUMAN	Normal-Triple-negative breast cancer	-0.302173601344912	0.432769266868515	22.0000000248292	0.492346843550843	0.66910445131213	nan
sp|O00625|PIR_HUMAN	metaplastic breast carcinomas-Normal	-0.0203090273930414	0.542392748936758	14.9999999999933	0.970625250503728	0.986050835169435	nan
sp|O00625|PIR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.557163597753729	0.542392748936757	14.9999999998566	0.32059182512183	0.867696529950794	nan
sp|O00625|PIR_HUMAN	Normal-Triple-negative breast cancer	0.57747262514677	0.64828333102474	14.9999999999383	0.387116455160396	0.574833537967588	nan
sp|O00754|MA2B1_HUMAN	metaplastic breast carcinomas-Normal	0.568947249894286	0.274655073818849	21.9999954037256	0.0502409551882643	0.169912927873181	nan
sp|O00754|MA2B1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.162937214747375	0.274655073818849	21.9999954052264	0.559068651752521	0.932694870083482	nan
sp|O00754|MA2B1_HUMAN	Normal-Triple-negative breast cancer	-0.406010035146911	0.328275601927138	21.9999954052523	0.229203419810557	0.411600306564177	nan
sp|O00764|PDXK_HUMAN	metaplastic breast carcinomas-Normal	0.0658651608231191	0.197007224820301	23.999999999595	0.74103561751276	0.857362475674352	nan
sp|O00764|PDXK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.163870763133816	0.197007224820301	23.9999999998849	0.413721452647934	0.885784822958391	nan
sp|O00764|PDXK_HUMAN	Normal-Triple-negative breast cancer	-0.229735923956935	0.235468671350797	23.9999999997255	0.338968289470963	0.530975774835759	nan
sp|O00767|SCD_HUMAN	metaplastic breast carcinomas-Normal	-0.671734725153694	0.772106196116789	23.9999999995638	0.392917320034606	0.597191207953833	nan
sp|O00767|SCD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.291837971478395	0.772106196116789	23.9999999995638	0.70877050429327	0.94948208919602	nan
sp|O00767|SCD_HUMAN	Normal-Triple-negative breast cancer	0.379896753675299	0.922843415043138	23.9999999996279	0.68424270609266	0.814550412235226	nan
sp|O14497|ARI1A_HUMAN	metaplastic breast carcinomas-Normal	0.831967706247016	0.24726411740684	22.0000055422932	0.0027971257421245	0.0379733940896436	nan
sp|O14497|ARI1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.160635876503339	0.24726411740684	22.0000055422425	0.522642299547227	0.917607105199968	nan
sp|O14497|ARI1A_HUMAN	Normal-Triple-negative breast cancer	-0.671331829743676	0.295537147186474	22.000005542533	0.0332436504071915	0.122643611491126	nan
sp|O14498|ISLR_HUMAN	metaplastic breast carcinomas-Normal	0.317545355757781	0.375944023470652	22.0000000467869	0.407392064004226	0.609712391152656	nan
sp|O14498|ISLR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.223158690411358	0.375944023470652	22.0000000475727	0.558837006405415	0.932694870083482	nan
sp|O14498|ISLR_HUMAN	Normal-Triple-negative breast cancer	-0.540704046169139	0.449339052360404	22.0000000474935	0.241637473644608	0.429737974303543	nan
sp|O14548|COX7R_HUMAN	metaplastic breast carcinomas-Normal	-0.105130470863435	0.210525384886153	22.000000057084	0.622474707656639	0.774365991111778	nan
sp|O14548|COX7R_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.107415542291311	0.210525384886153	22.0000000576944	0.614974319983477	0.941374262616245	nan
sp|O14548|COX7R_HUMAN	Normal-Triple-negative breast cancer	0.212546013154745	0.251625963007065	22.0000000573393	0.4073761912677	0.596265283916263	nan
sp|O14558|HSPB6_HUMAN	metaplastic breast carcinomas-Normal	-3.23394546555463	0.593484554943396	22.0000000051691	1.78880213482899e-05	0.0066066425513017	nan
sp|O14558|HSPB6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.19396198948683	0.593484554943396	22.0000000050956	0.746893892096332	0.954643368861838	nan
sp|O14558|HSPB6_HUMAN	Normal-Triple-negative breast cancer	3.03998347606781	0.709349719266437	22.0000000046974	0.0003003398837583	0.0227914720285933	nan
sp|O14561|ACPM_HUMAN	metaplastic breast carcinomas-Normal	0.0716027312312235	0.241294451697075	21.9999999206916	0.769445309055423	0.874803098019317	nan
sp|O14561|ACPM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.418872297796952	0.241294451697075	21.999999924978	0.0965612839327121	0.814943337126966	nan
sp|O14561|ACPM_HUMAN	Normal-Triple-negative breast cancer	-0.490475029028175	0.288402031941999	21.9999999199606	0.103100722872131	0.247263205502861	nan
sp|O14562|UBFD1_HUMAN	metaplastic breast carcinomas-Normal	0.253980292609711	0.277643281767765	23.9999999991279	0.369411150470505	0.578542078903062	nan
sp|O14562|UBFD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.621015705096468	0.277643281767765	23.9999999994185	0.0348579767176265	0.724424466074313	nan
sp|O14562|UBFD1_HUMAN	Normal-Triple-negative breast cancer	-0.874995997706179	0.331847193558323	23.9999999992401	0.0144494988603035	0.0775931085810159	nan
sp|O14579|COPE_HUMAN	metaplastic breast carcinomas-Normal	0.698836093306676	0.229303825468574	22.0000001428681	0.0059038550398785	0.0508404511724253	nan
sp|O14579|COPE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0976765285118241	0.229303825468574	22.0000001428734	0.674268371258117	0.946386428913156	nan
sp|O14579|COPE_HUMAN	Normal-Triple-negative breast cancer	-0.7965126218185	0.27407049242986	22.0000001431542	0.0081873973104732	0.0575911703148659	nan
sp|O14594|NCAN_HUMAN	metaplastic breast carcinomas-Normal	0.706965193649464	0.320908143853011	14.9999999994451	0.0436437418720233	0.155265014327307	nan
sp|O14594|NCAN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.674994401897913	0.320908143853011	14.9999999995427	0.0527180246370917	0.773286317778246	nan
sp|O14594|NCAN_HUMAN	Normal-Triple-negative breast cancer	-0.0319707917515509	0.383558594501516	14.9999999994842	0.934672995306414	0.963124296633419	nan
sp|O14617|AP3D1_HUMAN	metaplastic breast carcinomas-Normal	0.005494927570756	0.234206123205821	22.0000000789118	0.981493313581287	0.990131646234962	nan
sp|O14617|AP3D1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.170595665744353	0.234206123205821	22.0000000790092	0.474051635109413	0.913280230088743	nan
sp|O14617|AP3D1_HUMAN	Normal-Triple-negative breast cancer	-0.176090593315109	0.279929858936893	22.000000079351	0.535792494065052	0.702867070999919	nan
sp|O14618|CCS_HUMAN	metaplastic breast carcinomas-Normal	-0.211460128468106	0.128427507656771	22.0000000246854	0.113865949869974	0.277893111136413	nan
sp|O14618|CCS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.151236214188097	0.128427507656771	22.0000000256923	0.251538834733778	0.85518059866034	nan
sp|O14618|CCS_HUMAN	Normal-Triple-negative breast cancer	0.0602239142800087	0.153500231376885	22.0000000255963	0.698583994497812	0.823729406779257	nan
sp|O14672|ADA10_HUMAN	metaplastic breast carcinomas-Normal	-0.364953417959882	0.353646669809483	23.9999999991503	0.312373211279546	0.520465440748477	nan
sp|O14672|ADA10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.127671356789712	0.353646669809483	23.9999999991519	0.721247521745388	0.951268548117182	nan
sp|O14672|ADA10_HUMAN	Normal-Triple-negative breast cancer	0.23728206117017	0.422688617352128	23.9999999991204	0.579754173642809	0.738415621418319	nan
sp|O14732|IMPA2_HUMAN	metaplastic breast carcinomas-Normal	-0.772150113593295	0.36992623358953	14.9999999994975	0.0543361863712564	0.17803506467099	nan
sp|O14732|IMPA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.753361903185142	0.36992623358953	14.9999999995263	0.0597513101542117	0.773787875546141	nan
sp|O14732|IMPA2_HUMAN	Normal-Triple-negative breast cancer	0.0187882104081522	0.442146417729524	14.9999999995893	0.96666602780027	0.982929910189078	nan
sp|O14737|PDCD5_HUMAN	metaplastic breast carcinomas-Normal	-0.0448980415249503	0.180458639336933	22.0000000044688	0.805823729731372	0.897982429964831	nan
sp|O14737|PDCD5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.264867197069819	0.180458639336933	22.0000000041561	0.156325898403984	0.843465960034572	nan
sp|O14737|PDCD5_HUMAN	Normal-Triple-negative breast cancer	-0.219969155544869	0.215689328537059	22.0000000039659	0.318887877002152	0.511821971586264	nan
sp|O14744|ANM5_HUMAN	metaplastic breast carcinomas-Normal	0.218120742669666	0.186522691777481	22.0000000223561	0.2547544599206	0.456252060762972	nan
sp|O14744|ANM5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.286283926189532	0.186522691777481	22.0000000217228	0.139078405864	0.823891816737944	nan
sp|O14744|ANM5_HUMAN	Normal-Triple-negative breast cancer	-0.504404668859197	0.222937257502507	22.0000000219367	0.0338802237086891	0.123621534315429	nan
sp|O14745|NHRF1_HUMAN	metaplastic breast carcinomas-Normal	-0.137267076383658	0.447365051198806	21.9999996482386	0.761854650058601	0.869177898245259	nan
sp|O14745|NHRF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.37490603743807	0.447365051198806	21.9999996479423	0.411025634885932	0.885784822958391	nan
sp|O14745|NHRF1_HUMAN	Normal-Triple-negative breast cancer	-0.237638961054412	0.534703508009159	21.9999996472789	0.661072062182634	0.799725735949474	nan
sp|O14773|TPP1_HUMAN	metaplastic breast carcinomas-Normal	-0.268069808103571	0.22084423737331	23.9999999995254	0.236618811197326	0.435987210875783	nan
sp|O14773|TPP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0893730425227062	0.22084423737331	23.9999999995254	0.689291007612091	0.946568877415162	nan
sp|O14773|TPP1_HUMAN	Normal-Triple-negative breast cancer	0.357442850626278	0.263959350715216	23.9999999995206	0.188299856175726	0.367748955304415	nan
sp|O14776|TCRG1_HUMAN	metaplastic breast carcinomas-Normal	0.617304438513626	0.279988525724069	23.9999999993896	0.0373011875728126	0.141057050616643	nan
sp|O14776|TCRG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.135378320134643	0.279988525724069	23.9999999996364	0.633113116626117	0.941868024951375	nan
sp|O14776|TCRG1_HUMAN	Normal-Triple-negative breast cancer	-0.75268275864827	0.334650296230766	23.9999999995395	0.0339490376101213	0.123621534315429	nan
sp|O14787|TNPO2_HUMAN	metaplastic breast carcinomas-Normal	-0.339467976925403	0.216758693006623	23.9999999994832	0.130414355499271	0.301654598715168	nan
sp|O14787|TNPO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.178725930123527	0.216758693006623	23.999999999688	0.417753397331969	0.8860071777014	nan
sp|O14787|TNPO2_HUMAN	Normal-Triple-negative breast cancer	0.160742046801876	0.259076191203446	23.9999999995822	0.540813535325973	0.706073916505708	nan
sp|O14791|APOL1_HUMAN	metaplastic breast carcinomas-Normal	-0.917492356085178	0.385007094510003	21.9999999685695	0.026233543511097	0.11473723504064	nan
sp|O14791|APOL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.437181449268971	0.385007094510003	21.99999996834	0.268379222576388	0.867211773631185	nan
sp|O14791|APOL1_HUMAN	Normal-Triple-negative breast cancer	1.35467380535415	0.460171494155066	21.9999999684822	0.0075086101729632	0.0547338162608107	nan
sp|O14818|PSA7_HUMAN	metaplastic breast carcinomas-Normal	0.256451100979823	0.173023176558096	22.0000043923976	0.152476326360294	0.332566475604737	nan
sp|O14818|PSA7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0394587331810247	0.173023176558096	22.0000043918926	0.82171007347618	0.965774701272009	nan
sp|O14818|PSA7_HUMAN	Normal-Triple-negative breast cancer	-0.295909834160848	0.206802250700152	22.0000043919165	0.166515731165909	0.33749895755822	nan
sp|O14828|SCAM3_HUMAN	metaplastic breast carcinomas-Normal	-0.0001684569701097	0.221177779759326	21.9999999073178	0.999399166638252	0.999699918719696	nan
sp|O14828|SCAM3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.296960388648854	0.221177779759326	21.9999999069816	0.193081566857519	0.843662073010871	nan
sp|O14828|SCAM3_HUMAN	Normal-Triple-negative breast cancer	0.297128845618964	0.264358010117408	21.999999904906	0.27314344921415	0.464176290995825	nan
sp|O14841|OPLA_HUMAN	metaplastic breast carcinomas-Normal	0.0279558031904376	0.418594633409933	14.0000027585575	0.947697322889996	0.972567428615729	nan
sp|O14841|OPLA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.064013206100849	0.418594633409933	14.0000027589136	0.880640336513296	0.983583849145686	nan
sp|O14841|OPLA_HUMAN	Normal-Triple-negative breast cancer	-0.0919690092912866	0.500316281565395	14.0000027587729	0.856789158759363	0.917810880991339	nan
sp|O14879|IFIT3_HUMAN	metaplastic breast carcinomas-Normal	0.760925926078839	0.401420832716595	21.9999916736796	0.0712291175661332	0.207507087458218	nan
sp|O14879|IFIT3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.638680372932409	0.401420832716595	21.9999916736794	0.125866681135068	0.823891816737944	nan
sp|O14879|IFIT3_HUMAN	Normal-Triple-negative breast cancer	-0.12224555314643	0.47978966364571	21.9999916673627	0.801252013153891	0.886015200174163	nan
sp|O14880|MGST3_HUMAN	metaplastic breast carcinomas-Normal	-0.18290841802685	0.315239384461199	23.9999999992339	0.567174027390897	0.733574500796631	nan
sp|O14880|MGST3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0889334058216344	0.315239384461199	23.9999999992021	0.780274710974634	0.961606157891275	nan
sp|O14880|MGST3_HUMAN	Normal-Triple-negative breast cancer	0.0939750122052155	0.376783131096989	23.9999999991552	0.805162794610879	0.88801979396181	nan
sp|O14896|IRF6_HUMAN	metaplastic breast carcinomas-Normal	0.543945858128292	0.609689308561347	6.0	0.406657408055701	0.60916143505054	nan
sp|O14896|IRF6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0155057288303049	0.609689308561347	6.0	0.98053498972885	0.997332163000436	nan
sp|O14896|IRF6_HUMAN	Normal-Triple-negative breast cancer	-0.559451586958597	0.728718104397827	6.0	0.471775761854658	0.65150919501657	nan
sp|O14907|TX1B3_HUMAN	metaplastic breast carcinomas-Normal	0.10853031792932	0.262110349271442	21.0233858560639	0.683021564362398	0.815009772846929	nan
sp|O14907|TX1B3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.013482147593342	0.262110349271442	21.0233858567129	0.959462970621161	0.99709406933403	nan
sp|O14907|TX1B3_HUMAN	Normal-Triple-negative breast cancer	-0.0950481703359785	0.30993559552738	21.0048238307936	0.762113402629955	0.86312264066166	nan
sp|O14925|TIM23_HUMAN	metaplastic breast carcinomas-Normal	0.295747176691436	0.45311582332496	14.9999999995421	0.523829792635297	0.703164142194925	nan
sp|O14925|TIM23_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.624670812354048	0.45311582332496	14.9999999995415	0.188228867534611	0.843662073010871	nan
sp|O14925|TIM23_HUMAN	Normal-Triple-negative breast cancer	-0.920417989045484	0.541576995380101	14.9999999995243	0.109859289693474	0.256708441975905	nan
sp|O14929|HAT1_HUMAN	metaplastic breast carcinomas-Normal	1.14756990523073	0.429493996344662	22.0000000036439	0.0139279735639119	0.0787356872898695	nan
sp|O14929|HAT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.314458053996519	0.429493996344662	22.0000000048984	0.471799823081424	0.912607574317916	nan
sp|O14929|HAT1_HUMAN	Normal-Triple-negative breast cancer	-1.46202795922725	0.513343511968501	22.0000000041508	0.0093541531449643	0.0614527769571654	nan
sp|O14936|CSKP_HUMAN	metaplastic breast carcinomas-Normal	0.359943308241874	0.204669021760571	21.9999999802884	0.0925393540861534	0.246475010402543	nan
sp|O14936|CSKP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0477203358264662	0.204669021760571	21.9999999822901	0.817793962974322	0.965774701272009	nan
sp|O14936|CSKP_HUMAN	Normal-Triple-negative breast cancer	-0.312222972415408	0.244626270252718	21.999999982145	0.215149929293508	0.397531053347204	nan
sp|O14964|HGS_HUMAN	metaplastic breast carcinomas-Normal	0.1323710593806	0.270711366844599	14.999999999597	0.63193178653355	0.779421617230991	nan
sp|O14964|HGS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0016619524008081	0.270711366844599	14.9999999997611	0.995182559791099	0.998185231446144	nan
sp|O14964|HGS_HUMAN	Normal-Triple-negative breast cancer	-0.134033011781408	0.323561970524683	14.9999999996668	0.684559658804839	0.814550412235226	nan
sp|O14974|MYPT1_HUMAN	metaplastic breast carcinomas-Normal	0.207194094610399	0.155557282833633	23.9999999995811	0.195389078313219	0.387976879518004	nan
sp|O14974|MYPT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0894102432805027	0.155557282833633	23.9999999993813	0.570793566566329	0.935631258424823	nan
sp|O14974|MYPT1_HUMAN	Normal-Triple-negative breast cancer	-0.117783851329897	0.18592651483308	23.9999999994614	0.532400500952395	0.700316290132869	nan
sp|O14976|GAK_HUMAN	metaplastic breast carcinomas-Normal	-0.136531844048415	0.189779482681696	21.999999934475	0.479453181669925	0.668779847197159	nan
sp|O14976|GAK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0390110975836912	0.189779482681696	21.9999999347178	0.839024719057551	0.971085326089412	nan
sp|O14976|GAK_HUMAN	Normal-Triple-negative breast cancer	0.0975207464647241	0.226829867165845	21.9999999345996	0.671429129116877	0.806588516510481	nan
sp|O14979|HNRDL_HUMAN	metaplastic breast carcinomas-Normal	0.301465615328319	0.297546381417465	22.0000000035042	0.321992055076346	0.529897740936004	nan
sp|O14979|HNRDL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.195770890286048	0.297546381417465	22.0000000024332	0.517395905598685	0.915620969865368	nan
sp|O14979|HNRDL_HUMAN	Normal-Triple-negative breast cancer	-0.497236505614367	0.355635947674078	22.0000000031796	0.176002315697852	0.350586693141652	nan
sp|O14980|XPO1_HUMAN	metaplastic breast carcinomas-Normal	0.640922535052101	0.254321875277607	21.999997562405	0.0194901836547926	0.0951327025969614	nan
sp|O14980|XPO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.235605119387368	0.254321875277607	21.9999975619267	0.364287390039274	0.883542279876718	nan
sp|O14980|XPO1_HUMAN	Normal-Triple-negative breast cancer	-0.876527654439468	0.30397278131137	21.9999975628422	0.0086242461694092	0.0588076066258844	nan
sp|O15020|SPTN2_HUMAN	metaplastic breast carcinomas-Normal	-0.103541343710262	0.324181549240057	14.000000002184	0.754144518786065	0.865008944824138	nan
sp|O15020|SPTN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.424747405599176	0.324181549240057	14.0000000017468	0.211213498842338	0.843662073010871	nan
sp|O15020|SPTN2_HUMAN	Normal-Triple-negative breast cancer	-0.321206061888914	0.387471062270063	14.0000000019301	0.421024715555236	0.608128994802102	nan
sp|O15021|MAST4_HUMAN	metaplastic breast carcinomas-Normal	-0.153789103784067	0.473335112694727	13.0528112466854	0.750401372356206	0.862196391881102	nan
sp|O15021|MAST4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.237772254057754	0.422592356824982	13.000000015109	0.583245390484189	0.937761568355864	nan
sp|O15021|MAST4_HUMAN	Normal-Triple-negative breast cancer	0.391561357841821	0.54825382579719	13.0394698422686	0.487693934404406	0.665062857354938	nan
sp|O15027|SC16A_HUMAN	metaplastic breast carcinomas-Normal	-0.0234973550871053	0.266977089820694	22.0000000187772	0.930662883100559	0.962231702666505	nan
sp|O15027|SC16A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.284972943905192	0.266977089820694	22.0000000185765	0.297362230498535	0.867696529950794	nan
sp|O15027|SC16A_HUMAN	Normal-Triple-negative breast cancer	-0.261475588818087	0.319098655790532	22.0000000185841	0.421336063486535	0.608128994802102	nan
sp|O15031|PLXB2_HUMAN	metaplastic breast carcinomas-Normal	0.173824646316718	0.123829657946468	23.9999999992998	0.173204042892205	0.361439499568716	nan
sp|O15031|PLXB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.142778224868698	0.123829657946468	23.9999999992998	0.2602565104185	0.862813416943474	nan
sp|O15031|PLXB2_HUMAN	Normal-Triple-negative breast cancer	-0.0310464214480201	0.14800474986171	23.9999999992105	0.835620513542453	0.906528259469685	nan
sp|O15042|SR140_HUMAN	metaplastic breast carcinomas-Normal	0.508377406230286	0.238178825438964	21.9999999587536	0.0441974571618228	0.156153542341268	nan
sp|O15042|SR140_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.125499226700717	0.238178825438964	21.9999999587497	0.603527916454096	0.940559810632461	nan
sp|O15042|SR140_HUMAN	Normal-Triple-negative breast cancer	-0.633876632931003	0.284678146302312	21.9999999605564	0.0365242442130035	0.127127317030391	nan
sp|O15061|SYNEM_HUMAN	metaplastic breast carcinomas-Normal	-0.646942443787723	0.386220005881684	19.9622006101324	0.10951730718765	0.271263434494596	nan
sp|O15061|SYNEM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.696977303772873	0.412663358203128	20.0429578871371	0.106722440260888	0.823891816737944	nan
sp|O15061|SYNEM_HUMAN	Normal-Triple-negative breast cancer	1.3439197475606	0.480042980239417	20.1396640375576	0.0110193354990923	0.0670157251028676	nan
sp|O15067|PUR4_HUMAN	metaplastic breast carcinomas-Normal	0.460380059922087	0.245621333037947	14.0000000011196	0.0819018169149384	0.226868032854379	nan
sp|O15067|PUR4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.157806751140251	0.245621333037947	14.0000000016088	0.530942998769279	0.920933816822996	nan
sp|O15067|PUR4_HUMAN	Normal-Triple-negative breast cancer	-0.302573308781836	0.293573644309805	14.0000000015865	0.32018001963051	0.512558012885705	nan
sp|O15075|DCLK1_HUMAN	metaplastic breast carcinomas-Normal	-0.81269261320905	0.269237025718923	23.9999999995982	0.0059385869911251	0.0508759359755157	nan
sp|O15075|DCLK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.288004495101185	0.269237025718923	23.999999999556	0.295392530075167	0.867696529950794	nan
sp|O15075|DCLK1_HUMAN	Normal-Triple-negative breast cancer	1.10069710831024	0.321799795831357	23.9999999996432	0.0022419938687685	0.0322614182674753	nan
sp|O15083|ERC2_HUMAN	metaplastic breast carcinomas-Normal	0.738869103812868	1.06635644541137	6.0	0.514288637223753	0.69669792945721	nan
sp|O15083|ERC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.359401274609458	1.06635644541137	6.0	0.747566288518139	0.954643368861838	nan
sp|O15083|ERC2_HUMAN	Normal-Triple-negative breast cancer	-1.09827037842233	1.2745397313038	6.0	0.421949940906719	0.608222724880283	nan
sp|O15091|MRPP3_HUMAN	metaplastic breast carcinomas-Normal	-0.173759869317551	0.794698200146476	14.999999999913	0.829870620038593	0.909492232445857	nan
sp|O15091|MRPP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.871042071832767	0.794698200146476	15.0000000000646	0.290335908632732	0.867696529950794	nan
sp|O15091|MRPP3_HUMAN	Normal-Triple-negative breast cancer	1.04480194115032	0.949846024601618	14.9999999999584	0.288685698399902	0.481480813588196	nan
sp|O15117|FYB1_HUMAN	metaplastic breast carcinomas-Normal	0.409784728448724	0.587828324047173	11.259106311387	0.499871186241612	0.685466923707557	nan
sp|O15117|FYB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.400041678195398	0.587828324047173	11.2591063117687	0.509914264646993	0.913997266820081	nan
sp|O15117|FYB1_HUMAN	Normal-Triple-negative breast cancer	-0.0097430502533253	0.656178840121803	11.0000000082739	0.988419201398855	0.994402368477541	nan
sp|O15143|ARC1B_HUMAN	metaplastic breast carcinomas-Normal	0.496177472333128	0.252772415587218	22.0000000018624	0.0624196929635523	0.191703820219284	nan
sp|O15143|ARC1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0888390592767246	0.252772415587218	22.0000000015862	0.728588019962071	0.954643368861838	nan
sp|O15143|ARC1B_HUMAN	Normal-Triple-negative breast cancer	-0.407338413056403	0.302120822760407	22.0000000015537	0.191292255325485	0.372051508086296	nan
sp|O15144|ARPC2_HUMAN	metaplastic breast carcinomas-Normal	0.356086995230485	0.144708803438434	23.9999999991417	0.0214444369789203	0.100085016891408	nan
sp|O15144|ARPC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0839501977315568	0.144708803438434	23.9999999994091	0.567232924038976	0.935631258424823	nan
sp|O15144|ARPC2_HUMAN	Normal-Triple-negative breast cancer	-0.272136797498928	0.172960101892164	23.9999999992392	0.128715990411916	0.285695054896968	nan
sp|O15145|ARPC3_HUMAN	metaplastic breast carcinomas-Normal	0.342959082389016	0.193702320406925	21.9999999976361	0.0904932169066248	0.242775991119952	nan
sp|O15145|ARPC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.141942847187689	0.193702320406925	21.9999999978736	0.47142358715678	0.912607574317916	nan
sp|O15145|ARPC3_HUMAN	Normal-Triple-negative breast cancer	-0.484901929576705	0.231518555044814	21.9999999977675	0.047956889482457	0.151324664663751	nan
sp|O15155|BET1_HUMAN	metaplastic breast carcinomas-Normal	0.536407692933824	0.170757881696533	14.0000000776874	0.0072148350859883	0.0566147333802483	nan
sp|O15155|BET1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.311613213309925	0.170757881696533	14.000000077818	0.089426360054087	0.81309570430905	nan
sp|O15155|BET1_HUMAN	Normal-Triple-negative breast cancer	-0.224794479623899	0.204094705473034	14.0000000777764	0.289289279061633	0.482245518355501	nan
sp|O15173|PGRC2_HUMAN	metaplastic breast carcinomas-Normal	-0.726335185165777	0.360292925281984	21.9999999993515	0.0561780593155899	0.180456132482707	nan
sp|O15173|PGRC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.540341652198623	0.384687575688901	21.9999999992392	0.174095108644613	0.843662073010871	nan
sp|O15173|PGRC2_HUMAN	Normal-Triple-negative breast cancer	1.2666768373644	0.447111761970879	21.999999999248	0.0096803773980662	0.0620611678009953	nan
sp|O15213|WDR46_HUMAN	metaplastic breast carcinomas-Normal	0.644135715554717	0.347730572071599	10.0102423306144	0.0936454984529171	0.248029989527886	nan
sp|O15213|WDR46_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.156675893598382	0.282644019449552	10.0009704974665	0.591537115593196	0.940559810632461	nan
sp|O15213|WDR46_HUMAN	Normal-Triple-negative breast cancer	-0.8008116091531	0.393932625556958	10.0044936943755	0.0694586253550566	0.191761188272598	nan
sp|O15226|NKRF_HUMAN	metaplastic breast carcinomas-Normal	-0.319394514306507	0.351061977329456	22.9999999993274	0.372366633343933	0.581309388187715	nan
sp|O15226|NKRF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0132645151273083	0.351061977329456	22.9999999993274	0.970185967357684	0.99709406933403	nan
sp|O15226|NKRF_HUMAN	Normal-Triple-negative breast cancer	0.306129999179198	0.415382133338754	22.9999999994204	0.46858388209164	0.648178453629884	nan
sp|O15230|LAMA5_HUMAN	metaplastic breast carcinomas-Normal	0.585925113183005	0.293804087151728	14.0000000014535	0.0659730050726679	0.197562404379773	nan
sp|O15230|LAMA5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.3968997325849	0.293804087151728	14.0000000010852	0.198158052447442	0.843662073010871	nan
sp|O15230|LAMA5_HUMAN	Normal-Triple-negative breast cancer	-0.189025380598105	0.351163050503121	14.0000000013855	0.598835521532556	0.752067603720272	nan
sp|O15231|ZN185_HUMAN	metaplastic breast carcinomas-Normal	0.113173894991718	0.588343014630059	21.2681849249763	0.849284803844081	0.920659229733136	nan
sp|O15231|ZN185_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0373645004933133	0.548459089619605	21.0614539064944	0.946327713805818	0.996541950781621	nan
sp|O15231|ZN185_HUMAN	Normal-Triple-negative breast cancer	-0.075809394498405	0.689249554537086	21.212942042107	0.913452560443616	0.950631280812329	nan
sp|O15232|MATN3_HUMAN	metaplastic breast carcinomas-Normal	1.27412137309423	1.48709700220504	6.0	0.424456507058092	0.62208705002694	nan
sp|O15232|MATN3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.33323405776104	1.48709700220504	6.0	0.404500834066691	0.885297496092956	nan
sp|O15232|MATN3_HUMAN	Normal-Triple-negative breast cancer	0.0591126846668117	1.77742088189087	6.0	0.97454795615392	0.98792235628412	nan
sp|O15258|RER1_HUMAN	metaplastic breast carcinomas-Normal	0.500204835131697	0.330498123829829	23.9999999998578	0.143214596527159	0.319340083250317	nan
sp|O15258|RER1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.243919042878588	0.330498123829829	23.9999999998578	0.467649196188869	0.911843360423993	nan
sp|O15258|RER1_HUMAN	Normal-Triple-negative breast cancer	-0.744123878010285	0.395020812932752	23.9999999998714	0.0717695167344544	0.196024546939463	nan
sp|O15260|SURF4_HUMAN	metaplastic breast carcinomas-Normal	0.79417515395073	0.307104852401136	23.9999999994531	0.0162086010224678	0.0849683083360748	nan
sp|O15260|SURF4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0522194123909681	0.307104852401136	23.9999999992155	0.866405694977039	0.980530611231673	nan
sp|O15260|SURF4_HUMAN	Normal-Triple-negative breast cancer	-0.846394566341698	0.367060505655254	23.9999999993308	0.0300673291408798	0.116349012880424	nan
sp|O15270|SPTC2_HUMAN	metaplastic breast carcinomas-Normal	-0.174472649228079	0.288535665892306	21.9999879912014	0.551575807311968	0.722996021286722	nan
sp|O15270|SPTC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.52323429461759	0.288535665892306	21.9999879896782	0.0834345930875907	0.806849600316436	nan
sp|O15270|SPTC2_HUMAN	Normal-Triple-negative breast cancer	-0.348761645389511	0.344866082687835	21.9999879897695	0.322868821037265	0.514238601402908	nan
sp|O15294|OGT1_HUMAN	metaplastic breast carcinomas-Normal	0.350991992025726	0.20116991576513	22.0000055363683	0.0949834644432561	0.248994507736107	nan
sp|O15294|OGT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.171871610076591	0.20116991576513	22.0000055358106	0.402113234612016	0.885297496092956	nan
sp|O15294|OGT1_HUMAN	Normal-Triple-negative breast cancer	-0.179120381949135	0.240444038659874	22.0000055363194	0.464182505335549	0.643802123520201	nan
sp|O15296|LX15B_HUMAN	metaplastic breast carcinomas-Normal	-0.826723780701289	0.859633646661874	14.0000003045244	0.352509413422435	0.561744479911381	nan
sp|O15296|LX15B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.18867616700629	0.859633646661874	14.000000304502	0.188394581351051	0.843662073010871	nan
sp|O15296|LX15B_HUMAN	Normal-Triple-negative breast cancer	-0.361952386305005	1.02745872803672	14.00000030445	0.729875554760701	0.84440449749443	nan
sp|O15305|PMM2_HUMAN	metaplastic breast carcinomas-Normal	0.511179708947069	0.228195429994174	22.0000000023211	0.0355120899676846	0.136464956130155	nan
sp|O15305|PMM2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.154360262731717	0.228195429994174	22.0000000023238	0.505812221438634	0.913320451076758	nan
sp|O15305|PMM2_HUMAN	Normal-Triple-negative breast cancer	-0.356819446215352	0.272745706448401	22.0000000023133	0.204293056259796	0.38539734336411	nan
sp|O15335|CHAD_HUMAN	metaplastic breast carcinomas-Normal	-0.108723432341739	0.788383016990099	15.00000000015	0.892148242950618	0.94150288514576	nan
sp|O15335|CHAD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.169184662151503	0.788383016990099	15.00000000015	0.832971655438427	0.9684421207956	nan
sp|O15335|CHAD_HUMAN	Normal-Triple-negative breast cancer	-0.0604612298097642	0.942297937019929	15.000000000181	0.949687239462392	0.973407457284302	nan
sp|O15347|HMGB3_HUMAN	metaplastic breast carcinomas-Normal	1.40114889811235	0.417175163291896	23.9999999996209	0.0026093766034456	0.0366089055673638	nan
sp|O15347|HMGB3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.242340939015831	0.417175163291896	23.9999999996209	0.566717274183946	0.935631258424823	nan
sp|O15347|HMGB3_HUMAN	Normal-Triple-negative breast cancer	-1.64348983712818	0.498619690270221	23.9999999996522	0.0030408554885699	0.0368672607204164	nan
sp|O15355|PPM1G_HUMAN	metaplastic breast carcinomas-Normal	0.598713894387134	0.305380167507589	22.0000000260176	0.062714858949344	0.191918875745801	nan
sp|O15355|PPM1G_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.134808867703001	0.305380167507588	22.0000000261083	0.663198445601083	0.944724271291086	nan
sp|O15355|PPM1G_HUMAN	Normal-Triple-negative breast cancer	-0.733522762090135	0.364999112928399	22.0000000257676	0.0568896498677436	0.170519857235785	nan
sp|O15357|SHIP2_HUMAN	metaplastic breast carcinomas-Normal	0.533541907450228	0.197888489122869	14.9999999999308	0.0165855070534202	0.0862757831699042	nan
sp|O15357|SHIP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.277026521441128	0.197888489122869	14.9999999997772	0.181881860525515	0.843662073010871	nan
sp|O15357|SHIP2_HUMAN	Normal-Triple-negative breast cancer	-0.810568428891356	0.236521983657611	14.9999999998488	0.0037442225556328	0.0400819560687694	nan
sp|O15371|EIF3D_HUMAN	metaplastic breast carcinomas-Normal	0.397910239433658	0.138631782426072	22.0000000051323	0.0088910411090798	0.0619576952758522	nan
sp|O15371|EIF3D_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.169696622609161	0.138631782426072	22.0000000043298	0.23386916186719	0.847998869365766	nan
sp|O15371|EIF3D_HUMAN	Normal-Triple-negative breast cancer	-0.228213616824497	0.165696672518662	22.0000000043689	0.182272930051461	0.358294038729188	nan
sp|O15372|EIF3H_HUMAN	metaplastic breast carcinomas-Normal	0.636256509442444	0.145773818846934	22.0000000030816	0.000247556976276	0.0157578323963946	nan
sp|O15372|EIF3H_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0971910814748654	0.145773818846934	22.0000000031167	0.511880064395671	0.915620969865368	nan
sp|O15372|EIF3H_HUMAN	Normal-Triple-negative breast cancer	-0.539065427967579	0.174233038777784	22.0000000029848	0.0052997273850042	0.0461159524286754	nan
sp|O15382|BCAT2_HUMAN	metaplastic breast carcinomas-Normal	-0.197284669747248	0.255074640772356	14.0000011347266	0.452125253832564	0.647273626341931	nan
sp|O15382|BCAT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.597448868199999	0.255074640772356	14.0000011342482	0.0344685734208342	0.724424466074313	nan
sp|O15382|BCAT2_HUMAN	Normal-Triple-negative breast cancer	-0.400164198452751	0.304872508166813	14.0000011346407	0.210441753070235	0.392982240003068	nan
sp|O15397|IPO8_HUMAN	metaplastic breast carcinomas-Normal	0.732450050771199	0.476592623495647	14.0000000646418	0.146619546281877	0.32404479510702	nan
sp|O15397|IPO8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.624886084560714	0.476592623495647	14.0000000652579	0.210904609911005	0.843662073010871	nan
sp|O15397|IPO8_HUMAN	Normal-Triple-negative breast cancer	-0.107563966210485	0.569637138599733	14.0000000648279	0.852936886839948	0.916342020638651	nan
sp|O15400|STX7_HUMAN	metaplastic breast carcinomas-Normal	-0.665676989047402	0.201088254800642	23.9999999999201	0.0029365905405971	0.0380628964347452	nan
sp|O15400|STX7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0033204842850651	0.201088254800642	23.9999999999202	0.986961980294803	0.99777413090774	nan
sp|O15400|STX7_HUMAN	Normal-Triple-negative breast cancer	0.668997473332467	0.240346435138851	23.9999999999378	0.010317360624867	0.0646219965895228	nan
sp|O15446|RPA34_HUMAN	metaplastic breast carcinomas-Normal	0.804811822931915	0.430796048242986	18.2517152916442	0.0778742961054853	0.219740373730588	nan
sp|O15446|RPA34_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0599053433018264	0.319590255565536	18.0224116775282	0.853406504507464	0.977401079052892	nan
sp|O15446|RPA34_HUMAN	Normal-Triple-negative breast cancer	-0.744906479630089	0.475366200469662	18.2010625018059	0.134331817925758	0.294026603585124	nan
sp|O15460|P4HA2_HUMAN	metaplastic breast carcinomas-Normal	0.812467480938554	0.272666548219673	24.0000000004195	0.0065118892319071	0.0529230313126148	nan
sp|O15460|P4HA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.355404315839693	0.272666548219673	24.0000000001606	0.204790743984015	0.843662073010871	nan
sp|O15460|P4HA2_HUMAN	Normal-Triple-negative breast cancer	-0.457063165098861	0.325898859240609	24.0000000003034	0.173578548246282	0.347157096492564	nan
sp|O15498|YKT6_HUMAN	metaplastic breast carcinomas-Normal	0.0972521319252237	0.149157549731231	22.0000055551751	0.521149444254229	0.702436882783103	nan
sp|O15498|YKT6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.158592112617811	0.149157549731231	22.0000055552234	0.299199673115752	0.867696529950794	nan
sp|O15498|YKT6_HUMAN	Normal-Triple-negative breast cancer	0.061339980692587	0.178277370736985	22.0000055551651	0.734060243245722	0.846933789846852	nan
sp|O15511|ARPC5_HUMAN	metaplastic breast carcinomas-Normal	0.573234301966713	0.261593061197259	24.0000000001403	0.038372153813486	0.143798240446479	nan
sp|O15511|ARPC5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.024082137456469	0.261593061197259	23.9999999998575	0.9274148592341	0.995209711945114	nan
sp|O15511|ARPC5_HUMAN	Normal-Triple-negative breast cancer	-0.597316439423181	0.312663510746327	24.0000000000505	0.06809921756869	0.18894974891346	nan
sp|O15514|RPB4_HUMAN	metaplastic breast carcinomas-Normal	-0.935485565297009	0.653110387749382	6.0	0.202014497455468	0.395079844022346	nan
sp|O15514|RPB4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.58708789959162	0.653110387749382	6.0	0.403330804159198	0.885297496092956	nan
sp|O15514|RPB4_HUMAN	Normal-Triple-negative breast cancer	0.348397665705389	0.78061622049154	6.0	0.671028205844949	0.806588516510481	nan
sp|O15533|TPSN_HUMAN	metaplastic breast carcinomas-Normal	0.398425636111014	0.441608618268848	22.0000000434355	0.376715243023918	0.583233100983467	nan
sp|O15533|TPSN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0110428841432366	0.441608618268848	22.0000000441759	0.980275579530976	0.997332163000436	nan
sp|O15533|TPSN_HUMAN	Normal-Triple-negative breast cancer	-0.409468520254251	0.527823254683558	22.0000000439924	0.44614571835365	0.630254299960703	nan
sp|O15540|FABP7_HUMAN	metaplastic breast carcinomas-Normal	-0.298491483250044	1.03101515198283	23.9999999993581	0.774675789104862	0.878247722709605	nan
sp|O15540|FABP7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.662786937983813	1.03101515198283	23.9999999994057	0.526416705150179	0.918329246917285	nan
sp|O15540|FABP7_HUMAN	Normal-Triple-negative breast cancer	-0.364295454733769	1.23229880630712	23.9999999994251	0.770060883682157	0.869306111286004	nan
sp|O15541|R113A_HUMAN	metaplastic breast carcinomas-Normal	0.389839293050633	0.471992084427644	14.0000006350232	0.422688119297796	0.621951157325291	nan
sp|O15541|R113A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.145383451743509	0.471992084427643	14.0000006347787	0.762601485763787	0.955406910386056	nan
sp|O15541|R113A_HUMAN	Normal-Triple-negative breast cancer	-0.244455841307124	0.564138442687294	14.0000006348418	0.671379989027633	0.806588516510481	nan
sp|O43143|DHX15_HUMAN	metaplastic breast carcinomas-Normal	0.506788725933559	0.179693016803912	23.9999999998686	0.0094712678207631	0.0646796741313101	nan
sp|O43143|DHX15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.347332589151832	0.179693016803912	23.9999999998197	0.0651285857850711	0.773787875546141	nan
sp|O43143|DHX15_HUMAN	Normal-Triple-negative breast cancer	-0.854121315085391	0.214774234581642	23.9999999998091	0.0005586625985295	0.0237592699893802	nan
sp|O43148|MCES_HUMAN	metaplastic breast carcinomas-Normal	0.158102623067642	0.185312654616788	22.0000050257902	0.402760431087812	0.605445350319195	nan
sp|O43148|MCES_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.361115769467289	0.185312654616788	22.0000050257869	0.0641997036822106	0.773787875546141	nan
sp|O43148|MCES_HUMAN	Normal-Triple-negative breast cancer	-0.519218392534931	0.221490986469688	22.0000050256883	0.0285053611253816	0.112582478871981	nan
sp|O43149|ZZEF1_HUMAN	metaplastic breast carcinomas-Normal	-0.130830464749283	0.194420554434427	22.0000000165432	0.508002518576699	0.692604314932482	nan
sp|O43149|ZZEF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.18119819518255	0.194420554434427	22.0000000165803	0.361457149680153	0.883542279876718	nan
sp|O43149|ZZEF1_HUMAN	Normal-Triple-negative breast cancer	0.312028659931833	0.232377008902682	22.0000000164936	0.19303789175563	0.374362865925153	nan
sp|O43169|CYB5B_HUMAN	metaplastic breast carcinomas-Normal	0.257160317842169	0.171410136623157	22.0000000042202	0.147761885226684	0.325703253642902	nan
sp|O43169|CYB5B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.225610248867817	0.171410136623157	22.0000000043007	0.201656079635721	0.843662073010871	nan
sp|O43169|CYB5B_HUMAN	Normal-Triple-negative breast cancer	-0.031550068974352	0.204874299221914	22.0000000043816	0.879015876920547	0.930228836320885	nan
sp|O43172|PRP4_HUMAN	metaplastic breast carcinomas-Normal	0.38785640611596	0.213554214778774	22.0000000333674	0.0829931548281653	0.229127281269785	nan
sp|O43172|PRP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.229441583346931	0.213554214778774	22.000000033175	0.294288737165807	0.867696529950794	nan
sp|O43172|PRP4_HUMAN	Normal-Triple-negative breast cancer	-0.617297989462891	0.255246107147533	22.0000000333676	0.0243111274434346	0.104136839719042	nan
sp|O43175|SERA_HUMAN	metaplastic breast carcinomas-Normal	0.224873646428042	0.339455435730584	23.9999999995769	0.513992122902055	0.69669792945721	nan
sp|O43175|SERA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0929220259119243	0.339455435730585	23.9999999995769	0.786627672487775	0.962981271203673	nan
sp|O43175|SERA_HUMAN	Normal-Triple-negative breast cancer	-0.317795672339966	0.405726848379267	23.9999999995961	0.441127150441542	0.626091651608748	nan
sp|O43181|NDUS4_HUMAN	metaplastic breast carcinomas-Normal	-0.297538209153446	0.24894123464405	22.0000000052356	0.244728765107034	0.444727514478219	nan
sp|O43181|NDUS4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.154969100694404	0.24894123464405	22.0000000052349	0.540004120472105	0.923143290781362	nan
sp|O43181|NDUS4_HUMAN	Normal-Triple-negative breast cancer	0.142569108459043	0.297541685689595	22.0000000055487	0.636555561247291	0.782800845573805	nan
sp|O43237|DC1L2_HUMAN	metaplastic breast carcinomas-Normal	0.115785070150522	0.224683541593075	23.9999999992006	0.611040248520622	0.767610652336563	nan
sp|O43237|DC1L2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0812430647228941	0.224683541593075	23.9999999993913	0.720823274486917	0.951268548117182	nan
sp|O43237|DC1L2_HUMAN	Normal-Triple-negative breast cancer	-0.197028134873416	0.268548196958618	23.9999999993052	0.470251494043948	0.649674133916078	nan
sp|O43242|PSMD3_HUMAN	metaplastic breast carcinomas-Normal	0.330053135486788	0.132192861489345	22.0000000596022	0.0205119765626537	0.0972636377949512	nan
sp|O43242|PSMD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0873986273744005	0.132192861489345	22.0000000599528	0.515384260640619	0.915620969865368	nan
sp|O43242|PSMD3_HUMAN	Normal-Triple-negative breast cancer	-0.417451762861188	0.158000690001843	22.0000000597759	0.0148865944252012	0.0779324922305247	nan
sp|O43252|PAPS1_HUMAN	metaplastic breast carcinomas-Normal	0.69120818257101	0.327239155068896	22.0000000054419	0.0462495078559694	0.161315177453559	nan
sp|O43252|PAPS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0336044346599824	0.327239155068896	22.0000000056066	0.919138717064377	0.99419914168049	nan
sp|O43252|PAPS1_HUMAN	Normal-Triple-negative breast cancer	-0.657603747911028	0.391125600232758	22.000000005536	0.106846005833165	0.253140501346715	nan
sp|O43278|SPIT1_HUMAN	metaplastic breast carcinomas-Normal	0.341539077085075	0.461966999115173	23.9999999995953	0.466885902413661	0.658937327638352	nan
sp|O43278|SPIT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.725732794885481	0.461966999115173	23.9999999995953	0.129283068349164	0.823891816737944	nan
sp|O43278|SPIT1_HUMAN	Normal-Triple-negative breast cancer	-1.06727187197056	0.552156173910811	23.9999999995292	0.0651292784756778	0.184875936509951	nan
sp|O43290|SNUT1_HUMAN	metaplastic breast carcinomas-Normal	0.611089062464863	0.22682120682263	20.9917136813994	0.0135879683516849	0.0776608745126424	nan
sp|O43290|SNUT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.142638387549904	0.22682120682263	20.9917136818175	0.536225633363138	0.921388505638487	nan
sp|O43290|SNUT1_HUMAN	Normal-Triple-negative breast cancer	-0.753727450014767	0.268200023157197	20.9752217494714	0.0104917396152385	0.0653269336960234	nan
sp|O43291|SPIT2_HUMAN	metaplastic breast carcinomas-Normal	-0.46674444536272	0.534080920738129	14.99999999973	0.395937753161736	0.600135472644601	nan
sp|O43291|SPIT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.59590775844843	0.534080920738129	14.9999999999264	0.0091920416833508	0.547668704418496	nan
sp|O43291|SPIT2_HUMAN	Normal-Triple-negative breast cancer	-1.12916331308571	0.638348796165867	14.999999999824	0.097237295254048	0.23871253280979	nan
sp|O43294|TGFI1_HUMAN	metaplastic breast carcinomas-Normal	-0.0517723316582988	0.242697186263895	22.000000046631	0.833041296544754	0.911464539076617	nan
sp|O43294|TGFI1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.259869504334127	0.242697186263895	22.0000000462511	0.295886111441368	0.867696529950794	nan
sp|O43294|TGFI1_HUMAN	Normal-Triple-negative breast cancer	-0.208097172675828	0.290078620427566	22.0000000464114	0.480686792289933	0.659445519167003	nan
sp|O43324|MCA3_HUMAN	metaplastic breast carcinomas-Normal	0.501242554766178	0.247513854890301	23.9999999996596	0.0541170200794812	0.177607233516034	nan
sp|O43324|MCA3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.263712699523044	0.247513854890301	23.9999999996596	0.297275976466614	0.867696529950794	nan
sp|O43324|MCA3_HUMAN	Normal-Triple-negative breast cancer	-0.764955254289222	0.29583564057153	23.9999999996702	0.0162182001230879	0.0815571818595222	nan
sp|O43390|HNRPR_HUMAN	metaplastic breast carcinomas-Normal	0.659009500633102	0.260444804717484	23.999999999676	0.0183682994277701	0.0916760169638257	nan
sp|O43390|HNRPR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.129309053469688	0.260444804717484	23.9999999996745	0.624063581771106	0.941374262616245	nan
sp|O43390|HNRPR_HUMAN	Normal-Triple-negative breast cancer	-0.788318554102789	0.311291081750846	23.9999999995831	0.0182824933820875	0.0873480619203579	nan
sp|O43395|PRPF3_HUMAN	metaplastic breast carcinomas-Normal	0.25732075435756	0.336572165869569	14.9999999995289	0.456409100287017	0.649830006677249	nan
sp|O43395|PRPF3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.539239749749345	0.336572165869569	14.9999999995289	0.129967060388947	0.823891816737944	nan
sp|O43395|PRPF3_HUMAN	Normal-Triple-negative breast cancer	-0.796560504106905	0.40228068175295	14.9999999995501	0.0663399536883853	0.186338952556932	nan
sp|O43396|TXNL1_HUMAN	metaplastic breast carcinomas-Normal	-0.061879118381116	0.17058351368157	22.0000000151401	0.720253678767035	0.843892572513791	nan
sp|O43396|TXNL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.520698238289746	0.17058351368157	22.0000000152752	0.0058381055036763	0.519941801393686	nan
sp|O43396|TXNL1_HUMAN	Normal-Triple-negative breast cancer	-0.45881911990863	0.203886295832997	22.0000000155827	0.0347565950022627	0.124763414457366	nan
sp|O43399|TPD54_HUMAN	metaplastic breast carcinomas-Normal	0.233051882615086	0.237277517836421	23.9999999996958	0.335804043792288	0.544493971495397	nan
sp|O43399|TPD54_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.062973481674751	0.237277517836421	23.9999999996958	0.79296763030591	0.964028289128757	nan
sp|O43399|TPD54_HUMAN	Normal-Triple-negative breast cancer	-0.296025364289837	0.283600877669942	23.9999999996732	0.306973871845902	0.499207999029246	nan
sp|O43402|EMC8_HUMAN	metaplastic breast carcinomas-Normal	1.1086500604057	0.238140282081652	6.0	0.003483842241078	0.0407324763980233	nan
sp|O43402|EMC8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.574322299168458	0.238140282081652	6.0	0.0524525225802309	0.773286317778246	nan
sp|O43402|EMC8_HUMAN	Normal-Triple-negative breast cancer	-0.534327761237243	0.284632078178954	6.0	0.109570799456794	0.256488265770692	nan
sp|O43405|COCH_HUMAN	metaplastic breast carcinomas-Normal	-0.494598663463703	0.514683208363377	23.9999999994301	0.346146311226211	0.556378306825882	nan
sp|O43405|COCH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.64884774100933	0.514683208363377	23.9999999994301	0.003807199865365	0.475304411992737	nan
sp|O43405|COCH_HUMAN	Normal-Triple-negative breast cancer	-1.15424907754563	0.615164095379923	23.9999999994181	0.0728230832113037	0.197442029848592	nan
sp|O43414|ERI3_HUMAN	metaplastic breast carcinomas-Normal	0.179274004010199	0.222535155186904	22.0000003159304	0.429096209686883	0.626846629119879	nan
sp|O43414|ERI3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0693950442191865	0.222535155186904	22.0000003156601	0.758099348938202	0.955228196959647	nan
sp|O43414|ERI3_HUMAN	Normal-Triple-negative breast cancer	-0.248669048229386	0.265980384062057	22.0000003157644	0.35998144282915	0.551164585888575	nan
sp|O43432|IF4G3_HUMAN	metaplastic breast carcinomas-Normal	0.180625301725501	0.359967968506809	14.0000000139426	0.623619707097536	0.774713153324972	nan
sp|O43432|IF4G3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.192358234569918	0.359967968506809	14.0000000137693	0.601465064299163	0.940559810632461	nan
sp|O43432|IF4G3_HUMAN	Normal-Triple-negative breast cancer	0.0117329328444171	0.43024401440332	14.0000000138558	0.978628970905087	0.989644873528601	nan
sp|O43464|HTRA2_HUMAN	metaplastic breast carcinomas-Normal	0.271406290816283	0.222606497230716	22.0000000170541	0.235672104980893	0.435449737051968	nan
sp|O43464|HTRA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.516554964070188	0.222606497230716	22.0000000163343	0.0299793139134602	0.721684569712558	nan
sp|O43464|HTRA2_HUMAN	Normal-Triple-negative breast cancer	-0.787961254886471	0.266065654113869	22.0000000165865	0.0072084230517058	0.0535093121381869	nan
sp|O43488|ARK72_HUMAN	metaplastic breast carcinomas-Normal	-0.188568688468577	0.21979515463515	21.1515725999639	0.400548957335479	0.603000332510477	nan
sp|O43488|ARK72_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0199222101182929	0.204639725879137	21.0398353844955	0.923367825840357	0.994508979919649	nan
sp|O43488|ARK72_HUMAN	Normal-Triple-negative breast cancer	0.168646478350284	0.257405078824156	21.1215426228017	0.519424940042683	0.692288893625452	nan
sp|O43490|PROM1_HUMAN	metaplastic breast carcinomas-Normal	-0.319783629331054	0.488610462288917	21.9999999965254	0.519589603461839	0.701224458752396	nan
sp|O43490|PROM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.465499480128254	0.488610462288917	21.9999999976808	0.351092693046192	0.875099853357262	nan
sp|O43490|PROM1_HUMAN	Normal-Triple-negative breast cancer	-0.1457158507972	0.584001203347817	21.9999999971237	0.805278964952937	0.88801979396181	nan
sp|O43491|E41L2_HUMAN	metaplastic breast carcinomas-Normal	-0.601363690220127	0.224808249356581	21.9999999291068	0.0138318680307559	0.0787184055002298	nan
sp|O43491|E41L2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.208745403914938	0.224808249356581	21.9999999283018	0.363199574158905	0.883542279876718	nan
sp|O43491|E41L2_HUMAN	Normal-Triple-negative breast cancer	0.810109094135065	0.268697251245366	21.9999999286323	0.0063698840111339	0.0508978232043495	nan
sp|O43493|TGON2_HUMAN	metaplastic breast carcinomas-Normal	0.370387786966338	0.274402216950657	24.000000000347	0.189675261635806	0.382805446070079	nan
sp|O43493|TGON2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0342938249542475	0.274402216950657	24.0000000000914	0.90158311212628	0.990735309568793	nan
sp|O43493|TGON2_HUMAN	Normal-Triple-negative breast cancer	-0.336093962012091	0.327973380164209	24.0000000001829	0.315695092001045	0.508662377998776	nan
sp|O43504|LTOR5_HUMAN	metaplastic breast carcinomas-Normal	-0.111175618851758	0.177780686934516	22.0000000031227	0.538173083650274	0.713752342369794	nan
sp|O43504|LTOR5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.239640015030789	0.177780686934516	22.000000002368	0.191390499599923	0.843662073010871	nan
sp|O43504|LTOR5_HUMAN	Normal-Triple-negative breast cancer	-0.128464396179031	0.212488563211254	22.0000000029055	0.551649070469048	0.716281839937155	nan
sp|O43516|WIPF1_HUMAN	metaplastic breast carcinomas-Normal	0.247541447032025	0.267126849643893	23.9999999992644	0.363317772543837	0.574259760311799	nan
sp|O43516|WIPF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.260178081205013	0.267126849643893	23.9999999992644	0.339778354062075	0.870943310236299	nan
sp|O43516|WIPF1_HUMAN	Normal-Triple-negative breast cancer	0.0126366341729873	0.319277653015748	23.9999999992465	0.968756314145018	0.984453068852962	nan
sp|O43583|DENR_HUMAN	metaplastic breast carcinomas-Normal	0.327149212044479	0.190314166153258	22.0000000025836	0.099656711169815	0.254814544560358	nan
sp|O43583|DENR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0753603931928953	0.190314166153258	22.0000000021152	0.695934792375357	0.947043345959522	nan
sp|O43583|DENR_HUMAN	Normal-Triple-negative breast cancer	-0.402509605237374	0.227468936147993	22.0000000021894	0.0906693919355253	0.227804277243905	nan
sp|O43592|XPOT_HUMAN	metaplastic breast carcinomas-Normal	0.17775864369934	0.223717126113511	22.0000005317687	0.435352629325111	0.6319266986361	nan
sp|O43592|XPOT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.298940629765777	0.223717126113511	22.0000005325329	0.19512733383414	0.843662073010871	nan
sp|O43592|XPOT_HUMAN	Normal-Triple-negative breast cancer	0.121181986066437	0.267393109528939	22.0000005318288	0.654844542482847	0.797031075258555	nan
sp|O43598|DNPH1_HUMAN	metaplastic breast carcinomas-Normal	-0.453705295321603	0.324883296206908	14.9999999999243	0.182881465850113	0.373631218491564	nan
sp|O43598|DNPH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.110555958833043	0.324883296206908	14.9999999999243	0.738353629739774	0.954643368861838	nan
sp|O43598|DNPH1_HUMAN	Normal-Triple-negative breast cancer	0.564261254154646	0.388309810321357	14.999999999907	0.166789713224757	0.337642513251579	nan
sp|O43602|DCX_HUMAN	metaplastic breast carcinomas-Normal	-0.809488143391614	1.25078924339125	6.0	0.541467671940682	0.716496234685838	nan
sp|O43602|DCX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.44743916020436	1.25078924339125	6.0	0.291166386902142	0.867696529950794	nan
sp|O43602|DCX_HUMAN	Normal-Triple-negative breast cancer	-0.637951016812748	1.49497908794894	6.0	0.68446372819874	0.814550412235226	nan
sp|O43615|TIM44_HUMAN	metaplastic breast carcinomas-Normal	0.219744055732541	0.194677848674578	23.9999999998866	0.270157216797977	0.472716075635733	nan
sp|O43615|TIM44_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.42028393610776	0.194677848674578	23.9999999998853	0.0410758903444785	0.738255867002113	nan
sp|O43615|TIM44_HUMAN	Normal-Triple-negative breast cancer	-0.640027991840301	0.232684534339527	23.9999999998796	0.0111317499586255	0.067263535796389	nan
sp|O43633|CHM2A_HUMAN	metaplastic breast carcinomas-Normal	0.643215093520069	0.195338635270774	23.9999999995784	0.0030651203181604	0.0386458689304557	nan
sp|O43633|CHM2A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.176767042633976	0.195338635270774	23.9999999995784	0.374499483503049	0.885234295852111	nan
sp|O43633|CHM2A_HUMAN	Normal-Triple-negative breast cancer	-0.819982136154046	0.233474325383965	23.9999999995786	0.0017880764582581	0.0292559439806731	nan
sp|O43660|PLRG1_HUMAN	metaplastic breast carcinomas-Normal	0.0258681717305833	0.253408745846729	24.0000000000575	0.919540637851213	0.957866838049963	nan
sp|O43660|PLRG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.167650125235572	0.253408745846729	24.0000000001051	0.514542683819502	0.915620969865368	nan
sp|O43660|PLRG1_HUMAN	Normal-Triple-negative breast cancer	0.141781953504989	0.302881382891559	24.0000000000813	0.643928916394995	0.789822774205521	nan
sp|O43665|RGS10_HUMAN	metaplastic breast carcinomas-Normal	0.439011479981457	0.278101623183016	21.9999999975974	0.128699364983771	0.299374855792279	nan
sp|O43665|RGS10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.644289693012142	0.278101623183016	21.999999997805	0.030218264485335	0.721684569712558	nan
sp|O43665|RGS10_HUMAN	Normal-Triple-negative breast cancer	0.205278213030686	0.332395016330674	21.9999999971619	0.543197007748141	0.708351060711974	nan
sp|O43670|ZN207_HUMAN	metaplastic breast carcinomas-Normal	0.553192539198294	0.350429954996824	21.9999999973115	0.128697079299493	0.299374855792279	nan
sp|O43670|ZN207_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.68351525253709	0.350429954996823	21.9999999965426	0.0639699158059591	0.773787875546141	nan
sp|O43670|ZN207_HUMAN	Normal-Triple-negative breast cancer	-1.23670779173538	0.418843907779967	21.9999999962437	0.0073573482445247	0.0539863699002213	nan
sp|O43678|NDUA2_HUMAN	metaplastic breast carcinomas-Normal	0.205762925646977	0.297382156250384	21.9999999992024	0.496229447712355	0.683265088490911	nan
sp|O43678|NDUA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.140272043447742	0.297382156250384	21.9999999988277	0.641792962811667	0.941868024951375	nan
sp|O43678|NDUA2_HUMAN	Normal-Triple-negative breast cancer	-0.065490882199235	0.35543966105601	21.9999999990373	0.855502685672554	0.917615658978887	nan
sp|O43681|GET3_HUMAN	metaplastic breast carcinomas-Normal	-0.58538634192346	0.24597995359512	13.0366487094718	0.0332707267836037	0.130414971496107	nan
sp|O43681|GET3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.250757966727095	0.219540904307962	13.0000021038007	0.273975524085712	0.867696529950794	nan
sp|O43681|GET3_HUMAN	Normal-Triple-negative breast cancer	0.334628375196366	0.284890352087474	13.0273722152083	0.261184410211114	0.45217551017799	nan
sp|O43684|BUB3_HUMAN	metaplastic breast carcinomas-Normal	0.257515581149722	0.214790783158175	22.000000035701	0.243316460020369	0.44435597373584	nan
sp|O43684|BUB3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0206018425157492	0.214790783158175	22.0000000356243	0.92445575744796	0.994762263273291	nan
sp|O43684|BUB3_HUMAN	Normal-Triple-negative breast cancer	-0.236913738633973	0.25672408905199	22.000000035639	0.366104621156947	0.556438848068446	nan
sp|O43707|ACTN4_HUMAN	metaplastic breast carcinomas-Normal	0.382093511558168	0.195963582946252	23.9999999994855	0.0629738627950095	0.191989705242151	nan
sp|O43707|ACTN4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.138325059168937	0.195963582946252	23.9999999995266	0.487064124156725	0.913320451076758	nan
sp|O43707|ACTN4_HUMAN	Normal-Triple-negative breast cancer	-0.520418570727105	0.234221280725033	23.9999999995246	0.0359719302866814	0.126678556343412	nan
sp|O43708|MAAI_HUMAN	metaplastic breast carcinomas-Normal	-0.227620918044043	0.435524316293209	14.0000000077315	0.609399046919682	0.766127999985258	nan
sp|O43708|MAAI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.146820225571156	0.435524316293209	14.0000000077322	0.741033495153029	0.954643368861838	nan
sp|O43708|MAAI_HUMAN	Normal-Triple-negative breast cancer	0.374441143615199	0.520551122894445	14.0000000076975	0.483780901486088	0.661515532845801	nan
sp|O43719|HTSF1_HUMAN	metaplastic breast carcinomas-Normal	0.501478291506874	0.177144877508267	24.0000000000272	0.0092404169093016	0.0638568519886046	nan
sp|O43719|HTSF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0288700208835887	0.177144877508267	23.9999999997205	0.871903372204513	0.981704007186169	nan
sp|O43719|HTSF1_HUMAN	Normal-Triple-negative breast cancer	-0.530348312390463	0.211728625594918	23.9999999998383	0.0194430691391614	0.0907707328912537	nan
sp|O43747|AP1G1_HUMAN	metaplastic breast carcinomas-Normal	0.563451895444527	0.170816292166624	21.9999999907782	0.0032730485972123	0.0401633283746249	nan
sp|O43747|AP1G1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.128719579882014	0.170816292166624	21.9999999907589	0.459105487982719	0.908636575237228	nan
sp|O43747|AP1G1_HUMAN	Normal-Triple-negative breast cancer	-0.692171475326541	0.204164519337972	21.9999999884148	0.0026317438854115	0.0344406168311338	nan
sp|O43752|STX6_HUMAN	metaplastic breast carcinomas-Normal	0.196900809919592	0.597829110049931	21.7014399050845	0.745041527293779	0.859564245547108	nan
sp|O43752|STX6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.351391093114453	0.509772932291366	20.2304205533159	0.498459524871028	0.913320451076758	nan
sp|O43752|STX6_HUMAN	Normal-Triple-negative breast cancer	0.154490283194861	0.684669142334192	21.452914308818	0.823615432687204	0.899956642546629	nan
sp|O43760|SNG2_HUMAN	metaplastic breast carcinomas-Normal	0.113956788697811	0.31367508530439	22.9999999997817	0.719701828579156	0.843892572513791	nan
sp|O43760|SNG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.597168563012208	0.335332771421747	22.9999999996585	0.0881549950859677	0.809016644110817	nan
sp|O43760|SNG2_HUMAN	Normal-Triple-negative breast cancer	-0.711125351710019	0.393212528965458	22.9999999997274	0.0836223070996142	0.217294979248444	nan
sp|O43768|ENSA_HUMAN	metaplastic breast carcinomas-Normal	0.534054178476421	0.371625876446697	23.9999999994322	0.163606829888349	0.349866975013539	nan
sp|O43768|ENSA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.225918004272018	0.371625876446697	23.9999999994322	0.548952000538975	0.931092596888836	nan
sp|O43768|ENSA_HUMAN	Normal-Triple-negative breast cancer	-0.759972182748439	0.444177879498061	23.9999999994182	0.0999847275317931	0.242945346721989	nan
sp|O43776|SYNC_HUMAN	metaplastic breast carcinomas-Normal	0.332093577983812	0.202296191946541	22.0000001091686	0.1148881827261	0.279859636823745	nan
sp|O43776|SYNC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.303440445852888	0.202296191946541	22.000000108503	0.147834517821215	0.835968999584253	nan
sp|O43776|SYNC_HUMAN	Normal-Triple-negative breast cancer	-0.6355340238367	0.241790196173908	22.0000001088965	0.0153452920657919	0.0787156648560068	nan
sp|O43795|MYO1B_HUMAN	metaplastic breast carcinomas-Normal	0.33171882385333	0.247145989949165	22.0000000153749	0.193220087170072	0.386624153804669	nan
sp|O43795|MYO1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0623085390384747	0.247145989949165	22.0000000161189	0.803294649085147	0.965774701272009	nan
sp|O43795|MYO1B_HUMAN	Normal-Triple-negative breast cancer	-0.269410284814856	0.295395957869513	22.0000000157396	0.37163863089684	0.561055559292967	nan
sp|O43813|LANC1_HUMAN	metaplastic breast carcinomas-Normal	-0.267569127710504	0.283025074546479	22.0000000067991	0.354728086693358	0.564170411563982	nan
sp|O43813|LANC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.253159735977787	0.283025074546479	22.000000006795	0.380748052437302	0.885234295852111	nan
sp|O43813|LANC1_HUMAN	Normal-Triple-negative breast cancer	0.0144093917327173	0.338279666256951	22.0000000062991	0.966407752190653	0.982929910189078	nan
sp|O43815|STRN_HUMAN	metaplastic breast carcinomas-Normal	-0.454001345724518	0.599230221662519	6.0	0.477356647503558	0.667536178503083	nan
sp|O43815|STRN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.127177262096689	0.599230221662519	6.0	0.838950485627529	0.971085326089412	nan
sp|O43815|STRN_HUMAN	Normal-Triple-negative breast cancer	0.581178607821207	0.716217104508833	6.0	0.448089788671906	0.631926371466022	nan
sp|O43823|AKAP8_HUMAN	metaplastic breast carcinomas-Normal	0.422154694100973	0.327322952045109	14.0000001930081	0.218047269240796	0.415351932926307	nan
sp|O43823|AKAP8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.323088256818632	0.327322952045109	14.0000001925762	0.340364899175376	0.870943310236299	nan
sp|O43823|AKAP8_HUMAN	Normal-Triple-negative breast cancer	-0.745242950919605	0.391225756776104	14.0000001927948	0.0775447489773396	0.206206996480541	nan
sp|O43837|IDH3B_HUMAN	metaplastic breast carcinomas-Normal	-0.161400600219623	0.232881778964982	21.9999999612562	0.495525225041323	0.683171235187622	nan
sp|O43837|IDH3B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.277045882777305	0.232881778964982	21.9999999611497	0.246868198300828	0.84964799869723	nan
sp|O43837|IDH3B_HUMAN	Normal-Triple-negative breast cancer	-0.115645282557682	0.278346964811635	21.9999999604168	0.681820995456916	0.813486356388654	nan
sp|O43847|NRDC_HUMAN	metaplastic breast carcinomas-Normal	0.251083769578395	0.358519479813398	24.0000000002926	0.490452113276447	0.680126334806387	nan
sp|O43847|NRDC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.366680378210142	0.358519479813398	23.9999999999424	0.316619315319717	0.867696529950794	nan
sp|O43847|NRDC_HUMAN	Normal-Triple-negative breast cancer	0.115596608631748	0.428512739276658	24.0000000000426	0.789649025786225	0.879763182876798	nan
sp|O43852|CALU_HUMAN	metaplastic breast carcinomas-Normal	1.72753239821631	0.44828663462864	23.9999999995615	0.0007620904376003	0.0223481995864959	nan
sp|O43852|CALU_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.52139617526796	0.44828663462864	23.9999999993385	0.256228670027857	0.860579626235671	nan
sp|O43852|CALU_HUMAN	Normal-Triple-negative breast cancer	-1.20613622294835	0.535805010890385	23.9999999994435	0.0338111418964794	0.123621534315429	nan
sp|O43865|SAHH2_HUMAN	metaplastic breast carcinomas-Normal	-0.0100136675502479	0.196093064379477	23.9999999999004	0.959695658842868	0.980340617699352	nan
sp|O43865|SAHH2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0996057257363423	0.196093064379477	24.000000000152	0.616124389497099	0.941374262616245	nan
sp|O43865|SAHH2_HUMAN	Normal-Triple-negative breast cancer	-0.0895920581860944	0.234376040638402	23.9999999999928	0.705634283743144	0.827552573266692	nan
sp|O43866|CD5L_HUMAN	metaplastic breast carcinomas-Normal	-1.66629245022785	0.542178874838373	20.9878007181438	0.0057690160903284	0.0504637091690839	nan
sp|O43866|CD5L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.279929751606268	0.542178874838373	20.9878007138626	0.61103864285787	0.94077736515583	nan
sp|O43866|CD5L_HUMAN	Normal-Triple-negative breast cancer	1.94622220183412	0.641465954001732	20.9224055813531	0.0063286590510935	0.0506902715321328	nan
sp|O43896|KIF1C_HUMAN	metaplastic breast carcinomas-Normal	-0.143465757055546	0.587461754646705	14.0000000006827	0.81060859220924	0.900925915386606	nan
sp|O43896|KIF1C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.443246941391351	0.587461754646705	14.000000000577	0.463045495777257	0.909423669537079	nan
sp|O43896|KIF1C_HUMAN	Normal-Triple-negative breast cancer	0.586712698446897	0.702151096043524	14.0000000006125	0.417416841922439	0.604309051633356	nan
sp|O43920|NDUS5_HUMAN	metaplastic breast carcinomas-Normal	-1.19337732312861	0.701782350508408	13.9999990171811	0.111134658517103	0.273638225859889	nan
sp|O43920|NDUS5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.650513207887719	0.701782350508407	13.9999990217078	0.369660309666555	0.883542279876718	nan
sp|O43920|NDUS5_HUMAN	Normal-Triple-negative breast cancer	0.542864115240892	0.838790342853586	13.9999990186684	0.527973346243006	0.697552699510103	nan
sp|O60220|TIM8A_HUMAN	metaplastic breast carcinomas-Normal	0.412625725946606	0.291933476529306	21.9999905497275	0.171525131281047	0.360397937027939	nan
sp|O60220|TIM8A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0918739667540023	0.291933476529306	21.9999905494414	0.755948260833068	0.954748610837524	nan
sp|O60220|TIM8A_HUMAN	Normal-Triple-negative breast cancer	-0.320751759192603	0.348927243170277	21.9999905505636	0.367933927175658	0.558198253734317	nan
sp|O60240|PLIN1_HUMAN	metaplastic breast carcinomas-Normal	-2.81596642855214	0.757581372183856	22.0000001097351	0.0011995565869845	0.0261713412023794	nan
sp|O60240|PLIN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.1299695931746	0.757581372183856	22.0000001089322	0.865352809355701	0.980530611231673	nan
sp|O60240|PLIN1_HUMAN	Normal-Triple-negative breast cancer	2.68599683537754	0.905482929932952	22.0000001095473	0.0071282895932942	0.0535093121381869	nan
sp|O60242|AGRB3_HUMAN	metaplastic breast carcinomas-Normal	-1.61328612222407	0.566502516169053	22.0000000201064	0.009359481968101	0.0642787563263798	nan
sp|O60242|AGRB3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.982623777942137	0.566502516169053	22.0000000207153	0.0968128174932786	0.814943337126966	nan
sp|O60242|AGRB3_HUMAN	Normal-Triple-negative breast cancer	2.5959099001662	0.677100014585172	22.0000000206432	0.000903652348188	0.025773942907156	nan
sp|O60264|SMCA5_HUMAN	metaplastic breast carcinomas-Normal	0.663729598339371	0.175012649315547	23.9999999999508	0.0008886891392317	0.0227210419054423	nan
sp|O60264|SMCA5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.13355064635737	0.175012649315547	23.9999999999508	0.452844971396218	0.908567154037048	nan
sp|O60264|SMCA5_HUMAN	Normal-Triple-negative breast cancer	-0.797280244696741	0.209180125457349	23.9999999998986	0.0008473224838587	0.0257262735003663	nan
sp|O60271|JIP4_HUMAN	metaplastic breast carcinomas-Normal	0.163061387492245	0.17982311273107	22.0000000306362	0.374344510508389	0.581984288538432	nan
sp|O60271|JIP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.048826333207879	0.17982311273107	22.0000000306362	0.788519504671547	0.962981271203673	nan
sp|O60271|JIP4_HUMAN	Normal-Triple-negative breast cancer	-0.211887720700124	0.214929728955738	22.0000000308408	0.334927376213897	0.527629667552129	nan
sp|O60292|SI1L3_HUMAN	metaplastic breast carcinomas-Normal	-0.0508994174641064	0.330315890228248	14.9999999996803	0.879590381825874	0.937102060637565	nan
sp|O60292|SI1L3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.181528025300211	0.330315890228248	14.999999999773	0.590710874493916	0.940559810632461	nan
sp|O60292|SI1L3_HUMAN	Normal-Triple-negative breast cancer	-0.130628607836105	0.394803002118561	14.9999999997421	0.745319175634605	0.853407144267802	nan
sp|O60313|OPA1_HUMAN	metaplastic breast carcinomas-Normal	0.0379027010331711	0.169387929717394	23.9999999992838	0.824835766751548	0.907569094159468	nan
sp|O60313|OPA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.134423413097058	0.169387929717394	23.9999999992838	0.435214470893223	0.896584953977674	nan
sp|O60313|OPA1_HUMAN	Normal-Triple-negative breast cancer	-0.172326114130229	0.202457299674153	23.9999999992222	0.403086491583733	0.593242783972026	nan
sp|O60341|KDM1A_HUMAN	metaplastic breast carcinomas-Normal	0.936625992596811	0.315343856189569	21.1081528607589	0.0072755605882856	0.0569034432834392	nan
sp|O60341|KDM1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.306851323720966	0.315343856189569	21.1081528594661	0.341538929845194	0.870943310236299	nan
sp|O60341|KDM1A_HUMAN	Normal-Triple-negative breast cancer	-1.24347731631778	0.37295467101051	21.0749588507697	0.0031373481981872	0.037336569687701	nan
sp|O60343|TBCD4_HUMAN	metaplastic breast carcinomas-Normal	-0.126493219656658	0.273956241848526	23.9999999998243	0.648434447549076	0.79096884249651	nan
sp|O60343|TBCD4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.507543807050379	0.273956241848526	24.0000000001242	0.0762706386320536	0.799999600793622	nan
sp|O60343|TBCD4_HUMAN	Normal-Triple-negative breast cancer	-0.381050587393721	0.327440337963091	23.9999999999013	0.255974663978546	0.446645555414534	nan
sp|O60437|PEPL_HUMAN	metaplastic breast carcinomas-Normal	-0.534736488495227	0.317478587216586	23.9999999998096	0.1050822156841	0.263501246718047	nan
sp|O60437|PEPL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0156804618524282	0.317478587216586	23.9999999998409	0.961016755145909	0.99709406933403	nan
sp|O60437|PEPL_HUMAN	Normal-Triple-negative breast cancer	0.550416950347655	0.379459490292328	23.999999999817	0.159856052446027	0.329864241010448	nan
sp|O60493|SNX3_HUMAN	metaplastic breast carcinomas-Normal	-0.805519262774973	0.242213979721878	21.9999999918061	0.0030693469908665	0.0386458689304557	nan
sp|O60493|SNX3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0186176084076589	0.242213979721878	21.9999999904737	0.939426256291427	0.995571782532303	nan
sp|O60493|SNX3_HUMAN	Normal-Triple-negative breast cancer	0.786901654367314	0.28950107814433	21.9999999906365	0.0125566024086984	0.0726685666512126	nan
sp|O60502|OGA_HUMAN	metaplastic breast carcinomas-Normal	0.212728939264389	0.242845241996154	14.999999999902	0.394849726418923	0.599306160098858	nan
sp|O60502|OGA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.137062875261053	0.242845241996153	14.9999999999868	0.580821442625119	0.93702592209822	nan
sp|O60502|OGA_HUMAN	Normal-Triple-negative breast cancer	-0.0756660640033361	0.290255580874537	14.9999999999647	0.797878211504883	0.883985978072184	nan
sp|O60504|VINEX_HUMAN	metaplastic breast carcinomas-Normal	0.111468288005815	0.3117075471205	6.0	0.73288154196344	0.851109065467202	nan
sp|O60504|VINEX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.157732048714139	0.3117075471205	6.0	0.630888357725653	0.941868024951375	nan
sp|O60504|VINEX_HUMAN	Normal-Triple-negative breast cancer	0.0462637607083244	0.37256177806387	6.0	0.905230480192648	0.944736614179077	nan
sp|O60506|HNRPQ_HUMAN	metaplastic breast carcinomas-Normal	0.648827824658307	0.203120828861532	22.0000000047105	0.0041879794818498	0.042883667309653	nan
sp|O60506|HNRPQ_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.1760765241855	0.203120828861532	22.0000000046754	0.395377358958579	0.885234295852111	nan
sp|O60506|HNRPQ_HUMAN	Normal-Triple-negative breast cancer	-0.824904348843807	0.242775825807018	22.0000000042227	0.0025848309464072	0.0343679122634309	nan
sp|O60508|PRP17_HUMAN	metaplastic breast carcinomas-Normal	0.372804293734442	0.512000231982522	6.0	0.493956641239259	0.682423888395386	nan
sp|O60508|PRP17_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.426050936442078	0.512000231982522	6.0	0.437194711956453	0.897513075778899	nan
sp|O60508|PRP17_HUMAN	Normal-Triple-negative breast cancer	0.0532466427076361	0.611957325251356	6.0	0.933494428259408	0.962747589058105	nan
sp|O60524|NEMF_HUMAN	metaplastic breast carcinomas-Normal	0.218189879062449	0.255392739700179	14.9999999995841	0.406359786545205	0.608990049808954	nan
sp|O60524|NEMF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.366991466041273	0.255392739700179	14.9999999995841	0.171257716894752	0.843662073010871	nan
sp|O60524|NEMF_HUMAN	Normal-Triple-negative breast cancer	-0.585181345103722	0.305252709105946	14.9999999995379	0.0744821007488093	0.200468423391937	nan
sp|O60547|GMDS_HUMAN	metaplastic breast carcinomas-Normal	0.119471200103883	0.200838789676916	21.9999999498205	0.558005630143411	0.727985394360342	nan
sp|O60547|GMDS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.578560248757348	0.200838789676916	21.9999999515755	0.0086808032624328	0.547668704418496	nan
sp|O60547|GMDS_HUMAN	Normal-Triple-negative breast cancer	-0.698031448861232	0.240048267285944	21.9999999517617	0.0081564862515378	0.0575911703148659	nan
sp|O60568|PLOD3_HUMAN	metaplastic breast carcinomas-Normal	1.21358411388173	0.434865802151908	23.999999999151	0.0101456401425401	0.0667447335978891	nan
sp|O60568|PLOD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.552680367375992	0.434865802151908	23.999999999151	0.215937632496861	0.843662073010871	nan
sp|O60568|PLOD3_HUMAN	Normal-Triple-negative breast cancer	-0.660903746505741	0.51976404795311	23.9999999991202	0.215719419986144	0.398140672978314	nan
sp|O60573|IF4E2_HUMAN	metaplastic breast carcinomas-Normal	0.449356703863157	0.22928477615178	22.0000000288875	0.0628057302135399	0.191918875745801	nan
sp|O60573|IF4E2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.332232399053716	0.22928477615178	22.000000028891	0.161444146231916	0.843662073010871	nan
sp|O60573|IF4E2_HUMAN	Normal-Triple-negative breast cancer	-0.117124304809441	0.27404772414144	22.0000000285594	0.673251885904947	0.80744798152738	nan
sp|O60610|DIAP1_HUMAN	metaplastic breast carcinomas-Normal	0.105013499536771	0.207254231023358	22.0000000003399	0.617413631251423	0.771225334653059	nan
sp|O60610|DIAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.209464185055904	0.207254231023358	22.0000000003399	0.323164965953596	0.867696529950794	nan
sp|O60610|DIAP1_HUMAN	Normal-Triple-negative breast cancer	-0.314477684592674	0.247716186324717	22.0000000004431	0.2175254824399	0.399698564748605	nan
sp|O60645|EXOC3_HUMAN	metaplastic breast carcinomas-Normal	-0.119554895707123	0.257522727309296	22.0000000030646	0.647030015928754	0.790218493354369	nan
sp|O60645|EXOC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.110795743558779	0.257522727309296	22.000000003399	0.671208659757956	0.946386428913156	nan
sp|O60645|EXOC3_HUMAN	Normal-Triple-negative breast cancer	0.230350639265903	0.30779853123389	22.0000000034678	0.462156572161719	0.643034092032463	nan
sp|O60664|PLIN3_HUMAN	metaplastic breast carcinomas-Normal	0.342660697601236	0.351994204173638	23.999999999588	0.340023103124595	0.549726067502993	nan
sp|O60664|PLIN3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.130041436131081	0.351994204173639	23.999999999588	0.715038015418553	0.949812109346858	nan
sp|O60664|PLIN3_HUMAN	Normal-Triple-negative breast cancer	-0.472702133732317	0.420713543148225	23.9999999995154	0.272308083182223	0.463995415682386	nan
sp|O60684|IMA7_HUMAN	metaplastic breast carcinomas-Normal	-0.0575840765884515	0.313481367192311	22.0000000269588	0.855937473423865	0.925247532247456	nan
sp|O60684|IMA7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.377129043844473	0.313481367192311	22.000000026913	0.241750062188248	0.84964799869723	nan
sp|O60684|IMA7_HUMAN	Normal-Triple-negative breast cancer	0.434713120432924	0.37468189856151	22.0000000269217	0.258395956215913	0.44898492339869	nan
sp|O60701|UGDH_HUMAN	metaplastic breast carcinomas-Normal	0.183511089422249	0.241463576772062	21.9999999646274	0.455325488931227	0.649292975206949	nan
sp|O60701|UGDH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0337333089128698	0.241463576772062	21.9999999654262	0.890165342735438	0.98820634909787	nan
sp|O60701|UGDH_HUMAN	Normal-Triple-negative breast cancer	-0.217244398335119	0.28860417507018	21.999999965423	0.459584620823587	0.64133471016692	nan
sp|O60704|TPST2_HUMAN	metaplastic breast carcinomas-Normal	0.146194815291286	0.499245221073549	6.0	0.779514106426645	0.880401214470097	nan
sp|O60704|TPST2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.560581535293865	0.499245221073549	6.0	0.304409425821218	0.867696529950794	nan
sp|O60704|TPST2_HUMAN	Normal-Triple-negative breast cancer	0.414386720002579	0.59671217130058	6.0	0.513377872146002	0.686431233714123	nan
sp|O60711|LPXN_HUMAN	metaplastic breast carcinomas-Normal	-0.4190523416653	0.453377505427307	23.9999999998391	0.364535813688272	0.575091146036933	nan
sp|O60711|LPXN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0758547066532477	0.453377505427307	23.9999999998708	0.868527700291866	0.981143688073178	nan
sp|O60711|LPXN_HUMAN	Normal-Triple-negative breast cancer	0.494907048318547	0.541889765315377	23.9999999999049	0.370169782025761	0.560415862605876	nan
sp|O60716|CTND1_HUMAN	metaplastic breast carcinomas-Normal	0.188913730948315	0.199027740871152	23.9999999993903	0.351988447516401	0.561744479911381	nan
sp|O60716|CTND1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.28273382214662	0.199027740871152	23.9999999993903	0.1683026314246	0.843662073010871	nan
sp|O60716|CTND1_HUMAN	Normal-Triple-negative breast cancer	-0.471647553094935	0.237883649940393	23.9999999993762	0.0589619714826892	0.173903809413007	nan
sp|O60749|SNX2_HUMAN	metaplastic breast carcinomas-Normal	-0.348373989644488	0.182758164255102	23.9999999994652	0.0686679286353068	0.202890839807786	nan
sp|O60749|SNX2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.140974271978668	0.182758164255102	23.9999999991755	0.448015902914189	0.902988618897891	nan
sp|O60749|SNX2_HUMAN	Normal-Triple-negative breast cancer	0.20739971766582	0.218437786507132	23.999999999258	0.351846384203455	0.54220555451659	nan
sp|O60763|USO1_HUMAN	metaplastic breast carcinomas-Normal	0.392296951045418	0.192355635411422	23.9999999995771	0.0525626130104212	0.174369386872894	nan
sp|O60763|USO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0704019555884055	0.192355635411422	23.9999999992756	0.717572336444904	0.949812109346858	nan
sp|O60763|USO1_HUMAN	Normal-Triple-negative breast cancer	-0.462698906633823	0.229908958610427	23.9999999994199	0.0555151901346466	0.167604443240295	nan
sp|O60784|TOM1_HUMAN	metaplastic breast carcinomas-Normal	-0.18562575049994	0.22597047200062	23.9999999996076	0.419469996968616	0.620030732879251	nan
sp|O60784|TOM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0851930441957009	0.22597047200062	23.9999999996395	0.709479481552082	0.94948208919602	nan
sp|O60784|TOM1_HUMAN	Normal-Triple-negative breast cancer	0.10043270630424	0.270086372999937	23.9999999995969	0.713264571516467	0.833353755965109	nan
sp|O60826|CCD22_HUMAN	metaplastic breast carcinomas-Normal	-0.172851569868699	0.338680989894547	24.0000000000398	0.614456681224361	0.768460709404808	nan
sp|O60826|CCD22_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.156979018502943	0.338680989894547	24.0000000000398	0.64718129258256	0.943315325604231	nan
sp|O60826|CCD22_HUMAN	Normal-Triple-negative breast cancer	0.329830588371642	0.404801208559656	24.0000000000597	0.423200856942216	0.609359032919309	nan
sp|O60832|DKC1_HUMAN	metaplastic breast carcinomas-Normal	0.812901192140222	0.211814383793559	23.9999999995423	0.0007930458448557	0.022622527118123	nan
sp|O60832|DKC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.106553811755271	0.211814383793559	23.9999999995423	0.619512737949649	0.941374262616245	nan
sp|O60832|DKC1_HUMAN	Normal-Triple-negative breast cancer	-0.919455003895493	0.253166611378597	23.99999999956	0.0013281201725503	0.0266490250684039	nan
sp|O60841|IF2P_HUMAN	metaplastic breast carcinomas-Normal	0.347599661536587	0.182090890349785	24.0000000001905	0.0682983693827094	0.202338484695299	nan
sp|O60841|IF2P_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.124459075332406	0.182090890349785	24.0000000001444	0.500837249776861	0.913320451076758	nan
sp|O60841|IF2P_HUMAN	Normal-Triple-negative breast cancer	-0.223140586204181	0.217640241645235	24.0000000001505	0.315458098608642	0.508527022199382	nan
sp|O60884|DNJA2_HUMAN	metaplastic breast carcinomas-Normal	0.553573676393161	0.17577854628874	20.9991968807258	0.0048402895711339	0.046770705042004	nan
sp|O60884|DNJA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0047779702306006	0.17577854628874	20.9991968818182	0.978571430082053	0.99709406933403	nan
sp|O60884|DNJA2_HUMAN	Normal-Triple-negative breast cancer	-0.54879570616256	0.207880458253421	20.9688342061683	0.015323642797658	0.0787156648560068	nan
sp|O60885|BRD4_HUMAN	metaplastic breast carcinomas-Normal	0.30992767300847	0.294968046017182	21.9999999997344	0.304794375172298	0.512720902364735	nan
sp|O60885|BRD4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0760635737821088	0.276262886769669	21.9999999997092	0.785631809352304	0.962981271203673	nan
sp|O60885|BRD4_HUMAN	Normal-Triple-negative breast cancer	-0.233864099226362	0.342833226531092	21.9999999997075	0.502262887270441	0.677290806201601	nan
sp|O60888|CUTA_HUMAN	metaplastic breast carcinomas-Normal	0.357630253694581	0.237853554669914	23.9999999997077	0.145737520299036	0.322739185525647	nan
sp|O60888|CUTA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0535296575283672	0.237853554669914	23.9999999997077	0.823843267498951	0.965774701272009	nan
sp|O60888|CUTA_HUMAN	Normal-Triple-negative breast cancer	-0.411159911222948	0.284289373373364	23.9999999997304	0.161035106666479	0.330828612212222	nan
sp|O60934|NBN_HUMAN	metaplastic breast carcinomas-Normal	0.08572985989161	0.420752448178218	13.9999999998633	0.841477997111736	0.915277982513531	nan
sp|O60934|NBN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.357069246582561	0.420752448178218	13.9999999998633	0.410355394968888	0.885784822958391	nan
sp|O60934|NBN_HUMAN	Normal-Triple-negative breast cancer	-0.442799106474171	0.495098063919847	13.9999999998544	0.386243592914448	0.574697270746475	nan
sp|O60936|NOL3_HUMAN	metaplastic breast carcinomas-Normal	-1.50393311558161	0.376687373065386	14.0000000059628	0.0013354895016674	0.0271905743670284	nan
sp|O60936|NOL3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.123253282931579	0.376687373065386	14.0000000065116	0.748355353011321	0.954643368861838	nan
sp|O60936|NOL3_HUMAN	Normal-Triple-negative breast cancer	1.62718639851319	0.450227525062767	14.0000000063319	0.0028182884686699	0.0360167542953178	nan
sp|O75083|WDR1_HUMAN	metaplastic breast carcinomas-Normal	0.280173522175253	0.185879165133501	23.9999999997639	0.144787908247881	0.321923081616025	nan
sp|O75083|WDR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.184632623657325	0.185879165133501	23.9999999997625	0.330476493922106	0.870708670595089	nan
sp|O75083|WDR1_HUMAN	Normal-Triple-negative breast cancer	-0.464806145832578	0.222168096046752	23.9999999997821	0.0471807773087246	0.149218747644339	nan
sp|O75116|ROCK2_HUMAN	metaplastic breast carcinomas-Normal	-0.0465532196158127	0.132182311555033	24.0000000000128	0.727770010417071	0.849107586741433	nan
sp|O75116|ROCK2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.394110268442019	0.132182311555033	24.0000000002896	0.0064833095794028	0.519941801393686	nan
sp|O75116|ROCK2_HUMAN	Normal-Triple-negative breast cancer	0.440663488057832	0.157988080418527	24.0000000002222	0.0101807596148542	0.0642141270583974	nan
sp|O75122|CLAP2_HUMAN	metaplastic breast carcinomas-Normal	-0.719565812044206	0.963208962953871	14.0000000108454	0.46739501154094	0.658937327638352	nan
sp|O75122|CLAP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.07265782246073	0.963208962953871	14.0000000107005	0.284193192215944	0.867696529950794	nan
sp|O75122|CLAP2_HUMAN	Normal-Triple-negative breast cancer	1.79222363450494	1.15125490928978	14.0000000107843	0.141840292377578	0.304375165825092	nan
sp|O75131|CPNE3_HUMAN	metaplastic breast carcinomas-Normal	0.118929842610146	0.20143178032122	23.9999999994828	0.56042652037951	0.729102839037765	nan
sp|O75131|CPNE3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.322952364846965	0.20143178032122	23.9999999994828	0.121952742705637	0.823891816737944	nan
sp|O75131|CPNE3_HUMAN	Normal-Triple-negative breast cancer	0.204022522236819	0.240757026669082	23.9999999994647	0.405132488254242	0.594248116815048	nan
sp|O75151|PHF2_HUMAN	metaplastic breast carcinomas-Normal	0.0335330126212815	0.518230861758794	13.3432061574753	0.949366927143854	0.973761239736425	nan
sp|O75151|PHF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.556485059467009	0.465491844447543	12.9999983707827	0.253252956184741	0.855758210685228	nan
sp|O75151|PHF2_HUMAN	Normal-Triple-negative breast cancer	-0.590018072088291	0.601188175234957	13.260684293062	0.343953145305888	0.536005745427459	nan
sp|O75152|ZC11A_HUMAN	metaplastic breast carcinomas-Normal	-0.199808230210736	0.22548270560684	22.0000000040531	0.385128615676953	0.589673888540711	nan
sp|O75152|ZC11A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.122900023887637	0.22548270560684	22.0000000037768	0.591200439982549	0.940559810632461	nan
sp|O75152|ZC11A_HUMAN	Normal-Triple-negative breast cancer	0.322708254098373	0.26950338065142	22.0000000037594	0.243886670205583	0.431671614357485	nan
sp|O75153|CLU_HUMAN	metaplastic breast carcinomas-Normal	0.121742499038683	0.206680707383676	23.9999999998998	0.561340698876818	0.729720955442527	nan
sp|O75153|CLU_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.256174508914374	0.206680707383676	23.9999999999368	0.227155488570447	0.843662073010871	nan
sp|O75153|CLU_HUMAN	Normal-Triple-negative breast cancer	-0.377917007953056	0.24703069446244	23.9999999999428	0.139131768589276	0.301089842962729	nan
sp|O75165|DJC13_HUMAN	metaplastic breast carcinomas-Normal	-0.244383342104753	0.589170269736264	14.9999999996983	0.684165500541082	0.815405566080516	nan
sp|O75165|DJC13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.496720999652151	0.589170269736264	14.9999999996756	0.412423148707576	0.885784822958391	nan
sp|O75165|DJC13_HUMAN	Normal-Triple-negative breast cancer	0.741104341756904	0.704193162158044	14.9999999996925	0.309267800650439	0.501711161230873	nan
sp|O75167|PHAR2_HUMAN	metaplastic breast carcinomas-Normal	-0.043842202470497	0.495595103588879	14.9999999996061	0.930678376676539	0.962231702666505	nan
sp|O75167|PHAR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.575921026506444	0.495595103588878	14.9999999996222	0.263360163957874	0.86431258289795	nan
sp|O75167|PHAR2_HUMAN	Normal-Triple-negative breast cancer	-0.532078824035947	0.59234944645547	14.999999999619	0.383243651882219	0.571256456886322	nan
sp|O75173|ATS4_HUMAN	metaplastic breast carcinomas-Normal	-0.812984157663956	0.563086661656748	13.0273423547339	0.172411498355127	0.360525616455081	nan
sp|O75173|ATS4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.038230741021549	0.563086661656748	13.0273423547339	0.946900276567545	0.996541950781621	nan
sp|O75173|ATS4_HUMAN	Normal-Triple-negative breast cancer	0.851214898685505	0.662262475500609	12.9999999998846	0.221109451435021	0.404151514984296	nan
sp|O75175|CNOT3_HUMAN	metaplastic breast carcinomas-Normal	-0.14956506938279	0.321261941269517	22.9999999998312	0.645912456475197	0.790158386910385	nan
sp|O75175|CNOT3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0183306101828604	0.321261941269517	22.9999999998312	0.954991683822961	0.99696934025474	nan
sp|O75175|CNOT3_HUMAN	Normal-Triple-negative breast cancer	0.167895679565651	0.380122255164785	22.999999999861	0.662839408585524	0.800900260550763	nan
sp|O75190|DNJB6_HUMAN	metaplastic breast carcinomas-Normal	-0.926983559282033	0.344346841787546	21.9999995748119	0.0133152351345986	0.077107737957153	nan
sp|O75190|DNJB6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.411299827838602	0.344346841787546	21.9999995739893	0.245027332362277	0.84964799869723	nan
sp|O75190|DNJB6_HUMAN	Normal-Triple-negative breast cancer	1.33828338712064	0.411573196838419	21.9999995732554	0.0036580235307907	0.0400819560687694	nan
sp|O75223|GGCT_HUMAN	metaplastic breast carcinomas-Normal	-0.0625887836093866	0.272096246046009	23.9999999991361	0.820022071289651	0.905265149440983	nan
sp|O75223|GGCT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.780275709746748	0.272096246046009	23.9999999988747	0.0084800177222668	0.547668704418496	nan
sp|O75223|GGCT_HUMAN	Normal-Triple-negative breast cancer	-0.717686926137361	0.32521721776668	23.9999999989989	0.0371406036964832	0.12835519121726	nan
sp|O75306|NDUS2_HUMAN	metaplastic breast carcinomas-Normal	0.281341009568164	0.213949034221771	22.0000000252755	0.20205579761028	0.395079844022346	nan
sp|O75306|NDUS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.298837117998069	0.213949034221771	22.0000000265952	0.176415778313353	0.843662073010871	nan
sp|O75306|NDUS2_HUMAN	Normal-Triple-negative breast cancer	-0.580178127566233	0.255718006641324	22.0000000261869	0.0334361207088826	0.123080470915089	nan
sp|O75339|CILP1_HUMAN	metaplastic breast carcinomas-Normal	-0.0468517688880324	0.340787678889974	22.0000000384859	0.891901251611918	0.94150288514576	nan
sp|O75339|CILP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.420822449517902	0.340787678889974	22.0000000378813	0.229912149918536	0.843662073010871	nan
sp|O75339|CILP1_HUMAN	Normal-Triple-negative breast cancer	-0.373970680629869	0.407319183517959	22.0000000377669	0.368509176190695	0.558815922289174	nan
sp|O75340|PDCD6_HUMAN	metaplastic breast carcinomas-Normal	0.409711151225077	0.245802988028642	21.999999597402	0.109723733073562	0.271560045936216	nan
sp|O75340|PDCD6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.210786882406247	0.245802988028642	21.999999597402	0.400390132476369	0.885297496092956	nan
sp|O75340|PDCD6_HUMAN	Normal-Triple-negative breast cancer	-0.620498033631324	0.293790763551712	21.9999995979489	0.0462684812917786	0.14773912758297	nan
sp|O75348|VATG1_HUMAN	metaplastic breast carcinomas-Normal	0.510922679801957	0.27165407983134	21.9999991722139	0.0733044575956042	0.211185923021356	nan
sp|O75348|VATG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.161661216217649	0.27165407983134	21.9999991719819	0.557849136508451	0.932084612507839	nan
sp|O75348|VATG1_HUMAN	Normal-Triple-negative breast cancer	-0.349261463584308	0.324688728056827	21.9999991722757	0.293725744345686	0.486676821835238	nan
sp|O75351|VPS4B_HUMAN	metaplastic breast carcinomas-Normal	0.215286840388676	0.986765889382602	19.957185611406	0.829508819555856	0.909492232445857	nan
sp|O75351|VPS4B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.61513549580442	0.843094077824859	18.3403692091497	0.0711233440909662	0.7829758433102	nan
sp|O75351|VPS4B_HUMAN	Normal-Triple-negative breast cancer	1.39984865541574	1.1239053738344	20.0237774883162	0.22731815265497	0.410241843815848	nan
sp|O75367|H2AY_HUMAN	metaplastic breast carcinomas-Normal	0.613071525044615	0.225430006324797	21.9999969852171	0.0125161523935194	0.0734259802638074	nan
sp|O75367|H2AY_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.571321885817773	0.225430006324797	21.9999969856382	0.018890993598353	0.674062840112479	nan
sp|O75367|H2AY_HUMAN	Normal-Triple-negative breast cancer	-1.18439341086239	0.269440392961831	21.9999969855888	0.000229458059677	0.0227914720285933	nan
sp|O75368|SH3L1_HUMAN	metaplastic breast carcinomas-Normal	-0.0472729629339673	0.346704036956559	22.0000000288378	0.892784925986593	0.94150288514576	nan
sp|O75368|SH3L1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.178371003803055	0.346704036956559	22.0000000281246	0.612048985950132	0.94077736515583	nan
sp|O75368|SH3L1_HUMAN	Normal-Triple-negative breast cancer	0.225643966737022	0.414390583942208	22.0000000281383	0.591560845048753	0.74587811099687	nan
sp|O75369|FLNB_HUMAN	metaplastic breast carcinomas-Normal	0.59584177783318	0.348898497112227	21.9999999775754	0.101752063018406	0.258186150742887	nan
sp|O75369|FLNB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.211770354108265	0.348898497112227	21.9999999775827	0.550085393217053	0.931124086486988	nan
sp|O75369|FLNB_HUMAN	Normal-Triple-negative breast cancer	-0.807612131941445	0.417013465502307	21.9999999783569	0.0657358500379971	0.185885115818525	nan
sp|O75376|NCOR1_HUMAN	metaplastic breast carcinomas-Normal	0.296655326442361	0.319702660740921	10.000616704537	0.375306748204651	0.582483472587307	nan
sp|O75376|NCOR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.385002958886456	0.295485658259813	10.0145782212139	0.221753705593688	0.843662073010871	nan
sp|O75376|NCOR1_HUMAN	Normal-Triple-negative breast cancer	0.0883476324440958	0.35623486842998	10.0060768399437	0.809146692820214	0.889691111555245	nan
sp|O75390|CISY_HUMAN	metaplastic breast carcinomas-Normal	-0.160284809127639	0.246778942230422	24.0000000000554	0.522178561178414	0.702436882783103	nan
sp|O75390|CISY_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.13365476690765	0.246778942230422	24.0000000000554	0.593088900334665	0.940559810632461	nan
sp|O75390|CISY_HUMAN	Normal-Triple-negative breast cancer	0.0266300422199895	0.29495725193508	24.0000000000633	0.928810480577547	0.960426544797288	nan
sp|O75391|SPAG7_HUMAN	metaplastic breast carcinomas-Normal	0.765896356652682	0.468638171628265	13.999999997171	0.124473223440025	0.295324050474406	nan
sp|O75391|SPAG7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.126335507240554	0.468638171628265	13.9999999973939	0.791416031866872	0.963198501448518	nan
sp|O75391|SPAG7_HUMAN	Normal-Triple-negative breast cancer	-0.639560849412128	0.560129750156264	13.9999999972666	0.272687390842082	0.463995415682386	nan
sp|O75396|SC22B_HUMAN	metaplastic breast carcinomas-Normal	0.316374348555339	0.209279944140959	23.9999999996199	0.143659767418689	0.319842643603298	nan
sp|O75396|SC22B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0202018621348695	0.209279944140959	23.9999999996199	0.923900951672906	0.994508979919649	nan
sp|O75396|SC22B_HUMAN	Normal-Triple-negative breast cancer	-0.336576210690209	0.250137376597178	23.999999999618	0.191018275251513	0.371902303309095	nan
sp|O75400|PR40A_HUMAN	metaplastic breast carcinomas-Normal	0.656633063213914	0.201670017532096	22.0000003495676	0.0036205983188246	0.0407324763980233	nan
sp|O75400|PR40A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.209204628409588	0.201670017532096	22.0000003502704	0.310835715584737	0.867696529950794	nan
sp|O75400|PR40A_HUMAN	Normal-Triple-negative breast cancer	-0.865837691623502	0.24104177459933	22.000000349679	0.001622201078064	0.0283781197026415	nan
sp|O75410|TACC1_HUMAN	metaplastic breast carcinomas-Normal	0.0032284679493282	0.301378835153639	23.9999999994932	0.991541515767616	0.995007502963874	nan
sp|O75410|TACC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.522345089093189	0.301378835153639	23.9999999994922	0.0958947602764813	0.814943337126966	nan
sp|O75410|TACC1_HUMAN	Normal-Triple-negative breast cancer	0.519116621143861	0.360216606023504	23.9999999995102	0.162470762679808	0.332141436375708	nan
sp|O75427|LRCH4_HUMAN	metaplastic breast carcinomas-Normal	-0.0377364501081423	0.27094603128322	21.9999999977403	0.890498689350108	0.94150288514576	nan
sp|O75427|LRCH4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.288583100100133	0.27094603128322	21.9999999986365	0.298383806689831	0.867696529950794	nan
sp|O75427|LRCH4_HUMAN	Normal-Triple-negative breast cancer	0.326319550208275	0.323842448175316	21.9999999987231	0.32457794327035	0.516465813035253	nan
sp|O75436|VP26A_HUMAN	metaplastic breast carcinomas-Normal	-0.119654275301114	0.159911051655498	22.0000000072599	0.462231030551362	0.654925807993489	nan
sp|O75436|VP26A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0050068489120693	0.159911051655498	22.0000000067077	0.975304466026968	0.99709406933403	nan
sp|O75436|VP26A_HUMAN	Normal-Triple-negative breast cancer	0.124661124213183	0.191130263887402	22.0000000069862	0.521009074306344	0.693288295834382	nan
sp|O75439|MPPB_HUMAN	metaplastic breast carcinomas-Normal	0.312973978501383	0.233859220059605	24.0000000001437	0.193340277222504	0.386624153804669	nan
sp|O75439|MPPB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.474764968170018	0.233859220059605	24.0000000001437	0.0535675157946782	0.773286317778246	nan
sp|O75439|MPPB_HUMAN	Normal-Triple-negative breast cancer	-0.787738946671401	0.279515230371868	24.0000000001544	0.009517027005699	0.0620286230724387	nan
sp|O75475|PSIP1_HUMAN	metaplastic breast carcinomas-Normal	0.268394067242988	0.429911974700445	23.9999999998388	0.538320433911274	0.713752342369794	nan
sp|O75475|PSIP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.335747017396498	0.429911974700445	23.9999999996294	0.442457697053699	0.89755436380139	nan
sp|O75475|PSIP1_HUMAN	Normal-Triple-negative breast cancer	-0.604141084639487	0.513843091657416	23.999999999736	0.251234399003107	0.440317118741841	nan
sp|O75487|GPC4_HUMAN	metaplastic breast carcinomas-Normal	-0.168272398177567	0.52496392191364	14.9999999997384	0.752980401453224	0.864263416585124	nan
sp|O75487|GPC4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.456919696886338	0.524963921913639	14.9999999997106	0.397806612988448	0.885297496092956	nan
sp|O75487|GPC4_HUMAN	Normal-Triple-negative breast cancer	0.625192095063905	0.627451898339569	14.9999999996998	0.334859600301427	0.527629667552129	nan
sp|O75489|NDUS3_HUMAN	metaplastic breast carcinomas-Normal	0.16341500332496	0.147328316555326	23.9999999996837	0.278339744877091	0.481624837049167	nan
sp|O75489|NDUS3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.262056687616783	0.147328316555326	23.9999999997201	0.0879560202733908	0.809016644110817	nan
sp|O75489|NDUS3_HUMAN	Normal-Triple-negative breast cancer	-0.425471690941743	0.176091018912	23.9999999996799	0.0236545003017297	0.102137084892028	nan
sp|O75506|HSBP1_HUMAN	metaplastic breast carcinomas-Normal	0.761763199939788	0.631537785917007	14.0000000162746	0.247728020680294	0.447282966182128	nan
sp|O75506|HSBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0036011476724538	0.631537785917007	14.0000000161465	0.99553079344796	0.998185231446144	nan
sp|O75506|HSBP1_HUMAN	Normal-Triple-negative breast cancer	-0.765364347612241	0.754832029603706	14.0000000163414	0.327808992687861	0.520361552862679	nan
sp|O75531|BAF_HUMAN	metaplastic breast carcinomas-Normal	0.126011718383239	0.358869647496333	14.9999999994031	0.730370217113253	0.850350473444642	nan
sp|O75531|BAF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.169203780681379	0.358869647496333	14.9999999994031	0.644074937582996	0.941868024951375	nan
sp|O75531|BAF_HUMAN	Normal-Triple-negative breast cancer	-0.295215499064618	0.428931269709367	14.9999999993891	0.501796302939929	0.676936246336171	nan
sp|O75533|SF3B1_HUMAN	metaplastic breast carcinomas-Normal	0.765373614021138	0.192587760356625	22.0000017769048	0.0006423528777784	0.021351809657355	nan
sp|O75533|SF3B1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.182697331960856	0.192587760356625	22.0000017758324	0.353106588471244	0.878144657192885	nan
sp|O75533|SF3B1_HUMAN	Normal-Triple-negative breast cancer	-0.948070945981994	0.230186400985874	22.0000017763096	0.0004514943524401	0.0237592699893802	nan
sp|O75534|CSDE1_HUMAN	metaplastic breast carcinomas-Normal	0.182112031076987	0.173288829628391	21.9999999951874	0.30470451052679	0.512720902364735	nan
sp|O75534|CSDE1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.232675748138824	0.173288829628391	21.9999999951936	0.193058376476896	0.843662073010871	nan
sp|O75534|CSDE1_HUMAN	Normal-Triple-negative breast cancer	0.0505637170618367	0.207119766849927	21.9999999950519	0.809394079826432	0.889691111555245	nan
sp|O75569|PRKRA_HUMAN	metaplastic breast carcinomas-Normal	0.4434902965757	0.334013982519529	19.4148485924094	0.199658261381067	0.392933132522596	nan
sp|O75569|PRKRA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.466996620348513	0.28607950143358	18.0135476233698	0.119952496572711	0.823891816737944	nan
sp|O75569|PRKRA_HUMAN	Normal-Triple-negative breast cancer	-0.910486916924213	0.376783943444883	19.3053785461756	0.0257276254992654	0.106898283949448	nan
sp|O75592|MYCB2_HUMAN	metaplastic breast carcinomas-Normal	-0.416241774836221	0.483359077224665	22.0000000206151	0.398447394496146	0.601923998636815	nan
sp|O75592|MYCB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.488551025020153	0.483359077224665	22.0000000212704	0.323128278031731	0.867696529950794	nan
sp|O75592|MYCB2_HUMAN	Normal-Triple-negative breast cancer	0.904792799856374	0.577724597680393	22.0000000207109	0.131589672037552	0.290248221534721	nan
sp|O75608|LYPA1_HUMAN	metaplastic breast carcinomas-Normal	0.237116070399362	0.295866753644106	22.0000000050436	0.431454960180978	0.628189350697139	nan
sp|O75608|LYPA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.359492540239745	0.295866753644106	22.0000000040406	0.237227351989145	0.84876230490475	nan
sp|O75608|LYPA1_HUMAN	Normal-Triple-negative breast cancer	-0.596608610639106	0.353628408506326	22.0000000043575	0.105712624984635	0.25135104824673	nan
sp|O75629|CREG1_HUMAN	metaplastic breast carcinomas-Normal	-0.457422167730972	0.266412373516498	14.9999999995486	0.106555182915706	0.266508222732737	nan
sp|O75629|CREG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0117475107337671	0.266412373516498	14.9999999997172	0.965410162895529	0.99709406933403	nan
sp|O75629|CREG1_HUMAN	Normal-Triple-negative breast cancer	0.46916967846474	0.318423690707599	14.9999999995919	0.161313888816931	0.331094248668141	nan
sp|O75643|U520_HUMAN	metaplastic breast carcinomas-Normal	0.472313482105554	0.195523677791901	23.9999999997202	0.0236841219150381	0.107110232987193	nan
sp|O75643|U520_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.316767647301955	0.195523677791901	23.999999999719	0.118277959412201	0.823891816737944	nan
sp|O75643|U520_HUMAN	Normal-Triple-negative breast cancer	-0.789081129407509	0.23369549349916	23.9999999998096	0.0024974473231535	0.0337628805562287	nan
sp|O75683|SURF6_HUMAN	metaplastic breast carcinomas-Normal	-0.516836728956038	0.318836693664738	13.999999989829	0.127313524936192	0.298259002112784	nan
sp|O75683|SURF6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.347231852590702	0.318836693664738	13.9999999898291	0.29452013219696	0.867696529950794	nan
sp|O75683|SURF6_HUMAN	Normal-Triple-negative breast cancer	0.169604876365336	0.381082737973681	13.9999999902026	0.66307987877127	0.800900260550763	nan
sp|O75688|PPM1B_HUMAN	metaplastic breast carcinomas-Normal	-0.148440321602787	0.221188121701807	14.0000000100695	0.513075035828256	0.696106701670662	nan
sp|O75688|PPM1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.544668756981473	0.221188121701807	14.0000000099512	0.0273787673799036	0.721684569712558	nan
sp|O75688|PPM1B_HUMAN	Normal-Triple-negative breast cancer	0.693109078584261	0.264370371102938	14.0000000099406	0.0201078469020016	0.0928312265309073	nan
sp|O75691|UTP20_HUMAN	metaplastic breast carcinomas-Normal	0.0205914072572611	0.141028157709592	21.9999999985448	0.885243733285452	0.940412326443222	nan
sp|O75691|UTP20_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.009657072573357	0.141028157709592	21.9999999985482	0.946025134898748	0.996541950781621	nan
sp|O75691|UTP20_HUMAN	Normal-Triple-negative breast cancer	-0.0302484798306182	0.168560888816227	21.9999999990338	0.85922582433164	0.919761424425117	nan
sp|O75694|NU155_HUMAN	metaplastic breast carcinomas-Normal	0.596882121206274	0.209414908125622	23.9999999991831	0.0088324857339837	0.061808805431078	nan
sp|O75694|NU155_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.246124671568247	0.209414908125622	23.9999999994026	0.25140456935404	0.85518059866034	nan
sp|O75694|NU155_HUMAN	Normal-Triple-negative breast cancer	-0.843006792774522	0.250298689412877	23.9999999992783	0.0025502740786239	0.0341818993441375	nan
sp|O75718|CRTAP_HUMAN	metaplastic breast carcinomas-Normal	1.00052153166604	0.286188717092685	23.9999999991326	0.0018605889615293	0.0307691428264859	nan
sp|O75718|CRTAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.94610647760956	0.286188717092685	23.9999999993291	0.0029689577284678	0.448717474870704	nan
sp|O75718|CRTAP_HUMAN	Normal-Triple-negative breast cancer	-0.0544150540564767	0.342060942337884	23.9999999992129	0.874936974596177	0.927684371150779	nan
sp|O75746|S2512_HUMAN	metaplastic breast carcinomas-Normal	-0.327691178982755	0.299781726301278	21.9999999576443	0.286175614814893	0.489828910218694	nan
sp|O75746|S2512_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.195127170989696	0.299781726301278	21.999999957612	0.52185360644705	0.917607105199968	nan
sp|O75746|S2512_HUMAN	Normal-Triple-negative breast cancer	0.522818349972451	0.35830769583094	21.9999999576624	0.158660250169127	0.328385225132115	nan
sp|O75781|PALM_HUMAN	metaplastic breast carcinomas-Normal	-2.36025484054118	0.571872501645752	14.9999999997959	0.0008954441906176	0.0227210419054423	nan
sp|O75781|PALM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.257988159466319	0.571872501645752	14.9999999997717	0.658350045239937	0.944190045212043	nan
sp|O75781|PALM_HUMAN	Normal-Triple-negative breast cancer	2.10226668107486	0.683518374858633	14.9999999997802	0.0076901771634034	0.0555698888938111	nan
sp|O75822|EIF3J_HUMAN	metaplastic breast carcinomas-Normal	0.615831056091938	0.339562563837502	23.999999999655	0.0822638010493598	0.22768099474444	nan
sp|O75822|EIF3J_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0879415462904012	0.339562563837502	23.999999999655	0.797855355984526	0.965774701272009	nan
sp|O75822|EIF3J_HUMAN	Normal-Triple-negative breast cancer	-0.703772602382339	0.405854890957519	23.9999999996435	0.0957383880677068	0.237311261698029	nan
sp|O75828|CBR3_HUMAN	metaplastic breast carcinomas-Normal	-0.935278460464791	0.4365888638069	14.9999999998421	0.0489896363107851	0.167461202844699	nan
sp|O75828|CBR3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.722369122648682	0.4365888638069	14.9999999998628	0.118778556967838	0.823891816737944	nan
sp|O75828|CBR3_HUMAN	Normal-Triple-negative breast cancer	0.212909337816109	0.521823500538805	14.9999999998511	0.689030578620476	0.817102263051895	nan
sp|O75832|PSD10_HUMAN	metaplastic breast carcinomas-Normal	0.144146729008816	0.295300190388229	24.0000000001007	0.629883422555941	0.778515442309366	nan
sp|O75832|PSD10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0086742259136054	0.295300190388229	24.0000000003226	0.976809003192522	0.99709406933403	nan
sp|O75832|PSD10_HUMAN	Normal-Triple-negative breast cancer	-0.135472503095211	0.352951235893904	24.0000000002098	0.704485471147129	0.826751679625131	nan
sp|O75874|IDHC_HUMAN	metaplastic breast carcinomas-Normal	-0.573888261142875	0.247155218071735	21.9999999845922	0.0298846434097846	0.124170693367655	nan
sp|O75874|IDHC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.301639644324362	0.247155218071735	21.9999999847733	0.235216381115447	0.84876230490475	nan
sp|O75874|IDHC_HUMAN	Normal-Triple-negative breast cancer	0.272248616818513	0.295406987585619	21.9999999844347	0.366731347102743	0.55713665345956	nan
sp|O75880|SCO1_HUMAN	metaplastic breast carcinomas-Normal	0.349698816534737	0.310051368102488	23.9999999999699	0.270522865174084	0.472716075635733	nan
sp|O75880|SCO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0155668280632455	0.310051368102488	24.0000000002041	0.960372751256408	0.99709406933403	nan
sp|O75880|SCO1_HUMAN	Normal-Triple-negative breast cancer	-0.365265644597983	0.370582265519363	24.0000000001053	0.334136465978355	0.526883118079721	nan
sp|O75881|CP7B1_HUMAN	metaplastic breast carcinomas-Normal	-0.14796492264744	0.506894012528625	24.0000000004351	0.772867585582516	0.877095204669268	nan
sp|O75881|CP7B1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.721930229343729	0.506894012528625	24.0000000001831	0.167255178389044	0.843662073010871	nan
sp|O75881|CP7B1_HUMAN	Normal-Triple-negative breast cancer	0.869895151991168	0.60585422567452	24.0000000002638	0.16396135773402	0.334155458680493	nan
sp|O75882|ATRN_HUMAN	metaplastic breast carcinomas-Normal	-0.468646069632928	0.286633316214938	14.0000000417426	0.124325208930435	0.295324050474406	nan
sp|O75882|ATRN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.384505914304228	0.286633316214938	14.0000000414712	0.201128666392281	0.843662073010871	nan
sp|O75882|ATRN_HUMAN	Normal-Triple-negative breast cancer	0.853151983937156	0.342592339928486	14.000000041846	0.0259490495742495	0.10728189152339	nan
sp|O75884|RBBP9_HUMAN	metaplastic breast carcinomas-Normal	-0.777933831334065	0.515596702827372	21.9999999985153	0.145577515702887	0.322739185525647	nan
sp|O75884|RBBP9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.52791555252922	0.515596702827372	21.9999999989538	0.317013547932155	0.867696529950794	nan
sp|O75884|RBBP9_HUMAN	Normal-Triple-negative breast cancer	1.30584938386328	0.616255930097758	21.9999999978673	0.0456152701696873	0.146557555889407	nan
sp|O75911|DHRS3_HUMAN	metaplastic breast carcinomas-Normal	0.337431909081887	0.458590669937137	14.9999999999352	0.473201100374113	0.663502989002024	nan
sp|O75911|DHRS3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.415052935159645	0.458590669937137	14.9999999998214	0.37974022567022	0.885234295852111	nan
sp|O75911|DHRS3_HUMAN	Normal-Triple-negative breast cancer	0.0776210260777574	0.548120688682692	14.9999999998752	0.889270123273306	0.934958409367033	nan
sp|O75915|PRAF3_HUMAN	metaplastic breast carcinomas-Normal	0.541974907800667	0.34099013801399	21.9999999460085	0.126235556916861	0.296587153261396	nan
sp|O75915|PRAF3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0857734336485715	0.34099013801399	21.9999999463488	0.803729672300948	0.965774701272009	nan
sp|O75915|PRAF3_HUMAN	Normal-Triple-negative breast cancer	-0.627748341449238	0.407561168455204	21.9999999442952	0.137759335734363	0.298880903219892	nan
sp|O75937|DNJC8_HUMAN	metaplastic breast carcinomas-Normal	0.286864548025503	0.175207095052104	22.0000036383618	0.115796033837987	0.280543743788241	nan
sp|O75937|DNJC8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.133057057089073	0.175207095052104	22.0000036383853	0.455657913277304	0.908567154037048	nan
sp|O75937|DNJC8_HUMAN	Normal-Triple-negative breast cancer	-0.419921605114576	0.209412532564646	22.0000036384469	0.0573935777747391	0.171407234971458	nan
sp|O75940|SPF30_HUMAN	metaplastic breast carcinomas-Normal	0.0843868943706795	0.555027100879075	14.9999999996258	0.881180711940609	0.938194966845158	nan
sp|O75940|SPF30_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.3561796466753	0.555027100879075	14.9999999996506	0.0273915790345068	0.721684569712558	nan
sp|O75940|SPF30_HUMAN	Normal-Triple-negative breast cancer	-1.44056654104598	0.663384269926597	14.9999999996447	0.0463406923976644	0.147827698205217	nan
sp|O75947|ATP5H_HUMAN	metaplastic breast carcinomas-Normal	0.163045575444996	0.205806268509733	22.0000000314328	0.436687353523378	0.632758833091416	nan
sp|O75947|ATP5H_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.207950069628974	0.205806268509733	22.0000000314315	0.323280327459528	0.867696529950794	nan
sp|O75947|ATP5H_HUMAN	Normal-Triple-negative breast cancer	-0.370995645073971	0.245985540103189	22.00000003199	0.145730611297152	0.310843727714765	nan
sp|O75955|FLOT1_HUMAN	metaplastic breast carcinomas-Normal	0.0280776264086131	0.23529329382482	22.0000000100212	0.906096635003601	0.949352873280001	nan
sp|O75955|FLOT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.173312858421894	0.23529329382482	22.0000000100183	0.469158903547939	0.911843360423993	nan
sp|O75955|FLOT1_HUMAN	Normal-Triple-negative breast cancer	-0.201390484830507	0.281229276363949	22.0000000101677	0.481457595221663	0.659944349079097	nan
sp|O75964|ATP5L_HUMAN	metaplastic breast carcinomas-Normal	0.189778001467106	0.206031883790189	22.0000000017249	0.366984169155526	0.576763772233082	nan
sp|O75964|ATP5L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.285764562809851	0.206031883790189	22.0000000006511	0.179337592752834	0.843662073010871	nan
sp|O75964|ATP5L_HUMAN	Normal-Triple-negative breast cancer	-0.475542564276957	0.246255201941093	22.0000000009815	0.0664569936521321	0.186338952556932	nan
sp|O75976|CBPD_HUMAN	metaplastic breast carcinomas-Normal	0.289738892389921	0.287711985158053	14.9999999997306	0.329882972752746	0.538565069064444	nan
sp|O75976|CBPD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.429236409504637	0.287711985158053	14.9999999997305	0.15645721705979	0.843465960034572	nan
sp|O75976|CBPD_HUMAN	Normal-Triple-negative breast cancer	0.139497517114716	0.343881595909298	14.9999999997405	0.690722948029149	0.817652915259381	nan
sp|O75995|SASH3_HUMAN	metaplastic breast carcinomas-Normal	0.597107790756797	0.436235293843759	22.0000000338906	0.184884905929852	0.376061820192366	nan
sp|O75995|SASH3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.275042518035619	0.436235293843759	22.0000000338897	0.534868377723758	0.921388505638487	nan
sp|O75995|SASH3_HUMAN	Normal-Triple-negative breast cancer	-0.322065272721178	0.521400903603457	22.0000000343012	0.543119889995883	0.708351060711974	nan
sp|O76003|GLRX3_HUMAN	metaplastic breast carcinomas-Normal	0.491569194271525	0.251000080086217	23.9999999993463	0.0618985267672403	0.191082946906634	nan
sp|O76003|GLRX3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.195681159044974	0.251000080086217	23.9999999996534	0.443243388078761	0.89755436380139	nan
sp|O76003|GLRX3_HUMAN	Normal-Triple-negative breast cancer	-0.295888035226551	0.300002476664271	23.9999999995841	0.333832683172073	0.526883118079721	nan
sp|O76021|RL1D1_HUMAN	metaplastic breast carcinomas-Normal	0.849161021255283	0.235353030565319	22.0000000058083	0.0015609702461679	0.0282214103166084	nan
sp|O76021|RL1D1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.122133833596888	0.235353030565319	22.0000000057176	0.608984579137364	0.940559810632461	nan
sp|O76021|RL1D1_HUMAN	Normal-Triple-negative breast cancer	-0.97129485485217	0.281300675425221	22.0000000052908	0.0022660937471014	0.0323283073620821	nan
sp|O76024|WFS1_HUMAN	metaplastic breast carcinomas-Normal	-0.246592310508003	0.21295405237906	22.0000041177242	0.259297269945124	0.461404777996569	nan
sp|O76024|WFS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.312404944303716	0.21295405237906	22.0000041176089	0.156524909795587	0.843465960034572	nan
sp|O76024|WFS1_HUMAN	Normal-Triple-negative breast cancer	0.558997254811719	0.254528775877148	22.0000041176637	0.0389119146599541	0.131848322456358	nan
sp|O76031|CLPX_HUMAN	metaplastic breast carcinomas-Normal	-0.519377771287656	0.278021766428249	24.0000000000771	0.0740023457949164	0.212421241297325	nan
sp|O76031|CLPX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.262275305087494	0.278021766428249	24.0000000000363	0.354895928757143	0.878877489703816	nan
sp|O76031|CLPX_HUMAN	Normal-Triple-negative breast cancer	0.257102466200161	0.332299569252727	24.0000000000399	0.446658835657543	0.630711117130702	nan
sp|O76041|NEBL_HUMAN	metaplastic breast carcinomas-Normal	-0.923320340363672	0.684736901908709	6.0	0.226191672317245	0.426225124026373	nan
sp|O76041|NEBL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.93536110168606	0.684736901908709	6.0	0.0300986255417554	0.721684569712558	nan
sp|O76041|NEBL_HUMAN	Normal-Triple-negative breast cancer	-1.01204076132239	0.818417135028287	6.0	0.262447922677249	0.453182802586585	nan
sp|O76070|SYUG_HUMAN	metaplastic breast carcinomas-Normal	-2.4596203058289	0.581827663195662	22.0000000023196	0.0003462271767805	0.0175553082899795	nan
sp|O76070|SYUG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.291411257592414	0.581827663195662	22.000000002527	0.621447435224844	0.941374262616245	nan
sp|O76070|SYUG_HUMAN	Normal-Triple-negative breast cancer	2.75103156342131	0.695417068753632	22.0000000018373	0.0006714887695747	0.0247210772633291	nan
sp|O76071|CIAO1_HUMAN	metaplastic breast carcinomas-Normal	0.0101902902289035	0.32870042385725	13.9999999996679	0.975705771212224	0.987405141699193	nan
sp|O76071|CIAO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.144741953014029	0.32870042385725	13.9999999996679	0.666409046143034	0.945962438897701	nan
sp|O76071|CIAO1_HUMAN	Normal-Triple-negative breast cancer	-0.154932243242932	0.386780740471001	13.9999999996696	0.694783771755823	0.820704071540994	nan
sp|O76094|SRP72_HUMAN	metaplastic breast carcinomas-Normal	0.617679614961002	0.189724621357154	21.9999999995987	0.0036232852194585	0.0407324763980233	nan
sp|O76094|SRP72_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.131997393644974	0.189724621357154	21.9999999994751	0.49388165140905	0.913320451076758	nan
sp|O76094|SRP72_HUMAN	Normal-Triple-negative breast cancer	-0.749677008605976	0.226764295341205	21.9999999996258	0.0032161590378251	0.0374460323751388	nan
sp|O94760|DDAH1_HUMAN	metaplastic breast carcinomas-Normal	-0.115803084672758	0.35491221871679	23.9999999997903	0.747035785042947	0.860108189651783	nan
sp|O94760|DDAH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.295475133800198	0.35491221871679	23.9999999997903	0.413317842758499	0.885784822958391	nan
sp|O94760|DDAH1_HUMAN	Normal-Triple-negative breast cancer	-0.17967204912744	0.424201237612653	23.9999999998107	0.675663051762719	0.809043221923371	nan
sp|O94776|MTA2_HUMAN	metaplastic breast carcinomas-Normal	0.722317114388113	0.209534288225201	22.0000000012847	0.002296778219461	0.0344046144412164	nan
sp|O94776|MTA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.339375762902017	0.209534288225201	22.0000000011135	0.119551215575969	0.823891816737944	nan
sp|O94776|MTA2_HUMAN	Normal-Triple-negative breast cancer	-1.06169287729013	0.250441375923279	22.0000000013521	0.0003363192027044	0.0227914720285933	nan
sp|O94804|STK10_HUMAN	metaplastic breast carcinomas-Normal	0.141964640017917	0.216140146279964	22.9999999996027	0.517816993531412	0.69968442540586	nan
sp|O94804|STK10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.267479388521306	0.202180593726707	22.9999999995605	0.198847668756211	0.843662073010871	nan
sp|O94804|STK10_HUMAN	Normal-Triple-negative breast cancer	0.12551474850339	0.253446787110521	22.9999999995754	0.625135247884448	0.773622324634365	nan
sp|O94826|TOM70_HUMAN	metaplastic breast carcinomas-Normal	0.367406619326441	0.205728964155849	21.9999999886412	0.0879119241314371	0.238449315103716	nan
sp|O94826|TOM70_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.071458206457028	0.205728964155849	21.9999999890049	0.731635694316744	0.954643368861838	nan
sp|O94826|TOM70_HUMAN	Normal-Triple-negative breast cancer	-0.438864825783469	0.245893143727801	21.9999999877478	0.0880947345743676	0.223702748453169	nan
sp|O94830|DDHD2_HUMAN	metaplastic breast carcinomas-Normal	-0.873824943959225	0.278886623878087	22.0000002834471	0.0048337122689113	0.046770705042004	nan
sp|O94830|DDHD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.440811243325858	0.278886623878087	22.0000002835454	0.128238429287728	0.823891816737944	nan
sp|O94830|DDHD2_HUMAN	Normal-Triple-negative breast cancer	0.433013700633367	0.33333327161977	22.0000002837087	0.207380112993275	0.389436459261568	nan
sp|O94832|MYO1D_HUMAN	metaplastic breast carcinomas-Normal	0.0240075106770077	0.357093453946234	22.0000000385459	0.947005606144135	0.972567428615729	nan
sp|O94832|MYO1D_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.29760450347782	0.357093453946234	22.0000000382831	0.413571899731667	0.885784822958391	nan
sp|O94832|MYO1D_HUMAN	Normal-Triple-negative breast cancer	-0.321612014154828	0.426808312362573	22.0000000381253	0.459121751820352	0.64122718615582	nan
sp|O94855|SC24D_HUMAN	metaplastic breast carcinomas-Normal	0.580505364670574	0.317873285576202	23.9999999992892	0.0802844492152485	0.224816118300932	nan
sp|O94855|SC24D_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.157577365845673	0.317873285576202	23.9999999992892	0.624598285076447	0.941374262616245	nan
sp|O94855|SC24D_HUMAN	Normal-Triple-negative breast cancer	-0.422927998824901	0.379931245063798	23.999999999316	0.276660904194183	0.468477251931463	nan
sp|O94874|UFL1_HUMAN	metaplastic breast carcinomas-Normal	0.269907071096329	0.262717607881132	21.9999999564275	0.315412209514989	0.522386738628711	nan
sp|O94874|UFL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.198609581739179	0.262717607881132	21.9999999573785	0.457679403914375	0.908567154037048	nan
sp|O94874|UFL1_HUMAN	Normal-Triple-negative breast cancer	-0.468516652835509	0.314007601115424	21.999999956696	0.149886571290291	0.317137468471627	nan
sp|O94875|SRBS2_HUMAN	metaplastic breast carcinomas-Normal	-0.220494976512218	0.353022980101027	23.9999999993669	0.53813261228124	0.713752342369794	nan
sp|O94875|SRBS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0490190822526884	0.353022980101027	23.9999999992125	0.890723136314682	0.98820634909787	nan
sp|O94875|SRBS2_HUMAN	Normal-Triple-negative breast cancer	0.17147589425953	0.421943165569234	23.9999999992825	0.688052997263585	0.816817201037199	nan
sp|O94880|PHF14_HUMAN	metaplastic breast carcinomas-Normal	0.768170331112393	0.250865934007265	22.0000000213847	0.0057087181241652	0.05017239027102	nan
sp|O94880|PHF14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.234442715251487	0.250865934007265	22.0000000223169	0.360173550618198	0.883542279876718	nan
sp|O94880|PHF14_HUMAN	Normal-Triple-negative breast cancer	-0.533727615860907	0.299842141432877	22.0000000217609	0.0888890930864683	0.22451925943725	nan
sp|O94886|CSCL1_HUMAN	metaplastic breast carcinomas-Normal	0.21987030160122	0.335358628788096	14.9999999996465	0.521993447590485	0.702436882783103	nan
sp|O94886|CSCL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.30249733702505	0.335358628788095	14.9999999996464	0.381306747038806	0.885234295852111	nan
sp|O94886|CSCL1_HUMAN	Normal-Triple-negative breast cancer	-0.522367638626269	0.400830227514685	14.999999999652	0.212151832858606	0.394844732599108	nan
sp|O94888|UBXN7_HUMAN	metaplastic breast carcinomas-Normal	0.298385324939439	0.41554361513393	14.0012058054595	0.484530433769886	0.674279512932043	nan
sp|O94888|UBXN7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.234406567003799	0.41554361513393	14.0012058030088	0.581612762968244	0.93702592209822	nan
sp|O94888|UBXN7_HUMAN	Normal-Triple-negative breast cancer	-0.0639787579356402	0.496669617234314	14.0012058004583	0.899335727763162	0.941085638149985	nan
sp|O94905|ERLN2_HUMAN	metaplastic breast carcinomas-Normal	0.170791246431164	0.349181388021094	23.9999999999701	0.629197755372623	0.778360007018459	nan
sp|O94905|ERLN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0623421763001095	0.349181388021094	23.9999999999701	0.859798965505762	0.979177437622147	nan
sp|O94905|ERLN2_HUMAN	Normal-Triple-negative breast cancer	-0.233133422731273	0.417351584809905	24.0000000000728	0.581608265059902	0.739128739543979	nan
sp|O94906|PRP6_HUMAN	metaplastic breast carcinomas-Normal	0.367015288220215	0.170248545563391	22.0000000058599	0.0423034245655649	0.152285044160049	nan
sp|O94906|PRP6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.134161130896206	0.170248545563391	22.0000000058599	0.439087485447716	0.89755436380139	nan
sp|O94906|PRP6_HUMAN	Normal-Triple-negative breast cancer	-0.501176419116421	0.203485932354935	22.000000005627	0.0220784664424164	0.0981133990034656	nan
sp|O94915|FRYL_HUMAN	metaplastic breast carcinomas-Normal	0.076811174876514	0.35683074731572	14.9999999995078	0.832464522287857	0.911133379020361	nan
sp|O94915|FRYL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.253269639034579	0.356830747315719	14.9999999996968	0.48873122221854	0.913320451076758	nan
sp|O94915|FRYL_HUMAN	Normal-Triple-negative breast cancer	0.176458464158065	0.42649431788192	14.9999999996043	0.684918291876491	0.814550412235226	nan
sp|O94919|ENDD1_HUMAN	metaplastic breast carcinomas-Normal	0.060114567990898	0.207218935135681	22.0000004922082	0.774455217271132	0.878247722709605	nan
sp|O94919|ENDD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.211666995091563	0.207218935135681	22.0000004926493	0.3181358216518	0.867696529950794	nan
sp|O94919|ENDD1_HUMAN	Normal-Triple-negative breast cancer	-0.271781563082461	0.247673999669974	22.0000004926455	0.284360589623385	0.476658900609244	nan
sp|O94925|GLSK_HUMAN	metaplastic breast carcinomas-Normal	0.573579069576398	0.392921993205185	22.0000000040751	0.158484143462699	0.341192547195604	nan
sp|O94925|GLSK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.187851569691869	0.392921993205185	22.0000000036979	0.637303487638053	0.941868024951375	nan
sp|O94925|GLSK_HUMAN	Normal-Triple-negative breast cancer	-0.761430639268267	0.469631607515532	22.0000000038112	0.119191213899336	0.27173634773758	nan
sp|O94973|AP2A2_HUMAN	metaplastic breast carcinomas-Normal	-0.110747592702609	0.237878529970285	22.0000001684624	0.646103842968272	0.790158386910385	nan
sp|O94973|AP2A2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0924529300223469	0.237878529970285	22.0000001686264	0.701266499042199	0.948544168045527	nan
sp|O94973|AP2A2_HUMAN	Normal-Triple-negative breast cancer	0.203200522724956	0.284319224566894	22.0000001683205	0.482315272725746	0.660575181928463	nan
sp|O94979|SC31A_HUMAN	metaplastic breast carcinomas-Normal	0.475563621658722	0.160365760712238	23.9999999995649	0.0067349672205595	0.0538149784642791	nan
sp|O94979|SC31A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0240656598952091	0.160365760712238	23.9999999995649	0.881965562087364	0.983709256883903	nan
sp|O94979|SC31A_HUMAN	Normal-Triple-negative breast cancer	-0.499629281553931	0.19167374516094	23.9999999995523	0.0154694665553306	0.079108472046029	nan
sp|O94985|CSTN1_HUMAN	metaplastic breast carcinomas-Normal	0.359575474345198	0.376332566761659	21.9999999856882	0.349720805314737	0.559356361662505	nan
sp|O94985|CSTN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.212381382369774	0.376332566761659	21.99999998619	0.5782283207193	0.936496920456468	nan
sp|O94985|CSTN1_HUMAN	Normal-Triple-negative breast cancer	-0.571956856714972	0.449803450417781	21.9999999860857	0.216804743470363	0.399196535995467	nan
sp|O95071|UBR5_HUMAN	metaplastic breast carcinomas-Normal	-0.0781346269070739	0.499492405524805	14.9999999995454	0.877781555053252	0.936676047832106	nan
sp|O95071|UBR5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.838039105054651	0.499492405524804	14.9999999995454	0.114097368201865	0.823891816737944	nan
sp|O95071|UBR5_HUMAN	Normal-Triple-negative breast cancer	-0.759904478147577	0.597007613228503	14.9999999994972	0.222444622626499	0.405153931841361	nan
sp|O95073|FSBP_HUMAN	metaplastic breast carcinomas-Normal	1.87380346151137	0.575024281838634	22.0000000024916	0.0035977748229792	0.0407324763980233	nan
sp|O95073|FSBP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.244542084975953	0.575024281838634	22.0000000034961	0.674768932717316	0.946386428913156	nan
sp|O95073|FSBP_HUMAN	Normal-Triple-negative breast cancer	-2.11834554648732	0.687285472715498	22.0000000033101	0.0054470663440629	0.0465451118963115	nan
sp|O95104|SCAF4_HUMAN	metaplastic breast carcinomas-Normal	0.0034027085693483	0.276615224411564	22.0000000274604	0.99029615575518	0.994484719555957	nan
sp|O95104|SCAF4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.614904114598022	0.276615224411564	22.0000000279656	0.0368060198654701	0.73123935744099	nan
sp|O95104|SCAF4_HUMAN	Normal-Triple-negative breast cancer	-0.618306823167371	0.330618429994155	22.0000000272764	0.0748280316984909	0.201226601118689	nan
sp|O95140|MFN2_HUMAN	metaplastic breast carcinomas-Normal	0.672391873430088	0.414554913941669	14.9999999998218	0.125637335174768	0.296183334837538	nan
sp|O95140|MFN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0534623248971433	0.414554913941669	14.9999999996818	0.899100088215283	0.989671989983163	nan
sp|O95140|MFN2_HUMAN	Normal-Triple-negative breast cancer	-0.618929548532945	0.49548789328324	14.9999999997159	0.230759204439425	0.413946894525984	nan
sp|O95155|UBE4B_HUMAN	metaplastic breast carcinomas-Normal	0.700360294671107	0.357053268105721	15.5895850096788	0.0679322358123147	0.201556426886126	nan
sp|O95155|UBE4B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.118690459384582	0.290097378078074	15.3301004288333	0.688095941155166	0.946568877415162	nan
sp|O95155|UBE4B_HUMAN	Normal-Triple-negative breast cancer	-0.819050754055689	0.403840352161471	15.5970359890057	0.0599798743574535	0.176436373773607	nan
sp|O95171|SCEL_HUMAN	metaplastic breast carcinomas-Normal	-2.29659537190846	0.793394193389327	11.9999999999486	0.01345949003467	0.0774037108568218	nan
sp|O95171|SCEL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.06867867128929	0.717652050087019	11.9999999999945	0.162257513876799	0.843662073010871	nan
sp|O95171|SCEL_HUMAN	Normal-Triple-negative breast cancer	1.22791670061917	0.895069364780519	11.9999999999374	0.195207939674385	0.376375401089127	nan
sp|O95182|NDUA7_HUMAN	metaplastic breast carcinomas-Normal	-0.0233128201884838	0.188289529638306	22.0000000073115	0.902587055865938	0.948229890549424	nan
sp|O95182|NDUA7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.092803191875899	0.188289529638306	22.0000000071253	0.626984445251076	0.941374262616245	nan
sp|O95182|NDUA7_HUMAN	Normal-Triple-negative breast cancer	-0.0694903716874151	0.225049032661819	22.0000000069333	0.760394873454168	0.862351606742291	nan
sp|O95197|RTN3_HUMAN	metaplastic breast carcinomas-Normal	-0.343309869037673	0.355546485443301	21.9999999801781	0.344747748630946	0.555436608392647	nan
sp|O95197|RTN3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.874037443368965	0.355546485443301	21.9999999806081	0.0223029860593936	0.712051972579798	nan
sp|O95197|RTN3_HUMAN	Normal-Triple-negative breast cancer	-0.530727574331292	0.424959331350127	21.9999999801944	0.224831450310595	0.407491679843194	nan
sp|O95202|LETM1_HUMAN	metaplastic breast carcinomas-Normal	0.354800401482661	0.350872224763325	22.0000000395747	0.32291578926743	0.530322175654614	nan
sp|O95202|LETM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0630013501137655	0.350872224763325	22.0000000395722	0.859144347568857	0.979177437622147	nan
sp|O95202|LETM1_HUMAN	Normal-Triple-negative breast cancer	-0.417801751596426	0.419372521257934	22.0000000395481	0.329958769303913	0.52266154812188	nan
sp|O95218|ZRAB2_HUMAN	metaplastic breast carcinomas-Normal	-0.475571462550269	0.504485419637345	6.0	0.382232546814171	0.588910193766839	nan
sp|O95218|ZRAB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.896988254801172	0.504485419637345	6.0	0.125719673470686	0.823891816737944	nan
sp|O95218|ZRAB2_HUMAN	Normal-Triple-negative breast cancer	-0.421416792250902	0.602975406542622	6.0	0.51078599353492	0.684342056634451	nan
sp|O95232|LC7L3_HUMAN	metaplastic breast carcinomas-Normal	0.93270232461543	0.238385368085302	23.9999999998309	0.0006569710116724	0.0214095259097961	nan
sp|O95232|LC7L3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.144557918372542	0.238385368085302	23.9999999998309	0.549939769927421	0.931124086486988	nan
sp|O95232|LC7L3_HUMAN	Normal-Triple-negative breast cancer	-1.07726024298797	0.284925011982263	23.9999999998679	0.0009149594654164	0.025773942907156	nan
sp|O95249|GOSR1_HUMAN	metaplastic breast carcinomas-Normal	0.478425159998786	0.262508110334228	23.9999999991214	0.0808607687632565	0.225298571139199	nan
sp|O95249|GOSR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0855671705403613	0.262508110334228	23.99999999912	0.747279696106578	0.954643368861838	nan
sp|O95249|GOSR1_HUMAN	Normal-Triple-negative breast cancer	-0.392857989458425	0.313757203653779	23.999999999156	0.222595720040556	0.405207104827387	nan
sp|O95251|KAT7_HUMAN	metaplastic breast carcinomas-Normal	-0.444548142126977	0.191022054958179	6.0	0.0588651958134088	0.18546721410784	nan
sp|O95251|KAT7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.352362985517017	0.191022054958179	6.0	0.114641870969595	0.823891816737944	nan
sp|O95251|KAT7_HUMAN	Normal-Triple-negative breast cancer	0.796911127643994	0.228315025099862	6.0	0.0129770115350734	0.0738623053811371	nan
sp|O95292|VAPB_HUMAN	metaplastic breast carcinomas-Normal	0.439029418681025	0.238355443816963	22.0000000016153	0.079010092031797	0.222567411791265	nan
sp|O95292|VAPB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0912022518671887	0.238355443816963	22.0000000009537	0.705664920811412	0.94948208919602	nan
sp|O95292|VAPB_HUMAN	Normal-Triple-negative breast cancer	-0.530231670548214	0.284889245640631	22.0000000013753	0.0761344584525614	0.203596894526399	nan
sp|O95297|MPZL1_HUMAN	metaplastic breast carcinomas-Normal	0.0927961791368787	0.26014605693213	14.9999999998597	0.726278577810628	0.848436527664973	nan
sp|O95297|MPZL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.560025154918311	0.260146056932129	14.9999999998897	0.0480253347788372	0.760401133998256	nan
sp|O95297|MPZL1_HUMAN	Normal-Triple-negative breast cancer	-0.65282133405519	0.310934009850815	14.9999999998541	0.0531002476826716	0.162439494536208	nan
sp|O95299|NDUAA_HUMAN	metaplastic breast carcinomas-Normal	-0.0988508151821646	0.179454303270514	21.9999999336363	0.587293413584214	0.746525165106665	nan
sp|O95299|NDUAA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.330675927322014	0.179454303270514	21.999999933996	0.078894301400395	0.806849600316436	nan
sp|O95299|NDUAA_HUMAN	Normal-Triple-negative breast cancer	-0.231825112139849	0.214488917337089	21.9999999326198	0.291481000385229	0.484683764522512	nan
sp|O95302|FKBP9_HUMAN	metaplastic breast carcinomas-Normal	0.720503285724236	0.333628996854492	21.9999923646519	0.0419709183408481	0.152285044160049	nan
sp|O95302|FKBP9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.398803873781455	0.333628996854492	21.9999923664935	0.244676461326512	0.84964799869723	nan
sp|O95302|FKBP9_HUMAN	Normal-Triple-negative breast cancer	-0.321699411942781	0.398762921944024	21.9999923682534	0.428449970791188	0.613865389185306	nan
sp|O95319|CELF2_HUMAN	metaplastic breast carcinomas-Normal	0.208640073040862	0.614891730641003	14.0000000095885	0.739410942153202	0.856078708365463	nan
sp|O95319|CELF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.372903832127055	0.614891730641003	14.0000000093343	0.553920357272073	0.931642387063667	nan
sp|O95319|CELF2_HUMAN	Normal-Triple-negative breast cancer	0.164263759086193	0.734936188105264	14.0000000091035	0.82636902875377	0.901307530611401	nan
sp|O95336|6PGL_HUMAN	metaplastic breast carcinomas-Normal	-0.158657396826308	0.231430986592768	23.9999999993083	0.499566226634647	0.685331464025409	nan
sp|O95336|6PGL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.416364492515075	0.231430986592768	23.9999999993083	0.084593014161859	0.806849600316436	nan
sp|O95336|6PGL_HUMAN	Normal-Triple-negative breast cancer	-0.257707095688768	0.276612936262161	23.9999999992668	0.360794207545488	0.55139307856607	nan
sp|O95340|PAPS2_HUMAN	metaplastic breast carcinomas-Normal	0.294337162145633	0.379989323249105	22.0000000057665	0.446825640530681	0.643243148169764	nan
sp|O95340|PAPS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.283810344154225	0.379989323249105	22.0000000046894	0.463037921543108	0.909423669537079	nan
sp|O95340|PAPS2_HUMAN	Normal-Triple-negative breast cancer	-0.0105268179914073	0.454174110388945	22.0000000049036	0.981717285337139	0.990658244219991	nan
sp|O95347|SMC2_HUMAN	metaplastic breast carcinomas-Normal	0.337801606782345	0.714425522299609	15.0000000000666	0.643141340589816	0.788835614259151	nan
sp|O95347|SMC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.497083672892157	0.714425522299609	15.0000000000666	0.49720548372837	0.913320451076758	nan
sp|O95347|SMC2_HUMAN	Normal-Triple-negative breast cancer	0.159282066109812	0.85390182349116	15.0000000000177	0.854525078658631	0.917158980129574	nan
sp|O95352|ATG7_HUMAN	metaplastic breast carcinomas-Normal	-0.316238681607257	0.258569428680987	22.0000000017719	0.234257545437487	0.434042408603237	nan
sp|O95352|ATG7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.221037844828163	0.258569428680987	22.0000000015499	0.401848421790607	0.885297496092956	nan
sp|O95352|ATG7_HUMAN	Normal-Triple-negative breast cancer	0.0952008367790948	0.309049578658765	22.0000000018703	0.760946561009543	0.862388806271981	nan
sp|O95361|TRI16_HUMAN	metaplastic breast carcinomas-Normal	0.0371572849249246	0.483445911692609	6.0	0.941234389603804	0.9699612974793	nan
sp|O95361|TRI16_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0036757970291971	0.483445911692609	6.0	0.994179981092763	0.998185231446144	nan
sp|O95361|TRI16_HUMAN	Normal-Triple-negative breast cancer	-0.0408330819541218	0.577828384720756	6.0	0.945959731088991	0.971784999424025	nan
sp|O95372|LYPA2_HUMAN	metaplastic breast carcinomas-Normal	0.399013470359329	0.203998352616282	23.9999999997758	0.0622058914260146	0.191455910277845	nan
sp|O95372|LYPA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.611093094271818	0.203998352616282	24.0000000000071	0.0062712574577198	0.519941801393686	nan
sp|O95372|LYPA2_HUMAN	Normal-Triple-negative breast cancer	-1.01010656463115	0.243824667304066	23.999999999853	0.0003671171991372	0.023652081242523	nan
sp|O95373|IPO7_HUMAN	metaplastic breast carcinomas-Normal	0.707376211208308	0.229989697479492	22.000002152274	0.0055303859636086	0.0493306383422313	nan
sp|O95373|IPO7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.17540475088545	0.229989697479492	22.0000021523098	0.453764463602855	0.908567154037048	nan
sp|O95373|IPO7_HUMAN	Normal-Triple-negative breast cancer	-0.531971460322858	0.274890266279652	22.0000021523689	0.0659223617213242	0.186173262839152	nan
sp|O95379|TFIP8_HUMAN	metaplastic breast carcinomas-Normal	0.0797724918177115	0.433009200377023	23.9999999995883	0.855382256129895	0.925247532247456	nan
sp|O95379|TFIP8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0052357759913258	0.433009200377023	23.9999999995883	0.990452484403987	0.998185231446144	nan
sp|O95379|TFIP8_HUMAN	Normal-Triple-negative breast cancer	-0.0745367158263856	0.517544984395627	23.9999999996174	0.886687353978119	0.934183443620687	nan
sp|O95394|AGM1_HUMAN	metaplastic breast carcinomas-Normal	0.258307880185161	0.155123111510518	22.0000003134562	0.110055190893407	0.271987698535081	nan
sp|O95394|AGM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.134031812441893	0.155123111510518	22.0000003128199	0.396891622272412	0.885234295852111	nan
sp|O95394|AGM1_HUMAN	Normal-Triple-negative breast cancer	-0.392339692627054	0.18540758084634	22.0000003127511	0.0458873742215873	0.146945695484158	nan
sp|O95400|CD2B2_HUMAN	metaplastic breast carcinomas-Normal	0.689891970568719	0.225730123094622	23.9999999995492	0.0054270667865423	0.0486241778934414	nan
sp|O95400|CD2B2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0309734787365439	0.225730123094622	23.9999999995492	0.892005775063616	0.988218752026376	nan
sp|O95400|CD2B2_HUMAN	Normal-Triple-negative breast cancer	-0.720865449305263	0.269799101111267	23.9999999995289	0.0133385133622959	0.0751323816978138	nan
sp|O95425|SVIL_HUMAN	metaplastic breast carcinomas-Normal	0.306570957271007	0.241243357114571	21.9999999406016	0.217075403700634	0.413975124441139	nan
sp|O95425|SVIL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.120864882590656	0.241243357114571	21.9999999406016	0.621341364777028	0.941374262616245	nan
sp|O95425|SVIL_HUMAN	Normal-Triple-negative breast cancer	-0.427435839861663	0.288340962235209	21.9999999396383	0.152418391700134	0.319961049040858	nan
sp|O95433|AHSA1_HUMAN	metaplastic breast carcinomas-Normal	0.112995160929374	0.32713746727458	21.9999931316077	0.733070172813658	0.851109065467202	nan
sp|O95433|AHSA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.426994994530473	0.32713746727458	21.9999931313851	0.205295923394195	0.843662073010871	nan
sp|O95433|AHSA1_HUMAN	Normal-Triple-negative breast cancer	-0.539990155459847	0.391004060071772	21.9999931321287	0.181136901314053	0.356693755905161	nan
sp|O95460|MATN4_HUMAN	metaplastic breast carcinomas-Normal	0.177825482913275	0.431406774647229	23.9999999997621	0.683852152824287	0.815324446193662	nan
sp|O95460|MATN4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.721486298599683	0.431406774647229	23.9999999997621	0.107432954810952	0.823891816737944	nan
sp|O95460|MATN4_HUMAN	Normal-Triple-negative breast cancer	0.543660815686408	0.515629719319043	23.9999999997398	0.30221624713587	0.494885030728624	nan
sp|O95466|FMNL1_HUMAN	metaplastic breast carcinomas-Normal	0.149940714568323	0.377757991653081	22.00000005543	0.695248789969635	0.82242241204949	nan
sp|O95466|FMNL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.381312191721103	0.377757991653081	22.0000000556248	0.323752501919205	0.867696529950794	nan
sp|O95466|FMNL1_HUMAN	Normal-Triple-negative breast cancer	0.231371477152779	0.451507159028465	22.0000000553853	0.613447949016913	0.763422307200381	nan
sp|O95470|SGPL1_HUMAN	metaplastic breast carcinomas-Normal	0.462904497571795	0.251801259853455	22.0000055399781	0.0795480944239842	0.223520471753462	nan
sp|O95470|SGPL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.232876080417087	0.251801259853455	22.0000055403268	0.365082727375953	0.883542279876718	nan
sp|O95470|SGPL1_HUMAN	Normal-Triple-negative breast cancer	-0.695780577988882	0.300960069643294	22.0000055401564	0.030531920289757	0.116921777699484	nan
sp|O95479|G6PE_HUMAN	metaplastic breast carcinomas-Normal	-0.557723429482978	0.206483789252964	22.0000000118207	0.013047764450195	0.0759305205783505	nan
sp|O95479|G6PE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.317693415173283	0.206483789252964	22.0000000116084	0.138165050200454	0.823891816737944	nan
sp|O95479|G6PE_HUMAN	Normal-Triple-negative breast cancer	0.240030014309695	0.246795332278916	22.0000000119938	0.341331412452476	0.533628126847083	nan
sp|O95486|SC24A_HUMAN	metaplastic breast carcinomas-Normal	0.0405263130448958	0.246603502471426	24.0000000001054	0.870841337218113	0.93286387525395	nan
sp|O95486|SC24A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.076282405298106	0.246603502471426	24.0000000001054	0.75973846581908	0.955228196959647	nan
sp|O95486|SC24A_HUMAN	Normal-Triple-negative breast cancer	-0.116808718343002	0.294747561315913	24.0000000000424	0.695384637956357	0.821122037856814	nan
sp|O95487|SC24B_HUMAN	metaplastic breast carcinomas-Normal	1.25504980084294	0.734022949580059	13.0033210871281	0.111037320645926	0.273601225965202	nan
sp|O95487|SC24B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.15590006937636	0.734022949580059	13.0033210873083	0.13932255764208	0.823891816737944	nan
sp|O95487|SC24B_HUMAN	Normal-Triple-negative breast cancer	-0.0991497314665803	0.862904713601502	13.0000002041734	0.910278346091432	0.948515743701542	nan
sp|O95571|ETHE1_HUMAN	metaplastic breast carcinomas-Normal	0.150836797731123	0.2758665646069	23.9999999995593	0.589581788260078	0.748575196400496	nan
sp|O95571|ETHE1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.29294841680603	0.2758665646069	23.9999999998123	0.298841164127439	0.867696529950794	nan
sp|O95571|ETHE1_HUMAN	Normal-Triple-negative breast cancer	-0.443785214537153	0.329723610376962	23.9999999996206	0.190902025949928	0.371902303309095	nan
sp|O95573|ACSL3_HUMAN	metaplastic breast carcinomas-Normal	0.0357867489286614	0.404631428842995	23.999999999843	0.930258593358963	0.962231702666505	nan
sp|O95573|ACSL3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.928370728883601	0.404631428842995	23.9999999998816	0.0308208147065213	0.721684569712558	nan
sp|O95573|ACSL3_HUMAN	Normal-Triple-negative breast cancer	-0.964157477812262	0.483627059989002	23.999999999823	0.0576802156902617	0.171800212324758	nan
sp|O95630|STABP_HUMAN	metaplastic breast carcinomas-Normal	-0.0324349784673562	0.207158694511569	23.9999999993754	0.876892849473892	0.936028205411438	nan
sp|O95630|STABP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.530600290639097	0.207158694511569	23.9999999993742	0.0171349667404087	0.669250232341703	nan
sp|O95630|STABP_HUMAN	Normal-Triple-negative breast cancer	-0.498165312171741	0.247601998352591	23.9999999993542	0.055579416856294	0.16764608133423	nan
sp|O95674|CDS2_HUMAN	metaplastic breast carcinomas-Normal	0.281528209142379	0.192515320673237	23.9999999999326	0.156613024071369	0.338259708910481	nan
sp|O95674|CDS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.168565463508823	0.192515320673237	23.9999999996729	0.389929496626193	0.885234295852111	nan
sp|O95674|CDS2_HUMAN	Normal-Triple-negative breast cancer	-0.450093672651202	0.230099819003838	23.9999999998308	0.0621914865527715	0.180073607405412	nan
sp|O95684|CEP43_HUMAN	metaplastic breast carcinomas-Normal	-0.26513646802248	0.509463490325019	13.23430347244	0.61136507831279	0.767645648308312	nan
sp|O95684|CEP43_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.406535342736329	0.456530621296433	12.9999999951417	0.389386574169348	0.885234295852111	nan
sp|O95684|CEP43_HUMAN	Normal-Triple-negative breast cancer	-0.141398874713849	0.590657256230352	13.1767149193486	0.81448474975307	0.893808949547443	nan
sp|O95721|SNP29_HUMAN	metaplastic breast carcinomas-Normal	0.141286861870632	0.309324459347833	21.9999999996015	0.652321802589866	0.79425555743909	nan
sp|O95721|SNP29_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.259222913488396	0.265522592567504	21.9999999997399	0.339542230627322	0.870943310236299	nan
sp|O95721|SNP29_HUMAN	Normal-Triple-negative breast cancer	0.117936051617765	0.35481948922699	21.9999999996468	0.742746115557346	0.851634387068858	nan
sp|O95747|OXSR1_HUMAN	metaplastic breast carcinomas-Normal	-0.116519149647221	0.149829146533121	22.0000000500941	0.445040744753212	0.642063991128332	nan
sp|O95747|OXSR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.191144790110991	0.149829146533121	22.0000000500993	0.215349386039705	0.843662073010871	nan
sp|O95747|OXSR1_HUMAN	Normal-Triple-negative breast cancer	-0.0746256404637696	0.179080082448541	22.0000000503576	0.680923586510985	0.813291412706617	nan
sp|O95749|GGPPS_HUMAN	metaplastic breast carcinomas-Normal	-0.201572967785674	0.261115747942516	21.9999958895198	0.448347105497616	0.644038798044112	nan
sp|O95749|GGPPS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.552637107880267	0.261115747942516	21.9999958895669	0.045854415059155	0.759166737802103	nan
sp|O95749|GGPPS_HUMAN	Normal-Triple-negative breast cancer	-0.351064140094593	0.312093012288644	21.9999958880202	0.272767402308297	0.463995415682386	nan
sp|O95757|HS74L_HUMAN	metaplastic breast carcinomas-Normal	0.159721258061327	0.315322028386411	20.9857460109845	0.617762578970967	0.771225334653059	nan
sp|O95757|HS74L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.118861748770934	0.315322028386411	20.9857460109154	0.70999294396882	0.94948208919602	nan
sp|O95757|HS74L_HUMAN	Normal-Triple-negative breast cancer	-0.278583006832262	0.37283006726598	20.9727983839072	0.463231468205497	0.643483706785728	nan
sp|O95777|LSM8_HUMAN	metaplastic breast carcinomas-Normal	0.664891665754357	0.185608137967662	22.0000000021081	0.0016610731741036	0.0293674431135457	nan
sp|O95777|LSM8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0228747644256577	0.185608137967662	22.0000000021068	0.903034264003706	0.991280596834705	nan
sp|O95777|LSM8_HUMAN	Normal-Triple-negative breast cancer	-0.687766430180015	0.221844156624235	22.0000000021592	0.0052223894489385	0.0458026979637777	nan
sp|O95782|AP2A1_HUMAN	metaplastic breast carcinomas-Normal	0.124056616746573	0.191212895305995	23.9999999998061	0.522635746885989	0.70246950668001	nan
sp|O95782|AP2A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.102169470817373	0.191212895305995	23.9999999998061	0.598033386205068	0.940559810632461	nan
sp|O95782|AP2A1_HUMAN	Normal-Triple-negative breast cancer	-0.226226087563946	0.228543122943387	23.9999999997515	0.332117123191918	0.524643297305615	nan
sp|O95786|DDX58_HUMAN	metaplastic breast carcinomas-Normal	-0.613638694349481	0.428168156957676	14.0000000000681	0.17376163746206	0.361789963260442	nan
sp|O95786|DDX58_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.13887417993052	0.428168156957676	13.999999999698	0.750472155006941	0.954643368861838	nan
sp|O95786|DDX58_HUMAN	Normal-Triple-negative breast cancer	0.752512874280002	0.511758830801793	14.0000000001658	0.163556856947155	0.333535578216161	nan
sp|O95793|STAU1_HUMAN	metaplastic breast carcinomas-Normal	0.896131450067681	0.231544988285691	22.0000000029316	0.0008272330212683	0.0227210419054423	nan
sp|O95793|STAU1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.116539408633543	0.231544988285691	22.000000003269	0.619747045646756	0.941374262616245	nan
sp|O95793|STAU1_HUMAN	Normal-Triple-negative breast cancer	-1.01267085870122	0.276749194347055	22.0000000029179	0.0013797685801049	0.0266490250684039	nan
sp|O95801|TTC4_HUMAN	metaplastic breast carcinomas-Normal	0.235208031913778	0.261555565739709	14.0000000016971	0.383717768051451	0.589275343425259	nan
sp|O95801|TTC4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.322964939389436	0.261555565739709	14.0000000016072	0.237233973294341	0.84876230490475	nan
sp|O95801|TTC4_HUMAN	Normal-Triple-negative breast cancer	0.0877569074756578	0.312618695102743	14.0000000016325	0.783034380972477	0.876365751633843	nan
sp|O95810|CAVN2_HUMAN	metaplastic breast carcinomas-Normal	-2.69319837294192	0.660400859350119	22.0000000168405	0.0004985056541823	0.0205217420849069	nan
sp|O95810|CAVN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.341151840490929	0.660400859350119	22.0000000171051	0.610601432250887	0.94077736515583	nan
sp|O95810|CAVN2_HUMAN	Normal-Triple-negative breast cancer	3.03435021343284	0.789330000724281	22.0000000171966	0.0008812260428234	0.025773942907156	nan
sp|O95817|BAG3_HUMAN	metaplastic breast carcinomas-Normal	0.0504525704184263	0.302473167399985	21.9999999921031	0.869050897855659	0.931589682597953	nan
sp|O95817|BAG3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.464007753964168	0.302473167399985	21.9999999938364	0.139274839227324	0.823891816737944	nan
sp|O95817|BAG3_HUMAN	Normal-Triple-negative breast cancer	0.413555183545742	0.361524583232453	21.9999999930376	0.264951403737703	0.45561224315785	nan
sp|O95819|M4K4_HUMAN	metaplastic breast carcinomas-Normal	0.178872905597603	0.208016755685882	23.9999999995027	0.398354485216435	0.601923998636815	nan
sp|O95819|M4K4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.245002570455985	0.208016755685882	23.9999999997263	0.250423141386031	0.853132115889912	nan
sp|O95819|M4K4_HUMAN	Normal-Triple-negative breast cancer	0.0661296648583824	0.248627577616689	23.9999999995793	0.792527164178158	0.881351720885981	nan
sp|O95831|AIFM1_HUMAN	metaplastic breast carcinomas-Normal	0.0272199392323671	0.207176397428431	23.9999999995211	0.896565684135006	0.943693582667751	nan
sp|O95831|AIFM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.194150026495969	0.207176397428431	23.9999999994844	0.35802997014075	0.883542279876718	nan
sp|O95831|AIFM1_HUMAN	Normal-Triple-negative breast cancer	-0.221369965728336	0.247623157385294	23.9999999994615	0.380210722434305	0.568009187133316	nan
sp|O95834|EMAL2_HUMAN	metaplastic breast carcinomas-Normal	-0.314634705408878	0.287508319635794	23.9999999992176	0.284663538637178	0.487857391072236	nan
sp|O95834|EMAL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.120701113013761	0.287508319635794	23.9999999989859	0.678353039673129	0.946568877415162	nan
sp|O95834|EMAL2_HUMAN	Normal-Triple-negative breast cancer	0.435335818422639	0.343638169050358	23.9999999991115	0.217367769814602	0.399629682999854	nan
sp|O95861|BPNT1_HUMAN	metaplastic breast carcinomas-Normal	0.111454686275032	0.294686651978494	21.9999975270479	0.708896337184959	0.834704720086009	nan
sp|O95861|BPNT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.642878211377303	0.294686651978494	21.9999975281175	0.0401099841868032	0.738255867002113	nan
sp|O95861|BPNT1_HUMAN	Normal-Triple-negative breast cancer	-0.754332897652335	0.352217917233663	21.9999975292298	0.043546967698227	0.142190688240576	nan
sp|O95865|DDAH2_HUMAN	metaplastic breast carcinomas-Normal	-1.18841389569392	0.290518408152112	22.0000000239065	0.0004834818045883	0.0205217420849069	nan
sp|O95865|DDAH2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.424033060247769	0.290518408152112	22.0000000230234	0.158539909753113	0.843662073010871	nan
sp|O95865|DDAH2_HUMAN	Normal-Triple-negative breast cancer	0.764380835446154	0.34723591296169	22.000000023159	0.0385001870956704	0.131525819019536	nan
sp|O95881|TXD12_HUMAN	metaplastic breast carcinomas-Normal	0.69896251547319	0.215125412349655	22.0000005639941	0.0036800215572059	0.0407324763980233	nan
sp|O95881|TXD12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.283050442670173	0.215125412349655	22.0000005644265	0.201806290644944	0.843662073010871	nan
sp|O95881|TXD12_HUMAN	Normal-Triple-negative breast cancer	-0.415912072803018	0.257124047435166	22.0000005641849	0.120008232611835	0.272358121389775	nan
sp|O95965|ITGBL_HUMAN	metaplastic breast carcinomas-Normal	0.50371260892437	0.442548642291702	22.0000000167815	0.267277295076963	0.469984569238895	nan
sp|O95965|ITGBL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.286145599821391	0.442548642291702	22.0000000183307	0.524589046489699	0.918310760845185	nan
sp|O95965|ITGBL_HUMAN	Normal-Triple-negative breast cancer	-0.217567009102979	0.528946798289134	22.0000000180229	0.684816452366276	0.814550412235226	nan
sp|O95967|FBLN4_HUMAN	metaplastic breast carcinomas-Normal	-0.37922671267198	0.28738370702973	22.0000000370938	0.200542651394508	0.393658005706939	nan
sp|O95967|FBLN4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.130978123763294	0.28738370702973	22.0000000365572	0.653028982380114	0.944190045212043	nan
sp|O95967|FBLN4_HUMAN	Normal-Triple-negative breast cancer	0.510204836435273	0.343489228498507	22.0000000363247	0.151638271344973	0.31972470314917	nan
sp|O95980|RECK_HUMAN	metaplastic breast carcinomas-Normal	-0.93454988582471	0.255848766839664	14.0015080007979	0.0026102017507416	0.0366089055673638	nan
sp|O95980|RECK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0577459368795917	0.255848766839664	14.0015080233241	0.824693407788078	0.965774701272009	nan
sp|O95980|RECK_HUMAN	Normal-Triple-negative breast cancer	0.992295822704302	0.305797765789692	14.0015080459316	0.0058707839551059	0.0484230418530328	nan
sp|O95989|NUDT3_HUMAN	metaplastic breast carcinomas-Normal	0.264473923981863	0.317497433530499	21.9999999394585	0.41379950621416	0.615740710196163	nan
sp|O95989|NUDT3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.163670229547298	0.317497433530499	21.9999999394653	0.61134470970181	0.94077736515583	nan
sp|O95989|NUDT3_HUMAN	Normal-Triple-negative breast cancer	-0.428144153529161	0.379482015945897	21.9999999389392	0.271375520539878	0.463780066979206	nan
sp|O95994|AGR2_HUMAN	metaplastic breast carcinomas-Normal	-1.58859264167128	0.832237050483278	6.0	0.104879037297449	0.263306586085136	nan
sp|O95994|AGR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-3.4379327143621	0.832237050483278	6.0	0.0061404419037815	0.519941801393686	nan
sp|O95994|AGR2_HUMAN	Normal-Triple-negative breast cancer	-1.84934007269082	0.994713532485686	6.0	0.112353185384589	0.260281322178989	nan
sp|O96005|CLPT1_HUMAN	metaplastic breast carcinomas-Normal	0.662911850929113	0.308980534505995	22.0000000317814	0.0432071435681787	0.154264817637622	nan
sp|O96005|CLPT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.101343127835934	0.308980534505995	22.000000031575	0.746018838919542	0.954643368861838	nan
sp|O96005|CLPT1_HUMAN	Normal-Triple-negative breast cancer	-0.764254978765048	0.369302374568998	22.0000000311466	0.0504488275978473	0.15716204586246	nan
sp|O96008|TOM40_HUMAN	metaplastic breast carcinomas-Normal	0.338777510671968	0.25244195234754	20.1409259082428	0.194529542528667	0.387317707029823	nan
sp|O96008|TOM40_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.124466952718189	0.209400419582652	19.982196047475	0.558917316772722	0.932694870083482	nan
sp|O96008|TOM40_HUMAN	Normal-Triple-negative breast cancer	-0.463244463390157	0.287261499160468	20.1051863655901	0.122413776305112	0.27568207055417	nan
sp|O96011|PX11B_HUMAN	metaplastic breast carcinomas-Normal	0.0537926074837567	0.256682088928732	23.9999999999274	0.835772851811847	0.913250808488685	nan
sp|O96011|PX11B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0478990400076872	0.256682088928732	23.9999999996352	0.853536093626051	0.977401079052892	nan
sp|O96011|PX11B_HUMAN	Normal-Triple-negative breast cancer	-0.0058935674760694	0.306793776191335	23.9999999997371	0.984832243129893	0.992143541340918	nan
sp|O96019|ACL6A_HUMAN	metaplastic breast carcinomas-Normal	0.415037939716699	0.271900280012402	21.9999251931121	0.141151277474569	0.31659031465956	nan
sp|O96019|ACL6A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0189244419579606	0.271900280012402	21.9999251935227	0.945140281663725	0.996541950781621	nan
sp|O96019|ACL6A_HUMAN	Normal-Triple-negative breast cancer	-0.396113497758738	0.324982993556855	21.9999251926065	0.235800654981116	0.420720009209462	nan
sp|P00325|ADH1B_HUMAN	metaplastic breast carcinomas-Normal	-4.08015493776082	1.00593782566914	20.8841693934895	0.0005735256685782	0.0205217420849069	nan
sp|P00325|ADH1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.599242665973157	1.07787048814594	21.1991945270032	0.584065410020705	0.938626142251737	nan
sp|P00325|ADH1B_HUMAN	Normal-Triple-negative breast cancer	3.48091227178767	1.26312346709302	21.1153928763112	0.0118072358701778	0.0698349680293079	nan
sp|P00338|LDHA_HUMAN	metaplastic breast carcinomas-Normal	0.296356989282846	0.221725086416267	23.9999999995154	0.193888177301533	0.387077658468646	nan
sp|P00338|LDHA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.109337280631993	0.221725086416267	23.9999999997112	0.626409050724265	0.941374262616245	nan
sp|P00338|LDHA_HUMAN	Normal-Triple-negative breast cancer	-0.405694269914839	0.265012166691863	23.9999999996215	0.13888192679822	0.300744967216471	nan
sp|P00352|AL1A1_HUMAN	metaplastic breast carcinomas-Normal	-2.13266635836115	0.488821275644857	23.999999999921	0.0002099216111896	0.0157578323963946	nan
sp|P00352|AL1A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.309661145186934	0.488821275644857	23.999999999921	0.532407809363069	0.921388505638487	nan
sp|P00352|AL1A1_HUMAN	Normal-Triple-negative breast cancer	2.44232750354808	0.584253173502066	23.9999999999018	0.0003338159613414	0.0227914720285933	nan
sp|P00367|DHE3_HUMAN	metaplastic breast carcinomas-Normal	-0.48316238688061	0.458843370409179	14.999999999628	0.309008509003326	0.516672175013609	nan
sp|P00367|DHE3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.614501695470333	0.458843370409179	14.9999999995131	0.200433544473314	0.843662073010871	nan
sp|P00367|DHE3_HUMAN	Normal-Triple-negative breast cancer	-0.131339308589723	0.54842272351647	14.9999999996163	0.813970703253095	0.893734029867605	nan
sp|P00387|NB5R3_HUMAN	metaplastic breast carcinomas-Normal	-0.729937226626267	0.221741260828634	22.0000001906788	0.0033257977623275	0.0403465392772878	nan
sp|P00387|NB5R3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0917229107928821	0.221741260828634	22.0000001910928	0.683136235390766	0.946568877415162	nan
sp|P00387|NB5R3_HUMAN	Normal-Triple-negative breast cancer	0.821660137419149	0.265031498812263	22.000000191025	0.0052222373377626	0.0458026979637777	nan
sp|P00390|GSHR_HUMAN	metaplastic breast carcinomas-Normal	-0.0439765965078554	0.259847139971861	22.0000000307358	0.867154148322632	0.930413295359725	nan
sp|P00390|GSHR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0802269875782163	0.259847139971861	22.0000000304316	0.760418855338155	0.955228196959647	nan
sp|P00390|GSHR_HUMAN	Normal-Triple-negative breast cancer	-0.0362503910703609	0.310576735748087	22.0000000308042	0.908141232365463	0.946852738996183	nan
sp|P00395|COX1_HUMAN	metaplastic breast carcinomas-Normal	0.0616986178543126	0.30210697572407	13.0006940348798	0.841337915274708	0.915277982513531	nan
sp|P00395|COX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.2342330081409	0.269447546984241	13.0000000295671	0.400444192410207	0.885297496092956	nan
sp|P00395|COX1_HUMAN	Normal-Triple-negative breast cancer	-0.295931625995213	0.349833902464641	13.0005176067742	0.412896755376131	0.60128493320689	nan
sp|P00403|COX2_HUMAN	metaplastic breast carcinomas-Normal	-0.119347742499136	0.253694640596124	22.0000001649307	0.642672231737869	0.788678711145789	nan
sp|P00403|COX2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.286211007974677	0.253694640596124	22.0000001648394	0.271401040656934	0.867696529950794	nan
sp|P00403|COX2_HUMAN	Normal-Triple-negative breast cancer	-0.166863265475541	0.303223092475294	22.0000001651959	0.587659045432391	0.743208813016678	nan
sp|P00450|CERU_HUMAN	metaplastic breast carcinomas-Normal	-1.14577331847486	0.373512406151629	23.9999999998677	0.005282473630601	0.0480293654602841	nan
sp|P00450|CERU_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.325074214303159	0.373512406151629	23.9999999998224	0.392749147320825	0.885234295852111	nan
sp|P00450|CERU_HUMAN	Normal-Triple-negative breast cancer	1.47084753277802	0.446432713773754	23.9999999998933	0.0030513405321889	0.0368672607204164	nan
sp|P00488|F13A_HUMAN	metaplastic breast carcinomas-Normal	-1.35924053242173	0.440713299548902	23.9999999998346	0.0050764354463878	0.0472734838426424	nan
sp|P00488|F13A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.742809667012205	0.440713299548902	23.9999999996364	0.104858034829642	0.821630939204717	nan
sp|P00488|F13A_HUMAN	Normal-Triple-negative breast cancer	2.10205019943393	0.526753144135007	23.9999999997439	0.0005395996075254	0.0237592699893802	nan
sp|P00491|PNPH_HUMAN	metaplastic breast carcinomas-Normal	0.252849844750937	0.367615795828924	22.0000000141944	0.498760704236227	0.68507462019885	nan
sp|P00491|PNPH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.522877637454288	0.367615795828924	22.0000000143721	0.168949689650487	0.843662073010871	nan
sp|P00491|PNPH_HUMAN	Normal-Triple-negative breast cancer	-0.775727482205224	0.439384916417962	22.000000014503	0.0913597873515428	0.229019557433279	nan
sp|P00492|HPRT_HUMAN	metaplastic breast carcinomas-Normal	0.634251014887484	0.186612351722266	22.0000000028488	0.0025789189924072	0.0364779860883474	nan
sp|P00492|HPRT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.212724365852447	0.186612351722266	22.0000000030643	0.266576082041318	0.866437412304381	nan
sp|P00492|HPRT_HUMAN	Normal-Triple-negative breast cancer	-0.421526649035037	0.223044421633625	22.0000000029634	0.0720229243484306	0.196229738701925	nan
sp|P00505|AATM_HUMAN	metaplastic breast carcinomas-Normal	0.320518014265886	0.229179041367678	23.9999999997619	0.174738202259462	0.362339229139396	nan
sp|P00505|AATM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.194879594036998	0.229179041367678	23.9999999997619	0.403541209213589	0.885297496092956	nan
sp|P00505|AATM_HUMAN	Normal-Triple-negative breast cancer	-0.515397608302884	0.27392134690248	23.9999999998151	0.0720807794690284	0.196229738701925	nan
sp|P00533|EGFR_HUMAN	metaplastic breast carcinomas-Normal	0.188476193733317	0.420828853133383	23.9999999997586	0.658264488358588	0.79944141735621	nan
sp|P00533|EGFR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.381465981680572	0.420828853133383	23.9999999997586	0.373701980067278	0.885234295852111	nan
sp|P00533|EGFR_HUMAN	Normal-Triple-negative breast cancer	0.192989787947255	0.502986684898402	23.9999999998002	0.704587990326438	0.826751679625131	nan
sp|P00558|PGK1_HUMAN	metaplastic breast carcinomas-Normal	0.504548024108044	0.266864370422393	23.9999999997566	0.070803951353046	0.207008121073216	nan
sp|P00558|PGK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.432522771558605	0.266864370422393	23.9999999994863	0.11813559424569	0.823891816737944	nan
sp|P00558|PGK1_HUMAN	Normal-Triple-negative breast cancer	-0.937070795666649	0.318963930340855	23.9999999996664	0.0071896246094381	0.0535093121381869	nan
sp|P00734|THRB_HUMAN	metaplastic breast carcinomas-Normal	-0.824802003884363	0.409454715978215	22.0000000250482	0.0563541798204393	0.180456132482707	nan
sp|P00734|THRB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0189568036898621	0.409454715978215	22.0000000249531	0.963490687567071	0.99709406933403	nan
sp|P00734|THRB_HUMAN	Normal-Triple-negative breast cancer	0.843758807574225	0.489391990764051	22.0000000251671	0.098716073425749	0.241096420328574	nan
sp|P00736|C1R_HUMAN	metaplastic breast carcinomas-Normal	-0.366496418840954	0.335791813821557	21.9999999078498	0.286888988275017	0.490544751556665	nan
sp|P00736|C1R_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.22761025633462	0.335791813821557	21.9999999081457	0.504945648980192	0.913320451076758	nan
sp|P00736|C1R_HUMAN	Normal-Triple-negative breast cancer	0.594106675175574	0.401347982659813	21.9999999089709	0.152978518094858	0.320416253400949	nan
sp|P00738|HPT_HUMAN	metaplastic breast carcinomas-Normal	-0.955675130361009	0.621514550250427	23.9999999991854	0.137213749953881	0.31111767042749	nan
sp|P00738|HPT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.2203427432013	0.621514550250427	23.9999999991854	0.0612755993826177	0.773787875546141	nan
sp|P00738|HPT_HUMAN	Normal-Triple-negative breast cancer	2.1760178735623	0.742851971576909	23.9999999991621	0.0073366911387643	0.0539538967815321	nan
sp|P00739|HPTR_HUMAN	metaplastic breast carcinomas-Normal	-1.04482948855584	0.481023620667851	22.0000000007238	0.0409026706098101	0.149736208267631	nan
sp|P00739|HPTR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.340663985691479	0.481023620667851	21.9999999996637	0.486253658254053	0.913320451076758	nan
sp|P00739|HPTR_HUMAN	Normal-Triple-negative breast cancer	1.38549347424732	0.574933193187831	22.000000000183	0.0247663711475151	0.105004359304005	nan
sp|P00740|FA9_HUMAN	metaplastic breast carcinomas-Normal	-0.613437565099702	0.360576905357102	22.0000000044895	0.102985907352731	0.259730770895659	nan
sp|P00740|FA9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.232889190975937	0.360576905357102	22.0000000043085	0.525037845979394	0.918329246917285	nan
sp|P00740|FA9_HUMAN	Normal-Triple-negative breast cancer	0.380548374123765	0.430971833148068	22.0000000040298	0.386783197198362	0.574833537967588	nan
sp|P00746|CFAD_HUMAN	metaplastic breast carcinomas-Normal	-1.69023809720759	0.529585396753823	22.0000000026349	0.0042143891100681	0.042883667309653	nan
sp|P00746|CFAD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0883670293372931	0.529585396753823	22.0000000028865	0.8690037652555	0.981143688073178	nan
sp|P00746|CFAD_HUMAN	Normal-Triple-negative breast cancer	1.6018710678703	0.632975617285875	22.0000000021987	0.0190435429527571	0.0897882791134249	nan
sp|P00747|PLMN_HUMAN	metaplastic breast carcinomas-Normal	-0.977575112800356	0.397264385094758	23.9999999992492	0.0214419258211325	0.100085016891408	nan
sp|P00747|PLMN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.115451363918721	0.397264385094758	23.999999999248	0.773841569688631	0.960657739983943	nan
sp|P00747|PLMN_HUMAN	Normal-Triple-negative breast cancer	1.09302647671908	0.47482175853489	23.9999999991533	0.0303207097244102	0.116515652166404	nan
sp|P00748|FA12_HUMAN	metaplastic breast carcinomas-Normal	-1.12356618876959	0.52501227847211	21.9999999308616	0.0436892205051836	0.155265014327307	nan
sp|P00748|FA12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0706764194766316	0.52501227847211	21.9999999304158	0.894137440528723	0.988218752026376	nan
sp|P00748|FA12_HUMAN	Normal-Triple-negative breast cancer	1.05288976929296	0.627509695481702	21.9999999306325	0.107520659092427	0.253474234626404	nan
sp|P00751|CFAB_HUMAN	metaplastic breast carcinomas-Normal	-0.84616130333578	0.410287666471285	23.9999999992672	0.0501577231915812	0.169912927873181	nan
sp|P00751|CFAB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.449069046397081	0.410287666471285	23.9999999992296	0.284589440545545	0.867696529950794	nan
sp|P00751|CFAB_HUMAN	Normal-Triple-negative breast cancer	1.29523034973286	0.490387557023527	23.999999999203	0.0143026130725576	0.0773038794360676	nan
sp|P00813|ADA_HUMAN	metaplastic breast carcinomas-Normal	0.0520782642917166	0.261359810870262	22.0000002974514	0.843890370711117	0.916397122588615	nan
sp|P00813|ADA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.279162593376909	0.261359810870262	22.0000002974938	0.297048955551384	0.867696529950794	nan
sp|P00813|ADA_HUMAN	Normal-Triple-negative breast cancer	0.227084329085192	0.312384723282363	22.0000002975037	0.47492878559856	0.653420233166231	nan
sp|P00966|ASSY_HUMAN	metaplastic breast carcinomas-Normal	-0.345302867041553	0.317694148876904	21.9999999228914	0.288845020448336	0.492622292442416	nan
sp|P00966|ASSY_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.392368610863898	0.317694148876904	21.9999999226945	0.229839476786081	0.843662073010871	nan
sp|P00966|ASSY_HUMAN	Normal-Triple-negative breast cancer	0.737671477905451	0.379717135755816	21.9999999223448	0.0649616902898657	0.184795320809112	nan
sp|P00973|OAS1_HUMAN	metaplastic breast carcinomas-Normal	0.622777946691783	0.566448372903304	22.9999999993754	0.282950050975634	0.485873715935793	nan
sp|P00973|OAS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.515813939691792	0.529863934674932	22.999999999538	0.340440739143762	0.870943310236299	nan
sp|P00973|OAS1_HUMAN	Normal-Triple-negative breast cancer	-0.106964006999991	0.664219593847999	22.9999999994789	0.873470316630949	0.927016389681122	nan
sp|P01009|A1AT_HUMAN	metaplastic breast carcinomas-Normal	-1.60631388511873	0.510761143967737	23.9999999997391	0.0043869184638772	0.0441516366864034	nan
sp|P01009|A1AT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0056427036367471	0.510761143967737	24.0000000000342	0.991276763345646	0.998185231446144	nan
sp|P01009|A1AT_HUMAN	Normal-Triple-negative breast cancer	1.61195658875548	0.610476331806602	24.0000000000197	0.0143269709918856	0.0773098239886812	nan
sp|P01011|AACT_HUMAN	metaplastic breast carcinomas-Normal	-0.617784428477394	0.380195213549455	23.9999999998693	0.117242796792858	0.282607002566687	nan
sp|P01011|AACT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.106678117186304	0.380195213549455	23.999999999603	0.781431182415458	0.9619617480679	nan
sp|P01011|AACT_HUMAN	Normal-Triple-negative breast cancer	0.724462545663698	0.454420196366308	23.9999999997943	0.123964444681267	0.27776955473837	nan
sp|P01019|ANGT_HUMAN	metaplastic breast carcinomas-Normal	-0.935410597523403	0.51036092604343	22.0000003557951	0.0803955274652092	0.224816118300932	nan
sp|P01019|ANGT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.468182668885672	0.51036092604343	22.0000003567162	0.368903933482321	0.883542279876718	nan
sp|P01019|ANGT_HUMAN	Normal-Triple-negative breast cancer	1.40359326640908	0.609997979893502	22.0000003561244	0.0312438626844646	0.11855547895338	nan
sp|P01023|A2MG_HUMAN	metaplastic breast carcinomas-Normal	-1.41483177008862	0.518411085962178	23.9999999993156	0.0116960943555055	0.0712452568367856	nan
sp|P01023|A2MG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.235617839776683	0.518411085962178	23.9999999993156	0.653553143955832	0.944190045212043	nan
sp|P01023|A2MG_HUMAN	Normal-Triple-negative breast cancer	1.6504496098653	0.619619761338106	23.9999999992892	0.0135908629400705	0.0754897960437323	nan
sp|P01024|CO3_HUMAN	metaplastic breast carcinomas-Normal	-0.984600458782532	0.383295035168544	23.9999999999156	0.0168500390060659	0.0871065780033639	nan
sp|P01024|CO3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.3672877869473	0.383295035168545	23.9999999998726	0.347497231047529	0.871784737402991	nan
sp|P01024|CO3_HUMAN	Normal-Triple-negative breast cancer	1.35188824572983	0.458125191849277	23.9999999999378	0.0069712888898875	0.0530264628603803	nan
sp|P01033|TIMP1_HUMAN	metaplastic breast carcinomas-Normal	-0.465404206854892	0.369870582758914	23.9999999997391	0.220391197904994	0.418773822230466	nan
sp|P01033|TIMP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.413998794672372	0.369870582758914	23.9999999997391	0.27408675519975	0.867696529950794	nan
sp|P01033|TIMP1_HUMAN	Normal-Triple-negative breast cancer	0.0514054121825206	0.442079902264639	23.9999999996775	0.908397528477385	0.946852738996183	nan
sp|P01034|CYTC_HUMAN	metaplastic breast carcinomas-Normal	-0.957766078032268	0.461263424689811	14.9999999996139	0.0554600657374449	0.179470650068388	nan
sp|P01034|CYTC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.517244745384357	0.461263424689811	14.9999999996318	0.279764043779395	0.867696529950794	nan
sp|P01034|CYTC_HUMAN	Normal-Triple-negative breast cancer	1.47501082341662	0.551315241628822	14.9999999996407	0.0172889267430707	0.0847870753296437	nan
sp|P01042|KNG1_HUMAN	metaplastic breast carcinomas-Normal	-1.40315184605044	0.410993397537648	23.9999999994202	0.0022775320492179	0.0344046144412164	nan
sp|P01042|KNG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.162362125990053	0.410993397537648	23.999999999384	0.696296700059239	0.947043345959522	nan
sp|P01042|KNG1_HUMAN	Normal-Triple-negative breast cancer	1.56551397204049	0.49123106698454	23.9999999993598	0.003964182289848	0.0409221799113507	nan
sp|P01591|IGJ_HUMAN	metaplastic breast carcinomas-Normal	-1.52469550617529	0.859822002277358	14.0000009409823	0.0979301919389405	0.252341052717084	nan
sp|P01591|IGJ_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.761461410088017	0.859822002277358	14.0000009407761	0.390789103558275	0.885234295852111	nan
sp|P01591|IGJ_HUMAN	Normal-Triple-negative breast cancer	2.28615691626331	1.02768385605708	14.0000009406354	0.0430671917745548	0.141457851243696	nan
sp|P01597|KV139_HUMAN;sp|P04432|KVD39_HUMAN	metaplastic breast carcinomas-Normal	-0.791113483283752	0.689888427395354	20.9958874011016	0.264395386819056	0.467225021683435	nan
sp|P01597|KV139_HUMAN;sp|P04432|KVD39_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0580570650437333	0.689888427395354	20.9958874018075	0.933731011698999	0.995359816653149	nan
sp|P01597|KV139_HUMAN;sp|P04432|KVD39_HUMAN	Normal-Triple-negative breast cancer	0.849170548327486	0.815915476506716	20.961938842357	0.309843855478173	0.502133765198418	nan
sp|P01599|KV117_HUMAN	metaplastic breast carcinomas-Normal	-0.515363674009141	0.788554673586297	14.0000000000574	0.523988441701814	0.703164142194925	nan
sp|P01599|KV117_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.324868195978915	0.788554673586297	14.0000000000574	0.686593063030976	0.946568877415162	nan
sp|P01599|KV117_HUMAN	Normal-Triple-negative breast cancer	0.840231869988056	0.927889769573381	14.0000000000567	0.380505015077281	0.568193472649093	nan
sp|P01602|KV105_HUMAN	metaplastic breast carcinomas-Normal	-0.849954956990824	0.344759134480566	24.0000000001275	0.0212251723885328	0.0999326813307126	nan
sp|P01602|KV105_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.36078966689885	0.344759134480566	24.0000000001275	0.305757059739327	0.867696529950794	nan
sp|P01602|KV105_HUMAN	Normal-Triple-negative breast cancer	1.21074462388967	0.412065980860536	24.0000000001871	0.0071833178696305	0.0535093121381869	nan
sp|P01619|KV320_HUMAN	metaplastic breast carcinomas-Normal	-1.08405819367426	0.528909377278234	24.0000000001953	0.0514828950998255	0.171989088755598	nan
sp|P01619|KV320_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.308167719097308	0.528909377278234	24.0000000001967	0.565565187787704	0.935109025059232	nan
sp|P01619|KV320_HUMAN	Normal-Triple-negative breast cancer	1.39222591277157	0.632167619468184	24.0000000002348	0.0374940756911737	0.1289854745691	nan
sp|P01700|LV147_HUMAN	metaplastic breast carcinomas-Normal	-0.936614580837274	0.353937978449605	23.9999999994919	0.014139908313757	0.0795280122418412	nan
sp|P01700|LV147_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.100896704016409	0.353937978449605	23.9999999994399	0.778036947950691	0.960985457628546	nan
sp|P01700|LV147_HUMAN	Normal-Triple-negative breast cancer	1.03751128485368	0.423036797772948	23.9999999994123	0.0218358029111311	0.0972951861616619	nan
sp|P01714|LV319_HUMAN	metaplastic breast carcinomas-Normal	0.393150535586873	0.522962174780828	12.0859667436356	0.466574025211817	0.658832650723908	nan
sp|P01714|LV319_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.413921266408785	0.470824311128023	12.0268279382241	0.396550030614363	0.885234295852111	nan
sp|P01714|LV319_HUMAN	Normal-Triple-negative breast cancer	0.0207707308219119	0.599871605780787	12.1451830228439	0.972941108904136	0.987196656287347	nan
sp|P01833|PIGR_HUMAN	metaplastic breast carcinomas-Normal	-3.27594820501124	0.625092067847568	21.1446866943089	3.3305964839434e-05	0.007907787651877	nan
sp|P01833|PIGR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.102962126537423	0.581979906351	21.0340842378585	0.861266065224668	0.979395590401814	nan
sp|P01833|PIGR_HUMAN	Normal-Triple-negative breast cancer	3.17298607847381	0.732050201946619	21.114959006215	0.0002889306326207	0.0227914720285933	nan
sp|P01834|IGKC_HUMAN	metaplastic breast carcinomas-Normal	-1.1232385258136	0.488374255268303	23.9999999997268	0.0304525699688764	0.125588514362959	nan
sp|P01834|IGKC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.812663681517184	0.488374255268303	23.9999999997268	0.10911315684116	0.823891816737944	nan
sp|P01834|IGKC_HUMAN	Normal-Triple-negative breast cancer	1.93590220733078	0.583718881959054	23.9999999996838	0.0028929779541748	0.036154485561068	nan
sp|P01859|IGHG2_HUMAN	metaplastic breast carcinomas-Normal	-1.20876149336621	0.455287880406794	21.9999999961609	0.0144661491096864	0.0795450818130059	nan
sp|P01859|IGHG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0064125973370195	0.455287880406793	21.9999999963661	0.988889350147317	0.998185231446144	nan
sp|P01859|IGHG2_HUMAN	Normal-Triple-negative breast cancer	1.21517409070323	0.544173100145416	21.9999999948224	0.0360378276751357	0.126678556343412	nan
sp|P01860|IGHG3_HUMAN	metaplastic breast carcinomas-Normal	-1.19947439594223	0.468474949179427	23.9999999998177	0.0171712688887191	0.0882183891593542	nan
sp|P01860|IGHG3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.281063911592533	0.468474949179427	23.9999999996423	0.554159162208041	0.931642387063667	nan
sp|P01860|IGHG3_HUMAN	Normal-Triple-negative breast cancer	1.48053830753477	0.559934662015728	23.9999999997302	0.0142089467071772	0.0770525421586136	nan
sp|P01861|IGHG4_HUMAN	metaplastic breast carcinomas-Normal	-0.85123674916888	0.545637018429195	23.9999999990777	0.131831879740755	0.303468953087443	nan
sp|P01861|IGHG4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.242089684796901	0.545637018429195	23.9999999993376	0.661246346759662	0.944434752137403	nan
sp|P01861|IGHG4_HUMAN	Normal-Triple-negative breast cancer	1.09332643396578	0.652160974738492	23.9999999991089	0.106626636822776	0.252981399570954	nan
sp|P01871|IGHM_HUMAN	metaplastic breast carcinomas-Normal	-1.12557035409447	0.641342922799252	15.0000000000292	0.0996523653592402	0.254814544560358	nan
sp|P01871|IGHM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.338086731947065	0.641342922799251	15.0000000000286	0.60579586721247	0.940559810632461	nan
sp|P01871|IGHM_HUMAN	Normal-Triple-negative breast cancer	1.46365708604154	0.766551409723805	15.0000000000493	0.0755263897484681	0.202374585558016	nan
sp|P01876|IGHA1_HUMAN	metaplastic breast carcinomas-Normal	-1.21382617045471	0.58882587101824	22.000000001396	0.0512730783689679	0.171633144510019	nan
sp|P01876|IGHA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0085908024855632	0.58882587101824	22.000000001392	0.988491006739355	0.998185231446144	nan
sp|P01876|IGHA1_HUMAN	Normal-Triple-negative breast cancer	1.20523536796914	0.703781526957244	22.0000000013709	0.100863165088579	0.244442731665984	nan
sp|P01889|HLAB_HUMAN	metaplastic breast carcinomas-Normal	0.436496209666947	0.557552165870635	17.3602716709497	0.444246926433872	0.641475579264201	nan
sp|P01889|HLAB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0100813797922644	0.557695361287222	17.8094620558574	0.985778519310083	0.99777413090774	nan
sp|P01889|HLAB_HUMAN	Normal-Triple-negative breast cancer	-0.446577589459212	0.662722955547333	18.0052768794516	0.508964103518239	0.682726666704853	nan
sp|P01893|HLAH_HUMAN	metaplastic breast carcinomas-Normal	0.0490856464641813	0.670953995667143	23.9999999996174	0.942286704135453	0.97019065827596	nan
sp|P01893|HLAH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0729612141457006	0.670953995667143	23.9999999996174	0.91431080579542	0.99408739879047	nan
sp|P01893|HLAH_HUMAN	Normal-Triple-negative breast cancer	0.0238755676815193	0.801943411168594	23.9999999995639	0.976494980106133	0.988690013363627	nan
sp|P01903|DRA_HUMAN	metaplastic breast carcinomas-Normal	-0.148161497585055	0.532621045812848	23.9999999994429	0.78326106877795	0.882032001854638	nan
sp|P01903|DRA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0312838454496543	0.532621045812848	23.9999999997588	0.953648986571735	0.996541950781621	nan
sp|P01903|DRA_HUMAN	Normal-Triple-negative breast cancer	0.1168776521354	0.63660391188912	23.9999999995983	0.855873058328397	0.917716788994707	nan
sp|P01911|DRB1_HUMAN	metaplastic breast carcinomas-Normal	0.391052961355837	0.471013726814015	22.0000000241145	0.415323947858899	0.616586334382752	nan
sp|P01911|DRB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.275260509238566	0.471013726814015	22.0000000241145	0.564896430873444	0.935109025059232	nan
sp|P01911|DRB1_HUMAN	Normal-Triple-negative breast cancer	-0.115792452117271	0.562969081677326	22.0000000246529	0.838930900477034	0.908340818627252	nan
sp|P01920|DQB1_HUMAN	metaplastic breast carcinomas-Normal	-1.26266289403406	0.615170637446537	14.832336910277	0.0581990610379842	0.18371669410281	nan
sp|P01920|DQB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.311757973129577	0.406862323626783	13.8538752569244	0.456386440647497	0.908567154037048	nan
sp|P01920|DQB1_HUMAN	Normal-Triple-negative breast cancer	1.57442086716364	0.652593153015566	14.97701229281	0.029123256095691	0.114387188280896	nan
sp|P02042|HBD_HUMAN	metaplastic breast carcinomas-Normal	-0.383774355594062	0.71277088011754	22.0000000045388	0.595689333650753	0.753951545680441	nan
sp|P02042|HBD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.782208203448345	0.71277088011754	22.0000000048669	0.284325119751833	0.867696529950794	nan
sp|P02042|HBD_HUMAN	Normal-Triple-negative breast cancer	1.16598255904241	0.851924147816939	22.0000000040967	0.184924550188592	0.3625850221062	nan
sp|P02452|CO1A1_HUMAN	metaplastic breast carcinomas-Normal	0.427789812083171	0.444815583741341	22.0000000383295	0.346640391766133	0.556903171691941	nan
sp|P02452|CO1A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.08894230777287	0.444815583741341	22.000000038417	0.0228026242177603	0.712051972579798	nan
sp|P02452|CO1A1_HUMAN	Normal-Triple-negative breast cancer	0.661152495689696	0.53165631156543	22.0000000383571	0.226746366167001	0.409709885499404	nan
sp|P02458|CO2A1_HUMAN	metaplastic breast carcinomas-Normal	0.474636529225682	0.853244865825827	14.0000000155729	0.586806382972751	0.746191437261448	nan
sp|P02458|CO2A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.626433183162614	0.853244865825827	14.0000000157494	0.474958013010165	0.913280230088743	nan
sp|P02458|CO2A1_HUMAN	Normal-Triple-negative breast cancer	0.151796653936932	1.01982267440272	14.000000015532	0.883797832143748	0.93275221069853	nan
sp|P02461|CO3A1_HUMAN	metaplastic breast carcinomas-Normal	0.728606541299862	0.589933997057569	20.9985718125762	0.23044790286071	0.430342038825281	nan
sp|P02461|CO3A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.652410086237721	0.589933997057569	20.9985718123693	0.281278025479812	0.867696529950794	nan
sp|P02461|CO3A1_HUMAN	Normal-Triple-negative breast cancer	-0.076196455062141	0.697550303852108	20.9827168701088	0.914054550440876	0.950960039331917	nan
sp|P02462|CO4A1_HUMAN	metaplastic breast carcinomas-Normal	-0.152561932416963	0.436617879532938	23.9999999995112	0.729823255242006	0.850309323667868	nan
sp|P02462|CO4A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.360691741035971	0.436617879532938	23.9999999997142	0.416882302642232	0.8860071777014	nan
sp|P02462|CO4A1_HUMAN	Normal-Triple-negative breast cancer	0.513253673452934	0.521858180964686	23.999999999618	0.335167285486832	0.52775748790063	nan
sp|P02511|CRYAB_HUMAN	metaplastic breast carcinomas-Normal	-1.82043139774641	0.626255375272525	22.0000000178937	0.0081757686436197	0.0602577715551933	nan
sp|P02511|CRYAB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.221735005733499	0.626255375272525	22.0000000178995	0.726661222249913	0.953491935272676	nan
sp|P02511|CRYAB_HUMAN	Normal-Triple-negative breast cancer	1.59869639201291	0.748518341275168	22.0000000182448	0.0440727237836509	0.142646284183891	nan
sp|P02545|LMNA_HUMAN	metaplastic breast carcinomas-Normal	0.236024066409329	0.248314757264648	21.9999999690565	0.352182584248628	0.561744479911381	nan
sp|P02545|LMNA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.167798989500903	0.248314757264648	21.9999999675361	0.506240478596831	0.913320451076758	nan
sp|P02545|LMNA_HUMAN	Normal-Triple-negative breast cancer	-0.0682250769084262	0.296792902002633	21.9999999674147	0.820313288441854	0.898425492843731	nan
sp|P02549|SPTA1_HUMAN	metaplastic breast carcinomas-Normal	-0.510746424199602	0.632720699616961	22.0000000261343	0.428179778828375	0.626163477705903	nan
sp|P02549|SPTA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.799488748040231	0.632720699616961	22.0000000266032	0.219609657212964	0.843662073010871	nan
sp|P02549|SPTA1_HUMAN	Normal-Triple-negative breast cancer	1.31023517223983	0.756245881900265	22.000000025961	0.0971733486877704	0.23871253280979	nan
sp|P02647|APOA1_HUMAN	metaplastic breast carcinomas-Normal	-1.1679252786897	0.44162649016429	23.9999999997443	0.0141936716954037	0.0795361221927149	nan
sp|P02647|APOA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.517783822792587	0.44162649016429	23.9999999997443	0.252524270016827	0.855758210685228	nan
sp|P02647|APOA1_HUMAN	Normal-Triple-negative breast cancer	1.68570910148229	0.527844615684294	23.9999999997822	0.0039009165449159	0.0407011375973175	nan
sp|P02649|APOE_HUMAN	metaplastic breast carcinomas-Normal	-0.847247595153557	0.369178718424919	24.0000000000155	0.0307817100316867	0.126153237930521	nan
sp|P02649|APOE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.25832118199997	0.369178718424919	24.0000000002531	0.490830273373999	0.913320451076758	nan
sp|P02649|APOE_HUMAN	Normal-Triple-negative breast cancer	1.10556877715353	0.44125296621887	24.0000000001624	0.0194139773650505	0.0907623920695186	nan
sp|P02652|APOA2_HUMAN	metaplastic breast carcinomas-Normal	-1.58288145101315	0.571655107927182	23.9999999994506	0.0106703384417148	0.0687368313570928	nan
sp|P02652|APOA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.49677465148562	0.571655107927182	23.9999999994506	0.39344882542907	0.885234295852111	nan
sp|P02652|APOA2_HUMAN	Normal-Triple-negative breast cancer	2.07965610249877	0.683258539666709	23.9999999994367	0.0055919939514741	0.0473239987803939	nan
sp|P02654|APOC1_HUMAN	metaplastic breast carcinomas-Normal	-0.579296095958534	0.453366302946716	22.0000000742145	0.214650903600708	0.411002075788453	nan
sp|P02654|APOC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.715579844465524	0.453366302946716	22.0000000751972	0.12875237249281	0.823891816737944	nan
sp|P02654|APOC1_HUMAN	Normal-Triple-negative breast cancer	1.29487594042406	0.541876375790079	22.0000000745294	0.0258668021639245	0.107278050995882	nan
sp|P02655|APOC2_HUMAN	metaplastic breast carcinomas-Normal	-1.03536305536782	0.543494581560378	22.000000002576	0.0699336674219743	0.204990750009385	nan
sp|P02655|APOC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.369433136352486	0.543494581560378	22.0000000025094	0.503761501587734	0.913320451076758	nan
sp|P02655|APOC2_HUMAN	Normal-Triple-negative breast cancer	1.40479619172031	0.649600272899189	22.0000000023922	0.0417156906740502	0.13854792318675	nan
sp|P02656|APOC3_HUMAN	metaplastic breast carcinomas-Normal	-1.15198213282626	0.535159504036251	22.0000000067537	0.0425798751872323	0.152502316045985	nan
sp|P02656|APOC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.909378406684656	0.535159504036251	22.0000000056918	0.103367507375815	0.821630939204717	nan
sp|P02656|APOC3_HUMAN	Normal-Triple-negative breast cancer	2.06136053951092	0.639637949781332	22.0000000062795	0.0039167424325891	0.0407011375973175	nan
sp|P02671|FIBA_HUMAN	metaplastic breast carcinomas-Normal	-0.616203752775714	0.327384922011952	23.9999999992576	0.0719894447174072	0.209172127832746	nan
sp|P02671|FIBA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.304520108429172	0.327384922011952	23.9999999992576	0.361550958897478	0.883542279876718	nan
sp|P02671|FIBA_HUMAN	Normal-Triple-negative breast cancer	0.920723861204886	0.391299825053395	23.9999999992322	0.0271554210823633	0.110483010621512	nan
sp|P02675|FIBB_HUMAN	metaplastic breast carcinomas-Normal	-0.458726262037223	0.325985793142527	23.9999999997904	0.172188375127082	0.360525616455081	nan
sp|P02675|FIBB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.332126150202459	0.325985793142527	23.9999999997904	0.318441928466125	0.867696529950794	nan
sp|P02675|FIBB_HUMAN	Normal-Triple-negative breast cancer	0.790852412239682	0.389627546200512	23.9999999998312	0.0536074304051256	0.163628189776527	nan
sp|P02679|FIBG_HUMAN	metaplastic breast carcinomas-Normal	-0.542934025974136	0.352509444301422	23.999999999304	0.136594767341694	0.310163720098189	nan
sp|P02679|FIBG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.380122130013011	0.352509444301422	23.999999999304	0.291604916785495	0.867696529950794	nan
sp|P02679|FIBG_HUMAN	Normal-Triple-negative breast cancer	0.923056155987147	0.421329372889629	23.9999999993167	0.0384127494232126	0.131376411377847	nan
sp|P02686|MBP_HUMAN	metaplastic breast carcinomas-Normal	-0.68518952161869	0.435682564841655	14.999999999678	0.136644481139101	0.310163720098189	nan
sp|P02686|MBP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.867884283805917	0.435682564841654	14.9999999997846	0.0648974655274278	0.773787875546141	nan
sp|P02686|MBP_HUMAN	Normal-Triple-negative breast cancer	-0.182694762187227	0.520740266086932	14.999999999764	0.730589567865602	0.844553227042731	nan
sp|P02730|B3AT_HUMAN	metaplastic breast carcinomas-Normal	-0.339474766701477	0.706295035498625	22.000000003795	0.635516424086342	0.782101663703444	nan
sp|P02730|B3AT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.653283180365109	0.706295035498625	22.000000003795	0.365030358257475	0.883542279876718	nan
sp|P02730|B3AT_HUMAN	Normal-Triple-negative breast cancer	0.992757947066586	0.844184033058808	22.0000000041113	0.252165440355034	0.440948886776721	nan
sp|P02743|SAMP_HUMAN	metaplastic breast carcinomas-Normal	-1.07004076202641	0.429071762642697	23.9999999996237	0.0199249462438356	0.0961557351290508	nan
sp|P02743|SAMP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.569352938280056	0.429071762642697	23.9999999996237	0.19701529572059	0.843662073010871	nan
sp|P02743|SAMP_HUMAN	Normal-Triple-negative breast cancer	1.63939370030646	0.512838846168087	23.9999999996148	0.0038714558747569	0.0407011375973175	nan
sp|P02745|C1QA_HUMAN	metaplastic breast carcinomas-Normal	-0.485721156541042	0.453030175505661	24.0000000000183	0.294311141549834	0.498460812807163	nan
sp|P02745|C1QA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.235738868008961	0.453030175505661	24.0000000000193	0.607580031054031	0.940559810632461	nan
sp|P02745|C1QA_HUMAN	Normal-Triple-negative breast cancer	0.249982288532081	0.541474626656148	24.0000000000252	0.648475723934233	0.793024292875055	nan
sp|P02746|C1QB_HUMAN	metaplastic breast carcinomas-Normal	-0.260494795557268	0.524580658199655	22.9999999996819	0.624200165580339	0.774772722326007	nan
sp|P02746|C1QB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.393668167734388	0.524580658199655	22.9999999996819	0.460596511783062	0.909423669537079	nan
sp|P02746|C1QB_HUMAN	Normal-Triple-negative breast cancer	0.654162963291656	0.620692205316014	22.9999999997305	0.302863730158169	0.495432597955588	nan
sp|P02747|C1QC_HUMAN	metaplastic breast carcinomas-Normal	-0.251559391053047	0.221057946569484	22.0000000478032	0.267370884606122	0.469984569238895	nan
sp|P02747|C1QC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0377204016086895	0.221057946569484	22.0000000486267	0.866069719060639	0.980530611231673	nan
sp|P02747|C1QC_HUMAN	Normal-Triple-negative breast cancer	0.213838989444357	0.264214782060561	22.0000000481188	0.42698800282138	0.613504728886772	nan
sp|P02748|CO9_HUMAN	metaplastic breast carcinomas-Normal	-0.683224622941423	0.355925466804324	21.9999921475262	0.0679737528698396	0.201556426886126	nan
sp|P02748|CO9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0345479448736195	0.355925466804324	21.9999921472299	0.923553545958022	0.994508979919649	nan
sp|P02748|CO9_HUMAN	Normal-Triple-negative breast cancer	0.648676678067803	0.425412300715227	21.999992145069	0.141552165010619	0.30414957756645	nan
sp|P02749|APOH_HUMAN	metaplastic breast carcinomas-Normal	-1.30240683966829	0.45850171541395	21.9999999541841	0.0095151506167902	0.0646796741313101	nan
sp|P02749|APOH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.100731502106547	0.45850171541395	21.9999999528166	0.828132756621518	0.966828216776039	nan
sp|P02749|APOH_HUMAN	Normal-Triple-negative breast cancer	1.20167533756174	0.54801436769165	21.9999999527231	0.0391891766408977	0.132496466096553	nan
sp|P02750|A2GL_HUMAN	metaplastic breast carcinomas-Normal	-0.20019524323221	0.248929367535297	21.9999884564906	0.429872235572685	0.626846629119879	nan
sp|P02750|A2GL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.255679255412345	0.248929367535297	21.9999884564938	0.315527317130366	0.867696529950794	nan
sp|P02750|A2GL_HUMAN	Normal-Triple-negative breast cancer	0.455874498644555	0.297527501781703	21.9999884543886	0.139725659035825	0.30158966924356	nan
sp|P02751|FINC_HUMAN	metaplastic breast carcinomas-Normal	1.19670844544162	0.38933220785408	23.9999999999463	0.0052049090569547	0.0476983941525986	nan
sp|P02751|FINC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0217079422928893	0.38933220785408	23.9999999999892	0.955997084553105	0.99709406933403	nan
sp|P02751|FINC_HUMAN	Normal-Triple-negative breast cancer	-1.17500050314873	0.465340993362521	24.0000000000122	0.0185869204772971	0.0882613195236222	nan
sp|P02753|RET4_HUMAN	metaplastic breast carcinomas-Normal	-0.932812757640671	0.515678403318686	22.0000000147514	0.0841539302712083	0.231562635944947	nan
sp|P02753|RET4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.69047808476424	0.515678403318686	22.0000000159426	0.194252134578886	0.843662073010871	nan
sp|P02753|RET4_HUMAN	Normal-Triple-negative breast cancer	1.62329084240491	0.616353580862374	22.0000000157016	0.015167192818349	0.0782793040897244	nan
sp|P02760|AMBP_HUMAN	metaplastic breast carcinomas-Normal	-1.24837579896137	0.390411913746601	23.999999999906	0.0038631918199459	0.0416809642918909	nan
sp|P02760|AMBP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.121911237735893	0.390411913746601	24.0000000001585	0.757537500219847	0.955228196959647	nan
sp|P02760|AMBP_HUMAN	Normal-Triple-negative breast cancer	1.37028703669726	0.466631488734929	24.0000000000092	0.0072118447165787	0.0535093121381869	nan
sp|P02763|A1AG1_HUMAN	metaplastic breast carcinomas-Normal	-1.24028844270824	0.414455005163927	21.9999999920783	0.0067090100303592	0.053736745399793	nan
sp|P02763|A1AG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.449067175421034	0.414455005163927	21.9999999926475	0.290313562358847	0.867696529950794	nan
sp|P02763|A1AG1_HUMAN	Normal-Triple-negative breast cancer	1.68935561812927	0.495368479453759	21.9999999925841	0.0025088542410916	0.0337628805562287	nan
sp|P02765|FETUA_HUMAN	metaplastic breast carcinomas-Normal	-1.38585620940286	0.478575996993527	22.0000000053759	0.0083859982352865	0.0602818106368712	nan
sp|P02765|FETUA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0889367818260843	0.478575996993527	22.0000000053707	0.854275949406348	0.977449253880285	nan
sp|P02765|FETUA_HUMAN	Normal-Triple-negative breast cancer	1.47479299122894	0.572007723347395	22.0000000061044	0.0171501644128564	0.0845803360657786	nan
sp|P02766|TTHY_HUMAN	metaplastic breast carcinomas-Normal	-0.985043301240278	0.417523278360195	23.9999999994068	0.0267883052089614	0.116172877501596	nan
sp|P02766|TTHY_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.419318490264652	0.417523278360195	23.9999999994068	0.325253080782099	0.867950636918522	nan
sp|P02766|TTHY_HUMAN	Normal-Triple-negative breast cancer	1.40436179150493	0.499035767359193	23.9999999994655	0.0096078705795862	0.0620611678009953	nan
sp|P02774|VTDB_HUMAN	metaplastic breast carcinomas-Normal	-1.30379683814821	0.446096806800654	22.0000000152854	0.0078837078051085	0.0590212719463534	nan
sp|P02774|VTDB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.295212628087091	0.446096806800654	22.0000000151717	0.514992232972118	0.915620969865368	nan
sp|P02774|VTDB_HUMAN	Normal-Triple-negative breast cancer	1.5990094662353	0.533187666020859	22.0000000160902	0.0066105041611753	0.0520694687956083	nan
sp|P02786|TFR1_HUMAN	metaplastic breast carcinomas-Normal	0.99679335692763	0.462846905643001	22.0001521103518	0.0424907510110976	0.152502316045985	nan
sp|P02786|TFR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.388964053334846	0.462846905643001	22.0001521065109	0.40973993782091	0.885784822958391	nan
sp|P02786|TFR1_HUMAN	Normal-Triple-negative breast cancer	-0.607829303592785	0.553207863366411	22.0001521098884	0.283762578458581	0.47648423120551	nan
sp|P02790|HEMO_HUMAN	metaplastic breast carcinomas-Normal	-1.59828301077855	0.433375944134952	22.0000000506654	0.0012869417491962	0.0269043671341411	nan
sp|P02790|HEMO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.322532484940329	0.433375944134952	22.0000000508096	0.464611540894451	0.909423669537079	nan
sp|P02790|HEMO_HUMAN	Normal-Triple-negative breast cancer	1.92081549571888	0.517983327027399	22.0000000500661	0.0012253499849929	0.0266490250684039	nan
sp|P02792|FRIL_HUMAN	metaplastic breast carcinomas-Normal	0.244307587823508	0.322752246740714	22.0000000025804	0.457110081500279	0.650442598847143	nan
sp|P02792|FRIL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.37506235292925	0.322752246740714	22.0000000024756	0.257657194119652	0.862813416943474	nan
sp|P02792|FRIL_HUMAN	Normal-Triple-negative breast cancer	0.130754765105742	0.385762719031455	22.0000000028516	0.737860403285196	0.849843375093552	nan
sp|P02794|FRIH_HUMAN	metaplastic breast carcinomas-Normal	0.490247806684496	0.206400489878375	22.000000004406	0.0266772734556312	0.116172877501596	nan
sp|P02794|FRIH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.382776221392339	0.206400489878375	22.0000000044429	0.0771166655843862	0.803802235323147	nan
sp|P02794|FRIH_HUMAN	Normal-Triple-negative breast cancer	-0.107471585292158	0.246695770483268	22.0000000045862	0.667339400700769	0.8042915764791	nan
sp|P03897|NU3M_HUMAN	metaplastic breast carcinomas-Normal	-0.121663183127969	0.209085536692442	22.0000000055722	0.566561477790899	0.733067478465141	nan
sp|P03897|NU3M_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.163542741203524	0.209085536692442	22.0000000059367	0.442446038300799	0.89755436380139	nan
sp|P03897|NU3M_HUMAN	Normal-Triple-negative breast cancer	-0.0418795580755547	0.249905015252843	22.0000000055732	0.868443136390605	0.923450091286747	nan
sp|P03950|ANGI_HUMAN	metaplastic breast carcinomas-Normal	-0.513965119546593	0.407656946843932	22.0000000274604	0.220596240143352	0.418773822230466	nan
sp|P03950|ANGI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.289885141744724	0.407656946843932	22.0000000282037	0.484493635828642	0.913320451076758	nan
sp|P03950|ANGI_HUMAN	Normal-Triple-negative breast cancer	0.224079977801869	0.487243245661778	22.0000000277854	0.650105406247915	0.793591762896831	nan
sp|P03952|KLKB1_HUMAN	metaplastic breast carcinomas-Normal	-1.18592648427888	0.396247993618622	23.999999999374	0.0063114287434717	0.0524479728582505	nan
sp|P03952|KLKB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.272412945197428	0.396247993618622	23.9999999995777	0.498370238292844	0.913320451076758	nan
sp|P03952|KLKB1_HUMAN	Normal-Triple-negative breast cancer	1.45833942947631	0.473606938364329	23.9999999993922	0.0051371594434674	0.0454146755055477	nan
sp|P03956|MMP1_HUMAN	metaplastic breast carcinomas-Normal	1.56977985051126	0.747393679577272	20.9935863497006	0.0479595256170306	0.164882962783891	nan
sp|P03956|MMP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.34558875867733	0.747393679577272	20.993586350633	0.0861882181629239	0.809016644110817	nan
sp|P03956|MMP1_HUMAN	Normal-Triple-negative breast cancer	-0.224191091833932	0.883756608165253	20.9755475563751	0.802213025393325	0.88637179413689	nan
sp|P03973|SLPI_HUMAN	metaplastic breast carcinomas-Normal	0.472470650019219	0.688347021906912	23.9999999997136	0.499049047932393	0.685083822753451	nan
sp|P03973|SLPI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.102127820107475	0.688347021906912	23.9999999997136	0.883292877844848	0.984083618739117	nan
sp|P03973|SLPI_HUMAN	Normal-Triple-negative breast cancer	-0.370342829911744	0.822732053733269	23.9999999997463	0.656650829458001	0.798064847209651	nan
sp|P04003|C4BPA_HUMAN	metaplastic breast carcinomas-Normal	-0.516586446446789	0.404924002952725	23.9999999995389	0.214249710961913	0.410707058383736	nan
sp|P04003|C4BPA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.368077742806653	0.404924002952725	23.9999999993041	0.372386221972906	0.885234295852111	nan
sp|P04003|C4BPA_HUMAN	Normal-Triple-negative breast cancer	0.884664189253442	0.483976752935301	23.9999999994491	0.0800224157998272	0.210464269316822	nan
sp|P04004|VTNC_HUMAN	metaplastic breast carcinomas-Normal	-0.393459107178343	0.371586824720759	23.9999999996826	0.30020391472364	0.506536960680904	nan
sp|P04004|VTNC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0416730700394259	0.371586824720759	23.9999999999614	0.911638044499509	0.99408739879047	nan
sp|P04004|VTNC_HUMAN	Normal-Triple-negative breast cancer	0.435132177217769	0.444131203757976	23.9999999997797	0.336989118751854	0.529442092731762	nan
sp|P04062|GBA1_HUMAN	metaplastic breast carcinomas-Normal	-0.497463379253288	0.388125703599444	6.0	0.24724395920619	0.447023820508909	nan
sp|P04062|GBA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0266475103706311	0.388125703599444	6.0	0.947493621881941	0.996541950781621	nan
sp|P04062|GBA1_HUMAN	Normal-Triple-negative breast cancer	0.52411088962392	0.463898944960097	6.0	0.301695700890045	0.494495320393742	nan
sp|P04075|ALDOA_HUMAN	metaplastic breast carcinomas-Normal	0.411672645773549	0.33129151440253	21.9999376561146	0.227086690477614	0.426752157220841	nan
sp|P04075|ALDOA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.464939568670012	0.33129151440253	21.9999376561146	0.174450766924129	0.843662073010871	nan
sp|P04075|ALDOA_HUMAN	Normal-Triple-negative breast cancer	-0.876612214443561	0.395969096043621	21.9999376560189	0.0375118560421376	0.1289854745691	nan
sp|P04080|CYTB_HUMAN	metaplastic breast carcinomas-Normal	-0.133097599487246	0.269680614488138	24.0000000001368	0.626118827318705	0.7762845885891	nan
sp|P04080|CYTB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.247953431713701	0.269680614488138	24.0000000001789	0.367018001348284	0.883542279876718	nan
sp|P04080|CYTB_HUMAN	Normal-Triple-negative breast cancer	-0.114855832226456	0.322329985819101	24.000000000145	0.724706955678835	0.841098345877946	nan
sp|P04083|ANXA1_HUMAN	metaplastic breast carcinomas-Normal	-0.385370009325274	0.31856611573606	22.0000000079022	0.239232313215381	0.439341552004379	nan
sp|P04083|ANXA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.558545894250874	0.31856611573606	22.0000000080782	0.0934728388183144	0.81309570430905	nan
sp|P04083|ANXA1_HUMAN	Normal-Triple-negative breast cancer	0.943915903576148	0.38075933549227	22.0000000081684	0.0213197768848314	0.0961559543625231	nan
sp|P04114|APOB_HUMAN	metaplastic breast carcinomas-Normal	-0.971404150693005	0.439016172908228	24.000000000076	0.036681108944086	0.139187221609751	nan
sp|P04114|APOB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.365381519857518	0.439016172908228	24.0000000000432	0.413459856149539	0.885784822958391	nan
sp|P04114|APOB_HUMAN	Normal-Triple-negative breast cancer	1.33678567055052	0.524724689820409	24.0000000000528	0.0176713194191178	0.0857510448892666	nan
sp|P04156|PRIO_HUMAN	metaplastic breast carcinomas-Normal	-0.534773582106883	0.213901299397802	14.0000001172868	0.0254619879294115	0.112535677388055	nan
sp|P04156|PRIO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.282907773956238	0.213901299397802	14.0000001172868	0.20716491634061	0.843662073010871	nan
sp|P04156|PRIO_HUMAN	Normal-Triple-negative breast cancer	0.817681356063121	0.255660952614054	14.0000001172323	0.0064422383187076	0.0512296654817807	nan
sp|P04179|SODM_HUMAN	metaplastic breast carcinomas-Normal	-0.0161046843581838	0.425644486310321	23.9999999997628	0.970131408213502	0.985850443565172	nan
sp|P04179|SODM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.63655437552691	0.425644486310321	23.9999999997628	0.147816710232004	0.835968999584253	nan
sp|P04179|SODM_HUMAN	Normal-Triple-negative breast cancer	0.652659059885094	0.508742467443537	23.9999999997626	0.211783102437821	0.394600354542219	nan
sp|P04181|OAT_HUMAN	metaplastic breast carcinomas-Normal	0.34503602240747	0.278373633410718	23.9999999994835	0.227155107208409	0.426752157220841	nan
sp|P04181|OAT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.125748967351603	0.278373633410718	23.999999999444	0.655521388028076	0.944190045212043	nan
sp|P04181|OAT_HUMAN	Normal-Triple-negative breast cancer	-0.219287055055868	0.332720130736855	23.9999999994217	0.516122847436435	0.689290039346968	nan
sp|P04196|HRG_HUMAN	metaplastic breast carcinomas-Normal	-1.1827522708044	0.410587741152933	23.9999999998469	0.0082258407000329	0.0602818106368712	nan
sp|P04196|HRG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.125694927847554	0.410587741152933	23.9999999998481	0.762142414882091	0.955228196959647	nan
sp|P04196|HRG_HUMAN	Normal-Triple-negative breast cancer	1.30844719865195	0.49074621486797	23.9999999998704	0.013510755326128	0.0753519307114924	nan
sp|P04216|THY1_HUMAN	metaplastic breast carcinomas-Normal	0.121091685279568	0.412005709598754	23.9999999995041	0.771355177798177	0.876276353725612	nan
sp|P04216|THY1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.120312361787599	0.412005709598754	23.9999999995424	0.772783588139424	0.960203823080563	nan
sp|P04216|THY1_HUMAN	Normal-Triple-negative breast cancer	-0.0007793234919688	0.492441011321549	23.9999999995327	0.998750371759358	0.999945312570918	nan
sp|P04217|A1BG_HUMAN	metaplastic breast carcinomas-Normal	-1.39603453813431	0.425918125251713	23.999999999386	0.0031801544986087	0.0397203367103332	nan
sp|P04217|A1BG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.514876016263652	0.425918125251713	23.9999999995993	0.238491437181188	0.84876230490475	nan
sp|P04217|A1BG_HUMAN	Normal-Triple-negative breast cancer	1.91091055439796	0.509069528534918	23.9999999994997	0.0009793398876571	0.0260426062925799	nan
sp|P04233|HG2A_HUMAN	metaplastic breast carcinomas-Normal	0.139968335301963	0.426332477883281	22.0000000271686	0.745783178146167	0.859564245547108	nan
sp|P04233|HG2A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.159507178404069	0.426332477883281	22.0000000266337	0.711883396658362	0.94948208919602	nan
sp|P04233|HG2A_HUMAN	Normal-Triple-negative breast cancer	-0.299475513706033	0.50956477465452	22.0000000266017	0.562712519086805	0.725264216147553	nan
sp|P04264|K2C1_HUMAN	metaplastic breast carcinomas-Normal	-2.06191958772339	0.992288097930277	14.0000000001401	0.0565924282303679	0.180704352966131	nan
sp|P04264|K2C1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.28224223307397	0.992288097930277	14.0000000001401	0.780240270960809	0.961606157891275	nan
sp|P04264|K2C1_HUMAN	Normal-Triple-negative breast cancer	2.34416182079736	1.16762224025823	14.0000000001434	0.0643847655994642	0.18433674492043	nan
sp|P04271|S100B_HUMAN	metaplastic breast carcinomas-Normal	-1.5604622165242	0.817282681684047	22.0000000263362	0.0693472274732413	0.204216569909399	nan
sp|P04271|S100B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.327064845345692	0.817282681684047	22.0000000258533	0.69287907831508	0.946568877415162	nan
sp|P04271|S100B_HUMAN	Normal-Triple-negative breast cancer	1.88752706186989	0.976839643062308	22.000000025764	0.0663030178048125	0.186338952556932	nan
sp|P04275|VWF_HUMAN	metaplastic breast carcinomas-Normal	-1.25253513496625	0.339320713207014	21.9999930435385	0.0012766547993423	0.0268582313481894	nan
sp|P04275|VWF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.036872617144656	0.339320713207014	21.9999930358104	0.91445246529043	0.99408739879047	nan
sp|P04275|VWF_HUMAN	Normal-Triple-negative breast cancer	1.28940775211091	0.405565824164774	21.9999930439171	0.0043386151331614	0.0419484078096101	nan
sp|P04406|G3P_HUMAN	metaplastic breast carcinomas-Normal	0.745366897445122	0.268118017984179	22.000000003988	0.0109199667415974	0.0698037874020569	nan
sp|P04406|G3P_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0379341160265762	0.268118017984179	22.0000000026428	0.888776049730538	0.987363971050464	nan
sp|P04406|G3P_HUMAN	Normal-Triple-negative breast cancer	-0.783301013471698	0.320462325772724	22.0000000030366	0.022990672910737	0.100686425237536	nan
sp|P04439|HLAA_HUMAN	metaplastic breast carcinomas-Normal	0.277151418936229	0.586939602244851	17.0907180785884	0.642758913505999	0.788678711145789	nan
sp|P04439|HLAA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.1055048311268	0.540195345512829	16.7177402821765	0.847505368654651	0.974695644619665	nan
sp|P04439|HLAA_HUMAN	Normal-Triple-negative breast cancer	-0.171646587809429	0.682044658489762	17.114735844233	0.804297267883632	0.887610929098669	nan
sp|P04632|CPNS1_HUMAN	metaplastic breast carcinomas-Normal	-0.247853102738726	0.164528966164244	22.0000000001634	0.146179136431155	0.323501630823674	nan
sp|P04632|CPNS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.30706639230741	0.164528966164244	22.0000000004436	0.0753815756654088	0.795994790325479	nan
sp|P04632|CPNS1_HUMAN	Normal-Triple-negative breast cancer	-0.059213289568684	0.196649727423715	22.00000000026	0.766157775829619	0.86622521606503	nan
sp|P04637|P53_HUMAN	metaplastic breast carcinomas-Normal	-0.0242345640040508	1.54652705678933	5.0	0.988103472488807	0.994136910531496	nan
sp|P04637|P53_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0204005911822967	1.18117955033906	5.0	0.9868881256867	0.99777413090774	nan
sp|P04637|P53_HUMAN	Normal-Triple-negative breast cancer	0.003833972821754	1.72906981401181	5.0	0.998316551143522	0.999945312570918	nan
sp|P04792|HSPB1_HUMAN	metaplastic breast carcinomas-Normal	0.0506864791542052	0.390871288704869	22.000000202917	0.898001394093956	0.944829809649739	nan
sp|P04792|HSPB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.467649230130134	0.390871288704869	22.0000002029549	0.244264930315579	0.84964799869723	nan
sp|P04792|HSPB1_HUMAN	Normal-Triple-negative breast cancer	0.416962750975929	0.467180546827463	22.0000002026182	0.381779144235017	0.569584324702513	nan
sp|P04839|CY24B_HUMAN	metaplastic breast carcinomas-Normal	-0.463354155128228	0.363048069420389	22.0000002790947	0.215163010354018	0.411189983111795	nan
sp|P04839|CY24B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.524101144915383	0.363048069420389	22.0000002798608	0.162937735126224	0.843662073010871	nan
sp|P04839|CY24B_HUMAN	Normal-Triple-negative breast cancer	0.987455300043611	0.433925439134868	22.0000002795777	0.0329602390797762	0.121868559178171	nan
sp|P04843|RPN1_HUMAN	metaplastic breast carcinomas-Normal	0.876397446585492	0.203481783402114	24.000000000089	0.0002419538720253	0.0157578323963946	nan
sp|P04843|RPN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.117706176647689	0.203481783402114	24.0000000000509	0.568342408805838	0.935631258424823	nan
sp|P04843|RPN1_HUMAN	Normal-Triple-negative breast cancer	-0.758691269937804	0.243207249000591	24.0000000000563	0.0046636204058877	0.0436121424321106	nan
sp|P04844|RPN2_HUMAN	metaplastic breast carcinomas-Normal	0.593161391785299	0.218640812734329	23.9999999995463	0.0121405233065656	0.0721915911825116	nan
sp|P04844|RPN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0172957478193179	0.218640812734329	23.9999999995463	0.937604395256762	0.995571782532303	nan
sp|P04844|RPN2_HUMAN	Normal-Triple-negative breast cancer	-0.610457139604617	0.261325754548194	23.9999999995631	0.0281741198874285	0.112421067564965	nan
sp|P04899|GNAI2_HUMAN	metaplastic breast carcinomas-Normal	-0.268422993177206	0.251172758439604	22.0000000171005	0.296800811187033	0.501049210962772	nan
sp|P04899|GNAI2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0750920170761399	0.251172758439604	22.0000000173802	0.767772163916072	0.958994156657001	nan
sp|P04899|GNAI2_HUMAN	Normal-Triple-negative breast cancer	0.343515010253346	0.300208866772452	22.0000000170486	0.264816083770665	0.45561224315785	nan
sp|P05023|AT1A1_HUMAN	metaplastic breast carcinomas-Normal	0.574611183852267	0.24987012669992	21.9999999611943	0.0313325645495658	0.127477900321611	nan
sp|P05023|AT1A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.131756231682698	0.24987012669992	21.9999999614341	0.603263595116352	0.940559810632461	nan
sp|P05023|AT1A1_HUMAN	Normal-Triple-negative breast cancer	-0.706367415534966	0.298651924049754	21.9999999615387	0.0272565804589113	0.110759013991957	nan
sp|P05067|A4_HUMAN	metaplastic breast carcinomas-Normal	0.16083680559814	0.61305648251305	6.0	0.801824983972181	0.895586776452799	nan
sp|P05067|A4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.194872586068856	0.61305648251305	6.0	0.761355215765725	0.955228196959647	nan
sp|P05067|A4_HUMAN	Normal-Triple-negative breast cancer	-0.355709391666997	0.732742647037507	6.0	0.644574248522015	0.79032268612585	nan
sp|P05090|APOD_HUMAN	metaplastic breast carcinomas-Normal	-1.9828424375779	0.723888031348002	22.0000000251244	0.0119759185305467	0.0719854488165233	nan
sp|P05090|APOD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.32788772885867	0.723888031348002	22.0000000243184	0.655017677399294	0.944190045212043	nan
sp|P05090|APOD_HUMAN	Normal-Triple-negative breast cancer	1.65495470871923	0.865211685021884	22.0000000249689	0.0688826312387387	0.19032906586664	nan
sp|P05091|ALDH2_HUMAN	metaplastic breast carcinomas-Normal	-1.31568316918268	0.436926353466275	23.9999999996702	0.0060423355171104	0.0510320974930049	nan
sp|P05091|ALDH2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.120733853990542	0.436926353466275	23.9999999997033	0.784663798340077	0.962981271203673	nan
sp|P05091|ALDH2_HUMAN	Normal-Triple-negative breast cancer	1.19494931519214	0.522226877835043	23.9999999996614	0.0312324933715202	0.11855547895338	nan
sp|P05106|ITB3_HUMAN	metaplastic breast carcinomas-Normal	-0.0800007217981698	0.430207134919603	13.9999891796055	0.855144689910926	0.925247532247456	nan
sp|P05106|ITB3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.4788993971924	0.430207134919603	13.999989177666	0.284378248932305	0.867696529950794	nan
sp|P05106|ITB3_HUMAN	Normal-Triple-negative breast cancer	0.55890011899057	0.514195875595691	13.999989179935	0.295423470765106	0.487645781732731	nan
sp|P05107|ITB2_HUMAN	metaplastic breast carcinomas-Normal	0.543144098575877	0.393861607095791	22.0000000379142	0.18174779973268	0.37223024418449	nan
sp|P05107|ITB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.246668213736493	0.393861607095791	22.0000000378764	0.53757493738351	0.921388505638487	nan
sp|P05107|ITB2_HUMAN	Normal-Triple-negative breast cancer	-0.296475884839384	0.470754660919312	22.0000000379615	0.535319636635083	0.702867070999919	nan
sp|P05109|S10A8_HUMAN	metaplastic breast carcinomas-Normal	0.844039057516413	0.804216579545465	21.999999961109	0.305333327970345	0.513108181078577	nan
sp|P05109|S10A8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.816155064136066	0.804216579545465	21.999999961146	0.321211549548634	0.867696529950794	nan
sp|P05109|S10A8_HUMAN	Normal-Triple-negative breast cancer	-0.0278839933803472	0.961222663973789	21.9999999604384	0.977119058758114	0.988838748530576	nan
sp|P05114|HMGN1_HUMAN	metaplastic breast carcinomas-Normal	0.205785283573176	0.385353688374965	23.9999999994359	0.598242148568798	0.756392887730196	nan
sp|P05114|HMGN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.731602741957308	0.385353688374965	23.9999999996951	0.0697157497105825	0.781899532609971	nan
sp|P05114|HMGN1_HUMAN	Normal-Triple-negative breast cancer	-0.937388025530484	0.460585753058289	23.9999999995329	0.0530170817214353	0.162439494536208	nan
sp|P05120|PAI2_HUMAN	metaplastic breast carcinomas-Normal	-0.544624992670912	1.14407022182408	10.9973908845804	0.643361417044693	0.788835614259151	nan
sp|P05120|PAI2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.659257574619125	0.969006038802533	10.1610857005847	0.511490101879675	0.915620969865368	nan
sp|P05120|PAI2_HUMAN	Normal-Triple-negative breast cancer	-0.114632581948213	1.33013160934441	10.6613576893234	0.932919410564557	0.962453172165297	nan
sp|P05141|ADT2_HUMAN	metaplastic breast carcinomas-Normal	0.874563565022676	0.26396533375809	23.9999999990573	0.0029165502937902	0.0380628964347452	nan
sp|P05141|ADT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.144003723052594	0.26396533375809	23.9999999993336	0.59041690409222	0.940559810632461	nan
sp|P05141|ADT2_HUMAN	Normal-Triple-negative breast cancer	-1.01856728807527	0.315498918780171	23.9999999991717	0.0035849136997742	0.0399874266377507	nan
sp|P05154|IPSP_HUMAN	metaplastic breast carcinomas-Normal	-0.691495606498756	0.351719111981776	22.0000000034367	0.0620380675451405	0.191116345245641	nan
sp|P05154|IPSP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.135218551322876	0.351719111981776	22.0000000036962	0.704335754574398	0.94948208919602	nan
sp|P05154|IPSP_HUMAN	Normal-Triple-negative breast cancer	0.826714157821632	0.420384745090306	22.0000000030279	0.0619742612761372	0.179601084988562	nan
sp|P05155|IC1_HUMAN	metaplastic breast carcinomas-Normal	-0.969510003570481	0.366982038332429	23.9999999992038	0.0142828596281349	0.0795361221927149	nan
sp|P05155|IC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.303124773253797	0.366982038332429	23.9999999994897	0.416943724046127	0.8860071777014	nan
sp|P05155|IC1_HUMAN	Normal-Triple-negative breast cancer	1.27263477682428	0.438627431326771	23.9999999993851	0.0078343050846264	0.0561233407355565	nan
sp|P05156|CFAI_HUMAN	metaplastic breast carcinomas-Normal	-1.21108661938659	0.390902290942034	24.0000000000428	0.0049088832657277	0.0470009737236255	nan
sp|P05156|CFAI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.284834674336136	0.390902290942034	24.0000000000441	0.473260794438582	0.913280230088743	nan
sp|P05156|CFAI_HUMAN	Normal-Triple-negative breast cancer	1.49592129372273	0.467217601588276	24.0000000000749	0.0038243027407294	0.0403623732245556	nan
sp|P05161|ISG15_HUMAN	metaplastic breast carcinomas-Normal	0.608435162794382	0.407097470296568	23.9999999996553	0.148060155254656	0.3261444374198	nan
sp|P05161|ISG15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.646429383172413	0.407097470296568	23.9999999996945	0.125397931690331	0.823891816737944	nan
sp|P05161|ISG15_HUMAN	Normal-Triple-negative breast cancer	0.0379942203780317	0.486574543286116	23.9999999996981	0.938407742076349	0.96623130515859	nan
sp|P05164|PERM_HUMAN	metaplastic breast carcinomas-Normal	0.517034092646512	0.510179507388542	22.0000000108194	0.321868901616267	0.529897740936004	nan
sp|P05164|PERM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.990323622681258	0.510179507388542	22.0000000108251	0.0651610842565171	0.773787875546141	nan
sp|P05164|PERM_HUMAN	Normal-Triple-negative breast cancer	0.473289530034746	0.609781143126913	22.000000010814	0.445917462601382	0.630199679288687	nan
sp|P05165|PCCA_HUMAN	metaplastic breast carcinomas-Normal	-0.572700092837671	0.280678738641045	23.9999999999253	0.0524582114250439	0.174196897878967	nan
sp|P05165|PCCA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.292510868888435	0.280678738641045	23.999999999681	0.307724453382672	0.867696529950794	nan
sp|P05165|PCCA_HUMAN	Normal-Triple-negative breast cancer	0.280189223949236	0.335475258455669	23.9999999998583	0.411842157995163	0.600159286793477	nan
sp|P05166|PCCB_HUMAN	metaplastic breast carcinomas-Normal	-0.684407236410663	0.384812006544609	14.9999999997609	0.0955833334161754	0.24981566540925	nan
sp|P05166|PCCB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.625309223903658	0.384812006544609	14.9999999997883	0.124989878895788	0.823891816737944	nan
sp|P05166|PCCB_HUMAN	Normal-Triple-negative breast cancer	0.0590980125070059	0.45993831943749	14.9999999997908	0.899467229964652	0.941085638149985	nan
sp|P05186|PPBT_HUMAN	metaplastic breast carcinomas-Normal	0.167648697249462	0.248087753940392	23.9999999995409	0.505650617071966	0.690827230229023	nan
sp|P05186|PPBT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.385531876479538	0.248087753940392	23.9999999995152	0.133270026990034	0.823891816737944	nan
sp|P05186|PPBT_HUMAN	Normal-Triple-negative breast cancer	0.217883179230076	0.296521581135068	23.9999999994498	0.469582634918784	0.649289799696355	nan
sp|P05198|IF2A_HUMAN	metaplastic breast carcinomas-Normal	0.465222743096076	0.166056439559126	21.9999986314811	0.0103978559701716	0.0677695553820595	nan
sp|P05198|IF2A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0785662993955019	0.166056439559126	21.9999986036277	0.640781062754454	0.941868024951375	nan
sp|P05198|IF2A_HUMAN	Normal-Triple-negative breast cancer	-0.543789042491577	0.198475407325275	21.9999986153505	0.0119577165729399	0.0704742019298799	nan
sp|P05362|ICAM1_HUMAN	metaplastic breast carcinomas-Normal	0.315041729048217	0.354002271914153	23.9999999997006	0.382330986206028	0.588910193766839	nan
sp|P05362|ICAM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0590074683018841	0.354002271914153	23.9999999997006	0.869012980864814	0.981143688073178	nan
sp|P05362|ICAM1_HUMAN	Normal-Triple-negative breast cancer	-0.256034260746333	0.423113643161169	23.9999999997975	0.550779099213177	0.71563937817808	nan
sp|P05387|RLA2_HUMAN	metaplastic breast carcinomas-Normal	0.791590460993139	0.170390302967628	22.0000000627403	0.0001246347148416	0.0142544475449197	nan
sp|P05387|RLA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.157667806110716	0.170390302967628	22.0000000625907	0.364832273136468	0.883542279876718	nan
sp|P05387|RLA2_HUMAN	Normal-Triple-negative breast cancer	-0.633922654882423	0.203655364860064	22.0000000630611	0.005071922838574	0.045320084718871	nan
sp|P05388|RLA0_HUMAN	metaplastic breast carcinomas-Normal	0.480251300406955	0.261365669037651	22.000000000098	0.0796859914600094	0.223713036835364	nan
sp|P05388|RLA0_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.301930389101903	0.261365669037651	22.0000000000552	0.260400529848344	0.862813416943474	nan
sp|P05388|RLA0_HUMAN	Normal-Triple-negative breast cancer	-0.782181689508858	0.312391725131625	22.0000000004534	0.0201966188182456	0.0931117350233683	nan
sp|P05452|TETN_HUMAN	metaplastic breast carcinomas-Normal	-0.79283943171866	0.375110820124734	22.000000000827	0.0461201908012667	0.161202433463102	nan
sp|P05452|TETN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.199652146157923	0.375110820124734	22.0000000014055	0.599888681499816	0.940559810632461	nan
sp|P05452|TETN_HUMAN	Normal-Triple-negative breast cancer	0.992491577876583	0.44834318388397	22.0000000014994	0.0375237526799999	0.1289854745691	nan
sp|P05455|LA_HUMAN	metaplastic breast carcinomas-Normal	0.355655386066997	0.228774371894936	22.0000000141845	0.13430747656582	0.307676121367875	nan
sp|P05455|LA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.32855243886726	0.228774371894936	22.0000000132549	0.165030146442186	0.843662073010871	nan
sp|P05455|LA_HUMAN	Normal-Triple-negative breast cancer	-0.684207824934257	0.273437674371333	22.0000000140932	0.0202675562609031	0.0933093587413325	nan
sp|P05543|THBG_HUMAN	metaplastic breast carcinomas-Normal	-1.58553886974786	0.469317777779829	23.999999999616	0.0024861018409828	0.0358739474876542	nan
sp|P05543|THBG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.328260598758797	0.469317777779829	23.999999999616	0.490999872394536	0.913320451076758	nan
sp|P05543|THBG_HUMAN	Normal-Triple-negative breast cancer	1.91379946850666	0.560942034871693	23.9999999996276	0.002290397798341	0.0323969458795131	nan
sp|P05546|HEP2_HUMAN	metaplastic breast carcinomas-Normal	-1.58336266641898	0.46353185431233	23.9999999994177	0.0022673768257915	0.0344046144412164	nan
sp|P05546|HEP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.312965728798655	0.46353185431233	23.9999999994177	0.50601714099039	0.913320451076758	nan
sp|P05546|HEP2_HUMAN	Normal-Triple-negative breast cancer	1.89632839521763	0.554026533611919	23.9999999994121	0.0022289482654308	0.0322131479751828	nan
sp|P05556|ITB1_HUMAN	metaplastic breast carcinomas-Normal	-0.216709556370831	0.218685116905244	22.0000000040584	0.332476907111226	0.540733675944729	nan
sp|P05556|ITB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.161056331880996	0.218685116905244	22.000000004289	0.469222252536978	0.911843360423993	nan
sp|P05556|ITB1_HUMAN	Normal-Triple-negative breast cancer	0.377765888251827	0.261378708160784	22.0000000039112	0.162473518515915	0.332141436375708	nan
sp|P05783|K1C18_HUMAN	metaplastic breast carcinomas-Normal	-0.31435510504108	0.497143987373844	22.0000000394765	0.533693585183167	0.710451532698777	nan
sp|P05783|K1C18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.09770866907546	0.497143987373844	22.0000000401687	0.0379679699036744	0.73123935744099	nan
sp|P05783|K1C18_HUMAN	Normal-Triple-negative breast cancer	-0.783353564034378	0.594200716667795	22.0000000397517	0.200954170531721	0.38169809305568	nan
sp|P05997|CO5A2_HUMAN	metaplastic breast carcinomas-Normal	0.346486654432909	0.393576979549163	20.2200489037937	0.389012115950935	0.592689911608717	nan
sp|P05997|CO5A2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.261729000994669	0.368352403682771	20.1467365258835	0.48551429029492	0.913320451076758	nan
sp|P05997|CO5A2_HUMAN	Normal-Triple-negative breast cancer	-0.0847576534382395	0.457846643638721	20.307781273033	0.854969439449975	0.917339708435028	nan
sp|P06280|AGAL_HUMAN	metaplastic breast carcinomas-Normal	0.313956652343827	0.463871319399738	13.9999999993339	0.509550255212824	0.693305382041517	nan
sp|P06280|AGAL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.316725614448036	0.463871319399738	13.9999999995476	0.505883107846452	0.913320451076758	nan
sp|P06280|AGAL_HUMAN	Normal-Triple-negative breast cancer	-0.630682266791863	0.554432271996259	13.9999999992846	0.274411996009161	0.466093753057973	nan
sp|P06312|KV401_HUMAN	metaplastic breast carcinomas-Normal	-1.14010844723779	0.455986502382368	23.9999999999816	0.0196405364524933	0.0954461157428185	nan
sp|P06312|KV401_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.289892742408476	0.455986502382368	23.9999999999816	0.530956429127724	0.920933816822996	nan
sp|P06312|KV401_HUMAN	Normal-Triple-negative breast cancer	1.43000118964626	0.545008113117732	24.0000000000128	0.0148798991136738	0.0779324922305247	nan
sp|P06400|RB_HUMAN	metaplastic breast carcinomas-Normal	1.3248130038531	0.808496658195892	13.0059389784357	0.125246551287827	0.296183334837538	nan
sp|P06400|RB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.01999714299776	0.808496658195892	13.0059389784587	0.229251674746546	0.843662073010871	nan
sp|P06400|RB_HUMAN	Normal-Triple-negative breast cancer	-0.304815860855342	0.950502646450761	13.0000003062853	0.753542710651935	0.858093857556366	nan
sp|P06493|CDK1_HUMAN	metaplastic breast carcinomas-Normal	0.194050353335424	0.383747430150707	22.0000000271713	0.618116050854901	0.771252910300935	nan
sp|P06493|CDK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.248028967732993	0.383747430150707	22.0000000271803	0.524749006197249	0.918310760845185	nan
sp|P06493|CDK1_HUMAN	Normal-Triple-negative breast cancer	-0.442079321068417	0.458665907274676	22.0000000272038	0.345603205030399	0.537813772934957	nan
sp|P06576|ATPB_HUMAN	metaplastic breast carcinomas-Normal	-0.0064481979608151	0.142770313762526	23.9999999991947	0.964349622057615	0.982981891035447	nan
sp|P06576|ATPB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.253432208042474	0.142770313762526	23.9999999991935	0.0885660326184474	0.809016644110817	nan
sp|P06576|ATPB_HUMAN	Normal-Triple-negative breast cancer	-0.246984010081659	0.17064316357262	23.9999999992354	0.160730080952948	0.330610636811632	nan
sp|P06681|CO2_HUMAN	metaplastic breast carcinomas-Normal	-0.580912566658634	0.367886948314302	23.9999999999264	0.127415097172128	0.298259002112784	nan
sp|P06681|CO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.353502896479162	0.367886948314302	23.9999999995938	0.346183740608847	0.871355743773214	nan
sp|P06681|CO2_HUMAN	Normal-Triple-negative breast cancer	0.934415463137796	0.439709005625977	23.9999999998574	0.0440724600567158	0.142646284183891	nan
sp|P06702|S10A9_HUMAN	metaplastic breast carcinomas-Normal	0.377820634629834	0.599720875306813	22.0030090996566	0.535186694919881	0.711584229565474	nan
sp|P06702|S10A9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.409925896817727	0.599720875306813	22.0030091071558	0.50140868208743	0.913320451076758	nan
sp|P06702|S10A9_HUMAN	Normal-Triple-negative breast cancer	0.0321052621878929	0.716803547781767	22.0030091133599	0.964679116283744	0.982929910189078	nan
sp|P06703|S10A6_HUMAN	metaplastic breast carcinomas-Normal	-0.398608269378615	0.311034307931975	21.9999999417991	0.213341083214096	0.409674038476981	nan
sp|P06703|S10A6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.349553163264995	0.311034307931975	21.999999943403	0.273194371075814	0.867696529950794	nan
sp|P06703|S10A6_HUMAN	Normal-Triple-negative breast cancer	0.748161432643611	0.37175710332482	21.9999999392194	0.0565674398568046	0.170009195374339	nan
sp|P06727|APOA4_HUMAN	metaplastic breast carcinomas-Normal	-1.5734663207571	0.457047251301353	21.9999995796605	0.002322041411615	0.0344046144412164	nan
sp|P06727|APOA4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.116271747731288	0.457047251301353	21.9999995796921	0.801551140258536	0.965774701272009	nan
sp|P06727|APOA4_HUMAN	Normal-Triple-negative breast cancer	1.45719457302581	0.546275950573024	21.9999995758664	0.0140658082873916	0.0768992545185687	nan
sp|P06730|IF4E_HUMAN	metaplastic breast carcinomas-Normal	0.538960335967178	0.290087099571176	22.0000000083576	0.0766142292980499	0.217477112029648	nan
sp|P06730|IF4E_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0466829239895049	0.290087099571176	22.0000000085976	0.873619312528673	0.98181923303563	nan
sp|P06730|IF4E_HUMAN	Normal-Triple-negative breast cancer	-0.585643259956683	0.346720400606305	22.0000000087696	0.105326223977169	0.250970873476781	nan
sp|P06733|ENOA_HUMAN	metaplastic breast carcinomas-Normal	0.572086355316053	0.197960902829576	23.9999999994013	0.0080489727918525	0.0598541063984737	nan
sp|P06733|ENOA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0073055536838301	0.197960902829576	23.9999999994013	0.970866778989947	0.99709406933403	nan
sp|P06733|ENOA_HUMAN	Normal-Triple-negative breast cancer	-0.579391908999883	0.236608534591576	23.9999999993031	0.0220195921510939	0.0979827634675181	nan
sp|P06737|PYGL_HUMAN	metaplastic breast carcinomas-Normal	-0.377341624279373	0.237281610773734	23.9999999994522	0.124861851663024	0.296034803800209	nan
sp|P06737|PYGL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.744351997024314	0.237281610773734	23.9999999994522	0.0044716527691615	0.514807348186537	nan
sp|P06737|PYGL_HUMAN	Normal-Triple-negative breast cancer	1.12169362130369	0.283605769665715	23.9999999994035	0.000590146052382	0.0237592699893802	nan
sp|P06744|G6PI_HUMAN	metaplastic breast carcinomas-Normal	-0.227569626838601	0.22348922480958	23.9999999999646	0.31871110200676	0.526350188622422	nan
sp|P06744|G6PI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.679430022084205	0.22348922480958	23.9999999999646	0.0056406442932807	0.519941801393686	nan
sp|P06744|G6PI_HUMAN	Normal-Triple-negative breast cancer	-0.451860395245603	0.267120715370377	23.9999999999823	0.103669212304393	0.248268344164123	nan
sp|P06746|DPOLB_HUMAN	metaplastic breast carcinomas-Normal	-0.35068206502074	0.839414058346527	13.9999973555471	0.68245186406037	0.815009772846929	nan
sp|P06746|DPOLB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.612343102923212	0.839414058346527	13.999997355667	0.477731124405498	0.913280230088743	nan
sp|P06746|DPOLB_HUMAN	Normal-Triple-negative breast cancer	0.963025167943952	1.00329169761326	13.9999973557912	0.353408023890961	0.543675061879149	nan
sp|P06748|NPM_HUMAN	metaplastic breast carcinomas-Normal	1.06757676525737	0.255732943988242	21.9999979099728	0.0003939180281683	0.0189469278504515	nan
sp|P06748|NPM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.159760247810083	0.255732943988242	21.9999979099682	0.538583807422546	0.921388505638487	nan
sp|P06748|NPM_HUMAN	Normal-Triple-negative breast cancer	-1.22733701306745	0.305659331004057	21.9999979107682	0.0005809555610418	0.0237592699893802	nan
sp|P06753|TPM3_HUMAN	metaplastic breast carcinomas-Normal	0.803069836992173	0.210311820575905	23.9999999997534	0.0008325149717547	0.0227210419054423	nan
sp|P06753|TPM3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.166107186786252	0.210311820575905	23.9999999997534	0.437370859845687	0.897513075778899	nan
sp|P06753|TPM3_HUMAN	Normal-Triple-negative breast cancer	-0.636962650205921	0.251370704833524	23.9999999997646	0.0182195471470085	0.0873480619203579	nan
sp|P06756|ITAV_HUMAN	metaplastic breast carcinomas-Normal	0.350360752518423	0.170278465525908	23.9999999992526	0.0506515110323228	0.170583204327701	nan
sp|P06756|ITAV_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.292780228154315	0.170278465525908	23.9999999992526	0.0984110877269043	0.820234747280893	nan
sp|P06756|ITAV_HUMAN	Normal-Triple-negative breast cancer	-0.0575805243641079	0.203521693550125	23.9999999992302	0.779663438851204	0.874519294198955	nan
sp|P06865|HEXA_HUMAN	metaplastic breast carcinomas-Normal	-0.119732444051249	0.201674897523729	23.9999999997582	0.558273861063724	0.728011892575841	nan
sp|P06865|HEXA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0369717522828263	0.201674897523729	23.9999999997959	0.856084135927156	0.977691255315669	nan
sp|P06865|HEXA_HUMAN	Normal-Triple-negative breast cancer	0.0827606917684231	0.241047607304943	23.9999999998226	0.734333995943577	0.846955656667748	nan
sp|P07093|GDN_HUMAN	metaplastic breast carcinomas-Normal	1.0519077973302	0.511737179915146	14.9999999997514	0.0576655286675893	0.182897857373237	nan
sp|P07093|GDN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.539238921627996	0.511737179915146	14.9999999997816	0.308679872290222	0.867696529950794	nan
sp|P07093|GDN_HUMAN	Normal-Triple-negative breast cancer	-0.512668875702206	0.611642917894685	14.9999999997631	0.415084914374835	0.602507535101289	nan
sp|P07099|HYEP_HUMAN	metaplastic breast carcinomas-Normal	-0.70882019493904	0.246523541995322	23.9999999994042	0.008330026623363	0.0602818106368712	nan
sp|P07099|HYEP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0628402092712729	0.246523541995322	23.9999999994042	0.800967715656771	0.965774701272009	nan
sp|P07099|HYEP_HUMAN	Normal-Triple-negative breast cancer	0.771660404210313	0.294651990267258	23.9999999994411	0.0150471382202519	0.0781078712931399	nan
sp|P07108|ACBP_HUMAN	metaplastic breast carcinomas-Normal	-0.548749317443372	0.387620179823572	21.999997889738	0.170868694681049	0.359928733282514	nan
sp|P07108|ACBP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.480393686354276	0.387620179823572	21.9999978735204	0.228278063078009	0.843662073010871	nan
sp|P07108|ACBP_HUMAN	Normal-Triple-negative breast cancer	0.0683556310890953	0.463294728480476	21.9999978874363	0.884047740292135	0.93275221069853	nan
sp|P07195|LDHB_HUMAN	metaplastic breast carcinomas-Normal	0.133434048011266	0.330219362286082	22.0000001879578	0.690057295736558	0.818757775620021	nan
sp|P07195|LDHB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.486193158237217	0.330219362286082	22.0000001870638	0.155093398485276	0.843465960034572	nan
sp|P07195|LDHB_HUMAN	Normal-Triple-negative breast cancer	0.352759110225951	0.394687629160484	22.0000001874115	0.381119727442044	0.568855848234105	nan
sp|P07196|NFL_HUMAN	metaplastic breast carcinomas-Normal	-0.103573052048409	0.656627589147399	14.9999999996162	0.876769505014252	0.936028205411438	nan
sp|P07196|NFL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.599859104910521	0.656627589147399	14.999999999504	0.375406511774595	0.885234295852111	nan
sp|P07196|NFL_HUMAN	Normal-Triple-negative breast cancer	0.703432156958931	0.784820080227241	14.9999999995582	0.384252984052176	0.572504221868864	nan
sp|P07203|GPX1_HUMAN	metaplastic breast carcinomas-Normal	-0.350928913561887	0.211003639987999	23.9999999999738	0.109290101293277	0.270902532959621	nan
sp|P07203|GPX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0774146509853305	0.211003639987999	24.0000000002255	0.716917781901812	0.949812109346858	nan
sp|P07203|GPX1_HUMAN	Normal-Triple-negative breast cancer	0.428343564547217	0.252197587187351	24.0000000001085	0.10235350487181	0.246003651622484	nan
sp|P07225|PROS_HUMAN	metaplastic breast carcinomas-Normal	-0.644267209603264	0.337561794580757	21.9999948544912	0.0694473219372062	0.204216569909399	nan
sp|P07225|PROS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.489412051522139	0.337561794580757	21.9999948545023	0.161209301312425	0.843662073010871	nan
sp|P07225|PROS_HUMAN	Normal-Triple-negative breast cancer	1.1336792611254	0.403463514301181	21.999994854484	0.0102042026055637	0.0642400936759351	nan
sp|P07237|PDIA1_HUMAN	metaplastic breast carcinomas-Normal	0.761168689819823	0.271653443689677	23.9999999996551	0.0098835188007934	0.0662809589407996	nan
sp|P07237|PDIA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0998005305644347	0.271653443689677	23.9999999996551	0.716554049169783	0.949812109346858	nan
sp|P07237|PDIA1_HUMAN	Normal-Triple-negative breast cancer	-0.860969220384258	0.324687967722112	23.9999999997465	0.0139666867107216	0.0766840777488802	nan
sp|P07305|H10_HUMAN	metaplastic breast carcinomas-Normal	0.0194109075758675	0.335796682135369	23.9999999995454	0.954382126685658	0.975812423593703	nan
sp|P07305|H10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0761039098271326	0.335796682135369	23.9999999995454	0.822625369631422	0.965774701272009	nan
sp|P07305|H10_HUMAN	Normal-Triple-negative breast cancer	0.0566930022512651	0.401353801407761	23.9999999995766	0.888847921064393	0.934958409367033	nan
sp|P07355|ANXA2_HUMAN	metaplastic breast carcinomas-Normal	-1.06276194908998	0.362648948097649	23.9999999995657	0.0073146172000047	0.0569409545030814	nan
sp|P07355|ANXA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.589574112093584	0.362648948097649	23.9999999998585	0.117065213912964	0.823891816737944	nan
sp|P07355|ANXA2_HUMAN	Normal-Triple-negative breast cancer	1.65233606118356	0.433448397911334	23.9999999997683	0.0008460087101398	0.0257262735003663	nan
sp|P07357|CO8A_HUMAN	metaplastic breast carcinomas-Normal	-0.673364773901498	0.414039786216845	23.9999999995894	0.11694005385471	0.282336118991185	nan
sp|P07357|CO8A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.429918379068301	0.414039786216845	23.9999999998508	0.309455705404643	0.867696529950794	nan
sp|P07357|CO8A_HUMAN	Normal-Triple-negative breast cancer	1.1032831529698	0.494872197889069	23.9999999997143	0.035403036970844	0.12599539067568	nan
sp|P07358|CO8B_HUMAN	metaplastic breast carcinomas-Normal	-0.527759443933775	0.34335094705714	21.999999999078	0.138531535963805	0.312797603733859	nan
sp|P07358|CO8B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.197964821649136	0.34335094705714	21.9999999992763	0.570084774120101	0.935631258424823	nan
sp|P07358|CO8B_HUMAN	Normal-Triple-negative breast cancer	0.725724265582912	0.410382874964752	21.9999999991557	0.0908585788822365	0.227935031097777	nan
sp|P07360|CO8G_HUMAN	metaplastic breast carcinomas-Normal	-0.709341869403719	0.469059133233585	22.0000000047031	0.144699443743445	0.321923081616025	nan
sp|P07360|CO8G_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.289885816143771	0.469059133233585	22.0000000040198	0.54291062660848	0.923837171685362	nan
sp|P07360|CO8G_HUMAN	Normal-Triple-negative breast cancer	0.999227685547491	0.560632895510374	22.0000000040646	0.0885049991980724	0.224059876111495	nan
sp|P07384|CAN1_HUMAN	metaplastic breast carcinomas-Normal	-0.423564287399965	0.21104018979193	24.0000000001109	0.0561365117457485	0.180456132482707	nan
sp|P07384|CAN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.477118129740018	0.21104018979193	23.9999999998949	0.0331176164832914	0.724424466074313	nan
sp|P07384|CAN1_HUMAN	Normal-Triple-negative breast cancer	-0.0535538423400535	0.252241272558676	24.0000000000029	0.833656517668902	0.905875862939337	nan
sp|P07437|TBB5_HUMAN	metaplastic breast carcinomas-Normal	0.391884112748142	0.362648679838151	23.9999999998739	0.290607543363191	0.494613146000639	nan
sp|P07437|TBB5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.575208590052367	0.362648679838151	24.0000000001171	0.125798610318526	0.823891816737944	nan
sp|P07437|TBB5_HUMAN	Normal-Triple-negative breast cancer	-0.967092702800509	0.433448077279907	24.0000000000226	0.0352732470019607	0.125937994666506	nan
sp|P07585|PGS2_HUMAN	metaplastic breast carcinomas-Normal	-2.71713841808142	0.622750436127082	22.000000304356	0.0002485008506416	0.0157578323963946	nan
sp|P07585|PGS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.600707872496608	0.622750436127082	22.0000003045129	0.345227215708578	0.870943310236299	nan
sp|P07585|PGS2_HUMAN	Normal-Triple-negative breast cancer	3.31784629057803	0.74432913773456	22.0000003049575	0.0001973279346054	0.0227914720285933	nan
sp|P07602|SAP_HUMAN	metaplastic breast carcinomas-Normal	0.215908208965882	0.271977278110665	22.0000028608651	0.435764283915019	0.632248136068757	nan
sp|P07602|SAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0161793345011728	0.271977278110665	22.0000028608663	0.953100640392405	0.996541950781621	nan
sp|P07602|SAP_HUMAN	Normal-Triple-negative breast cancer	-0.232087543467055	0.325075023886764	22.0000028611031	0.482764190453705	0.660917697309768	nan
sp|P07686|HEXB_HUMAN	metaplastic breast carcinomas-Normal	0.256680091871017	0.219178522672096	21.9999999994738	0.254086922123606	0.455301848592381	nan
sp|P07686|HEXB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0343338034795207	0.219178522672096	21.999999999326	0.876951190716253	0.983181130777328	nan
sp|P07686|HEXB_HUMAN	Normal-Triple-negative breast cancer	-0.222346288391497	0.261968440849337	21.9999999982925	0.405160179381917	0.594248116815048	nan
sp|P07711|CATL1_HUMAN	metaplastic breast carcinomas-Normal	0.466138163806437	0.26792895374114	22.0000001769557	0.0958704800081012	0.250332659502693	nan
sp|P07711|CATL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0539899243712659	0.26792895374114	22.0000001764033	0.842152646791525	0.972169455774446	nan
sp|P07711|CATL1_HUMAN	Normal-Triple-negative breast cancer	-0.412148239435171	0.320236350780441	22.0000001767377	0.211467092012399	0.394285546333942	nan
sp|P07737|PROF1_HUMAN	metaplastic breast carcinomas-Normal	0.329227834464923	0.214873681216512	22.0000000369758	0.139729868057227	0.314676206925626	nan
sp|P07737|PROF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0074831403593257	0.214873681216512	22.0000000368449	0.972532730400078	0.99709406933403	nan
sp|P07737|PROF1_HUMAN	Normal-Triple-negative breast cancer	-0.321744694105597	0.256823171182973	22.0000000365349	0.223436489550044	0.406070470893574	nan
sp|P07738|PMGE_HUMAN	metaplastic breast carcinomas-Normal	0.293637878112091	0.326166057659681	22.0000000071	0.377725577722596	0.584253057398747	nan
sp|P07738|PMGE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.584318853911544	0.326166057659681	22.0000000074776	0.0869849959686894	0.809016644110817	nan
sp|P07738|PMGE_HUMAN	Normal-Triple-negative breast cancer	0.290680975799454	0.389843003508662	22.0000000069972	0.463780187433293	0.643676552412636	nan
sp|P07741|APT_HUMAN	metaplastic breast carcinomas-Normal	0.238535948420972	0.23913768674955	22.0000000570538	0.329375335422042	0.538535964064372	nan
sp|P07741|APT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0939409789025277	0.23913768674955	22.0000000568383	0.698223941857497	0.947043345959522	nan
sp|P07741|APT_HUMAN	Normal-Triple-negative breast cancer	-0.144594969518444	0.285824204773108	22.0000000565636	0.617967067249709	0.767322574351151	nan
sp|P07814|SYEP_HUMAN	metaplastic breast carcinomas-Normal	0.567464926547041	0.208089802566257	22.000000016316	0.0123079299574097	0.0727963686448927	nan
sp|P07814|SYEP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.396553596406939	0.208089802566257	22.0000000163102	0.0698418529880184	0.781899532609971	nan
sp|P07814|SYEP_HUMAN	Normal-Triple-negative breast cancer	-0.964018522953981	0.248714885337935	22.0000000165785	0.0008157044620623	0.0257262735003663	nan
sp|P07858|CATB_HUMAN	metaplastic breast carcinomas-Normal	0.460607661122799	0.247532488134158	22.0000003876089	0.0761915039620126	0.216462016384384	nan
sp|P07858|CATB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0387990696252618	0.247532488134158	22.0000003876089	0.8768766740905	0.983181130777328	nan
sp|P07858|CATB_HUMAN	Normal-Triple-negative breast cancer	-0.499406730748061	0.295857911557672	22.0000003869793	0.105539626146252	0.251136044881527	nan
sp|P07900|HS90A_HUMAN	metaplastic breast carcinomas-Normal	0.353615735040951	0.217444716229653	23.9999999994758	0.116960540268009	0.282336118991185	nan
sp|P07900|HS90A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.260320002149373	0.217444716229653	23.9999999994758	0.242928794295504	0.84964799869723	nan
sp|P07900|HS90A_HUMAN	Normal-Triple-negative breast cancer	-0.613935737190324	0.25989614578628	23.9999999994893	0.0266152259894072	0.109086326989876	nan
sp|P07910|HNRPC_HUMAN	metaplastic breast carcinomas-Normal	0.953160967589578	0.233868253886165	22.000000023006	0.0005015493468895	0.0205217420849069	nan
sp|P07910|HNRPC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0877927988428738	0.233868253886165	22.000000023006	0.710962305041643	0.94948208919602	nan
sp|P07910|HNRPC_HUMAN	Normal-Triple-negative breast cancer	-1.04095376643245	0.279526027859824	22.0000000227161	0.0011795504417404	0.0266490250684039	nan
sp|P07919|QCR6_HUMAN	metaplastic breast carcinomas-Normal	0.767729985735601	0.25466843435198	22.0000000119287	0.0063746982780978	0.0524492501891023	nan
sp|P07919|QCR6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.294402736911379	0.25466843435198	22.0000000116567	0.260071768131059	0.862813416943474	nan
sp|P07919|QCR6_HUMAN	Normal-Triple-negative breast cancer	-0.473327248824222	0.304386998631885	22.0000000115245	0.134210919547833	0.294026603585124	nan
sp|P07942|LAMB1_HUMAN	metaplastic breast carcinomas-Normal	0.579517148496296	0.271891409979013	23.9999999996309	0.0434946513960378	0.154958436484919	nan
sp|P07942|LAMB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.731021142557741	0.271891409979013	23.9999999993719	0.0128361141868457	0.61942302453215	nan
sp|P07942|LAMB1_HUMAN	Normal-Triple-negative breast cancer	0.151503994061445	0.324972391839183	23.9999999995945	0.645272038160865	0.790886524648494	nan
sp|P07948|LYN_HUMAN	metaplastic breast carcinomas-Normal	0.147710452091379	0.388604898975271	14.0000000013435	0.709572230577099	0.835150965157955	nan
sp|P07948|LYN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.994789919715516	0.388604898975271	14.0000000013425	0.0226775911732806	0.712051972579798	nan
sp|P07948|LYN_HUMAN	Normal-Triple-negative breast cancer	0.847079467624137	0.464471692982746	14.0000000013604	0.0896060482080919	0.225986725526326	nan
sp|P07954|FUMH_HUMAN	metaplastic breast carcinomas-Normal	0.311671011345349	0.266893942063859	22.0000000773916	0.25539970913589	0.456669517572726	nan
sp|P07954|FUMH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.464029161587159	0.266893942063859	22.0000000786947	0.0960776100084544	0.814943337126966	nan
sp|P07954|FUMH_HUMAN	Normal-Triple-negative breast cancer	-0.775700172932507	0.318999275212761	22.0000000781847	0.0236268161483916	0.102137084892028	nan
sp|P07996|TSP1_HUMAN	metaplastic breast carcinomas-Normal	1.62579873124488	0.613304583094519	21.9999998961775	0.0145976233170679	0.0795450818130059	nan
sp|P07996|TSP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.383969697778701	0.613304583094519	21.9999998968189	0.537713067162638	0.921388505638487	nan
sp|P07996|TSP1_HUMAN	Normal-Triple-negative breast cancer	-2.00976842902358	0.733039183950471	21.9999998955236	0.0119076035785467	0.0703035067408332	nan
sp|P08123|CO1A2_HUMAN	metaplastic breast carcinomas-Normal	0.833604596240712	0.422906901402928	22.0000000257066	0.0614172093032153	0.190261699649476	nan
sp|P08123|CO1A2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.909922905020435	0.422906901402928	22.0000000258017	0.0426679181871516	0.751726370995712	nan
sp|P08123|CO1A2_HUMAN	Normal-Triple-negative breast cancer	0.0763183087797237	0.505470427641739	22.0000000257354	0.881363646356207	0.93152710985311	nan
sp|P08133|ANXA6_HUMAN	metaplastic breast carcinomas-Normal	-0.141672979550365	0.239537237413453	21.9999998927012	0.560251437901527	0.729102839037765	nan
sp|P08133|ANXA6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.62598674922899	0.239537237413453	21.9999998913547	0.0158699846045092	0.656412655960811	nan
sp|P08133|ANXA6_HUMAN	Normal-Triple-negative breast cancer	0.767659728779355	0.286301759157484	21.9999998916561	0.0136385677312225	0.0754897960437323	nan
sp|P08174|DAF_HUMAN	metaplastic breast carcinomas-Normal	-0.0057440757877716	0.371264128028128	22.0000003509123	0.987795340966734	0.994136910531496	nan
sp|P08174|DAF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.174097245290227	0.371264128028128	22.0000003512812	0.64373261139396	0.941868024951375	nan
sp|P08174|DAF_HUMAN	Normal-Triple-negative breast cancer	-0.168353169502455	0.443745507438806	22.0000003511731	0.708034697777872	0.828645386712288	nan
sp|P08185|CBG_HUMAN	metaplastic breast carcinomas-Normal	-1.27311955439096	0.499255110415084	21.9999999444327	0.0182514748184217	0.0915235238665563	nan
sp|P08185|CBG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.32962083191692	0.499255110415084	21.9999999444334	0.515962985285294	0.915620969865368	nan
sp|P08185|CBG_HUMAN	Normal-Triple-negative breast cancer	1.60274038630788	0.596723991324509	21.9999999439868	0.0134986958509434	0.0753519307114924	nan
sp|P08195|4F2_HUMAN	metaplastic breast carcinomas-Normal	0.583604486887606	0.285680528899974	22.0000063210681	0.0532285793217044	0.175527577048954	nan
sp|P08195|4F2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.146003026203073	0.285680528899974	22.0000063203462	0.614392271072996	0.941374262616245	nan
sp|P08195|4F2_HUMAN	Normal-Triple-negative breast cancer	-0.72960751309068	0.34145354127103	22.0000063205906	0.0439865208695721	0.142646284183891	nan
sp|P08236|BGLR_HUMAN	metaplastic breast carcinomas-Normal	-0.038173101043715	0.386288463504263	21.9999361434018	0.922175935707017	0.95843058885501	nan
sp|P08236|BGLR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.841894656509471	0.386288463504263	21.9999361436371	0.040286255517781	0.738255867002113	nan
sp|P08236|BGLR_HUMAN	Normal-Triple-negative breast cancer	-0.803721555465757	0.46170302303612	21.9999361432647	0.0956927182295418	0.237311261698029	nan
sp|P08237|PFKAM_HUMAN	metaplastic breast carcinomas-Normal	0.282575747802275	0.22156597196193	21.9999999939967	0.215486401294148	0.41141688564144	nan
sp|P08237|PFKAM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.234544571556527	0.22156597196193	21.9999999939942	0.301277711246506	0.867696529950794	nan
sp|P08237|PFKAM_HUMAN	Normal-Triple-negative breast cancer	-0.048031176245748	0.26482198854388	21.9999999944202	0.857736566694004	0.918529751189068	nan
sp|P08238|HS90B_HUMAN	metaplastic breast carcinomas-Normal	0.547160483638282	0.236380091893521	21.9999999855616	0.0303462402158458	0.125461321489392	nan
sp|P08238|HS90B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.253123981956906	0.236380091893521	21.9999999854054	0.295851606162029	0.867696529950794	nan
sp|P08238|HS90B_HUMAN	Normal-Triple-negative breast cancer	-0.800284465595188	0.282528248508229	21.9999999853323	0.0096900559833684	0.0620611678009953	nan
sp|P08240|SRPRA_HUMAN	metaplastic breast carcinomas-Normal	0.542155525010198	0.201814642235038	23.9999999997432	0.0129023230955193	0.0752409157359757	nan
sp|P08240|SRPRA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.27338696001828	0.201814642235038	23.9999999997056	0.18814729701491	0.843662073010871	nan
sp|P08240|SRPRA_HUMAN	Normal-Triple-negative breast cancer	-0.815542485028478	0.241214634181902	23.9999999997105	0.0024703364895753	0.0337628805562287	nan
sp|P08243|ASNS_HUMAN	metaplastic breast carcinomas-Normal	0.821765803183344	0.365039833432812	22.0000000299635	0.0346983832635354	0.134113286009293	nan
sp|P08243|ASNS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.244791089868199	0.365039833432812	22.0000000300056	0.509462658043976	0.913997266820081	nan
sp|P08243|ASNS_HUMAN	Normal-Triple-negative breast cancer	-0.576974713315145	0.436306052465559	22.0000000299724	0.19961624099923	0.380455395099225	nan
sp|P08246|ELNE_HUMAN	metaplastic breast carcinomas-Normal	0.868536649485947	0.417822509615499	22.0000000271511	0.0495114695125119	0.168969327165903	nan
sp|P08246|ELNE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.445473290082485	0.417822509615499	22.0000000269854	0.297904481838447	0.867696529950794	nan
sp|P08246|ELNE_HUMAN	Normal-Triple-negative breast cancer	-0.423063359403462	0.499393417116339	22.000000027089	0.406030923571179	0.594820092530013	nan
sp|P08253|MMP2_HUMAN	metaplastic breast carcinomas-Normal	-0.242084195783695	0.239781369873308	23.9999999994222	0.322756198615434	0.530322175654614	nan
sp|P08253|MMP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.443679236376132	0.239781369873308	23.9999999994222	0.0766123668105034	0.801056980015483	nan
sp|P08253|MMP2_HUMAN	Normal-Triple-negative breast cancer	0.685763432159826	0.28659355325797	23.9999999994277	0.0248986029536795	0.10516426302168	nan
sp|P08294|SODE_HUMAN	metaplastic breast carcinomas-Normal	-2.55441481943322	0.841441400278351	22.000000035312	0.0060693073413841	0.0510743736778758	nan
sp|P08294|SODE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.579433732657789	0.841441400278351	22.0000000354332	0.498260324997693	0.913320451076758	nan
sp|P08294|SODE_HUMAN	Normal-Triple-negative breast cancer	3.13384855209101	1.00571483469108	22.0000000353367	0.0050326853202468	0.0452771179429151	nan
sp|P08397|HEM3_HUMAN	metaplastic breast carcinomas-Normal	0.447647157627647	0.247343064329993	14.0000000219728	0.0918369742387179	0.245248171876744	nan
sp|P08397|HEM3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.149591147865739	0.247343064329993	14.0000000220646	0.554993514385376	0.931642387063667	nan
sp|P08397|HEM3_HUMAN	Normal-Triple-negative breast cancer	-0.597238305493386	0.295631506807645	14.0000000218962	0.0629225326082965	0.18140025879443	nan
sp|P08519|APOA_HUMAN	metaplastic breast carcinomas-Normal	0.0873477527783184	0.601490672532853	22.0000000253528	0.885860382688158	0.940415790777734	nan
sp|P08519|APOA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.441191212571541	0.601490672532853	22.0000000253518	0.471000580390636	0.912607574317916	nan
sp|P08519|APOA_HUMAN	Normal-Triple-negative breast cancer	0.353843459793223	0.718918860059051	22.0000000253215	0.627461933257688	0.775923908537409	nan
sp|P08559|ODPA_HUMAN	metaplastic breast carcinomas-Normal	-0.133419658125216	0.201950034772549	23.9999999992089	0.515124371755094	0.696895975463546	nan
sp|P08559|ODPA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.453064628565465	0.201950034772549	23.9999999994449	0.0343643385251266	0.724424466074313	nan
sp|P08559|ODPA_HUMAN	Normal-Triple-negative breast cancer	-0.319644970440249	0.241376459216227	23.999999999268	0.19789083369662	0.3786926489393	nan
sp|P08567|PLEK_HUMAN	metaplastic breast carcinomas-Normal	0.0081728184198008	0.314286858563201	23.9999999997127	0.979468905047662	0.989752057128702	nan
sp|P08567|PLEK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.135970107664067	0.314286858563201	23.9999999997127	0.669145983306351	0.946277260710207	nan
sp|P08567|PLEK_HUMAN	Normal-Triple-negative breast cancer	0.127797289244266	0.37564464489257	23.9999999996753	0.736659670017811	0.848754503687766	nan
sp|P08571|CD14_HUMAN	metaplastic breast carcinomas-Normal	-0.146313237843431	0.508539897827055	24.0000000001459	0.776036718543382	0.878891329621193	nan
sp|P08571|CD14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.296426709825071	0.508539897827055	24.0000000004421	0.565399475815361	0.935109025059232	nan
sp|P08571|CD14_HUMAN	Normal-Triple-negative breast cancer	0.442739947668502	0.607821434870885	24.0000000003607	0.473413909093589	0.651993752355154	nan
sp|P08572|CO4A2_HUMAN	metaplastic breast carcinomas-Normal	-0.402222945499627	0.403805514702105	22.0000000413629	0.330041229146893	0.538565069064444	nan
sp|P08572|CO4A2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.603433988559536	0.403805514702105	22.0000000408745	0.149285402673073	0.841301410938567	nan
sp|P08572|CO4A2_HUMAN	Normal-Triple-negative breast cancer	1.00565693405916	0.482639903778956	22.0000000410459	0.0490183834194089	0.153859401781034	nan
sp|P08574|CY1_HUMAN	metaplastic breast carcinomas-Normal	0.594169159269352	0.236094822450181	23.9999999999977	0.0189379182364787	0.0931207695533363	nan
sp|P08574|CY1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0155246822991648	0.236094822450181	23.9999999999977	0.948116671703243	0.996541950781621	nan
sp|P08574|CY1_HUMAN	Normal-Triple-negative breast cancer	-0.609693841568517	0.282187286308181	24.000000000061	0.040927434180572	0.136589147807451	nan
sp|P08575|PTPRC_HUMAN	metaplastic breast carcinomas-Normal	0.106667947078217	0.327197774071302	23.9999999993766	0.747246521700283	0.860108189651783	nan
sp|P08575|PTPRC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.42261340233118	0.327197774071302	23.9999999993766	0.208791677947869	0.843662073010871	nan
sp|P08575|PTPRC_HUMAN	Normal-Triple-negative breast cancer	0.315945455252963	0.391076140480551	23.9999999993853	0.427090837137181	0.613504728886772	nan
sp|P08579|RU2B_HUMAN	metaplastic breast carcinomas-Normal	0.615507808147276	0.20259373087567	21.9999997226639	0.0060358454373856	0.0510320974930049	nan
sp|P08579|RU2B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0562759484882851	0.20259373087567	21.9999997223262	0.783777013328447	0.962981271203673	nan
sp|P08579|RU2B_HUMAN	Normal-Triple-negative breast cancer	-0.559231859658991	0.242145823214393	21.9999997210833	0.0306866418239913	0.116975226402462	nan
sp|P08582|TRFM_HUMAN	metaplastic breast carcinomas-Normal	-0.340952016845312	0.388660681061863	6.0	0.414093143939299	0.615740710196163	nan
sp|P08582|TRFM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.261418622494107	0.388660681061863	6.0	0.526234057520248	0.918329246917285	nan
sp|P08582|TRFM_HUMAN	Normal-Triple-negative breast cancer	0.602370639339419	0.464538365328528	6.0	0.242364456207978	0.430352271600064	nan
sp|P08603|CFAH_HUMAN	metaplastic breast carcinomas-Normal	-0.858626028193995	0.384934194712632	23.9999999999225	0.0353168981863941	0.136029396954315	nan
sp|P08603|CFAH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.224690328426169	0.384934194712632	24.0000000001836	0.564860856390196	0.935109025059232	nan
sp|P08603|CFAH_HUMAN	Normal-Triple-negative breast cancer	1.08331635662016	0.460084362231634	24.0000000000375	0.0270603202831189	0.110231010565058	nan
sp|P08648|ITA5_HUMAN	metaplastic breast carcinomas-Normal	0.207268352514711	0.227967755157249	22.0000000145949	0.373097848967135	0.581423933411512	nan
sp|P08648|ITA5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.47465311699079	0.227967755157249	22.0000000144714	0.0491729548132388	0.764019040906631	nan
sp|P08648|ITA5_HUMAN	Normal-Triple-negative breast cancer	0.267384764476079	0.272473582969682	22.0000000141028	0.337102515471317	0.529442092731762	nan
sp|P08670|VIME_HUMAN	metaplastic breast carcinomas-Normal	-0.0274901941615973	0.19401537292245	22.0000000020351	0.888613752831268	0.940458943542306	nan
sp|P08670|VIME_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.477554067719662	0.19401537292245	22.0000000011941	0.0221519294000748	0.712051972579798	nan
sp|P08670|VIME_HUMAN	Normal-Triple-negative breast cancer	0.50504426188126	0.231892724367593	22.000000001628	0.0404133141800846	0.135417193885687	nan
sp|P08697|A2AP_HUMAN	metaplastic breast carcinomas-Normal	-0.606031839510846	0.286377419445752	22.0000000057821	0.045877372544669	0.160698136074458	nan
sp|P08697|A2AP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.376234385051728	0.286377419445752	22.0000000055305	0.202459154187004	0.843662073010871	nan
sp|P08697|A2AP_HUMAN	Normal-Triple-negative breast cancer	0.982266224562574	0.342286484788918	22.0000000057436	0.008902185977968	0.0594194100216179	nan
sp|P08708|RS17_HUMAN	metaplastic breast carcinomas-Normal	1.07433417185439	0.259381342974509	23.9999999999402	0.0003679071681646	0.0182525884623785	nan
sp|P08708|RS17_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0200496116992834	0.259381342974509	23.9999999999856	0.939027441733689	0.995571782532303	nan
sp|P08708|RS17_HUMAN	Normal-Triple-negative breast cancer	-1.09438378355367	0.31002000185071	24.0000000000294	0.0017103022658635	0.0289979437553501	nan
sp|P08727|K1C19_HUMAN	metaplastic breast carcinomas-Normal	-0.143633098097394	0.996495875780339	11.9999999998677	0.887783728999227	0.940415790777734	nan
sp|P08727|K1C19_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.12791190891139	1.1016676417	11.9999999998989	0.326116150175044	0.867975899287892	nan
sp|P08727|K1C19_HUMAN	Normal-Triple-negative breast cancer	-0.984278810813997	1.24284871816776	11.9999999998756	0.443761595482837	0.62876910019052	nan
sp|P08729|K2C7_HUMAN;tr|CONTAMINANT_Q3KNV1|CONTAMINANT_Q3KNV1_HUMAN	metaplastic breast carcinomas-Normal	-0.861221502783295	0.647096705153619	22.000000000081	0.196851403304584	0.389716536381439	nan
sp|P08729|K2C7_HUMAN;tr|CONTAMINANT_Q3KNV1|CONTAMINANT_Q3KNV1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.14779355967283	0.647096705153619	21.9999999998946	0.0899470634405591	0.81309570430905	nan
sp|P08729|K2C7_HUMAN;tr|CONTAMINANT_Q3KNV1|CONTAMINANT_Q3KNV1_HUMAN	Normal-Triple-negative breast cancer	-0.28657205688953	0.773428495005628	22.0000000002625	0.714537361226917	0.834097504094609	nan
sp|P08754|GNAI3_HUMAN	metaplastic breast carcinomas-Normal	0.168735020162516	0.187337891915358	22.0000000051258	0.377503043088244	0.584180686790187	nan
sp|P08754|GNAI3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.178605904780833	0.187337891915358	22.0000000056089	0.350751612212715	0.874993100365995	nan
sp|P08754|GNAI3_HUMAN	Normal-Triple-negative breast cancer	-0.347340924943348	0.22391160802963	22.0000000052644	0.135111449213242	0.294691901039905	nan
sp|P08865|RSSA_HUMAN	metaplastic breast carcinomas-Normal	0.729673480216182	0.183442914456805	23.9999999997998	0.0005574979420375	0.0205217420849069	nan
sp|P08865|RSSA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0049790155221732	0.183442914456805	23.9999999997544	0.978570873746525	0.99709406933403	nan
sp|P08865|RSSA_HUMAN	Normal-Triple-negative breast cancer	-0.724694464694008	0.219256219538456	23.999999999837	0.0029736224569982	0.0364735093987536	nan
sp|P08962|CD63_HUMAN	metaplastic breast carcinomas-Normal	-0.473917977192375	0.401928409517987	6.0	0.282987820111821	0.485873715935793	nan
sp|P08962|CD63_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.614105675879483	0.401928409517987	6.0	0.177398445285034	0.843662073010871	nan
sp|P08962|CD63_HUMAN	Normal-Triple-negative breast cancer	1.08802365307186	0.480396333960168	6.0	0.0641199321676622	0.1838953015749	nan
sp|P09012|SNRPA_HUMAN	metaplastic breast carcinomas-Normal	0.655348816881573	0.205403468438721	21.9999999817207	0.0042251299770994	0.042883667309653	nan
sp|P09012|SNRPA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.1492462116363	0.205403468438721	21.9999999817125	0.475131610784452	0.913280230088743	nan
sp|P09012|SNRPA_HUMAN	Normal-Triple-negative breast cancer	-0.804595028517873	0.245504101934474	21.999999981105	0.0034422593318926	0.0391851712986683	nan
sp|P09104|ENOG_HUMAN	metaplastic breast carcinomas-Normal	0.689109047036985	0.443504428666888	20.9999999995792	0.13517850202821	0.308396253082891	nan
sp|P09104|ENOG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0608927758069332	0.415956471786529	20.9999999995845	0.885008012832865	0.985399312526605	nan
sp|P09104|ENOG_HUMAN	Normal-Triple-negative breast cancer	-0.750001822843918	0.510333528279785	20.9999999995395	0.156485194267096	0.325912773022447	nan
sp|P09110|THIK_HUMAN	metaplastic breast carcinomas-Normal	0.288117093700346	0.220409289235288	22.0000000009226	0.204646023405291	0.398735862719336	nan
sp|P09110|THIK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.213549335210063	0.220409289235288	22.000000001208	0.343138727057885	0.870943310236299	nan
sp|P09110|THIK_HUMAN	Normal-Triple-negative breast cancer	-0.501666428910409	0.263439488257075	22.0000000014739	0.0700313171346052	0.192542678375044	nan
sp|P09132|SRP19_HUMAN	metaplastic breast carcinomas-Normal	0.623452318067176	0.369512549161947	15.0000000000885	0.112237893452749	0.275131827313376	nan
sp|P09132|SRP19_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.131092019484014	0.369512549161947	15.0000000001174	0.727700381114109	0.954478803630933	nan
sp|P09132|SRP19_HUMAN	Normal-Triple-negative breast cancer	-0.492360298583162	0.441651970266441	15.0000000000806	0.282473166474694	0.475172472349132	nan
sp|P09382|LEG1_HUMAN	metaplastic breast carcinomas-Normal	0.499722276402577	0.358339012024397	23.9999999995746	0.175926663973749	0.363443275978086	nan
sp|P09382|LEG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.999610837518775	0.358339012024397	23.9999999996238	0.0101725545103859	0.547668704418496	nan
sp|P09382|LEG1_HUMAN	Normal-Triple-negative breast cancer	0.499888561116199	0.428297039012181	23.9999999996539	0.254614185887662	0.444972425809983	nan
sp|P09417|DHPR_HUMAN	metaplastic breast carcinomas-Normal	-0.755598114833129	0.268961752940167	23.9999999997969	0.0097165602439627	0.0653802555686883	nan
sp|P09417|DHPR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0716314384482852	0.268961752940167	23.9999999998405	0.792263121278679	0.963876647732018	nan
sp|P09417|DHPR_HUMAN	Normal-Triple-negative breast cancer	0.683966676384844	0.321470781930817	23.9999999998653	0.0438405790699862	0.142589124098468	nan
sp|P09429|HMGB1_HUMAN	metaplastic breast carcinomas-Normal	1.06895385620339	0.534772168885781	21.9999915477597	0.0581233903456836	0.18371669410281	nan
sp|P09429|HMGB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.413493405061841	0.534772168885781	21.9999915433493	0.447624470687935	0.902988618897891	nan
sp|P09429|HMGB1_HUMAN	Normal-Triple-negative breast cancer	-1.48244726126524	0.639174995728089	21.9999915464892	0.0300538961369617	0.116349012880424	nan
sp|P09467|F16P1_HUMAN	metaplastic breast carcinomas-Normal	-0.204382675574773	0.769459255551975	23.9999999999631	0.792801339092806	0.88789476116728	nan
sp|P09467|F16P1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.823558768046762	0.769459255551975	23.9999999999204	0.295126894667756	0.867696529950794	nan
sp|P09467|F16P1_HUMAN	Normal-Triple-negative breast cancer	-0.619176092471989	0.919679715952865	23.999999999903	0.507219026418085	0.680935397339949	nan
sp|P09486|SPRC_HUMAN	metaplastic breast carcinomas-Normal	0.337246149213157	0.557102302859842	22.9999999991866	0.550868481802679	0.722996021286722	nan
sp|P09486|SPRC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.140221567270905	0.595567413338371	22.9999999991233	0.815949445796012	0.965774701272009	nan
sp|P09486|SPRC_HUMAN	Normal-Triple-negative breast cancer	-0.477467716484062	0.698364695389893	22.9999999991511	0.50099902340718	0.676135101017241	nan
sp|P09493|TPM1_HUMAN	metaplastic breast carcinomas-Normal	0.232732568447195	0.267785116660014	23.9999999998666	0.393400137745033	0.59765176319218	nan
sp|P09493|TPM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.000586512378454	0.267785116660014	23.9999999998666	0.99827055063139	0.998570872698367	nan
sp|P09493|TPM1_HUMAN	Normal-Triple-negative breast cancer	-0.233319080825649	0.320064432585997	23.9999999998759	0.473071109556861	0.651943767896769	nan
sp|P09497|CLCB_HUMAN	metaplastic breast carcinomas-Normal	-0.26498588051618	0.206671850057078	23.9999999999141	0.212034570233164	0.407872055240183	nan
sp|P09497|CLCB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.12375275602104	0.206671850057079	23.9999999999141	0.554924073520789	0.931642387063667	nan
sp|P09497|CLCB_HUMAN	Normal-Triple-negative breast cancer	0.388738636537219	0.247020107932288	23.9999999998972	0.128645507010344	0.285695054896968	nan
sp|P09525|ANXA4_HUMAN	metaplastic breast carcinomas-Normal	0.0838503303259856	0.333291434926479	22.0000000281618	0.803698881025896	0.897076924288139	nan
sp|P09525|ANXA4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0334786514575868	0.333291434926479	22.0000000281617	0.920897992187654	0.994508979919649	nan
sp|P09525|ANXA4_HUMAN	Normal-Triple-negative breast cancer	-0.117328981783572	0.39835945827024	22.0000000289479	0.771113857469558	0.869314697292624	nan
sp|P09543|CN37_HUMAN	metaplastic breast carcinomas-Normal	-0.360628880239598	0.166665951587395	21.9999990262624	0.0416102585222575	0.151658442245597	nan
sp|P09543|CN37_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.284996275395149	0.166665951587395	21.9999990067544	0.101337137540833	0.821630939204717	nan
sp|P09543|CN37_HUMAN	Normal-Triple-negative breast cancer	0.0756326048444483	0.199203913539196	21.9999989996734	0.7078275694346	0.828645386712288	nan
sp|P09601|HMOX1_HUMAN	metaplastic breast carcinomas-Normal	-0.0296435189020533	0.310326571791734	21.9999951055285	0.924763702595361	0.959399047261854	nan
sp|P09601|HMOX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.548942147070013	0.310326571791734	21.9999951054995	0.0907713901115083	0.81309570430905	nan
sp|P09601|HMOX1_HUMAN	Normal-Triple-negative breast cancer	0.578585665972066	0.370911196842144	21.9999951038863	0.133053368160837	0.292119812263291	nan
sp|P09622|DLDH_HUMAN	metaplastic breast carcinomas-Normal	0.158247336591995	0.243289730803218	21.9999999963763	0.522138346431264	0.702436882783103	nan
sp|P09622|DLDH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.211630570384624	0.243289730803218	21.999999997773	0.393763364108526	0.885234295852111	nan
sp|P09622|DLDH_HUMAN	Normal-Triple-negative breast cancer	-0.369877906976619	0.290786846613269	21.9999999972497	0.216658492660253	0.399196535995467	nan
sp|P09651|ROA1_HUMAN	metaplastic breast carcinomas-Normal	0.973767821958266	0.265135555239581	21.9999999996053	0.0013353215361128	0.0271905743670284	nan
sp|P09651|ROA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0610936796880982	0.265135555239581	22.0000000009785	0.819891271111174	0.965774701272009	nan
sp|P09651|ROA1_HUMAN	Normal-Triple-negative breast cancer	-0.912674142270167	0.316897600974106	22.0000000006585	0.008694555718624	0.0588076066258844	nan
sp|P09661|RU2A_HUMAN	metaplastic breast carcinomas-Normal	0.519520897047905	0.187246836347096	22.0000000330038	0.011056124635622	0.0704033683693629	nan
sp|P09661|RU2A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0265237832968465	0.187246836347096	22.0000000330616	0.888644484929368	0.987363971050464	nan
sp|P09661|RU2A_HUMAN	Normal-Triple-negative breast cancer	-0.546044680344752	0.223802775809404	22.0000000326683	0.0232125338487207	0.101390883722927	nan
sp|P09668|CATH_HUMAN	metaplastic breast carcinomas-Normal	-0.295678230710444	0.286648652559625	22.0000000023802	0.313513345063438	0.520961847459193	nan
sp|P09668|CATH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.347932493931072	0.286648652559625	22.000000002376	0.237696614349329	0.84876230490475	nan
sp|P09668|CATH_HUMAN	Normal-Triple-negative breast cancer	-0.0522542632206278	0.342610670366419	22.0000000021435	0.880168617222203	0.930560598838421	nan
sp|P09758|TACD2_HUMAN	metaplastic breast carcinomas-Normal	-0.036478196833796	0.704604477714065	23.9999999999225	0.959139527137649	0.980073712943605	nan
sp|P09758|TACD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.208414423112643	0.704604477714065	23.9999999999225	0.76993519677308	0.959745866833315	nan
sp|P09758|TACD2_HUMAN	Normal-Triple-negative breast cancer	-0.171936226278847	0.842163430028968	23.9999999999256	0.839949705132707	0.908556075451063	nan
sp|P09871|C1S_HUMAN	metaplastic breast carcinomas-Normal	-0.230770980051601	0.26846950340037	22.0000000282308	0.399290739167923	0.601923998636815	nan
sp|P09871|C1S_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.472536255362057	0.26846950340037	22.0000000285943	0.0922874631639987	0.81309570430905	nan
sp|P09871|C1S_HUMAN	Normal-Triple-negative breast cancer	0.703307235413658	0.32088243119792	22.0000000285325	0.0392696539161617	0.132496466096553	nan
sp|P09874|PARP1_HUMAN	metaplastic breast carcinomas-Normal	0.736806761041697	0.323081474213824	22.0000001098757	0.0326200150140788	0.129407306133986	nan
sp|P09874|PARP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.495574146174336	0.323081474213824	22.0000001100468	0.139311037803889	0.823891816737944	nan
sp|P09874|PARP1_HUMAN	Normal-Triple-negative breast cancer	-1.23238090721603	0.386156221126294	22.0000001092377	0.0042165742600787	0.0419484078096101	nan
sp|P09913|IFIT2_HUMAN	metaplastic breast carcinomas-Normal	0.541650678430293	0.420324057235481	6.0	0.244974753011317	0.444727514478219	nan
sp|P09913|IFIT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.673167287114058	0.420324057235481	6.0	0.160375703183807	0.843662073010871	nan
sp|P09913|IFIT2_HUMAN	Normal-Triple-negative breast cancer	0.131516608683765	0.502383338399354	6.0	0.802242033815367	0.88637179413689	nan
sp|P09914|IFIT1_HUMAN	metaplastic breast carcinomas-Normal	0.531157377765658	0.384604752919312	21.9999960294066	0.181133046329922	0.371428899445195	nan
sp|P09914|IFIT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.743100123754465	0.384604752919312	21.9999960309429	0.0663245600275623	0.774640662531106	nan
sp|P09914|IFIT1_HUMAN	Normal-Triple-negative breast cancer	0.211942745988807	0.459690603975147	21.9999960296786	0.649284648513006	0.793024292875055	nan
sp|P09936|UCHL1_HUMAN	metaplastic breast carcinomas-Normal	-0.910595248356101	0.502558382815034	21.9999867038576	0.0836722862207735	0.230619137145814	nan
sp|P09936|UCHL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.42222128340826	0.502558382815034	21.9999867241919	0.0097480775988246	0.547668704418496	nan
sp|P09936|UCHL1_HUMAN	Normal-Triple-negative breast cancer	-0.511626035052163	0.600672157001355	21.9999867115789	0.403526454440659	0.593242783972026	nan
sp|P09960|LKHA4_HUMAN	metaplastic breast carcinomas-Normal	-0.366384311428962	0.239413891022264	23.9999999997687	0.139008356561298	0.313263577769325	nan
sp|P09960|LKHA4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.206579628995061	0.239413891022264	23.9999999997687	0.396757580297093	0.885234295852111	nan
sp|P09960|LKHA4_HUMAN	Normal-Triple-negative breast cancer	0.159804682433901	0.286154332021877	23.9999999997181	0.581706166885383	0.739128739543979	nan
sp|P09972|ALDOC_HUMAN	metaplastic breast carcinomas-Normal	-0.726336796414426	0.316593742931156	22.0000000202522	0.0316932113434975	0.128466389195289	nan
sp|P09972|ALDOC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.328806010870962	0.316593742931156	22.0000000202522	0.310283597891158	0.867696529950794	nan
sp|P09972|ALDOC_HUMAN	Normal-Triple-negative breast cancer	1.05514280728539	0.378401899087575	22.0000000200373	0.010713463602134	0.0663669646889177	nan
sp|P0C0L4|CO4A_HUMAN	metaplastic breast carcinomas-Normal	-0.015265098900132	0.467870311500797	21.9999941805997	0.974266421785724	0.986747848285733	nan
sp|P0C0L4|CO4A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.436323743395008	0.467870311500797	21.9999941794166	0.361162510774637	0.883542279876718	nan
sp|P0C0L4|CO4A_HUMAN	Normal-Triple-negative breast cancer	0.45158884229514	0.559211981763947	21.9999941794327	0.427997968835313	0.613746871617162	nan
sp|P0C0L5|CO4B_HUMAN	metaplastic breast carcinomas-Normal	-0.853007546619316	0.493041147950759	23.9999999991134	0.0964549115983944	0.250873338147937	nan
sp|P0C0L5|CO4B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.277518147143329	0.493041147950759	23.999999998955	0.578744089469089	0.936538590276875	nan
sp|P0C0L5|CO4B_HUMAN	Normal-Triple-negative breast cancer	0.575489399475986	0.589296885609819	23.9999999990393	0.338523853716645	0.530779853657608	nan
sp|P0DMV8|HS71A_HUMAN;sp|P0DMV9|HS71B_HUMAN	metaplastic breast carcinomas-Normal	0.346685063594623	0.290685903921365	23.9999999996898	0.244666904921062	0.444727514478219	nan
sp|P0DMV8|HS71A_HUMAN;sp|P0DMV9|HS71B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.158462395831948	0.290685903921365	23.9999999996909	0.590692811718414	0.940559810632461	nan
sp|P0DMV8|HS71A_HUMAN;sp|P0DMV9|HS71B_HUMAN	Normal-Triple-negative breast cancer	-0.188222667762676	0.347436108697044	23.9999999996237	0.592986849593114	0.746341646364071	nan
sp|P0DOX2|IGA2_HUMAN	metaplastic breast carcinomas-Normal	-1.26898476340587	1.13280767220814	21.9999999998537	0.274704066675477	0.477548285858522	nan
sp|P0DOX2|IGA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.242575124440949	1.06097159304103	21.9999999999095	0.821264600962143	0.965774701272009	nan
sp|P0DOX2|IGA2_HUMAN	Normal-Triple-negative breast cancer	1.51155988784682	1.31663112173062	21.9999999998706	0.263278367591579	0.45414493714292	nan
sp|P0DOX7|IGK_HUMAN	metaplastic breast carcinomas-Normal	-1.22839292686865	0.367553822126141	22.0000000210012	0.0029518128684038	0.0380628964347452	nan
sp|P0DOX7|IGK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.444597776998629	0.367553822126141	22.00000002168	0.239265831879697	0.848884141578285	nan
sp|P0DOX7|IGK_HUMAN	Normal-Triple-negative breast cancer	1.67299070386728	0.439310843675368	22.0000000215198	0.0009617176022516	0.0259501424890038	nan
sp|P0DP23|CALM1_HUMAN;sp|P0DP24|CALM2_HUMAN;sp|P0DP25|CALM3_HUMAN	metaplastic breast carcinomas-Normal	-0.034812137579011	0.162233980698025	23.9999999992656	0.831907739867837	0.910823889104312	nan
sp|P0DP23|CALM1_HUMAN;sp|P0DP24|CALM2_HUMAN;sp|P0DP25|CALM3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0188906333081571	0.162233980698025	23.9999999990828	0.908272192721439	0.994076708623694	nan
sp|P0DP23|CALM1_HUMAN;sp|P0DP24|CALM2_HUMAN;sp|P0DP25|CALM3_HUMAN	Normal-Triple-negative breast cancer	0.0537027708871681	0.193906695136483	23.9999999991363	0.784188632306787	0.877066962916474	nan
sp|P10155|RO60_HUMAN	metaplastic breast carcinomas-Normal	0.178986039082205	0.244409034801471	23.9999999988836	0.471064058047205	0.662359107000385	nan
sp|P10155|RO60_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.302350857354435	0.244409034801471	23.9999999988837	0.228029615065757	0.843662073010871	nan
sp|P10155|RO60_HUMAN	Normal-Triple-negative breast cancer	-0.48133689643664	0.292124670774524	23.9999999989213	0.112444036898023	0.260281322178989	nan
sp|P10253|LYAG_HUMAN	metaplastic breast carcinomas-Normal	0.171801209074191	0.222623979082406	23.999999999583	0.447818443436421	0.643557503667386	nan
sp|P10253|LYAG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.225550132065371	0.222623979082406	23.999999999584	0.321097168904535	0.867696529950794	nan
sp|P10253|LYAG_HUMAN	Normal-Triple-negative breast cancer	-0.397351341139561	0.266086548923153	23.9999999995578	0.148385624720915	0.315165378001484	nan
sp|P10301|RRAS_HUMAN	metaplastic breast carcinomas-Normal	-0.472997238699749	0.304140382383443	14.9999999997331	0.140742825531331	0.31610077842307	nan
sp|P10301|RRAS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.191572355002098	0.304140382383443	14.9999999997118	0.538249448250982	0.921388505638487	nan
sp|P10301|RRAS_HUMAN	Normal-Triple-negative breast cancer	0.664569593701847	0.363517286278593	14.9999999997367	0.0874804784592259	0.223337258370558	nan
sp|P10412|H14_HUMAN	metaplastic breast carcinomas-Normal	0.220424136951269	0.280041983508712	23.9999999995317	0.438921112416808	0.634888502033712	nan
sp|P10412|H14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0632188315815057	0.280041983508712	23.9999999995317	0.82330903981132	0.965774701272009	nan
sp|P10412|H14_HUMAN	Normal-Triple-negative breast cancer	-0.283642968532774	0.334714190504363	23.9999999994399	0.40513381430409	0.594248116815048	nan
sp|P10515|ODP2_HUMAN	metaplastic breast carcinomas-Normal	0.0845851353391713	0.253398453597234	23.9999999990729	0.741427384857483	0.85741667200675	nan
sp|P10515|ODP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.561548572871316	0.253398453597234	23.9999999993711	0.0364194257981684	0.73123935744099	nan
sp|P10515|ODP2_HUMAN	Normal-Triple-negative breast cancer	-0.646133708210487	0.302869081300508	23.999999999337	0.0433188503100413	0.141863899931603	nan
sp|P10586|PTPRF_HUMAN	metaplastic breast carcinomas-Normal	-0.349266334764383	0.379139792169554	22.0000000052623	0.366934443262781	0.576763772233082	nan
sp|P10586|PTPRF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.287391181767047	0.379139792169554	22.0000000058547	0.456489559741284	0.908567154037048	nan
sp|P10586|PTPRF_HUMAN	Normal-Triple-negative breast cancer	0.0618751529973356	0.453158726538146	22.000000005636	0.892634709252417	0.937477969527657	nan
sp|P10619|PPGB_HUMAN	metaplastic breast carcinomas-Normal	0.446780066238308	0.256714733988203	23.9999999999136	0.0946019951594654	0.248386281129592	nan
sp|P10619|PPGB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.117668797958893	0.256714733988203	24.0000000001562	0.650814493103496	0.94416849774672	nan
sp|P10619|PPGB_HUMAN	Normal-Triple-negative breast cancer	-0.564448864197201	0.306832794500369	23.9999999999686	0.0782299690418349	0.207365563871658	nan
sp|P10620|MGST1_HUMAN	metaplastic breast carcinomas-Normal	-1.2905000695598	0.491562374045269	23.9999999990955	0.0148298056303565	0.0800735738756976	nan
sp|P10620|MGST1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.520938573430693	0.491562374045269	23.9999999990955	0.29980292740627	0.867696529950794	nan
sp|P10620|MGST1_HUMAN	Normal-Triple-negative breast cancer	0.769561496129107	0.58752941273124	23.9999999990636	0.20265450979672	0.382901192452517	nan
sp|P10643|CO7_HUMAN	metaplastic breast carcinomas-Normal	-0.870975815116	0.343834424025821	23.9999999994171	0.0182534884779594	0.0915235238665563	nan
sp|P10643|CO7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.13779820093202	0.343834424025821	23.9999999994172	0.692135710424852	0.946568877415162	nan
sp|P10643|CO7_HUMAN	Normal-Triple-negative breast cancer	1.00877401604802	0.410960740469674	23.9999999994958	0.0217327871369284	0.0972271661415208	nan
sp|P10644|KAP0_HUMAN	metaplastic breast carcinomas-Normal	-0.104425978343156	0.210036550878325	23.9999999995864	0.623586309112944	0.774713153324972	nan
sp|P10644|KAP0_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0341758155134954	0.210036550878325	23.9999999998045	0.872106175997982	0.981704007186169	nan
sp|P10644|KAP0_HUMAN	Normal-Triple-negative breast cancer	0.138601793856651	0.251041694615694	23.9999999996336	0.585980452677663	0.742584454708559	nan
sp|P10645|CMGA_HUMAN	metaplastic breast carcinomas-Normal	-1.57257863762774	1.88491194719783	6.0	0.43606354683608	0.632406295673268	nan
sp|P10645|CMGA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-2.14379648328191	1.88491194719783	6.0	0.298765346205051	0.867696529950794	nan
sp|P10645|CMGA_HUMAN	Normal-Triple-negative breast cancer	-0.571217845654175	2.25290068536704	6.0	0.808309399431221	0.889381146543985	nan
sp|P10768|ESTD_HUMAN	metaplastic breast carcinomas-Normal	-0.684853122268112	0.244847972718492	23.9999999991603	0.009997330587464	0.0665555756942394	nan
sp|P10768|ESTD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0843397676505219	0.244847972718492	23.9999999991603	0.733502212373416	0.954643368861838	nan
sp|P10768|ESTD_HUMAN	Normal-Triple-negative breast cancer	0.60051335461759	0.292649301930668	23.9999999991816	0.0512332803870348	0.159010310044248	nan
sp|P10809|CH60_HUMAN	metaplastic breast carcinomas-Normal	0.48178321200604	0.251627300764701	21.9999999968942	0.0686281277442581	0.202890839807786	nan
sp|P10809|CH60_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.723262583549194	0.251627300764701	21.9999999969494	0.0088085354049324	0.547668704418496	nan
sp|P10809|CH60_HUMAN	Normal-Triple-negative breast cancer	-1.20504579555523	0.300752148763561	21.999999997188	0.0005932669702522	0.0237592699893802	nan
sp|P10909|CLUS_HUMAN	metaplastic breast carcinomas-Normal	-1.17181667447597	0.475975078458699	23.9999999996567	0.0213869006015226	0.100085016891408	nan
sp|P10909|CLUS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.298506641538448	0.475975078458699	23.9999999996567	0.536483703258935	0.921388505638487	nan
sp|P10909|CLUS_HUMAN	Normal-Triple-negative breast cancer	0.873310032937522	0.56889903110402	23.9999999996028	0.137841282983181	0.298880903219892	nan
sp|P10915|HPLN1_HUMAN	metaplastic breast carcinomas-Normal	0.59713958854965	0.559716733832875	24.0000000000682	0.296649797304114	0.501048743007558	nan
sp|P10915|HPLN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.995945799114935	0.559716733832875	23.9999999998224	0.0878471097096813	0.809016644110817	nan
sp|P10915|HPLN1_HUMAN	Normal-Triple-negative breast cancer	0.398806210565286	0.668989453400256	23.9999999999944	0.556668111491918	0.720266563876658	nan
sp|P11021|BIP_HUMAN	metaplastic breast carcinomas-Normal	0.928400176437236	0.217102551795959	22.0000000016122	0.0003072217493168	0.0165412624404528	nan
sp|P11021|BIP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.351226613553991	0.217102551795959	22.0000000014743	0.11995687075304	0.823891816737944	nan
sp|P11021|BIP_HUMAN	Normal-Triple-negative breast cancer	-0.577173562883246	0.259487181066032	22.0000000017715	0.0367043066396825	0.127353982536852	nan
sp|P11047|LAMC1_HUMAN	metaplastic breast carcinomas-Normal	-0.35526771573149	0.401887591891573	23.9999999997356	0.385467657101937	0.589914591255451	nan
sp|P11047|LAMC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.481625768275998	0.401887591891573	23.9999999995364	0.242458271156532	0.84964799869723	nan
sp|P11047|LAMC1_HUMAN	Normal-Triple-negative breast cancer	0.836893484007488	0.480347547565313	23.9999999997038	0.0942645338858869	0.23435700122415	nan
sp|P11137|MTAP2_HUMAN	metaplastic breast carcinomas-Normal	0.476769994032007	0.52892412568268	23.9999999993767	0.37633515230889	0.583004250833278	nan
sp|P11137|MTAP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.223787254303926	0.528924125682681	23.9999999993767	0.67599030636654	0.946386428913156	nan
sp|P11137|MTAP2_HUMAN	Normal-Triple-negative breast cancer	-0.700557248335933	0.63218524718312	23.9999999994572	0.278778553870324	0.470624638428115	nan
sp|P11142|HSP7C_HUMAN	metaplastic breast carcinomas-Normal	0.70948614137734	0.229122793322636	23.9999999996815	0.0049283529798018	0.0470009737236255	nan
sp|P11142|HSP7C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.136794290369723	0.229122793322636	23.9999999996515	0.556075216704752	0.931642387063667	nan
sp|P11142|HSP7C_HUMAN	Normal-Triple-negative breast cancer	-0.846280431747064	0.273854117629826	23.999999999638	0.0050030397979394	0.0452771179429151	nan
sp|P11171|EPB41_HUMAN	metaplastic breast carcinomas-Normal	-0.111202301943032	0.30409287399734	22.0000000043629	0.718092539046326	0.842845903880646	nan
sp|P11171|EPB41_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.121743525208739	0.30409287399734	22.0000000050031	0.692759981808539	0.946568877415162	nan
sp|P11171|EPB41_HUMAN	Normal-Triple-negative breast cancer	0.232945827151771	0.36346050289634	22.0000000045228	0.528201006217487	0.697552699510103	nan
sp|P11172|UMPS_HUMAN	metaplastic breast carcinomas-Normal	0.691624218686634	0.277982470717554	23.9999999991837	0.0201851286549589	0.0964013903004072	nan
sp|P11172|UMPS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.100418209435668	0.277982470717554	23.9999999989755	0.721081141386689	0.951268548117182	nan
sp|P11172|UMPS_HUMAN	Normal-Triple-negative breast cancer	-0.591206009250965	0.332252601895081	23.9999999991067	0.0878450227461862	0.223602777631342	nan
sp|P11177|ODPB_HUMAN	metaplastic breast carcinomas-Normal	-0.0937914150816283	0.244317772743412	23.999999999042	0.704439194029626	0.830928275711312	nan
sp|P11177|ODPB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.473497498374104	0.244317772743412	23.999999999042	0.0644692674985338	0.773787875546141	nan
sp|P11177|ODPB_HUMAN	Normal-Triple-negative breast cancer	-0.379706083292476	0.292015591751784	23.9999999990207	0.205849197079993	0.387234143233672	nan
sp|P11182|ODB2_HUMAN	metaplastic breast carcinomas-Normal	-0.0896987113283606	0.214544580303454	21.9999995495718	0.679934875453129	0.812986879858346	nan
sp|P11182|ODB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.187765984546187	0.214544580303455	21.9999995489385	0.390928856788712	0.885234295852111	nan
sp|P11182|ODB2_HUMAN	Normal-Triple-negative breast cancer	-0.0980672732178268	0.256429820356329	21.9999995471484	0.705809730809588	0.827552573266692	nan
sp|P11215|ITAM_HUMAN	metaplastic breast carcinomas-Normal	0.679824754307894	0.339706701203875	21.9999996647081	0.0578559627374751	0.183155447751778	nan
sp|P11215|ITAM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.50665271771765	0.339706701203875	21.9999996726486	0.150046373504153	0.842743567400859	nan
sp|P11215|ITAM_HUMAN	Normal-Triple-negative breast cancer	-0.173172036590245	0.406027168061482	21.9999996732182	0.673885369143781	0.807787582774587	nan
sp|P11216|PYGB_HUMAN	metaplastic breast carcinomas-Normal	-0.297632814574764	0.328908791753343	23.9999999993064	0.374507940187637	0.581984288538432	nan
sp|P11216|PYGB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0816525538352863	0.328908791753343	23.9999999993064	0.806050629676961	0.965774701272009	nan
sp|P11216|PYGB_HUMAN	Normal-Triple-negative breast cancer	0.215980260739478	0.393121197765204	23.9999999992794	0.587808070890054	0.743208813016678	nan
sp|P11233|RALA_HUMAN	metaplastic breast carcinomas-Normal	-0.340101758294161	0.195761331540538	22.0000000189281	0.0963109810078528	0.250751547601932	nan
sp|P11233|RALA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.16420534267453	0.195761331540538	22.0000000191595	0.410601357332818	0.885784822958391	nan
sp|P11233|RALA_HUMAN	Normal-Triple-negative breast cancer	0.17589641561963	0.233979544058647	22.0000000186342	0.460163028455046	0.64148519448451	nan
sp|P11234|RALB_HUMAN	metaplastic breast carcinomas-Normal	0.0329513112104204	0.330472769592919	23.9999999992899	0.921403087318374	0.95843058885501	nan
sp|P11234|RALB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0308696342400575	0.330472769592919	23.9999999992899	0.926352866062105	0.995193305220193	nan
sp|P11234|RALB_HUMAN	Normal-Triple-negative breast cancer	-0.063820945450478	0.39499050882343	23.9999999993046	0.872992362607477	0.926805050561244	nan
sp|P11277|SPTB1_HUMAN	metaplastic breast carcinomas-Normal	-1.56926230536561	0.94241111598727	6.0	0.146935044996284	0.324526305360564	nan
sp|P11277|SPTB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0412941868020343	0.94241111598727	6.0	0.966471658635131	0.99709406933403	nan
sp|P11277|SPTB1_HUMAN	Normal-Triple-negative breast cancer	1.61055649216764	1.12639672758274	6.0	0.202705702949847	0.382901192452517	nan
sp|P11279|LAMP1_HUMAN	metaplastic breast carcinomas-Normal	0.392418611544411	0.297407559706744	22.0000000322422	0.200581767665718	0.393658005706939	nan
sp|P11279|LAMP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0015785231600093	0.297407559706744	22.0000000327142	0.995812995620679	0.998185231446144	nan
sp|P11279|LAMP1_HUMAN	Normal-Triple-negative breast cancer	-0.393997134704421	0.355470023993827	22.0000000324052	0.279666832144349	0.471405958442097	nan
sp|P11310|ACADM_HUMAN	metaplastic breast carcinomas-Normal	0.0035660191213885	0.237737130230778	14.9999999995422	0.988230000778046	0.994136910531496	nan
sp|P11310|ACADM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.289695637736215	0.237737130230778	14.9999999995421	0.241832210881816	0.84964799869723	nan
sp|P11310|ACADM_HUMAN	Normal-Triple-negative breast cancer	-0.293261656857604	0.284150219552882	14.9999999995294	0.318395815098487	0.511279076998729	nan
sp|P11387|TOP1_HUMAN	metaplastic breast carcinomas-Normal	0.74488115008219	0.311893902838493	22.9999999997101	0.0255270459538489	0.112535677388055	nan
sp|P11387|TOP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0049668054012537	0.311893902838493	22.9999999997101	0.98743182962041	0.99777413090774	nan
sp|P11387|TOP1_HUMAN	Normal-Triple-negative breast cancer	-0.749847955483444	0.369037842610969	22.999999999717	0.0538711832144716	0.164282397252205	nan
sp|P11388|TOP2A_HUMAN	metaplastic breast carcinomas-Normal	0.772476127808175	0.482895848585425	19.9999999999473	0.125349478599861	0.296183334837538	nan
sp|P11388|TOP2A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.364777108752101	0.416831164910655	20.0000000000531	0.391897487987138	0.885234295852111	nan
sp|P11388|TOP2A_HUMAN	Normal-Triple-negative breast cancer	-0.407699019056074	0.545161354739423	19.9999999999965	0.463254064482023	0.643483706785728	nan
sp|P11413|G6PD_HUMAN	metaplastic breast carcinomas-Normal	-0.103582839908746	0.400073864705423	22.0000000229621	0.798112325034336	0.891739619635003	nan
sp|P11413|G6PD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.290026666876556	0.400073864705423	22.0000000230545	0.476133662369229	0.913280230088743	nan
sp|P11413|G6PD_HUMAN	Normal-Triple-negative breast cancer	-0.18644382696781	0.478179728942899	22.000000022926	0.700357306433501	0.824399407135586	nan
sp|P11498|PYC_HUMAN	metaplastic breast carcinomas-Normal	-0.896123087243456	0.512465537332084	24.0000000002442	0.0931328414369742	0.247065893804072	nan
sp|P11498|PYC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.338365623244919	0.512465537332084	23.9999999999977	0.515368199638389	0.915620969865368	nan
sp|P11498|PYC_HUMAN	Normal-Triple-negative breast cancer	0.557757463998537	0.61251347151723	24.0000000001674	0.371559357129989	0.561055559292967	nan
sp|P11586|C1TC_HUMAN	metaplastic breast carcinomas-Normal	-0.184776019163988	0.256278657834603	23.9999999996215	0.477876739104886	0.667645385160279	nan
sp|P11586|C1TC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.105006489462165	0.256278657834603	23.9999999996215	0.685634122419449	0.946568877415162	nan
sp|P11586|C1TC_HUMAN	Normal-Triple-negative breast cancer	0.0797695297018232	0.306311583805738	23.9999999996216	0.796761498107725	0.883106108606228	nan
sp|P11678|PERE_HUMAN	metaplastic breast carcinomas-Normal	0.814815831258301	0.959937871676638	9.99999999971557	0.41583741970975	0.617073028176433	nan
sp|P11678|PERE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.980422104462369	0.822041681517014	9.99999999979208	0.260530728003383	0.862813416943474	nan
sp|P11678|PERE_HUMAN	Normal-Triple-negative breast cancer	0.165606273204068	1.10844077723565	9.99999999974726	0.884204497827696	0.93275221069853	nan
sp|P11717|MPRI_HUMAN	metaplastic breast carcinomas-Normal	0.149617702680735	0.14328022640588	23.9999999996574	0.306782806260162	0.514273682117424	nan
sp|P11717|MPRI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.160619148483571	0.14328022640588	23.9999999996959	0.273373945336881	0.867696529950794	nan
sp|P11717|MPRI_HUMAN	Normal-Triple-negative breast cancer	0.0110014458028355	0.171252625752217	23.9999999996903	0.949310391799741	0.973407457284302	nan
sp|P11766|ADHX_HUMAN	metaplastic breast carcinomas-Normal	-0.7662077019254	0.225089167291368	22.0000000066702	0.0025467682013854	0.0361771688094236	nan
sp|P11766|ADHX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.021751549991616	0.225089167291368	22.000000006731	0.923890985462721	0.994508979919649	nan
sp|P11766|ADHX_HUMAN	Normal-Triple-negative breast cancer	0.787959251917016	0.269033012397899	22.0000000068283	0.0077723832095966	0.0560420863095431	nan
sp|P11908|PRPS2_HUMAN	metaplastic breast carcinomas-Normal	0.769386069912588	0.298229702896316	6.0	0.0417782229371022	0.151937432213269	nan
sp|P11908|PRPS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.171266309603814	0.298229702896316	6.0	0.586649446537594	0.939599908351397	nan
sp|P11908|PRPS2_HUMAN	Normal-Triple-negative breast cancer	-0.940652379516401	0.356452673054973	6.0	0.0385958239581627	0.131717165130321	nan
sp|P11940|PABP1_HUMAN	metaplastic breast carcinomas-Normal	0.85121610249251	0.19080652358053	22.0000001003702	0.0001955769075705	0.0157578323963946	nan
sp|P11940|PABP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0081835867491696	0.19080652358053	22.0000001001291	0.96617655144732	0.99709406933403	nan
sp|P11940|PABP1_HUMAN	Normal-Triple-negative breast cancer	-0.859399689241679	0.228057415831087	22.0000001000248	0.0010593755815486	0.0264764243087785	nan
sp|P12004|PCNA_HUMAN	metaplastic breast carcinomas-Normal	0.987374589925466	0.325092934423563	21.9999996395761	0.0060489309302779	0.0510320974930049	nan
sp|P12004|PCNA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.27487428506052	0.325092934423563	21.9999996395684	0.406920049298821	0.885784822958391	nan
sp|P12004|PCNA_HUMAN	Normal-Triple-negative breast cancer	-1.26224887498599	0.388560375915512	21.9999996395661	0.003684950800192	0.0400819560687694	nan
sp|P12036|NFH_HUMAN	metaplastic breast carcinomas-Normal	-0.245869566461571	0.60168723307287	14.9999999998728	0.688582895282235	0.817738315083298	nan
sp|P12036|NFH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.528451358651057	0.601687233072869	14.9999999998728	0.393641746187211	0.885234295852111	nan
sp|P12036|NFH_HUMAN	Normal-Triple-negative breast cancer	-0.282581792189486	0.719153794839945	14.999999999896	0.699894182802264	0.824399407135586	nan
sp|P12081|HARS1_HUMAN	metaplastic breast carcinomas-Normal	0.484627609428953	0.183919598439321	22.0005867510432	0.0151233002843806	0.0809498392033512	nan
sp|P12081|HARS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0863257293748139	0.183919598439321	22.0005868046339	0.643425953073542	0.941868024951375	nan
sp|P12081|HARS1_HUMAN	Normal-Triple-negative breast cancer	-0.398301880054139	0.219825965871969	22.0005867522816	0.0836755636095092	0.217294979248444	nan
sp|P12109|CO6A1_HUMAN	metaplastic breast carcinomas-Normal	-1.10408888685881	0.411568431825972	22.0000000952025	0.0135976621439103	0.0776608745126424	nan
sp|P12109|CO6A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.930020470738209	0.411568431825972	22.0000000952066	0.03408304482661	0.724424466074313	nan
sp|P12109|CO6A1_HUMAN	Normal-Triple-negative breast cancer	2.03410935759702	0.491918364417293	22.0000000954835	0.0004338319246352	0.0237592699893802	nan
sp|P12110|CO6A2_HUMAN	metaplastic breast carcinomas-Normal	-0.87640825994026	0.375756416693541	21.9999999842831	0.0292310986021334	0.122436415365631	nan
sp|P12110|CO6A2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.713093730272705	0.375756416693541	21.9999999834152	0.0709286204945761	0.7829758433102	nan
sp|P12110|CO6A2_HUMAN	Normal-Triple-negative breast cancer	1.58950199021296	0.449114819373097	21.9999999829645	0.0018423128486256	0.0296663640706879	nan
sp|P12111|CO6A3_HUMAN	metaplastic breast carcinomas-Normal	-0.753831819465905	0.365666104772332	23.9999999996677	0.0502431107541269	0.169912927873181	nan
sp|P12111|CO6A3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.791245597845705	0.365666104772332	23.9999999993812	0.0406502637850046	0.738255867002113	nan
sp|P12111|CO6A3_HUMAN	Normal-Triple-negative breast cancer	1.54507741731161	0.437054589887759	23.9999999995295	0.0016885607239484	0.0289979437553501	nan
sp|P12268|IMDH2_HUMAN	metaplastic breast carcinomas-Normal	0.32474530125819	0.234537251829111	21.9999865388446	0.180051872444476	0.369667958002123	nan
sp|P12268|IMDH2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.125787965987323	0.234537251829111	21.9999865388446	0.59711657456378	0.940559810632461	nan
sp|P12268|IMDH2_HUMAN	Normal-Triple-negative breast cancer	-0.198957335270867	0.280325633340819	21.9999865414509	0.485322734974656	0.663054981938247	nan
sp|P12270|TPR_HUMAN	metaplastic breast carcinomas-Normal	0.501692990820915	0.158796100623705	23.999999999488	0.0042371104524419	0.042883667309653	nan
sp|P12270|TPR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0710338987547971	0.158796100623705	23.9999999992972	0.65864969839206	0.944190045212043	nan
sp|P12270|TPR_HUMAN	Normal-Triple-negative breast cancer	-0.572726889575712	0.189797642516195	23.9999999993909	0.0059518406641804	0.0487851488979678	nan
sp|P12273|PIP_HUMAN	metaplastic breast carcinomas-Normal	-3.93646489015172	1.23257647789671	12.1551447825496	0.0076093845634686	0.0580128309380038	nan
sp|P12273|PIP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.62383219284421	1.11084932035001	12.0488177857344	0.169384513879774	0.843662073010871	nan
sp|P12273|PIP_HUMAN	Normal-Triple-negative breast cancer	2.31263269730751	1.41232988690128	12.2594824961429	0.126929550258764	0.283163640979955	nan
sp|P12277|KCRB_HUMAN	metaplastic breast carcinomas-Normal	-1.13202899866355	0.759903126899291	22.0000015258015	0.150500334526413	0.329502322711024	nan
sp|P12277|KCRB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.433791816367903	0.759903126899291	22.0000015258656	0.573885742408279	0.935843259183841	nan
sp|P12277|KCRB_HUMAN	Normal-Triple-negative breast cancer	0.698237182295643	0.908257957592697	22.0000015261579	0.450207331670742	0.633568658117505	nan
sp|P12429|ANXA3_HUMAN	metaplastic breast carcinomas-Normal	-0.60263772292012	0.533173927676979	21.9999999968479	0.270529368834822	0.472716075635733	nan
sp|P12429|ANXA3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.716470126019893	0.533173927676979	21.9999999968363	0.192714765341935	0.843662073010871	nan
sp|P12429|ANXA3_HUMAN	Normal-Triple-negative breast cancer	-0.113832403099773	0.637264732110713	21.9999999975545	0.859865682611186	0.919920672352618	nan
sp|P12694|ODBA_HUMAN	metaplastic breast carcinomas-Normal	-0.0110942287595376	0.331624760140629	22.0000000028604	0.973614090010317	0.986747848285733	nan
sp|P12694|ODBA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.426579258060908	0.331624760140629	22.0000000028605	0.211700502658795	0.843662073010871	nan
sp|P12694|ODBA_HUMAN	Normal-Triple-negative breast cancer	-0.41548502930137	0.396367400883736	22.0000000028876	0.305911701329834	0.49870058617968	nan
sp|P12814|ACTN1_HUMAN	metaplastic breast carcinomas-Normal	0.797427209403844	0.234193491708183	23.9999999995892	0.0023288322049559	0.0344046144412164	nan
sp|P12814|ACTN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.185340257688425	0.234193491708183	23.9999999995893	0.436463797264636	0.897513075778899	nan
sp|P12814|ACTN1_HUMAN	Normal-Triple-negative breast cancer	-0.612086951715419	0.279914761409537	23.9999999996652	0.0387478290257021	0.131848322456358	nan
sp|P12821|ACE_HUMAN	metaplastic breast carcinomas-Normal	-0.699886434671476	0.339644286169208	23.999999999749	0.0503342443794346	0.169912927873181	nan
sp|P12821|ACE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.477960132125885	0.339644286169208	23.999999999749	0.172176571285591	0.843662073010871	nan
sp|P12821|ACE_HUMAN	Normal-Triple-negative breast cancer	1.17784656679736	0.405952567826395	23.9999999996993	0.0078336371213098	0.0561233407355565	nan
sp|P12830|CADH1_HUMAN	metaplastic breast carcinomas-Normal	-0.374606402366532	0.319134997788911	14.0000000042179	0.260050575217349	0.462250327284743	nan
sp|P12830|CADH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.108209029958832	0.319134997788911	14.0000000047938	0.739589409782082	0.954643368861838	nan
sp|P12830|CADH1_HUMAN	Normal-Triple-negative breast cancer	0.266397372407701	0.381439279597175	14.0000000046531	0.496364810704764	0.673160600074514	nan
sp|P12931|SRC_HUMAN	metaplastic breast carcinomas-Normal	0.116048736924908	0.274960134317097	14.0000001121441	0.679393218906687	0.812952881869051	nan
sp|P12931|SRC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.355864091083078	0.274960134317097	14.0000001121461	0.216525302910277	0.843662073010871	nan
sp|P12931|SRC_HUMAN	Normal-Triple-negative breast cancer	-0.471912828007985	0.328640218962222	14.0000001121555	0.172981664181103	0.3461716145322	nan
sp|P12955|PEPD_HUMAN	metaplastic breast carcinomas-Normal	-0.0474043710289332	0.202216398307714	23.9999999995009	0.816644224171786	0.903262544710797	nan
sp|P12955|PEPD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0447884272513657	0.202216398307714	23.999999999227	0.82658648793183	0.966045719639133	nan
sp|P12955|PEPD_HUMAN	Normal-Triple-negative breast cancer	0.0921927982802989	0.241694824533939	23.9999999993581	0.70623071748464	0.827754197785241	nan
sp|P12956|XRCC6_HUMAN	metaplastic breast carcinomas-Normal	0.668405160409543	0.208145495873975	22.000000115126	0.0040240515843419	0.0421954178749296	nan
sp|P12956|XRCC6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.175449182873993	0.208145495873975	22.000000115035	0.408346574065446	0.885784822958391	nan
sp|P12956|XRCC6_HUMAN	Normal-Triple-negative breast cancer	-0.843854343283537	0.248781451572669	22.0000001150618	0.0026211743976454	0.0344406168311338	nan
sp|P13010|XRCC5_HUMAN	metaplastic breast carcinomas-Normal	0.472057113563147	0.207123380028953	23.9999999993257	0.0318456559418263	0.128466389195289	nan
sp|P13010|XRCC5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.255162234112593	0.207123380028953	23.9999999991003	0.229908013141118	0.843662073010871	nan
sp|P13010|XRCC5_HUMAN	Normal-Triple-negative breast cancer	-0.72721934767574	0.247559789472644	23.9999999992189	0.0071948503306722	0.0535093121381869	nan
sp|P13073|COX41_HUMAN	metaplastic breast carcinomas-Normal	0.449363268223643	0.18596457648444	23.9999999998963	0.0236447127916693	0.107110232987193	nan
sp|P13073|COX41_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0886377847777434	0.18596457648444	23.9999999998506	0.637931013956011	0.941868024951375	nan
sp|P13073|COX41_HUMAN	Normal-Triple-negative breast cancer	-0.360725483445899	0.222270182136957	23.9999999998344	0.117671696493937	0.26864060380896	nan
sp|P13284|GILT_HUMAN	metaplastic breast carcinomas-Normal	0.761060075194591	0.493769814234063	20.9234396569738	0.138226482927196	0.312561108333333	nan
sp|P13284|GILT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0721470431060581	0.493769814234063	20.9234396524892	0.885229397448712	0.985399312526605	nan
sp|P13284|GILT_HUMAN	Normal-Triple-negative breast cancer	-0.688913032088533	0.584144449338636	20.8630236375158	0.251531905164369	0.440317118741841	nan
sp|P13473|LAMP2_HUMAN	metaplastic breast carcinomas-Normal	0.439639477406629	0.262413230421281	23.9999999990997	0.106843671284864	0.26662790041358	nan
sp|P13473|LAMP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.123741324466771	0.262413230421281	23.9999999990998	0.641505728628405	0.941868024951375	nan
sp|P13473|LAMP2_HUMAN	Normal-Triple-negative breast cancer	-0.315898152939859	0.313643800467373	23.9999999990622	0.323891959890272	0.515621108560951	nan
sp|P13489|RINI_HUMAN	metaplastic breast carcinomas-Normal	-0.259923554364518	0.241021931338529	23.9999999998356	0.291565111617348	0.494975705319747	nan
sp|P13489|RINI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0023560407491734	0.241021931338529	23.9999999998356	0.992281436210801	0.998185231446144	nan
sp|P13489|RINI_HUMAN	Normal-Triple-negative breast cancer	0.262279595113692	0.288076307812839	23.9999999998826	0.371638169785537	0.561055559292967	nan
sp|P13611|CSPG2_HUMAN	metaplastic breast carcinomas-Normal	0.453157114661828	0.488620941118024	22.0011379989822	0.363771313260212	0.574430330297836	nan
sp|P13611|CSPG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.260541548133421	0.488620941118024	22.0011379989822	0.599228277257501	0.940559810632461	nan
sp|P13611|CSPG2_HUMAN	Normal-Triple-negative breast cancer	-0.713698662795249	0.584013727944159	22.0011379978541	0.2346176898502	0.41938534294221	nan
sp|P13639|EF2_HUMAN	metaplastic breast carcinomas-Normal	0.615978001584059	0.182228269439767	21.9999998499156	0.0026953056390229	0.0374448413967682	nan
sp|P13639|EF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0561960018866539	0.182228269439767	21.9999998487762	0.760692390511405	0.955228196959647	nan
sp|P13639|EF2_HUMAN	Normal-Triple-negative breast cancer	-0.672174003470713	0.217804441063906	21.9999998480509	0.0053971436934629	0.0463568621112942	nan
sp|P13667|PDIA4_HUMAN	metaplastic breast carcinomas-Normal	0.995071473519434	0.265179182593225	22.0000000028984	0.001100995625313	0.0252393755761414	nan
sp|P13667|PDIA4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.199308871101515	0.265179182593225	22.0000000031493	0.460256764921591	0.909423669537079	nan
sp|P13667|PDIA4_HUMAN	Normal-Triple-negative breast cancer	-0.795762602417919	0.316949745635331	22.0000000029261	0.0198967994053839	0.092370057574715	nan
sp|P13671|CO6_HUMAN	metaplastic breast carcinomas-Normal	-0.6830532679454	0.405576337981678	24.0000000002015	0.105115118275611	0.263501246718047	nan
sp|P13671|CO6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.406451789199282	0.405576337981678	23.9999999999675	0.326264769777851	0.867975899287892	nan
sp|P13671|CO6_HUMAN	Normal-Triple-negative breast cancer	1.08950505714468	0.484756442424778	24.0000000000691	0.0340671522392553	0.123894107268364	nan
sp|P13674|P4HA1_HUMAN	metaplastic breast carcinomas-Normal	1.20809164205595	0.363166891743965	24.0000000000428	0.0028227821584632	0.0379733940896436	nan
sp|P13674|P4HA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.331264103480393	0.363166891743965	23.9999999997031	0.370759686347984	0.884580780585171	nan
sp|P13674|P4HA1_HUMAN	Normal-Triple-negative breast cancer	-0.876827538575554	0.434067458975433	23.9999999998656	0.0546782509340415	0.16598219735594	nan
sp|P13693|TCTP_HUMAN	metaplastic breast carcinomas-Normal	0.492025727011523	0.252868502379669	23.9999999994924	0.0634835164896725	0.192535774463204	nan
sp|P13693|TCTP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.568099477123809	0.252868502379669	23.9999999997934	0.0341332547994289	0.724424466074313	nan
sp|P13693|TCTP_HUMAN	Normal-Triple-negative breast cancer	0.0760737501122862	0.302235668443722	23.9999999996184	0.803413157934061	0.887224364442797	nan
sp|P13716|HEM2_HUMAN	metaplastic breast carcinomas-Normal	-0.709862642787272	0.31176301667326	22.0000000202635	0.0328703805874451	0.129407306133986	nan
sp|P13716|HEM2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.655105962286761	0.31176301667326	22.0000000203625	0.0472929088855537	0.760401133998256	nan
sp|P13716|HEM2_HUMAN	Normal-Triple-negative breast cancer	1.36496860507403	0.372628076860276	22.0000000202745	0.0013667607740899	0.0266490250684039	nan
sp|P13747|HLAE_HUMAN	metaplastic breast carcinomas-Normal	-0.249002239925972	0.635450854155832	6.0	0.708707387009158	0.834704720086009	nan
sp|P13747|HLAE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.616271095071458	0.635450854155832	6.0	0.369591693404957	0.883542279876718	nan
sp|P13747|HLAE_HUMAN	Normal-Triple-negative breast cancer	-0.367268855145486	0.759509040713028	6.0	0.645838068970903	0.790996956985734	nan
sp|P13796|PLSL_HUMAN	metaplastic breast carcinomas-Normal	0.10457059753366	0.443967224125874	22.0000000354983	0.815970907241915	0.902891909344915	nan
sp|P13796|PLSL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.169779355823263	0.443967224125874	22.0000000354983	0.705823634260044	0.94948208919602	nan
sp|P13796|PLSL_HUMAN	Normal-Triple-negative breast cancer	0.0652087582896025	0.530642327882019	22.000000035043	0.903312722257177	0.943920618919477	nan
sp|P13797|PLST_HUMAN	metaplastic breast carcinomas-Normal	0.316397264398291	0.20639656850224	23.9999999998504	0.138363686733726	0.312658663972063	nan
sp|P13797|PLST_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.433686271758734	0.20639656850224	23.9999999998492	0.0463039008033055	0.759166737802103	nan
sp|P13797|PLST_HUMAN	Normal-Triple-negative breast cancer	0.117289007360443	0.246691083542323	23.999999999867	0.638765874594203	0.784938176395981	nan
sp|P13798|ACPH_HUMAN	metaplastic breast carcinomas-Normal	-0.0523998382057343	0.213561342267202	23.9999999994371	0.808262124205503	0.899627572407098	nan
sp|P13798|ACPH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.326376219022539	0.213561342267202	23.9999999994707	0.13952287100315	0.823891816737944	nan
sp|P13798|ACPH_HUMAN	Normal-Triple-negative breast cancer	-0.273976380816805	0.255254626125614	23.9999999994555	0.293790226710863	0.486676821835238	nan
sp|P13804|ETFA_HUMAN	metaplastic breast carcinomas-Normal	-0.125098908735526	0.292998989822252	23.9999999992042	0.673214213458106	0.808148806621432	nan
sp|P13804|ETFA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.168677747935896	0.292998989822252	23.999999999241	0.570181263624195	0.935631258424823	nan
sp|P13804|ETFA_HUMAN	Normal-Triple-negative breast cancer	0.293776656671421	0.350200775141632	23.9999999992356	0.409814334801301	0.597728323334588	nan
sp|P13807|GYS1_HUMAN	metaplastic breast carcinomas-Normal	-0.505605899965763	0.287634456882052	22.0000000286236	0.0926877528317602	0.246477679267175	nan
sp|P13807|GYS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.493139145582861	0.287634456882052	22.0000000282147	0.100498688841939	0.821630939204717	nan
sp|P13807|GYS1_HUMAN	Normal-Triple-negative breast cancer	0.998745045548624	0.343788931895788	22.0000000282482	0.0082085127724641	0.0575911703148659	nan
sp|P13861|KAP2_HUMAN	metaplastic breast carcinomas-Normal	-0.40627591474996	0.142451543632963	22.0000000131957	0.0092695569693538	0.0639253264857513	nan
sp|P13861|KAP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.204548167671171	0.142451543632963	22.0000000134585	0.165094274814926	0.843662073010871	nan
sp|P13861|KAP2_HUMAN	Normal-Triple-negative breast cancer	0.201727747078789	0.170262160393964	22.0000000133784	0.248735686054976	0.437458952617323	nan
sp|P13928|ANXA8_HUMAN	metaplastic breast carcinomas-Normal	inf	nan	nan	nan	nan	oneConditionMissing
sp|P13928|ANXA8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.787726323579762	1.86885912004507	5.0	0.690896295775553	0.946568877415162	nan
sp|P13928|ANXA8_HUMAN	Normal-Triple-negative breast cancer	-inf	nan	nan	nan	nan	oneConditionMissing
sp|P13942|COBA2_HUMAN	metaplastic breast carcinomas-Normal	0.515461493324918	0.733000682346692	13.9999999998091	0.493447514615494	0.682164331485943	nan
sp|P13942|COBA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.14627934539664	0.733000682346692	14.0000000001463	0.140177466912041	0.823891816737944	nan
sp|P13942|COBA2_HUMAN	Normal-Triple-negative breast cancer	0.630817852071724	0.876103386202398	14.0000000002384	0.483357153023622	0.661457050905937	nan
sp|P14136|GFAP_HUMAN	metaplastic breast carcinomas-Normal	-1.219009375875	0.643545849661938	10.0966515455472	0.0871717834318267	0.236924781788546	nan
sp|P14136|GFAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.532799286290319	0.524131865872031	10.0092559495114	0.333315630040214	0.870890600099115	nan
sp|P14136|GFAP_HUMAN	Normal-Triple-negative breast cancer	1.75180866216532	0.72995331698963	10.0426894575467	0.037224550040144	0.12835519121726	nan
sp|P14174|MIF_HUMAN	metaplastic breast carcinomas-Normal	0.229114539375609	0.254988106799523	14.9999999996728	0.383099842367211	0.589002717867072	nan
sp|P14174|MIF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.338601632792139	0.254988106799523	14.9999999996728	0.20406121766608	0.843662073010871	nan
sp|P14174|MIF_HUMAN	Normal-Triple-negative breast cancer	0.109487093416529	0.304769080286804	14.9999999996741	0.724417971314961	0.841063687268924	nan
sp|P14207|FOLR2_HUMAN	metaplastic breast carcinomas-Normal	-0.0995457838929812	0.577906162698456	12.9999999997405	0.865891715947449	0.929959309792995	nan
sp|P14207|FOLR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.767181249035419	0.520917575503979	12.9999999996479	0.164613470551904	0.843662073010871	nan
sp|P14207|FOLR2_HUMAN	Normal-Triple-negative breast cancer	0.8667270329284	0.662074683786784	12.9999999996832	0.213165705625512	0.39562412367348	nan
sp|P14314|GLU2B_HUMAN	metaplastic breast carcinomas-Normal	0.525766538124218	0.18634800436052	22.0000000035749	0.0099394900501713	0.0664765893898782	nan
sp|P14314|GLU2B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0986036413440058	0.18634800436052	22.0000000031098	0.602009109984284	0.940559810632461	nan
sp|P14314|GLU2B_HUMAN	Normal-Triple-negative breast cancer	-0.427162896780213	0.222728466104064	22.0000000032832	0.0682011434545694	0.18907472964386	nan
sp|P14317|HCLS1_HUMAN	metaplastic breast carcinomas-Normal	0.506587004699686	0.385293033586393	21.9999999042257	0.202115657975303	0.395079844022346	nan
sp|P14317|HCLS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.300110098073443	0.385293033586393	21.9999999042106	0.444328572943027	0.898657241505819	nan
sp|P14317|HCLS1_HUMAN	Normal-Triple-negative breast cancer	-0.206476906626243	0.460513256719694	21.9999999035614	0.658276251165988	0.798580386451002	nan
sp|P14324|FPPS_HUMAN	metaplastic breast carcinomas-Normal	0.527619176573936	0.589274258323125	18.7739414985878	0.38192540714458	0.58883119357541	nan
sp|P14324|FPPS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.230062289333945	0.503915966121857	18.4190705218549	0.653333198918959	0.944190045212043	nan
sp|P14324|FPPS_HUMAN	Normal-Triple-negative breast cancer	-0.757681465907881	0.670583907059235	19.0426318749781	0.272557311085419	0.463995415682386	nan
sp|P14543|NID1_HUMAN	metaplastic breast carcinomas-Normal	-0.215756235855825	0.40997544288346	23.9999999993901	0.603533153437552	0.761345048207371	nan
sp|P14543|NID1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.508937033957317	0.40997544288346	23.9999999993901	0.226460308132229	0.843662073010871	nan
sp|P14543|NID1_HUMAN	Normal-Triple-negative breast cancer	0.724693269813142	0.49001437845885	23.999999999413	0.152167412870634	0.31972470314917	nan
sp|P14550|AK1A1_HUMAN	metaplastic breast carcinomas-Normal	-0.070465893141818	0.267664996875044	24.0000000002136	0.794596048910958	0.888748096689471	nan
sp|P14550|AK1A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.332296442370288	0.267664996875044	23.9999999999436	0.226431382011154	0.843662073010871	nan
sp|P14550|AK1A1_HUMAN	Normal-Triple-negative breast cancer	-0.26183054922847	0.319920861982453	23.9999999999954	0.421167966072061	0.608128994802102	nan
sp|P14618|KPYM_HUMAN	metaplastic breast carcinomas-Normal	0.698685282013562	0.197731891859501	23.9999999992818	0.0016957178131173	0.0294579152472248	nan
sp|P14618|KPYM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0306639592572036	0.197731891859501	23.999999999076	0.878056329592887	0.98320986943871	nan
sp|P14618|KPYM_HUMAN	Normal-Triple-negative breast cancer	-0.729349241270765	0.23633481412829	23.9999999992162	0.00505335897941	0.0452771179429151	nan
sp|P14621|ACYP2_HUMAN	metaplastic breast carcinomas-Normal	-0.344892979263229	0.34633841424169	23.999999999951	0.329269372115548	0.538535964064372	nan
sp|P14621|ACYP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.319136493824128	0.34633841424169	23.999999999951	0.365981692313113	0.883542279876718	nan
sp|P14621|ACYP2_HUMAN	Normal-Triple-negative breast cancer	0.0257564854391011	0.413953581213174	23.9999999998468	0.950902359827982	0.974052216970173	nan
sp|P14625|ENPL_HUMAN	metaplastic breast carcinomas-Normal	0.769690100214017	0.196499584885251	22.0000000010697	0.0007382615262244	0.0221825773337916	nan
sp|P14625|ENPL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.170885959649913	0.196499584885251	22.0000000008787	0.393881041488819	0.885234295852111	nan
sp|P14625|ENPL_HUMAN	Normal-Triple-negative breast cancer	-0.598804140564103	0.234861925577184	22.0000000006519	0.0182690423291457	0.0873480619203579	nan
sp|P14678|RSMB_HUMAN;sp|P63162|RSMN_HUMAN	metaplastic breast carcinomas-Normal	0.928385012427368	0.287520043296242	23.9999999989187	0.0035805090669688	0.0407324763980233	nan
sp|P14678|RSMB_HUMAN;sp|P63162|RSMN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.373623884196433	0.287520043296242	23.9999999991504	0.206126872397646	0.843662073010871	nan
sp|P14678|RSMB_HUMAN;sp|P63162|RSMN_HUMAN	Normal-Triple-negative breast cancer	-1.3020088966238	0.343652181504732	23.9999999990174	0.0008970374565479	0.025773942907156	nan
sp|P14780|MMP9_HUMAN	metaplastic breast carcinomas-Normal	0.647771800714124	0.533748541953408	14.9999999994978	0.243654479820576	0.444409884435255	nan
sp|P14780|MMP9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.11685549231896	0.533748541953408	14.9999999994977	0.0538113365522243	0.773286317778246	nan
sp|P14780|MMP9_HUMAN	Normal-Triple-negative breast cancer	0.469083691604838	0.637951527533232	14.9999999994655	0.473499674544327	0.651993752355154	nan
sp|P14854|CX6B1_HUMAN	metaplastic breast carcinomas-Normal	-0.0047763109912776	0.213272926040283	21.9999999614869	0.982334517278586	0.990679592061293	nan
sp|P14854|CX6B1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.146257048141585	0.213272926040283	21.9999999616241	0.500019134570506	0.913320451076758	nan
sp|P14854|CX6B1_HUMAN	Normal-Triple-negative breast cancer	-0.141480737150308	0.254909902799804	21.9999999617694	0.584478948203026	0.741722294140206	nan
sp|P14866|HNRPL_HUMAN	metaplastic breast carcinomas-Normal	0.708940634893354	0.190816429748062	21.9999990531833	0.0012046375463189	0.0261713412023794	nan
sp|P14866|HNRPL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.336375650578326	0.190816429748062	21.9999990529275	0.0918182921731607	0.81309570430905	nan
sp|P14866|HNRPL_HUMAN	Normal-Triple-negative breast cancer	-1.04531628547168	0.22806925596593	21.9999990530076	0.0001451321582203	0.0227914720285933	nan
sp|P14868|SYDC_HUMAN	metaplastic breast carcinomas-Normal	0.71229756475661	0.165220899190123	22.0000000031993	0.0002821328460994	0.0159975668038937	nan
sp|P14868|SYDC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0078680857132604	0.165220899190123	22.0000000031993	0.962447477582172	0.99709406933403	nan
sp|P14868|SYDC_HUMAN	Normal-Triple-negative breast cancer	-0.720165650469871	0.197476745571989	22.0000000030676	0.0014214598915908	0.0270744331513255	nan
sp|P14923|PLAK_HUMAN	metaplastic breast carcinomas-Normal	-0.535620014294006	0.345889092152827	22.0000002715534	0.135760742442018	0.308708630279932	nan
sp|P14923|PLAK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.764282217958184	0.345889092152827	22.0000002715495	0.0378429014636809	0.73123935744099	nan
sp|P14923|PLAK_HUMAN	Normal-Triple-negative breast cancer	-0.228662203664179	0.41341653859776	22.0000002719242	0.58576968936784	0.742584454708559	nan
sp|P15086|CBPB1_HUMAN	metaplastic breast carcinomas-Normal	-3.58844122569574	1.2031217375795	5.0	0.0307075115426024	0.126153237930521	nan
sp|P15086|CBPB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.915020038218911	1.2031217375795	5.0	0.481238315948269	0.913320451076758	nan
sp|P15086|CBPB1_HUMAN	Normal-Triple-negative breast cancer	2.67342118747683	1.38924531811883	5.0	0.11229783232256	0.260281322178989	nan
sp|P15088|CBPA3_HUMAN	metaplastic breast carcinomas-Normal	-2.35542532250408	0.567243075014069	22.0000000180682	0.0004158317286487	0.0191975648059513	nan
sp|P15088|CBPA3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.3668439002941	0.567243075014069	22.00000001763	0.524507659414408	0.918310760845185	nan
sp|P15088|CBPA3_HUMAN	Normal-Triple-negative breast cancer	2.72226922279818	0.677985151703631	22.0000000180248	0.0005811556402209	0.0237592699893802	nan
sp|P15090|FABP4_HUMAN	metaplastic breast carcinomas-Normal	-2.59127178024065	0.904511912395094	21.9999999250441	0.009002336156906	0.0626020196350538	nan
sp|P15090|FABP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.642301265729195	0.904511912395094	21.9999999267815	0.485096791169663	0.913320451076758	nan
sp|P15090|FABP4_HUMAN	Normal-Triple-negative breast cancer	3.23357304596984	1.08109851517838	21.9999999260318	0.0067334463205599	0.0524989501286484	nan
sp|P15104|GLNA_HUMAN	metaplastic breast carcinomas-Normal	0.232309521798377	0.454277469116568	13.9999999995974	0.617053200010491	0.771225334653059	nan
sp|P15104|GLNA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.695306913792603	0.505473304491318	13.9999999995772	0.190569540917801	0.843662073010871	nan
sp|P15104|GLNA_HUMAN	Normal-Triple-negative breast cancer	-0.92761643559098	0.586469690815241	13.9999999995933	0.136041576463583	0.296137655641749	nan
sp|P15121|ALDR_HUMAN	metaplastic breast carcinomas-Normal	-0.255826297108735	0.214910585580575	23.9999999998007	0.245536973009845	0.445019028508574	nan
sp|P15121|ALDR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0926096752254532	0.214910585580575	23.9999999995923	0.670370813673608	0.946277260710207	nan
sp|P15121|ALDR_HUMAN	Normal-Triple-negative breast cancer	0.163216621883282	0.256867280334711	23.9999999996965	0.531171935615758	0.698976846392232	nan
sp|P15144|AMPN_HUMAN	metaplastic breast carcinomas-Normal	-0.408424336780566	0.308178710872854	22.0000003293891	0.198676601279722	0.391943393868757	nan
sp|P15144|AMPN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.531363798568829	0.308178710872854	22.0000003292527	0.0986957544912833	0.820234747280893	nan
sp|P15144|AMPN_HUMAN	Normal-Triple-negative breast cancer	0.939788135349396	0.368344012023027	22.0000003292498	0.018197391049771	0.0873480619203579	nan
sp|P15170|ERF3A_HUMAN	metaplastic breast carcinomas-Normal	0.350757530341894	0.209330269941212	22.0000000315425	0.107969453260071	0.268630585805746	nan
sp|P15170|ERF3A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.149855820561978	0.209330269941212	22.0000000313081	0.481594143404065	0.913320451076758	nan
sp|P15170|ERF3A_HUMAN	Normal-Triple-negative breast cancer	-0.500613350903871	0.250197527433429	22.0000000313119	0.0578949849655244	0.172124240434689	nan
sp|P15291|B4GT1_HUMAN	metaplastic breast carcinomas-Normal	0.0092748163400524	0.357334087995072	14.000000000182	0.979659108416784	0.989752057128702	nan
sp|P15291|B4GT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.379197665069114	0.357334087995072	14.0000000003571	0.306570077550965	0.867696529950794	nan
sp|P15291|B4GT1_HUMAN	Normal-Triple-negative breast cancer	-0.388472481409167	0.427095925062124	14.0000000003135	0.378443927454743	0.566133039990803	nan
sp|P15311|EZRI_HUMAN	metaplastic breast carcinomas-Normal	0.778117659130909	0.373224788158825	23.9999999993041	0.0478943798719274	0.164882962783891	nan
sp|P15311|EZRI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.444291628293787	0.373224788158825	23.9999999993494	0.245526119301257	0.84964799869723	nan
sp|P15311|EZRI_HUMAN	Normal-Triple-negative breast cancer	-1.2224092874247	0.446088944520196	23.9999999993199	0.0114005362464307	0.0681571627394525	nan
sp|P15374|UCHL3_HUMAN	metaplastic breast carcinomas-Normal	-0.300864435853122	0.218655246447966	22.000000005613	0.182675914011769	0.373490887701788	nan
sp|P15374|UCHL3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.739628162621401	0.218655246447966	22.0000000053982	0.0026801352684598	0.448717474870704	nan
sp|P15374|UCHL3_HUMAN	Normal-Triple-negative breast cancer	-0.438763726768279	0.261343006135671	22.0000000057418	0.107324359382821	0.253315936205068	nan
sp|P15428|PGDH_HUMAN	metaplastic breast carcinomas-Normal	-1.22178249417228	1.05805257697714	10.0016839095263	0.275037919161669	0.477548285858522	nan
sp|P15428|PGDH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.71978991651073	1.05805257697714	10.0016839096902	0.135127072656579	0.823891816737944	nan
sp|P15428|PGDH_HUMAN	Normal-Triple-negative breast cancer	-0.498007422338449	1.27536049022295	10.0000005325918	0.704367955963909	0.826751679625131	nan
sp|P15498|VAV_HUMAN	metaplastic breast carcinomas-Normal	-0.461343247575106	0.595691760215336	17.8943476546092	0.448767829079614	0.644364692812371	nan
sp|P15498|VAV_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.181155580853361	0.449339216267067	16.9653205536158	0.691865936530345	0.946568877415162	nan
sp|P15498|VAV_HUMAN	Normal-Triple-negative breast cancer	0.280187666721745	0.653628324848355	17.6286509034366	0.673359147049909	0.80744798152738	nan
sp|P15531|NDKA_HUMAN	metaplastic breast carcinomas-Normal	0.689030076208289	0.200028238113195	21.999999994197	0.0023110332302015	0.0344046144412164	nan
sp|P15531|NDKA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0724685006198065	0.200028238113195	21.999999994173	0.720591320855698	0.951268548117182	nan
sp|P15531|NDKA_HUMAN	Normal-Triple-negative breast cancer	-0.761498576828096	0.239079472867643	21.9999999944613	0.0042793440187732	0.0419484078096101	nan
sp|P15586|GNS_HUMAN	metaplastic breast carcinomas-Normal	-0.432821680034723	0.251294757795675	23.9999999991584	0.0978677764505089	0.252341052717084	nan
sp|P15586|GNS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.190394468944628	0.251294757795675	23.9999999992084	0.456033446109853	0.908567154037048	nan
sp|P15586|GNS_HUMAN	Normal-Triple-negative breast cancer	0.242427211090096	0.300354683893148	23.9999999992216	0.427514927781776	0.613583601013223	nan
sp|P15880|RS2_HUMAN	metaplastic breast carcinomas-Normal	0.845963714179106	0.264680678154063	21.9999833512157	0.0041695557598957	0.042883667309653	nan
sp|P15880|RS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0413353141439074	0.264680678154063	21.9999833508695	0.87732283158386	0.983181130777328	nan
sp|P15880|RS2_HUMAN	Normal-Triple-negative breast cancer	-0.887299028323014	0.316353918867765	21.9999833478677	0.0103231889858714	0.0646219965895228	nan
sp|P15907|SIAT1_HUMAN	metaplastic breast carcinomas-Normal	-1.03903268413751	0.638586090186567	22.0000000274576	0.117958541895514	0.283305052934023	nan
sp|P15907|SIAT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.307433540687777	0.638586090186567	22.0000000274533	0.634966028971739	0.941868024951375	nan
sp|P15907|SIAT1_HUMAN	Normal-Triple-negative breast cancer	0.731599143449737	0.763256364513978	22.0000000276156	0.348215160994767	0.539109080180067	nan
sp|P15924|DESP_HUMAN	metaplastic breast carcinomas-Normal	0.246821468135577	0.386652293744885	22.0000000016722	0.52983224790331	0.707578301338128	nan
sp|P15924|DESP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.61959781916689	0.386652293744885	22.0000000017061	0.123314240272833	0.823891816737944	nan
sp|P15924|DESP_HUMAN	Normal-Triple-negative breast cancer	-0.866419287302468	0.462137883348652	22.000000001762	0.0741576446284557	0.199918905713696	nan
sp|P15927|RFA2_HUMAN	metaplastic breast carcinomas-Normal	0.233890775328538	0.202301779978248	22.0000000362531	0.260022035127367	0.462250327284743	nan
sp|P15927|RFA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.153961067244864	0.202301779978248	22.0000000364676	0.454709949827704	0.908567154037048	nan
sp|P15927|RFA2_HUMAN	Normal-Triple-negative breast cancer	-0.387851842573402	0.241796875149274	22.0000000365264	0.122966197199416	0.276549147152136	nan
sp|P15954|COX7C_HUMAN	metaplastic breast carcinomas-Normal	0.44781425102805	0.175769819745617	23.9999999997482	0.0176658983190148	0.0896510626143592	nan
sp|P15954|COX7C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.041357669923263	0.175769819745617	23.9999999997482	0.81597629096596	0.965774701272009	nan
sp|P15954|COX7C_HUMAN	Normal-Triple-negative breast cancer	-0.406456581104787	0.210085117217511	23.9999999997873	0.0648958386679291	0.184795320809112	nan
sp|P16066|ANPRA_HUMAN	metaplastic breast carcinomas-Normal	0.215654445065933	0.32570095800086	22.0000000464736	0.514768385904605	0.69669792945721	nan
sp|P16066|ANPRA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.106141683633784	0.32570095800086	22.0000000458421	0.747589406623374	0.954643368861838	nan
sp|P16066|ANPRA_HUMAN	Normal-Triple-negative breast cancer	-0.321796128699717	0.389287103090248	22.0000000458579	0.417322881573264	0.604309051633356	nan
sp|P16070|CD44_HUMAN	metaplastic breast carcinomas-Normal	0.294539258266496	0.33018883045664	24.0000000000435	0.381232175156449	0.588308147734464	nan
sp|P16070|CD44_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.738539515661657	0.33018883045664	24.0000000000716	0.0348595231795158	0.724424466074313	nan
sp|P16070|CD44_HUMAN	Normal-Triple-negative breast cancer	0.44400025739516	0.39465113664444	24.000000000054	0.271695982856697	0.463995415682386	nan
sp|P16104|H2AX_HUMAN	metaplastic breast carcinomas-Normal	0.738311761628838	0.259777317070192	22.0000000191647	0.0094821416230526	0.0646796741313101	nan
sp|P16104|H2AX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.330366768086096	0.259777317070192	22.0000000191691	0.216748915453068	0.843662073010871	nan
sp|P16104|H2AX_HUMAN	Normal-Triple-negative breast cancer	-1.06867852971493	0.310493281418426	22.0000000190895	0.0023265129687021	0.0327683436778212	nan
sp|P16112|PGCA_HUMAN	metaplastic breast carcinomas-Normal	0.961259356576569	0.718107391698546	22.0000000335721	0.194370472048946	0.387317707029823	nan
sp|P16112|PGCA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.13792133949707	0.718107391698546	22.0000000333024	0.127325057660948	0.823891816737944	nan
sp|P16112|PGCA_HUMAN	Normal-Triple-negative breast cancer	0.176661982920502	0.858302499132602	22.0000000331249	0.838818664514417	0.908340818627252	nan
sp|P16144|ITB4_HUMAN	metaplastic breast carcinomas-Normal	-0.136078057305242	0.266306889209994	23.9999999990966	0.614032289561876	0.768460709404808	nan
sp|P16144|ITB4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.335400752563126	0.266306889209994	23.9999999993694	0.219978377441745	0.843662073010871	nan
sp|P16144|ITB4_HUMAN	Normal-Triple-negative breast cancer	-0.199322695257884	0.318297612846629	23.9999999992394	0.537084982848331	0.70361651736533	nan
sp|P16150|LEUK_HUMAN	metaplastic breast carcinomas-Normal	-0.463980976944348	0.235203592737733	22.0000000271862	0.0612293298417389	0.189856616039123	nan
sp|P16150|LEUK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0888396690689926	0.235203592737733	22.0000000271849	0.709262715313618	0.94948208919602	nan
sp|P16150|LEUK_HUMAN	Normal-Triple-negative breast cancer	0.375141307875355	0.281122063058374	22.00000002685	0.195707159316712	0.376900693840528	nan
sp|P16152|CBR1_HUMAN	metaplastic breast carcinomas-Normal	-0.0397145705889637	0.289751036800842	22.0000000492479	0.892226483598839	0.94150288514576	nan
sp|P16152|CBR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0834665253529503	0.289751036800842	22.0000000490657	0.775994956719488	0.960657739983943	nan
sp|P16152|CBR1_HUMAN	Normal-Triple-negative breast cancer	0.123181095941914	0.346318728768669	22.0000000495611	0.725462789515576	0.841098345877946	nan
sp|P16157|ANK1_HUMAN	metaplastic breast carcinomas-Normal	-0.547127176206224	0.601082796722972	22.0000000368905	0.37256354028245	0.581309388187715	nan
sp|P16157|ANK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.667611746367257	0.601082796722972	22.0000000369027	0.278697497482975	0.867696529950794	nan
sp|P16157|ANK1_HUMAN	Normal-Triple-negative breast cancer	1.21473892257348	0.718431355222025	22.0000000368886	0.10499140616324	0.250712237131185	nan
sp|P16219|ACADS_HUMAN	metaplastic breast carcinomas-Normal	-1.00331123322464	0.321251905829891	14.0000000057712	0.0074806407696292	0.0574264432292092	nan
sp|P16219|ACADS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.311627050164149	0.321251905829891	14.0000000057704	0.348488239501081	0.871876144726181	nan
sp|P16219|ACADS_HUMAN	Normal-Triple-negative breast cancer	1.31493828338879	0.383969468651085	14.0000000058976	0.0041070160865531	0.0415041773018799	nan
sp|P16278|BGAL_HUMAN	metaplastic breast carcinomas-Normal	0.249842276224531	0.260605411629173	24.0000000001429	0.347269268436722	0.557013864291281	nan
sp|P16278|BGAL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.457191918336286	0.260605411629173	24.0000000001414	0.0921330654466978	0.81309570430905	nan
sp|P16278|BGAL_HUMAN	Normal-Triple-negative breast cancer	-0.707034194560817	0.311483043726554	24.0000000001656	0.0324798188014508	0.121245596403811	nan
sp|P16284|PECA1_HUMAN	metaplastic breast carcinomas-Normal	-0.44394816997559	0.54298668573527	23.9999999998569	0.421626385812421	0.621744176877671	nan
sp|P16284|PECA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.02665323691088	0.54298668573527	23.9999999998569	0.0707902036239588	0.7829758433102	nan
sp|P16284|PECA1_HUMAN	Normal-Triple-negative breast cancer	1.47060140688647	0.648993221278458	23.9999999998414	0.0327532696648282	0.121510585324113	nan
sp|P16401|H15_HUMAN	metaplastic breast carcinomas-Normal	0.648130560002549	0.434875677324753	22.000000019857	0.150322903900889	0.329382552779535	nan
sp|P16401|H15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.794228961469018	0.434875677324753	22.000000019741	0.0814022903866208	0.806849600316436	nan
sp|P16401|H15_HUMAN	Normal-Triple-negative breast cancer	-1.44235952147157	0.519775851042218	22.0000000201288	0.0110451110354746	0.0670157251028676	nan
sp|P16402|H13_HUMAN	metaplastic breast carcinomas-Normal	0.155516902103099	0.378216351884705	22.0000000278756	0.684914785922825	0.815421471492646	nan
sp|P16402|H13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.638112570231079	0.378216351884705	22.00000002777	0.105701561681342	0.822178316735448	nan
sp|P16402|H13_HUMAN	Normal-Triple-negative breast cancer	-0.793629472334177	0.452055004290684	22.0000000278804	0.0930718918284814	0.232510913997802	nan
sp|P16403|H12_HUMAN	metaplastic breast carcinomas-Normal	0.359535056244823	0.622618059467932	19.1978236164914	0.570341994068249	0.734528007858528	nan
sp|P16403|H12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0954988688023518	0.473710740982886	17.6699644442087	0.842534073911209	0.972169455774446	nan
sp|P16403|H12_HUMAN	Normal-Triple-negative breast cancer	-0.264036187442471	0.692088790045962	19.2220655072496	0.707012099706994	0.828086053356606	nan
sp|P16422|EPCAM_HUMAN	metaplastic breast carcinomas-Normal	0.362003598023721	0.490045612974714	14.9999999994356	0.471482212443901	0.662666754403183	nan
sp|P16422|EPCAM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.46082512105256	0.490045612974714	14.9999999995358	0.0093265837713342	0.547668704418496	nan
sp|P16422|EPCAM_HUMAN	Normal-Triple-negative breast cancer	-1.82282871907628	0.585716536506188	14.9999999995173	0.007138058783666	0.0535093121381869	nan
sp|P16435|NCPR_HUMAN	metaplastic breast carcinomas-Normal	0.0692641016141744	0.224557741320853	23.9999999998549	0.760403821042955	0.868883568630726	nan
sp|P16435|NCPR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.114314462023988	0.224557741320853	23.9999999996954	0.615355314494756	0.941374262616245	nan
sp|P16435|NCPR_HUMAN	Normal-Triple-negative breast cancer	-0.183578563638162	0.268397836874196	23.9999999997657	0.500539718790232	0.676135101017241	nan
sp|P16455|MGMT_HUMAN	metaplastic breast carcinomas-Normal	-0.115941626787196	0.287727448184383	23.9999999997377	0.690547409583135	0.818757775620021	nan
sp|P16455|MGMT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.167848151752609	0.287727448184383	23.9999999996996	0.565094493677518	0.935109025059232	nan
sp|P16455|MGMT_HUMAN	Normal-Triple-negative breast cancer	0.283789778539806	0.343900077760753	23.9999999996875	0.417379663802028	0.604309051633356	nan
sp|P16615|AT2A2_HUMAN	metaplastic breast carcinomas-Normal	0.538937781491802	0.149336365053604	23.9999999995992	0.0014061710878668	0.0278220993813646	nan
sp|P16615|AT2A2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0013514388281416	0.149336365053604	23.9999999993834	0.992854343941182	0.998185231446144	nan
sp|P16615|AT2A2_HUMAN	Normal-Triple-negative breast cancer	-0.537586342663661	0.178491095926073	23.9999999995145	0.0060335120353303	0.049155377464309	nan
sp|P16671|CD36_HUMAN	metaplastic breast carcinomas-Normal	-2.61501498066309	0.850967549663452	22.0000022798039	0.0055652795963708	0.0493306383422313	nan
sp|P16671|CD36_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0594728657843265	0.850967549663452	22.0000022803587	0.944913777161009	0.996541950781621	nan
sp|P16671|CD36_HUMAN	Normal-Triple-negative breast cancer	2.67448784644741	1.01710076097294	22.0000022797082	0.015308868916095	0.0787156648560068	nan
sp|P16885|PLCG2_HUMAN	metaplastic breast carcinomas-Normal	0.144602536512076	0.295961499387275	22.0000000072125	0.629969976921915	0.778515442309366	nan
sp|P16885|PLCG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.304599747884258	0.295961499387275	22.0000000065188	0.314574784694432	0.867696529950794	nan
sp|P16885|PLCG2_HUMAN	Normal-Triple-negative breast cancer	0.159997211372181	0.353741651329174	22.0000000070704	0.655481464479009	0.797226632977762	nan
sp|P16930|FAAA_HUMAN	metaplastic breast carcinomas-Normal	-0.756502793910711	0.496024523079149	23.9999999991654	0.140297105622013	0.315526102224338	nan
sp|P16930|FAAA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.290287288033439	0.496024523079149	23.9999999991654	0.563857194206324	0.935109025059232	nan
sp|P16930|FAAA_HUMAN	Normal-Triple-negative breast cancer	0.466215505877272	0.592862700915647	23.999999999254	0.439340862354656	0.624341863388512	nan
sp|P16949|STMN1_HUMAN	metaplastic breast carcinomas-Normal	0.923486994656796	0.454771470758063	21.9999999299071	0.0545482171501491	0.178287388207567	nan
sp|P16949|STMN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.738137264050816	0.454771470758063	21.9999999320969	0.11881281657839	0.823891816737944	nan
sp|P16949|STMN1_HUMAN	Normal-Triple-negative breast cancer	-1.66162425870761	0.543555872559117	21.9999999314407	0.0057772624914441	0.0481913978366351	nan
sp|P16989|YBOX3_HUMAN	metaplastic breast carcinomas-Normal	0.355603094508955	0.305380607801025	13.9999999810584	0.263698143433702	0.466567822034205	nan
sp|P16989|YBOX3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0410499656912776	0.305380607801025	13.9999999791683	0.894982004752173	0.988642912226238	nan
sp|P16989|YBOX3_HUMAN	Normal-Triple-negative breast cancer	-0.396653060200233	0.364999639179711	13.9999999800338	0.295516663053603	0.487645781732731	nan
sp|P17026|ZNF22_HUMAN	metaplastic breast carcinomas-Normal	-0.154359767122614	0.267663270804898	23.9999999996845	0.569516301385712	0.734528007858528	nan
sp|P17026|ZNF22_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.242093167516542	0.267663270804898	23.9999999996845	0.37473679254288	0.885234295852111	nan
sp|P17026|ZNF22_HUMAN	Normal-Triple-negative breast cancer	-0.0877334003939273	0.319918798934034	23.9999999996844	0.786249533352985	0.877895011375654	nan
sp|P17050|NAGAB_HUMAN	metaplastic breast carcinomas-Normal	0.19089688019465	0.254967652369425	22.0000000354838	0.461962232460706	0.654925807993489	nan
sp|P17050|NAGAB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.135193322750903	0.254967652369425	22.0000000350383	0.601258986678507	0.940559810632461	nan
sp|P17050|NAGAB_HUMAN	Normal-Triple-negative breast cancer	-0.326090202945553	0.304744632566763	22.0000000352616	0.296199398325143	0.487892368698105	nan
sp|P17096|HMGA1_HUMAN	metaplastic breast carcinomas-Normal	1.13346181795416	0.471227822902544	21.9999999736261	0.0250072932537458	0.1111286668121	nan
sp|P17096|HMGA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.763342240579359	0.471227822902544	21.9999999713792	0.119500762509709	0.823891816737944	nan
sp|P17096|HMGA1_HUMAN	Normal-Triple-negative breast cancer	-1.89680405853351	0.563224975447481	21.9999999736219	0.0027767929986081	0.035775426075091	nan
sp|P17174|AATC_HUMAN	metaplastic breast carcinomas-Normal	0.165115946225816	0.318391419640051	22.0000000403134	0.609220988152725	0.766127999985258	nan
sp|P17174|AATC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.970207322875957	0.318391419640051	22.0000000403393	0.0059097232997967	0.519941801393686	nan
sp|P17174|AATC_HUMAN	Normal-Triple-negative breast cancer	-1.13532326910177	0.380550533720382	22.0000000401952	0.0068535249218109	0.0524989501286484	nan
sp|P17213|BPI_HUMAN	metaplastic breast carcinomas-Normal	0.897158815500469	1.18562237486484	6.0	0.477880739627225	0.667645385160279	nan
sp|P17213|BPI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.984030503745178	1.18562237486484	6.0	0.438324319535211	0.897513075778899	nan
sp|P17213|BPI_HUMAN	Normal-Triple-negative breast cancer	0.0868716882447088	1.41708978230545	6.0	0.953109016497639	0.975719280019253	nan
sp|P17301|ITA2_HUMAN	metaplastic breast carcinomas-Normal	-0.151306164138442	0.43695109031463	19.4228199271118	0.732857435855703	0.851109065467202	nan
sp|P17301|ITA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0814261477287682	0.40688762250992	19.1603702932365	0.843495846158297	0.972477007099978	nan
sp|P17301|ITA2_HUMAN	Normal-Triple-negative breast cancer	0.0698800164096734	0.499311026162566	19.1632472277535	0.890157723380676	0.935467680214153	nan
sp|P17480|UBF1_HUMAN	metaplastic breast carcinomas-Normal	0.528534002155742	0.187749329403583	22.0000000235809	0.0100834173912505	0.0665555756942394	nan
sp|P17480|UBF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0421050407786105	0.187749329403583	22.000000023583	0.824623112753391	0.965774701272009	nan
sp|P17480|UBF1_HUMAN	Normal-Triple-negative breast cancer	-0.570639042934353	0.224403369886509	22.0000000235656	0.0185395053224907	0.0881621111472949	nan
sp|P17612|KAPCA_HUMAN	metaplastic breast carcinomas-Normal	-0.346030964638231	0.211020877836073	22.0000000065354	0.115270028948195	0.280085947532017	nan
sp|P17612|KAPCA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0728710266846758	0.211020877836073	22.0000000065307	0.733129179552957	0.954643368861838	nan
sp|P17612|KAPCA_HUMAN	Normal-Triple-negative breast cancer	0.273159937953556	0.252218190356532	22.0000000060901	0.290522831059687	0.483574306681222	nan
sp|P17655|CAN2_HUMAN	metaplastic breast carcinomas-Normal	-0.0528003577159448	0.271963397045894	22.0000000036538	0.84784379608718	0.919788765729042	nan
sp|P17655|CAN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.216986636025086	0.271963397045894	22.0000000038416	0.433484230001579	0.896102083258464	nan
sp|P17655|CAN2_HUMAN	Normal-Triple-negative breast cancer	-0.164186278309141	0.325058432841021	22.0000000037849	0.618512798339988	0.767713421091158	nan
sp|P17661|DESM_HUMAN	metaplastic breast carcinomas-Normal	-2.7011576997656	0.635076198353861	14.9999999998124	0.0006941233120244	0.0221825773337916	nan
sp|P17661|DESM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.391876461383313	0.63507619835386	14.9999999998319	0.546451947055408	0.928912435561979	nan
sp|P17661|DESM_HUMAN	Normal-Triple-negative breast cancer	3.09303416114892	0.759061241379858	14.999999999838	0.0009958492472975	0.0260939352025391	nan
sp|P17677|NEUM_HUMAN	metaplastic breast carcinomas-Normal	-0.0196369953867654	1.11831614394347	6.0	0.986559666226056	0.993572774672199	nan
sp|P17677|NEUM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.16517449135621	1.11831614394347	6.0	0.337608099649865	0.870943310236299	nan
sp|P17677|NEUM_HUMAN	Normal-Triple-negative breast cancer	1.18481148674298	1.33664344952176	6.0	0.40951641037463	0.597658705349739	nan
sp|P17812|PYRG1_HUMAN	metaplastic breast carcinomas-Normal	0.358474289533204	0.289541901237313	21.9999405737693	0.228738526922283	0.428594624289555	nan
sp|P17812|PYRG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.565602046266117	0.289541901237313	21.9999405732278	0.0636013298654539	0.773787875546141	nan
sp|P17812|PYRG1_HUMAN	Normal-Triple-negative breast cancer	-0.92407633579932	0.34606876395991	21.9999405733256	0.0139810728586345	0.0766840777488802	nan
sp|P17813|EGLN_HUMAN	metaplastic breast carcinomas-Normal	-0.164305434424999	0.219005018910049	22.0000000088146	0.461061554597891	0.65466407837821	nan
sp|P17813|EGLN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.109193838890543	0.219005018910049	22.0000000087108	0.623016279136272	0.941374262616245	nan
sp|P17813|EGLN_HUMAN	Normal-Triple-negative breast cancer	0.0551115955344556	0.26176106418911	22.0000000089395	0.835182815538764	0.906349225873604	nan
sp|P17844|DDX5_HUMAN	metaplastic breast carcinomas-Normal	0.457852878691435	0.317311542543584	23.9999999997467	0.161970718257273	0.347573058416512	nan
sp|P17844|DDX5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.459299925937167	0.317311542543584	23.9999999995555	0.160701827647702	0.843662073010871	nan
sp|P17844|DDX5_HUMAN	Normal-Triple-negative breast cancer	-0.917152804628602	0.37925983372012	23.9999999996291	0.0235473778035591	0.102137084892028	nan
sp|P17858|PFKAL_HUMAN	metaplastic breast carcinomas-Normal	-0.101536453214327	0.203738468139001	23.9999999999906	0.622762242196629	0.774433854493676	nan
sp|P17858|PFKAL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.369342900705251	0.203738468139001	23.9999999999906	0.0823863887112341	0.806849600316436	nan
sp|P17858|PFKAL_HUMAN	Normal-Triple-negative breast cancer	-0.267806447490924	0.243514045941698	24.0000000000194	0.282347151729683	0.475172472349132	nan
sp|P17900|SAP3_HUMAN	metaplastic breast carcinomas-Normal	-0.585768618684275	0.338734158581982	23.9999999996735	0.0966016275287578	0.250914384676006	nan
sp|P17900|SAP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.232297396144423	0.338734158581982	23.9999999996735	0.499422889671442	0.913320451076758	nan
sp|P17900|SAP3_HUMAN	Normal-Triple-negative breast cancer	0.353471222539852	0.404864757295998	23.9999999996515	0.391282156939632	0.578568456257712	nan
sp|P17931|LEG3_HUMAN	metaplastic breast carcinomas-Normal	-0.20803571469569	0.25750245662446	21.9999999976841	0.427798992674643	0.625931347267381	nan
sp|P17931|LEG3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0458806522733513	0.25750245662446	21.999999998628	0.860215569701554	0.979177437622147	nan
sp|P17931|LEG3_HUMAN	Normal-Triple-negative breast cancer	0.162155062422338	0.307774303131443	21.9999999978103	0.603560847051314	0.754791668772975	nan
sp|P17980|PRS6A_HUMAN	metaplastic breast carcinomas-Normal	0.37013914069298	0.1457846047783	22.0000000205453	0.0187019613061355	0.0929781777313555	nan
sp|P17980|PRS6A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0657425400642725	0.1457846047783	22.0000000205144	0.656434199750511	0.944190045212043	nan
sp|P17980|PRS6A_HUMAN	Normal-Triple-negative breast cancer	-0.435881680757253	0.174245930431532	22.000000020351	0.0202991340223803	0.0933254792398229	nan
sp|P17987|TCPA_HUMAN	metaplastic breast carcinomas-Normal	0.392413328044333	0.102578929967223	23.9999999993752	0.000817991853401	0.0227210419054423	nan
sp|P17987|TCPA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.238500594392793	0.102578929967223	23.9999999994127	0.0288495694770213	0.721684569712558	nan
sp|P17987|TCPA_HUMAN	Normal-Triple-negative breast cancer	-0.630913922437126	0.122605271811735	23.999999999417	2.87348064506141e-05	0.022319699811492	nan
sp|P18031|PTN1_HUMAN	metaplastic breast carcinomas-Normal	0.649217777366198	0.296832443299782	22.0000000208163	0.0396488560901951	0.146926195812496	nan
sp|P18031|PTN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.105560183273477	0.296832443299781	22.0000000206171	0.725510760674494	0.953491935272676	nan
sp|P18031|PTN1_HUMAN	Normal-Triple-negative breast cancer	-0.543657594092721	0.354782628410528	22.0000000204375	0.139686689632766	0.30158966924356	nan
sp|P18077|RL35A_HUMAN	metaplastic breast carcinomas-Normal	0.70346065052337	0.240358979412773	22.0000000196835	0.0078109160288558	0.0587409160179117	nan
sp|P18077|RL35A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0257331090692004	0.240358979412773	22.0000000197773	0.915710793726584	0.99408739879047	nan
sp|P18077|RL35A_HUMAN	Normal-Triple-negative breast cancer	-0.67772754145417	0.287283928704563	22.000000019599	0.0276142040083774	0.111517044374766	nan
sp|P18084|ITB5_HUMAN	metaplastic breast carcinomas-Normal	-0.019884820563905	0.273771085060525	22.0000070847409	0.942754460358409	0.97019065827596	nan
sp|P18084|ITB5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.484532474416433	0.273771085060525	22.0000070850138	0.0906129253684447	0.81309570430905	nan
sp|P18084|ITB5_HUMAN	Normal-Triple-negative breast cancer	0.504417294980338	0.32721903327286	22.0000070845036	0.137450458072062	0.298649994758107	nan
sp|P18124|RL7_HUMAN	metaplastic breast carcinomas-Normal	0.494976981689887	0.319612278973468	22.0000000050354	0.135725123440553	0.308708630279932	nan
sp|P18124|RL7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.210202665645169	0.319612278973468	22.000000005157	0.517566560757609	0.915620969865368	nan
sp|P18124|RL7_HUMAN	Normal-Triple-negative breast cancer	-0.705179647335055	0.382009739723655	22.0000000051656	0.0783962818763704	0.207475510316127	nan
sp|P18206|VINC_HUMAN	metaplastic breast carcinomas-Normal	-0.427900610629058	0.216998591405326	23.999999999711	0.0602520313921049	0.188054227556203	nan
sp|P18206|VINC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.172752764521833	0.216998591405326	23.9999999995066	0.433777789028401	0.896102083258464	nan
sp|P18206|VINC_HUMAN	Normal-Triple-negative breast cancer	0.600653375150891	0.25936292463291	23.9999999995834	0.0294259365031516	0.115047565436672	nan
sp|P18405|S5A1_HUMAN	metaplastic breast carcinomas-Normal	0.865590250469506	0.686198967634781	5.0	0.262803985709788	0.465650558901565	nan
sp|P18405|S5A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.838454082072107	0.686198967634781	5.0	0.276210694292319	0.867696529950794	nan
sp|P18405|S5A1_HUMAN	Normal-Triple-negative breast cancer	-1.70404433254161	0.792354317363169	5.0	0.0841801829134364	0.217870762433392	nan
sp|P18583|SON_HUMAN	metaplastic breast carcinomas-Normal	0.561043385310983	0.193588024849559	21.999999997583	0.0083411066239052	0.0602818106368712	nan
sp|P18583|SON_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0938987006575311	0.193588024849559	21.999999997701	0.63244001112972	0.941868024951375	nan
sp|P18583|SON_HUMAN	Normal-Triple-negative breast cancer	-0.654942085968514	0.23138194572473	21.9999999973969	0.0097346547401518	0.0621074709333296	nan
sp|P18615|NELFE_HUMAN	metaplastic breast carcinomas-Normal	0.3628083453669	0.238754119582405	22.9999999997349	0.142242537219665	0.318277876154584	nan
sp|P18615|NELFE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.169576801856895	0.238754119582405	22.9999999997349	0.484684688890799	0.913320451076758	nan
sp|P18615|NELFE_HUMAN	Normal-Triple-negative breast cancer	-0.193231543510005	0.282497683998643	22.9999999996618	0.500802440533619	0.676135101017241	nan
sp|P18621|RL17_HUMAN	metaplastic breast carcinomas-Normal	1.09285212617927	0.338835521199531	22.0000000115793	0.0038926129166718	0.0416809642918909	nan
sp|P18621|RL17_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0591933613615911	0.338835521199531	22.000000011583	0.862915899725127	0.979916450336765	nan
sp|P18621|RL17_HUMAN	Normal-Triple-negative breast cancer	-1.15204548754086	0.404985908796409	22.0000000117343	0.0094268986085808	0.0616490592892753	nan
sp|P18669|PGAM1_HUMAN	metaplastic breast carcinomas-Normal	-0.0010157129279742	0.157715180277777	21.9999912106018	0.994919564581196	0.996859918937684	nan
sp|P18669|PGAM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0028872123553365	0.157715180277777	21.9999912084483	0.985559359319853	0.99777413090774	nan
sp|P18669|PGAM1_HUMAN	Normal-Triple-negative breast cancer	0.0039029252833107	0.188505695594331	21.999991212055	0.983667979634237	0.991723495391023	nan
sp|P18754|RCC1_HUMAN	metaplastic breast carcinomas-Normal	0.62218052302182	0.179824323664144	22.0000000006829	0.0022280936242917	0.0341298765306264	nan
sp|P18754|RCC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.304179750859402	0.179824323664144	22.0000000013285	0.104852644107342	0.821630939204717	nan
sp|P18754|RCC1_HUMAN	Normal-Triple-negative breast cancer	-0.926360273881222	0.214931176297593	22.0000000010237	0.0002829275746662	0.0227914720285933	nan
sp|P18859|ATP5J_HUMAN	metaplastic breast carcinomas-Normal	0.0375970980762456	0.181902036618335	23.9999999991662	0.837996483103565	0.914223915690573	nan
sp|P18859|ATP5J_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.116962702479455	0.181902036618335	23.9999999992139	0.526321392055708	0.918329246917285	nan
sp|P18859|ATP5J_HUMAN	Normal-Triple-negative breast cancer	-0.1545598005557	0.217414518262427	23.9999999990977	0.483998851193077	0.661518166680012	nan
sp|P18887|XRCC1_HUMAN	metaplastic breast carcinomas-Normal	0.467819204374245	0.228999373320209	22.000000028364	0.0532256774259861	0.175527577048954	nan
sp|P18887|XRCC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.302690204506506	0.228999373320209	22.0000000283305	0.199817083808435	0.843662073010871	nan
sp|P18887|XRCC1_HUMAN	Normal-Triple-negative breast cancer	-0.770509408880751	0.273706602511961	22.0000000281297	0.0100836946562422	0.0638441924520933	nan
sp|P19174|PLCG1_HUMAN	metaplastic breast carcinomas-Normal	0.287708126052656	0.248978452758036	23.9999999994268	0.259238487022236	0.461404777996569	nan
sp|P19174|PLCG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.279128066271522	0.248978452758036	23.9999999994268	0.273340902433321	0.867696529950794	nan
sp|P19174|PLCG1_HUMAN	Normal-Triple-negative breast cancer	-0.0085800597811337	0.297586169844216	23.9999999994164	0.977236849856481	0.988838748530576	nan
sp|P19320|VCAM1_HUMAN	metaplastic breast carcinomas-Normal	-0.651838537731026	0.37024150846215	6.0	0.128792431944332	0.299374855792279	nan
sp|P19320|VCAM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.293183403611086	0.37024150846215	6.0	0.458589670216521	0.908567154037048	nan
sp|P19320|VCAM1_HUMAN	Normal-Triple-negative breast cancer	0.945021941342111	0.442523243277083	6.0	0.0766218205529256	0.20440684712514	nan
sp|P19338|NUCL_HUMAN	metaplastic breast carcinomas-Normal	0.943330348316641	0.24065511214519	22.0000000250157	0.0007331815083066	0.0221825773337916	nan
sp|P19338|NUCL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0005657840027056	0.24065511214519	22.0000000250157	0.998145350930154	0.998570872698367	nan
sp|P19338|NUCL_HUMAN	Normal-Triple-negative breast cancer	-0.942764564313935	0.287637875018507	22.0000000249299	0.0034398858542389	0.0391851712986683	nan
sp|P19367|HXK1_HUMAN	metaplastic breast carcinomas-Normal	0.39507747916034	0.224496274245116	22.0013175473236	0.0923337476469269	0.246322132566922	nan
sp|P19367|HXK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.30209472536373	0.224496274245116	22.0013175691193	0.192118330405877	0.843662073010871	nan
sp|P19367|HXK1_HUMAN	Normal-Triple-negative breast cancer	-0.69717220452407	0.268324369666743	22.0013175664863	0.0164087663806145	0.0822665753381034	nan
sp|P19440|GGT1_HUMAN	metaplastic breast carcinomas-Normal	-0.831843079466353	0.883478789194345	6.0	0.382767255864583	0.589002717867072	nan
sp|P19440|GGT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-2.08359292546483	0.883478789194345	6.0	0.0564075360282631	0.773787875546141	nan
sp|P19440|GGT1_HUMAN	Normal-Triple-negative breast cancer	-1.25174984599847	1.05595912458519	6.0	0.280668997317195	0.47261587998093	nan
sp|P19474|RO52_HUMAN	metaplastic breast carcinomas-Normal	-0.106809393774306	0.297955631118782	14.0000000072722	0.725336404300424	0.848054241257337	nan
sp|P19474|RO52_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.123992997470658	0.297955631118782	14.0000000079099	0.683612340953931	0.946568877415162	nan
sp|P19474|RO52_HUMAN	Normal-Triple-negative breast cancer	0.230802391244964	0.356125094625454	14.0000000077139	0.527411325372607	0.697340988678817	nan
sp|P19525|E2AK2_HUMAN	metaplastic breast carcinomas-Normal	0.608642291424217	0.267065071701848	21.9999968926732	0.0327271570940348	0.129407306133986	nan
sp|P19525|E2AK2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.2289954664035	0.267065071701848	21.9999968926732	0.400439898990611	0.885297496092956	nan
sp|P19525|E2AK2_HUMAN	Normal-Triple-negative breast cancer	-0.379646825020716	0.31920381425199	21.9999968931467	0.246978445453065	0.435751779557319	nan
sp|P19623|SPEE_HUMAN	metaplastic breast carcinomas-Normal	0.0029203725603409	0.21712700336675	23.99999999985	0.989379908761538	0.994165301306939	nan
sp|P19623|SPEE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.137303993242904	0.21712700336675	23.99999999985	0.533125733574104	0.921388505638487	nan
sp|P19623|SPEE_HUMAN	Normal-Triple-negative breast cancer	0.134383620682563	0.259516406282985	23.9999999998602	0.609322330915048	0.760087890531964	nan
sp|P19634|SL9A1_HUMAN	metaplastic breast carcinomas-Normal	-1.00505113530924	0.500994728986277	6.0	0.0916469761505203	0.245248171876744	nan
sp|P19634|SL9A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.02385897499482	0.500994728986277	6.0	0.0870033107653405	0.809016644110817	nan
sp|P19634|SL9A1_HUMAN	Normal-Triple-negative breast cancer	-0.0188078396855804	0.59880323321013	6.0	0.975962066658741	0.988457088173338	nan
sp|P19652|A1AG2_HUMAN	metaplastic breast carcinomas-Normal	-1.1012573687016	0.315691771134067	22.0000000483879	0.0020812309612733	0.0326321307324174	nan
sp|P19652|A1AG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.39059768639863	0.315691771134067	22.00000004839	0.229028956964325	0.843662073010871	nan
sp|P19652|A1AG2_HUMAN	Normal-Triple-negative breast cancer	1.49185505510023	0.377323836590882	22.0000000487441	0.0006750401940718	0.0247210772633291	nan
sp|P19823|ITIH2_HUMAN	metaplastic breast carcinomas-Normal	-0.462203686497557	0.469463240748318	23.99999999972	0.33467378485948	0.543261540657086	nan
sp|P19823|ITIH2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0101272962288263	0.469463240748318	23.9999999997209	0.982967660608596	0.99777413090774	nan
sp|P19823|ITIH2_HUMAN	Normal-Triple-negative breast cancer	0.472330982726383	0.56111589637323	23.9999999997667	0.408226095863008	0.59670272927701	nan
sp|P19827|ITIH1_HUMAN	metaplastic breast carcinomas-Normal	-0.14519235234402	0.519557989984473	24.0000000000882	0.782290941902881	0.882032001854638	nan
sp|P19827|ITIH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.3249988480759	0.519557989984473	23.9999999998029	0.537527010727725	0.921388505638487	nan
sp|P19827|ITIH1_HUMAN	Normal-Triple-negative breast cancer	-0.179806495731879	0.620990573837715	24.0000000000259	0.774648840774395	0.871971807224548	nan
sp|P19838|NFKB1_HUMAN	metaplastic breast carcinomas-Normal	-0.304833506313505	0.343422244700964	21.9999999779026	0.384338984634445	0.589275343425259	nan
sp|P19838|NFKB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.128150291732249	0.343422244700964	21.9999999741573	0.71260323886856	0.94948208919602	nan
sp|P19838|NFKB1_HUMAN	Normal-Triple-negative breast cancer	0.176683214581255	0.410468091948429	21.9999999758859	0.671060743309249	0.806588516510481	nan
sp|P19878|NCF2_HUMAN	metaplastic breast carcinomas-Normal	0.185247289884804	0.278473591834523	22.0000000833133	0.512821505073299	0.696102499523405	nan
sp|P19878|NCF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.285354345657332	0.278473591834523	22.000000082715	0.316636641784724	0.867696529950794	nan
sp|P19878|NCF2_HUMAN	Normal-Triple-negative breast cancer	0.100107055772528	0.33283960390473	22.0000000827433	0.76641647426211	0.86622521606503	nan
sp|P19971|TYPH_HUMAN	metaplastic breast carcinomas-Normal	0.155282738144744	0.504180578263012	22.000003017758	0.760986785078743	0.869067988363487	nan
sp|P19971|TYPH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0310764314321685	0.504180578263012	22.0000030172733	0.951408062022175	0.996541950781621	nan
sp|P19971|TYPH_HUMAN	Normal-Triple-negative breast cancer	-0.186359169576913	0.602611051410711	22.0000030178658	0.760039102410087	0.862351606742291	nan
sp|P20042|IF2B_HUMAN	metaplastic breast carcinomas-Normal	0.784208289326112	0.230941098994654	23.9999999999301	0.002382599146427	0.0348888086463593	nan
sp|P20042|IF2B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.292517486860722	0.230941098994654	23.9999999999301	0.217442023221975	0.843662073010871	nan
sp|P20042|IF2B_HUMAN	Normal-Triple-negative breast cancer	-1.07672577618683	0.276027408589537	23.999999999987	0.0006767803943931	0.0247210772633291	nan
sp|P20073|ANXA7_HUMAN	metaplastic breast carcinomas-Normal	-0.0971219945709321	0.156292676536173	22.000000414794	0.540715385340363	0.715851119316988	nan
sp|P20073|ANXA7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0686309605635064	0.156292676536173	22.000000414332	0.664858584908614	0.944724271291086	nan
sp|P20073|ANXA7_HUMAN	Normal-Triple-negative breast cancer	0.0284910340074257	0.18680547842548	22.0000004142433	0.880169230670275	0.930560598838421	nan
sp|P20231|TRYB2_HUMAN;sp|Q15661|TRYB1_HUMAN	metaplastic breast carcinomas-Normal	-1.75680021377461	0.713545639939928	21.0377465488315	0.0225306791460085	0.103441957847144	nan
sp|P20231|TRYB2_HUMAN;sp|Q15661|TRYB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.340028863140651	0.764867129986309	21.3028643764071	0.661121914120661	0.944434752137403	nan
sp|P20231|TRYB2_HUMAN;sp|Q15661|TRYB1_HUMAN	Normal-Triple-negative breast cancer	2.09682907691526	0.89622973988388	21.2322619730619	0.0291473972544884	0.114387188280896	nan
sp|P20290|BTF3_HUMAN	metaplastic breast carcinomas-Normal	0.758531212660638	0.309237838428156	21.9999996359647	0.0225651626040784	0.103457379994423	nan
sp|P20290|BTF3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0751566562562995	0.309237838428156	21.9999996347471	0.81022738835574	0.965774701272009	nan
sp|P20290|BTF3_HUMAN	Normal-Triple-negative breast cancer	-0.833687868916937	0.369609911578059	21.9999996344396	0.034378233262606	0.124196152475544	nan
sp|P20292|AL5AP_HUMAN	metaplastic breast carcinomas-Normal	-0.228728314771708	0.236616120885349	23.9999999998993	0.343352738833241	0.553762495818386	nan
sp|P20292|AL5AP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.349422595446244	0.236616120885349	23.9999999998993	0.152745217154371	0.843465960034572	nan
sp|P20292|AL5AP_HUMAN	Normal-Triple-negative breast cancer	0.578150910217952	0.282810357111895	23.9999999998942	0.0520433038660851	0.160773180344672	nan
sp|P20338|RAB4A_HUMAN	metaplastic breast carcinomas-Normal	0.0370063426857249	0.238495295116892	22.0000040616824	0.878105343922166	0.936720848266136	nan
sp|P20338|RAB4A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.505845941806476	0.238495295116892	22.0000040615902	0.0454306878387113	0.759166737802103	nan
sp|P20338|RAB4A_HUMAN	Normal-Triple-negative breast cancer	-0.542852284492201	0.285056399915359	22.0000040616377	0.0700213183414627	0.192542678375044	nan
sp|P20339|RAB5A_HUMAN	metaplastic breast carcinomas-Normal	-0.198928459950805	0.33737270403392	14.000000079571	0.56482728444934	0.732167091151825	nan
sp|P20339|RAB5A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.452960408767085	0.33737270403392	14.0000000791154	0.200763244897186	0.843662073010871	nan
sp|P20339|RAB5A_HUMAN	Normal-Triple-negative breast cancer	-0.25403194881628	0.403237507869846	14.0000000795292	0.538853776661521	0.704899627557219	nan
sp|P20585|MSH3_HUMAN	metaplastic breast carcinomas-Normal	0.419030255242723	0.333175163705559	23.9999999999316	0.220605092361043	0.418773822230466	nan
sp|P20585|MSH3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.53171458607102	0.333175163705559	23.9999999999317	0.123596018698713	0.823891816737944	nan
sp|P20585|MSH3_HUMAN	Normal-Triple-negative breast cancer	-0.950744841313742	0.398220487580554	23.9999999999262	0.0251900562941602	0.105455600909054	nan
sp|P20591|MX1_HUMAN	metaplastic breast carcinomas-Normal	1.24941949831466	0.503427985317653	21.9999998893657	0.0211907318084599	0.0999120461437174	nan
sp|P20591|MX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.94297500780049	0.503427985317652	21.9999998892367	0.0744017152936074	0.795994790325479	nan
sp|P20591|MX1_HUMAN	Normal-Triple-negative breast cancer	-0.306444490514175	0.601711530791233	21.9999998884735	0.615620837322234	0.764980808694993	nan
sp|P20618|PSB1_HUMAN	metaplastic breast carcinomas-Normal	0.152745345664391	0.117684213686396	22.0000000233335	0.207756635269105	0.402437678108685	nan
sp|P20618|PSB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0382581484903279	0.117684213686396	22.000000023175	0.748183099388216	0.954643368861838	nan
sp|P20618|PSB1_HUMAN	Normal-Triple-negative breast cancer	-0.191003494154719	0.140659539065002	22.0000000236619	0.188256240288936	0.367748955304415	nan
sp|P20700|LMNB1_HUMAN	metaplastic breast carcinomas-Normal	0.501401913891067	0.256337712271758	22.0000000286505	0.0632781869130601	0.1924397925883	nan
sp|P20700|LMNB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.336165868345622	0.256337712271758	22.000000028696	0.20323916032354	0.843662073010871	nan
sp|P20700|LMNB1_HUMAN	Normal-Triple-negative breast cancer	-0.83756778223669	0.306382167358533	22.0000000286204	0.0121231473406343	0.0710711494890094	nan
sp|P20702|ITAX_HUMAN	metaplastic breast carcinomas-Normal	1.04905591307167	0.373333292474355	20.9995859681059	0.010492439283029	0.0678538291377207	nan
sp|P20702|ITAX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.347468096123419	0.373333292474355	20.9995859683435	0.362576344708374	0.883542279876718	nan
sp|P20702|ITAX_HUMAN	Normal-Triple-negative breast cancer	-0.70158781694825	0.44139967670125	20.9908282014258	0.126905600090309	0.283163640979955	nan
sp|P20742|PZP_HUMAN	metaplastic breast carcinomas-Normal	-1.24173007129668	0.450862958204815	22.9999999999003	0.0112973659075369	0.0705294023488664	nan
sp|P20742|PZP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.357412471698035	0.42174367949745	22.9999999999036	0.405469463943162	0.885297496092956	nan
sp|P20742|PZP_HUMAN	Normal-Triple-negative breast cancer	1.59914254299472	0.52868368117112	22.9999999999684	0.0060290112036737	0.049155377464309	nan
sp|P20774|MIME_HUMAN	metaplastic breast carcinomas-Normal	-3.23398090265512	0.802251340040772	22.0000018167036	0.0005590589624969	0.0205217420849069	nan
sp|P20774|MIME_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.670057468635151	0.802251340040772	22.000001817326	0.412572023922231	0.885784822958391	nan
sp|P20774|MIME_HUMAN	Normal-Triple-negative breast cancer	3.90403837129027	0.958873753493585	22.0000018170775	0.0005066524961119	0.0237592699893802	nan
sp|P20810|ICAL_HUMAN	metaplastic breast carcinomas-Normal	-0.149305615485812	0.274316389041136	24.0000000001937	0.591268561347467	0.7497673671045	nan
sp|P20810|ICAL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0026489426764399	0.274316389041136	24.0000000001504	0.99237515111252	0.998185231446144	nan
sp|P20810|ICAL_HUMAN	Normal-Triple-negative breast cancer	0.151954558162252	0.327870796191269	24.0000000001745	0.647211290263102	0.792095113709334	nan
sp|P20839|IMDH1_HUMAN	metaplastic breast carcinomas-Normal	0.436908439878867	0.24465181262684	21.9999999954353	0.0879184482942885	0.238449315103716	nan
sp|P20839|IMDH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0704424949070244	0.24465181262684	21.9999999949089	0.776095674770925	0.960657739983943	nan
sp|P20839|IMDH1_HUMAN	Normal-Triple-negative breast cancer	-0.366465944971843	0.292414845777117	21.9999999948915	0.223274742355644	0.406070470893574	nan
sp|P20851|C4BPB_HUMAN	metaplastic breast carcinomas-Normal	-0.84846272504407	0.432072795861488	22.0000000280697	0.0623258431556252	0.191647643523865	nan
sp|P20851|C4BPB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.586586366579378	0.432072795861488	22.0000000279953	0.188351143301395	0.843662073010871	nan
sp|P20851|C4BPB_HUMAN	Normal-Triple-negative breast cancer	1.43504909162345	0.51642576692875	22.0000000278279	0.0109493343670854	0.0670157251028676	nan
sp|P20908|CO5A1_HUMAN	metaplastic breast carcinomas-Normal	0.135749721201978	0.307764840593655	22.0000022338934	0.663457515937951	0.802822376058803	nan
sp|P20908|CO5A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0812623102665842	0.307764840593655	22.0000022338549	0.794206531535399	0.964213712979656	nan
sp|P20908|CO5A1_HUMAN	Normal-Triple-negative breast cancer	-0.0544874109353941	0.367849342424775	22.0000022340656	0.88359396493709	0.93275221069853	nan
sp|P20933|ASPG_HUMAN	metaplastic breast carcinomas-Normal	-0.466320453260726	0.199964694087433	22.000001406413	0.0292541070532783	0.122436415365631	nan
sp|P20933|ASPG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.114701822987813	0.199964694087433	22.0000014064116	0.572049396345713	0.935631258424823	nan
sp|P20933|ASPG_HUMAN	Normal-Triple-negative breast cancer	0.581022276248539	0.2390035232301	22.000001406864	0.0236599143702953	0.102137084892028	nan
sp|P20936|RASA1_HUMAN	metaplastic breast carcinomas-Normal	0.354509919767245	0.246134524615944	14.9999999996904	0.170325642586245	0.359263099581065	nan
sp|P20936|RASA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.182448437345607	0.246134524615944	14.9999999997892	0.469985569046015	0.912260371907764	nan
sp|P20936|RASA1_HUMAN	Normal-Triple-negative breast cancer	-0.536958357112852	0.294187025565897	14.999999999791	0.0879426196989515	0.223602777631342	nan
sp|P20962|PTMS_HUMAN	metaplastic breast carcinomas-Normal	0.444203581531736	0.233205394632358	23.9999999995406	0.0688617307185971	0.203282764572484	nan
sp|P20962|PTMS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.164897034528669	0.233205394632358	23.9999999995406	0.486320529585003	0.913320451076758	nan
sp|P20962|PTMS_HUMAN	Normal-Triple-negative breast cancer	-0.609100616060405	0.278733759515711	23.9999999995155	0.0388660641724603	0.131848322456358	nan
sp|P21127|CD11B_HUMAN;sp|Q9UQ88|CD11A_HUMAN	metaplastic breast carcinomas-Normal	-0.287025719448937	0.370711905278942	22.0000000238444	0.447021212937639	0.643246109006369	nan
sp|P21127|CD11B_HUMAN;sp|Q9UQ88|CD11A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.241978176089452	0.370711905278943	22.0000000238036	0.520687639200709	0.917480869285828	nan
sp|P21127|CD11B_HUMAN;sp|Q9UQ88|CD11A_HUMAN	Normal-Triple-negative breast cancer	0.045047543359485	0.443085475010254	22.0000000237455	0.919941271869676	0.953928574984042	nan
sp|P21266|GSTM3_HUMAN	metaplastic breast carcinomas-Normal	-0.460689377368159	0.307957660100477	22.9999999996501	0.14826325528415	0.326350351183687	nan
sp|P21266|GSTM3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.196294532005925	0.329220586779591	22.9999999994923	0.556838043875719	0.931799947602801	nan
sp|P21266|GSTM3_HUMAN	Normal-Triple-negative breast cancer	0.264394845362234	0.386045357172328	22.9999999995927	0.500263856381515	0.676135101017241	nan
sp|P21281|VATB2_HUMAN	metaplastic breast carcinomas-Normal	0.377393314823504	0.206897531373804	23.9999999994509	0.0806199798479876	0.224816118300932	nan
sp|P21281|VATB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0955842267324191	0.206897531373804	23.9999999992272	0.648250349414951	0.943315325604231	nan
sp|P21281|VATB2_HUMAN	Normal-Triple-negative breast cancer	-0.281809088091085	0.247289848698631	23.9999999993411	0.265703485657915	0.456669279383097	nan
sp|P21283|VATC1_HUMAN	metaplastic breast carcinomas-Normal	0.346155048673959	0.20644451443503	22.0000067096572	0.107745995643069	0.268275422859596	nan
sp|P21283|VATC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.412762218870729	0.20644451443503	22.0000067094486	0.0580666981137503	0.773787875546141	nan
sp|P21283|VATC1_HUMAN	Normal-Triple-negative breast cancer	0.0666071701967706	0.246748389892895	22.0000067097857	0.789722639800421	0.879763182876798	nan
sp|P21291|CSRP1_HUMAN	metaplastic breast carcinomas-Normal	8.87582171187962e-06	0.310247252291557	21.9999996371091	0.999977431264946	0.999977431264946	nan
sp|P21291|CSRP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.480404046851809	0.310247252291557	21.9999996371124	0.135778903716561	0.823891816737944	nan
sp|P21291|CSRP1_HUMAN	Normal-Triple-negative breast cancer	-0.480412922673521	0.370816391906255	21.9999996370761	0.208558412153774	0.39056234478825	nan
sp|P21333|FLNA_HUMAN	metaplastic breast carcinomas-Normal	0.577999292136468	0.191629525452345	23.9999999993273	0.0059707524751055	0.0508891826339769	nan
sp|P21333|FLNA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0565852673484954	0.191629525452345	23.9999999993274	0.770315903805432	0.959745866833315	nan
sp|P21333|FLNA_HUMAN	Normal-Triple-negative breast cancer	-0.521414024787972	0.229041091213816	23.999999999319	0.0320235839097953	0.120414471624615	nan
sp|P21397|AOFA_HUMAN	metaplastic breast carcinomas-Normal	-0.183515737547841	0.403848038951392	13.0402810298039	0.65699993546014	0.798197290010784	nan
sp|P21397|AOFA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.175780432455663	0.360466147299067	13.000000014025	0.633920184767947	0.941868024951375	nan
sp|P21397|AOFA_HUMAN	Normal-Triple-negative breast cancer	0.0077353050921779	0.46773927413832	13.0300891068214	0.987056016557459	0.993331577062366	nan
sp|P21399|ACOHC_HUMAN	metaplastic breast carcinomas-Normal	-0.873718180508985	0.273287141328775	22.0000038623135	0.0041606941167285	0.042883667309653	nan
sp|P21399|ACOHC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.242551552354328	0.273287141328775	22.0000038628864	0.384392144977911	0.885234295852111	nan
sp|P21399|ACOHC_HUMAN	Normal-Triple-negative breast cancer	0.631166628154657	0.326640609879364	22.0000038630456	0.0663007359956656	0.186338952556932	nan
sp|P21580|TNAP3_HUMAN	metaplastic breast carcinomas-Normal	0.0888974337486774	0.30810170217408	14.0000000001865	0.777166892242589	0.879280610496282	nan
sp|P21580|TNAP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.117322153432669	0.30810170217408	14.0000000001865	0.709074555687646	0.94948208919602	nan
sp|P21580|TNAP3_HUMAN	Normal-Triple-negative breast cancer	0.0284247196839917	0.362542290359258	14.0000000002192	0.938616391202493	0.96623130515859	nan
sp|P21589|5NTD_HUMAN	metaplastic breast carcinomas-Normal	-0.87981454231096	0.373236224510102	14.0000001450592	0.0334965757387826	0.130991315006722	nan
sp|P21589|5NTD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0148093694339954	0.373236224510102	14.000000144958	0.968909904288115	0.99709406933403	nan
sp|P21589|5NTD_HUMAN	Normal-Triple-negative breast cancer	0.865005172876964	0.446102613574429	14.0000001449705	0.07292397219761	0.197554428349515	nan
sp|P21695|GPDA_HUMAN	metaplastic breast carcinomas-Normal	-2.67185153923697	0.960921716822133	21.9999999709082	0.0109072696113941	0.0698037874020569	nan
sp|P21695|GPDA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.101099234639871	0.960921716822133	21.9999999706745	0.917162004272783	0.99408739879047	nan
sp|P21695|GPDA_HUMAN	Normal-Triple-negative breast cancer	2.5707523045971	1.14852112727654	21.9999999721219	0.0356445981544062	0.12639885742052	nan
sp|P21741|MK_HUMAN	metaplastic breast carcinomas-Normal	0.0252765800881695	0.579901565689275	23.9999999998055	0.965593676122521	0.983042382674199	nan
sp|P21741|MK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0235482133311246	0.579901565689275	23.9999999995777	0.967944922153731	0.99709406933403	nan
sp|P21741|MK_HUMAN	Normal-Triple-negative breast cancer	-0.0017283667570448	0.69311494190963	23.9999999996628	0.998030991271299	0.999945312570918	nan
sp|P21796|VDAC1_HUMAN	metaplastic breast carcinomas-Normal	0.662482391854382	0.253908217352959	24.0000000002077	0.0153830252715604	0.0817474695422512	nan
sp|P21796|VDAC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.318306750432631	0.253908217352959	23.9999999998586	0.222051724299489	0.843662073010871	nan
sp|P21796|VDAC1_HUMAN	Normal-Triple-negative breast cancer	-0.980789142287013	0.303478365525352	24.000000000031	0.0035555224302587	0.0397931197245121	nan
sp|P21810|PGS1_HUMAN	metaplastic breast carcinomas-Normal	-0.275916762947052	0.624952031449527	23.9999999995094	0.662802794390737	0.802822376058803	nan
sp|P21810|PGS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.392862990900917	0.624952031449527	23.9999999997066	0.535529502884956	0.921388505638487	nan
sp|P21810|PGS1_HUMAN	Normal-Triple-negative breast cancer	0.668779753847969	0.746960547450122	23.9999999996192	0.379500445012459	0.567203003247039	nan
sp|P21912|SDHB_HUMAN	metaplastic breast carcinomas-Normal	0.0337369557747379	0.35621158055502	24.0000000000275	0.925331144797532	0.959688213824336	nan
sp|P21912|SDHB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.527732808365298	0.35621158055502	24.0000000000291	0.15148053921503	0.843465960034572	nan
sp|P21912|SDHB_HUMAN	Normal-Triple-negative breast cancer	-0.561469764140035	0.425754272055583	24.0000000001321	0.199693900695452	0.380455395099225	nan
sp|P21953|ODBB_HUMAN	metaplastic breast carcinomas-Normal	-0.0651792516894101	0.352594058910168	15.0000000000614	0.85581788657663	0.925247532247456	nan
sp|P21953|ODBB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.511040292323451	0.352594058910168	15.0000000001581	0.167817883171184	0.843662073010871	nan
sp|P21953|ODBB_HUMAN	Normal-Triple-negative breast cancer	-0.445861040634041	0.421430506690769	15.0000000000984	0.306809947637978	0.499185641678237	nan
sp|P21964|COMT_HUMAN	metaplastic breast carcinomas-Normal	0.0858178256515444	0.281147087126178	23.9999999996457	0.762813666424067	0.869843096807409	nan
sp|P21964|COMT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.192588322673161	0.281147087126178	23.9999999996456	0.499901120601288	0.913320451076758	nan
sp|P21964|COMT_HUMAN	Normal-Triple-negative breast cancer	-0.278406148324706	0.336035041964237	23.9999999996377	0.415549173878522	0.602918137918902	nan
sp|P21980|TGM2_HUMAN	metaplastic breast carcinomas-Normal	-0.145865233400153	0.324206304979818	23.9999999996458	0.656809345069382	0.798197290010784	nan
sp|P21980|TGM2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.367498951155583	0.324206304979818	23.9999999996458	0.268186614920224	0.867211773631185	nan
sp|P21980|TGM2_HUMAN	Normal-Triple-negative breast cancer	0.513364184555736	0.38750065103847	23.9999999996458	0.197711207044918	0.3786926489393	nan
sp|P22033|MUTA_HUMAN	metaplastic breast carcinomas-Normal	-0.0044733905328882	0.405278167646991	6.0	0.991551123458813	0.995007502963874	nan
sp|P22033|MUTA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.601535748142349	0.405278167646991	6.0	0.188274551373471	0.843662073010871	nan
sp|P22033|MUTA_HUMAN	Normal-Triple-negative breast cancer	0.606009138675237	0.484400060710304	6.0	0.257486162456921	0.448179004801382	nan
sp|P22059|OSBP1_HUMAN	metaplastic breast carcinomas-Normal	0.434065732592923	0.164259652035122	23.999999999296	0.0142597322239053	0.0795361221927149	nan
sp|P22059|OSBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0760435950279623	0.164259652035122	23.9999999994743	0.64757241317056	0.943315325604231	nan
sp|P22059|OSBP1_HUMAN	Normal-Triple-negative breast cancer	-0.358022137564961	0.196327835471691	23.9999999993774	0.0806925713079525	0.211531630147976	nan
sp|P22061|PIMT_HUMAN	metaplastic breast carcinomas-Normal	0.250668990586389	0.199313089225948	22.0000000335177	0.221699669281623	0.420142360713862	nan
sp|P22061|PIMT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0335731753943736	0.199313089225948	22.0000000338216	0.867772690018742	0.981143688073178	nan
sp|P22061|PIMT_HUMAN	Normal-Triple-negative breast cancer	-0.217095815192015	0.238224706457672	22.0000000337725	0.372011568195457	0.561055559292967	nan
sp|P22087|FBRL_HUMAN	metaplastic breast carcinomas-Normal	0.553486668738217	0.242636929680228	23.9999999996185	0.0317081179258044	0.128466389195289	nan
sp|P22087|FBRL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.152396226355404	0.242636929680228	23.9999999996185	0.535880852955589	0.921388505638487	nan
sp|P22087|FBRL_HUMAN	Normal-Triple-negative breast cancer	-0.705882895093621	0.290006600034866	23.9999999995854	0.0227455856443566	0.0998762571754838	nan
sp|P22102|PUR2_HUMAN	metaplastic breast carcinomas-Normal	0.363616424703731	0.19501947262324	23.9999999995109	0.0745256041416207	0.213238102699799	nan
sp|P22102|PUR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.400345148400009	0.19501947262324	23.9999999995122	0.0511435979023161	0.772965741023641	nan
sp|P22102|PUR2_HUMAN	Normal-Triple-negative breast cancer	-0.76396157310374	0.233092853056602	23.9999999995011	0.0031817618848221	0.0373716484280873	nan
sp|P22105|TENX_HUMAN	metaplastic breast carcinomas-Normal	-1.80710895760133	0.560561494609485	22.0000000026931	0.0039070586971175	0.0416809642918909	nan
sp|P22105|TENX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.438273924279059	0.560561494609485	22.0000000032372	0.442637667791764	0.89755436380139	nan
sp|P22105|TENX_HUMAN	Normal-Triple-negative breast cancer	2.24538288188039	0.669999135648504	22.0000000031781	0.0028875930201329	0.036154485561068	nan
sp|P22234|PUR6_HUMAN	metaplastic breast carcinomas-Normal	0.850508134131084	0.319838153997239	21.9999999344906	0.0143297703600401	0.0795361221927149	nan
sp|P22234|PUR6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.322094798120395	0.319838153997239	21.9999999367471	0.324856699844898	0.867950636918522	nan
sp|P22234|PUR6_HUMAN	Normal-Triple-negative breast cancer	-1.17260293225148	0.3822797120142	21.9999999364874	0.0056383670746815	0.047568355726501	nan
sp|P22307|SCP2_HUMAN	metaplastic breast carcinomas-Normal	0.464561873068963	0.221738051439829	23.999999999674	0.046894043309574	0.162879623783724	nan
sp|P22307|SCP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.21270421721458	0.221738051439829	23.999999999674	0.346993162598737	0.871784737402991	nan
sp|P22307|SCP2_HUMAN	Normal-Triple-negative breast cancer	-0.677266090283543	0.265027662858945	23.9999999997049	0.0173623569643253	0.0847870753296437	nan
sp|P22314|UBA1_HUMAN	metaplastic breast carcinomas-Normal	0.221112309715335	0.186564158262242	22.0000003396038	0.248590707675024	0.448353506408996	nan
sp|P22314|UBA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.220608379782102	0.186564158262242	22.0000003391546	0.2496381173803	0.853073118408704	nan
sp|P22314|UBA1_HUMAN	Normal-Triple-negative breast cancer	-0.441720689497437	0.222986819431421	22.0000003390073	0.0602365713875299	0.176722297698278	nan
sp|P22392|NDKB_HUMAN	metaplastic breast carcinomas-Normal	0.691826822279935	0.231508166052816	21.9999999873359	0.0067750346612528	0.053876112952164	nan
sp|P22392|NDKB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.130962487761811	0.231508166052816	21.9999999875005	0.577327424633844	0.936117741743138	nan
sp|P22392|NDKB_HUMAN	Normal-Triple-negative breast cancer	-0.560864334518123	0.276705183360863	21.9999999864172	0.0549568863303984	0.166675812191829	nan
sp|P22413|ENPP1_HUMAN	metaplastic breast carcinomas-Normal	0.339624822720161	0.411181394728943	21.999961538023	0.417687080513091	0.619264877620657	nan
sp|P22413|ENPP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0677371599389573	0.411181394728943	21.9999615391183	0.870654565622781	0.981704007186169	nan
sp|P22413|ENPP1_HUMAN	Normal-Triple-negative breast cancer	-0.271887662781204	0.491455766606051	21.9999615351804	0.585685239218178	0.742584454708559	nan
sp|P22528|SPR1B_HUMAN	metaplastic breast carcinomas-Normal	2.71175109625773	3.95417673349018	4.0	0.530525405110694	0.708219456461023	nan
sp|P22528|SPR1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.87599118059093	3.06289212735366	4.0	0.573321706008828	0.935843259183841	nan
sp|P22528|SPR1B_HUMAN	Normal-Triple-negative breast cancer	-0.835759915666797	4.33158358658933	4.0	0.856402294223472	0.917810880991339	nan
sp|P22626|ROA2_HUMAN	metaplastic breast carcinomas-Normal	0.440360390788823	0.184214340312354	22.000000007173	0.025818907364826	0.11321693931385	nan
sp|P22626|ROA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.37249282825433	0.184214340312354	22.0000000069909	0.0554962177887906	0.773787875546141	nan
sp|P22626|ROA2_HUMAN	Normal-Triple-negative breast cancer	-0.812853219043153	0.220178249790988	22.0000000075023	0.0012751286649795	0.0266490250684039	nan
sp|P22676|CALB2_HUMAN	metaplastic breast carcinomas-Normal	-0.581106707200593	0.575538240235301	22.0000000341047	0.323627580439668	0.530966474521942	nan
sp|P22676|CALB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.428954090684422	0.575538240235301	22.0000000340484	0.463973541377972	0.909423669537079	nan
sp|P22676|CALB2_HUMAN	Normal-Triple-negative breast cancer	1.01006079788502	0.687899770495203	22.0000000337496	0.156169449719886	0.32586770299366	nan
sp|P22695|QCR2_HUMAN	metaplastic breast carcinomas-Normal	0.199557675266163	0.178137219729409	21.9999994481296	0.274689509020784	0.477548285858522	nan
sp|P22695|QCR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0115532124108953	0.178137219729409	21.9999994441065	0.948874626529675	0.996541950781621	nan
sp|P22695|QCR2_HUMAN	Normal-Triple-negative breast cancer	-0.188004462855268	0.212914701407876	21.9999994428076	0.386781558475197	0.574833537967588	nan
sp|P22792|CPN2_HUMAN	metaplastic breast carcinomas-Normal	-1.23053150930088	0.492922165105315	13.9999994373792	0.025644314389887	0.11275357279363	nan
sp|P22792|CPN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0296487790752809	0.492922165105315	13.9999994361333	0.952887153942178	0.996541950781621	nan
sp|P22792|CPN2_HUMAN	Normal-Triple-negative breast cancer	1.2008827302256	0.589154673908924	13.9999994361391	0.0608708834413187	0.177642507953418	nan
sp|P22897|MRC1_HUMAN	metaplastic breast carcinomas-Normal	-0.98123447176436	0.304710633450539	21.9999999210711	0.0039397437290732	0.0418393231803179	nan
sp|P22897|MRC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.404727887305741	0.304710633450539	21.9999999210613	0.197715430932483	0.843662073010871	nan
sp|P22897|MRC1_HUMAN	Normal-Triple-negative breast cancer	1.3859623590701	0.36419886666849	21.9999999214077	0.0009680558569905	0.0259501424890038	nan
sp|P23083|HV102_HUMAN	metaplastic breast carcinomas-Normal	-0.561702710694941	0.38335650613552	22.0000000001775	0.157006523586648	0.338889405455855	nan
sp|P23083|HV102_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.599934598384104	0.38335650613552	21.9999999999414	0.131865841121829	0.823891816737944	nan
sp|P23083|HV102_HUMAN	Normal-Triple-negative breast cancer	1.16163730907905	0.45819866370765	22.0000000000104	0.0188553052902912	0.0893916847470849	nan
sp|P23141|EST1_HUMAN	metaplastic breast carcinomas-Normal	-3.26409961068547	0.537847514164829	22.0000000145796	4.15196859589952e-06	0.0043931546677194	nan
sp|P23141|EST1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.12080425812923	0.537847514164829	22.0000000139145	0.824358102724764	0.965774701272009	nan
sp|P23141|EST1_HUMAN	Normal-Triple-negative breast cancer	3.14329535255624	0.642850736389189	22.0000000140618	6.88510921827593e-05	0.022319699811492	nan
sp|P23142|FBLN1_HUMAN	metaplastic breast carcinomas-Normal	0.237284516780276	0.264160761044551	23.9999999995229	0.377971664165192	0.58436177287679	nan
sp|P23142|FBLN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.025601006538254	0.264160761044551	23.9999999998002	0.923599082831483	0.994508979919649	nan
sp|P23142|FBLN1_HUMAN	Normal-Triple-negative breast cancer	-0.262885523318531	0.315732499063994	23.9999999996178	0.413267581289024	0.60128493320689	nan
sp|P23193|TCEA1_HUMAN	metaplastic breast carcinomas-Normal	0.605951445864851	0.215291595850402	23.9999999997149	0.0095986877493105	0.0650005124722237	nan
sp|P23193|TCEA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0726889055708184	0.215291595850402	23.9999999996808	0.738577305793037	0.954643368861838	nan
sp|P23193|TCEA1_HUMAN	Normal-Triple-negative breast cancer	-0.533262540294032	0.257322674709659	23.9999999997173	0.0491409305877277	0.154098540824157	nan
sp|P23219|PGH1_HUMAN	metaplastic breast carcinomas-Normal	0.10342500052853	0.358322830238025	22.0000000406599	0.775561772461185	0.878652805610422	nan
sp|P23219|PGH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.37038713025221	0.358322830238025	22.000000041129	0.312520791260275	0.867696529950794	nan
sp|P23219|PGH1_HUMAN	Normal-Triple-negative breast cancer	0.26696212972368	0.428277698078159	22.0000000409214	0.539471152450427	0.705429626571684	nan
sp|P23229|ITA6_HUMAN	metaplastic breast carcinomas-Normal	-0.344669052091744	0.277180241853562	21.9999999913852	0.226778062355161	0.426752157220841	nan
sp|P23229|ITA6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.148512732324234	0.277180241853562	21.999999991616	0.59747373970026	0.940559810632461	nan
sp|P23229|ITA6_HUMAN	Normal-Triple-negative breast cancer	0.196156319767511	0.331293755005604	21.9999999890656	0.559825591400269	0.722916613286098	nan
sp|P23246|SFPQ_HUMAN	metaplastic breast carcinomas-Normal	1.00778646121567	0.227985991527394	21.999997057855	0.0002160542809714	0.0157578323963946	nan
sp|P23246|SFPQ_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.29372743432376	0.227985991527394	21.9999970448777	0.211007132258051	0.843662073010871	nan
sp|P23246|SFPQ_HUMAN	Normal-Triple-negative breast cancer	-1.30151389553943	0.27249537960101	21.9999970499343	9.06883744597131e-05	0.022319699811492	nan
sp|P23258|TBG1_HUMAN;sp|Q9NRH3|TBG2_HUMAN	metaplastic breast carcinomas-Normal	-0.333125899864549	0.314439373770861	15.0000000001474	0.306167307809403	0.51373050538034	nan
sp|P23258|TBG1_HUMAN;sp|Q9NRH3|TBG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.408000108135905	0.314439373770861	15.0000000000257	0.214043693910341	0.843662073010871	nan
sp|P23258|TBG1_HUMAN;sp|Q9NRH3|TBG2_HUMAN	Normal-Triple-negative breast cancer	-0.0748742082713569	0.375826935432124	15.000000000113	0.844761975926113	0.911630088050377	nan
sp|P23284|PPIB_HUMAN	metaplastic breast carcinomas-Normal	0.571793149077973	0.215385682162927	21.9999999487392	0.0144725453644727	0.0795450818130059	nan
sp|P23284|PPIB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0282443767222447	0.215385682162927	21.9999999488929	0.89686113523553	0.989403873476489	nan
sp|P23284|PPIB_HUMAN	Normal-Triple-negative breast cancer	-0.600037525800218	0.257435129362135	21.9999999495517	0.0293278281289252	0.114824146879326	nan
sp|P23297|S10A1_HUMAN	metaplastic breast carcinomas-Normal	0.682546669648268	1.16925018916368	21.0000000001897	0.565608250728972	0.73240429506159	nan
sp|P23297|S10A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.919003205154842	1.35854595305424	21.0000000001948	0.506131129710755	0.913320451076758	nan
sp|P23297|S10A1_HUMAN	Normal-Triple-negative breast cancer	-1.60154987480311	1.54677261047116	21.0000000001941	0.312252498117285	0.50512608733217	nan
sp|P23368|MAOM_HUMAN	metaplastic breast carcinomas-Normal	0.209377034989127	0.233696762360225	22.0000000258542	0.379986602230456	0.586658367772427	nan
sp|P23368|MAOM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.466892080835087	0.233696762360225	22.0000000262067	0.0582440538604866	0.773787875546141	nan
sp|P23368|MAOM_HUMAN	Normal-Triple-negative breast cancer	-0.676269115824214	0.279321056281762	22.000000026347	0.0241712383425647	0.103755694107856	nan
sp|P23381|SYWC_HUMAN	metaplastic breast carcinomas-Normal	0.0171995725635535	0.475351922692217	23.9999999995423	0.971435859175526	0.986271470952795	nan
sp|P23381|SYWC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.240228769362019	0.475351922692217	23.9999999995423	0.61790856742455	0.941374262616245	nan
sp|P23381|SYWC_HUMAN	Normal-Triple-negative breast cancer	-0.257428341925573	0.568154217503849	23.9999999995963	0.654549550288294	0.797031075258555	nan
sp|P23396|RS3_HUMAN	metaplastic breast carcinomas-Normal	0.703916377795451	0.212705619724585	22.000000016189	0.0031905324613895	0.0397203367103332	nan
sp|P23396|RS3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0172297967817059	0.212705619724585	22.0000000157062	0.936171956829864	0.995571782532303	nan
sp|P23396|RS3_HUMAN	Normal-Triple-negative breast cancer	-0.721146174577157	0.254231842061026	22.0000000157616	0.0096023923624592	0.0620611678009953	nan
sp|P23434|GCSH_HUMAN	metaplastic breast carcinomas-Normal	0.345338400515238	0.379484137203308	21.9999999051016	0.372674580694351	0.581309388187715	nan
sp|P23434|GCSH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.528412360262616	0.379484137203308	21.9999999069373	0.177701829926472	0.843662073010871	nan
sp|P23434|GCSH_HUMAN	Normal-Triple-negative breast cancer	0.183073959747378	0.453570297573972	21.999999907151	0.69038219303543	0.817652915259381	nan
sp|P23497|SP100_HUMAN	metaplastic breast carcinomas-Normal	-0.246282828409073	0.813663290336975	15.0000000001533	0.766287689953083	0.872906196505843	nan
sp|P23497|SP100_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.12876623741201	0.813663290336975	15.0000000000087	0.185629142472238	0.843662073010871	nan
sp|P23497|SP100_HUMAN	Normal-Triple-negative breast cancer	1.37504906582108	0.97251364297591	15.0000000000714	0.177806245691922	0.353293295263538	nan
sp|P23526|SAHH_HUMAN	metaplastic breast carcinomas-Normal	0.289757292524861	0.184663375561285	23.9999999992211	0.129713806936031	0.300492493931573	nan
sp|P23526|SAHH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.524969663310555	0.184663375561285	23.9999999991734	0.008986279934408	0.547668704418496	nan
sp|P23526|SAHH_HUMAN	Normal-Triple-negative breast cancer	-0.814726955835416	0.22071494956711	23.9999999991969	0.0011449053833751	0.026613045414958	nan
sp|P23528|COF1_HUMAN	metaplastic breast carcinomas-Normal	0.287283194009621	0.199473222877628	22.0000000032413	0.163888413961979	0.3500859086114	nan
sp|P23528|COF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.477093091686999	0.199473222877628	22.0000000029821	0.0257476717078875	0.721684569712558	nan
sp|P23528|COF1_HUMAN	Normal-Triple-negative breast cancer	-0.764376285696621	0.238416102779477	22.0000000031009	0.0040734940163676	0.041407627248948	nan
sp|P23588|IF4B_HUMAN	metaplastic breast carcinomas-Normal	0.576018913885004	0.230135365150345	23.9999999995253	0.0195251988246144	0.095163872277153	nan
sp|P23588|IF4B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.079100189791734	0.230135365150345	23.9999999995253	0.734056209822257	0.954643368861838	nan
sp|P23588|IF4B_HUMAN	Normal-Triple-negative breast cancer	-0.49691872409327	0.27506437244731	23.9999999995559	0.0833876826712371	0.21726078673375	nan
sp|P23634|AT2B4_HUMAN	metaplastic breast carcinomas-Normal	-0.444215932987279	0.253667477880634	23.9999999996452	0.0926886579674998	0.246477679267175	nan
sp|P23634|AT2B4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.417850004321967	0.253667477880634	23.9999999993461	0.112542384419908	0.823891816737944	nan
sp|P23634|AT2B4_HUMAN	Normal-Triple-negative breast cancer	0.862065937309247	0.303190626820633	23.9999999994385	0.0089764950117508	0.0594985311923575	nan
sp|P23786|CPT2_HUMAN	metaplastic breast carcinomas-Normal	0.201225917509963	0.219500419948825	21.9999999935275	0.369217037332011	0.578542078903062	nan
sp|P23786|CPT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.478894055415621	0.219500419948825	21.9999999935275	0.0400950439334217	0.738255867002113	nan
sp|P23786|CPT2_HUMAN	Normal-Triple-negative breast cancer	-0.680119972925584	0.26235318168375	21.9999999935341	0.0166235166408583	0.082843432255192	nan
sp|P23919|KTHY_HUMAN	metaplastic breast carcinomas-Normal	0.541341165832425	0.212424909600092	22.0000000033186	0.0183178237788154	0.0915615732944096	nan
sp|P23919|KTHY_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.120579066845626	0.212424909600092	22.0000000028004	0.576032756779567	0.935847692353991	nan
sp|P23919|KTHY_HUMAN	Normal-Triple-negative breast cancer	-0.420762098986799	0.253896329289302	22.0000000025976	0.111668511071766	0.259389329701293	nan
sp|P23921|RIR1_HUMAN	metaplastic breast carcinomas-Normal	0.807766861541565	0.368428889729291	22.0000003550625	0.0392149619023227	0.145969242288153	nan
sp|P23921|RIR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0846605466931474	0.368428889729291	22.0000003549324	0.82037953966019	0.965774701272009	nan
sp|P23921|RIR1_HUMAN	Normal-Triple-negative breast cancer	-0.723106314848418	0.440356749509755	22.0000003551464	0.114789728043341	0.264605448000046	nan
sp|P23946|CMA1_HUMAN	metaplastic breast carcinomas-Normal	-2.51054239787475	0.602145948856408	21.9999996653476	0.0003990026923981	0.0189469278504515	nan
sp|P23946|CMA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.149024977433417	0.602145948856408	21.9999996646055	0.806824332632518	0.965774701272009	nan
sp|P23946|CMA1_HUMAN	Normal-Triple-negative breast cancer	2.65956737530816	0.719702065067983	21.9999996603757	0.0012641464829111	0.0266490250684039	nan
sp|P24043|LAMA2_HUMAN	metaplastic breast carcinomas-Normal	0.505490382374795	0.7071241899823	14.9999999998248	0.485677276493323	0.675087247966402	nan
sp|P24043|LAMA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.278809042759553	0.7071241899823	14.9999999998406	0.698918937542434	0.947043345959522	nan
sp|P24043|LAMA2_HUMAN	Normal-Triple-negative breast cancer	-0.226681339615242	0.845175062219254	14.9999999998357	0.792193789603717	0.881275822169597	nan
sp|P24158|PRTN3_HUMAN	metaplastic breast carcinomas-Normal	-0.244795536927717	0.482517163995388	6.0	0.630026034841214	0.778515442309366	nan
sp|P24158|PRTN3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.540302279043914	0.482517163995388	6.0	0.30562886743882	0.867696529950794	nan
sp|P24158|PRTN3_HUMAN	Normal-Triple-negative breast cancer	0.785097815971631	0.576718318902183	6.0	0.222315596066164	0.405153931841361	nan
sp|P24534|EF1B_HUMAN	metaplastic breast carcinomas-Normal	0.500333840491701	0.257111185338978	23.9999999993825	0.0634575361591902	0.192535774463204	nan
sp|P24534|EF1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.256956127491624	0.257111185338978	23.999999999723	0.3275728454349	0.867975899287892	nan
sp|P24534|EF1B_HUMAN	Normal-Triple-negative breast cancer	-0.757289967983325	0.307306644497024	23.9999999995801	0.0212758595749406	0.0960882571020416	nan
sp|P24539|AT5F1_HUMAN	metaplastic breast carcinomas-Normal	0.140098139472992	0.159555105124761	23.9999999994256	0.388619876049126	0.592689911608717	nan
sp|P24539|AT5F1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.316064490074931	0.159555105124761	23.9999999992376	0.0591722285589342	0.773787875546141	nan
sp|P24539|AT5F1_HUMAN	Normal-Triple-negative breast cancer	-0.456162629547923	0.190704826410471	23.9999999993645	0.0249435924254909	0.10516426302168	nan
sp|P24557|THAS_HUMAN	metaplastic breast carcinomas-Normal	0.21096817423529	0.298118942570469	21.9992167503539	0.486583865142102	0.675607672402818	nan
sp|P24557|THAS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.350813673647394	0.298118942570469	21.9992167443703	0.251868484733199	0.855426671846665	nan
sp|P24557|THAS_HUMAN	Normal-Triple-negative breast cancer	0.139845499412104	0.356320289144741	21.9992167503785	0.698486769193114	0.823729406779257	nan
sp|P24666|PPAC_HUMAN	metaplastic breast carcinomas-Normal	0.558809924041782	0.152342164666445	24.0000000000988	0.0012131535699471	0.0261852108214574	nan
sp|P24666|PPAC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.237200351869982	0.152342164666445	24.0000000000637	0.132554761411277	0.823891816737944	nan
sp|P24666|PPAC_HUMAN	Normal-Triple-negative breast cancer	-0.796010275911764	0.182083713617266	24.000000000083	0.0002052785485235	0.0227914720285933	nan
sp|P24752|THIL_HUMAN	metaplastic breast carcinomas-Normal	-0.491900485709623	0.351034423037007	23.999999999565	0.173927176637615	0.361789963260442	nan
sp|P24752|THIL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.224187707425848	0.351034423037007	23.999999999565	0.529099550727036	0.920112973936922	nan
sp|P24752|THIL_HUMAN	Normal-Triple-negative breast cancer	0.267712778283775	0.419566385275023	23.9999999995363	0.529469749186156	0.697841969189049	nan
sp|P24821|TENA_HUMAN	metaplastic breast carcinomas-Normal	1.55813622881696	0.477970158114161	23.9999999994563	0.0033210222914975	0.0403465392772878	nan
sp|P24821|TENA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.458267620753235	0.477970158114161	23.9999999994563	0.34723015693352	0.871784737402991	nan
sp|P24821|TENA_HUMAN	Normal-Triple-negative breast cancer	-1.09986860806372	0.571283607386128	23.9999999993973	0.0661269815973374	0.186338952556932	nan
sp|P24928|RPB1_HUMAN	metaplastic breast carcinomas-Normal	0.237295743074194	0.195005386060796	22.0000000149025	0.236548236911407	0.435987210875783	nan
sp|P24928|RPB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.168874886375001	0.195005386060796	22.0000000150319	0.395835881877589	0.885234295852111	nan
sp|P24928|RPB1_HUMAN	Normal-Triple-negative breast cancer	-0.406170629449195	0.233076016394162	22.0000000139978	0.0953574630245668	0.236720094916848	nan
sp|P24941|CDK2_HUMAN	metaplastic breast carcinomas-Normal	0.928016926574477	0.277391354735217	14.9999999998487	0.0044258739994453	0.0441841632960889	nan
sp|P24941|CDK2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.167523704786196	0.277391354735217	14.9999999996675	0.554917565055262	0.931642387063667	nan
sp|P24941|CDK2_HUMAN	Normal-Triple-negative breast cancer	-0.760493221788281	0.331546083161556	14.9999999997477	0.0366623630642594	0.127341373903446	nan
sp|P25205|MCM3_HUMAN	metaplastic breast carcinomas-Normal	1.07605176085419	0.443331007416685	22.0000000037861	0.0238561028175124	0.107449438706519	nan
sp|P25205|MCM3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0320242281330813	0.443331007416685	22.0000000037861	0.94306720954984	0.996541950781621	nan
sp|P25205|MCM3_HUMAN	Normal-Triple-negative breast cancer	-1.10807598898727	0.52988190346946	22.000000003807	0.0482761822922924	0.151960255624602	nan
sp|P25311|ZA2G_HUMAN	metaplastic breast carcinomas-Normal	-2.03334484266181	0.379659860431537	24.0000000000313	1.69317730664884e-05	0.0066066425513017	nan
sp|P25311|ZA2G_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.102783394364936	0.379659860431537	23.9999999997656	0.788917278977696	0.962981271203673	nan
sp|P25311|ZA2G_HUMAN	Normal-Triple-negative breast cancer	2.13612823702675	0.453780327003676	23.9999999998854	8.73836079441282e-05	0.022319699811492	nan
sp|P25325|THTM_HUMAN	metaplastic breast carcinomas-Normal	0.0686567514015708	0.208321336929761	22.0000000036963	0.74484115598208	0.859564245547108	nan
sp|P25325|THTM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.4167626224338	0.208321336929761	22.0000000030864	0.0579292181734732	0.773787875546141	nan
sp|P25325|THTM_HUMAN	Normal-Triple-negative breast cancer	0.348105871032229	0.24899162183324	22.0000000033848	0.176031645864446	0.350586693141652	nan
sp|P25398|RS12_HUMAN	metaplastic breast carcinomas-Normal	0.726456808288605	0.375214759557894	24.0000000001256	0.064717250411624	0.195563763971126	nan
sp|P25398|RS12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.271272879966752	0.375214759557894	24.0000000001242	0.476679264006623	0.913280230088743	nan
sp|P25398|RS12_HUMAN	Normal-Triple-negative breast cancer	-0.997729688255357	0.44846741526812	24.0000000001618	0.0357558165484746	0.126573305864888	nan
sp|P25440|BRD2_HUMAN	metaplastic breast carcinomas-Normal	0.965859064471455	0.498742601550513	14.0000000439105	0.0732456782309224	0.211185923021356	nan
sp|P25440|BRD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.62412023220067	0.498742601550513	14.0000000439735	0.231300125170239	0.846996603734631	nan
sp|P25440|BRD2_HUMAN	Normal-Triple-negative breast cancer	-0.341738832270785	0.596111426067037	14.0000000439942	0.57554849884038	0.735384313245616	nan
sp|P25490|TYY1_HUMAN	metaplastic breast carcinomas-Normal	0.0335231337375244	0.35757074499447	11.6531153996895	0.926898432627476	0.96071418461295	nan
sp|P25490|TYY1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0641336333618484	0.266887583323791	11.0219075524389	0.814507040797221	0.965774701272009	nan
sp|P25490|TYY1_HUMAN	Normal-Triple-negative breast cancer	-0.0976567670993728	0.396488834118499	11.6677581926509	0.809726616522188	0.889762404403225	nan
sp|P25685|DNJB1_HUMAN	metaplastic breast carcinomas-Normal	0.432934280384968	0.289592161608432	22.0000000255532	0.149126805267907	0.3278194157764	nan
sp|P25685|DNJB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0308744061456241	0.289592161608432	22.0000000247588	0.916061908384266	0.99408739879047	nan
sp|P25685|DNJB1_HUMAN	Normal-Triple-negative breast cancer	-0.402059874239344	0.346128836593387	22.0000000249712	0.25785005139281	0.448270696040638	nan
sp|P25705|ATPA_HUMAN	metaplastic breast carcinomas-Normal	-0.0181492518613472	0.133201816449129	23.9999999993903	0.892757137692133	0.94150288514576	nan
sp|P25705|ATPA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.283317014931682	0.133201816449129	23.9999999993903	0.0438990222229235	0.759166737802103	nan
sp|P25705|ATPA_HUMAN	Normal-Triple-negative breast cancer	-0.265167763070335	0.159206621835308	23.9999999993635	0.108803119019973	0.255591213867413	nan
sp|P25774|CATS_HUMAN	metaplastic breast carcinomas-Normal	0.16891542088166	0.473278572857974	22.0000000042195	0.724563625073207	0.847448800050436	nan
sp|P25774|CATS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.168198300759519	0.473278572857975	22.0000000049116	0.725682468225927	0.953491935272676	nan
sp|P25774|CATS_HUMAN	Normal-Triple-negative breast cancer	-0.337113721641179	0.565676090464803	22.0000000045905	0.557292026436266	0.720512911658556	nan
sp|P25786|PSA1_HUMAN	metaplastic breast carcinomas-Normal	0.281702314463207	0.129269026484901	23.9999999994339	0.0393630882999752	0.14619319051298	nan
sp|P25786|PSA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.00344432326617	0.129269026484901	23.9999999994827	0.97896350559332	0.99709406933403	nan
sp|P25786|PSA1_HUMAN	Normal-Triple-negative breast cancer	-0.278257991197037	0.15450603875556	23.9999999994201	0.0842905536971547	0.217870762433392	nan
sp|P25787|PSA2_HUMAN	metaplastic breast carcinomas-Normal	0.407485724367073	0.209825928702791	23.9999999996974	0.0639607522784912	0.193712585253101	nan
sp|P25787|PSA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.178196762553585	0.209825928702791	23.9999999998802	0.404128716902251	0.885297496092956	nan
sp|P25787|PSA2_HUMAN	Normal-Triple-negative breast cancer	-0.585682486920658	0.250789952965734	23.9999999998177	0.0282137853226157	0.112421067564965	nan
sp|P25788|PSA3_HUMAN	metaplastic breast carcinomas-Normal	0.0424048669300267	0.208390008777578	23.999999999473	0.840469106308124	0.915167571605857	nan
sp|P25788|PSA3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.109616355687738	0.208390008777578	23.999999999473	0.603704764491143	0.940559810632461	nan
sp|P25788|PSA3_HUMAN	Normal-Triple-negative breast cancer	0.0672114887577114	0.249073700390407	23.9999999994603	0.789585598692274	0.879763182876798	nan
sp|P25789|PSA4_HUMAN	metaplastic breast carcinomas-Normal	0.47106860197513	0.299098379451312	23.9999999995171	0.128356681418634	0.299374855792279	nan
sp|P25789|PSA4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.268173923073065	0.299098379451312	23.9999999995171	0.378834214630907	0.885234295852111	nan
sp|P25789|PSA4_HUMAN	Normal-Triple-negative breast cancer	-0.739242525048195	0.357490940125763	23.9999999994562	0.0495952838567417	0.155084405964073	nan
sp|P25815|S100P_HUMAN	metaplastic breast carcinomas-Normal	1.57462743310211	0.749327045490353	21.9999998853282	0.0472838502712032	0.163885567316822	nan
sp|P25815|S100P_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.190565272023569	0.749327045490353	21.9999998848867	0.801614009885355	0.965774701272009	nan
sp|P25815|S100P_HUMAN	Normal-Triple-negative breast cancer	-1.76519270512568	0.895617122518084	21.9999998841294	0.0614423641528148	0.178995984613459	nan
sp|P25942|TNR5_HUMAN	metaplastic breast carcinomas-Normal	-0.527912363194449	0.644876561006824	13.9999999874478	0.426715457352391	0.624846775435835	nan
sp|P25942|TNR5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.681065282236303	0.644876561006824	13.9999999875609	0.308799474578658	0.867696529950794	nan
sp|P25942|TNR5_HUMAN	Normal-Triple-negative breast cancer	-0.153152919041854	0.770774915204533	13.9999999873823	0.845354121879758	0.911630088050377	nan
sp|P26006|ITA3_HUMAN	metaplastic breast carcinomas-Normal	0.119575747512306	0.406034034090997	14.000000001655	0.772699809122629	0.877095204669268	nan
sp|P26006|ITA3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.168748355133654	0.406034034090997	14.0000000016308	0.68400144850262	0.946568877415162	nan
sp|P26006|ITA3_HUMAN	Normal-Triple-negative breast cancer	0.0491726076213475	0.485303493909017	14.0000000017679	0.920730567492569	0.954023817439307	nan
sp|P26022|PTX3_HUMAN	metaplastic breast carcinomas-Normal	1.49743310721626	0.73488896167264	14.9999999998679	0.0596275867582624	0.187159677416869	nan
sp|P26022|PTX3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.72939552758906	0.73488896167264	14.9999999997189	0.0326695104730313	0.724424466074313	nan
sp|P26022|PTX3_HUMAN	Normal-Triple-negative breast cancer	0.231962420372795	0.878360311675186	14.9999999997708	0.795307687324512	0.882623906102887	nan
sp|P26038|MOES_HUMAN	metaplastic breast carcinomas-Normal	0.181448378634662	0.199013718021548	22.0000000310267	0.371789493534814	0.580767576263948	nan
sp|P26038|MOES_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.387300211381356	0.199013718021548	22.0000000307645	0.0645272820456637	0.773787875546141	nan
sp|P26038|MOES_HUMAN	Normal-Triple-negative breast cancer	0.205851832746693	0.237866889429362	22.0000000311631	0.396154370832463	0.584472760162941	nan
sp|P26196|DDX6_HUMAN	metaplastic breast carcinomas-Normal	0.601610402127651	0.207503548884912	22.000000018664	0.0083191794173527	0.0602818106368712	nan
sp|P26196|DDX6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.200448083403073	0.207503548884912	22.0000000192164	0.344544814419094	0.870943310236299	nan
sp|P26196|DDX6_HUMAN	Normal-Triple-negative breast cancer	-0.802058485530724	0.248014178165664	22.0000000188622	0.0038143351066153	0.0403623732245556	nan
sp|P26358|DNMT1_HUMAN	metaplastic breast carcinomas-Normal	-0.072883893240207	0.308140893693743	24.0000000000575	0.815030223095769	0.902183034510288	nan
sp|P26358|DNMT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.283744965224346	0.308140893693743	24.0000000000908	0.366303853469167	0.883542279876718	nan
sp|P26358|DNMT1_HUMAN	Normal-Triple-negative breast cancer	0.356628858464553	0.36829881184863	24.0000000000891	0.342545242238687	0.534563561127415	nan
sp|P26368|U2AF2_HUMAN	metaplastic breast carcinomas-Normal	1.04884169789819	0.260479447689999	22.0000000047345	0.0005652971276558	0.0205217420849069	nan
sp|P26368|U2AF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.13977274415567	0.260479447689999	22.0000000037473	0.596930470919793	0.940559810632461	nan
sp|P26368|U2AF2_HUMAN	Normal-Triple-negative breast cancer	-1.18861444205386	0.311332488022709	22.0000000038533	0.0009395337472546	0.025828508049811	nan
sp|P26373|RL13_HUMAN	metaplastic breast carcinomas-Normal	1.32513975754999	0.286037753280572	22.0000000103322	0.0001286502486003	0.0142544475449197	nan
sp|P26373|RL13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0025628650365469	0.286037753280572	22.0000000102516	0.992931896580312	0.998185231446144	nan
sp|P26373|RL13_HUMAN	Normal-Triple-negative breast cancer	-1.32770262258654	0.341880506070673	22.0000000101084	0.00080090496855	0.0257262735003663	nan
sp|P26440|IVD_HUMAN	metaplastic breast carcinomas-Normal	-0.381187243166039	0.401617197392999	21.9999999638552	0.352864763554442	0.561744479911381	nan
sp|P26440|IVD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.908374410545593	0.401617197392999	21.9999999641043	0.0339335788152343	0.724424466074313	nan
sp|P26440|IVD_HUMAN	Normal-Triple-negative breast cancer	-0.527187167379554	0.480024364324811	21.9999999648441	0.283969693747929	0.47648423120551	nan
sp|P26447|S10A4_HUMAN	metaplastic breast carcinomas-Normal	-0.580332708980706	0.369844541451611	21.9999873877282	0.130890735162158	0.302349411868669	nan
sp|P26447|S10A4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.415008676571478	0.369844541451611	21.9999873902725	0.273911052672314	0.867696529950794	nan
sp|P26447|S10A4_HUMAN	Normal-Triple-negative breast cancer	0.995341385552185	0.442048776949125	21.9999873946776	0.0346629450430336	0.124561761430317	nan
sp|P26583|HMGB2_HUMAN	metaplastic breast carcinomas-Normal	1.10740841184242	0.342469414351751	22.0000008320025	0.0038172539139503	0.0413307883060947	nan
sp|P26583|HMGB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.113965551724714	0.342469414351751	22.0000008325814	0.742453751245468	0.954643368861838	nan
sp|P26583|HMGB2_HUMAN	Normal-Triple-negative breast cancer	-1.22137396356713	0.409329241855208	22.0000008325064	0.0068460457571682	0.0524989501286484	nan
sp|P26599|PTBP1_HUMAN	metaplastic breast carcinomas-Normal	0.398890800321614	0.282091442878263	21.9999937264891	0.171344020961265	0.360397937027939	nan
sp|P26599|PTBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.443325302230309	0.282091442878263	21.9999937263162	0.13032349565089	0.823891816737944	nan
sp|P26599|PTBP1_HUMAN	Normal-Triple-negative breast cancer	-0.842216102551923	0.337163762976519	21.9999937174689	0.0204588024812865	0.0939296401212656	nan
sp|P26639|SYTC_HUMAN	metaplastic breast carcinomas-Normal	0.815378425603444	0.228099698168611	22.0000000327192	0.0016916473730088	0.0294579152472248	nan
sp|P26639|SYTC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.120416120938603	0.228099698168611	22.0000000325221	0.602846358682104	0.940559810632461	nan
sp|P26639|SYTC_HUMAN	Normal-Triple-negative breast cancer	-0.694962304664841	0.272631285031663	22.000000032338	0.0182894858894612	0.0873480619203579	nan
sp|P26640|SYVC_HUMAN	metaplastic breast carcinomas-Normal	0.673454691354927	0.22659929284411	23.9999999994276	0.006631875338917	0.0534585445819025	nan
sp|P26640|SYVC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0593823704136776	0.22659929284411	23.9999999994276	0.795512158811338	0.964785038807592	nan
sp|P26640|SYVC_HUMAN	Normal-Triple-negative breast cancer	-0.614072320941249	0.270837957662223	23.9999999994122	0.032660198986376	0.12149957795704	nan
sp|P26641|EF1G_HUMAN	metaplastic breast carcinomas-Normal	0.841907893100781	0.170688314249145	21.9999554534895	6.20581944603632e-05	0.0108569178098025	nan
sp|P26641|EF1G_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0955969496728375	0.170688314249145	21.9999554534895	0.581092268201575	0.93702592209822	nan
sp|P26641|EF1G_HUMAN	Normal-Triple-negative breast cancer	-0.746310943427943	0.204011556469637	21.9999554534544	0.0013830583270427	0.0266490250684039	nan
sp|P27105|STOM_HUMAN	metaplastic breast carcinomas-Normal	-0.413285451411113	0.315260721198915	22.0000000264307	0.203400427106336	0.397007057957405	nan
sp|P27105|STOM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.268161560898333	0.315260721198915	22.0000000264281	0.404153272855242	0.885297496092956	nan
sp|P27105|STOM_HUMAN	Normal-Triple-negative breast cancer	0.681447012309446	0.376808633376338	22.0000000261923	0.084223504440562	0.217870762433392	nan
sp|P27144|KAD4_HUMAN	metaplastic breast carcinomas-Normal	-1.09122779308933	0.409501760518099	23.9999999994481	0.0135561675691177	0.0776608745126424	nan
sp|P27144|KAD4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.997716097043374	0.409501760518099	23.9999999994481	0.0226261119375732	0.712051972579798	nan
sp|P27144|KAD4_HUMAN	Normal-Triple-negative breast cancer	0.0935116960459508	0.489448219744034	23.9999999994426	0.850089290269362	0.914169136478602	nan
sp|P27169|PON1_HUMAN	metaplastic breast carcinomas-Normal	-1.218020861861	0.53397033959453	23.9999999997267	0.0317126394603711	0.128466389195289	nan
sp|P27169|PON1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.32446063472465	0.53397033959453	23.9999999994124	0.549134611277897	0.931092596888836	nan
sp|P27169|PON1_HUMAN	Normal-Triple-negative breast cancer	1.54248149658565	0.638216626419383	23.9999999995963	0.0236203142191769	0.102137084892028	nan
sp|P27338|AOFB_HUMAN	metaplastic breast carcinomas-Normal	-0.729275403525221	0.51312797292546	22.0000000235731	0.169269236789452	0.357920447257086	nan
sp|P27338|AOFB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.517514074056697	0.51312797292546	22.0000000245492	0.32415617832622	0.867696529950794	nan
sp|P27338|AOFB_HUMAN	Normal-Triple-negative breast cancer	1.24678947758192	0.613305233490274	22.0000000241603	0.0543036232739957	0.16537415252347	nan
sp|P27348|1433T_HUMAN	metaplastic breast carcinomas-Normal	0.625420446835265	0.216685762745034	22.0000001447384	0.0085704848512851	0.060872418046307	nan
sp|P27348|1433T_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.202859142580575	0.216685762745034	22.0000001449004	0.359339012290377	0.883542279876718	nan
sp|P27348|1433T_HUMAN	Normal-Triple-negative breast cancer	-0.82827958941584	0.25898902286831	22.0000001444244	0.0041503581214607	0.0416791250626451	nan
sp|P27448|MARK3_HUMAN	metaplastic breast carcinomas-Normal	0.59625408671876	0.3173779271284	14.0000001718094	0.0812696934845329	0.226058963299236	nan
sp|P27448|MARK3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0705405297315838	0.3173779271284	14.0000001716979	0.82732089585916	0.966564293299967	nan
sp|P27448|MARK3_HUMAN	Normal-Triple-negative breast cancer	-0.525713556987176	0.37933917847511	14.0000001717402	0.187467441061704	0.366553984758297	nan
sp|P27449|VATL_HUMAN	metaplastic breast carcinomas-Normal	0.64023063245698	0.310717647006486	23.9999999998426	0.0503502508890144	0.169912927873181	nan
sp|P27449|VATL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.324355378629542	0.310717647006486	23.9999999998426	0.30693701240911	0.867696529950794	nan
sp|P27449|VATL_HUMAN	Normal-Triple-negative breast cancer	-0.964586011086522	0.371378621127218	23.9999999998127	0.0158001310455662	0.0801826497640644	nan
sp|P27635|RL10_HUMAN	metaplastic breast carcinomas-Normal	0.764781495922154	0.287142279804342	21.0639984658468	0.0145169349204807	0.0795450818130059	nan
sp|P27635|RL10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.259517534721267	0.267290255769682	20.964635438731	0.342657450294075	0.870943310236299	nan
sp|P27635|RL10_HUMAN	Normal-Triple-negative breast cancer	-1.02429903064342	0.336258205305495	21.0372676603548	0.0061290914556772	0.0496904878016373	nan
sp|P27694|RFA1_HUMAN	metaplastic breast carcinomas-Normal	0.125295893851491	0.19976308384938	22.0000000219923	0.536969291540568	0.713383663101857	nan
sp|P27694|RFA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.17578559648459	0.19976308384938	22.0000000210604	0.388386899562382	0.885234295852111	nan
sp|P27694|RFA1_HUMAN	Normal-Triple-negative breast cancer	-0.301081490336081	0.238762552905645	22.0000000212753	0.220515089438955	0.403934589352605	nan
sp|P27695|APEX1_HUMAN	metaplastic breast carcinomas-Normal	0.389730127227155	0.222705668761407	23.9999999996911	0.0928988764435618	0.246642064934824	nan
sp|P27695|APEX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.161545281006831	0.222705668761407	23.9999999996921	0.475235657330837	0.913280230088743	nan
sp|P27695|APEX1_HUMAN	Normal-Triple-negative breast cancer	-0.551275408233986	0.266184186764583	23.9999999996902	0.04927420807284	0.154292834351142	nan
sp|P27707|DCK_HUMAN	metaplastic breast carcinomas-Normal	-0.0363081319000917	0.153204478920956	22.0000000040821	0.814856394457942	0.902183034510288	nan
sp|P27707|DCK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.222877257660733	0.153204478920956	22.0000000043407	0.1598534226899	0.843662073010871	nan
sp|P27707|DCK_HUMAN	Normal-Triple-negative breast cancer	-0.186569125760641	0.183114376284494	22.0000000042441	0.319340709346051	0.511905730194303	nan
sp|P27708|PYR1_HUMAN	metaplastic breast carcinomas-Normal	0.741935964627186	0.236022582123577	22.0000000028382	0.004719101038857	0.0458663504478383	nan
sp|P27708|PYR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.116286667348734	0.236022582123577	22.0000000036842	0.62711097494586	0.941374262616245	nan
sp|P27708|PYR1_HUMAN	Normal-Triple-negative breast cancer	-0.625649297278452	0.282100942603075	22.0000000030828	0.0372021999345677	0.12835519121726	nan
sp|P27797|CALR_HUMAN	metaplastic breast carcinomas-Normal	0.713580714252244	0.212793439588586	22.0000000190262	0.0028733742852891	0.0379733940896436	nan
sp|P27797|CALR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0245905474976413	0.212793439588586	22.0000000188601	0.909049073249606	0.99408739879047	nan
sp|P27797|CALR_HUMAN	Normal-Triple-negative breast cancer	-0.688990166754602	0.254336806874948	22.0000000189445	0.0128178990834899	0.0732073823943651	nan
sp|P27816|MAP4_HUMAN	metaplastic breast carcinomas-Normal	0.217074742479705	0.235444726966831	23.9999999996091	0.365716413274753	0.576002240523302	nan
sp|P27816|MAP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0187608389274625	0.235444726966831	23.9999999996091	0.937150435200716	0.995571782532303	nan
sp|P27816|MAP4_HUMAN	Normal-Triple-negative breast cancer	-0.198313903552242	0.281410273587681	23.999999999531	0.487770904676743	0.665062857354938	nan
sp|P27824|CALX_HUMAN	metaplastic breast carcinomas-Normal	0.439047589922786	0.220934609477992	23.9999999996513	0.0584250085377777	0.184254960511929	nan
sp|P27824|CALX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0096115315737217	0.220934609477992	23.9999999996513	0.965659735661739	0.99709406933403	nan
sp|P27824|CALX_HUMAN	Normal-Triple-negative breast cancer	-0.429436058349064	0.264067366040217	23.9999999996202	0.116959698525478	0.267382419462647	nan
sp|P27918|PROP_HUMAN	metaplastic breast carcinomas-Normal	-0.456362699771215	0.513914535416745	21.9999641370355	0.38414001685992	0.589275343425259	nan
sp|P27918|PROP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.187947530905048	0.513914535416745	21.9999641397249	0.71806888445337	0.949836203815091	nan
sp|P27918|PROP_HUMAN	Normal-Triple-negative breast cancer	0.644310230676264	0.614245355482887	21.9999641426407	0.305590283908113	0.498421051869759	nan
sp|P27986|P85A_HUMAN	metaplastic breast carcinomas-Normal	0.309041886091689	0.286480904529366	23.9999999996962	0.29142121901573	0.494975705319747	nan
sp|P27986|P85A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.256030922413091	0.286480904529366	23.9999999996565	0.380351778274498	0.885234295852111	nan
sp|P27986|P85A_HUMAN	Normal-Triple-negative breast cancer	-0.0530109636785974	0.342410173121494	23.9999999996978	0.878260117730661	0.92972504182698	nan
sp|P28062|PSB8_HUMAN	metaplastic breast carcinomas-Normal	0.284994977930528	0.385389874666674	22.0000000088515	0.46742276464462	0.658937327638352	nan
sp|P28062|PSB8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.307248135468038	0.385389874666674	22.0000000085045	0.4338324205512	0.896102083258464	nan
sp|P28062|PSB8_HUMAN	Normal-Triple-negative breast cancer	0.0222531575375104	0.460629003949405	22.0000000082705	0.961904789538738	0.981692207683993	nan
sp|P28065|PSB9_HUMAN	metaplastic breast carcinomas-Normal	0.139380722974295	0.3280116493354	22.0000000350058	0.675017724848238	0.80948812816229	nan
sp|P28065|PSB9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.215212795406082	0.3280116493354	22.00000003482	0.518555209692062	0.91593707377131	nan
sp|P28065|PSB9_HUMAN	Normal-Triple-negative breast cancer	0.0758320724317869	0.392048907480631	22.0000000346189	0.848400796117206	0.913239717063987	nan
sp|P28066|PSA5_HUMAN	metaplastic breast carcinomas-Normal	0.361418084766502	0.163234843936312	22.0000000040196	0.037491615825799	0.141455313285988	nan
sp|P28066|PSA5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.146542176420921	0.163234843936312	22.0000000036815	0.379045096480542	0.885234295852111	nan
sp|P28066|PSA5_HUMAN	Normal-Triple-negative breast cancer	-0.507960261187423	0.195102955512914	22.0000000042023	0.0162174828497567	0.0815571818595222	nan
sp|P28070|PSB4_HUMAN	metaplastic breast carcinomas-Normal	0.0201494463425471	0.228235054770475	21.9999936243084	0.930449869544373	0.962231702666505	nan
sp|P28070|PSB4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0966981637206113	0.228235054770475	21.9999936264971	0.675914280152275	0.946386428913156	nan
sp|P28070|PSB4_HUMAN	Normal-Triple-negative breast cancer	-0.116847610063158	0.272793067114674	21.9999936249954	0.672569593210588	0.807083511852705	nan
sp|P28072|PSB6_HUMAN	metaplastic breast carcinomas-Normal	0.2200507192624	0.216760234094451	22.0000000046293	0.321055219262404	0.529096454550436	nan
sp|P28072|PSB6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0540801441481361	0.216760234094451	22.0000000045994	0.805294243413784	0.965774701272009	nan
sp|P28072|PSB6_HUMAN	Normal-Triple-negative breast cancer	-0.274130863410536	0.259078033155708	22.0000000048225	0.301489460683709	0.494401069221829	nan
sp|P28074|PSB5_HUMAN	metaplastic breast carcinomas-Normal	0.149128610195991	0.32078354817754	22.0000000624358	0.646579666785874	0.790158386910385	nan
sp|P28074|PSB5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.318031318056773	0.32078354817754	22.0000000610995	0.332260156403052	0.870890600099115	nan
sp|P28074|PSB5_HUMAN	Normal-Triple-negative breast cancer	-0.467159928252765	0.383409674185594	22.0000000620676	0.235964042589545	0.420785663931141	nan
sp|P28288|ABCD3_HUMAN	metaplastic breast carcinomas-Normal	0.45315418876946	0.22969871911933	23.9999999999303	0.0601415612487308	0.188054227556203	nan
sp|P28288|ABCD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0646347620500265	0.22969871911933	23.9999999999303	0.780823716063177	0.961926215602098	nan
sp|P28288|ABCD3_HUMAN	Normal-Triple-negative breast cancer	-0.517788950819487	0.274542480618888	23.9999999999456	0.0714534428961112	0.195321746864041	nan
sp|P28300|LYOX_HUMAN	metaplastic breast carcinomas-Normal	0.409690819693903	0.329287665049823	13.9999999955586	0.233864144846309	0.433797107962684	nan
sp|P28300|LYOX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.30573699170354	0.329287665049823	13.9999999968853	0.368890940373524	0.883542279876718	nan
sp|P28300|LYOX_HUMAN	Normal-Triple-negative breast cancer	-0.103953827990363	0.39357403796847	13.9999999964575	0.795529850386357	0.882623906102887	nan
sp|P28331|NDUS1_HUMAN	metaplastic breast carcinomas-Normal	-0.0775256092900842	0.187757251082093	23.9999999993059	0.683343031565701	0.815009772846929	nan
sp|P28331|NDUS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.017692427753362	0.187757251082093	23.9999999992625	0.925708491352633	0.994822473738689	nan
sp|P28331|NDUS1_HUMAN	Normal-Triple-negative breast cancer	0.0598331815367222	0.224412838103299	23.999999999309	0.792038411559109	0.881275822169597	nan
sp|P28482|MK01_HUMAN	metaplastic breast carcinomas-Normal	0.420169826639672	0.511038559594751	14.999999999801	0.423847197679294	0.621951157325291	nan
sp|P28482|MK01_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0417729192314375	0.511038559594751	14.999999999801	0.935933241841259	0.995571782532303	nan
sp|P28482|MK01_HUMAN	Normal-Triple-negative breast cancer	-0.461942745871109	0.610807906900686	14.9999999998006	0.461193862139195	0.642232257122196	nan
sp|P28799|GRN_HUMAN	metaplastic breast carcinomas-Normal	-0.0207713676280311	0.311687512834487	21.9999999369811	0.9474689193001	0.972567428615729	nan
sp|P28799|GRN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.354910368313618	0.311687512834487	21.9999999350441	0.267087282512524	0.866855338270227	nan
sp|P28799|GRN_HUMAN	Normal-Triple-negative breast cancer	-0.334139000685586	0.372537832512059	21.9999999350714	0.37946875830211	0.567203003247039	nan
sp|P28838|AMPL_HUMAN	metaplastic breast carcinomas-Normal	-0.362981784703111	0.27610964545478	22.0000000030493	0.202175335343565	0.395079844022346	nan
sp|P28838|AMPL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.157903430529073	0.27610964545478	22.0000000030481	0.573196344327226	0.935843259183841	nan
sp|P28838|AMPL_HUMAN	Normal-Triple-negative breast cancer	0.520885215232184	0.330014147560729	22.000000002856	0.12875186288678	0.285695054896968	nan
sp|P28906|CD34_HUMAN	metaplastic breast carcinomas-Normal	-1.46570517314795	0.409489932017995	23.9999999999425	0.0015133609621517	0.0281210167842065	nan
sp|P28906|CD34_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.55060015319876	0.409489932017995	23.9999999997518	0.191325604933948	0.843662073010871	nan
sp|P28906|CD34_HUMAN	Normal-Triple-negative breast cancer	2.01630532634671	0.489434081982304	23.999999999874	0.0003892436576356	0.0237592699893802	nan
sp|P28907|CD38_HUMAN	metaplastic breast carcinomas-Normal	-0.087111759010769	1.07330279744995	6.0	0.937952489310417	0.968246606977586	nan
sp|P28907|CD38_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.489644622756979	1.07330279744995	6.0	0.664290683106588	0.944724271291086	nan
sp|P28907|CD38_HUMAN	Normal-Triple-negative breast cancer	0.576756381767748	1.28284220999081	6.0	0.668789488652618	0.805747104125154	nan
sp|P29034|S10A2_HUMAN	metaplastic breast carcinomas-Normal	2.08138758090312	1.09883799722414	22.9999999992612	0.0708459104669144	0.207008121073216	nan
sp|P29034|S10A2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.6489543639809	1.09883799722414	22.9999999992612	0.147054002278686	0.834393442963536	nan
sp|P29034|S10A2_HUMAN	Normal-Triple-negative breast cancer	-0.43243321692222	1.30016265205588	22.999999999212	0.742449204906211	0.851587700865509	nan
sp|P29144|TPP2_HUMAN	metaplastic breast carcinomas-Normal	0.158103215976657	0.172580336278979	21.9999929197023	0.369540728057727	0.578542078903062	nan
sp|P29144|TPP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.186128012814789	0.172580336278979	21.9999929197023	0.29249387801369	0.867696529950794	nan
sp|P29144|TPP2_HUMAN	Normal-Triple-negative breast cancer	-0.344231228791446	0.206272955329186	21.9999929190072	0.109325149447936	0.256250128434269	nan
sp|P29218|IMPA1_HUMAN	metaplastic breast carcinomas-Normal	0.290479117982524	0.264197774546364	23.9999999991965	0.282467471103739	0.485732992213569	nan
sp|P29218|IMPA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.609385051370944	0.264197774546364	23.9999999994723	0.0300235603857409	0.721684569712558	nan
sp|P29218|IMPA1_HUMAN	Normal-Triple-negative breast cancer	0.318905933388419	0.315776738660293	23.999999999263	0.322612719191071	0.514231959877533	nan
sp|P29350|PTN6_HUMAN	metaplastic breast carcinomas-Normal	0.19850629567266	0.339500008608155	22.000000000618	0.564697084341869	0.732167091151825	nan
sp|P29350|PTN6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0372974177963772	0.339500008608155	22.0000000015831	0.913516515357429	0.99408739879047	nan
sp|P29350|PTN6_HUMAN	Normal-Triple-negative breast cancer	-0.235803713469037	0.40578012315774	22.0000000011237	0.567071388442914	0.728059210190902	nan
sp|P29373|RABP2_HUMAN	metaplastic breast carcinomas-Normal	0.517639730474309	0.55057032980914	23.9999999999489	0.356488355626044	0.565616846826239	nan
sp|P29373|RABP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.42528200135101	0.55057032980914	24.0000000002016	0.016109036937519	0.656412655960811	nan
sp|P29373|RABP2_HUMAN	Normal-Triple-negative breast cancer	0.907642270876702	0.658057409638556	24.0000000000606	0.180528265708276	0.356629951661897	nan
sp|P29401|TKT_HUMAN	metaplastic breast carcinomas-Normal	-0.226885649002324	0.24985078823929	22.0000000004632	0.373674032771523	0.581984288538432	nan
sp|P29401|TKT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0556664432533552	0.24985078823929	22.0000000013932	0.825747707231556	0.965774701272009	nan
sp|P29401|TKT_HUMAN	Normal-Triple-negative breast cancer	0.171219205748969	0.298628810168349	22.0000000013282	0.5722217351326	0.732690696294593	nan
sp|P29466|CASP1_HUMAN	metaplastic breast carcinomas-Normal	-0.186596454002781	0.236056885866011	23.9999999999455	0.436993634523824	0.632867548894702	nan
sp|P29466|CASP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.043247904284019	0.236056885866011	23.9999999999464	0.856172476449441	0.977691255315669	nan
sp|P29466|CASP1_HUMAN	Normal-Triple-negative breast cancer	0.2298443582868	0.28214194341744	24.0000000000061	0.423288209088654	0.609359032919309	nan
sp|P29508|SPB3_HUMAN	metaplastic breast carcinomas-Normal	0.524186003889714	0.824055937250921	15.0000000001303	0.534294376448157	0.710966576186419	nan
sp|P29508|SPB3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.384860770911648	0.82405593725092	15.0000000001303	0.647188585335406	0.943315325604231	nan
sp|P29508|SPB3_HUMAN	Normal-Triple-negative breast cancer	-0.139325232978067	0.984935231894168	15.0000000001823	0.889391844289579	0.934958409367033	nan
sp|P29536|LMOD1_HUMAN	metaplastic breast carcinomas-Normal	-1.57968072815973	0.501320977754656	22.000000003326	0.0046363306626646	0.0458663504478383	nan
sp|P29536|LMOD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.201806126817172	0.501320977754656	22.0000000032412	0.691164970484043	0.946568877415162	nan
sp|P29536|LMOD1_HUMAN	Normal-Triple-negative breast cancer	1.37787460134255	0.599193175071856	22.0000000031956	0.0313384929915022	0.118778963174177	nan
sp|P29590|PML_HUMAN	metaplastic breast carcinomas-Normal	0.214855422313531	0.338715708571747	24.0000000001869	0.531869906201684	0.708682730508622	nan
sp|P29590|PML_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.133939922309128	0.338715708571747	24.0000000001869	0.696015199133673	0.947043345959522	nan
sp|P29590|PML_HUMAN	Normal-Triple-negative breast cancer	-0.348795344622658	0.404842705315923	24.0000000002932	0.397457549241147	0.58613526782501	nan
sp|P29622|KAIN_HUMAN	metaplastic breast carcinomas-Normal	-0.969461460698525	0.397006521910184	21.9999955001599	0.0231082428515113	0.105510713239593	nan
sp|P29622|KAIN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.673902486684138	0.397006521910184	21.9999954977105	0.103713102999747	0.821630939204717	nan
sp|P29622|KAIN_HUMAN	Normal-Triple-negative breast cancer	1.64336394738266	0.474513553079394	21.9999954973055	0.0022104255439487	0.0322131479751828	nan
sp|P29692|EF1D_HUMAN	metaplastic breast carcinomas-Normal	1.10700349403235	0.213168549156161	22.000000216619	3.30493349770184e-05	0.007907787651877	nan
sp|P29692|EF1D_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.4149832188829	0.213168549156161	22.000000216846	0.0644461317555018	0.773787875546141	nan
sp|P29692|EF1D_HUMAN	Normal-Triple-negative breast cancer	-0.692020275149453	0.254785148561749	22.0000002167259	0.0126142487839199	0.0726685666512126	nan
sp|P29728|OAS2_HUMAN	metaplastic breast carcinomas-Normal	0.769140952438551	0.476675106551198	23.9999999998444	0.119697190638231	0.286459208491087	nan
sp|P29728|OAS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.362504923163891	0.476675106551198	23.9999999998444	0.454370864956069	0.908567154037048	nan
sp|P29728|OAS2_HUMAN	Normal-Triple-negative breast cancer	-0.40663602927466	0.569735724707512	23.9999999998559	0.482279486908875	0.660575181928463	nan
sp|P29762|RABP1_HUMAN	metaplastic breast carcinomas-Normal	0.131298478928045	0.74083262570461	21.9999977340716	0.860948569769618	0.927647664802013	nan
sp|P29762|RABP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.805339886270559	0.74083262570461	21.9999977313495	0.28877130267706	0.867696529950794	nan
sp|P29762|RABP1_HUMAN	Normal-Triple-negative breast cancer	0.674041407342514	0.885464348970468	21.9999977321092	0.454603020035028	0.637057520487534	nan
sp|P29966|MARCS_HUMAN	metaplastic breast carcinomas-Normal	0.259488822187083	0.315135199407717	24.0000000001569	0.418376337662204	0.619494915770806	nan
sp|P29966|MARCS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.153066690827731	0.315135199407717	24.0000000003507	0.631572449606185	0.941868024951375	nan
sp|P29966|MARCS_HUMAN	Normal-Triple-negative breast cancer	-0.412555513014813	0.376658606140403	24.0000000002782	0.284254060874976	0.476658900609244	nan
sp|P29972|AQP1_HUMAN	metaplastic breast carcinomas-Normal	-1.22095254207227	0.461001473282181	22.0000000319212	0.0146760969983271	0.079711350363463	nan
sp|P29972|AQP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.740471304548104	0.461001473282181	22.0000000322095	0.122484222884362	0.823891816737944	nan
sp|P29972|AQP1_HUMAN	Normal-Triple-negative breast cancer	1.96142384662038	0.551002149812167	22.000000032164	0.0017534857685996	0.0289979437553501	nan
sp|P30038|AL4A1_HUMAN	metaplastic breast carcinomas-Normal	-1.30381919358476	0.43246164819514	22.0000001249315	0.0063709628988963	0.0524492501891023	nan
sp|P30038|AL4A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.735034504598878	0.43246164819514	22.0000001256065	0.103293727744722	0.821630939204717	nan
sp|P30038|AL4A1_HUMAN	Normal-Triple-negative breast cancer	0.568784688985886	0.516890534362737	22.0000001257102	0.283054438811611	0.475909435816791	nan
sp|P30040|ERP29_HUMAN	metaplastic breast carcinomas-Normal	0.37965127831704	0.344311050509877	21.9998352774704	0.282099903893521	0.485732992213569	nan
sp|P30040|ERP29_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.128237094798004	0.344311050509877	21.9998352911165	0.71312508804016	0.94948208919602	nan
sp|P30040|ERP29_HUMAN	Normal-Triple-negative breast cancer	-0.507888373115044	0.411530418079384	21.9998352911301	0.230170382688228	0.413113581023579	nan
sp|P30041|PRDX6_HUMAN	metaplastic breast carcinomas-Normal	-0.471702092049824	0.247326137534358	21.9999998965179	0.069634953662656	0.204295309774641	nan
sp|P30041|PRDX6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.30919386764208	0.247326137534358	21.999999895287	0.22438105555646	0.843662073010871	nan
sp|P30041|PRDX6_HUMAN	Normal-Triple-negative breast cancer	0.162508224407745	0.295611275417238	21.9999998958632	0.588038260599838	0.743208813016678	nan
sp|P30043|BLVRB_HUMAN	metaplastic breast carcinomas-Normal	-0.781757004199597	0.30971962455543	22.0000000146004	0.0193219754151893	0.0944503621766016	nan
sp|P30043|BLVRB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0070970140119818	0.30971962455543	22.0000000147541	0.981925187559515	0.99777413090774	nan
sp|P30043|BLVRB_HUMAN	Normal-Triple-negative breast cancer	0.774659990187615	0.370185756140958	22.0000000144007	0.0481342016246051	0.151656953744253	nan
sp|P30044|PRDX5_HUMAN	metaplastic breast carcinomas-Normal	-0.157528763922393	0.117393188498819	22.0000002793359	0.193318299901307	0.386624153804669	nan
sp|P30044|PRDX5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.581264274055914	0.117393188498819	22.0000002794959	5.92632341376982e-05	0.0985251267539232	nan
sp|P30044|PRDX5_HUMAN	Normal-Triple-negative breast cancer	-0.423735510133521	0.140311697434773	22.0000002792726	0.0062962756890635	0.0506751099042307	nan
sp|P30048|PRDX3_HUMAN	metaplastic breast carcinomas-Normal	-0.0990273005982833	0.171421779127119	21.9999999103892	0.569344667139231	0.734528007858528	nan
sp|P30048|PRDX3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.154948159827504	0.171421779127119	21.9999999097651	0.375840247898009	0.885234295852111	nan
sp|P30048|PRDX3_HUMAN	Normal-Triple-negative breast cancer	0.253975460425788	0.204888214675734	21.999999909317	0.228191181913571	0.410804747922291	nan
sp|P30050|RL12_HUMAN	metaplastic breast carcinomas-Normal	0.940290127159596	0.190521327612338	23.9999999999852	4.89723953057569e-05	0.0097236156253848	nan
sp|P30050|RL12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.109595456311088	0.190521327612338	23.9999999996752	0.570483397144741	0.935631258424823	nan
sp|P30050|RL12_HUMAN	Normal-Triple-negative breast cancer	-0.830694670848508	0.227716541450637	23.999999999923	0.0012758286542706	0.0266490250684039	nan
sp|P30084|ECHM_HUMAN	metaplastic breast carcinomas-Normal	0.0049389181173689	0.337767131815178	24.0000000001592	0.988454419165642	0.994136910531496	nan
sp|P30084|ECHM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0146620994804148	0.337767131815178	24.0000000001592	0.965734727568677	0.99709406933403	nan
sp|P30084|ECHM_HUMAN	Normal-Triple-negative breast cancer	-0.0196010175977837	0.403708939238322	24.0000000001593	0.961677836893291	0.981692207683993	nan
sp|P30085|KCY_HUMAN	metaplastic breast carcinomas-Normal	0.173403755238521	0.207007285519961	23.9999999998745	0.410480893124594	0.612955295932682	nan
sp|P30085|KCY_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.181128109928118	0.207007285519961	23.9999999998757	0.390255146949925	0.885234295852111	nan
sp|P30085|KCY_HUMAN	Normal-Triple-negative breast cancer	-0.35453186516664	0.24742102999411	23.999999999905	0.164782331105407	0.334802242417098	nan
sp|P30086|PEBP1_HUMAN	metaplastic breast carcinomas-Normal	-0.847105421401466	0.252545237034345	21.9999999534331	0.0028673909985475	0.0379733940896436	nan
sp|P30086|PEBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.543593856397482	0.252545237034345	21.9999999552923	0.0425916591248222	0.751726370995712	nan
sp|P30086|PEBP1_HUMAN	Normal-Triple-negative breast cancer	0.303511565003985	0.301849292454585	21.9999999546885	0.325584825423002	0.517820076414382	nan
sp|P30101|PDIA3_HUMAN	metaplastic breast carcinomas-Normal	0.751956721201055	0.280488358672548	23.9999999997972	0.0130662628672733	0.0759305205783505	nan
sp|P30101|PDIA3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.070129447928563	0.280488358672548	23.9999999995926	0.804694842270884	0.965774701272009	nan
sp|P30101|PDIA3_HUMAN	Normal-Triple-negative breast cancer	-0.681827273272492	0.335247710870676	23.9999999996954	0.0531691245654014	0.162439494536208	nan
sp|P30153|2AAA_HUMAN	metaplastic breast carcinomas-Normal	0.362810925556714	0.139513510138328	23.999999999777	0.0156851457013098	0.082757816366911	nan
sp|P30153|2AAA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.101463847768792	0.139513510138328	23.999999999777	0.474096468820291	0.913280230088743	nan
sp|P30153|2AAA_HUMAN	Normal-Triple-negative breast cancer	-0.464274773325506	0.166750538705993	23.9999999997853	0.0102988208175951	0.0646219965895228	nan
sp|P30260|CDC27_HUMAN	metaplastic breast carcinomas-Normal	0.586508064156982	0.222104123029847	19.1992334944986	0.01602810690216	0.0842997268081962	nan
sp|P30260|CDC27_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.008738329843277	0.164005611625862	18.9761795486619	0.958065198135597	0.99709406933403	nan
sp|P30260|CDC27_HUMAN	Normal-Triple-negative breast cancer	-0.577769734313705	0.246693914512447	19.1576886899804	0.0301269606935403	0.116444206215498	nan
sp|P30273|FCERG_HUMAN	metaplastic breast carcinomas-Normal	0.850660905758686	0.452515787242482	22.0000000108538	0.0734375067120027	0.211185923021356	nan
sp|P30273|FCERG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.158519006025113	0.452515787242482	22.0000000113117	0.72944079397646	0.954643368861838	nan
sp|P30273|FCERG_HUMAN	Normal-Triple-negative breast cancer	-0.692141899733573	0.54085981508769	22.0000000111844	0.213979683369636	0.396326979149687	nan
sp|P30405|PPIF_HUMAN	metaplastic breast carcinomas-Normal	0.223785358796073	0.284288485352777	23.9999999998714	0.438883236219516	0.634888502033712	nan
sp|P30405|PPIF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.43222129003839	0.284288485352777	23.9999999996333	0.141486384167629	0.823891816737944	nan
sp|P30405|PPIF_HUMAN	Normal-Triple-negative breast cancer	-0.656006648834463	0.339789730997981	23.9999999998215	0.0654264044777841	0.185483878787247	nan
sp|P30419|NMT1_HUMAN	metaplastic breast carcinomas-Normal	0.315881315109442	0.25817393128744	23.999999999665	0.233010127263916	0.432937765805063	nan
sp|P30419|NMT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0089315458586142	0.25817393128744	24.0000000000011	0.972688756011332	0.99709406933403	nan
sp|P30419|NMT1_HUMAN	Normal-Triple-negative breast cancer	-0.306949769250828	0.308576868859081	23.9999999998424	0.329793003805368	0.52266154812188	nan
sp|P30511|HLAF_HUMAN	metaplastic breast carcinomas-Normal	-0.274937432380641	0.351457190165041	14.999999999872	0.446224995121758	0.642935363582456	nan
sp|P30511|HLAF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.36902188645862	0.351457190165041	14.9999999999688	0.310351849339738	0.867696529950794	nan
sp|P30511|HLAF_HUMAN	Normal-Triple-negative breast cancer	0.643959318839261	0.420071688641536	14.999999999933	0.146100011113717	0.310906809822021	nan
sp|P30519|HMOX2_HUMAN	metaplastic breast carcinomas-Normal	0.899770778032199	0.232698888207899	14.0000000161721	0.0017104024195891	0.0294579152472248	nan
sp|P30519|HMOX2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.289981318326123	0.232698888207899	14.0000000163251	0.233153794474249	0.847998869365766	nan
sp|P30519|HMOX2_HUMAN	Normal-Triple-negative breast cancer	-0.609789459706075	0.278128368546386	14.0000000162041	0.045740653201738	0.146617098594578	nan
sp|P30533|AMRP_HUMAN	metaplastic breast carcinomas-Normal	0.208925307469944	0.156860750258776	21.9999827033944	0.196522983630859	0.389298210720485	nan
sp|P30533|AMRP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.325683561837656	0.156860750258776	21.9999827039747	0.0497590552577417	0.765966938574033	nan
sp|P30533|AMRP_HUMAN	Normal-Triple-negative breast cancer	0.116758254367712	0.187484456390946	21.9999827038399	0.5398431006226	0.705629131486033	nan
sp|P30566|PUR8_HUMAN	metaplastic breast carcinomas-Normal	0.427723951279427	0.162865543353749	22.0000021879664	0.0154209682165508	0.0817474695422512	nan
sp|P30566|PUR8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.218601201569495	0.162865543353749	22.0000021887	0.19321339608429	0.843662073010871	nan
sp|P30566|PUR8_HUMAN	Normal-Triple-negative breast cancer	-0.209122749709932	0.194661556891192	22.0000021885245	0.294335229657562	0.487061439596019	nan
sp|P30622|CLIP1_HUMAN	metaplastic breast carcinomas-Normal	0.24124544776995	0.274655331626294	22.0000000076364	0.389242502118481	0.592689911608717	nan
sp|P30622|CLIP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.481172492373339	0.274655331626294	22.0000000074421	0.0937182536373267	0.81309570430905	nan
sp|P30622|CLIP1_HUMAN	Normal-Triple-negative breast cancer	0.239927044603389	0.328275910065972	22.0000000075519	0.472571307122651	0.651795446006512	nan
sp|P30626|SORCN_HUMAN	metaplastic breast carcinomas-Normal	0.295546660133189	0.28845471297725	22.0000000384258	0.316693324005984	0.523986365851613	nan
sp|P30626|SORCN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.319768941733593	0.28845471297725	22.0000000377534	0.279592940833516	0.867696529950794	nan
sp|P30626|SORCN_HUMAN	Normal-Triple-negative breast cancer	0.0242222816004041	0.34476932544775	22.0000000377409	0.944624245344238	0.971212802822223	nan
sp|P30711|GSTT1_HUMAN	metaplastic breast carcinomas-Normal	-1.87066019183306	0.554090984896687	21.9999673068647	0.0027222093724464	0.0374448413967682	nan
sp|P30711|GSTT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.123445485873896	0.554090984896687	21.9999673069702	0.825755052997755	0.965774701272009	nan
sp|P30711|GSTT1_HUMAN	Normal-Triple-negative breast cancer	1.74721470595917	0.662265397322791	21.9999672888468	0.0150147505580423	0.0781078712931399	nan
sp|P30740|ILEU_HUMAN	metaplastic breast carcinomas-Normal	0.0551055182086335	0.388126028266205	23.9999999998325	0.888282186569758	0.940458943542306	nan
sp|P30740|ILEU_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.360585524247203	0.388126028266205	23.9999999997893	0.362117703618663	0.883542279876718	nan
sp|P30740|ILEU_HUMAN	Normal-Triple-negative breast cancer	0.305480006038569	0.463899333011098	23.9999999998513	0.516481747477505	0.689472019524187	nan
sp|P30837|AL1B1_HUMAN	metaplastic breast carcinomas-Normal	0.197177694904239	0.366786500731144	21.9999961972476	0.596262435196908	0.754176687440838	nan
sp|P30837|AL1B1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0830342427204599	0.366786500731144	21.9999961975112	0.822993659537533	0.965774701272009	nan
sp|P30837|AL1B1_HUMAN	Normal-Triple-negative breast cancer	-0.280211937624699	0.438393719191514	21.9999961990291	0.529306293528377	0.697841969189049	nan
sp|P30876|RPB2_HUMAN	metaplastic breast carcinomas-Normal	0.53317373685321	0.16399144144595	24.0000000001219	0.0033918202708378	0.04050243156379	nan
sp|P30876|RPB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.187721279178516	0.16399144144595	24.0000000001219	0.263620751916256	0.86431258289795	nan
sp|P30876|RPB2_HUMAN	Normal-Triple-negative breast cancer	-0.720895016031726	0.196007262502185	24.0000000001545	0.0011839035939054	0.0266490250684039	nan
sp|P31040|SDHA_HUMAN	metaplastic breast carcinomas-Normal	0.0302620746591732	0.146202267726985	21.999999919747	0.837923287920301	0.914223915690573	nan
sp|P31040|SDHA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.357406599642025	0.146202267726985	21.9999999176924	0.0229747756894965	0.712051972579798	nan
sp|P31040|SDHA_HUMAN	Normal-Triple-negative breast cancer	-0.387668674301198	0.174745133136859	21.9999999181968	0.0371510994239095	0.12835519121726	nan
sp|P31146|COR1A_HUMAN	metaplastic breast carcinomas-Normal	0.273418285192861	0.421763688189534	22.0000000118474	0.523517238283955	0.703099515174088	nan
sp|P31146|COR1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.199460520586814	0.421763688189534	22.0000000113775	0.640928533076251	0.941868024951375	nan
sp|P31146|COR1A_HUMAN	Normal-Triple-negative breast cancer	-0.0739577646060472	0.504104026502521	22.0000000112386	0.884696012093818	0.93275221069853	nan
sp|P31150|GDIA_HUMAN	metaplastic breast carcinomas-Normal	0.125323673458509	0.209417698449741	22.0000000429872	0.555659082825949	0.726597478880195	nan
sp|P31150|GDIA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.169021938771156	0.209417698449741	22.0000000429008	0.428246436745651	0.894058800058913	nan
sp|P31150|GDIA_HUMAN	Normal-Triple-negative breast cancer	-0.294345612229665	0.250302024488093	22.0000000430766	0.25217925203446	0.440948886776721	nan
sp|P31151|S10A7_HUMAN	metaplastic breast carcinomas-Normal	-0.0802470390949948	0.8575653126792	22.9999999998508	0.92625681704556	0.960348615052852	nan
sp|P31151|S10A7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0330171755245484	0.8575653126792	22.9999999998508	0.969620423205557	0.99709406933403	nan
sp|P31151|S10A7_HUMAN	Normal-Triple-negative breast cancer	0.113264214619543	1.01468496180578	22.9999999999056	0.912089184831425	0.949509693197512	nan
sp|P31153|METK2_HUMAN	metaplastic breast carcinomas-Normal	0.0008838505074404	0.292749549184691	14.999999999625	0.997630869245829	0.998231489877524	nan
sp|P31153|METK2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.244576619017556	0.292749549184691	14.9999999996257	0.416575671713686	0.8860071777014	nan
sp|P31153|METK2_HUMAN	Normal-Triple-negative breast cancer	0.243692768510115	0.349902636555289	14.9999999996127	0.496793037359183	0.673338948952405	nan
sp|P31323|KAP3_HUMAN	metaplastic breast carcinomas-Normal	-1.79184923156244	0.5346745322341	22.0000000001095	0.0028878156527168	0.0379733940896436	nan
sp|P31323|KAP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.467245081454257	0.500768580704537	22.0000000001067	0.360919214944307	0.883542279876718	nan
sp|P31323|KAP3_HUMAN	Normal-Triple-negative breast cancer	1.32460415010818	0.621437465870934	22.0000000001547	0.0444626083516772	0.143489038991238	nan
sp|P31327|CPSM_HUMAN	metaplastic breast carcinomas-Normal	0.454857802411788	0.595048991309588	15.0000000000853	0.456484075087658	0.649830006677249	nan
sp|P31327|CPSM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.293987814567543	0.595048991309588	15.0000000000853	0.628422685031214	0.941868024951375	nan
sp|P31327|CPSM_HUMAN	Normal-Triple-negative breast cancer	-0.160869987844246	0.711219578368792	15.0000000001395	0.824107730745674	0.899956642546629	nan
sp|P31483|TIA1_HUMAN	metaplastic breast carcinomas-Normal	0.613566902469317	0.233410912740929	21.9999944693026	0.0153369011940607	0.0817474695422512	nan
sp|P31483|TIA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0561298016617011	0.233410912740929	21.9999944676408	0.812187758516564	0.965774701272009	nan
sp|P31483|TIA1_HUMAN	Normal-Triple-negative breast cancer	-0.669696704131018	0.278979400638811	21.9999944686217	0.025267588462438	0.105514402071789	nan
sp|P31513|FMO3_HUMAN	metaplastic breast carcinomas-Normal	0.415452310370204	1.61398509841769	6.0	0.805464465607716	0.897982429964831	nan
sp|P31513|FMO3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.22116582444095	1.61398509841769	6.0	0.477927097850951	0.913280230088743	nan
sp|P31513|FMO3_HUMAN	Normal-Triple-negative breast cancer	0.805713514070742	1.92908116466821	6.0	0.690724845381571	0.817652915259381	nan
sp|P31689|DNJA1_HUMAN	metaplastic breast carcinomas-Normal	0.706093779128795	0.351895360900652	23.9999999994807	0.056191789813338	0.180456132482707	nan
sp|P31689|DNJA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.286779320769026	0.351895360900652	23.9999999994807	0.423111153647077	0.888720521716064	nan
sp|P31689|DNJA1_HUMAN	Normal-Triple-negative breast cancer	-0.992873099897821	0.420595402840511	23.9999999994753	0.026707859166055	0.109196708324682	nan
sp|P31930|QCR1_HUMAN	metaplastic breast carcinomas-Normal	0.298683400349221	0.189971904102288	23.9999999999298	0.128984151420273	0.299610984850445	nan
sp|P31930|QCR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.175632788452387	0.189971904102288	24.0000000001528	0.364418685974309	0.883542279876718	nan
sp|P31930|QCR1_HUMAN	Normal-Triple-negative breast cancer	-0.123050611896834	0.227059854752785	24.0000000000632	0.592862916829872	0.746341646364071	nan
sp|P31937|3HIDH_HUMAN	metaplastic breast carcinomas-Normal	-0.453791713232416	0.346880127133651	22.0000000251226	0.204306561411291	0.39844385557551	nan
sp|P31937|3HIDH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.704246804715089	0.346880127133651	22.0000000244408	0.0545953422118325	0.773286317778246	nan
sp|P31937|3HIDH_HUMAN	Normal-Triple-negative breast cancer	-0.250455091482673	0.414601051959692	22.0000000247762	0.551964963137946	0.716412158325081	nan
sp|P31939|PUR9_HUMAN	metaplastic breast carcinomas-Normal	0.147058284541925	0.256300993823107	21.9999999322159	0.571942037976622	0.735164475728651	nan
sp|P31939|PUR9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.40848661790254	0.256300993823107	21.9999999320937	0.125252993247655	0.823891816737944	nan
sp|P31939|PUR9_HUMAN	Normal-Triple-negative breast cancer	-0.555544902444465	0.306338280418215	21.9999999320348	0.0834205163941673	0.21726078673375	nan
sp|P31942|HNRH3_HUMAN	metaplastic breast carcinomas-Normal	0.731418974269804	0.464371265514806	23.9999999995384	0.128330900782459	0.299374855792279	nan
sp|P31942|HNRH3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.268371018121998	0.464371265514806	23.9999999995384	0.568699180433516	0.935631258424823	nan
sp|P31942|HNRH3_HUMAN	Normal-Triple-negative breast cancer	-0.999789992391802	0.555029821896114	23.9999999995234	0.0842299494247632	0.217870762433392	nan
sp|P31943|HNRH1_HUMAN	metaplastic breast carcinomas-Normal	0.857846809564806	0.220629622985494	23.9999999993726	0.0006986340812719	0.0221825773337916	nan
sp|P31943|HNRH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.122149957986713	0.220629622985494	23.9999999993726	0.584945109332967	0.938678807206619	nan
sp|P31943|HNRH1_HUMAN	Normal-Triple-negative breast cancer	-0.979996767551519	0.263702837458924	23.9999999993777	0.0010755784474833	0.026613045414958	nan
sp|P31944|CASPE_HUMAN	metaplastic breast carcinomas-Normal	0.59377992907563	1.47211177129747	19.9999999997339	0.690968626427835	0.818816297413948	nan
sp|P31944|CASPE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.08827769187891	1.47211177129747	19.9999999997339	0.468335879940771	0.911843360423993	nan
sp|P31944|CASPE_HUMAN	Normal-Triple-negative breast cancer	0.494497762803282	1.76925815820904	19.9999999996942	0.782735407857002	0.876326202666444	nan
sp|P31946|1433B_HUMAN	metaplastic breast carcinomas-Normal	0.129907527220438	0.173625419310392	24.0000000003765	0.461605680925837	0.654925807993489	nan
sp|P31946|1433B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.164090159647788	0.173625419310392	24.0000000003765	0.354035590686724	0.878594237407845	nan
sp|P31946|1433B_HUMAN	Normal-Triple-negative breast cancer	-0.293997686868226	0.207522068467461	24.0000000003898	0.169419251970058	0.3406862602091	nan
sp|P31947|1433S_HUMAN	metaplastic breast carcinomas-Normal	0.317707040992928	0.768496996667114	22.0000000034338	0.68330572420504	0.815009772846929	nan
sp|P31947|1433S_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.343445798332059	0.768496996667114	22.0000000030575	0.659311634473014	0.944434752137403	nan
sp|P31947|1433S_HUMAN	Normal-Triple-negative breast cancer	0.0257387573391317	0.918529596604092	22.0000000032297	0.977897489900807	0.989206103600207	nan
sp|P31948|STIP1_HUMAN	metaplastic breast carcinomas-Normal	0.57144426402449	0.180915183121312	23.9999999995472	0.0042445025706606	0.042883667309653	nan
sp|P31948|STIP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.196787182528058	0.180915183121312	23.9999999995487	0.287516962318982	0.867696529950794	nan
sp|P31948|STIP1_HUMAN	Normal-Triple-negative breast cancer	-0.768231446552548	0.216235002729563	23.9999999995256	0.0016166171129085	0.0283781197026415	nan
sp|P31949|S10AB_HUMAN	metaplastic breast carcinomas-Normal	0.535429169789788	0.485068049831471	23.9999999997346	0.28061486762764	0.484049724958109	nan
sp|P31949|S10AB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0982804393682533	0.485068049831471	23.9999999997346	0.84114640103747	0.972169455774446	nan
sp|P31949|S10AB_HUMAN	Normal-Triple-negative breast cancer	-0.633709609158042	0.579767210632615	23.9999999997424	0.285226047307539	0.477479290351984	nan
sp|P31997|CEAM8_HUMAN	metaplastic breast carcinomas-Normal	-0.592692027597137	0.5576565463343	13.0122959761234	0.307188058497409	0.514404587629917	nan
sp|P31997|CEAM8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.2428931488284	0.5576565463343	13.0122959759988	0.670293563585925	0.946277260710207	nan
sp|P31997|CEAM8_HUMAN	Normal-Triple-negative breast cancer	0.349798878768738	0.655684852358045	13.0000022881769	0.602699325620041	0.754501023538688	nan
sp|P32119|PRDX2_HUMAN	metaplastic breast carcinomas-Normal	-0.569474427396806	0.355917549787373	21.9999999974857	0.123858214073792	0.294495496123951	nan
sp|P32119|PRDX2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.144718020061196	0.355917549787373	21.9999999965404	0.688226234083231	0.946568877415162	nan
sp|P32119|PRDX2_HUMAN	Normal-Triple-negative breast cancer	0.42475640733561	0.425402838070066	21.9999999971812	0.328902791675497	0.521599656264004	nan
sp|P32322|P5CR1_HUMAN	metaplastic breast carcinomas-Normal	1.09955575693359	0.400984306196556	23.9999999992922	0.0113517539881599	0.0705294023488664	nan
sp|P32322|P5CR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.440053390041728	0.400984306196556	23.9999999992935	0.283341272375554	0.867696529950794	nan
sp|P32322|P5CR1_HUMAN	Normal-Triple-negative breast cancer	-1.53960914697531	0.479267914660226	23.9999999992709	0.0037268793450409	0.0400819560687694	nan
sp|P32455|GBP1_HUMAN	metaplastic breast carcinomas-Normal	0.255508320124795	0.527993077547974	21.999927747189	0.633222284661927	0.780144875543456	nan
sp|P32455|GBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0268258572166281	0.527993077547974	21.9999277478735	0.959937628022247	0.99709406933403	nan
sp|P32455|GBP1_HUMAN	Normal-Triple-negative breast cancer	-0.282334177341423	0.631072431815852	21.9999277476468	0.658968935986821	0.799129056264208	nan
sp|P32456|GBP2_HUMAN	metaplastic breast carcinomas-Normal	-0.717184120765341	0.652136502906622	14.9999999997543	0.288780378224246	0.492622292442416	nan
sp|P32456|GBP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.2102111381896	0.652136502906622	14.9999999997549	0.751642402362454	0.954643368861838	nan
sp|P32456|GBP2_HUMAN	Normal-Triple-negative breast cancer	0.506972982575741	0.779452205465277	14.9999999997547	0.525257454986479	0.695444310582923	nan
sp|P32754|HPPD_HUMAN	metaplastic breast carcinomas-Normal	-0.697620850428457	0.756816291610473	6.0	0.392198437166476	0.596644212879344	nan
sp|P32754|HPPD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.75295114619848	0.756816291610473	6.0	0.0597577091277553	0.773787875546141	nan
sp|P32754|HPPD_HUMAN	Normal-Triple-negative breast cancer	-1.05533029577003	0.904568483743199	6.0	0.287612569643962	0.479931818020346	nan
sp|P32926|DSG3_HUMAN	metaplastic breast carcinomas-Normal	0.182302845398577	0.907986117206999	11.0000000000695	0.844536972948803	0.916799770764802	nan
sp|P32926|DSG3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.50562124414968	0.703323022106048	11.0000000001291	0.0555352735184814	0.773787875546141	nan
sp|P32926|DSG3_HUMAN	Normal-Triple-negative breast cancer	1.32331839875111	0.994648956591606	11.0000000000932	0.210297216088532	0.392933078290208	nan
sp|P32969|RL9_HUMAN	metaplastic breast carcinomas-Normal	0.690937873513134	0.238553341597683	22.0000000184551	0.0083749415744202	0.0602818106368712	nan
sp|P32969|RL9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.15485472422938	0.238553341597683	22.0000000184551	0.522967056948553	0.917607105199968	nan
sp|P32969|RL9_HUMAN	Normal-Triple-negative breast cancer	-0.845792597742514	0.285125778729871	22.0000000188349	0.0071280459457493	0.0535093121381869	nan
sp|P33121|ACSL1_HUMAN	metaplastic breast carcinomas-Normal	-1.27650878952986	0.503631805969374	22.0000000204979	0.0188809476440027	0.0929781777313555	nan
sp|P33121|ACSL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.19558189519511	0.503631805969374	22.0000000207627	0.701494769691414	0.948544168045527	nan
sp|P33121|ACSL1_HUMAN	Normal-Triple-negative breast cancer	1.08092689433475	0.601955143065344	22.0000000204387	0.0862925402111179	0.221683695534398	nan
sp|P33176|KINH_HUMAN	metaplastic breast carcinomas-Normal	0.373216334729861	0.1423809807143	24.00000000026	0.0149667127760878	0.0805005716306081	nan
sp|P33176|KINH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0469681868682486	0.1423809807143	24.0000000000227	0.744355057131624	0.954643368861838	nan
sp|P33176|KINH_HUMAN	Normal-Triple-negative breast cancer	-0.420184521598109	0.17017782157482	24.0000000002128	0.0210504893017949	0.0953699510109521	nan
sp|P33240|CSTF2_HUMAN	metaplastic breast carcinomas-Normal	-0.0913989966010893	0.2613491816557	14.0000000101632	0.731753965686384	0.851067243506488	nan
sp|P33240|CSTF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0846646221140654	0.2613491816557	14.0000000108604	0.750763253417072	0.954643368861838	nan
sp|P33240|CSTF2_HUMAN	Normal-Triple-negative breast cancer	0.176063618715155	0.312372018941024	14.0000000107336	0.581919347589228	0.739128739543979	nan
sp|P33241|LSP1_HUMAN	metaplastic breast carcinomas-Normal	0.219594858525483	0.34924773857042	23.9999999990748	0.53544177722291	0.71163873150298	nan
sp|P33241|LSP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.18158315197736	0.34924773857042	23.9999999990748	0.607877710426253	0.940559810632461	nan
sp|P33241|LSP1_HUMAN	Normal-Triple-negative breast cancer	-0.0380117065481234	0.417430888884705	23.9999999991249	0.928199831314904	0.960266492153982	nan
sp|P33316|DUT_HUMAN	metaplastic breast carcinomas-Normal	0.147347870761444	0.225155180297163	23.9999999998439	0.519058846724334	0.700792691515714	nan
sp|P33316|DUT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.356379702024958	0.225155180297163	24.0000000000338	0.126553052481882	0.823891816737944	nan
sp|P33316|DUT_HUMAN	Normal-Triple-negative breast cancer	0.209031831263514	0.269111913031013	23.9999999999628	0.444896771422669	0.629578712212468	nan
sp|P33947|ERD22_HUMAN	metaplastic breast carcinomas-Normal	1.00858252509401	0.379437518515979	21.3679402218045	0.0145799656609107	0.0795450818130059	nan
sp|P33947|ERD22_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.118460991711312	0.354250914433	21.0473366859055	0.741388135777399	0.954643368861838	nan
sp|P33947|ERD22_HUMAN	Normal-Triple-negative breast cancer	-0.890121533382699	0.444697480530753	21.2828891784217	0.0582343887005143	0.172831346464741	nan
sp|P33991|MCM4_HUMAN	metaplastic breast carcinomas-Normal	0.811846638381624	0.317954383514504	23.9999646356731	0.0174448581469759	0.0890732849163562	nan
sp|P33991|MCM4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0428810954253578	0.317954383514504	23.9999646012913	0.893842872877047	0.988218752026376	nan
sp|P33991|MCM4_HUMAN	Normal-Triple-negative breast cancer	-0.854727733806982	0.380028175639815	23.9999645232634	0.0339523301240697	0.123621534315429	nan
sp|P33992|MCM5_HUMAN	metaplastic breast carcinomas-Normal	1.19347149237827	0.43318952645425	22.0000000195274	0.0115531854209661	0.070984821329559	nan
sp|P33992|MCM5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.162361507475144	0.43318952645425	22.0000000201738	0.711394448718847	0.94948208919602	nan
sp|P33992|MCM5_HUMAN	Normal-Triple-negative breast cancer	-1.35583299985341	0.517760515282138	22.0000000198893	0.0156832531465126	0.079711213240073	nan
sp|P33993|MCM7_HUMAN	metaplastic breast carcinomas-Normal	0.809688720124042	0.33322691924867	21.999940899179	0.0237202310656524	0.107127782693245	nan
sp|P33993|MCM7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.141701472270696	0.33322691924867	21.9999408997852	0.674792244143933	0.946386428913156	nan
sp|P33993|MCM7_HUMAN	Normal-Triple-negative breast cancer	-0.951390192394738	0.398282347286372	21.9999408992941	0.0259158468561051	0.107278050995882	nan
sp|P34897|GLYM_HUMAN	metaplastic breast carcinomas-Normal	0.977275888057273	0.226779885861482	21.9999985569483	0.0002833935501925	0.0159975668038937	nan
sp|P34897|GLYM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.391137233457054	0.226779885861482	21.9999985569317	0.09859713747426	0.820234747280893	nan
sp|P34897|GLYM_HUMAN	Normal-Triple-negative breast cancer	-1.36841312151433	0.271053807603231	21.9999985587946	4.68508607496389e-05	0.022319699811492	nan
sp|P34932|HSP74_HUMAN	metaplastic breast carcinomas-Normal	0.382131071758883	0.220787094822018	23.9999999996224	0.0963326493043523	0.250751547601932	nan
sp|P34932|HSP74_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.271858005983931	0.220787094822018	23.9999999996224	0.230135789540108	0.843662073010871	nan
sp|P34932|HSP74_HUMAN	Normal-Triple-negative breast cancer	-0.653989077742814	0.263891052303101	23.999999999652	0.0206272460634937	0.0941826454877103	nan
sp|P34949|MPI_HUMAN	metaplastic breast carcinomas-Normal	-0.183218711296329	0.321235136884435	23.9999999996821	0.573737091825361	0.736604149359617	nan
sp|P34949|MPI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.551245883425075	0.321235136884435	23.9999999997127	0.0990412835874975	0.820234747280893	nan
sp|P34949|MPI_HUMAN	Normal-Triple-negative breast cancer	-0.368027172128746	0.383949425927727	23.9999999996801	0.347352776959049	0.538591737262258	nan
sp|P35080|PROF2_HUMAN	metaplastic breast carcinomas-Normal	0.571811815603927	0.327753510227669	23.9999999998832	0.0938424648528968	0.248130450375174	nan
sp|P35080|PROF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.284366032937041	0.327753510227669	23.9999999998832	0.394194169677402	0.885234295852111	nan
sp|P35080|PROF2_HUMAN	Normal-Triple-negative breast cancer	-0.856177848540968	0.391740372233882	23.9999999999353	0.0388388551339802	0.131848322456358	nan
sp|P35221|CTNA1_HUMAN	metaplastic breast carcinomas-Normal	0.0078831212943858	0.178119117853668	22.0000000017439	0.965098341291231	0.983042382674199	nan
sp|P35221|CTNA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.365113745755985	0.178119117853668	22.0000000007358	0.0524870299457226	0.773286317778246	nan
sp|P35221|CTNA1_HUMAN	Normal-Triple-negative breast cancer	-0.37299686705037	0.212893065528108	22.0000000006988	0.0936963477276305	0.233468260754606	nan
sp|P35222|CTNB1_HUMAN	metaplastic breast carcinomas-Normal	-0.0063180031746227	0.208655722239408	22.0000033987766	0.976117116613583	0.987405141699193	nan
sp|P35222|CTNB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.089321326613603	0.208655722239408	22.0000033995187	0.672754572770374	0.946386428913156	nan
sp|P35222|CTNB1_HUMAN	Normal-Triple-negative breast cancer	-0.0830033234389802	0.249391288721871	22.0000033992892	0.742418148210445	0.851587700865509	nan
sp|P35232|PHB1_HUMAN	metaplastic breast carcinomas-Normal	0.571974940992114	0.231035081760601	22.0000000158489	0.0214748312295332	0.100085016891408	nan
sp|P35232|PHB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.163371206997136	0.231035081760601	22.0000000158282	0.486910783479999	0.913320451076758	nan
sp|P35232|PHB1_HUMAN	Normal-Triple-negative breast cancer	-0.73534614798925	0.276139739480182	22.000000015627	0.0142097498024158	0.0770525421586136	nan
sp|P35237|SPB6_HUMAN	metaplastic breast carcinomas-Normal	-0.453889849754395	0.215664417742356	23.9999999998229	0.0459812765274628	0.160886066502407	nan
sp|P35237|SPB6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0324655265054266	0.215664417742356	23.9999999998229	0.881598841470738	0.983709256883903	nan
sp|P35237|SPB6_HUMAN	Normal-Triple-negative breast cancer	0.421424323248968	0.257768282101108	23.9999999998659	0.115120869913179	0.265184872897718	nan
sp|P35241|RADI_HUMAN	metaplastic breast carcinomas-Normal	0.176647335786205	0.146478294551642	22.0000003255306	0.240642012405683	0.44107417536677	nan
sp|P35241|RADI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.20458369596027	0.146478294551642	22.0000003255341	0.176441050995102	0.843662073010871	nan
sp|P35241|RADI_HUMAN	Normal-Triple-negative breast cancer	0.0279363601740646	0.175075048294633	22.0000003254688	0.874677377988691	0.927684371150779	nan
sp|P35249|RFC4_HUMAN	metaplastic breast carcinomas-Normal	0.534899364757411	0.372273279124958	24.0000000000296	0.163671223268969	0.349866975013539	nan
sp|P35249|RFC4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.31977763526121	0.372273279124958	24.0000000002604	0.398846604135256	0.885297496092956	nan
sp|P35249|RFC4_HUMAN	Normal-Triple-negative breast cancer	-0.854677000018621	0.444951673700878	24.0000000001987	0.0667098670426144	0.186495877249496	nan
sp|P35268|RL22_HUMAN	metaplastic breast carcinomas-Normal	1.1352921831002	0.317400755915723	23.9999999997821	0.001522798742827	0.0281210167842065	nan
sp|P35268|RL22_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.121358523713388	0.317400755915723	23.9999999997821	0.705565970932291	0.94948208919602	nan
sp|P35268|RL22_HUMAN	Normal-Triple-negative breast cancer	-1.25665070681358	0.379366464094835	23.9999999997442	0.0029213824131741	0.0362338624678768	nan
sp|P35269|T2FA_HUMAN	metaplastic breast carcinomas-Normal	0.400971743159475	0.295278458268585	23.9999999991645	0.187111928398424	0.378782003651864	nan
sp|P35269|T2FA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.208638129017417	0.295278458268586	23.9999999992008	0.486630789542199	0.913320451076758	nan
sp|P35269|T2FA_HUMAN	Normal-Triple-negative breast cancer	-0.192333614142058	0.352925261042765	23.9999999991886	0.590803105675331	0.745569295089142	nan
sp|P35442|TSP2_HUMAN	metaplastic breast carcinomas-Normal	1.20403141502984	0.641553669037	23.9999999996729	0.0727637582199128	0.210562461081628	nan
sp|P35442|TSP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.961718766692066	0.641553669037	23.9999999996729	0.146901438822067	0.834393442963536	nan
sp|P35442|TSP2_HUMAN	Normal-Triple-negative breast cancer	-2.16575018172191	0.766803299656472	23.9999999996416	0.0093815772892677	0.0615076191509386	nan
sp|P35520|CBS_HUMAN	metaplastic breast carcinomas-Normal	0.328435742446467	0.604030320118933	6.0	0.606217802250995	0.763792351667953	nan
sp|P35520|CBS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.478674151983569	0.604030320118933	6.0	0.458267374786634	0.908567154037048	nan
sp|P35520|CBS_HUMAN	Normal-Triple-negative breast cancer	0.150238409537102	0.721954319511561	6.0	0.84203530244384	0.909627996530167	nan
sp|P35527|K1C9_HUMAN	metaplastic breast carcinomas-Normal	-0.590098502730365	0.39119140965043	22.0000051134743	0.145663484011452	0.322739185525647	nan
sp|P35527|K1C9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.375403006221227	0.39119140965043	22.0000051137008	0.347665131367328	0.871784737402991	nan
sp|P35527|K1C9_HUMAN	Normal-Triple-negative breast cancer	0.965501508951592	0.467563164540044	22.0000051132653	0.0509088538497565	0.158298437976231	nan
sp|P35555|FBN1_HUMAN	metaplastic breast carcinomas-Normal	-0.373672934007594	0.434941668401535	21.999999824605	0.399531648503689	0.602014143076274	nan
sp|P35555|FBN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.381811314122172	0.434941668401534	21.9999998250139	0.389514385029509	0.885234295852111	nan
sp|P35555|FBN1_HUMAN	Normal-Triple-negative breast cancer	0.755484248129766	0.519854725465147	21.9999998245475	0.160267975099842	0.329864241010448	nan
sp|P35556|FBN2_HUMAN	metaplastic breast carcinomas-Normal	2.14881126058668	0.785428913722473	21.9999999998755	0.0120656666279658	0.0721478521661814	nan
sp|P35556|FBN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.6393072333843	0.674208311521068	21.9999999997295	0.023637664667143	0.71450213652955	nan
sp|P35556|FBN2_HUMAN	Normal-Triple-negative breast cancer	-0.509504027202387	0.900948753223997	21.9999999997764	0.577443225490271	0.736821989070887	nan
sp|P35573|GDE_HUMAN	metaplastic breast carcinomas-Normal	0.0930807370196665	0.210859835198482	23.9999999996905	0.662850278194932	0.802822376058803	nan
sp|P35573|GDE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.27232883152759	0.210859835198482	23.9999999996905	0.208825301524914	0.843662073010871	nan
sp|P35573|GDE_HUMAN	Normal-Triple-negative breast cancer	0.179248094507924	0.252025707588761	23.9999999996849	0.483797912258767	0.661515532845801	nan
sp|P35579|MYH9_HUMAN	metaplastic breast carcinomas-Normal	0.709838713355131	0.2629648192615	24.0000000002895	0.0125248287634112	0.0734259802638074	nan
sp|P35579|MYH9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.216386744826983	0.2629648192615	24.0000000003352	0.418681458965535	0.8860071777014	nan
sp|P35579|MYH9_HUMAN	Normal-Triple-negative breast cancer	-0.493451968528149	0.314303075229793	24.0000000002797	0.129509660385844	0.286802205944401	nan
sp|P35580|MYH10_HUMAN	metaplastic breast carcinomas-Normal	0.128703695818304	0.321724355555999	21.9999989897089	0.692982378268213	0.820033259296383	nan
sp|P35580|MYH10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.377625602065906	0.321724355555999	21.9999989898967	0.25304388521965	0.855758210685228	nan
sp|P35580|MYH10_HUMAN	Normal-Triple-negative breast cancer	0.248921906247602	0.384534154080201	21.9999989910656	0.524113934295465	0.695444310582923	nan
sp|P35606|COPB2_HUMAN	metaplastic breast carcinomas-Normal	0.62033873215282	0.182111905304792	23.999999999707	0.0023210170719361	0.0344046144412164	nan
sp|P35606|COPB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0960749021998373	0.182111905304792	23.9999999997546	0.602648587892911	0.940559810632461	nan
sp|P35606|COPB2_HUMAN	Normal-Triple-negative breast cancer	-0.716413634352657	0.217665359320683	23.9999999997136	0.003076107997198	0.0369132959663764	nan
sp|P35611|ADDA_HUMAN	metaplastic breast carcinomas-Normal	-0.590140140468978	0.259002093701149	23.9999999992565	0.0318863145880863	0.128466389195289	nan
sp|P35611|ADDA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.296492463396887	0.259002093701149	23.9999999993035	0.263601409905099	0.86431258289795	nan
sp|P35611|ADDA_HUMAN	Normal-Triple-negative breast cancer	0.886632603865865	0.30956671226912	23.9999999992892	0.0085505424766863	0.0588076066258844	nan
sp|P35613|BASI_HUMAN	metaplastic breast carcinomas-Normal	0.454460582274239	0.275799268362333	22.0000001211031	0.113604634253626	0.277663091366951	nan
sp|P35613|BASI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.499110042555758	0.275799268362333	22.0000001205657	0.0840288138042834	0.806849600316436	nan
sp|P35613|BASI_HUMAN	Normal-Triple-negative breast cancer	0.0446494602815194	0.329643175980155	22.0000001208217	0.893489471717819	0.937783076725618	nan
sp|P35637|FUS_HUMAN	metaplastic breast carcinomas-Normal	0.930361601264393	0.289952916734503	24.0000000000084	0.0037609356364172	0.0411228620245091	nan
sp|P35637|FUS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.239724849075447	0.289952916734503	24.0000000000084	0.416511040474325	0.8860071777014	nan
sp|P35637|FUS_HUMAN	Normal-Triple-negative breast cancer	-1.17008645033984	0.346560021441031	24.0000000000215	0.0024989644439679	0.0337628805562287	nan
sp|P35658|NU214_HUMAN	metaplastic breast carcinomas-Normal	0.29782402009874	0.162343539031594	22.0000057665453	0.0801360414370004	0.224786668132143	nan
sp|P35658|NU214_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.157697858140833	0.162343539031594	22.0000057663812	0.341916905053955	0.870943310236299	nan
sp|P35658|NU214_HUMAN	Normal-Triple-negative breast cancer	-0.455521878239573	0.194037642391156	22.0000057663911	0.0282996311247123	0.112421067564965	nan
sp|P35659|DEK_HUMAN	metaplastic breast carcinomas-Normal	0.582034622931244	0.28435285536175	22.0000022991671	0.0528001416422945	0.174808437070704	nan
sp|P35659|DEK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.353116872585931	0.28435285536175	22.0000022991674	0.227377240798691	0.843662073010871	nan
sp|P35659|DEK_HUMAN	Normal-Triple-negative breast cancer	-0.935151495517175	0.339866667874289	22.0000022992215	0.0116463123162644	0.069129182391541	nan
sp|P35712|SOX6_HUMAN	metaplastic breast carcinomas-Normal	0.0871943778190356	0.591942711255413	6.0	0.887718756555434	0.940415790777734	nan
sp|P35712|SOX6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.851989737306906	0.591942711255413	6.0	0.200120490080238	0.843662073010871	nan
sp|P35712|SOX6_HUMAN	Normal-Triple-negative breast cancer	-0.939184115125941	0.707506863579438	6.0	0.23262988214182	0.416852683687014	nan
sp|P35749|MYH11_HUMAN	metaplastic breast carcinomas-Normal	-1.41760163601073	0.506655277062689	22.0000000043088	0.010483991773742	0.0678538291377207	nan
sp|P35749|MYH11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.262693616929897	0.506655277062689	22.0000000047068	0.609295290146792	0.940559810632461	nan
sp|P35749|MYH11_HUMAN	Normal-Triple-negative breast cancer	1.15490801908084	0.60556888221557	22.0000000046348	0.06964326593257	0.191896263628731	nan
sp|P35754|GLRX1_HUMAN	metaplastic breast carcinomas-Normal	-0.343486568424126	0.333313098337162	23.9999999993805	0.313038937275342	0.520705650113393	nan
sp|P35754|GLRX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.160134281142506	0.333313098337162	23.9999999993805	0.635270517005994	0.941868024951375	nan
sp|P35754|GLRX1_HUMAN	Normal-Triple-negative breast cancer	0.503620849566632	0.398385350998464	23.9999999994381	0.218314582402904	0.400705506298869	nan
sp|P35813|PPM1A_HUMAN	metaplastic breast carcinomas-Normal	-0.2559922203471	0.186565157711493	22.0002925177686	0.183851960935725	0.374692776303095	nan
sp|P35813|PPM1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.352590195523155	0.186565157711493	22.0002925077949	0.0720190824171437	0.785126062416402	nan
sp|P35813|PPM1A_HUMAN	Normal-Triple-negative breast cancer	-0.0965979751760553	0.222988014001759	22.0002925030403	0.669088506777431	0.805815288597167	nan
sp|P35908|K22E_HUMAN	metaplastic breast carcinomas-Normal	-0.807618482028512	0.263825748289254	22.000000015381	0.0057206185056307	0.05017239027102	nan
sp|P35908|K22E_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.457936963929145	0.263825748289254	22.0000000153124	0.0965942709689457	0.814943337126966	nan
sp|P35908|K22E_HUMAN	Normal-Triple-negative breast cancer	1.26555544595766	0.315332082234371	22.0000000151991	0.0005837528550448	0.0237592699893802	nan
sp|P35998|PRS7_HUMAN	metaplastic breast carcinomas-Normal	0.156473424024629	0.100775017665358	22.0000000037506	0.134762903795403	0.308294488792787	nan
sp|P35998|PRS7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0195751945752023	0.100775017665358	22.0000000037506	0.847765354658668	0.974695644619665	nan
sp|P35998|PRS7_HUMAN	Normal-Triple-negative breast cancer	-0.176048618599831	0.120449184219815	22.0000000036078	0.15798832296573	0.328015731129349	nan
sp|P36222|CH3L1_HUMAN	metaplastic breast carcinomas-Normal	0.101609443392834	0.605828284307757	6.0	0.872314020586655	0.933058251731125	nan
sp|P36222|CH3L1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.620520240040034	0.605828284307757	6.0	0.34522574395163	0.870943310236299	nan
sp|P36222|CH3L1_HUMAN	Normal-Triple-negative breast cancer	0.5189107966472	0.724103297748602	6.0	0.500535470255267	0.676135101017241	nan
sp|P36405|ARL3_HUMAN	metaplastic breast carcinomas-Normal	0.0815383072435474	0.236406317385612	22.0000061791979	0.733439569520538	0.85124061769772	nan
sp|P36405|ARL3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.343442733191109	0.236406317385612	22.0000061791971	0.160404293930598	0.843662073010871	nan
sp|P36405|ARL3_HUMAN	Normal-Triple-negative breast cancer	-0.424981040434657	0.28255959396667	22.0000061792302	0.146792438554562	0.312180464334846	nan
sp|P36507|MP2K2_HUMAN	metaplastic breast carcinomas-Normal	-0.128504955076248	0.312315167899308	15.0000000001101	0.686554716455955	0.816878528157591	nan
sp|P36507|MP2K2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.342800674397798	0.312315167899308	15.0000000001094	0.289681949783418	0.867696529950794	nan
sp|P36507|MP2K2_HUMAN	Normal-Triple-negative breast cancer	-0.21429571932155	0.373288023802327	15.0000000000975	0.574424665295626	0.734662403787095	nan
sp|P36542|ATPG_HUMAN	metaplastic breast carcinomas-Normal	-0.0552265053021152	0.227859350329222	22.0000000006687	0.810737882862056	0.900925915386606	nan
sp|P36542|ATPG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.480504627737026	0.227859350329222	22.0000000007126	0.0465774479734223	0.759166737802103	nan
sp|P36542|ATPG_HUMAN	Normal-Triple-negative breast cancer	-0.425278122434911	0.272344014417834	21.999999999802	0.132665693476575	0.291621375393624	nan
sp|P36543|VATE1_HUMAN	metaplastic breast carcinomas-Normal	0.796126630087735	0.28083764029213	21.9999773108804	0.0096405693889308	0.0650005124722237	nan
sp|P36543|VATE1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.148286775218858	0.28083764029213	21.9999773103044	0.602774024470334	0.940559810632461	nan
sp|P36543|VATE1_HUMAN	Normal-Triple-negative breast cancer	-0.647839854868877	0.335665182255115	21.9999773085607	0.0665976761846076	0.186338952556932	nan
sp|P36578|RL4_HUMAN	metaplastic breast carcinomas-Normal	0.998137609253185	0.317282353966124	22.0000000124337	0.0046925895695221	0.0458663504478383	nan
sp|P36578|RL4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.27577141489584	0.317282353966124	22.0000000124337	0.394139563919271	0.885234295852111	nan
sp|P36578|RL4_HUMAN	Normal-Triple-negative breast cancer	-1.27390902414902	0.379224946697273	22.0000000120008	0.0028336548560152	0.0360167542953178	nan
sp|P36776|LONM_HUMAN	metaplastic breast carcinomas-Normal	0.120177565912364	0.213920007613381	22.0000001356561	0.579939787659802	0.740806329817694	nan
sp|P36776|LONM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.931965799816308	0.213920007613381	22.0000001356244	0.0002524898635407	0.209882199068289	nan
sp|P36776|LONM_HUMAN	Normal-Triple-negative breast cancer	-1.05214336572867	0.255683313208544	22.0000001356583	0.0004555732992959	0.0237592699893802	nan
sp|P36871|PGM1_HUMAN	metaplastic breast carcinomas-Normal	-0.350964060248698	0.177893336101634	22.0000000056531	0.0612035967415879	0.189856616039123	nan
sp|P36871|PGM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.111611761281397	0.177893336101634	22.0000000056466	0.536849710669322	0.921388505638487	nan
sp|P36871|PGM1_HUMAN	Normal-Triple-negative breast cancer	0.462575821530095	0.212623204718612	22.0000000061191	0.0406105616314469	0.13580433286009	nan
sp|P36915|GNL1_HUMAN	metaplastic breast carcinomas-Normal	0.399967283799183	0.20964213354558	22.0000000357251	0.0695466778391816	0.204216569909399	nan
sp|P36915|GNL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0162959541693838	0.20964213354558	22.000000036034	0.938743693129446	0.995571782532303	nan
sp|P36915|GNL1_HUMAN	Normal-Triple-negative breast cancer	-0.416263237968567	0.250570275735578	22.000000036182	0.110846511454708	0.258020871201295	nan
sp|P36952|SPB5_HUMAN	metaplastic breast carcinomas-Normal	-0.0952771075615885	0.757730452753058	23.9999999997504	0.900985057102095	0.946846136518294	nan
sp|P36952|SPB5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.287418025927576	0.757730452753058	23.9999999997944	0.707789888910776	0.94948208919602	nan
sp|P36952|SPB5_HUMAN	Normal-Triple-negative breast cancer	0.382695133489165	0.905661115294358	23.9999999997119	0.676378999846387	0.8096088568561	nan
sp|P36955|PEDF_HUMAN	metaplastic breast carcinomas-Normal	-0.560471610607907	0.47021095825152	23.9999999997523	0.244931184399986	0.444727514478219	nan
sp|P36955|PEDF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.37054109001057	0.47021095825152	23.9999999997514	0.438392732417261	0.897513075778899	nan
sp|P36955|PEDF_HUMAN	Normal-Triple-negative breast cancer	0.931012700618477	0.562009589724757	23.9999999997349	0.110622423060888	0.25767970164989	nan
sp|P36957|ODO2_HUMAN	metaplastic breast carcinomas-Normal	-0.113034501969861	0.206995298874675	24.0000000000654	0.590056509104425	0.748883077821839	nan
sp|P36957|ODO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.271156299113817	0.206995298874675	23.9999999998408	0.202608800993128	0.843662073010871	nan
sp|P36957|ODO2_HUMAN	Normal-Triple-negative breast cancer	-0.158121797143956	0.247406703212735	23.9999999999306	0.528800192829342	0.697773467790188	nan
sp|P36969|GPX4_HUMAN	metaplastic breast carcinomas-Normal	-0.623579707079753	0.207941175096965	22.0000000201001	0.0066125629272093	0.0534585445819025	nan
sp|P36969|GPX4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.16545799441458	0.207941175096965	22.0000000201033	0.434710574525083	0.896102083258464	nan
sp|P36969|GPX4_HUMAN	Normal-Triple-negative breast cancer	0.458121712665173	0.248537241534505	22.0000000201126	0.0788039399778728	0.208222811197495	nan
sp|P37108|SRP14_HUMAN	metaplastic breast carcinomas-Normal	0.60016478470623	0.277992536796854	23.9999999997665	0.0410711425028124	0.149857824016848	nan
sp|P37108|SRP14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.299477347439469	0.277992536796854	23.9999999995187	0.292062454702921	0.867696529950794	nan
sp|P37108|SRP14_HUMAN	Normal-Triple-negative breast cancer	-0.899642132145698	0.332264633161045	23.9999999996648	0.0122903333619584	0.0716720492897364	nan
sp|P37198|NUP62_HUMAN	metaplastic breast carcinomas-Normal	0.869773309556029	0.161148115438241	23.9999999995877	1.5249185254866e-05	0.0066066425513017	nan
sp|P37198|NUP62_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0069241899686072	0.161148115438241	23.9999999995877	0.966082641002061	0.99709406933403	nan
sp|P37198|NUP62_HUMAN	Normal-Triple-negative breast cancer	-0.876697499524636	0.192608837912108	23.9999999996448	0.0001298535153738	0.0227914720285933	nan
sp|P37235|HPCL1_HUMAN	metaplastic breast carcinomas-Normal	0.59451817832846	0.271614655524997	22.0000000233667	0.0395113690046724	0.146580123405727	nan
sp|P37235|HPCL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.271193839898032	0.271614655524997	22.0000000231649	0.328916883757355	0.868661960140967	nan
sp|P37235|HPCL1_HUMAN	Normal-Triple-negative breast cancer	-0.865712018226491	0.324641606997983	22.0000000232588	0.014092124453297	0.0769166201687341	nan
sp|P37268|FDFT_HUMAN	metaplastic breast carcinomas-Normal	-0.0598033030197715	0.504973261640894	13.999996711362	0.907410474692684	0.949994462323931	nan
sp|P37268|FDFT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.410709747086605	0.504973261640894	13.9999967074678	0.429644882670663	0.894615500363341	nan
sp|P37268|FDFT_HUMAN	Normal-Triple-negative breast cancer	-0.350906444066833	0.603558489262098	13.9999967080032	0.570216609788201	0.731250004219129	nan
sp|P37802|TAGL2_HUMAN	metaplastic breast carcinomas-Normal	0.45879024364328	0.254909826710393	23.9999999993068	0.08447503894613	0.23206200781565	nan
sp|P37802|TAGL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.178733623082785	0.254909826710393	23.9999999993554	0.489943910668362	0.913320451076758	nan
sp|P37802|TAGL2_HUMAN	Normal-Triple-negative breast cancer	-0.637523866726066	0.304675517684734	23.9999999993683	0.047148583642562	0.149218747644339	nan
sp|P37837|TALDO_HUMAN	metaplastic breast carcinomas-Normal	0.0885806683762486	0.180929319684358	23.9999999996893	0.628871235494379	0.778360007018459	nan
sp|P37837|TALDO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.074295476726193	0.180929319684358	23.9999999996893	0.684985062423613	0.946568877415162	nan
sp|P37837|TALDO_HUMAN	Normal-Triple-negative breast cancer	-0.0142851916500556	0.216251899154153	23.9999999996795	0.947878763303526	0.973054048554948	nan
sp|P38117|ETFB_HUMAN	metaplastic breast carcinomas-Normal	-0.10072824836886	0.302595081841083	23.9999999999476	0.742114249507647	0.85741667200675	nan
sp|P38117|ETFB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.285950072409522	0.302595081841083	23.9999999997374	0.354080083647071	0.878594237407845	nan
sp|P38117|ETFB_HUMAN	Normal-Triple-negative breast cancer	0.386678320778382	0.361670298860344	23.99999999986	0.295639732575428	0.487645781732731	nan
sp|P38159|RBMX_HUMAN	metaplastic breast carcinomas-Normal	1.04531166960415	0.444079563033705	23.9999999999997	0.0271026643724455	0.116847284531788	nan
sp|P38159|RBMX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.165135608017485	0.444079563033705	24.0000000000007	0.713259883597664	0.94948208919602	nan
sp|P38159|RBMX_HUMAN	Normal-Triple-negative breast cancer	-1.21044727762163	0.5307765985586	24.0000000000457	0.0317495850873921	0.119654898900784	nan
sp|P38606|VATA_HUMAN	metaplastic breast carcinomas-Normal	0.206810277861672	0.174856796646119	23.9999999999197	0.24849675821707	0.448353506408996	nan
sp|P38606|VATA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.05535798364695	0.174856796646119	24.000000000077	0.754291736336419	0.954748610837524	nan
sp|P38606|VATA_HUMAN	Normal-Triple-negative breast cancer	-0.262168261508622	0.208993845888007	24.0000000000034	0.221765505915898	0.404582075556776	nan
sp|P38646|GRP75_HUMAN	metaplastic breast carcinomas-Normal	0.6613186880573	0.217625681312068	23.999999999703	0.0056583281887414	0.0500220289877039	nan
sp|P38646|GRP75_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.291246213264289	0.217625681312068	23.9999999997031	0.193343829947556	0.843662073010871	nan
sp|P38646|GRP75_HUMAN	Normal-Triple-negative breast cancer	-0.952564901321589	0.260112440430073	23.999999999671	0.0012314450358867	0.0266490250684039	nan
sp|P38919|IF4A3_HUMAN	metaplastic breast carcinomas-Normal	0.466315460189376	0.270444881859561	22.0000000158871	0.0986872109528622	0.253505633081386	nan
sp|P38919|IF4A3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.520613389669622	0.270444881859561	22.0000000148971	0.0672522194807038	0.777898601552022	nan
sp|P38919|IF4A3_HUMAN	Normal-Triple-negative breast cancer	-0.986928849858998	0.323243460046608	22.0000000155557	0.0058278857862525	0.0482220814133169	nan
sp|P39019|RS19_HUMAN	metaplastic breast carcinomas-Normal	1.00756392732966	0.213789786968867	22.0000000220116	0.0001058262461475	0.0136889536397125	nan
sp|P39019|RS19_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0415530388390909	0.213789786968867	22.0000000222276	0.847674470370702	0.974695644619665	nan
sp|P39019|RS19_HUMAN	Normal-Triple-negative breast cancer	-0.966010888490568	0.255527669768695	22.0000000222871	0.0010287263037121	0.0263037402579926	nan
sp|P39023|RL3_HUMAN	metaplastic breast carcinomas-Normal	1.02411357042028	0.217663981289037	21.9999999576449	0.0001078697571952	0.0136889536397125	nan
sp|P39023|RL3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.150771271243638	0.217663981289037	21.9999999583945	0.49575852869647	0.913320451076758	nan
sp|P39023|RL3_HUMAN	Normal-Triple-negative breast cancer	-0.873342299176644	0.260158217658284	21.9999999583079	0.002849062145846	0.0360167542953178	nan
sp|P39059|COFA1_HUMAN	metaplastic breast carcinomas-Normal	-0.274989124205671	0.364940337690976	22.000000003665	0.4591276195255	0.652754579684672	nan
sp|P39059|COFA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0438820247083847	0.364940337690976	22.0000000032732	0.905380952863062	0.992873241513747	nan
sp|P39059|COFA1_HUMAN	Normal-Triple-negative breast cancer	0.231107099497287	0.436187132308409	22.0000000033903	0.601533332408908	0.754242473378804	nan
sp|P39060|COIA1_HUMAN	metaplastic breast carcinomas-Normal	-0.550924294553041	0.302661719623471	21.9999948980507	0.0823517114484969	0.227726158783141	nan
sp|P39060|COIA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.365014110439889	0.302661719623471	21.9999948941631	0.240622772507022	0.849331973021071	nan
sp|P39060|COIA1_HUMAN	Normal-Triple-negative breast cancer	0.185910184113152	0.361749946244317	21.999994896524	0.612432153079947	0.763015171228539	nan
sp|P39210|MPV17_HUMAN	metaplastic breast carcinomas-Normal	0.0487464020303232	0.263438592356013	20.0883150045911	0.855053916389516	0.925247532247456	nan
sp|P39210|MPV17_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0049968669745018	0.263438592356013	20.088315004135	0.98505387789587	0.99777413090774	nan
sp|P39210|MPV17_HUMAN	Normal-Triple-negative breast cancer	-0.0437495350558213	0.308016416548488	20.0532091289757	0.888468604111031	0.934942137942837	nan
sp|P39656|OST48_HUMAN	metaplastic breast carcinomas-Normal	0.742503875642546	0.15650934945711	22.0000000020852	9.80647481062722e-05	0.0136889536397125	nan
sp|P39656|OST48_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.154094903170345	0.15650934945711	22.0000000019372	0.33553877490487	0.870890600099115	nan
sp|P39656|OST48_HUMAN	Normal-Triple-negative breast cancer	-0.588408972472202	0.187064452099452	22.0000000021142	0.0046970959659132	0.0436121424321106	nan
sp|P39748|FEN1_HUMAN	metaplastic breast carcinomas-Normal	0.616860766841996	0.352125815871114	22.0000000022209	0.0937348915113161	0.248069091865935	nan
sp|P39748|FEN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.463531503888473	0.352125815871114	22.000000003144	0.20159701866717	0.843662073010871	nan
sp|P39748|FEN1_HUMAN	Normal-Triple-negative breast cancer	-1.08039227073047	0.42087084921437	22.0000000033434	0.0175806781716176	0.085435927255054	nan
sp|P39880|CUX1_HUMAN	metaplastic breast carcinomas-Normal	0.396971278360481	0.321628645986454	9.99999999985416	0.245326829808642	0.444890244559939	nan
sp|P39880|CUX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.32845304532922	0.251428678324256	9.99999999989049	0.220681385144226	0.843662073010871	nan
sp|P39880|CUX1_HUMAN	Normal-Triple-negative breast cancer	-0.068518233031261	0.347398642636371	9.99999999986882	0.847596923420809	0.912669962245147	nan
sp|P40121|CAPG_HUMAN	metaplastic breast carcinomas-Normal	0.470041731126652	0.370039584229744	23.9999999999539	0.216173675362766	0.41249213370025	nan
sp|P40121|CAPG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.109369344851413	0.370039584229744	23.9999999999078	0.770107258135719	0.959745866833315	nan
sp|P40121|CAPG_HUMAN	Normal-Triple-negative breast cancer	-0.579411075978065	0.442281897657594	24.0000000000081	0.202580258204134	0.382901192452517	nan
sp|P40123|CAP2_HUMAN	metaplastic breast carcinomas-Normal	-0.302400722623515	0.43215445437419	14.9999999998922	0.494792386160852	0.68301075232503	nan
sp|P40123|CAP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.199946648839211	0.43215445437419	14.999999999871	0.650238792322281	0.944124010686281	nan
sp|P40123|CAP2_HUMAN	Normal-Triple-negative breast cancer	0.502347371462726	0.516523367519326	14.9999999998762	0.346197785117454	0.537813772934957	nan
sp|P40222|TXLNA_HUMAN	metaplastic breast carcinomas-Normal	0.48241005466511	0.230421615484054	23.9999999998189	0.0470389579283585	0.163212417697144	nan
sp|P40222|TXLNA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.087906459004744	0.230421615484054	23.9999999998198	0.706187036029375	0.94948208919602	nan
sp|P40222|TXLNA_HUMAN	Normal-Triple-negative breast cancer	-0.570316513669854	0.275406507035591	23.9999999998858	0.0492957250544264	0.154292834351142	nan
sp|P40227|TCPZ_HUMAN	metaplastic breast carcinomas-Normal	0.61898745353116	0.16859156665694	23.999999999266	0.0012029097739584	0.0261713412023794	nan
sp|P40227|TCPZ_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0884535500363692	0.16859156665694	23.999999999266	0.604631275360117	0.940559810632461	nan
sp|P40227|TCPZ_HUMAN	Normal-Triple-negative breast cancer	-0.707441003567529	0.201505463760881	23.9999999993305	0.0017938781820676	0.0292559439806731	nan
sp|P40261|NNMT_HUMAN	metaplastic breast carcinomas-Normal	0.596085984552316	0.437847967725873	23.999999999213	0.186032928104768	0.377426009200792	nan
sp|P40261|NNMT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.207847582039604	0.437847967725873	23.9999999994467	0.639290087075669	0.941868024951375	nan
sp|P40261|NNMT_HUMAN	Normal-Triple-negative breast cancer	-0.388238402512712	0.523328417564886	23.9999999993146	0.465368481559318	0.644804015299364	nan
sp|P40306|PSB10_HUMAN	metaplastic breast carcinomas-Normal	0.314864296889157	0.405719720235189	23.9999999997511	0.445292453489753	0.642148423167002	nan
sp|P40306|PSB10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.140967905092668	0.405719720235189	23.9999999997115	0.731280799974859	0.954643368861838	nan
sp|P40306|PSB10_HUMAN	Normal-Triple-negative breast cancer	-0.455832201981825	0.484927816996244	23.9999999996926	0.356582866079541	0.547980326790751	nan
sp|P40429|RL13A_HUMAN	metaplastic breast carcinomas-Normal	1.12804153412158	0.414466191872968	23.9999999999992	0.0118995489885361	0.0718417777804499	nan
sp|P40429|RL13A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.1690811813492	0.414466191872968	23.9999999999993	0.686927425965703	0.946568877415162	nan
sp|P40429|RL13A_HUMAN	Normal-Triple-negative breast cancer	-1.29712271547078	0.49538185012845	23.9999999999989	0.0150627479807885	0.0781078712931399	nan
sp|P40616|ARL1_HUMAN	metaplastic breast carcinomas-Normal	0.274760624216679	0.255354716424476	23.9999999995195	0.292627183002004	0.496271814438092	nan
sp|P40616|ARL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.258993060899505	0.255354716424476	23.9999999998147	0.320580873243703	0.867696529950794	nan
sp|P40616|ARL1_HUMAN	Normal-Triple-negative breast cancer	-0.533753685116184	0.305207262599005	23.9999999996204	0.0931022943835965	0.232510913997802	nan
sp|P40763|STAT3_HUMAN	metaplastic breast carcinomas-Normal	0.228689354515791	0.20794132946789	24.0000000000352	0.282338369642263	0.485732992213569	nan
sp|P40763|STAT3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.163908648464686	0.20794132946789	23.9999999999975	0.438270474371611	0.897513075778899	nan
sp|P40763|STAT3_HUMAN	Normal-Triple-negative breast cancer	-0.0647807060511051	0.248537426043051	24.0000000000517	0.796587615095607	0.883106108606228	nan
sp|P40855|PEX19_HUMAN	metaplastic breast carcinomas-Normal	-0.451325838790846	0.328023213191529	22.0000000204056	0.182700416186254	0.373490887701788	nan
sp|P40855|PEX19_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0831447485970955	0.328023213191529	22.0000000203067	0.802257079671718	0.965774701272009	nan
sp|P40855|PEX19_HUMAN	Normal-Triple-negative breast cancer	0.368181090193751	0.39206272893231	22.0000000205467	0.357882830918365	0.549174505544052	nan
sp|P40925|MDHC_HUMAN	metaplastic breast carcinomas-Normal	-0.606721587096685	0.338276227865041	22.0000000177535	0.0866408810331665	0.236642800784097	nan
sp|P40925|MDHC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.451172602706271	0.338276227865041	22.0000000177535	0.195933713509049	0.843662073010871	nan
sp|P40925|MDHC_HUMAN	Normal-Triple-negative breast cancer	0.155548984390414	0.404317425402017	22.0000000175433	0.704138871288015	0.826751679625131	nan
sp|P40926|MDHM_HUMAN	metaplastic breast carcinomas-Normal	0.508669858234703	0.307411763929812	23.9999999998534	0.111009046991057	0.273601225965202	nan
sp|P40926|MDHM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.538769885098251	0.307411763929812	23.9999999996497	0.0924384902691779	0.81309570430905	nan
sp|P40926|MDHM_HUMAN	Normal-Triple-negative breast cancer	-1.04743974333295	0.367427335094862	23.9999999997671	0.0088221129443462	0.0590034274185249	nan
sp|P40938|RFC3_HUMAN	metaplastic breast carcinomas-Normal	-0.190570546184489	0.59341107404935	6.0	0.758992990508731	0.868333102587984	nan
sp|P40938|RFC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.199828866192514	0.59341107404935	6.0	0.747774621391401	0.954643368861838	nan
sp|P40938|RFC3_HUMAN	Normal-Triple-negative breast cancer	-0.0092583200080254	0.709261892799633	6.0	0.990008359049471	0.99539860419856	nan
sp|P40939|ECHA_HUMAN	metaplastic breast carcinomas-Normal	-0.0378130467540236	0.25434539493539	23.9999999993189	0.883057653425348	0.939478318898811	nan
sp|P40939|ECHA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0950213616817062	0.25434539493539	23.9999999993204	0.711987884810248	0.94948208919602	nan
sp|P40939|ECHA_HUMAN	Normal-Triple-negative breast cancer	-0.0572083149276826	0.304000892679234	23.9999999993869	0.852313983088808	0.916001932139882	nan
sp|P41091|IF2G_HUMAN	metaplastic breast carcinomas-Normal	0.886737904573007	0.19984423974198	22.0397934727501	0.0002066157072989	0.0157578323963946	nan
sp|P41091|IF2G_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0631334489202431	0.19984423974198	22.0397934727875	0.755040581810214	0.954748610837524	nan
sp|P41091|IF2G_HUMAN	Normal-Triple-negative breast cancer	-0.94987135349325	0.238859552750296	22.0397936432667	0.0006365962203641	0.0247210772633291	nan
sp|P41218|MNDA_HUMAN	metaplastic breast carcinomas-Normal	0.685279046112704	0.31785736346934	22.0000000179111	0.0422885458314722	0.152285044160049	nan
sp|P41218|MNDA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.724459244494141	0.31785736346934	22.0000000178825	0.0327138998702754	0.724424466074313	nan
sp|P41218|MNDA_HUMAN	Normal-Triple-negative breast cancer	0.0391801983814376	0.379912214506156	22.000000017818	0.918794424704694	0.953503798850578	nan
sp|P41226|UBA7_HUMAN	metaplastic breast carcinomas-Normal	-0.266536367065804	0.415963659686582	23.9999999995544	0.527744707680984	0.705924912809494	nan
sp|P41226|UBA7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.255839627298705	0.415963659686582	23.9999999995168	0.544308085161405	0.925741372461213	nan
sp|P41226|UBA7_HUMAN	Normal-Triple-negative breast cancer	0.522375994364509	0.497171666500838	23.9999999995762	0.303863674933373	0.496257807075582	nan
sp|P41227|NAA10_HUMAN	metaplastic breast carcinomas-Normal	0.207925831079159	0.430535310719801	21.6207686511065	0.633987431783964	0.780798156076286	nan
sp|P41227|NAA10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0049263059831616	0.365996222155458	20.2757507140935	0.989392369196431	0.998185231446144	nan
sp|P41227|NAA10_HUMAN	Normal-Triple-negative breast cancer	-0.202999525095997	0.492716128114987	21.3814905781782	0.68443993869627	0.814550412235226	nan
sp|P41240|CSK_HUMAN	metaplastic breast carcinomas-Normal	0.373034876915583	0.208329830387148	21.9999911420506	0.0871299566997553	0.236924781788546	nan
sp|P41240|CSK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0297710605046949	0.208329830387148	21.999991140606	0.887667164323694	0.98730926571735	nan
sp|P41240|CSK_HUMAN	Normal-Triple-negative breast cancer	-0.402805937420278	0.249001773456501	21.9999911379165	0.119980326435646	0.272358121389775	nan
sp|P41250|GARS_HUMAN	metaplastic breast carcinomas-Normal	0.391814015443494	0.273085324953203	22.0000001713435	0.165417281993784	0.351573921141067	nan
sp|P41250|GARS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0162990030767551	0.273085324953203	22.0000001703979	0.952945649165915	0.996541950781621	nan
sp|P41250|GARS_HUMAN	Normal-Triple-negative breast cancer	-0.408113018520249	0.326399393173447	22.0000001707409	0.224308604283583	0.407158932437803	nan
sp|P41252|SYIC_HUMAN	metaplastic breast carcinomas-Normal	0.449530472715386	0.179287023509626	22.0000000185857	0.0200438449020831	0.0963683261948199	nan
sp|P41252|SYIC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.23189125011307	0.179287023509626	22.0000000186964	0.209286501741366	0.843662073010871	nan
sp|P41252|SYIC_HUMAN	Normal-Triple-negative breast cancer	-0.681421722828456	0.214288979781112	22.0000000184789	0.0043321023858378	0.0419484078096101	nan
sp|P42126|ECI1_HUMAN	metaplastic breast carcinomas-Normal	0.300850590560591	0.40731374357968	14.000001656627	0.472338879834553	0.662749867695253	nan
sp|P42126|ECI1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.667629681909984	0.40731374357968	14.000001656686	0.123460827063345	0.823891816737944	nan
sp|P42126|ECI1_HUMAN	Normal-Triple-negative breast cancer	-0.968480272470575	0.486833039301527	14.0000016566609	0.0665670404161362	0.186338952556932	nan
sp|P42167|LAP2B_HUMAN	metaplastic breast carcinomas-Normal	1.00857839168391	0.610214664163463	13.1720875089415	0.121990314621049	0.291095337975856	nan
sp|P42167|LAP2B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0671069689217191	0.546103893021833	13.0000000101426	0.904079068443872	0.991772650140507	nan
sp|P42167|LAP2B_HUMAN	Normal-Triple-negative breast cancer	-1.07568536060562	0.707230205039521	13.1293436863468	0.151976810834369	0.31972470314917	nan
sp|P42224|STAT1_HUMAN	metaplastic breast carcinomas-Normal	0.301540467118926	0.466929349333811	22.0000001727731	0.525091719492615	0.703647458668982	nan
sp|P42224|STAT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0058036822067535	0.466929349333811	22.0000001728734	0.990195005544049	0.998185231446144	nan
sp|P42224|STAT1_HUMAN	Normal-Triple-negative breast cancer	-0.307344149325679	0.558087316861664	22.0000001726723	0.587381941267315	0.743208813016678	nan
sp|P42229|STA5A_HUMAN;sp|P51692|STA5B_HUMAN	metaplastic breast carcinomas-Normal	-0.356695627397731	0.213183983713802	14.9999999994897	0.115012246122479	0.279859636823745	nan
sp|P42229|STA5A_HUMAN;sp|P51692|STA5B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.381284233421678	0.213183983713802	14.9999999996221	0.0939033835953911	0.81309570430905	nan
sp|P42229|STA5A_HUMAN;sp|P51692|STA5B_HUMAN	Normal-Triple-negative breast cancer	0.73797986081941	0.254803596386613	14.999999999589	0.0110781652305794	0.0670743556037265	nan
sp|P42285|MTREX_HUMAN	metaplastic breast carcinomas-Normal	0.226608765400638	0.11459041763097	22.0000000021452	0.0606407742487366	0.189061824566636	nan
sp|P42285|MTREX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0032969025705784	0.11459041763097	22.0000000021452	0.977306485099271	0.99709406933403	nan
sp|P42285|MTREX_HUMAN	Normal-Triple-negative breast cancer	-0.229905667971217	0.136961745508111	22.0000000020294	0.10737730268139	0.253315936205068	nan
sp|P42330|AK1C3_HUMAN	metaplastic breast carcinomas-Normal	-2.07223178267945	0.534942165081104	20.9683485354925	0.0008802070556688	0.0227210419054423	nan
sp|P42330|AK1C3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.26210345456279	0.534942165081104	20.9683485358688	0.0280848992732592	0.721684569712558	nan
sp|P42330|AK1C3_HUMAN	Normal-Triple-negative breast cancer	0.810128328116664	0.632608862299545	20.9413174953143	0.214331590305437	0.396459769713563	nan
sp|P42331|RHG25_HUMAN	metaplastic breast carcinomas-Normal	-0.517517332008253	0.338672503562022	6.99999764707132	0.170336535782117	0.359263099581065	nan
sp|P42331|RHG25_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.442826312260898	0.286169022463871	4.72127553871682	0.18583200687333	0.843662073010871	nan
sp|P42331|RHG25_HUMAN	Normal-Triple-negative breast cancer	0.960343644269151	0.362007529505829	6.99529807398511	0.0328268669136743	0.121510585324113	nan
sp|P42345|MTOR_HUMAN	metaplastic breast carcinomas-Normal	-0.0312892005414655	0.212404696525651	6.0	0.887713232786685	0.940415790777734	nan
sp|P42345|MTOR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.135049212680454	0.212404696525651	6.0	0.548368333596479	0.930742577441701	nan
sp|P42345|MTOR_HUMAN	Normal-Triple-negative breast cancer	0.166338413221919	0.253872170044448	6.0	0.53663167123218	0.703574630690713	nan
sp|P42356|PI4KA_HUMAN	metaplastic breast carcinomas-Normal	-0.336414381765321	0.176461731486214	9.99999999984317	0.0857064947524225	0.234476039964652	nan
sp|P42356|PI4KA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.163904191945903	0.151112798811625	9.99999999984328	0.30353407400818	0.867696529950794	nan
sp|P42356|PI4KA_HUMAN	Normal-Triple-negative breast cancer	0.500318573711224	0.203760456350466	9.9999999998432	0.0339411844004058	0.123621534315429	nan
sp|P42566|EPS15_HUMAN	metaplastic breast carcinomas-Normal	0.0034704938149218	0.269410507145614	22.0000000255011	0.989838196784291	0.994325223968263	nan
sp|P42566|EPS15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.348915136539081	0.269410507145614	22.0000000255012	0.208710462897415	0.843662073010871	nan
sp|P42566|EPS15_HUMAN	Normal-Triple-negative breast cancer	-0.352385630354002	0.322007145795726	22.0000000258795	0.2856427545373	0.477844245637637	nan
sp|P42574|CASP3_HUMAN	metaplastic breast carcinomas-Normal	0.52398306235876	0.258754025087208	23.9999999992511	0.0541263921635809	0.177607233516034	nan
sp|P42574|CASP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0857953931055756	0.258754025087208	23.9999999989636	0.743091046002889	0.954643368861838	nan
sp|P42574|CASP3_HUMAN	Normal-Triple-negative breast cancer	-0.438187669253184	0.30927021356466	23.9999999990399	0.169379203292298	0.3406862602091	nan
sp|P42677|RS27_HUMAN;sp|Q71UM5|RS27L_HUMAN	metaplastic breast carcinomas-Normal	0.8482982840392	0.422494698868168	22.0000033181655	0.0570971825335754	0.181792178871269	nan
sp|P42677|RS27_HUMAN;sp|Q71UM5|RS27L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.317032277259675	0.422494698868168	22.0000033196317	0.460975576429606	0.909423669537079	nan
sp|P42677|RS27_HUMAN;sp|Q71UM5|RS27L_HUMAN	Normal-Triple-negative breast cancer	-1.16533056129888	0.504977751379354	22.0000033140226	0.0308036195167611	0.117152438528277	nan
sp|P42696|RBM34_HUMAN	metaplastic breast carcinomas-Normal	0.39931363138961	0.286252914227751	14.9999999998564	0.183339353851945	0.374106821487947	nan
sp|P42696|RBM34_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0472408059633888	0.286252914227751	14.9999999998564	0.871122545681009	0.981704007186169	nan
sp|P42696|RBM34_HUMAN	Normal-Triple-negative breast cancer	-0.446554437352999	0.342137672590352	14.9999999998407	0.211495526207407	0.394285546333942	nan
sp|P42704|LPPRC_HUMAN	metaplastic breast carcinomas-Normal	0.535997640404532	0.245760851835831	21.999999945748	0.0401592117987948	0.148486340399548	nan
sp|P42704|LPPRC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.419628803090906	0.245760851835831	21.9999999457573	0.101810820461121	0.821630939204717	nan
sp|P42704|LPPRC_HUMAN	Normal-Triple-negative breast cancer	-0.955626443495438	0.293740401168576	21.999999944336	0.0036435754904993	0.0400819560687694	nan
sp|P42765|THIM_HUMAN	metaplastic breast carcinomas-Normal	-0.613252104409761	0.368000057784511	21.9999999388065	0.109800451786484	0.271560045936216	nan
sp|P42765|THIM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.535631243638248	0.368000057784511	21.9999999387516	0.159647887272949	0.843662073010871	nan
sp|P42765|THIM_HUMAN	Normal-Triple-negative breast cancer	0.0776208607715129	0.439844197300757	21.9999999400661	0.861536399251749	0.920618363364173	nan
sp|P42766|RL35_HUMAN	metaplastic breast carcinomas-Normal	1.10050084760812	0.24581710445652	22.0000000221037	0.0001881906194497	0.0157578323963946	nan
sp|P42766|RL35_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.096099003334783	0.24581710445652	22.0000000216418	0.699604048005658	0.947402103397677	nan
sp|P42766|RL35_HUMAN	Normal-Triple-negative breast cancer	-1.19659985094291	0.293807635910174	22.0000000219058	0.0005051107311644	0.0237592699893802	nan
sp|P42785|PCP_HUMAN	metaplastic breast carcinomas-Normal	0.213352670111337	0.224900119380995	22.0000000374012	0.353101292858735	0.561851937511937	nan
sp|P42785|PCP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.14443708029584	0.224900119380995	22.0000000367508	0.527361717415493	0.918405578985386	nan
sp|P42785|PCP_HUMAN	Normal-Triple-negative breast cancer	-0.0689155898154965	0.268807056926886	22.0000000371261	0.80004296296774	0.885267246639403	nan
sp|P43034|LIS1_HUMAN	metaplastic breast carcinomas-Normal	0.0482961903947436	0.150388944941883	23.9999999998892	0.750882785269486	0.862451409203791	nan
sp|P43034|LIS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0107961486219973	0.150388944941883	23.9999999998892	0.943365378246516	0.996541950781621	nan
sp|P43034|LIS1_HUMAN	Normal-Triple-negative breast cancer	-0.0590923390167409	0.179749169522153	23.9999999998575	0.745196900622569	0.853407144267802	nan
sp|P43121|MUC18_HUMAN	metaplastic breast carcinomas-Normal	-1.4389332632193	0.486384043043473	24.0000000002231	0.0068484889114901	0.0543302557083374	nan
sp|P43121|MUC18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0742672364044259	0.486384043043473	24.0000000002231	0.879917187445733	0.983583849145686	nan
sp|P43121|MUC18_HUMAN	Normal-Triple-negative breast cancer	1.51320049962373	0.58134012336929	24.0000000002742	0.0155999485045711	0.0794092325102516	nan
sp|P43155|CACP_HUMAN	metaplastic breast carcinomas-Normal	-0.433159017419525	0.42266064628947	22.0000000336267	0.316576676816248	0.523986365851613	nan
sp|P43155|CACP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.231045405449304	0.42266064628947	22.0000000331446	0.590124435048744	0.940559810632461	nan
sp|P43155|CACP_HUMAN	Normal-Triple-negative breast cancer	0.202113611970221	0.505176096484939	22.0000000331771	0.692951829554489	0.8191222906967	nan
sp|P43243|MATR3_HUMAN	metaplastic breast carcinomas-Normal	0.810597536113403	0.198599989878268	22.0000000000989	0.0004943480704683	0.0205217420849069	nan
sp|P43243|MATR3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.152537133825604	0.198599989878268	21.9999999986257	0.450616374853924	0.906412248269387	nan
sp|P43243|MATR3_HUMAN	Normal-Triple-negative breast cancer	-0.963134669939007	0.237372389716027	21.9999999994885	0.0005242559330724	0.0237592699893802	nan
sp|P43246|MSH2_HUMAN	metaplastic breast carcinomas-Normal	0.986710475340129	0.323895315005951	23.9999999995132	0.0055566740340326	0.0493306383422313	nan
sp|P43246|MSH2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.109067948954304	0.323895315005951	23.9999999995132	0.739241052743745	0.954643368861838	nan
sp|P43246|MSH2_HUMAN	Normal-Triple-negative breast cancer	-0.877642526385825	0.387128946924488	23.999999999512	0.0326776843241857	0.12149957795704	nan
sp|P43304|GPDM_HUMAN	metaplastic breast carcinomas-Normal	0.143875058289547	0.217506701227402	23.9999999995606	0.514609290704384	0.69669792945721	nan
sp|P43304|GPDM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.335315988076439	0.217506701227402	23.999999999764	0.136245578794474	0.823891816737944	nan
sp|P43304|GPDM_HUMAN	Normal-Triple-negative breast cancer	-0.479191046365986	0.259970232028939	23.9999999996553	0.0776766312124228	0.206392583653152	nan
sp|P43307|SSRA_HUMAN	metaplastic breast carcinomas-Normal	1.34312556725391	0.450154659204926	23.9999999999583	0.0064506076479975	0.052627448945006	nan
sp|P43307|SSRA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.186919097718118	0.450154659204926	23.9999999999895	0.681660107125434	0.946568877415162	nan
sp|P43307|SSRA_HUMAN	Normal-Triple-negative breast cancer	-1.15620646953579	0.538037727306901	23.9999999999803	0.0419374482847486	0.138844699301299	nan
sp|P43378|PTN9_HUMAN	metaplastic breast carcinomas-Normal	-0.531498901043274	0.461643487305305	15.0000000000244	0.267623017379414	0.470179127784974	nan
sp|P43378|PTN9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.194617226086632	0.461643487305305	15.0000000000238	0.679314688563526	0.946568877415162	nan
sp|P43378|PTN9_HUMAN	Normal-Triple-negative breast cancer	0.726116127129906	0.551769503340199	15.0000000000279	0.207939372432433	0.389842342902092	nan
sp|P43405|KSYK_HUMAN	metaplastic breast carcinomas-Normal	0.582501438680816	0.425444022163688	13.9999999998057	0.192514549702205	0.386190925292775	nan
sp|P43405|KSYK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.260983007810651	0.382353789848091	13.9999999997132	0.506016906531098	0.913320451076758	nan
sp|P43405|KSYK_HUMAN	Normal-Triple-negative breast cancer	-0.321518430870165	0.493616620146982	13.9999999997259	0.525367216335292	0.695444310582923	nan
sp|P43487|RANG_HUMAN	metaplastic breast carcinomas-Normal	0.69867543654222	0.280684946839889	23.9999999998719	0.0201328775917074	0.0964013903004072	nan
sp|P43487|RANG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.079430752578207	0.280684946839889	24.0000000001175	0.779611797193868	0.961606157891275	nan
sp|P43487|RANG_HUMAN	Normal-Triple-negative breast cancer	-0.778106189120427	0.335482678672539	23.999999999978	0.0292056412907572	0.114480603361412	nan
sp|P43490|NAMPT_HUMAN	metaplastic breast carcinomas-Normal	0.429041596534309	0.3619271289754	23.9999999998326	0.247450008945967	0.447023820508909	nan
sp|P43490|NAMPT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.53293668622315	0.3619271289754	23.9999999998311	0.153880587040009	0.843465960034572	nan
sp|P43490|NAMPT_HUMAN	Normal-Triple-negative breast cancer	-0.961978282757459	0.432585659045657	23.9999999997589	0.0358291777737176	0.126674226032043	nan
sp|P43652|AFAM_HUMAN	metaplastic breast carcinomas-Normal	-1.37935439648251	0.44880618972942	21.9999969263752	0.0055601533823777	0.0493306383422313	nan
sp|P43652|AFAM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.220434722731498	0.44880618972942	21.9999969330372	0.62817877149431	0.941868024951375	nan
sp|P43652|AFAM_HUMAN	Normal-Triple-negative breast cancer	1.59978911921401	0.536425998010963	21.9999969304583	0.0068703499717094	0.0524989501286484	nan
sp|P43686|PRS6B_HUMAN	metaplastic breast carcinomas-Normal	0.308333295176875	0.219853196909236	21.9999942392489	0.174734742789324	0.362339229139396	nan
sp|P43686|PRS6B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.16397113091801	0.219853196909236	21.9999942388556	0.463670665380781	0.909423669537079	nan
sp|P43686|PRS6B_HUMAN	Normal-Triple-negative breast cancer	-0.472304426094884	0.262774830799546	21.9999942404321	0.0860180415981137	0.221356781866067	nan
sp|P43897|EFTS_HUMAN	metaplastic breast carcinomas-Normal	0.661437574174038	0.360656964611469	22.0000048875431	0.0802204656838354	0.224816118300932	nan
sp|P43897|EFTS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0857517262832786	0.360656964611469	22.0000048877713	0.814263491879919	0.965774701272009	nan
sp|P43897|EFTS_HUMAN	Normal-Triple-negative breast cancer	-0.747189300457317	0.431067522259329	22.0000048875122	0.0970294555693868	0.23871253280979	nan
sp|P45877|PPIC_HUMAN	metaplastic breast carcinomas-Normal	0.53600536330185	0.295619270708291	22.0000000232638	0.0834746144732077	0.230265243575886	nan
sp|P45877|PPIC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.135647252327957	0.295619270708291	22.0000000238847	0.650837352431724	0.94416849774672	nan
sp|P45877|PPIC_HUMAN	Normal-Triple-negative breast cancer	-0.400358110973893	0.353332609821118	22.0000000236414	0.269373870933883	0.461070415542857	nan
sp|P45880|VDAC2_HUMAN	metaplastic breast carcinomas-Normal	0.331648435104601	0.236033332646983	21.9999728894201	0.173957997299306	0.361789963260442	nan
sp|P45880|VDAC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.41379792605919	0.236033332646983	21.99997288942	0.0935042187293602	0.81309570430905	nan
sp|P45880|VDAC2_HUMAN	Normal-Triple-negative breast cancer	-0.745446361163791	0.282113791936216	21.999972889389	0.0148775748337381	0.0779324922305247	nan
sp|P45973|CBX5_HUMAN	metaplastic breast carcinomas-Normal	0.944197529540976	0.291851186080372	22.0000000018056	0.0038028213268702	0.0413090787271785	nan
sp|P45973|CBX5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.153113613829834	0.291851186080372	22.0000000010398	0.605087801741999	0.940559810632461	nan
sp|P45973|CBX5_HUMAN	Normal-Triple-negative breast cancer	-1.09731114337081	0.348828887271436	22.000000001748	0.0046947556430682	0.0436121424321106	nan
sp|P45974|UBP5_HUMAN	metaplastic breast carcinomas-Normal	0.247045963242656	0.217577214675083	22.0011467477282	0.268409283458027	0.471168652607142	nan
sp|P45974|UBP5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0416695697331836	0.217577214675083	22.0011467463503	0.849877644544843	0.975774574624172	nan
sp|P45974|UBP5_HUMAN	Normal-Triple-negative breast cancer	-0.205376393509473	0.26005451171895	22.0011467465236	0.438106772524782	0.623668913007442	nan
sp|P46060|RAGP1_HUMAN	metaplastic breast carcinomas-Normal	0.782920230903223	0.17567784274964	23.999999999803	0.0001654127093244	0.0157578323963946	nan
sp|P46060|RAGP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.293100352353827	0.17567784274964	23.999999999803	0.108233087703699	0.823891816737944	nan
sp|P46060|RAGP1_HUMAN	Normal-Triple-negative breast cancer	-1.07602058325705	0.209975183680518	23.9999999998157	3.03306295016107e-05	0.022319699811492	nan
sp|P46063|RECQ1_HUMAN	metaplastic breast carcinomas-Normal	0.698011879657376	0.219048988490014	23.9999999995829	0.003967669939283	0.0418809542360266	nan
sp|P46063|RECQ1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.100684924194311	0.219048988490014	23.9999999996158	0.649907203152636	0.944054805802759	nan
sp|P46063|RECQ1_HUMAN	Normal-Triple-negative breast cancer	-0.597326955463065	0.261813617889025	23.9999999995725	0.0316832820314147	0.119654898900784	nan
sp|P46087|NOP2_HUMAN	metaplastic breast carcinomas-Normal	0.974150465599628	0.389877439153465	22.0000000143953	0.0204291977820989	0.0970095048967095	nan
sp|P46087|NOP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0079985524713091	0.389877439153465	22.0000000144279	0.98381703715628	0.99777413090774	nan
sp|P46087|NOP2_HUMAN	Normal-Triple-negative breast cancer	-0.982149018070937	0.465992669410251	22.0000000145223	0.046684698343047	0.148213884710877	nan
sp|P46100|ATRX_HUMAN	metaplastic breast carcinomas-Normal	0.307359107989812	0.257193102092342	22.0000046011006	0.244791037898259	0.444727514478219	nan
sp|P46100|ATRX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.006643912750004	0.257193102092342	22.0000046008325	0.979623916922626	0.99709406933403	nan
sp|P46100|ATRX_HUMAN	Normal-Triple-negative breast cancer	-0.314003020739816	0.307404553744229	22.0000046011124	0.31813601280973	0.511108799700117	nan
sp|P46108|CRK_HUMAN	metaplastic breast carcinomas-Normal	-0.087476198056729	0.175061784280763	23.9999999998927	0.62184546535646	0.773872829219346	nan
sp|P46108|CRK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.187102470469683	0.175061784280763	23.9999999998927	0.295801434984047	0.867696529950794	nan
sp|P46108|CRK_HUMAN	Normal-Triple-negative breast cancer	0.274578668526412	0.209238852973494	23.9999999998794	0.201840492969159	0.382901192452517	nan
sp|P46109|CRKL_HUMAN	metaplastic breast carcinomas-Normal	-0.428832284499416	0.384089122023337	23.9999999996051	0.275265498106176	0.477548285858522	nan
sp|P46109|CRKL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.488157094677327	0.384089122023337	23.9999999996038	0.215928607258062	0.843662073010871	nan
sp|P46109|CRKL_HUMAN	Normal-Triple-negative breast cancer	0.916989379176743	0.459074307176421	23.9999999995958	0.0572308213986001	0.17122884818087	nan
sp|P46199|IF2M_HUMAN	metaplastic breast carcinomas-Normal	0.286505037489499	0.224288303409635	22.0000000040567	0.214779019143518	0.411010627307458	nan
sp|P46199|IF2M_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.62843290370893	0.224288303409635	22.0000000051535	0.0103906863528412	0.547668704418496	nan
sp|P46199|IF2M_HUMAN	Normal-Triple-negative breast cancer	-0.914937941198429	0.268075796974268	22.0000000048087	0.0024928413657818	0.0337628805562287	nan
sp|P46379|BAG6_HUMAN	metaplastic breast carcinomas-Normal	0.635628422518687	0.213482865297176	23.9999999992957	0.006547331280523	0.0530812906742896	nan
sp|P46379|BAG6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.264430671376822	0.213482865297176	23.9999999992958	0.227453509792169	0.843662073010871	nan
sp|P46379|BAG6_HUMAN	Normal-Triple-negative breast cancer	-0.900059093895509	0.255160828205865	23.9999999993097	0.001721457301587	0.0289979437553501	nan
sp|P46459|NSF_HUMAN	metaplastic breast carcinomas-Normal	0.231004978694821	0.134038915553894	21.9999046351274	0.0988408849281213	0.253704325483456	nan
sp|P46459|NSF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.125522044465632	0.134038915553894	21.9999046325717	0.359203532675566	0.883542279876718	nan
sp|P46459|NSF_HUMAN	Normal-Triple-negative breast cancer	-0.356527023160453	0.160207146634171	21.9999046278207	0.036618159880148	0.1273208822611	nan
sp|P46734|MP2K3_HUMAN	metaplastic breast carcinomas-Normal	0.0464882271446124	0.360260166599508	22.0000000261119	0.898497902618178	0.944829809649739	nan
sp|P46734|MP2K3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.282946564435377	0.360260166599508	22.0000000263885	0.440598859976244	0.89755436380139	nan
sp|P46734|MP2K3_HUMAN	Normal-Triple-negative breast cancer	-0.329434791579989	0.430593257923307	22.0000000261205	0.452358445682905	0.635251150591456	nan
sp|P46736|BRCC3_HUMAN	metaplastic breast carcinomas-Normal	-0.448451831796791	0.177109460858059	13.9999992918967	0.0239352878571608	0.107514725455679	nan
sp|P46736|BRCC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0981769713608173	0.177109460858059	13.9999992905534	0.588099693151539	0.940559810632461	nan
sp|P46736|BRCC3_HUMAN	Normal-Triple-negative breast cancer	0.546628803157608	0.211686294601342	13.9999992911871	0.0217138475066511	0.0972271661415208	nan
sp|P46776|RL27A_HUMAN	metaplastic breast carcinomas-Normal	1.00449396764442	0.188424239730213	22.0000002408318	2.37258765910143e-05	0.0078864813788531	nan
sp|P46776|RL27A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0039745743425454	0.188424239730213	22.0000002409935	0.983361017066013	0.99777413090774	nan
sp|P46776|RL27A_HUMAN	Normal-Triple-negative breast cancer	-1.00051939330188	0.225210042017633	22.0000002408063	0.0002046393269766	0.0227914720285933	nan
sp|P46777|RL5_HUMAN	metaplastic breast carcinomas-Normal	0.867161309224123	0.200972786385969	22.0000000026103	0.0002796368584118	0.0159975668038937	nan
sp|P46777|RL5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.148147732815836	0.200972786385969	22.0000000025733	0.468818609225173	0.911843360423993	nan
sp|P46777|RL5_HUMAN	Normal-Triple-negative breast cancer	-0.719013576408287	0.24020842398616	22.0000000027911	0.006697931207105	0.0523857019586285	nan
sp|P46779|RL28_HUMAN	metaplastic breast carcinomas-Normal	1.21829307489508	0.336074501122945	22.0000000051968	0.0014981358249081	0.0281210167842065	nan
sp|P46779|RL28_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.350978894858787	0.336074501122945	22.0000000051969	0.307664395805897	0.867696529950794	nan
sp|P46779|RL28_HUMAN	Normal-Triple-negative breast cancer	-1.56927196975386	0.401685858609928	22.0000000052432	0.0007569838790965	0.0257262735003663	nan
sp|P46781|RS9_HUMAN	metaplastic breast carcinomas-Normal	0.548656128854471	0.181606356635677	23.9999999994134	0.0059015747896165	0.0508404511724253	nan
sp|P46781|RS9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0671114504090288	0.181606356635677	23.9999999994134	0.714963334111943	0.949812109346858	nan
sp|P46781|RS9_HUMAN	Normal-Triple-negative breast cancer	-0.481544678445443	0.217061113087946	23.9999999993887	0.0362344947634352	0.126678556343412	nan
sp|P46782|RS5_HUMAN	metaplastic breast carcinomas-Normal	0.708706678133522	0.193981990395881	23.9999999991243	0.0012583431109784	0.0266416082859394	nan
sp|P46782|RS5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0912357352910987	0.193981990395881	23.9999999991662	0.642364734236958	0.941868024951375	nan
sp|P46782|RS5_HUMAN	Normal-Triple-negative breast cancer	-0.617470942842424	0.231852824616787	23.9999999990835	0.0136047261921919	0.0754897960437323	nan
sp|P46783|RS10_HUMAN	metaplastic breast carcinomas-Normal	0.754303202824757	0.206958408230447	22.0000001714572	0.001428783630203	0.0280426514467702	nan
sp|P46783|RS10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0317865989440004	0.206958408230447	22.0000001712777	0.879333700951721	0.983583849145686	nan
sp|P46783|RS10_HUMAN	Normal-Triple-negative breast cancer	-0.786089801768758	0.247362610459337	22.0000001714499	0.0043528898512946	0.0419484078096101	nan
sp|P46821|MAP1B_HUMAN	metaplastic breast carcinomas-Normal	-0.16561038530366	0.358934983589876	23.9999999999288	0.648670597065429	0.79096884249651	nan
sp|P46821|MAP1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.315359472840777	0.358934983589876	24.000000000226	0.388331231035851	0.885234295852111	nan
sp|P46821|MAP1B_HUMAN	Normal-Triple-negative breast cancer	-0.149749087537117	0.429009361277591	24.0000000001789	0.730089809205473	0.84440449749443	nan
sp|P46937|YAP1_HUMAN	metaplastic breast carcinomas-Normal	-0.439139024633694	0.283030113718206	21.9999999980813	0.135034561685221	0.308396253082891	nan
sp|P46937|YAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.287394381608921	0.283030113718206	21.9999999984979	0.320943632046255	0.867696529950794	nan
sp|P46937|YAP1_HUMAN	Normal-Triple-negative breast cancer	0.151744643024773	0.338285689219167	21.999999997411	0.658129227961897	0.798580386451002	nan
sp|P46939|UTRN_HUMAN	metaplastic breast carcinomas-Normal	-0.549813434741412	0.17073098826863	23.9999999997522	0.0036559103621903	0.0407324763980233	nan
sp|P46939|UTRN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.308634744691512	0.17073098826863	23.9999999997522	0.0831999951559009	0.806849600316436	nan
sp|P46939|UTRN_HUMAN	Normal-Triple-negative breast cancer	0.858448179432924	0.204062561678601	23.9999999997217	0.0003120816650681	0.0227914720285933	nan
sp|P46940|IQGA1_HUMAN	metaplastic breast carcinomas-Normal	0.250669716075503	0.206610309945672	24.000000000034	0.236840953820682	0.436154753739583	nan
sp|P46940|IQGA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0332391480042569	0.206610309945672	24.000000000034	0.873535671492029	0.98181923303563	nan
sp|P46940|IQGA1_HUMAN	Normal-Triple-negative breast cancer	-0.217430568071246	0.246946553430513	24.000000000064	0.387333533012843	0.574833537967588	nan
sp|P46952|3HAO_HUMAN	metaplastic breast carcinomas-Normal	-0.648912024044756	0.357328795021359	14.0000000002236	0.0908400182593818	0.243509855398536	nan
sp|P46952|3HAO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.206509568833423	0.357328795021359	13.9999999998741	0.572493125150398	0.935843259183841	nan
sp|P46952|3HAO_HUMAN	Normal-Triple-negative breast cancer	0.442402455211333	0.427089598748514	14.0000000001347	0.317832073819492	0.510867414591873	nan
sp|P46977|STT3A_HUMAN	metaplastic breast carcinomas-Normal	0.796554675858181	0.270343606945389	22.0000000140284	0.0074636108917602	0.0574264432292092	nan
sp|P46977|STT3A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0141372986095303	0.270343606945389	22.0000000141645	0.958766516229765	0.99709406933403	nan
sp|P46977|STT3A_HUMAN	Normal-Triple-negative breast cancer	-0.810691974467711	0.323122413371781	22.000000014527	0.0199734776073765	0.0923910023003994	nan
sp|P47712|PA24A_HUMAN	metaplastic breast carcinomas-Normal	0.209406923175665	0.582943776606124	6.0	0.731731643833409	0.851067243506488	nan
sp|P47712|PA24A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.413158496276005	0.582943776606124	6.0	0.505074393662674	0.913320451076758	nan
sp|P47712|PA24A_HUMAN	Normal-Triple-negative breast cancer	0.203751573100339	0.696751079433076	6.0	0.779806013238779	0.874519294198955	nan
sp|P47755|CAZA2_HUMAN	metaplastic breast carcinomas-Normal	0.1652457408632	0.200774502924244	24.0000000001275	0.418587719861983	0.619494915770806	nan
sp|P47755|CAZA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0104398172278797	0.200774502924244	24.0000000000883	0.95896088479731	0.99709406933403	nan
sp|P47755|CAZA2_HUMAN	Normal-Triple-negative breast cancer	-0.15480592363532	0.239971429919948	24.0000000001158	0.524980893343947	0.695444310582923	nan
sp|P47756|CAPZB_HUMAN	metaplastic breast carcinomas-Normal	0.308998297826641	0.159737108576344	24.0000000000772	0.0649352732779866	0.196044367280679	nan
sp|P47756|CAPZB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0646845930667614	0.159737108576344	23.9999999998577	0.689105404122504	0.946568877415162	nan
sp|P47756|CAPZB_HUMAN	Normal-Triple-negative breast cancer	-0.24431370475988	0.190922362142801	23.999999999939	0.212901082395798	0.395387250954292	nan
sp|P47869|GBRA2_HUMAN	metaplastic breast carcinomas-Normal	-1.27034097660488	1.52443240811917	6.0	0.436573370008455	0.632758833091416	nan
sp|P47869|GBRA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.949983869076358	1.52443240811917	6.0	0.556102508719896	0.931642387063667	nan
sp|P47869|GBRA2_HUMAN	Normal-Triple-negative breast cancer	2.22032484568124	1.82204522718056	6.0	0.268735088693703	0.460926436954525	nan
sp|P47897|SYQ_HUMAN	metaplastic breast carcinomas-Normal	0.396196520791932	0.154081347894275	23.9999999998011	0.0167529854600782	0.0867397564942368	nan
sp|P47897|SYQ_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.086112380058699	0.154081347894275	24.0000000000038	0.581424117677812	0.93702592209822	nan
sp|P47897|SYQ_HUMAN	Normal-Triple-negative breast cancer	-0.310084140733233	0.184162435168043	23.9999999999245	0.105193543624918	0.250947516506902	nan
sp|P47914|RL29_HUMAN	metaplastic breast carcinomas-Normal	0.67251238139772	0.195418854014745	23.9999999996245	0.0021292494954512	0.0330730155274758	nan
sp|P47914|RL29_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0581191055826826	0.195418854014745	23.9999999996672	0.768714231210361	0.959450007047466	nan
sp|P47914|RL29_HUMAN	Normal-Triple-negative breast cancer	-0.730631486980402	0.233570205121765	23.9999999996688	0.0045684211897132	0.043471142411956	nan
sp|P47929|LEG7_HUMAN	metaplastic breast carcinomas-Normal	-0.18146808498484	1.0439064431918	23.0000000002483	0.86351563380926	0.928908079864718	nan
sp|P47929|LEG7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.936082703238429	1.0439064431918	23.0000000002483	0.379163306927732	0.885234295852111	nan
sp|P47929|LEG7_HUMAN	Normal-Triple-negative breast cancer	1.11755078822327	1.23516676080289	23.0000000002672	0.374963740587399	0.56312537905329	nan
sp|P48047|ATPO_HUMAN	metaplastic breast carcinomas-Normal	-0.143772243365814	0.207441327518782	21.9999973282745	0.495515277105498	0.683171235187622	nan
sp|P48047|ATPO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.397968199973552	0.207441327518782	21.9999973287672	0.0681215252489418	0.777898601552022	nan
sp|P48047|ATPO_HUMAN	Normal-Triple-negative breast cancer	-0.254195956607738	0.247939809408754	21.9999973273937	0.316395032916496	0.509296411338708	nan
sp|P48147|PPCE_HUMAN	metaplastic breast carcinomas-Normal	0.225571573124392	0.128975728081533	22.000000029869	0.0942409484726246	0.248130450375174	nan
sp|P48147|PPCE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.237670163351791	0.128975728081533	22.0000000301342	0.0788827548251695	0.806849600316436	nan
sp|P48147|PPCE_HUMAN	Normal-Triple-negative breast cancer	-0.463241736476182	0.154155480112782	22.0000000294508	0.0065181855459936	0.0515867827497208	nan
sp|P48163|MAOX_HUMAN	metaplastic breast carcinomas-Normal	-0.674947113957403	0.495773067259765	23.999999999558	0.186031714809065	0.377426009200792	nan
sp|P48163|MAOX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.3027438311155	0.495773067259765	23.999999999558	0.547171273845616	0.929659931291096	nan
sp|P48163|MAOX_HUMAN	Normal-Triple-negative breast cancer	0.977690945072903	0.592562153726336	23.9999999994983	0.111984058981917	0.25994065087702	nan
sp|P48426|PI42A_HUMAN	metaplastic breast carcinomas-Normal	-1.39865992667785	0.672422920740489	13.9999999928233	0.0563751290965471	0.180456132482707	nan
sp|P48426|PI42A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.237256386461248	0.672422920740489	13.9999999927181	0.729465678484107	0.954643368861838	nan
sp|P48426|PI42A_HUMAN	Normal-Triple-negative breast cancer	1.6359163131391	0.803699112441225	13.9999999928447	0.0611876601558777	0.178410335401875	nan
sp|P48444|COPD_HUMAN	metaplastic breast carcinomas-Normal	0.689103226470922	0.194458679493524	23.9999999991832	0.0016533669906948	0.0293674431135457	nan
sp|P48444|COPD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.101632177755877	0.194458679493524	23.9999999994808	0.606015324913126	0.940559810632461	nan
sp|P48444|COPD_HUMAN	Normal-Triple-negative breast cancer	-0.790735404226799	0.232422577064048	23.9999999992937	0.0023451933726381	0.0328595275636502	nan
sp|P48449|LSS_HUMAN	metaplastic breast carcinomas-Normal	0.085022383124371	0.363100397498065	24.0000000002157	0.816849340974927	0.903262544710797	nan
sp|P48449|LSS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.10956036297375	0.363100397498065	24.0000000002142	0.765452648824894	0.95753576273242	nan
sp|P48449|LSS_HUMAN	Normal-Triple-negative breast cancer	-0.194582746098121	0.433987983150377	24.0000000002344	0.65791530099222	0.798580386451002	nan
sp|P48509|CD151_HUMAN	metaplastic breast carcinomas-Normal	-1.34274172022063	0.360123395201078	14.9999999997354	0.0020175771531189	0.0320881648658721	nan
sp|P48509|CD151_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.339479640709476	0.360123395201078	14.9999999999218	0.360782888194781	0.883542279876718	nan
sp|P48509|CD151_HUMAN	Normal-Triple-negative breast cancer	1.00326207951115	0.430429784834965	14.9999999998796	0.0341246209705272	0.123967475525718	nan
sp|P48539|PCP4_HUMAN	metaplastic breast carcinomas-Normal	-2.24657704576033	0.605775422044116	5.0	0.0138750731796202	0.0787184055002298	nan
sp|P48539|PCP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-5.73331865528007	0.793146207331709	5.0	0.0007904437803406	0.380618665421151	nan
sp|P48539|PCP4_HUMAN	Normal-Triple-negative breast cancer	-3.48674160951974	0.886764417844921	5.0	0.0110483205043235	0.0670157251028676	nan
sp|P48553|TPC10_HUMAN	metaplastic breast carcinomas-Normal	-0.335348027053392	0.356663728411008	12.9999999999265	0.364240025756352	0.574897362589797	nan
sp|P48553|TPC10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.906145754417462	0.272406422181436	12.9999999997237	0.0054626074198515	0.519941801393686	nan
sp|P48553|TPC10_HUMAN	Normal-Triple-negative breast cancer	-0.57079772736407	0.398762170917768	12.9999999998882	0.17590872316988	0.350586693141652	nan
sp|P48556|PSMD8_HUMAN	metaplastic breast carcinomas-Normal	0.507087551686031	0.18402506842695	22.0000000035867	0.0115412927323692	0.070984821329559	nan
sp|P48556|PSMD8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0156128517702709	0.18402506842695	22.0000000037363	0.933155223087415	0.995359816653149	nan
sp|P48556|PSMD8_HUMAN	Normal-Triple-negative breast cancer	-0.49147469991576	0.21995202661861	22.0000000037003	0.0359327431287496	0.126678556343412	nan
sp|P48634|PRC2A_HUMAN	metaplastic breast carcinomas-Normal	-0.233520694393686	0.348283954602959	23.9999999992674	0.508947089901471	0.693052079816669	nan
sp|P48634|PRC2A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0472067594785538	0.348283954602959	23.9999999992666	0.893314572606547	0.988218752026376	nan
sp|P48634|PRC2A_HUMAN	Normal-Triple-negative breast cancer	0.280727453872239	0.416278946713578	23.9999999992883	0.506518389479054	0.680269546112475	nan
sp|P48637|GSHB_HUMAN	metaplastic breast carcinomas-Normal	0.179816682528134	0.223285446496861	22.0000000187952	0.429252404919952	0.626846629119879	nan
sp|P48637|GSHB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0688407914025268	0.223285446496861	22.0000000194315	0.76074794461407	0.955228196959647	nan
sp|P48637|GSHB_HUMAN	Normal-Triple-negative breast cancer	-0.110975891125607	0.266877153701053	22.0000000191834	0.681561664186286	0.813486356388654	nan
sp|P48643|TCPE_HUMAN	metaplastic breast carcinomas-Normal	0.725449127838442	0.16412133590559	22.0000000007152	0.0002161533020641	0.0157578323963946	nan
sp|P48643|TCPE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.208458195372239	0.16412133590559	21.9999999996264	0.217302063614981	0.843662073010871	nan
sp|P48643|TCPE_HUMAN	Normal-Triple-negative breast cancer	-0.93390732321068	0.196162516076542	21.9999999997786	9.41499962733208e-05	0.022319699811492	nan
sp|P48651|PTSS1_HUMAN	metaplastic breast carcinomas-Normal	0.887593359385409	0.390734009583533	15.0000000000143	0.0382642973861593	0.143718106792761	nan
sp|P48651|PTSS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.617913784291199	0.390734009583533	14.9999999998575	0.134635017289102	0.823891816737944	nan
sp|P48651|PTSS1_HUMAN	Normal-Triple-negative breast cancer	-0.269679575094211	0.467016466894178	14.9999999999266	0.572200595959587	0.732690696294593	nan
sp|P48681|NEST_HUMAN	metaplastic breast carcinomas-Normal	0.26069680544019	0.309893456141557	21.9999998149439	0.409261014243336	0.611683278482395	nan
sp|P48681|NEST_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.269740775719924	0.309893456141557	21.999999814417	0.393463922022359	0.885234295852111	nan
sp|P48681|NEST_HUMAN	Normal-Triple-negative breast cancer	0.009043970279734	0.370393524625902	21.9999998145593	0.980739958463343	0.990321607142567	nan
sp|P48735|IDHP_HUMAN	metaplastic breast carcinomas-Normal	0.346057601788448	0.301911391207211	23.9999999992128	0.263003432785077	0.465755679583163	nan
sp|P48735|IDHP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.69314034801021	0.301911391207211	23.9999999992128	0.0307230483193523	0.721684569712558	nan
sp|P48735|IDHP_HUMAN	Normal-Triple-negative breast cancer	-1.03919794979866	0.360853132254806	23.9999999991758	0.0082412081649954	0.0575911703148659	nan
sp|P48739|PIPNB_HUMAN	metaplastic breast carcinomas-Normal	0.346043152417759	0.171732358218333	22.0000000301171	0.0562840603531013	0.180456132482707	nan
sp|P48739|PIPNB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.2545043536648	0.171732358218333	22.0000000298962	0.152527877924983	0.843465960034572	nan
sp|P48739|PIPNB_HUMAN	Normal-Triple-negative breast cancer	-0.0915387987529593	0.205259427691014	22.0000000298205	0.659979756772082	0.799725735949474	nan
sp|P49006|MRP_HUMAN	metaplastic breast carcinomas-Normal	0.799133790166677	0.459599752465917	23.9999999997159	0.0948910863550717	0.248948674857347	nan
sp|P49006|MRP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.791056895062214	0.459599752465917	23.9999999997159	0.098085066093778	0.820234747280893	nan
sp|P49006|MRP_HUMAN	Normal-Triple-negative breast cancer	-1.59019068522889	0.54932677299027	23.9999999996808	0.0079568200807231	0.0567563732796645	nan
sp|P49023|PAXI_HUMAN	metaplastic breast carcinomas-Normal	0.064451507559968	0.293651344071152	21.9999962839562	0.828297385651086	0.909492232445857	nan
sp|P49023|PAXI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.136635204778303	0.293651344071152	21.999996290772	0.646291491594427	0.943315325604231	nan
sp|P49023|PAXI_HUMAN	Normal-Triple-negative breast cancer	-0.201086712338271	0.350980487603339	21.9999962880727	0.572503002527803	0.732768571583526	nan
sp|P49189|AL9A1_HUMAN	metaplastic breast carcinomas-Normal	-0.665074780764488	0.371287275829098	22.0038491431866	0.0870170658443045	0.236924781788546	nan
sp|P49189|AL9A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.21140050096495	0.371287275829099	22.0038491483533	0.574870855333602	0.935847692353991	nan
sp|P49189|AL9A1_HUMAN	Normal-Triple-negative breast cancer	0.453674279799538	0.443773174352769	22.0038491669384	0.317742519551334	0.510867414591873	nan
sp|P49207|RL34_HUMAN	metaplastic breast carcinomas-Normal	1.03989017920066	0.366028614988438	23.9999999999136	0.0090249385359013	0.0626281747251275	nan
sp|P49207|RL34_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.146597495643964	0.366028614988438	24.000000000201	0.692325160371866	0.946568877415162	nan
sp|P49207|RL34_HUMAN	Normal-Triple-negative breast cancer	-1.18648767484462	0.437487872469225	24.0000000000573	0.01216570048202	0.071195050003934	nan
sp|P49247|RPIA_HUMAN	metaplastic breast carcinomas-Normal	-0.576069488842679	0.2642500354028	13.9999999999907	0.0468194853237382	0.162790762778353	nan
sp|P49247|RPIA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0285294354599746	0.2642500354028	14.0000000003938	0.915556448182454	0.99408739879047	nan
sp|P49247|RPIA_HUMAN	Normal-Triple-negative breast cancer	0.604598924302653	0.315839202331053	14.0000000002023	0.0762507522623774	0.203743971479214	nan
sp|P49257|LMAN1_HUMAN	metaplastic breast carcinomas-Normal	0.671924285475186	0.25286067696652	22.0000000203507	0.0143904287061808	0.0795450818130059	nan
sp|P49257|LMAN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0753416012552362	0.25286067696652	22.0000000205556	0.768531722187483	0.959450007047466	nan
sp|P49257|LMAN1_HUMAN	Normal-Triple-negative breast cancer	-0.747265886730422	0.302226315286047	22.0000000206998	0.0216233650765042	0.0969987388856952	nan
sp|P49321|NASP_HUMAN	metaplastic breast carcinomas-Normal	1.12410597197713	0.408975969439559	22.0000000683113	0.0117238138971332	0.0712452568367856	nan
sp|P49321|NASP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.279146176041616	0.408975969439559	22.0000000683113	0.502016189009771	0.913320451076758	nan
sp|P49321|NASP_HUMAN	Normal-Triple-negative breast cancer	-0.844959795935514	0.488819779204429	22.0000000684889	0.097897012881272	0.239977633346127	nan
sp|P49327|FAS_HUMAN	metaplastic breast carcinomas-Normal	-0.739560340867432	0.59562921899924	22.000000018544	0.227442711136791	0.426760510655196	nan
sp|P49327|FAS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.774149383387701	0.59562921899924	22.000000019655	0.207152396459154	0.843662073010871	nan
sp|P49327|FAS_HUMAN	Normal-Triple-negative breast cancer	-0.034589042520269	0.711913083103393	22.0000000195577	0.961687582166392	0.981692207683993	nan
sp|P49354|FNTA_HUMAN	metaplastic breast carcinomas-Normal	-0.003577281610995	0.190187596170266	22.000000008603	0.985162840624539	0.993230598191073	nan
sp|P49354|FNTA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0169302605186999	0.190187596170266	22.0000000086736	0.929872430850275	0.995359816653149	nan
sp|P49354|FNTA_HUMAN	Normal-Triple-negative breast cancer	0.0205075421296949	0.227317656083239	22.0000000087749	0.928932413213983	0.960426544797288	nan
sp|P49356|FNTB_HUMAN	metaplastic breast carcinomas-Normal	-0.12253734036536	0.182465908629663	14.9999999998905	0.51207273786967	0.695598602647643	nan
sp|P49356|FNTB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0240666807972889	0.182465908629663	14.9999999998905	0.89681880005029	0.989403873476489	nan
sp|P49356|FNTB_HUMAN	Normal-Triple-negative breast cancer	0.146604021162649	0.218088474222369	14.9999999999191	0.511664350667872	0.684966694168348	nan
sp|P49368|TCPG_HUMAN	metaplastic breast carcinomas-Normal	0.565612137351017	0.174320616678982	22.0000026569406	0.0037187361453397	0.0407956400894701	nan
sp|P49368|TCPG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.297079646556784	0.174320616678982	22.0000026569367	0.102426005884298	0.821630939204717	nan
sp|P49368|TCPG_HUMAN	Normal-Triple-negative breast cancer	-0.862691783907801	0.208352988251534	22.0000026561518	0.0004280706114766	0.0237592699893802	nan
sp|P49411|EFTU_HUMAN	metaplastic breast carcinomas-Normal	-0.063570889197068	0.256679634752935	22.0000000176041	0.806689495846761	0.898604518831982	nan
sp|P49411|EFTU_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.877349256668646	0.256679634752935	22.0000000173864	0.00246272399938	0.448717474870704	nan
sp|P49411|EFTU_HUMAN	Normal-Triple-negative breast cancer	-0.813778367471578	0.306790842890211	22.0000000175544	0.0145434182505062	0.0779324922305247	nan
sp|P49419|AL7A1_HUMAN	metaplastic breast carcinomas-Normal	-0.207209758571587	0.307977663725334	24.000000000244	0.507496625980291	0.692495396042072	nan
sp|P49419|AL7A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.897073692643986	0.307977663725334	24.0000000000411	0.0076272730388527	0.539588996897564	nan
sp|P49419|AL7A1_HUMAN	Normal-Triple-negative breast cancer	-0.689863934072399	0.368103714720486	24.0000000001409	0.073141134680782	0.197981377588696	nan
sp|P49458|SRP09_HUMAN	metaplastic breast carcinomas-Normal	0.883648997272264	0.247426161439349	23.999999999728	0.0015436586469903	0.0282214103166084	nan
sp|P49458|SRP09_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.519438529930924	0.247426161439349	23.999999999728	0.0464821391704833	0.759166737802103	nan
sp|P49458|SRP09_HUMAN	Normal-Triple-negative breast cancer	-1.40308752720319	0.2957308268501	23.9999999996598	7.95236029300234e-05	0.022319699811492	nan
sp|P49585|PCY1A_HUMAN	metaplastic breast carcinomas-Normal	0.557674125621221	0.297153349060536	23.9999999997745	0.0727668139216339	0.210562461081628	nan
sp|P49585|PCY1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0654111152970647	0.297153349060536	23.9999999997745	0.82763487406752	0.96659148446593	nan
sp|P49585|PCY1A_HUMAN	Normal-Triple-negative breast cancer	-0.492263010324156	0.355166184156682	23.9999999997384	0.178488753882098	0.354400546180335	nan
sp|P49588|SYAC_HUMAN	metaplastic breast carcinomas-Normal	0.562014859768019	0.212673587743213	23.9999999997664	0.0142578303228067	0.0795361221927149	nan
sp|P49588|SYAC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.136052050714295	0.212673587743213	23.9999999999781	0.528413088634904	0.919400062643149	nan
sp|P49588|SYAC_HUMAN	Normal-Triple-negative breast cancer	-0.425962809053724	0.254193556520477	23.9999999998813	0.106770159219532	0.253140501346715	nan
sp|P49589|SYCC_HUMAN	metaplastic breast carcinomas-Normal	0.479991626583528	0.20154827862248	23.9999999995663	0.0255200899177612	0.112535677388055	nan
sp|P49589|SYCC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.103504004658474	0.20154827862248	23.999999999367	0.612266158649596	0.94077736515583	nan
sp|P49589|SYCC_HUMAN	Normal-Triple-negative breast cancer	-0.583495631242002	0.240896268771688	23.9999999994728	0.0233456693534957	0.101651301814296	nan
sp|P49591|SYSC_HUMAN	metaplastic breast carcinomas-Normal	0.325440283090515	0.227830839220807	21.9999999992894	0.167212534090923	0.354473509769277	nan
sp|P49591|SYSC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.541423127821377	0.227830839220807	21.9999999995283	0.0266087969190376	0.721684569712558	nan
sp|P49591|SYSC_HUMAN	Normal-Triple-negative breast cancer	-0.866863410911892	0.272309937125373	22.0000000001186	0.0042970728383968	0.0419484078096101	nan
sp|P49593|PPM1F_HUMAN	metaplastic breast carcinomas-Normal	-0.450158711441189	0.391312956315599	22.9999999994933	0.261807937620365	0.464133111813383	nan
sp|P49593|PPM1F_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.80276278316341	0.391312956315599	22.9999999994933	0.0517791942129416	0.773286317778246	nan
sp|P49593|PPM1F_HUMAN	Normal-Triple-negative breast cancer	1.2529214946046	0.463007733944731	22.9999999994674	0.012604688413625	0.0726685666512126	nan
sp|P49662|CASP4_HUMAN	metaplastic breast carcinomas-Normal	0.751775006626526	0.402820012700358	23.9999999999319	0.0742688105143337	0.213002179594172	nan
sp|P49662|CASP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.533900752755902	0.402820012700358	24.0000000001692	0.197515490988938	0.843662073010871	nan
sp|P49662|CASP4_HUMAN	Normal-Triple-negative breast cancer	-0.217874253870623	0.481462003591911	24.0000000000663	0.654953888328889	0.797031075258555	nan
sp|P49711|CTCF_HUMAN	metaplastic breast carcinomas-Normal	0.675620091956895	0.258400920118833	22.0000035789615	0.0158241764282213	0.083359053006985	nan
sp|P49711|CTCF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0704050656780135	0.258400920118833	22.0000035793905	0.787805881500374	0.962981271203673	nan
sp|P49711|CTCF_HUMAN	Normal-Triple-negative breast cancer	-0.746025157634909	0.30884817240436	22.000003579409	0.0244654374893045	0.104394241610331	nan
sp|P49720|PSB3_HUMAN	metaplastic breast carcinomas-Normal	-0.038107950609933	0.185555037028497	22.0000000042658	0.839169314747017	0.914257492902453	nan
sp|P49720|PSB3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.15589903358865	0.185555037028497	22.0000000055972	0.409847653678308	0.885784822958391	nan
sp|P49720|PSB3_HUMAN	Normal-Triple-negative breast cancer	-0.117791082978717	0.221780688862563	22.0000000051935	0.600660616245963	0.753716832163677	nan
sp|P49721|PSB2_HUMAN	metaplastic breast carcinomas-Normal	0.121293338765745	0.210477064518584	22.0000000968895	0.570276534039345	0.734528007858528	nan
sp|P49721|PSB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0752725779791928	0.210477064518584	22.0000000968568	0.72402957122357	0.952670488452066	nan
sp|P49721|PSB2_HUMAN	Normal-Triple-negative breast cancer	-0.0460207607865518	0.251568209121333	22.000000096924	0.856523998910481	0.917810880991339	nan
sp|P49736|MCM2_HUMAN	metaplastic breast carcinomas-Normal	0.600181602733835	0.442542857545271	14.9999999999317	0.195096731384268	0.387852664274868	nan
sp|P49736|MCM2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.215517224169412	0.442542857545271	14.9999999999317	0.633299815291686	0.941868024951375	nan
sp|P49736|MCM2_HUMAN	Normal-Triple-negative breast cancer	-0.384664378564423	0.528939884194703	14.9999999999347	0.478278846748624	0.657213264403649	nan
sp|P49746|TSP3_HUMAN	metaplastic breast carcinomas-Normal	-0.117289837848122	0.493445077012712	21.9999999684598	0.814316732535139	0.902183034510288	nan
sp|P49746|TSP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0945804688590405	0.493445077012712	21.9999999699638	0.849755837865805	0.975774574624172	nan
sp|P49746|TSP3_HUMAN	Normal-Triple-negative breast cancer	0.0227093689890812	0.589779673180806	21.9999999688993	0.969632455350783	0.985042262098412	nan
sp|P49747|COMP_HUMAN	metaplastic breast carcinomas-Normal	0.156529323102917	0.527693581459347	22.0000000026804	0.769531967090398	0.874803098019317	nan
sp|P49747|COMP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0664162251393981	0.527693581459347	22.0000000028347	0.900984812296003	0.990666170927318	nan
sp|P49747|COMP_HUMAN	Normal-Triple-negative breast cancer	-0.0901130979635194	0.63071446552234	22.0000000026898	0.887689689029847	0.934942137942837	nan
sp|P49748|ACADV_HUMAN	metaplastic breast carcinomas-Normal	-0.359791911411571	0.246738909028437	23.9999999987721	0.157751672195096	0.3400561338369	nan
sp|P49748|ACADV_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0176686349715411	0.246738909028437	23.9999999987461	0.943506775973888	0.996541950781621	nan
sp|P49748|ACADV_HUMAN	Normal-Triple-negative breast cancer	0.377460546383112	0.294909403106744	23.9999999986956	0.212807375673482	0.395387250954292	nan
sp|P49750|YLPM1_HUMAN	metaplastic breast carcinomas-Normal	0.307121540503875	0.196775041232755	22.0000000240465	0.132847770395023	0.305173454590916	nan
sp|P49750|YLPM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.135174146593228	0.196775041232755	22.0000000240436	0.499293560053273	0.913320451076758	nan
sp|P49750|YLPM1_HUMAN	Normal-Triple-negative breast cancer	-0.442295687097103	0.235191158884344	22.0000000241676	0.0733335130215048	0.198081837574995	nan
sp|P49753|ACOT2_HUMAN;sp|Q86TX2|ACOT1_HUMAN	metaplastic breast carcinomas-Normal	-0.651812116342523	0.333497878587292	22.0000000029861	0.0634717989386893	0.192535774463204	nan
sp|P49753|ACOT2_HUMAN;sp|Q86TX2|ACOT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.230709008094809	0.333497878587292	22.0000000028936	0.496308669687595	0.913320451076758	nan
sp|P49753|ACOT2_HUMAN;sp|Q86TX2|ACOT1_HUMAN	Normal-Triple-negative breast cancer	0.421103108247714	0.398606205639859	22.0000000029016	0.302231231160983	0.494885030728624	nan
sp|P49755|TMEDA_HUMAN	metaplastic breast carcinomas-Normal	0.657517240919228	0.212414482971288	23.9999999996123	0.0049412292590447	0.0470009737236255	nan
sp|P49755|TMEDA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0531960537374166	0.212414482971288	23.9999999996473	0.80438229828268	0.965774701272009	nan
sp|P49755|TMEDA_HUMAN	Normal-Triple-negative breast cancer	-0.710713294656645	0.253883867084257	23.9999999996491	0.009943864629845	0.0630790191404677	nan
sp|P49756|RBM25_HUMAN	metaplastic breast carcinomas-Normal	0.645038478364969	0.27659735006468	24.0000000001031	0.0284160786348811	0.120246014908263	nan
sp|P49756|RBM25_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.332831870305244	0.27659735006468	24.0000000000632	0.240592881224913	0.849331973021071	nan
sp|P49756|RBM25_HUMAN	Normal-Triple-negative breast cancer	-0.977870348670213	0.330597066063386	24.0000000001732	0.0068572174961226	0.0524989501286484	nan
sp|P49773|HINT1_HUMAN	metaplastic breast carcinomas-Normal	-0.487726470536726	0.1925593168017	23.9999999990866	0.0182642000271997	0.0915235238665563	nan
sp|P49773|HINT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.00427205781507	0.1925593168017	23.9999999993449	2.41098000388615e-05	0.0801650851292146	nan
sp|P49773|HINT1_HUMAN	Normal-Triple-negative breast cancer	-0.51654558727834	0.230152404435277	23.9999999991577	0.0342975815206907	0.124196152475544	nan
sp|P49790|NU153_HUMAN	metaplastic breast carcinomas-Normal	0.538883829613918	0.224390666797384	23.9999999994683	0.0244272238665698	0.109428695596332	nan
sp|P49790|NU153_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.348143354211262	0.224390666797384	23.9999999994683	0.133868675334774	0.823891816737944	nan
sp|P49790|NU153_HUMAN	Normal-Triple-negative breast cancer	-0.88702718382518	0.268198144623855	23.9999999994655	0.0029582888851788	0.0364198231642014	nan
sp|P49792|RBP2_HUMAN	metaplastic breast carcinomas-Normal	0.543094353735191	0.170439664668489	23.9999999996857	0.0039688629916812	0.0418809542360266	nan
sp|P49792|RBP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.404494866500815	0.170439664668489	23.9999999996857	0.0259849555861568	0.721684569712558	nan
sp|P49792|RBP2_HUMAN	Normal-Triple-negative breast cancer	-0.947589220236007	0.203714363377138	23.9999999997466	0.0001007206670193	0.022319699811492	nan
sp|P49815|TSC2_HUMAN	metaplastic breast carcinomas-Normal	0.0412428706068162	0.401655129390667	6.0	0.921561001180635	0.95843058885501	nan
sp|P49815|TSC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.142133921769784	0.401655129390667	6.0	0.735539002536353	0.954643368861838	nan
sp|P49815|TSC2_HUMAN	Normal-Triple-negative breast cancer	-0.1833767923766	0.480069701733633	6.0	0.715639397849538	0.834802230036303	nan
sp|P49821|NDUV1_HUMAN	metaplastic breast carcinomas-Normal	0.0495870859176956	0.203579813492602	23.9999999992699	0.809629480723346	0.900672153254486	nan
sp|P49821|NDUV1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0483652871312306	0.203579813492602	23.9999999992687	0.814227875423504	0.965774701272009	nan
sp|P49821|NDUV1_HUMAN	Normal-Triple-negative breast cancer	-0.0012217987864649	0.243324417369318	23.9999999993197	0.996035124422608	0.999643947337183	nan
sp|P49841|GSK3B_HUMAN	metaplastic breast carcinomas-Normal	0.79922981389226	0.730602287609147	12.9917940186359	0.293852554820327	0.498095814494017	nan
sp|P49841|GSK3B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.510568287492831	0.545698693273352	11.9999998945452	0.367914577175176	0.883542279876718	nan
sp|P49841|GSK3B_HUMAN	Normal-Triple-negative breast cancer	-1.30979810138509	0.813266702884007	12.9253725913718	0.131419799573895	0.290248221534721	nan
sp|P49902|5NTC_HUMAN	metaplastic breast carcinomas-Normal	0.179010834407463	0.424550821358614	14.000000012423	0.679684802892657	0.812980311196542	nan
sp|P49902|5NTC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.446292789281709	0.424550821358613	14.000000012423	0.310968747725671	0.867696529950794	nan
sp|P49902|5NTC_HUMAN	Normal-Triple-negative breast cancer	-0.625303623689172	0.50743528780423	14.0000000124381	0.238138735920012	0.424436009757704	nan
sp|P49903|SPS1_HUMAN	metaplastic breast carcinomas-Normal	0.528166586215062	0.226530401420436	22.0000000122143	0.0292830776822131	0.122436415365631	nan
sp|P49903|SPS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.259175241636946	0.226530401420436	22.000000011821	0.264875083974701	0.864992243302031	nan
sp|P49903|SPS1_HUMAN	Normal-Triple-negative breast cancer	-0.787341827852008	0.270755616661709	22.0000000121175	0.0081553026582429	0.0575911703148659	nan
sp|P49908|SEPP1_HUMAN	metaplastic breast carcinomas-Normal	-1.40282078054525	0.406657205925963	21.9999999813374	0.0022836844223374	0.0344046144412164	nan
sp|P49908|SEPP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.297169628241183	0.406657205925963	21.9999999831556	0.472636028627185	0.913140496911905	nan
sp|P49908|SEPP1_HUMAN	Normal-Triple-negative breast cancer	1.69999040878643	0.486048326714698	21.9999999828452	0.0020359090750102	0.0312748437634516	nan
sp|P49913|CAMP_HUMAN	metaplastic breast carcinomas-Normal	1.61500826996937	0.797553097338945	20.9831613937252	0.0557827119987509	0.179846493388795	nan
sp|P49913|CAMP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.24697749115643	0.797553097338945	20.9831613960172	0.132891104224095	0.823891816737944	nan
sp|P49913|CAMP_HUMAN	Normal-Triple-negative breast cancer	-0.368030778812946	0.943390910307007	20.9364195086689	0.700392276098343	0.824399407135586	nan
sp|P49915|GUAA_HUMAN	metaplastic breast carcinomas-Normal	0.30009439028046	0.259415979504888	24.0000000003064	0.25873586919441	0.460899265381682	nan
sp|P49915|GUAA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0592827751629903	0.259415979504889	24.0000000003064	0.821174881789889	0.965774701272009	nan
sp|P49915|GUAA_HUMAN	Normal-Triple-negative breast cancer	-0.35937716544345	0.310061400422747	24.0000000002759	0.257837782083426	0.448270696040638	nan
sp|P49916|DNLI3_HUMAN	metaplastic breast carcinomas-Normal	0.160506253243311	0.21763508784597	22.0000000282524	0.468610963012903	0.660026627565631	nan
sp|P49916|DNLI3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.181397378670272	0.21763508784597	22.0000000280671	0.413524798842903	0.885784822958391	nan
sp|P49916|DNLI3_HUMAN	Normal-Triple-negative breast cancer	-0.341903631913584	0.260123683388508	22.0000000280866	0.202254834985792	0.382901192452517	nan
sp|P49959|MRE11_HUMAN	metaplastic breast carcinomas-Normal	0.039918986027485	0.38327653762351	22.0000000308685	0.917992469618192	0.957161477410571	nan
sp|P49959|MRE11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.824384817164564	0.38327653762351	22.0000000310693	0.0427297095092299	0.751726370995712	nan
sp|P49959|MRE11_HUMAN	Normal-Triple-negative breast cancer	-0.864303803192049	0.45810308305425	22.0000000309496	0.0724682704206894	0.196962003988856	nan
sp|P49961|ENTP1_HUMAN	metaplastic breast carcinomas-Normal	-0.777061364815736	0.375496638271778	14.9999999996979	0.0561895653404508	0.180456132482707	nan
sp|P49961|ENTP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.229275360383364	0.375496638271778	14.9999999996988	0.550609865717972	0.931124086486988	nan
sp|P49961|ENTP1_HUMAN	Normal-Triple-negative breast cancer	1.0063367251991	0.448804324771317	14.9999999996909	0.040485072669135	0.135521028753479	nan
sp|P50135|HNMT_HUMAN	metaplastic breast carcinomas-Normal	-0.934822812850046	0.257022667488994	22.0000000235779	0.0014551913404247	0.0280426514467702	nan
sp|P50135|HNMT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.069267206480272	0.257022667488994	22.000000023503	0.790057725102807	0.962981271203673	nan
sp|P50135|HNMT_HUMAN	Normal-Triple-negative breast cancer	1.00409001933032	0.307200845430287	22.0000000234153	0.0035147812007701	0.0397157239889247	nan
sp|P50213|IDH3A_HUMAN	metaplastic breast carcinomas-Normal	-0.206589387867894	0.237885935625305	23.9999999995767	0.393755693170671	0.597918649657063	nan
sp|P50213|IDH3A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.21684639448314	0.237885935625305	23.9999999995767	0.371068031962979	0.884580780585171	nan
sp|P50213|IDH3A_HUMAN	Normal-Triple-negative breast cancer	-0.0102570066152457	0.284328076017644	23.9999999995768	0.971521294448013	0.986659573096607	nan
sp|P50281|MMP14_HUMAN	metaplastic breast carcinomas-Normal	0.348016262312763	0.27851118541007	23.9999999993891	0.223509677314461	0.422849270001861	nan
sp|P50281|MMP14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.518647745404072	0.27851118541007	23.999999999678	0.0748608079776114	0.795994790325479	nan
sp|P50281|MMP14_HUMAN	Normal-Triple-negative breast cancer	0.170631483091308	0.332884536821751	23.9999999994303	0.612927489386099	0.763171031011915	nan
sp|P50395|GDIB_HUMAN	metaplastic breast carcinomas-Normal	0.0289930062981897	0.190148710658502	22.0000000039182	0.880201723944175	0.937452909449035	nan
sp|P50395|GDIB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.489589342456518	0.190148710658502	22.0000000037143	0.0172833600365323	0.669250232341703	nan
sp|P50395|GDIB_HUMAN	Normal-Triple-negative breast cancer	-0.518582348754708	0.22727117900709	22.0000000039968	0.0325364235836942	0.121245596403811	nan
sp|P50402|EMD_HUMAN	metaplastic breast carcinomas-Normal	0.199497726207532	0.195607363194772	6.0	0.34712978676642	0.557013864291281	nan
sp|P50402|EMD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.2130474986091	0.195607363194772	6.0	0.31788414673051	0.867696529950794	nan
sp|P50402|EMD_HUMAN	Normal-Triple-negative breast cancer	0.0135497724015678	0.233795516686855	6.0	0.95566589479973	0.977726511023177	nan
sp|P50416|CPT1A_HUMAN	metaplastic breast carcinomas-Normal	-0.274820239765243	0.29312427745161	22.0000000200071	0.358652380728548	0.567965942611573	nan
sp|P50416|CPT1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.39739227475228	0.29312427745161	22.000000019204	0.188945304552438	0.843662073010871	nan
sp|P50416|CPT1A_HUMAN	Normal-Triple-negative breast cancer	-0.122572034987037	0.350350522500636	22.0000000194407	0.729774251099539	0.84440449749443	nan
sp|P50440|GATM_HUMAN	metaplastic breast carcinomas-Normal	0.212234013982392	0.924273166394823	10.0290720413186	0.823000411942343	0.907569094159468	nan
sp|P50440|GATM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.346906481950313	0.838958435516635	10.0198808345612	0.68795355560271	0.946568877415162	nan
sp|P50440|GATM_HUMAN	Normal-Triple-negative breast cancer	0.134672467967921	1.02616149175018	10.0716649031203	0.89817075500498	0.941085638149985	nan
sp|P50453|SPB9_HUMAN	metaplastic breast carcinomas-Normal	-0.243200387891388	0.362939663262824	21.9997753912992	0.509776856064644	0.693329897528182	nan
sp|P50453|SPB9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.364265807114775	0.362939663262824	21.9997753912553	0.326457695273969	0.867975899287892	nan
sp|P50453|SPB9_HUMAN	Normal-Triple-negative breast cancer	0.607466195006164	0.433795868993918	21.9997753911918	0.17535470299872	0.350084614767438	nan
sp|P50454|SERPH_HUMAN	metaplastic breast carcinomas-Normal	0.931852340011989	0.334464504275823	23.999999999867	0.0102546297266466	0.0670991913609714	nan
sp|P50454|SERPH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.200239581650819	0.334464504275823	23.999999999867	0.554990692473956	0.931642387063667	nan
sp|P50454|SERPH_HUMAN	Normal-Triple-negative breast cancer	-0.731612758361171	0.399761544317309	23.9999999998926	0.0796798845992304	0.210203124133208	nan
sp|P50479|PDLI4_HUMAN	metaplastic breast carcinomas-Normal	-0.0667327144100999	0.296266161385404	23.9999999992484	0.823694981269753	0.907569094159468	nan
sp|P50479|PDLI4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0818101134643816	0.296266161385404	23.9999999992484	0.784806618226668	0.962981271203673	nan
sp|P50479|PDLI4_HUMAN	Normal-Triple-negative breast cancer	0.148542827874482	0.354105792065516	23.9999999992668	0.678591334939472	0.811672399186328	nan
sp|P50502|F10A1_HUMAN;sp|Q8NFI4|F10A5_HUMAN	metaplastic breast carcinomas-Normal	0.239824902148763	0.194940970696838	22.0000000398747	0.231599022944142	0.431726840756277	nan
sp|P50502|F10A1_HUMAN;sp|Q8NFI4|F10A5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.132438188611553	0.194940970696838	22.0000000396818	0.50398558314556	0.913320451076758	nan
sp|P50502|F10A1_HUMAN;sp|Q8NFI4|F10A5_HUMAN	Normal-Triple-negative breast cancer	-0.10738671353721	0.232999025308278	22.0000000399431	0.649401963058333	0.793024292875055	nan
sp|P50552|VASP_HUMAN	metaplastic breast carcinomas-Normal	0.481596435959781	0.244914817576327	22.0000001850275	0.0619965800958423	0.191116345245641	nan
sp|P50552|VASP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.290631925090529	0.244914817576327	22.0000001850275	0.248016555013796	0.850159840640073	nan
sp|P50552|VASP_HUMAN	Normal-Triple-negative breast cancer	-0.190964510869253	0.29272919681714	22.0000001850103	0.520928231938371	0.693288295834382	nan
sp|P50570|DYN2_HUMAN	metaplastic breast carcinomas-Normal	0.107809831430893	0.194131640332027	23.9999999995266	0.583799317588741	0.744075510607736	nan
sp|P50570|DYN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.22152180350899	0.194131640332027	23.9999999995685	0.265090855917224	0.864992243302031	nan
sp|P50570|DYN2_HUMAN	Normal-Triple-negative breast cancer	-0.329331634939884	0.232031690501854	23.9999999994991	0.168658657373659	0.340182874459978	nan
sp|P50579|MAP2_HUMAN	metaplastic breast carcinomas-Normal	0.496083021062247	0.170716885822071	21.9978949434032	0.0081945190261801	0.0602623478827939	nan
sp|P50579|MAP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.264673658102506	0.170716885822071	21.9978949186444	0.135322210042704	0.823891816737944	nan
sp|P50579|MAP2_HUMAN	Normal-Triple-negative breast cancer	-0.23140936295974	0.204045706031013	21.9978950940604	0.268958529097399	0.461070415542857	nan
sp|P50851|LRBA_HUMAN	metaplastic breast carcinomas-Normal	-0.156085329318042	0.189724249797926	22.0000000029398	0.419509361686352	0.620030732879251	nan
sp|P50851|LRBA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.661074891558926	0.189724249797926	22.0000000023389	0.0021012642432981	0.448717474870704	nan
sp|P50851|LRBA_HUMAN	Normal-Triple-negative breast cancer	-0.504989562240885	0.226763851242986	22.0000000028206	0.0365016027562386	0.127127317030391	nan
sp|P50895|BCAM_HUMAN	metaplastic breast carcinomas-Normal	-0.834315007196372	0.273745209221196	22.00000002836	0.005901974955234	0.0508404511724253	nan
sp|P50895|BCAM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0098005977317535	0.273745209221196	22.0000000283998	0.971763189206389	0.99709406933403	nan
sp|P50895|BCAM_HUMAN	Normal-Triple-negative breast cancer	0.844115604928125	0.327188105729403	22.0000000284584	0.0170883564610009	0.0845300333812879	nan
sp|P50897|PPT1_HUMAN	metaplastic breast carcinomas-Normal	-0.0415832507884213	0.288442332518819	23.9999999996772	0.886574023018404	0.940415790777734	nan
sp|P50897|PPT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.379567511245536	0.288442332518819	23.9999999996772	0.200631955425557	0.843662073010871	nan
sp|P50897|PPT1_HUMAN	Normal-Triple-negative breast cancer	-0.337984260457115	0.344754527969637	23.9999999996754	0.336687343204504	0.52939864182203	nan
sp|P50914|RL14_HUMAN	metaplastic breast carcinomas-Normal	1.0131065268662	0.324874486397664	23.9999999997775	0.004675636469847	0.0458663504478383	nan
sp|P50914|RL14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0065830176149318	0.324874486397664	23.9999999995951	0.98400088645179	0.99777413090774	nan
sp|P50914|RL14_HUMAN	Normal-Triple-negative breast cancer	-1.00652350925127	0.388299280585305	23.9999999996727	0.0159860218635293	0.0806335913116407	nan
sp|P50990|TCPQ_HUMAN	metaplastic breast carcinomas-Normal	0.408442469351744	0.114363558073353	22.0000000028287	0.0017048064162922	0.0294579152472248	nan
sp|P50990|TCPQ_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.175231567082237	0.114363558073353	22.0000000028628	0.139720011827974	0.823891816737944	nan
sp|P50990|TCPQ_HUMAN	Normal-Triple-negative breast cancer	-0.583674036433981	0.136690596474547	22.0000000027839	0.0003119748504228	0.0227914720285933	nan
sp|P50991|TCPD_HUMAN	metaplastic breast carcinomas-Normal	0.688977018334028	0.167445199540821	22.0000001189259	0.0004560002685191	0.0200356889942306	nan
sp|P50991|TCPD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.250126145694092	0.167445199540821	22.000000119056	0.149438250542041	0.841301410938567	nan
sp|P50991|TCPD_HUMAN	Normal-Triple-negative breast cancer	-0.939103164028121	0.200135292986896	22.0000001190211	0.0001112540724772	0.0227914720285933	nan
sp|P50995|ANX11_HUMAN	metaplastic breast carcinomas-Normal	-0.0484079995855756	0.277580535105262	21.9999972253544	0.863151787848773	0.928817268633642	nan
sp|P50995|ANX11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.777876871202783	0.277580535105262	21.999997225392	0.0103801005964056	0.547668704418496	nan
sp|P50995|ANX11_HUMAN	Normal-Triple-negative breast cancer	0.826284870788359	0.33177219695216	21.9999972301074	0.0207929580768063	0.0948090434119398	nan
sp|P51114|FXR1_HUMAN	metaplastic breast carcinomas-Normal	1.07912781999808	0.248151799664874	22.000000016391	0.0002574422408577	0.0157578323963946	nan
sp|P51114|FXR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.172040857079115	0.248151799664874	22.0000000172607	0.495383278330666	0.913320451076758	nan
sp|P51114|FXR1_HUMAN	Normal-Triple-negative breast cancer	-0.907086962918967	0.296598130417274	22.0000000169117	0.0057591106317531	0.0481913978366351	nan
sp|P51116|FXR2_HUMAN	metaplastic breast carcinomas-Normal	0.562118999188277	0.173432408733572	23.9999999999444	0.0034759940532347	0.0407324763980233	nan
sp|P51116|FXR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0205110106965729	0.173432408733572	23.9999999999444	0.906841838353552	0.993018358159133	nan
sp|P51116|FXR2_HUMAN	Normal-Triple-negative breast cancer	-0.58263000988485	0.207291376704141	23.9999999999497	0.0096857204925414	0.0620611678009953	nan
sp|P51148|RAB5C_HUMAN	metaplastic breast carcinomas-Normal	-0.377920214650025	0.549409780375666	23.9999999997981	0.498132103925841	0.684494052686852	nan
sp|P51148|RAB5C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.616743642696008	0.549409780375666	23.9999999997575	0.27273087972406	0.867696529950794	nan
sp|P51148|RAB5C_HUMAN	Normal-Triple-negative breast cancer	-0.238823428045983	0.656670287753122	23.9999999997541	0.719274825562307	0.837432406363961	nan
sp|P51149|RAB7A_HUMAN	metaplastic breast carcinomas-Normal	0.124338106825633	0.21598286819533	23.9999999997345	0.570187193404318	0.734528007858528	nan
sp|P51149|RAB7A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0552569042269937	0.21598286819533	23.9999999997356	0.800254974553168	0.965774701272009	nan
sp|P51149|RAB7A_HUMAN	Normal-Triple-negative breast cancer	-0.179595011052626	0.258148903193157	23.9999999997128	0.493297045920464	0.670093739533969	nan
sp|P51151|RAB9A_HUMAN	metaplastic breast carcinomas-Normal	0.521974250818151	0.400807842691231	20.2851717471271	0.207405236559978	0.402225791321684	nan
sp|P51151|RAB9A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.259338132806625	0.373335202308649	20.0759593008796	0.495234757355612	0.913320451076758	nan
sp|P51151|RAB9A_HUMAN	Normal-Triple-negative breast cancer	-0.262636118011526	0.464420133569491	20.1686930970549	0.577961865334586	0.736918005512913	nan
sp|P51153|RAB13_HUMAN	metaplastic breast carcinomas-Normal	-0.185941398053681	0.169121888236355	22.0000000564269	0.2834571361235	0.486428250115908	nan
sp|P51153|RAB13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.294691110759307	0.169121888236355	22.0000000560079	0.0953887434602659	0.814943337126966	nan
sp|P51153|RAB13_HUMAN	Normal-Triple-negative breast cancer	0.480632508812988	0.202139319284746	22.0000000559057	0.0265346299791231	0.108975739784405	nan
sp|P51159|RB27A_HUMAN	metaplastic breast carcinomas-Normal	0.447742502286407	0.25307815507883	23.9999999996453	0.0895706209707069	0.241435046240126	nan
sp|P51159|RB27A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.358672940972408	0.25307815507883	23.999999999596	0.169264174344863	0.843662073010871	nan
sp|P51159|RB27A_HUMAN	Normal-Triple-negative breast cancer	-0.0890695613139982	0.302486251347784	23.9999999995556	0.770939670511842	0.869314697292624	nan
sp|P51398|RT29_HUMAN	metaplastic breast carcinomas-Normal	0.37317812849964	0.181986167513943	23.9999999998837	0.051380509037149	0.171819730422015	nan
sp|P51398|RT29_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.157529192269639	0.181986167513943	23.9999999999299	0.395274402300245	0.885234295852111	nan
sp|P51398|RT29_HUMAN	Normal-Triple-negative breast cancer	-0.530707320769279	0.217515073915786	23.9999999998926	0.0224547570553805	0.0989915284510406	nan
sp|P51452|DUS3_HUMAN	metaplastic breast carcinomas-Normal	-0.174013027769849	0.190864097368232	22.0000000120616	0.371803069280891	0.580767576263948	nan
sp|P51452|DUS3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0469721073830901	0.190864097368232	22.0000000123054	0.807884579018483	0.965774701272009	nan
sp|P51452|DUS3_HUMAN	Normal-Triple-negative breast cancer	0.220985135152939	0.228126229669297	22.0000000123406	0.343226336636248	0.535123988264019	nan
sp|P51531|SMCA2_HUMAN	metaplastic breast carcinomas-Normal	-0.102431886831111	0.468126457067095	15.0000000000684	0.829745508825751	0.909492232445857	nan
sp|P51531|SMCA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.26139415222082	0.468126457067095	15.0000000000498	0.584821823322532	0.938678807206619	nan
sp|P51531|SMCA2_HUMAN	Normal-Triple-negative breast cancer	0.363826039051931	0.559518134272941	15.0000000000666	0.525366307769596	0.695444310582923	nan
sp|P51570|GALK1_HUMAN	metaplastic breast carcinomas-Normal	-0.103650031414086	0.259267984421634	23.9999999999733	0.69285471421412	0.820033259296383	nan
sp|P51570|GALK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.46515530178457	0.259267984421634	24.0000000003066	0.0854046760351103	0.806849600316436	nan
sp|P51570|GALK1_HUMAN	Normal-Triple-negative breast cancer	-0.361505270370484	0.309884512465201	24.0000000001757	0.254841284803799	0.445135276241633	nan
sp|P51571|SSRD_HUMAN	metaplastic breast carcinomas-Normal	0.690533274894537	0.258753450994086	23.9999999997569	0.0134353513828309	0.0773988006872268	nan
sp|P51571|SSRD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0036636303102738	0.258753450994086	23.9999999997112	0.98882035933499	0.998185231446144	nan
sp|P51571|SSRD_HUMAN	Normal-Triple-negative breast cancer	-0.686869644584263	0.309269527392137	23.9999999997725	0.0360457509503466	0.126678556343412	nan
sp|P51572|BAP31_HUMAN	metaplastic breast carcinomas-Normal	0.386554240288906	0.308917487480616	23.9999999994415	0.222878518073759	0.421895326923221	nan
sp|P51572|BAP31_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.252125334919241	0.308917487480616	23.9999999992398	0.422437147949052	0.88788356341846	nan
sp|P51572|BAP31_HUMAN	Normal-Triple-negative breast cancer	-0.134428905369665	0.369227018960531	23.9999999993438	0.718984769692322	0.837388007868703	nan
sp|P51580|TPMT_HUMAN	metaplastic breast carcinomas-Normal	0.362630505712331	0.392942486306033	22.99999999983	0.365661258927014	0.576002240523302	nan
sp|P51580|TPMT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.262169075126471	0.392942486306033	22.99999999983	0.51128685617831	0.915620969865368	nan
sp|P51580|TPMT_HUMAN	Normal-Triple-negative breast cancer	-0.624799580838802	0.464935819831204	22.9999999998586	0.192107813425764	0.372776632707086	nan
sp|P51608|MECP2_HUMAN	metaplastic breast carcinomas-Normal	-0.314293718751978	0.292935881567465	22.000000003309	0.294940050813595	0.499005315715621	nan
sp|P51608|MECP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.155302684702302	0.292935881567465	22.0000000026575	0.60131205441251	0.940559810632461	nan
sp|P51608|MECP2_HUMAN	Normal-Triple-negative breast cancer	0.46959640345428	0.350125346350026	22.0000000028648	0.193531146991463	0.375069779849379	nan
sp|P51610|HCFC1_HUMAN	metaplastic breast carcinomas-Normal	0.430044893348705	0.199072850684324	23.9999999998041	0.0409583675196249	0.149775152514008	nan
sp|P51610|HCFC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.309206750234213	0.199072850684324	23.9999999998041	0.133455922366924	0.823891816737944	nan
sp|P51610|HCFC1_HUMAN	Normal-Triple-negative breast cancer	-0.739251643582918	0.237937566479658	23.9999999998667	0.0048070791538289	0.0443853641870203	nan
sp|P51649|SSDH_HUMAN	metaplastic breast carcinomas-Normal	-0.226215218225015	0.424394557294972	22.9999999994858	0.599125691993778	0.757221977257535	nan
sp|P51649|SSDH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.374243370802745	0.424394557294972	22.9999999994858	0.38699254647962	0.885234295852111	nan
sp|P51649|SSDH_HUMAN	Normal-Triple-negative breast cancer	-0.14802815257773	0.502150412094059	22.9999999994638	0.770799911286141	0.869314697292624	nan
sp|P51659|DHB4_HUMAN	metaplastic breast carcinomas-Normal	0.0134541829210236	0.265301396208542	22.0000000069884	0.960011988123451	0.980362472664316	nan
sp|P51659|DHB4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0654754057514304	0.265301396208542	22.000000007011	0.807354235613063	0.965774701272009	nan
sp|P51659|DHB4_HUMAN	Normal-Triple-negative breast cancer	-0.0789295886724541	0.317095818844809	22.0000000074041	0.805736371416612	0.88801979396181	nan
sp|P51665|PSMD7_HUMAN	metaplastic breast carcinomas-Normal	0.481593363710704	0.211338543178854	21.9999999433366	0.0327428039122507	0.129407306133986	nan
sp|P51665|PSMD7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.114033451458096	0.211338543178854	21.9999999435441	0.59490836999892	0.940559810632461	nan
sp|P51665|PSMD7_HUMAN	Normal-Triple-negative breast cancer	-0.595626815168799	0.252597873062418	21.9999999430122	0.0276780924731162	0.111517044374766	nan
sp|P51668|UB2D1_HUMAN;sp|Q9Y2X8|UB2D4_HUMAN	metaplastic breast carcinomas-Normal	0.206522809836843	0.225114910081077	21.9999999311127	0.368875962377913	0.578542078903062	nan
sp|P51668|UB2D1_HUMAN;sp|Q9Y2X8|UB2D4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.146737629801961	0.225114910081077	21.9999999301659	0.52126029793798	0.917607105199968	nan
sp|P51668|UB2D1_HUMAN;sp|Q9Y2X8|UB2D4_HUMAN	Normal-Triple-negative breast cancer	-0.353260439638805	0.269063780916643	21.9999999300691	0.202739500215532	0.382901192452517	nan
sp|P51687|SUOX_HUMAN	metaplastic breast carcinomas-Normal	-0.522577022367682	0.678525348222967	6.0	0.470428492666182	0.661881666495989	nan
sp|P51687|SUOX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.448768373855607	0.678525348222967	6.0	0.532924179100022	0.921388505638487	nan
sp|P51687|SUOX_HUMAN	Normal-Triple-negative breast cancer	0.0738086485120747	0.810992908354672	6.0	0.930446798184199	0.961693145884415	nan
sp|P51812|KS6A3_HUMAN	metaplastic breast carcinomas-Normal	-1.20104197937107	0.446010287098481	23.9999999993984	0.0127130832271408	0.07439839550531	nan
sp|P51812|KS6A3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.111673884077285	0.446010287098481	23.9999999993984	0.804421318189636	0.965774701272009	nan
sp|P51812|KS6A3_HUMAN	Normal-Triple-negative breast cancer	1.31271586344835	0.533084255197551	23.9999999993869	0.0213602470335944	0.0962079419236691	nan
sp|P51858|HDGF_HUMAN	metaplastic breast carcinomas-Normal	0.589813566339103	0.289357673642455	22.0000000249448	0.0537124211908287	0.176597515369253	nan
sp|P51858|HDGF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.371651041911248	0.289357673642455	22.0000000255477	0.212362920154794	0.843662073010871	nan
sp|P51858|HDGF_HUMAN	Normal-Triple-negative breast cancer	-0.96146460825035	0.345848569867907	22.0000000252742	0.0109194572594824	0.0669672987647959	nan
sp|P51884|LUM_HUMAN	metaplastic breast carcinomas-Normal	-1.89758629797784	0.556291073230969	22.0000000010118	0.002503837490113	0.0358739474876542	nan
sp|P51884|LUM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.634292558096659	0.556291073230969	22.0000000001212	0.266457637183932	0.866437412304381	nan
sp|P51884|LUM_HUMAN	Normal-Triple-negative breast cancer	2.5318788560745	0.664895005842989	22.000000000798	0.000962367753066	0.0259501424890038	nan
sp|P51888|PRELP_HUMAN	metaplastic breast carcinomas-Normal	-0.688184321095869	0.585521646177636	23.999999999226	0.251389424910885	0.451929934236767	nan
sp|P51888|PRELP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.689731279159357	0.585521646177636	23.9999999991891	0.250354564866724	0.853132115889912	nan
sp|P51888|PRELP_HUMAN	Normal-Triple-negative breast cancer	1.37791560025523	0.699832222896081	23.9999999992319	0.0606133988159135	0.177268633173166	nan
sp|P51911|CNN1_HUMAN	metaplastic breast carcinomas-Normal	-1.41779953030198	0.635138208401121	22.0000001354835	0.036097796655094	0.13776013327386	nan
sp|P51911|CNN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.975628216634964	0.635138208401121	22.0000001346158	0.138774945611876	0.823891816737944	nan
sp|P51911|CNN1_HUMAN	Normal-Triple-negative breast cancer	0.442171313667018	0.75913535756241	22.000000134806	0.566174606210393	0.727697294239603	nan
sp|P51991|ROA3_HUMAN	metaplastic breast carcinomas-Normal	0.751525208047462	0.216478026000533	21.9999416349906	0.0021667141642609	0.0333433235277928	nan
sp|P51991|ROA3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.3502443194926	0.216478026000533	21.999941623869	0.119928839865059	0.823891816737944	nan
sp|P51991|ROA3_HUMAN	Normal-Triple-negative breast cancer	-1.10176952754006	0.258740729968072	21.9999416293341	0.0003211332430796	0.0227914720285933	nan
sp|P52209|6PGD_HUMAN	metaplastic breast carcinomas-Normal	-0.28797311567895	0.335072481611582	23.9999999995597	0.39860382335985	0.601923998636815	nan
sp|P52209|6PGD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.160705506053752	0.335072481611582	23.9999999995597	0.635843602656273	0.941868024951375	nan
sp|P52209|6PGD_HUMAN	Normal-Triple-negative breast cancer	0.127267609625197	0.400488216222835	23.9999999995887	0.753399394472573	0.858093857556366	nan
sp|P52272|HNRPM_HUMAN	metaplastic breast carcinomas-Normal	0.67174825673031	0.208859560596737	23.9999999996423	0.0036922708770922	0.0407324763980233	nan
sp|P52272|HNRPM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.249748151173147	0.208859560596737	23.9999999996423	0.243467351477778	0.84964799869723	nan
sp|P52272|HNRPM_HUMAN	Normal-Triple-negative breast cancer	-0.921496407903457	0.249634922158231	23.9999999996496	0.0011447115731281	0.026613045414958	nan
sp|P52292|IMA1_HUMAN	metaplastic breast carcinomas-Normal	0.609327318484841	0.310832011536013	21.9999999932766	0.0627448214221488	0.191918875745801	nan
sp|P52292|IMA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0531107706476933	0.310832011536013	21.9999999932163	0.865890502445586	0.980530611231673	nan
sp|P52292|IMA1_HUMAN	Normal-Triple-negative breast cancer	-0.556216547837148	0.371515312884801	21.9999999924282	0.148563163973969	0.315340968741682	nan
sp|P52306|GDS1_HUMAN	metaplastic breast carcinomas-Normal	0.198429962326728	0.133655456195847	22.0000039763412	0.151827901742097	0.331805355286476	nan
sp|P52306|GDS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.151658125670188	0.133655456195847	22.0000039768782	0.268715678641892	0.867455952897369	nan
sp|P52306|GDS1_HUMAN	Normal-Triple-negative breast cancer	-0.350088087996916	0.159748825038916	22.0000039768774	0.039294091490628	0.132496466096553	nan
sp|P52565|GDIR1_HUMAN	metaplastic breast carcinomas-Normal	-0.0200658474931169	0.157752187047216	23.9999999994811	0.899843002745306	0.94594501616869	nan
sp|P52565|GDIR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.147933543139982	0.157752187047216	23.9999999994801	0.357710201919958	0.883542279876718	nan
sp|P52565|GDIR1_HUMAN	Normal-Triple-negative breast cancer	-0.127867695646865	0.188549927143904	23.9999999994854	0.504154634610738	0.677916668869779	nan
sp|P52566|GDIR2_HUMAN	metaplastic breast carcinomas-Normal	0.0742508433355643	0.436521777285166	23.9999999996913	0.866359953524134	0.930161655527849	nan
sp|P52566|GDIR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0515335985881644	0.436521777285166	23.9999999996913	0.907006542474973	0.993018358159133	nan
sp|P52566|GDIR2_HUMAN	Normal-Triple-negative breast cancer	-0.0227172447473999	0.521743316808727	23.9999999997249	0.965630492452639	0.982929910189078	nan
sp|P52594|AGFG1_HUMAN	metaplastic breast carcinomas-Normal	0.312373260803731	0.224893834771273	21.9999653775406	0.178740028600007	0.367883501589116	nan
sp|P52594|AGFG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0928296444260804	0.224893834771273	21.999965377808	0.683769521784508	0.946568877415162	nan
sp|P52594|AGFG1_HUMAN	Normal-Triple-negative breast cancer	-0.405202905229812	0.268799545381548	21.9999653749289	0.14592085987735	0.310843727714765	nan
sp|P52597|HNRPF_HUMAN	metaplastic breast carcinomas-Normal	0.546339564782981	0.252859812034141	21.9999999733735	0.0418804207437491	0.152142643226472	nan
sp|P52597|HNRPF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.404666077211196	0.252859812034141	21.9999999730976	0.123782692364645	0.823891816737944	nan
sp|P52597|HNRPF_HUMAN	Normal-Triple-negative breast cancer	-0.951005641994177	0.302225281494122	21.9999999732421	0.0046839984170549	0.0436121424321106	nan
sp|P52701|MSH6_HUMAN	metaplastic breast carcinomas-Normal	1.30398146918345	0.376431699937574	23.9999999991004	0.002013466737448	0.0320881648658721	nan
sp|P52701|MSH6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.226931734839788	0.376431699937574	23.999999999099	0.55226327964916	0.931642387063667	nan
sp|P52701|MSH6_HUMAN	Normal-Triple-negative breast cancer	-1.07704973434366	0.449921937225769	23.9999999991567	0.0248414538477045	0.10516426302168	nan
sp|P52735|VAV2_HUMAN	metaplastic breast carcinomas-Normal	0.264145185709594	0.260726367811246	22.0000000022094	0.322019686128378	0.529897740936004	nan
sp|P52735|VAV2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.113170570603096	0.260726367811245	22.0000000010307	0.668472867559158	0.946277260710207	nan
sp|P52735|VAV2_HUMAN	Normal-Triple-negative breast cancer	-0.37731575631269	0.311627614015843	22.0000000014015	0.238823053448776	0.425427561448945	nan
sp|P52788|SPSY_HUMAN	metaplastic breast carcinomas-Normal	0.0387030790946064	0.182166784801887	15.0000000000577	0.834608697627489	0.912407687537956	nan
sp|P52788|SPSY_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.256908983642775	0.182166784801887	15.0000000002092	0.17885194309767	0.843662073010871	nan
sp|P52788|SPSY_HUMAN	Normal-Triple-negative breast cancer	-0.295612062737382	0.217730952865677	15.0000000000759	0.194635871684624	0.37574072096641	nan
sp|P52789|HXK2_HUMAN	metaplastic breast carcinomas-Normal	-0.215496499568772	0.35453339837317	14.9999999997653	0.552391651897086	0.72346329822928	nan
sp|P52789|HXK2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.160441424284695	0.35453339837317	14.9999999997643	0.657354436858899	0.944190045212043	nan
sp|P52789|HXK2_HUMAN	Normal-Triple-negative breast cancer	0.0550550752840771	0.423748460700161	14.9999999998208	0.898352876041019	0.941085638149985	nan
sp|P52790|HXK3_HUMAN	metaplastic breast carcinomas-Normal	0.6030909843617	0.348190168574108	22.0000000347024	0.0972600514999261	0.251765208771212	nan
sp|P52790|HXK3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.28776829510151	0.348190168574108	22.0000000347031	0.417411984184363	0.8860071777014	nan
sp|P52790|HXK3_HUMAN	Normal-Triple-negative breast cancer	-0.31532268926019	0.416166850968739	22.0000000349492	0.456680273799355	0.638891090113239	nan
sp|P52815|RM12_HUMAN	metaplastic breast carcinomas-Normal	0.618305622827789	0.304670218396032	22.0000006207214	0.0546835544181673	0.178554160005882	nan
sp|P52815|RM12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.678694646178918	0.304670218396032	22.0000006202289	0.0364485794836427	0.73123935744099	nan
sp|P52815|RM12_HUMAN	Normal-Triple-negative breast cancer	-1.29700026900671	0.364150561439095	22.0000006202804	0.0017451724780428	0.0289979437553501	nan
sp|P52888|THOP1_HUMAN	metaplastic breast carcinomas-Normal	-0.937415422962915	0.542444606901999	14.9999999998775	0.104488404942196	0.262722736783554	nan
sp|P52888|THOP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.13463902096517	0.542444606901999	14.9999999998507	0.807339485799692	0.965774701272009	nan
sp|P52888|THOP1_HUMAN	Normal-Triple-negative breast cancer	0.802776401997745	0.648345313148418	14.99999999986	0.23467410886658	0.41938534294221	nan
sp|P52895|AK1C2_HUMAN	metaplastic breast carcinomas-Normal	-1.08430801641726	0.49336167500992	13.9999998663904	0.0452870262641471	0.159129202788283	nan
sp|P52895|AK1C2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.643397209310698	0.493361675009919	13.9999998652651	0.21323123182547	0.843662073010871	nan
sp|P52895|AK1C2_HUMAN	Normal-Triple-negative breast cancer	0.440910807106564	0.589679988720993	13.9999998656094	0.46700842935497	0.646537284121583	nan
sp|P52907|CAZA1_HUMAN	metaplastic breast carcinomas-Normal	0.359390482010841	0.220224133968322	22.0000000052922	0.116927197690626	0.282336118991185	nan
sp|P52907|CAZA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0313393824513765	0.220224133968322	22.0000000053794	0.888132936469351	0.98730926571735	nan
sp|P52907|CAZA1_HUMAN	Normal-Triple-negative breast cancer	-0.328051099559464	0.263218185384829	22.0000000052559	0.225759318518964	0.408505157733826	nan
sp|P52926|HMGA2_HUMAN	metaplastic breast carcinomas-Normal	0.802244937105459	1.17832902778032	4.0	0.533348957245212	0.710277217100594	nan
sp|P52926|HMGA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.46051044412732	1.52121623364865	4.0	0.391377239709125	0.885234295852111	nan
sp|P52926|HMGA2_HUMAN	Normal-Triple-negative breast cancer	-2.26275538123278	1.66640889202484	4.0	0.246054517210562	0.434814043172732	nan
sp|P52943|CRIP2_HUMAN	metaplastic breast carcinomas-Normal	-0.11931814133823	0.316569963462235	22.000004982137	0.709852121696061	0.835150965157955	nan
sp|P52943|CRIP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.669522471344651	0.316569963462235	22.0000049820297	0.0459967094467133	0.759166737802103	nan
sp|P52943|CRIP2_HUMAN	Normal-Triple-negative breast cancer	-0.550204330006421	0.378373477186007	22.0000049821458	0.160028956352739	0.329864241010448	nan
sp|P52948|NUP98_HUMAN	metaplastic breast carcinomas-Normal	0.608362933125787	0.169777602418014	23.9999999993968	0.0014985798941249	0.0281210167842065	nan
sp|P52948|NUP98_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.164685511042646	0.169777602418014	23.9999999993968	0.341717744961087	0.870943310236299	nan
sp|P52948|NUP98_HUMAN	Normal-Triple-negative breast cancer	-0.773048444168433	0.202923047634211	23.9999999994412	0.0008513508077738	0.0257262735003663	nan
sp|P53004|BIEA_HUMAN	metaplastic breast carcinomas-Normal	-0.179547981992942	0.213006988292911	23.9999999997498	0.407595322720167	0.609742057930618	nan
sp|P53004|BIEA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0577718482643187	0.213006988292911	23.9999999995725	0.788540686929276	0.962981271203673	nan
sp|P53004|BIEA_HUMAN	Normal-Triple-negative breast cancer	0.237319830257261	0.254592046395844	23.9999999996633	0.360538541861856	0.55139307856607	nan
sp|P53007|TXTP_HUMAN	metaplastic breast carcinomas-Normal	0.190682773902205	0.320573756599874	22.0000000442047	0.558034532139034	0.727985394360342	nan
sp|P53007|TXTP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.228947186116074	0.320573756599875	22.0000000433655	0.482625547232776	0.913320451076758	nan
sp|P53007|TXTP_HUMAN	Normal-Triple-negative breast cancer	-0.419629960018279	0.38315892528997	22.0000000433746	0.28528094784568	0.477479290351984	nan
sp|P53041|PPP5_HUMAN	metaplastic breast carcinomas-Normal	-0.336929499481519	0.388584522484163	22.000000059915	0.395263344099528	0.599660135000835	nan
sp|P53041|PPP5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0879254843394313	0.388584522484163	22.0000000592877	0.823079561216689	0.965774701272009	nan
sp|P53041|PPP5_HUMAN	Normal-Triple-negative breast cancer	0.42485498382095	0.464447338417615	22.0000000595604	0.370238638472474	0.560415862605876	nan
sp|P53365|ARFP2_HUMAN	metaplastic breast carcinomas-Normal	0.227659679586497	0.534166954217213	11.9999999997226	0.677510270232199	0.811547437207867	nan
sp|P53365|ARFP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.466420854873896	0.483172189785122	11.9999999997259	0.35343125018419	0.878295147131863	nan
sp|P53365|ARFP2_HUMAN	Normal-Triple-negative breast cancer	0.238761175287399	0.602621597664414	11.9999999997056	0.698909094523553	0.823820507161805	nan
sp|P53367|ARFP1_HUMAN	metaplastic breast carcinomas-Normal	0.155063135552671	0.15200763228015	22.0000012547316	0.318768039097438	0.526350188622422	nan
sp|P53367|ARFP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.236493717160829	0.15200763228015	22.0000012547316	0.134024687548448	0.823891816737944	nan
sp|P53367|ARFP1_HUMAN	Normal-Triple-negative breast cancer	-0.391556852713499	0.181683870938418	22.0000012547524	0.0423562984279782	0.139813640491162	nan
sp|P53384|NUBP1_HUMAN	metaplastic breast carcinomas-Normal	0.249652361911241	0.369412012844974	14.9999999999537	0.509447067236675	0.693305382041517	nan
sp|P53384|NUBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.416770364868778	0.369412012844974	14.9999999999537	0.276958242875096	0.867696529950794	nan
sp|P53384|NUBP1_HUMAN	Normal-Triple-negative breast cancer	-0.666422726780018	0.441531806384118	14.9999999999345	0.15198563291079	0.31972470314917	nan
sp|P53396|ACLY_HUMAN	metaplastic breast carcinomas-Normal	0.491784007806822	0.217279272281721	23.9999999993922	0.0329357045265793	0.129407306133986	nan
sp|P53396|ACLY_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.118318250061467	0.217279272281721	23.9999999994256	0.591091065668933	0.940559810632461	nan
sp|P53396|ACLY_HUMAN	Normal-Triple-negative breast cancer	-0.373465757745355	0.259698402446471	23.9999999994091	0.163325605896621	0.333286836250319	nan
sp|P53582|MAP11_HUMAN	metaplastic breast carcinomas-Normal	0.0728486669060462	0.180373938177278	22.0000000490681	0.690203088081317	0.818757775620021	nan
sp|P53582|MAP11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.272973197646636	0.180373938177278	22.0000000486504	0.144419245036919	0.827647387111815	nan
sp|P53582|MAP11_HUMAN	Normal-Triple-negative breast cancer	-0.345821864552683	0.215588091287796	22.0000000491127	0.122955984665583	0.276549147152136	nan
sp|P53597|SUCA_HUMAN	metaplastic breast carcinomas-Normal	-0.126508741504113	0.272851537266354	22.0000000036767	0.647450205478566	0.790350526261752	nan
sp|P53597|SUCA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.289398592546464	0.272851537266354	22.0000000038354	0.300357251046272	0.867696529950794	nan
sp|P53597|SUCA_HUMAN	Normal-Triple-negative breast cancer	-0.162889851042351	0.326119963441616	22.0000000037106	0.622400995918458	0.771675087815351	nan
sp|P53602|MVD1_HUMAN	metaplastic breast carcinomas-Normal	0.579964464191576	0.329039770685423	21.9999993908288	0.0918573928960729	0.245248171876744	nan
sp|P53602|MVD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0602895500354272	0.329039770685423	21.9999993910548	0.856296681814892	0.977691255315669	nan
sp|P53602|MVD1_HUMAN	Normal-Triple-negative breast cancer	-0.519674914156148	0.393277747532046	21.999999391896	0.199948403182276	0.380657784752511	nan
sp|P53609|PGTB1_HUMAN	metaplastic breast carcinomas-Normal	-0.0026123181118126	0.187008621605882	14.9999999996538	0.989038839918343	0.994165301306939	nan
sp|P53609|PGTB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0306705787264836	0.187008621605882	14.9999999994536	0.871915719675099	0.981704007186169	nan
sp|P53609|PGTB1_HUMAN	Normal-Triple-negative breast cancer	-0.0280582606146709	0.22351805473554	14.999999999581	0.901770845686398	0.942605751906159	nan
sp|P53611|PGTB2_HUMAN	metaplastic breast carcinomas-Normal	0.11027509647699	0.110849138014357	22.0000082287064	0.330639841385687	0.539277150523073	nan
sp|P53611|PGTB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0965995368569473	0.110849138014357	22.0000082287075	0.39291913252603	0.885234295852111	nan
sp|P53611|PGTB2_HUMAN	Normal-Triple-negative breast cancer	-0.0136755596200426	0.132490061074816	22.0000082287704	0.918723895332778	0.953503798850578	nan
sp|P53618|COPB_HUMAN	metaplastic breast carcinomas-Normal	0.599421342083334	0.167962202311534	23.99999999938	0.0015535712515822	0.0282214103166084	nan
sp|P53618|COPB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.059502023063431	0.167962202311534	23.99999999938	0.726238870312031	0.953491935272676	nan
sp|P53618|COPB_HUMAN	Normal-Triple-negative breast cancer	-0.658923365146765	0.200753229489557	23.9999999993939	0.0031450993921702	0.037336569687701	nan
sp|P53621|COPA_HUMAN	metaplastic breast carcinomas-Normal	0.396727121829457	0.15971369801168	23.9999999996288	0.0203663622984697	0.0968494825180447	nan
sp|P53621|COPA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.116650020774111	0.15971369801168	23.9999999996288	0.472234299739793	0.912894794555123	nan
sp|P53621|COPA_HUMAN	Normal-Triple-negative breast cancer	-0.513377142603569	0.190894381166154	23.9999999996208	0.0128163101301542	0.0732073823943651	nan
sp|P53634|CATC_HUMAN	metaplastic breast carcinomas-Normal	-0.230151380175761	0.401185269131341	13.999993772232	0.575286142162284	0.737466693616442	nan
sp|P53634|CATC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.508906666823566	0.401185269131341	13.9999937785289	0.225304257845586	0.843662073010871	nan
sp|P53634|CATC_HUMAN	Normal-Triple-negative breast cancer	0.739058046999327	0.479508111309297	13.9999937804238	0.145542888877519	0.31071583983871	nan
sp|P53814|SMTN_HUMAN	metaplastic breast carcinomas-Normal	0.481903805221504	0.575096297572044	7.06343931291959	0.429496429811692	0.626846629119879	nan
sp|P53814|SMTN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.941294392596477	0.575096297572044	7.06343931290762	0.145308430017356	0.827647387111815	nan
sp|P53814|SMTN_HUMAN	Normal-Triple-negative breast cancer	0.459390587374973	0.665581048661427	7.00000247951297	0.512289458497596	0.685527439632049	nan
sp|P53985|MOT1_HUMAN	metaplastic breast carcinomas-Normal	0.788623100071595	0.278185566540304	22.0000000054088	0.0096394064881617	0.0650005124722237	nan
sp|P53985|MOT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.631931486478157	0.278185566540304	22.0000000054462	0.0332399077715895	0.724424466074313	nan
sp|P53985|MOT1_HUMAN	Normal-Triple-negative breast cancer	-0.156691613593438	0.332495347832868	22.0000000055611	0.642095102059365	0.787864200533529	nan
sp|P53990|IST1_HUMAN	metaplastic breast carcinomas-Normal	0.262497581581593	0.194428803836093	22.0000000056417	0.190712679516048	0.384199361643239	nan
sp|P53990|IST1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.006149000381454	0.194428803836093	22.0000000045572	0.975055498669194	0.99709406933403	nan
sp|P53990|IST1_HUMAN	Normal-Triple-negative breast cancer	-0.268646581963047	0.232386868823563	22.0000000051142	0.260068559871935	0.451040274578656	nan
sp|P53992|SC24C_HUMAN	metaplastic breast carcinomas-Normal	0.359804420922614	0.138531120536352	22.0000000270627	0.0164442186222573	0.0857398039769952	nan
sp|P53992|SC24C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0652771326875295	0.138531120536352	22.0000000268694	0.642130530541236	0.941868024951375	nan
sp|P53992|SC24C_HUMAN	Normal-Triple-negative breast cancer	-0.425081553610144	0.165576358548199	22.0000000274183	0.0175712142507669	0.085435927255054	nan
sp|P53999|TCP4_HUMAN	metaplastic breast carcinomas-Normal	0.688604001964742	0.300534545875999	22.000005485537	0.0318918806757322	0.128466389195289	nan
sp|P53999|TCP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.004735123677438	0.300534545875999	22.0000054857298	0.987571327764623	0.99777413090774	nan
sp|P53999|TCP4_HUMAN	Normal-Triple-negative breast cancer	-0.683868878287304	0.359207487324314	22.0000054855655	0.0700951739332773	0.192558973681169	nan
sp|P54105|ICLN_HUMAN	metaplastic breast carcinomas-Normal	-0.297015229279919	0.333105191455188	20.9976552090928	0.382681628751861	0.589002717867072	nan
sp|P54105|ICLN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.107516865118389	0.333105191455188	20.9976552085849	0.750060331690253	0.954643368861838	nan
sp|P54105|ICLN_HUMAN	Normal-Triple-negative breast cancer	0.18949836416153	0.393893857263804	20.976852555497	0.635432686583489	0.781906844086648	nan
sp|P54136|SYRC_HUMAN	metaplastic breast carcinomas-Normal	0.481421103099307	0.144080500145128	23.9999999993076	0.0027224847462551	0.0374448413967682	nan
sp|P54136|SYRC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0082277962112973	0.144080500145128	23.9999999995406	0.954933900178664	0.99696934025474	nan
sp|P54136|SYRC_HUMAN	Normal-Triple-negative breast cancer	-0.489648899310604	0.172209135820665	23.9999999993855	0.0089759624855063	0.0594985311923575	nan
sp|P54577|SYYC_HUMAN	metaplastic breast carcinomas-Normal	0.6515852341588	0.233729676395193	21.9999999988847	0.0107291590207942	0.0689820591588391	nan
sp|P54577|SYYC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.318184597761036	0.233729676395193	22.0000000000363	0.187188729841997	0.843662073010871	nan
sp|P54577|SYYC_HUMAN	Normal-Triple-negative breast cancer	-0.969769831919836	0.279360396078004	21.9999999999186	0.002167782894289	0.032066107359435	nan
sp|P54578|UBP14_HUMAN	metaplastic breast carcinomas-Normal	0.131999178113642	0.132124736207282	22.0000000279696	0.328633108214862	0.537851527181782	nan
sp|P54578|UBP14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.380524045535325	0.132124736207282	22.0000000278694	0.0086944002519366	0.547668704418496	nan
sp|P54578|UBP14_HUMAN	Normal-Triple-negative breast cancer	-0.512523223648967	0.157919264715703	22.0000000279966	0.0037116199478014	0.0400819560687694	nan
sp|P54619|AAKG1_HUMAN	metaplastic breast carcinomas-Normal	-0.207078756226655	0.269587008766808	13.9999999978755	0.455170069010385	0.649292975206949	nan
sp|P54619|AAKG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.517541385241634	0.269587008766808	13.9999999980511	0.0755010201887966	0.795994790325479	nan
sp|P54619|AAKG1_HUMAN	Normal-Triple-negative breast cancer	0.724620141468289	0.322218105582971	13.9999999979004	0.0411430248574794	0.137170927408487	nan
sp|P54652|HSP72_HUMAN	metaplastic breast carcinomas-Normal	-0.10326277665078	0.637334716778295	17.3753701708443	0.873157107973311	0.933539474719616	nan
sp|P54652|HSP72_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0234375018236722	0.553709823676258	17.447961655074	0.966717745463207	0.99709406933403	nan
sp|P54652|HSP72_HUMAN	Normal-Triple-negative breast cancer	0.126700278474452	0.727441728742198	17.816124052447	0.863693812880293	0.921503984775206	nan
sp|P54709|AT1B3_HUMAN	metaplastic breast carcinomas-Normal	-0.0925523897930759	0.238134931700542	23.9999999998051	0.700957762895874	0.827408950236465	nan
sp|P54709|AT1B3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0444946855067542	0.238134931700542	23.9999999998051	0.853351461989012	0.977401079052892	nan
sp|P54709|AT1B3_HUMAN	Normal-Triple-negative breast cancer	0.0480577042863217	0.28462568325038	23.9999999997966	0.86733330712529	0.922860407453414	nan
sp|P54725|RD23A_HUMAN	metaplastic breast carcinomas-Normal	-0.0429453864796002	0.175175814644399	23.9999999991958	0.808419843194947	0.899627572407098	nan
sp|P54725|RD23A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0590546864248779	0.175175814644399	23.9999999991958	0.738959381526421	0.954643368861838	nan
sp|P54725|RD23A_HUMAN	Normal-Triple-negative breast cancer	-0.0161092999452777	0.209375145326445	23.9999999992557	0.939309196628227	0.966645129904714	nan
sp|P54727|RD23B_HUMAN	metaplastic breast carcinomas-Normal	-0.0897336645246805	0.139472937264273	23.9999999998692	0.526079960063106	0.703981395833238	nan
sp|P54727|RD23B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0275258723833256	0.139472937264273	24.000000000076	0.845210594598816	0.973108514760438	nan
sp|P54727|RD23B_HUMAN	Normal-Triple-negative breast cancer	0.117259536908006	0.16670204484616	23.9999999999086	0.488569961457835	0.665576455690919	nan
sp|P54819|KAD2_HUMAN	metaplastic breast carcinomas-Normal	0.283733617893397	0.231674230557249	22.0000000192	0.233637114174309	0.433797107962684	nan
sp|P54819|KAD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.421061732254152	0.231674230557249	22.0000000188545	0.0827913401984599	0.806849600316436	nan
sp|P54819|KAD2_HUMAN	Normal-Triple-negative breast cancer	-0.704795350147549	0.276903668407556	22.0000000182921	0.018443743460766	0.0878323828991207	nan
sp|P54821|PRRX1_HUMAN	metaplastic breast carcinomas-Normal	0.330166251574466	0.437435698740681	6.0	0.478950925471149	0.668640435223057	nan
sp|P54821|PRRX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.767228275017415	0.437435698740681	6.0	0.129983468391737	0.823891816737944	nan
sp|P54821|PRRX1_HUMAN	Normal-Triple-negative breast cancer	-1.09739452659188	0.522835661879043	6.0	0.0805970343747843	0.211447941800934	nan
sp|P54868|HMCS2_HUMAN	metaplastic breast carcinomas-Normal	-2.48734551768644	1.39137768947541	4.0	0.148349994175256	0.326350351183687	nan
sp|P54868|HMCS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-6.69074832226807	1.79626087320761	4.0	0.0203886686362968	0.70617003349674	nan
sp|P54868|HMCS2_HUMAN	Normal-Triple-negative breast cancer	-4.20340280458164	1.96770519883947	4.0	0.0995123208627748	0.242219740646098	nan
sp|P54886|P5CS_HUMAN	metaplastic breast carcinomas-Normal	0.733667218133061	0.287745008135374	23.9999999995768	0.0175875352767964	0.0895151554375756	nan
sp|P54886|P5CS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.371777233085982	0.287745008135374	23.9999999993455	0.208647665496173	0.843662073010871	nan
sp|P54886|P5CS_HUMAN	Normal-Triple-negative breast cancer	-1.10544445121904	0.343921065916556	23.9999999994263	0.0037104738457996	0.0400819560687694	nan
sp|P54920|SNAA_HUMAN	metaplastic breast carcinomas-Normal	0.141216693762561	0.23220026887633	23.999999999638	0.548789059029378	0.722159474352198	nan
sp|P54920|SNAA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.332071519044521	0.23220026887633	23.9999999996673	0.16557652705206	0.843662073010871	nan
sp|P54920|SNAA_HUMAN	Normal-Triple-negative breast cancer	-0.473288212807082	0.277532404456128	23.9999999996425	0.101042212186842	0.244442731665984	nan
sp|P55001|MFAP2_HUMAN	metaplastic breast carcinomas-Normal	0.469314417060961	0.306918030249848	22.0000000245061	0.14048688960337	0.315739297526439	nan
sp|P55001|MFAP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.560366857530726	0.306918030249848	22.000000024507	0.0814877428145616	0.806849600316436	nan
sp|P55001|MFAP2_HUMAN	Normal-Triple-negative breast cancer	0.0910524404697645	0.366837210475177	22.0000000243648	0.806274577857404	0.888025877792472	nan
sp|P55008|AIF1_HUMAN	metaplastic breast carcinomas-Normal	-0.016532271380454	0.368775362302125	22.0000003219225	0.964647090420466	0.982981891035447	nan
sp|P55008|AIF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.464037312083786	0.368775362302125	22.0000003224006	0.221467135902039	0.843662073010871	nan
sp|P55008|AIF1_HUMAN	Normal-Triple-negative breast cancer	0.48056958346424	0.440770863441156	22.0000003226008	0.287382254753332	0.479824851705054	nan
sp|P55010|IF5_HUMAN	metaplastic breast carcinomas-Normal	0.227035991219111	0.218812669539987	22.0000000057149	0.310735299170625	0.518776561749451	nan
sp|P55010|IF5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.154230718852425	0.218812669539987	22.0000000059226	0.488297547863222	0.913320451076758	nan
sp|P55010|IF5_HUMAN	Normal-Triple-negative breast cancer	-0.0728052723666864	0.261531162719024	22.0000000055635	0.78331973791795	0.876390039999753	nan
sp|P55036|PSMD4_HUMAN	metaplastic breast carcinomas-Normal	0.395552967991983	0.193839606012052	23.9999999999754	0.0524359171150506	0.174196897878967	nan
sp|P55036|PSMD4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.198137331550483	0.193839606012052	23.9999999999321	0.316893282837535	0.867696529950794	nan
sp|P55036|PSMD4_HUMAN	Normal-Triple-negative breast cancer	-0.593690299542466	0.231682642727712	24.0000000000303	0.0170891042214878	0.0845300333812879	nan
sp|P55039|DRG2_HUMAN	metaplastic breast carcinomas-Normal	0.238004484174058	0.249504624325656	23.9999999988362	0.349639895401913	0.559356361662505	nan
sp|P55039|DRG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.102752496512011	0.249504624325656	23.9999999989908	0.684121897525709	0.946568877415162	nan
sp|P55039|DRG2_HUMAN	Normal-Triple-negative breast cancer	-0.340756980686069	0.298215065155254	23.9999999988566	0.264453193179121	0.455462390739585	nan
sp|P55058|PLTP_HUMAN	metaplastic breast carcinomas-Normal	-0.78369478357905	0.399998858880596	6.0	0.0977977908882793	0.252341052717084	nan
sp|P55058|PLTP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.016924757809398	0.399998858880596	6.0	0.967622880567258	0.99709406933403	nan
sp|P55058|PLTP_HUMAN	Normal-Triple-negative breast cancer	0.766770025769652	0.478090079835199	6.0	0.159875246032806	0.329864241010448	nan
sp|P55060|XPO2_HUMAN	metaplastic breast carcinomas-Normal	0.502933214389481	0.224818435416052	21.9999999972109	0.035737965102699	0.13717436027872	nan
sp|P55060|XPO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.476064254591573	0.224818435416052	21.9999999974311	0.045751057563544	0.759166737802103	nan
sp|P55060|XPO2_HUMAN	Normal-Triple-negative breast cancer	-0.978997468981054	0.268709425915062	21.9999999974075	0.0014335439935719	0.0270744331513255	nan
sp|P55072|TERA_HUMAN	metaplastic breast carcinomas-Normal	0.235379931915163	0.146036681176606	22.0000000028842	0.121263311337065	0.289653617034366	nan
sp|P55072|TERA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.026073376327331	0.146036681176606	22.0000000027113	0.859932902259294	0.979177437622147	nan
sp|P55072|TERA_HUMAN	Normal-Triple-negative breast cancer	-0.209306555587832	0.174547219354524	22.0000000023368	0.243230191945343	0.431198484280704	nan
sp|P55083|MFAP4_HUMAN	metaplastic breast carcinomas-Normal	-2.31933402945914	0.59993209463221	6.0	0.0083043533512965	0.0602818106368712	nan
sp|P55083|MFAP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0179129462103542	0.59993209463221	6.0	0.977148469323627	0.99709406933403	nan
sp|P55083|MFAP4_HUMAN	Normal-Triple-negative breast cancer	2.30142108324878	0.717056003162326	6.0	0.0183776400118553	0.087643149783941	nan
sp|P55084|ECHB_HUMAN	metaplastic breast carcinomas-Normal	0.0920720274455789	0.215016006375268	23.9999999996589	0.672316586899954	0.808148806621432	nan
sp|P55084|ECHB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.191941438160856	0.215016006375268	23.9999999994507	0.380890014043416	0.885234295852111	nan
sp|P55084|ECHB_HUMAN	Normal-Triple-negative breast cancer	-0.284013465606435	0.256993282284546	23.9999999995338	0.280055356827085	0.471821594573355	nan
sp|P55145|MANF_HUMAN	metaplastic breast carcinomas-Normal	0.836240100507229	0.279647629823002	23.9999999993331	0.0063498190207581	0.0524492501891023	nan
sp|P55145|MANF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.192405589023959	0.279647629823002	23.9999999992915	0.498031366811817	0.913320451076758	nan
sp|P55145|MANF_HUMAN	Normal-Triple-negative breast cancer	-0.64383451148327	0.334242847697006	23.9999999993266	0.0659973598785254	0.186226845701374	nan
sp|P55160|NCKPL_HUMAN	metaplastic breast carcinomas-Normal	0.335547604736125	0.29640570165233	23.999999999568	0.268795656045419	0.471491694298138	nan
sp|P55160|NCKPL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.142238776423783	0.29640570165233	23.999999999568	0.635658221730978	0.941868024951375	nan
sp|P55160|NCKPL_HUMAN	Normal-Triple-negative breast cancer	-0.193308828312342	0.354272574584699	23.9999999995607	0.590342645262031	0.745271155659321	nan
sp|P55196|AFAD_HUMAN	metaplastic breast carcinomas-Normal	0.363538521189457	0.237364883266468	23.9999999993751	0.138707481318805	0.312797603733859	nan
sp|P55196|AFAD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.2816622924045	0.237364883266468	23.9999999993751	0.246990819166382	0.84964799869723	nan
sp|P55196|AFAD_HUMAN	Normal-Triple-negative breast cancer	-0.645200813593957	0.283705299331401	23.9999999994778	0.0321826376668327	0.120603255473001	nan
sp|P55209|NP1L1_HUMAN	metaplastic breast carcinomas-Normal	0.887497706839163	0.264850990801465	22.000000053826	0.0028902733768591	0.0379733940896436	nan
sp|P55209|NP1L1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0644264920658202	0.264850990801465	22.0000000532436	0.810061204341524	0.965774701272009	nan
sp|P55209|NP1L1_HUMAN	Normal-Triple-negative breast cancer	-0.823071214773343	0.316557481416471	22.0000000536884	0.0163430489962018	0.0820608683736778	nan
sp|P55263|ADK_HUMAN	metaplastic breast carcinomas-Normal	-0.25561143622215	0.314021954174069	23.9999999996053	0.423652502913076	0.621951157325291	nan
sp|P55263|ADK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.380982445458487	0.314021954174069	23.9999999996053	0.236846117942897	0.84876230490475	nan
sp|P55263|ADK_HUMAN	Normal-Triple-negative breast cancer	-0.125371009236337	0.375328023587942	23.9999999995809	0.741257770826791	0.851557700975204	nan
sp|P55265|DSRAD_HUMAN	metaplastic breast carcinomas-Normal	0.827202218078864	0.219481733061322	23.9999999998361	0.0009428335526627	0.0232146572522289	nan
sp|P55265|DSRAD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0888659365064471	0.219481733061322	23.9999999998361	0.689144681398048	0.946568877415162	nan
sp|P55265|DSRAD_HUMAN	Normal-Triple-negative breast cancer	-0.916068154585311	0.262330846581187	23.9999999998094	0.0018790204463287	0.0298845165722326	nan
sp|P55268|LAMB2_HUMAN	metaplastic breast carcinomas-Normal	-1.43960651040415	0.486232389540566	21.9999998996682	0.0072216146068668	0.0566147333802483	nan
sp|P55268|LAMB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.331662510781685	0.486232389540566	21.9999999011645	0.502290308257342	0.913320451076758	nan
sp|P55268|LAMB2_HUMAN	Normal-Triple-negative breast cancer	1.77126902118583	0.58115886276391	21.9999998990126	0.0059013837295735	0.0485549492997589	nan
sp|P55287|CAD11_HUMAN	metaplastic breast carcinomas-Normal	0.770910885775541	0.320605988228708	14.9999999996565	0.0295612128455446	0.123134676063396	nan
sp|P55287|CAD11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.13787125788186	0.320605988228708	14.9999999997921	0.0029144484508012	0.448717474870704	nan
sp|P55287|CAD11_HUMAN	Normal-Triple-negative breast cancer	0.366960372106316	0.383197449454878	14.9999999997165	0.353432066130006	0.543675061879149	nan
sp|P55327|TPD52_HUMAN	metaplastic breast carcinomas-Normal	1.39381799069122	0.508204483667629	23.999999999364	0.0113389208015006	0.0705294023488664	nan
sp|P55327|TPD52_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0177820345365244	0.508204483667629	23.9999999996606	0.97237717299984	0.99709406933403	nan
sp|P55327|TPD52_HUMAN	Normal-Triple-negative breast cancer	-1.41160002522775	0.607420538271564	23.9999999994724	0.0289194007298033	0.113895838893206	nan
sp|P55735|SEC13_HUMAN	metaplastic breast carcinomas-Normal	0.451608448437972	0.176254356540315	23.9999999997937	0.0170991376859362	0.0881576638161481	nan
sp|P55735|SEC13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.09981856228406	0.176254356540315	23.9999999997937	0.576425886899541	0.935847692353991	nan
sp|P55735|SEC13_HUMAN	Normal-Triple-negative breast cancer	-0.551427010722032	0.210664249456809	23.9999999997725	0.0150923663542402	0.0781078712931399	nan
sp|P55769|NH2L1_HUMAN	metaplastic breast carcinomas-Normal	0.267071239236313	0.326768439153587	23.9999999994479	0.421790950318637	0.621744176877671	nan
sp|P55769|NH2L1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.202086294444674	0.326768439153587	23.9999999994479	0.542111536368342	0.923837171685362	nan
sp|P55769|NH2L1_HUMAN	Normal-Triple-negative breast cancer	-0.469157533680987	0.390562987103912	23.9999999994407	0.241381363503018	0.429524439124214	nan
sp|P55786|PSA_HUMAN	metaplastic breast carcinomas-Normal	-0.048375930790098	0.215982761060104	22.0000000319979	0.824839420413885	0.907569094159468	nan
sp|P55786|PSA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.225500847067297	0.215982761060104	22.0000000320364	0.30779092295774	0.867696529950794	nan
sp|P55786|PSA_HUMAN	Normal-Triple-negative breast cancer	-0.177124916277198	0.258148775142071	22.0000000319758	0.499795913711255	0.676135101017241	nan
sp|P55795|HNRH2_HUMAN	metaplastic breast carcinomas-Normal	0.344703267903907	0.149812084186494	22.000000028757	0.0312488774393883	0.127293221333979	nan
sp|P55795|HNRH2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.142818592263183	0.149812084186494	22.000000028757	0.350786707605375	0.874993100365995	nan
sp|P55795|HNRH2_HUMAN	Normal-Triple-negative breast cancer	-0.48752186016709	0.179059689043711	22.0000000287583	0.0124287950900989	0.072100025967694	nan
sp|P55809|SCOT1_HUMAN	metaplastic breast carcinomas-Normal	-0.4025025089187	0.384883221977938	21.9999999852597	0.307018300582642	0.514379451177773	nan
sp|P55809|SCOT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.406769354887299	0.384883221977938	21.9999999852609	0.302041303486126	0.867696529950794	nan
sp|P55809|SCOT1_HUMAN	Normal-Triple-negative breast cancer	-0.004266845968599	0.460023438160831	21.9999999851522	0.992683100535129	0.997484469824296	nan
sp|P55884|EIF3B_HUMAN	metaplastic breast carcinomas-Normal	0.42925855112052	0.140928576190778	22.0000000030755	0.005927434080801	0.0508759359755157	nan
sp|P55884|EIF3B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0740130151460947	0.140928576190778	22.0000000031394	0.604710436215851	0.940559810632461	nan
sp|P55884|EIF3B_HUMAN	Normal-Triple-negative breast cancer	-0.503271566266614	0.16844186613598	22.0000000030076	0.0067835357928379	0.0524989501286484	nan
sp|P55899|FCGRN_HUMAN	metaplastic breast carcinomas-Normal	-1.27389041067875	0.475803068248195	14.9999999995854	0.0172230103346529	0.0883476641240526	nan
sp|P55899|FCGRN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.479766026397804	0.475803068248195	14.9999999995853	0.329286326859312	0.868661960140967	nan
sp|P55899|FCGRN_HUMAN	Normal-Triple-negative breast cancer	1.75365643707655	0.568693439579328	14.9999999995057	0.0075655445540514	0.0549447605771803	nan
sp|P56134|ATPK_HUMAN	metaplastic breast carcinomas-Normal	0.0822510846588976	0.277160744204596	22.0000000014003	0.769431067510732	0.874803098019317	nan
sp|P56134|ATPK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.327555420657875	0.277160744204596	22.0000000003862	0.249892696941377	0.853073118408704	nan
sp|P56134|ATPK_HUMAN	Normal-Triple-negative breast cancer	-0.409806505316773	0.331270450857745	22.0000000011473	0.229101804469091	0.411600306564177	nan
sp|P56192|SYMC_HUMAN	metaplastic breast carcinomas-Normal	0.44823872808197	0.18958985541597	22.000000431063	0.0273109075883677	0.117188655633742	nan
sp|P56192|SYMC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.353490026174538	0.18958985541597	22.0000004300658	0.0756494296970981	0.795994790325479	nan
sp|P56192|SYMC_HUMAN	Normal-Triple-negative breast cancer	-0.801728754256508	0.226603219232739	22.0000004304119	0.0018474540802143	0.0296663640706879	nan
sp|P56199|ITA1_HUMAN	metaplastic breast carcinomas-Normal	-0.533741605270844	0.248063771442138	23.9999999997479	0.0417018720971691	0.151825873878412	nan
sp|P56199|ITA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0024902469834496	0.248063771442138	23.9999999997735	0.992073363384402	0.998185231446144	nan
sp|P56199|ITA1_HUMAN	Normal-Triple-negative breast cancer	0.536231852254294	0.296492916567032	23.999999999706	0.0830628890760719	0.21671981419848	nan
sp|P56378|ATP68_HUMAN	metaplastic breast carcinomas-Normal	-0.304663249786508	0.374394747418927	23.9999999995588	0.423789323583236	0.621951157325291	nan
sp|P56378|ATP68_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.493370229578048	0.374394747418927	23.9999999996024	0.200018162026184	0.843662073010871	nan
sp|P56378|ATP68_HUMAN	Normal-Triple-negative breast cancer	-0.18870697979154	0.447487313299626	23.9999999995944	0.67699473786096	0.810054178779636	nan
sp|P56381|ATP5E_HUMAN	metaplastic breast carcinomas-Normal	0.108561346088762	0.17746128834251	21.9999999970746	0.546975938887676	0.720915154981219	nan
sp|P56381|ATP5E_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.166080209003132	0.17746128834251	21.9999999984075	0.359501728984697	0.883542279876718	nan
sp|P56381|ATP5E_HUMAN	Normal-Triple-negative breast cancer	-0.274641555091894	0.212106808876308	21.999999998541	0.208805101046779	0.390804141824038	nan
sp|P56385|ATP5I_HUMAN	metaplastic breast carcinomas-Normal	0.251700238904259	0.235286653911789	14.0000001568648	0.30282507095409	0.510182734846121	nan
sp|P56385|ATP5I_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.244911751535728	0.235286653911789	14.0000001565611	0.31556138414424	0.867696529950794	nan
sp|P56385|ATP5I_HUMAN	Normal-Triple-negative breast cancer	-0.496611990439987	0.281221340149931	14.0000001566674	0.0991990604229988	0.241796218507804	nan
sp|P56537|IF6_HUMAN	metaplastic breast carcinomas-Normal	0.371279191732545	0.138133020742881	23.9999999997319	0.012860025536521	0.0751260542766182	nan
sp|P56537|IF6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.189614375377216	0.138133020742881	23.9999999997306	0.182539726713022	0.843662073010871	nan
sp|P56537|IF6_HUMAN	Normal-Triple-negative breast cancer	-0.560893567109761	0.165100538285673	23.9999999996602	0.0023733781998127	0.0328595275636502	nan
sp|P56945|BCAR1_HUMAN	metaplastic breast carcinomas-Normal	-0.137979329004306	0.596760944175139	6.0	0.824831739314063	0.907569094159468	nan
sp|P56945|BCAR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.501460621515718	0.596760944175139	6.0	0.432940903011265	0.896102083258464	nan
sp|P56945|BCAR1_HUMAN	Normal-Triple-negative breast cancer	0.639439950520025	0.713265753411531	6.0	0.404519872000248	0.594248116815048	nan
sp|P57678|GEMI4_HUMAN	metaplastic breast carcinomas-Normal	0.0733629581432619	0.302561554806111	14.0000000031457	0.811929937890922	0.900925915386606	nan
sp|P57678|GEMI4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.220334668826311	0.302561554806111	14.000000003295	0.478476733557447	0.913320451076758	nan
sp|P57678|GEMI4_HUMAN	Normal-Triple-negative breast cancer	-0.293697626969573	0.36163022638896	14.0000000033385	0.43029975974796	0.615984668993204	nan
sp|P57723|PCBP4_HUMAN	metaplastic breast carcinomas-Normal	0.61344957870326	0.193921445827456	23.9999999996333	0.0041960201027068	0.042883667309653	nan
sp|P57723|PCBP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.209684013542086	0.193921445827456	23.9999999995913	0.290316884045105	0.867696529950794	nan
sp|P57723|PCBP4_HUMAN	Normal-Triple-negative breast cancer	-0.823133592245346	0.231780460016466	23.9999999995783	0.0016222885408675	0.0283781197026415	nan
sp|P57735|RAB25_HUMAN	metaplastic breast carcinomas-Normal	0.215534841222268	0.335839605585535	14.0000000570601	0.531384762693516	0.708682730508622	nan
sp|P57735|RAB25_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.356087364249413	0.335839605585535	14.0000000569437	0.306963051145775	0.867696529950794	nan
sp|P57735|RAB25_HUMAN	Normal-Triple-negative breast cancer	-0.57162220547168	0.40140510474341	14.0000000571468	0.176337244817809	0.350985031002633	nan
sp|P57737|CORO7_HUMAN	metaplastic breast carcinomas-Normal	0.209705341721994	0.294204288129649	23.9999999995235	0.482850091665221	0.672671292831179	nan
sp|P57737|CORO7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0717564155409875	0.294204288129649	23.9999999995235	0.80938119045389	0.965774701272009	nan
sp|P57737|CORO7_HUMAN	Normal-Triple-negative breast cancer	-0.281461757262981	0.351641382161416	23.9999999995238	0.431318362527529	0.616646123458712	nan
sp|P57740|NU107_HUMAN	metaplastic breast carcinomas-Normal	0.499462427577954	0.287349032933286	21.1077054159286	0.096748824502301	0.251048472010654	nan
sp|P57740|NU107_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.484745864091796	0.287349032933286	21.1077054164681	0.106336032335094	0.823891816737944	nan
sp|P57740|NU107_HUMAN	Normal-Triple-negative breast cancer	-0.98420829166975	0.339846333483247	21.0742917448764	0.0086215315457716	0.0588076066258844	nan
sp|P57764|GSDMD_HUMAN	metaplastic breast carcinomas-Normal	0.686999775406991	0.386904817721707	22.0000002798111	0.0896302187305403	0.241435046240126	nan
sp|P57764|GSDMD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.317071014131304	0.386904817721707	22.0000002789553	0.421287366478649	0.887693595400195	nan
sp|P57764|GSDMD_HUMAN	Normal-Triple-negative breast cancer	-0.369928761275688	0.462439707230293	22.000000279042	0.432293094137374	0.617201755042369	nan
sp|P58107|EPIPL_HUMAN	metaplastic breast carcinomas-Normal	-0.0487040881046548	0.436395729172401	23.9999999997372	0.912064506227512	0.953365540471776	nan
sp|P58107|EPIPL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.78643483666945	0.436395729172401	23.9999999997373	0.0841026287684246	0.806849600316436	nan
sp|P58107|EPIPL_HUMAN	Normal-Triple-negative breast cancer	-0.737730748564796	0.521592660498198	23.9999999997138	0.170092946830328	0.341450778401612	nan
sp|P59998|ARPC4_HUMAN	metaplastic breast carcinomas-Normal	0.383597676891855	0.228125663470066	22.0000064820734	0.106805097277298	0.26662790041358	nan
sp|P59998|ARPC4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0549703237116789	0.228125663470066	22.0000064821012	0.811813674655279	0.965774701272009	nan
sp|P59998|ARPC4_HUMAN	Normal-Triple-negative breast cancer	-0.438568000603534	0.272662319502813	22.0000064824587	0.121990844654284	0.27510011372513	nan
sp|P60033|CD81_HUMAN	metaplastic breast carcinomas-Normal	-0.224439386644212	0.195966498486048	14.0000000176343	0.271288810933865	0.473099091660176	nan
sp|P60033|CD81_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0581836906135801	0.195966498486048	14.000000017313	0.770897497634746	0.959745866833315	nan
sp|P60033|CD81_HUMAN	Normal-Triple-negative breast cancer	0.166255696030632	0.234224765461609	14.0000000172693	0.489474964485632	0.666263219471843	nan
sp|P60174|TPIS_HUMAN	metaplastic breast carcinomas-Normal	0.436721794671479	0.198574585249794	22.000005038703	0.0386641100283518	0.144403934532856	nan
sp|P60174|TPIS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0842210853253403	0.198574585249794	22.0000050387044	0.675590806416998	0.946386428913156	nan
sp|P60174|TPIS_HUMAN	Normal-Triple-negative breast cancer	-0.520942879996819	0.237342025377265	22.000005038527	0.039017048877863	0.132069929195536	nan
sp|P60228|EIF3E_HUMAN	metaplastic breast carcinomas-Normal	0.451963624806008	0.199366228010684	23.9999999997159	0.0326813739075537	0.129407306133986	nan
sp|P60228|EIF3E_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.057060399840249	0.199366228010684	23.9999999997171	0.777174116160696	0.960657739983943	nan
sp|P60228|EIF3E_HUMAN	Normal-Triple-negative breast cancer	-0.394903224965759	0.238288219453454	23.9999999997931	0.110485320936513	0.257540818227888	nan
sp|P60468|SC61B_HUMAN	metaplastic breast carcinomas-Normal	0.464695258153503	0.254466661392252	21.9999999782192	0.0814305931195872	0.226317133385876	nan
sp|P60468|SC61B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.231455456565779	0.254466661392252	21.9999999783061	0.372906623235952	0.885234295852111	nan
sp|P60468|SC61B_HUMAN	Normal-Triple-negative breast cancer	-0.233239801587724	0.304145833817828	21.9999999781146	0.451311390820471	0.634554313221944	nan
sp|P60520|GBRL2_HUMAN	metaplastic breast carcinomas-Normal	0.291737407425085	0.315336127891636	21.3131423922283	0.365238475051726	0.575926324037921	nan
sp|P60520|GBRL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.130194344524293	0.294848953271585	20.8449362315656	0.663352159565284	0.944724271291086	nan
sp|P60520|GBRL2_HUMAN	Normal-Triple-negative breast cancer	-0.161543062900793	0.369723029657121	21.1897088507097	0.666582415186608	0.8042915764791	nan
sp|P60604|UB2G2_HUMAN	metaplastic breast carcinomas-Normal	-0.127933821486973	0.252813651108143	22.0000000082469	0.617861933267478	0.771225334653059	nan
sp|P60604|UB2G2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.545725484319742	0.252813651108143	22.0000000083417	0.0420562871696794	0.751726370995712	nan
sp|P60604|UB2G2_HUMAN	Normal-Triple-negative breast cancer	-0.417791662832769	0.302170108634736	22.0000000084274	0.180651439573864	0.356629951661897	nan
sp|P60660|MYL6_HUMAN	metaplastic breast carcinomas-Normal	0.0655126636856711	0.220359481963817	23.9999999993118	0.768796302189968	0.874803098019317	nan
sp|P60660|MYL6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.397800865739131	0.220359481963817	23.9999999993443	0.0835993988095992	0.806849600316436	nan
sp|P60660|MYL6_HUMAN	Normal-Triple-negative breast cancer	0.33228820205346	0.26337995718126	23.9999999992817	0.219206476010123	0.402120489104662	nan
sp|P60842|IF4A1_HUMAN	metaplastic breast carcinomas-Normal	0.200175966089804	0.241000298412969	23.9999999995217	0.414383865435865	0.615740710196163	nan
sp|P60842|IF4A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0888150203098116	0.241000298412969	23.9999999995217	0.715711473583974	0.949812109346858	nan
sp|P60842|IF4A1_HUMAN	Normal-Triple-negative breast cancer	-0.288990986399616	0.288050451521307	23.9999999994742	0.325741610170544	0.51782167011329	nan
sp|P60866|RS20_HUMAN	metaplastic breast carcinomas-Normal	0.196544952129046	0.162246641003053	22.0000002185928	0.238595617609847	0.438899741524699	nan
sp|P60866|RS20_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0633856114835217	0.162246641003053	22.0000002184501	0.699795358178856	0.947402103397677	nan
sp|P60866|RS20_HUMAN	Normal-Triple-negative breast cancer	-0.133159340645525	0.193921827095255	22.0000002184467	0.499468216956358	0.676135101017241	nan
sp|P60891|PRPS1_HUMAN	metaplastic breast carcinomas-Normal	-0.255836292389036	0.617435603675513	15.0000000001059	0.684480256796316	0.815421471492646	nan
sp|P60891|PRPS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.09692219383959	0.617435603675512	15.0000000001059	0.0959186779040015	0.814943337126966	nan
sp|P60891|PRPS1_HUMAN	Normal-Triple-negative breast cancer	1.35275848622863	0.737976697934625	15.0000000001007	0.0867144725153171	0.22206387260471	nan
sp|P60900|PSA6_HUMAN	metaplastic breast carcinomas-Normal	0.104285498869694	0.154684452381925	22.0000000323547	0.507218311654174	0.692399863629763	nan
sp|P60900|PSA6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.103626242174257	0.154684452381925	22.0000000321416	0.509879768856869	0.913997266820081	nan
sp|P60900|PSA6_HUMAN	Normal-Triple-negative breast cancer	-0.207911741043951	0.1848832829061	22.000000032501	0.272897424085158	0.463995415682386	nan
sp|P60953|CDC42_HUMAN	metaplastic breast carcinomas-Normal	0.0401959324643729	0.279436093105533	22.0000000014807	0.886931119647897	0.940415790777734	nan
sp|P60953|CDC42_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.367058779895916	0.279436093105533	22.0000000015645	0.202525834697718	0.843662073010871	nan
sp|P60953|CDC42_HUMAN	Normal-Triple-negative breast cancer	-0.407254712360289	0.333990012960363	22.000000001159	0.235619311129346	0.420622228890412	nan
sp|P60981|DEST_HUMAN	metaplastic breast carcinomas-Normal	0.149818920204126	0.204748035677865	22.0000000334613	0.47206064303258	0.662749867695253	nan
sp|P60981|DEST_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.264707481939164	0.204748035677865	22.0000000335346	0.209477715769527	0.843662073010871	nan
sp|P60981|DEST_HUMAN	Normal-Triple-negative breast cancer	-0.41452640214329	0.244720709947204	22.0000000337795	0.104401605097496	0.249662543413005	nan
sp|P61006|RAB8A_HUMAN	metaplastic breast carcinomas-Normal	-0.0340535281568175	0.256005140654018	23.9999999996413	0.895287452301488	0.943166914388092	nan
sp|P61006|RAB8A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.132626801268659	0.256005140654018	23.9999999993943	0.60915752932771	0.940559810632461	nan
sp|P61006|RAB8A_HUMAN	Normal-Triple-negative breast cancer	-0.0985732731118413	0.305984668246357	23.9999999995276	0.750127671097069	0.856258371815473	nan
sp|P61009|SPCS3_HUMAN	metaplastic breast carcinomas-Normal	-0.0290833894291272	0.279231770349795	21.7770935447561	0.917999635976204	0.957161477410571	nan
sp|P61009|SPCS3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.125264462318442	0.239624120553966	19.4811218928729	0.60704025215288	0.940559810632461	nan
sp|P61009|SPCS3_HUMAN	Normal-Triple-negative breast cancer	0.154347851747569	0.320279304104257	21.4294939079595	0.634750607645386	0.781738058471013	nan
sp|P61011|SRP54_HUMAN	metaplastic breast carcinomas-Normal	0.49637012367624	0.231235385199707	23.9999999998729	0.0421418847075025	0.152285044160049	nan
sp|P61011|SRP54_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.188985270526829	0.231235385199707	23.9999999998729	0.421805030925143	0.88788356341846	nan
sp|P61011|SRP54_HUMAN	Normal-Triple-negative breast cancer	-0.685355394203069	0.276379147881148	23.9999999999002	0.0205582095992855	0.0940086378976347	nan
sp|P61019|RAB2A_HUMAN	metaplastic breast carcinomas-Normal	0.339431290604617	0.273153347531705	21.999999994916	0.227082877811876	0.426752157220841	nan
sp|P61019|RAB2A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0325276262914644	0.273153347531705	21.9999999962805	0.906291145514606	0.992888981494585	nan
sp|P61019|RAB2A_HUMAN	Normal-Triple-negative breast cancer	-0.371958916896081	0.326480695705353	21.9999999956205	0.266832305172947	0.458135631402312	nan
sp|P61020|RAB5B_HUMAN	metaplastic breast carcinomas-Normal	-0.512205440872686	0.324661679891486	21.1290883441808	0.129499222466806	0.300387589308908	nan
sp|P61020|RAB5B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0084015113897183	0.302247979917205	21.0237845184937	0.978086431257674	0.99709406933403	nan
sp|P61020|RAB5B_HUMAN	Normal-Triple-negative breast cancer	0.503803929482968	0.380206329101492	21.1007752834159	0.199315248528639	0.380323700407116	nan
sp|P61026|RAB10_HUMAN	metaplastic breast carcinomas-Normal	0.21223955862417	0.208103396719981	23.9999999994143	0.317958821214649	0.525596065955444	nan
sp|P61026|RAB10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.308858797836672	0.208103396719981	23.9999999996365	0.150782293012714	0.843465960034572	nan
sp|P61026|RAB10_HUMAN	Normal-Triple-negative breast cancer	-0.521098356460842	0.248731133459386	23.9999999994978	0.0469004757989343	0.148615044380989	nan
sp|P61077|UB2D3_HUMAN;sp|P62837|UB2D2_HUMAN	metaplastic breast carcinomas-Normal	0.264319779798779	0.225894057280918	23.9999999994984	0.253447467831762	0.454891675525257	nan
sp|P61077|UB2D3_HUMAN;sp|P62837|UB2D2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.223230380373546	0.225894057280918	23.9999999994984	0.332909496703429	0.870890600099115	nan
sp|P61077|UB2D3_HUMAN;sp|P62837|UB2D2_HUMAN	Normal-Triple-negative breast cancer	-0.487550160172326	0.269995039940775	23.9999999995124	0.0835128579644855	0.21726078673375	nan
sp|P61081|UBC12_HUMAN	metaplastic breast carcinomas-Normal	0.387126703114483	0.269240664332355	14.000000001184	0.172453589098549	0.360525616455081	nan
sp|P61081|UBC12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.239089142428973	0.269240664332355	14.0000000015534	0.389535815822819	0.885234295852111	nan
sp|P61081|UBC12_HUMAN	Normal-Triple-negative breast cancer	-0.626215845543456	0.321804144806229	14.0000000013352	0.0720174489546927	0.196229738701925	nan
sp|P61086|UBE2K_HUMAN	metaplastic breast carcinomas-Normal	0.103076134720388	0.316747907334766	21.9999957560457	0.747937861642134	0.860108189651783	nan
sp|P61086|UBE2K_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.467541788375225	0.316747907334766	21.9999957567888	0.154096110332917	0.843465960034572	nan
sp|P61086|UBE2K_HUMAN	Normal-Triple-negative breast cancer	-0.570617923095614	0.378586160793312	21.9999957545534	0.14597685287688	0.310843727714765	nan
sp|P61088|UBE2N_HUMAN	metaplastic breast carcinomas-Normal	0.0297992528554999	0.214352877581174	22.0000040061531	0.890699406171426	0.94150288514576	nan
sp|P61088|UBE2N_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.415184141149064	0.214352877581174	22.0000040057818	0.0657020789372253	0.774640662531106	nan
sp|P61088|UBE2N_HUMAN	Normal-Triple-negative breast cancer	-0.444983394004564	0.256200691778173	22.0000040058921	0.0963962252208144	0.23840852130505	nan
sp|P61106|RAB14_HUMAN	metaplastic breast carcinomas-Normal	0.0118430068134704	0.124040781272017	23.9999999999386	0.924728919608471	0.959399047261854	nan
sp|P61106|RAB14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.182408138298736	0.124040781272017	23.9999999999386	0.154402911359529	0.843465960034572	nan
sp|P61106|RAB14_HUMAN	Normal-Triple-negative breast cancer	-0.194251145112207	0.148257090500504	23.9999999999621	0.202519499907106	0.382901192452517	nan
sp|P61158|ARP3_HUMAN	metaplastic breast carcinomas-Normal	0.411635470895398	0.1795715743273	21.9999996580116	0.0318208801421524	0.128466389195289	nan
sp|P61158|ARP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0389774881476726	0.1795715743273	21.999999658181	0.830163297243922	0.967844657551207	nan
sp|P61158|ARP3_HUMAN	Normal-Triple-negative breast cancer	-0.372657982747725	0.214629083059207	21.999999657792	0.0964982145792131	0.238470343344679	nan
sp|P61160|ARP2_HUMAN	metaplastic breast carcinomas-Normal	0.459913596887139	0.193713813807798	22.0000000104011	0.0267364627556652	0.116172877501596	nan
sp|P61160|ARP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.15324342649699	0.193713813807798	22.00000000926	0.437342336390894	0.897513075778899	nan
sp|P61160|ARP2_HUMAN	Normal-Triple-negative breast cancer	-0.306670170390149	0.231532292286356	22.0000000102106	0.198924476514164	0.380200088223779	nan
sp|P61163|ACTZ_HUMAN	metaplastic breast carcinomas-Normal	-0.278700089910031	0.165721090430735	22.0000000037116	0.106761379558239	0.26662790041358	nan
sp|P61163|ACTZ_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0625355772834798	0.165721090430735	22.0000000037703	0.709526048663166	0.94948208919602	nan
sp|P61163|ACTZ_HUMAN	Normal-Triple-negative breast cancer	0.341235667193511	0.198074588452907	22.0000000037849	0.0989610974652563	0.241517392051771	nan
sp|P61201|CSN2_HUMAN	metaplastic breast carcinomas-Normal	0.306720507974237	0.159807739455658	23.9999999993654	0.0669112276161394	0.20001161924105	nan
sp|P61201|CSN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.244037626792944	0.159807739455658	23.9999999993654	0.139816208436881	0.823891816737944	nan
sp|P61201|CSN2_HUMAN	Normal-Triple-negative breast cancer	-0.550758134767181	0.19100678219046	23.9999999993559	0.0081716902472481	0.0575911703148659	nan
sp|P61218|RPAB2_HUMAN	metaplastic breast carcinomas-Normal	0.812672917889756	0.254528323149906	6.0	0.0187684562940571	0.0929781777313555	nan
sp|P61218|RPAB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0255233988625441	0.254528323149906	6.0	0.923390967614642	0.994508979919649	nan
sp|P61218|RPAB2_HUMAN	Normal-Triple-negative breast cancer	-0.8381963167523	0.304219533714677	6.0	0.033061813940806	0.122108299488044	nan
sp|P61221|ABCE1_HUMAN	metaplastic breast carcinomas-Normal	0.2838349713537	0.209061703334943	22.0000000282677	0.188335131825475	0.380341321943206	nan
sp|P61221|ABCE1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.156724586780575	0.209061703334943	22.0000000282677	0.461403138140872	0.909423669537079	nan
sp|P61221|ABCE1_HUMAN	Normal-Triple-negative breast cancer	-0.440559558134275	0.249876528942104	22.0000000285794	0.0917689835554073	0.229698871489589	nan
sp|P61225|RAP2B_HUMAN	metaplastic breast carcinomas-Normal	0.164166400493562	0.285822176538788	23.9999999997111	0.571065317057462	0.734890094424702	nan
sp|P61225|RAP2B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.143870327697258	0.285822176538788	23.999999999751	0.61930268925927	0.941374262616245	nan
sp|P61225|RAP2B_HUMAN	Normal-Triple-negative breast cancer	-0.0202960727963036	0.341622842581385	23.9999999997781	0.953116877924944	0.975719280019253	nan
sp|P61247|RS3A_HUMAN	metaplastic breast carcinomas-Normal	0.82504151246756	0.276020174530897	22.0000001117084	0.0067638297955896	0.053876112952164	nan
sp|P61247|RS3A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0572945261963029	0.276020174530897	22.0000001117464	0.837471291800496	0.970579311689316	nan
sp|P61247|RS3A_HUMAN	Normal-Triple-negative breast cancer	-0.882336038663863	0.329907209352801	22.0000001118017	0.0138476454107894	0.0764610852914686	nan
sp|P61254|RL26_HUMAN;sp|Q9UNX3|RL26L_HUMAN	metaplastic breast carcinomas-Normal	0.755550807725751	0.433898094322107	21.9999999565591	0.0955973304454168	0.24981566540925	nan
sp|P61254|RL26_HUMAN;sp|Q9UNX3|RL26L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.130450911097767	0.433898094322107	21.999999956567	0.766505218847438	0.957818390309474	nan
sp|P61254|RL26_HUMAN;sp|Q9UNX3|RL26L_HUMAN	Normal-Triple-negative breast cancer	-0.886001718823517	0.518607415869455	21.9999999560561	0.101630559382949	0.244442821554936	nan
sp|P61289|PSME3_HUMAN	metaplastic breast carcinomas-Normal	0.681100582041433	0.218416431604342	21.9999999728135	0.0050054628930466	0.047133593927725	nan
sp|P61289|PSME3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0510657763736095	0.218416431604342	21.9999999729125	0.817302100920527	0.965774701272009	nan
sp|P61289|PSME3_HUMAN	Normal-Triple-negative breast cancer	-0.630034805667824	0.261057567802239	21.9999999728094	0.0245771429896568	0.104602334568014	nan
sp|P61313|RL15_HUMAN	metaplastic breast carcinomas-Normal	0.471439898066983	0.205625032151043	22.0000000307842	0.0317942373568207	0.128466389195289	nan
sp|P61313|RL15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.120545453887909	0.205625032151043	22.0000000303484	0.563681883181723	0.935109025059232	nan
sp|P61313|RL15_HUMAN	Normal-Triple-negative breast cancer	-0.350894444179074	0.245768921222231	22.0000000303966	0.167408381357143	0.33848263967831	nan
sp|P61326|MGN_HUMAN;sp|Q96A72|MGN2_HUMAN	metaplastic breast carcinomas-Normal	0.580360798637207	0.296215332479224	21.9999999261322	0.0628759493643733	0.191918875745801	nan
sp|P61326|MGN_HUMAN;sp|Q96A72|MGN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.201594440005914	0.296215332479224	21.999999925161	0.50324569083212	0.913320451076758	nan
sp|P61326|MGN_HUMAN;sp|Q96A72|MGN2_HUMAN	Normal-Triple-negative breast cancer	-0.781955238643121	0.354045039902668	21.9999999260088	0.0379204418047612	0.130214409668415	nan
sp|P61353|RL27_HUMAN	metaplastic breast carcinomas-Normal	1.19157748647616	0.308168246670417	23.9999999996916	0.0007375451250437	0.0221825773337916	nan
sp|P61353|RL27_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.14744190070133	0.308168246670417	23.9999999994889	0.636662477304549	0.941868024951375	nan
sp|P61353|RL27_HUMAN	Normal-Triple-negative breast cancer	-1.33901938717749	0.368331504908901	23.9999999995598	0.0013164332896694	0.0266490250684039	nan
sp|P61604|CH10_HUMAN	metaplastic breast carcinomas-Normal	0.408590260356538	0.31640492318426	22.0000050580985	0.209985451431113	0.405450235922205	nan
sp|P61604|CH10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.19600268080353	0.31640492318426	22.0000050583096	0.0010299247103249	0.428062457728796	nan
sp|P61604|CH10_HUMAN	Normal-Triple-negative breast cancer	-1.60459294116007	0.378176216324079	22.0000050585024	0.0003333006012779	0.0227914720285933	nan
sp|P61619|S61A1_HUMAN	metaplastic breast carcinomas-Normal	0.94287142781996	0.24881229616128	23.9999999999085	0.000895354266836	0.0227210419054423	nan
sp|P61619|S61A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.269001524087134	0.24881229616128	23.9999999999085	0.290378261653824	0.867696529950794	nan
sp|P61619|S61A1_HUMAN	Normal-Triple-negative breast cancer	-0.673869903732826	0.297387574726144	23.9999999998519	0.032753844769059	0.121510585324113	nan
sp|P61758|PFD3_HUMAN	metaplastic breast carcinomas-Normal	0.596339781655187	0.152043155070397	23.9999999998762	0.0006412761669134	0.021351809657355	nan
sp|P61758|PFD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.157683094650088	0.152043155070397	23.9999999996339	0.31002870660454	0.867696529950794	nan
sp|P61758|PFD3_HUMAN	Normal-Triple-negative breast cancer	-0.4386566870051	0.181726328793605	23.999999999729	0.0237779785430151	0.1025136195551	nan
sp|P61764|STXB1_HUMAN	metaplastic breast carcinomas-Normal	-1.07619158160961	0.491232008349266	10.9999999999005	0.0508970345084318	0.171023961647509	nan
sp|P61764|STXB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.165485518658486	0.380506677492146	10.9999999998553	0.672038345811467	0.946386428913156	nan
sp|P61764|STXB1_HUMAN	Normal-Triple-negative breast cancer	0.910706062951128	0.538117703882918	10.9999999998861	0.118668481870831	0.270730290829543	nan
sp|P61803|DAD1_HUMAN	metaplastic breast carcinomas-Normal	-0.12535754425183	0.682392738563921	13.0091116915754	0.857078919004868	0.925879209220728	nan
sp|P61803|DAD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.852347076358145	0.682392738563921	13.0091116915028	0.233652935181386	0.847998869365766	nan
sp|P61803|DAD1_HUMAN	Normal-Triple-negative breast cancer	0.977704620609975	0.802298662124191	13.0000000047009	0.244638145713768	0.432541061889663	nan
sp|P61916|NPC2_HUMAN	metaplastic breast carcinomas-Normal	0.213350745933985	0.260147158843656	23.9999999992949	0.420221140314775	0.620624545122429	nan
sp|P61916|NPC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0845616412274467	0.260147158843656	23.999999999295	0.747957510549714	0.954643368861838	nan
sp|P61916|NPC2_HUMAN	Normal-Triple-negative breast cancer	-0.297912387161432	0.310935326886996	23.9999999992524	0.34755694236689	0.538591737262258	nan
sp|P61923|COPZ1_HUMAN	metaplastic breast carcinomas-Normal	0.74495390375008	0.394981675352152	23.9999999999709	0.0714478196918321	0.207900875843011	nan
sp|P61923|COPZ1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.359972414806627	0.394981675352152	23.9999999999709	0.371166765831204	0.884580780585171	nan
sp|P61923|COPZ1_HUMAN	Normal-Triple-negative breast cancer	-1.10492631855671	0.472093398543721	23.9999999999691	0.0279020113863272	0.112012422521922	nan
sp|P61956|SUMO2_HUMAN	metaplastic breast carcinomas-Normal	-0.213633916337549	0.258467018984268	22.0000000431978	0.417371184404117	0.619072653707847	nan
sp|P61956|SUMO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.639128132150548	0.258467018984268	22.000000042973	0.0216126789190092	0.712051972579798	nan
sp|P61956|SUMO2_HUMAN	Normal-Triple-negative breast cancer	-0.425494215812999	0.308927175659372	22.0000000432234	0.182263478468182	0.358294038729188	nan
sp|P61960|UFM1_HUMAN	metaplastic breast carcinomas-Normal	0.235375580296499	0.368454921820856	23.9999999996782	0.528991416947609	0.707023510226719	nan
sp|P61960|UFM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.137696989174545	0.368454921820856	23.9999999997247	0.711897712949737	0.94948208919602	nan
sp|P61960|UFM1_HUMAN	Normal-Triple-negative breast cancer	-0.373072569471044	0.440387863810354	23.9999999997465	0.405282936468024	0.594248116815048	nan
sp|P61964|WDR5_HUMAN	metaplastic breast carcinomas-Normal	1.22193643387256	0.384043932471572	14.9999999995652	0.0061907055866925	0.0518335147863123	nan
sp|P61964|WDR5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.304778556379675	0.384043932471572	14.9999999995928	0.439800650225021	0.89755436380139	nan
sp|P61964|WDR5_HUMAN	Normal-Triple-negative breast cancer	-1.52671499025224	0.459020295331309	14.9999999995587	0.0046063469497998	0.0436121424321106	nan
sp|P61970|NTF2_HUMAN	metaplastic breast carcinomas-Normal	0.230899498185469	0.230193467718503	23.9999999995805	0.325835198065659	0.533798027782283	nan
sp|P61970|NTF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0999344982490494	0.230193467718503	23.9999999995805	0.668070050616495	0.946277260710207	nan
sp|P61970|NTF2_HUMAN	Normal-Triple-negative breast cancer	-0.130964999936419	0.275133818299048	23.9999999996197	0.638375572353787	0.784748669565085	nan
sp|P61978|HNRPK_HUMAN	metaplastic breast carcinomas-Normal	0.812000323753845	0.242988989184733	21.9999961703644	0.0029543403369928	0.0380628964347452	nan
sp|P61978|HNRPK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.244500880034555	0.242988989184733	21.9999961702822	0.325248465882989	0.867950636918522	nan
sp|P61978|HNRPK_HUMAN	Normal-Triple-negative breast cancer	-1.0565012037884	0.290427391626838	21.9999961769263	0.0014530004760386	0.0272868563974719	nan
sp|P61981|1433G_HUMAN	metaplastic breast carcinomas-Normal	-0.156451918875601	0.201695407051549	22.000000293157	0.446194392694924	0.642935363582456	nan
sp|P61981|1433G_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.111427736459824	0.201695407051549	22.0000002930267	0.586206008284052	0.939599908351397	nan
sp|P61981|1433G_HUMAN	Normal-Triple-negative breast cancer	0.267879655335425	0.241072120879358	22.0000002926884	0.278478742718778	0.470624638428115	nan
sp|P62081|RS7_HUMAN	metaplastic breast carcinomas-Normal	1.17848790726122	0.321246332066411	22.0000179983975	0.0013490400518257	0.0271905743670284	nan
sp|P62081|RS7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.141109537410734	0.321246332066411	22.0000179985032	0.664759913672924	0.944724271291086	nan
sp|P62081|RS7_HUMAN	Normal-Triple-negative breast cancer	-1.31959744467195	0.383962806729511	22.0000179860895	0.0023549985546612	0.0328595275636502	nan
sp|P62136|PP1A_HUMAN	metaplastic breast carcinomas-Normal	0.75109788908763	0.287913824027943	21.0699521587563	0.0163713302811732	0.0855633676959429	nan
sp|P62136|PP1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.346402765972141	0.287913824027943	21.0699521577802	0.242264556359589	0.84964799869723	nan
sp|P62136|PP1A_HUMAN	Normal-Triple-negative breast cancer	-1.09750065505977	0.340478543036558	21.0443711877168	0.0040680973189811	0.041407627248948	nan
sp|P62191|PRS4_HUMAN	metaplastic breast carcinomas-Normal	0.336398900680592	0.143183960952223	23.9999999997703	0.0273667007515054	0.117225403734541	nan
sp|P62191|PRS4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.061907756673385	0.143183960952223	23.9999999998088	0.669336182183404	0.946277260710207	nan
sp|P62191|PRS4_HUMAN	Normal-Triple-negative breast cancer	-0.398306657353977	0.171137566527916	23.9999999997485	0.0287027292260052	0.113176597802184	nan
sp|P62195|PRS8_HUMAN	metaplastic breast carcinomas-Normal	0.368135390086927	0.133919981948906	24.0000000000446	0.0111756352519836	0.0705294023488664	nan
sp|P62195|PRS8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.183562671818159	0.133919981948906	23.9999999997762	0.183155988532044	0.843662073010871	nan
sp|P62195|PRS8_HUMAN	Normal-Triple-negative breast cancer	-0.551698061905086	0.160064993786878	23.999999999973	0.0021014912529105	0.0318966069619849	nan
sp|P62241|RS8_HUMAN	metaplastic breast carcinomas-Normal	1.10234109343062	0.174812770455234	22.0000000095456	2.40146977085232e-06	0.0043931546677194	nan
sp|P62241|RS8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.053930637923967	0.174812770455234	22.0000000098109	0.760600297751582	0.955228196959647	nan
sp|P62241|RS8_HUMAN	Normal-Triple-negative breast cancer	-1.04841045550665	0.208941224525102	22.0000000100263	5.04708072452169e-05	0.022319699811492	nan
sp|P62244|RS15A_HUMAN	metaplastic breast carcinomas-Normal	0.737693424457374	0.149248489590983	22.0000000491306	6.05282633956726e-05	0.0108569178098025	nan
sp|P62244|RS15A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.180377078806151	0.149248489590983	22.0000000497989	0.239658771667178	0.848884141578285	nan
sp|P62244|RS15A_HUMAN	Normal-Triple-negative breast cancer	-0.557316345651223	0.17838606465909	22.000000049302	0.0049372810269356	0.0450865992679507	nan
sp|P62249|RS16_HUMAN	metaplastic breast carcinomas-Normal	0.808065584342847	0.135465284006348	22.0000000013433	5.2865880477972e-06	0.0043931546677194	nan
sp|P62249|RS16_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.271749639348279	0.135465284006348	22.0000000016383	0.0573009251052383	0.773787875546141	nan
sp|P62249|RS16_HUMAN	Normal-Triple-negative breast cancer	-0.536315944994568	0.161911983015996	22.0000000011422	0.0031675429157435	0.037336569687701	nan
sp|P62256|UBE2H_HUMAN	metaplastic breast carcinomas-Normal	0.516085862332403	0.27404338382809	21.9999823029306	0.0729582695947511	0.21069790454644	nan
sp|P62256|UBE2H_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0734671748970239	0.27404338382809	21.9999822970205	0.791130782041929	0.963198501448518	nan
sp|P62256|UBE2H_HUMAN	Normal-Triple-negative breast cancer	-0.589553037229426	0.32754449255014	21.9999822963343	0.085603699160054	0.220578834114744	nan
sp|P62258|1433E_HUMAN	metaplastic breast carcinomas-Normal	0.109370282682855	0.117610600765087	24.0000000000233	0.361664401178127	0.572190609003376	nan
sp|P62258|1433E_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0570337892232975	0.117610600765087	24.0000000000233	0.632117601099354	0.941868024951375	nan
sp|P62258|1433E_HUMAN	Normal-Triple-negative breast cancer	-0.166404071906153	0.140571554795438	24.0000000000295	0.248097606673805	0.436665698996733	nan
sp|P62263|RS14_HUMAN	metaplastic breast carcinomas-Normal	1.29419290650967	0.301115850727112	23.9999999995846	0.0002475617279324	0.0157578323963946	nan
sp|P62263|RS14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.109768082592184	0.301115850727112	23.9999999993724	0.71864889029228	0.950102409630946	nan
sp|P62263|RS14_HUMAN	Normal-Triple-negative breast cancer	-1.40396098910185	0.359902279513109	23.9999999994605	0.0006765117993714	0.0247210772633291	nan
sp|P62266|RS23_HUMAN	metaplastic breast carcinomas-Normal	0.699231279084539	0.524700192684699	23.9999999994766	0.195168067260005	0.387852664274868	nan
sp|P62266|RS23_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.578867604922299	0.524700192684699	23.9999999997562	0.280864882060425	0.867696529950794	nan
sp|P62266|RS23_HUMAN	Normal-Triple-negative breast cancer	-1.27809888400684	0.627136681620021	23.9999999995699	0.0527175469232811	0.162252894419432	nan
sp|P62269|RS18_HUMAN	metaplastic breast carcinomas-Normal	1.06646431679115	0.299430123922934	22.0000000012833	0.0017454564178891	0.0298263306532335	nan
sp|P62269|RS18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0962384380797025	0.299430123922934	22.0000000012833	0.750936869924158	0.954643368861838	nan
sp|P62269|RS18_HUMAN	Normal-Triple-negative breast cancer	-0.970225878711446	0.357887450609234	22.0000000014387	0.0127600609619156	0.0731283493748405	nan
sp|P62277|RS13_HUMAN	metaplastic breast carcinomas-Normal	0.966223263551985	0.165540762127446	21.9999998917327	7.14056155840499e-06	0.0047470453240276	nan
sp|P62277|RS13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.159017845291476	0.165540762127446	21.9999998915602	0.347194692983663	0.871784737402991	nan
sp|P62277|RS13_HUMAN	Normal-Triple-negative breast cancer	-0.807205418260508	0.197859054905742	21.9999998914086	0.0004965965142015	0.0237592699893802	nan
sp|P62280|RS11_HUMAN	metaplastic breast carcinomas-Normal	0.56801927229738	0.215707139832644	23.9999999994924	0.0145633572228342	0.0795450818130059	nan
sp|P62280|RS11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0240921751733979	0.215707139832644	23.9999999997004	0.911998644196314	0.99408739879047	nan
sp|P62280|RS11_HUMAN	Normal-Triple-negative breast cancer	-0.592111447470778	0.25781934476567	23.999999999586	0.0306720347115452	0.116975226402462	nan
sp|P62310|LSM3_HUMAN	metaplastic breast carcinomas-Normal	-0.0027600037027386	0.602748380882891	18.4898532527051	0.996395517995045	0.99759599452275	nan
sp|P62310|LSM3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.631927003887958	0.518558078094315	17.9848575125257	0.238731507134941	0.84876230490475	nan
sp|P62310|LSM3_HUMAN	Normal-Triple-negative breast cancer	0.634687007590696	0.679379817703565	18.2553077609521	0.362386459363031	0.55306363219592	nan
sp|P62312|LSM6_HUMAN	metaplastic breast carcinomas-Normal	0.312822556398578	0.168753991806203	22.0000000283303	0.0772372996046478	0.218736289861715	nan
sp|P62312|LSM6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.230244007084076	0.168753991806203	22.0000000283302	0.186244257671739	0.843662073010871	nan
sp|P62312|LSM6_HUMAN	Normal-Triple-negative breast cancer	-0.543066563482654	0.201699598946156	22.0000000280752	0.0133018991678352	0.0750687824004828	nan
sp|P62314|SMD1_HUMAN	metaplastic breast carcinomas-Normal	0.449116256450871	0.110728155465404	22.0000000033815	0.0005261241469199	0.0205217420849069	nan
sp|P62314|SMD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0380081596333046	0.110728155465404	22.0000000032003	0.734664023241094	0.954643368861838	nan
sp|P62314|SMD1_HUMAN	Normal-Triple-negative breast cancer	-0.487124416084176	0.132345459271077	22.0000000029642	0.0013097909235533	0.0266490250684039	nan
sp|P62316|SMD2_HUMAN	metaplastic breast carcinomas-Normal	0.648041945251466	0.167770981618085	23.9999999994415	0.0007449832448731	0.0221825773337916	nan
sp|P62316|SMD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.116784410860313	0.167770981618085	23.9999999994415	0.493056499907975	0.913320451076758	nan
sp|P62316|SMD2_HUMAN	Normal-Triple-negative breast cancer	-0.764826356111778	0.20052467704605	23.9999999995009	0.0008416537239783	0.0257262735003663	nan
sp|P62328|TYB4_HUMAN	metaplastic breast carcinomas-Normal	-0.217020425473985	0.356362338425638	23.9999999998043	0.548254084672785	0.722027170147518	nan
sp|P62328|TYB4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0823181707936224	0.356362338425638	23.9999999998059	0.819276041662878	0.965774701272009	nan
sp|P62328|TYB4_HUMAN	Normal-Triple-negative breast cancer	0.299338596267608	0.425934462175628	23.9999999997954	0.488953689687287	0.665826327128449	nan
sp|P62330|ARF6_HUMAN	metaplastic breast carcinomas-Normal	-0.288044729600533	0.29611052916044	19.0929939412984	0.342835857049869	0.553197276132895	nan
sp|P62330|ARF6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.270301125731698	0.277413190231908	18.8749235033417	0.342199298815144	0.870943310236299	nan
sp|P62330|ARF6_HUMAN	Normal-Triple-negative breast cancer	0.0177436038688354	0.340724234434928	19.0896531582808	0.959009108026773	0.980241782005226	nan
sp|P62333|PRS10_HUMAN	metaplastic breast carcinomas-Normal	0.281285503708241	0.17725163414201	21.999999982418	0.12679880915239	0.29765483165434	nan
sp|P62333|PRS10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.219537420705385	0.17725163414201	21.9999999815615	0.22856051974824	0.843662073010871	nan
sp|P62333|PRS10_HUMAN	Normal-Triple-negative breast cancer	-0.500822924413626	0.211856224177804	21.999999980479	0.0273272187739233	0.11091047033519	nan
sp|P62424|RL7A_HUMAN	metaplastic breast carcinomas-Normal	1.02206363377831	0.292328321906198	22.0000000052637	0.0020422093875837	0.0323252571634685	nan
sp|P62424|RL7A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0222731420937876	0.292328321906198	22.0000000041119	0.939954826978389	0.995571782532303	nan
sp|P62424|RL7A_HUMAN	Normal-Triple-negative breast cancer	-1.0443367758721	0.349399173661002	22.0000000045207	0.006765584226578	0.0524989501286484	nan
sp|P62495|ERF1_HUMAN	metaplastic breast carcinomas-Normal	0.387017316429367	0.166898795369725	22.0000000200366	0.0300819167680741	0.124822860832029	nan
sp|P62495|ERF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0832498174292124	0.166898795369725	22.0000000209087	0.622868205300189	0.941374262616245	nan
sp|P62495|ERF1_HUMAN	Normal-Triple-negative breast cancer	-0.47026713385858	0.199482215089342	22.0000000207335	0.0277115158404201	0.111517044374766	nan
sp|P62633|CNBP_HUMAN	metaplastic breast carcinomas-Normal	-0.538349780781555	0.692251683994549	6.0	0.466306270900263	0.658734400540788	nan
sp|P62633|CNBP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.315599949574808	0.692251683994549	6.0	0.66449460217716	0.944724271291086	nan
sp|P62633|CNBP_HUMAN	Normal-Triple-negative breast cancer	0.853949730356363	0.827399017570197	6.0	0.341825730822535	0.533942072017907	nan
sp|P62701|RS4X_HUMAN	metaplastic breast carcinomas-Normal	0.763548756918997	0.233335607146143	22.0000001545946	0.0034832464404595	0.0407324763980233	nan
sp|P62701|RS4X_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.141359620075389	0.233335607146143	22.0000001545926	0.550833406953355	0.931124086486988	nan
sp|P62701|RS4X_HUMAN	Normal-Triple-negative breast cancer	-0.622189136843609	0.278889393237481	22.0000001545355	0.0361971579180764	0.126678556343412	nan
sp|P62714|PP2AB_HUMAN;sp|P67775|PP2AA_HUMAN	metaplastic breast carcinomas-Normal	0.0950444964572123	0.149842841050159	23.9999999993254	0.531888648049875	0.708682730508622	nan
sp|P62714|PP2AB_HUMAN;sp|P67775|PP2AA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.154993219162057	0.149842841050159	23.99999999911	0.311273214363203	0.867696529950794	nan
sp|P62714|PP2AB_HUMAN;sp|P67775|PP2AA_HUMAN	Normal-Triple-negative breast cancer	-0.250037715619269	0.179096450527096	23.9999999992018	0.17546358850859	0.350084614767438	nan
sp|P62750|RL23A_HUMAN	metaplastic breast carcinomas-Normal	0.845126425056661	0.286181332584615	22.0000000441674	0.0073497938127072	0.0569480527585987	nan
sp|P62750|RL23A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.162779262940076	0.286181332584615	22.000000044384	0.575254730675375	0.935847692353991	nan
sp|P62750|RL23A_HUMAN	Normal-Triple-negative breast cancer	-0.682347162116585	0.342052116162573	22.0000000442716	0.0585918366049911	0.173156229478903	nan
sp|P62753|RS6_HUMAN	metaplastic breast carcinomas-Normal	0.981719861700184	0.24533838450816	22.0000000170992	0.0006009528146919	0.0205934758354237	nan
sp|P62753|RS6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.199600672582293	0.24533838450816	22.0000000170992	0.424607906251584	0.891301318362699	nan
sp|P62753|RS6_HUMAN	Normal-Triple-negative breast cancer	-1.18132053428248	0.293235456132035	22.0000000173238	0.0005625579689721	0.0237592699893802	nan
sp|P62760|VISL1_HUMAN	metaplastic breast carcinomas-Normal	1.58802991471562	0.870381455393706	6.0	0.11787951513093	0.283305052934023	nan
sp|P62760|VISL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.4963866186033	0.870381455393706	6.0	0.136369270991233	0.823891816737944	nan
sp|P62760|VISL1_HUMAN	Normal-Triple-negative breast cancer	-0.0916432961123139	1.04030481652067	6.0	0.93266962121157	0.962453172165297	nan
sp|P62805|H4_HUMAN	metaplastic breast carcinomas-Normal	0.790869987627343	0.212072109050651	22.0000000156745	0.00116463882265	0.0258553603828806	nan
sp|P62805|H4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.232787201682016	0.212072109050651	22.0000000156768	0.284213748726943	0.867696529950794	nan
sp|P62805|H4_HUMAN	Normal-Triple-negative breast cancer	-1.02365718930936	0.253474651979221	22.0000000156301	0.0005491039309513	0.0237592699893802	nan
sp|P62820|RAB1A_HUMAN	metaplastic breast carcinomas-Normal	0.398264105523494	0.348634457281227	21.9999999799136	0.265587456010359	0.468584237674327	nan
sp|P62820|RAB1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.345718105974279	0.348634457281227	21.9999999799077	0.332157738254191	0.870890600099115	nan
sp|P62820|RAB1A_HUMAN	Normal-Triple-negative breast cancer	-0.743982211497773	0.416697877542292	21.9999999795208	0.0879873491556506	0.223602777631342	nan
sp|P62826|RAN_HUMAN	metaplastic breast carcinomas-Normal	0.398129514659516	0.201394007425409	22.0000001139209	0.060723212078	0.189061824566636	nan
sp|P62826|RAN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.182088452771393	0.201394007425409	22.0000001148877	0.375715630478533	0.885234295852111	nan
sp|P62826|RAN_HUMAN	Normal-Triple-negative breast cancer	-0.580217967430909	0.240711879423352	22.0000001147249	0.0247348510947201	0.105004359304005	nan
sp|P62829|RL23_HUMAN	metaplastic breast carcinomas-Normal	0.843261059087269	0.215561067580572	21.9999999999002	0.0007474273951217	0.0221825773337916	nan
sp|P62829|RL23_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.210343439465612	0.215561067580572	22.0000000007549	0.339774443487939	0.870943310236299	nan
sp|P62829|RL23_HUMAN	Normal-Triple-negative breast cancer	-1.05360449855288	0.257644755030965	22.0000000004191	0.0004850149941185	0.0237592699893802	nan
sp|P62841|RS15_HUMAN	metaplastic breast carcinomas-Normal	1.18787683828683	0.436505091230291	23.9999999997592	0.0119087904804536	0.0718417777804499	nan
sp|P62841|RS15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.222780116227338	0.436505091230291	23.9999999999613	0.614452947555398	0.941374262616245	nan
sp|P62841|RS15_HUMAN	Normal-Triple-negative breast cancer	-0.965096722059489	0.521723373158564	23.9999999998368	0.0766906007694366	0.204426268610751	nan
sp|P62847|RS24_HUMAN	metaplastic breast carcinomas-Normal	0.472810423477607	0.230812943785856	22.0000000355581	0.0526322165711296	0.174426209254671	nan
sp|P62847|RS24_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.198494238647705	0.230812943785856	22.0000000353305	0.399075535700267	0.885297496092956	nan
sp|P62847|RS24_HUMAN	Normal-Triple-negative breast cancer	-0.274316184829902	0.275874233817547	22.0000000351415	0.330862998532925	0.523210564759012	nan
sp|P62851|RS25_HUMAN	metaplastic breast carcinomas-Normal	0.569364718938055	0.350415110885018	19.9969522923476	0.119856957308716	0.286621961218829	nan
sp|P62851|RS25_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.153576042355494	0.327738944083526	19.9678366833588	0.644436017071993	0.941868024951375	nan
sp|P62851|RS25_HUMAN	Normal-Triple-negative breast cancer	-0.415788676582561	0.407965876916178	20.0320802019022	0.320271658472807	0.512558012885705	nan
sp|P62854|RS26_HUMAN	metaplastic breast carcinomas-Normal	1.07848193539902	0.573557591829196	24.0000000004066	0.0722528521863646	0.209754131587315	nan
sp|P62854|RS26_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.594526295466433	0.573557591829196	24.0000000001714	0.310273135491922	0.867696529950794	nan
sp|P62854|RS26_HUMAN	Normal-Triple-negative breast cancer	-1.67300823086545	0.685532442855193	24.0000000003006	0.0224257560005995	0.0989915284510406	nan
sp|P62861|RS30_HUMAN	metaplastic breast carcinomas-Normal	0.227415838263184	0.233080916888507	22.0000000355665	0.33982306639766	0.549670011049062	nan
sp|P62861|RS30_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.408312201966602	0.233080916888507	22.0000000349662	0.093737473289434	0.81309570430905	nan
sp|P62861|RS30_HUMAN	Normal-Triple-negative breast cancer	0.180896363703418	0.278584980155036	22.0000000349283	0.522840788292648	0.695169112113905	nan
sp|P62873|GBB1_HUMAN	metaplastic breast carcinomas-Normal	-0.638398825280695	0.238208658932533	21.9999996877543	0.0136782397945557	0.0779870824650138	nan
sp|P62873|GBB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.279482958004701	0.238208658932533	21.9999996877543	0.253234443960087	0.855758210685228	nan
sp|P62873|GBB1_HUMAN	Normal-Triple-negative breast cancer	0.358915867275994	0.284713804147342	21.9999996880882	0.220652366393964	0.403934589352605	nan
sp|P62879|GBB2_HUMAN	metaplastic breast carcinomas-Normal	-0.891198321530357	0.23677130212941	23.9999999995384	0.0009545492068713	0.0233303056150036	nan
sp|P62879|GBB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.230786591128861	0.23677130212941	23.9999999995384	0.339420193390988	0.870943310236299	nan
sp|P62879|GBB2_HUMAN	Normal-Triple-negative breast cancer	0.660411730401497	0.282995834174429	23.999999999438	0.0283181338032268	0.112421067564965	nan
sp|P62888|RL30_HUMAN	metaplastic breast carcinomas-Normal	0.45622444626487	0.158781513695527	22.0000000019271	0.0088298583437182	0.061808805431078	nan
sp|P62888|RL30_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.153341136276631	0.158781513695527	22.0000000013515	0.344672834376589	0.870943310236299	nan
sp|P62888|RL30_HUMAN	Normal-Triple-negative breast cancer	-0.302883309988239	0.189780207802314	22.0000000015674	0.124761629159927	0.279264414362019	nan
sp|P62899|RL31_HUMAN	metaplastic breast carcinomas-Normal	0.833228964292186	0.202309856327315	22.0000000253693	0.0004516392968732	0.0200356889942306	nan
sp|P62899|RL31_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.227408780573642	0.202309856327315	22.0000000252147	0.273102792235007	0.867696529950794	nan
sp|P62899|RL31_HUMAN	Normal-Triple-negative breast cancer	-1.06063774486583	0.241806528232738	22.0000000252977	0.0002348155228644	0.0227914720285933	nan
sp|P62906|RL10A_HUMAN	metaplastic breast carcinomas-Normal	0.765574947658414	0.195684819898625	22.0000000078819	0.0007467910515262	0.0221825773337916	nan
sp|P62906|RL10A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0149916524980078	0.195684819898625	22.0000000076137	0.939625292999126	0.995571782532303	nan
sp|P62906|RL10A_HUMAN	Normal-Triple-negative breast cancer	-0.750583295160406	0.233888095155285	22.0000000076162	0.0040438761600452	0.041407627248948	nan
sp|P62910|RL32_HUMAN	metaplastic breast carcinomas-Normal	1.0874690440196	0.348670870828502	21.9999998961996	0.0049991307889673	0.047133593927725	nan
sp|P62910|RL32_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.17718268580365	0.348670870828502	21.9999998993109	0.616394591894055	0.941374262616245	nan
sp|P62910|RL32_HUMAN	Normal-Triple-negative breast cancer	-1.26465172982325	0.416741400055762	21.9999998990165	0.0060854275858436	0.0494571180815263	nan
sp|P62913|RL11_HUMAN	metaplastic breast carcinomas-Normal	0.482827370224335	0.200920174296542	22.000000002209	0.0251290146500247	0.111493559230289	nan
sp|P62913|RL11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0612015964431414	0.200920174296542	22.000000001103	0.763528677720605	0.955731302757062	nan
sp|P62913|RL11_HUMAN	Normal-Triple-negative breast cancer	-0.544028966667476	0.24014554051168	22.0000000017971	0.0336763840006814	0.123621534315429	nan
sp|P62917|RL8_HUMAN	metaplastic breast carcinomas-Normal	0.361253120447667	0.264356809001263	23.9999999996218	0.184437801820701	0.375426364514396	nan
sp|P62917|RL8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.109706886584809	0.264356809001263	23.9999999998521	0.681831642415633	0.946568877415162	nan
sp|P62917|RL8_HUMAN	Normal-Triple-negative breast cancer	-0.470960007032476	0.315966821190657	23.9999999997341	0.149110004065986	0.316299715070413	nan
sp|P62993|GRB2_HUMAN	metaplastic breast carcinomas-Normal	0.245607644499187	0.210154825697305	21.999999343906	0.255033485656563	0.456340762905879	nan
sp|P62993|GRB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0240294936754599	0.210154825697305	21.999999343413	0.910003923799772	0.99408739879047	nan
sp|P62993|GRB2_HUMAN	Normal-Triple-negative breast cancer	-0.269637138174647	0.251183060063102	21.9999993405488	0.294694804815924	0.487103695280026	nan
sp|P62995|TRA2B_HUMAN	metaplastic breast carcinomas-Normal	0.627034280806832	0.307596814933601	22.000000001369	0.0536973834476177	0.176597515369253	nan
sp|P62995|TRA2B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0266918657719922	0.307596814933601	22.0000000014541	0.931634934456281	0.995359816653149	nan
sp|P62995|TRA2B_HUMAN	Normal-Triple-negative breast cancer	-0.60034241503484	0.367648513348777	22.0000000016895	0.116716561045306	0.267194110822725	nan
sp|P63010|AP2B1_HUMAN	metaplastic breast carcinomas-Normal	0.0776806237768899	0.260505391419225	23.9999999999418	0.768122967310166	0.874697068632749	nan
sp|P63010|AP2B1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.130403040454344	0.260505391419225	23.9999999997047	0.621228438419813	0.941374262616245	nan
sp|P63010|AP2B1_HUMAN	Normal-Triple-negative breast cancer	-0.208083664231234	0.311363496710112	23.9999999998258	0.51032010640315	0.683993561969384	nan
sp|P63092|GNAS2_HUMAN;sp|Q5JWF2|GNAS1_HUMAN	metaplastic breast carcinomas-Normal	-0.328106614532502	0.224412841216596	22.0000001922694	0.157861658854546	0.340072685698321	nan
sp|P63092|GNAS2_HUMAN;sp|Q5JWF2|GNAS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0959754202362497	0.224412841216595	22.0000001924164	0.673046063825178	0.946386428913156	nan
sp|P63092|GNAS2_HUMAN;sp|Q5JWF2|GNAS1_HUMAN	Normal-Triple-negative breast cancer	0.424082034768752	0.268224648124092	22.000000192527	0.128133268032352	0.285465806259743	nan
sp|P63096|GNAI1_HUMAN	metaplastic breast carcinomas-Normal	-1.32889298492018	0.338028510330226	15.0000000001229	0.0013333523465245	0.0271905743670284	nan
sp|P63096|GNAI1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.508464866546594	0.338028510330226	15.0000000001229	0.153290615770892	0.843465960034572	nan
sp|P63096|GNAI1_HUMAN	Normal-Triple-negative breast cancer	1.83735785146677	0.404021346317372	15.0000000000945	0.0003849717568033	0.0237592699893802	nan
sp|P63104|1433Z_HUMAN	metaplastic breast carcinomas-Normal	0.552488849193121	0.189768889281418	22.0000000242133	0.008091203636897	0.0598781084433848	nan
sp|P63104|1433Z_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.10347123874378	0.189768889281418	22.0000000245236	0.591068134649887	0.940559810632461	nan
sp|P63104|1433Z_HUMAN	Normal-Triple-negative breast cancer	-0.449017610449341	0.226817205630762	22.0000000239291	0.0603899208239655	0.177015958394058	nan
sp|P63151|2ABA_HUMAN	metaplastic breast carcinomas-Normal	-0.86287279010608	0.455667688404626	14.9999999995542	0.0777240102128555	0.219502642266382	nan
sp|P63151|2ABA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0615772535737759	0.455667688404626	14.9999999995738	0.894300819502967	0.988218752026376	nan
sp|P63151|2ABA_HUMAN	Normal-Triple-negative breast cancer	0.801295536532305	0.544627057530479	14.9999999995622	0.161884070265541	0.331752558300036	nan
sp|P63167|DYL1_HUMAN	metaplastic breast carcinomas-Normal	0.563776343815328	0.24393565783376	21.9999977772887	0.0305773547580458	0.125790999029386	nan
sp|P63167|DYL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0411915740341774	0.24393565783376	21.9999977775294	0.867447768888279	0.981143688073178	nan
sp|P63167|DYL1_HUMAN	Normal-Triple-negative breast cancer	-0.604967917849506	0.291558877079715	21.9999977786935	0.049891871393933	0.155838025008143	nan
sp|P63172|DYLT1_HUMAN	metaplastic breast carcinomas-Normal	-0.163672911007615	0.238837032786498	22.0000000045354	0.500317891410754	0.685513879245402	nan
sp|P63172|DYLT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0506173855623671	0.238837032786498	22.0000000045354	0.834110670372679	0.9684421207956	nan
sp|P63172|DYLT1_HUMAN	Normal-Triple-negative breast cancer	0.214290296569982	0.28546485455496	22.000000004346	0.460804691831197	0.641959260539353	nan
sp|P63173|RL38_HUMAN	metaplastic breast carcinomas-Normal	0.76073694479898	0.202242739917945	21.999997488497	0.0010770973539183	0.0249056665902193	nan
sp|P63173|RL38_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0090436219233381	0.202242739917945	21.999997482589	0.964736553091922	0.99709406933403	nan
sp|P63173|RL38_HUMAN	Normal-Triple-negative breast cancer	-0.769780566722318	0.241726308780103	21.9999974839115	0.0042855362988916	0.0419484078096101	nan
sp|P63208|SKP1_HUMAN	metaplastic breast carcinomas-Normal	0.45844278114617	0.18045337414117	22.0000000358942	0.0186379810356653	0.0928825321777383	nan
sp|P63208|SKP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.179975306149852	0.18045337414117	22.000000035889	0.329438415560229	0.868661960140967	nan
sp|P63208|SKP1_HUMAN	Normal-Triple-negative breast cancer	-0.638418087296022	0.215683035424449	22.000000036026	0.0072342098891207	0.0535557097359409	nan
sp|P63220|RS21_HUMAN	metaplastic breast carcinomas-Normal	0.322919301145661	0.162996329286538	22.0000000023201	0.0602106179036421	0.188054227556203	nan
sp|P63220|RS21_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.257279654202903	0.162996329286538	22.0000000023217	0.128736711397316	0.823891816737944	nan
sp|P63220|RS21_HUMAN	Normal-Triple-negative breast cancer	-0.0656396469427586	0.194817875979759	22.0000000023126	0.739364055747894	0.850288269338703	nan
sp|P63241|IF5A1_HUMAN	metaplastic breast carcinomas-Normal	0.539854066266219	0.226719284241799	20.988134762636	0.0268064371371012	0.116172877501596	nan
sp|P63241|IF5A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.116377353173357	0.226719284241799	20.9881347630532	0.613095514394857	0.94077736515583	nan
sp|P63241|IF5A1_HUMAN	Normal-Triple-negative breast cancer	-0.423476713092863	0.268078733071604	20.9718585760497	0.129147224896571	0.286190250370801	nan
sp|P63244|RACK1_HUMAN	metaplastic breast carcinomas-Normal	0.402033535459781	0.187890445216162	22.0000521853797	0.0437208343593138	0.155265014327307	nan
sp|P63244|RACK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.113120901633267	0.187890445216162	22.0000521865779	0.553290635743092	0.931642387063667	nan
sp|P63244|RACK1_HUMAN	Normal-Triple-negative breast cancer	-0.515154437093048	0.224572035542933	22.0000521876836	0.0317122684281472	0.119654898900784	nan
sp|P63261|ACTG_HUMAN	metaplastic breast carcinomas-Normal	1.94351322325648	0.582238619002054	22.000000001474	0.002980557978831	0.0382524120526418	nan
sp|P63261|ACTG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.776373271031642	0.582238619002054	22.0000000014436	0.196034453222374	0.843662073010871	nan
sp|P63261|ACTG_HUMAN	Normal-Triple-negative breast cancer	-1.16713995222484	0.695908254890603	22.000000001709	0.107666854600373	0.253638996946591	nan
sp|P67809|YBOX1_HUMAN	metaplastic breast carcinomas-Normal	0.898709129396399	0.383749536990366	22.0000003517101	0.0286441753484911	0.120828983322823	nan
sp|P67809|YBOX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.784494860316942	0.383749536990366	22.0000003527273	0.0530755479215043	0.773286317778246	nan
sp|P67809|YBOX1_HUMAN	Normal-Triple-negative breast cancer	-1.68320398971334	0.458668425429713	22.000000352706	0.0013448904561767	0.0266490250684039	nan
sp|P67936|TPM4_HUMAN	metaplastic breast carcinomas-Normal	0.681104909029211	0.230962176417302	22.0000002454785	0.0074200861973847	0.0573589919072252	nan
sp|P67936|TPM4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.218418937070472	0.230962176417302	22.0000002454771	0.354577810207292	0.878877489703816	nan
sp|P67936|TPM4_HUMAN	Normal-Triple-negative breast cancer	-0.462685971958739	0.276052600928096	22.0000002455183	0.107878072218948	0.253956594940356	nan
sp|P68133|ACTS_HUMAN	metaplastic breast carcinomas-Normal	-1.6165357502475	1.72802740694286	3.0	0.418550294917143	0.619494915770806	nan
sp|P68133|ACTS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.74059978878574	1.36612561628353	3.0	0.292366041518253	0.867696529950794	nan
sp|P68133|ACTS_HUMAN	Normal-Triple-negative breast cancer	-0.124064038538238	1.83284984628826	3.0	0.950291951958861	0.973727018591632	nan
sp|P68402|PA1B2_HUMAN	metaplastic breast carcinomas-Normal	0.13842073656847	0.250622552448114	22.0000000211888	0.586305599382266	0.746056437269984	nan
sp|P68402|PA1B2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.532116126990576	0.250622552448114	22.0000000216042	0.0452279170195498	0.759166737802103	nan
sp|P68402|PA1B2_HUMAN	Normal-Triple-negative breast cancer	-0.670536863559046	0.299551244830395	22.0000000209425	0.0356329666333367	0.12639885742052	nan
sp|P68431|H31_HUMAN	metaplastic breast carcinomas-Normal	1.16545804782681	0.465984058794501	24.0000000001421	0.019607478736175	0.0954249770410623	nan
sp|P68431|H31_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.611028991496844	0.465984058794501	24.000000000113	0.20217542269586	0.843662073010871	nan
sp|P68431|H31_HUMAN	Normal-Triple-negative breast cancer	-1.77648703932365	0.556957478564948	24.0000000001661	0.0039383041045098	0.0407816911009052	nan
sp|P69849|NOMO3_HUMAN;sp|Q15155|NOMO1_HUMAN;sp|Q5JPE7|NOMO2_HUMAN	metaplastic breast carcinomas-Normal	0.573094755176425	0.171357265623081	21.9999999942781	0.0029352368783963	0.0380628964347452	nan
sp|P69849|NOMO3_HUMAN;sp|Q15155|NOMO1_HUMAN;sp|Q5JPE7|NOMO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.203934624374747	0.171357265623081	21.9999999924483	0.246686480295488	0.84964799869723	nan
sp|P69849|NOMO3_HUMAN;sp|Q15155|NOMO1_HUMAN;sp|Q5JPE7|NOMO2_HUMAN	Normal-Triple-negative breast cancer	-0.369160130801678	0.20481110629002	21.9999999933663	0.0851942565335972	0.219694110719688	nan
sp|P69891|HBG1_HUMAN;sp|P69892|HBG2_HUMAN	metaplastic breast carcinomas-Normal	-0.51715591282537	0.799510332026158	22.0000001917989	0.524426949801652	0.703468596101973	nan
sp|P69891|HBG1_HUMAN;sp|P69892|HBG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.08813654474379	0.799510332026158	22.0000001917292	0.187292129235407	0.843662073010871	nan
sp|P69891|HBG1_HUMAN;sp|P69892|HBG2_HUMAN	Normal-Triple-negative breast cancer	1.60529245756916	0.955597622296104	22.0000001917813	0.107126798840602	0.253315936205068	nan
sp|P78324|SHPS1_HUMAN	metaplastic breast carcinomas-Normal	-0.0286421177464828	0.298558313613354	19.6315120632862	0.924544957159293	0.959399047261854	nan
sp|P78324|SHPS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.881832023859008	0.251637194681858	19.1513278076903	0.0023493338080217	0.448717474870704	nan
sp|P78324|SHPS1_HUMAN	Normal-Triple-negative breast cancer	0.910474141605491	0.340285270921512	19.653921792688	0.0146728203178546	0.0779324922305247	nan
sp|P78344|IF4G2_HUMAN	metaplastic breast carcinomas-Normal	0.564365139240259	0.210607657727077	24.0000000000999	0.0131017096902506	0.0760036352711922	nan
sp|P78344|IF4G2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.227481286303451	0.210607657727077	24.0000000000644	0.290824576187926	0.867696529950794	nan
sp|P78344|IF4G2_HUMAN	Normal-Triple-negative breast cancer	-0.79184642554371	0.251724297860309	24.000000000075	0.0043790208918313	0.0420689752729698	nan
sp|P78347|GTF2I_HUMAN	metaplastic breast carcinomas-Normal	0.63027905509052	0.248345547707859	23.9999999998845	0.0180589719373542	0.091089564066412	nan
sp|P78347|GTF2I_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.326191766084616	0.248345547707859	23.9999999998846	0.201447126419053	0.843662073010871	nan
sp|P78347|GTF2I_HUMAN	Normal-Triple-negative breast cancer	-0.956470821175136	0.296829703621252	23.9999999999547	0.0036387614447173	0.0400819560687694	nan
sp|P78356|PI42B_HUMAN	metaplastic breast carcinomas-Normal	0.0950065539624151	0.215108146741278	22.0000000025074	0.663039687676696	0.802822376058803	nan
sp|P78356|PI42B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0218682909787975	0.215108146741278	22.0000000025387	0.919945976341641	0.994508979919649	nan
sp|P78356|PI42B_HUMAN	Normal-Triple-negative breast cancer	-0.116874844941213	0.257103411086077	22.0000000026459	0.653862900028509	0.79700780333508	nan
sp|P78362|SRPK2_HUMAN	metaplastic breast carcinomas-Normal	0.34848352994912	0.392446196129039	14.9999999995	0.388569934853487	0.592689911608717	nan
sp|P78362|SRPK2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.238969174926494	0.392446196129039	14.9999999996562	0.551687326295531	0.93162029453156	nan
sp|P78362|SRPK2_HUMAN	Normal-Triple-negative breast cancer	-0.109514355022625	0.469062921237884	14.999999999577	0.818549038429507	0.896788728984734	nan
sp|P78368|KC1G2_HUMAN;sp|Q9HCP0|KC1G1_HUMAN;sp|Q9Y6M4|KC1G3_HUMAN	metaplastic breast carcinomas-Normal	0.150649738808336	0.685629846621571	14.9999999997259	0.82904781977774	0.909492232445857	nan
sp|P78368|KC1G2_HUMAN;sp|Q9HCP0|KC1G1_HUMAN;sp|Q9Y6M4|KC1G3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.618781029798351	0.685629846621571	14.9999999997258	0.381055511132278	0.885234295852111	nan
sp|P78368|KC1G2_HUMAN;sp|Q9HCP0|KC1G1_HUMAN;sp|Q9Y6M4|KC1G3_HUMAN	Normal-Triple-negative breast cancer	-0.769430768606687	0.819484408095654	14.9999999996796	0.362645677248106	0.553205246063655	nan
sp|P78371|TCPB_HUMAN	metaplastic breast carcinomas-Normal	0.54706138809071	0.106647162217957	24.0000000002484	2.99401484773078e-05	0.007907787651877	nan
sp|P78371|TCPB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.138991618076373	0.106647162217957	24.0000000002495	0.204842683557993	0.843662073010871	nan
sp|P78371|TCPB_HUMAN	Normal-Triple-negative breast cancer	-0.686053006167083	0.127467739387228	24.0000000002719	1.58420283976694e-05	0.022319699811492	nan
sp|P78406|RAE1L_HUMAN	metaplastic breast carcinomas-Normal	0.47810996750052	0.253607923070694	22.0000000344565	0.0726750413875442	0.210562461081628	nan
sp|P78406|RAE1L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0847247070940988	0.253607923070694	22.000000034074	0.741484730942712	0.954643368861838	nan
sp|P78406|RAE1L_HUMAN	Normal-Triple-negative breast cancer	-0.562834674594619	0.30311944520797	22.0000000339867	0.0767793556820141	0.204498860806903	nan
sp|P78417|GSTO1_HUMAN	metaplastic breast carcinomas-Normal	0.0830425622721482	0.287750568244049	23.9999999996622	0.775371389102708	0.878652805610422	nan
sp|P78417|GSTO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0049129171301435	0.287750568244049	23.999999999661	0.98651910465749	0.99777413090774	nan
sp|P78417|GSTO1_HUMAN	Normal-Triple-negative breast cancer	-0.0879554794022918	0.343927711517516	23.9999999995959	0.800332071785587	0.885292448124889	nan
sp|P78504|JAG1_HUMAN	metaplastic breast carcinomas-Normal	0.296891254716327	0.340290394669364	14.9999999998046	0.396706416329787	0.600951119377521	nan
sp|P78504|JAG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.27024806936209	0.340290394669364	14.9999999998046	0.439481337007693	0.89755436380139	nan
sp|P78504|JAG1_HUMAN	Normal-Triple-negative breast cancer	-0.0266431853542369	0.406724815190516	14.999999999803	0.94863569098613	0.973407457284302	nan
sp|P78527|PRKDC_HUMAN	metaplastic breast carcinomas-Normal	0.796947739641363	0.228102509515291	23.9999999997418	0.0018707673432814	0.0307843101438982	nan
sp|P78527|PRKDC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.20629584558111	0.228102509515291	23.9999999997418	0.374772845606498	0.885234295852111	nan
sp|P78527|PRKDC_HUMAN	Normal-Triple-negative breast cancer	-1.00324358522247	0.272634645233647	23.9999999997895	0.0011782697527513	0.0266490250684039	nan
sp|P78536|ADA17_HUMAN	metaplastic breast carcinomas-Normal	0.285314095399386	0.190308657570713	15.000000000008	0.154567463551023	0.33536700316162	nan
sp|P78536|ADA17_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0206172711943435	0.190308657570713	15.0000000000352	0.915165091662431	0.99408739879047	nan
sp|P78536|ADA17_HUMAN	Normal-Triple-negative breast cancer	-0.264696824205043	0.227462352132539	15.000000000001	0.262724722967039	0.453425222815388	nan
sp|P78559|MAP1A_HUMAN	metaplastic breast carcinomas-Normal	-0.334763914772168	0.57304869389176	13.9999999756586	0.568393194240274	0.734528007858528	nan
sp|P78559|MAP1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.11162607737637	0.57304869389176	13.999999976738	0.0728163174101821	0.788645783025588	nan
sp|P78559|MAP1A_HUMAN	Normal-Triple-negative breast cancer	1.44638999214854	0.684924193481139	13.9999999765432	0.0531636617090273	0.162439494536208	nan
sp|P80188|NGAL_HUMAN	metaplastic breast carcinomas-Normal	0.474169151076945	0.670104401554735	23.9999999998809	0.486005951980626	0.675087247966402	nan
sp|P80188|NGAL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.453171033529313	0.670104401554735	23.9999999998809	0.505335241007763	0.913320451076758	nan
sp|P80188|NGAL_HUMAN	Normal-Triple-negative breast cancer	-0.020998117547632	0.800927951979122	23.999999999898	0.979300847830342	0.990023119886878	nan
sp|P80217|IN35_HUMAN	metaplastic breast carcinomas-Normal	0.343589140590719	0.159269724259598	22.0000000004635	0.0421715506376399	0.152285044160049	nan
sp|P80217|IN35_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.196797875310761	0.159269724259598	22.0000000006925	0.229629728769474	0.843662073010871	nan
sp|P80217|IN35_HUMAN	Normal-Triple-negative breast cancer	-0.146791265279958	0.190363731035872	22.0000000008575	0.44884528010922	0.632088735336703	nan
sp|P80303|NUCB2_HUMAN	metaplastic breast carcinomas-Normal	0.660995396546909	0.231283697968693	23.9999999994728	0.0086748052072047	0.0613511755505287	nan
sp|P80303|NUCB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.133678928272533	0.231283697968693	23.9999999994433	0.568657047613214	0.935631258424823	nan
sp|P80303|NUCB2_HUMAN	Normal-Triple-negative breast cancer	-0.794674324819442	0.276436892684837	23.99999999947	0.0083409549506109	0.0580027913301897	nan
sp|P80723|BASP1_HUMAN	metaplastic breast carcinomas-Normal	0.255708832984677	0.488115490380927	23.9999999997637	0.605173847098137	0.763125139512218	nan
sp|P80723|BASP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.358696048013214	0.488115490380927	23.9999999997637	0.46954560303094	0.911938744204366	nan
sp|P80723|BASP1_HUMAN	Normal-Triple-negative breast cancer	0.102987215028537	0.583409598762571	23.9999999997454	0.861361558630784	0.920618363364173	nan
sp|P80748|LV321_HUMAN	metaplastic breast carcinomas-Normal	-1.57508973429813	0.570404137015302	22.0000000105848	0.0113904282475924	0.0706376557742485	nan
sp|P80748|LV321_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.475634949860442	0.570404137015302	22.0000000104429	0.413324654607286	0.885784822958391	nan
sp|P80748|LV321_HUMAN	Normal-Triple-negative breast cancer	2.05072468415857	0.681763343443384	22.0000000105575	0.0064738667930508	0.0513583131744655	nan
sp|P82909|KGD4_HUMAN	metaplastic breast carcinomas-Normal	-0.13185921640886	0.278212367051831	14.9999999998751	0.642359414767671	0.788678711145789	nan
sp|P82909|KGD4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.139933891803033	0.278212367051831	14.9999999998758	0.622286306743483	0.941374262616245	nan
sp|P82909|KGD4_HUMAN	Normal-Triple-negative breast cancer	-0.0080746753941731	0.33252738057099	14.9999999998523	0.980947178816295	0.990321607142567	nan
sp|P82914|RT15_HUMAN	metaplastic breast carcinomas-Normal	0.0459826751768851	0.397085749610883	14.9999999997948	0.909346826349765	0.951423234700707	nan
sp|P82914|RT15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0788757590464581	0.397085749610882	14.9999999997956	0.845214252820495	0.973108514760438	nan
sp|P82914|RT15_HUMAN	Normal-Triple-negative breast cancer	-0.124858434223343	0.47460824829392	14.9999999998104	0.796070640349699	0.882929198706172	nan
sp|P82933|RT09_HUMAN	metaplastic breast carcinomas-Normal	0.289184303350835	0.319561880019673	6.0	0.400373273751236	0.603000332510477	nan
sp|P82933|RT09_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.276038884272263	0.319561880019673	6.0	0.420880074227677	0.887693595400195	nan
sp|P82933|RT09_HUMAN	Normal-Triple-negative breast cancer	-0.565223187623098	0.381949501452198	6.0	0.189409157804273	0.369698203488787	nan
sp|P82970|HMGN5_HUMAN	metaplastic breast carcinomas-Normal	0.152705108233746	0.467565819721183	23.9999999999696	0.746804633212231	0.860108189651783	nan
sp|P82970|HMGN5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.226317265110868	0.467565819721183	23.9999999999408	0.632750021623849	0.941868024951375	nan
sp|P82970|HMGN5_HUMAN	Normal-Triple-negative breast cancer	-0.379022373344614	0.558848044477645	23.999999999929	0.504118997265363	0.677916668869779	nan
sp|P82979|SARNP_HUMAN	metaplastic breast carcinomas-Normal	0.765301205908403	0.341237568947903	23.9999999991941	0.0344174826352978	0.133337659999685	nan
sp|P82979|SARNP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.493375212325863	0.341237568947903	23.9999999991941	0.161155079257366	0.843662073010871	nan
sp|P82979|SARNP_HUMAN	Normal-Triple-negative breast cancer	-1.25867641823427	0.407856904986252	23.9999999992382	0.0050534930074673	0.0452771179429151	nan
sp|P83111|LACTB_HUMAN	metaplastic breast carcinomas-Normal	-0.371367506441705	0.297051396086987	14.0000000036875	0.231727951185503	0.431726840756277	nan
sp|P83111|LACTB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.427586393909521	0.297051396086987	14.0000000036889	0.172010666666552	0.843662073010871	nan
sp|P83111|LACTB_HUMAN	Normal-Triple-negative breast cancer	-0.056218887467816	0.35504432704589	14.0000000039061	0.876447624494983	0.928106102051286	nan
sp|P83731|RL24_HUMAN	metaplastic breast carcinomas-Normal	0.871678828572397	0.234084143978332	23.999999999623	0.0010556043983932	0.0247100635229515	nan
sp|P83731|RL24_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.139671776365695	0.234084143978332	23.999999999623	0.556312625721956	0.931642387063667	nan
sp|P83731|RL24_HUMAN	Normal-Triple-negative breast cancer	-1.01135060493809	0.279784065874454	23.999999999714	0.0013857784919947	0.0266490250684039	nan
sp|P83881|RL36A_HUMAN	metaplastic breast carcinomas-Normal	1.68961915249571	0.600910602791087	22.000000013917	0.0101602993984753	0.0667447335978891	nan
sp|P83881|RL36A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.162424346574284	0.600910602791087	22.000000014682	0.789451240778354	0.962981271203673	nan
sp|P83881|RL36A_HUMAN	Normal-Triple-negative breast cancer	-1.85204349906999	0.718225544108283	22.00000001406	0.0171364152965056	0.0845803360657786	nan
sp|P83916|CBX1_HUMAN	metaplastic breast carcinomas-Normal	0.755912523148478	0.287343357650118	23.9999999995966	0.014649434483359	0.0796967597752624	nan
sp|P83916|CBX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0350868686890077	0.287343357650118	23.999999999636	0.903830341200601	0.991772650140507	nan
sp|P83916|CBX1_HUMAN	Normal-Triple-negative breast cancer	-0.790999391837486	0.343441001765626	23.9999999996668	0.0302433647946571	0.116487768919398	nan
sp|P84085|ARF5_HUMAN	metaplastic breast carcinomas-Normal	0.527074796296916	0.246594072359945	21.9999999824592	0.0439280029457916	0.155668104255662	nan
sp|P84085|ARF5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.141700575527157	0.246594072359945	21.9999999822375	0.571370880197811	0.935631258424823	nan
sp|P84085|ARF5_HUMAN	Normal-Triple-negative breast cancer	-0.668775371824073	0.294736290176881	21.9999999822364	0.0334190029323314	0.123080470915089	nan
sp|P84090|ERH_HUMAN	metaplastic breast carcinomas-Normal	0.497072403318629	0.209749200742568	22.0000000098985	0.026986525414882	0.1166491683733	nan
sp|P84090|ERH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.182286684022243	0.209749200742568	22.0000000097677	0.394191708731027	0.885234295852111	nan
sp|P84090|ERH_HUMAN	Normal-Triple-negative breast cancer	-0.314785719296386	0.25069824551254	22.0000000098942	0.222420739631385	0.405153931841361	nan
sp|P84095|RHOG_HUMAN	metaplastic breast carcinomas-Normal	-0.15370148486217	0.377952291839765	23.9999999997119	0.687854937041927	0.817457923034453	nan
sp|P84095|RHOG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.174566439994398	0.377952291839765	23.9999999997119	0.648330915275116	0.943315325604231	nan
sp|P84095|RHOG_HUMAN	Normal-Triple-negative breast cancer	-0.0208649551322277	0.451739392170389	23.9999999996898	0.963542562738226	0.982458735749038	nan
sp|P84098|RL19_HUMAN	metaplastic breast carcinomas-Normal	0.604074708572127	0.270385007568288	22.0000000245821	0.0359579161513723	0.137542132666469	nan
sp|P84098|RL19_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0196947239323422	0.270385007568288	22.0000000244733	0.942591979518781	0.996541950781621	nan
sp|P84098|RL19_HUMAN	Normal-Triple-negative breast cancer	-0.623769432504469	0.323171896580714	22.0000000244604	0.0665807605515738	0.186338952556932	nan
sp|P84103|SRSF3_HUMAN	metaplastic breast carcinomas-Normal	0.707019470115327	0.216805696373004	21.9999999879642	0.0035772079614757	0.0407324763980233	nan
sp|P84103|SRSF3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.224778598717009	0.216805696373004	21.9999999890312	0.31110303068143	0.867696529950794	nan
sp|P84103|SRSF3_HUMAN	Normal-Triple-negative breast cancer	-0.931798068832336	0.259132370971681	21.9999999885917	0.0016075207184079	0.0283781197026415	nan
sp|P84157|MXRA7_HUMAN	metaplastic breast carcinomas-Normal	-0.288378657875611	0.221736299009808	22.0000000040094	0.20687260692615	0.401661533541193	nan
sp|P84157|MXRA7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0874070344741921	0.221736299009808	22.0000000034096	0.697233169269837	0.947043345959522	nan
sp|P84157|MXRA7_HUMAN	Normal-Triple-negative breast cancer	0.375785692349803	0.265025568304448	22.0000000038751	0.170222988492628	0.341473273234457	nan
sp|P84243|H33_HUMAN	metaplastic breast carcinomas-Normal	0.152008471447952	0.340511646041563	21.9999999710661	0.659662825747003	0.800847053609582	nan
sp|P84243|H33_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.495171494380057	0.340511646041563	21.9999999718873	0.16001025297265	0.843662073010871	nan
sp|P84243|H33_HUMAN	Normal-Triple-negative breast cancer	-0.647179965828009	0.406989261160423	21.9999999738511	0.126066257811718	0.281615753337467	nan
sp|P85037|FOXK1_HUMAN	metaplastic breast carcinomas-Normal	0.112278843864608	0.345571831225927	23.9999999995646	0.748066418857793	0.860108189651783	nan
sp|P85037|FOXK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.383453889853067	0.345571831225927	23.9999999995646	0.278157184512275	0.867696529950794	nan
sp|P85037|FOXK1_HUMAN	Normal-Triple-negative breast cancer	0.271175045988459	0.413037339261304	23.9999999995028	0.517723709206361	0.690852512806882	nan
sp|P98082|DAB2_HUMAN	metaplastic breast carcinomas-Normal	0.0435887238776303	0.360575263862953	15.0000000000324	0.90538530466825	0.949297674765436	nan
sp|P98082|DAB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.485402174300545	0.360575263862953	15.000000000002	0.198234668485122	0.843662073010871	nan
sp|P98082|DAB2_HUMAN	Normal-Triple-negative breast cancer	0.441813450422915	0.430969871187299	15.0000000000466	0.321536614063555	0.513346640320489	nan
sp|P98095|FBLN2_HUMAN	metaplastic breast carcinomas-Normal	0.5747268312613	0.396121370704519	22.0000000034455	0.160921862143249	0.345768758735721	nan
sp|P98095|FBLN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.158905625032328	0.396121370704519	22.0000000033173	0.692176574146253	0.946568877415162	nan
sp|P98095|FBLN2_HUMAN	Normal-Triple-negative breast cancer	-0.415821206228972	0.473455595034797	22.0000000034474	0.389289420975079	0.576905053642962	nan
sp|P98160|PGBM_HUMAN	metaplastic breast carcinomas-Normal	0.412200238289737	0.279747900719331	23.9999999991219	0.153620117803384	0.333747236325783	nan
sp|P98160|PGBM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.202066677767971	0.279747900719331	23.9999999991219	0.477079429918557	0.913280230088743	nan
sp|P98160|PGBM_HUMAN	Normal-Triple-negative breast cancer	-0.210133560521766	0.334362694340982	23.9999999991039	0.535638369291451	0.702867070999919	nan
sp|P98171|RHG04_HUMAN	metaplastic breast carcinomas-Normal	-1.09583879813414	0.440620679978802	13.0274841819521	0.0272128953880645	0.117018970594989	nan
sp|P98171|RHG04_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.364037089878247	0.393190676952314	13.0000001781479	0.371390908179518	0.884580780585171	nan
sp|P98171|RHG04_HUMAN	Normal-Triple-negative breast cancer	1.45987588801239	0.510297225812219	13.0205192877966	0.0133583747242503	0.0751323816978138	nan
sp|P98175|RBM10_HUMAN	metaplastic breast carcinomas-Normal	0.667812190280279	0.20527552680531	22.0000000080993	0.0036440472007977	0.0407324763980233	nan
sp|P98175|RBM10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.01587817196248	0.20527552680531	22.0000000080649	0.939043869958769	0.995571782532303	nan
sp|P98175|RBM10_HUMAN	Normal-Triple-negative breast cancer	-0.683690362242759	0.245351182433895	22.0000000079994	0.0107582496496487	0.0663669646889177	nan
sp|Q00059|TFAM_HUMAN	metaplastic breast carcinomas-Normal	0.429205910275802	0.318640652413708	22.0000000179227	0.191695560243029	0.384853332717282	nan
sp|Q00059|TFAM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.14991617078181	0.318640652413708	22.000000018215	0.642638428359933	0.941868024951375	nan
sp|Q00059|TFAM_HUMAN	Normal-Triple-negative breast cancer	-0.579122081057612	0.38084842386184	22.000000018395	0.142600924916514	0.305809983498383	nan
sp|Q00169|PIPNA_HUMAN	metaplastic breast carcinomas-Normal	-0.415068337076213	0.290106478048802	23.0000000001612	0.165950419744098	0.352472329220051	nan
sp|Q00169|PIPNA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.204838786021872	0.271369761635568	23.00000000015	0.458009438549821	0.908567154037048	nan
sp|Q00169|PIPNA_HUMAN	Normal-Triple-negative breast cancer	0.210229551054341	0.340179999166743	23.0000000002468	0.542650209136089	0.708193676940856	nan
sp|Q00325|MPCP_HUMAN	metaplastic breast carcinomas-Normal	0.155687874355083	0.172523475760902	23.9999999995581	0.375804296735125	0.582830487052147	nan
sp|Q00325|MPCP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0539499431922707	0.172523475760902	23.9999999995581	0.757201536596867	0.955228196959647	nan
sp|Q00325|MPCP_HUMAN	Normal-Triple-negative breast cancer	-0.209637817547353	0.206204994011239	23.9999999996276	0.319461025330862	0.511905730194303	nan
sp|Q00341|VIGLN_HUMAN	metaplastic breast carcinomas-Normal	0.906114593455983	0.208762191275527	23.9999999998536	0.0002222571340093	0.0157578323963946	nan
sp|Q00341|VIGLN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.187598607360147	0.208762191275527	23.9999999996328	0.37778080883704	0.885234295852111	nan
sp|Q00341|VIGLN_HUMAN	Normal-Triple-negative breast cancer	-0.718515986095835	0.249518543559849	23.9999999997155	0.0082455909147367	0.0575911703148659	nan
sp|Q00577|PURA_HUMAN	metaplastic breast carcinomas-Normal	-0.257325530967877	0.229964276022745	22.0000004208712	0.275217762765483	0.477548285858522	nan
sp|Q00577|PURA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.301237493353356	0.229964276022745	22.0000004207838	0.203732994542967	0.843662073010871	nan
sp|Q00577|PURA_HUMAN	Normal-Triple-negative breast cancer	0.558563024321233	0.274859881827257	22.0000004210923	0.054383034125514	0.165388111100831	nan
sp|Q00587|BORG5_HUMAN	metaplastic breast carcinomas-Normal	0.210805694229867	0.106846101697686	14.999999999868	0.0672177671071866	0.200207757942911	nan
sp|Q00587|BORG5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.2137125225498	0.106846101697686	14.999999999868	0.0639224915659632	0.773787875546141	nan
sp|Q00587|BORG5_HUMAN	Normal-Triple-negative breast cancer	0.0029068283199328	0.127705517544926	14.9999999998482	0.982140188341002	0.990784214277842	nan
sp|Q00610|CLH1_HUMAN	metaplastic breast carcinomas-Normal	0.117244051815532	0.122715196932677	23.9999999996928	0.348892706104706	0.558631673936437	nan
sp|Q00610|CLH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0953342348465237	0.122715196932677	23.9999999996928	0.444823216242668	0.899110756235179	nan
sp|Q00610|CLH1_HUMAN	Normal-Triple-negative breast cancer	-0.212578286662056	0.146672714174039	23.9999999996716	0.160185335194868	0.329864241010448	nan
sp|Q00613|HSF1_HUMAN	metaplastic breast carcinomas-Normal	0.765361368255081	0.327553482008794	13.9999995447356	0.0348414652562277	0.134509907679095	nan
sp|Q00613|HSF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.2869706703339	0.327553482008794	13.9999995441469	0.395757695126773	0.885234295852111	nan
sp|Q00613|HSF1_HUMAN	Normal-Triple-negative breast cancer	-0.478390697921181	0.391501292784009	13.9999995453514	0.241906761626116	0.429769147859546	nan
sp|Q00653|NFKB2_HUMAN	metaplastic breast carcinomas-Normal	-0.0652372024207871	0.385150334686182	22.0000000247705	0.867044661499547	0.930413295359725	nan
sp|Q00653|NFKB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.260893139770298	0.385150334686182	22.0000000246403	0.505226483893484	0.913320451076758	nan
sp|Q00653|NFKB2_HUMAN	Normal-Triple-negative breast cancer	0.326130342191085	0.460342698911642	22.0000000246026	0.486104622067392	0.663850354869355	nan
sp|Q00688|FKBP3_HUMAN	metaplastic breast carcinomas-Normal	0.458734366075351	0.203666974584161	23.99999999962	0.0337174978063034	0.131237661250764	nan
sp|Q00688|FKBP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.13239933829778	0.203666974584161	23.999999999814	0.521816664633975	0.917607105199968	nan
sp|Q00688|FKBP3_HUMAN	Normal-Triple-negative breast cancer	-0.59113370437313	0.24342859479957	23.9999999997226	0.0230305962289481	0.100728555085557	nan
sp|Q00765|REEP5_HUMAN	metaplastic breast carcinomas-Normal	-0.174844400798303	0.417207259390706	20.9697780120024	0.679417300190199	0.812952881869051	nan
sp|Q00765|REEP5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.451663650015518	0.447242728298338	21.2384782446427	0.323918247710174	0.867696529950794	nan
sp|Q00765|REEP5_HUMAN	Normal-Triple-negative breast cancer	-0.276819249217215	0.524045812879411	21.1668777042272	0.602831158263819	0.754501023538688	nan
sp|Q00796|DHSO_HUMAN	metaplastic breast carcinomas-Normal	0.451990409926633	0.291172649618174	23.9999999998479	0.133676294096202	0.306441380397087	nan
sp|Q00796|DHSO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.677555498770293	0.291172649618174	23.9999999998479	0.0287286396008157	0.721684569712558	nan
sp|Q00796|DHSO_HUMAN	Normal-Triple-negative breast cancer	-1.12954590869693	0.348017881079341	23.9999999998498	0.003438087373191	0.0391851712986683	nan
sp|Q00839|HNRPU_HUMAN	metaplastic breast carcinomas-Normal	0.550947878458296	0.209840566802075	21.9999999837601	0.0154444677715204	0.0817474695422512	nan
sp|Q00839|HNRPU_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.356516873042049	0.209840566802075	21.9999999820824	0.103420399022839	0.821630939204717	nan
sp|Q00839|HNRPU_HUMAN	Normal-Triple-negative breast cancer	-0.907464751500345	0.250807448840785	21.9999999827754	0.0015232607686118	0.0276684087151132	nan
sp|Q01081|U2AF1_HUMAN	metaplastic breast carcinomas-Normal	0.505695201103133	0.389517385609819	20.0879418549076	0.208906021276853	0.404383792994515	nan
sp|Q01081|U2AF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.651378239465106	0.332121555949656	20.0113699413922	0.063912840807809	0.773787875546141	nan
sp|Q01081|U2AF1_HUMAN	Normal-Triple-negative breast cancer	-1.15707344056824	0.446091076483174	20.0698482191011	0.0173275303186673	0.0847870753296437	nan
sp|Q01082|SPTB2_HUMAN	metaplastic breast carcinomas-Normal	-0.852190713891249	0.288490085877034	21.9999999999294	0.0073353308427574	0.0569480527585987	nan
sp|Q01082|SPTB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0580205153539903	0.288490085877034	21.9999999988234	0.842454232951849	0.972169455774446	nan
sp|Q01082|SPTB2_HUMAN	Normal-Triple-negative breast cancer	0.910211229245239	0.344811604149567	22.0000000000805	0.0149648255370204	0.0781078712931399	nan
sp|Q01085|TIAR_HUMAN	metaplastic breast carcinomas-Normal	0.311647685136959	0.205498746567567	24.0000000001582	0.142444322292781	0.318416225488368	nan
sp|Q01085|TIAR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.224460834660377	0.205498746567567	24.0000000001208	0.285556581115767	0.867696529950794	nan
sp|Q01085|TIAR_HUMAN	Normal-Triple-negative breast cancer	-0.0871868504765818	0.245617981079915	24.0000000002056	0.72571301323043	0.841098345877946	nan
sp|Q01105|SET_HUMAN	metaplastic breast carcinomas-Normal	0.693130092275418	0.252745565478522	22.0000018729086	0.0118885611848583	0.0718417777804499	nan
sp|Q01105|SET_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.19107991700916	0.252745565478522	22.0000018732651	0.45765845908961	0.908567154037048	nan
sp|Q01105|SET_HUMAN	Normal-Triple-negative breast cancer	-0.884210009284577	0.302088730742329	22.0000018734006	0.0078058964100591	0.0561233407355565	nan
sp|Q01130|SRSF2_HUMAN	metaplastic breast carcinomas-Normal	-0.556698536081788	0.534736661234799	17.0801984591525	0.312355888185403	0.520465440748477	nan
sp|Q01130|SRSF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.867751038103826	0.565057167422792	16.6757397005788	0.143370365346775	0.82761539023963	nan
sp|Q01130|SRSF2_HUMAN	Normal-Triple-negative breast cancer	1.42444957418561	0.636014427737435	16.870617755082	0.0388795259143391	0.131848322456358	nan
sp|Q01415|GALK2_HUMAN	metaplastic breast carcinomas-Normal	-0.294569421742526	0.298484881012601	20.9872681265908	0.33494214334521	0.543361485836739	nan
sp|Q01415|GALK2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0697005911555408	0.298484881012601	20.9872681268278	0.817624405283871	0.965774701272009	nan
sp|Q01415|GALK2_HUMAN	Normal-Triple-negative breast cancer	0.224868830586985	0.352956828001026	20.966089575151	0.530955539046286	0.698968796748458	nan
sp|Q01433|AMPD2_HUMAN	metaplastic breast carcinomas-Normal	0.14132643901542	0.173510577577258	22.000000002159	0.42408133361578	0.621951157325291	nan
sp|Q01433|AMPD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.237209907016646	0.173510577577258	22.0000000016078	0.185395175076528	0.843662073010871	nan
sp|Q01433|AMPD2_HUMAN	Normal-Triple-negative breast cancer	0.0958834680012259	0.207384806342473	22.000000001406	0.648373489020847	0.793024292875055	nan
sp|Q01469|FABP5_HUMAN	metaplastic breast carcinomas-Normal	1.14335981854961	0.491825918700289	22.0000000015622	0.0297107169186456	0.123602531961925	nan
sp|Q01469|FABP5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.18358874066524	0.491825918700289	22.0000000015985	0.0249437307773436	0.721684569712558	nan
sp|Q01469|FABP5_HUMAN	Normal-Triple-negative breast cancer	0.0402289221156333	0.587844408842757	22.0000000017799	0.946057839391139	0.971784999424025	nan
sp|Q01518|CAP1_HUMAN	metaplastic breast carcinomas-Normal	0.368042180127173	0.202237865975985	22.0000000379619	0.0824171386931765	0.227726158783141	nan
sp|Q01518|CAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0554994076947281	0.202237865975985	22.0000000377833	0.786317392757609	0.962981271203673	nan
sp|Q01518|CAP1_HUMAN	Normal-Triple-negative breast cancer	-0.423541587821902	0.241720483305232	22.0000000381035	0.0936687569954932	0.233468260754606	nan
sp|Q01650|LAT1_HUMAN	metaplastic breast carcinomas-Normal	0.843846909329916	0.403771244519506	17.9999999996389	0.051089143919416	0.171354373828667	nan
sp|Q01650|LAT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.460367910854423	0.437951404638125	17.999999999619	0.307082187083129	0.867696529950794	nan
sp|Q01650|LAT1_HUMAN	Normal-Triple-negative breast cancer	-1.30421482018434	0.508853548983482	17.9999999996315	0.0195585528399174	0.0910541031370946	nan
sp|Q01658|NC2B_HUMAN	metaplastic breast carcinomas-Normal	0.140561321712421	0.237446255558661	23.9999999994384	0.55940584649296	0.728590102294824	nan
sp|Q01658|NC2B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0379422886411021	0.237446255558661	23.9999999994384	0.874381247384027	0.981870195052985	nan
sp|Q01658|NC2B_HUMAN	Normal-Triple-negative breast cancer	-0.178503610353523	0.283802557823037	23.9999999994981	0.535309292437585	0.702867070999919	nan
sp|Q01740|FMO1_HUMAN	metaplastic breast carcinomas-Normal	-0.480327240324004	0.609125208328911	15.0000000001981	0.442658627470469	0.639737946831234	nan
sp|Q01740|FMO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0640128701550421	0.609125208328911	15.0000000001987	0.917696924616613	0.99408739879047	nan
sp|Q01740|FMO1_HUMAN	Normal-Triple-negative breast cancer	0.416314370168962	0.728043875661488	15.0000000001986	0.575909570320171	0.735429662598635	nan
sp|Q01780|EXOSX_HUMAN	metaplastic breast carcinomas-Normal	-0.0755178269651272	0.326256733059738	23.9999999997402	0.818913734116159	0.904642489930911	nan
sp|Q01780|EXOSX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.176245439366419	0.326256733059738	23.9999999997402	0.594033818772225	0.940559810632461	nan
sp|Q01780|EXOSX_HUMAN	Normal-Triple-negative breast cancer	0.251763266331546	0.389951381340974	23.9999999997148	0.524646023822043	0.695444310582923	nan
sp|Q01813|PFKAP_HUMAN	metaplastic breast carcinomas-Normal	0.127011107155145	0.296760895548539	21.9999369879348	0.672818079437627	0.808148806621432	nan
sp|Q01813|PFKAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.69332750218451	0.296760895548539	21.9999369881352	0.0289876312193881	0.721684569712558	nan
sp|Q01813|PFKAP_HUMAN	Normal-Triple-negative breast cancer	-0.820338609339655	0.354697112491309	21.9999369878893	0.030472739164441	0.116829740464362	nan
sp|Q01831|XPC_HUMAN	metaplastic breast carcinomas-Normal	0.24347906167761	0.358506993256067	13.99999674433	0.508117687073906	0.692604314932482	nan
sp|Q01831|XPC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.279386578765746	0.358506993256067	13.9999967464721	0.448773339772256	0.903251425389074	nan
sp|Q01831|XPC_HUMAN	Normal-Triple-negative breast cancer	-0.522865640443356	0.428497814986104	13.9999967478919	0.242534007495071	0.430423406787835	nan
sp|Q01844|EWS_HUMAN	metaplastic breast carcinomas-Normal	0.491856026076875	0.199764206583171	21.999999892037	0.022115447625993	0.101847869536815	nan
sp|Q01844|EWS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.21759970370508	0.199764206583171	21.9999998920359	0.287817806182403	0.867696529950794	nan
sp|Q01844|EWS_HUMAN	Normal-Triple-negative breast cancer	-0.709455729781955	0.238763894829192	21.9999998931745	0.0070464039408331	0.0534754490852272	nan
sp|Q01970|PLCB3_HUMAN	metaplastic breast carcinomas-Normal	-0.0836706813729601	0.299942765476607	14.5876914742007	0.784194731315673	0.882032001854638	nan
sp|Q01970|PLCB3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.203159940415284	0.198259570060677	13.9752305835062	0.322907889750892	0.867696529950794	nan
sp|Q01970|PLCB3_HUMAN	Normal-Triple-negative breast cancer	-0.119489259042324	0.326720567487103	14.5161384840764	0.719846283193229	0.837804287582036	nan
sp|Q01995|TAGL_HUMAN	metaplastic breast carcinomas-Normal	-0.277763663399855	0.396419904060205	23.9999999998347	0.490240384815174	0.680116460403021	nan
sp|Q01995|TAGL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.42215848195649	0.396419904060205	23.9999999995898	0.297505871217994	0.867696529950794	nan
sp|Q01995|TAGL_HUMAN	Normal-Triple-negative breast cancer	-0.144394818556634	0.473812410642353	23.9999999997678	0.763182850911502	0.863451258144939	nan
sp|Q02127|PYRD_HUMAN	metaplastic breast carcinomas-Normal	0.126256194364563	0.398258416651182	6.0	0.761968831373852	0.869177898245259	nan
sp|Q02127|PYRD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0157357445702034	0.398258416651182	6.0	0.969764568248936	0.99709406933403	nan
sp|Q02127|PYRD_HUMAN	Normal-Triple-negative breast cancer	-0.141991938934766	0.47600985348971	6.0	0.775537549571662	0.872176795236645	nan
sp|Q02218|ODO1_HUMAN	metaplastic breast carcinomas-Normal	-0.0618702179336642	0.223375365497817	21.999999949453	0.784382249543414	0.882032001854638	nan
sp|Q02218|ODO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0566986071482466	0.223375365497817	21.999999948049	0.801986705175898	0.965774701272009	nan
sp|Q02218|ODO1_HUMAN	Normal-Triple-negative breast cancer	0.118568825081911	0.266984627463518	21.9999999488346	0.661305346594277	0.799725735949474	nan
sp|Q02252|MMSA_HUMAN	metaplastic breast carcinomas-Normal	-0.927407491401644	0.482851056797488	21.9999999562644	0.0678252255137538	0.201475468818336	nan
sp|Q02252|MMSA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.241435388958563	0.482851056797488	21.9999999565373	0.622025409281126	0.941374262616245	nan
sp|Q02252|MMSA_HUMAN	Normal-Triple-negative breast cancer	0.685972102443081	0.577117397131704	21.9999999552668	0.247262742062885	0.435790750062052	nan
sp|Q02539|H11_HUMAN	metaplastic breast carcinomas-Normal	0.588595548568636	0.527712638907383	22.000000101635	0.276727209325751	0.479333634079622	nan
sp|Q02539|H11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.309356955973091	0.527712638907383	22.0000001014218	0.563692988053714	0.935109025059232	nan
sp|Q02539|H11_HUMAN	Normal-Triple-negative breast cancer	-0.897952504541728	0.630737243529454	22.0000001015307	0.168575035085003	0.340182874459978	nan
sp|Q02543|RL18A_HUMAN	metaplastic breast carcinomas-Normal	0.691821329688183	0.173222869045366	22.0000000211539	0.0006122944762818	0.0207680289710309	nan
sp|Q02543|RL18A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0498117044962134	0.173222869045366	22.0000000212178	0.77637605372131	0.960657739983943	nan
sp|Q02543|RL18A_HUMAN	Normal-Triple-negative breast cancer	-0.741633034184396	0.207040928874006	22.0000000212147	0.0016617667098321	0.028769336163969	nan
sp|Q02750|MP2K1_HUMAN	metaplastic breast carcinomas-Normal	-0.263201721136065	0.243442030872463	22.0000000055357	0.291332063514174	0.494975705319747	nan
sp|Q02750|MP2K1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.12593277586549	0.243442030872463	22.0000000048541	0.610108518225091	0.940559810632461	nan
sp|Q02750|MP2K1_HUMAN	Normal-Triple-negative breast cancer	0.137268945270575	0.290968880013235	22.0000000052902	0.641739891022439	0.787836836040423	nan
sp|Q02790|FKBP4_HUMAN	metaplastic breast carcinomas-Normal	0.716059582492591	0.333135418396809	22.0000002779041	0.042855761905886	0.153174787715231	nan
sp|Q02790|FKBP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.203184847050709	0.333135418396809	22.0000002776311	0.548165685695956	0.930742577441701	nan
sp|Q02790|FKBP4_HUMAN	Normal-Triple-negative breast cancer	-0.9192444295433	0.398172982850449	22.0000002774848	0.0307404855358315	0.117046247332307	nan
sp|Q02809|PLOD1_HUMAN	metaplastic breast carcinomas-Normal	1.40011096478955	0.371011616617994	22.0000000695173	0.0010455502503439	0.0247100635229515	nan
sp|Q02809|PLOD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.812583340704441	0.371011616617994	22.0000000704221	0.0394007318408957	0.738255867002113	nan
sp|Q02809|PLOD1_HUMAN	Normal-Triple-negative breast cancer	-0.58752762408511	0.44344369857723	22.0000000701489	0.19879521862045	0.380200088223779	nan
sp|Q02818|NUCB1_HUMAN	metaplastic breast carcinomas-Normal	0.334993588472672	0.249990493941647	23.9999999995516	0.192787083072609	0.386504381262578	nan
sp|Q02818|NUCB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.195851293774504	0.249990493941647	23.9999999995508	0.441034989090211	0.89755436380139	nan
sp|Q02818|NUCB1_HUMAN	Normal-Triple-negative breast cancer	-0.139142294698168	0.298795790420693	23.9999999994843	0.645645169623351	0.790996956985734	nan
sp|Q02878|RL6_HUMAN	metaplastic breast carcinomas-Normal	1.10365885483095	0.286821784333707	23.9999999999799	0.0007731777835279	0.0223481995864959	nan
sp|Q02878|RL6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0019653848956518	0.286821784333707	23.9999999999799	0.99458935042348	0.998185231446144	nan
sp|Q02878|RL6_HUMAN	Normal-Triple-negative breast cancer	-1.1056242397266	0.342817602415986	23.9999999999315	0.0036139450297481	0.0400819560687694	nan
sp|Q02880|TOP2B_HUMAN	metaplastic breast carcinomas-Normal	-0.147667496618287	0.151828009012099	22.0000003428677	0.3413266156912	0.5513254615851	nan
sp|Q02880|TOP2B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.152139248528098	0.151828009012099	22.0000003428376	0.327214326365139	0.867975899287892	nan
sp|Q02880|TOP2B_HUMAN	Normal-Triple-negative breast cancer	-0.0044717519098113	0.181469180069541	22.0000003428494	0.980562721000552	0.990321607142567	nan
sp|Q02952|AKA12_HUMAN	metaplastic breast carcinomas-Normal	-2.12494254913906	0.420936746032517	23.999999999331	3.67974631327491e-05	0.0081543178302172	nan
sp|Q02952|AKA12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0162654475328369	0.420936746032517	23.9999999995483	0.969496190604918	0.99709406933403	nan
sp|Q02952|AKA12_HUMAN	Normal-Triple-negative breast cancer	2.14120799667189	0.50311564157819	23.999999999427	0.0002755012026994	0.0227914720285933	nan
sp|Q02978|M2OM_HUMAN	metaplastic breast carcinomas-Normal	0.295512303031586	0.353391219091859	22.0000000017497	0.41202286423394	0.614429789463264	nan
sp|Q02978|M2OM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.291386497154122	0.353391219091859	22.0000000008971	0.418481279822962	0.8860071777014	nan
sp|Q02978|M2OM_HUMAN	Normal-Triple-negative breast cancer	-0.586898800185708	0.422383295346148	22.0000000013647	0.178586316140813	0.354400546180335	nan
sp|Q03135|CAV1_HUMAN	metaplastic breast carcinomas-Normal	-2.01563309476165	0.522812733621256	22.0000000028001	0.0008576640389288	0.0227210419054423	nan
sp|Q03135|CAV1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.296026795220387	0.522812733621256	22.0000000027425	0.576975475121006	0.936117741743138	nan
sp|Q03135|CAV1_HUMAN	Normal-Triple-negative breast cancer	2.31165988998203	0.624880736548446	22.0000000028191	0.0012520076336815	0.0266490250684039	nan
sp|Q03154|ACY1_HUMAN	metaplastic breast carcinomas-Normal	-1.26173297142909	0.329646112389485	19.0130647298444	0.0011348929348194	0.0256624769751011	nan
sp|Q03154|ACY1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.235428733648317	0.283249526833521	18.4663631838483	0.416495367061176	0.8860071777014	nan
sp|Q03154|ACY1_HUMAN	Normal-Triple-negative breast cancer	1.02630423778078	0.373616525612909	19.3964332282037	0.0126595749222028	0.0726831421091115	nan
sp|Q03164|KMT2A_HUMAN	metaplastic breast carcinomas-Normal	0.888036973192749	0.221283985860909	22.0000000222413	0.0005841732703342	0.0205217420849069	nan
sp|Q03164|KMT2A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0130000034146005	0.221283985860909	22.0000000221323	0.953683154101389	0.996541950781621	nan
sp|Q03164|KMT2A_HUMAN	Normal-Triple-negative breast cancer	-0.875036969778148	0.264484950688506	22.0000000216803	0.003197270966807	0.0374215799072767	nan
sp|Q03169|TNAP2_HUMAN	metaplastic breast carcinomas-Normal	-0.80241021082535	0.527036476015679	13.0386291802628	0.151763544525298	0.331805355286476	nan
sp|Q03169|TNAP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.305604875310795	0.527036476015679	13.0386291808284	0.571896502158132	0.935631258424823	nan
sp|Q03169|TNAP2_HUMAN	Normal-Triple-negative breast cancer	0.496805335514555	0.619998953699122	12.9999999847192	0.437359261983167	0.623138528432081	nan
sp|Q03252|LMNB2_HUMAN	metaplastic breast carcinomas-Normal	0.204167405386274	0.178980952046351	23.9999999996168	0.265241522437484	0.468222421976738	nan
sp|Q03252|LMNB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0727468217518843	0.178980952046351	23.9999999996153	0.688013598518477	0.946568877415162	nan
sp|Q03252|LMNB2_HUMAN	Normal-Triple-negative breast cancer	-0.13142058363439	0.213923154411706	23.9999999995311	0.54477404548575	0.709850618265242	nan
sp|Q03405|UPAR_HUMAN	metaplastic breast carcinomas-Normal	2.06086494206773	0.582335076366998	10.0596548134972	0.0053170583665385	0.0481577711454335	nan
sp|Q03405|UPAR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.579308391303448	0.438062761097566	10.0118156735913	0.215436983306185	0.843662073010871	nan
sp|Q03405|UPAR_HUMAN	Normal-Triple-negative breast cancer	-1.48155655076428	0.648544537611931	10.0850943414629	0.0452327773325868	0.145550582626833	nan
sp|Q03426|KIME_HUMAN	metaplastic breast carcinomas-Normal	-0.697497288365437	0.508430734884695	14.999999999705	0.190277039830881	0.383786941988986	nan
sp|Q03426|KIME_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.806977468940989	0.508430734884695	14.9999999997356	0.133320809933118	0.823891816737944	nan
sp|Q03426|KIME_HUMAN	Normal-Triple-negative breast cancer	-0.109480180575552	0.607690960199098	14.9999999996953	0.859440127636707	0.919761424425117	nan
sp|Q03518|TAP1_HUMAN	metaplastic breast carcinomas-Normal	0.527233910912715	0.485903939789985	23.9999999996597	0.288675572710454	0.492622292442416	nan
sp|Q03518|TAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.190817359922226	0.485903939789985	23.9999999996597	0.698002942782536	0.947043345959522	nan
sp|Q03518|TAP1_HUMAN	Normal-Triple-negative breast cancer	-0.33641655099049	0.580766290225287	23.9999999995918	0.567809435845155	0.728725314575018	nan
sp|Q03519|TAP2_HUMAN	metaplastic breast carcinomas-Normal	0.52520426101664	0.407104638146133	22.0000000358901	0.210413414664898	0.405457501649924	nan
sp|Q03519|TAP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.242365343248788	0.407104638146133	22.0000000358876	0.557691811529545	0.932084612507839	nan
sp|Q03519|TAP2_HUMAN	Normal-Triple-negative breast cancer	-0.282838917767852	0.486583110504984	22.0000000358882	0.56696305855662	0.728059210190902	nan
sp|Q03591|FHR1_HUMAN	metaplastic breast carcinomas-Normal	-0.544635225231418	0.467077553675603	14.999999999609	0.261800925555606	0.464133111813383	nan
sp|Q03591|FHR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.312470983603387	0.467077553675603	14.9999999995915	0.513666129338906	0.915620969865368	nan
sp|Q03591|FHR1_HUMAN	Normal-Triple-negative breast cancer	0.857106208834805	0.558264454931002	14.9999999996048	0.145530221992663	0.31071583983871	nan
sp|Q03701|CEBPZ_HUMAN	metaplastic breast carcinomas-Normal	0.827377351451217	0.374426591830593	13.9999999999584	0.0442856882279228	0.156269243810632	nan
sp|Q03701|CEBPZ_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0436675099870387	0.374426591830593	13.9999999999313	0.908813696965272	0.99408739879047	nan
sp|Q03701|CEBPZ_HUMAN	Normal-Triple-negative breast cancer	-0.871044861438255	0.440586576496669	13.9999999999503	0.0680769051102788	0.18894974891346	nan
sp|Q04206|TF65_HUMAN	metaplastic breast carcinomas-Normal	-0.157628506187841	0.287287232091869	23.9999999991233	0.588294156986781	0.747511382960268	nan
sp|Q04206|TF65_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.132245657844552	0.287287232091869	23.9999999993565	0.649426147674983	0.943768330865086	nan
sp|Q04206|TF65_HUMAN	Normal-Triple-negative breast cancer	0.289874164032393	0.343373918892692	23.9999999991697	0.406897538939473	0.595827057019739	nan
sp|Q04323|UBXN1_HUMAN	metaplastic breast carcinomas-Normal	-0.101448052039685	0.30743512687933	22.0000000033046	0.744535105189796	0.859564245547108	nan
sp|Q04323|UBXN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.756555792043982	0.30743512687933	22.0000000033046	0.022178909646389	0.712051972579798	nan
sp|Q04323|UBXN1_HUMAN	Normal-Triple-negative breast cancer	-0.655107740004297	0.367455259160524	22.0000000035783	0.0884210169374133	0.22401788132619	nan
sp|Q04446|GLGB_HUMAN	metaplastic breast carcinomas-Normal	-0.555465013111179	0.261699294695603	22.0000050186233	0.0452876732363766	0.159129202788283	nan
sp|Q04446|GLGB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.058233341913467	0.261699294695603	22.0000050186744	0.825961941773433	0.965774701272009	nan
sp|Q04446|GLGB_HUMAN	Normal-Triple-negative breast cancer	0.613698355024646	0.312790484062817	22.0000050184547	0.0625345241786931	0.180909276214078	nan
sp|Q04637|IF4G1_HUMAN	metaplastic breast carcinomas-Normal	0.563784878129381	0.293831639644629	23.9999999995262	0.0669874664994582	0.200059603453908	nan
sp|Q04637|IF4G1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.141515765520589	0.293831639644629	23.9999999993044	0.634437117619557	0.941868024951375	nan
sp|Q04637|IF4G1_HUMAN	Normal-Triple-negative breast cancer	-0.70530064364997	0.351195982030895	23.9999999994281	0.0559946619071538	0.168592623350887	nan
sp|Q04760|LGUL_HUMAN	metaplastic breast carcinomas-Normal	0.473949223903458	0.322986067332295	23.9999999997761	0.155251166488255	0.336336266919337	nan
sp|Q04760|LGUL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.211993581609527	0.322986067332295	23.9999999997752	0.517839786003796	0.915620969865368	nan
sp|Q04760|LGUL_HUMAN	Normal-Triple-negative breast cancer	-0.261955642293932	0.386042188091964	23.9999999998402	0.503903165749442	0.677916668869779	nan
sp|Q04837|SSBP_HUMAN	metaplastic breast carcinomas-Normal	0.565092143102131	0.192949492239386	21.9999998600331	0.0077751050781631	0.0587373847268506	nan
sp|Q04837|SSBP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.304341637999371	0.192949492239386	21.999999861317	0.128995562116265	0.823891816737944	nan
sp|Q04837|SSBP_HUMAN	Normal-Triple-negative breast cancer	-0.869433781101501	0.230618753281059	21.999999860143	0.0010551288414771	0.0264764243087785	nan
sp|Q04917|1433F_HUMAN	metaplastic breast carcinomas-Normal	0.571746753505255	0.185089376984866	22.0000000685677	0.0053607758275156	0.0484217903550601	nan
sp|Q04917|1433F_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.255036657466263	0.185089376984866	22.0000000685677	0.182086106577849	0.843662073010871	nan
sp|Q04917|1433F_HUMAN	Normal-Triple-negative breast cancer	-0.826783410971518	0.221224118656191	22.0000000686162	0.0011421234802	0.026613045414958	nan
sp|Q04941|PLP2_HUMAN	metaplastic breast carcinomas-Normal	0.466044268482181	0.29173165652936	20.9759998689175	0.125108096736853	0.296183334837538	nan
sp|Q04941|PLP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.115017829634209	0.29173165652936	20.9759998683865	0.697369535477901	0.947043345959522	nan
sp|Q04941|PLP2_HUMAN	Normal-Triple-negative breast cancer	-0.581062098116391	0.3449620909493	20.9569330444523	0.106936425107263	0.253174271407793	nan
sp|Q05048|CSTF1_HUMAN	metaplastic breast carcinomas-Normal	-0.362882004715768	0.322640159841543	22.0040162784387	0.272824737200698	0.475298441538323	nan
sp|Q05048|CSTF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.054937544756945	0.322640159841542	22.0040162830597	0.866349802104506	0.980530611231673	nan
sp|Q05048|CSTF1_HUMAN	Normal-Triple-negative breast cancer	0.417819549472713	0.385628749562833	22.0040162731826	0.290327218691816	0.483564417899242	nan
sp|Q05209|PTN12_HUMAN	metaplastic breast carcinomas-Normal	0.470414919543426	0.218170202852459	21.9999998653327	0.0422667399278705	0.152285044160049	nan
sp|Q05209|PTN12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0399049569877984	0.218170202852459	21.999999866015	0.856545752401366	0.977691255315669	nan
sp|Q05209|PTN12_HUMAN	Normal-Triple-negative breast cancer	-0.430509962555628	0.260763268153548	21.9999998663482	0.112951120290964	0.261273155078054	nan
sp|Q05397|FAK1_HUMAN	metaplastic breast carcinomas-Normal	-0.362554571259406	0.402263353925992	23.9999999996795	0.376392034382736	0.583004250833278	nan
sp|Q05397|FAK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0253107639118762	0.402263353925992	23.9999999996795	0.95035061863288	0.996541950781621	nan
sp|Q05397|FAK1_HUMAN	Normal-Triple-negative breast cancer	0.387865335171282	0.480796669099153	23.9999999996577	0.427753716131632	0.613661351929885	nan
sp|Q05469|LIPS_HUMAN	metaplastic breast carcinomas-Normal	-2.51976367019126	0.994787114047575	14.0000014440547	0.0238932540030821	0.107471145204662	nan
sp|Q05469|LIPS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.570099457457449	0.994787114047575	14.0000014440522	0.575675763730641	0.935847692353991	nan
sp|Q05469|LIPS_HUMAN	Normal-Triple-negative breast cancer	3.08986312764871	1.18899801890686	14.0000014440527	0.0210299913799255	0.0953699510109521	nan
sp|Q05519|SRS11_HUMAN	metaplastic breast carcinomas-Normal	1.07839189201175	0.306510209478059	23.9999999992847	0.0017608242206868	0.0298263306532335	nan
sp|Q05519|SRS11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.265589802245007	0.306510209478059	23.9999999992836	0.394798750720133	0.885234295852111	nan
sp|Q05519|SRS11_HUMAN	Normal-Triple-negative breast cancer	-1.34398169425675	0.366349771421254	23.9999999993337	0.0012117874657116	0.0266490250684039	nan
sp|Q05639|EF1A2_HUMAN	metaplastic breast carcinomas-Normal	0.413225519356464	0.529655245058498	23.9999999990853	0.442912872697569	0.639827200715653	nan
sp|Q05639|EF1A2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.162927537849297	0.529655245058498	23.9999999990853	0.761032317044202	0.955228196959647	nan
sp|Q05639|EF1A2_HUMAN	Normal-Triple-negative breast cancer	-0.57615305720576	0.633059101977936	23.9999999990188	0.371815042283847	0.561055559292967	nan
sp|Q05682|CALD1_HUMAN	metaplastic breast carcinomas-Normal	0.552990945734342	0.2640408404095	22.0000000229155	0.0479668546967578	0.164882962783891	nan
sp|Q05682|CALD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.106656557102984	0.2640408404095	22.0000000236761	0.690156835438002	0.946568877415162	nan
sp|Q05682|CALD1_HUMAN	Normal-Triple-negative breast cancer	-0.659647502837326	0.315589166490132	22.0000000234654	0.0483709789070673	0.152114601596113	nan
sp|Q05707|COEA1_HUMAN	metaplastic breast carcinomas-Normal	-1.55056999559763	0.557391886135481	24.0000000001633	0.0103566656444379	0.0676337064874491	nan
sp|Q05707|COEA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.367208141325583	0.557391886135481	24.0000000001633	0.516297360607589	0.915620969865368	nan
sp|Q05707|COEA1_HUMAN	Normal-Triple-negative breast cancer	1.91777813692322	0.666210728919985	24.0000000001184	0.0082644368953643	0.0575911703148659	nan
sp|Q05D32|CTSL2_HUMAN	metaplastic breast carcinomas-Normal	0.0513164627016655	0.856818359813644	14.0000000004395	0.953088295309792	0.975193989958575	nan
sp|Q05D32|CTSL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.836492044403337	0.856818359813644	14.0000000003598	0.345496007880204	0.870943310236299	nan
sp|Q05D32|CTSL2_HUMAN	Normal-Triple-negative breast cancer	-0.887808507105003	1.02409381665224	14.000000000387	0.400600004219464	0.590245750897827	nan
sp|Q06033|ITIH3_HUMAN	metaplastic breast carcinomas-Normal	0.567025388184346	0.554572590881016	14.9999999997143	0.322773631744324	0.530322175654614	nan
sp|Q06033|ITIH3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.40460629687542	0.554572590881016	14.9999999997143	0.476885002523188	0.913280230088743	nan
sp|Q06033|ITIH3_HUMAN	Normal-Triple-negative breast cancer	-0.971631685059766	0.662841026573688	14.9999999997181	0.163334613794155	0.333286836250319	nan
sp|Q06124|PTN11_HUMAN	metaplastic breast carcinomas-Normal	-0.172994829732702	0.187341605239778	22.0000000353483	0.365806477059173	0.576002240523302	nan
sp|Q06124|PTN11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.204145052391915	0.187341605239778	22.0000000357396	0.287640455836955	0.867696529950794	nan
sp|Q06124|PTN11_HUMAN	Normal-Triple-negative breast cancer	0.377139882124617	0.223916046301212	22.0000000354804	0.106261806760523	0.252295889765698	nan
sp|Q06203|PUR1_HUMAN	metaplastic breast carcinomas-Normal	0.505214550503624	0.253619399491552	21.211985352871	0.0593976061226902	0.186790579708441	nan
sp|Q06203|PUR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0669570042188659	0.236329340169639	21.0342658763125	0.779700715080068	0.961606157891275	nan
sp|Q06203|PUR1_HUMAN	Normal-Triple-negative breast cancer	-0.572171554722489	0.297084468427088	21.1644000897489	0.0676487518900273	0.188013755252885	nan
sp|Q06210|GFPT1_HUMAN	metaplastic breast carcinomas-Normal	0.822770508798966	0.251942543258079	23.9999999992171	0.003274447048593	0.0401633283746249	nan
sp|Q06210|GFPT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.104476175324548	0.251942543258079	23.9999999992155	0.682057644689201	0.946568877415162	nan
sp|Q06210|GFPT1_HUMAN	Normal-Triple-negative breast cancer	-0.718294333474418	0.301128935610524	23.9999999992817	0.0253083672131339	0.105546655163719	nan
sp|Q06323|PSME1_HUMAN	metaplastic breast carcinomas-Normal	0.140582771574905	0.395548082877142	21.9999999898793	0.725665510273506	0.848140701880849	nan
sp|Q06323|PSME1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0770545098379041	0.395548082877142	21.9999999923399	0.847333850686868	0.974695644619665	nan
sp|Q06323|PSME1_HUMAN	Normal-Triple-negative breast cancer	-0.0635282617370005	0.472770385022132	21.9999999921182	0.894328231984234	0.938071013920982	nan
sp|Q06787|FMR1_HUMAN	metaplastic breast carcinomas-Normal	0.695200828746593	0.246878190352924	21.9999999841261	0.010063657316359	0.0665555756942394	nan
sp|Q06787|FMR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.112022956454115	0.246878190352924	21.9999999829713	0.654447496802094	0.944190045212043	nan
sp|Q06787|FMR1_HUMAN	Normal-Triple-negative breast cancer	-0.583177872292479	0.295075876130517	21.9999999834064	0.060783755139782	0.177544114309873	nan
sp|Q06828|FMOD_HUMAN	metaplastic breast carcinomas-Normal	-0.249504125977915	0.587035478823262	22.0000000268421	0.674947501698992	0.80948812816229	nan
sp|Q06828|FMOD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0491797885035361	0.587035478823262	22.0000000267414	0.933991767806865	0.995359816653149	nan
sp|Q06828|FMOD_HUMAN	Normal-Triple-negative breast cancer	0.298683914481451	0.701641598983878	22.0000000271371	0.67446713856221	0.808193499848878	nan
sp|Q07020|RL18_HUMAN	metaplastic breast carcinomas-Normal	0.76513640908997	0.245511758871221	22.0000000043367	0.0050273270514272	0.0471834693610991	nan
sp|Q07020|RL18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.038636892677321	0.245511758871221	22.0000000045793	0.876386408341425	0.983181130777328	nan
sp|Q07020|RL18_HUMAN	Normal-Triple-negative breast cancer	-0.72649951641265	0.29344267813089	22.0000000045622	0.0214713738067251	0.0965111405182511	nan
sp|Q07021|C1QBP_HUMAN	metaplastic breast carcinomas-Normal	0.780911400790334	0.301964998253332	23.9999999992049	0.0162052178101772	0.0849683083360748	nan
sp|Q07021|C1QBP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0761667739168896	0.301964998253332	23.9999999992049	0.803005443825672	0.965774701272009	nan
sp|Q07021|C1QBP_HUMAN	Normal-Triple-negative breast cancer	-0.857078174707224	0.360917204929993	23.9999999991821	0.0259013523199975	0.107278050995882	nan
sp|Q07065|CKAP4_HUMAN	metaplastic breast carcinomas-Normal	1.4049312153011	0.323202732818394	21.999999997481	0.000258549439733	0.0157578323963946	nan
sp|Q07065|CKAP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.487916719094789	0.323202732818394	21.9999999976966	0.145367240322797	0.827647387111815	nan
sp|Q07065|CKAP4_HUMAN	Normal-Triple-negative breast cancer	-0.917014496206315	0.386301152879605	21.9999999973545	0.0267569552847466	0.109263045904788	nan
sp|Q07092|COGA1_HUMAN	metaplastic breast carcinomas-Normal	-0.441401192984532	0.360343215272947	6.0	0.266499000398917	0.469444980034975	nan
sp|Q07092|COGA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.273017986235259	0.360343215272947	6.0	0.477345514975235	0.913280230088743	nan
sp|Q07092|COGA1_HUMAN	Normal-Triple-negative breast cancer	0.714419179219791	0.430692520073768	6.0	0.148234353237501	0.315045390128806	nan
sp|Q07157|ZO1_HUMAN	metaplastic breast carcinomas-Normal	0.105495803770566	0.174681233881843	23.9999999998519	0.551554468319373	0.722996021286722	nan
sp|Q07157|ZO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0558722780229653	0.174681233881843	23.9999999996942	0.751847777691694	0.954643368861838	nan
sp|Q07157|ZO1_HUMAN	Normal-Triple-negative breast cancer	-0.0496235257476011	0.208784008249411	23.9999999998648	0.814147606028612	0.893734029867605	nan
sp|Q07666|KHDR1_HUMAN	metaplastic breast carcinomas-Normal	0.803293730366939	0.276282882238104	24.0000000001314	0.0077226931309568	0.0584743324995458	nan
sp|Q07666|KHDR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.490936159354599	0.276282882238104	24.0000000001727	0.0882575698736488	0.809016644110817	nan
sp|Q07666|KHDR1_HUMAN	Normal-Triple-negative breast cancer	-1.29422988972154	0.330221205120347	24.0000000001481	0.000645970041599	0.0247210772633291	nan
sp|Q07812|BAX_HUMAN	metaplastic breast carcinomas-Normal	0.576059975291743	0.227037751130533	22.0000000012652	0.0187701861524622	0.0929781777313555	nan
sp|Q07812|BAX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0747764562851779	0.227037751130533	22.0000000001235	0.74500102481694	0.954643368861838	nan
sp|Q07812|BAX_HUMAN	Normal-Triple-negative breast cancer	-0.501283519006565	0.271362015550155	22.0000000000083	0.0781986255168653	0.207365563871658	nan
sp|Q07866|KLC1_HUMAN	metaplastic breast carcinomas-Normal	0.146875095739894	0.173558181620968	23.9999999993592	0.405767665160991	0.608376959402406	nan
sp|Q07866|KLC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.174627617365717	0.173558181620968	23.9999999993592	0.324374973452282	0.867696529950794	nan
sp|Q07866|KLC1_HUMAN	Normal-Triple-negative breast cancer	-0.321502713105611	0.207441704057436	23.9999999993332	0.13426588467678	0.294026603585124	nan
sp|Q07954|LRP1_HUMAN	metaplastic breast carcinomas-Normal	-0.204921187314943	0.185103818529914	23.9999999994671	0.279240522926438	0.482280749047078	nan
sp|Q07954|LRP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.591956283359829	0.185103818529914	23.9999999994686	0.0038596147740763	0.475304411992737	nan
sp|Q07954|LRP1_HUMAN	Normal-Triple-negative breast cancer	0.796877470674772	0.221241379603995	23.9999999994791	0.00143101549769	0.0270744331513255	nan
sp|Q07955|SRSF1_HUMAN	metaplastic breast carcinomas-Normal	0.295689705518035	0.255495881267887	23.9999999997708	0.2585318472099	0.460899265381682	nan
sp|Q07955|SRSF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.405792750336442	0.255495881267887	23.9999999994759	0.12531703278994	0.823891816737944	nan
sp|Q07955|SRSF1_HUMAN	Normal-Triple-negative breast cancer	-0.701482455854477	0.305375986858482	23.9999999996675	0.0306392935457029	0.116975226402462	nan
sp|Q07960|RHG01_HUMAN	metaplastic breast carcinomas-Normal	-0.0966299208299299	0.20108512639832	23.9999999994814	0.63519321003982	0.781993418582356	nan
sp|Q07960|RHG01_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.320634831384466	0.20108512639832	23.9999999995217	0.123904789466464	0.823891816737944	nan
sp|Q07960|RHG01_HUMAN	Normal-Triple-negative breast cancer	-0.224004910554536	0.240342695982895	23.9999999995473	0.360606545151222	0.55139307856607	nan
sp|Q08174|PCDH1_HUMAN	metaplastic breast carcinomas-Normal	0.0488419272916472	0.622517130722237	6.0	0.940014303017367	0.969471778848814	nan
sp|Q08174|PCDH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.410897385578338	0.622517130722237	6.0	0.533720268314791	0.921388505638487	nan
sp|Q08174|PCDH1_HUMAN	Normal-Triple-negative breast cancer	-0.459739312869985	0.744050284439976	6.0	0.55935640059755	0.722759236230799	nan
sp|Q08188|TGM3_HUMAN	metaplastic breast carcinomas-Normal	-0.108877295261198	0.388618677793919	23.9999999998015	0.781751729639203	0.881827883814783	nan
sp|Q08188|TGM3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0972016720610744	0.388618677793919	23.9999999995048	0.804622447828273	0.965774701272009	nan
sp|Q08188|TGM3_HUMAN	Normal-Triple-negative breast cancer	0.206078967322272	0.464488161820997	23.9999999996593	0.661256134860217	0.799725735949474	nan
sp|Q08211|DHX9_HUMAN	metaplastic breast carcinomas-Normal	0.402509516371385	0.190520127335285	23.9999999996773	0.0452193490717265	0.159129202788283	nan
sp|Q08211|DHX9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.46381061434571	0.190520127335285	23.9999999996773	0.0227245268395773	0.712051972579798	nan
sp|Q08211|DHX9_HUMAN	Normal-Triple-negative breast cancer	-0.866320130717095	0.227715106845165	23.9999999996887	0.0008624556936541	0.025773942907156	nan
sp|Q08257|QOR_HUMAN	metaplastic breast carcinomas-Normal	-0.239574037751992	0.346566487397398	23.999999999245	0.496023314158388	0.683265088490911	nan
sp|Q08257|QOR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.363517181697862	0.346566487397398	23.999999999245	0.304667824754401	0.867696529950794	nan
sp|Q08257|QOR_HUMAN	Normal-Triple-negative breast cancer	0.603091219449854	0.414226180773898	23.9999999992477	0.158365326227758	0.328183506471987	nan
sp|Q08378|GOGA3_HUMAN	metaplastic breast carcinomas-Normal	0.152397931498104	0.200091075684209	21.9999973785474	0.454361147290282	0.649292975206949	nan
sp|Q08378|GOGA3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.095836803455227	0.200091075684209	21.9999973790874	0.636689179397803	0.941868024951375	nan
sp|Q08378|GOGA3_HUMAN	Normal-Triple-negative breast cancer	-0.0565611280428773	0.239154578130261	21.9999973759997	0.815229378635771	0.89433084309746	nan
sp|Q08379|GOGA2_HUMAN	metaplastic breast carcinomas-Normal	0.42896549144976	0.189072626110818	22.0000000245746	0.0334384498633274	0.130918029853593	nan
sp|Q08379|GOGA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.118085477654716	0.189072626110818	22.00000002447	0.538689674699749	0.921388505638487	nan
sp|Q08379|GOGA2_HUMAN	Normal-Triple-negative breast cancer	-0.547050969104475	0.225985011969635	22.0000000245136	0.0241909334938593	0.103755694107856	nan
sp|Q08380|LG3BP_HUMAN	metaplastic breast carcinomas-Normal	0.0156637185747346	0.452086789812251	22.0000000349216	0.97267319772003	0.986686483715501	nan
sp|Q08380|LG3BP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.206069131974183	0.452086789812251	22.0000000349462	0.652988481779292	0.944190045212043	nan
sp|Q08380|LG3BP_HUMAN	Normal-Triple-negative breast cancer	-0.221732850548918	0.540347065085747	22.0000000349129	0.685516193843821	0.814969895685573	nan
sp|Q08426|ECHP_HUMAN	metaplastic breast carcinomas-Normal	0.28544191176691	0.228377946768444	14.0000000008656	0.231838872066774	0.431726840756277	nan
sp|Q08426|ECHP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.615676786169896	0.228377946768444	14.0000000009631	0.0173968375327746	0.669250232341703	nan
sp|Q08426|ECHP_HUMAN	Normal-Triple-negative breast cancer	0.330234874402986	0.272963855718692	14.000000001079	0.246383694938988	0.435164400625502	nan
sp|Q08431|MFGM_HUMAN	metaplastic breast carcinomas-Normal	0.23612442923868	0.533885215245074	21.9999999746733	0.66260722703358	0.802822376058803	nan
sp|Q08431|MFGM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.372794787786728	0.533885215245074	21.9999999766874	0.492325326416499	0.913320451076758	nan
sp|Q08431|MFGM_HUMAN	Normal-Triple-negative breast cancer	0.136670358548047	0.638114883361563	21.9999999764212	0.83238070619115	0.905361542648761	nan
sp|Q08722|CD47_HUMAN	metaplastic breast carcinomas-Normal	-0.270586950815784	0.329594479737725	22.0000000194592	0.420471262218926	0.620624545122429	nan
sp|Q08722|CD47_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.315789783235369	0.329594479737725	22.0000000185818	0.348415945317571	0.871876144726181	nan
sp|Q08722|CD47_HUMAN	Normal-Triple-negative breast cancer	0.586376734051153	0.393940751661214	22.0000000193589	0.150817238875375	0.318700891304353	nan
sp|Q08752|PPID_HUMAN	metaplastic breast carcinomas-Normal	0.535032625138697	0.264049872706154	21.9999949381559	0.0550320780946689	0.179164179810656	nan
sp|Q08752|PPID_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.147784897849368	0.264049872706154	21.99999493813	0.581348217264746	0.93702592209822	nan
sp|Q08752|PPID_HUMAN	Normal-Triple-negative breast cancer	-0.682817522988065	0.3155999621495	21.9999949397015	0.0416298803767349	0.138516238610878	nan
sp|Q08945|SSRP1_HUMAN	metaplastic breast carcinomas-Normal	0.69966998638842	0.326271168534766	23.9999999996293	0.0423319436834794	0.152285044160049	nan
sp|Q08945|SSRP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0576301528277143	0.326271168534766	23.9999999996293	0.861279009424032	0.979395590401814	nan
sp|Q08945|SSRP1_HUMAN	Normal-Triple-negative breast cancer	-0.757300139216134	0.389968635033716	23.9999999996534	0.0639692313803007	0.183621524272988	nan
sp|Q08AD1|CAMP2_HUMAN	metaplastic breast carcinomas-Normal	0.174415088587128	0.306367136447179	22.0000006452404	0.57491911700173	0.737280534303145	nan
sp|Q08AD1|CAMP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0932423337268244	0.30636713644718	22.0000006457903	0.763722728248275	0.955731302757062	nan
sp|Q08AD1|CAMP2_HUMAN	Normal-Triple-negative breast cancer	-0.267657422313953	0.366178766441523	22.0000006452332	0.472525017846236	0.651795446006512	nan
sp|Q08J23|NSUN2_HUMAN	metaplastic breast carcinomas-Normal	0.660525544967741	0.287570126685313	20.9920950785512	0.0320121339261205	0.128667875659522	nan
sp|Q08J23|NSUN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.332977423263741	0.287570126685313	20.9920950789676	0.259909734562621	0.862813416943474	nan
sp|Q08J23|NSUN2_HUMAN	Normal-Triple-negative breast cancer	-0.993502968231482	0.340101883468351	20.9582881338477	0.0081740853289774	0.0575911703148659	nan
sp|Q09028|RBBP4_HUMAN	metaplastic breast carcinomas-Normal	0.911833397691031	0.293257183214294	22.0000060500429	0.0051123413010624	0.0474676605718757	nan
sp|Q09028|RBBP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.329340147239321	0.293257183214294	22.0000060506138	0.273526276671703	0.867696529950794	nan
sp|Q09028|RBBP4_HUMAN	Normal-Triple-negative breast cancer	-1.24117354493035	0.350509375270542	22.0000060504859	0.001834058300586	0.0296663640706879	nan
sp|Q09161|NCBP1_HUMAN	metaplastic breast carcinomas-Normal	0.884239153118667	0.296195693018377	23.9999999999049	0.0064258245798867	0.0526094603535555	nan
sp|Q09161|NCBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0799235684328952	0.296195693018377	23.9999999999049	0.789594817441683	0.962981271203673	nan
sp|Q09161|NCBP1_HUMAN	Normal-Triple-negative breast cancer	-0.804315584685772	0.354021566257191	23.999999999892	0.0323382123145214	0.121049794744898	nan
sp|Q09666|AHNK_HUMAN	metaplastic breast carcinomas-Normal	-1.11903855093254	0.286904334259226	22.000000082694	0.0007687234318938	0.0223481995864959	nan
sp|Q09666|AHNK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.213263308857862	0.286904334259226	22.0000000829424	0.465149317840142	0.909423669537079	nan
sp|Q09666|AHNK_HUMAN	Normal-Triple-negative breast cancer	1.33230185979041	0.342916268448665	22.0000000828267	0.0007976353589362	0.0257262735003663	nan
sp|Q0JRZ9|FCHO2_HUMAN	metaplastic breast carcinomas-Normal	-0.0091079640351655	0.297063418761161	13.9999999584584	0.975973495384625	0.987405141699193	nan
sp|Q0JRZ9|FCHO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0475267482552574	0.297063418761161	13.9999999583976	0.875175472694565	0.982430265600753	nan
sp|Q0JRZ9|FCHO2_HUMAN	Normal-Triple-negative breast cancer	0.0566347122904229	0.355058696890023	13.9999999584066	0.875546992029168	0.928020507436381	nan
sp|Q0VDF9|HSP7E_HUMAN	metaplastic breast carcinomas-Normal	-0.661705499875871	0.26710433845686	22.000000203924	0.0213990868851792	0.100085016891408	nan
sp|Q0VDF9|HSP7E_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.1600803722971	0.26710433845686	22.00000020417	0.555083358168068	0.931642387063667	nan
sp|Q0VDF9|HSP7E_HUMAN	Normal-Triple-negative breast cancer	0.821785872172972	0.319250747000976	22.0000002036664	0.0173086670060261	0.0847870753296437	nan
sp|Q0ZGT2|NEXN_HUMAN	metaplastic breast carcinomas-Normal	-0.0639281492617911	0.169720282386433	22.0000000030783	0.710029069655951	0.835150965157955	nan
sp|Q0ZGT2|NEXN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0528496068093958	0.169720282386433	22.0000000024662	0.758433933065684	0.955228196959647	nan
sp|Q0ZGT2|NEXN_HUMAN	Normal-Triple-negative breast cancer	0.116777756071187	0.202854537092577	22.0000000028454	0.570678857835672	0.731278536409319	nan
sp|Q10471|GALT2_HUMAN	metaplastic breast carcinomas-Normal	0.458410205831305	0.512393257761933	14.0000014743649	0.386099559429491	0.590338056827796	nan
sp|Q10471|GALT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.51921343372663	0.512393257761933	14.000001474805	0.328105175223661	0.867975899287892	nan
sp|Q10471|GALT2_HUMAN	Normal-Triple-negative breast cancer	-0.977623639557935	0.612427080907115	14.0000014747381	0.132738610400287	0.291621375393624	nan
sp|Q10567|AP1B1_HUMAN	metaplastic breast carcinomas-Normal	0.256249635001396	0.314349032453404	24.0000000000226	0.422988075634817	0.621951157325291	nan
sp|Q10567|AP1B1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.134609753332912	0.314349032453404	24.0000000000226	0.672311288138549	0.946386428913156	nan
sp|Q10567|AP1B1_HUMAN	Normal-Triple-negative breast cancer	-0.390859388334308	0.375718956904894	24.000000000013	0.308569063913751	0.500822054906888	nan
sp|Q12765|SCRN1_HUMAN	metaplastic breast carcinomas-Normal	-0.0593569827989573	0.331362320912438	23.9999999991788	0.85933917620031	0.926760402276236	nan
sp|Q12765|SCRN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.588412883497528	0.331362320912438	23.9999999991788	0.0884589306474144	0.809016644110817	nan
sp|Q12765|SCRN1_HUMAN	Normal-Triple-negative breast cancer	-0.529055900698571	0.396053726009991	23.9999999991786	0.194138719954638	0.375518092845606	nan
sp|Q12768|WASC5_HUMAN	metaplastic breast carcinomas-Normal	0.165962951279137	0.124357648040483	23.9999999997302	0.194543972828493	0.387317707029823	nan
sp|Q12768|WASC5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0455728868045862	0.124357648040483	23.9999999997302	0.717228123658995	0.949812109346858	nan
sp|Q12768|WASC5_HUMAN	Normal-Triple-negative breast cancer	-0.120390064474551	0.148635818727522	23.9999999996676	0.425917776001289	0.612613884650924	nan
sp|Q12788|TBL3_HUMAN	metaplastic breast carcinomas-Normal	0.159826456097397	0.258827332073869	6.0	0.559594022610916	0.728590102294824	nan
sp|Q12788|TBL3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.06095992408714	0.258827332073869	6.0	0.0063637787720932	0.519941801393686	nan
sp|Q12788|TBL3_HUMAN	Normal-Triple-negative breast cancer	-1.22078638018454	0.309357832172381	6.0	0.007570607805159	0.0549447605771803	nan
sp|Q12792|TWF1_HUMAN	metaplastic breast carcinomas-Normal	0.21282448387891	0.311745690475636	22.9999999999048	0.501624006192815	0.687020270533546	nan
sp|Q12792|TWF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.158513832437872	0.311745690475636	22.9999999999048	0.615965364799167	0.941374262616245	nan
sp|Q12792|TWF1_HUMAN	Normal-Triple-negative breast cancer	-0.0543106514410378	0.368862475378268	22.9999999998777	0.884227074720564	0.93275221069853	nan
sp|Q12797|ASPH_HUMAN	metaplastic breast carcinomas-Normal	-0.120991482814567	0.249964886529483	22.000000158867	0.633145235407308	0.780144875543456	nan
sp|Q12797|ASPH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.412429575509513	0.249964886529483	22.0000001596605	0.113159422886411	0.823891816737944	nan
sp|Q12797|ASPH_HUMAN	Normal-Triple-negative breast cancer	0.53342105832408	0.298765183709064	22.0000001590174	0.0879880966130553	0.223602777631342	nan
sp|Q12802|AKP13_HUMAN	metaplastic breast carcinomas-Normal	-0.301978432415268	0.3670739289092	14.9999999995707	0.42358490062985	0.621951157325291	nan
sp|Q12802|AKP13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.108500987898788	0.3670739289092	14.999999999393	0.771600570000921	0.959745866833315	nan
sp|Q12802|AKP13_HUMAN	Normal-Triple-negative breast cancer	0.19347744451648	0.438737261573056	14.9999999994356	0.665512086303764	0.803546013394011	nan
sp|Q12805|FBLN3_HUMAN	metaplastic breast carcinomas-Normal	-0.611796582369341	0.42550194317342	21.9998164910579	0.164557517024845	0.350409472511586	nan
sp|Q12805|FBLN3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.182887768068714	0.42550194317342	21.9998164910587	0.671509779207171	0.946386428913156	nan
sp|Q12805|FBLN3_HUMAN	Normal-Triple-negative breast cancer	0.428908814300627	0.508572095808249	21.9998164615451	0.408104302260518	0.59670272927701	nan
sp|Q12824|SNF5_HUMAN	metaplastic breast carcinomas-Normal	1.04415787119222	0.328878598096101	11.9999999996652	0.0079964922878897	0.059731101943698	nan
sp|Q12824|SNF5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.150349915924227	0.252810989378657	11.9999999996639	0.563081414571091	0.935109025059232	nan
sp|Q12824|SNF5_HUMAN	Normal-Triple-negative breast cancer	-1.19450778711645	0.364339412917577	11.9999999996667	0.0065977359483278	0.0520694687956083	nan
sp|Q12841|FSTL1_HUMAN	metaplastic breast carcinomas-Normal	-0.349604540574222	0.437732833042851	6.0	0.454924234718384	0.649292975206949	nan
sp|Q12841|FSTL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.276556833200422	0.437732833042851	6.0	0.550819327924765	0.931124086486988	nan
sp|Q12841|FSTL1_HUMAN	Normal-Triple-negative breast cancer	0.626161373774645	0.523190805297811	6.0	0.2765183894468	0.468477251931463	nan
sp|Q12846|STX4_HUMAN	metaplastic breast carcinomas-Normal	-0.394086216550885	0.171072640960021	22.0000000005002	0.0310699513345359	0.126870319423363	nan
sp|Q12846|STX4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.097095093686355	0.171072640960021	22.0000000012334	0.576076153842984	0.935847692353991	nan
sp|Q12846|STX4_HUMAN	Normal-Triple-negative breast cancer	0.49118131023724	0.204470914749808	22.0000000012509	0.0251763228500214	0.105455600909054	nan
sp|Q12849|GRSF1_HUMAN	metaplastic breast carcinomas-Normal	0.322185678949737	0.213191440424649	22.0000000212581	0.144956350637581	0.322082158769599	nan
sp|Q12849|GRSF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.178974358555575	0.213191440424649	22.0000000215728	0.410218685215047	0.885784822958391	nan
sp|Q12849|GRSF1_HUMAN	Normal-Triple-negative breast cancer	-0.501160037505312	0.254812508860749	22.0000000217006	0.0619480436782922	0.179601084988562	nan
sp|Q12857|NFIA_HUMAN	metaplastic breast carcinomas-Normal	-1.03474685651172	0.374055492321744	19.070579067069	0.0122642395629326	0.0726945552141608	nan
sp|Q12857|NFIA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0247793901822768	0.374055492321744	19.0705790681354	0.947872150063878	0.996541950781621	nan
sp|Q12857|NFIA_HUMAN	Normal-Triple-negative breast cancer	1.00996746632945	0.43145055343109	18.8784613992609	0.0303730078025263	0.116581845191221	nan
sp|Q12873|CHD3_HUMAN	metaplastic breast carcinomas-Normal	0.209694374676827	0.257501647105256	22.0000002101124	0.424176676791948	0.621951157325291	nan
sp|Q12873|CHD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.10603823835614	0.257501647105256	22.0000002103772	0.684473233344052	0.946568877415162	nan
sp|Q12873|CHD3_HUMAN	Normal-Triple-negative breast cancer	-0.103656136320687	0.307773335570931	22.0000002099523	0.739464065934313	0.850288269338703	nan
sp|Q12874|SF3A3_HUMAN	metaplastic breast carcinomas-Normal	0.803592997329584	0.185837466147687	23.9999999997262	0.0002316263078906	0.0157578323963946	nan
sp|Q12874|SF3A3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.15873380180406	0.185837466147687	24.0000000000049	0.401465384894282	0.885297496092956	nan
sp|Q12874|SF3A3_HUMAN	Normal-Triple-negative breast cancer	-0.962326799133644	0.222118256225927	23.9999999998213	0.000226775699255	0.0227914720285933	nan
sp|Q12882|DPYD_HUMAN	metaplastic breast carcinomas-Normal	-0.398423058231546	0.288498774047424	23.9999999996837	0.17999742826205	0.369667958002123	nan
sp|Q12882|DPYD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0500966862876268	0.288498774047424	23.9999999996849	0.863599922226808	0.980358395836168	nan
sp|Q12882|DPYD_HUMAN	Normal-Triple-negative breast cancer	0.348326371943919	0.34482198849938	23.9999999996651	0.322493822885033	0.514231959877533	nan
sp|Q12884|SEPR_HUMAN	metaplastic breast carcinomas-Normal	-0.634988428543286	0.408025294013798	23.9999999999078	0.132738873404801	0.305134173718921	nan
sp|Q12884|SEPR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.300157470987715	0.408025294013798	23.9999999999078	0.46908207482722	0.911843360423993	nan
sp|Q12884|SEPR_HUMAN	Normal-Triple-negative breast cancer	0.935145899531001	0.487683504737369	23.9999999998538	0.0671478928534564	0.18724798309135	nan
sp|Q12888|TP53B_HUMAN	metaplastic breast carcinomas-Normal	0.0920295419884668	0.185938099909858	22.0000002148003	0.625544407928321	0.776151404238051	nan
sp|Q12888|TP53B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.14685776056042	0.185938099909858	22.0000002145883	0.438063123455282	0.897513075778899	nan
sp|Q12888|TP53B_HUMAN	Normal-Triple-negative breast cancer	0.0548282185719534	0.222238536577539	22.0000002147022	0.807421055860316	0.888992245670649	nan
sp|Q12904|AIMP1_HUMAN	metaplastic breast carcinomas-Normal	0.671003085836838	0.20228028311612	24.0000000000196	0.0028880535754952	0.0379733940896436	nan
sp|Q12904|AIMP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.182131039286651	0.20228028311612	23.9999999997856	0.376859493612598	0.885234295852111	nan
sp|Q12904|AIMP1_HUMAN	Normal-Triple-negative breast cancer	-0.853134125123489	0.241771181484647	23.9999999998929	0.0017160687678209	0.0289979437553501	nan
sp|Q12905|ILF2_HUMAN	metaplastic breast carcinomas-Normal	0.953548565846713	0.334409978937834	23.9999999992353	0.0088077765855607	0.061808805431078	nan
sp|Q12905|ILF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.525274396617657	0.334409978937834	23.9999999992353	0.129332476546774	0.823891816737944	nan
sp|Q12905|ILF2_HUMAN	Normal-Triple-negative breast cancer	-1.47882296246437	0.399696374073411	23.9999999992813	0.0011206792645074	0.026613045414958	nan
sp|Q12906|ILF3_HUMAN	metaplastic breast carcinomas-Normal	0.894724433225001	0.223573232488665	21.9999397339996	0.0006003157857417	0.0205934758354237	nan
sp|Q12906|ILF3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0888840032379131	0.223573232488665	21.9999397341438	0.694784963440879	0.947043345959522	nan
sp|Q12906|ILF3_HUMAN	Normal-Triple-negative breast cancer	-0.983608436462914	0.267221123751822	21.9999397335196	0.0013092426135416	0.0266490250684039	nan
sp|Q12907|LMAN2_HUMAN	metaplastic breast carcinomas-Normal	0.559866604516728	0.249611766422993	23.9999999993313	0.0344008717257586	0.133337659999685	nan
sp|Q12907|LMAN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.240548999395339	0.249611766422993	23.9999999993313	0.344810459324676	0.870943310236299	nan
sp|Q12907|LMAN2_HUMAN	Normal-Triple-negative breast cancer	-0.800415603912067	0.298343124455255	23.9999999994009	0.0130070679480817	0.0739068271101257	nan
sp|Q12929|EPS8_HUMAN	metaplastic breast carcinomas-Normal	-1.1084757658471	0.364682816285635	14.0000000490597	0.0088308230260052	0.061808805431078	nan
sp|Q12929|EPS8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.572547833289167	0.364682816285635	14.0000000490621	0.138737894361383	0.823891816737944	nan
sp|Q12929|EPS8_HUMAN	Normal-Triple-negative breast cancer	1.68102359913627	0.43587933535723	14.0000000490934	0.0017446097201503	0.0289979437553501	nan
sp|Q12931|TRAP1_HUMAN	metaplastic breast carcinomas-Normal	0.503216553874943	0.208997312644618	22.0000000007771	0.0248769130123038	0.110697267540693	nan
sp|Q12931|TRAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.259576683510969	0.208997312644618	22.0000000000698	0.227310902927105	0.843662073010871	nan
sp|Q12931|TRAP1_HUMAN	Normal-Triple-negative breast cancer	-0.762793237385912	0.249799567346853	21.9999999999005	0.0058222540639477	0.0482220814133169	nan
sp|Q12959|DLG1_HUMAN	metaplastic breast carcinomas-Normal	0.370397597280516	0.257929667599493	14.9999999997273	0.171517388938257	0.360397937027939	nan
sp|Q12959|DLG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.42318351796165	0.257929667599493	14.9999999998784	0.121657398152378	0.823891816737944	nan
sp|Q12959|DLG1_HUMAN	Normal-Triple-negative breast cancer	0.0527859206811349	0.308284917911025	14.9999999998374	0.866335696056149	0.922230408959565	nan
sp|Q12962|TAF10_HUMAN	metaplastic breast carcinomas-Normal	-0.738216263755049	0.585591971472622	23.0000000001469	0.220080505707586	0.418745049211228	nan
sp|Q12962|TAF10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.320447560573486	0.547771131424013	23.0000000001573	0.564241613501847	0.935109025059232	nan
sp|Q12962|TAF10_HUMAN	Normal-Triple-negative breast cancer	0.417768703181563	0.686667452955314	23.0000000001663	0.548883837200626	0.714018242745883	nan
sp|Q12965|MYO1E_HUMAN	metaplastic breast carcinomas-Normal	0.410372083032436	0.150039217496865	22.0000002813292	0.0120859578132314	0.0721478521661814	nan
sp|Q12965|MYO1E_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0268640379884401	0.150039217496865	22.0000002809845	0.859539674188918	0.979177437622147	nan
sp|Q12965|MYO1E_HUMAN	Normal-Triple-negative breast cancer	-0.437236121020876	0.179331165274399	22.0000002810241	0.0232979984383534	0.101630638857069	nan
sp|Q12972|PP1R8_HUMAN	metaplastic breast carcinomas-Normal	0.0705676130495737	0.338021858836676	13.0018377303954	0.837865688460644	0.914223915690573	nan
sp|Q12972|PP1R8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.589633216495824	0.338021858836676	13.0018377305726	0.10467227427493	0.821630939204717	nan
sp|Q12972|PP1R8_HUMAN	Normal-Triple-negative breast cancer	-0.660200829545397	0.397361320586577	13.0000000030891	0.120532228647389	0.272921749335095	nan
sp|Q12979|ABR_HUMAN	metaplastic breast carcinomas-Normal	-0.559215253891903	0.479548403991578	6.0	0.287814048752209	0.491620708146116	nan
sp|Q12979|ABR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0308483934814221	0.479548403991578	6.0	0.950798710244894	0.996541950781621	nan
sp|Q12979|ABR_HUMAN	Normal-Triple-negative breast cancer	0.590063647373325	0.573169972011382	6.0	0.342957121800524	0.5349551726255	nan
sp|Q13011|ECH1_HUMAN	metaplastic breast carcinomas-Normal	-0.432468235640875	0.327246005591869	23.9999999992485	0.198782029896482	0.391943393868757	nan
sp|Q13011|ECH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.830033727569381	0.327246005591869	23.9999999992485	0.0181193377538469	0.674062840112479	nan
sp|Q13011|ECH1_HUMAN	Normal-Triple-negative breast cancer	-0.397565491928506	0.391133788173805	23.9999999992054	0.319556074053303	0.511905730194303	nan
sp|Q13045|FLII_HUMAN	metaplastic breast carcinomas-Normal	0.355484183389419	0.180860698436648	23.9999999995141	0.0610288220579887	0.189588602355845	nan
sp|Q13045|FLII_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0836564448333897	0.180860698436648	23.9999999998098	0.64785592271777	0.943315325604231	nan
sp|Q13045|FLII_HUMAN	Normal-Triple-negative breast cancer	-0.271827738556029	0.216169881075682	23.9999999996036	0.220681472402025	0.403934589352605	nan
sp|Q13085|ACACA_HUMAN	metaplastic breast carcinomas-Normal	0.629687651720189	0.479694893447315	14.9999999997972	0.209019980697553	0.404383792994515	nan
sp|Q13085|ACACA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.496340898688945	0.479694893447314	14.9999999997972	0.317202763026408	0.867696529950794	nan
sp|Q13085|ACACA_HUMAN	Normal-Triple-negative breast cancer	-1.12602855040913	0.573345060399844	14.999999999797	0.0683440172324757	0.189312927733958	nan
sp|Q13098|CSN1_HUMAN	metaplastic breast carcinomas-Normal	-0.233537189911837	0.13660688152256	23.999999999598	0.100248616190489	0.255832857856663	nan
sp|Q13098|CSN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0603003836072593	0.13660688152256	23.9999999998572	0.662863664471322	0.944724271291086	nan
sp|Q13098|CSN1_HUMAN	Normal-Triple-negative breast cancer	0.173236806304577	0.163276453027717	23.9999999996951	0.299249547671366	0.491455284812066	nan
sp|Q13126|MTAP_HUMAN	metaplastic breast carcinomas-Normal	0.165531354349446	0.303684073309237	21.0734329985603	0.591422995351384	0.7497673671045	nan
sp|Q13126|MTAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.480063409894175	0.303684073309237	21.0734329982602	0.128817757129623	0.823891816737944	nan
sp|Q13126|MTAP_HUMAN	Normal-Triple-negative breast cancer	-0.645594764243621	0.359115231184284	21.0507489518702	0.0865788472910327	0.22205871018163	nan
sp|Q13131|AAPK1_HUMAN	metaplastic breast carcinomas-Normal	-0.0298173535347118	0.495035593288326	14.9999999999814	0.95276544744668	0.975193989958575	nan
sp|Q13131|AAPK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.532699785776123	0.495035593288326	14.9999999999975	0.298893664718808	0.867696529950794	nan
sp|Q13131|AAPK1_HUMAN	Normal-Triple-negative breast cancer	0.562517139310835	0.591680703737033	14.9999999999957	0.356819587606321	0.548090715898064	nan
sp|Q13144|EI2BE_HUMAN	metaplastic breast carcinomas-Normal	0.303669637383867	0.247876252212922	22.9999999996059	0.232941597397811	0.432937765805063	nan
sp|Q13144|EI2BE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.192209197209873	0.23186700252458	22.9999999997245	0.415645696318315	0.8860071777014	nan
sp|Q13144|EI2BE_HUMAN	Normal-Triple-negative breast cancer	-0.49587883459374	0.290660669966364	22.9999999996906	0.101470176315191	0.244442821554936	nan
sp|Q13148|TADBP_HUMAN	metaplastic breast carcinomas-Normal	0.446179826795283	0.35639027452897	22.0000000184826	0.223738508721901	0.423041412395677	nan
sp|Q13148|TADBP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.482781043325886	0.35639027452897	22.0000000184851	0.189281367175683	0.843662073010871	nan
sp|Q13148|TADBP_HUMAN	Normal-Triple-negative breast cancer	-0.928960870121169	0.425967852205564	22.0000000184482	0.0401715506198025	0.134755459774463	nan
sp|Q13151|ROA0_HUMAN	metaplastic breast carcinomas-Normal	0.630349173062326	0.368977746031009	22.9999999992799	0.101031601300226	0.256896548541066	nan
sp|Q13151|ROA0_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.180429053992545	0.368977746031009	22.9999999992799	0.629474384694484	0.941868024951375	nan
sp|Q13151|ROA0_HUMAN	Normal-Triple-negative breast cancer	-0.44992011906978	0.436580356741544	22.9999999993185	0.313465487592619	0.506209790748339	nan
sp|Q13153|PAK1_HUMAN	metaplastic breast carcinomas-Normal	0.0300577885848453	0.283628210859011	22.0000000473144	0.91656176374486	0.956862846321581	nan
sp|Q13153|PAK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.225124196890115	0.283628210859011	22.0000000473515	0.435830748252992	0.897298599344396	nan
sp|Q13153|PAK1_HUMAN	Normal-Triple-negative breast cancer	-0.25518198547496	0.339000552033018	22.0000000471909	0.459580916627361	0.64133471016692	nan
sp|Q13155|AIMP2_HUMAN	metaplastic breast carcinomas-Normal	0.312845861161088	0.141891695716485	22.0000000050664	0.0382219849342428	0.143718106792761	nan
sp|Q13155|AIMP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.249054728217699	0.141891695716485	22.0000000039145	0.0931345231043868	0.81309570430905	nan
sp|Q13155|AIMP2_HUMAN	Normal-Triple-negative breast cancer	-0.561900589378787	0.169593014147313	22.0000000047296	0.003161250087156	0.037336569687701	nan
sp|Q13158|FADD_HUMAN	metaplastic breast carcinomas-Normal	-0.415540346575338	0.336752435352234	13.0032330913287	0.239054517994899	0.439341552004379	nan
sp|Q13158|FADD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.538908953403406	0.336752435352234	13.0032330913307	0.133534026320455	0.823891816737944	nan
sp|Q13158|FADD_HUMAN	Normal-Triple-negative breast cancer	-0.123368606828068	0.395879682797847	13.0000000333377	0.760261952624195	0.862351606742291	nan
sp|Q13162|PRDX4_HUMAN	metaplastic breast carcinomas-Normal	0.515483812913216	0.249562159873109	22.0000000202879	0.0508484225675282	0.171023961647509	nan
sp|Q13162|PRDX4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.244304855844652	0.249562159873109	22.0000000201739	0.338255700238831	0.870943310236299	nan
sp|Q13162|PRDX4_HUMAN	Normal-Triple-negative breast cancer	-0.271178957068564	0.298283833287624	22.0000000202219	0.373133834597202	0.561474362245857	nan
sp|Q13177|PAK2_HUMAN	metaplastic breast carcinomas-Normal	0.390186262216401	0.203988057941241	23.9999999997667	0.0677800504575119	0.201475468818336	nan
sp|Q13177|PAK2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0436207446881407	0.203988057941241	23.9999999997299	0.832478362119353	0.9684421207956	nan
sp|Q13177|PAK2_HUMAN	Normal-Triple-negative breast cancer	-0.433807006904542	0.243812362813933	23.9999999997193	0.0878653765038562	0.223602777631342	nan
sp|Q13185|CBX3_HUMAN	metaplastic breast carcinomas-Normal	0.909982846659617	0.315630668528828	22.0000002574189	0.0086343418981711	0.0611952078241383	nan
sp|Q13185|CBX3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0271679240207776	0.315630668528828	22.000000258272	0.932185346689521	0.995359816653149	nan
sp|Q13185|CBX3_HUMAN	Normal-Triple-negative breast cancer	-0.937150770680395	0.377250805008996	22.0000002581387	0.0210832330142946	0.0953699510109521	nan
sp|Q13190|STX5_HUMAN	metaplastic breast carcinomas-Normal	0.233267554873803	0.147796463726216	22.000000009804	0.128767876371945	0.299374855792279	nan
sp|Q13190|STX5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.040494773816072	0.147796463726216	22.0000000093731	0.786648297131382	0.962981271203673	nan
sp|Q13190|STX5_HUMAN	Normal-Triple-negative breast cancer	-0.192772781057731	0.176650561804026	22.000000009685	0.286963520047834	0.479571010879337	nan
sp|Q13200|PSMD2_HUMAN	metaplastic breast carcinomas-Normal	0.376377667939007	0.126961007968791	21.9999999842187	0.0071589090898754	0.0563891322624312	nan
sp|Q13200|PSMD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0640496479708981	0.126961007968791	21.9999999875129	0.618937715015476	0.941374262616245	nan
sp|Q13200|PSMD2_HUMAN	Normal-Triple-negative breast cancer	-0.440427315909905	0.151747428994231	21.9999999855072	0.0082603217487211	0.0575911703148659	nan
sp|Q13217|DNJC3_HUMAN	metaplastic breast carcinomas-Normal	-0.334506249504781	0.224648027078821	24.0000000000865	0.149505337216725	0.328099856986626	nan
sp|Q13217|DNJC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.122752208684193	0.224648027078821	24.0000000000865	0.58982148594501	0.940559810632461	nan
sp|Q13217|DNJC3_HUMAN	Normal-Triple-negative breast cancer	0.457258458188974	0.268505748995134	24.0000000001008	0.101490913137438	0.244442821554936	nan
sp|Q13228|SBP1_HUMAN	metaplastic breast carcinomas-Normal	-1.47522286799714	0.391294915151435	22.0000000027801	0.0010548725601895	0.0247100635229515	nan
sp|Q13228|SBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.159992326440178	0.391294915151435	22.00000000291	0.686581355951885	0.946568877415162	nan
sp|Q13228|SBP1_HUMAN	Normal-Triple-negative breast cancer	1.63521519443731	0.467686877276069	22.0000000030673	0.0020417091145213	0.0312748437634516	nan
sp|Q13232|NDK3_HUMAN	metaplastic breast carcinomas-Normal	-0.279172480882609	0.192885060827382	14.0000000007423	0.169818797561011	0.358854216842213	nan
sp|Q13232|NDK3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.357085748141884	0.192885060827382	14.0000000007415	0.0853361096362093	0.806849600316436	nan
sp|Q13232|NDK3_HUMAN	Normal-Triple-negative breast cancer	-0.0779132672592748	0.230541743014091	14.0000000005238	0.74040961655419	0.851010223176393	nan
sp|Q13242|SRSF9_HUMAN	metaplastic breast carcinomas-Normal	0.451896347955663	0.160432415800621	22.0000021143015	0.0100459825973422	0.0665555756942394	nan
sp|Q13242|SRSF9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.201841989725014	0.160432415800621	22.0000021139245	0.221540737174807	0.843662073010871	nan
sp|Q13242|SRSF9_HUMAN	Normal-Triple-negative breast cancer	-0.250054358230649	0.191753413229533	22.0000021140169	0.205699431359236	0.387171523124631	nan
sp|Q13247|SRSF6_HUMAN	metaplastic breast carcinomas-Normal	1.08057712119134	0.282409780825137	22.0000000005564	0.000920466629501	0.0230047449357996	nan
sp|Q13247|SRSF6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0914416200424359	0.282409780825137	21.9999999993766	0.749154630572443	0.954643368861838	nan
sp|Q13247|SRSF6_HUMAN	Normal-Triple-negative breast cancer	-1.17201874123378	0.337544249598059	21.9999999998956	0.0021636348313987	0.032066107359435	nan
sp|Q13263|TIF1B_HUMAN	metaplastic breast carcinomas-Normal	0.829229861123422	0.266157430042209	21.9955538796765	0.0050391491044495	0.0471834693610991	nan
sp|Q13263|TIF1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.346145361300987	0.266157430042209	21.9955538327922	0.206881744951791	0.843662073010871	nan
sp|Q13263|TIF1B_HUMAN	Normal-Triple-negative breast cancer	-1.17537522242441	0.318118974973366	21.9955538613351	0.0012663305185822	0.0266490250684039	nan
sp|Q13268|DHRS2_HUMAN	metaplastic breast carcinomas-Normal	-0.94873597166338	1.90473424864446	5.0	0.639549828618557	0.785892843462682	nan
sp|Q13268|DHRS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-3.41323284667617	1.90473424864446	5.0	0.133126310885575	0.823891816737944	nan
sp|Q13268|DHRS2_HUMAN	Normal-Triple-negative breast cancer	-2.46449687501279	2.19939766237916	5.0	0.313402669557724	0.506209790748339	nan
sp|Q13277|STX3_HUMAN	metaplastic breast carcinomas-Normal	0.421215059121869	0.457677744304746	14.0000025426844	0.372986436856086	0.581423933411512	nan
sp|Q13277|STX3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.778505425523764	0.457677744304746	14.0000025424745	0.111039719095767	0.823891816737944	nan
sp|Q13277|STX3_HUMAN	Normal-Triple-negative breast cancer	-1.19972048464563	0.547029533848664	14.0000025424675	0.045682438113762	0.1465718381179	nan
sp|Q13283|G3BP1_HUMAN	metaplastic breast carcinomas-Normal	0.635767789662244	0.278164926613571	22.0000038279213	0.0322767656785407	0.128806032097332	nan
sp|Q13283|G3BP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.222150387585896	0.278164926613571	22.0000038279209	0.433043418098137	0.896102083258464	nan
sp|Q13283|G3BP1_HUMAN	Normal-Triple-negative breast cancer	-0.85791817724814	0.332470678401943	22.0000038282503	0.0170686082815102	0.0845300333812879	nan
sp|Q13287|NMI_HUMAN	metaplastic breast carcinomas-Normal	0.287538779470427	0.340819145177754	22.0000000305496	0.407934222570018	0.609974519038569	nan
sp|Q13287|NMI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.25767108309276	0.340819145177754	22.0000000305496	0.457648029755097	0.908567154037048	nan
sp|Q13287|NMI_HUMAN	Normal-Triple-negative breast cancer	-0.0298676963776666	0.407356792925344	22.0000000305259	0.942213454996757	0.969033887502853	nan
sp|Q13308|PTK7_HUMAN	metaplastic breast carcinomas-Normal	0.786055124727052	0.254618111799741	21.9999999920352	0.0053838379018802	0.048498312156775	nan
sp|Q13308|PTK7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.106942933897135	0.254618111799741	21.9999999920423	0.67854959287832	0.946568877415162	nan
sp|Q13308|PTK7_HUMAN	Normal-Triple-negative breast cancer	-0.679112190829917	0.304326851677754	21.9999999925698	0.0361541466651964	0.126678556343412	nan
sp|Q13310|PABP4_HUMAN	metaplastic breast carcinomas-Normal	0.640057785723771	0.259610764244927	22.000000994003	0.0219589946426348	0.10165974678568	nan
sp|Q13310|PABP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.412453047493051	0.259610764244927	22.0000009933385	0.126389063671937	0.823891816737944	nan
sp|Q13310|PABP4_HUMAN	Normal-Triple-negative breast cancer	-1.05251083321682	0.310294212716704	22.0000009934749	0.0026210079470442	0.0344406168311338	nan
sp|Q13330|MTA1_HUMAN	metaplastic breast carcinomas-Normal	0.616781106881593	0.315557975714192	14.0000003963909	0.0709035348821632	0.207008121073216	nan
sp|Q13330|MTA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.188668004503192	0.315557975714192	14.0000003966281	0.559463471397389	0.932694870083482	nan
sp|Q13330|MTA1_HUMAN	Normal-Triple-negative breast cancer	-0.428113102378401	0.37716392047725	14.0000003964567	0.275400044770335	0.467294409809389	nan
sp|Q13347|EIF3I_HUMAN	metaplastic breast carcinomas-Normal	0.298944999702005	0.11199584042963	22.0000000032936	0.0140110675289304	0.0790709481598719	nan
sp|Q13347|EIF3I_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.055520768714827	0.11199584042963	22.0000000032144	0.624994189241755	0.941374262616245	nan
sp|Q13347|EIF3I_HUMAN	Normal-Triple-negative breast cancer	-0.354465768416832	0.133860632607943	22.0000000032115	0.0146910764210706	0.0779324922305247	nan
sp|Q13363|CTBP1_HUMAN	metaplastic breast carcinomas-Normal	0.0649470497602604	0.233161484964199	18.334795144093	0.783707714076	0.882032001854638	nan
sp|Q13363|CTBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0827171243363491	0.198820442187716	18.0834435274484	0.682277021032604	0.946568877415162	nan
sp|Q13363|CTBP1_HUMAN	Normal-Triple-negative breast cancer	0.0177700745760887	0.265963683864929	18.5331889113422	0.947445362508627	0.972909603020907	nan
sp|Q13404|UB2V1_HUMAN	metaplastic breast carcinomas-Normal	0.0976467092646951	0.213541050462617	22.0000055857207	0.651957867451	0.794103316748671	nan
sp|Q13404|UB2V1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.42406552908383	0.213541050462617	22.0000055857512	0.0596481766787965	0.773787875546141	nan
sp|Q13404|UB2V1_HUMAN	Normal-Triple-negative breast cancer	-0.521712238348525	0.255230372780239	22.0000055858339	0.0530974413683037	0.162439494536208	nan
sp|Q13409|DC1I2_HUMAN	metaplastic breast carcinomas-Normal	0.126721897398644	0.203109885316634	24.0000000000378	0.538573526583239	0.713803190734723	nan
sp|Q13409|DC1I2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0038505438975221	0.203109885316634	24.0000000002317	0.985031392963324	0.99777413090774	nan
sp|Q13409|DC1I2_HUMAN	Normal-Triple-negative breast cancer	-0.130572441296167	0.242762745769069	24.0000000001502	0.595626517298205	0.748530262192527	nan
sp|Q13418|ILK_HUMAN	metaplastic breast carcinomas-Normal	-0.696776293478952	0.252139895125519	22.0000005006178	0.0113366356799138	0.0705294023488664	nan
sp|Q13418|ILK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.28080799229857	0.252139895125519	22.0000005006209	0.277428598861705	0.867696529950794	nan
sp|Q13418|ILK_HUMAN	Normal-Triple-negative breast cancer	0.977584285777522	0.301364816208594	22.0000005007603	0.0037258535835807	0.0400819560687694	nan
sp|Q13423|NNTM_HUMAN	metaplastic breast carcinomas-Normal	0.274698388108746	0.250529452462877	22.0000000033789	0.284730246293664	0.487857391072236	nan
sp|Q13423|NNTM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.210785624500287	0.250529452462877	22.0000000031439	0.409198481271672	0.885784822958391	nan
sp|Q13423|NNTM_HUMAN	Normal-Triple-negative breast cancer	-0.063912763608459	0.299439969064512	22.0000000029073	0.832948625905578	0.905402626720125	nan
sp|Q13427|PPIG_HUMAN	metaplastic breast carcinomas-Normal	0.677856324989799	0.296437219978689	21.9999999980723	0.0322020424087915	0.128806032097332	nan
sp|Q13427|PPIG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.193501770163363	0.296437219978689	21.9999999980755	0.520675709218252	0.917480869285828	nan
sp|Q13427|PPIG_HUMAN	Normal-Triple-negative breast cancer	-0.871358095153162	0.354310246190082	21.9999999974991	0.0222539009245523	0.0987609701912042	nan
sp|Q13428|TCOF_HUMAN	metaplastic breast carcinomas-Normal	0.619734522135729	0.226216481632317	23.9999999998855	0.0114194069372218	0.0706854909857084	nan
sp|Q13428|TCOF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.208193622625535	0.226216481632317	23.9999999996975	0.366559459860575	0.883542279876718	nan
sp|Q13428|TCOF_HUMAN	Normal-Triple-negative breast cancer	-0.827928144761264	0.270380410749914	23.9999999998133	0.0053521307933177	0.0462052266409448	nan
sp|Q13435|SF3B2_HUMAN	metaplastic breast carcinomas-Normal	0.729075610293863	0.181130728441271	22.0000002960206	0.0005672945907263	0.0205217420849069	nan
sp|Q13435|SF3B2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.380445356799457	0.181130728441271	22.0000002961604	0.0473799757154244	0.760401133998256	nan
sp|Q13435|SF3B2_HUMAN	Normal-Triple-negative breast cancer	-1.10952096709332	0.216492628662586	22.0000002963797	3.89464583399101e-05	0.022319699811492	nan
sp|Q13438|OS9_HUMAN	metaplastic breast carcinomas-Normal	0.156381803087979	0.260982953051732	13.9996871300581	0.558610197823523	0.728154928574331	nan
sp|Q13438|OS9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.358019084360612	0.260982953051732	13.9996871293942	0.191707367828712	0.843662073010871	nan
sp|Q13438|OS9_HUMAN	Normal-Triple-negative breast cancer	0.201637281272633	0.311934292036005	13.9996871294535	0.528469652205898	0.697630311331377	nan
sp|Q13439|GOGA4_HUMAN	metaplastic breast carcinomas-Normal	0.640961996438114	0.272231701574572	14.0000000024949	0.0336750870993061	0.131226247969629	nan
sp|Q13439|GOGA4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0682929220430711	0.272231701574572	14.0000000024949	0.805564230196537	0.965774701272009	nan
sp|Q13439|GOGA4_HUMAN	Normal-Triple-negative breast cancer	-0.572669074395043	0.325379118089712	14.0000000025263	0.100228112074603	0.243181200391226	nan
sp|Q13442|HAP28_HUMAN	metaplastic breast carcinomas-Normal	0.383314339359161	0.31210486485418	22.0000002525939	0.232365232770749	0.432464744529658	nan
sp|Q13442|HAP28_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.13243059879128	0.31210486485418	22.0000002525939	0.675457046565281	0.946386428913156	nan
sp|Q13442|HAP28_HUMAN	Normal-Triple-negative breast cancer	-0.515744938150441	0.373036663586161	22.0000002525352	0.180675342538698	0.356629951661897	nan
sp|Q13443|ADAM9_HUMAN	metaplastic breast carcinomas-Normal	0.632179757004695	0.517129624321488	12.699777423133	0.243730210386724	0.444409884435255	nan
sp|Q13443|ADAM9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.136091007930211	0.380017394186276	12.0000000005811	0.72647560153995	0.953491935272676	nan
sp|Q13443|ADAM9_HUMAN	Normal-Triple-negative breast cancer	-0.496088749074484	0.573859240843278	12.5959167751993	0.403488446431807	0.593242783972026	nan
sp|Q13451|FKBP5_HUMAN	metaplastic breast carcinomas-Normal	0.0022734339664462	0.374462031299079	23.9999999995274	0.995206096988813	0.996859918937684	nan
sp|Q13451|FKBP5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.71530120183237	0.374462031299079	23.999999999526	0.068126510149197	0.777898601552022	nan
sp|Q13451|FKBP5_HUMAN	Normal-Triple-negative breast cancer	-0.717574635798817	0.447567732918131	23.999999999604	0.121954513764355	0.27510011372513	nan
sp|Q13459|MYO9B_HUMAN	metaplastic breast carcinomas-Normal	0.240804012296396	0.212710723207028	14.0000000134254	0.276621985578558	0.479333634079622	nan
sp|Q13459|MYO9B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.107071248869027	0.212710723207028	14.0000000131309	0.622534053475293	0.941374262616245	nan
sp|Q13459|MYO9B_HUMAN	Normal-Triple-negative breast cancer	-0.13373276342737	0.25423794188925	14.0000000131675	0.607111002599596	0.758090523155919	nan
sp|Q13464|ROCK1_HUMAN	metaplastic breast carcinomas-Normal	-0.296389996913631	0.231471793680908	22.0028616201595	0.213718387058933	0.410161615810562	nan
sp|Q13464|ROCK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.015244654032845	0.231471793680908	22.0028616201595	0.948084311207466	0.996541950781621	nan
sp|Q13464|ROCK1_HUMAN	Normal-Triple-negative breast cancer	0.281145342880786	0.276661710061369	22.0028616304526	0.320576011622865	0.512798201460252	nan
sp|Q13480|GAB1_HUMAN	metaplastic breast carcinomas-Normal	0.0365597722622356	0.297561250147946	6.0	0.906226434090686	0.949352873280001	nan
sp|Q13480|GAB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.070379621138016	0.297561250147946	6.0	0.82089587759238	0.965774701272009	nan
sp|Q13480|GAB1_HUMAN	Normal-Triple-negative breast cancer	-0.106939393400252	0.355653719206134	6.0	0.773802264756093	0.871313932266007	nan
sp|Q13492|PICAL_HUMAN	metaplastic breast carcinomas-Normal	0.0376852975906793	0.186513506172084	22.0000000065307	0.841733343621241	0.915277982513531	nan
sp|Q13492|PICAL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.112889693414542	0.186513506172084	22.0000000065246	0.551197526044053	0.931266145374226	nan
sp|Q13492|PICAL_HUMAN	Normal-Triple-negative breast cancer	-0.150574991005222	0.222926278604142	22.000000006763	0.506429670368373	0.680269546112475	nan
sp|Q13501|SQSTM_HUMAN	metaplastic breast carcinomas-Normal	0.358838595921806	0.371002622885368	14.0000000105313	0.34985014316978	0.559356361662505	nan
sp|Q13501|SQSTM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.096111339182231	0.371002622885368	14.000000009901	0.799360418154945	0.965774701272009	nan
sp|Q13501|SQSTM_HUMAN	Normal-Triple-negative breast cancer	-0.262727256739575	0.443432949010691	14.0000000099692	0.562973995005043	0.725319984262311	nan
sp|Q13505|MTX1_HUMAN	metaplastic breast carcinomas-Normal	-0.304311925438221	0.426540906419864	6.0	0.502366093652542	0.687470109222334	nan
sp|Q13505|MTX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.211719133356348	0.426540906419864	6.0	0.637295777758934	0.941868024951375	nan
sp|Q13505|MTX1_HUMAN	Normal-Triple-negative breast cancer	0.0925927920818726	0.509813894404445	6.0	0.861860685450412	0.920618363364173	nan
sp|Q13509|TBB3_HUMAN	metaplastic breast carcinomas-Normal	0.877519689246474	0.538232362764518	23.9999999995911	0.116078238068848	0.280818095590138	nan
sp|Q13509|TBB3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.565298180695059	0.538232362764518	23.9999999998555	0.304047761296109	0.867696529950794	nan
sp|Q13509|TBB3_HUMAN	Normal-Triple-negative breast cancer	-1.44281786994153	0.6433107184458	23.9999999996904	0.0344117498285128	0.124196152475544	nan
sp|Q13510|ASAH1_HUMAN	metaplastic breast carcinomas-Normal	-0.604554950438041	0.286398086549888	23.9999999997015	0.0453879304977427	0.159313073890704	nan
sp|Q13510|ASAH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.566204903123003	0.286398086549888	23.9999999997015	0.0596407685294371	0.773787875546141	nan
sp|Q13510|ASAH1_HUMAN	Normal-Triple-negative breast cancer	0.0383500473150372	0.342311186703054	23.9999999997583	0.911729232595676	0.949432321161663	nan
sp|Q13523|PRP4B_HUMAN	metaplastic breast carcinomas-Normal	0.263126734371542	0.423111819048518	14.9999999996672	0.54335508000881	0.717850670091131	nan
sp|Q13523|PRP4B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0419992168977081	0.423111819048518	14.9999999996672	0.922244138769036	0.994508979919649	nan
sp|Q13523|PRP4B_HUMAN	Normal-Triple-negative breast cancer	-0.30512595126925	0.505715351074305	14.9999999997378	0.555286926819431	0.719599900486467	nan
sp|Q13526|PIN1_HUMAN	metaplastic breast carcinomas-Normal	0.398764023921412	0.415134611194643	21.3033663410168	0.347547158405571	0.557013864291281	nan
sp|Q13526|PIN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.123960022375594	0.387343674821413	21.0241668264471	0.752107357536398	0.954643368861838	nan
sp|Q13526|PIN1_HUMAN	Normal-Triple-negative breast cancer	-0.522724046297006	0.486454018551535	21.2290684350163	0.294634005443316	0.487103695280026	nan
sp|Q13547|HDAC1_HUMAN	metaplastic breast carcinomas-Normal	0.614568098077848	0.178794556021139	23.9999999996904	0.0021508878410414	0.0332537264354498	nan
sp|Q13547|HDAC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0474624155014127	0.178794556021139	24.0000000000409	0.792923697998824	0.964028289128757	nan
sp|Q13547|HDAC1_HUMAN	Normal-Triple-negative breast cancer	-0.662030513579261	0.213700368549706	23.9999999998778	0.0049117617643962	0.0450865992679507	nan
sp|Q13557|KCC2D_HUMAN	metaplastic breast carcinomas-Normal	0.0322980719409638	0.23398174528072	23.9999999993528	0.891363021381801	0.94150288514576	nan
sp|Q13557|KCC2D_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0778062766785458	0.23398174528072	23.9999999993528	0.742375105697574	0.954643368861838	nan
sp|Q13557|KCC2D_HUMAN	Normal-Triple-negative breast cancer	0.045508204737582	0.279661676021509	23.9999999993678	0.872096622858267	0.926445885068993	nan
sp|Q13561|DCTN2_HUMAN	metaplastic breast carcinomas-Normal	0.0376519063081209	0.161539209368403	22.000000027834	0.817852559487297	0.904071136593207	nan
sp|Q13561|DCTN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.176276878368872	0.161539209368403	22.0000000277813	0.286977889831589	0.867696529950794	nan
sp|Q13561|DCTN2_HUMAN	Normal-Triple-negative breast cancer	0.138624972060751	0.193076284566374	22.0000000278973	0.48032506823841	0.659445519167003	nan
sp|Q13564|ULA1_HUMAN	metaplastic breast carcinomas-Normal	0.206275663771667	0.277270464947151	23.9999999998365	0.464128040519053	0.656494300717162	nan
sp|Q13564|ULA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.23260512973805	0.277270464947151	24.0000000000882	0.409797865317605	0.885784822958391	nan
sp|Q13564|ULA1_HUMAN	Normal-Triple-negative breast cancer	-0.438880793509718	0.331401592228285	23.99999999986	0.197871866441488	0.3786926489393	nan
sp|Q13576|IQGA2_HUMAN	metaplastic breast carcinomas-Normal	-0.207127682377421	0.284273742716766	22.0000000003841	0.473919192854051	0.663846353580642	nan
sp|Q13576|IQGA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.397930178489742	0.284273742716766	22.000000000131	0.17551330594781	0.843662073010871	nan
sp|Q13576|IQGA2_HUMAN	Normal-Triple-negative breast cancer	-0.190802496112321	0.339772110177643	22.0000000005085	0.58009194848422	0.738415621418319	nan
sp|Q13586|STIM1_HUMAN	metaplastic breast carcinomas-Normal	0.116302924323679	0.209662334784894	23.999999999828	0.584222495364251	0.744329465155527	nan
sp|Q13586|STIM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.260385896038533	0.209662334784894	23.999999999609	0.226262477837834	0.843662073010871	nan
sp|Q13586|STIM1_HUMAN	Normal-Triple-negative breast cancer	0.144082971714854	0.250594420834751	23.9999999997477	0.570666415027809	0.731278536409319	nan
sp|Q13595|TRA2A_HUMAN	metaplastic breast carcinomas-Normal	0.397261672770329	0.195888249124943	20.625812784467	0.0556731441815981	0.179667506077313	nan
sp|Q13595|TRA2A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.148759467812385	0.163411576950838	20.0779751241951	0.373445030370712	0.885234295852111	nan
sp|Q13595|TRA2A_HUMAN	Normal-Triple-negative breast cancer	-0.248502204957944	0.223196093623435	20.506220966612	0.278426213877293	0.470624638428115	nan
sp|Q13596|SNX1_HUMAN	metaplastic breast carcinomas-Normal	-0.0973663071383508	0.164232051321192	23.9999999995472	0.558821667506955	0.728154928574331	nan
sp|Q13596|SNX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.202664020589728	0.164232051321192	23.9999999995472	0.229147046642102	0.843662073010871	nan
sp|Q13596|SNX1_HUMAN	Normal-Triple-negative breast cancer	0.300030327728078	0.196294846308764	23.9999999995296	0.139470312536867	0.301429986263034	nan
sp|Q13616|CUL1_HUMAN	metaplastic breast carcinomas-Normal	0.39966909403348	0.214475475720248	22.0000000283144	0.0757993913277121	0.21565472430157	nan
sp|Q13616|CUL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.246318861129298	0.214475475720248	22.00000002828	0.263108786153236	0.86431258289795	nan
sp|Q13616|CUL1_HUMAN	Normal-Triple-negative breast cancer	-0.645987955162779	0.256347224581444	22.00000002856	0.0194966302148056	0.0908931259944094	nan
sp|Q13617|CUL2_HUMAN	metaplastic breast carcinomas-Normal	0.624325725556712	0.215918521348244	14.0000000016058	0.0118395130675608	0.0718148566360804	nan
sp|Q13617|CUL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.102796072045661	0.215918521348244	14.0000000012589	0.641356278684594	0.941868024951375	nan
sp|Q13617|CUL2_HUMAN	Normal-Triple-negative breast cancer	-0.521529653511051	0.2580719940006	14.0000000015128	0.0628469902292902	0.181387677362224	nan
sp|Q13618|CUL3_HUMAN	metaplastic breast carcinomas-Normal	-0.105910302003647	0.147446897609572	22.0000001909972	0.480135169358533	0.669450210968022	nan
sp|Q13618|CUL3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0593672536362504	0.147446897609572	22.000000191166	0.691102566722249	0.946568877415162	nan
sp|Q13618|CUL3_HUMAN	Normal-Triple-negative breast cancer	0.046543048367397	0.17623275038056	22.0000001911759	0.794161183814126	0.882283347258742	nan
sp|Q13619|CUL4A_HUMAN	metaplastic breast carcinomas-Normal	0.102416687001543	0.23233560547935	22.9999999995743	0.663463618241135	0.802822376058803	nan
sp|Q13619|CUL4A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.360752324455232	0.217330058613101	22.9999999996685	0.110503568095818	0.823891816737944	nan
sp|Q13619|CUL4A_HUMAN	Normal-Triple-negative breast cancer	-0.463169011456775	0.272437646377115	22.999999999624	0.102599147433541	0.246415871437205	nan
sp|Q13620|CUL4B_HUMAN	metaplastic breast carcinomas-Normal	0.459492306164631	0.407755995329531	18.280636805525	0.274368289062177	0.477548285858522	nan
sp|Q13620|CUL4B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.472305181477293	0.365662813861335	17.8889431929686	0.21292122464035	0.843662073010871	nan
sp|Q13620|CUL4B_HUMAN	Normal-Triple-negative breast cancer	-0.931797487641924	0.47402412556052	18.002241795968	0.0649493236602809	0.184795320809112	nan
sp|Q13630|FCL_HUMAN	metaplastic breast carcinomas-Normal	0.212293911260187	0.303431433498925	23.9999999992867	0.490876124861366	0.680430458314921	nan
sp|Q13630|FCL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.179002721689213	0.303431433498925	23.9999999993199	0.560752539259884	0.933069710577483	nan
sp|Q13630|FCL_HUMAN	Normal-Triple-negative breast cancer	-0.0332911895709742	0.362669930289262	23.9999999993016	0.927623039086332	0.959968549789218	nan
sp|Q13637|RAB32_HUMAN	metaplastic breast carcinomas-Normal	0.0992404685397976	0.244184776318092	6.0	0.698536104278224	0.825136464328648	nan
sp|Q13637|RAB32_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0066141826006974	0.244184776318092	6.0	0.979268950380062	0.99709406933403	nan
sp|Q13637|RAB32_HUMAN	Normal-Triple-negative breast cancer	-0.105854651140495	0.291856630619303	6.0	0.729267291532179	0.84433454442806	nan
sp|Q13683|ITA7_HUMAN	metaplastic breast carcinomas-Normal	-3.39521176944128	0.713548521458797	6.0	0.0031321558064973	0.0392878713237624	nan
sp|Q13683|ITA7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.651162410539609	0.713548521458797	6.0	0.396654550939331	0.885234295852111	nan
sp|Q13683|ITA7_HUMAN	Normal-Triple-negative breast cancer	2.74404935890167	0.852853606995811	6.0	0.018194542328049	0.0873480619203579	nan
sp|Q13724|MOGS_HUMAN	metaplastic breast carcinomas-Normal	0.407684156886386	0.187433771383609	21.9999999978512	0.0406510441045058	0.149310692394896	nan
sp|Q13724|MOGS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.131611275158329	0.187433771383609	21.9999999978937	0.489933224890019	0.913320451076758	nan
sp|Q13724|MOGS_HUMAN	Normal-Triple-negative breast cancer	-0.539295432044715	0.224026205913132	21.9999999977796	0.0249025479850458	0.10516426302168	nan
sp|Q13740|CD166_HUMAN	metaplastic breast carcinomas-Normal	-0.634023258998053	0.480556685299029	22.0000000038219	0.200618730946918	0.393658005706939	nan
sp|Q13740|CD166_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.520795565292468	0.480556685299029	22.0000000032844	0.290217517152861	0.867696529950794	nan
sp|Q13740|CD166_HUMAN	Normal-Triple-negative breast cancer	0.113227693705584	0.574375098676304	22.0000000036881	0.845534164097266	0.911630088050377	nan
sp|Q13769|THOC5_HUMAN	metaplastic breast carcinomas-Normal	0.194602774355235	0.25038229661907	14.0000002296857	0.449961756536609	0.644964587635915	nan
sp|Q13769|THOC5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.288626143610738	0.25038229661907	14.0000002301941	0.268319541901374	0.867211773631185	nan
sp|Q13769|THOC5_HUMAN	Normal-Triple-negative breast cancer	-0.483228917965972	0.299264084189963	14.0000002298932	0.128675350754252	0.285695054896968	nan
sp|Q13813|SPTN1_HUMAN	metaplastic breast carcinomas-Normal	-0.785959534852934	0.252987586505961	22.0000001189636	0.0051437504447898	0.0475250339167534	nan
sp|Q13813|SPTN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.179809520335243	0.252987586505961	22.0000001187268	0.484710076942022	0.913320451076758	nan
sp|Q13813|SPTN1_HUMAN	Normal-Triple-negative breast cancer	0.60615001451769	0.302378001198384	22.000000118504	0.057465282242833	0.171467323317035	nan
sp|Q13835|PKP1_HUMAN	metaplastic breast carcinomas-Normal	0.02891623873091	0.464985229897284	23.9999999999106	0.950928580995236	0.974980445165997	nan
sp|Q13835|PKP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.243811347204944	0.464985229897284	24.0000000000887	0.604850154301766	0.940559810632461	nan
sp|Q13835|PKP1_HUMAN	Normal-Triple-negative breast cancer	0.214895108474034	0.555763649691164	24.0000000000276	0.702410340920487	0.825897408284294	nan
sp|Q13838|DX39B_HUMAN	metaplastic breast carcinomas-Normal	-0.696484675252831	0.394222979018031	24.0000000000629	0.0899909113774671	0.242077168447222	nan
sp|Q13838|DX39B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0021392977417017	0.394222979018031	23.9999999998559	0.995715061985418	0.998185231446144	nan
sp|Q13838|DX39B_HUMAN	Normal-Triple-negative breast cancer	0.694345377511129	0.471186582979383	23.9999999999485	0.153582703520847	0.321276844873062	nan
sp|Q13867|BLMH_HUMAN	metaplastic breast carcinomas-Normal	0.409204356876514	0.226114989378937	13.9999780450594	0.0918540169131627	0.245248171876744	nan
sp|Q13867|BLMH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.409897247842567	0.226114989378937	13.9999780450774	0.0913588047544822	0.81309570430905	nan
sp|Q13867|BLMH_HUMAN	Normal-Triple-negative breast cancer	-0.819101604719082	0.270259104305048	13.9999780450986	0.0089856385856087	0.0594985311923575	nan
sp|Q13905|RPGF1_HUMAN	metaplastic breast carcinomas-Normal	-0.0837050254326357	0.344972066480869	12.9999999998234	0.812068247122845	0.900925915386606	nan
sp|Q13905|RPGF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0846483259966462	0.310953618574887	12.9999999999634	0.789727218215585	0.962981271203673	nan
sp|Q13905|RPGF1_HUMAN	Normal-Triple-negative breast cancer	-0.0009433005640104	0.395215151823481	12.9999999999101	0.998131846803637	0.999945312570918	nan
sp|Q13907|IDI1_HUMAN	metaplastic breast carcinomas-Normal	-0.649835101091063	1.34205644943941	6.0	0.645404517111397	0.790158386910385	nan
sp|Q13907|IDI1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-2.28783669111198	1.34205644943941	6.0	0.139129124940869	0.823891816737944	nan
sp|Q13907|IDI1_HUMAN	Normal-Triple-negative breast cancer	-1.63800159002092	1.60406426371171	6.0	0.346575277701201	0.537822699850043	nan
sp|Q13938|CAYP1_HUMAN	metaplastic breast carcinomas-Normal	0.609059224019101	0.838281948762919	22.0000000480781	0.47515786863706	0.665301076389885	nan
sp|Q13938|CAYP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.270524000292963	0.838281948762919	22.0000000488199	0.749960033274824	0.954643368861838	nan
sp|Q13938|CAYP1_HUMAN	Normal-Triple-negative breast cancer	-0.338535223726138	1.00193856785003	22.000000048363	0.73865635398822	0.850288269338703	nan
sp|Q13951|PEBB_HUMAN	metaplastic breast carcinomas-Normal	0.762857094015744	0.414891493819185	6.0	0.115587710354532	0.280543743788241	nan
sp|Q13951|PEBB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0533194307258567	0.414891493819185	6.0	0.901941588590898	0.990735309568793	nan
sp|Q13951|PEBB_HUMAN	Normal-Triple-negative breast cancer	-0.709537663289887	0.495890183182174	6.0	0.202430015306675	0.382901192452517	nan
sp|Q14004|CDK13_HUMAN	metaplastic breast carcinomas-Normal	-0.309491603003175	0.288925359137941	12.0618781418416	0.305053651857212	0.512897490527755	nan
sp|Q14004|CDK13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.160288211649317	0.208874597745682	12.0000009458299	0.457683675914016	0.908567154037048	nan
sp|Q14004|CDK13_HUMAN	Normal-Triple-negative breast cancer	0.149203391353858	0.319649548014513	12.0506672137721	0.648989156388948	0.793024292875055	nan
sp|Q14005|IL16_HUMAN	metaplastic breast carcinomas-Normal	0.0943257422104054	0.339594950867795	22.0000000425226	0.783790493323452	0.882032001854638	nan
sp|Q14005|IL16_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.405143772022879	0.339594950867795	22.0000000416453	0.245569389383833	0.84964799869723	nan
sp|Q14005|IL16_HUMAN	Normal-Triple-negative breast cancer	0.310818029812474	0.405893600862697	22.0000000418388	0.451955839271999	0.634954019332259	nan
sp|Q14008|CKAP5_HUMAN	metaplastic breast carcinomas-Normal	0.393941115004134	0.155270050471276	21.999999997065	0.0187764498519753	0.0929781777313555	nan
sp|Q14008|CKAP5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.267318998457627	0.155270050471276	21.9999999945218	0.0991682310998253	0.820234747280893	nan
sp|Q14008|CKAP5_HUMAN	Normal-Triple-negative breast cancer	-0.66126011346176	0.185583206496064	21.9999999958659	0.0017391701902628	0.0289979437553501	nan
sp|Q14011|CIRBP_HUMAN	metaplastic breast carcinomas-Normal	0.585258405055489	0.465029931788023	22.0000000141592	0.221389286267213	0.419793489761675	nan
sp|Q14011|CIRBP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.687669760468625	0.465029931788023	22.0000000141618	0.153379666557817	0.843465960034572	nan
sp|Q14011|CIRBP_HUMAN	Normal-Triple-negative breast cancer	-1.27292816552411	0.555817078669867	22.000000014153	0.0319640924557209	0.120326889380313	nan
sp|Q14019|COTL1_HUMAN	metaplastic breast carcinomas-Normal	0.506450773315601	0.310905462726879	22.0000061864792	0.117559538359796	0.283165148918813	nan
sp|Q14019|COTL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0324948648449954	0.310905462726879	22.0000061862945	0.917706203556643	0.99408739879047	nan
sp|Q14019|COTL1_HUMAN	Normal-Triple-negative breast cancer	-0.473955908470605	0.371603103849514	22.0000061864451	0.215459075852404	0.39788109340744	nan
sp|Q14103|HNRPD_HUMAN	metaplastic breast carcinomas-Normal	0.502515641316947	0.207940404329252	24.0000000001111	0.0236321925915334	0.107110232987193	nan
sp|Q14103|HNRPD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.283353125389361	0.207940404329252	24.0000000001122	0.185638902137734	0.843662073010871	nan
sp|Q14103|HNRPD_HUMAN	Normal-Triple-negative breast cancer	-0.785868766706308	0.248536320290884	24.0000000001264	0.004210265898622	0.0419484078096101	nan
sp|Q14108|SCRB2_HUMAN	metaplastic breast carcinomas-Normal	-0.0407127741225682	0.256081366932588	22.0000000316785	0.875132146868395	0.935049584117823	nan
sp|Q14108|SCRB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.178431808244969	0.256081366932588	22.0000000316785	0.49323925223099	0.913320451076758	nan
sp|Q14108|SCRB2_HUMAN	Normal-Triple-negative breast cancer	-0.1377190341224	0.306075776075288	22.0000000319237	0.657148210807669	0.798377431551422	nan
sp|Q14112|NID2_HUMAN	metaplastic breast carcinomas-Normal	-0.598853623722792	0.343564870938718	23.9999999995612	0.0941235380763779	0.248130450375174	nan
sp|Q14112|NID2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0838893540412888	0.343564870938718	23.9999999995612	0.80917197543723	0.965774701272009	nan
sp|Q14112|NID2_HUMAN	Normal-Triple-negative breast cancer	0.682742977764081	0.410638562908234	23.9999999995176	0.109391977210658	0.256250128434269	nan
sp|Q14116|IL18_HUMAN	metaplastic breast carcinomas-Normal	0.14799430850748	0.435466113747764	24.0000000000001	0.73692386053599	0.854389575312742	nan
sp|Q14116|IL18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.187570378019345	0.435466113747764	24.0000000000011	0.67050503044609	0.946277260710207	nan
sp|Q14116|IL18_HUMAN	Normal-Triple-negative breast cancer	-0.335564686526825	0.520481557546993	24.0000000000123	0.525224121853908	0.695444310582923	nan
sp|Q14126|DSG2_HUMAN	metaplastic breast carcinomas-Normal	0.0162305654928661	0.44452522532464	21.9999915176344	0.97120328419404	0.986271470952795	nan
sp|Q14126|DSG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.376575189448222	0.44452522532464	21.9999915157002	0.406038701215566	0.885297496092956	nan
sp|Q14126|DSG2_HUMAN	Normal-Triple-negative breast cancer	-0.392805754941088	0.531309266878827	21.9999915176454	0.467530581864013	0.646990696967518	nan
sp|Q14134|TRI29_HUMAN	metaplastic breast carcinomas-Normal	0.281211833951985	0.742175090730276	23.9999999995748	0.708091859487916	0.834456481451765	nan
sp|Q14134|TRI29_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.20847632886478	0.742175090730276	23.9999999993411	0.781195187762592	0.9619617480679	nan
sp|Q14134|TRI29_HUMAN	Normal-Triple-negative breast cancer	-0.0727355050872044	0.887068901576176	23.9999999995157	0.935330436421105	0.963445420100326	nan
sp|Q14137|BOP1_HUMAN	metaplastic breast carcinomas-Normal	-0.0371144814824197	0.520659377574049	13.4858537607135	0.944218359536491	0.971095862345079	nan
sp|Q14137|BOP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.329711590005874	0.371445414877546	13.0842267166332	0.390757203267013	0.885234295852111	nan
sp|Q14137|BOP1_HUMAN	Normal-Triple-negative breast cancer	0.366826071488294	0.575710478214045	13.3234434100838	0.534809452639888	0.702867070999919	nan
sp|Q14139|UBE4A_HUMAN	metaplastic breast carcinomas-Normal	0.141562177603683	0.219582319119648	21.9999998598757	0.525795137820477	0.703883623888549	nan
sp|Q14139|UBE4A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.482613290438395	0.219582319119648	21.9999998599655	0.0387777312750372	0.738255867002113	nan
sp|Q14139|UBE4A_HUMAN	Normal-Triple-negative breast cancer	-0.624175468042078	0.262451069915798	21.9999998599895	0.0265047612957291	0.108975739784405	nan
sp|Q14141|SEPT6_HUMAN	metaplastic breast carcinomas-Normal	0.088212124898366	0.403876206168964	21.9999999971322	0.829120096760491	0.909492232445857	nan
sp|Q14141|SEPT6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0971775283636883	0.403876206168964	21.9999999969242	0.812083796396495	0.965774701272009	nan
sp|Q14141|SEPT6_HUMAN	Normal-Triple-negative breast cancer	-0.185389653262054	0.482724396242582	21.9999999970365	0.704629214313477	0.826751679625131	nan
sp|Q14151|SAFB2_HUMAN	metaplastic breast carcinomas-Normal	0.567036552740636	0.191814527664151	21.9999996887699	0.0072981459769099	0.0569409545030814	nan
sp|Q14151|SAFB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.280895968446013	0.191814527664151	21.9999996884211	0.15722521335364	0.843662073010871	nan
sp|Q14151|SAFB2_HUMAN	Normal-Triple-negative breast cancer	-0.847932521186649	0.229262211150157	21.9999996884442	0.0012545377084329	0.0266490250684039	nan
sp|Q14152|EIF3A_HUMAN	metaplastic breast carcinomas-Normal	0.418617644900587	0.151366774160837	21.9999999722876	0.011282066911373	0.0705294023488664	nan
sp|Q14152|EIF3A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0114898128379087	0.151366774160837	21.9999999712271	0.940179066812461	0.995571782532303	nan
sp|Q14152|EIF3A_HUMAN	Normal-Triple-negative breast cancer	-0.430107457738496	0.18091789897969	21.9999999714829	0.0265554600557666	0.108975739784405	nan
sp|Q14155|ARHG7_HUMAN	metaplastic breast carcinomas-Normal	0.0729082380359237	0.26529998560563	22.000000034913	0.786023167849688	0.883153569547624	nan
sp|Q14155|ARHG7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0812912833808973	0.26529998560563	22.0000000352847	0.762171550837276	0.955228196959647	nan
sp|Q14155|ARHG7_HUMAN	Normal-Triple-negative breast cancer	-0.154199521416821	0.317094132851852	22.0000000353063	0.631570897788451	0.779314007614477	nan
sp|Q14157|UBP2L_HUMAN	metaplastic breast carcinomas-Normal	0.893550998699968	0.325332067694873	23.9999999998447	0.0112361142813553	0.0705294023488664	nan
sp|Q14157|UBP2L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.268227625287451	0.325332067694873	23.9999999998447	0.41778977977297	0.8860071777014	nan
sp|Q14157|UBP2L_HUMAN	Normal-Triple-negative breast cancer	-1.16177862398742	0.388846194842826	23.9999999999174	0.0063887617490052	0.0509262447330776	nan
sp|Q14160|SCRIB_HUMAN	metaplastic breast carcinomas-Normal	-0.258394711569138	0.294724058871567	6.0	0.414351195083094	0.615740710196163	nan
sp|Q14160|SCRIB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.184257262928662	0.294724058871567	6.0	0.554865849801104	0.931642387063667	nan
sp|Q14160|SCRIB_HUMAN	Normal-Triple-negative breast cancer	0.0741374486404753	0.352262627022452	6.0	0.840273373758115	0.90861050565126	nan
sp|Q14165|MLEC_HUMAN	metaplastic breast carcinomas-Normal	0.199173036748231	0.144876729337014	22.0000000341032	0.183042652895292	0.373730822004884	nan
sp|Q14165|MLEC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.136813146176231	0.144876729337014	22.0000000339468	0.355251532680279	0.878877489703816	nan
sp|Q14165|MLEC_HUMAN	Normal-Triple-negative breast cancer	-0.0623598905719996	0.173160811730395	22.00000003402	0.722186443965826	0.839810061841149	nan
sp|Q14166|TTL12_HUMAN	metaplastic breast carcinomas-Normal	-0.0734581310166856	0.264916747829413	14.9999999996868	0.785344234545927	0.882815094903842	nan
sp|Q14166|TTL12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.412524951911772	0.264916747829413	14.9999999994882	0.140270450748414	0.823891816737944	nan
sp|Q14166|TTL12_HUMAN	Normal-Triple-negative breast cancer	-0.339066820895086	0.316636076097539	14.9999999996157	0.301169497600515	0.494120143151091	nan
sp|Q14185|DOCK1_HUMAN	metaplastic breast carcinomas-Normal	-0.319334608122287	0.172820895657977	22.0000000150562	0.0781249135602725	0.220260570546519	nan
sp|Q14185|DOCK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.117389070344393	0.172820895657977	22.0000000155075	0.504062066886514	0.913320451076758	nan
sp|Q14185|DOCK1_HUMAN	Normal-Triple-negative breast cancer	0.43672367846668	0.206560478781208	22.0000000154175	0.0460589012094254	0.147211334250125	nan
sp|Q14194|DPYL1_HUMAN	metaplastic breast carcinomas-Normal	0.112561888333917	0.724269702228984	14.0000000100391	0.878713230780984	0.936980460800664	nan
sp|Q14194|DPYL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.742399687431987	0.724269702228984	14.0000000099275	0.322734095737985	0.867696529950794	nan
sp|Q14194|DPYL1_HUMAN	Normal-Triple-negative breast cancer	-0.854961575765904	0.865667868978184	14.0000000099862	0.340095390858986	0.532239679479882	nan
sp|Q14195|DPYL3_HUMAN	metaplastic breast carcinomas-Normal	0.211770021884887	0.371033405187841	22.0000003234628	0.573948479795851	0.736604149359617	nan
sp|Q14195|DPYL3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.179341679599431	0.371033405187841	22.0000003231358	0.633617907047069	0.941868024951375	nan
sp|Q14195|DPYL3_HUMAN	Normal-Triple-negative breast cancer	-0.391111701484318	0.443469740899268	22.0000003238431	0.387346390256579	0.574833537967588	nan
sp|Q14197|ICT1_HUMAN	metaplastic breast carcinomas-Normal	0.28877496632311	0.286837846320624	14.9999999998254	0.33001855177149	0.538565069064444	nan
sp|Q14197|ICT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.310262948659997	0.286837846320624	14.9999999998494	0.296484244404441	0.867696529950794	nan
sp|Q14197|ICT1_HUMAN	Normal-Triple-negative breast cancer	-0.599037914983107	0.342836800162272	14.9999999998814	0.101020880542336	0.244442731665984	nan
sp|Q14203|DCTN1_HUMAN	metaplastic breast carcinomas-Normal	0.0008141758453073	0.138565588957533	23.9999999995215	0.995360430491628	0.996859918937684	nan
sp|Q14203|DCTN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.136187653154653	0.138565588957533	23.9999999994817	0.335491619120012	0.870890600099115	nan
sp|Q14203|DCTN1_HUMAN	Normal-Triple-negative breast cancer	0.135373477309346	0.165617556191313	23.9999999995219	0.421748570121797	0.608196202639849	nan
sp|Q14204|DYHC1_HUMAN	metaplastic breast carcinomas-Normal	0.0920309792314775	0.11284156851961	21.999999833079	0.423484614934356	0.621951157325291	nan
sp|Q14204|DYHC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.216581277382719	0.11284156851961	21.9999998348408	0.0680046851847607	0.777898601552022	nan
sp|Q14204|DYHC1_HUMAN	Normal-Triple-negative breast cancer	-0.308612256614197	0.134871471016806	21.9999998338631	0.0320991042833852	0.120560933789297	nan
sp|Q14210|LY6D_HUMAN	metaplastic breast carcinomas-Normal	-0.756104546554333	1.08618421867057	9.00000000003204	0.503937856613	0.688770327048361	nan
sp|Q14210|LY6D_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.22362130478915	0.934838531072093	9.00000000003194	0.22299671693116	0.843662073010871	nan
sp|Q14210|LY6D_HUMAN	Normal-Triple-negative breast cancer	1.97972585134348	1.23667513460884	9.00000000006466	0.14387521521196	0.307748529835621	nan
sp|Q14232|EI2BA_HUMAN	metaplastic breast carcinomas-Normal	0.454226782223619	0.20927274970525	13.9999999963419	0.0476594157324247	0.164677648539064	nan
sp|Q14232|EI2BA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.168485022443204	0.20927274970525	13.9999999973739	0.434224165586171	0.896102083258464	nan
sp|Q14232|EI2BA_HUMAN	Normal-Triple-negative breast cancer	-0.622711804666823	0.250128777601791	13.9999999974336	0.0259850642648874	0.107297333685075	nan
sp|Q14240|IF4A2_HUMAN	metaplastic breast carcinomas-Normal	-0.0215043052429019	0.322734747749107	23.9999999996927	0.947427028183178	0.972567428615729	nan
sp|Q14240|IF4A2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.475919077106906	0.322734747749107	23.9999999996927	0.153306278037979	0.843465960034572	nan
sp|Q14240|IF4A2_HUMAN	Normal-Triple-negative breast cancer	-0.454414771864004	0.385741803736051	23.9999999996927	0.250334656585882	0.439573374797396	nan
sp|Q14241|ELOA1_HUMAN	metaplastic breast carcinomas-Normal	-0.0121746155973774	0.345566484766201	15.0000000001556	0.97236019497392	0.986686483715501	nan
sp|Q14241|ELOA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.176923970884355	0.345566484766201	15.000000000155	0.616118115238716	0.941374262616245	nan
sp|Q14241|ELOA1_HUMAN	Normal-Triple-negative breast cancer	0.189098586481732	0.413030949019681	15.000000000155	0.653635486775158	0.79700780333508	nan
sp|Q14244|MAP7_HUMAN	metaplastic breast carcinomas-Normal	0.202515402013975	0.557911339901959	12.0343202104632	0.722909104948385	0.846109107340998	nan
sp|Q14244|MAP7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.27369706538777	0.50190770743928	12.0106498386688	0.0260326891066983	0.721684569712558	nan
sp|Q14244|MAP7_HUMAN	Normal-Triple-negative breast cancer	-1.47621246740174	0.640459150816772	12.0583222283972	0.0397436872184682	0.133712567119624	nan
sp|Q14247|SRC8_HUMAN	metaplastic breast carcinomas-Normal	0.500531734658009	0.317744200304925	21.9999745130081	0.129467116302529	0.300387589308908	nan
sp|Q14247|SRC8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.733442173953212	0.317744200304925	21.9999744996632	0.0307650624343015	0.721684569712558	nan
sp|Q14247|SRC8_HUMAN	Normal-Triple-negative breast cancer	-1.23397390861122	0.379776958654524	21.9999744955199	0.0036790366022653	0.0400819560687694	nan
sp|Q14254|FLOT2_HUMAN	metaplastic breast carcinomas-Normal	0.104924267042752	0.241025588484836	22.0000000410303	0.66756813613276	0.805151119196406	nan
sp|Q14254|FLOT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.190126435151536	0.241025588484836	22.000000041543	0.438634209967131	0.897513075778899	nan
sp|Q14254|FLOT2_HUMAN	Normal-Triple-negative breast cancer	0.0852021681087839	0.288080678938734	22.000000041536	0.770188477056944	0.869306111286004	nan
sp|Q14257|RCN2_HUMAN	metaplastic breast carcinomas-Normal	1.34497931106967	0.364753980308543	21.0392543225312	0.001365246748235	0.0273378324767058	nan
sp|Q14257|RCN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.251608646850387	0.364753980308543	21.0392543229642	0.497856439365211	0.913320451076758	nan
sp|Q14257|RCN2_HUMAN	Normal-Triple-negative breast cancer	-1.09337066421928	0.431303120346015	21.0217181621655	0.019250725211143	0.0904418632943601	nan
sp|Q14258|TRI25_HUMAN	metaplastic breast carcinomas-Normal	0.196470170771928	0.156257487744962	23.9999999997673	0.220725552511365	0.418773822230466	nan
sp|Q14258|TRI25_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.159568361074647	0.156257487744962	23.9999999999654	0.317349155864686	0.867696529950794	nan
sp|Q14258|TRI25_HUMAN	Normal-Triple-negative breast cancer	-0.356038531846574	0.186763419775497	23.9999999998747	0.0686463648280179	0.1898340405061	nan
sp|Q14314|FGL2_HUMAN	metaplastic breast carcinomas-Normal	-0.609636985905455	0.460113283071491	23.9999999998377	0.197657971001814	0.390383301016061	nan
sp|Q14314|FGL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.188026314510915	0.460113283071491	23.9999999998367	0.686418374242895	0.946568877415162	nan
sp|Q14314|FGL2_HUMAN	Normal-Triple-negative breast cancer	0.79766330041637	0.54994055946182	23.9999999998067	0.15987682782647	0.329864241010448	nan
sp|Q14315|FLNC_HUMAN	metaplastic breast carcinomas-Normal	-0.136881780935531	0.25769266682741	21.9999999402655	0.600614867916234	0.758239202792846	nan
sp|Q14315|FLNC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.167370477675058	0.25769266682741	21.9999999422039	0.522741550829568	0.917607105199968	nan
sp|Q14315|FLNC_HUMAN	Normal-Triple-negative breast cancer	0.304252258610589	0.308001647807797	21.9999999420294	0.333978096379062	0.526883118079721	nan
sp|Q14318|FKBP8_HUMAN	metaplastic breast carcinomas-Normal	-0.636794196351081	0.58479567038936	6.0	0.31798245747184	0.525596065955444	nan
sp|Q14318|FKBP8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.483108330724768	0.58479567038936	6.0	0.44034480734885	0.89755436380139	nan
sp|Q14318|FKBP8_HUMAN	Normal-Triple-negative breast cancer	1.11990252707585	0.698964515864249	6.0	0.160224389173484	0.329864241010448	nan
sp|Q14320|FA50A_HUMAN	metaplastic breast carcinomas-Normal	-0.110870002841866	0.549924291597357	6.0	0.846883464632654	0.919046894038178	nan
sp|Q14320|FA50A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.7772576149033	0.549924291597357	6.0	0.20726162870215	0.843662073010871	nan
sp|Q14320|FA50A_HUMAN	Normal-Triple-negative breast cancer	-0.666387612061434	0.657285246285111	6.0	0.349780081251076	0.540621525911544	nan
sp|Q14344|GNA13_HUMAN	metaplastic breast carcinomas-Normal	-0.268863409206528	0.411299710107497	21.0183928406672	0.520398344142903	0.701746083541992	nan
sp|Q14344|GNA13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.224024479613248	0.411299710107497	21.0183928413124	0.591710110470869	0.940559810632461	nan
sp|Q14344|GNA13_HUMAN	Normal-Triple-negative breast cancer	0.492887888819775	0.486293628490296	21.008775648311	0.322324185030627	0.514231959877533	nan
sp|Q14376|GALE_HUMAN	metaplastic breast carcinomas-Normal	0.0859422197143058	0.467304522051811	15.0000000001225	0.856546762728241	0.925605149320115	nan
sp|Q14376|GALE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.479778991216558	0.467304522051811	14.9999999999937	0.320837071575551	0.867696529950794	nan
sp|Q14376|GALE_HUMAN	Normal-Triple-negative breast cancer	-0.565721210930864	0.558535734027659	15.0000000000674	0.327184903870044	0.519619025544207	nan
sp|Q14435|GALT3_HUMAN	metaplastic breast carcinomas-Normal	0.285169638516153	0.256823650605377	6.0	0.309345544848841	0.516975661678003	nan
sp|Q14435|GALT3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.725334282032165	0.256823650605377	6.0	0.030184991905885	0.721684569712558	nan
sp|Q14435|GALT3_HUMAN	Normal-Triple-negative breast cancer	-1.01050392054832	0.306962974757247	6.0	0.0165736218422757	0.0827187973028894	nan
sp|Q14444|CAPR1_HUMAN	metaplastic breast carcinomas-Normal	0.471496757403823	0.441372717484227	23.9999999993399	0.296035019801284	0.50026456828646	nan
sp|Q14444|CAPR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.686920565695338	0.441372717484227	23.9999999993399	0.132719894327325	0.823891816737944	nan
sp|Q14444|CAPR1_HUMAN	Normal-Triple-negative breast cancer	-1.15841732309916	0.527541299316815	23.9999999993513	0.0380054666120524	0.130371693517505	nan
sp|Q14498|RBM39_HUMAN	metaplastic breast carcinomas-Normal	0.587779177325732	0.214623596814934	24.0000000000787	0.011443453639522	0.070702676389909	nan
sp|Q14498|RBM39_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.264750776341464	0.214623596814934	24.0000000000787	0.229312367822354	0.843662073010871	nan
sp|Q14498|RBM39_HUMAN	Normal-Triple-negative breast cancer	-0.852529953667196	0.256524263151459	24.0000000001013	0.0028446586005937	0.0360167542953178	nan
sp|Q14517|FAT1_HUMAN	metaplastic breast carcinomas-Normal	1.23336921161531	0.418023084814307	6.0	0.0255969783844076	0.11269451145665	nan
sp|Q14517|FAT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.370496121887952	0.418023084814307	6.0	0.409567474764693	0.885784822958391	nan
sp|Q14517|FAT1_HUMAN	Normal-Triple-negative breast cancer	-0.862873089727359	0.499633150332278	6.0	0.134910641740165	0.294691901039905	nan
sp|Q14520|HABP2_HUMAN	metaplastic breast carcinomas-Normal	-0.562659412113375	0.68087927427909	14.0000000049632	0.422453810680342	0.621951157325291	nan
sp|Q14520|HABP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0719386544647689	0.68087927427909	14.0000000049836	0.917354592801003	0.99408739879047	nan
sp|Q14520|HABP2_HUMAN	Normal-Triple-negative breast cancer	0.490720757648607	0.813806388121208	14.0000000050379	0.556155350918477	0.719883328058029	nan
sp|Q14554|PDIA5_HUMAN	metaplastic breast carcinomas-Normal	0.55308764109079	0.279161292500013	22.0000001561066	0.0601983200862848	0.188054227556203	nan
sp|Q14554|PDIA5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.274814698576885	0.279161292500013	22.0000001568645	0.335607646812369	0.870890600099115	nan
sp|Q14554|PDIA5_HUMAN	Normal-Triple-negative breast cancer	-0.278272942513906	0.333661563414783	22.0000001563493	0.413246594392619	0.60128493320689	nan
sp|Q14566|MCM6_HUMAN	metaplastic breast carcinomas-Normal	0.708148806947608	0.411769107168082	21.9999999572221	0.0995131111162325	0.254814544560358	nan
sp|Q14566|MCM6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0266534733246332	0.411769107168082	21.9999999572147	0.948974214837656	0.996541950781621	nan
sp|Q14566|MCM6_HUMAN	Normal-Triple-negative breast cancer	-0.734802280272241	0.492158217327371	21.9999999571211	0.149635410793319	0.316920285343583	nan
sp|Q14571|ITPR2_HUMAN	metaplastic breast carcinomas-Normal	0.0137907749275731	0.305990205797969	22.0000000333044	0.96445863905989	0.982981891035447	nan
sp|Q14571|ITPR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.291337866168078	0.305990205797969	22.0000000340575	0.351382969877399	0.875167321979289	nan
sp|Q14571|ITPR2_HUMAN	Normal-Triple-negative breast cancer	0.277547091240505	0.365728248145851	22.0000000337933	0.455973433367958	0.63843963458934	nan
sp|Q14573|ITPR3_HUMAN	metaplastic breast carcinomas-Normal	0.465011818385225	0.31045337185883	23.9999999990157	0.147210968176442	0.324919826174297	nan
sp|Q14573|ITPR3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.565069861857174	0.31045337185883	23.9999999990157	0.0812320053723257	0.806849600316436	nan
sp|Q14573|ITPR3_HUMAN	Normal-Triple-negative breast cancer	-1.0300816802424	0.371062751910002	23.9999999990292	0.0104967544707033	0.0653269336960234	nan
sp|Q14574|DSC3_HUMAN	metaplastic breast carcinomas-Normal	-0.958144057741487	0.473422157671531	22.0000000197232	0.0552959024819714	0.179470650068388	nan
sp|Q14574|DSC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.303893549862911	0.473422157671531	22.0000000197203	0.527565310033711	0.918405578985386	nan
sp|Q14574|DSC3_HUMAN	Normal-Triple-negative breast cancer	1.2620376076044	0.565847707141832	22.0000000199498	0.0362428721668427	0.126678556343412	nan
sp|Q14624|ITIH4_HUMAN	metaplastic breast carcinomas-Normal	-0.892261082861725	0.325168637747623	23.9999999997282	0.0113033469844856	0.0705294023488664	nan
sp|Q14624|ITIH4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.182447831938764	0.325168637747623	23.9999999997282	0.57993995691854	0.93702592209822	nan
sp|Q14624|ITIH4_HUMAN	Normal-Triple-negative breast cancer	1.07470891480049	0.388650858694251	23.9999999996587	0.0107624245357397	0.0663669646889177	nan
sp|Q14643|ITPR1_HUMAN	metaplastic breast carcinomas-Normal	-0.269311726140965	0.784210018387878	20.9928623670748	0.734699604616704	0.852107985256777	nan
sp|Q14643|ITPR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.07391248055291	0.784210018387878	20.9928623664921	0.185341001913001	0.843662073010871	nan
sp|Q14643|ITPR1_HUMAN	Normal-Triple-negative breast cancer	1.34322420669387	0.927532071258205	20.9530903304833	0.162368963033491	0.332141436375708	nan
sp|Q14669|TRIPC_HUMAN	metaplastic breast carcinomas-Normal	0.652966509470268	0.204357748930197	23.9999999992366	0.0038854464938135	0.0416809642918909	nan
sp|Q14669|TRIPC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.180052398517617	0.204357748930197	23.9999999994671	0.387021319442316	0.885234295852111	nan
sp|Q14669|TRIPC_HUMAN	Normal-Triple-negative breast cancer	-0.472914110952651	0.244254228060547	23.9999999993729	0.0647113423436264	0.1846356239916	nan
sp|Q14671|PUM1_HUMAN	metaplastic breast carcinomas-Normal	0.171534178153439	0.639088794418419	14.9999999994179	0.792044315584589	0.887345906640773	nan
sp|Q14671|PUM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.417091067143742	0.639088794418419	14.9999999995363	0.523869092136337	0.918220733449299	nan
sp|Q14671|PUM1_HUMAN	Normal-Triple-negative breast cancer	0.245556888990302	0.763857210993921	14.9999999994917	0.752290454385529	0.857843386064322	nan
sp|Q14677|EPN4_HUMAN	metaplastic breast carcinomas-Normal	0.595886469346202	0.208094617871701	23.9999999994338	0.00856200086383	0.060872418046307	nan
sp|Q14677|EPN4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.008746127851839	0.208094617871701	23.9999999994338	0.96682283520822	0.99709406933403	nan
sp|Q14677|EPN4_HUMAN	Normal-Triple-negative breast cancer	-0.604632597198041	0.248720640728765	23.9999999994486	0.0228989686596384	0.100417113225116	nan
sp|Q14678|KANK1_HUMAN	metaplastic breast carcinomas-Normal	-0.641343058278778	0.715603664444228	13.0150598666359	0.386408524574972	0.590538821005613	nan
sp|Q14678|KANK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.751363505265151	0.715603664444228	13.0150598674901	0.312837368754687	0.867696529950794	nan
sp|Q14678|KANK1_HUMAN	Normal-Triple-negative breast cancer	1.39270656354393	0.841441863233018	13.0000000145806	0.121823186286878	0.275095292946727	nan
sp|Q14683|SMC1A_HUMAN	metaplastic breast carcinomas-Normal	0.654932807609383	0.211620444926784	22.0000000915007	0.0052884319369626	0.0480293654602841	nan
sp|Q14683|SMC1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.133798980638695	0.211620444926784	22.0000000908621	0.533733868155282	0.921388505638487	nan
sp|Q14683|SMC1A_HUMAN	Normal-Triple-negative breast cancer	-0.521133826970688	0.252934810096565	22.0000000909824	0.0513856463842751	0.159333851288554	nan
sp|Q14684|RRP1B_HUMAN	metaplastic breast carcinomas-Normal	0.354041565261029	0.311849994470006	21.9999926832612	0.268469743693721	0.471168652607142	nan
sp|Q14684|RRP1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.526586919388498	0.311849994470006	21.9999926782155	0.105423953633359	0.822178316735448	nan
sp|Q14684|RRP1B_HUMAN	Normal-Triple-negative breast cancer	-0.880628484649527	0.372732035211324	21.999992680213	0.0274058287574808	0.111013441319332	nan
sp|Q14686|NCOA6_HUMAN	metaplastic breast carcinomas-Normal	0.0791284373957221	0.2249890402398	20.2711373131179	0.728693464021359	0.849886692774385	nan
sp|Q14686|NCOA6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0553682635841065	0.2249890402398	20.2711373127813	0.808084808732552	0.965774701272009	nan
sp|Q14686|NCOA6_HUMAN	Normal-Triple-negative breast cancer	-0.134496700979829	0.262718740663139	20.0903312383754	0.614273417769428	0.764161617174263	nan
sp|Q14690|RRP5_HUMAN	metaplastic breast carcinomas-Normal	0.663335757842984	0.220173002861459	22.000000022109	0.0064018584667381	0.0525426606010802	nan
sp|Q14690|RRP5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0573200353006939	0.220173002861459	22.0000000224343	0.797022016420801	0.965774701272009	nan
sp|Q14690|RRP5_HUMAN	Normal-Triple-negative breast cancer	-0.720655793143678	0.263157072023079	22.0000000223233	0.0119936364977328	0.0705000316960767	nan
sp|Q14692|BMS1_HUMAN	metaplastic breast carcinomas-Normal	0.276572140288204	0.268841364601842	23.9999999994208	0.313851469235861	0.520961847459193	nan
sp|Q14692|BMS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.124135713048416	0.268841364601842	23.9999999991968	0.648423469682973	0.943315325604231	nan
sp|Q14692|BMS1_HUMAN	Normal-Triple-negative breast cancer	-0.40070785333662	0.321326890344621	23.9999999992756	0.224415437968251	0.407158932437803	nan
sp|Q14694|UBP10_HUMAN	metaplastic breast carcinomas-Normal	0.17284116328998	0.238201991024045	14.9999999999115	0.479248205133102	0.66877457340992	nan
sp|Q14694|UBP10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0829248222375661	0.238201991024045	14.9999999999115	0.732581411713022	0.954643368861838	nan
sp|Q14694|UBP10_HUMAN	Normal-Triple-negative breast cancer	-0.0899163410524135	0.284705834472353	14.9999999999063	0.756489400457771	0.859388505509785	nan
sp|Q14696|MESD_HUMAN	metaplastic breast carcinomas-Normal	0.878786539391817	0.208014444978212	22.0000000047847	0.0003485711032306	0.0175553082899795	nan
sp|Q14696|MESD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.00989972728485	0.208014444978212	22.0000000051126	0.962471175080256	0.99709406933403	nan
sp|Q14696|MESD_HUMAN	Normal-Triple-negative breast cancer	-0.888686266676667	0.248624815792774	22.0000000048575	0.0016926703370361	0.0289979437553501	nan
sp|Q14697|GANAB_HUMAN	metaplastic breast carcinomas-Normal	0.320010717663903	0.163778166205852	23.9999999991062	0.0624594576707235	0.191703820219284	nan
sp|Q14697|GANAB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.057405632957177	0.163778166205852	23.9999999992552	0.729014922952429	0.954643368861838	nan
sp|Q14697|GANAB_HUMAN	Normal-Triple-negative breast cancer	-0.37741635062108	0.195752349833558	23.9999999992047	0.0657644092065539	0.185885115818525	nan
sp|Q14699|RFTN1_HUMAN	metaplastic breast carcinomas-Normal	-0.477483862852184	0.203346149830052	22.0000000004533	0.0282672026734728	0.120153685021258	nan
sp|Q14699|RFTN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.161886185752071	0.203346149830052	22.0000000000344	0.434474244484375	0.896102083258464	nan
sp|Q14699|RFTN1_HUMAN	Normal-Triple-negative breast cancer	0.315597677100113	0.243045135874876	22.0000000005785	0.207557765204263	0.389436459261568	nan
sp|Q14738|2A5D_HUMAN	metaplastic breast carcinomas-Normal	-0.0781145050592803	0.273452495616939	22.9999999995383	0.777695249185622	0.879570945319159	nan
sp|Q14738|2A5D_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.444577744285819	0.255791387539222	22.9999999996097	0.0955750015088993	0.814943337126966	nan
sp|Q14738|2A5D_HUMAN	Normal-Triple-negative breast cancer	-0.366463239226538	0.320651473751184	22.9999999995837	0.26484967726738	0.45561224315785	nan
sp|Q14739|LBR_HUMAN	metaplastic breast carcinomas-Normal	0.344074711079418	0.288476534748154	23.9999999995504	0.244634067734518	0.444727514478219	nan
sp|Q14739|LBR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.316242610963383	0.288476534748154	23.9999999995504	0.283847785855919	0.867696529950794	nan
sp|Q14739|LBR_HUMAN	Normal-Triple-negative breast cancer	-0.6603173220428	0.344795407452641	23.999999999564	0.0674712013747943	0.187677216209051	nan
sp|Q14764|MVP_HUMAN	metaplastic breast carcinomas-Normal	0.128261091655033	0.353014273262255	21.9999999687888	0.719825417774167	0.843892572513791	nan
sp|Q14764|MVP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.121148195006471	0.353014273262255	21.9999999687765	0.73471919061387	0.954643368861838	nan
sp|Q14764|MVP_HUMAN	Normal-Triple-negative breast cancer	-0.0071128966485621	0.421932758906437	21.9999999700567	0.986701938398648	0.99327596706151	nan
sp|Q14766|LTBP1_HUMAN	metaplastic breast carcinomas-Normal	0.523323458506687	0.314981766970328	21.9999999573932	0.110810636339461	0.273448073639471	nan
sp|Q14766|LTBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.345405742620475	0.314981766970328	21.9999999559344	0.284679677433199	0.867696529950794	nan
sp|Q14766|LTBP1_HUMAN	Normal-Triple-negative breast cancer	-0.177917715886212	0.376475219301636	21.9999999559487	0.641161675961529	0.787591060937221	nan
sp|Q14767|LTBP2_HUMAN	metaplastic breast carcinomas-Normal	0.430169142812604	0.336483661135718	23.9999999996981	0.213325097915538	0.409674038476981	nan
sp|Q14767|LTBP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.68256450650609	0.336483661135718	23.9999999996981	0.0537430705176105	0.773286317778246	nan
sp|Q14767|LTBP2_HUMAN	Normal-Triple-negative breast cancer	-1.11273364931869	0.402174898362989	23.9999999997941	0.0107236492092775	0.0663669646889177	nan
sp|Q14789|GOGB1_HUMAN	metaplastic breast carcinomas-Normal	0.188008727146719	0.144103934577096	23.9999999995286	0.204376285726909	0.39844385557551	nan
sp|Q14789|GOGB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0744888364432398	0.144103934577096	23.9999999997223	0.609949732276074	0.940559810632461	nan
sp|Q14789|GOGB1_HUMAN	Normal-Triple-negative breast cancer	-0.113519890703479	0.172237145324197	23.9999999996214	0.516112094954261	0.689290039346968	nan
sp|Q14814|MEF2D_HUMAN	metaplastic breast carcinomas-Normal	0.37630678042992	0.447089697009448	14.9999999997342	0.413184819129481	0.615610192194709	nan
sp|Q14814|MEF2D_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.242445320300885	0.447089697009448	14.9999999997348	0.595594565147517	0.940559810632461	nan
sp|Q14814|MEF2D_HUMAN	Normal-Triple-negative breast cancer	-0.133861460129035	0.534374396804338	14.9999999997334	0.805598429211133	0.88801979396181	nan
sp|Q14839|CHD4_HUMAN	metaplastic breast carcinomas-Normal	0.825118942152064	0.227984879443726	22.0000000888576	0.0015195559716648	0.0281210167842065	nan
sp|Q14839|CHD4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.115901497589583	0.227984879443726	22.0000000889614	0.616251393596198	0.941374262616245	nan
sp|Q14839|CHD4_HUMAN	Normal-Triple-negative breast cancer	-0.941020439741647	0.272494050406793	22.0000000888436	0.0022634337398285	0.0323283073620821	nan
sp|Q14847|LASP1_HUMAN	metaplastic breast carcinomas-Normal	0.0909442841372122	0.247999632501493	21.9999999585635	0.717337759860852	0.842257405078584	nan
sp|Q14847|LASP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.139156107722273	0.247999632501493	21.9999999583105	0.580390728493408	0.93702592209822	nan
sp|Q14847|LASP1_HUMAN	Normal-Triple-negative breast cancer	-0.230100391859485	0.2964162558702	21.9999999582041	0.445852944067775	0.630199679288687	nan
sp|Q14894|CRYM_HUMAN	metaplastic breast carcinomas-Normal	1.08649025891594	0.984595214731162	15.0000000000326	0.287203743577183	0.49083045946044	nan
sp|Q14894|CRYM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.852133339354798	0.984595214731162	15.0000000000326	0.400413975173621	0.885297496092956	nan
sp|Q14894|CRYM_HUMAN	Normal-Triple-negative breast cancer	-0.234356919561144	1.17681636926042	15.0000000000276	0.844823732835766	0.911630088050377	nan
sp|Q14914|PTGR1_HUMAN	metaplastic breast carcinomas-Normal	-0.642301041663641	0.262149492456119	22.0000000198833	0.0227012146850895	0.103937792855699	nan
sp|Q14914|PTGR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0646555775740577	0.262149492456119	22.0000000204574	0.807476525314062	0.965774701272009	nan
sp|Q14914|PTGR1_HUMAN	Normal-Triple-negative breast cancer	0.706956619237699	0.313328573306044	22.0000000203216	0.0343284890036894	0.124196152475544	nan
sp|Q14938|NFIX_HUMAN	metaplastic breast carcinomas-Normal	0.138991704284218	0.330755430032588	22.999999999655	0.678221071336207	0.812106210778657	nan
sp|Q14938|NFIX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0133455414378631	0.309393374499256	22.9999999997684	0.965966576783309	0.99709406933403	nan
sp|Q14938|NFIX_HUMAN	Normal-Triple-negative breast cancer	-0.125646162846355	0.387845120418007	22.9999999997784	0.748896180525942	0.856006830048239	nan
sp|Q14966|ZN638_HUMAN	metaplastic breast carcinomas-Normal	0.657629666650454	0.218361004132673	23.9999999992052	0.0060360364307442	0.0510320974930049	nan
sp|Q14966|ZN638_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.413461237808257	0.218361004132673	23.9999999992052	0.0704119910630407	0.7829758433102	nan
sp|Q14966|ZN638_HUMAN	Normal-Triple-negative breast cancer	-1.07109090445871	0.260991319302357	23.9999999991966	0.0004050728983823	0.0237592699893802	nan
sp|Q14974|IMB1_HUMAN	metaplastic breast carcinomas-Normal	0.636379186219577	0.195006720431792	23.9999999997714	0.0032931187202683	0.0402438478903383	nan
sp|Q14974|IMB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0764366804562011	0.195006720431792	23.9999999997701	0.698539804831632	0.947043345959522	nan
sp|Q14974|IMB1_HUMAN	Normal-Triple-negative breast cancer	-0.559942505763376	0.233077611272552	23.99999999979	0.024382139997464	0.104306606630078	nan
sp|Q14978|NOLC1_HUMAN	metaplastic breast carcinomas-Normal	0.909831400536094	0.328326967750791	23.9999999995031	0.0106169197219445	0.0685255168072687	nan
sp|Q14978|NOLC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0866990534852542	0.328326967750791	23.9999999995022	0.793985540853129	0.964213712979656	nan
sp|Q14978|NOLC1_HUMAN	Normal-Triple-negative breast cancer	-0.823132347050839	0.392425785071756	23.9999999995369	0.0466569957916883	0.148213884710877	nan
sp|Q14980|NUMA1_HUMAN	metaplastic breast carcinomas-Normal	0.246771775968272	0.175363113946195	23.9999999994691	0.172186183961569	0.360525616455081	nan
sp|Q14980|NUMA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.774626256202036	0.175363113946195	23.999999999287	0.0001828024806833	0.202606082757421	nan
sp|Q14980|NUMA1_HUMAN	Normal-Triple-negative breast cancer	-1.02139803217031	0.20959901081046	23.9999999993855	5.73536633987315e-05	0.022319699811492	nan
sp|Q14CX7|NAA25_HUMAN	metaplastic breast carcinomas-Normal	0.0521230911250141	0.417101257911842	6.0	0.904632982152643	0.949235187913294	nan
sp|Q14CX7|NAA25_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.23349814479102	0.417101257911842	6.0	0.59587275377323	0.940559810632461	nan
sp|Q14CX7|NAA25_HUMAN	Normal-Triple-negative breast cancer	-0.285621235916034	0.498531356445597	6.0	0.587507454467142	0.743208813016678	nan
sp|Q15005|SPCS2_HUMAN	metaplastic breast carcinomas-Normal	0.45453186666474	0.254691871098433	22.0000000715662	0.0881187681478487	0.238622588769244	nan
sp|Q15005|SPCS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0381709315408758	0.254691871098433	22.0000000712928	0.882231880910616	0.983709256883903	nan
sp|Q15005|SPCS2_HUMAN	Normal-Triple-negative breast cancer	-0.416360935123864	0.304415010901754	22.0000000709884	0.185203627967442	0.362767742701107	nan
sp|Q15006|EMC2_HUMAN	metaplastic breast carcinomas-Normal	0.46017994507636	0.210552062324913	23.9999999997774	0.0388378142981697	0.14488989307196	nan
sp|Q15006|EMC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0793166161671218	0.210552062324913	23.9999999997418	0.709700826111681	0.94948208919602	nan
sp|Q15006|EMC2_HUMAN	Normal-Triple-negative breast cancer	-0.380863328909238	0.251657848645094	23.9999999998009	0.143232390135611	0.306570807991482	nan
sp|Q15007|FL2D_HUMAN	metaplastic breast carcinomas-Normal	0.460302135928366	0.288555658680794	21.1430009376744	0.125509025185785	0.296183334837538	nan
sp|Q15007|FL2D_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.277351694558511	0.243014920703123	20.0042880645125	0.267226081722401	0.866855338270227	nan
sp|Q15007|FL2D_HUMAN	Normal-Triple-negative breast cancer	-0.182950441369856	0.329505979167512	20.9126264925915	0.584630689123748	0.741722294140206	nan
sp|Q15008|PSMD6_HUMAN	metaplastic breast carcinomas-Normal	0.329032319438612	0.164340465239318	24.0000000000841	0.0566944936757816	0.180856523011802	nan
sp|Q15008|PSMD6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0183336454403062	0.164340465239318	24.0000000000841	0.91210091037288	0.99408739879047	nan
sp|Q15008|PSMD6_HUMAN	Normal-Triple-negative breast cancer	-0.347365964878918	0.196424425725357	24.0000000001135	0.0896970660999036	0.226044767032661	nan
sp|Q15019|SEPT2_HUMAN	metaplastic breast carcinomas-Normal	-0.107495517995354	0.2310595291294	22.0000000456009	0.646339929183456	0.790158386910385	nan
sp|Q15019|SEPT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.180502612457141	0.2310595291294	22.0000000449583	0.443013520818062	0.89755436380139	nan
sp|Q15019|SEPT2_HUMAN	Normal-Triple-negative breast cancer	-0.0730070944617865	0.276168959674793	22.0000000453523	0.793965891624799	0.882283347258742	nan
sp|Q15020|SART3_HUMAN	metaplastic breast carcinomas-Normal	0.30298280406704	0.193399066123702	22.0000000310768	0.131475529533268	0.303121430943313	nan
sp|Q15020|SART3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0058926112014243	0.193399066123702	22.0000000312787	0.975968008475765	0.99709406933403	nan
sp|Q15020|SART3_HUMAN	Normal-Triple-negative breast cancer	-0.308875415268465	0.231156096849602	22.0000000312417	0.195134975970392	0.376375401089127	nan
sp|Q15029|U5S1_HUMAN	metaplastic breast carcinomas-Normal	0.637336900700287	0.153171845105568	21.9999993788198	0.0004072709558635	0.0190671641871872	nan
sp|Q15029|U5S1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.153103284950929	0.153171845105568	21.9999993786486	0.328395092121554	0.867975899287892	nan
sp|Q15029|U5S1_HUMAN	Normal-Triple-negative breast cancer	-0.790440185651216	0.183075371414712	21.9999993783562	0.0002777656750433	0.0227914720285933	nan
sp|Q15031|SYLM_HUMAN	metaplastic breast carcinomas-Normal	-0.212845659824675	0.473637790739676	6.0	0.668931100264768	0.806502349394301	nan
sp|Q15031|SYLM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.827678866383467	0.473637790739676	6.0	0.131144444725617	0.823891816737944	nan
sp|Q15031|SYLM_HUMAN	Normal-Triple-negative breast cancer	-0.614833206558792	0.566105437953998	6.0	0.319141455167097	0.511905730194303	nan
sp|Q15036|SNX17_HUMAN	metaplastic breast carcinomas-Normal	-0.177725106566521	0.254739349549783	24.0000000000993	0.492085204014406	0.680970532116522	nan
sp|Q15036|SNX17_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.535497487876496	0.254739349549783	23.9999999998027	0.0462168608578341	0.759166737802103	nan
sp|Q15036|SNX17_HUMAN	Normal-Triple-negative breast cancer	0.713222594443017	0.304471758505136	23.9999999999016	0.0277807997661853	0.111660675239178	nan
sp|Q15042|RB3GP_HUMAN	metaplastic breast carcinomas-Normal	0.0246310781047295	0.248258517834792	22.0000000229258	0.921865728352309	0.95843058885501	nan
sp|Q15042|RB3GP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0235244246692986	0.248258517834792	22.0000000229284	0.925365008691107	0.994822473738689	nan
sp|Q15042|RB3GP_HUMAN	Normal-Triple-negative breast cancer	-0.0011066534354308	0.296725683027096	22.0000000230352	0.9970578687837	0.999945312570918	nan
sp|Q15046|SYK_HUMAN	metaplastic breast carcinomas-Normal	0.618949367364927	0.17450858673734	22.0000000040462	0.0018088521461176	0.0302141936366583	nan
sp|Q15046|SYK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0447602053119453	0.17450858673734	22.0000000040462	0.799953640882906	0.965774701272009	nan
sp|Q15046|SYK_HUMAN	Normal-Triple-negative breast cancer	-0.574189162052981	0.208577655442982	22.0000000036348	0.01161073164649	0.0690412736903982	nan
sp|Q15050|RRS1_HUMAN	metaplastic breast carcinomas-Normal	1.34697150006228	0.254971350267082	21.1326825573175	3.0223780509013e-05	0.007907787651877	nan
sp|Q15050|RRS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0265510468284067	0.237569989269921	20.9549085794324	0.912076584049415	0.99408739879047	nan
sp|Q15050|RRS1_HUMAN	Normal-Triple-negative breast cancer	-1.32042045323387	0.298661591964709	21.0850537552055	0.0002353922937358	0.0227914720285933	nan
sp|Q15052|ARHG6_HUMAN	metaplastic breast carcinomas-Normal	-0.549944332599735	0.467988025303247	14.9999999994122	0.258261894836315	0.460795780158835	nan
sp|Q15052|ARHG6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.267253034360296	0.467988025303247	14.9999999995035	0.576410127941118	0.935847692353991	nan
sp|Q15052|ARHG6_HUMAN	Normal-Triple-negative breast cancer	0.817197366960031	0.559352676668349	14.9999999994614	0.164653767444273	0.334802242417098	nan
sp|Q15054|DPOD3_HUMAN	metaplastic breast carcinomas-Normal	0.204855708329823	0.292923125462578	21.9999937908388	0.49166218466841	0.680970532116522	nan
sp|Q15054|DPOD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.378029946392559	0.292923125462578	21.9999937902346	0.21026112238766	0.843662073010871	nan
sp|Q15054|DPOD3_HUMAN	Normal-Triple-negative breast cancer	-0.582885654722382	0.350110099888521	21.9999937885289	0.110118863569184	0.256866738599276	nan
sp|Q15056|IF4H_HUMAN	metaplastic breast carcinomas-Normal	0.0878734768028821	0.468182998722265	21.9999999994271	0.852839653373944	0.923400328278499	nan
sp|Q15056|IF4H_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.183906741060406	0.401885980432525	21.9999999993432	0.651720478441507	0.944190045212043	nan
sp|Q15056|IF4H_HUMAN	Normal-Triple-negative breast cancer	-0.271780217863288	0.537042731187944	21.999999999368	0.617842502479812	0.767322574351151	nan
sp|Q15057|ACAP2_HUMAN	metaplastic breast carcinomas-Normal	-0.159582521847947	0.192257510026092	14.000000005585	0.420442297541275	0.620624545122429	nan
sp|Q15057|ACAP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.817937338528242	0.192257510026091	14.0000000056123	0.0008013024535182	0.380618665421151	nan
sp|Q15057|ACAP2_HUMAN	Normal-Triple-negative breast cancer	0.977519860376189	0.229791676342579	14.0000000056595	0.0008019941174695	0.0257262735003663	nan
sp|Q15061|WDR43_HUMAN	metaplastic breast carcinomas-Normal	0.548306324423993	0.334149197891966	22.000004649253	0.115038190564501	0.279859636823745	nan
sp|Q15061|WDR43_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0287303884054695	0.334149197891966	22.000004649253	0.932259470204693	0.995359816653149	nan
sp|Q15061|WDR43_HUMAN	Normal-Triple-negative breast cancer	-0.519575936018524	0.399384681106617	22.0000046488615	0.206740277759504	0.388690431715266	nan
sp|Q15063|POSTN_HUMAN	metaplastic breast carcinomas-Normal	1.23553988933975	0.409539167973174	23.9999999999893	0.0059612405344464	0.0508891826339769	nan
sp|Q15063|POSTN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.104143243036776	0.409539167973174	23.9999999999528	0.801434772540848	0.965774701272009	nan
sp|Q15063|POSTN_HUMAN	Normal-Triple-negative breast cancer	-1.13139664630298	0.489492930204542	24.0000000000281	0.029713750206974	0.115653987925037	nan
sp|Q15067|ACOX1_HUMAN	metaplastic breast carcinomas-Normal	0.015548379023014	0.263777255805707	24.0000000002495	0.953483895115935	0.975193989958575	nan
sp|Q15067|ACOX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.127547067718775	0.263777255805707	24.0000000004794	0.633094233884071	0.941868024951375	nan
sp|Q15067|ACOX1_HUMAN	Normal-Triple-negative breast cancer	0.111998688695761	0.315274122630697	24.0000000003045	0.725511175486274	0.841098345877946	nan
sp|Q15075|EEA1_HUMAN	metaplastic breast carcinomas-Normal	-0.411589478434603	0.180682352219934	24.0000000001425	0.031923356641188	0.128466389195289	nan
sp|Q15075|EEA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.335691895134937	0.180682352219934	23.9999999998461	0.0754919515225559	0.795994790325479	nan
sp|Q15075|EEA1_HUMAN	Normal-Triple-negative breast cancer	0.74728137356954	0.215956716575099	24.0000000000016	0.0020320828143277	0.0312748437634516	nan
sp|Q15080|NCF4_HUMAN	metaplastic breast carcinomas-Normal	-0.280370072354765	0.268940889823528	22.0000000232295	0.308502474274459	0.516085669093257	nan
sp|Q15080|NCF4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.410658261646684	0.268940889823528	22.0000000236266	0.141024420341154	0.823891816737944	nan
sp|Q15080|NCF4_HUMAN	Normal-Triple-negative breast cancer	0.691028334001449	0.32144584573693	22.0000000233659	0.0428297444777204	0.14081708273387	nan
sp|Q15084|PDIA6_HUMAN	metaplastic breast carcinomas-Normal	1.17877817804529	0.290730263104084	22.0000000011611	0.0005280314877842	0.0205217420849069	nan
sp|Q15084|PDIA6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.301209802793448	0.290730263104084	22.0000000017751	0.311435348506931	0.867696529950794	nan
sp|Q15084|PDIA6_HUMAN	Normal-Triple-negative breast cancer	-0.877568375251845	0.347489128061316	22.0000000015905	0.0192637903767771	0.0904418632943601	nan
sp|Q15113|PCOC1_HUMAN	metaplastic breast carcinomas-Normal	-0.176550698013747	0.391120146913485	22.0000000417433	0.656121316871661	0.798197290010784	nan
sp|Q15113|PCOC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.731257518905721	0.391120146913485	22.0000000417471	0.0749007923240756	0.795994790325479	nan
sp|Q15113|PCOC1_HUMAN	Normal-Triple-negative breast cancer	0.907808216919468	0.467477989278068	22.00000004202	0.0650587779119379	0.184833656221608	nan
sp|Q15120|PDK3_HUMAN	metaplastic breast carcinomas-Normal	-0.145208273341019	0.239253768290993	21.0712513430234	0.55038735751955	0.722880426895562	nan
sp|Q15120|PDK3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.603808572502467	0.222739931634757	20.9616266920758	0.0131049644280111	0.622485810330526	nan
sp|Q15120|PDK3_HUMAN	Normal-Triple-negative breast cancer	-0.458600299161448	0.280187638894278	21.0417751444362	0.116550614870715	0.267182237124314	nan
sp|Q15121|PEA15_HUMAN	metaplastic breast carcinomas-Normal	-0.142266029897926	0.16569618417633	23.9999999998264	0.399057862001101	0.601923998636815	nan
sp|Q15121|PEA15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.054423248495912	0.16569618417633	23.9999999998264	0.745418510048186	0.954643368861838	nan
sp|Q15121|PEA15_HUMAN	Normal-Triple-negative breast cancer	0.196689278393838	0.198044819785091	23.999999999841	0.330542557351248	0.522952622863184	nan
sp|Q15126|PMVK_HUMAN	metaplastic breast carcinomas-Normal	0.0752770757345886	0.194894247301973	21.999945788319	0.703024889542429	0.829554395754005	nan
sp|Q15126|PMVK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.553028723534348	0.194894247301973	21.9999457882809	0.0095802195474884	0.547668704418496	nan
sp|Q15126|PMVK_HUMAN	Normal-Triple-negative breast cancer	-0.628305799268936	0.232943180170011	21.9999457879008	0.0131595894398328	0.0746230686012789	nan
sp|Q15149|PLEC_HUMAN	metaplastic breast carcinomas-Normal	0.404903268357223	0.255026876418713	23.9999999990313	0.125445437135318	0.296183334837538	nan
sp|Q15149|PLEC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.204901480577601	0.255026876418713	23.9999999993773	0.429600482432387	0.894615500363341	nan
sp|Q15149|PLEC_HUMAN	Normal-Triple-negative breast cancer	-0.200001787779622	0.304815418844833	23.9999999992809	0.517975420839841	0.690911034860205	nan
sp|Q15154|PCM1_HUMAN	metaplastic breast carcinomas-Normal	0.184505926788237	0.260373700729611	23.9999999997539	0.48538716640521	0.675074033945991	nan
sp|Q15154|PCM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.100239958864379	0.260373700729611	23.9999999999912	0.703639253857134	0.94948208919602	nan
sp|Q15154|PCM1_HUMAN	Normal-Triple-negative breast cancer	-0.284745885652616	0.311206096230303	23.9999999998914	0.369306563632111	0.559623919119128	nan
sp|Q15165|PON2_HUMAN	metaplastic breast carcinomas-Normal	0.171156703527273	0.416650010002704	23.9999999995194	0.684869377917511	0.815421471492646	nan
sp|Q15165|PON2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.036631617401053	0.416650010002704	23.9999999995194	0.930670236583415	0.995359816653149	nan
sp|Q15165|PON2_HUMAN	Normal-Triple-negative breast cancer	-0.13452508612622	0.497992012034693	23.9999999995176	0.789365704597724	0.879763182876798	nan
sp|Q15172|2A5A_HUMAN	metaplastic breast carcinomas-Normal	0.0847853268386235	0.270723881413611	13.9999990282553	0.758760887234883	0.868333102587984	nan
sp|Q15172|2A5A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.456249686658382	0.270723881413611	13.999999027977	0.114081935946653	0.823891816737944	nan
sp|Q15172|2A5A_HUMAN	Normal-Triple-negative breast cancer	-0.541035013497005	0.3235769282956	13.9999990276674	0.11670679268796	0.267194110822725	nan
sp|Q15181|IPYR_HUMAN	metaplastic breast carcinomas-Normal	0.0622199975865529	0.28191434027023	22.0000000356352	0.827357284679065	0.909436380381353	nan
sp|Q15181|IPYR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.471604082572666	0.28191434027023	22.0000000357952	0.108516643504609	0.823891816737944	nan
sp|Q15181|IPYR_HUMAN	Normal-Triple-negative breast cancer	-0.533824080159218	0.33695208487261	22.0000000356376	0.127402168814125	0.284027370313984	nan
sp|Q15185|TEBP_HUMAN	metaplastic breast carcinomas-Normal	0.46052803095406	0.166489605269855	21.9999996716581	0.0112687530807943	0.0705294023488664	nan
sp|Q15185|TEBP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.192904900488403	0.166489605269855	21.9999996736185	0.259017668291184	0.862813416943474	nan
sp|Q15185|TEBP_HUMAN	Normal-Triple-negative breast cancer	-0.653432931442462	0.198993139375321	21.9999996716885	0.0033906393579247	0.0390607324212323	nan
sp|Q15233|NONO_HUMAN	metaplastic breast carcinomas-Normal	0.96057607166724	0.256456228245371	21.999999490368	0.001119487684222	0.0254875141257118	nan
sp|Q15233|NONO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.148709906614116	0.256456228245371	21.9999994904106	0.56789758319994	0.935631258424823	nan
sp|Q15233|NONO_HUMAN	Normal-Triple-negative breast cancer	-1.10928597828136	0.306523821040858	21.9999994903768	0.0015205097645551	0.0276684087151132	nan
sp|Q15257|PTPA_HUMAN	metaplastic breast carcinomas-Normal	0.15676584798143	0.337210163346629	14.0000000106721	0.649157832269541	0.79127269323944	nan
sp|Q15257|PTPA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.27180663131482	0.337210163346629	14.000000011016	0.433695535760241	0.896102083258464	nan
sp|Q15257|PTPA_HUMAN	Normal-Triple-negative breast cancer	0.11504078333339	0.403043234590215	14.0000000107296	0.779493808507151	0.874519294198955	nan
sp|Q15276|RABE1_HUMAN	metaplastic breast carcinomas-Normal	0.282167495175216	0.389702323144067	21.0013995640089	0.47701848529956	0.667369987890944	nan
sp|Q15276|RABE1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.368493832811938	0.389702323144067	21.0013995641042	0.355117109085228	0.878877489703816	nan
sp|Q15276|RABE1_HUMAN	Normal-Triple-negative breast cancer	-0.650661327987154	0.460956998802284	20.9559224131366	0.172760079889475	0.345936449128081	nan
sp|Q15286|RAB35_HUMAN	metaplastic breast carcinomas-Normal	0.584496187372897	0.275441040962581	21.0289531027268	0.0458792211596451	0.160698136074458	nan
sp|Q15286|RAB35_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.206343289011363	0.275441040962581	21.0289531030688	0.46207249887699	0.909423669537079	nan
sp|Q15286|RAB35_HUMAN	Normal-Triple-negative breast cancer	-0.378152898361535	0.325664439400114	21.0190947588851	0.25858909744391	0.44908576797469	nan
sp|Q15291|RBBP5_HUMAN	metaplastic breast carcinomas-Normal	0.166711431425303	0.272924094249112	13.2039565845515	0.551679751975233	0.722996021286722	nan
sp|Q15291|RBBP5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0020616618315601	0.244411393245766	13.0000000024521	0.993397827591824	0.998185231446144	nan
sp|Q15291|RBBP5_HUMAN	Normal-Triple-negative breast cancer	-0.168773093256863	0.316368617731391	13.1535608995715	0.602606781374639	0.754501023538688	nan
sp|Q15293|RCN1_HUMAN	metaplastic breast carcinomas-Normal	0.879030279590825	0.386202353828723	23.9999999999908	0.0320524793338614	0.128674446021444	nan
sp|Q15293|RCN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0717959077560418	0.386202353828723	23.9999999996904	0.854083681622624	0.977449253880285	nan
sp|Q15293|RCN1_HUMAN	Normal-Triple-negative breast cancer	-0.950826187346867	0.461600102288374	23.9999999998756	0.0504164442345059	0.15716204586246	nan
sp|Q15363|TMED2_HUMAN	metaplastic breast carcinomas-Normal	0.593855303987189	0.258310932193734	23.9999999989945	0.0305155115837664	0.125692144367335	nan
sp|Q15363|TMED2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0745688887601938	0.258310932193734	23.999999998993	0.77530589118608	0.960657739983943	nan
sp|Q15363|TMED2_HUMAN	Normal-Triple-negative breast cancer	-0.519286415226996	0.308740616261787	23.9999999989329	0.105546647021508	0.251136044881527	nan
sp|Q15365|PCBP1_HUMAN	metaplastic breast carcinomas-Normal	0.477489114539001	0.26551094818994	23.9999999996309	0.0847082017471808	0.232318533504644	nan
sp|Q15365|PCBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.521542809073519	0.26551094818994	23.9999999996309	0.0611774877898219	0.773787875546141	nan
sp|Q15365|PCBP1_HUMAN	Normal-Triple-negative breast cancer	-0.99903192361252	0.317346281368119	23.9999999996334	0.0043538509910696	0.0419484078096101	nan
sp|Q15366|PCBP2_HUMAN	metaplastic breast carcinomas-Normal	0.548488441720656	0.291059382634603	22.0000000016658	0.0727846774316458	0.210562461081628	nan
sp|Q15366|PCBP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.483196873147164	0.291059382634603	22.0000000015424	0.111076098452659	0.823891816737944	nan
sp|Q15366|PCBP2_HUMAN	Normal-Triple-negative breast cancer	-1.03168531486782	0.347882501140083	22.0000000014672	0.0071407348660831	0.0535093121381869	nan
sp|Q15369|ELOC_HUMAN	metaplastic breast carcinomas-Normal	0.541673331008662	0.151875668883267	23.9999999997141	0.0015621959982719	0.0282214103166084	nan
sp|Q15369|ELOC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0637421284935224	0.151875668883267	23.9999999997141	0.678438361817957	0.946568877415162	nan
sp|Q15369|ELOC_HUMAN	Normal-Triple-negative breast cancer	-0.477931202515139	0.181526144511078	23.9999999997418	0.014577874501222	0.0779324922305247	nan
sp|Q15370|ELOB_HUMAN	metaplastic breast carcinomas-Normal	0.451040028471969	0.233852186302444	22.0000000041343	0.0667647185301669	0.199753307285576	nan
sp|Q15370|ELOB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.115712358756967	0.233852186302444	22.0000000033757	0.625639826637516	0.941374262616245	nan
sp|Q15370|ELOB_HUMAN	Normal-Triple-negative breast cancer	-0.335327669715002	0.279506823424078	22.0000000037153	0.243012432988124	0.43104233044425	nan
sp|Q15386|UBE3C_HUMAN	metaplastic breast carcinomas-Normal	-0.0631475226923758	0.230074118455098	22.9999999996757	0.786176718499223	0.883153569547624	nan
sp|Q15386|UBE3C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.218352017399824	0.230074118455098	22.9999999996757	0.352461136958786	0.877195569152668	nan
sp|Q15386|UBE3C_HUMAN	Normal-Triple-negative breast cancer	-0.155204494707448	0.272227368161334	22.999999999692	0.574118424486741	0.734553365278648	nan
sp|Q15388|TOM20_HUMAN	metaplastic breast carcinomas-Normal	0.742080947534291	0.199029379750516	22.0000000030045	0.0011667581400216	0.0258553603828806	nan
sp|Q15388|TOM20_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.273455841858538	0.199029379750516	22.0000000022808	0.183296202803188	0.843662073010871	nan
sp|Q15388|TOM20_HUMAN	Normal-Triple-negative breast cancer	-1.01553678939283	0.237885608775896	22.0000000024692	0.0003127570821785	0.0227914720285933	nan
sp|Q15393|SF3B3_HUMAN	metaplastic breast carcinomas-Normal	0.671082761710288	0.184478944994198	23.9999999996962	0.001308728722653	0.0271888392131161	nan
sp|Q15393|SF3B3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.154600884465374	0.184478944994198	23.9999999996962	0.41027659222851	0.885784822958391	nan
sp|Q15393|SF3B3_HUMAN	Normal-Triple-negative breast cancer	-0.825683646175662	0.220494512876891	23.9999999997198	0.0010017759025774	0.0260939352025391	nan
sp|Q15397|PUM3_HUMAN	metaplastic breast carcinomas-Normal	0.175450635056345	0.299995191433633	22.0000000377214	0.564602652435523	0.732167091151825	nan
sp|Q15397|PUM3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.156548862049297	0.299995191433633	22.0000000372833	0.606997755878146	0.940559810632461	nan
sp|Q15397|PUM3_HUMAN	Normal-Triple-negative breast cancer	-0.331999497105642	0.358562835464226	22.0000000373437	0.364535380245371	0.55430722961373	nan
sp|Q15404|RSU1_HUMAN	metaplastic breast carcinomas-Normal	-0.356324364507886	0.23011654245769	22.000000032755	0.135779788648995	0.308708630279932	nan
sp|Q15404|RSU1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.142272200594633	0.23011654245769	22.000000032642	0.542751422874834	0.923837171685362	nan
sp|Q15404|RSU1_HUMAN	Normal-Triple-negative breast cancer	0.498596565102519	0.275041875026544	22.0000000326324	0.083531674321821	0.21726078673375	nan
sp|Q15417|CNN3_HUMAN	metaplastic breast carcinomas-Normal	0.622860990921717	0.305027667827231	22.0000000008651	0.0533223195817545	0.175662428433847	nan
sp|Q15417|CNN3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.406260390734178	0.305027667827231	22.0000000013814	0.196534392114358	0.843662073010871	nan
sp|Q15417|CNN3_HUMAN	Normal-Triple-negative breast cancer	-1.0291213816559	0.364577795225654	22.0000000013194	0.0099089282406517	0.062977585988387	nan
sp|Q15424|SAFB1_HUMAN	metaplastic breast carcinomas-Normal	0.274776531359719	0.198063328255149	23.9999999997436	0.178094327190284	0.367464645301367	nan
sp|Q15424|SAFB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0401370438579354	0.198063328255149	23.9999999997449	0.84111867226535	0.972169455774446	nan
sp|Q15424|SAFB1_HUMAN	Normal-Triple-negative breast cancer	-0.314913575217654	0.236730956390543	23.99999999984	0.195936194171931	0.377123282818471	nan
sp|Q15427|SF3B4_HUMAN	metaplastic breast carcinomas-Normal	0.552258020231931	0.315864329486497	22.0000000231195	0.0943368999931011	0.248130450375174	nan
sp|Q15427|SF3B4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.209052137973161	0.315864329486497	22.0000000224489	0.514946030691346	0.915620969865368	nan
sp|Q15427|SF3B4_HUMAN	Normal-Triple-negative breast cancer	-0.761310158205092	0.377530083270486	22.0000000224124	0.0561109890450027	0.168789979715465	nan
sp|Q15428|SF3A2_HUMAN	metaplastic breast carcinomas-Normal	0.730757553318271	0.229543894983065	23.9999999998568	0.0039969034270095	0.0420433765549994	nan
sp|Q15428|SF3A2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.363799511774963	0.229543894983065	23.9999999998568	0.126083187214863	0.823891816737944	nan
sp|Q15428|SF3A2_HUMAN	Normal-Triple-negative breast cancer	-1.09455706509323	0.274357430381809	23.9999999998612	0.0005410324903889	0.0237592699893802	nan
sp|Q15435|PP1R7_HUMAN	metaplastic breast carcinomas-Normal	-0.288433056296286	0.169861653811041	23.9999999996138	0.102429474151444	0.258720039574013	nan
sp|Q15435|PP1R7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0254970468397881	0.169861653811041	23.9999999996138	0.881936324588048	0.983709256883903	nan
sp|Q15435|PP1R7_HUMAN	Normal-Triple-negative breast cancer	0.262936009456498	0.20302350826381	23.9999999996136	0.207605717753158	0.389436459261568	nan
sp|Q15436|SC23A_HUMAN	metaplastic breast carcinomas-Normal	0.441914644161024	0.262578997509682	24.0000000001759	0.10534531312338	0.263879292254795	nan
sp|Q15436|SC23A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.118836402854844	0.262578997509682	23.9999999998953	0.65492013614526	0.944190045212043	nan
sp|Q15436|SC23A_HUMAN	Normal-Triple-negative breast cancer	-0.32307824130618	0.313841930033916	24.0000000001101	0.313541290876682	0.506209790748339	nan
sp|Q15437|SC23B_HUMAN	metaplastic breast carcinomas-Normal	0.135579113636533	0.408783091057045	13.9999992856321	0.745054900875392	0.859564245547108	nan
sp|Q15437|SC23B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.878286782078037	0.408783091057045	13.9999992857651	0.0496518406786215	0.765966938574033	nan
sp|Q15437|SC23B_HUMAN	Normal-Triple-negative breast cancer	-1.01386589571457	0.488589245443527	13.9999992855898	0.0568912520079679	0.170519857235785	nan
sp|Q15459|SF3A1_HUMAN	metaplastic breast carcinomas-Normal	0.670058775481569	0.172588362146385	22.0000000077128	0.0008030861010645	0.022622527118123	nan
sp|Q15459|SF3A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.214114134169729	0.172588362146385	22.0000000077128	0.227819321293346	0.843662073010871	nan
sp|Q15459|SF3A1_HUMAN	Normal-Triple-negative breast cancer	-0.884172909651298	0.206282548075524	22.00000000751	0.0002998774577367	0.0227914720285933	nan
sp|Q15555|MARE2_HUMAN	metaplastic breast carcinomas-Normal	0.28881234015352	0.287251061234662	24.000000000397	0.324717402373641	0.532229115133127	nan
sp|Q15555|MARE2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.36605351173718	0.287251061234662	24.000000000202	0.214746842444043	0.843662073010871	nan
sp|Q15555|MARE2_HUMAN	Normal-Triple-negative breast cancer	-0.6548658518907	0.343330686449333	24.0000000003265	0.068506941136968	0.189606221764598	nan
sp|Q15582|BGH3_HUMAN	metaplastic breast carcinomas-Normal	0.575722548544771	0.362996116340232	23.9999999997907	0.12582183788028	0.29640807166127	nan
sp|Q15582|BGH3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.535274545609787	0.362996116340232	23.9999999995464	0.153317860379445	0.843465960034572	nan
sp|Q15582|BGH3_HUMAN	Normal-Triple-negative breast cancer	-0.0404480029349845	0.433863343327121	23.9999999996297	0.926496715900073	0.959101552056009	nan
sp|Q15599|NHRF2_HUMAN	metaplastic breast carcinomas-Normal	0.0143194470998582	0.184980481375219	22.0000000524941	0.938996647503299	0.968722798355358	nan
sp|Q15599|NHRF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.227270916489535	0.184980481375219	22.0000000522869	0.232195185056538	0.847474193537857	nan
sp|Q15599|NHRF2_HUMAN	Normal-Triple-negative breast cancer	0.212951469389677	0.221093963508109	22.0000000523654	0.345929605347962	0.537813772934957	nan
sp|Q15628|TRADD_HUMAN	metaplastic breast carcinomas-Normal	0.307693129853403	0.304113320415271	22.0000000295695	0.322646459117826	0.530322175654614	nan
sp|Q15628|TRADD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.367484401143543	0.304113320415271	22.000000029297	0.239729987651732	0.848884141578285	nan
sp|Q15628|TRADD_HUMAN	Normal-Triple-negative breast cancer	0.0597912712901399	0.363484941040009	22.000000029802	0.870843881302698	0.92570676733296	nan
sp|Q15629|TRAM1_HUMAN	metaplastic breast carcinomas-Normal	0.845485252746989	0.318650664799405	22.0000000338768	0.0145181804934769	0.0795450818130059	nan
sp|Q15629|TRAM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.828139213789723	0.318650664799405	22.0000000341917	0.0163856392315029	0.656412655960811	nan
sp|Q15629|TRAM1_HUMAN	Normal-Triple-negative breast cancer	-0.0173460389572663	0.380860390951673	22.0000000343618	0.964084314391336	0.982709678330819	nan
sp|Q15631|TSN_HUMAN	metaplastic breast carcinomas-Normal	0.305044953596507	0.197258913655649	24.0000000000758	0.135089256417306	0.308396253082891	nan
sp|Q15631|TSN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.394842160701138	0.197258913655649	24.0000000003232	0.056751094229296	0.773787875546141	nan
sp|Q15631|TSN_HUMAN	Normal-Triple-negative breast cancer	-0.699887114297645	0.235769497047455	24.0000000002099	0.0066868334164304	0.0523857019586285	nan
sp|Q15642|CIP4_HUMAN	metaplastic breast carcinomas-Normal	-0.138274816386886	0.161577313734189	21.9999977377014	0.401343693648431	0.603923240238744	nan
sp|Q15642|CIP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0106032346232974	0.161577313734189	21.9999977377012	0.948270435881326	0.996541950781621	nan
sp|Q15642|CIP4_HUMAN	Normal-Triple-negative breast cancer	0.148878051010184	0.193121827994502	21.9999977386483	0.448965554792405	0.632088735336703	nan
sp|Q15643|TRIPB_HUMAN	metaplastic breast carcinomas-Normal	-0.132539902323327	0.218550978878401	22.0000004319716	0.550424296171079	0.722880426895562	nan
sp|Q15643|TRIPB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0831914862062067	0.218550978878401	22.0000004329404	0.707113502773847	0.94948208919602	nan
sp|Q15643|TRIPB_HUMAN	Normal-Triple-negative breast cancer	0.215731388529534	0.261218382553502	22.0000004325624	0.417746586786973	0.604523140827121	nan
sp|Q15648|MED1_HUMAN	metaplastic breast carcinomas-Normal	0.359104609821036	0.300006366911049	19.9631772659956	0.245332075294334	0.444890244559939	nan
sp|Q15648|MED1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.415466809977775	0.28062330724742	19.9246875251107	0.154376338965052	0.843465960034572	nan
sp|Q15648|MED1_HUMAN	Normal-Triple-negative breast cancer	-0.774571419798811	0.349231316306253	20.0095622830639	0.0382950440248049	0.131229614781909	nan
sp|Q15650|TRIP4_HUMAN	metaplastic breast carcinomas-Normal	0.601280858594503	0.17232434239681	14.0000000157043	0.0036116279006612	0.0407324763980233	nan
sp|Q15650|TRIP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.30939299789577	0.17232434239681	14.000000015947	0.0941978635778404	0.813527003626803	nan
sp|Q15650|TRIP4_HUMAN	Normal-Triple-negative breast cancer	-0.910673856490273	0.205966984117403	14.0000000158719	0.0005803622170954	0.0237592699893802	nan
sp|Q15651|HMGN3_HUMAN	metaplastic breast carcinomas-Normal	-0.0372518794123394	0.524573900055495	23.9999999995813	0.943975381857943	0.971095862345079	nan
sp|Q15651|HMGN3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.830675649315298	0.524573900055495	23.999999999346	0.126391902995002	0.823891816737944	nan
sp|Q15651|HMGN3_HUMAN	Normal-Triple-negative breast cancer	-0.793423769902958	0.626985733056449	23.9999999994618	0.217855528410896	0.400083854385535	nan
sp|Q15654|TRIP6_HUMAN	metaplastic breast carcinomas-Normal	-0.164464064203548	0.333683688527252	22.0000001201016	0.626984999433234	0.777068657015686	nan
sp|Q15654|TRIP6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0906511566431019	0.333683688527252	22.0000001201276	0.788410429392338	0.962981271203673	nan
sp|Q15654|TRIP6_HUMAN	Normal-Triple-negative breast cancer	0.25511522084665	0.398828290995998	22.0000001200739	0.528997935869817	0.697773467790188	nan
sp|Q15691|MARE1_HUMAN	metaplastic breast carcinomas-Normal	0.249138462053635	0.313793283134134	23.9999999997376	0.435000813162744	0.63185785083265	nan
sp|Q15691|MARE1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.374986659314736	0.313793283134134	23.9999999997376	0.2437582142194	0.84964799869723	nan
sp|Q15691|MARE1_HUMAN	Normal-Triple-negative breast cancer	-0.62412512136837	0.375054709418885	23.9999999997098	0.109098512891282	0.256104136193941	nan
sp|Q15714|T22D1_HUMAN	metaplastic breast carcinomas-Normal	-0.0361638902528675	0.314958288988698	14.0000000168339	0.910217382621479	0.952033536763309	nan
sp|Q15714|T22D1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.170132015278309	0.314958288988698	14.0000000165206	0.597566260728687	0.940559810632461	nan
sp|Q15714|T22D1_HUMAN	Normal-Triple-negative breast cancer	0.206295905531176	0.376447157746302	14.0000000166197	0.592317677595274	0.746329052001478	nan
sp|Q15717|ELAV1_HUMAN	metaplastic breast carcinomas-Normal	0.548052210987276	0.226856926926462	23.9999999995608	0.0236728732215735	0.107110232987193	nan
sp|Q15717|ELAV1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.586403544545392	0.226856926926462	23.9999999995608	0.0162489336775469	0.656412655960811	nan
sp|Q15717|ELAV1_HUMAN	Normal-Triple-negative breast cancer	-1.13445575553267	0.271145889288189	23.9999999995873	0.0003307176072232	0.0227914720285933	nan
sp|Q15746|MYLK_HUMAN	metaplastic breast carcinomas-Normal	-0.402547401056358	0.325024276842452	23.9999999996806	0.227502895571903	0.426760510655196	nan
sp|Q15746|MYLK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.112774140666473	0.325024276842452	23.9999999998628	0.731636815433154	0.954643368861838	nan
sp|Q15746|MYLK_HUMAN	Normal-Triple-negative breast cancer	0.289773260389886	0.388478314410321	23.9999999998309	0.462960488225579	0.643483706785728	nan
sp|Q15758|AAAT_HUMAN	metaplastic breast carcinomas-Normal	0.417897539979116	0.22910421041525	22.0000000219361	0.0817585858549431	0.226670151240873	nan
sp|Q15758|AAAT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.329414869704337	0.22910421041525	22.0000000210546	0.164553096390917	0.843662073010871	nan
sp|Q15758|AAAT_HUMAN	Normal-Triple-negative breast cancer	-0.0884826702747787	0.273831906807273	22.0000000215597	0.749649784076542	0.856006830048239	nan
sp|Q15785|TOM34_HUMAN	metaplastic breast carcinomas-Normal	0.660703454866508	0.305695988480565	23.9999999998459	0.0408667804333842	0.149736208267631	nan
sp|Q15785|TOM34_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0316928498377426	0.305695988480565	23.9999999998469	0.918289226215271	0.99408739879047	nan
sp|Q15785|TOM34_HUMAN	Normal-Triple-negative breast cancer	-0.629010605028765	0.365376591190729	23.999999999848	0.0980198366958513	0.240101648619757	nan
sp|Q15813|TBCE_HUMAN	metaplastic breast carcinomas-Normal	0.0621108236343062	0.272999337025094	14.999999999857	0.823097006338783	0.907569094159468	nan
sp|Q15813|TBCE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.396744384515518	0.272999337025094	14.999999999857	0.166746387800959	0.843662073010871	nan
sp|Q15813|TBCE_HUMAN	Normal-Triple-negative breast cancer	-0.458855208149824	0.326296617941714	14.9999999998583	0.180026961859038	0.356408350934747	nan
sp|Q15814|TBCC_HUMAN	metaplastic breast carcinomas-Normal	0.276251253133572	0.662631686565086	8.05567848003517	0.68763928415147	0.817457923034453	nan
sp|Q15814|TBCC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.423701140832341	0.413925310483096	8.00177720282823	0.335962812995702	0.870890600099115	nan
sp|Q15814|TBCC_HUMAN	Normal-Triple-negative breast cancer	0.147449887698769	0.716129467516359	8.03777705691436	0.841989750664632	0.909627996530167	nan
sp|Q15833|STXB2_HUMAN	metaplastic breast carcinomas-Normal	0.155392059436074	0.258723608527711	23.9999999991009	0.553729713530685	0.724644711722834	nan
sp|Q15833|STXB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.326733535782995	0.258723608527711	23.9999999993413	0.218769257952124	0.843662073010871	nan
sp|Q15833|STXB2_HUMAN	Normal-Triple-negative breast cancer	-0.482125595219069	0.309233858822552	23.9999999991925	0.132063819420246	0.290907975979388	nan
sp|Q15836|VAMP3_HUMAN	metaplastic breast carcinomas-Normal	-0.0036306728652851	0.376715820446353	14.0000000152608	0.992446340315595	0.995441048644852	nan
sp|Q15836|VAMP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.334658683013817	0.376715820446353	14.0000000153231	0.389356201272418	0.885234295852111	nan
sp|Q15836|VAMP3_HUMAN	Normal-Triple-negative breast cancer	0.338289355879102	0.450261526186359	14.0000000152962	0.464904615201969	0.644429916985549	nan
sp|Q15847|ADIRF_HUMAN	metaplastic breast carcinomas-Normal	-3.07434711647912	0.651866276011001	22.0000000181031	0.0001049658402382	0.0136889536397125	nan
sp|Q15847|ADIRF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.739207863130209	0.651866276011001	22.0000000182981	0.269006037532422	0.867507810336388	nan
sp|Q15847|ADIRF_HUMAN	Normal-Triple-negative breast cancer	2.33513925334892	0.779129222548619	22.0000000178681	0.0066388653116322	0.0521692394701316	nan
sp|Q15907|RB11B_HUMAN	metaplastic breast carcinomas-Normal	-0.400239955407806	0.232849420072481	19.9852487976996	0.101089255563091	0.256896548541066	nan
sp|Q15907|RB11B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.188878701328735	0.217746205862542	19.9688683119804	0.396013191590145	0.885234295852111	nan
sp|Q15907|RB11B_HUMAN	Normal-Triple-negative breast cancer	0.211361254079071	0.271144511597251	20.0050468706132	0.444801068467895	0.629578712212468	nan
sp|Q15942|ZYX_HUMAN	metaplastic breast carcinomas-Normal	0.49968054226052	0.282376634891895	23.9999999995975	0.0895080802333497	0.241435046240126	nan
sp|Q15942|ZYX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0120377164600801	0.282376634891895	23.9999999995975	0.96634916726968	0.99709406933403	nan
sp|Q15942|ZYX_HUMAN	Normal-Triple-negative breast cancer	-0.48764282580044	0.337504632630365	23.9999999996031	0.161431328784102	0.331094248668141	nan
sp|Q16134|ETFD_HUMAN	metaplastic breast carcinomas-Normal	-0.638830081527062	0.256475143077802	24.0000000001646	0.0200602218668966	0.0963683261948199	nan
sp|Q16134|ETFD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.164748366560966	0.256475143077802	24.0000000004587	0.526731105735352	0.918395871300496	nan
sp|Q16134|ETFD_HUMAN	Normal-Triple-negative breast cancer	0.474081714966097	0.306546428589721	24.0000000002773	0.135063753394931	0.294691901039905	nan
sp|Q16181|SEPT7_HUMAN	metaplastic breast carcinomas-Normal	-0.0862091944223384	0.103421253071708	22.0000000029875	0.413480642877389	0.615740710196163	nan
sp|Q16181|SEPT7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0679503429710754	0.103421253071708	22.0000000029288	0.517979862952408	0.915620969865368	nan
sp|Q16181|SEPT7_HUMAN	Normal-Triple-negative breast cancer	0.154159537393414	0.123612040484518	22.0000000032688	0.225465968673823	0.408196557664373	nan
sp|Q16186|ADRM1_HUMAN	metaplastic breast carcinomas-Normal	0.527247527686037	0.138960447004014	23.9999999999735	0.0008847704394082	0.0227210419054423	nan
sp|Q16186|ADRM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.205901769739656	0.138960447004014	23.9999999999748	0.151423874155802	0.843465960034572	nan
sp|Q16186|ADRM1_HUMAN	Normal-Triple-negative breast cancer	-0.733149297425693	0.166089501825094	23.9999999999094	0.0001842439687764	0.0227914720285933	nan
sp|Q16204|CCDC6_HUMAN	metaplastic breast carcinomas-Normal	0.427152252136601	0.362064998417643	22.0000000012785	0.250693532710937	0.451135812614665	nan
sp|Q16204|CCDC6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.035473839561516	0.362064998417643	22.0000000010107	0.922838187908916	0.994508979919649	nan
sp|Q16204|CCDC6_HUMAN	Normal-Triple-negative breast cancer	-0.391678412575085	0.432750444547379	22.0000000008834	0.375223038772037	0.56312537905329	nan
sp|Q16222|UAP1_HUMAN	metaplastic breast carcinomas-Normal	-0.0838489058092788	0.213490834364671	22.0000000303101	0.698282467530905	0.825130082500081	nan
sp|Q16222|UAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0357928050706351	0.213490834364671	22.0000000299915	0.868386315311634	0.981143688073178	nan
sp|Q16222|UAP1_HUMAN	Normal-Triple-negative breast cancer	0.0480561007386437	0.255170353063325	22.0000000303569	0.852344758155432	0.916001932139882	nan
sp|Q16270|IBP7_HUMAN	metaplastic breast carcinomas-Normal	0.501340296958657	0.400489529002543	23.9999999995275	0.222699393857535	0.421796458793417	nan
sp|Q16270|IBP7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0414400108513821	0.400489529002543	23.9999999995669	0.918447064386263	0.99408739879047	nan
sp|Q16270|IBP7_HUMAN	Normal-Triple-negative breast cancer	-0.459900286107275	0.478676542802696	23.9999999995672	0.346245930830568	0.537813772934957	nan
sp|Q16363|LAMA4_HUMAN	metaplastic breast carcinomas-Normal	-0.676701156453229	0.385695931935961	21.9999999826711	0.0932659087242221	0.247221595374254	nan
sp|Q16363|LAMA4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.316225826857453	0.385695931935961	21.999999984376	0.421076803763054	0.887693595400195	nan
sp|Q16363|LAMA4_HUMAN	Normal-Triple-negative breast cancer	0.992926983310682	0.460994812353751	21.999999983195	0.042467641953325	0.139903312044452	nan
sp|Q16401|PSMD5_HUMAN	metaplastic breast carcinomas-Normal	-0.043343897534947	0.213121814777188	24.0000000000603	0.840555534329929	0.915167571605857	nan
sp|Q16401|PSMD5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.1741187825568	0.213121814777188	23.9999999998832	0.42196944327758	0.88788356341846	nan
sp|Q16401|PSMD5_HUMAN	Normal-Triple-negative breast cancer	-0.130774885021853	0.254729290294961	23.9999999999787	0.612374146256802	0.763015171228539	nan
sp|Q16527|CSRP2_HUMAN	metaplastic breast carcinomas-Normal	0.671646430165613	0.358847164352473	21.9999999727041	0.0746076755234254	0.213238102699799	nan
sp|Q16527|CSRP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.446103331265502	0.358847164352473	21.9999999734163	0.226896049301748	0.843662073010871	nan
sp|Q16527|CSRP2_HUMAN	Normal-Triple-negative breast cancer	-0.225543098900111	0.428904397212596	21.9999999724603	0.604247305997716	0.755365944015196	nan
sp|Q16531|DDB1_HUMAN	metaplastic breast carcinomas-Normal	0.209886206136474	0.138248716943547	22.0000000451109	0.143209923012064	0.319340083250317	nan
sp|Q16531|DDB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.350432273775741	0.138248716943547	22.0000000442088	0.0188731300776665	0.674062840112479	nan
sp|Q16531|DDB1_HUMAN	Normal-Triple-negative breast cancer	-0.560318479912214	0.1652388216947	22.0000000445776	0.0026273647699949	0.0344406168311338	nan
sp|Q16539|MK14_HUMAN	metaplastic breast carcinomas-Normal	0.390220237509366	0.275033045202684	22.0000000002713	0.169966378344855	0.358937891752414	nan
sp|Q16539|MK14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0391480255524307	0.275033045202684	21.9999999999998	0.88810749401567	0.98730926571735	nan
sp|Q16539|MK14_HUMAN	Normal-Triple-negative breast cancer	-0.429368263061797	0.328727364138607	22.0000000008893	0.204992733326632	0.386497927156962	nan
sp|Q16543|CDC37_HUMAN	metaplastic breast carcinomas-Normal	0.425099846025432	0.187804513489759	23.9999999998628	0.0329251430273409	0.129407306133986	nan
sp|Q16543|CDC37_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0472377242926001	0.187804513489759	23.9999999996333	0.803548685261854	0.965774701272009	nan
sp|Q16543|CDC37_HUMAN	Normal-Triple-negative breast cancer	-0.472337570318032	0.224469327485087	23.9999999997391	0.0460165179907508	0.147211334250125	nan
sp|Q16555|DPYL2_HUMAN	metaplastic breast carcinomas-Normal	-0.396081021090495	0.296041014290345	22.000000042248	0.194586943244163	0.387317707029823	nan
sp|Q16555|DPYL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0117173249563511	0.296041014290345	22.000000041713	0.968784905698484	0.99709406933403	nan
sp|Q16555|DPYL2_HUMAN	Normal-Triple-negative breast cancer	0.407798346046846	0.353836689816192	22.0000000422538	0.261483657830618	0.452457927448712	nan
sp|Q16576|RBBP7_HUMAN	metaplastic breast carcinomas-Normal	0.135228224864508	0.273622600745124	22.0000000030621	0.626053478359101	0.7762845885891	nan
sp|Q16576|RBBP7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.236162253140098	0.273622600745124	22.0000000020978	0.397397172565412	0.885297496092956	nan
sp|Q16576|RBBP7_HUMAN	Normal-Triple-negative breast cancer	-0.371390478004606	0.327041560571055	22.0000000022189	0.268341910856678	0.460489680788641	nan
sp|Q16630|CPSF6_HUMAN	metaplastic breast carcinomas-Normal	0.511846628414166	0.184673476466083	22.0000000279189	0.0111287913145842	0.0705294023488664	nan
sp|Q16630|CPSF6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.199453389600484	0.184673476466083	22.0000000270353	0.291826161800508	0.867696529950794	nan
sp|Q16630|CPSF6_HUMAN	Normal-Triple-negative breast cancer	-0.71130001801465	0.220727022457504	22.0000000278246	0.0039182803944469	0.0407011375973175	nan
sp|Q16637|SMN_HUMAN	metaplastic breast carcinomas-Normal	0.634138523375633	0.312063672421265	20.9999999994951	0.0549872497550847	0.179164179810656	nan
sp|Q16637|SMN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.13215797511194	0.286369265691468	20.9999999995955	0.649188152851893	0.943768330865086	nan
sp|Q16637|SMN_HUMAN	Normal-Triple-negative breast cancer	-0.501980548263693	0.37200458842786	20.9999999995246	0.191580085996364	0.372062106251712	nan
sp|Q16643|DREB_HUMAN	metaplastic breast carcinomas-Normal	0.833898009347038	0.303562763653576	23.9999999995261	0.0112243214903743	0.0705294023488664	nan
sp|Q16643|DREB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.213448322290794	0.303562763653576	23.9999999995604	0.488731474760195	0.913320451076758	nan
sp|Q16643|DREB_HUMAN	Normal-Triple-negative breast cancer	-0.620449687056244	0.362826899847369	23.9999999995222	0.100157272772603	0.243181200391226	nan
sp|Q16647|PTGIS_HUMAN	metaplastic breast carcinomas-Normal	-0.617025658096068	0.428961704451851	21.9999999940433	0.16439082059112	0.350278902336463	nan
sp|Q16647|PTGIS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.301134063695677	0.428961704451851	21.9999999940108	0.490035913683813	0.913320451076758	nan
sp|Q16647|PTGIS_HUMAN	Normal-Triple-negative breast cancer	0.918159721791746	0.512707301469697	21.9999999957852	0.0870954220732525	0.222525121423129	nan
sp|Q16658|FSCN1_HUMAN	metaplastic breast carcinomas-Normal	0.935454923425816	0.283853263029008	24.0000000001904	0.0030447213405169	0.0386458689304557	nan
sp|Q16658|FSCN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.498448911531586	0.283853263029008	24.0000000001892	0.0918427430458209	0.81309570430905	nan
sp|Q16658|FSCN1_HUMAN	Normal-Triple-negative breast cancer	-0.437006011894231	0.339269540825191	24.0000000001505	0.209999511572686	0.39259751207402	nan
sp|Q16666|IF16_HUMAN	metaplastic breast carcinomas-Normal	0.253617973063616	0.32656746528135	23.9999999999573	0.444971724942361	0.642063991128332	nan
sp|Q16666|IF16_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.143539894972162	0.32656746528135	23.9999999999573	0.664201797224053	0.944724271291086	nan
sp|Q16666|IF16_HUMAN	Normal-Triple-negative breast cancer	-0.110078078091455	0.390322777382086	23.9999999999242	0.780347294944327	0.874536213214749	nan
sp|Q16678|CP1B1_HUMAN	metaplastic breast carcinomas-Normal	0.641589929745796	0.443970534068141	21.9999999614158	0.162518977312052	0.34847631330495	nan
sp|Q16678|CP1B1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.577084170145094	0.443970534068141	21.9999999615854	0.207115860665758	0.843662073010871	nan
sp|Q16678|CP1B1_HUMAN	Normal-Triple-negative breast cancer	-0.0645057596007018	0.530646284019712	21.9999999615818	0.904350408367152	0.944114559488823	nan
sp|Q16698|DECR_HUMAN	metaplastic breast carcinomas-Normal	0.0963183838540634	0.358261789171248	23.9999999997983	0.790343410833262	0.886876704217463	nan
sp|Q16698|DECR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.322337392433574	0.358261789171248	23.9999999997491	0.377205535386396	0.885234295852111	nan
sp|Q16698|DECR_HUMAN	Normal-Triple-negative breast cancer	0.226019008579511	0.428204740048803	23.9999999997386	0.60246429263479	0.754501023538688	nan
sp|Q16706|MA2A1_HUMAN	metaplastic breast carcinomas-Normal	0.338382313551532	0.334861253110104	22.0000000347373	0.323234263525932	0.530583057758122	nan
sp|Q16706|MA2A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0702523921138201	0.334861253110104	22.0000000339874	0.835757960200559	0.96926934693647	nan
sp|Q16706|MA2A1_HUMAN	Normal-Triple-negative breast cancer	-0.268129921437712	0.400235749874762	22.0000000345076	0.509873674430959	0.683670872855389	nan
sp|Q16719|KYNU_HUMAN	metaplastic breast carcinomas-Normal	-0.0752009444578486	0.622298279363157	23.99999999999	0.90482071948077	0.949235187913294	nan
sp|Q16719|KYNU_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.278813482000419	0.622298279363157	24.0000000000226	0.658143991547749	0.944190045212043	nan
sp|Q16719|KYNU_HUMAN	Normal-Triple-negative breast cancer	-0.203612537542571	0.743788707034412	24.0000000000063	0.786618561169103	0.8780121213318	nan
sp|Q16740|CLPP_HUMAN	metaplastic breast carcinomas-Normal	-0.054614103958972	0.185106422979557	22.0000000362501	0.770728445647357	0.875863710540792	nan
sp|Q16740|CLPP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.380559906280712	0.185106422979557	22.0000000364722	0.0518490692633548	0.773286317778246	nan
sp|Q16740|CLPP_HUMAN	Normal-Triple-negative breast cancer	-0.32594580232174	0.22124449251672	22.0000000361636	0.15485151171032	0.323523837162228	nan
sp|Q16762|THTR_HUMAN	metaplastic breast carcinomas-Normal	-0.276285473282298	0.377804883197141	22.000000003846	0.472319103418218	0.662749867695253	nan
sp|Q16762|THTR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.163819438095826	0.377804883197141	22.00000000459	0.668794881020059	0.946277260710207	nan
sp|Q16762|THTR_HUMAN	Normal-Triple-negative breast cancer	0.440104911378124	0.451563205143462	22.0000000042919	0.340341692537876	0.532374487527483	nan
sp|Q16775|GLO2_HUMAN	metaplastic breast carcinomas-Normal	-0.405366551518199	0.386751061010413	22.0000000553173	0.305956331339839	0.51373050538034	nan
sp|Q16775|GLO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.546676750201724	0.386751061010413	22.0000000550802	0.171499908252405	0.843662073010871	nan
sp|Q16775|GLO2_HUMAN	Normal-Triple-negative breast cancer	-0.141310198683525	0.462255932810078	22.0000000552635	0.762709305864992	0.86320930633137	nan
sp|Q16795|NDUA9_HUMAN	metaplastic breast carcinomas-Normal	0.0652248961571469	0.195746164956672	23.9999999994365	0.7418680434825	0.85741667200675	nan
sp|Q16795|NDUA9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.320330716987447	0.195746164956672	23.9999999994352	0.114791384321881	0.823891816737944	nan
sp|Q16795|NDUA9_HUMAN	Normal-Triple-negative breast cancer	-0.385555613144594	0.233961416523704	23.9999999994153	0.112395489954153	0.260281322178989	nan
sp|Q16799|RTN1_HUMAN	metaplastic breast carcinomas-Normal	-0.334526903598261	0.420796115923645	22.0000000339946	0.435115108470498	0.63185785083265	nan
sp|Q16799|RTN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.318235111576517	0.420796115923645	22.0000000332169	0.457510319655695	0.908567154037048	nan
sp|Q16799|RTN1_HUMAN	Normal-Triple-negative breast cancer	0.0162917920217442	0.502947556448732	22.0000000332557	0.974451032602482	0.98792235628412	nan
sp|Q16822|PCKGM_HUMAN	metaplastic breast carcinomas-Normal	0.599480952207853	0.31021909563358	23.9999999991493	0.0651905055062323	0.196458060111257	nan
sp|Q16822|PCKGM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.346691210075439	0.31021909563358	23.9999999993494	0.274814059282617	0.867696529950794	nan
sp|Q16822|PCKGM_HUMAN	Normal-Triple-negative breast cancer	-0.946172162283292	0.370782738263097	23.9999999992594	0.0175044424635976	0.0853149072565958	nan
sp|Q16836|HCDH_HUMAN	metaplastic breast carcinomas-Normal	-0.607179520186499	0.381792953948424	21.9999961906886	0.126027338948293	0.296587153261396	nan
sp|Q16836|HCDH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.188985308967915	0.381792953948424	21.9999961858244	0.625511745500646	0.941374262616245	nan
sp|Q16836|HCDH_HUMAN	Normal-Triple-negative breast cancer	0.418194211218584	0.456329861401445	21.9999961814751	0.369378723991386	0.559623919119128	nan
sp|Q16851|UGPA_HUMAN	metaplastic breast carcinomas-Normal	-0.584172184264443	0.284623924144382	21.9999999030613	0.0522122081634569	0.173727107042373	nan
sp|Q16851|UGPA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0944251984577306	0.284623924144382	21.9999999043115	0.743214578533479	0.954643368861838	nan
sp|Q16851|UGPA_HUMAN	Normal-Triple-negative breast cancer	0.678597382722174	0.340190657038388	21.9999999002531	0.0586043195438527	0.173156229478903	nan
sp|Q16853|AOC3_HUMAN	metaplastic breast carcinomas-Normal	-1.98333073261936	0.601242772714421	23.9999999999909	0.0030213333605864	0.0386265849638047	nan
sp|Q16853|AOC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0750490229689837	0.601242772714421	24.0000000000258	0.901703202003986	0.990735309568793	nan
sp|Q16853|AOC3_HUMAN	Normal-Triple-negative breast cancer	2.05837975558834	0.718622563103812	23.9999999999837	0.0085458960959249	0.0588076066258844	nan
sp|Q16881|TRXR1_HUMAN	metaplastic breast carcinomas-Normal	-0.965086432370415	0.34394209260204	22.9999999995862	0.0100317702041885	0.0665555756942394	nan
sp|Q16881|TRXR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.490090905546278	0.321728367851728	22.9999999997025	0.141314415886394	0.823891816737944	nan
sp|Q16881|TRXR1_HUMAN	Normal-Triple-negative breast cancer	0.474995526824138	0.403307852901815	22.9999999996509	0.25093988154454	0.440317118741841	nan
sp|Q16890|TPD53_HUMAN	metaplastic breast carcinomas-Normal	-0.477660690622068	0.489399064260029	15.0000000000678	0.344536044725217	0.555401461041039	nan
sp|Q16890|TPD53_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.49191002712546	0.489399064260029	14.9999999999673	0.0081290773023989	0.547668704418496	nan
sp|Q16890|TPD53_HUMAN	Normal-Triple-negative breast cancer	-1.01424933650339	0.584943762985068	14.9999999999842	0.103429148136418	0.247872017595857	nan
sp|Q16891|MIC60_HUMAN	metaplastic breast carcinomas-Normal	0.372548351130991	0.151215753979547	24.000000000153	0.0213038332542226	0.100019691718977	nan
sp|Q16891|MIC60_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0964968351014771	0.151215753979547	24.0000000001875	0.529424983622087	0.920197632275713	nan
sp|Q16891|MIC60_HUMAN	Normal-Triple-negative breast cancer	-0.469045186232468	0.180737395338426	24.000000000188	0.0158765825364721	0.0804478054134652	nan
sp|Q1KMD3|HNRL2_HUMAN	metaplastic breast carcinomas-Normal	0.295578840792973	0.191075629958969	23.9999999993249	0.134968492931674	0.308396253082891	nan
sp|Q1KMD3|HNRL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.376997509205073	0.191075629958969	23.9999999993695	0.0601164858753474	0.773787875546141	nan
sp|Q1KMD3|HNRL2_HUMAN	Normal-Triple-negative breast cancer	-0.672576349998046	0.228379059473552	23.9999999993558	0.0070693974580317	0.0535093121381869	nan
sp|Q27J81|INF2_HUMAN	metaplastic breast carcinomas-Normal	-0.305343984585167	0.25238197720073	22.0000000067978	0.23917709983756	0.439341552004379	nan
sp|Q27J81|INF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.249038446558362	0.25238197720073	22.0000000063688	0.334493017648606	0.870890600099115	nan
sp|Q27J81|INF2_HUMAN	Normal-Triple-negative breast cancer	0.0563055380268054	0.301654159630693	22.0000000067056	0.853640957236332	0.916802113684513	nan
sp|Q29RF7|PDS5A_HUMAN	metaplastic breast carcinomas-Normal	0.474732835178052	0.209705399043667	23.9999999994748	0.0329050893487119	0.129407306133986	nan
sp|Q29RF7|PDS5A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.137352815506935	0.209705399043667	23.9999999994748	0.518709627041016	0.91593707377131	nan
sp|Q29RF7|PDS5A_HUMAN	Normal-Triple-negative breast cancer	-0.612085650684987	0.250645892468876	23.999999999462	0.0223476444187952	0.098904085612922	nan
sp|Q2M389|WASC4_HUMAN	metaplastic breast carcinomas-Normal	-0.104424369310061	0.258971353315322	22.0000000413981	0.690672925041679	0.818757775620021	nan
sp|Q2M389|WASC4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0930728646212993	0.258971353315322	22.0000000414414	0.722726671765784	0.952374507131316	nan
sp|Q2M389|WASC4_HUMAN	Normal-Triple-negative breast cancer	0.19749723393136	0.309529970480519	22.0000000413301	0.530023785852805	0.698295308828665	nan
sp|Q2NL82|TSR1_HUMAN	metaplastic breast carcinomas-Normal	0.827568165158173	0.26473498538153	21.9999999689996	0.0049163880216537	0.0470009737236255	nan
sp|Q2NL82|TSR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.35760594920201	0.26473498538153	21.9999999694735	0.190488183695288	0.843662073010871	nan
sp|Q2NL82|TSR1_HUMAN	Normal-Triple-negative breast cancer	-0.469962215956163	0.316418828419727	21.999999970266	0.151665981838172	0.31972470314917	nan
sp|Q2TAA2|IAH1_HUMAN	metaplastic breast carcinomas-Normal	-0.388481914276193	0.154261039910114	24.0000000000245	0.0188667644517975	0.0929781777313555	nan
sp|Q2TAA2|IAH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.246349149600535	0.154261039910114	24.0000000000235	0.123358559056064	0.823891816737944	nan
sp|Q2TAA2|IAH1_HUMAN	Normal-Triple-negative breast cancer	0.142132764675658	0.184377208206242	24.0000000000425	0.448300983311643	0.631956093523283	nan
sp|Q32MZ4|LRRF1_HUMAN	metaplastic breast carcinomas-Normal	0.160766234607261	0.246726254834495	22.000000342089	0.521410193705434	0.702436882783103	nan
sp|Q32MZ4|LRRF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.077666443328728	0.246726254834495	22.0000003416696	0.755888817983554	0.954748610837524	nan
sp|Q32MZ4|LRRF1_HUMAN	Normal-Triple-negative breast cancer	-0.23843267793599	0.294894278452116	22.0000003415304	0.42743941302033	0.613583601013223	nan
sp|Q32P28|P3H1_HUMAN	metaplastic breast carcinomas-Normal	1.07060810608803	0.331178326051453	24.0000000001524	0.0035477772843813	0.0407324763980233	nan
sp|Q32P28|P3H1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.438423276212291	0.331178326051453	24.0000000001227	0.198031713314597	0.843662073010871	nan
sp|Q32P28|P3H1_HUMAN	Normal-Triple-negative breast cancer	-0.632184829875742	0.395833810088171	24.0000000001525	0.123328675672916	0.277022255921903	nan
sp|Q3KQU3|MA7D1_HUMAN	metaplastic breast carcinomas-Normal	-0.526422602485538	0.54224953659779	22.0000000052519	0.342194983572551	0.552431338220086	nan
sp|Q3KQU3|MA7D1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.198724555199098	0.54224953659779	22.0000000049737	0.717506650903958	0.949812109346858	nan
sp|Q3KQU3|MA7D1_HUMAN	Normal-Triple-negative breast cancer	0.725147157684636	0.648112159539995	22.0000000051795	0.275267795999073	0.467294409809389	nan
sp|Q3LXA3|TKFC_HUMAN	metaplastic breast carcinomas-Normal	-0.465083995105061	0.181480680049427	22.0000013528353	0.0177489327628967	0.0899351410119947	nan
sp|Q3LXA3|TKFC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.423460616051282	0.181480680049427	22.00000135318	0.0291702047406763	0.721684569712558	nan
sp|Q3LXA3|TKFC_HUMAN	Normal-Triple-negative breast cancer	0.0416233790537792	0.216910900836537	22.0000013528201	0.849587255400714	0.913962261648839	nan
sp|Q3MHD2|LSM12_HUMAN	metaplastic breast carcinomas-Normal	0.443776557229681	0.392777805608544	23.9999999997255	0.269709170114225	0.472595298608161	nan
sp|Q3MHD2|LSM12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.359563783085448	0.392777805608544	23.9999999997677	0.369068532923438	0.883542279876718	nan
sp|Q3MHD2|LSM12_HUMAN	Normal-Triple-negative breast cancer	-0.803340340315129	0.469459270374915	23.9999999997982	0.0999397955189899	0.242945346721989	nan
sp|Q3SY69|AL1L2_HUMAN	metaplastic breast carcinomas-Normal	0.098643190564106	0.318460042647545	21.999966752784	0.759665560644884	0.868338488164922	nan
sp|Q3SY69|AL1L2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.32742843684025	0.318460042647545	21.9999667564285	0.315046036346338	0.867696529950794	nan
sp|Q3SY69|AL1L2_HUMAN	Normal-Triple-negative breast cancer	0.228785246276144	0.380632553902197	21.9999667547404	0.553939261105326	0.718133425863536	nan
sp|Q3ZCQ8|TIM50_HUMAN	metaplastic breast carcinomas-Normal	0.317138293941252	0.24275542755796	22.0000037814628	0.204906647677753	0.398876426107058	nan
sp|Q3ZCQ8|TIM50_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.678634200660413	0.24275542755796	22.0000037814645	0.0105415931076041	0.547668704418496	nan
sp|Q3ZCQ8|TIM50_HUMAN	Normal-Triple-negative breast cancer	-0.995772494601664	0.290148232088476	22.0000037816127	0.0023824146037423	0.0328595275636502	nan
sp|Q460N5|PAR14_HUMAN	metaplastic breast carcinomas-Normal	0.220056562348212	0.340862645379363	21.0750650424915	0.525513966929314	0.703790663204286	nan
sp|Q460N5|PAR14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.254985701828125	0.340862645379363	21.0750650415135	0.462690631231673	0.909423669537079	nan
sp|Q460N5|PAR14_HUMAN	Normal-Triple-negative breast cancer	0.0349291394799139	0.403231575536744	21.022391528941	0.931790935911267	0.962453172165297	nan
sp|Q49A26|GLYR1_HUMAN	metaplastic breast carcinomas-Normal	0.47941798865854	0.302227159499244	22.0000037181306	0.126944951915127	0.297787593624475	nan
sp|Q49A26|GLYR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0673237949347055	0.302227159499244	22.0000037182233	0.82577832552834	0.965774701272009	nan
sp|Q49A26|GLYR1_HUMAN	Normal-Triple-negative breast cancer	-0.546741783593246	0.361230547551365	22.0000037179102	0.144373851681928	0.308616516392751	nan
sp|Q4G0F5|VP26B_HUMAN	metaplastic breast carcinomas-Normal	-0.0076613007812009	0.301326478355817	23.9999999998893	0.979925998799807	0.989752057128702	nan
sp|Q4G0F5|VP26B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.468887060538451	0.301326478355817	23.9999999998882	0.132779518744538	0.823891816737944	nan
sp|Q4G0F5|VP26B_HUMAN	Normal-Triple-negative breast cancer	-0.46122575975725	0.360154027680853	23.9999999998992	0.212560370069358	0.395383698998627	nan
sp|Q4G0J3|LARP7_HUMAN	metaplastic breast carcinomas-Normal	-0.201539272969142	0.141806475305811	6.0	0.205078162520145	0.398876426107058	nan
sp|Q4G0J3|LARP7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.155416342334014	0.141806475305811	6.0	0.315119407870039	0.867696529950794	nan
sp|Q4G0J3|LARP7_HUMAN	Normal-Triple-negative breast cancer	0.0461229306351285	0.169491156274377	6.0	0.794647207537418	0.882528338741857	nan
sp|Q4G0N4|NAKD2_HUMAN	metaplastic breast carcinomas-Normal	-0.0105209886247745	0.252417632166466	24.0000000002832	0.967097919627008	0.983971069739876	nan
sp|Q4G0N4|NAKD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.100024231583439	0.252417632166466	24.0000000002832	0.695410871859613	0.947043345959522	nan
sp|Q4G0N4|NAKD2_HUMAN	Normal-Triple-negative breast cancer	0.110545220208214	0.301696775465806	24.0000000003059	0.717268350411487	0.835974753424888	nan
sp|Q4KWH8|PLCH1_HUMAN	metaplastic breast carcinomas-Normal	-0.213523468787129	0.168529575286061	22.0000000111401	0.218411634764807	0.415807717043653	nan
sp|Q4KWH8|PLCH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0541219605069796	0.168529575286061	22.0000000111401	0.75113355995921	0.954643368861838	nan
sp|Q4KWH8|PLCH1_HUMAN	Normal-Triple-negative breast cancer	0.267645429294108	0.201431369900875	22.0000000112615	0.197559242248388	0.3786926489393	nan
sp|Q4V328|GRAP1_HUMAN	metaplastic breast carcinomas-Normal	0.16367894430371	0.31641188094734	14.9999999996365	0.612492595291102	0.767983925593218	nan
sp|Q4V328|GRAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0082791673356758	0.31641188094734	14.9999999996568	0.979470036624595	0.99709406933403	nan
sp|Q4V328|GRAP1_HUMAN	Normal-Triple-negative breast cancer	-0.171958111639386	0.378184532441569	14.9999999996236	0.65584071012755	0.797371807046078	nan
sp|Q4VC31|MIX23_HUMAN	metaplastic breast carcinomas-Normal	0.553801431457888	0.28561489919404	14.0000001782472	0.0729302736060667	0.21069790454644	nan
sp|Q4VC31|MIX23_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0185942228781389	0.28561489919404	14.0000001784148	0.949012940358429	0.996541950781621	nan
sp|Q4VC31|MIX23_HUMAN	Normal-Triple-negative breast cancer	-0.535207208579749	0.341375098768876	14.000000178173	0.139247442556908	0.301144111294185	nan
sp|Q4ZHG4|FNDC1_HUMAN	metaplastic breast carcinomas-Normal	-0.174990890307843	0.405303857609173	23.9999999995609	0.669775409013138	0.807227505279068	nan
sp|Q4ZHG4|FNDC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.68111137331558	0.405303857609173	23.9999999995597	0.105832276560232	0.822178316735448	nan
sp|Q4ZHG4|FNDC1_HUMAN	Normal-Triple-negative breast cancer	-0.506120483007737	0.484430766088077	23.9999999996327	0.306537161586822	0.499185641678237	nan
sp|Q52LJ0|FA98B_HUMAN	metaplastic breast carcinomas-Normal	0.327325387747055	0.184086972353853	22.0000000187856	0.0892130842308251	0.241092920311596	nan
sp|Q52LJ0|FA98B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0668203493763168	0.184086972353853	22.0000000199216	0.720082209405495	0.951268548117182	nan
sp|Q52LJ0|FA98B_HUMAN	Normal-Triple-negative breast cancer	-0.394145737123371	0.220026015963075	22.0000000190263	0.0870042579582761	0.222463194964084	nan
sp|Q53EL6|PDCD4_HUMAN	metaplastic breast carcinomas-Normal	-0.13040656689758	0.296474235181088	24.0000000000461	0.663975596717081	0.803149520919788	nan
sp|Q53EL6|PDCD4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0543135115302239	0.296474235181088	24.0000000000461	0.8561814677635	0.977691255315669	nan
sp|Q53EL6|PDCD4_HUMAN	Normal-Triple-negative breast cancer	0.0760930553673565	0.35435448781897	23.9999999999914	0.831786486434753	0.905361542648761	nan
sp|Q53EP0|FND3B_HUMAN	metaplastic breast carcinomas-Normal	1.07963853010476	0.283634080066718	23.9999999995704	0.0008580383535902	0.0227210419054423	nan
sp|Q53EP0|FND3B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.63856763701991	0.283634080066718	23.9999999993312	0.0337891565219532	0.724424466074313	nan
sp|Q53EP0|FND3B_HUMAN	Normal-Triple-negative breast cancer	-0.441070893084851	0.339007567077983	23.9999999995026	0.205589310784321	0.387171523124631	nan
sp|Q53ET0|CRTC2_HUMAN	metaplastic breast carcinomas-Normal	0.448789374594493	0.377059787180292	14.0000000879512	0.253746644731219	0.454937350100632	nan
sp|Q53ET0|CRTC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.21267117889007	0.377059787180292	14.0000000879103	0.581660602469391	0.93702592209822	nan
sp|Q53ET0|CRTC2_HUMAN	Normal-Triple-negative breast cancer	-0.661460553484563	0.450672645067423	14.0000000878471	0.16428583252142	0.334611585356127	nan
sp|Q53FA7|QORX_HUMAN	metaplastic breast carcinomas-Normal	-0.244221354516434	0.299280311860977	21.9999998965736	0.423231579309291	0.621951157325291	nan
sp|Q53FA7|QORX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.497867829020954	0.299280311860977	21.9999998993884	0.110383880635077	0.823891816737944	nan
sp|Q53FA7|QORX_HUMAN	Normal-Triple-negative breast cancer	0.742089183537388	0.357708390946759	21.9999998989455	0.0499300531388907	0.155838025008143	nan
sp|Q53GG5|PDLI3_HUMAN	metaplastic breast carcinomas-Normal	0.0150773991247947	0.394662180220658	22.9999999997966	0.96985525235185	0.985850443565172	nan
sp|Q53GG5|PDLI3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.43017154576376	0.394662180220658	22.9999999997966	0.287012978187708	0.867696529950794	nan
sp|Q53GG5|PDLI3_HUMAN	Normal-Triple-negative breast cancer	-0.445248944888554	0.466970589111491	22.9999999998221	0.350259111522842	0.541013609062233	nan
sp|Q53GL7|PAR10_HUMAN	metaplastic breast carcinomas-Normal	0.233070538912025	0.323380882779312	23.9999999993821	0.478037309470958	0.667645385160279	nan
sp|Q53GL7|PAR10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.670185382432274	0.323380882779312	23.9999999993821	0.0491324652663114	0.764019040906631	nan
sp|Q53GL7|PAR10_HUMAN	Normal-Triple-negative breast cancer	0.437114843520249	0.386514082809646	23.9999999994037	0.269265539285458	0.461070415542857	nan
sp|Q53GQ0|DHB12_HUMAN	metaplastic breast carcinomas-Normal	-0.0656087528408496	0.271893470866968	23.9999999988979	0.811369851046035	0.900925915386606	nan
sp|Q53GQ0|DHB12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.708124925316947	0.271893470866968	23.9999999991569	0.0155482256748582	0.656412655960811	nan
sp|Q53GQ0|DHB12_HUMAN	Normal-Triple-negative breast cancer	-0.642516172476097	0.324974855071427	23.9999999990321	0.0596239819513193	0.175544832600696	nan
sp|Q53H12|AGK_HUMAN	metaplastic breast carcinomas-Normal	0.230792013797844	0.311163335209139	14.0000000049896	0.470525384455482	0.661881666495989	nan
sp|Q53H12|AGK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0426562088812098	0.311163335209139	14.0000000048927	0.892914586933584	0.988218752026376	nan
sp|Q53H12|AGK_HUMAN	Normal-Triple-negative breast cancer	-0.273448222679054	0.371911320417871	14.0000000049289	0.474324404545865	0.652858931971204	nan
sp|Q53H96|P5CR3_HUMAN	metaplastic breast carcinomas-Normal	0.215235482509127	0.368224490998863	21.3874322833344	0.564984533334667	0.732167091151825	nan
sp|Q53H96|P5CR3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.304801627694847	0.343770051659415	21.073298658844	0.385277699462872	0.885234295852111	nan
sp|Q53H96|P5CR3_HUMAN	Normal-Triple-negative breast cancer	0.0895661451857199	0.431551764094802	21.3040951707063	0.837555839554732	0.908035098069123	nan
sp|Q53LP3|SWAHC_HUMAN	metaplastic breast carcinomas-Normal	-0.0808800800810411	0.30084896460211	21.9999999996816	0.790558265522366	0.886876704217463	nan
sp|Q53LP3|SWAHC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.213133208009056	0.28177087167538	21.9999999997975	0.457429882812342	0.908567154037048	nan
sp|Q53LP3|SWAHC_HUMAN	Normal-Triple-negative breast cancer	0.294013288090098	0.349668456043783	21.9999999997333	0.409486936444418	0.597658705349739	nan
sp|Q53TN4|CYBR1_HUMAN	metaplastic breast carcinomas-Normal	-0.623013418827787	0.42217443103822	6.0	0.190471331400189	0.383945849347621	nan
sp|Q53TN4|CYBR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.393336385430165	0.42217443103822	6.0	0.387449848658741	0.885234295852111	nan
sp|Q53TN4|CYBR1_HUMAN	Normal-Triple-negative breast cancer	1.01634980425795	0.50459495810635	6.0	0.0906269856736005	0.227804277243905	nan
sp|Q562E7|WDR81_HUMAN	metaplastic breast carcinomas-Normal	0.343250401175196	0.28632000714585	14.0000000113192	0.25049126707526	0.451047113628475	nan
sp|Q562E7|WDR81_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.215451891188686	0.28632000714585	14.0000000111003	0.464223843972265	0.909423669537079	nan
sp|Q562E7|WDR81_HUMAN	Normal-Triple-negative breast cancer	-0.12779850998651	0.342217863965548	14.0000000111234	0.714413575201539	0.834097504094609	nan
sp|Q562R1|ACTBL_HUMAN	metaplastic breast carcinomas-Normal	0.564337027743596	0.278228514401571	20.8438952140538	0.0554981302488883	0.179470650068388	nan
sp|Q562R1|ACTBL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.550732915987778	0.232829886694272	20.1098097477025	0.028168268552308	0.721684569712558	nan
sp|Q562R1|ACTBL_HUMAN	Normal-Triple-negative breast cancer	-0.0136041117558174	0.31724416284103	20.6871523446507	0.966206686607227	0.982929910189078	nan
sp|Q567U6|CCD93_HUMAN	metaplastic breast carcinomas-Normal	-0.256757203241148	0.306863725294682	6.0	0.434805464161432	0.63185785083265	nan
sp|Q567U6|CCD93_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0148333621838689	0.306863725294682	6.0	0.963015271484942	0.99709406933403	nan
sp|Q567U6|CCD93_HUMAN	Normal-Triple-negative breast cancer	0.271590565425017	0.366772303639134	6.0	0.486958812393646	0.664743775111491	nan
sp|Q56VL3|OCAD2_HUMAN	metaplastic breast carcinomas-Normal	0.119159418783719	0.446114603232463	23.9999999998319	0.791670190846845	0.887345906640773	nan
sp|Q56VL3|OCAD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.847368244924681	0.446114603232463	23.9999999998319	0.0695897638894239	0.781899532609971	nan
sp|Q56VL3|OCAD2_HUMAN	Normal-Triple-negative breast cancer	-0.9665276637084	0.533208936825302	23.9999999998239	0.0824127996083903	0.215361749920039	nan
sp|Q58FF6|H90B4_HUMAN	metaplastic breast carcinomas-Normal	0.648865341320883	0.257962500321466	24.0000000002705	0.018993247466497	0.0932548812092111	nan
sp|Q58FF6|H90B4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.318319465361708	0.257962500321466	24.000000000272	0.229159648075833	0.843662073010871	nan
sp|Q58FF6|H90B4_HUMAN	Normal-Triple-negative breast cancer	-0.967184806682591	0.308324160519649	24.0000000002187	0.0044726146623807	0.0428442972269558	nan
sp|Q5F1R6|DJC21_HUMAN	metaplastic breast carcinomas-Normal	0.0308695973976796	0.368901410824916	14.9999999995438	0.934417568558426	0.964897172379064	nan
sp|Q5F1R6|DJC21_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.044430418096815	0.368901410824915	14.9999999995148	0.905733201581074	0.992888981494585	nan
sp|Q5F1R6|DJC21_HUMAN	Normal-Triple-negative breast cancer	0.0135608206991353	0.44092152024176	14.9999999995176	0.975869917550812	0.988457088173338	nan
sp|Q5GLZ8|HERC4_HUMAN	metaplastic breast carcinomas-Normal	0.155934260922492	0.224167608635476	14.0000000014252	0.498055406705533	0.684494052686852	nan
sp|Q5GLZ8|HERC4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.261636894370323	0.224167608635476	14.000000001695	0.2626458444212	0.86431258289795	nan
sp|Q5GLZ8|HERC4_HUMAN	Normal-Triple-negative breast cancer	-0.417571155292816	0.267931539127197	14.0000000014096	0.141428298377329	0.304079989525384	nan
sp|Q5H9R7|PP6R3_HUMAN	metaplastic breast carcinomas-Normal	0.150227089212298	0.188954421870586	21.9999999757588	0.435081885191149	0.63185785083265	nan
sp|Q5H9R7|PP6R3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.116999299574765	0.188954421870586	21.9999999775629	0.542148676562373	0.923837171685362	nan
sp|Q5H9R7|PP6R3_HUMAN	Normal-Triple-negative breast cancer	-0.267226388787063	0.225843730879965	21.999999977252	0.249344694301275	0.438066471383425	nan
sp|Q5HYK7|SH319_HUMAN	metaplastic breast carcinomas-Normal	0.594274632702457	0.370240896374702	21.9999703791183	0.122731431519247	0.292234440093108	nan
sp|Q5HYK7|SH319_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.179507755800383	0.370240896374702	21.9999703788173	0.632582090606687	0.941868024951375	nan
sp|Q5HYK7|SH319_HUMAN	Normal-Triple-negative breast cancer	-0.414766876902073	0.442522511692654	21.9999703797422	0.358791557138175	0.549849301948959	nan
sp|Q5JRA6|TGO1_HUMAN	metaplastic breast carcinomas-Normal	0.146091506575017	0.14812304223671	22.0000000250636	0.334717098455388	0.543261540657086	nan
sp|Q5JRA6|TGO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0475496914801516	0.14812304223671	22.0000000252992	0.75122879660223	0.954643368861838	nan
sp|Q5JRA6|TGO1_HUMAN	Normal-Triple-negative breast cancer	-0.193641198055168	0.177040897782963	22.0000000248088	0.285889697255797	0.47801677750416	nan
sp|Q5JRX3|PREP_HUMAN	metaplastic breast carcinomas-Normal	-0.0264639768364764	0.265874518728811	21.9999998489742	0.921614471876367	0.95843058885501	nan
sp|Q5JRX3|PREP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.870498113128356	0.265874518728811	21.9999998481406	0.0034686458774963	0.475304411992737	nan
sp|Q5JRX3|PREP_HUMAN	Normal-Triple-negative breast cancer	-0.844034136291879	0.317780831277688	21.999999844476	0.014431100143141	0.0775931085810159	nan
sp|Q5JSH3|WDR44_HUMAN	metaplastic breast carcinomas-Normal	-0.970597580510958	0.54365057871523	6.0	0.124454360425372	0.295324050474406	nan
sp|Q5JSH3|WDR44_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.354333677385998	0.54365057871523	6.0	0.538700527807885	0.921388505638487	nan
sp|Q5JSH3|WDR44_HUMAN	Normal-Triple-negative breast cancer	1.32493125789696	0.649786725161642	6.0	0.0875625607972325	0.223375251028397	nan
sp|Q5JTH9|RRP12_HUMAN	metaplastic breast carcinomas-Normal	0.591200812260617	0.249171527272152	14.0000000953182	0.0325258189752904	0.129407306133986	nan
sp|Q5JTH9|RRP12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.170744970482103	0.249171527272152	14.0000000950311	0.504374452241854	0.913320451076758	nan
sp|Q5JTH9|RRP12_HUMAN	Normal-Triple-negative breast cancer	-0.761945782742719	0.297816938027221	14.0000000951039	0.0227421095597429	0.0998762571754838	nan
sp|Q5JTV8|TOIP1_HUMAN	metaplastic breast carcinomas-Normal	0.362811352618075	0.228956739391914	24.0000000001436	0.126140429801192	0.296587153261396	nan
sp|Q5JTV8|TOIP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.085834462630983	0.228956739391914	24.0000000001436	0.711031944469765	0.94948208919602	nan
sp|Q5JTV8|TOIP1_HUMAN	Normal-Triple-negative breast cancer	-0.448645815249058	0.273655645221135	24.000000000177	0.114162716811348	0.263525604639529	nan
sp|Q5K4L6|S27A3_HUMAN	metaplastic breast carcinomas-Normal	-1.0803805745445	0.258828651222602	23.9999999998575	0.0003390561458711	0.0175553082899795	nan
sp|Q5K4L6|S27A3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.209570426888808	0.258828651222602	23.9999999996173	0.426074945347512	0.892690102886249	nan
sp|Q5K4L6|S27A3_HUMAN	Normal-Triple-negative breast cancer	1.2899510014333	0.309359408856688	23.9999999997393	0.000342832010057	0.0227914720285933	nan
sp|Q5KU26|COL12_HUMAN	metaplastic breast carcinomas-Normal	-0.33116743319831	0.702615459565614	6.0	0.65405130818355	0.796069772391842	nan
sp|Q5KU26|COL12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	2.43690132859211	0.702615459565614	6.0	0.0133309722983584	0.624302575944249	nan
sp|Q5KU26|COL12_HUMAN	Normal-Triple-negative breast cancer	2.76806876179042	0.839786098633454	6.0	0.0164866352957396	0.0825324935587927	nan
sp|Q5M775|CYTSB_HUMAN	metaplastic breast carcinomas-Normal	-0.680094364293341	0.469840772811913	12.1414789610524	0.173080977790149	0.361439499568716	nan
sp|Q5M775|CYTSB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.281454465878211	0.469840772811913	12.1414789613356	0.560156275761754	0.933033207887896	nan
sp|Q5M775|CYTSB_HUMAN	Normal-Triple-negative breast cancer	0.961548830171552	0.54126596989722	12.0000000027726	0.100990337780364	0.244442731665984	nan
sp|Q5MNZ6|WIPI3_HUMAN	metaplastic breast carcinomas-Normal	0.195603375007926	0.217246035787023	20.1231423862768	0.378569001648875	0.584741338978095	nan
sp|Q5MNZ6|WIPI3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.371961373607708	0.202024993557372	20.0339136258513	0.0804554258955427	0.806849600316436	nan
sp|Q5MNZ6|WIPI3_HUMAN	Normal-Triple-negative breast cancer	-0.567564748615634	0.251493904636981	20.0730471578532	0.0353248876930907	0.125987045806688	nan
sp|Q5QJE6|TDIF2_HUMAN	metaplastic breast carcinomas-Normal	0.939612571771573	0.380111190137277	14.0000000040624	0.0268835867399074	0.116355523858662	nan
sp|Q5QJE6|TDIF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.375723953286583	0.380111190137277	14.0000000041241	0.339705047446251	0.870943310236299	nan
sp|Q5QJE6|TDIF2_HUMAN	Normal-Triple-negative breast cancer	-0.56388861848499	0.454319769180219	14.0000000041727	0.234937542850047	0.419630517159353	nan
sp|Q5SRE5|NU188_HUMAN	metaplastic breast carcinomas-Normal	0.697268797053284	0.179963506193325	23.9999999994069	0.0007231069942201	0.0221825773337916	nan
sp|Q5SRE5|NU188_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.19316255420171	0.179963506193325	23.9999999994054	0.293791322508586	0.867696529950794	nan
sp|Q5SRE5|NU188_HUMAN	Normal-Triple-negative breast cancer	-0.890431351254994	0.215097531238389	23.9999999994033	0.0003700084911586	0.023652081242523	nan
sp|Q5SRE7|PHYD1_HUMAN	metaplastic breast carcinomas-Normal	-2.15171475794364	0.798276407088487	6.0	0.0357920087281461	0.137223341421404	nan
sp|Q5SRE7|PHYD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.990078745174387	0.798276407088487	6.0	0.261175412588393	0.864087807817319	nan
sp|Q5SRE7|PHYD1_HUMAN	Normal-Triple-negative breast cancer	1.16163601276926	0.954122799908828	6.0	0.269123018269556	0.461070415542857	nan
sp|Q5SSJ5|HP1B3_HUMAN	metaplastic breast carcinomas-Normal	0.218709551827196	0.191743209709717	21.9999999610683	0.266286168416836	0.469318782511964	nan
sp|Q5SSJ5|HP1B3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.10945565411405	0.191743209709717	21.9999999610754	0.573890046759655	0.935843259183841	nan
sp|Q5SSJ5|HP1B3_HUMAN	Normal-Triple-negative breast cancer	-0.328165205941245	0.229176969890658	21.9999999609841	0.16621933054886	0.337103755182679	nan
sp|Q5SW79|CE170_HUMAN	metaplastic breast carcinomas-Normal	0.14215692830825	0.321505871000757	21.0154634731005	0.662890532064824	0.802822376058803	nan
sp|Q5SW79|CE170_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.12097119652503	0.321505871000757	21.0154634719687	0.710492232648573	0.94948208919602	nan
sp|Q5SW79|CE170_HUMAN	Normal-Triple-negative breast cancer	-0.0211857317832198	0.380249509274511	20.9792702711909	0.956095786231786	0.977865351825987	nan
sp|Q5T1M5|FKB15_HUMAN	metaplastic breast carcinomas-Normal	0.387467388011658	0.207821577918755	22.0000000348504	0.0756604304466962	0.215505801889304	nan
sp|Q5T1M5|FKB15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.274975484727239	0.207821577918755	22.0000000347498	0.199379267957971	0.843662073010871	nan
sp|Q5T1M5|FKB15_HUMAN	Normal-Triple-negative breast cancer	-0.112491903284419	0.248394295565513	22.0000000348361	0.655072483012556	0.797031075258555	nan
sp|Q5T4B2|GT253_HUMAN	metaplastic breast carcinomas-Normal	0.358176641190765	0.666698165444231	14.0000000768693	0.599537602226422	0.757454576130987	nan
sp|Q5T4B2|GT253_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.277322038204133	0.666698165444231	14.0000000768655	0.683742743005209	0.946568877415162	nan
sp|Q5T4B2|GT253_HUMAN	Normal-Triple-negative breast cancer	-0.0808546029866317	0.7968567211297	14.0000000771042	0.920618704223489	0.954023817439307	nan
sp|Q5T4S7|UBR4_HUMAN	metaplastic breast carcinomas-Normal	0.140554636551166	0.116600207611961	22.0000000841207	0.240839238354599	0.44107417536677	nan
sp|Q5T4S7|UBR4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.233073502415374	0.116600207611961	22.0000000844854	0.0581215646969626	0.773787875546141	nan
sp|Q5T4S7|UBR4_HUMAN	Normal-Triple-negative breast cancer	-0.37362813896654	0.139363903992146	22.0000000847267	0.0136490275036953	0.0754897960437323	nan
sp|Q5T5P2|SKT_HUMAN	metaplastic breast carcinomas-Normal	0.15259571829978	0.245916482555608	23.9999999993152	0.540764789592346	0.715851119316988	nan
sp|Q5T5P2|SKT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.177646829357079	0.245916482555608	23.9999999993152	0.477037315820855	0.913280230088743	nan
sp|Q5T5P2|SKT_HUMAN	Normal-Triple-negative breast cancer	-0.330242547656859	0.293926415457345	23.999999999307	0.272315254039478	0.463995415682386	nan
sp|Q5T619|ZN648_HUMAN	metaplastic breast carcinomas-Normal	-0.490085450971277	0.79082737003128	22.0000000180695	0.541813038470554	0.716667942648676	nan
sp|Q5T619|ZN648_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.710383725814715	0.79082737003128	22.0000000180046	0.378763095805125	0.885234295852111	nan
sp|Q5T619|ZN648_HUMAN	Normal-Triple-negative breast cancer	1.20046917678599	0.945219497706063	22.0000000183738	0.217338451653981	0.399629682999854	nan
sp|Q5T6F2|UBAP2_HUMAN	metaplastic breast carcinomas-Normal	0.852355913011554	0.513795895839867	13.9999999998853	0.119354498736849	0.286037746071584	nan
sp|Q5T6F2|UBAP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.13673471857773	0.461757123730802	13.9999999999368	0.771486819752895	0.959745866833315	nan
sp|Q5T6F2|UBAP2_HUMAN	Normal-Triple-negative breast cancer	-0.989090631589284	0.596125883400678	13.9999999998963	0.119301700643589	0.271801818327135	nan
sp|Q5T6V5|QSPP_HUMAN	metaplastic breast carcinomas-Normal	-0.37254523542529	0.315266610845194	22.0000060312574	0.249947733166171	0.450312338777427	nan
sp|Q5T6V5|QSPP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.159131356662184	0.315266610845194	22.0000060312157	0.618751900782151	0.941374262616245	nan
sp|Q5T6V5|QSPP_HUMAN	Normal-Triple-negative breast cancer	0.531676592087474	0.376815672850069	22.0000060311898	0.172237979027208	0.345117520686375	nan
sp|Q5T8P6|RBM26_HUMAN	metaplastic breast carcinomas-Normal	0.84512767302417	0.9490614998731	5.0	0.413994408224223	0.615740710196163	nan
sp|Q5T8P6|RBM26_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.264467205771254	0.724857693722801	5.0	0.730144428872326	0.954643368861838	nan
sp|Q5T8P6|RBM26_HUMAN	Normal-Triple-negative breast cancer	-0.580660467252916	1.06108301427208	5.0	0.607747113523935	0.758599851803815	nan
sp|Q5TFE4|NT5D1_HUMAN	metaplastic breast carcinomas-Normal	0.154586909230062	0.347024055112949	23.9999999997643	0.659976443305454	0.80093526745065	nan
sp|Q5TFE4|NT5D1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.217709708872979	0.347024055112949	23.9999999997643	0.536345559371077	0.921388505638487	nan
sp|Q5TFE4|NT5D1_HUMAN	Normal-Triple-negative breast cancer	-0.372296618103041	0.414773078798231	23.9999999997273	0.378320089527493	0.566133039990803	nan
sp|Q5VT52|RPRD2_HUMAN	metaplastic breast carcinomas-Normal	0.0856306742820449	0.262799735563356	22.0000000297252	0.747624406291494	0.860108189651783	nan
sp|Q5VT52|RPRD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.432376069756071	0.262799735563356	22.0000000301663	0.11412838736219	0.823891816737944	nan
sp|Q5VT52|RPRD2_HUMAN	Normal-Triple-negative breast cancer	-0.518006744038116	0.314105762470836	22.0000000298599	0.113325021098904	0.261955751135437	nan
sp|Q5VTR2|BRE1A_HUMAN	metaplastic breast carcinomas-Normal	0.259899629683102	0.623173784380551	14.0000001477946	0.682960498124494	0.815009772846929	nan
sp|Q5VTR2|BRE1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.164893317596501	0.623173784380551	14.0000001481699	0.795171427973509	0.964785038807592	nan
sp|Q5VTR2|BRE1A_HUMAN	Normal-Triple-negative breast cancer	-0.0950063120866016	0.744835135678817	14.0000001482235	0.900316381481389	0.941381457075854	nan
sp|Q5VUA4|ZN318_HUMAN	metaplastic breast carcinomas-Normal	1.69606999977536	0.625073211944088	10.9999999999055	0.0201681731578432	0.0964013903004072	nan
sp|Q5VUA4|ZN318_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.32415230005448	0.484179628003966	10.9999999998601	0.516990486896274	0.915620969865368	nan
sp|Q5VUA4|ZN318_HUMAN	Normal-Triple-negative breast cancer	-2.02022229982985	0.684733396547969	10.9999999998979	0.0132004706189988	0.0746230686012789	nan
sp|Q5VV41|ARHGG_HUMAN	metaplastic breast carcinomas-Normal	0.0450058862847512	0.488942339796623	21.3016231055051	0.927520527256521	0.961059299439113	nan
sp|Q5VV41|ARHGG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.172170048661955	0.45616476120813	21.0307512998515	0.709636458419048	0.94948208919602	nan
sp|Q5VV41|ARHGG_HUMAN	Normal-Triple-negative breast cancer	0.127164162377204	0.57292621684332	21.2295087050506	0.826469721210455	0.901307530611401	nan
sp|Q5VW32|BROX_HUMAN	metaplastic breast carcinomas-Normal	0.356391088252537	0.289339485546823	23.9999999999667	0.229978933744365	0.429707687333485	nan
sp|Q5VW32|BROX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.578702915219859	0.289339485546823	23.9999999997379	0.0569303364044486	0.773787875546141	nan
sp|Q5VW32|BROX_HUMAN	Normal-Triple-negative breast cancer	-0.935094003472396	0.345826830935658	23.9999999998483	0.0123942682885386	0.072025433201228	nan
sp|Q5VW36|FOCAD_HUMAN	metaplastic breast carcinomas-Normal	0.74452437864421	0.33041302372061	13.0822711031687	0.0420294195786039	0.152285044160049	nan
sp|Q5VW36|FOCAD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0510102037931468	0.295163221224846	13.00000000456	0.865454340994674	0.980530611231673	nan
sp|Q5VW36|FOCAD_HUMAN	Normal-Triple-negative breast cancer	-0.795534582437356	0.382766871458119	13.0615668976793	0.0579443516986813	0.172124240434689	nan
sp|Q5VWZ2|LYPL1_HUMAN	metaplastic breast carcinomas-Normal	-0.263696162490731	0.231032961419758	22.0000000174302	0.265984322356991	0.469035484092645	nan
sp|Q5VWZ2|LYPL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.522614875659234	0.231032961419758	22.0000000181616	0.0339130862788171	0.724424466074313	nan
sp|Q5VWZ2|LYPL1_HUMAN	Normal-Triple-negative breast cancer	-0.258918713168503	0.276137205188144	22.0000000178053	0.358607242360488	0.54982032915418	nan
sp|Q5VYK3|ECM29_HUMAN	metaplastic breast carcinomas-Normal	0.259388490502938	0.12336440249376	23.9999999995359	0.0461709151682478	0.161210212205101	nan
sp|Q5VYK3|ECM29_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.124767818983836	0.12336440249376	23.9999999995359	0.321924866061943	0.867696529950794	nan
sp|Q5VYK3|ECM29_HUMAN	Normal-Triple-negative breast cancer	-0.384156309486774	0.147448663233985	23.9999999995623	0.0155153444092971	0.079221205555305	nan
sp|Q5VZ89|DEN4C_HUMAN	metaplastic breast carcinomas-Normal	-0.173495917756086	0.341762243674107	14.9999999999196	0.619080629125999	0.771757642090732	nan
sp|Q5VZ89|DEN4C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.178083160179143	0.341762243674107	14.9999999999196	0.609922932301301	0.940559810632461	nan
sp|Q5VZ89|DEN4C_HUMAN	Normal-Triple-negative breast cancer	-0.0045872424230566	0.408484011229605	14.9999999999676	0.991188008963151	0.996283320772154	nan
sp|Q5VZK9|CARL1_HUMAN	metaplastic breast carcinomas-Normal	-0.632719129751041	0.479870326436244	14.999999999829	0.207107835978576	0.401883506592403	nan
sp|Q5VZK9|CARL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.305846063287244	0.479870326436244	14.999999999829	0.533504106621045	0.921388505638487	nan
sp|Q5VZK9|CARL1_HUMAN	Normal-Triple-negative breast cancer	0.326873066463797	0.573554742927234	14.9999999998289	0.577177256742695	0.736765438330537	nan
sp|Q5VZL5|ZMYM4_HUMAN	metaplastic breast carcinomas-Normal	-0.244528835240625	0.285634656179906	6.0	0.424811702746702	0.622333230467182	nan
sp|Q5VZL5|ZMYM4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.292455249085137	0.285634656179906	6.0	0.345387908620572	0.870943310236299	nan
sp|Q5VZL5|ZMYM4_HUMAN	Normal-Triple-negative breast cancer	-0.0479264138445119	0.341398712883617	6.0	0.892951970236765	0.937514955485473	nan
sp|Q5VZM2|RRAGB_HUMAN;sp|Q7L523|RRAGA_HUMAN	metaplastic breast carcinomas-Normal	0.0328061920818648	0.436419503970627	14.9999999999093	0.941071854981402	0.9699612974793	nan
sp|Q5VZM2|RRAGB_HUMAN;sp|Q7L523|RRAGA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.260404626789586	0.436419503970627	14.99999999993	0.559616922050089	0.932694870083482	nan
sp|Q5VZM2|RRAGB_HUMAN;sp|Q7L523|RRAGA_HUMAN	Normal-Triple-negative breast cancer	-0.293210818871451	0.521621076817219	14.9999999999438	0.582341114746495	0.739381919563541	nan
sp|Q5XKP0|MIC13_HUMAN	metaplastic breast carcinomas-Normal	0.151387713179824	0.178127210522673	22.0000000306583	0.404543327206679	0.607088947916478	nan
sp|Q5XKP0|MIC13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.323917829302739	0.178127210522673	22.0000000307269	0.0826351316372499	0.806849600316436	nan
sp|Q5XKP0|MIC13_HUMAN	Normal-Triple-negative breast cancer	-0.475305542482564	0.21290273811763	22.0000000307666	0.0360803447849384	0.126678556343412	nan
sp|Q5ZPR3|CD276_HUMAN	metaplastic breast carcinomas-Normal	-0.0341095742459302	0.233423672348314	22.9999999994204	0.885094081082539	0.940412326443222	nan
sp|Q5ZPR3|CD276_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.492299422294513	0.218347851972492	22.9999999992918	0.0339796469006101	0.724424466074313	nan
sp|Q5ZPR3|CD276_HUMAN	Normal-Triple-negative breast cancer	0.526408996540443	0.273713517874598	22.9999999993284	0.0669197310868583	0.186925366498082	nan
sp|Q63HN8|RN213_HUMAN	metaplastic breast carcinomas-Normal	0.288807743722697	0.237380367214525	23.9999999996012	0.235569078734657	0.435449737051968	nan
sp|Q63HN8|RN213_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.128755617271667	0.237380367214525	23.9999999996013	0.592542929036003	0.940559810632461	nan
sp|Q63HN8|RN213_HUMAN	Normal-Triple-negative breast cancer	-0.16005212645103	0.283723806189105	23.9999999996241	0.577911779373258	0.736918005512913	nan
sp|Q63HR2|TNS2_HUMAN	metaplastic breast carcinomas-Normal	-0.360029457357418	0.270893082006888	13.0164220148995	0.206659671413203	0.40148261120835	nan
sp|Q63HR2|TNS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.290519735203001	0.270893082006888	13.0164220152138	0.302998703782716	0.867696529950794	nan
sp|Q63HR2|TNS2_HUMAN	Normal-Triple-negative breast cancer	0.650549192560419	0.318537753043089	13.000000090717	0.0619505970006718	0.179601084988562	nan
sp|Q63ZY3|KANK2_HUMAN	metaplastic breast carcinomas-Normal	-0.45210653065932	0.222455148198728	22.0000016169553	0.0543638961014002	0.17803506467099	nan
sp|Q63ZY3|KANK2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.250601030315774	0.222455148198728	22.0000016169846	0.272082311588953	0.867696529950794	nan
sp|Q63ZY3|KANK2_HUMAN	Normal-Triple-negative breast cancer	0.702707560975095	0.265884757420842	22.0000016170026	0.0148596060116141	0.0779324922305247	nan
sp|Q658Y4|F91A1_HUMAN	metaplastic breast carcinomas-Normal	-1.29725900782732	0.581704203913928	14.0000000002789	0.0426217363437786	0.152502316045985	nan
sp|Q658Y4|F91A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.632286576209024	0.581704203913928	14.0000000006282	0.29541689067068	0.867696529950794	nan
sp|Q658Y4|F91A1_HUMAN	Normal-Triple-negative breast cancer	1.92954558403634	0.695269506688015	14.0000000001477	0.0148878256818241	0.0779324922305247	nan
sp|Q66K74|MAP1S_HUMAN	metaplastic breast carcinomas-Normal	0.263582724911781	0.467822773086861	21.1451600916908	0.579072538372717	0.740541107639066	nan
sp|Q66K74|MAP1S_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.26060037951009	0.436022100349297	20.9428399065895	0.556463693446148	0.931642387063667	nan
sp|Q66K74|MAP1S_HUMAN	Normal-Triple-negative breast cancer	-0.0029823454016912	0.548029306451737	21.0910234684243	0.995709123279332	0.999618582235125	nan
sp|Q68CZ2|TENS3_HUMAN	metaplastic breast carcinomas-Normal	0.286369321489954	0.238258762132214	23.9999999997039	0.241118221408816	0.441099046759991	nan
sp|Q68CZ2|TENS3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0657770984405801	0.238258762132214	23.9999999997039	0.784854439950255	0.962981271203673	nan
sp|Q68CZ2|TENS3_HUMAN	Normal-Triple-negative breast cancer	-0.352146419930534	0.28477368892502	23.9999999996504	0.228206751794606	0.410804747922291	nan
sp|Q68E01|INT3_HUMAN	metaplastic breast carcinomas-Normal	0.98496820546001	0.220168528036451	21.1331560898847	0.0002065518745821	0.0157578323963946	nan
sp|Q68E01|INT3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0765246621354254	0.220168528036451	21.1331560894672	0.731598644662742	0.954643368861838	nan
sp|Q68E01|INT3_HUMAN	Normal-Triple-negative breast cancer	-0.908443543324585	0.260435108205306	21.0874014631127	0.0021824368314749	0.0320992036629325	nan
sp|Q68EM7|RHG17_HUMAN	metaplastic breast carcinomas-Normal	-0.042874366250474	0.31260081776325	14.9999999993214	0.892733311407053	0.94150288514576	nan
sp|Q68EM7|RHG17_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.109136448637327	0.31260081776325	14.9999999993214	0.731848828374528	0.954643368861838	nan
sp|Q68EM7|RHG17_HUMAN	Normal-Triple-negative breast cancer	0.152010814887801	0.373629440691964	14.9999999993306	0.689864921923292	0.817508378065248	nan
sp|Q69YN2|C19L1_HUMAN	metaplastic breast carcinomas-Normal	-0.0021782267120436	0.264628185441888	13.9999999877928	0.99354861315963	0.995945594132271	nan
sp|Q69YN2|C19L1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.209736250210407	0.264628185441888	13.999999987484	0.441253200645516	0.89755436380139	nan
sp|Q69YN2|C19L1_HUMAN	Normal-Triple-negative breast cancer	-0.207558023498363	0.316291178076392	13.9999999876558	0.522319755530515	0.694754248652834	nan
sp|Q69YQ0|CYTSA_HUMAN	metaplastic breast carcinomas-Normal	0.077948370862138	0.290631514842323	22.000000022312	0.791041495364369	0.887119409781094	nan
sp|Q69YQ0|CYTSA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0636328681660369	0.290631514842323	22.0000000226455	0.828709900093748	0.966828216776039	nan
sp|Q69YQ0|CYTSA_HUMAN	Normal-Triple-negative breast cancer	-0.141581239028175	0.347371101313738	22.000000022434	0.68752158732764	0.816650896854548	nan
sp|Q6BCY4|NB5R2_HUMAN	metaplastic breast carcinomas-Normal	-0.694768821703893	0.509962552848688	14.0000000038983	0.194591026095007	0.387317707029823	nan
sp|Q6BCY4|NB5R2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.808667594881749	0.509962552848688	14.0000000035161	0.135120715609052	0.823891816737944	nan
sp|Q6BCY4|NB5R2_HUMAN	Normal-Triple-negative breast cancer	-0.113898773177857	0.609521832853955	14.0000000036801	0.854446769600882	0.917158980129574	nan
sp|Q6DD87|ZN787_HUMAN	metaplastic breast carcinomas-Normal	0.370604807846838	0.283652298480628	13.9999999987724	0.212423914425768	0.408384668335021	nan
sp|Q6DD87|ZN787_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.354612794263996	0.283652298480628	13.9999999996692	0.231732246048843	0.847224386663791	nan
sp|Q6DD87|ZN787_HUMAN	Normal-Triple-negative breast cancer	-0.0159920135828422	0.339029342247505	13.999999999946	0.963044021898472	0.982251711810532	nan
sp|Q6DD88|ATLA3_HUMAN	metaplastic breast carcinomas-Normal	-0.222224050643081	0.19837772636417	22.0000004935429	0.274706297118627	0.477548285858522	nan
sp|Q6DD88|ATLA3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.162160582357016	0.19837772636417	22.0000004937683	0.42244565333173	0.88788356341846	nan
sp|Q6DD88|ATLA3_HUMAN	Normal-Triple-negative breast cancer	0.0600634682860649	0.237106734005166	22.0000004933599	0.802374467075181	0.88637179413689	nan
sp|Q6DKJ4|NXN_HUMAN	metaplastic breast carcinomas-Normal	0.718726507027157	0.732397800614904	10.999999999762	0.347519420056721	0.557013864291281	nan
sp|Q6DKJ4|NXN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0346957409213963	0.567312896916092	10.9999999997952	0.952330403932273	0.996541950781621	nan
sp|Q6DKJ4|NXN_HUMAN	Normal-Triple-negative breast cancer	-0.753422247948553	0.802301592927907	10.9999999997766	0.367854772846286	0.558198253734317	nan
sp|Q6FHJ7|SFRP4_HUMAN	metaplastic breast carcinomas-Normal	-0.661114204605077	0.40684122738468	23.999999999956	0.117225791350239	0.282607002566687	nan
sp|Q6FHJ7|SFRP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0523254840308435	0.40684122738468	23.999999999993	0.898734794661043	0.989671989983163	nan
sp|Q6FHJ7|SFRP4_HUMAN	Normal-Triple-negative breast cancer	0.71343968863592	0.486268274426889	23.9999999999649	0.155311965858198	0.324282019166237	nan
sp|Q6FI81|CPIN1_HUMAN	metaplastic breast carcinomas-Normal	0.282899199916628	0.270548735772173	24.0000000001518	0.306140606421329	0.51373050538034	nan
sp|Q6FI81|CPIN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.407193315953414	0.270548735772173	24.000000000373	0.145355738724585	0.827647387111815	nan
sp|Q6FI81|CPIN1_HUMAN	Normal-Triple-negative breast cancer	-0.690092515870042	0.323367589214153	24.0000000002993	0.0432554247820927	0.141795889522363	nan
sp|Q6GQQ9|OTU7B_HUMAN	metaplastic breast carcinomas-Normal	-0.334717943611922	0.566762505169841	6.0	0.576355629997502	0.738268252066164	nan
sp|Q6GQQ9|OTU7B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.373154789147239	0.566762505169841	6.0	0.534715597264052	0.921388505638487	nan
sp|Q6GQQ9|OTU7B_HUMAN	Normal-Triple-negative breast cancer	-0.0384368455353172	0.677410760877026	6.0	0.956594023627062	0.978073987861075	nan
sp|Q6IA69|NADE_HUMAN	metaplastic breast carcinomas-Normal	-0.0219620195229058	0.70301156343212	6.0	0.976091460446365	0.987405141699193	nan
sp|Q6IA69|NADE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.712367328092691	0.70301156343212	6.0	0.350017942167073	0.8746743570231	nan
sp|Q6IA69|NADE_HUMAN	Normal-Triple-negative breast cancer	0.734329347615596	0.84025953330697	6.0	0.415759950290625	0.602960765604728	nan
sp|Q6IAA8|LTOR1_HUMAN	metaplastic breast carcinomas-Normal	-0.169494504641839	0.224019301658559	21.9999998620491	0.457312105334186	0.650451620937456	nan
sp|Q6IAA8|LTOR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.369603468723556	0.224019301658559	21.9999998626211	0.113175246518894	0.823891816737944	nan
sp|Q6IAA8|LTOR1_HUMAN	Normal-Triple-negative breast cancer	-0.200108964081717	0.267754278385421	21.9999998617132	0.46275987752439	0.643483706785728	nan
sp|Q6IAN0|DRS7B_HUMAN	metaplastic breast carcinomas-Normal	-0.288788175828364	0.216694540124264	6.0	0.23100586806845	0.431141777349538	nan
sp|Q6IAN0|DRS7B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.219521823688095	0.216694540124264	6.0	0.350132802766239	0.8746743570231	nan
sp|Q6IAN0|DRS7B_HUMAN	Normal-Triple-negative breast cancer	0.0692663521402687	0.25899951384308	6.0	0.798087220275158	0.883985978072184	nan
sp|Q6IBS0|TWF2_HUMAN	metaplastic breast carcinomas-Normal	0.135460447879425	0.193988460186318	23.9999999991298	0.491706272515117	0.680970532116522	nan
sp|Q6IBS0|TWF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.111186656539493	0.193988460186318	23.9999999991298	0.571867367500119	0.935631258424823	nan
sp|Q6IBS0|TWF2_HUMAN	Normal-Triple-negative breast cancer	-0.0242737913399319	0.231860557495413	23.9999999991043	0.917490764985842	0.953341451332584	nan
sp|Q6IN85|P4R3A_HUMAN	metaplastic breast carcinomas-Normal	0.12467718521804	0.358611228280018	21.9999999974027	0.731394796979718	0.851067243506488	nan
sp|Q6IN85|P4R3A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.226348979888141	0.358611228280018	21.9999999965811	0.534424905978646	0.921388505638487	nan
sp|Q6IN85|P4R3A_HUMAN	Normal-Triple-negative breast cancer	-0.351026165106182	0.428622399668824	21.9999999957084	0.42159047936794	0.608196202639849	nan
sp|Q6IQ22|RAB12_HUMAN	metaplastic breast carcinomas-Normal	-0.132086565827516	0.32290203643164	21.0346724768183	0.686630146712488	0.816878528157591	nan
sp|Q6IQ22|RAB12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.291476760931159	0.322902036431639	21.0346724769204	0.376917736685924	0.885234295852111	nan
sp|Q6IQ22|RAB12_HUMAN	Normal-Triple-negative breast cancer	-0.159390195103642	0.38178533773813	21.0235555305107	0.680555394536795	0.813211981542944	nan
sp|Q6IQ23|PKHA7_HUMAN	metaplastic breast carcinomas-Normal	0.0903186859120012	0.46654856961361	22.0000434605907	0.848273923215706	0.919955145438501	nan
sp|Q6IQ23|PKHA7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.413428846274771	0.46654856961361	22.0000434658526	0.38512453465474	0.885234295852111	nan
sp|Q6IQ23|PKHA7_HUMAN	Normal-Triple-negative breast cancer	-0.503747532186772	0.557632198046226	22.0000434838589	0.376115848911805	0.563665050398035	nan
sp|Q6JBY9|CPZIP_HUMAN	metaplastic breast carcinomas-Normal	-0.180328486374193	0.424881367759906	22.000000027638	0.675380652200645	0.809579981217073	nan
sp|Q6JBY9|CPZIP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.810319938665883	0.424881367759906	22.0000000280562	0.0696402891212593	0.781899532609971	nan
sp|Q6JBY9|CPZIP_HUMAN	Normal-Triple-negative breast cancer	0.990648425040076	0.507830366319767	22.0000000281229	0.0639394186064383	0.183621524272988	nan
sp|Q6NUK1|SCMC1_HUMAN	metaplastic breast carcinomas-Normal	0.2705190812554	0.171060482386359	22.0000002522294	0.128052457597817	0.299374855792279	nan
sp|Q6NUK1|SCMC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.220650017810301	0.171060482386359	22.0000002522335	0.210482218218522	0.843662073010871	nan
sp|Q6NUK1|SCMC1_HUMAN	Normal-Triple-negative breast cancer	-0.491169099065701	0.204456382474719	22.0000002524837	0.0251703112333109	0.105455600909054	nan
sp|Q6NUM9|RETST_HUMAN	metaplastic breast carcinomas-Normal	-0.658224170787446	0.614099301374627	13.0000000202442	0.303281740933896	0.510693265888688	nan
sp|Q6NUM9|RETST_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.30337283610219	0.687897387074685	13.0483465123234	0.0805041521045093	0.806849600316436	nan
sp|Q6NUM9|RETST_HUMAN	Normal-Triple-negative breast cancer	-0.645148665314748	0.796758931265166	13.0361261382022	0.432635405911167	0.617201755042369	nan
sp|Q6NUQ4|TM214_HUMAN	metaplastic breast carcinomas-Normal	0.878519385304533	0.236333287998097	14.9999999997396	0.0020646727690453	0.0325259349967141	nan
sp|Q6NUQ4|TM214_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.397714938589597	0.236333287998097	14.9999999997396	0.113095266040031	0.823891816737944	nan
sp|Q6NUQ4|TM214_HUMAN	Normal-Triple-negative breast cancer	-0.480804446714936	0.28247230715339	14.9999999997616	0.109358709776584	0.256250128434269	nan
sp|Q6NVY1|HIBCH_HUMAN	metaplastic breast carcinomas-Normal	-0.549391193158002	0.324328254234118	23.999999999485	0.103218147433691	0.260119122114926	nan
sp|Q6NVY1|HIBCH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.377963059049305	0.324328254234118	23.999999999668	0.255320578084829	0.860074605064301	nan
sp|Q6NVY1|HIBCH_HUMAN	Normal-Triple-negative breast cancer	0.171428134108697	0.387646408276096	23.9999999996284	0.66228375302737	0.800520434568355	nan
sp|Q6NXG1|ESRP1_HUMAN	metaplastic breast carcinomas-Normal	0.266693292421251	0.880445358940173	6.0	0.77218787100438	0.876922611280683	nan
sp|Q6NXG1|ESRP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.510717765869798	0.880445358940173	6.0	0.582980453709741	0.937761568355864	nan
sp|Q6NXG1|ESRP1_HUMAN	Normal-Triple-negative breast cancer	-0.777411058291049	1.05233348196098	6.0	0.487939366208481	0.665062857354938	nan
sp|Q6NXT6|TAPT1_HUMAN	metaplastic breast carcinomas-Normal	0.353770067292688	0.204257763386618	22.0000000004788	0.0972772814304011	0.251765208771212	nan
sp|Q6NXT6|TAPT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.348806109864614	0.204257763386618	22.0000000004759	0.10177158652639	0.821630939204717	nan
sp|Q6NXT6|TAPT1_HUMAN	Normal-Triple-negative breast cancer	-0.702576177157302	0.244134722478341	22.0000000007323	0.0087386129083552	0.0588076066258844	nan
sp|Q6NYC8|PPR18_HUMAN	metaplastic breast carcinomas-Normal	0.848864292895643	0.32021342868738	21.9999999703326	0.0145960029849861	0.0795450818130059	nan
sp|Q6NYC8|PPR18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.515740144666776	0.32021342868738	21.9999999719931	0.121519816973395	0.823891816737944	nan
sp|Q6NYC8|PPR18_HUMAN	Normal-Triple-negative breast cancer	-0.333124148228867	0.382728251060215	21.999999970532	0.393483846890947	0.581306803140226	nan
sp|Q6NZI2|CAVN1_HUMAN	metaplastic breast carcinomas-Normal	-2.69481153075774	0.596182930649184	22.0000000018213	0.0001693486824096	0.0157578323963946	nan
sp|Q6NZI2|CAVN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0283715391731112	0.596182930649184	22.0000000009217	0.96247345253256	0.99709406933403	nan
sp|Q6NZI2|CAVN1_HUMAN	Normal-Triple-negative breast cancer	2.66643999158463	0.712574895108728	22.0000000010039	0.0011292842759906	0.026613045414958	nan
sp|Q6NZY4|ZCHC8_HUMAN	metaplastic breast carcinomas-Normal	-0.866375451968977	1.24686444433679	14.9999999998621	0.497776330382341	0.684494052686852	nan
sp|Q6NZY4|ZCHC8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.15853860738814	1.24686444433678	14.9999999997383	0.367517502001924	0.883542279876718	nan
sp|Q6NZY4|ZCHC8_HUMAN	Normal-Triple-negative breast cancer	2.02491405935712	1.49028805583316	14.9999999998126	0.194311407850314	0.375518092845606	nan
sp|Q6P179|ERAP2_HUMAN	metaplastic breast carcinomas-Normal	-0.977535453344253	0.498657466109843	23.999999999471	0.061664747789158	0.190673136419685	nan
sp|Q6P179|ERAP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.408671921477182	0.498657466109843	23.999999999471	0.420540508578297	0.887693595400195	nan
sp|Q6P179|ERAP2_HUMAN	Normal-Triple-negative breast cancer	0.568863531867071	0.59600966975268	23.999999999458	0.349369489210258	0.540392825563005	nan
sp|Q6P1A2|MBOA5_HUMAN	metaplastic breast carcinomas-Normal	0.113178242210349	1.2512744943848	5.0	0.931441011372561	0.962720746829102	nan
sp|Q6P1A2|MBOA5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.300548619322269	1.2512744943848	5.0	0.819716932707266	0.965774701272009	nan
sp|Q6P1A2|MBOA5_HUMAN	Normal-Triple-negative breast cancer	-0.413726861532618	1.44484733232635	5.0	0.78609823323585	0.877895011375654	nan
sp|Q6P1J9|CDC73_HUMAN	metaplastic breast carcinomas-Normal	-0.367641021029131	0.222103590927778	21.9999999966691	0.112067152883101	0.274916026703636	nan
sp|Q6P1J9|CDC73_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.400023691355372	0.222103590927778	21.9999999991458	0.0854168599432739	0.806849600316436	nan
sp|Q6P1J9|CDC73_HUMAN	Normal-Triple-negative breast cancer	-0.0323826703262404	0.265464566112783	21.9999999952615	0.904018384748642	0.944064439492456	nan
sp|Q6P1N0|C2D1A_HUMAN	metaplastic breast carcinomas-Normal	0.322040069474985	0.261950870325618	22.9999999999108	0.231354215034547	0.431549613229425	nan
sp|Q6P1N0|C2D1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.252047592569755	0.261950870325618	22.9999999999108	0.345959742370549	0.871355743773214	nan
sp|Q6P1N0|C2D1A_HUMAN	Normal-Triple-negative breast cancer	-0.574087662044739	0.309944449619747	23.0000000000126	0.0768714788713841	0.204580300855469	nan
sp|Q6P1N9|TATD1_HUMAN	metaplastic breast carcinomas-Normal	0.423411271302414	0.358446668833299	19.0163752054322	0.252070654307068	0.452909651306321	nan
sp|Q6P1N9|TATD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.291427678306722	0.324271070999217	18.2401175851335	0.380514904418174	0.885234295852111	nan
sp|Q6P1N9|TATD1_HUMAN	Normal-Triple-negative breast cancer	-0.131983592995692	0.419335024005436	18.4737353797045	0.756482480088786	0.859388505509785	nan
sp|Q6P2C8|MED27_HUMAN	metaplastic breast carcinomas-Normal	1.09791550585091	0.395535104643224	14.9999999996699	0.0141335182118612	0.0795280122418412	nan
sp|Q6P2C8|MED27_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.335982674328094	0.395535104643224	14.9999999998237	0.408990558649345	0.885784822958391	nan
sp|Q6P2C8|MED27_HUMAN	Normal-Triple-negative breast cancer	-1.433898180179	0.472754873065655	14.9999999997417	0.0083881172799435	0.0581796349243527	nan
sp|Q6P2E9|EDC4_HUMAN	metaplastic breast carcinomas-Normal	0.307009854260657	0.181079603625825	21.9999999808882	0.104100307429937	0.261945058211288	nan
sp|Q6P2E9|EDC4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.141098184830929	0.181079603625825	21.9999999792517	0.444160473446449	0.898657241505819	nan
sp|Q6P2E9|EDC4_HUMAN	Normal-Triple-negative breast cancer	-0.165911669429728	0.216431522820518	21.9999999809655	0.45148043043619	0.634554313221944	nan
sp|Q6P2Q9|PRP8_HUMAN	metaplastic breast carcinomas-Normal	0.568613363552908	0.155599837210236	24.0000000001554	0.0012556311013147	0.0266416082859394	nan
sp|Q6P2Q9|PRP8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.184273890487987	0.155599837210236	24.0000000001554	0.247898381314503	0.850159840640073	nan
sp|Q6P2Q9|PRP8_HUMAN	Normal-Triple-negative breast cancer	-0.752887254040895	0.185977377041449	24.0000000001836	0.0004663666460069	0.0237592699893802	nan
sp|Q6P3W7|SCYL2_HUMAN	metaplastic breast carcinomas-Normal	0.535354787390212	0.286232056059726	23.9999999992073	0.0736798634206599	0.211678363016658	nan
sp|Q6P3W7|SCYL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0297430682826383	0.286232056059726	23.99999999917	0.918102329472864	0.99408739879047	nan
sp|Q6P3W7|SCYL2_HUMAN	Normal-Triple-negative breast cancer	-0.565097855672851	0.34211274231119	23.9999999992082	0.111603232440214	0.259389329701293	nan
sp|Q6P4A8|PLBL1_HUMAN	metaplastic breast carcinomas-Normal	-0.225631084136263	0.414674255349888	15.0000000000197	0.594357715613482	0.752626684456844	nan
sp|Q6P4A8|PLBL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0840967915426159	0.414674255349888	15.0000000000434	0.84201498002397	0.972169455774446	nan
sp|Q6P4A8|PLBL1_HUMAN	Normal-Triple-negative breast cancer	0.141534292593647	0.495630533548622	15.0000000000375	0.779117556195079	0.874519294198955	nan
sp|Q6P996|PDXD1_HUMAN	metaplastic breast carcinomas-Normal	0.799122196975342	0.408798416604342	14.9999999995429	0.069504481607558	0.204216569909399	nan
sp|Q6P996|PDXD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.351907391437189	0.408798416604342	14.9999999995193	0.402880401324273	0.885297496092956	nan
sp|Q6P996|PDXD1_HUMAN	Normal-Triple-negative breast cancer	-1.15102958841253	0.488607562976109	14.9999999994842	0.0325135949682102	0.121245596403811	nan
sp|Q6P9B6|MEAK7_HUMAN	metaplastic breast carcinomas-Normal	1.0657983329565	0.248198420610897	23.9999999990168	0.0002499964763081	0.0157578323963946	nan
sp|Q6P9B6|MEAK7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.118461532051998	0.248198420610897	23.9999999990168	0.637476543843561	0.941868024951375	nan
sp|Q6P9B6|MEAK7_HUMAN	Normal-Triple-negative breast cancer	-0.947336800904502	0.296653853105755	23.9999999990248	0.003902452124632	0.0407011375973175	nan
sp|Q6PCB0|VWA1_HUMAN	metaplastic breast carcinomas-Normal	0.476754352265823	0.320235658341823	24.000000000032	0.149574107733896	0.328099856986626	nan
sp|Q6PCB0|VWA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.075034252958091	0.320235658341823	24.000000000032	0.816732075695925	0.965774701272009	nan
sp|Q6PCB0|VWA1_HUMAN	Normal-Triple-negative breast cancer	-0.551788605223914	0.382754820579181	24.0000000000352	0.162330716499723	0.332141436375708	nan
sp|Q6PCB7|S27A1_HUMAN	metaplastic breast carcinomas-Normal	-0.0043020917135065	0.24824548575389	14.0000000020216	0.986417917255388	0.993572774672199	nan
sp|Q6PCB7|S27A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.126254901700016	0.24824548575389	14.0000000021206	0.618960367774435	0.941374262616245	nan
sp|Q6PCB7|S27A1_HUMAN	Normal-Triple-negative breast cancer	0.130556993413522	0.296710106711163	14.0000000019472	0.666642913450938	0.8042915764791	nan
sp|Q6PCE3|PGM2L_HUMAN	metaplastic breast carcinomas-Normal	0.451065062657495	0.315662117517774	14.6174835898797	0.174039851701547	0.361789963260442	nan
sp|Q6PCE3|PGM2L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0208344860093294	0.251479902958257	15.4716013516907	0.935035181766308	0.995571782532303	nan
sp|Q6PCE3|PGM2L_HUMAN	Normal-Triple-negative breast cancer	-0.471899548666824	0.351876507139059	15.5220809374097	0.199185361180585	0.38029416459751	nan
sp|Q6PGP7|TTC37_HUMAN	metaplastic breast carcinomas-Normal	-0.393559916776233	0.348271982408144	22.00000004454	0.270631375431649	0.472716075635733	nan
sp|Q6PGP7|TTC37_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.187079197246838	0.348271982408144	22.0000000445424	0.596545977573256	0.940559810632461	nan
sp|Q6PGP7|TTC37_HUMAN	Normal-Triple-negative breast cancer	0.206480719529395	0.416264637203818	22.000000044309	0.624790942466857	0.773622324634365	nan
sp|Q6PI48|SYDM_HUMAN	metaplastic breast carcinomas-Normal	0.0669114471007106	0.205102416591761	21.9999999036029	0.747330137357278	0.860108189651783	nan
sp|Q6PI48|SYDM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.564735445532297	0.205102416591761	21.9999999046107	0.0115962680531391	0.584205928434659	nan
sp|Q6PI48|SYDM_HUMAN	Normal-Triple-negative breast cancer	-0.631646892633007	0.245144276154094	21.9999999037067	0.0172124393205983	0.0846363140557232	nan
sp|Q6PI78|TMM65_HUMAN	metaplastic breast carcinomas-Normal	0.397688967122933	0.435196423599926	14.9999999995044	0.375269398316612	0.582483472587307	nan
sp|Q6PI78|TMM65_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.216286952785233	0.435196423599926	14.9999999996314	0.626403232595794	0.941374262616245	nan
sp|Q6PI78|TMM65_HUMAN	Normal-Triple-negative breast cancer	-0.181402014337699	0.520159216166641	14.9999999995582	0.732128897352269	0.845292273288969	nan
sp|Q6PIU2|NCEH1_HUMAN	metaplastic breast carcinomas-Normal	0.91044311124603	0.514654416552676	22.9999999998831	0.0901483698095021	0.242241860345016	nan
sp|Q6PIU2|NCEH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.565672465763456	0.514654416552676	22.9999999998831	0.283083570600311	0.867696529950794	nan
sp|Q6PIU2|NCEH1_HUMAN	Normal-Triple-negative breast cancer	-1.47611557700949	0.608947317810042	22.9999999997643	0.023617116600642	0.102137084892028	nan
sp|Q6PJG2|MDEAS_HUMAN	metaplastic breast carcinomas-Normal	-0.475806680234761	0.368403839095899	21.0071181810869	0.210548497095056	0.405482737163364	nan
sp|Q6PJG2|MDEAS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.807365019419402	0.368403839095899	21.0071181805618	0.0398242908198287	0.738255867002113	nan
sp|Q6PJG2|MDEAS_HUMAN	Normal-Triple-negative breast cancer	-0.331558339184641	0.435578430702351	20.9970591017109	0.455007648135482	0.637355845934405	nan
sp|Q6PJT7|ZC3HE_HUMAN	metaplastic breast carcinomas-Normal	0.38798020070123	0.30061962609561	22.000000002174	0.210241179134802	0.405450235922205	nan
sp|Q6PJT7|ZC3HE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.146020100699849	0.30061962609561	22.0000000026382	0.631960903667037	0.941868024951375	nan
sp|Q6PJT7|ZC3HE_HUMAN	Normal-Triple-negative breast cancer	-0.241960100001381	0.359309177636882	22.0000000023613	0.507703907589934	0.681311178372604	nan
sp|Q6PKG0|LARP1_HUMAN	metaplastic breast carcinomas-Normal	0.82663773219129	0.20203847665853	21.9999999892741	0.0004825149235239	0.0205217420849069	nan
sp|Q6PKG0|LARP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.351763667487262	0.20203847665853	21.9999999893868	0.0956396362299001	0.814943337126966	nan
sp|Q6PKG0|LARP1_HUMAN	Normal-Triple-negative breast cancer	-1.17840139967855	0.241482167488615	21.9999999894637	7.05004453249791e-05	0.022319699811492	nan
sp|Q6RW13|ATRAP_HUMAN	metaplastic breast carcinomas-Normal	0.294323612079661	0.212722318204864	21.2272754481457	0.180858053187338	0.371093931354759	nan
sp|Q6RW13|ATRAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0423487803259367	0.198502560888488	20.9273682718643	0.833125482275268	0.9684421207956	nan
sp|Q6RW13|ATRAP_HUMAN	Normal-Triple-negative breast cancer	-0.336672392405597	0.249274745920189	21.1474684657375	0.191097814095047	0.371902303309095	nan
sp|Q6UB35|C1TM_HUMAN	metaplastic breast carcinomas-Normal	0.631534392851541	0.302385921271993	21.9998484439263	0.0485388217291006	0.166333034461371	nan
sp|Q6UB35|C1TM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.226976801250448	0.302385921271993	21.9998484437017	0.460835282285615	0.909423669537079	nan
sp|Q6UB35|C1TM_HUMAN	Normal-Triple-negative breast cancer	-0.858511194101988	0.361420304164223	21.9998483480592	0.0266684426267596	0.109169831639592	nan
sp|Q6UN15|FIP1_HUMAN	metaplastic breast carcinomas-Normal	0.603897187456786	0.236431096888444	14.9999999995474	0.0220129718373155	0.101767897617854	nan
sp|Q6UN15|FIP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.436072378510756	0.236431096888443	14.9999999995474	0.0849655120667301	0.806849600316436	nan
sp|Q6UN15|FIP1_HUMAN	Normal-Triple-negative breast cancer	-1.03996956596754	0.28258921113738	14.9999999995975	0.0022278788543745	0.0322131479751828	nan
sp|Q6UVK1|CSPG4_HUMAN	metaplastic breast carcinomas-Normal	0.626726673142342	0.374994814049293	21.9999999726179	0.108829308449328	0.269961657675796	nan
sp|Q6UVK1|CSPG4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.380935445591162	0.374994814049293	21.9999999729604	0.320747034256587	0.867696529950794	nan
sp|Q6UVK1|CSPG4_HUMAN	Normal-Triple-negative breast cancer	-0.24579122755118	0.448204530103746	21.9999999736919	0.588945869470715	0.743790300197818	nan
sp|Q6UW02|CP20A_HUMAN	metaplastic breast carcinomas-Normal	-1.19784704499674	0.620619272811008	23.999999999583	0.0654968273555407	0.196845799394048	nan
sp|Q6UW02|CP20A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.470479405234086	0.620619272811008	23.9999999995502	0.455782807981037	0.908567154037048	nan
sp|Q6UW02|CP20A_HUMAN	Normal-Triple-negative breast cancer	1.66832645023082	0.741781910368024	23.9999999995784	0.0339550122833896	0.123621534315429	nan
sp|Q6UW63|PLGT2_HUMAN	metaplastic breast carcinomas-Normal	0.407351675443103	0.236435030805356	24.000000000075	0.0977714178493202	0.252341052717084	nan
sp|Q6UW63|PLGT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.242894919938802	0.236435030805356	24.000000000075	0.314512130483461	0.867696529950794	nan
sp|Q6UW63|PLGT2_HUMAN	Normal-Triple-negative breast cancer	-0.164456755504302	0.28259391306742	24.0000000000408	0.566024469491157	0.727697294239603	nan
sp|Q6UWY5|OLFL1_HUMAN	metaplastic breast carcinomas-Normal	-1.29320722485691	0.503395085159102	22.0000000050537	0.0175059772998487	0.089248264639106	nan
sp|Q6UWY5|OLFL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.133160010054208	0.503395085159102	22.0000000039204	0.793838695013178	0.964213712979656	nan
sp|Q6UWY5|OLFL1_HUMAN	Normal-Triple-negative breast cancer	1.42636723491112	0.601672207580482	22.0000000046871	0.0269386429301398	0.109869998895441	nan
sp|Q6UX71|PXDC2_HUMAN	metaplastic breast carcinomas-Normal	-0.204360924115591	0.302919096533364	23.9999999998707	0.50635278482191	0.691502324054244	nan
sp|Q6UX71|PXDC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.213200184336792	0.302919096533364	23.9999999999051	0.488318540084073	0.913320451076758	nan
sp|Q6UX71|PXDC2_HUMAN	Normal-Triple-negative breast cancer	0.417561108452382	0.362057570490404	23.9999999998843	0.260144207686672	0.451040274578656	nan
sp|Q6UXB8|PI16_HUMAN	metaplastic breast carcinomas-Normal	-2.68285059191395	0.920355423358743	12.9999999998373	0.0120553348611394	0.0721478521661814	nan
sp|Q6UXB8|PI16_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.21299077185863	0.920355423358743	12.9999999997384	0.210270027750396	0.843662073010871	nan
sp|Q6UXB8|PI16_HUMAN	Normal-Triple-negative breast cancer	3.89584136377259	1.0627349028526	12.9999999997878	0.0028497010769159	0.0360167542953178	nan
sp|Q6UXG2|ELAP1_HUMAN	metaplastic breast carcinomas-Normal	0.0234352714055328	0.534973341274727	23.9999999995805	0.965421141964482	0.983042382674199	nan
sp|Q6UXG2|ELAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.869433751398614	0.534973341274727	23.9999999995805	0.117183465986834	0.823891816737944	nan
sp|Q6UXG2|ELAP1_HUMAN	Normal-Triple-negative breast cancer	-0.892869022804147	0.639415442722766	23.9999999995691	0.175381254001545	0.350084614767438	nan
sp|Q6UXN9|WDR82_HUMAN	metaplastic breast carcinomas-Normal	0.381475616933804	0.272168476919825	22.0000000345123	0.174980954556852	0.362341903651542	nan
sp|Q6UXN9|WDR82_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.284140894983456	0.272168476919825	22.0000000343131	0.307826992178227	0.867696529950794	nan
sp|Q6UXN9|WDR82_HUMAN	Normal-Triple-negative breast cancer	-0.665616511917259	0.325303550173542	22.000000034561	0.052878278139906	0.162439494536208	nan
sp|Q6UXV4|MIC27_HUMAN	metaplastic breast carcinomas-Normal	-0.587960784840361	0.347283709275106	14.0000000274871	0.112574245144801	0.275752977790213	nan
sp|Q6UXV4|MIC27_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.690685573665731	0.347283709275106	14.0000000280949	0.0666307457094425	0.774640662531106	nan
sp|Q6UXV4|MIC27_HUMAN	Normal-Triple-negative breast cancer	-0.10272478882537	0.415083424881375	14.0000000277542	0.808129461236303	0.889381146543985	nan
sp|Q6VY07|PACS1_HUMAN	metaplastic breast carcinomas-Normal	-0.656049228640489	0.343760078355	22.0000000023517	0.0694662209879036	0.204216569909399	nan
sp|Q6VY07|PACS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.221576157230286	0.343760078355	22.0000000017413	0.525872829027152	0.918329246917285	nan
sp|Q6VY07|PACS1_HUMAN	Normal-Triple-negative breast cancer	0.877625385870774	0.410871880396929	22.0000000021742	0.0440553044571494	0.142646284183891	nan
sp|Q6WCQ1|MPRIP_HUMAN	metaplastic breast carcinomas-Normal	-0.224201884298504	0.240479631713587	23.9999999993727	0.360460566527785	0.570557582446837	nan
sp|Q6WCQ1|MPRIP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0147983041760848	0.240479631713587	23.9999999993727	0.951441451981163	0.996541950781621	nan
sp|Q6WCQ1|MPRIP_HUMAN	Normal-Triple-negative breast cancer	0.239000188474589	0.287428135786278	23.9999999992925	0.413880844517859	0.60128493320689	nan
sp|Q6XQN6|PNCB_HUMAN	metaplastic breast carcinomas-Normal	-0.261326213019438	0.351659156621472	22.0000000014628	0.465269083577813	0.657828342753148	nan
sp|Q6XQN6|PNCB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.117558923592769	0.351659156621472	22.0000000014628	0.74132070429581	0.954643368861838	nan
sp|Q6XQN6|PNCB_HUMAN	Normal-Triple-negative breast cancer	0.378885136612207	0.420313084728387	22.0000000011797	0.377119971643578	0.564915180596329	nan
sp|Q6Y7W6|GGYF2_HUMAN	metaplastic breast carcinomas-Normal	0.379234481311911	0.34376339927218	21.9999975285899	0.281868633668004	0.485708314314384	nan
sp|Q6Y7W6|GGYF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0636495403540106	0.34376339927218	21.9999975278878	0.854803754228022	0.977691255315669	nan
sp|Q6Y7W6|GGYF2_HUMAN	Normal-Triple-negative breast cancer	-0.3155849409579	0.410875849652151	21.9999975269551	0.450606808578375	0.633862476392094	nan
sp|Q6YHK3|CD109_HUMAN	metaplastic breast carcinomas-Normal	0.0654325073669725	0.400410899443717	22.9999999994931	0.871620366207243	0.932886600115491	nan
sp|Q6YHK3|CD109_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.158141327888312	0.374550099912096	22.9999999996834	0.67678754458235	0.946446689298437	nan
sp|Q6YHK3|CD109_HUMAN	Normal-Triple-negative breast cancer	0.0927088205213399	0.469523398288971	22.9999999996142	0.845207644285751	0.911630088050377	nan
sp|Q6YN16|HSDL2_HUMAN	metaplastic breast carcinomas-Normal	-0.699142722008459	0.275100473238178	23.9999999996691	0.0179180633402578	0.0905161740775332	nan
sp|Q6YN16|HSDL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0644102462320063	0.275100473238178	23.9999999996678	0.8168671019716	0.965774701272009	nan
sp|Q6YN16|HSDL2_HUMAN	Normal-Triple-negative breast cancer	0.634732475776452	0.328807956055702	23.9999999996577	0.0654550510882794	0.185483878787247	nan
sp|Q6YP21|KAT3_HUMAN	metaplastic breast carcinomas-Normal	0.154386292779593	0.316885299614988	22.0000000237923	0.630936314037516	0.779350541754257	nan
sp|Q6YP21|KAT3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.333015789926806	0.316885299614988	22.0000000237954	0.30471030985059	0.867696529950794	nan
sp|Q6YP21|KAT3_HUMAN	Normal-Triple-negative breast cancer	0.178629497147213	0.378750375977334	22.0000000237984	0.641835785799478	0.787836836040423	nan
sp|Q6ZMI0|PPR21_HUMAN	metaplastic breast carcinomas-Normal	-0.613676690064093	0.505425513041673	12.9999718671731	0.246276325143138	0.445872823951956	nan
sp|Q6ZMI0|PPR21_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.183560095572095	0.566191204232835	13.0458565839323	0.750924686435616	0.954643368861838	nan
sp|Q6ZMI0|PPR21_HUMAN	Normal-Triple-negative breast cancer	0.430116594491998	0.655784394659742	13.0342548861794	0.52331011647021	0.695236941305747	nan
sp|Q6ZNB6|NFXL1_HUMAN	metaplastic breast carcinomas-Normal	0.384050631733545	0.240815652123189	14.999999999771	0.131608195151772	0.303163992158343	nan
sp|Q6ZNB6|NFXL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.001201837026289	0.240815652123189	14.999999999771	0.996083788853625	0.998185231446144	nan
sp|Q6ZNB6|NFXL1_HUMAN	Normal-Triple-negative breast cancer	-0.382848794707256	0.287829756993155	14.9999999998228	0.203349171709232	0.383834552391531	nan
sp|Q6ZRV2|FA83H_HUMAN	metaplastic breast carcinomas-Normal	0.526668222642226	0.394216489736459	22.0000000397589	0.195209839750858	0.387852664274868	nan
sp|Q6ZRV2|FA83H_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.424204956139326	0.394216489736459	22.0000000397173	0.293555075479853	0.867696529950794	nan
sp|Q6ZRV2|FA83H_HUMAN	Normal-Triple-negative breast cancer	-0.102463266502899	0.471178826804394	22.0000000395195	0.829852894504893	0.903810950633769	nan
sp|Q6ZSR9|YJ005_HUMAN	metaplastic breast carcinomas-Normal	0.0921871655218674	0.445852427771645	13.9999999998004	0.83916955801606	0.914257492902453	nan
sp|Q6ZSR9|YJ005_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.312236148113087	0.445852427771645	13.9999999998004	0.495206309041891	0.913320451076758	nan
sp|Q6ZSR9|YJ005_HUMAN	Normal-Triple-negative breast cancer	-0.404423313634954	0.524633129859308	13.9999999997896	0.453598621511673	0.636186421056878	nan
sp|Q6ZT62|BGIN_HUMAN;sp|Q9Y3L3|3BP1_HUMAN	metaplastic breast carcinomas-Normal	0.504309211462551	0.295783768057366	22.0000000320651	0.102278484875308	0.258601320429514	nan
sp|Q6ZT62|BGIN_HUMAN;sp|Q9Y3L3|3BP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.5413655018638	0.295783768057366	22.0000000314741	0.0807914435998672	0.806849600316436	nan
sp|Q6ZT62|BGIN_HUMAN;sp|Q9Y3L3|3BP1_HUMAN	Normal-Triple-negative breast cancer	0.0370562904012484	0.353529221758893	22.0000000317188	0.917469861475759	0.953341451332584	nan
sp|Q709C8|VP13C_HUMAN	metaplastic breast carcinomas-Normal	-0.33606444617052	0.205216341514521	22.0000042067807	0.115728319465155	0.280543743788241	nan
sp|Q709C8|VP13C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.178179418342803	0.205216341514521	22.0000042068162	0.394629635590298	0.885234295852111	nan
sp|Q709C8|VP13C_HUMAN	Normal-Triple-negative breast cancer	0.514243864513323	0.245280442481093	22.000004206798	0.0477512179282723	0.150879323568039	nan
sp|Q70E73|RAPH1_HUMAN	metaplastic breast carcinomas-Normal	0.18988792577142	0.370781455733851	23.9999999998036	0.613241511520714	0.768343303541219	nan
sp|Q70E73|RAPH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.404821474166136	0.370781455733851	24.0000000000377	0.285757858476132	0.867696529950794	nan
sp|Q70E73|RAPH1_HUMAN	Normal-Triple-negative breast cancer	0.214933548394716	0.443168603703753	23.999999999944	0.632078990532079	0.779314007614477	nan
sp|Q70UQ0|IKIP_HUMAN	metaplastic breast carcinomas-Normal	0.875807374456775	0.387042727695835	23.9999999996618	0.0329747257206637	0.129407306133986	nan
sp|Q70UQ0|IKIP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.386439443844692	0.387042727695835	23.9999999998753	0.328026331628482	0.867975899287892	nan
sp|Q70UQ0|IKIP_HUMAN	Normal-Triple-negative breast cancer	-0.489367930612083	0.462604541176883	23.9999999997598	0.300654005823622	0.493517982892701	nan
sp|Q71DI3|H32_HUMAN	metaplastic breast carcinomas-Normal	1.70149729284749	0.357101521778877	22.9999999995401	8.36793305150455e-05	0.0136889536397125	nan
sp|Q71DI3|H32_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.131766663681098	0.357101521778877	22.9999999995401	0.715510718181996	0.949812109346858	nan
sp|Q71DI3|H32_HUMAN	Normal-Triple-negative breast cancer	-1.83326395652859	0.422528218702024	22.9999999994234	0.0002419922046143	0.0227914720285933	nan
sp|Q765P7|MTSS2_HUMAN	metaplastic breast carcinomas-Normal	-0.140114114080246	0.232519233808526	22.0000000218159	0.552941796515024	0.723898594571068	nan
sp|Q765P7|MTSS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.075985638387602	0.232519233808526	22.0000000224471	0.746913305162125	0.954643368861838	nan
sp|Q765P7|MTSS2_HUMAN	Normal-Triple-negative breast cancer	0.216099752467848	0.277913640468464	22.0000000224422	0.445099270065975	0.629578712212468	nan
sp|Q76M96|CCD80_HUMAN	metaplastic breast carcinomas-Normal	-0.456478879777108	0.549756459694854	13.1580457354344	0.42116332162863	0.621370120325595	nan
sp|Q76M96|CCD80_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.237284825902707	0.491855867623291	13.0000000013693	0.637523823864601	0.941868024951375	nan
sp|Q76M96|CCD80_HUMAN	Normal-Triple-negative breast cancer	0.219194053874401	0.637113102582929	13.1187032227779	0.736266315000419	0.848754503687766	nan
sp|Q7KZ85|SPT6H_HUMAN	metaplastic breast carcinomas-Normal	0.355689425450494	0.30426048148103	14.9999999998683	0.260634669088154	0.462793611137298	nan
sp|Q7KZ85|SPT6H_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.282774374613607	0.30426048148103	14.9999999998683	0.367406735396907	0.883542279876718	nan
sp|Q7KZ85|SPT6H_HUMAN	Normal-Triple-negative breast cancer	-0.638463800064102	0.363660832155985	14.9999999998964	0.0995403627324216	0.242219740646098	nan
sp|Q7KZF4|SND1_HUMAN	metaplastic breast carcinomas-Normal	0.940426819344201	0.16802668555868	22.0000000138119	1.25821763973485e-05	0.0066066425513017	nan
sp|Q7KZF4|SND1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.233031257321739	0.16802668555868	22.0000000146075	0.179374123277215	0.843662073010871	nan
sp|Q7KZF4|SND1_HUMAN	Normal-Triple-negative breast cancer	-0.707395562022462	0.200830301711369	22.0000000139792	0.0019183507414503	0.030220842960099	nan
sp|Q7KZI7|MARK2_HUMAN	metaplastic breast carcinomas-Normal	0.101186377085288	0.326087655836122	21.0590866604384	0.759379743913892	0.868333102587984	nan
sp|Q7KZI7|MARK2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.498644632461327	0.326087655836122	21.059086660139	0.141104262486657	0.823891816737944	nan
sp|Q7KZI7|MARK2_HUMAN	Normal-Triple-negative breast cancer	-0.599831009546615	0.385609872371626	21.0358808942218	0.134735331683839	0.294644896392816	nan
sp|Q7L014|DDX46_HUMAN	metaplastic breast carcinomas-Normal	0.604637769590335	0.222721271106198	23.9999999998854	0.0120897574177386	0.0721478521661814	nan
sp|Q7L014|DDX46_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.203531105950518	0.222721271106198	23.9999999999172	0.369891986041621	0.883542279876718	nan
sp|Q7L014|DDX46_HUMAN	Normal-Triple-negative breast cancer	-0.808168875540853	0.26620283513345	23.999999999929	0.0056972717348579	0.047943623409286	nan
sp|Q7L0Y3|TM10C_HUMAN	metaplastic breast carcinomas-Normal	0.604959311028145	0.174350790474627	23.9999999996967	0.0019852165297336	0.0320881648658721	nan
sp|Q7L0Y3|TM10C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.271032782872383	0.174350790474627	23.9999999996967	0.133148222846964	0.823891816737944	nan
sp|Q7L0Y3|TM10C_HUMAN	Normal-Triple-negative breast cancer	-0.875992093900528	0.208389052835341	23.9999999996729	0.0003145876108975	0.0227914720285933	nan
sp|Q7L1Q6|5MP2_HUMAN	metaplastic breast carcinomas-Normal	0.618899337183043	0.210250066544532	23.9999999994876	0.0070922375281701	0.055996668749733	nan
sp|Q7L1Q6|5MP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0179890071201431	0.210250066544532	23.9999999992699	0.932525932027568	0.995359816653149	nan
sp|Q7L1Q6|5MP2_HUMAN	Normal-Triple-negative breast cancer	-0.6009103300629	0.251296894648485	23.9999999994349	0.0249843058472874	0.10516426302168	nan
sp|Q7L2E3|DHX30_HUMAN	metaplastic breast carcinomas-Normal	0.0459734809374945	0.173299801364197	21.9999999861092	0.793261409930646	0.888110787002178	nan
sp|Q7L2E3|DHX30_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0545163132026199	0.173299801364197	21.9999999821245	0.75604604280758	0.954748610837524	nan
sp|Q7L2E3|DHX30_HUMAN	Normal-Triple-negative breast cancer	-0.100489794140114	0.207132880582456	21.9999999831625	0.632368423419249	0.779381772134069	nan
sp|Q7L2H7|EIF3M_HUMAN	metaplastic breast carcinomas-Normal	0.395687819579541	0.17769363678425	21.999999901732	0.0365124495263315	0.13886428172257	nan
sp|Q7L2H7|EIF3M_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0477637604454232	0.17769363678425	21.9999999013488	0.790589495813728	0.962981271203673	nan
sp|Q7L2H7|EIF3M_HUMAN	Normal-Triple-negative breast cancer	-0.347924059134118	0.21238451838121	21.9999999008029	0.11560871263786	0.265756127806534	nan
sp|Q7L2J0|MEPCE_HUMAN	metaplastic breast carcinomas-Normal	0.830301637621249	0.354048283159621	21.0424103069565	0.0289005962995175	0.121448270669527	nan
sp|Q7L2J0|MEPCE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.081948345443079	0.297807308122224	19.9311167152652	0.78601622256973	0.962981271203673	nan
sp|Q7L2J0|MEPCE_HUMAN	Normal-Triple-negative breast cancer	-0.74835329217817	0.404177981652874	20.8145000573681	0.0783317174865031	0.20746982384473	nan
sp|Q7L311|ARMX2_HUMAN	metaplastic breast carcinomas-Normal	0.109673434851139	0.455335509296334	21.9999999485788	0.811891887175789	0.900925915386606	nan
sp|Q7L311|ARMX2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.343363052394246	0.455335509296334	21.9999999506292	0.458792256128783	0.908567154037048	nan
sp|Q7L311|ARMX2_HUMAN	Normal-Triple-negative breast cancer	0.233689617543107	0.544230027556825	21.9999999506766	0.67181186229765	0.806711202237428	nan
sp|Q7L576|CYFP1_HUMAN	metaplastic breast carcinomas-Normal	0.133145234574083	0.11609115355737	22.0000000296946	0.263742761011513	0.466567822034205	nan
sp|Q7L576|CYFP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.140029078573557	0.11609115355737	22.0000000295926	0.24055253465657	0.849331973021071	nan
sp|Q7L576|CYFP1_HUMAN	Normal-Triple-negative breast cancer	-0.27317431314764	0.138755468022401	22.0000000293112	0.0617075812745612	0.179297202934127	nan
sp|Q7L5D6|GET4_HUMAN	metaplastic breast carcinomas-Normal	0.187325030777666	0.348072618566746	21.9999999992429	0.595857614471275	0.753951545680441	nan
sp|Q7L5D6|GET4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.307750368957658	0.298783821617144	21.9999999989974	0.314196853648006	0.867696529950794	nan
sp|Q7L5D6|GET4_HUMAN	Normal-Triple-negative breast cancer	-0.495075399735325	0.399266676143691	21.9999999991338	0.228052896782016	0.410804747922291	nan
sp|Q7L5N1|CSN6_HUMAN	metaplastic breast carcinomas-Normal	0.123675691313444	0.15808678452055	23.9999999993687	0.441672844553548	0.638590924443668	nan
sp|Q7L5N1|CSN6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0137504769237537	0.15808678452055	23.9999999993687	0.931408613634565	0.995359816653149	nan
sp|Q7L5N1|CSN6_HUMAN	Normal-Triple-negative breast cancer	-0.10992521438969	0.188949847616643	23.9999999994087	0.566147135698176	0.727697294239603	nan
sp|Q7LBC6|KDM3B_HUMAN	metaplastic breast carcinomas-Normal	-0.260590930374941	0.336895290144162	23.9999999997993	0.446774734016276	0.643243148169764	nan
sp|Q7LBC6|KDM3B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.246295698902171	0.336895290144162	23.9999999997993	0.471811254211277	0.912607574317916	nan
sp|Q7LBC6|KDM3B_HUMAN	Normal-Triple-negative breast cancer	0.0142952314727698	0.402666889130313	23.9999999998217	0.971973573866675	0.986817397535989	nan
sp|Q7LG56|RIR2B_HUMAN	metaplastic breast carcinomas-Normal	0.0586150398559483	0.439512350691899	6.0	0.898266243374541	0.944829809649739	nan
sp|Q7LG56|RIR2B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.454425887687034	0.439512350691899	6.0	0.341030398396096	0.870943310236299	nan
sp|Q7LG56|RIR2B_HUMAN	Normal-Triple-negative breast cancer	0.395810847831085	0.525317735702768	6.0	0.479679761825639	0.658865920788605	nan
sp|Q7RTP6|MICA3_HUMAN	metaplastic breast carcinomas-Normal	0.38763878629156	0.232430388220502	23.9999999993476	0.108360123109798	0.269400934343284	nan
sp|Q7RTP6|MICA3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.428685902203158	0.232430388220502	23.9999999995258	0.0775094493566704	0.805371622221653	nan
sp|Q7RTP6|MICA3_HUMAN	Normal-Triple-negative breast cancer	0.0410471159115981	0.277807449679844	23.9999999994706	0.88377136652713	0.93275221069853	nan
sp|Q7Z2K6|ERMP1_HUMAN	metaplastic breast carcinomas-Normal	-0.0173491474088582	0.270534359469248	22.0000000430725	0.949446503605823	0.973761239736425	nan
sp|Q7Z2K6|ERMP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.344461906443528	0.270534359469248	22.0000000429947	0.216214086847275	0.843662073010871	nan
sp|Q7Z2K6|ERMP1_HUMAN	Normal-Triple-negative breast cancer	-0.327112759034669	0.3233504062456	22.0000000428996	0.322709948346731	0.514231959877533	nan
sp|Q7Z2W4|ZCCHV_HUMAN	metaplastic breast carcinomas-Normal	0.455844854673149	0.16404467309714	24.0000000003527	0.0104300164036405	0.0678461341011759	nan
sp|Q7Z2W4|ZCCHV_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.225438974673472	0.16404467309714	24.0000000003527	0.182061490474974	0.843662073010871	nan
sp|Q7Z2W4|ZCCHV_HUMAN	Normal-Triple-negative breast cancer	-0.681283829346621	0.196070886494609	24.0000000004393	0.0019613455182343	0.0306080399183612	nan
sp|Q7Z3B1|NEGR1_HUMAN	metaplastic breast carcinomas-Normal	0.351179955190649	0.793824098537869	14.9999999996031	0.664519195286045	0.803514661742747	nan
sp|Q7Z3B1|NEGR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.09988848408656	0.793824098537869	14.9999999996038	0.186139866188257	0.843662073010871	nan
sp|Q7Z3B1|NEGR1_HUMAN	Normal-Triple-negative breast cancer	0.748708528895911	0.948801273351546	14.9999999996237	0.442342652846909	0.627281133985975	nan
sp|Q7Z3B4|NUP54_HUMAN	metaplastic breast carcinomas-Normal	0.0193978581215246	0.231538157293217	22.0000000310548	0.9339904185748	0.964755795942398	nan
sp|Q7Z3B4|NUP54_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.294284384516874	0.231538157293217	22.0000000310519	0.217004879844767	0.843662073010871	nan
sp|Q7Z3B4|NUP54_HUMAN	Normal-Triple-negative breast cancer	0.274886526395349	0.276741029749419	22.0000000311378	0.331364559983523	0.523754539888364	nan
sp|Q7Z3K3|POGZ_HUMAN	metaplastic breast carcinomas-Normal	0.645817493074578	0.313083605136463	14.000000001567	0.0581975239704728	0.18371669410281	nan
sp|Q7Z3K3|POGZ_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.222881054363858	0.313083605136463	14.00000000147	0.488227031168701	0.913320451076758	nan
sp|Q7Z3K3|POGZ_HUMAN	Normal-Triple-negative breast cancer	-0.868698547438436	0.374206481972653	14.0000000015207	0.0358605435307317	0.126674226032043	nan
sp|Q7Z3T8|ZFY16_HUMAN	metaplastic breast carcinomas-Normal	0.211904198822875	0.225068535701009	18.9586131959168	0.358286965151826	0.56792840828072	nan
sp|Q7Z3T8|ZFY16_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.149461714557377	0.211950194758048	18.9876775536912	0.489263168640693	0.913320451076758	nan
sp|Q7Z3T8|ZFY16_HUMAN	Normal-Triple-negative breast cancer	-0.361365913380252	0.260180494972859	18.9915050145847	0.180935517204485	0.356693755905161	nan
sp|Q7Z3U7|MON2_HUMAN	metaplastic breast carcinomas-Normal	0.417482669972743	0.336721010468515	14.0000000150444	0.23541214854282	0.435449737051968	nan
sp|Q7Z3U7|MON2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0202687678311183	0.336721010468514	14.0000000148847	0.952851532451222	0.996541950781621	nan
sp|Q7Z3U7|MON2_HUMAN	Normal-Triple-negative breast cancer	-0.437751437803861	0.402458585075954	14.000000014946	0.295102136656416	0.487534543859805	nan
sp|Q7Z406|MYH14_HUMAN	metaplastic breast carcinomas-Normal	0.266005707102715	0.470803902150304	22.000000005709	0.577788245254216	0.739533356651911	nan
sp|Q7Z406|MYH14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.605155004364665	0.470803902150304	22.0000000058854	0.212031628610131	0.843662073010871	nan
sp|Q7Z406|MYH14_HUMAN	Normal-Triple-negative breast cancer	0.33914929726195	0.562718293236314	22.0000000058692	0.552872076940912	0.717309439403431	nan
sp|Q7Z417|NUFP2_HUMAN	metaplastic breast carcinomas-Normal	1.04339548717171	0.271266079256578	22.000000001683	0.0008765679808959	0.0227210419054423	nan
sp|Q7Z417|NUFP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.125352013063952	0.271266079256578	22.0000000015747	0.648547017843991	0.943315325604231	nan
sp|Q7Z417|NUFP2_HUMAN	Normal-Triple-negative breast cancer	-0.918043474107759	0.324224978669434	22.0000000020893	0.0097139500649745	0.0620945577230293	nan
sp|Q7Z422|SZRD1_HUMAN	metaplastic breast carcinomas-Normal	0.707016838658466	0.253957601021481	14.9999999997565	0.0139012346656543	0.0787184055002298	nan
sp|Q7Z422|SZRD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.261238024729568	0.253957601021481	14.9999999997565	0.319938577566308	0.867696529950794	nan
sp|Q7Z422|SZRD1_HUMAN	Normal-Triple-negative breast cancer	-0.445778813928898	0.303537390298803	14.9999999997799	0.162595684905693	0.332186881761846	nan
sp|Q7Z434|MAVS_HUMAN	metaplastic breast carcinomas-Normal	-0.124135696900559	0.260077141023908	22.000000101138	0.637853694687232	0.784397218327917	nan
sp|Q7Z434|MAVS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.37018263678245	0.260077141023908	22.000000101737	0.168660483577363	0.843662073010871	nan
sp|Q7Z434|MAVS_HUMAN	Normal-Triple-negative breast cancer	-0.246046939881891	0.310851639585671	22.0000001020251	0.437088837081084	0.623020280642163	nan
sp|Q7Z460|CLAP1_HUMAN	metaplastic breast carcinomas-Normal	0.363645673610509	0.257803704373705	22.0000000327811	0.172360379852345	0.360525616455081	nan
sp|Q7Z460|CLAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0886125788976519	0.257803704373705	22.0000000330465	0.734319363793505	0.954643368861838	nan
sp|Q7Z460|CLAP1_HUMAN	Normal-Triple-negative breast cancer	-0.452258252508161	0.308134363059839	22.0000000329256	0.156329659269027	0.325912773022447	nan
sp|Q7Z4H8|PLGT3_HUMAN	metaplastic breast carcinomas-Normal	-0.380755417829094	0.204358079213778	22.0000000277855	0.0758424707306064	0.21565472430157	nan
sp|Q7Z4H8|PLGT3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.375041546262858	0.204358079213778	22.0000000274358	0.080030498007762	0.806849600316436	nan
sp|Q7Z4H8|PLGT3_HUMAN	Normal-Triple-negative breast cancer	0.755796964091952	0.244254622824932	22.0000000272711	0.0052951961889137	0.0461159524286754	nan
sp|Q7Z4Q2|HEAT3_HUMAN	metaplastic breast carcinomas-Normal	-0.200297110723215	0.621350121312839	6.0	0.758117975246016	0.868062056396058	nan
sp|Q7Z4Q2|HEAT3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.303059655059321	0.621350121312839	6.0	0.643040403127509	0.941868024951375	nan
sp|Q7Z4Q2|HEAT3_HUMAN	Normal-Triple-negative breast cancer	0.503356765782536	0.742655441406502	6.0	0.523173969033868	0.695236941305747	nan
sp|Q7Z4W1|DCXR_HUMAN	metaplastic breast carcinomas-Normal	-0.267618135355992	0.332704370521549	22.0000000343391	0.429789091392702	0.626846629119879	nan
sp|Q7Z4W1|DCXR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.48405659899397	0.332704370521549	22.0000000343391	0.159813591995578	0.843662073010871	nan
sp|Q7Z4W1|DCXR_HUMAN	Normal-Triple-negative breast cancer	-0.216438463637978	0.397657782097945	22.0000000349329	0.591720992388311	0.74587811099687	nan
sp|Q7Z5L7|PODN_HUMAN	metaplastic breast carcinomas-Normal	-1.19213892634515	0.426173492675408	23.9999999999961	0.0099914258176582	0.0665555756942394	nan
sp|Q7Z5L7|PODN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.467191216234319	0.426173492675408	23.9999999999961	0.283849581487294	0.867696529950794	nan
sp|Q7Z5L7|PODN_HUMAN	Normal-Triple-negative breast cancer	0.724947710110835	0.509374750985609	24.000000000014	0.1675452971673	0.338553536646872	nan
sp|Q7Z5L9|I2BP2_HUMAN	metaplastic breast carcinomas-Normal	0.271540039317731	0.240557083509715	21.9999996817045	0.271142740328017	0.473099091660176	nan
sp|Q7Z5L9|I2BP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.496778711839571	0.240557083509715	21.9999996799471	0.0508931315794955	0.772811405794299	nan
sp|Q7Z5L9|I2BP2_HUMAN	Normal-Triple-negative breast cancer	-0.768318751157302	0.287520708388855	21.9999996806997	0.0139183476921126	0.0765969995506332	nan
sp|Q7Z601|GP142_HUMAN	metaplastic breast carcinomas-Normal	0.691342494023745	0.280584445715053	23.9999999996498	0.0212920537350188	0.100019691718977	nan
sp|Q7Z601|GP142_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0490273965973089	0.280584445715053	23.9999999996498	0.862755035612375	0.979916450336765	nan
sp|Q7Z601|GP142_HUMAN	Normal-Triple-negative breast cancer	-0.740369890621054	0.335362556852865	23.999999999727	0.0370718325706619	0.12835519121726	nan
sp|Q7Z6E9|RBBP6_HUMAN	metaplastic breast carcinomas-Normal	0.853303450867211	0.266505630099046	19.2563343299779	0.0046365844723863	0.0458663504478383	nan
sp|Q7Z6E9|RBBP6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.345463921815175	0.224021823347784	18.9024044794382	0.139624893715528	0.823891816737944	nan
sp|Q7Z6E9|RBBP6_HUMAN	Normal-Triple-negative breast cancer	-1.19876737268239	0.303793139215917	19.2732230361682	0.0008469739605451	0.0257262735003663	nan
sp|Q7Z6I6|RHG30_HUMAN	metaplastic breast carcinomas-Normal	-0.0585438779788994	0.426368167329622	14.0000000006006	0.892742298678632	0.94150288514576	nan
sp|Q7Z6I6|RHG30_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.590827391961475	0.426368167329622	14.0000000005797	0.187510956388064	0.843662073010871	nan
sp|Q7Z6I6|RHG30_HUMAN	Normal-Triple-negative breast cancer	0.649371269940374	0.509607431701838	14.0000000006666	0.223318340279208	0.406070470893574	nan
sp|Q7Z6I8|CE024_HUMAN	metaplastic breast carcinomas-Normal	0.219450124256981	0.32803843386157	22.0000000707191	0.510469917502497	0.693988550420573	nan
sp|Q7Z6I8|CE024_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.149399030800412	0.32803843386157	22.0000000701756	0.653261919634303	0.944190045212043	nan
sp|Q7Z6I8|CE024_HUMAN	Normal-Triple-negative breast cancer	-0.368849155057392	0.392080921112596	22.0000000702992	0.35704998661034	0.548191295839617	nan
sp|Q7Z6Z7|HUWE1_HUMAN	metaplastic breast carcinomas-Normal	0.315692482416518	0.173396379728517	23.9999999999476	0.0811541668702716	0.225926675608696	nan
sp|Q7Z6Z7|HUWE1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0698704978861026	0.173396379728517	23.9999999999476	0.690550294152536	0.946568877415162	nan
sp|Q7Z6Z7|HUWE1_HUMAN	Normal-Triple-negative breast cancer	-0.385562980302621	0.207248313806534	24.0000000000117	0.075127730084922	0.201716134735283	nan
sp|Q7Z739|YTHD3_HUMAN	metaplastic breast carcinomas-Normal	0.181098346718369	0.434058682762891	14.9999999996454	0.682426943931817	0.815009772846929	nan
sp|Q7Z739|YTHD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.430154684324738	0.434058682762891	14.9999999997731	0.337400599255067	0.870943310236299	nan
sp|Q7Z739|YTHD3_HUMAN	Normal-Triple-negative breast cancer	-0.611253031043107	0.518799355768208	14.9999999997028	0.257068391193544	0.448038461981399	nan
sp|Q7Z7G0|TARSH_HUMAN	metaplastic breast carcinomas-Normal	-1.92242219160372	0.703442406438962	14.9999999997624	0.01540760256108	0.0817474695422512	nan
sp|Q7Z7G0|TARSH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0686982037414887	0.703442406438961	14.9999999997464	0.923495274742982	0.994508979919649	nan
sp|Q7Z7G0|TARSH_HUMAN	Normal-Triple-negative breast cancer	1.9911203953452	0.840774489194879	14.9999999997286	0.0317342749706384	0.119654898900784	nan
sp|Q7Z7H5|TMED4_HUMAN	metaplastic breast carcinomas-Normal	0.755383920716373	0.311024973642483	22.0000000388176	0.0237791938584162	0.107248358731853	nan
sp|Q7Z7H5|TMED4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0820930334842754	0.311024973642483	22.0000000390296	0.794280108225948	0.964213712979656	nan
sp|Q7Z7H5|TMED4_HUMAN	Normal-Triple-negative breast cancer	-0.837476954200648	0.371745946714971	22.0000000381501	0.0345783496213901	0.124501280252024	nan
sp|Q7Z7K6|CENPV_HUMAN	metaplastic breast carcinomas-Normal	0.248274962888016	0.510800117945882	24.0000000005189	0.631339386680844	0.779400517681372	nan
sp|Q7Z7K6|CENPV_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.590551790626679	0.510800117945882	24.0000000002722	0.259007181585141	0.862813416943474	nan
sp|Q7Z7K6|CENPV_HUMAN	Normal-Triple-negative breast cancer	0.342276827738663	0.610522914620301	24.0000000003337	0.580247173027873	0.738415621418319	nan
sp|Q7Z7N9|T179B_HUMAN	metaplastic breast carcinomas-Normal	-0.28941510573399	0.292273643953758	22.000000071577	0.332833453174052	0.540996771809559	nan
sp|Q7Z7N9|T179B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.245519104356228	0.292273643953758	22.0000000719941	0.409927293382661	0.885784822958391	nan
sp|Q7Z7N9|T179B_HUMAN	Normal-Triple-negative breast cancer	0.534934210090218	0.349333821007945	22.0000000724109	0.139949867458751	0.301744921269454	nan
sp|Q86SF2|GALT7_HUMAN	metaplastic breast carcinomas-Normal	0.4112565753976	0.228072145682214	21.999960296111	0.0850738814308505	0.233129086460138	nan
sp|Q86SF2|GALT7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.104128586193931	0.228072145682214	21.9999602846598	0.652463056771416	0.944190045212043	nan
sp|Q86SF2|GALT7_HUMAN	Normal-Triple-negative breast cancer	-0.307127989203669	0.272598353511664	21.9999602433894	0.272022449747733	0.463995415682386	nan
sp|Q86TB9|PATL1_HUMAN	metaplastic breast carcinomas-Normal	0.615344567213476	0.222088768490016	14.0000000008242	0.0150211059403862	0.0806387639386771	nan
sp|Q86TB9|PATL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0686871461719897	0.222088768490016	14.0000000007863	0.761665182689157	0.955228196959647	nan
sp|Q86TB9|PATL1_HUMAN	Normal-Triple-negative breast cancer	-0.546657421041486	0.26544684991111	14.0000000007645	0.0585603542286843	0.173156229478903	nan
sp|Q86TI2|DPP9_HUMAN	metaplastic breast carcinomas-Normal	0.470030494978668	0.250607848546762	14.000000001693	0.0817246754582152	0.226670151240873	nan
sp|Q86TI2|DPP9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.266019773707655	0.250607848546762	14.0000000018718	0.306432813098571	0.867696529950794	nan
sp|Q86TI2|DPP9_HUMAN	Normal-Triple-negative breast cancer	-0.736050268686324	0.299533670306831	14.0000000016624	0.0276515001086271	0.111517044374766	nan
sp|Q86TU7|SETD3_HUMAN	metaplastic breast carcinomas-Normal	0.279884724915772	0.349202347564869	23.9999999999563	0.430708226296178	0.627376925595309	nan
sp|Q86TU7|SETD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.230327076450718	0.349202347564869	23.9999999999822	0.515803008802629	0.915620969865368	nan
sp|Q86TU7|SETD3_HUMAN	Normal-Triple-negative breast cancer	-0.51021180136649	0.417376636256263	24.0000000000301	0.233416586520044	0.418037033185682	nan
sp|Q86U86|PB1_HUMAN	metaplastic breast carcinomas-Normal	0.303983039470336	0.232776663066478	22.0000050367506	0.205077330814102	0.398876426107058	nan
sp|Q86U86|PB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.168144017381084	0.232776663066478	22.0000050367515	0.477693939716047	0.913280230088743	nan
sp|Q86U86|PB1_HUMAN	Normal-Triple-negative breast cancer	-0.47212705685142	0.278221327282447	22.0000050371133	0.103811165329831	0.248429311415666	nan
sp|Q86UE4|LYRIC_HUMAN	metaplastic breast carcinomas-Normal	0.635010968304298	0.231440686904862	23.999999999982	0.0113102301553011	0.0705294023488664	nan
sp|Q86UE4|LYRIC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.257904471418174	0.231440686904862	23.999999999982	0.276167203033456	0.867696529950794	nan
sp|Q86UE4|LYRIC_HUMAN	Normal-Triple-negative breast cancer	-0.377106496886123	0.276624530352695	24.0	0.185459144661585	0.363054297323386	nan
sp|Q86UP2|KTN1_HUMAN	metaplastic breast carcinomas-Normal	0.227328558665115	0.205160434808589	23.9999999994967	0.278820543345828	0.482074791728931	nan
sp|Q86UP2|KTN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0210454351245455	0.205160434808589	23.999999999268	0.919148319255888	0.99419914168049	nan
sp|Q86UP2|KTN1_HUMAN	Normal-Triple-negative breast cancer	-0.248373993789661	0.245213621186709	23.9999999994129	0.321216794218978	0.513128887887703	nan
sp|Q86UX7|URP2_HUMAN	metaplastic breast carcinomas-Normal	0.144616917803889	0.34126411803494	22.000000007376	0.675849370292608	0.809849786176146	nan
sp|Q86UX7|URP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.330223562921861	0.34126411803494	22.000000007372	0.343738325277525	0.870943310236299	nan
sp|Q86UX7|URP2_HUMAN	Normal-Triple-negative breast cancer	0.185606645117971	0.407888637214629	22.0000000072651	0.653537448079647	0.79700780333508	nan
sp|Q86V21|AACS_HUMAN	metaplastic breast carcinomas-Normal	-0.323819830191844	0.493229936152491	22.0000000251415	0.518292709049721	0.700042651312991	nan
sp|Q86V21|AACS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.767208972616889	0.493229936152491	22.0000000251142	0.134101248019364	0.823891816737944	nan
sp|Q86V21|AACS_HUMAN	Normal-Triple-negative breast cancer	-0.443389142425045	0.589522530669633	22.0000000251042	0.459953337898835	0.64148519448451	nan
sp|Q86V48|LUZP1_HUMAN	metaplastic breast carcinomas-Normal	0.656784321489681	0.255412166884833	14.0000000004386	0.0221739316798326	0.101944880918069	nan
sp|Q86V48|LUZP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.275217612585212	0.255412166884833	14.0000000007826	0.299455108553762	0.867696529950794	nan
sp|Q86V48|LUZP1_HUMAN	Normal-Triple-negative breast cancer	-0.381566708904469	0.305275929032843	14.0000000006872	0.231824244614673	0.415633111703977	nan
sp|Q86V81|THOC4_HUMAN	metaplastic breast carcinomas-Normal	0.781046120611394	0.330193973193591	23.99999999984	0.0264316730547615	0.115451880728025	nan
sp|Q86V81|THOC4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.462777879327821	0.330193973193591	23.99999999984	0.173854821305446	0.843662073010871	nan
sp|Q86V81|THOC4_HUMAN	Normal-Triple-negative breast cancer	-1.24382399993921	0.394657283390774	23.9999999998534	0.0043164981932029	0.0419484078096101	nan
sp|Q86V85|GP180_HUMAN	metaplastic breast carcinomas-Normal	-1.32202183395044	0.641996395259226	14.9999999994242	0.0572709759911864	0.182171027937515	nan
sp|Q86V85|GP180_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.788585306836267	0.641996395259226	14.9999999995607	0.238247051026487	0.84876230490475	nan
sp|Q86V85|GP180_HUMAN	Normal-Triple-negative breast cancer	2.1106071407867	0.767332458703378	14.999999999476	0.0148689382286275	0.0779324922305247	nan
sp|Q86VB7|C163A_HUMAN	metaplastic breast carcinomas-Normal	-0.239971251340066	0.362256592436374	22.0000002708	0.514573257495621	0.69669792945721	nan
sp|Q86VB7|C163A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.735272830279719	0.362256592436374	22.0000002709341	0.0546533187001166	0.773286317778246	nan
sp|Q86VB7|C163A_HUMAN	Normal-Triple-negative breast cancer	0.975244081619785	0.432979443199944	22.0000002708845	0.034608659131429	0.124501280252024	nan
sp|Q86VM9|ZCH18_HUMAN	metaplastic breast carcinomas-Normal	0.550859112946847	0.234895795532512	22.0000000306122	0.0284492557610853	0.120246014908263	nan
sp|Q86VM9|ZCH18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.116162258126469	0.234895795532512	22.0000000306122	0.625836450202339	0.941374262616245	nan
sp|Q86VM9|ZCH18_HUMAN	Normal-Triple-negative breast cancer	-0.434696854820378	0.28075417503282	22.0000000305869	0.135811808264192	0.296025213554213	nan
sp|Q86VN1|VPS36_HUMAN	metaplastic breast carcinomas-Normal	0.0347860160033381	0.197035426009118	14.0000000050267	0.862392695897939	0.928300945973041	nan
sp|Q86VN1|VPS36_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0511870587139767	0.197035426009118	14.0000000050524	0.798810224624777	0.965774701272009	nan
sp|Q86VN1|VPS36_HUMAN	Normal-Triple-negative breast cancer	0.0164010427106387	0.235502378218488	14.0000000051224	0.945462961591952	0.971774546793955	nan
sp|Q86VP6|CAND1_HUMAN	metaplastic breast carcinomas-Normal	0.359677728823759	0.153396474472743	23.9999999997569	0.027644625002961	0.117959863298899	nan
sp|Q86VP6|CAND1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.221691048481821	0.153396474472743	23.9999999997569	0.161328839366721	0.843662073010871	nan
sp|Q86VP6|CAND1_HUMAN	Normal-Triple-negative breast cancer	-0.58136877730558	0.183343854860855	23.9999999997569	0.0041204508151685	0.0415041773018799	nan
sp|Q86VS8|HOOK3_HUMAN	metaplastic breast carcinomas-Normal	0.355769225272313	0.147339333453042	22.0000000230554	0.0245120399671083	0.109660862517723	nan
sp|Q86VS8|HOOK3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.325808854860227	0.147339333453042	22.0000000232954	0.0377120031951282	0.73123935744099	nan
sp|Q86VS8|HOOK3_HUMAN	Normal-Triple-negative breast cancer	-0.0299603704120864	0.176104186623336	22.0000000231973	0.866463768706595	0.922230408959565	nan
sp|Q86VY4|TSYL5_HUMAN	metaplastic breast carcinomas-Normal	1.02580215116393	0.501669962425898	21.999999177648	0.053023671565026	0.175373815206116	nan
sp|Q86VY4|TSYL5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.44019322597399	0.501669962425898	21.9999991785723	0.389720993877669	0.885234295852111	nan
sp|Q86VY4|TSYL5_HUMAN	Normal-Triple-negative breast cancer	-0.58560892518994	0.599610291535143	21.9999991790421	0.339360713161138	0.531340089753944	nan
sp|Q86W42|THOC6_HUMAN	metaplastic breast carcinomas-Normal	0.113077680591298	0.220035073613555	23.999999999655	0.612016113783699	0.767676061213969	nan
sp|Q86W42|THOC6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.178427957207506	0.220035073613555	23.999999999655	0.425388039131017	0.892375539501976	nan
sp|Q86W42|THOC6_HUMAN	Normal-Triple-negative breast cancer	-0.291505637798804	0.26299221503992	23.9999999996399	0.278665404377535	0.470624638428115	nan
sp|Q86W92|LIPB1_HUMAN	metaplastic breast carcinomas-Normal	-0.625311307458932	0.353584303905281	14.9999999996445	0.0973042924027568	0.251765208771212	nan
sp|Q86W92|LIPB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.361933251360978	0.353584303905281	14.9999999996445	0.322244069608481	0.867696529950794	nan
sp|Q86W92|LIPB1_HUMAN	Normal-Triple-negative breast cancer	0.98724455881991	0.422614075839178	14.9999999996253	0.0337817292012946	0.123621534315429	nan
sp|Q86WB0|ZC3C1_HUMAN	metaplastic breast carcinomas-Normal	0.269397652620988	0.199840169713386	22.0000047504839	0.191354854399465	0.384853332717282	nan
sp|Q86WB0|ZC3C1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.203284068492941	0.199840169713386	22.0000047508089	0.320099589178959	0.867696529950794	nan
sp|Q86WB0|ZC3C1_HUMAN	Normal-Triple-negative breast cancer	-0.472681721113929	0.238854688135679	22.0000047505931	0.0604731069262102	0.177103618874646	nan
sp|Q86WJ1|CHD1L_HUMAN	metaplastic breast carcinomas-Normal	0.971558155258938	0.496668753412957	14.9999999998089	0.0693333191646669	0.204216569909399	nan
sp|Q86WJ1|CHD1L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.65813305961398	0.496668753412957	14.9999999998089	0.204971342108159	0.843662073010871	nan
sp|Q86WJ1|CHD1L_HUMAN	Normal-Triple-negative breast cancer	-1.62969121487292	0.593632703441615	14.9999999997829	0.0150280458353402	0.0781078712931399	nan
sp|Q86X10|RLGPB_HUMAN	metaplastic breast carcinomas-Normal	0.218163433202282	0.384296376543582	14.9999999998865	0.578640329949948	0.740338897903629	nan
sp|Q86X10|RLGPB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.291840118796879	0.384296376543582	14.9999999997511	0.459373859540987	0.908636575237228	nan
sp|Q86X10|RLGPB_HUMAN	Normal-Triple-negative breast cancer	0.0736766855945969	0.459322023708432	14.9999999998175	0.874703737277981	0.927684371150779	nan
sp|Q86X29|LSR_HUMAN	metaplastic breast carcinomas-Normal	-0.0041439999436024	0.506147963976079	20.2197763968317	0.993547771722189	0.995945594132271	nan
sp|Q86X29|LSR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.963227097350445	0.471275196786778	20.0351350751495	0.05433619813774	0.773286317778246	nan
sp|Q86X29|LSR_HUMAN	Normal-Triple-negative breast cancer	-0.959083097406842	0.586353086946403	20.1167633695615	0.117458622441808	0.268338461166028	nan
sp|Q86X55|CARM1_HUMAN	metaplastic breast carcinomas-Normal	0.382869530883168	0.19362807788325	23.9999999996829	0.0595977283390176	0.187159677416869	nan
sp|Q86X55|CARM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.115656926328279	0.19362807788325	23.9999999997263	0.555891343384395	0.931642387063667	nan
sp|Q86X55|CARM1_HUMAN	Normal-Triple-negative breast cancer	-0.498526457211447	0.231429818256489	23.999999999758	0.0414860483187703	0.138175976564722	nan
sp|Q86XP3|DDX42_HUMAN	metaplastic breast carcinomas-Normal	1.39865552946467	0.38373508893736	21.0448258205908	0.0015097616397209	0.0281210167842065	nan
sp|Q86XP3|DDX42_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.402516065729385	0.38373508893736	21.0448258202018	0.306102195911157	0.867696529950794	nan
sp|Q86XP3|DDX42_HUMAN	Normal-Triple-negative breast cancer	-1.80117159519405	0.453869775274516	21.0053894269436	0.0007002438095563	0.0253001132931023	nan
sp|Q86Y82|STX12_HUMAN	metaplastic breast carcinomas-Normal	-0.0664467758691264	0.219213394261717	24.0000000002714	0.764414436626004	0.871070821852876	nan
sp|Q86Y82|STX12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.201775135812859	0.219213394261717	24.0000000000711	0.366497218542748	0.883542279876718	nan
sp|Q86Y82|STX12_HUMAN	Normal-Triple-negative breast cancer	-0.135328359943732	0.262010120370904	24.0000000001612	0.610231657448311	0.76084397200232	nan
sp|Q8IU81|I2BP1_HUMAN	metaplastic breast carcinomas-Normal	1.4998689828869	0.479433341495674	6.0	0.0203654937793072	0.0968494825180447	nan
sp|Q8IU81|I2BP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.210875629398097	0.479433341495674	6.0	0.675451333860452	0.946386428913156	nan
sp|Q8IU81|I2BP1_HUMAN	Normal-Triple-negative breast cancer	-1.71074461228499	0.573032446024416	6.0	0.0244644698941057	0.104394241610331	nan
sp|Q8IUD2|RB6I2_HUMAN	metaplastic breast carcinomas-Normal	0.134891576780135	0.336269616685956	21.0080452832208	0.692367174925896	0.820033259296383	nan
sp|Q8IUD2|RB6I2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.129661063144953	0.312697029992016	20.9956247453996	0.682601376698425	0.946568877415162	nan
sp|Q8IUD2|RB6I2_HUMAN	Normal-Triple-negative breast cancer	-0.0052305136351827	0.393678455348728	21.0046896406642	0.989524800666318	0.995213445511299	nan
sp|Q8IUE6|H2A2B_HUMAN	metaplastic breast carcinomas-Normal	0.677869986342397	0.310574948303053	21.9995215675746	0.0400220464094568	0.148143966887566	nan
sp|Q8IUE6|H2A2B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.124678470207129	0.310574948303053	21.9995215673617	0.69196615538134	0.946568877415162	nan
sp|Q8IUE6|H2A2B_HUMAN	Normal-Triple-negative breast cancer	-0.802548456549526	0.371208063554359	21.9995215232074	0.0417644461591829	0.13854792318675	nan
sp|Q8IUX7|AEBP1_HUMAN	metaplastic breast carcinomas-Normal	0.343256341520019	0.500247099537982	23.9999999992718	0.499179608516504	0.685083822753451	nan
sp|Q8IUX7|AEBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.675417081932812	0.500247099537982	23.9999999993223	0.189558834698035	0.843662073010871	nan
sp|Q8IUX7|AEBP1_HUMAN	Normal-Triple-negative breast cancer	-1.01867342345283	0.597909645104346	23.9999999993483	0.10134867677431	0.244442821554936	nan
sp|Q8IV08|PLD3_HUMAN	metaplastic breast carcinomas-Normal	-0.580006484266966	0.42825138639734	13.9999999969257	0.19707842836623	0.389933747553184	nan
sp|Q8IV08|PLD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.367192492778726	0.42825138639734	13.9999999959278	0.40565042730228	0.885297496092956	nan
sp|Q8IV08|PLD3_HUMAN	Normal-Triple-negative breast cancer	0.21281399148824	0.511858309009218	13.9999999953202	0.683882861412707	0.814550412235226	nan
sp|Q8IV36|HID1_HUMAN	metaplastic breast carcinomas-Normal	-1.28384157351128	0.357240677536144	11.9999999997304	0.0036878241141249	0.0407324763980233	nan
sp|Q8IV36|HID1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.54129055580729	0.357240677536144	11.9999999997304	0.155610988224774	0.843465960034572	nan
sp|Q8IV36|HID1_HUMAN	Normal-Triple-negative breast cancer	0.742551017703991	0.437528687664849	11.9999999997304	0.11542916065171	0.265530231549829	nan
sp|Q8IVD9|NUDC3_HUMAN	metaplastic breast carcinomas-Normal	0.380171276738124	0.225404974183453	23.9999999998841	0.104635311007123	0.26289325305191	nan
sp|Q8IVD9|NUDC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.658247318708572	0.225404974183453	23.9999999998841	0.0074937651649747	0.539588996897564	nan
sp|Q8IVD9|NUDC3_HUMAN	Normal-Triple-negative breast cancer	0.278076041970448	0.269410473830343	23.9999999999317	0.312284629803733	0.50512608733217	nan
sp|Q8IVF2|AHNK2_HUMAN	metaplastic breast carcinomas-Normal	-0.317117190976338	0.454752015690728	21.9999991605762	0.492893699153921	0.68180551643264	nan
sp|Q8IVF2|AHNK2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.732077853700921	0.454752015690728	21.9999991605762	0.121689376472027	0.823891816737944	nan
sp|Q8IVF2|AHNK2_HUMAN	Normal-Triple-negative breast cancer	1.04919504467726	0.543532619306041	21.9999991601268	0.0665574924287665	0.186338952556932	nan
sp|Q8IVH4|MMAA_HUMAN	metaplastic breast carcinomas-Normal	0.0584696557166929	0.539929312940993	14.9999999997297	0.915199906177879	0.955741278082083	nan
sp|Q8IVH4|MMAA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.293363517497504	0.539929312940992	14.999999999756	0.594881005665678	0.940559810632461	nan
sp|Q8IVH4|MMAA_HUMAN	Normal-Triple-negative breast cancer	0.234893861780812	0.645338961845337	14.9999999997305	0.720948583641278	0.838793521884357	nan
sp|Q8IVL6|P3H3_HUMAN	metaplastic breast carcinomas-Normal	0.339092894424808	0.304779871890759	20.3000353329432	0.278889838897333	0.482074791728931	nan
sp|Q8IVL6|P3H3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.225328429828914	0.257094708097752	18.9057133645043	0.391790726396459	0.885234295852111	nan
sp|Q8IVL6|P3H3_HUMAN	Normal-Triple-negative breast cancer	-0.113764464595894	0.344630665325222	19.8960581021533	0.74477080131559	0.853367164278876	nan
sp|Q8IW45|NNRD_HUMAN	metaplastic breast carcinomas-Normal	-0.4518844371318	0.164222381016057	22.0000000441784	0.0116427077141703	0.0712452568367856	nan
sp|Q8IW45|NNRD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.640317616551855	0.164222381016057	22.000000044182	0.0007711594168023	0.380618665421151	nan
sp|Q8IW45|NNRD_HUMAN	Normal-Triple-negative breast cancer	-0.188433179420054	0.196283288083404	22.0000000444025	0.347484985323097	0.538591737262258	nan
sp|Q8IWA0|WDR75_HUMAN	metaplastic breast carcinomas-Normal	0.542465330323811	0.22809413680555	22.0000022232982	0.0265049103948205	0.115619845344335	nan
sp|Q8IWA0|WDR75_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0720906018068648	0.22809413680555	22.0000022228958	0.754938778181336	0.954748610837524	nan
sp|Q8IWA0|WDR75_HUMAN	Normal-Triple-negative breast cancer	-0.614555932130675	0.272624637931426	22.0000022230196	0.0344770381307317	0.124296827273918	nan
sp|Q8IWE2|NXP20_HUMAN	metaplastic breast carcinomas-Normal	0.101399556916825	0.213131551712711	22.000000002101	0.638935306819303	0.785436745513078	nan
sp|Q8IWE2|NXP20_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.154413367190927	0.213131551712711	22.0000000021636	0.476395202520236	0.913280230088743	nan
sp|Q8IWE2|NXP20_HUMAN	Normal-Triple-negative breast cancer	0.053013810274102	0.254740928158865	22.0000000020799	0.837058631061756	0.907792133653925	nan
sp|Q8IWI9|MGAP_HUMAN	metaplastic breast carcinomas-Normal	1.25904596402132	0.51046788150455	22.9999999995725	0.0215254330219664	0.100085016891408	nan
sp|Q8IWI9|MGAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.228921790595179	0.51046788150455	22.9999999995725	0.658021341257644	0.944190045212043	nan
sp|Q8IWI9|MGAP_HUMAN	Normal-Triple-negative breast cancer	-1.03012417342615	0.603993742738151	22.9999999995961	0.101568273261614	0.244442821554936	nan
sp|Q8IWV7|UBR1_HUMAN	metaplastic breast carcinomas-Normal	-0.95181656143596	0.362350045979212	14.0000000515615	0.0199107778620695	0.0961557351290508	nan
sp|Q8IWV7|UBR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0133622762007466	0.362350045979212	14.000000051566	0.97110397983792	0.99709406933403	nan
sp|Q8IWV7|UBR1_HUMAN	Normal-Triple-negative breast cancer	0.938454285235213	0.433091141547988	14.0000000516885	0.0479832119601666	0.151324664663751	nan
sp|Q8IWV8|UBR2_HUMAN	metaplastic breast carcinomas-Normal	0.155684736070491	0.501368157008656	13.0000000000119	0.761088120976568	0.869067988363487	nan
sp|Q8IWV8|UBR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.430620310605239	0.382926255088779	12.9999999999135	0.281114923652521	0.867696529950794	nan
sp|Q8IWV8|UBR2_HUMAN	Normal-Triple-negative breast cancer	0.274935574534748	0.560546640412571	12.9999999999457	0.631970487170629	0.779314007614477	nan
sp|Q8IWZ3|ANKH1_HUMAN	metaplastic breast carcinomas-Normal	0.314200715561626	0.217338517408822	14.9999999995342	0.168837550988502	0.357673264770574	nan
sp|Q8IWZ3|ANKH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.063093865138396	0.217338517408822	14.9999999994284	0.775559879523227	0.960657739983943	nan
sp|Q8IWZ3|ANKH1_HUMAN	Normal-Triple-negative breast cancer	-0.377294580700022	0.259769213917345	14.9999999994505	0.166981070101373	0.337824149127792	nan
sp|Q8IX12|CCAR1_HUMAN	metaplastic breast carcinomas-Normal	0.661258131601795	0.213565689640358	23.9999999994925	0.0049313947015499	0.0470009737236255	nan
sp|Q8IX12|CCAR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.205733526937181	0.213565689640358	23.9999999994925	0.344990227603521	0.870943310236299	nan
sp|Q8IX12|CCAR1_HUMAN	Normal-Triple-negative breast cancer	-0.866991658538976	0.255259822230386	23.9999999994836	0.0023779221865098	0.0328595275636502	nan
sp|Q8IXB1|DJC10_HUMAN	metaplastic breast carcinomas-Normal	0.690858832300949	0.209446728810486	21.9999999972423	0.0032737456984068	0.0401633283746249	nan
sp|Q8IXB1|DJC10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.265590585067341	0.209446728810486	21.9999999972423	0.218033289090616	0.843662073010871	nan
sp|Q8IXB1|DJC10_HUMAN	Normal-Triple-negative breast cancer	-0.95644941736829	0.250336722405795	21.9999999978674	0.000933118604311	0.025828508049811	nan
sp|Q8IXB3|TARG1_HUMAN	metaplastic breast carcinomas-Normal	-2.53533046828164	0.987992443843423	6.0	0.0425552715109372	0.152502316045985	nan
sp|Q8IXB3|TARG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.862411054633608	0.987992443843423	6.0	0.416283203981575	0.8860071777014	nan
sp|Q8IXB3|TARG1_HUMAN	Normal-Triple-negative breast cancer	3.39774152291525	1.18087683468786	6.0	0.0281568062469339	0.112421067564965	nan
sp|Q8IXI1|MIRO2_HUMAN	metaplastic breast carcinomas-Normal	-0.362847560432905	0.33769648855219	20.0859642363381	0.295347063324436	0.499355869018528	nan
sp|Q8IXI1|MIRO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.196255836772419	0.316135273544126	19.9883862389054	0.541747983972755	0.923837171685362	nan
sp|Q8IXI1|MIRO2_HUMAN	Normal-Triple-negative breast cancer	0.559103397205325	0.392717091715216	20.2024766219867	0.169801159382087	0.341244893461945	nan
sp|Q8IXK0|PHC2_HUMAN	metaplastic breast carcinomas-Normal	-0.557715820275065	0.514684961085798	21.0202375264976	0.290812837411665	0.494709248493539	nan
sp|Q8IXK0|PHC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0861685187909188	0.514684961085798	21.0202375253954	0.868639859540663	0.981143688073178	nan
sp|Q8IXK0|PHC2_HUMAN	Normal-Triple-negative breast cancer	0.471547301484146	0.60871617041755	20.9853301918051	0.447182369441504	0.63109394571365	nan
sp|Q8IXM2|BAP18_HUMAN	metaplastic breast carcinomas-Normal	0.403636998626129	0.259998464198092	24.0000000001896	0.133640837711252	0.306441380397087	nan
sp|Q8IXM2|BAP18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.256759102857889	0.259998464198092	23.9999999999034	0.333229726170542	0.870890600099115	nan
sp|Q8IXM2|BAP18_HUMAN	Normal-Triple-negative breast cancer	-0.660396101484018	0.310757602792564	24.0000000000533	0.0440688413534938	0.142646284183891	nan
sp|Q8IXQ6|PARP9_HUMAN	metaplastic breast carcinomas-Normal	0.4456748990509	0.374607786942922	23.9999999992501	0.245796925083338	0.445247399987474	nan
sp|Q8IXQ6|PARP9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.474263035111411	0.374607786942922	23.9999999990222	0.217655521307698	0.843662073010871	nan
sp|Q8IXQ6|PARP9_HUMAN	Normal-Triple-negative breast cancer	0.0285881360605108	0.447741944233623	23.9999999990836	0.949618830156167	0.973407457284302	nan
sp|Q8IXT5|RB12B_HUMAN	metaplastic breast carcinomas-Normal	0.886550188706332	0.610615997696112	14.9999999996742	0.167125566263434	0.354473509769277	nan
sp|Q8IXT5|RB12B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.457206699566857	0.610615997696111	14.9999999998039	0.465580042306475	0.909423669537079	nan
sp|Q8IXT5|RB12B_HUMAN	Normal-Triple-negative breast cancer	-0.429343489139475	0.729825709763657	14.9999999997488	0.565096119525276	0.727490124439201	nan
sp|Q8IXZ2|ZC3H3_HUMAN	metaplastic breast carcinomas-Normal	-1.07623436626424	0.416278757111726	23.9999999996412	0.0162319120918795	0.0849683083360748	nan
sp|Q8IXZ2|ZC3H3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.166436121722244	0.416278757111726	23.9999999996412	0.692826085763415	0.946568877415162	nan
sp|Q8IXZ2|ZC3H3_HUMAN	Normal-Triple-negative breast cancer	0.909798244541991	0.497548279958098	23.9999999996354	0.0799208519808404	0.210464269316822	nan
sp|Q8IY17|PLPL6_HUMAN	metaplastic breast carcinomas-Normal	-0.173060796195459	0.124463758682587	13.9999999993838	0.186101452791847	0.377426009200792	nan
sp|Q8IY17|PLPL6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.452298511092296	0.124463758682587	13.9999999986392	0.0027095745428761	0.448717474870704	nan
sp|Q8IY17|PLPL6_HUMAN	Normal-Triple-negative breast cancer	-0.279237714896837	0.148762645202719	13.9999999992064	0.0815050614844405	0.213157218233108	nan
sp|Q8IY21|DDX60_HUMAN	metaplastic breast carcinomas-Normal	-1.35054943257298	0.577717343968326	21.07453919367	0.0293412094268823	0.122525351928338	nan
sp|Q8IY21|DDX60_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.115044110332365	0.577717343968326	21.074539193906	0.844065374707928	0.972796315737907	nan
sp|Q8IY21|DDX60_HUMAN	Normal-Triple-negative breast cancer	1.46559354290534	0.683177416713087	21.0507032087061	0.0437515791596266	0.142578675614312	nan
sp|Q8IY33|MILK2_HUMAN	metaplastic breast carcinomas-Normal	0.0574113590391901	0.333186088480986	21.0042580541597	0.864843151760745	0.92965253911881	nan
sp|Q8IY33|MILK2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.355291506260493	0.333186088480986	21.0042580536618	0.298371790918717	0.867696529950794	nan
sp|Q8IY33|MILK2_HUMAN	Normal-Triple-negative breast cancer	-0.412702865299683	0.393955432102302	20.9907235000886	0.306742019148994	0.499185641678237	nan
sp|Q8IY67|RAVR1_HUMAN	metaplastic breast carcinomas-Normal	-0.590367261953443	0.382883763282746	22.0000001865523	0.137361034362127	0.311126485533497	nan
sp|Q8IY67|RAVR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.478528566059023	0.382883763282746	22.0000001860185	0.224504766681637	0.843662073010871	nan
sp|Q8IY67|RAVR1_HUMAN	Normal-Triple-negative breast cancer	0.11183869589442	0.457633627925155	22.0000001859121	0.80919765659981	0.889691111555245	nan
sp|Q8IY81|SPB1_HUMAN	metaplastic breast carcinomas-Normal	0.986528338984091	0.429512478229178	14.0000000044556	0.0375735573179671	0.141603746626896	nan
sp|Q8IY81|SPB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0111252014761829	0.429512478229178	14.0000000043182	0.979701150229858	0.99709406933403	nan
sp|Q8IY81|SPB1_HUMAN	Normal-Triple-negative breast cancer	-0.997653540460274	0.513365602045629	14.0000000045428	0.0723558400914045	0.19681735880837	nan
sp|Q8IYB3|SRRM1_HUMAN	metaplastic breast carcinomas-Normal	0.358657889705518	0.295176026537069	23.9999999994349	0.23616045626018	0.435867493952714	nan
sp|Q8IYB3|SRRM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0329014644194757	0.295176026537069	23.9999999994349	0.912175476473586	0.99408739879047	nan
sp|Q8IYB3|SRRM1_HUMAN	Normal-Triple-negative breast cancer	-0.391559354124993	0.352802831706753	23.9999999994572	0.278059248463868	0.470605367563084	nan
sp|Q8IYB8|SUV3_HUMAN	metaplastic breast carcinomas-Normal	0.268847354533447	0.281184021778078	6.0	0.375929170950603	0.582830487052147	nan
sp|Q8IYB8|SUV3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0150681374630326	0.281184021778078	6.0	0.959002991529905	0.99709406933403	nan
sp|Q8IYB8|SUV3_HUMAN	Normal-Triple-negative breast cancer	-0.283915491996479	0.336079187316865	6.0	0.430620484210297	0.616178428547148	nan
sp|Q8IYQ7|THNS1_HUMAN	metaplastic breast carcinomas-Normal	-0.0663270141550377	0.3107270703746	6.0	0.838038589383025	0.914223915690573	nan
sp|Q8IYQ7|THNS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.224710859883123	0.3107270703746	6.0	0.496782424913902	0.913320451076758	nan
sp|Q8IYQ7|THNS1_HUMAN	Normal-Triple-negative breast cancer	-0.158383845728086	0.371389884206384	6.0	0.684647531779631	0.814550412235226	nan
sp|Q8IZ83|A16A1_HUMAN	metaplastic breast carcinomas-Normal	0.200524563061498	0.279719977962389	21.9999999628378	0.480992744235934	0.670364730331339	nan
sp|Q8IZ83|A16A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0499497740348995	0.279719977962389	21.9999999630805	0.859909066814633	0.979177437622147	nan
sp|Q8IZ83|A16A1_HUMAN	Normal-Triple-negative breast cancer	-0.250474337096397	0.334329320263034	21.9999999631064	0.46168213923674	0.642642977731543	nan
sp|Q8IZH2|XRN1_HUMAN	metaplastic breast carcinomas-Normal	-0.0996670131528488	0.274737946648033	6.0	0.729212527509713	0.850193771112692	nan
sp|Q8IZH2|XRN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0160309043444241	0.274737946648033	6.0	0.955364784818827	0.997045797088073	nan
sp|Q8IZH2|XRN1_HUMAN	Normal-Triple-negative breast cancer	0.115697917497273	0.328374653903515	6.0	0.736632701168169	0.848754503687766	nan
sp|Q8IZL8|PELP1_HUMAN	metaplastic breast carcinomas-Normal	0.691384699124835	0.252955006171149	22.0000000016443	0.0121369086382474	0.0721915911825116	nan
sp|Q8IZL8|PELP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.162460242035324	0.252955006171149	22.0000000015974	0.527347770665123	0.918405578985386	nan
sp|Q8IZL8|PELP1_HUMAN	Normal-Triple-negative breast cancer	-0.853844941160159	0.302339060250115	22.0000000020568	0.0098784160368801	0.0629039366026618	nan
sp|Q8N163|CCAR2_HUMAN	metaplastic breast carcinomas-Normal	0.476678842334594	0.216116540380246	23.999999999448	0.0372298033991476	0.140947456148937	nan
sp|Q8N163|CCAR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.507825311545381	0.216116540380246	23.9999999994469	0.0273454597676109	0.721684569712558	nan
sp|Q8N163|CCAR2_HUMAN	Normal-Triple-negative breast cancer	-0.984504153879975	0.258308672012842	23.9999999994611	0.000847546949414	0.0257262735003663	nan
sp|Q8N183|NDUF2_HUMAN	metaplastic breast carcinomas-Normal	0.010878834903545	0.176879298602948	23.9999999992407	0.951466935042803	0.975193989958575	nan
sp|Q8N183|NDUF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.105227505428181	0.176879298602948	23.9999999995483	0.557470659359997	0.932084612507839	nan
sp|Q8N183|NDUF2_HUMAN	Normal-Triple-negative breast cancer	-0.116106340331726	0.211411198089245	23.999999999417	0.587944461851739	0.743208813016678	nan
sp|Q8N1B4|VPS52_HUMAN	metaplastic breast carcinomas-Normal	-0.312734104975928	0.238088231685168	14.0000000091978	0.210127020855797	0.405450235922205	nan
sp|Q8N1B4|VPS52_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.243615539673662	0.238088231685168	14.0000000098258	0.323562358065212	0.867696529950794	nan
sp|Q8N1B4|VPS52_HUMAN	Normal-Triple-negative breast cancer	0.55634964464959	0.284569866055948	14.0000000091383	0.0708417577554593	0.194128609051234	nan
sp|Q8N1F7|NUP93_HUMAN	metaplastic breast carcinomas-Normal	0.519796460583044	0.144632087210075	23.9999999997844	0.0014595002106772	0.0280426514467702	nan
sp|Q8N1F7|NUP93_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0098339424167226	0.144632087210075	23.9999999995543	0.946354655577532	0.996541950781621	nan
sp|Q8N1F7|NUP93_HUMAN	Normal-Triple-negative breast cancer	-0.529630402999767	0.172868408461229	23.9999999996675	0.0053305274441141	0.0461452265276174	nan
sp|Q8N1G4|LRC47_HUMAN	metaplastic breast carcinomas-Normal	0.244552939219432	0.146938880241511	22.0000000033843	0.110229035382749	0.272214943248335	nan
sp|Q8N1G4|LRC47_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.187250902891904	0.146938880241511	22.0000000031455	0.215838015324105	0.843662073010871	nan
sp|Q8N1G4|LRC47_HUMAN	Normal-Triple-negative breast cancer	-0.431803842111336	0.175625553488215	22.0000000032212	0.0222851428200782	0.0987677529785866	nan
sp|Q8N2F6|ARM10_HUMAN	metaplastic breast carcinomas-Normal	0.583219666391065	0.236884477253583	22.0000000015479	0.0221221906755658	0.101847869536815	nan
sp|Q8N2F6|ARM10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.167179207166618	0.236884477253583	22.0000000020917	0.487755420141724	0.913320451076758	nan
sp|Q8N2F6|ARM10_HUMAN	Normal-Triple-negative breast cancer	-0.750398873557683	0.283131104320705	22.0000000018115	0.0146147159457193	0.0779324922305247	nan
sp|Q8N2K0|ABD12_HUMAN	metaplastic breast carcinomas-Normal	-0.440001307743203	0.268666257855046	21.9999998420239	0.11570438140354	0.280543743788241	nan
sp|Q8N2K0|ABD12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0602388351786502	0.268666257855046	21.9999998420251	0.824659717465179	0.965774701272009	nan
sp|Q8N2K0|ABD12_HUMAN	Normal-Triple-negative breast cancer	0.500240142921854	0.321117597751162	21.9999998422195	0.133548415235397	0.293013156595684	nan
sp|Q8N2S1|LTBP4_HUMAN	metaplastic breast carcinomas-Normal	-0.472410212330387	0.547887197545839	14.0000000808275	0.403083802724542	0.605445350319195	nan
sp|Q8N2S1|LTBP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.290718152235411	0.547887197545839	14.0000000807021	0.604000030824	0.940559810632461	nan
sp|Q8N2S1|LTBP4_HUMAN	Normal-Triple-negative breast cancer	0.181692060094976	0.654850453194832	14.0000000805453	0.785485104662127	0.877631088368709	nan
sp|Q8N335|GPD1L_HUMAN	metaplastic breast carcinomas-Normal	-0.738867465904982	0.492301201849508	13.9999999420515	0.155609042289522	0.336747693079668	nan
sp|Q8N335|GPD1L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.687947903759997	0.492301201849508	13.9999999438432	0.184042920733959	0.843662073010871	nan
sp|Q8N335|GPD1L_HUMAN	Normal-Triple-negative breast cancer	0.0509195621449849	0.588412480860238	13.9999999431886	0.932264899593491	0.962453172165297	nan
sp|Q8N392|RHG18_HUMAN	metaplastic breast carcinomas-Normal	0.157044002540698	0.428895703862361	6.0	0.726810638073311	0.848436527664973	nan
sp|Q8N392|RHG18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.297281426452804	0.428895703862361	6.0	0.514147795177771	0.915620969865368	nan
sp|Q8N392|RHG18_HUMAN	Normal-Triple-negative breast cancer	-0.454325428993503	0.512628415676906	6.0	0.409586802282402	0.597658705349739	nan
sp|Q8N3C0|ASCC3_HUMAN	metaplastic breast carcinomas-Normal	0.229390659095349	0.251111672117996	22.0000000026751	0.370882594588725	0.580094553185955	nan
sp|Q8N3C0|ASCC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.16925662560116	0.251111672117996	22.0000000031895	0.507313633126422	0.913875433881631	nan
sp|Q8N3C0|ASCC3_HUMAN	Normal-Triple-negative breast cancer	-0.060134033494189	0.300135854653226	22.0000000029642	0.843042708669393	0.910420391038682	nan
sp|Q8N3D4|EH1L1_HUMAN	metaplastic breast carcinomas-Normal	0.206934325262416	0.332274295177417	14.9999999997792	0.542781054865496	0.717662778986837	nan
sp|Q8N3D4|EH1L1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.479402457722306	0.332274295177417	14.9999999996702	0.169635921320286	0.843662073010871	nan
sp|Q8N3D4|EH1L1_HUMAN	Normal-Triple-negative breast cancer	0.27246813245989	0.39714374374247	14.9999999997443	0.503136791692237	0.677916668869779	nan
sp|Q8N3F8|MILK1_HUMAN	metaplastic breast carcinomas-Normal	0.458971817993147	0.362711394973622	23.9999999997539	0.217878852639808	0.415269097577249	nan
sp|Q8N3F8|MILK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.100177429195999	0.362711394973622	23.9999999997059	0.784766207149078	0.962981271203673	nan
sp|Q8N3F8|MILK1_HUMAN	Normal-Triple-negative breast cancer	-0.358794388797148	0.433523036204061	23.9999999997036	0.416037011774594	0.603099444892609	nan
sp|Q8N3U4|STAG2_HUMAN	metaplastic breast carcinomas-Normal	0.354139827315872	0.323874353618572	22.0000000258545	0.286025804860923	0.489824716825197	nan
sp|Q8N3U4|STAG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0256618545435169	0.323874353618572	22.0000000258579	0.937562824787029	0.995571782532303	nan
sp|Q8N3U4|STAG2_HUMAN	Normal-Triple-negative breast cancer	-0.379801681859388	0.387103893274601	22.0000000252829	0.337192812970259	0.529442092731762	nan
sp|Q8N3V7|SYNPO_HUMAN	metaplastic breast carcinomas-Normal	0.179440090742544	0.541523650806523	13.363500034841	0.745510351340962	0.859564245547108	nan
sp|Q8N3V7|SYNPO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.579794312688492	0.48662700876818	13.0014520048967	0.254771168563082	0.860014350733246	nan
sp|Q8N3V7|SYNPO_HUMAN	Normal-Triple-negative breast cancer	-0.759234403431036	0.628280259082314	13.2768393675648	0.247964235950301	0.436665698996733	nan
sp|Q8N474|SFRP1_HUMAN	metaplastic breast carcinomas-Normal	-0.739677295913464	0.685766555171557	22.0000000235735	0.292444524174853	0.496215211004192	nan
sp|Q8N474|SFRP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.229633678996774	0.685766555171557	22.0000000235695	0.740904721770198	0.954643368861838	nan
sp|Q8N474|SFRP1_HUMAN	Normal-Triple-negative breast cancer	0.51004361691669	0.819647806065738	22.0000000241452	0.540159729344145	0.705629131486033	nan
sp|Q8N556|AFAP1_HUMAN	metaplastic breast carcinomas-Normal	-0.175282717424408	0.300763161819539	21.9999999998106	0.565958858451326	0.732572914911296	nan
sp|Q8N556|AFAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.277952428881773	0.28169051000663	21.9999999998406	0.334503695787968	0.870890600099115	nan
sp|Q8N556|AFAP1_HUMAN	Normal-Triple-negative breast cancer	-0.102669711457365	0.349568729835499	21.9999999998209	0.771737084472539	0.869577650436176	nan
sp|Q8N573|OXR1_HUMAN	metaplastic breast carcinomas-Normal	0.567873530758519	0.380148111231729	14.9999999994901	0.15595833140443	0.337283990623504	nan
sp|Q8N573|OXR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.12162974762503	0.380148111231729	14.9999999994628	0.0099231890666793	0.547668704418496	nan
sp|Q8N573|OXR1_HUMAN	Normal-Triple-negative breast cancer	0.553756216866508	0.454363898328596	14.9999999994488	0.241759931392186	0.429737974303543	nan
sp|Q8N5M9|JAGN1_HUMAN	metaplastic breast carcinomas-Normal	0.538298212742577	0.184946026538747	22.0000002883966	0.0081062421177867	0.0598781084433848	nan
sp|Q8N5M9|JAGN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.192330805920551	0.184946026538747	22.000000288488	0.309667392801655	0.867696529950794	nan
sp|Q8N5M9|JAGN1_HUMAN	Normal-Triple-negative breast cancer	-0.730629018663128	0.221052782101828	22.0000002889022	0.0032218908722291	0.0374460323751388	nan
sp|Q8N668|COMD1_HUMAN	metaplastic breast carcinomas-Normal	0.314877511715553	0.204940806848956	22.0000000015236	0.138691015856001	0.312797603733859	nan
sp|Q8N668|COMD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.135774028935434	0.204940806848956	22.0000000017273	0.514529779610767	0.915620969865368	nan
sp|Q8N668|COMD1_HUMAN	Normal-Triple-negative breast cancer	-0.179103482780119	0.244951115565946	22.0000000015758	0.472385487133413	0.651795446006512	nan
sp|Q8N684|CPSF7_HUMAN	metaplastic breast carcinomas-Normal	0.476906466763358	0.184938510018598	22.0000003260073	0.0171329274444139	0.0881576638161481	nan
sp|Q8N684|CPSF7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.464125367493778	0.184938510018598	22.0000003251298	0.0199434271691014	0.69801995091855	nan
sp|Q8N684|CPSF7_HUMAN	Normal-Triple-negative breast cancer	-0.941031834257136	0.221043798141904	22.0000003256846	0.000321901665074	0.0227914720285933	nan
sp|Q8N6H7|ARFG2_HUMAN	metaplastic breast carcinomas-Normal	0.167184937784872	0.306005648605685	13.9999999812072	0.593428938751831	0.751736963571298	nan
sp|Q8N6H7|ARFG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.126414087598003	0.306005648605685	13.9999999803668	0.685783404403465	0.946568877415162	nan
sp|Q8N6H7|ARFG2_HUMAN	Normal-Triple-negative breast cancer	-0.293599025382875	0.365746705831441	13.9999999797832	0.435542239903215	0.621082113015138	nan
sp|Q8N6T3|ARFG1_HUMAN	metaplastic breast carcinomas-Normal	1.05881310662585	0.307207692894847	23.9999999998841	0.002102226351333	0.0328065746095349	nan
sp|Q8N6T3|ARFG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.138348231073566	0.307207692894847	23.9999999998841	0.656506394028779	0.944190045212043	nan
sp|Q8N6T3|ARFG1_HUMAN	Normal-Triple-negative breast cancer	-0.920464875552282	0.367183423555536	23.9999999999042	0.019357635175193	0.090754272669029	nan
sp|Q8N766|EMC1_HUMAN	metaplastic breast carcinomas-Normal	0.577281357117307	0.0938321179320174	22.000000307227	3.42139479752274e-06	0.0043931546677194	nan
sp|Q8N766|EMC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.196041241434171	0.0938321179320174	22.0000003070933	0.0484627224452453	0.763689820523415	nan
sp|Q8N766|EMC1_HUMAN	Normal-Triple-negative breast cancer	-0.381240115683137	0.112150831826786	22.0000003073924	0.0025752941186406	0.0343679122634309	nan
sp|Q8N7H5|PAF1_HUMAN	metaplastic breast carcinomas-Normal	-1.00384900429856	0.221646249616367	18.967473104104	0.0002304396530922	0.0157578323963946	nan
sp|Q8N7H5|PAF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0437621703617391	0.208740196660081	18.9917999757949	0.836174202791682	0.969413955468042	nan
sp|Q8N7H5|PAF1_HUMAN	Normal-Triple-negative breast cancer	0.960086833936821	0.256242123717346	18.9950045310714	0.0013664380173146	0.0266490250684039	nan
sp|Q8N8S7|ENAH_HUMAN	metaplastic breast carcinomas-Normal	0.734217443469615	0.215530199555949	22.0000000206353	0.002531339015753	0.0361123214092835	nan
sp|Q8N8S7|ENAH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0132426209373663	0.215530199555949	22.0000000213965	0.951561930571795	0.996541950781621	nan
sp|Q8N8S7|ENAH_HUMAN	Normal-Triple-negative breast cancer	-0.720974822532249	0.257607860684822	22.0000000211435	0.0104657031895771	0.0653269336960234	nan
sp|Q8N8V2|GBP7_HUMAN	metaplastic breast carcinomas-Normal	-0.479196060167684	1.0061096856899	6.0	0.650718810822926	0.792884650724122	nan
sp|Q8N8V2|GBP7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.455598252075619	1.0061096856899	6.0	0.666583456943553	0.945962438897701	nan
sp|Q8N8V2|GBP7_HUMAN	Normal-Triple-negative breast cancer	0.0235978080920649	1.202531080465	6.0	0.984980050067699	0.992143541340918	nan
sp|Q8NB16|MLKL_HUMAN	metaplastic breast carcinomas-Normal	-0.120340892822782	0.343744472203885	22.0000000380491	0.72960196756203	0.850309323667868	nan
sp|Q8NB16|MLKL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.246967018432853	0.343744472203885	22.0000000380491	0.480034553880019	0.913320451076758	nan
sp|Q8NB16|MLKL_HUMAN	Normal-Triple-negative breast cancer	-0.126626125610071	0.410853227478635	22.0000000380788	0.760827244605016	0.862388806271981	nan
sp|Q8NB90|SPAT5_HUMAN	metaplastic breast carcinomas-Normal	0.307525596025237	0.677529221628452	14.9999999996051	0.656404116354498	0.798197290010784	nan
sp|Q8NB90|SPAT5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.02922172246673	0.677529221628451	14.9999999996051	0.149536581613442	0.841301410938567	nan
sp|Q8NB90|SPAT5_HUMAN	Normal-Triple-negative breast cancer	-1.33674731849197	0.809802309350388	14.9999999995702	0.119574542629249	0.272050499452172	nan
sp|Q8NBJ4|GOLM1_HUMAN	metaplastic breast carcinomas-Normal	0.141756874146383	0.329503647557198	14.9999999995295	0.673157388030905	0.808148806621432	nan
sp|Q8NBJ4|GOLM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.296448049183486	0.329503647557198	14.9999999995294	0.382506699345699	0.885234295852111	nan
sp|Q8NBJ4|GOLM1_HUMAN	Normal-Triple-negative breast cancer	-0.438204923329868	0.3938321864404	14.9999999995305	0.283365002321292	0.476190731908986	nan
sp|Q8NBJ5|GT251_HUMAN	metaplastic breast carcinomas-Normal	0.912423078940058	0.205864750904926	22.0000000219881	0.0002099347429156	0.0157578323963946	nan
sp|Q8NBJ5|GT251_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.389144810076239	0.205864750904926	22.0000000222542	0.0719647727023911	0.785126062416402	nan
sp|Q8NBJ5|GT251_HUMAN	Normal-Triple-negative breast cancer	-0.523278268863819	0.246055439935066	22.0000000223889	0.0449061184823147	0.144779765116599	nan
sp|Q8NBJ7|SUMF2_HUMAN	metaplastic breast carcinomas-Normal	0.299169148585888	0.235003002446874	23.9999999997864	0.215196222569359	0.411189983111795	nan
sp|Q8NBJ7|SUMF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.121467715000297	0.235003002446874	23.9999999997864	0.609972564546115	0.940559810632461	nan
sp|Q8NBJ7|SUMF2_HUMAN	Normal-Triple-negative breast cancer	-0.177701433585592	0.280882311803985	23.999999999676	0.532941281169554	0.700750323816296	nan
sp|Q8NBQ5|DHB11_HUMAN	metaplastic breast carcinomas-Normal	-0.686804598390971	0.447687278300988	23.999999999615	0.13807925214728	0.312440731203239	nan
sp|Q8NBQ5|DHB11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.146148648303871	0.447687278300988	23.9999999996465	0.746911778427148	0.954643368861838	nan
sp|Q8NBQ5|DHB11_HUMAN	Normal-Triple-negative breast cancer	0.832953246694842	0.53508864306039	23.9999999996036	0.132640061645788	0.291621375393624	nan
sp|Q8NBS9|TXND5_HUMAN	metaplastic breast carcinomas-Normal	0.683024915381893	0.385662324989036	21.9999622490276	0.0904085739932351	0.242744830334017	nan
sp|Q8NBS9|TXND5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.242708950098175	0.385662324989036	21.9999622484575	0.535614090860819	0.921388505638487	nan
sp|Q8NBS9|TXND5_HUMAN	Normal-Triple-negative breast cancer	-0.440315965283718	0.460954644369315	21.9999622509006	0.349842630034817	0.540621525911544	nan
sp|Q8NBX0|SCPDL_HUMAN	metaplastic breast carcinomas-Normal	-0.0903296456951556	0.30459264463845	23.999999999766	0.769354586159868	0.874803098019317	nan
sp|Q8NBX0|SCPDL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.421117136570654	0.30459264463845	23.9999999995586	0.179531341437376	0.843662073010871	nan
sp|Q8NBX0|SCPDL_HUMAN	Normal-Triple-negative breast cancer	-0.330787490875499	0.3640578430647	23.9999999996522	0.372589026937882	0.561417010671586	nan
sp|Q8NC51|PAIRB_HUMAN	metaplastic breast carcinomas-Normal	0.514570657932692	0.311773658170873	23.9999999994105	0.11187608263906	0.274649999034147	nan
sp|Q8NC51|PAIRB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.45580348000495	0.311773658170873	23.999999999378	0.156721352298607	0.843465960034572	nan
sp|Q8NC51|PAIRB_HUMAN	Normal-Triple-negative breast cancer	-0.970374137937642	0.37264079588267	23.9999999994172	0.0155613670890817	0.0793343316013922	nan
sp|Q8NC56|LEMD2_HUMAN	metaplastic breast carcinomas-Normal	0.459805289293366	0.325839670328036	22.0000000179005	0.172189318356233	0.360525616455081	nan
sp|Q8NC56|LEMD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0118194606294842	0.325839670328036	22.0000000179048	0.971391128013533	0.99709406933403	nan
sp|Q8NC56|LEMD2_HUMAN	Normal-Triple-negative breast cancer	-0.447985828663882	0.389452896032155	22.0000000175517	0.262372828803819	0.453182802586585	nan
sp|Q8NCA5|FA98A_HUMAN	metaplastic breast carcinomas-Normal	0.314219324597125	0.274190735719146	21.9999919413656	0.2641128766807	0.46697404366311	nan
sp|Q8NCA5|FA98A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0758627368361322	0.274190735719146	21.9999919447407	0.784609632080885	0.962981271203673	nan
sp|Q8NCA5|FA98A_HUMAN	Normal-Triple-negative breast cancer	-0.390082061433257	0.327720611745969	21.9999919441548	0.246619209423651	0.435349045206699	nan
sp|Q8NCN5|PDPR_HUMAN	metaplastic breast carcinomas-Normal	0.0504167656284139	0.166256168583937	23.9999999996624	0.764314385853746	0.871070821852876	nan
sp|Q8NCN5|PDPR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.16367497541234	0.166256168583937	23.9999999996624	0.334703571673461	0.870890600099115	nan
sp|Q8NCN5|PDPR_HUMAN	Normal-Triple-negative breast cancer	-0.214091741040754	0.198714129169843	23.9999999996945	0.292018684835203	0.485092507942137	nan
sp|Q8NCW5|NNRE_HUMAN	metaplastic breast carcinomas-Normal	-0.0471584490829121	0.249855935797237	23.9999999991874	0.851881549247058	0.922663496154194	nan
sp|Q8NCW5|NNRE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.480134397090867	0.249855935797237	23.9999999991874	0.0666023805387306	0.774640662531106	nan
sp|Q8NCW5|NNRE_HUMAN	Normal-Triple-negative breast cancer	-0.432975948007955	0.298634962676875	23.9999999991077	0.160043599569182	0.329864241010448	nan
sp|Q8ND04|SMG8_HUMAN	metaplastic breast carcinomas-Normal	0.487699235281684	0.770441509075799	13.1708767197693	0.537561785712699	0.713600389660149	nan
sp|Q8ND04|SMG8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.788048845768138	0.689479703833673	13.000000002505	0.273667420466427	0.867696529950794	nan
sp|Q8ND04|SMG8_HUMAN	Normal-Triple-negative breast cancer	0.300349610486454	0.892925178304004	13.1284254841767	0.741910680512693	0.851557700975204	nan
sp|Q8ND07|BBOF1_HUMAN	metaplastic breast carcinomas-Normal	0.153830889895324	0.620886752373642	13.016526054127	0.808185550869902	0.899627572407098	nan
sp|Q8ND07|BBOF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.309386487556852	0.620886752373642	13.0165260540448	0.626587458080131	0.941374262616245	nan
sp|Q8ND07|BBOF1_HUMAN	Normal-Triple-negative breast cancer	-0.463217377452176	0.730089774943062	13.0000000152347	0.536782570226128	0.703574630690713	nan
sp|Q8ND30|LIPB2_HUMAN	metaplastic breast carcinomas-Normal	-0.0890397656078383	0.390354166422183	14.000000549838	0.822866407633006	0.907569094159468	nan
sp|Q8ND30|LIPB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.391966133134647	0.390354166422183	14.0000005498656	0.332356782142537	0.870890600099115	nan
sp|Q8ND30|LIPB2_HUMAN	Normal-Triple-negative breast cancer	-0.302926367526808	0.466562467480673	14.0000005498995	0.526671102103762	0.696639372619541	nan
sp|Q8ND56|LS14A_HUMAN	metaplastic breast carcinomas-Normal	-0.406440734493119	0.345979665285892	20.9999999992708	0.253242749417467	0.454769799602193	nan
sp|Q8ND56|LS14A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.138804391665514	0.297771884839706	20.9999999991283	0.645911837199119	0.943315325604231	nan
sp|Q8ND56|LS14A_HUMAN	Normal-Triple-negative breast cancer	0.545245126158633	0.393915177356413	20.9999999991965	0.180841479020841	0.356693755905161	nan
sp|Q8NDI1|EHBP1_HUMAN	metaplastic breast carcinomas-Normal	-2.22954546356699	0.604836064597599	13.0458766185917	0.002726128645613	0.0374448413967682	nan
sp|Q8NDI1|EHBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.126554940894146	0.539922770081327	13.0000000208069	0.818329900564017	0.965774701272009	nan
sp|Q8NDI1|EHBP1_HUMAN	Normal-Triple-negative breast cancer	2.10299052267285	0.700544323898236	13.0342769653512	0.0101751927481609	0.0642141270583974	nan
sp|Q8NDT2|RB15B_HUMAN	metaplastic breast carcinomas-Normal	0.37681258082823	0.26533213236072	18.4652297122821	0.172227400692762	0.360525616455081	nan
sp|Q8NDT2|RB15B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.234164312990146	0.228889398178741	18.4139961212353	0.319539425074207	0.867696529950794	nan
sp|Q8NDT2|RB15B_HUMAN	Normal-Triple-negative breast cancer	-0.610976893818376	0.299569302938419	18.476138172563	0.0559615066155597	0.168592623350887	nan
sp|Q8NE71|ABCF1_HUMAN	metaplastic breast carcinomas-Normal	0.400814926957951	0.233150504762758	23.999999999923	0.0984656062818705	0.253131999443881	nan
sp|Q8NE71|ABCF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.28263502438643	0.233150504762758	23.999999999923	0.237218646372611	0.84876230490475	nan
sp|Q8NE71|ABCF1_HUMAN	Normal-Triple-negative breast cancer	-0.683449951344381	0.278668153573204	23.999999999879	0.021834524447326	0.0972951861616619	nan
sp|Q8NEB9|PK3C3_HUMAN	metaplastic breast carcinomas-Normal	0.0764038008331956	0.675779630351852	15.0000000001017	0.911482069936267	0.95305643298778	nan
sp|Q8NEB9|PK3C3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.05472681209878	0.675779630351852	15.0000000001017	0.13942817131004	0.823891816737944	nan
sp|Q8NEB9|PK3C3_HUMAN	Normal-Triple-negative breast cancer	0.978323011265587	0.807711147801954	15.0000000001489	0.244545382185813	0.432541061889663	nan
sp|Q8NEU8|DP13B_HUMAN	metaplastic breast carcinomas-Normal	-0.101531236057161	0.217007905584265	22.0000000022148	0.644480131627892	0.789333808965038	nan
sp|Q8NEU8|DP13B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.151291306594239	0.217007905584265	22.0000000022158	0.492998835641371	0.913320451076758	nan
sp|Q8NEU8|DP13B_HUMAN	Normal-Triple-negative breast cancer	-0.0497600705370782	0.25937405720605	22.0000000019508	0.849621958030961	0.913962261648839	nan
sp|Q8NEW0|ZNT7_HUMAN	metaplastic breast carcinomas-Normal	-0.523077262148486	0.254801051766108	14.0000000018111	0.05926442792196	0.186548256072533	nan
sp|Q8NEW0|ZNT7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.220403064658554	0.254801051766108	14.0000000013897	0.401617755983685	0.885297496092956	nan
sp|Q8NEW0|ZNT7_HUMAN	Normal-Triple-negative breast cancer	0.74348032680704	0.304545506759346	14.0000000014599	0.0285181850812899	0.112582478871981	nan
sp|Q8NEY1|NAV1_HUMAN	metaplastic breast carcinomas-Normal	0.179158978398407	0.40487790940544	13.9999999997961	0.664886243701293	0.803666136022945	nan
sp|Q8NEY1|NAV1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.569634666538212	0.363870673983476	13.9999999999616	0.139786857729137	0.823891816737944	nan
sp|Q8NEY1|NAV1_HUMAN	Normal-Triple-negative breast cancer	0.390475688139805	0.469755020170424	13.9999999998603	0.419793801385389	0.606957196957386	nan
sp|Q8NEY8|PPHLN_HUMAN	metaplastic breast carcinomas-Normal	0.381230320422991	0.288566060409059	23.9999999992477	0.198919526310648	0.391943393868757	nan
sp|Q8NEY8|PPHLN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.108054516219997	0.288566060409059	23.9999999992109	0.71135531169468	0.94948208919602	nan
sp|Q8NEY8|PPHLN_HUMAN	Normal-Triple-negative breast cancer	-0.489284836642987	0.344902411083824	23.9999999992576	0.168866583304709	0.340395708250365	nan
sp|Q8NF50|DOCK8_HUMAN	metaplastic breast carcinomas-Normal	-0.0725939728800555	0.413356732429365	23.9999999994714	0.862065342485395	0.928249173443943	nan
sp|Q8NF50|DOCK8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.137109641389623	0.413356732429365	23.9999999994356	0.742996442268923	0.954643368861838	nan
sp|Q8NF50|DOCK8_HUMAN	Normal-Triple-negative breast cancer	0.209703614269678	0.494055792460559	23.9999999994924	0.675016051613321	0.808559767770335	nan
sp|Q8NF91|SYNE1_HUMAN	metaplastic breast carcinomas-Normal	-0.480923517549871	0.345203485778225	22.0000000037957	0.177489778025723	0.366444734259319	nan
sp|Q8NF91|SYNE1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.410438777524659	0.345203485778225	22.0000000037982	0.247124574084172	0.84964799869723	nan
sp|Q8NF91|SYNE1_HUMAN	Normal-Triple-negative breast cancer	0.891362295074529	0.412597082244093	22.0000000041615	0.0419039198359748	0.138844699301299	nan
sp|Q8NFC6|BD1L1_HUMAN	metaplastic breast carcinomas-Normal	-0.307291998190944	0.346780900774144	22.0000000874095	0.385132975939195	0.589673888540711	nan
sp|Q8NFC6|BD1L1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.362636476668306	0.346780900774144	22.0000000877176	0.307043630935011	0.867696529950794	nan
sp|Q8NFC6|BD1L1_HUMAN	Normal-Triple-negative breast cancer	0.66992847485925	0.414482453776009	22.0000000876817	0.120279956856469	0.272536180361898	nan
sp|Q8NFD5|ARI1B_HUMAN	metaplastic breast carcinomas-Normal	-0.0833502493032322	0.235289821061969	22.0000000915273	0.726528068448623	0.848436527664973	nan
sp|Q8NFD5|ARI1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.18457318077188	0.235289821061969	22.0000000914961	0.441141331000047	0.89755436380139	nan
sp|Q8NFD5|ARI1B_HUMAN	Normal-Triple-negative breast cancer	-0.101222931468648	0.281225125618436	22.0000000914286	0.72232760734171	0.839810061841149	nan
sp|Q8NFF5|FAD1_HUMAN	metaplastic breast carcinomas-Normal	0.230613665585332	0.410015611476137	14.0000000111024	0.582703526910534	0.743248857809139	nan
sp|Q8NFF5|FAD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.415502406644139	0.410015611476137	14.0000000108512	0.328072227203925	0.867975899287892	nan
sp|Q8NFF5|FAD1_HUMAN	Normal-Triple-negative breast cancer	-0.646116072229471	0.490062389110014	14.0000000107887	0.20852085661157	0.39056234478825	nan
sp|Q8NFH3|NUP43_HUMAN	metaplastic breast carcinomas-Normal	0.946018834634565	0.243082535320672	14.9999999997863	0.0014453207184167	0.0280426514467702	nan
sp|Q8NFH3|NUP43_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0012990059192167	0.243082535320672	14.9999999997858	0.995806638327245	0.998185231446144	nan
sp|Q8NFH3|NUP43_HUMAN	Normal-Triple-negative breast cancer	-0.944719828715348	0.290539200644805	14.999999999786	0.0053655888939243	0.0462052266409448	nan
sp|Q8NFH4|NUP37_HUMAN	metaplastic breast carcinomas-Normal	1.06587683233756	0.227141324787894	22.0000000019875	0.0001111918616944	0.0136889536397125	nan
sp|Q8NFH4|NUP37_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.149999717502133	0.227141324787894	22.0000000019866	0.515865213893251	0.915620969865368	nan
sp|Q8NFH4|NUP37_HUMAN	Normal-Triple-negative breast cancer	-1.2158765498397	0.271485809748606	22.0000000021258	0.00018741469937	0.0227914720285933	nan
sp|Q8NFH5|NUP35_HUMAN	metaplastic breast carcinomas-Normal	0.371476316572241	0.224180217252984	22.0000000051786	0.111704579491115	0.274616780730611	nan
sp|Q8NFH5|NUP35_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.359433362687033	0.224180217252984	22.0000000060912	0.12312473991344	0.823891816737944	nan
sp|Q8NFH5|NUP35_HUMAN	Normal-Triple-negative breast cancer	-0.730909679259275	0.267946609307567	22.000000006181	0.0122858085940066	0.0716720492897364	nan
sp|Q8NFU3|TSTD1_HUMAN	metaplastic breast carcinomas-Normal	-0.429285580143707	0.359586437849326	23.9999999998864	0.244211064980856	0.444727514478219	nan
sp|Q8NFU3|TSTD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.26597937105516	0.359586437849326	23.9999999999353	0.0017505477879113	0.448717474870704	nan
sp|Q8NFU3|TSTD1_HUMAN	Normal-Triple-negative breast cancer	-0.836693790911454	0.429787998046158	23.9999999998784	0.0633593273844223	0.182343207121922	nan
sp|Q8NFW8|NEUA_HUMAN	metaplastic breast carcinomas-Normal	0.220771643133159	0.253065550983135	21.9999999533946	0.392418133231579	0.596705340741889	nan
sp|Q8NFW8|NEUA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.108747510356787	0.253065550983135	21.999999954391	0.671578398083696	0.946386428913156	nan
sp|Q8NFW8|NEUA_HUMAN	Normal-Triple-negative breast cancer	-0.112024132776372	0.302471186572014	21.9999999526513	0.714653938526307	0.834097504094609	nan
sp|Q8NHG8|ZNRF2_HUMAN	metaplastic breast carcinomas-Normal	0.760004342469879	0.283795794242843	6.0	0.0366338201039022	0.139166649171852	nan
sp|Q8NHG8|ZNRF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0176704503938057	0.283795794242843	6.0	0.95237444115891	0.996541950781621	nan
sp|Q8NHG8|ZNRF2_HUMAN	Normal-Triple-negative breast cancer	-0.742333892076073	0.339200852487823	6.0	0.0712239637271128	0.194854695826274	nan
sp|Q8NHH9|ATLA2_HUMAN	metaplastic breast carcinomas-Normal	-0.0178963220865882	0.292792399585622	23.9999999993896	0.951767491162441	0.975193989958575	nan
sp|Q8NHH9|ATLA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.478415849866852	0.292792399585622	23.9999999993884	0.115315004862346	0.823891816737944	nan
sp|Q8NHH9|ATLA2_HUMAN	Normal-Triple-negative breast cancer	-0.460519527780264	0.349953852580403	23.9999999994318	0.200624706185348	0.381511189239756	nan
sp|Q8NHP8|PLBL2_HUMAN	metaplastic breast carcinomas-Normal	-0.267771675724116	0.356008129333334	14.9999999997353	0.463600724568176	0.656027589810394	nan
sp|Q8NHP8|PLBL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.353875338815751	0.356008129333334	14.9999999997352	0.335983752522096	0.870890600099115	nan
sp|Q8NHP8|PLBL2_HUMAN	Normal-Triple-negative breast cancer	0.621647014539867	0.42551110133482	14.9999999997164	0.164661308130934	0.334802242417098	nan
sp|Q8NI27|THOC2_HUMAN	metaplastic breast carcinomas-Normal	0.561381072706848	0.227008584297352	23.9999999995523	0.0208712303551637	0.098545411506483	nan
sp|Q8NI27|THOC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.156063366271853	0.227008584297352	23.9999999995523	0.498372173225827	0.913320451076758	nan
sp|Q8NI27|THOC2_HUMAN	Normal-Triple-negative breast cancer	-0.7174444389787	0.271327154516693	23.999999999557	0.0142064440281035	0.0770525421586136	nan
sp|Q8NI36|WDR36_HUMAN	metaplastic breast carcinomas-Normal	0.273228433663346	0.279606012807368	14.0000001356727	0.345059144503856	0.555436608392647	nan
sp|Q8NI36|WDR36_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.331771261970945	0.279606012807368	14.0000001356727	0.255144489086022	0.860074605064301	nan
sp|Q8NI36|WDR36_HUMAN	Normal-Triple-negative breast cancer	-0.604999695634291	0.334193105849285	14.0000001356297	0.091754936083439	0.229698871489589	nan
sp|Q8TAQ2|SMRC2_HUMAN	metaplastic breast carcinomas-Normal	0.584667146991726	0.181453958652564	23.999999999625	0.0036402103629521	0.0407324763980233	nan
sp|Q8TAQ2|SMRC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.155719900406058	0.181453958652564	23.9999999996235	0.399283551471555	0.885297496092956	nan
sp|Q8TAQ2|SMRC2_HUMAN	Normal-Triple-negative breast cancer	-0.740387047397784	0.216878962658524	23.9999999996047	0.0022787851441803	0.0323704351250232	nan
sp|Q8TAT6|NPL4_HUMAN	metaplastic breast carcinomas-Normal	-0.0635892300316854	0.22979545933663	23.999999999925	0.784363607700875	0.882032001854638	nan
sp|Q8TAT6|NPL4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0246518057586059	0.22979545933663	23.999999999925	0.915460852286553	0.99408739879047	nan
sp|Q8TAT6|NPL4_HUMAN	Normal-Triple-negative breast cancer	0.0389374242730795	0.274658107294278	23.9999999999419	0.88844747340092	0.934942137942837	nan
sp|Q8TB37|NUBPL_HUMAN	metaplastic breast carcinomas-Normal	-0.301402926404662	0.408636153977999	20.9824005696124	0.468937062041432	0.660206181374722	nan
sp|Q8TB37|NUBPL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.207009142856536	0.408636153977999	20.9824005694866	0.617727746609217	0.941374262616245	nan
sp|Q8TB37|NUBPL_HUMAN	Normal-Triple-negative breast cancer	0.0943937835481254	0.483188162848879	20.9649980997032	0.846995068658909	0.912613163119032	nan
sp|Q8TB61|S35B2_HUMAN	metaplastic breast carcinomas-Normal	0.542841510583475	0.36904808217149	23.9999999998996	0.154302544623069	0.335010880683919	nan
sp|Q8TB61|S35B2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.194601825170671	0.36904808217149	23.9999999998518	0.60282100646897	0.940559810632461	nan
sp|Q8TB61|S35B2_HUMAN	Normal-Triple-negative breast cancer	-0.348239685412804	0.441096826031355	23.9999999999583	0.437558829949337	0.623155762961266	nan
sp|Q8TBA6|GOGA5_HUMAN	metaplastic breast carcinomas-Normal	1.14047712247167	0.454644365082391	23.9999999996431	0.0192853740505953	0.0944102847484224	nan
sp|Q8TBA6|GOGA5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0580377810637794	0.454644365082392	23.9999999996431	0.899485339467404	0.989671989983163	nan
sp|Q8TBA6|GOGA5_HUMAN	Normal-Triple-negative breast cancer	-1.08243934140789	0.543403952219145	23.9999999996058	0.0578707787391606	0.172124240434689	nan
sp|Q8TBC4|UBA3_HUMAN	metaplastic breast carcinomas-Normal	-0.0478084791799503	0.172037970652027	23.9999999995991	0.783472991505811	0.882032001854638	nan
sp|Q8TBC4|UBA3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.389045650309464	0.172037970652027	23.9999999995991	0.033075136766766	0.724424466074313	nan
sp|Q8TBC4|UBA3_HUMAN	Normal-Triple-negative breast cancer	-0.341237171129514	0.205624704415134	23.9999999996427	0.110024671929099	0.256827253856969	nan
sp|Q8TBM8|DJB14_HUMAN	metaplastic breast carcinomas-Normal	-0.0271972569262616	0.306836527557467	23.9999999996021	0.930105417314749	0.962231702666505	nan
sp|Q8TBM8|DJB14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0265219780889041	0.306836527557467	23.9999999996021	0.931836271385581	0.995359816653149	nan
sp|Q8TBM8|DJB14_HUMAN	Normal-Triple-negative breast cancer	0.0537192350151656	0.366739796125506	23.9999999995665	0.884767665563316	0.93275221069853	nan
sp|Q8TBX8|PI42C_HUMAN	metaplastic breast carcinomas-Normal	0.754838787255497	0.382312444109488	23.9999999997027	0.0599508210729745	0.187838885508438	nan
sp|Q8TBX8|PI42C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0849708205826162	0.382312444109488	23.9999999997014	0.825995930882881	0.965774701272009	nan
sp|Q8TBX8|PI42C_HUMAN	Normal-Triple-negative breast cancer	-0.839809607838113	0.456950770904217	23.9999999996933	0.0784947942355975	0.207570959458334	nan
sp|Q8TC07|TBC15_HUMAN	metaplastic breast carcinomas-Normal	-0.305237410443314	0.337995339619603	14.0000000010451	0.381758483700594	0.58883119357541	nan
sp|Q8TC07|TBC15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.336721498290221	0.337995339619603	14.000000000623	0.336045906745012	0.870890600099115	nan
sp|Q8TC07|TBC15_HUMAN	Normal-Triple-negative breast cancer	0.641958908733535	0.403981699735044	14.0000000005394	0.134364142853731	0.294026603585124	nan
sp|Q8TC12|RDH11_HUMAN	metaplastic breast carcinomas-Normal	-0.328296382940023	0.627270798920408	14.9999999994211	0.60836077893606	0.765691491549968	nan
sp|Q8TC12|RDH11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.175599234181446	0.627270798920408	14.9999999995434	0.783345825496578	0.962981271203673	nan
sp|Q8TC12|RDH11_HUMAN	Normal-Triple-negative breast cancer	0.152697148758577	0.749732004669713	14.9999999994986	0.841349505281475	0.909478294489634	nan
sp|Q8TC84|FANK1_HUMAN	metaplastic breast carcinomas-Normal	-0.609666203006007	0.554256480797035	22.9999999998751	0.282724809421567	0.485873715935793	nan
sp|Q8TC84|FANK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.824753254945681	0.554256480797035	22.9999999998751	0.150324916742646	0.84288422962782	nan
sp|Q8TC84|FANK1_HUMAN	Normal-Triple-negative breast cancer	-0.215087051939674	0.655805112139055	22.999999999758	0.74589825043579	0.853776096573198	nan
sp|Q8TCJ2|STT3B_HUMAN	metaplastic breast carcinomas-Normal	0.380615959973781	0.241009777253753	23.9999999995288	0.127368414688442	0.298259002112784	nan
sp|Q8TCJ2|STT3B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0459935680972004	0.241009777253753	23.9999999995288	0.850258502496012	0.975874877735326	nan
sp|Q8TCJ2|STT3B_HUMAN	Normal-Triple-negative breast cancer	-0.334622391876581	0.288061780902996	23.9999999995377	0.256807048244713	0.447862869026982	nan
sp|Q8TCS8|PNPT1_HUMAN	metaplastic breast carcinomas-Normal	1.17970318681624	0.337362063987226	23.9999999995454	0.0018567928964755	0.0307691428264859	nan
sp|Q8TCS8|PNPT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0837976042788354	0.337362063987226	23.9999999995454	0.805945225919182	0.965774701272009	nan
sp|Q8TCS8|PNPT1_HUMAN	Normal-Triple-negative breast cancer	-1.0959055825374	0.403224790581632	23.9999999995149	0.0120045180324848	0.0705000316960767	nan
sp|Q8TCT9|HM13_HUMAN	metaplastic breast carcinomas-Normal	0.788118946805395	0.34634210674601	21.9999999533626	0.032966005701789	0.129407306133986	nan
sp|Q8TCT9|HM13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.353837429322331	0.34634210674601	21.9999999533385	0.318054398595198	0.867696529950794	nan
sp|Q8TCT9|HM13_HUMAN	Normal-Triple-negative breast cancer	-1.14195637612773	0.413957994599978	21.9999999536563	0.0114609026902819	0.0682724740904964	nan
sp|Q8TD55|PKHO2_HUMAN	metaplastic breast carcinomas-Normal	0.249379827472629	0.328469556754853	22.000000046455	0.455780864552832	0.649663633693659	nan
sp|Q8TD55|PKHO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.373023017593237	0.328469556754853	22.0000000469179	0.268328316791144	0.867211773631185	nan
sp|Q8TD55|PKHO2_HUMAN	Normal-Triple-negative breast cancer	0.123643190120608	0.392596211528787	22.00000004683	0.755776912209416	0.859388505509785	nan
sp|Q8TDB6|DTX3L_HUMAN	metaplastic breast carcinomas-Normal	1.18788127367143	0.463694679736974	23.99999999989	0.0171175749617124	0.0881576638161481	nan
sp|Q8TDB6|DTX3L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.551453071815347	0.463694679736974	24.0000000000691	0.245971235800974	0.84964799869723	nan
sp|Q8TDB6|DTX3L_HUMAN	Normal-Triple-negative breast cancer	-0.636428201856082	0.55422114721778	23.9999999999991	0.262150051859827	0.453139247208563	nan
sp|Q8TDN6|BRX1_HUMAN	metaplastic breast carcinomas-Normal	0.247733245664307	0.377675587693155	14.0000000143	0.522496249259743	0.70246950668001	nan
sp|Q8TDN6|BRX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.242353778899125	0.377675587693155	14.000000014301	0.53143572450826	0.921279697758795	nan
sp|Q8TDN6|BRX1_HUMAN	Normal-Triple-negative breast cancer	-0.490087024563431	0.451408667458039	14.0000000142692	0.295960158735043	0.487739993869748	nan
sp|Q8TDZ2|MICA1_HUMAN	metaplastic breast carcinomas-Normal	0.231345527927982	0.268812780149517	22.0000000049642	0.398730054153498	0.601923998636815	nan
sp|Q8TDZ2|MICA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.237572229590493	0.268812780149517	22.0000000048297	0.386369679044223	0.885234295852111	nan
sp|Q8TDZ2|MICA1_HUMAN	Normal-Triple-negative breast cancer	0.0062267016625105	0.321292725389419	22.0000000051595	0.984712539893354	0.992143541340918	nan
sp|Q8TEM1|PO210_HUMAN	metaplastic breast carcinomas-Normal	0.202426928369687	0.472523788997901	22.000000003136	0.672528501098568	0.808148806621432	nan
sp|Q8TEM1|PO210_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.55480442491846	0.472523788997902	22.000000003142	0.003336984676779	0.475304411992737	nan
sp|Q8TEM1|PO210_HUMAN	Normal-Triple-negative breast cancer	-1.75723135328815	0.56477395120138	22.0000000030571	0.0050877772829905	0.0453398704789826	nan
sp|Q8TEQ6|GEMI5_HUMAN	metaplastic breast carcinomas-Normal	-0.0991064751033902	0.241974651939925	14.0000000166078	0.688316413980214	0.817713995736323	nan
sp|Q8TEQ6|GEMI5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.133863282046956	0.241974651939925	14.0000000163294	0.588844081686545	0.940559810632461	nan
sp|Q8TEQ6|GEMI5_HUMAN	Normal-Triple-negative breast cancer	-0.034756806943566	0.28921502673233	14.000000016663	0.906051070956081	0.945296220922163	nan
sp|Q8TEW0|PARD3_HUMAN	metaplastic breast carcinomas-Normal	0.229951896218704	0.19617657670941	22.0000002546298	0.25366713272174	0.454937350100632	nan
sp|Q8TEW0|PARD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.369759406668155	0.19617657670941	22.0000002546287	0.0727318968612201	0.788645783025588	nan
sp|Q8TEW0|PARD3_HUMAN	Normal-Triple-negative breast cancer	-0.59971130288686	0.234475856964371	22.00000025418	0.0179475479057475	0.0866867362677038	nan
sp|Q8TEX9|IPO4_HUMAN	metaplastic breast carcinomas-Normal	0.530940529776561	0.286095806713912	21.0476685979272	0.0775376791718514	0.219327794162161	nan
sp|Q8TEX9|IPO4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.324289269305208	0.266235685068739	20.9736493032286	0.23672943062086	0.84876230490475	nan
sp|Q8TEX9|IPO4_HUMAN	Normal-Triple-negative breast cancer	-0.206651260471353	0.335005329242696	21.0277307574188	0.543949178763117	0.709053753022981	nan
sp|Q8TF66|LRC15_HUMAN	metaplastic breast carcinomas-Normal	1.05648121819939	0.506857617008915	24.0000000003198	0.0479412406722253	0.164882962783891	nan
sp|Q8TF66|LRC15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.553048292974235	0.506857617008916	24.0000000003183	0.286048614217754	0.867696529950794	nan
sp|Q8TF66|LRC15_HUMAN	Normal-Triple-negative breast cancer	-0.503432925225155	0.605810724708111	24.0000000003513	0.414160992409872	0.601429068925476	nan
sp|Q8WTS1|ABHD5_HUMAN	metaplastic breast carcinomas-Normal	-2.13449585404638	0.726935295948594	14.9999999996135	0.0102139201599672	0.0669646363150514	nan
sp|Q8WTS1|ABHD5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.60487786334196	0.726935295948594	14.9999999997648	0.418407163189472	0.8860071777014	nan
sp|Q8WTS1|ABHD5_HUMAN	Normal-Triple-negative breast cancer	1.52961799070442	0.868853862852724	14.9999999997238	0.0986913133502648	0.241096420328574	nan
sp|Q8WTT2|NOC3L_HUMAN	metaplastic breast carcinomas-Normal	-0.0034404542752915	0.143171575208042	22.0000000381968	0.981045083137049	0.989979919959791	nan
sp|Q8WTT2|NOC3L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.247331118278525	0.143171575208042	22.000000038159	0.0980897047448494	0.820234747280893	nan
sp|Q8WTT2|NOC3L_HUMAN	Normal-Triple-negative breast cancer	-0.243890664003234	0.171122762732123	22.0000000379726	0.168122389445743	0.339513257908658	nan
sp|Q8WTW3|COG1_HUMAN	metaplastic breast carcinomas-Normal	-0.16785278448674	0.619534149789808	22.9999999998104	0.788858566710615	0.885866849914217	nan
sp|Q8WTW3|COG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.197074107296558	0.619534149789808	22.9999999998104	0.753279019193767	0.954748610837524	nan
sp|Q8WTW3|COG1_HUMAN	Normal-Triple-negative breast cancer	0.364926891783298	0.733042691702259	22.9999999998104	0.623333984997804	0.772313077548906	nan
sp|Q8WU39|MZB1_HUMAN	metaplastic breast carcinomas-Normal	-0.263232818133922	0.657015550709188	22.0000000129089	0.692542662635364	0.820033259296383	nan
sp|Q8WU39|MZB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0112781794283095	0.657015550709188	22.0000000127454	0.986459096423178	0.99777413090774	nan
sp|Q8WU39|MZB1_HUMAN	Normal-Triple-negative breast cancer	0.251954638705612	0.785283782985213	22.0000000128703	0.751355504899276	0.857071276007272	nan
sp|Q8WU90|ZC3HF_HUMAN	metaplastic breast carcinomas-Normal	0.736520894990031	0.235978391394454	23.9999999998432	0.0046455906487283	0.0458663504478383	nan
sp|Q8WU90|ZC3HF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.138073319728148	0.235978391394454	23.9999999998432	0.563935036821387	0.935109025059232	nan
sp|Q8WU90|ZC3HF_HUMAN	Normal-Triple-negative breast cancer	-0.598447575261884	0.282048124579361	23.9999999998372	0.0443739395582242	0.143342055482543	nan
sp|Q8WUA2|PPIL4_HUMAN	metaplastic breast carcinomas-Normal	0.476177016068406	0.194517135357027	6.0	0.0499264881175948	0.169912927873181	nan
sp|Q8WUA2|PPIL4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.14060327354196	0.194517135357027	6.0	0.496979724080118	0.913320451076758	nan
sp|Q8WUA2|PPIL4_HUMAN	Normal-Triple-negative breast cancer	-0.335573742526446	0.232492445184489	6.0	0.199021706831942	0.380200088223779	nan
sp|Q8WUD1|RAB2B_HUMAN	metaplastic breast carcinomas-Normal	0.159720043058262	0.179700549475823	14.0000000015375	0.389120528551874	0.592689911608717	nan
sp|Q8WUD1|RAB2B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.311454791936515	0.179700549475823	14.0000000018141	0.105020495988573	0.821630939204717	nan
sp|Q8WUD1|RAB2B_HUMAN	Normal-Triple-negative breast cancer	-0.471174834994777	0.214783237846615	14.0000000014951	0.0456338960124959	0.146557555889407	nan
sp|Q8WUH6|TM263_HUMAN	metaplastic breast carcinomas-Normal	0.319059553597428	0.398884539073983	14.000000979025	0.437143168550613	0.632867548894702	nan
sp|Q8WUH6|TM263_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.175166844754579	0.398884539073983	14.0000009790266	0.667260721408385	0.946277260710207	nan
sp|Q8WUH6|TM263_HUMAN	Normal-Triple-negative breast cancer	-0.143892708842849	0.476758212922388	14.0000009789781	0.767230087430442	0.866850037599861	nan
sp|Q8WUM0|NU133_HUMAN	metaplastic breast carcinomas-Normal	0.251954233443383	0.166511811887127	23.9999999997735	0.143304662553693	0.319340083250317	nan
sp|Q8WUM0|NU133_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.212048602773178	0.166511811887127	23.9999999997726	0.215045929096533	0.843662073010871	nan
sp|Q8WUM0|NU133_HUMAN	Normal-Triple-negative breast cancer	-0.46400283621656	0.199019681359601	23.9999999997846	0.028453390935145	0.112582478871981	nan
sp|Q8WUM4|PDC6I_HUMAN	metaplastic breast carcinomas-Normal	-0.125008182489475	0.166866963238691	21.9999999695922	0.461703215201591	0.654925807993489	nan
sp|Q8WUM4|PDC6I_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.214465039749889	0.166866963238691	21.9999999702323	0.212072678809211	0.843662073010871	nan
sp|Q8WUM4|PDC6I_HUMAN	Normal-Triple-negative breast cancer	-0.0894568572604134	0.199444168415634	21.9999999699698	0.658156706625111	0.798580386451002	nan
sp|Q8WUX9|CHMP7_HUMAN	metaplastic breast carcinomas-Normal	-0.340260465428792	0.245069423252384	13.0000000167424	0.188339896485715	0.380341321943206	nan
sp|Q8WUX9|CHMP7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.183871606957719	0.274755810165878	13.0041350374979	0.515062363783668	0.915620969865368	nan
sp|Q8WUX9|CHMP7_HUMAN	Normal-Triple-negative breast cancer	0.52413207238651	0.318167151303283	13.0030842614853	0.123426582737767	0.277022255921903	nan
sp|Q8WV28|BLNK_HUMAN	metaplastic breast carcinomas-Normal	-0.326481204817616	0.276013726858337	6.0	0.281612616729955	0.485518847515752	nan
sp|Q8WV28|BLNK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.12780041658324	0.276013726858337	6.0	0.006458067306995	0.519941801393686	nan
sp|Q8WV28|BLNK_HUMAN	Normal-Triple-negative breast cancer	-0.801319211765625	0.329899502910093	6.0	0.051233466322921	0.159010310044248	nan
sp|Q8WVM8|SCFD1_HUMAN	metaplastic breast carcinomas-Normal	0.0756586296103189	0.161805636036948	24.000000000012	0.644296110476612	0.789333808965038	nan
sp|Q8WVM8|SCFD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0175467946304645	0.161805636036948	24.0000000001958	0.914545333747886	0.99408739879047	nan
sp|Q8WVM8|SCFD1_HUMAN	Normal-Triple-negative breast cancer	-0.0932054242407834	0.193394725342908	24.000000000147	0.634211654774711	0.781363802991527	nan
sp|Q8WVV9|HNRLL_HUMAN	metaplastic breast carcinomas-Normal	0.316889126073757	0.210554397079106	22.0000000017933	0.146541204321857	0.32404479510702	nan
sp|Q8WVV9|HNRLL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0504287595959849	0.210554397079106	22.0000000017772	0.812931582349964	0.965774701272009	nan
sp|Q8WVV9|HNRLL_HUMAN	Normal-Triple-negative breast cancer	-0.367317885669742	0.251660639210101	22.0000000016324	0.15853925211208	0.328339236149878	nan
sp|Q8WVY7|UBCP1_HUMAN	metaplastic breast carcinomas-Normal	0.731852187161433	0.417948187569179	6.0	0.130499191622266	0.301654598715168	nan
sp|Q8WVY7|UBCP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.362447446355827	0.417948187569179	6.0	0.419154673841896	0.8860071777014	nan
sp|Q8WVY7|UBCP1_HUMAN	Normal-Triple-negative breast cancer	-1.09429963351726	0.49954363100214	6.0	0.0710161796453035	0.194446277710864	nan
sp|Q8WW12|PCNP_HUMAN	metaplastic breast carcinomas-Normal	0.533942871120702	0.325249109163227	24.000000000068	0.113704944133765	0.27770406634874	nan
sp|Q8WW12|PCNP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0027889869363036	0.325249109163228	24.000000000068	0.993229164115305	0.998185231446144	nan
sp|Q8WW12|PCNP_HUMAN	Normal-Triple-negative breast cancer	-0.531153884184398	0.388747040432415	24.0000000000591	0.184503870436497	0.362037110584957	nan
sp|Q8WWI1|LMO7_HUMAN	metaplastic breast carcinomas-Normal	0.463630430059272	0.372030396335042	23.9999999996299	0.224712642080582	0.42440046720219	nan
sp|Q8WWI1|LMO7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.606529067368498	0.372030396335042	23.9999999993532	0.116089297301517	0.823891816737944	nan
sp|Q8WWI1|LMO7_HUMAN	Normal-Triple-negative breast cancer	-1.07015949742777	0.444661373241656	23.9999999995618	0.0241536275700584	0.103755694107856	nan
sp|Q8WWI5|CTL1_HUMAN	metaplastic breast carcinomas-Normal	0.0193940284919695	0.423501417414734	15.0000000002143	0.964078171904869	0.982981891035447	nan
sp|Q8WWI5|CTL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.106300506731662	0.423501417414734	15.0000000002143	0.805216986983497	0.965774701272009	nan
sp|Q8WWI5|CTL1_HUMAN	Normal-Triple-negative breast cancer	0.0869064782396922	0.506181010187757	15.0000000002143	0.865975668841702	0.922230408959565	nan
sp|Q8WWM7|ATX2L_HUMAN	metaplastic breast carcinomas-Normal	0.612165868514961	0.250161052594362	23.9999999994841	0.0220998954127681	0.101847869536815	nan
sp|Q8WWM7|ATX2L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.314923164307886	0.250161052594362	23.9999999991245	0.220180810744195	0.843662073010871	nan
sp|Q8WWM7|ATX2L_HUMAN	Normal-Triple-negative breast cancer	-0.927089032822846	0.298999647001988	23.9999999992557	0.0048800717495051	0.0449345110674657	nan
sp|Q8WWM9|CYGB_HUMAN	metaplastic breast carcinomas-Normal	-1.00384286782489	0.408591643678112	13.0006050364318	0.0288392449971817	0.121343861228648	nan
sp|Q8WWM9|CYGB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.640847619542603	0.454864552098672	13.3455394853844	0.181743682269026	0.843662073010871	nan
sp|Q8WWM9|CYGB_HUMAN	Normal-Triple-negative breast cancer	0.362995248282288	0.527684120763579	13.2626397512907	0.5033683827529	0.677916668869779	nan
sp|Q8WWP7|GIMA1_HUMAN	metaplastic breast carcinomas-Normal	-0.0440048621969391	0.27884730795349	21.9999973668093	0.8760461101473	0.935725343871987	nan
sp|Q8WWP7|GIMA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.207437737227758	0.27884730795349	21.9999973667707	0.464801808670868	0.909423669537079	nan
sp|Q8WWP7|GIMA1_HUMAN	Normal-Triple-negative breast cancer	0.251442599424697	0.333286280101889	21.9999973672579	0.458588592121054	0.640751778146441	nan
sp|Q8WWQ0|PHIP_HUMAN	metaplastic breast carcinomas-Normal	-0.651575284510684	0.782532089305265	14.9999999998872	0.418102709498419	0.619494915770806	nan
sp|Q8WWQ0|PHIP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.689126869935017	0.782532089305265	14.9999999999138	0.392405905675641	0.885234295852111	nan
sp|Q8WWQ0|PHIP_HUMAN	Normal-Triple-negative breast cancer	1.3407021544457	0.93530474085987	14.9999999998966	0.172247282436431	0.345117520686375	nan
sp|Q8WWY3|PRP31_HUMAN	metaplastic breast carcinomas-Normal	0.457616407184187	0.198666408767999	22.0000000204513	0.0310816468882373	0.126870319423363	nan
sp|Q8WWY3|PRP31_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.325716562628458	0.198666408767999	22.0000000210986	0.115328667656474	0.823891816737944	nan
sp|Q8WWY3|PRP31_HUMAN	Normal-Triple-negative breast cancer	-0.783332969812645	0.237451775473234	22.0000000209544	0.0032704885150218	0.03787841053635	nan
sp|Q8WX93|PALLD_HUMAN	metaplastic breast carcinomas-Normal	0.603047941328336	0.26029860201122	22.0000058671741	0.0302174607323101	0.125084482533249	nan
sp|Q8WX93|PALLD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.032213546540063	0.26029860201122	22.0000058674769	0.902632098948516	0.991166357002581	nan
sp|Q8WX93|PALLD_HUMAN	Normal-Triple-negative breast cancer	-0.570834394788273	0.311116336093557	22.0000058673292	0.0800954574866966	0.210464269316822	nan
sp|Q8WXA9|SREK1_HUMAN	metaplastic breast carcinomas-Normal	0.479588819631283	0.228449060938246	23.9999999997338	0.0464862547409949	0.161801372522583	nan
sp|Q8WXA9|SREK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.110784230247452	0.228449060938246	23.9999999997338	0.632115408310126	0.941868024951375	nan
sp|Q8WXA9|SREK1_HUMAN	Normal-Triple-negative breast cancer	-0.590373049878735	0.273048853408968	23.9999999997984	0.0407947730465326	0.136283241815753	nan
sp|Q8WXF1|PSPC1_HUMAN	metaplastic breast carcinomas-Normal	0.564729606534261	0.283262669650364	23.9999999996386	0.0576728324690926	0.182897857373237	nan
sp|Q8WXF1|PSPC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.504542295709306	0.283262669650364	23.9999999996386	0.087544400027891	0.809016644110817	nan
sp|Q8WXF1|PSPC1_HUMAN	Normal-Triple-negative breast cancer	-1.06927190224357	0.338563646722552	23.9999999997063	0.0042483041281508	0.0419484078096101	nan
sp|Q8WXF7|ATLA1_HUMAN	metaplastic breast carcinomas-Normal	0.394065245505027	0.263096804657582	14.0000000011452	0.156391163342501	0.338000147562077	nan
sp|Q8WXF7|ATLA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0532067057134674	0.263096804657582	14.0000000009106	0.842644322268257	0.972169455774446	nan
sp|Q8WXF7|ATLA1_HUMAN	Normal-Triple-negative breast cancer	-0.34085853979156	0.314460827951204	14.0000000009101	0.296703655329522	0.488480906545483	nan
sp|Q8WXH0|SYNE2_HUMAN	metaplastic breast carcinomas-Normal	-0.140030119834199	0.273949722355545	23.9999999989673	0.613914688937346	0.768460709404808	nan
sp|Q8WXH0|SYNE2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.016559894250634	0.273949722355545	23.9999999990107	0.952298862529876	0.996541950781621	nan
sp|Q8WXH0|SYNE2_HUMAN	Normal-Triple-negative breast cancer	0.123470225583565	0.327432545678561	23.999999998976	0.70942347791572	0.829740900982355	nan
sp|Q8WXI9|P66B_HUMAN	metaplastic breast carcinomas-Normal	0.632127107189619	0.363715531575859	22.0000000181442	0.0961954754475746	0.250751547601932	nan
sp|Q8WXI9|P66B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.493762645467263	0.363715531575859	22.0000000183766	0.188369384158912	0.843662073010871	nan
sp|Q8WXI9|P66B_HUMAN	Normal-Triple-negative breast cancer	-1.12588975265688	0.434723208998734	22.0000000179825	0.0167150856340038	0.0831750668374681	nan
sp|Q8WYA6|CTBL1_HUMAN	metaplastic breast carcinomas-Normal	-0.418260987332103	0.559920714286692	16.5287928960239	0.465557638924446	0.657956459092202	nan
sp|Q8WYA6|CTBL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.224151149575508	0.607804849421934	16.9588158435187	0.716849398463315	0.949812109346858	nan
sp|Q8WYA6|CTBL1_HUMAN	Normal-Triple-negative breast cancer	0.642412136907612	0.706244870066981	16.9866230293475	0.375751100467066	0.563372421268618	nan
sp|Q8WYP5|ELYS_HUMAN	metaplastic breast carcinomas-Normal	0.995221147808123	0.3608080252982	21.9999999997795	0.0114691035910113	0.0707296852254575	nan
sp|Q8WYP5|ELYS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0781701431248907	0.337927677199103	22.0000000000818	0.819202467010901	0.965774701272009	nan
sp|Q8WYP5|ELYS_HUMAN	Normal-Triple-negative breast cancer	-1.07339129093301	0.419357218998861	21.9999999998244	0.0178708973275284	0.0864670490781721	nan
sp|Q8WZ42|TITIN_HUMAN	metaplastic breast carcinomas-Normal	-1.03526443167976	0.241354399482799	22.0000000006486	0.0002975614604772	0.0164849049104415	nan
sp|Q8WZ42|TITIN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.186274106970299	0.241354399482799	22.0000000013328	0.448452232632429	0.903151831316067	nan
sp|Q8WZ42|TITIN_HUMAN	Normal-Triple-negative breast cancer	1.22153853865006	0.288473683250564	22.0000000012743	0.0003402853516439	0.0227914720285933	nan
sp|Q8WZA0|LZIC_HUMAN	metaplastic breast carcinomas-Normal	-0.0942540143388636	0.183728173702698	21.9999996494371	0.613058865168486	0.768343303541219	nan
sp|Q8WZA0|LZIC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.148759626777981	0.183728173702698	21.9999996527687	0.426799633015369	0.893645327314926	nan
sp|Q8WZA0|LZIC_HUMAN	Normal-Triple-negative breast cancer	-0.0545056124391176	0.219597169550223	21.9999996564651	0.806276203122046	0.888025877792472	nan
sp|Q8WZA9|IRGQ_HUMAN	metaplastic breast carcinomas-Normal	0.719178498556759	0.46226857184023	13.9999999989501	0.142076558455469	0.318236172712923	nan
sp|Q8WZA9|IRGQ_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.69178024052133	0.46226857184023	13.9999999997277	0.156727155629014	0.843465960034572	nan
sp|Q8WZA9|IRGQ_HUMAN	Normal-Triple-negative breast cancer	-0.0273982580354294	0.552516622259595	13.9999999996325	0.961151137754185	0.981692207683993	nan
sp|Q92499|DDX1_HUMAN	metaplastic breast carcinomas-Normal	0.338868948752058	0.110299086540365	23.9999999993391	0.0052232898530523	0.0476983941525986	nan
sp|Q92499|DDX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.134236239488724	0.110299086540365	23.9999999993715	0.235428989673357	0.84876230490475	nan
sp|Q92499|DDX1_HUMAN	Normal-Triple-negative breast cancer	-0.473105188240782	0.131832623816494	23.9999999993483	0.0014786454409067	0.0274581980199673	nan
sp|Q92504|S39A7_HUMAN	metaplastic breast carcinomas-Normal	0.314825451900904	0.414023229963832	11.0113132133916	0.46298402035191	0.65571320138464	nan
sp|Q92504|S39A7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.106823796937545	0.30388597411106	11.0003307326617	0.731834681114657	0.954643368861838	nan
sp|Q92504|S39A7_HUMAN	Normal-Triple-negative breast cancer	-0.208001654963359	0.459314182869966	11.0116330356489	0.659447317159457	0.799417535462449	nan
sp|Q92506|DHB8_HUMAN	metaplastic breast carcinomas-Normal	-0.605476473269595	0.350218139848287	22.0000000241628	0.0978452207095726	0.252341052717084	nan
sp|Q92506|DHB8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.466929954558929	0.350218139848287	22.000000024904	0.196090410178796	0.843662073010871	nan
sp|Q92506|DHB8_HUMAN	Normal-Triple-negative breast cancer	0.138546518710666	0.418590740254546	22.0000000241462	0.743788967051557	0.852536043613578	nan
sp|Q92508|PIEZ1_HUMAN	metaplastic breast carcinomas-Normal	0.254424262861816	0.21816858062281	22.000000040863	0.256028025702051	0.45730099808362	nan
sp|Q92508|PIEZ1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.11541805326006	0.21816858062281	22.000000040863	0.602081131163396	0.940559810632461	nan
sp|Q92508|PIEZ1_HUMAN	Normal-Triple-negative breast cancer	-0.369842316121876	0.260761329218259	22.0000000404648	0.170109052055677	0.341450778401612	nan
sp|Q92520|FAM3C_HUMAN	metaplastic breast carcinomas-Normal	0.966918295928752	0.235101870323978	22.0000000017669	0.0004580963789294	0.0200356889942306	nan
sp|Q92520|FAM3C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.341079971580126	0.235101870323978	22.0000000024307	0.160952331445697	0.843662073010871	nan
sp|Q92520|FAM3C_HUMAN	Normal-Triple-negative breast cancer	-0.625838324348625	0.281000481519244	22.0000000021275	0.0364834414290287	0.127127317030391	nan
sp|Q92522|H1X_HUMAN	metaplastic breast carcinomas-Normal	0.416825190327698	0.32296168248447	23.9999999999974	0.209126275619004	0.404383792994515	nan
sp|Q92522|H1X_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0478494921289827	0.32296168248447	23.9999999999974	0.883455519379327	0.984083618739117	nan
sp|Q92522|H1X_HUMAN	Normal-Triple-negative breast cancer	-0.368975698198715	0.386013042624209	23.9999999999881	0.348671214888663	0.539563835330501	nan
sp|Q92530|PSMF1_HUMAN	metaplastic breast carcinomas-Normal	-0.166662975015419	0.134488828895946	23.999999999971	0.227241672166333	0.426752157220841	nan
sp|Q92530|PSMF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.007127674399715	0.134488828895946	23.9999999997049	0.958171973340963	0.99709406933403	nan
sp|Q92530|PSMF1_HUMAN	Normal-Triple-negative breast cancer	0.173790649415134	0.160744895932313	23.9999999998981	0.290371413395574	0.483564417899242	nan
sp|Q92538|GBF1_HUMAN	metaplastic breast carcinomas-Normal	-0.0459334949198876	0.273882315800147	23.9999999992151	0.868214666627501	0.931250581435887	nan
sp|Q92538|GBF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.218655295912625	0.273882315800147	23.9999999989993	0.432494004938972	0.896102083258464	nan
sp|Q92538|GBF1_HUMAN	Normal-Triple-negative breast cancer	0.264588790832512	0.327351979435093	23.9999999990627	0.426874791672963	0.613504728886772	nan
sp|Q92541|RTF1_HUMAN	metaplastic breast carcinomas-Normal	0.119356633190477	0.416455285340455	6.0	0.784056882415764	0.882032001854638	nan
sp|Q92541|RTF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.054207069967197	0.416455285340455	6.0	0.900691694683741	0.990666170927318	nan
sp|Q92541|RTF1_HUMAN	Normal-Triple-negative breast cancer	-0.0651495632232804	0.49775927154743	6.0	0.900143968107949	0.941381457075854	nan
sp|Q92556|ELMO1_HUMAN	metaplastic breast carcinomas-Normal	-0.342823573810988	0.302965287835595	23.9999999996074	0.268999538413245	0.471600456585246	nan
sp|Q92556|ELMO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.513337192791486	0.302965287835595	23.9999999996429	0.103133378827395	0.821630939204717	nan
sp|Q92556|ELMO1_HUMAN	Normal-Triple-negative breast cancer	0.856160766602474	0.362112779656333	23.999999999604	0.0264931463781883	0.108975739784405	nan
sp|Q92572|AP3S1_HUMAN	metaplastic breast carcinomas-Normal	0.259074697609973	0.209399981831582	22.000000031599	0.22904766676174	0.428932081304801	nan
sp|Q92572|AP3S1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0287289160426271	0.209399981831582	22.0000000315107	0.89212344915608	0.988218752026376	nan
sp|Q92572|AP3S1_HUMAN	Normal-Triple-negative breast cancer	-0.230345781567346	0.250280849079209	22.0000000312676	0.367372641173267	0.557855943015048	nan
sp|Q92575|UBXN4_HUMAN	metaplastic breast carcinomas-Normal	-0.122652942410852	0.211543773196789	22.000000001724	0.567940865391903	0.734280605430838	nan
sp|Q92575|UBXN4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0478630474614671	0.211543773196789	22.0000000014511	0.823091233890297	0.965774701272009	nan
sp|Q92575|UBXN4_HUMAN	Normal-Triple-negative breast cancer	0.0747898949493854	0.252843169851349	22.0000000012409	0.770160152269614	0.869306111286004	nan
sp|Q92576|PHF3_HUMAN	metaplastic breast carcinomas-Normal	0.55471022808868	0.894490646911094	6.0	0.557967480765867	0.727985394360342	nan
sp|Q92576|PHF3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.773081674024563	0.894490646911094	6.0	0.420643401827401	0.887693595400195	nan
sp|Q92576|PHF3_HUMAN	Normal-Triple-negative breast cancer	-1.32779190211324	1.06912081197017	6.0	0.260598524362609	0.45139629754107	nan
sp|Q92597|NDRG1_HUMAN	metaplastic breast carcinomas-Normal	0.917781507656724	0.42279508360814	22.0000000019149	0.0410166746109338	0.149823545501916	nan
sp|Q92597|NDRG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.773676757217633	0.42279508360814	22.0000000028423	0.080847881504606	0.806849600316436	nan
sp|Q92597|NDRG1_HUMAN	Normal-Triple-negative breast cancer	-0.144104750439091	0.505336779814376	22.0000000025719	0.778184539393062	0.87447106455123	nan
sp|Q92598|HS105_HUMAN	metaplastic breast carcinomas-Normal	0.427047696959855	0.275522650116832	22.0000000026363	0.135419297618951	0.308708630279932	nan
sp|Q92598|HS105_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0060990481650848	0.275522650116832	22.0000000027334	0.982538792672986	0.99777413090774	nan
sp|Q92598|HS105_HUMAN	Normal-Triple-negative breast cancer	-0.42094864879477	0.329312553939268	22.0000000026779	0.214478251028191	0.396510404014298	nan
sp|Q92599|SEPT8_HUMAN	metaplastic breast carcinomas-Normal	-0.238294844584098	0.343442776189971	22.0000000647529	0.495043281132144	0.683073419046594	nan
sp|Q92599|SEPT8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0114447119741318	0.343442776189971	22.0000000653023	0.973717114060545	0.99709406933403	nan
sp|Q92599|SEPT8_HUMAN	Normal-Triple-negative breast cancer	0.24973955655823	0.410492631771483	22.0000000650777	0.549159386639017	0.714018242745883	nan
sp|Q92608|DOCK2_HUMAN	metaplastic breast carcinomas-Normal	-0.0050033562038346	0.296986285035918	24.0000000000792	0.986697872801724	0.993572774672199	nan
sp|Q92608|DOCK2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0665319653869579	0.296986285035918	24.0000000000434	0.82463498694896	0.965774701272009	nan
sp|Q92608|DOCK2_HUMAN	Normal-Triple-negative breast cancer	-0.0615286091831232	0.354966504454868	24.0000000001215	0.863840678868695	0.921503984775206	nan
sp|Q92609|TBCD5_HUMAN	metaplastic breast carcinomas-Normal	0.496378438513733	0.262896419033258	23.9999999996782	0.0711582362133439	0.207482436116803	nan
sp|Q92609|TBCD5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0470642217671715	0.262896419033258	23.9999999996767	0.859423223133035	0.979177437622147	nan
sp|Q92609|TBCD5_HUMAN	Normal-Triple-negative breast cancer	-0.543442660280905	0.314221321320113	23.9999999996864	0.0965647058188742	0.238470343344679	nan
sp|Q92614|MY18A_HUMAN	metaplastic breast carcinomas-Normal	0.0601555737749322	0.252677593079999	24.0000000001048	0.813845763770506	0.902041786853338	nan
sp|Q92614|MY18A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.261598426164593	0.252677593079999	24.0000000004573	0.310846169930418	0.867696529950794	nan
sp|Q92614|MY18A_HUMAN	Normal-Triple-negative breast cancer	0.201442852389661	0.302007488186969	24.0000000003417	0.511126523646353	0.684522387026784	nan
sp|Q92615|LAR4B_HUMAN	metaplastic breast carcinomas-Normal	-0.0855006827861928	0.263765120374394	21.4854247616529	0.748955545271591	0.860832722158633	nan
sp|Q92615|LAR4B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.324859002566309	0.246418040661557	21.1326974893952	0.201505942536234	0.843662073010871	nan
sp|Q92615|LAR4B_HUMAN	Normal-Triple-negative breast cancer	-0.239358319780117	0.309185525297231	21.3922150193148	0.447309667900529	0.63109394571365	nan
sp|Q92616|GCN1_HUMAN	metaplastic breast carcinomas-Normal	0.441149244438673	0.152744303448425	22.0000000035184	0.0085341476537329	0.060872418046307	nan
sp|Q92616|GCN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.215983101216839	0.152744303448425	22.0000000036644	0.17135285562618	0.843662073010871	nan
sp|Q92616|GCN1_HUMAN	Normal-Triple-negative breast cancer	-0.657132345655512	0.182564361394412	22.0000000034203	0.0015935686072472	0.0283781197026415	nan
sp|Q92619|HMHA1_HUMAN	metaplastic breast carcinomas-Normal	0.370093254915382	0.506444551920993	20.2928230876954	0.473274845644945	0.663502989002024	nan
sp|Q92619|HMHA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.772990679466768	0.506444551920993	20.2928230871075	0.142369128200271	0.827137892189782	nan
sp|Q92619|HMHA1_HUMAN	Normal-Triple-negative breast cancer	0.402897424551386	0.591489163631499	20.0999772556842	0.503544441042646	0.677916668869779	nan
sp|Q92621|NU205_HUMAN	metaplastic breast carcinomas-Normal	0.699826671570217	0.210825005720132	23.9999999995035	0.0028720603634338	0.0379733940896436	nan
sp|Q92621|NU205_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0362441595930009	0.210825005720132	23.9999999995035	0.864945094074737	0.980530611231673	nan
sp|Q92621|NU205_HUMAN	Normal-Triple-negative breast cancer	-0.736070831163218	0.251984078399789	23.9999999995286	0.007479424324808	0.054640893309147	nan
sp|Q92626|PXDN_HUMAN	metaplastic breast carcinomas-Normal	0.585357712343422	0.316732548366985	24.0000000002012	0.0769463035396717	0.218233372837772	nan
sp|Q92626|PXDN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0124218434369524	0.316732548366985	24.0000000002003	0.969040433793723	0.99709406933403	nan
sp|Q92626|PXDN_HUMAN	Normal-Triple-negative breast cancer	-0.57293586890647	0.37856780331561	24.0000000001624	0.143229169161156	0.306570807991482	nan
sp|Q92643|GPI8_HUMAN	metaplastic breast carcinomas-Normal	0.344281433102495	0.310888420126121	13.9999999976389	0.286780484650353	0.490544751556665	nan
sp|Q92643|GPI8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.149078460784487	0.310888420126121	13.9999999988139	0.638970429033353	0.941868024951375	nan
sp|Q92643|GPI8_HUMAN	Normal-Triple-negative breast cancer	-0.493359893886982	0.37158273404551	13.9999999984062	0.20551190790135	0.387171523124631	nan
sp|Q92665|RT31_HUMAN	metaplastic breast carcinomas-Normal	0.0538199841648395	0.296434563288304	14.0000011898393	0.858532230399713	0.926545822678132	nan
sp|Q92665|RT31_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0597359258929797	0.296434563288304	14.0000011898393	0.843194718965741	0.972467027596631	nan
sp|Q92665|RT31_HUMAN	Normal-Triple-negative breast cancer	-0.113555910057819	0.354307070837728	14.0000011898067	0.753322040585715	0.858093857556366	nan
sp|Q92667|AKAP1_HUMAN	metaplastic breast carcinomas-Normal	0.0438452719597833	0.268436462627724	23.99999999955	0.871621706535322	0.932886600115491	nan
sp|Q92667|AKAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.452364046245874	0.268436462627724	23.9999999995486	0.104914673721477	0.821630939204717	nan
sp|Q92667|AKAP1_HUMAN	Normal-Triple-negative breast cancer	-0.496209318205658	0.320842939921178	23.9999999995654	0.13505047480396	0.294691901039905	nan
sp|Q92696|PGTA_HUMAN	metaplastic breast carcinomas-Normal	0.008796582088674	0.359080969159116	14.0000001931299	0.980801540136406	0.989979919959791	nan
sp|Q92696|PGTA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.393947944089533	0.359080969159116	14.0000001936315	0.291109799192019	0.867696529950794	nan
sp|Q92696|PGTA_HUMAN	Normal-Triple-negative breast cancer	-0.402744526178207	0.429183847406496	14.0000001934942	0.363949147118255	0.5541195703899	nan
sp|Q92734|TFG_HUMAN	metaplastic breast carcinomas-Normal	0.412883255121174	0.247679453541442	23.9999999991961	0.108511887958589	0.269576618515957	nan
sp|Q92734|TFG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.137284917002301	0.247679453541442	23.9999999991961	0.584512588630724	0.938678807206619	nan
sp|Q92734|TFG_HUMAN	Normal-Triple-negative breast cancer	-0.275598338118873	0.296033568817041	23.9999999992142	0.361139970587784	0.551667859482443	nan
sp|Q92747|ARC1A_HUMAN	metaplastic breast carcinomas-Normal	0.0218571112628859	0.323100545062114	22.0000000089732	0.946676886472889	0.972567428615729	nan
sp|Q92747|ARC1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.21302983264207	0.323100545062114	22.0000000093689	0.516526843754936	0.915620969865368	nan
sp|Q92747|ARC1A_HUMAN	Normal-Triple-negative breast cancer	-0.234886943904956	0.386179015149775	22.0000000091237	0.549261325722389	0.714018242745883	nan
sp|Q92769|HDAC2_HUMAN	metaplastic breast carcinomas-Normal	0.972140055171451	0.253151232028112	22.0000000010079	0.0008899492162809	0.0227210419054423	nan
sp|Q92769|HDAC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.186551881411459	0.253151232028112	22.0000000015532	0.468958340864211	0.911843360423993	nan
sp|Q92769|HDAC2_HUMAN	Normal-Triple-negative breast cancer	-1.15869193658291	0.302573595008248	22.0000000015711	0.0009133829308435	0.025773942907156	nan
sp|Q92783|STAM1_HUMAN	metaplastic breast carcinomas-Normal	0.168437070564517	0.186011275009342	23.9999999995306	0.374190896510395	0.581984288538432	nan
sp|Q92783|STAM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0594489567859474	0.186011275009342	23.9999999992068	0.752038041811023	0.954643368861838	nan
sp|Q92783|STAM1_HUMAN	Normal-Triple-negative breast cancer	-0.10898811377857	0.222325997549934	23.9999999994432	0.628431647042992	0.776834062763445	nan
sp|Q92785|REQU_HUMAN	metaplastic breast carcinomas-Normal	-0.17148266009009	0.222248289097584	14.999999999562	0.452347095191761	0.647273626341931	nan
sp|Q92785|REQU_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0382364095473757	0.222248289097584	14.9999999995626	0.865702879166234	0.980530611231673	nan
sp|Q92785|REQU_HUMAN	Normal-Triple-negative breast cancer	0.209719069637465	0.265637513505054	14.9999999995685	0.442125356597981	0.627240582727993	nan
sp|Q92791|SC65_HUMAN	metaplastic breast carcinomas-Normal	-0.971133660592207	0.301815496515459	10.0048968400449	0.0092062978067493	0.0637536123117391	nan
sp|Q92791|SC65_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.44982317963288	0.301815496515459	10.004896839934	0.166957645501771	0.843662073010871	nan
sp|Q92791|SC65_HUMAN	Normal-Triple-negative breast cancer	1.42095684022509	0.363833055626523	10.0000013257935	0.0029345677447302	0.0362620936188969	nan
sp|Q92797|SYMPK_HUMAN	metaplastic breast carcinomas-Normal	0.845354901256764	0.290088407634535	23.9999999999505	0.0076032459407108	0.0580128309380038	nan
sp|Q92797|SYMPK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.143950586839113	0.290088407634535	24.0000000001417	0.624246405456165	0.941374262616245	nan
sp|Q92797|SYMPK_HUMAN	Normal-Triple-negative breast cancer	-0.989305488095877	0.346721964041054	24.0000000000746	0.0087692601846519	0.0588076066258844	nan
sp|Q92804|RBP56_HUMAN	metaplastic breast carcinomas-Normal	0.756171747424445	0.376520256558067	22.0000000203493	0.0570420120995382	0.18179065025778	nan
sp|Q92804|RBP56_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.208115423783308	0.376520256558067	22.0000000206241	0.586018734400165	0.939599908351397	nan
sp|Q92804|RBP56_HUMAN	Normal-Triple-negative breast cancer	-0.964287171207753	0.450027782632128	22.0000000209314	0.0434520735424458	0.142160130369183	nan
sp|Q92817|EVPL_HUMAN	metaplastic breast carcinomas-Normal	0.704554835076516	0.489612299913893	22.0000038872827	0.164225628097486	0.350151371261094	nan
sp|Q92817|EVPL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.421017910100515	0.489612299913893	22.0000038872789	0.399117713850461	0.885297496092956	nan
sp|Q92817|EVPL_HUMAN	Normal-Triple-negative breast cancer	-1.12557274517703	0.585198628339096	22.0000038872795	0.0674662273748851	0.187677216209051	nan
sp|Q92820|GGH_HUMAN	metaplastic breast carcinomas-Normal	0.99380807461481	0.41651774436417	23.9999999996367	0.0252722451164903	0.111857447093494	nan
sp|Q92820|GGH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.122938028829248	0.41651774436417	23.9999999996743	0.770412452246647	0.959745866833315	nan
sp|Q92820|GGH_HUMAN	Normal-Triple-negative breast cancer	-1.11674610344406	0.497833924359486	23.9999999996258	0.034381812005234	0.124196152475544	nan
sp|Q92835|SHIP1_HUMAN	metaplastic breast carcinomas-Normal	0.209957052573506	0.244165480663064	22.0000000023117	0.399119903750911	0.601923998636815	nan
sp|Q92835|SHIP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.096855250118756	0.244165480663063	22.0000000014127	0.695426090751404	0.947043345959522	nan
sp|Q92835|SHIP1_HUMAN	Normal-Triple-negative breast cancer	-0.11310180245475	0.291833567900377	22.0000000016175	0.702068926331428	0.825788078954588	nan
sp|Q92841|DDX17_HUMAN	metaplastic breast carcinomas-Normal	0.478889510227098	0.320754948596246	22.0000001636621	0.149638803607619	0.328099856986626	nan
sp|Q92841|DDX17_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.58336495345319	0.320754948596246	22.0000001637231	0.0825939635516028	0.806849600316436	nan
sp|Q92841|DDX17_HUMAN	Normal-Triple-negative breast cancer	-1.06225446368029	0.383375491147816	22.0000001631638	0.0111498821371271	0.067263535796389	nan
sp|Q92854|SEM4D_HUMAN	metaplastic breast carcinomas-Normal	0.794327724994377	0.279104390981054	22.0000000210244	0.0093982828498867	0.0644121488515948	nan
sp|Q92854|SEM4D_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.150145104680571	0.279104390981054	22.0000000210615	0.59601019678724	0.940559810632461	nan
sp|Q92854|SEM4D_HUMAN	Normal-Triple-negative breast cancer	-0.644182620313806	0.333593553091408	22.0000000214632	0.0664643104875208	0.186338952556932	nan
sp|Q92878|RAD50_HUMAN	metaplastic breast carcinomas-Normal	0.049593541448939	0.16009110040701	23.9999999991852	0.759399617696531	0.868333102587984	nan
sp|Q92878|RAD50_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.279552749826366	0.16009110040701	23.9999999992151	0.0935640161511388	0.81309570430905	nan
sp|Q92878|RAD50_HUMAN	Normal-Triple-negative breast cancer	-0.329146291275305	0.191345463306283	23.9999999992	0.0982729951357801	0.240367502451312	nan
sp|Q92879|CELF1_HUMAN	metaplastic breast carcinomas-Normal	0.738985305875274	0.359590869134597	14.9999999995314	0.0577183604102723	0.182897857373237	nan
sp|Q92879|CELF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.713949118261714	0.359590869134597	14.9999999995305	0.0656893994309138	0.774640662531106	nan
sp|Q92879|CELF1_HUMAN	Normal-Triple-negative breast cancer	-1.45293442413699	0.42979329444509	14.9999999995541	0.0041189901763279	0.0415041773018799	nan
sp|Q92882|OSTF1_HUMAN	metaplastic breast carcinomas-Normal	-0.267560254406969	0.28494619660613	24.0000000000511	0.357093123717816	0.566306079789131	nan
sp|Q92882|OSTF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.153534833700424	0.28494619660613	24.0000000000511	0.594973999214171	0.940559810632461	nan
sp|Q92882|OSTF1_HUMAN	Normal-Triple-negative breast cancer	0.421095088107393	0.340575846304669	24.0000000000161	0.228266055779925	0.410804747922291	nan
sp|Q92888|ARHG1_HUMAN	metaplastic breast carcinomas-Normal	0.0707924770770132	0.221914202155409	22.0000000072039	0.752729347436981	0.864263416585124	nan
sp|Q92888|ARHG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0103411254849773	0.221914202155409	22.0000000072062	0.963252736142055	0.99709406933403	nan
sp|Q92888|ARHG1_HUMAN	Normal-Triple-negative breast cancer	-0.0604513515920359	0.265238203233762	22.0000000073284	0.821818457209528	0.898940081069813	nan
sp|Q92890|UFD1_HUMAN	metaplastic breast carcinomas-Normal	-0.139078543442244	0.186346535278964	21.9999999555346	0.463361363345897	0.655968131074004	nan
sp|Q92890|UFD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0502151874237318	0.186346535278964	21.9999999632505	0.79007774636604	0.962981271203673	nan
sp|Q92890|UFD1_HUMAN	Normal-Triple-negative breast cancer	0.0888633560185118	0.222726710215758	21.9999999632852	0.693754804894454	0.819779940088576	nan
sp|Q92896|GSLG1_HUMAN	metaplastic breast carcinomas-Normal	0.423389421694084	0.177158998821219	22.0000016085676	0.0258518823523501	0.11321693931385	nan
sp|Q92896|GSLG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.258252918558613	0.177158998821219	22.0000016089272	0.15903849262679	0.843662073010871	nan
sp|Q92896|GSLG1_HUMAN	Normal-Triple-negative breast cancer	-0.165136503135471	0.21174550379216	22.0000016092969	0.443770249412443	0.62876910019052	nan
sp|Q92900|RENT1_HUMAN	metaplastic breast carcinomas-Normal	0.242786770591943	0.102699506679072	22.0000000175572	0.0273228664609357	0.117188655633742	nan
sp|Q92900|RENT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.250743654836219	0.102699506679072	22.0000000167788	0.0231283046732686	0.712051972579798	nan
sp|Q92900|RENT1_HUMAN	Normal-Triple-negative breast cancer	-0.493530425428162	0.122749388547356	22.0000000172234	0.0005735540205097	0.0237592699893802	nan
sp|Q92905|CSN5_HUMAN	metaplastic breast carcinomas-Normal	0.0232440925349271	0.230469920270472	21.9999990257055	0.920578906130961	0.95843058885501	nan
sp|Q92905|CSN5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.385437622031751	0.230469920270472	21.9999990257055	0.108609086644584	0.823891816737944	nan
sp|Q92905|CSN5_HUMAN	Normal-Triple-negative breast cancer	-0.408681714566678	0.275464242298285	21.9999990163567	0.152098361881925	0.31972470314917	nan
sp|Q92922|SMRC1_HUMAN	metaplastic breast carcinomas-Normal	1.5489854580291	0.374732287440294	23.9999999996398	0.0003757592169408	0.0183679946634034	nan
sp|Q92922|SMRC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0698751210576159	0.374732287440294	23.9999999993657	0.85364593490815	0.977401079052892	nan
sp|Q92922|SMRC1_HUMAN	Normal-Triple-negative breast cancer	-1.61886057908671	0.447890750789959	23.9999999994661	0.0013869679112015	0.0266490250684039	nan
sp|Q92925|SMRD2_HUMAN	metaplastic breast carcinomas-Normal	0.58236367409141	0.408842912862575	23.9999999991708	0.167199076936972	0.354473509769277	nan
sp|Q92925|SMRD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0082271203836071	0.408842912862575	23.9999999994012	0.984111667676365	0.99777413090774	nan
sp|Q92925|SMRD2_HUMAN	Normal-Triple-negative breast cancer	-0.574136553707802	0.488660746176958	23.9999999992915	0.251553010977965	0.440317118741841	nan
sp|Q92930|RAB8B_HUMAN	metaplastic breast carcinomas-Normal	-0.766589945808903	0.292695514722834	23.9999999997281	0.0150409246817027	0.0806387639386771	nan
sp|Q92930|RAB8B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0806587318226022	0.292695514722834	23.9999999997649	0.785235496256707	0.962981271203673	nan
sp|Q92930|RAB8B_HUMAN	Normal-Triple-negative breast cancer	0.847248677631505	0.349838053020587	23.9999999997055	0.0233638972882438	0.101651301814296	nan
sp|Q92945|FUBP2_HUMAN	metaplastic breast carcinomas-Normal	0.568264328848483	0.247672781617514	23.9999999995182	0.0308172169673835	0.126153237930521	nan
sp|Q92945|FUBP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.372915373048247	0.247672781617514	23.999999999544	0.145199017806349	0.827647387111815	nan
sp|Q92945|FUBP2_HUMAN	Normal-Triple-negative breast cancer	-0.941179701896729	0.296025594342682	23.9999999995472	0.0040370379303416	0.041407627248948	nan
sp|Q92947|GCDH_HUMAN	metaplastic breast carcinomas-Normal	0.258215194406975	0.282750226051489	22.0000000022068	0.371023170900524	0.580094553185955	nan
sp|Q92947|GCDH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.174880348891794	0.282750226051489	22.000000002477	0.542598629041875	0.923837171685362	nan
sp|Q92947|GCDH_HUMAN	Normal-Triple-negative breast cancer	-0.433095543298769	0.337951159472506	22.0000000022298	0.213349458889969	0.395742624294729	nan
sp|Q92973|TNPO1_HUMAN	metaplastic breast carcinomas-Normal	0.359258851519706	0.151805555849717	22.0000000280394	0.0271759066690196	0.117011287264017	nan
sp|Q92973|TNPO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.118917699374191	0.151805555849717	22.0000000281408	0.441770568063241	0.89755436380139	nan
sp|Q92973|TNPO1_HUMAN	Normal-Triple-negative breast cancer	-0.478176550893896	0.181442343407492	22.000000028302	0.0151093144529149	0.0781078712931399	nan
sp|Q92974|ARHG2_HUMAN	metaplastic breast carcinomas-Normal	0.1478579642579	0.258114209645488	22.0000085295938	0.572562323148567	0.735677294992592	nan
sp|Q92974|ARHG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.271468490138956	0.258114209645488	22.0000085296329	0.304335606593117	0.867696529950794	nan
sp|Q92974|ARHG2_HUMAN	Normal-Triple-negative breast cancer	0.123610525881055	0.308505487844023	22.0000085291781	0.692523800111146	0.8191222906967	nan
sp|Q92979|NEP1_HUMAN	metaplastic breast carcinomas-Normal	-0.0895108615349957	0.25039452637191	6.0	0.732971164785037	0.851109065467202	nan
sp|Q92979|NEP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.612059883738553	0.25039452637191	6.0	0.0501721049103046	0.768766123625635	nan
sp|Q92979|NEP1_HUMAN	Normal-Triple-negative breast cancer	-0.522549022203557	0.299278701540442	6.0	0.131410447190976	0.290248221534721	nan
sp|Q92990|GLMN_HUMAN	metaplastic breast carcinomas-Normal	0.489786080919886	0.362533723837715	12.0567947351936	0.201501534997633	0.394923999016586	nan
sp|Q92990|GLMN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.237830713849597	0.326249509202306	12.0176666335735	0.479977696983218	0.913320451076758	nan
sp|Q92990|GLMN_HUMAN	Normal-Triple-negative breast cancer	-0.251955367070289	0.416033610855101	12.0962633659255	0.555964733616536	0.719883328058029	nan
sp|Q93008|USP9X_HUMAN	metaplastic breast carcinomas-Normal	0.111075107857228	0.150209686919421	22.000000006464	0.467441100653199	0.658937327638352	nan
sp|Q93008|USP9X_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0600450282422891	0.150209686919421	22.0000000055391	0.693201568873961	0.946568877415162	nan
sp|Q93008|USP9X_HUMAN	Normal-Triple-negative breast cancer	-0.0510300796149394	0.179534915205254	22.0000000056667	0.778888504025674	0.874519294198955	nan
sp|Q93009|UBP7_HUMAN	metaplastic breast carcinomas-Normal	0.0582465487535254	0.157303668875699	23.9999999995587	0.714420997568628	0.839696280422969	nan
sp|Q93009|UBP7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.215666520748445	0.157303668875699	23.9999999995906	0.183054103071445	0.843662073010871	nan
sp|Q93009|UBP7_HUMAN	Normal-Triple-negative breast cancer	-0.27391306950197	0.1880138453935	23.9999999995551	0.158110431783156	0.328064341602503	nan
sp|Q93034|CUL5_HUMAN	metaplastic breast carcinomas-Normal	-0.212037191025746	0.329111315714174	6.0	0.543228367729805	0.717850670091131	nan
sp|Q93034|CUL5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.376902407312031	0.329111315714174	6.0	0.295737718701137	0.867696529950794	nan
sp|Q93034|CUL5_HUMAN	Normal-Triple-negative breast cancer	-0.164865216286285	0.393363260197265	6.0	0.689721211657575	0.817508378065248	nan
sp|Q93052|LPP_HUMAN	metaplastic breast carcinomas-Normal	-0.237704449775694	0.177020060454012	22.0000000032313	0.193024584508968	0.386624153804669	nan
sp|Q93052|LPP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.126018250705809	0.177020060454012	22.0000000028989	0.484016235437367	0.913320451076758	nan
sp|Q93052|LPP_HUMAN	Normal-Triple-negative breast cancer	0.111686199069884	0.211579440680739	22.0000000030333	0.602874464054981	0.754501023538688	nan
sp|Q93084|AT2A3_HUMAN	metaplastic breast carcinomas-Normal	-0.540540177534242	0.436131344639309	21.9999999111677	0.228257583469328	0.427934691174306	nan
sp|Q93084|AT2A3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.23504788987083	0.436131344639309	21.999999911162	0.595341704391375	0.940559810632461	nan
sp|Q93084|AT2A3_HUMAN	Normal-Triple-negative breast cancer	0.775588067405072	0.52127666054038	21.9999999104299	0.150981390301432	0.318845070750927	nan
sp|Q969G3|SMCE1_HUMAN	metaplastic breast carcinomas-Normal	-0.20798255421557	0.272393515433121	12.3065831117644	0.459531211848432	0.653049058650785	nan
sp|Q969G3|SMCE1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.437890469785344	0.198006459959821	12.0000000030796	0.0471535644509672	0.760401133998256	nan
sp|Q969G3|SMCE1_HUMAN	Normal-Triple-negative breast cancer	0.645873024000915	0.30166378287935	12.2533755844426	0.0530356507069823	0.162439494536208	nan
sp|Q969G5|CAVN3_HUMAN	metaplastic breast carcinomas-Normal	-2.24111918210235	0.454652178557889	23.999999999466	4.97296828013065e-05	0.0097236156253848	nan
sp|Q969G5|CAVN3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0440592932764434	0.454652178557889	23.999999999466	0.923604427772904	0.994508979919649	nan
sp|Q969G5|CAVN3_HUMAN	Normal-Triple-negative breast cancer	2.1970598888259	0.543413291108598	23.9999999994723	0.0004725418749804	0.0237592699893802	nan
sp|Q969H8|MYDGF_HUMAN	metaplastic breast carcinomas-Normal	0.37928771835193	0.218492183359029	23.9999999997006	0.0953989383316311	0.249801473689487	nan
sp|Q969H8|MYDGF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.071293749898165	0.218492183359029	23.9999999996996	0.74702659226164	0.954643368861838	nan
sp|Q969H8|MYDGF_HUMAN	Normal-Triple-negative breast cancer	-0.450581468250095	0.261148108466648	23.9999999996412	0.0973135046088841	0.23872331315124	nan
sp|Q969S9|RRF2M_HUMAN	metaplastic breast carcinomas-Normal	0.23203514829102	0.184578856572615	13.9999999920929	0.229283610791878	0.429132163441556	nan
sp|Q969S9|RRF2M_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0034674345599249	0.184578856572615	13.9999999925875	0.985277203392641	0.99777413090774	nan
sp|Q969S9|RRF2M_HUMAN	Normal-Triple-negative breast cancer	-0.235502582850945	0.220613930053819	13.9999999923748	0.303814322551864	0.496257807075582	nan
sp|Q969V3|NCLN_HUMAN	metaplastic breast carcinomas-Normal	0.145854071950146	0.334357366437892	23.9999999996829	0.666574565156159	0.804536621125299	nan
sp|Q969V3|NCLN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0809333770385635	0.334357366437892	23.9999999996829	0.810792792375231	0.965774701272009	nan
sp|Q969V3|NCLN_HUMAN	Normal-Triple-negative breast cancer	-0.226787448988709	0.399633490108272	23.9999999997143	0.575652822823434	0.735384313245616	nan
sp|Q969X5|ERGI1_HUMAN	metaplastic breast carcinomas-Normal	0.0777557091720908	0.291424411477367	24.0000000001139	0.791892625558544	0.887345906640773	nan
sp|Q969X5|ERGI1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.196130401765122	0.291424411477367	24.0000000000768	0.507372646900899	0.913875433881631	nan
sp|Q969X5|ERGI1_HUMAN	Normal-Triple-negative breast cancer	-0.273886110937212	0.348318794056187	24.0000000000801	0.439381937249723	0.624341863388512	nan
sp|Q969Z0|FAKD4_HUMAN	metaplastic breast carcinomas-Normal	0.61107238603209	0.305374316901831	14.0000000057164	0.0651618850091193	0.196458060111257	nan
sp|Q969Z0|FAKD4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.283053194472254	0.305374316901831	14.0000000055293	0.369679705220892	0.883542279876718	nan
sp|Q969Z0|FAKD4_HUMAN	Normal-Triple-negative breast cancer	-0.894125580504344	0.364992120117016	14.0000000052626	0.0280593706209216	0.112372708366197	nan
sp|Q96A26|F162A_HUMAN	metaplastic breast carcinomas-Normal	-0.0595518724919559	0.205004207427215	6.0	0.781219686333407	0.881756956662901	nan
sp|Q96A26|F162A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0463788839757014	0.205004207427215	6.0	0.8285296123264	0.966828216776039	nan
sp|Q96A26|F162A_HUMAN	Normal-Triple-negative breast cancer	0.105930756467657	0.24502689375093	6.0	0.680612434612656	0.813211981542944	nan
sp|Q96A33|CCD47_HUMAN	metaplastic breast carcinomas-Normal	0.747751519030746	0.224563512372378	23.9999999996084	0.0028004156188787	0.0379733940896436	nan
sp|Q96A33|CCD47_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.238469931166482	0.224563512372378	23.999999999577	0.298838613483634	0.867696529950794	nan
sp|Q96A33|CCD47_HUMAN	Normal-Triple-negative breast cancer	-0.986221450197227	0.268404734600084	23.9999999995499	0.0011943486677419	0.0266490250684039	nan
sp|Q96A49|SYAP1_HUMAN	metaplastic breast carcinomas-Normal	0.182102431973953	0.227124596803772	23.9999999998605	0.430551585356177	0.627376925595309	nan
sp|Q96A49|SYAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.288232887791844	0.227124596803772	24.0000000000776	0.21659246517961	0.843662073010871	nan
sp|Q96A49|SYAP1_HUMAN	Normal-Triple-negative breast cancer	-0.470335319765797	0.271465815983408	23.9999999999862	0.0960047064573359	0.237794071731881	nan
sp|Q96A65|EXOC4_HUMAN	metaplastic breast carcinomas-Normal	-0.194314667199626	0.172216415863405	23.9999999995669	0.270339512877911	0.472716075635733	nan
sp|Q96A65|EXOC4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.156455339001036	0.172216415863405	23.9999999995669	0.372657052815394	0.885234295852111	nan
sp|Q96A65|EXOC4_HUMAN	Normal-Triple-negative breast cancer	0.350770006200662	0.205837987236972	23.9999999995453	0.101276202538364	0.244442821554936	nan
sp|Q96AB3|ISOC2_HUMAN	metaplastic breast carcinomas-Normal	0.307128455321657	0.346328573302699	15.0000000001572	0.389177300629323	0.592689911608717	nan
sp|Q96AB3|ISOC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0805508711101776	0.346328573302699	15.0000000001407	0.819227258756206	0.965774701272009	nan
sp|Q96AB3|ISOC2_HUMAN	Normal-Triple-negative breast cancer	-0.387679326431835	0.41394181904135	15.0000000001471	0.363822444447979	0.5541195703899	nan
sp|Q96AC1|FERM2_HUMAN	metaplastic breast carcinomas-Normal	-0.627871853358271	0.213045172124782	22.0000000495969	0.0074519622399869	0.0574264432292092	nan
sp|Q96AC1|FERM2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.286255286368341	0.213045172124782	22.0000000497519	0.192761435016736	0.843662073010871	nan
sp|Q96AC1|FERM2_HUMAN	Normal-Triple-negative breast cancer	0.914127139726612	0.254637684804109	22.0000000492642	0.0016306320286415	0.0283781197026415	nan
sp|Q96AE4|FUBP1_HUMAN	metaplastic breast carcinomas-Normal	0.837935893064823	0.266516552964685	23.9999999993238	0.0043965679131165	0.0441516366864034	nan
sp|Q96AE4|FUBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0346948931807452	0.266516552964685	23.999999999007	0.897509677320419	0.989671989983163	nan
sp|Q96AE4|FUBP1_HUMAN	Normal-Triple-negative breast cancer	-0.872630786245568	0.318548208964576	23.9999999991385	0.0114237379395093	0.0681732583679152	nan
sp|Q96AG4|LRC59_HUMAN	metaplastic breast carcinomas-Normal	1.53459336742077	0.472529299900726	23.9999999995632	0.0034217460879089	0.0406210142721759	nan
sp|Q96AG4|LRC59_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.483963875339162	0.472529299900726	23.9999999995632	0.315954624517858	0.867696529950794	nan
sp|Q96AG4|LRC59_HUMAN	Normal-Triple-negative breast cancer	-2.01855724275993	0.5647805379901	23.9999999995954	0.0015333730270549	0.0277007170757102	nan
sp|Q96AQ6|PBIP1_HUMAN	metaplastic breast carcinomas-Normal	-0.215834206110065	0.33969473578308	21.3365441474824	0.531938451449763	0.708682730508622	nan
sp|Q96AQ6|PBIP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0990269582763816	0.317690667677606	20.8546629797922	0.758356731976977	0.955228196959647	nan
sp|Q96AQ6|PBIP1_HUMAN	Normal-Triple-negative breast cancer	0.116807247833684	0.398305280553835	21.2096499632612	0.772173152849862	0.869774164714653	nan
sp|Q96AT9|RPE_HUMAN	metaplastic breast carcinomas-Normal	-0.0709116416933421	0.121271909479635	22.000004010125	0.5646767769616	0.732167091151825	nan
sp|Q96AT9|RPE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.296308254033347	0.121271909479635	22.0000040101771	0.0230378289404972	0.712051972579798	nan
sp|Q96AT9|RPE_HUMAN	Normal-Triple-negative breast cancer	0.367219895726689	0.144947655718671	22.0000040159559	0.0189283124998705	0.0894988773109097	nan
sp|Q96AX1|VP33A_HUMAN	metaplastic breast carcinomas-Normal	0.0100914173127702	0.207152823137916	14.0000000175832	0.961834701354243	0.981620677710011	nan
sp|Q96AX1|VP33A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0790039257504844	0.207152823137916	14.0000000178362	0.708646882760484	0.94948208919602	nan
sp|Q96AX1|VP33A_HUMAN	Normal-Triple-negative breast cancer	-0.0890953430632546	0.247594980718825	14.000000017757	0.724334792685771	0.841063687268924	nan
sp|Q96AY3|FKB10_HUMAN	metaplastic breast carcinomas-Normal	0.428647050940607	0.265230704330792	14.0000000812425	0.128369763856087	0.299374855792279	nan
sp|Q96AY3|FKB10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.203881972819251	0.265230704330792	14.0000000813473	0.45484612176293	0.908567154037048	nan
sp|Q96AY3|FKB10_HUMAN	Normal-Triple-negative breast cancer	-0.224765078121356	0.317011325890074	14.0000000812715	0.489955992555626	0.666372225554378	nan
sp|Q96B49|TOM6_HUMAN	metaplastic breast carcinomas-Normal	0.984655427503809	0.310542076990154	22.0000000124405	0.0044263918103482	0.0441841632960889	nan
sp|Q96B49|TOM6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.230499032158049	0.310542076990154	22.0000000119109	0.465789025329818	0.909423669537079	nan
sp|Q96B49|TOM6_HUMAN	Normal-Triple-negative breast cancer	-1.21515445966186	0.371168774820755	22.000000012069	0.0034705700495105	0.0393726103910342	nan
sp|Q96B97|SH3K1_HUMAN	metaplastic breast carcinomas-Normal	0.134028844919564	0.232074245366182	22.0000000034355	0.569448454223894	0.734528007858528	nan
sp|Q96B97|SH3K1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.456457692134276	0.232074245366182	22.0000000037826	0.0619381191773092	0.773787875546141	nan
sp|Q96B97|SH3K1_HUMAN	Normal-Triple-negative breast cancer	0.322428847214712	0.27738177755135	22.0000000036241	0.257527647163249	0.448179004801382	nan
sp|Q96BM9|ARL8A_HUMAN	metaplastic breast carcinomas-Normal	-0.922232492926038	0.221085217811708	14.0000000663354	0.0009415158330153	0.0232146572522289	nan
sp|Q96BM9|ARL8A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.609140473118209	0.221085217811708	14.000000066336	0.0154851447196096	0.656412655960811	nan
sp|Q96BM9|ARL8A_HUMAN	Normal-Triple-negative breast cancer	0.313092019807829	0.264247377429479	14.0000000663293	0.255803182888938	0.446580766766192	nan
sp|Q96BN8|OTUL_HUMAN	metaplastic breast carcinomas-Normal	-0.189062846977929	0.434645356678794	8.00782615737674	0.675060496770718	0.80948812816229	nan
sp|Q96BN8|OTUL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0972586627402297	0.363230374469158	8.04455884261777	0.795621225988095	0.964785038807592	nan
sp|Q96BN8|OTUL_HUMAN	Normal-Triple-negative breast cancer	0.286321509718158	0.494852688004757	8.05393296448427	0.578676305666085	0.737546027620424	nan
sp|Q96BY6|DOC10_HUMAN	metaplastic breast carcinomas-Normal	0.735845688499504	0.378010718492792	6.0	0.099523346428147	0.254814544560358	nan
sp|Q96BY6|DOC10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.10492452417233	0.378010718492792	6.0	0.790658306883016	0.962981271203673	nan
sp|Q96BY6|DOC10_HUMAN	Normal-Triple-negative breast cancer	-0.630921164327175	0.451809225377635	6.0	0.212058957549005	0.394844732599108	nan
sp|Q96C19|EFHD2_HUMAN	metaplastic breast carcinomas-Normal	0.307906774552409	0.320043925369593	23.9999999993246	0.345604926500902	0.556045874002419	nan
sp|Q96C19|EFHD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.174973904164339	0.320043925369593	23.9999999993246	0.58961971996556	0.940559810632461	nan
sp|Q96C19|EFHD2_HUMAN	Normal-Triple-negative breast cancer	-0.13293287038807	0.382525655845419	23.999999999342	0.731234703959062	0.844553227042731	nan
sp|Q96C23|GALM_HUMAN	metaplastic breast carcinomas-Normal	-0.331326170042678	0.334355991856194	21.9999963118801	0.332490205871171	0.540733675944729	nan
sp|Q96C23|GALM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.184136984074723	0.334355991856194	21.9999963141762	0.587374149991106	0.940307678729141	nan
sp|Q96C23|GALM_HUMAN	Normal-Triple-negative breast cancer	0.147189185967955	0.399631847168901	21.9999963117778	0.716160920925115	0.834976815557728	nan
sp|Q96C36|P5CR2_HUMAN	metaplastic breast carcinomas-Normal	0.427386442540034	0.320662717263201	22.999999999973	0.195643781802493	0.38825070490238	nan
sp|Q96C36|P5CR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.149611660384868	0.299952506177715	23.0000000000415	0.622668165637354	0.941374262616245	nan
sp|Q96C36|P5CR2_HUMAN	Normal-Triple-negative breast cancer	-0.576998102924901	0.376010365659781	23.0000000000162	0.13854241817559	0.300205344208385	nan
sp|Q96C86|DCPS_HUMAN	metaplastic breast carcinomas-Normal	-0.134372509427591	0.265524999674851	22.0000000384618	0.617845712219227	0.771225334653059	nan
sp|Q96C86|DCPS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.149528179413172	0.265524999674851	22.000000038464	0.579033249329095	0.936538590276875	nan
sp|Q96C86|DCPS_HUMAN	Normal-Triple-negative breast cancer	-0.0151556699855817	0.317363076104888	22.0000000381989	0.962342386492815	0.981837351965046	nan
sp|Q96C90|PP14B_HUMAN	metaplastic breast carcinomas-Normal	0.885870940594028	0.424344082248528	22.000000000042	0.04862557903947	0.166458727834396	nan
sp|Q96C90|PP14B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.478371312385053	0.397434646662627	21.9999999998386	0.241517817465645	0.84964799869723	nan
sp|Q96C90|PP14B_HUMAN	Normal-Triple-negative breast cancer	-1.36424225297908	0.493203426069289	21.9999999999406	0.0112693267948154	0.0674941302089485	nan
sp|Q96CG8|CTHR1_HUMAN	metaplastic breast carcinomas-Normal	1.43832617855413	0.445861933472829	23.9999999998688	0.0036066233570413	0.0407324763980233	nan
sp|Q96CG8|CTHR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.04127820693366	0.445861933472829	24.0000000000307	0.028209096611946	0.721684569712558	nan
sp|Q96CG8|CTHR1_HUMAN	Normal-Triple-negative breast cancer	-0.397047971620474	0.532906938699873	23.9999999999499	0.463469466883029	0.643513996624556	nan
sp|Q96CM8|ACSF2_HUMAN	metaplastic breast carcinomas-Normal	-0.407250076689138	0.551803167596733	15.0000000000283	0.471882676343171	0.662749867695253	nan
sp|Q96CM8|ACSF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.492796796695952	0.551803167596733	14.9999999998702	0.385925721749696	0.885234295852111	nan
sp|Q96CM8|ACSF2_HUMAN	Normal-Triple-negative breast cancer	-0.085546720006814	0.659530932632956	14.999999999995	0.898520488387537	0.941085638149985	nan
sp|Q96CN7|ISOC1_HUMAN	metaplastic breast carcinomas-Normal	-0.337999214972556	0.216459093572681	23.9999999996708	0.131498526901401	0.303121430943313	nan
sp|Q96CN7|ISOC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.409363928026241	0.216459093572681	23.9999999994655	0.0707301424399604	0.7829758433102	nan
sp|Q96CN7|ISOC1_HUMAN	Normal-Triple-negative breast cancer	-0.0713647130536851	0.258718101388659	23.9999999995578	0.785032450989776	0.877631088368709	nan
sp|Q96CS3|FAF2_HUMAN	metaplastic breast carcinomas-Normal	0.217907829753128	0.337414151328273	22.0000000019861	0.525077435724157	0.703647458668982	nan
sp|Q96CS3|FAF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.315265066867499	0.337414151328273	22.0000000021369	0.36026304606997	0.883542279876718	nan
sp|Q96CS3|FAF2_HUMAN	Normal-Triple-negative breast cancer	-0.533172896620627	0.403287046861836	22.0000000023403	0.199727636717252	0.380455395099225	nan
sp|Q96CT7|CC124_HUMAN	metaplastic breast carcinomas-Normal	0.7090873548065	0.293503424252588	23.9999999998305	0.0236680519987042	0.107110232987193	nan
sp|Q96CT7|CC124_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.190678681583623	0.293503424252588	23.9999999995704	0.522079110383562	0.917607105199968	nan
sp|Q96CT7|CC124_HUMAN	Normal-Triple-negative breast cancer	-0.518408673222877	0.350803689604303	23.9999999996983	0.152472413261348	0.319961049040858	nan
sp|Q96CV9|OPTN_HUMAN	metaplastic breast carcinomas-Normal	-0.546263523080374	0.319648899887062	23.9999999999492	0.100362829917295	0.255832857856663	nan
sp|Q96CV9|OPTN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.338148856712008	0.319648899887062	23.9999999997608	0.300644109382288	0.867696529950794	nan
sp|Q96CV9|OPTN_HUMAN	Normal-Triple-negative breast cancer	0.884412379792382	0.382053510087282	23.9999999998442	0.0294887261588583	0.115047565436672	nan
sp|Q96CW1|AP2M1_HUMAN	metaplastic breast carcinomas-Normal	0.102387527767477	0.152434849303597	23.9999999991804	0.508201541552444	0.692604314932482	nan
sp|Q96CW1|AP2M1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0290250176388336	0.152434849303597	23.9999999991804	0.850589824439504	0.975918276832764	nan
sp|Q96CW1|AP2M1_HUMAN	Normal-Triple-negative breast cancer	-0.131412545406311	0.182194492947236	23.9999999992009	0.477707826987967	0.656971790197767	nan
sp|Q96CW5|GCP3_HUMAN	metaplastic breast carcinomas-Normal	0.291467541851229	0.16385865641961	23.9999999996254	0.0879479122494453	0.238449315103716	nan
sp|Q96CW5|GCP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0465509703254758	0.16385865641961	23.9999999996254	0.778776335027056	0.961541520224642	nan
sp|Q96CW5|GCP3_HUMAN	Normal-Triple-negative breast cancer	-0.338018512176705	0.195848554039813	23.9999999996662	0.0972163014600923	0.23871253280979	nan
sp|Q96CX2|KCD12_HUMAN	metaplastic breast carcinomas-Normal	-0.114385084363916	0.280893594216482	24.0000000002348	0.687456745560768	0.817457923034453	nan
sp|Q96CX2|KCD12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.454953426727204	0.280893594216482	24.0000000000309	0.118371634950296	0.823891816737944	nan
sp|Q96CX2|KCD12_HUMAN	Normal-Triple-negative breast cancer	0.56933851109112	0.335732059986306	24.0000000001492	0.102857536798044	0.246858088315305	nan
sp|Q96D15|RCN3_HUMAN	metaplastic breast carcinomas-Normal	0.917720971330298	0.464273081936669	22.0000000279148	0.0607454959798938	0.189061824566636	nan
sp|Q96D15|RCN3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.403367327638055	0.464273081936669	22.0000000279417	0.394328136731949	0.885234295852111	nan
sp|Q96D15|RCN3_HUMAN	Normal-Triple-negative breast cancer	-0.514353643692244	0.554912470074558	22.0000000278695	0.364031276215926	0.5541195703899	nan
sp|Q96D71|REPS1_HUMAN	metaplastic breast carcinomas-Normal	0.131515265359023	0.202534882153338	22.0000000036651	0.522836810928503	0.70246950668001	nan
sp|Q96D71|REPS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.623559704765806	0.202534882153338	22.0000000040712	0.0054906523684537	0.519941801393686	nan
sp|Q96D71|REPS1_HUMAN	Normal-Triple-negative breast cancer	-0.755074970124828	0.24207548553784	22.0000000037774	0.0049959353251745	0.0452771179429151	nan
sp|Q96DB5|RMD1_HUMAN	metaplastic breast carcinomas-Normal	-0.757200215720638	0.535982759702844	23.9999999997223	0.170572008752739	0.359531615151621	nan
sp|Q96DB5|RMD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.360084669193326	0.535982759702844	23.9999999997649	0.508113465980461	0.913992324008525	nan
sp|Q96DB5|RMD1_HUMAN	Normal-Triple-negative breast cancer	1.11728488491396	0.640621928506841	23.9999999997704	0.093944930133296	0.23391232042178	nan
sp|Q96DG6|CMBL_HUMAN	metaplastic breast carcinomas-Normal	-0.813262473002451	0.333854390180129	21.9999999816514	0.0234075859362945	0.106584678975675	nan
sp|Q96DG6|CMBL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.632554905513459	0.333854390180129	21.9999999818986	0.0713508813602979	0.7829758433102	nan
sp|Q96DG6|CMBL_HUMAN	Normal-Triple-negative breast cancer	0.180707567488992	0.399032318495177	21.9999999829682	0.655080895790124	0.797031075258555	nan
sp|Q96DI7|SNR40_HUMAN	metaplastic breast carcinomas-Normal	0.145241640738326	0.235556466775166	22.0000000379919	0.543833971838383	0.718197903214456	nan
sp|Q96DI7|SNR40_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.202983062745916	0.235556466775166	22.0000000375441	0.398138625600035	0.885297496092956	nan
sp|Q96DI7|SNR40_HUMAN	Normal-Triple-negative breast cancer	-0.348224703484242	0.281543828203405	22.0000000380134	0.229187442360631	0.411600306564177	nan
sp|Q96DZ1|ERLEC_HUMAN	metaplastic breast carcinomas-Normal	-0.0489273507368938	0.237301278806726	22.0000004088449	0.838544571768847	0.914228696159918	nan
sp|Q96DZ1|ERLEC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0367813995317261	0.237301278806726	22.0000004090921	0.878235582626456	0.98320986943871	nan
sp|Q96DZ1|ERLEC_HUMAN	Normal-Triple-negative breast cancer	0.0121459512051677	0.283629277461436	22.0000004091643	0.966228658242931	0.982929910189078	nan
sp|Q96E11|RRFM_HUMAN	metaplastic breast carcinomas-Normal	-0.549137432990338	0.26733744053731	22.0000000290821	0.0520374979409546	0.173361579027869	nan
sp|Q96E11|RRFM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0517100785014665	0.26733744053731	22.0000000294818	0.84839985408673	0.974751041754795	nan
sp|Q96E11|RRFM_HUMAN	Normal-Triple-negative breast cancer	0.600847511491805	0.319529357276425	22.0000000292734	0.0733570222788265	0.198081837574995	nan
sp|Q96EE3|SEH1_HUMAN	metaplastic breast carcinomas-Normal	-0.538134489176831	0.275082660309511	6.0	0.0982023597277687	0.252650653045745	nan
sp|Q96EE3|SEH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.419785420811073	0.275082660309511	6.0	0.177850763516816	0.843662073010871	nan
sp|Q96EE3|SEH1_HUMAN	Normal-Triple-negative breast cancer	0.118349068365758	0.328786665533742	6.0	0.731210315846542	0.844553227042731	nan
sp|Q96EK6|GNA1_HUMAN	metaplastic breast carcinomas-Normal	0.0643724067369913	0.529805238325066	14.9999999998412	0.904906160390052	0.949235187913294	nan
sp|Q96EK6|GNA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.789775114505725	0.529805238325066	14.9999999998693	0.156770515278606	0.843465960034572	nan
sp|Q96EK6|GNA1_HUMAN	Normal-Triple-negative breast cancer	-0.854147521242716	0.633238378221346	14.999999999851	0.19739544467658	0.3786926489393	nan
sp|Q96EM0|T3HPD_HUMAN	metaplastic breast carcinomas-Normal	-0.0486862528269379	0.223360517475226	23.9999999996359	0.829293908719061	0.909492232445857	nan
sp|Q96EM0|T3HPD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.476901016579702	0.223360517475226	23.9999999996369	0.0431621888271571	0.75533830447525	nan
sp|Q96EM0|T3HPD_HUMAN	Normal-Triple-negative breast cancer	0.52558726940664	0.266966880682125	23.9999999996429	0.0606361118886551	0.177268633173166	nan
sp|Q96EP5|DAZP1_HUMAN	metaplastic breast carcinomas-Normal	0.7554356452883	0.328014236781284	21.9999999778182	0.0311068923977258	0.126870319423363	nan
sp|Q96EP5|DAZP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.285912358293849	0.328014236781284	21.9999999782545	0.392814656408572	0.885234295852111	nan
sp|Q96EP5|DAZP1_HUMAN	Normal-Triple-negative breast cancer	-1.04134800358215	0.392052000069976	21.9999999764315	0.0144271811018525	0.0775931085810159	nan
sp|Q96EV2|RBM33_HUMAN	metaplastic breast carcinomas-Normal	0.806129577188819	0.225172406234484	22.000000196948	0.0016698094911131	0.0293674431135457	nan
sp|Q96EV2|RBM33_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0212519345566249	0.225172406234484	22.0000001969471	0.925661066940015	0.994822473738689	nan
sp|Q96EV2|RBM33_HUMAN	Normal-Triple-negative breast cancer	-0.827381511745443	0.269132501964122	22.0000001967503	0.0055489064950619	0.0471728009963832	nan
sp|Q96EY1|DNJA3_HUMAN	metaplastic breast carcinomas-Normal	0.155681665480124	0.345430832307361	21.2593387913003	0.656777092925507	0.798197290010784	nan
sp|Q96EY1|DNJA3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0237518477350167	0.322673480747858	20.8705718638202	0.942022012068882	0.996541950781621	nan
sp|Q96EY1|DNJA3_HUMAN	Normal-Triple-negative breast cancer	-0.131929817745107	0.404900648288954	21.156366351279	0.747751884929889	0.855308763078786	nan
sp|Q96EY7|PTCD3_HUMAN	metaplastic breast carcinomas-Normal	0.434432117605756	0.169521784823506	14.9999999997167	0.0216461047211057	0.100491134208038	nan
sp|Q96EY7|PTCD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0136310156970887	0.169521784823506	14.9999999997166	0.936975275247748	0.995571782532303	nan
sp|Q96EY7|PTCD3_HUMAN	Normal-Triple-negative breast cancer	-0.420801101908667	0.202617287126483	14.9999999997376	0.0554153679232739	0.167455166342693	nan
sp|Q96F85|CNRP1_HUMAN	metaplastic breast carcinomas-Normal	-0.464351248888911	0.432924598942315	14.9999999999332	0.300408148470647	0.506624396507576	nan
sp|Q96F85|CNRP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.985026377259509	0.432924598942315	14.9999999998048	0.0379940561577026	0.73123935744099	nan
sp|Q96F85|CNRP1_HUMAN	Normal-Triple-negative breast cancer	1.44937762614842	0.517443866340474	14.9999999998624	0.0134316877927827	0.0752899329227817	nan
sp|Q96F86|EDC3_HUMAN	metaplastic breast carcinomas-Normal	0.677152029969021	0.329678418645641	21.9999999962813	0.0520501973134215	0.173361579027869	nan
sp|Q96F86|EDC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.248839821388344	0.329678418645641	21.9999999979201	0.458376140293015	0.908567154037048	nan
sp|Q96F86|EDC3_HUMAN	Normal-Triple-negative breast cancer	-0.925991851357364	0.394041077845391	21.9999999971307	0.0281556286708681	0.112421067564965	nan
sp|Q96FJ2|DYL2_HUMAN	metaplastic breast carcinomas-Normal	0.188166629913499	0.294003106026676	22.0000002071436	0.528772035832177	0.707014580493224	nan
sp|Q96FJ2|DYL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.347980548846843	0.294003106026676	22.0000002071436	0.249205417620356	0.852477380234241	nan
sp|Q96FJ2|DYL2_HUMAN	Normal-Triple-negative breast cancer	-0.536147178760343	0.351400923556256	22.0000002071074	0.141322921003629	0.304050090236933	nan
sp|Q96FQ6|S10AG_HUMAN	metaplastic breast carcinomas-Normal	0.086508705449113	0.483259360272516	22.0000000567188	0.859567485023356	0.926760402276236	nan
sp|Q96FQ6|S10AG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0532076890339891	0.483259360272516	22.0000000574164	0.913326904339025	0.99408739879047	nan
sp|Q96FQ6|S10AG_HUMAN	Normal-Triple-negative breast cancer	-0.139716394483102	0.577605413126348	22.0000000572947	0.81110668251076	0.890984339942421	nan
sp|Q96FV9|THOC1_HUMAN	metaplastic breast carcinomas-Normal	-0.457689670708115	0.303345947375977	13.9999999987062	0.153582478688645	0.333747236325783	nan
sp|Q96FV9|THOC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.382829008654555	0.303345947375977	13.9999999975766	0.227561364268483	0.843662073010871	nan
sp|Q96FV9|THOC1_HUMAN	Normal-Triple-negative breast cancer	0.0748606620535597	0.362567754829413	13.9999999982226	0.83939364852763	0.908491071144951	nan
sp|Q96FW1|OTUB1_HUMAN	metaplastic breast carcinomas-Normal	0.206699478197141	0.153312146786123	22.0000000204342	0.191303944514546	0.384853332717282	nan
sp|Q96FW1|OTUB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.363227006914157	0.153312146786123	22.0000000203059	0.0270236516248794	0.721684569712558	nan
sp|Q96FW1|OTUB1_HUMAN	Normal-Triple-negative breast cancer	-0.569926485111298	0.183243063997249	22.0000000203213	0.0051016943094815	0.0453423312425578	nan
sp|Q96FX7|TRM61_HUMAN	metaplastic breast carcinomas-Normal	0.199539350851338	0.32126901232969	14.0000000119186	0.544516000278019	0.718813020224041	nan
sp|Q96FX7|TRM61_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.143049966769034	0.32126901232969	14.0000000117828	0.662935374410728	0.944724271291086	nan
sp|Q96FX7|TRM61_HUMAN	Normal-Triple-negative breast cancer	-0.342589317620373	0.383989914829049	14.0000000118196	0.387372781301864	0.574833537967588	nan
sp|Q96G03|PGM2_HUMAN	metaplastic breast carcinomas-Normal	0.365783903657436	0.262230759832505	23.9999999997983	0.175824867656643	0.363443275978086	nan
sp|Q96G03|PGM2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0420997316329647	0.262230759832505	23.9999999997524	0.873795773552289	0.98181923303563	nan
sp|Q96G03|PGM2_HUMAN	Normal-Triple-negative breast cancer	-0.323684172024471	0.313425706399306	23.9999999998688	0.312025382213877	0.50512608733217	nan
sp|Q96GA7|SDSL_HUMAN	metaplastic breast carcinomas-Normal	-0.658677955876956	0.690072931803247	14.0000000000725	0.356019814745935	0.565143201631083	nan
sp|Q96GA7|SDSL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.21514794616616	0.620180298702231	14.0000000001188	0.733816827579161	0.954643368861838	nan
sp|Q96GA7|SDSL_HUMAN	Normal-Triple-negative breast cancer	0.443530009710795	0.800649322839894	14.0000000000996	0.588343779488635	0.743312323458845	nan
sp|Q96GC9|VMP1_HUMAN	metaplastic breast carcinomas-Normal	0.938761928592031	0.423760189067566	13.1478036779625	0.0449885830957061	0.158581177317208	nan
sp|Q96GC9|VMP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.221456037093552	0.379050344171763	13.0000000006739	0.569059672399486	0.935631258424823	nan
sp|Q96GC9|VMP1_HUMAN	Normal-Triple-negative breast cancer	-1.16021796568558	0.491069732482095	13.1109530356445	0.0342569940348298	0.124196152475544	nan
sp|Q96GD0|PLPP_HUMAN	metaplastic breast carcinomas-Normal	0.419738861610291	0.472789998991228	17.2830073603838	0.38684159736491	0.59092898421	nan
sp|Q96GD0|PLPP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.07295688553199	0.4277378211686	16.7583800015623	0.0227200468668406	0.712051972579798	nan
sp|Q96GD0|PLPP_HUMAN	Normal-Triple-negative breast cancer	0.653218023921704	0.550335379859729	17.0496893503325	0.251524629651821	0.440317118741841	nan
sp|Q96GM5|SMRD1_HUMAN	metaplastic breast carcinomas-Normal	-0.636178524772489	0.357527204050566	14.9999999999828	0.0954415979499543	0.249801473689487	nan
sp|Q96GM5|SMRD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.14685248506754	0.357527204050566	14.9999999997955	0.68706717263266	0.946568877415162	nan
sp|Q96GM5|SMRD1_HUMAN	Normal-Triple-negative breast cancer	0.783031009840029	0.427326742896572	14.9999999998546	0.0868188569687205	0.222160031227118	nan
sp|Q96GQ7|DDX27_HUMAN	metaplastic breast carcinomas-Normal	-0.819603924514344	0.491889955599548	13.999999999812	0.117874221233476	0.283305052934023	nan
sp|Q96GQ7|DDX27_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0239409806281301	0.442069882085063	13.9999999998112	0.95757567211215	0.99709406933403	nan
sp|Q96GQ7|DDX27_HUMAN	Normal-Triple-negative breast cancer	0.795662943886214	0.570709763725108	13.9999999998266	0.185001262783428	0.3625850221062	nan
sp|Q96GY0|ZC21A_HUMAN	metaplastic breast carcinomas-Normal	-0.260434094689881	0.547095226126393	17.9999999999966	0.639779192060776	0.785892843462682	nan
sp|Q96GY0|ZC21A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.216670698187107	0.547095226126394	17.9999999999966	0.696731922295161	0.947043345959522	nan
sp|Q96GY0|ZC21A_HUMAN	Normal-Triple-negative breast cancer	0.477104792876988	0.676589320554706	18.0000000000225	0.489735026476153	0.666344342204966	nan
sp|Q96GZ6|S41A3_HUMAN	metaplastic breast carcinomas-Normal	-0.561811257357543	0.304300963450124	15.0000000000235	0.0846844398965998	0.232318533504644	nan
sp|Q96GZ6|S41A3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.177813640040829	0.304300963450123	14.9999999998935	0.56768014940798	0.935631258424823	nan
sp|Q96GZ6|S41A3_HUMAN	Normal-Triple-negative breast cancer	0.383997617316714	0.363709217363607	14.999999999965	0.307776724884773	0.500024356557666	nan
sp|Q96H79|ZCCHL_HUMAN	metaplastic breast carcinomas-Normal	0.306637287861745	0.314721069945043	6.0	0.36752830886521	0.577073263423692	nan
sp|Q96H79|ZCCHL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.10752887650683	0.314721069945043	6.0	0.744252240732944	0.954643368861838	nan
sp|Q96H79|ZCCHL_HUMAN	Normal-Triple-negative breast cancer	-0.199108411354915	0.376163626758646	6.0	0.615590701959049	0.764980808694993	nan
sp|Q96HC4|PDLI5_HUMAN	metaplastic breast carcinomas-Normal	0.696636943380629	0.218440760227683	22.0000003501522	0.0042391744513804	0.042883667309653	nan
sp|Q96HC4|PDLI5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0092900924701295	0.218440760227683	22.0000003502054	0.966460537409611	0.99709406933403	nan
sp|Q96HC4|PDLI5_HUMAN	Normal-Triple-negative breast cancer	-0.705927035850758	0.261086646068882	22.0000003502397	0.0129674163240036	0.0738623053811371	nan
sp|Q96HE7|ERO1A_HUMAN	metaplastic breast carcinomas-Normal	0.275049856148352	0.394215939698384	23.9999999996495	0.492061029899319	0.680970532116522	nan
sp|Q96HE7|ERO1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.426939557287711	0.394215939698384	23.9999999994031	0.289565500291754	0.867696529950794	nan
sp|Q96HE7|ERO1A_HUMAN	Normal-Triple-negative breast cancer	-0.701989413436062	0.471178169383151	23.9999999996227	0.149286711407216	0.316472594845399	nan
sp|Q96HF1|SFRP2_HUMAN	metaplastic breast carcinomas-Normal	-0.654154541936887	0.634920435538852	23.9999999991879	0.313143981521261	0.520705650113393	nan
sp|Q96HF1|SFRP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.652192659266224	0.634920435538852	23.9999999991889	0.314566675485787	0.867696529950794	nan
sp|Q96HF1|SFRP2_HUMAN	Normal-Triple-negative breast cancer	0.0019618826706633	0.758875069207089	23.9999999991421	0.997958639492527	0.999945312570918	nan
sp|Q96HS1|PGAM5_HUMAN	metaplastic breast carcinomas-Normal	0.179283307234234	0.220257146100735	23.9999999994443	0.423663476113998	0.621951157325291	nan
sp|Q96HS1|PGAM5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.279673575568281	0.220257146100735	23.9999999996427	0.216344501021295	0.843662073010871	nan
sp|Q96HS1|PGAM5_HUMAN	Normal-Triple-negative breast cancer	-0.458956882802516	0.263257642429944	23.999999999555	0.0940671434008317	0.2340413058865	nan
sp|Q96HY6|DDRGK_HUMAN	metaplastic breast carcinomas-Normal	0.0797302904720068	0.196670858557818	22.0000000734486	0.689099240003871	0.818059240633166	nan
sp|Q96HY6|DDRGK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0260653427589	0.196670858557818	22.0000000742745	0.895767590263457	0.989182078255063	nan
sp|Q96HY6|DDRGK_HUMAN	Normal-Triple-negative breast cancer	-0.0536649477131069	0.235066636770663	22.0000000740474	0.821524184385643	0.898940081069813	nan
sp|Q96HY7|DHTK1_HUMAN	metaplastic breast carcinomas-Normal	-0.459758425963443	0.39197834065686	14.0000000045175	0.260399658099908	0.462623443893155	nan
sp|Q96HY7|DHTK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.31570870592111	0.39197834065686	14.0000000045037	0.434042172176419	0.896102083258464	nan
sp|Q96HY7|DHTK1_HUMAN	Normal-Triple-negative breast cancer	0.775467131884552	0.468503726992502	14.0000000045196	0.120119436208607	0.272358121389775	nan
sp|Q96I24|FUBP3_HUMAN	metaplastic breast carcinomas-Normal	0.130432777141914	0.240717905082515	22.0000000288691	0.593368569877579	0.751736963571298	nan
sp|Q96I24|FUBP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.214429103743018	0.240717905082515	22.0000000283401	0.38268056753754	0.885234295852111	nan
sp|Q96I24|FUBP3_HUMAN	Normal-Triple-negative breast cancer	-0.344861880884932	0.287712926933663	22.0000000284182	0.243423799331526	0.431311678559698	nan
sp|Q96I25|SPF45_HUMAN	metaplastic breast carcinomas-Normal	0.365392197235397	0.246745873560495	22.0000000102524	0.152828743046525	0.33289825811707	nan
sp|Q96I25|SPF45_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.525742635235436	0.246745873560495	22.0000000108325	0.0445365693129252	0.759166737802103	nan
sp|Q96I25|SPF45_HUMAN	Normal-Triple-negative breast cancer	-0.891134832470833	0.29491772731471	22.0000000104913	0.0062717605726037	0.05060032073625	nan
sp|Q96I59|SYNM_HUMAN	metaplastic breast carcinomas-Normal	-0.197918827246649	0.302510784018598	6.0	0.53720378595618	0.713410061733257	nan
sp|Q96I59|SYNM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.55605880612531	0.302510784018598	6.0	0.0021280744112278	0.448717474870704	nan
sp|Q96I59|SYNM_HUMAN	Normal-Triple-negative breast cancer	-1.35813997887866	0.361569543691206	6.0	0.0094402440367753	0.0616490592892753	nan
sp|Q96I99|SUCB2_HUMAN	metaplastic breast carcinomas-Normal	-0.359683814738917	0.279422935023106	23.9999999997353	0.210287667487931	0.405450235922205	nan
sp|Q96I99|SUCB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.348644929356133	0.279422935023106	23.9999999997353	0.224166683453825	0.843662073010871	nan
sp|Q96I99|SUCB2_HUMAN	Normal-Triple-negative breast cancer	0.0110388853827837	0.333974286043801	23.999999999735	0.973905601224661	0.987873731605362	nan
sp|Q96IJ6|GMPPA_HUMAN	metaplastic breast carcinomas-Normal	0.0621487244553378	0.237642350194407	23.9999999997113	0.79592122059642	0.88959049672579	nan
sp|Q96IJ6|GMPPA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.103049076410481	0.237642350194407	23.9999999997113	0.668429340190214	0.946277260710207	nan
sp|Q96IJ6|GMPPA_HUMAN	Normal-Triple-negative breast cancer	-0.165197800865819	0.284036935741819	23.9999999996457	0.566254856345003	0.727697294239603	nan
sp|Q96IU4|ABHEB_HUMAN	metaplastic breast carcinomas-Normal	-1.01055566071624	0.306179318805447	22.0000004572781	0.0032579339163274	0.0401633283746249	nan
sp|Q96IU4|ABHEB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.023809854957456	0.306179318805447	22.0000004572791	0.938718398642625	0.995571782532303	nan
sp|Q96IU4|ABHEB_HUMAN	Normal-Triple-negative breast cancer	0.986745805758787	0.365954281422786	22.0000004573195	0.0131857392068039	0.0746230686012789	nan
sp|Q96JJ3|ELMO2_HUMAN	metaplastic breast carcinomas-Normal	0.558429062100589	0.27583424645015	22.0000000036512	0.055224930871124	0.179470650068388	nan
sp|Q96JJ3|ELMO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.321995836383813	0.27583424645015	22.0000000037846	0.255565025504821	0.860074605064301	nan
sp|Q96JJ3|ELMO2_HUMAN	Normal-Triple-negative breast cancer	-0.236433225716776	0.329684982791414	22.0000000037086	0.480827731067293	0.659445519167003	nan
sp|Q96JJ7|TMX3_HUMAN	metaplastic breast carcinomas-Normal	-0.0360320810961114	0.17835994205569	22.0000000776077	0.841758361174447	0.915277982513531	nan
sp|Q96JJ7|TMX3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.255904839407754	0.17835994205569	22.0000000776546	0.165417680771308	0.843662073010871	nan
sp|Q96JJ7|TMX3_HUMAN	Normal-Triple-negative breast cancer	-0.219872758311643	0.213180905504185	22.0000000773746	0.313563766290864	0.506209790748339	nan
sp|Q96JM3|CHAP1_HUMAN	metaplastic breast carcinomas-Normal	0.516089951188263	0.219181341423371	23.9999999996737	0.0270590475763449	0.11681074564126	nan
sp|Q96JM3|CHAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.182788841928954	0.219181341423371	23.9999999996726	0.412526447836067	0.885784822958391	nan
sp|Q96JM3|CHAP1_HUMAN	Normal-Triple-negative breast cancer	-0.698878793117217	0.261971809901502	23.9999999996682	0.0134638636519013	0.0753432370015487	nan
sp|Q96JQ0|PCD16_HUMAN	metaplastic breast carcinomas-Normal	-1.10681593583489	0.705246484465877	14.9999999995506	0.137404837774721	0.311126485533497	nan
sp|Q96JQ0|PCD16_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.299799560448745	0.705246484465877	14.9999999995506	0.676799850788443	0.946446689298437	nan
sp|Q96JQ0|PCD16_HUMAN	Normal-Triple-negative breast cancer	1.40661549628364	0.84293077486612	14.9999999995649	0.11590587760943	0.26588760329451	nan
sp|Q96JY6|PDLI2_HUMAN	metaplastic breast carcinomas-Normal	-0.501460529407613	0.198575117506808	22.0000000012643	0.0192706216763278	0.0944102847484224	nan
sp|Q96JY6|PDLI2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.123495139704297	0.198575117506808	22.0000000016518	0.540395517330188	0.92333766450302	nan
sp|Q96JY6|PDLI2_HUMAN	Normal-Triple-negative breast cancer	0.377965389703315	0.237342661546076	22.0000000014341	0.125542641416102	0.280823512831173	nan
sp|Q96K21|ANCHR_HUMAN	metaplastic breast carcinomas-Normal	-1.76690118247524	0.873745586710978	13.9999999998756	0.0626924751734782	0.191918875745801	nan
sp|Q96K21|ANCHR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0360156549829609	0.78525004239794	13.9999999997879	0.964065500741933	0.99709406933403	nan
sp|Q96K21|ANCHR_HUMAN	Normal-Triple-negative breast cancer	1.8029168374582	1.0137534456053	13.9999999997998	0.0970440908357671	0.23871253280979	nan
sp|Q96K76|UBP47_HUMAN	metaplastic breast carcinomas-Normal	-0.0865374679500284	0.275176738903979	14.0000000137274	0.757794531650041	0.867990704067793	nan
sp|Q96K76|UBP47_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.190111062417964	0.275176738903979	14.0000000141688	0.500943106753719	0.913320451076758	nan
sp|Q96K76|UBP47_HUMAN	Normal-Triple-negative breast cancer	-0.103573594467935	0.328899110961376	14.0000000139921	0.75747461342012	0.860213739326437	nan
sp|Q96KA5|CLP1L_HUMAN	metaplastic breast carcinomas-Normal	0.93457671640505	0.342532544355434	22.0000018897188	0.0122688464124983	0.0726945552141608	nan
sp|Q96KA5|CLP1L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.134211189986704	0.342532544355434	22.0000018896277	0.698960713078095	0.947043345959522	nan
sp|Q96KA5|CLP1L_HUMAN	Normal-Triple-negative breast cancer	-1.06878790639175	0.409404696641717	22.0000018898467	0.0159662879448871	0.0806335913116407	nan
sp|Q96KB5|TOPK_HUMAN	metaplastic breast carcinomas-Normal	0.718925456609373	0.358366636654573	14.9999999997898	0.0632243626750145	0.1924397925883	nan
sp|Q96KB5|TOPK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.251602589501127	0.358366636654573	14.9999999999771	0.493379530195727	0.913320451076758	nan
sp|Q96KB5|TOPK_HUMAN	Normal-Triple-negative breast cancer	-0.467322867108246	0.428330056760489	14.999999999873	0.29247361271882	0.485363099689145	nan
sp|Q96KC8|DNJC1_HUMAN	metaplastic breast carcinomas-Normal	0.175554111155829	0.313031968925152	23.9999999994002	0.580119998951702	0.740806329817694	nan
sp|Q96KC8|DNJC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.023808907478462	0.313031968925152	23.999999999236	0.940002622114999	0.995571782532303	nan
sp|Q96KC8|DNJC1_HUMAN	Normal-Triple-negative breast cancer	-0.151745203677367	0.374144764895617	23.9999999993099	0.688645120223445	0.816936609429954	nan
sp|Q96KG9|SCYL1_HUMAN	metaplastic breast carcinomas-Normal	0.246901533755057	0.169810603951307	22.0000001738134	0.160069723003832	0.344383015705332	nan
sp|Q96KG9|SCYL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0359751538369295	0.169810603951307	22.0000001736882	0.834170897431157	0.9684421207956	nan
sp|Q96KG9|SCYL1_HUMAN	Normal-Triple-negative breast cancer	-0.210926379918128	0.202962492010955	22.000000173748	0.309981494039457	0.502133765198418	nan
sp|Q96KP1|EXOC2_HUMAN	metaplastic breast carcinomas-Normal	-0.0719035588363435	0.23400547231153	22.0000000296826	0.761525419694743	0.869177898245259	nan
sp|Q96KP1|EXOC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.017257145019444	0.23400547231153	22.0000000296826	0.941878319571664	0.996541950781621	nan
sp|Q96KP1|EXOC2_HUMAN	Normal-Triple-negative breast cancer	0.0546464138168995	0.279690035247548	22.0000000295132	0.846887129627607	0.912613163119032	nan
sp|Q96KP4|CNDP2_HUMAN	metaplastic breast carcinomas-Normal	-0.184086756110181	0.274313396108348	24.0000000002077	0.508576165853712	0.692830809548254	nan
sp|Q96KP4|CNDP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.816745414959066	0.274313396108348	24.000000000167	0.0065473948420631	0.519941801393686	nan
sp|Q96KP4|CNDP2_HUMAN	Normal-Triple-negative breast cancer	-0.632658658848885	0.327867218952375	24.000000000272	0.0655573290116328	0.185615469876208	nan
sp|Q96KR1|ZFR_HUMAN	metaplastic breast carcinomas-Normal	0.686432762063135	0.32834417231212	23.9999999993015	0.0473315717882519	0.163885567316822	nan
sp|Q96KR1|ZFR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.351794311447565	0.32834417231212	23.9999999993006	0.294637441529135	0.867696529950794	nan
sp|Q96KR1|ZFR_HUMAN	Normal-Triple-negative breast cancer	-1.0382270735107	0.392446348455668	23.9999999993081	0.0141637836733938	0.0770525421586136	nan
sp|Q96KR6|F210B_HUMAN	metaplastic breast carcinomas-Normal	0.669336182863714	0.494473459983083	14.0000000089829	0.197304422321711	0.390148661390463	nan
sp|Q96KR6|F210B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0757416172562782	0.494473459983083	14.0000000090831	0.880445125660189	0.983583849145686	nan
sp|Q96KR6|F210B_HUMAN	Normal-Triple-negative breast cancer	-0.593594565607436	0.591008825928347	14.0000000088046	0.332242521308158	0.524643297305615	nan
sp|Q96L91|EP400_HUMAN	metaplastic breast carcinomas-Normal	-1.15552295268309	0.642362026731386	6.0	0.122144158080779	0.291253358293047	nan
sp|Q96L91|EP400_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.888125591403565	0.642362026731386	6.0	0.216048913837947	0.843662073010871	nan
sp|Q96L91|EP400_HUMAN	Normal-Triple-negative breast cancer	0.267397361279528	0.767769471899377	6.0	0.739525687923643	0.850288269338703	nan
sp|Q96L92|SNX27_HUMAN	metaplastic breast carcinomas-Normal	-0.144189964811938	0.188463004801517	22.0000000065984	0.45235157460659	0.647273626341931	nan
sp|Q96L92|SNX27_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.24130502282825	0.188463004801517	22.0000000066934	0.213745759593446	0.843662073010871	nan
sp|Q96L92|SNX27_HUMAN	Normal-Triple-negative breast cancer	-0.0971150580163117	0.225256375139898	22.0000000065071	0.670567981397806	0.806588516510481	nan
sp|Q96LD4|TRI47_HUMAN	metaplastic breast carcinomas-Normal	-0.285853118605213	0.315881262451896	23.9999999996076	0.37449307690448	0.581984288538432	nan
sp|Q96LD4|TRI47_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.117787356052207	0.315881262451896	23.9999999996076	0.712507125550041	0.94948208919602	nan
sp|Q96LD4|TRI47_HUMAN	Normal-Triple-negative breast cancer	0.168065762553006	0.377550322035172	23.9999999995833	0.660201970484398	0.799725735949474	nan
sp|Q96LJ7|DHRS1_HUMAN	metaplastic breast carcinomas-Normal	-0.513945769814821	0.3641235572872	22.9999999993411	0.171494523540446	0.360397937027939	nan
sp|Q96LJ7|DHRS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.430862232376143	0.340606399455514	22.9999999992946	0.21854351314154	0.843662073010871	nan
sp|Q96LJ7|DHRS1_HUMAN	Normal-Triple-negative breast cancer	0.0830835374386784	0.426972717905713	22.9999999993115	0.84742447905902	0.912669962245147	nan
sp|Q96LR5|UB2E2_HUMAN	metaplastic breast carcinomas-Normal	-0.55446276971004	0.287677803546962	23.9999999993983	0.0658500200648586	0.197371926686736	nan
sp|Q96LR5|UB2E2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0720173171074019	0.287677803546962	23.999999999632	0.804454874760679	0.965774701272009	nan
sp|Q96LR5|UB2E2_HUMAN	Normal-Triple-negative breast cancer	0.626480086817442	0.343840741069808	23.9999999994956	0.0809403447883914	0.211879976376502	nan
sp|Q96M27|PRRC1_HUMAN	metaplastic breast carcinomas-Normal	0.592547649435942	0.283696124425127	21.9999993245829	0.0485224208282358	0.166333034461371	nan
sp|Q96M27|PRRC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.287037654362536	0.283696124425127	21.9999993246188	0.322643068418472	0.867696529950794	nan
sp|Q96M27|PRRC1_HUMAN	Normal-Triple-negative breast cancer	-0.879585303798478	0.339081724270202	21.9999993250534	0.016563351437602	0.0827187973028894	nan
sp|Q96ME7|ZN512_HUMAN	metaplastic breast carcinomas-Normal	0.635545134896499	0.365112711732865	14.9999999994793	0.102206169769592	0.258601320429514	nan
sp|Q96ME7|ZN512_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.658328367883402	0.365112711732865	14.9999999994793	0.09149734635369	0.81309570430905	nan
sp|Q96ME7|ZN512_HUMAN	Normal-Triple-negative breast cancer	-1.2938735027799	0.436393158694782	14.9999999994775	0.009636536201059	0.0620611678009953	nan
sp|Q96MG7|NSE3_HUMAN	metaplastic breast carcinomas-Normal	-2.50118880210564	0.526201671359504	14.000000000016	0.0003085313692262	0.0165412624404528	nan
sp|Q96MG7|NSE3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.356822817943025	0.526201671359504	14.0000000000152	0.508755239520005	0.913992324008525	nan
sp|Q96MG7|NSE3_HUMAN	Normal-Triple-negative breast cancer	2.85801162004866	0.628931291888454	14.0000000000908	0.0004587175153051	0.0237592699893802	nan
sp|Q96MU7|YTDC1_HUMAN	metaplastic breast carcinomas-Normal	0.708188499262529	0.224980920188719	21.9999999884993	0.0046719962847701	0.0458663504478383	nan
sp|Q96MU7|YTDC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.299063051286121	0.224980920188719	21.9999999893533	0.197376138517198	0.843662073010871	nan
sp|Q96MU7|YTDC1_HUMAN	Normal-Triple-negative breast cancer	-1.00725155054865	0.268903632363935	21.9999999896768	0.0011189553136814	0.026613045414958	nan
sp|Q96MW1|CCD43_HUMAN	metaplastic breast carcinomas-Normal	0.212058092265868	0.21184548029279	21.9999999573755	0.327708639927563	0.536602718777941	nan
sp|Q96MW1|CCD43_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.112275657961211	0.21184548029279	21.9999999581189	0.601428536733536	0.940559810632461	nan
sp|Q96MW1|CCD43_HUMAN	Normal-Triple-negative breast cancer	-0.0997824343046573	0.253203778804128	21.9999999580384	0.697316152651008	0.822818207813969	nan
sp|Q96N66|MBOA7_HUMAN	metaplastic breast carcinomas-Normal	0.539340090558714	0.242626317218816	22.0000023761861	0.0368085806370226	0.139511655686959	nan
sp|Q96N66|MBOA7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.200120428884959	0.242626317218816	22.0000023761889	0.418333669246259	0.8860071777014	nan
sp|Q96N66|MBOA7_HUMAN	Normal-Triple-negative breast cancer	-0.739460519443673	0.289993915717371	22.0000023760925	0.0182563223315364	0.0873480619203579	nan
sp|Q96N67|DOCK7_HUMAN	metaplastic breast carcinomas-Normal	0.23112144919563	0.16842326197175	23.9999999997094	0.182671286428418	0.373490887701788	nan
sp|Q96N67|DOCK7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0217399255839662	0.16842326197175	23.9999999997094	0.898370704339211	0.989671989983163	nan
sp|Q96N67|DOCK7_HUMAN	Normal-Triple-negative breast cancer	-0.252861374779596	0.201304301186057	23.9999999997544	0.221164743007351	0.404151514984296	nan
sp|Q96P16|RPR1A_HUMAN	metaplastic breast carcinomas-Normal	0.906423513713544	0.401646138720559	14.0000000013539	0.0405328517800187	0.149310692394896	nan
sp|Q96P16|RPR1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.366412036412972	0.401646138720559	14.0000000017469	0.377065555585922	0.885234295852111	nan
sp|Q96P16|RPR1A_HUMAN	Normal-Triple-negative breast cancer	-1.27283555012652	0.480058955827503	14.0000000014761	0.0189766182247203	0.0895998280951281	nan
sp|Q96P70|IPO9_HUMAN	metaplastic breast carcinomas-Normal	0.138850178804225	0.261228581733965	24.0000000001634	0.599938973550358	0.757673688480771	nan
sp|Q96P70|IPO9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.192722316110667	0.261228581733965	24.0000000001634	0.467816831498973	0.911843360423993	nan
sp|Q96P70|IPO9_HUMAN	Normal-Triple-negative breast cancer	0.0538721373064419	0.312227874464283	24.0000000001917	0.864458956400479	0.921572024077996	nan
sp|Q96PD5|PGRP2_HUMAN	metaplastic breast carcinomas-Normal	-0.984158262123741	0.411692027728205	22.0000000024312	0.0258165665189255	0.11321693931385	nan
sp|Q96PD5|PGRP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.195281069250774	0.411692027728205	22.0000000014945	0.639933331892068	0.941868024951375	nan
sp|Q96PD5|PGRP2_HUMAN	Normal-Triple-negative breast cancer	1.17943933137452	0.492066089775639	22.0000000022334	0.0254645233159322	0.105937516273039	nan
sp|Q96PK6|RBM14_HUMAN	metaplastic breast carcinomas-Normal	0.898796923691454	0.299496691268383	24.0000000000061	0.0061906475589198	0.0518335147863123	nan
sp|Q96PK6|RBM14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.23097981688876	0.299496691268383	23.9999999997904	0.448099615392938	0.902988618897891	nan
sp|Q96PK6|RBM14_HUMAN	Normal-Triple-negative breast cancer	-1.12977674058021	0.357967013804962	23.9999999999107	0.0042705761391259	0.0419484078096101	nan
sp|Q96PP9|GBP4_HUMAN	metaplastic breast carcinomas-Normal	-0.746131211398498	0.47368776999177	21.4761806101805	0.129838259759176	0.300544829693245	nan
sp|Q96PP9|GBP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0909520942513813	0.442778858778452	21.0750460043258	0.839221362454526	0.971085326089412	nan
sp|Q96PP9|GBP4_HUMAN	Normal-Triple-negative breast cancer	0.655179117147117	0.555340317465899	21.370445297876	0.251055011759804	0.440317118741841	nan
sp|Q96PU8|QKI_HUMAN	metaplastic breast carcinomas-Normal	0.618447107642893	0.390250875550473	6.0	0.164117121550467	0.350144616196247	nan
sp|Q96PU8|QKI_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0715858895096083	0.390250875550473	6.0	0.860498187287794	0.979177437622147	nan
sp|Q96PU8|QKI_HUMAN	Normal-Triple-negative breast cancer	-0.690032997152502	0.466439011275721	6.0	0.189531217899616	0.369719347592913	nan
sp|Q96PZ0|PUS7_HUMAN	metaplastic breast carcinomas-Normal	0.639817494545185	0.567133620789366	14.9999999996285	0.276974285938059	0.479511732530264	nan
sp|Q96PZ0|PUS7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.526823803149344	0.567133620789366	14.9999999996039	0.367636894370632	0.883542279876718	nan
sp|Q96PZ0|PUS7_HUMAN	Normal-Triple-negative breast cancer	-1.16664129769453	0.677854328882854	14.9999999996225	0.105790104933042	0.251355474479938	nan
sp|Q96Q06|PLIN4_HUMAN	metaplastic breast carcinomas-Normal	-2.9858231166465	0.629903298519149	22.0000000023956	9.90294993697472e-05	0.0136889536397125	nan
sp|Q96Q06|PLIN4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.13640707159994	0.629903298519149	22.0000000020276	0.830552657163803	0.967959195608007	nan
sp|Q96Q06|PLIN4_HUMAN	Normal-Triple-negative breast cancer	2.84941604504656	0.75287844350419	22.0000000019136	0.0010181990192522	0.0262363840309652	nan
sp|Q96QC0|PP1RA_HUMAN	metaplastic breast carcinomas-Normal	0.0794271931380661	0.352796667040135	21.9999999998291	0.823951660995542	0.907569094159468	nan
sp|Q96QC0|PP1RA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0953993995091234	0.302838921562081	21.9999999997878	0.755717230632204	0.954748610837524	nan
sp|Q96QC0|PP1RA_HUMAN	Normal-Triple-negative breast cancer	-0.174826592647189	0.404685531380505	21.9999999997898	0.669941634989967	0.806258506410807	nan
sp|Q96QG7|MTMR9_HUMAN	metaplastic breast carcinomas-Normal	0.0042436299324958	0.392055983655719	6.0	0.991714758519649	0.995007502963874	nan
sp|Q96QG7|MTMR9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0800797113726575	0.392055983655719	6.0	0.844905784079722	0.973108514760438	nan
sp|Q96QG7|MTMR9_HUMAN	Normal-Triple-negative breast cancer	-0.0843233413051534	0.468596528126053	6.0	0.863116483282552	0.921322797184073	nan
sp|Q96QK1|VPS35_HUMAN	metaplastic breast carcinomas-Normal	-0.040592158899171	0.141334809982017	22.000000040956	0.776642634971932	0.879277969566315	nan
sp|Q96QK1|VPS35_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.193423584907689	0.141334809982017	22.0000000408642	0.184954506304825	0.843662073010871	nan
sp|Q96QK1|VPS35_HUMAN	Normal-Triple-negative breast cancer	-0.152831426008518	0.168927408385347	22.0000000413693	0.37541691936886	0.56312537905329	nan
sp|Q96QR8|PURB_HUMAN	metaplastic breast carcinomas-Normal	0.408600935474525	0.27676218537202	14.9999999995636	0.160530966595666	0.345151961813709	nan
sp|Q96QR8|PURB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0916388854497065	0.27676218537202	14.9999999995644	0.745141333469069	0.954643368861838	nan
sp|Q96QR8|PURB_HUMAN	Normal-Triple-negative breast cancer	-0.316962050024818	0.330794081938548	14.9999999995493	0.353159769895847	0.543675061879149	nan
sp|Q96RF0|SNX18_HUMAN	metaplastic breast carcinomas-Normal	0.645026609814802	0.344387219218407	22.000000028627	0.074421712033355	0.213238102699799	nan
sp|Q96RF0|SNX18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.572580535832532	0.344387219218407	22.0000000286295	0.110574540922989	0.823891816737944	nan
sp|Q96RF0|SNX18_HUMAN	Normal-Triple-negative breast cancer	-0.0724460739822702	0.411621457098955	22.0000000286584	0.861902631404725	0.920618363364173	nan
sp|Q96RP9|EFGM_HUMAN	metaplastic breast carcinomas-Normal	0.410409571777262	0.164663836041574	22.0001191502675	0.0207073756244578	0.0980503085123898	nan
sp|Q96RP9|EFGM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.204611487672419	0.164663836041574	22.000119153578	0.227096841068077	0.843662073010871	nan
sp|Q96RP9|EFGM_HUMAN	Normal-Triple-negative breast cancer	-0.615021059449681	0.196810927759637	22.0001191527945	0.0049289524909934	0.0450865992679507	nan
sp|Q96RQ3|MCCA_HUMAN	metaplastic breast carcinomas-Normal	-0.175328907061367	0.303179156598366	14.9999999998063	0.571641741628015	0.735062726952232	nan
sp|Q96RQ3|MCCA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.561048089578261	0.303179156598366	14.9999999999378	0.0840288033640371	0.806849600316436	nan
sp|Q96RQ3|MCCA_HUMAN	Normal-Triple-negative breast cancer	-0.385719182516894	0.362368401720239	14.9999999998883	0.303965371602252	0.496257807075582	nan
sp|Q96RQ9|OXLA_HUMAN	metaplastic breast carcinomas-Normal	-0.243641313963367	0.412560439419194	13.9999999980362	0.564228191127522	0.732167091151825	nan
sp|Q96RQ9|OXLA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.195097661222527	0.412560439419194	13.9999999981622	0.643576366257015	0.941868024951375	nan
sp|Q96RQ9|OXLA_HUMAN	Normal-Triple-negative breast cancer	0.438738975185894	0.49310404027339	13.9999999981071	0.388634132459977	0.576447950154826	nan
sp|Q96RS6|NUDC1_HUMAN	metaplastic breast carcinomas-Normal	0.502751407862842	0.287319004327217	22.000000008828	0.0940899026981761	0.248130450375174	nan
sp|Q96RS6|NUDC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0387300263048843	0.287319004327217	22.000000008863	0.89399725702665	0.988218752026376	nan
sp|Q96RS6|NUDC1_HUMAN	Normal-Triple-negative breast cancer	-0.464021381557958	0.343411893977362	22.0000000089737	0.190361333766833	0.371120864188242	nan
sp|Q96RT1|ERBIN_HUMAN	metaplastic breast carcinomas-Normal	-0.516574736429378	0.597831998949413	14.0000023853738	0.402106185619799	0.604796814932222	nan
sp|Q96RT1|ERBIN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.136747750497669	0.597831998949413	14.0000023853978	0.822378988668065	0.965774701272009	nan
sp|Q96RT1|ERBIN_HUMAN	Normal-Triple-negative breast cancer	0.379826985931709	0.714545908719907	14.0000023854804	0.603360693665829	0.754791668772975	nan
sp|Q96RU3|FNBP1_HUMAN	metaplastic breast carcinomas-Normal	-0.46648175225947	0.42869190807544	19.1787217268043	0.290014159327623	0.494110465278348	nan
sp|Q96RU3|FNBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.198320195219272	0.403143219228788	19.2950424780307	0.628315452299262	0.941868024951375	nan
sp|Q96RU3|FNBP1_HUMAN	Normal-Triple-negative breast cancer	0.664801947478743	0.494789256680309	19.3102409032673	0.194652683966353	0.37574072096641	nan
sp|Q96S52|PIGS_HUMAN	metaplastic breast carcinomas-Normal	0.352733156942188	0.187442727147404	19.9163528590575	0.0745578669180353	0.213238102699799	nan
sp|Q96S52|PIGS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0418315370040719	0.175401352887432	19.8448351271617	0.813946181169352	0.965774701272009	nan
sp|Q96S52|PIGS_HUMAN	Normal-Triple-negative breast cancer	-0.310901619938116	0.218093867046403	20.0021952037145	0.169420694381962	0.3406862602091	nan
sp|Q96S55|WRIP1_HUMAN	metaplastic breast carcinomas-Normal	-0.0851630219987131	0.695516291323134	9.99999999989741	0.90497181422901	0.949235187913294	nan
sp|Q96S55|WRIP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.225573966515965	0.695516291323134	9.99999999989741	0.752373420157089	0.954643368861838	nan
sp|Q96S55|WRIP1_HUMAN	Normal-Triple-negative breast cancer	-0.140410944517252	0.822945973982643	9.99999999990057	0.867925393950384	0.923194883037145	nan
sp|Q96S66|CLCC1_HUMAN	metaplastic breast carcinomas-Normal	0.19942018613074	0.360775383385889	14.0000000006605	0.589149073110568	0.748311623622288	nan
sp|Q96S66|CLCC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.114937312052203	0.360775383385889	14.000000000833	0.754745034810496	0.954748610837524	nan
sp|Q96S66|CLCC1_HUMAN	Normal-Triple-negative breast cancer	-0.314357498182943	0.431209059766399	14.0000000007115	0.478012369849804	0.657118741679384	nan
sp|Q96S97|MYADM_HUMAN	metaplastic breast carcinomas-Normal	-0.236143166350032	0.261213521635485	22.9999999996714	0.375354873129365	0.582483472587307	nan
sp|Q96S97|MYADM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.222154699356067	0.261213521635485	22.9999999996714	0.403830068819513	0.885297496092956	nan
sp|Q96S97|MYADM_HUMAN	Normal-Triple-negative breast cancer	0.458297865706098	0.309072006883989	22.999999999701	0.151696335118895	0.31972470314917	nan
sp|Q96SB3|NEB2_HUMAN	metaplastic breast carcinomas-Normal	0.184110803340092	0.250618415153569	14.999999999643	0.473896281520036	0.663846353580642	nan
sp|Q96SB3|NEB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.152947003209473	0.250618415153569	14.999999999642	0.550812293972865	0.931124086486988	nan
sp|Q96SB3|NEB2_HUMAN	Normal-Triple-negative breast cancer	-0.031163800130619	0.29954629981759	14.9999999996696	0.918518548238968	0.953503798850578	nan
sp|Q96SI9|STRBP_HUMAN	metaplastic breast carcinomas-Normal	0.134985067308836	0.231674026075398	23.9999999999902	0.565562961959749	0.73240429506159	nan
sp|Q96SI9|STRBP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.244952810474088	0.231674026075398	23.9999999999902	0.300893969035087	0.867696529950794	nan
sp|Q96SI9|STRBP_HUMAN	Normal-Triple-negative breast cancer	-0.379937877782924	0.276903424004998	23.9999999999675	0.182723610938021	0.358967661204482	nan
sp|Q96SM3|CPXM1_HUMAN	metaplastic breast carcinomas-Normal	-0.315400037349065	0.343955099711771	23.9999999993582	0.368276205306987	0.57797455450445	nan
sp|Q96SM3|CPXM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.450098190955682	0.343955099711771	23.9999999993582	0.203064743903182	0.843662073010871	nan
sp|Q96SM3|CPXM1_HUMAN	Normal-Triple-negative breast cancer	0.765498228304748	0.411104975501972	23.9999999993827	0.0748848693092112	0.201226601118689	nan
sp|Q96ST2|IWS1_HUMAN	metaplastic breast carcinomas-Normal	0.0310806398945968	0.220466038534567	6.0	0.892502138664709	0.94150288514576	nan
sp|Q96ST2|IWS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.217315453420658	0.220466038534567	6.0	0.362340975101288	0.883542279876718	nan
sp|Q96ST2|IWS1_HUMAN	Normal-Triple-negative breast cancer	-0.248396093315255	0.263507316643133	6.0	0.382248002841633	0.57002797731969	nan
sp|Q96ST3|SIN3A_HUMAN	metaplastic breast carcinomas-Normal	-0.644143179921668	0.434718551168479	22.0000069694289	0.15258991986837	0.332595995831123	nan
sp|Q96ST3|SIN3A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.288856353150926	0.434718551168479	22.0000069691754	0.513296185424548	0.915620969865368	nan
sp|Q96ST3|SIN3A_HUMAN	Normal-Triple-negative breast cancer	0.932999533072594	0.519588049364963	22.0000069696302	0.0862992485022598	0.221683695534398	nan
sp|Q96SZ5|AEDO_HUMAN	metaplastic breast carcinomas-Normal	0.141088251776986	0.169027498968051	22.0000000221923	0.412856076337996	0.615396232173766	nan
sp|Q96SZ5|AEDO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.217209301467544	0.169027498968051	22.0000000217664	0.212138772842149	0.843662073010871	nan
sp|Q96SZ5|AEDO_HUMAN	Normal-Triple-negative breast cancer	0.0761210496905586	0.202026502530854	22.0000000222778	0.709941343370935	0.830054528795282	nan
sp|Q96T37|RBM15_HUMAN	metaplastic breast carcinomas-Normal	0.835155925320912	0.262711926069444	22.9999999996582	0.0041834310544894	0.042883667309653	nan
sp|Q96T37|RBM15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.357298356424851	0.262711926069444	22.9999999996582	0.187000685686824	0.843662073010871	nan
sp|Q96T37|RBM15_HUMAN	Normal-Triple-negative breast cancer	-1.19245428174576	0.31084494291972	22.9999999995754	0.0008442682140578	0.0257262735003663	nan
sp|Q96T51|RUFY1_HUMAN	metaplastic breast carcinomas-Normal	0.0330971732950144	0.182136450534827	22.0000033151183	0.857469201083191	0.925999877972881	nan
sp|Q96T51|RUFY1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0373589282683253	0.182136450534827	22.0000033155441	0.839368188625856	0.971085326089412	nan
sp|Q96T51|RUFY1_HUMAN	Normal-Triple-negative breast cancer	-0.0704561015633397	0.217694696481844	22.0000033158123	0.749262314256653	0.856006830048239	nan
sp|Q96T76|MMS19_HUMAN	metaplastic breast carcinomas-Normal	0.0267035044642269	0.275390918859971	11.000611293332	0.924497618098954	0.959399047261854	nan
sp|Q96T76|MMS19_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0834204402441591	0.25039324049246	11.0066396170288	0.745275151170234	0.954643368861838	nan
sp|Q96T76|MMS19_HUMAN	Normal-Triple-negative breast cancer	-0.110123944708386	0.312547857381328	11.0075744610926	0.731234713426288	0.844553227042731	nan
sp|Q96T88|UHRF1_HUMAN	metaplastic breast carcinomas-Normal	0.446632293358297	0.415775681076463	22.0000000230717	0.294367802509164	0.498460812807163	nan
sp|Q96T88|UHRF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.219007437655842	0.415775681076463	22.0000000236903	0.603642344902972	0.940559810632461	nan
sp|Q96T88|UHRF1_HUMAN	Normal-Triple-negative breast cancer	-0.665639731014139	0.496946989088081	22.0000000231777	0.194095849527427	0.375518092845606	nan
sp|Q96TA1|NIBA2_HUMAN	metaplastic breast carcinomas-Normal	0.523221683983191	0.269810115039942	24.0000000004536	0.0643177692896439	0.194533453247294	nan
sp|Q96TA1|NIBA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.119917085913493	0.269810115039942	24.0000000001891	0.660699405639524	0.944434752137403	nan
sp|Q96TA1|NIBA2_HUMAN	Normal-Triple-negative breast cancer	-0.643138769896685	0.322484768583543	24.0000000003915	0.0575958566016492	0.171702804792719	nan
sp|Q99426|TBCB_HUMAN	metaplastic breast carcinomas-Normal	0.260424541062542	0.341263043499277	23.9999999997465	0.452828425131578	0.64739857425263	nan
sp|Q99426|TBCB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.68602744830481	0.341263043499277	23.9999999997465	0.0557710153410459	0.773787875546141	nan
sp|Q99426|TBCB_HUMAN	Normal-Triple-negative breast cancer	-0.946451989367352	0.407887352898864	23.9999999997765	0.0291418805760642	0.114387188280896	nan
sp|Q99439|CNN2_HUMAN	metaplastic breast carcinomas-Normal	0.997494517901721	0.327053348437509	21.999995190399	0.0058723091945725	0.0508404511724253	nan
sp|Q99439|CNN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.202915860023876	0.327053348437509	21.9999951911139	0.541344898694959	0.923837171685362	nan
sp|Q99439|CNN2_HUMAN	Normal-Triple-negative breast cancer	-0.794578657877845	0.390903518831121	21.999995191553	0.0543286927062662	0.16537415252347	nan
sp|Q99442|SEC62_HUMAN	metaplastic breast carcinomas-Normal	1.38772514276674	0.46519860018886	10.9999999997984	0.0124507425946637	0.0733799084834434	nan
sp|Q99442|SEC62_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.534959513368237	0.360341286242091	10.9999999997758	0.165734096435461	0.843662073010871	nan
sp|Q99442|SEC62_HUMAN	Normal-Triple-negative breast cancer	-0.852765629398503	0.509599534086531	10.9999999998098	0.122414782231635	0.27568207055417	nan
sp|Q99459|CDC5L_HUMAN	metaplastic breast carcinomas-Normal	0.137170473810203	0.295533967241353	22.0000000041365	0.647104313751683	0.790218493354369	nan
sp|Q99459|CDC5L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.273736669707676	0.295533967241353	22.0000000039035	0.364369128904019	0.883542279876718	nan
sp|Q99459|CDC5L_HUMAN	Normal-Triple-negative breast cancer	-0.410907143517879	0.353230652676959	22.000000004224	0.257177312112067	0.448038461981399	nan
sp|Q99460|PSMD1_HUMAN	metaplastic breast carcinomas-Normal	0.12873098603892	0.181889367366059	23.9999999998876	0.485921510055977	0.675087247966402	nan
sp|Q99460|PSMD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.355960100160257	0.181889367366059	23.9999999996459	0.0620754793177078	0.773787875546141	nan
sp|Q99460|PSMD1_HUMAN	Normal-Triple-negative breast cancer	-0.484691086199177	0.217399375609647	23.9999999997497	0.0353980989353835	0.12599539067568	nan
sp|Q99470|SDF2_HUMAN	metaplastic breast carcinomas-Normal	0.447226101971531	0.135249892353571	13.9999999998164	0.0051929592809148	0.0476983941525986	nan
sp|Q99470|SDF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0174050115597322	0.135249892353571	13.9999999997912	0.899435105010481	0.989671989983163	nan
sp|Q99470|SDF2_HUMAN	Normal-Triple-negative breast cancer	-0.464631113531263	0.159148116997427	13.9999999998071	0.0112020794922795	0.0674560004209003	nan
sp|Q99471|PFD5_HUMAN	metaplastic breast carcinomas-Normal	0.609443763332801	0.208429272856174	14.9999999999118	0.0104724643457135	0.0678538291377207	nan
sp|Q99471|PFD5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.00565642835499	0.208429272856174	14.9999999997961	0.978707146221195	0.99709406933403	nan
sp|Q99471|PFD5_HUMAN	Normal-Triple-negative breast cancer	-0.603787334977811	0.249120629940463	14.9999999998665	0.0284746850773935	0.112582478871981	nan
sp|Q99497|PARK7_HUMAN	metaplastic breast carcinomas-Normal	0.0356501357579148	0.214183952454183	21.9999955224079	0.869325989143137	0.931589682597953	nan
sp|Q99497|PARK7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.152534404249626	0.214183952454183	21.9999955227006	0.483847125084581	0.913320451076758	nan
sp|Q99497|PARK7_HUMAN	Normal-Triple-negative breast cancer	-0.188184540007541	0.255998787633557	21.9999955217459	0.470043371816189	0.649656618676512	nan
sp|Q99536|VAT1_HUMAN	metaplastic breast carcinomas-Normal	-0.823075576030651	0.311663105047298	23.9999999996319	0.0143131490107142	0.0795361221927149	nan
sp|Q99536|VAT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0638657451801473	0.311663105047298	23.9999999996319	0.839363287754126	0.971085326089412	nan
sp|Q99536|VAT1_HUMAN	Normal-Triple-negative breast cancer	0.759209830850504	0.372508659626521	23.999999999617	0.0527058584688775	0.162252894419432	nan
sp|Q99538|LGMN_HUMAN	metaplastic breast carcinomas-Normal	-0.461960377298245	0.470621480942171	22.00000036298	0.336971031892757	0.545322156772893	nan
sp|Q99538|LGMN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.127009949241907	0.470621480942171	22.0000003630108	0.789770150125525	0.962981271203673	nan
sp|Q99538|LGMN_HUMAN	Normal-Triple-negative breast cancer	0.588970326540152	0.562500258189404	22.0000003627948	0.306440881977725	0.499185641678237	nan
sp|Q99541|PLIN2_HUMAN	metaplastic breast carcinomas-Normal	0.785187920856992	0.413648157100275	21.0161237169951	0.0714893805922269	0.207900875843011	nan
sp|Q99541|PLIN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.634456895319113	0.413648157100275	21.0161237287709	0.13999424259281	0.823891816737944	nan
sp|Q99541|PLIN2_HUMAN	Normal-Triple-negative breast cancer	-1.41964481617611	0.489422239554259	20.9475479420556	0.0085664010426454	0.0588076066258844	nan
sp|Q99543|DNJC2_HUMAN	metaplastic breast carcinomas-Normal	0.419397887880853	0.337772560750999	14.0000004467736	0.234763331750728	0.434737222696055	nan
sp|Q99543|DNJC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.434759445448029	0.337772560750999	14.0000004466578	0.218920743173621	0.843662073010871	nan
sp|Q99543|DNJC2_HUMAN	Normal-Triple-negative breast cancer	-0.854157333328882	0.403715428057733	14.0000004466628	0.0527720084330018	0.162270264598795	nan
sp|Q99567|NUP88_HUMAN	metaplastic breast carcinomas-Normal	0.437196627666933	0.194448934464761	23.9999999995806	0.0340050497363104	0.132202088097656	nan
sp|Q99567|NUP88_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0391557312745861	0.194448934464761	23.9999999998756	0.842108028064548	0.972169455774446	nan
sp|Q99567|NUP88_HUMAN	Normal-Triple-negative breast cancer	-0.476352358941519	0.232410929526871	23.9999999997516	0.0514826752130747	0.159485938870699	nan
sp|Q99571|P2RX4_HUMAN	metaplastic breast carcinomas-Normal	0.129936768791981	0.359706480888974	12.9999999995436	0.723730300718664	0.846772094188257	nan
sp|Q99571|P2RX4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0277088352223469	0.324235040240476	12.9999999994192	0.933198556182999	0.995359816653149	nan
sp|Q99571|P2RX4_HUMAN	Normal-Triple-negative breast cancer	-0.157645604014328	0.412095544159977	12.9999999994666	0.70823752817377	0.828645386712288	nan
sp|Q99575|POP1_HUMAN	metaplastic breast carcinomas-Normal	0.788267885460301	0.49922924864297	6.0	0.165421664459876	0.351573921141067	nan
sp|Q99575|POP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.180600217255438	0.49922924864297	6.0	0.729931468465098	0.954643368861838	nan
sp|Q99575|POP1_HUMAN	Normal-Triple-negative breast cancer	-0.607667668204863	0.596693080594591	6.0	0.347784809945867	0.538693713075518	nan
sp|Q99584|S10AD_HUMAN	metaplastic breast carcinomas-Normal	0.607580643139411	0.379499181108223	23.9999999999395	0.122457731397772	0.29179175567469	nan
sp|Q99584|S10AD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.03163936923618	0.379499181108223	23.999999999897	0.0119887887575929	0.594966009238753	nan
sp|Q99584|S10AD_HUMAN	Normal-Triple-negative breast cancer	0.424058726096767	0.453588278479522	23.9999999999559	0.35915294689402	0.550149491002637	nan
sp|Q99590|SCAFB_HUMAN	metaplastic breast carcinomas-Normal	0.0540861461289604	0.205641480907543	21.9999451818947	0.794988948997721	0.888847381926816	nan
sp|Q99590|SCAFB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.161877097483537	0.205641480907543	21.9999452020214	0.439574441312335	0.89755436380139	nan
sp|Q99590|SCAFB_HUMAN	Normal-Triple-negative breast cancer	-0.215963243612497	0.245788581246588	21.9999451976265	0.389084685622958	0.576858829175162	nan
sp|Q99598|TSNAX_HUMAN	metaplastic breast carcinomas-Normal	0.0269917061336647	0.18213343480414	23.9999999993686	0.883425068830024	0.939478318898811	nan
sp|Q99598|TSNAX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.308174224805606	0.18213343480414	23.9999999993671	0.103586522908381	0.821630939204717	nan
sp|Q99598|TSNAX_HUMAN	Normal-Triple-negative breast cancer	-0.335165930939271	0.217691091994248	23.9999999993601	0.136730216657496	0.297441911105704	nan
sp|Q99615|DNJC7_HUMAN	metaplastic breast carcinomas-Normal	0.491605164499842	0.227458371607763	23.9999999998521	0.0408677706286237	0.149736208267631	nan
sp|Q99615|DNJC7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.245237720028254	0.227458371607763	23.9999999998521	0.291677688552261	0.867696529950794	nan
sp|Q99615|DNJC7_HUMAN	Normal-Triple-negative breast cancer	-0.246367444471588	0.271864753178212	23.9999999998602	0.373831703600043	0.56195892239259	nan
sp|Q99622|C10_HUMAN	metaplastic breast carcinomas-Normal	0.32701253269447	0.347014073508627	24.0000000000671	0.355397818896616	0.564965255864349	nan
sp|Q99622|C10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.109417135209002	0.347014073508627	24.0000000000671	0.75525137148479	0.954748610837524	nan
sp|Q99622|C10_HUMAN	Normal-Triple-negative breast cancer	-0.436429667903473	0.41476114849918	23.999999999995	0.303167555623976	0.495685663991193	nan
sp|Q99623|PHB2_HUMAN	metaplastic breast carcinomas-Normal	0.572545977071329	0.196116718929433	23.9999999996004	0.0075091923303346	0.0575128002443146	nan
sp|Q99623|PHB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.237311261884674	0.196116718929433	23.9999999996004	0.238043041851815	0.84876230490475	nan
sp|Q99623|PHB2_HUMAN	Normal-Triple-negative breast cancer	-0.809857238956004	0.23440431323325	23.9999999996795	0.0020591877338611	0.0313978900337361	nan
sp|Q99627|CSN8_HUMAN	metaplastic breast carcinomas-Normal	0.236894611402062	0.178258086653171	22.0000000140624	0.197486512700371	0.390276556608819	nan
sp|Q99627|CSN8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.127565643868461	0.178258086653171	22.0000000139392	0.481750886151067	0.913320451076758	nan
sp|Q99627|CSN8_HUMAN	Normal-Triple-negative breast cancer	-0.364460255270522	0.21305916501308	22.0000000145688	0.10122057967277	0.244442821554936	nan
sp|Q99685|MGLL_HUMAN	metaplastic breast carcinomas-Normal	-2.62420150482081	0.337713181689077	6.0	0.0002390439453722	0.0157578323963946	nan
sp|Q99685|MGLL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.353481252964206	0.337713181689077	6.0	0.335564469388377	0.870890600099115	nan
sp|Q99685|MGLL_HUMAN	Normal-Triple-negative breast cancer	2.2707202518566	0.403644456504129	6.0	0.0013488377185948	0.0266490250684039	nan
sp|Q99700|ATX2_HUMAN	metaplastic breast carcinomas-Normal	0.890333761787369	0.31021824404511	24.0000000000827	0.0084329247732085	0.0602818106368712	nan
sp|Q99700|ATX2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.133758136188825	0.31021824404511	24.0000000000827	0.670189815942124	0.946277260710207	nan
sp|Q99700|ATX2_HUMAN	Normal-Triple-negative breast cancer	-0.756575625598543	0.370781720420195	24.000000000086	0.052450028069547	0.161879195267571	nan
sp|Q99714|HCD2_HUMAN	metaplastic breast carcinomas-Normal	-0.15331830211199	0.218149065110426	22.0000000369793	0.489542295678033	0.679431561934773	nan
sp|Q99714|HCD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.443012068738167	0.218149065110426	22.0000000371224	0.0545356198461122	0.773286317778246	nan
sp|Q99714|HCD2_HUMAN	Normal-Triple-negative breast cancer	-0.289693766626177	0.260738003719533	22.0000000371827	0.27854114258137	0.470624638428115	nan
sp|Q99715|COCA1_HUMAN	metaplastic breast carcinomas-Normal	1.21143235740113	0.477601475521678	23.9999999998954	0.0181164654625644	0.091241107875097	nan
sp|Q99715|COCA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.225982512323388	0.477601475521678	23.9999999998954	0.640373407354084	0.941868024951375	nan
sp|Q99715|COCA1_HUMAN	Normal-Triple-negative breast cancer	-1.43741486972452	0.57084294740383	23.9999999998757	0.0188787493057923	0.0893916847470849	nan
sp|Q99729|ROAA_HUMAN	metaplastic breast carcinomas-Normal	0.646895531565943	0.334167076848166	21.9999999296148	0.0658408014762606	0.197371926686736	nan
sp|Q99729|ROAA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.212784380189557	0.334167076848166	21.9999999304356	0.530851396618109	0.920933816822996	nan
sp|Q99729|ROAA_HUMAN	Normal-Triple-negative breast cancer	-0.859679911755499	0.399406050546573	21.9999999277296	0.0425973986540612	0.140191834778316	nan
sp|Q99733|NP1L4_HUMAN	metaplastic breast carcinomas-Normal	0.514935347463729	0.204927321992409	21.999996315854	0.0198064506617589	0.0959717813406512	nan
sp|Q99733|NP1L4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.255684351596376	0.204927321992409	21.9999963214172	0.2252649694611	0.843662073010871	nan
sp|Q99733|NP1L4_HUMAN	Normal-Triple-negative breast cancer	-0.770619699060106	0.244934998079609	21.9999963162332	0.0046890214487321	0.0436121424321106	nan
sp|Q99798|ACON_HUMAN	metaplastic breast carcinomas-Normal	0.0333463973030253	0.2519635406884	21.9999456413105	0.895913528052025	0.943305849618287	nan
sp|Q99798|ACON_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0076629887687526	0.2519635406884	21.9999456415818	0.976011832202256	0.99709406933403	nan
sp|Q99798|ACON_HUMAN	Normal-Triple-negative breast cancer	-0.0256834085342727	0.301154032339967	21.999945638046	0.932807545444543	0.962453172165297	nan
sp|Q99805|TM9S2_HUMAN	metaplastic breast carcinomas-Normal	0.544746840252282	0.316578084702479	21.9999999866239	0.0993351588555948	0.254776287064813	nan
sp|Q99805|TM9S2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.404493452694383	0.316578084702479	21.9999999866248	0.214672010739399	0.843662073010871	nan
sp|Q99805|TM9S2_HUMAN	Normal-Triple-negative breast cancer	-0.949240292946665	0.37838318392469	21.9999999867868	0.0199846963459649	0.0923910023003994	nan
sp|Q99808|S29A1_HUMAN	metaplastic breast carcinomas-Normal	-0.080806213394411	0.55439822542409	13.0115892515598	0.886348757300816	0.940415790777734	nan
sp|Q99808|S29A1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0631394927986135	0.55439822542409	13.0115892518506	0.911064869567111	0.99408739879047	nan
sp|Q99808|S29A1_HUMAN	Normal-Triple-negative breast cancer	0.143945706193024	0.651844861675772	13.0000027488607	0.828656688825508	0.902911374434681	nan
sp|Q99829|CPNE1_HUMAN	metaplastic breast carcinomas-Normal	0.616019110050911	0.348259450824322	23.9999999996435	0.0896278824609905	0.241435046240126	nan
sp|Q99829|CPNE1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.172203699756833	0.348259450824322	23.9999999996436	0.625470544837891	0.941374262616245	nan
sp|Q99829|CPNE1_HUMAN	Normal-Triple-negative breast cancer	-0.788222809807744	0.416249659096314	23.9999999995534	0.0703906158192268	0.193210905848976	nan
sp|Q99832|TCPH_HUMAN	metaplastic breast carcinomas-Normal	0.442041991226111	0.122699007120138	21.9999959277742	0.0015813359037642	0.0284127596979038	nan
sp|Q99832|TCPH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.157531668666308	0.122699007120138	21.9999959265251	0.212539204655585	0.843662073010871	nan
sp|Q99832|TCPH_HUMAN	Normal-Triple-negative breast cancer	-0.599573659892419	0.146653363646913	21.9999959239076	0.0004861955611247	0.0237592699893802	nan
sp|Q99836|MYD88_HUMAN	metaplastic breast carcinomas-Normal	-0.14870369807537	0.515359872671575	9.36963378557301	0.77921283600909	0.880388669916456	nan
sp|Q99836|MYD88_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.803373763152352	0.427902006029872	9.00714318384861	0.0931555067901	0.81309570430905	nan
sp|Q99836|MYD88_HUMAN	Normal-Triple-negative breast cancer	-0.654670065076982	0.587652253411186	9.23215749618495	0.293422232400683	0.486676821835238	nan
sp|Q99873|ANM1_HUMAN	metaplastic breast carcinomas-Normal	0.646793549087707	0.223511214524639	22.0000000027913	0.0084246699140795	0.0602818106368712	nan
sp|Q99873|ANM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.29323221191425	0.223511214524639	22.0000000027019	0.203067525329479	0.843662073010871	nan
sp|Q99873|ANM1_HUMAN	Normal-Triple-negative breast cancer	-0.940025761001958	0.267146998106925	22.0000000026823	0.0019349895611727	0.030339175949708	nan
sp|Q99961|SH3G1_HUMAN	metaplastic breast carcinomas-Normal	0.434569044383078	0.194643123083384	21.9999999994934	0.0360694639521648	0.13776013327386	nan
sp|Q99961|SH3G1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.168154561854177	0.194643123083384	21.9999999992162	0.396957694771578	0.885234295852111	nan
sp|Q99961|SH3G1_HUMAN	Normal-Triple-negative breast cancer	-0.266414482528901	0.232643029319456	21.9999999992296	0.264446667423586	0.455462390739585	nan
sp|Q99986|VRK1_HUMAN	metaplastic breast carcinomas-Normal	0.605963690225867	0.31843296729778	21.9999999992986	0.0702142963163397	0.205632000841862	nan
sp|Q99986|VRK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.356608078191737	0.31843296729778	22.0000000002863	0.274840694723056	0.867696529950794	nan
sp|Q99986|VRK1_HUMAN	Normal-Triple-negative breast cancer	-0.962571768417604	0.38060019266955	21.9999999998826	0.0191109326293699	0.089978385354144	nan
sp|Q99996|AKAP9_HUMAN	metaplastic breast carcinomas-Normal	-0.0344331327946623	0.320091599182916	6.0	0.917841566766257	0.957161477410571	nan
sp|Q99996|AKAP9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.130978103110493	0.320091599182916	6.0	0.69660648571902	0.947043345959522	nan
sp|Q99996|AKAP9_HUMAN	Normal-Triple-negative breast cancer	0.165411235905156	0.382582636951019	6.0	0.680590921906421	0.813211981542944	nan
sp|Q9BPW8|NIPS1_HUMAN	metaplastic breast carcinomas-Normal	0.245574320731085	0.19736009568336	23.9999999999994	0.225406095769409	0.42522693662742	nan
sp|Q9BPW8|NIPS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.582499031879905	0.19736009568336	24.0000000002465	0.0069624212519063	0.538373271222988	nan
sp|Q9BPW8|NIPS1_HUMAN	Normal-Triple-negative breast cancer	-0.82807335261099	0.235890432701725	24.0000000001002	0.0017954911468283	0.0292559439806731	nan
sp|Q9BPX3|CND3_HUMAN	metaplastic breast carcinomas-Normal	0.928670446602228	0.490547246470659	6.0	0.107185724395351	0.267080470682269	nan
sp|Q9BPX3|CND3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.216491266208895	0.490547246470659	6.0	0.674436171864758	0.946386428913156	nan
sp|Q9BPX3|CND3_HUMAN	Normal-Triple-negative breast cancer	-0.712179180393333	0.586316103211941	6.0	0.270122601210723	0.462114012570481	nan
sp|Q9BPX5|ARP5L_HUMAN	metaplastic breast carcinomas-Normal	0.298472353607743	0.24830568924169	23.9999999998945	0.241076302725271	0.441099046759991	nan
sp|Q9BPX5|ARP5L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0228113651467633	0.24830568924169	24.0000000000762	0.927565382652003	0.995209711945114	nan
sp|Q9BPX5|ARP5L_HUMAN	Normal-Triple-negative breast cancer	-0.27566098846098	0.296782063642163	23.9999999999073	0.36222398747512	0.55306363219592	nan
sp|Q9BPX6|MICU1_HUMAN	metaplastic breast carcinomas-Normal	0.68868609679377	0.151105499907139	14.000000000893	0.0004471226107091	0.0200356889942306	nan
sp|Q9BPX6|MICU1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.116553285905318	0.151105499907139	14.0000000001992	0.453329915060728	0.908567154037048	nan
sp|Q9BPX6|MICU1_HUMAN	Normal-Triple-negative breast cancer	-0.572132810888451	0.180605616516789	14.0000000006376	0.0068443082190429	0.0524989501286484	nan
sp|Q9BQ39|DDX50_HUMAN	metaplastic breast carcinomas-Normal	0.0187861527099976	0.533101059369365	6.0	0.973031977623169	0.986686483715501	nan
sp|Q9BQ39|DDX50_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.396335019315444	0.533101059369365	6.0	0.485290299171623	0.913320451076758	nan
sp|Q9BQ39|DDX50_HUMAN	Normal-Triple-negative breast cancer	0.377548866605446	0.637177637824738	6.0	0.575128889644581	0.735280165068687	nan
sp|Q9BQ61|TRIR_HUMAN	metaplastic breast carcinomas-Normal	0.42227361013235	0.326022085670755	23.9999999996475	0.207562017202247	0.402295128384997	nan
sp|Q9BQ61|TRIR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.844434896979678	0.326022085670755	23.9999999996475	0.0160590056174272	0.656412655960811	nan
sp|Q9BQ61|TRIR_HUMAN	Normal-Triple-negative breast cancer	-1.26670850711203	0.389670924068555	23.9999999996886	0.0033960745095475	0.0390607324212323	nan
sp|Q9BQ67|GRWD1_HUMAN	metaplastic breast carcinomas-Normal	0.437846970224614	0.312078175875099	23.9999999999142	0.173420855104532	0.361439499568716	nan
sp|Q9BQ67|GRWD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0603166996626361	0.312078175875099	23.9999999999142	0.848370487954562	0.974751041754795	nan
sp|Q9BQ67|GRWD1_HUMAN	Normal-Triple-negative breast cancer	-0.49816366988725	0.373004764154809	23.9999999998859	0.194227700809435	0.375518092845606	nan
sp|Q9BQA1|MEP50_HUMAN	metaplastic breast carcinomas-Normal	-0.0202916285430486	0.241330405902148	22.0000004064787	0.933751389360052	0.964755795942398	nan
sp|Q9BQA1|MEP50_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0629425750473235	0.241330405902148	22.0000004063607	0.796661072561989	0.965693790108864	nan
sp|Q9BQA1|MEP50_HUMAN	Normal-Triple-negative breast cancer	0.0832342035903722	0.288445005436529	22.0000004063047	0.775618112731505	0.872176795236645	nan
sp|Q9BQA9|CYBC1_HUMAN	metaplastic breast carcinomas-Normal	0.0035523382257068	0.264052991595239	23.9999999992277	0.989377492705166	0.994165301306939	nan
sp|Q9BQA9|CYBC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0613821746404668	0.264052991595239	23.9999999989078	0.818150453352688	0.965774701272009	nan
sp|Q9BQA9|CYBC1_HUMAN	Normal-Triple-negative breast cancer	-0.0649345128661736	0.315603689934964	23.9999999990378	0.838723802732239	0.908340818627252	nan
sp|Q9BQE3|TBA1C_HUMAN	metaplastic breast carcinomas-Normal	0.73773472138867	0.397775667377406	21.2194175480301	0.0775961149021365	0.219327794162161	nan
sp|Q9BQE3|TBA1C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.133350231870797	0.371105979351677	20.9375989945307	0.722945340150208	0.952374507131316	nan
sp|Q9BQE3|TBA1C_HUMAN	Normal-Triple-negative breast cancer	-0.871084953259467	0.466098903458189	21.1443516938689	0.0755556139222317	0.202374585558016	nan
sp|Q9BQE4|SELS_HUMAN	metaplastic breast carcinomas-Normal	0.713177986369621	0.312210004176221	14.0000008362754	0.0384786748319494	0.144035039573648	nan
sp|Q9BQE4|SELS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0675613226911436	0.312210004176221	14.0000008358552	0.831799682907021	0.968394238678517	nan
sp|Q9BQE4|SELS_HUMAN	Normal-Triple-negative breast cancer	-0.780739309060765	0.37316232911183	14.0000008361647	0.0551199652320779	0.166865905675252	nan
sp|Q9BQE5|APOL2_HUMAN	metaplastic breast carcinomas-Normal	0.0125306904220914	0.501797692736101	21.9999998715554	0.980302743191279	0.98983180995377	nan
sp|Q9BQE5|APOL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.559754901274781	0.501797692736101	21.9999998715554	0.276673647604653	0.867696529950794	nan
sp|Q9BQE5|APOL2_HUMAN	Normal-Triple-negative breast cancer	0.54722421085269	0.599762958456178	21.9999998716533	0.371448300488506	0.561055559292967	nan
sp|Q9BQG0|MBB1A_HUMAN	metaplastic breast carcinomas-Normal	0.669026295442876	0.221089043104773	22.0000000041056	0.0062078468968203	0.0518464399121381	nan
sp|Q9BQG0|MBB1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.156221999945323	0.221089043104773	22.0000000041051	0.487230731216805	0.913320451076758	nan
sp|Q9BQG0|MBB1A_HUMAN	Normal-Triple-negative breast cancer	-0.825248295388199	0.26425194952919	22.0000000042388	0.004951809220691	0.0450953804098005	nan
sp|Q9BQI0|AIF1L_HUMAN	metaplastic breast carcinomas-Normal	-0.492608716036463	0.533853771839407	22.0000000030592	0.366152112147031	0.576273494685952	nan
sp|Q9BQI0|AIF1L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.545466187840192	0.533853771839408	22.0000000035799	0.31800317023806	0.867696529950794	nan
sp|Q9BQI0|AIF1L_HUMAN	Normal-Triple-negative breast cancer	-0.0528574718037287	0.638077301303536	22.0000000035491	0.934728935300664	0.963124296633419	nan
sp|Q9BQS8|FYCO1_HUMAN	metaplastic breast carcinomas-Normal	-0.277660287790887	0.466638455418445	14.9999999995413	0.560698446382365	0.729171219004296	nan
sp|Q9BQS8|FYCO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.186119632787229	0.466638455418445	14.9999999996337	0.695622744352405	0.947043345959522	nan
sp|Q9BQS8|FYCO1_HUMAN	Normal-Triple-negative breast cancer	0.0915406550036587	0.557739632131738	14.9999999995975	0.871821574619609	0.926445885068993	nan
sp|Q9BR76|COR1B_HUMAN	metaplastic breast carcinomas-Normal	0.0845892228440421	0.214986513250736	22.0000000551068	0.697764854367738	0.824811655731992	nan
sp|Q9BR76|COR1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.23654245134623	0.214986513250736	22.0000000550751	0.283109964673696	0.867696529950794	nan
sp|Q9BR76|COR1B_HUMAN	Normal-Triple-negative breast cancer	-0.321131674190272	0.256958031258328	22.0000000551007	0.224525367977886	0.407158932437803	nan
sp|Q9BRA2|TXD17_HUMAN	metaplastic breast carcinomas-Normal	0.256736381141952	0.261482475509173	23.9999999993483	0.335969024354745	0.544495873698279	nan
sp|Q9BRA2|TXD17_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.139891129577372	0.261482475509173	23.9999999996313	0.597577634086591	0.940559810632461	nan
sp|Q9BRA2|TXD17_HUMAN	Normal-Triple-negative breast cancer	-0.396627510719325	0.312531335568143	23.9999999993982	0.216582319408446	0.399196535995467	nan
sp|Q9BRF8|CPPED_HUMAN	metaplastic breast carcinomas-Normal	0.162678113368611	0.23858042751129	23.9999999999552	0.501856209779451	0.687055206469067	nan
sp|Q9BRF8|CPPED_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.465797922515146	0.23858042751129	23.9999999999552	0.062653710328	0.773787875546141	nan
sp|Q9BRF8|CPPED_HUMAN	Normal-Triple-negative breast cancer	0.303119809146535	0.285158152588725	23.999999999941	0.298366531814701	0.490247331563059	nan
sp|Q9BRG1|VPS25_HUMAN	metaplastic breast carcinomas-Normal	-0.14456532348751	0.345024864632828	15.0000000001568	0.681154650768944	0.814152484414229	nan
sp|Q9BRG1|VPS25_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0795178533377786	0.345024864632828	15.0000000001568	0.820840365974697	0.965774701272009	nan
sp|Q9BRG1|VPS25_HUMAN	Normal-Triple-negative breast cancer	0.224083176825289	0.412383589140883	15.0000000001568	0.594848513163688	0.747835271465998	nan
sp|Q9BRP8|PYM1_HUMAN	metaplastic breast carcinomas-Normal	0.282493705476934	0.317956872425436	22.0000057147674	0.383901877163003	0.589275343425259	nan
sp|Q9BRP8|PYM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.403004317305181	0.317956872425436	22.0000057152784	0.21823554840612	0.843662073010871	nan
sp|Q9BRP8|PYM1_HUMAN	Normal-Triple-negative breast cancer	-0.685498022782115	0.380031150457367	22.0000057146773	0.0849756255272678	0.219300449730309	nan
sp|Q9BRX2|PELO_HUMAN	metaplastic breast carcinomas-Normal	0.448347847729545	0.249644495242666	21.1955329488393	0.0867735944800901	0.236810696265862	nan
sp|Q9BRX2|PELO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0984216236561688	0.232886102084138	20.9182296887069	0.676887286361408	0.946446689298437	nan
sp|Q9BRX2|PELO_HUMAN	Normal-Triple-negative breast cancer	-0.546769471385714	0.292517258994256	21.1216326299358	0.0755267522418082	0.202374585558016	nan
sp|Q9BRX8|PXL2A_HUMAN	metaplastic breast carcinomas-Normal	-1.63640089687555	0.508938056628746	23.9999999995707	0.0037007243899527	0.0407324763980233	nan
sp|Q9BRX8|PXL2A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.494610354385847	0.508938056628746	23.9999999999152	0.340819871435264	0.870943310236299	nan
sp|Q9BRX8|PXL2A_HUMAN	Normal-Triple-negative breast cancer	1.1417905424897	0.608297325661725	23.9999999998193	0.0727232822077647	0.197332400047845	nan
sp|Q9BS26|ERP44_HUMAN	metaplastic breast carcinomas-Normal	0.544677342838631	0.232293335254839	21.9999933115896	0.0284697995586051	0.120246014908263	nan
sp|Q9BS26|ERP44_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0006755475929661	0.232293335254839	21.9999933127214	0.997705832347527	0.998570872698367	nan
sp|Q9BS26|ERP44_HUMAN	Normal-Triple-negative breast cancer	-0.544001795245665	0.277643640054289	21.9999933125091	0.0628635993746337	0.181387677362224	nan
sp|Q9BSD7|NTPCR_HUMAN	metaplastic breast carcinomas-Normal	0.322416188946064	0.272715903519158	21.9999999074922	0.249730561076307	0.450165067796987	nan
sp|Q9BSD7|NTPCR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.150588416026698	0.272715903519158	21.999999904078	0.586391143340249	0.939599908351397	nan
sp|Q9BSD7|NTPCR_HUMAN	Normal-Triple-negative breast cancer	-0.473004604972762	0.325957850106576	21.9999999063071	0.160856698666373	0.330666460338296	nan
sp|Q9BSJ8|ESYT1_HUMAN	metaplastic breast carcinomas-Normal	-0.316190850917175	0.184155873849074	22.000000002471	0.100031641188479	0.255576614381633	nan
sp|Q9BSJ8|ESYT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0866060671880189	0.184155873849074	22.000000002515	0.642778976883086	0.941868024951375	nan
sp|Q9BSJ8|ESYT1_HUMAN	Normal-Triple-negative breast cancer	0.229584783729156	0.220108369001389	22.0000000022172	0.30825044826769	0.500549335633514	nan
sp|Q9BT09|CNPY3_HUMAN	metaplastic breast carcinomas-Normal	0.433297630276047	0.187304814435584	22.0000000273722	0.0304376926323267	0.125588514362959	nan
sp|Q9BT09|CNPY3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.263902882709477	0.187304814435584	22.0000000276924	0.172828346559592	0.843662073010871	nan
sp|Q9BT09|CNPY3_HUMAN	Normal-Triple-negative breast cancer	-0.697200512985525	0.22387207287948	22.0000000273757	0.0050534602565388	0.0452771179429151	nan
sp|Q9BT78|CSN4_HUMAN	metaplastic breast carcinomas-Normal	0.350702532358719	0.173399879269713	22.0000000315193	0.0554467706760291	0.179470650068388	nan
sp|Q9BT78|CSN4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0027700996686746	0.173399879269713	22.0000000315935	0.987398162213773	0.99777413090774	nan
sp|Q9BT78|CSN4_HUMAN	Normal-Triple-negative breast cancer	-0.347932432690044	0.207252496558291	22.0000000313904	0.107343183833526	0.253315936205068	nan
sp|Q9BTC0|DIDO1_HUMAN	metaplastic breast carcinomas-Normal	0.926377463255311	0.256989696152922	21.0328589757024	0.0016616304093744	0.0293674431135457	nan
sp|Q9BTC0|DIDO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0815634132340929	0.256989696152922	21.0328589769954	0.754084375460371	0.954748610837524	nan
sp|Q9BTC0|DIDO1_HUMAN	Normal-Triple-negative breast cancer	-0.844814050021218	0.304041569754475	20.9713301317867	0.0112651902891306	0.0674941302089485	nan
sp|Q9BTE1|DCTN5_HUMAN	metaplastic breast carcinomas-Normal	-0.218972315028771	0.126449411817658	22.0000039205305	0.0973280063992201	0.251765208771212	nan
sp|Q9BTE1|DCTN5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.149793309743782	0.126449411817658	22.0000039209094	0.24881165676033	0.852006960585063	nan
sp|Q9BTE1|DCTN5_HUMAN	Normal-Triple-negative breast cancer	0.0691790052849891	0.151135954637971	22.0000039206669	0.651637185074224	0.795169604694097	nan
sp|Q9BTE7|DCNL5_HUMAN	metaplastic breast carcinomas-Normal	-0.586823899667735	0.640750710795126	22.0000000392163	0.369682122620368	0.578542078903062	nan
sp|Q9BTE7|DCNL5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.488036127787993	0.640750710795126	22.0000000393631	0.454349328368966	0.908567154037048	nan
sp|Q9BTE7|DCNL5_HUMAN	Normal-Triple-negative breast cancer	1.07486002745573	0.765843580993683	22.000000039245	0.174426345523936	0.34864291793239	nan
sp|Q9BTT0|AN32E_HUMAN	metaplastic breast carcinomas-Normal	1.02294374841185	0.376000017376951	21.9999834019121	0.0124871868953076	0.0734259802638074	nan
sp|Q9BTT0|AN32E_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0811564106738057	0.376000017376951	21.999983401545	0.831099940534758	0.968257639200445	nan
sp|Q9BTT0|AN32E_HUMAN	Normal-Triple-negative breast cancer	-1.10410015908566	0.449405977879161	21.999983400426	0.0223754128703121	0.098904085612922	nan
sp|Q9BTV4|TMM43_HUMAN	metaplastic breast carcinomas-Normal	0.249553263844797	0.189370469788606	24.0000000001974	0.20001035313298	0.393160504916632	nan
sp|Q9BTV4|TMM43_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.427677895983466	0.189370469788606	23.999999999885	0.0332857740293725	0.724424466074313	nan
sp|Q9BTV4|TMM43_HUMAN	Normal-Triple-negative breast cancer	0.178124632138669	0.226341003254436	24.0000000001596	0.438999430206182	0.624341863388512	nan
sp|Q9BTW9|TBCD_HUMAN	metaplastic breast carcinomas-Normal	0.34070644207396	0.23023426287199	23.9999999998077	0.151927980771684	0.331805918584152	nan
sp|Q9BTW9|TBCD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.236439997325397	0.23023426287199	23.9999999998077	0.31468186819365	0.867696529950794	nan
sp|Q9BTW9|TBCD_HUMAN	Normal-Triple-negative breast cancer	-0.577146439399357	0.275182577833618	23.9999999998094	0.046678881487724	0.148213884710877	nan
sp|Q9BTX1|NDC1_HUMAN	metaplastic breast carcinomas-Normal	0.515667949342703	0.292692831394216	6.0	0.128573576525819	0.299374855792279	nan
sp|Q9BTX1|NDC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.211232430515325	0.292692831394216	6.0	0.497634911428088	0.913320451076758	nan
sp|Q9BTX1|NDC1_HUMAN	Normal-Triple-negative breast cancer	-0.726900379858027	0.349834845829454	6.0	0.0829825401887273	0.216680254192718	nan
sp|Q9BU23|LMF2_HUMAN	metaplastic breast carcinomas-Normal	0.162599113330946	0.269064372597418	21.9999999587808	0.551817360410473	0.722996021286722	nan
sp|Q9BU23|LMF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.472256888504743	0.269064372597418	21.9999999568531	0.0931456166810135	0.81309570430905	nan
sp|Q9BU23|LMF2_HUMAN	Normal-Triple-negative breast cancer	0.309657775173797	0.321593435881043	21.9999999576649	0.346069897223906	0.537813772934957	nan
sp|Q9BU61|NDUF3_HUMAN	metaplastic breast carcinomas-Normal	-0.295848789236938	0.491114856483434	14.0000000183881	0.556538267601981	0.727460952225319	nan
sp|Q9BU61|NDUF3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.104779117298109	0.491114856483434	14.0000000179103	0.834129999207772	0.9684421207956	nan
sp|Q9BU61|NDUF3_HUMAN	Normal-Triple-negative breast cancer	0.191069671938829	0.586994526938155	14.0000000178158	0.749612729138891	0.856006830048239	nan
sp|Q9BUF5|TBB6_HUMAN	metaplastic breast carcinomas-Normal	-0.158211406784241	0.260597335956166	22.0000000619258	0.549992701944741	0.722880426895562	nan
sp|Q9BUF5|TBB6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.110402624092917	0.260597335956166	22.00000006154	0.675932820764508	0.946386428913156	nan
sp|Q9BUF5|TBB6_HUMAN	Normal-Triple-negative breast cancer	0.0478087826913243	0.311473391451136	22.0000000615804	0.879409253345219	0.930348936384312	nan
sp|Q9BUJ2|HNRL1_HUMAN	metaplastic breast carcinomas-Normal	0.457921219770343	0.28720797011295	22.0000000091354	0.125115637303124	0.296183334837538	nan
sp|Q9BUJ2|HNRL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.607684827878967	0.28720797011295	22.0000000105178	0.0459115080377354	0.759166737802103	nan
sp|Q9BUJ2|HNRL1_HUMAN	Normal-Triple-negative breast cancer	-1.06560604764931	0.343279182707856	22.0000000100528	0.0051740988887139	0.0456199063821889	nan
sp|Q9BUK6|MSTO1_HUMAN	metaplastic breast carcinomas-Normal	0.0865775937695222	0.37109155365495	13.9999979445682	0.818901125805103	0.904642489930911	nan
sp|Q9BUK6|MSTO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.34645898152828	0.37109155365495	13.9999979503616	0.366322990868817	0.883542279876718	nan
sp|Q9BUK6|MSTO1_HUMAN	Normal-Triple-negative breast cancer	-0.433036575297802	0.443539241610745	13.9999979502405	0.345475068262202	0.537813772934957	nan
sp|Q9BUL8|PDC10_HUMAN	metaplastic breast carcinomas-Normal	-0.925330117038676	0.229451594953532	13.999999998838	0.0012341415101371	0.0264663637399729	nan
sp|Q9BUL8|PDC10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0514079400485345	0.229451594953532	13.9999999987101	0.825957369389624	0.965774701272009	nan
sp|Q9BUL8|PDC10_HUMAN	Normal-Triple-negative breast cancer	0.97673805708721	0.274247110745868	13.9999999989019	0.0031285018901492	0.037336569687701	nan
sp|Q9BUP3|HTAI2_HUMAN	metaplastic breast carcinomas-Normal	-0.575066948587911	0.351716552389875	24.0000000001355	0.115092696611931	0.279859636823745	nan
sp|Q9BUP3|HTAI2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.42017285805144	0.351716552389875	24.0000000001355	0.243902737770487	0.84964799869723	nan
sp|Q9BUP3|HTAI2_HUMAN	Normal-Triple-negative breast cancer	0.154894090536471	0.420381685792837	24.0000000000938	0.715760034778419	0.834802230036303	nan
sp|Q9BUQ8|DDX23_HUMAN	metaplastic breast carcinomas-Normal	-0.120767920914681	0.236468230758971	23.9999999995856	0.614216396753773	0.768460709404808	nan
sp|Q9BUQ8|DDX23_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.12139821438937	0.236468230758971	23.9999999996138	0.612379003060184	0.94077736515583	nan
sp|Q9BUQ8|DDX23_HUMAN	Normal-Triple-negative breast cancer	0.242166135304051	0.28263359460181	23.9999999996027	0.400019175278769	0.589651325333316	nan
sp|Q9BUR5|MIC26_HUMAN	metaplastic breast carcinomas-Normal	0.538536528666302	0.207373480000832	22.0000014055181	0.0164566771772933	0.0857398039769952	nan
sp|Q9BUR5|MIC26_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0229082221865926	0.207373480000832	22.0000014059012	0.913039455727599	0.99408739879047	nan
sp|Q9BUR5|MIC26_HUMAN	Normal-Triple-negative breast cancer	-0.561444750852895	0.247858716114228	22.0000014060267	0.0336928741387654	0.123621534315429	nan
sp|Q9BUT1|DHRS6_HUMAN	metaplastic breast carcinomas-Normal	-0.466621693032002	0.342775377025757	22.9999999996885	0.186606071163153	0.378218646674585	nan
sp|Q9BUT1|DHRS6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0981723646304351	0.342775377025757	22.9999999996885	0.777132437302617	0.960657739983943	nan
sp|Q9BUT1|DHRS6_HUMAN	Normal-Triple-negative breast cancer	0.368449328401567	0.405577295633286	22.9999999997633	0.373058346792734	0.561474362245857	nan
sp|Q9BV20|MTNA_HUMAN	metaplastic breast carcinomas-Normal	-0.25520258675499	0.199448472232483	22.0000000164965	0.214036761458614	0.410535600166436	nan
sp|Q9BV20|MTNA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.435076687043993	0.199448472232483	22.0000000165363	0.0401237979170472	0.738255867002113	nan
sp|Q9BV20|MTNA_HUMAN	Normal-Triple-negative breast cancer	-0.179874100289003	0.238386520100301	22.0000000165466	0.458521655768253	0.640751778146441	nan
sp|Q9BV38|WDR18_HUMAN	metaplastic breast carcinomas-Normal	-0.152930882292135	0.301120052669381	14.0000000197697	0.619449274698578	0.771757642090732	nan
sp|Q9BV38|WDR18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.101559129331227	0.301120052669381	14.0000000194915	0.740915623822643	0.954643368861838	nan
sp|Q9BV38|WDR18_HUMAN	Normal-Triple-negative breast cancer	0.0513717529609075	0.359907301794723	14.0000000192244	0.888532555283219	0.934942137942837	nan
sp|Q9BVC6|TM109_HUMAN	metaplastic breast carcinomas-Normal	0.144679254539462	0.261003257563734	23.9999999995105	0.584488956873117	0.744369740990134	nan
sp|Q9BVC6|TM109_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0932642591742213	0.261003257563734	23.9999999998409	0.723967945575247	0.952670488452066	nan
sp|Q9BVC6|TM109_HUMAN	Normal-Triple-negative breast cancer	-0.237943513713683	0.311958560569649	23.9999999996637	0.453050167976791	0.635685419313995	nan
sp|Q9BVG4|PBDC1_HUMAN	metaplastic breast carcinomas-Normal	0.257623130983294	0.418325552492837	14.0000000010458	0.547880054988551	0.721820571851741	nan
sp|Q9BVG4|PBDC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.492080654096117	0.418325552492837	14.0000000010458	0.259085823211301	0.862813416943474	nan
sp|Q9BVG4|PBDC1_HUMAN	Normal-Triple-negative breast cancer	0.234457523112823	0.499994668355055	14.0000000010872	0.646345259766655	0.791326572178402	nan
sp|Q9BVI4|NOC4L_HUMAN	metaplastic breast carcinomas-Normal	0.2749536480259	0.196956768979153	23.9999999991408	0.175492252842573	0.362997043216374	nan
sp|Q9BVI4|NOC4L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.277675975920019	0.196956768979153	23.9999999993482	0.171417413635681	0.843662073010871	nan
sp|Q9BVI4|NOC4L_HUMAN	Normal-Triple-negative breast cancer	-0.552629623945919	0.235408365085948	23.9999999992364	0.0274786310944418	0.111117968075334	nan
sp|Q9BVK6|TMED9_HUMAN	metaplastic breast carcinomas-Normal	0.850611065402162	0.24179182351302	22.0000001652865	0.0019387587480732	0.0316878588674408	nan
sp|Q9BVK6|TMED9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.203825232058172	0.24179182351302	22.0000001652865	0.408312576567776	0.885784822958391	nan
sp|Q9BVK6|TMED9_HUMAN	Normal-Triple-negative breast cancer	-0.646785833343991	0.288996504965894	22.0000001657297	0.035665089688587	0.12639885742052	nan
sp|Q9BVP2|GNL3_HUMAN	metaplastic breast carcinomas-Normal	0.508726510826831	0.377205062942396	21.1240888608999	0.191724239030408	0.384853332717282	nan
sp|Q9BVP2|GNL3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.432843100164464	0.351535380454656	20.9269938486691	0.231871937402722	0.847224386663791	nan
sp|Q9BVP2|GNL3_HUMAN	Normal-Triple-negative breast cancer	-0.0758834106623663	0.441865685426148	21.0713282322421	0.865285183844766	0.921861522788462	nan
sp|Q9BVS5|TR61B_HUMAN	metaplastic breast carcinomas-Normal	0.653885193205026	0.333728338767378	22.0000001858938	0.0628659390066256	0.191918875745801	nan
sp|Q9BVS5|TR61B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0535253547589884	0.333728338767378	22.0000001849294	0.874040580386606	0.98181923303563	nan
sp|Q9BVS5|TR61B_HUMAN	Normal-Triple-negative breast cancer	-0.707410547964014	0.39888165824041	22.0000001853409	0.0899935709827811	0.226620174202094	nan
sp|Q9BW30|TPPP3_HUMAN	metaplastic breast carcinomas-Normal	-1.06079191628701	0.407852630021509	14.9999999999143	0.0200622387866472	0.0963683261948199	nan
sp|Q9BW30|TPPP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.264893894471552	0.407852630021509	14.9999999999143	0.525846748249987	0.918329246917285	nan
sp|Q9BW30|TPPP3_HUMAN	Normal-Triple-negative breast cancer	0.795898021815454	0.487477131793983	14.9999999999	0.123344790559448	0.277022255921903	nan
sp|Q9BW61|DDA1_HUMAN	metaplastic breast carcinomas-Normal	0.329063878424882	0.337433944386664	14.9999999998289	0.344929278433693	0.555436608392647	nan
sp|Q9BW61|DDA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.126345194777166	0.337433944386664	14.9999999998289	0.713325190620048	0.94948208919602	nan
sp|Q9BW61|DDA1_HUMAN	Normal-Triple-negative breast cancer	-0.455409073202048	0.403310704091492	14.9999999997748	0.276558661168407	0.468477251931463	nan
sp|Q9BW91|NUDT9_HUMAN	metaplastic breast carcinomas-Normal	-0.0278221284254628	0.282151955524178	20.9336572416646	0.922388523991329	0.95843058885501	nan
sp|Q9BW91|NUDT9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.04835009775817	0.30268642507663	21.1484747680338	0.0023060218818367	0.448717474870704	nan
sp|Q9BW91|NUDT9_HUMAN	Normal-Triple-negative breast cancer	-1.02052796933271	0.354594875778391	21.0910297273953	0.0089760824089692	0.0594985311923575	nan
sp|Q9BWD1|THIC_HUMAN	metaplastic breast carcinomas-Normal	-0.0885593054427338	0.260516204955351	14.0000015822369	0.738949645869911	0.855842725739228	nan
sp|Q9BWD1|THIC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.361324405034599	0.260516204955351	14.0000015822078	0.18714227643035	0.843662073010871	nan
sp|Q9BWD1|THIC_HUMAN	Normal-Triple-negative breast cancer	-0.272765099591865	0.311376421357858	14.0000015823434	0.395813013147129	0.584228443916988	nan
sp|Q9BWH2|FUND2_HUMAN	metaplastic breast carcinomas-Normal	-0.363406206765671	0.269752011983838	21.9999784154051	0.191633478867122	0.384853332717282	nan
sp|Q9BWH2|FUND2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0229976931343918	0.269752011983838	21.9999784144349	0.932829824374011	0.995359816653149	nan
sp|Q9BWH2|FUND2_HUMAN	Normal-Triple-negative breast cancer	0.340408513631279	0.322415322148597	21.9999784183013	0.302513289457707	0.49510299072251	nan
sp|Q9BWM7|SFXN3_HUMAN	metaplastic breast carcinomas-Normal	0.148367803596999	0.192691715896347	22.0000000047225	0.449504116621205	0.644864774988729	nan
sp|Q9BWM7|SFXN3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0094604090157357	0.192691715896347	22.0000000044836	0.961285728177902	0.99709406933403	nan
sp|Q9BWM7|SFXN3_HUMAN	Normal-Triple-negative breast cancer	-0.157828212612735	0.230310651621049	22.000000004775	0.500322309847205	0.676135101017241	nan
sp|Q9BWS9|CHID1_HUMAN	metaplastic breast carcinomas-Normal	-0.305614854205627	0.249630039257545	21.9999999024209	0.233799104269618	0.433797107962684	nan
sp|Q9BWS9|CHID1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.241730914381116	0.249630039257545	21.9999999027267	0.343392308376425	0.870943310236299	nan
sp|Q9BWS9|CHID1_HUMAN	Normal-Triple-negative breast cancer	0.0638839398245116	0.298364964669886	21.9999999015336	0.832430682460843	0.905361542648761	nan
sp|Q9BWU0|NADAP_HUMAN	metaplastic breast carcinomas-Normal	0.772938343073347	0.245640324294992	22.0000001005059	0.0046845648504347	0.0458663504478383	nan
sp|Q9BWU0|NADAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.115258794077687	0.245640324294992	22.0000001017793	0.643530856451749	0.941868024951375	nan
sp|Q9BWU0|NADAP_HUMAN	Normal-Triple-negative breast cancer	-0.888197137151034	0.293596343203553	22.0000001012086	0.0062196362160942	0.0503018753827185	nan
sp|Q9BX66|SRBS1_HUMAN	metaplastic breast carcinomas-Normal	-1.09253643164265	0.256405122152715	22.0000000039155	0.0003189589130348	0.016828879792505	nan
sp|Q9BX66|SRBS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.223272876465473	0.256405122152715	22.0000000041349	0.393276381549432	0.885234295852111	nan
sp|Q9BX66|SRBS1_HUMAN	Normal-Triple-negative breast cancer	0.869263555177172	0.306462737576805	22.0000000041426	0.0096051902968431	0.0620611678009953	nan
sp|Q9BX97|PLVAP_HUMAN	metaplastic breast carcinomas-Normal	-0.350545025280323	0.323039268967358	15.0000000000725	0.294989604506978	0.499005315715621	nan
sp|Q9BX97|PLVAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.192083678047133	0.323039268967357	15.000000000092	0.560964316223876	0.933069710577483	nan
sp|Q9BX97|PLVAP_HUMAN	Normal-Triple-negative breast cancer	0.542628703327455	0.386105776208254	15.0000000000602	0.180278578633916	0.356629951661897	nan
sp|Q9BXB4|OSB11_HUMAN	metaplastic breast carcinomas-Normal	0.273625838903713	0.372683229526384	8.0028017116464	0.483777600617956	0.673681082720606	nan
sp|Q9BXB4|OSB11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.142269445862196	0.311835387598275	8.00011122251382	0.660353158661157	0.944434752137403	nan
sp|Q9BXB4|OSB11_HUMAN	Normal-Triple-negative breast cancer	-0.131356393041517	0.424922510004596	8.00293337895895	0.765117351041459	0.865345381034981	nan
sp|Q9BXK5|B2L13_HUMAN	metaplastic breast carcinomas-Normal	0.242720157761117	0.168072804095605	22.0000000311992	0.162791974297383	0.348660130518364	nan
sp|Q9BXK5|B2L13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.170669004672559	0.168072804095605	22.0000000311992	0.320931016615758	0.867696529950794	nan
sp|Q9BXK5|B2L13_HUMAN	Normal-Triple-negative breast cancer	-0.0720511530885588	0.200885423906123	22.0000000311074	0.723262577729143	0.840406027589934	nan
sp|Q9BXN1|ASPN_HUMAN	metaplastic breast carcinomas-Normal	-1.56674220009537	0.625614422634988	22.0000000041265	0.0201755941300242	0.0964013903004072	nan
sp|Q9BXN1|ASPN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.35733765934725	0.625614422634988	22.000000004306	0.57366775118633	0.935843259183841	nan
sp|Q9BXN1|ASPN_HUMAN	Normal-Triple-negative breast cancer	1.20940454074812	0.747752256345556	22.0000000039279	0.120044522737708	0.272358121389775	nan
sp|Q9BXP5|SRRT_HUMAN	metaplastic breast carcinomas-Normal	0.615287581727813	0.201492620750313	22.000000003005	0.005821886878475	0.0506595601676731	nan
sp|Q9BXP5|SRRT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.289430844724848	0.201492620750313	22.0000000030049	0.16494792416883	0.843662073010871	nan
sp|Q9BXP5|SRRT_HUMAN	Normal-Triple-negative breast cancer	-0.904718426452661	0.240829744890539	22.0000000030095	0.0010897859164694	0.026613045414958	nan
sp|Q9BXS5|AP1M1_HUMAN	metaplastic breast carcinomas-Normal	0.0788617104214391	0.229914649191389	23.9999999994459	0.734581517996569	0.852107985256777	nan
sp|Q9BXS5|AP1M1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.171375620799053	0.229914649191389	23.9999999994459	0.463275248956263	0.909423669537079	nan
sp|Q9BXS5|AP1M1_HUMAN	Normal-Triple-negative breast cancer	0.0925139103776142	0.274800566418629	23.9999999994991	0.739300537395895	0.850288269338703	nan
sp|Q9BXV9|GON7_HUMAN	metaplastic breast carcinomas-Normal	0.44597910434004	0.204971178536532	12.0276247813218	0.0502194120904591	0.169912927873181	nan
sp|Q9BXV9|GON7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0171753297132885	0.184378027625123	12.0085662188835	0.927318284112927	0.995209711945114	nan
sp|Q9BXV9|GON7_HUMAN	Normal-Triple-negative breast cancer	-0.428803774626752	0.235321897897742	12.0469793211409	0.0933281201918719	0.232899903541878	nan
sp|Q9BY42|RTF2_HUMAN	metaplastic breast carcinomas-Normal	1.39873185425205	0.531460638145229	14.9999999999721	0.018862259172831	0.0929781777313555	nan
sp|Q9BY42|RTF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.309654140945387	0.531460638145229	14.9999999999992	0.56878665683663	0.935631258424823	nan
sp|Q9BY42|RTF2_HUMAN	Normal-Triple-negative breast cancer	-1.70838599519743	0.635216959446292	14.9999999999747	0.0168104597530322	0.0835246161720166	nan
sp|Q9BY44|EIF2A_HUMAN	metaplastic breast carcinomas-Normal	0.930585834138564	0.262015850763969	22.0000000592094	0.0017879816493298	0.0300164192039004	nan
sp|Q9BY44|EIF2A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.285951977697157	0.262015850763969	22.0000000591543	0.286925843896367	0.867696529950794	nan
sp|Q9BY44|EIF2A_HUMAN	Normal-Triple-negative breast cancer	-1.21653781183572	0.313168840932187	22.0000000584889	0.0007988071057732	0.0257262735003663	nan
sp|Q9BY77|PDIP3_HUMAN	metaplastic breast carcinomas-Normal	0.620708958573186	0.51262459399019	14.9999999999411	0.244688155645802	0.444727514478219	nan
sp|Q9BY77|PDIP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.24557993735262	0.51262459399019	14.999999999911	0.638802129131377	0.941868024951375	nan
sp|Q9BY77|PDIP3_HUMAN	Normal-Triple-negative breast cancer	-0.866288895925806	0.612703580585503	14.9999999998896	0.177815789102256	0.353293295263538	nan
sp|Q9BYG3|MK67I_HUMAN	metaplastic breast carcinomas-Normal	0.0957948037938834	0.395279269882725	14.0000000191446	0.812025402022655	0.900925915386606	nan
sp|Q9BYG3|MK67I_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0047187715977685	0.395279269882725	14.0000000192014	0.990643676620287	0.998185231446144	nan
sp|Q9BYG3|MK67I_HUMAN	Normal-Triple-negative breast cancer	-0.100513575391652	0.472449092040644	14.0000000190943	0.834588565090692	0.906349225873604	nan
sp|Q9BYT8|NEUL_HUMAN	metaplastic breast carcinomas-Normal	-0.119597128379993	0.332578460659821	22.9999999992726	0.722422734498436	0.845837678574428	nan
sp|Q9BYT8|NEUL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.204915475098515	0.311098663502431	22.9999999992447	0.516639545380024	0.915620969865368	nan
sp|Q9BYT8|NEUL_HUMAN	Normal-Triple-negative breast cancer	-0.0853183467185228	0.38998281331416	22.9999999991939	0.828755295848439	0.902911374434681	nan
sp|Q9BZE4|GTPB4_HUMAN	metaplastic breast carcinomas-Normal	0.479224737448363	0.264636213710114	22.0000063156913	0.0838378366706042	0.230883984335616	nan
sp|Q9BZE4|GTPB4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0835202038274249	0.264636213710114	22.0000063160462	0.755277662835264	0.954748610837524	nan
sp|Q9BZE4|GTPB4_HUMAN	Normal-Triple-negative breast cancer	-0.562744941275788	0.316300773692259	22.0000063156525	0.0890375528958618	0.22472348202418	nan
sp|Q9BZE9|ASPC1_HUMAN	metaplastic breast carcinomas-Normal	0.258846391053371	0.195864614448358	22.0000000269844	0.1998947993613	0.393160504916632	nan
sp|Q9BZE9|ASPC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.267324734813304	0.195864614448358	22.0000000269466	0.186099289520044	0.843662073010871	nan
sp|Q9BZE9|ASPC1_HUMAN	Normal-Triple-negative breast cancer	-0.526171125866675	0.234102990744928	22.0000000266489	0.0349583162073297	0.125082285331716	nan
sp|Q9BZF1|OSBL8_HUMAN	metaplastic breast carcinomas-Normal	-0.0225107161394021	0.288261500825735	23.999999999393	0.93840285736367	0.968410772392686	nan
sp|Q9BZF1|OSBL8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.214929142965852	0.288261500825735	23.999999999431	0.46314669440393	0.909423669537079	nan
sp|Q9BZF1|OSBL8_HUMAN	Normal-Triple-negative breast cancer	-0.19241842682645	0.344538392756589	23.9999999993736	0.581689006195268	0.739128739543979	nan
sp|Q9BZF3|OSBL6_HUMAN	metaplastic breast carcinomas-Normal	-0.766053654569857	0.320603210942129	9.00841314818111	0.0405719488699204	0.149310692394896	nan
sp|Q9BZF3|OSBL6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.101899644814365	0.242363788977038	9.00684356795209	0.684016789149039	0.946568877415162	nan
sp|Q9BZF3|OSBL6_HUMAN	Normal-Triple-negative breast cancer	0.664154009755491	0.357689990517098	9.01072598763296	0.096265697626655	0.238262977595682	nan
sp|Q9BZF9|UACA_HUMAN	metaplastic breast carcinomas-Normal	-0.297160144821984	0.155136412603411	22.0000000328034	0.0685200836392061	0.20281456635505	nan
sp|Q9BZF9|UACA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0877341387261639	0.155136412603411	22.0000000321271	0.57743683859103	0.936117741743138	nan
sp|Q9BZF9|UACA_HUMAN	Normal-Triple-negative breast cancer	0.20942600609582	0.185423478693102	22.0000000323544	0.270874312672103	0.463161633396127	nan
sp|Q9BZH6|WDR11_HUMAN	metaplastic breast carcinomas-Normal	0.679075722017061	0.25584914150243	22.0000000476387	0.014489899663726	0.0795450818130059	nan
sp|Q9BZH6|WDR11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0386000793091283	0.25584914150243	22.0000000468045	0.881452708113661	0.983709256883903	nan
sp|Q9BZH6|WDR11_HUMAN	Normal-Triple-negative breast cancer	-0.71767580132619	0.305798213597348	22.0000000473564	0.0283420140251025	0.112421067564965	nan
sp|Q9BZK7|TBL1R_HUMAN	metaplastic breast carcinomas-Normal	0.0661616018771309	0.300871799332999	20.5968283674473	0.828114131033375	0.909492232445857	nan
sp|Q9BZK7|TBL1R_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.163153711450041	0.251100598375044	19.9978139416547	0.523245121046807	0.917610773987677	nan
sp|Q9BZK7|TBL1R_HUMAN	Normal-Triple-negative breast cancer	0.09699210957291	0.342849698212341	20.4663123374166	0.780095182581471	0.874536213214749	nan
sp|Q9BZL4|PP12C_HUMAN	metaplastic breast carcinomas-Normal	0.471708556504256	0.199090781284711	13.9999996412199	0.0327347309131916	0.129407306133986	nan
sp|Q9BZL4|PP12C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.22487160869838	0.199090781284711	13.9999996404719	0.277671810266308	0.867696529950794	nan
sp|Q9BZL4|PP12C_HUMAN	Normal-Triple-negative breast cancer	-0.696580165202636	0.237958997646224	13.999999639943	0.011030100481894	0.0670157251028676	nan
sp|Q9BZQ8|NIBA1_HUMAN	metaplastic breast carcinomas-Normal	-0.441996424615254	0.317594947337995	14.9999999996352	0.184308328867986	0.375392699238471	nan
sp|Q9BZQ8|NIBA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.258389686764179	0.317594947337995	14.9999999997355	0.428610444298919	0.894058800058913	nan
sp|Q9BZQ8|NIBA1_HUMAN	Normal-Triple-negative breast cancer	0.183606737851076	0.379598567238422	14.9999999997022	0.635593349194381	0.781906844086648	nan
sp|Q9BZV1|UBXN6_HUMAN	metaplastic breast carcinomas-Normal	-0.323087041363488	0.107270146611829	14.0000000015372	0.0093288120352628	0.0642007685408151	nan
sp|Q9BZV1|UBXN6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0687884222338973	0.107270146611829	14.0000000018524	0.531709996992219	0.921279697758795	nan
sp|Q9BZV1|UBXN6_HUMAN	Normal-Triple-negative breast cancer	0.254298619129591	0.128212348157953	14.0000000016135	0.0672890258149066	0.187484259688809	nan
sp|Q9BZZ2|SN_HUMAN	metaplastic breast carcinomas-Normal	-0.402480252038622	0.33489734708493	20.064988606281	0.243433281640483	0.44435597373584	nan
sp|Q9BZZ2|SN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.519013502844451	0.33489734708493	20.064988609712	0.136826579207713	0.823891816737944	nan
sp|Q9BZZ2|SN_HUMAN	Normal-Triple-negative breast cancer	0.921493754883073	0.409987909813014	19.5315987338976	0.0363275252306713	0.126841064986083	nan
sp|Q9BZZ5|API5_HUMAN	metaplastic breast carcinomas-Normal	0.481387071719377	0.243653638761082	22.0000000541675	0.0608637038411023	0.189252527191604	nan
sp|Q9BZZ5|API5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.644199536253463	0.243653638761082	22.0000000541675	0.0148261291938837	0.656412655960811	nan
sp|Q9BZZ5|API5_HUMAN	Normal-Triple-negative breast cancer	-1.12558660797284	0.291221799815673	22.0000000539585	0.0008377091128761	0.0257262735003663	nan
sp|Q9C040|TRIM2_HUMAN	metaplastic breast carcinomas-Normal	1.29406255509452	1.03504956477049	6.0	0.257761358907678	0.460149708382987	nan
sp|Q9C040|TRIM2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0420925618227911	1.03504956477049	6.0	0.968880670652453	0.99709406933403	nan
sp|Q9C040|TRIM2_HUMAN	Normal-Triple-negative breast cancer	-1.25196999327173	1.2371208518928	6.0	0.350593048218825	0.54119935402295	nan
sp|Q9C0B1|FTO_HUMAN	metaplastic breast carcinomas-Normal	-0.290451007724142	0.340399889687698	15.0000000000849	0.406932407603974	0.609298794088112	nan
sp|Q9C0B1|FTO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.182800828443701	0.340399889687698	15.0000000000849	0.599131300100512	0.940559810632461	nan
sp|Q9C0B1|FTO_HUMAN	Normal-Triple-negative breast cancer	0.107650179280441	0.406855686769008	15.0000000001765	0.794925989152423	0.882543082145175	nan
sp|Q9C0C2|TB182_HUMAN	metaplastic breast carcinomas-Normal	-0.0472226517420146	0.229103177194516	22.0000000113755	0.838593048914438	0.914228696159918	nan
sp|Q9C0C2|TB182_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0238577213630778	0.229103177194516	22.0000000106347	0.918005527022345	0.99408739879047	nan
sp|Q9C0C2|TB182_HUMAN	Normal-Triple-negative breast cancer	0.0233649303789368	0.273830671872293	22.000000010664	0.932773827245005	0.962453172165297	nan
sp|Q9C0C9|UBE2O_HUMAN	metaplastic breast carcinomas-Normal	0.266812002525781	0.31291791004385	22.0000032747668	0.403036519316483	0.605445350319195	nan
sp|Q9C0C9|UBE2O_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0729491190173272	0.31291791004385	22.0000032737684	0.817819380252488	0.965774701272009	nan
sp|Q9C0C9|UBE2O_HUMAN	Normal-Triple-negative breast cancer	-0.193862883508454	0.374008438457536	22.0000032741772	0.609396578901228	0.760087890531964	nan
sp|Q9C0D6|FHDC1_HUMAN	metaplastic breast carcinomas-Normal	-0.439937763094955	0.374991917071468	9.00549286063247	0.27081397483419	0.472786582115992	nan
sp|Q9C0D6|FHDC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.347924385063788	0.292568146171812	9.00507624263941	0.26476896788147	0.864992243302031	nan
sp|Q9C0D6|FHDC1_HUMAN	Normal-Triple-negative breast cancer	0.0920133780311673	0.420980712980247	9.01332945136143	0.831854450734603	0.905361542648761	nan
sp|Q9C0E2|XPO4_HUMAN	metaplastic breast carcinomas-Normal	0.0549916523867643	0.328307121788578	13.9999688631855	0.869371599103144	0.931589682597953	nan
sp|Q9C0E2|XPO4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.248546123632668	0.328307121788578	13.9999688633379	0.461569609215697	0.909423669537079	nan
sp|Q9C0E2|XPO4_HUMAN	Normal-Triple-negative breast cancer	0.193554471245903	0.392402064609939	13.9999688632725	0.629479161296279	0.777550625101758	nan
sp|Q9C0E8|LNP_HUMAN	metaplastic breast carcinomas-Normal	-0.0258439101105665	0.179907543029867	22.000000004731	0.88708371709012	0.940415790777734	nan
sp|Q9C0E8|LNP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.200411740301369	0.179907543029867	22.0000000050503	0.277314597939939	0.867696529950794	nan
sp|Q9C0E8|LNP_HUMAN	Normal-Triple-negative breast cancer	0.226255650411936	0.215030642464356	22.0000000045957	0.304127432574143	0.49627863813277	nan
sp|Q9C0J8|WDR33_HUMAN	metaplastic breast carcinomas-Normal	1.48643633193253	0.394204115928934	23.0000000001442	0.0009923796851452	0.023903406329151	nan
sp|Q9C0J8|WDR33_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.132196619038638	0.394204115928934	23.0000000001442	0.740400139881763	0.954643368861838	nan
sp|Q9C0J8|WDR33_HUMAN	Normal-Triple-negative breast cancer	-1.35423971289389	0.466428600132364	23.0000000001781	0.0080077728119991	0.0569975092657069	nan
sp|Q9GZL7|WDR12_HUMAN	metaplastic breast carcinomas-Normal	0.613515394857034	0.272247869373477	22.000003809471	0.034527851665945	0.133609521464029	nan
sp|Q9GZL7|WDR12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0351732564678214	0.272247869373477	22.0000038097622	0.898376687527365	0.989671989983163	nan
sp|Q9GZL7|WDR12_HUMAN	Normal-Triple-negative breast cancer	-0.648688651324856	0.325398442305512	22.0000038095134	0.0587484771625533	0.173428008959438	nan
sp|Q9GZN8|CT027_HUMAN	metaplastic breast carcinomas-Normal	-0.256297578460277	0.341879629048998	23.9999999992562	0.46073827701679	0.654484629403338	nan
sp|Q9GZN8|CT027_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0080064479207474	0.341879629048999	23.9999999992562	0.981509750308222	0.99777413090774	nan
sp|Q9GZN8|CT027_HUMAN	Normal-Triple-negative breast cancer	0.24829113053953	0.408624313587993	23.9999999993493	0.549141802229983	0.714018242745883	nan
sp|Q9GZP4|PITH1_HUMAN	metaplastic breast carcinomas-Normal	-0.167538937921481	0.259823787791174	13.9999703805696	0.529470719172696	0.707379690727509	nan
sp|Q9GZP4|PITH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0282491811524251	0.259823787791174	13.9999703804992	0.914964053126154	0.99408739879047	nan
sp|Q9GZP4|PITH1_HUMAN	Normal-Triple-negative breast cancer	0.139289756769056	0.31054882455364	13.9999703805764	0.660636149159921	0.799725735949474	nan
sp|Q9GZR2|REXO4_HUMAN	metaplastic breast carcinomas-Normal	0.573829950848543	0.257131217347883	22.0000000156851	0.0361436141350111	0.13777680434034	nan
sp|Q9GZR2|REXO4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.33219460699196	0.257131217347883	22.0000000153015	0.209790092417481	0.843662073010871	nan
sp|Q9GZR2|REXO4_HUMAN	Normal-Triple-negative breast cancer	-0.906024557840503	0.30733058732717	22.0000000152908	0.0074362489098221	0.0544451351899752	nan
sp|Q9GZR7|DDX24_HUMAN	metaplastic breast carcinomas-Normal	1.06564932345909	0.321493476243496	14.999999999671	0.0047147810546083	0.0458663504478383	nan
sp|Q9GZR7|DDX24_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.175950239156063	0.321493476243496	14.9999999995349	0.592229654983822	0.940559810632461	nan
sp|Q9GZR7|DDX24_HUMAN	Normal-Triple-negative breast cancer	-1.24159956261515	0.384258200520594	14.9999999995932	0.0055951659207866	0.0473239987803939	nan
sp|Q9GZS3|WDR61_HUMAN	metaplastic breast carcinomas-Normal	-0.211992515513512	0.140114063018315	23.9999999997346	0.143337967572044	0.319340083250317	nan
sp|Q9GZS3|WDR61_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0535742649245819	0.140114063018315	23.9999999997346	0.705558131563923	0.94948208919602	nan
sp|Q9GZS3|WDR61_HUMAN	Normal-Triple-negative breast cancer	0.15841825058893	0.167468336689572	23.9999999997261	0.353596694645142	0.543675061879149	nan
sp|Q9GZT3|SLIRP_HUMAN	metaplastic breast carcinomas-Normal	0.183947250665612	0.35570477786015	23.9999999995968	0.609795651280234	0.766336765540832	nan
sp|Q9GZT3|SLIRP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.42346500792414	0.35570477786015	23.999999999291	0.245494231574788	0.84964799869723	nan
sp|Q9GZT3|SLIRP_HUMAN	Normal-Triple-negative breast cancer	-0.607412258589752	0.425148526975387	23.9999999995144	0.165975273110764	0.33681429048851	nan
sp|Q9GZT9|EGLN1_HUMAN	metaplastic breast carcinomas-Normal	-0.170994002834158	0.447606063819116	13.9999999996059	0.708183433867457	0.834456481451765	nan
sp|Q9GZT9|EGLN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.443459016543702	0.447606063819116	13.9999999996243	0.338630230545534	0.870943310236299	nan
sp|Q9GZT9|EGLN1_HUMAN	Normal-Triple-negative breast cancer	-0.272465013709544	0.526696627803722	13.9999999996113	0.613016441877802	0.763171031011915	nan
sp|Q9GZU8|PIP30_HUMAN	metaplastic breast carcinomas-Normal	0.261554885380612	0.275169900669322	6.0	0.378547855874022	0.584741338978095	nan
sp|Q9GZU8|PIP30_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.481343128327026	0.275169900669322	6.0	0.130824782240647	0.823891816737944	nan
sp|Q9GZU8|PIP30_HUMAN	Normal-Triple-negative breast cancer	-0.742898013707639	0.328890937707677	6.0	0.0646548661267485	0.184632968217622	nan
sp|Q9GZV5|WWTR1_HUMAN	metaplastic breast carcinomas-Normal	-0.200121211886935	0.441530126241461	6.0	0.666302322338595	0.804500152362328	nan
sp|Q9GZV5|WWTR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.630118711102983	0.441530126241461	6.0	0.20344907401131	0.843662073010871	nan
sp|Q9GZV5|WWTR1_HUMAN	Normal-Triple-negative breast cancer	0.830239922989918	0.527729438766821	6.0	0.166728469774664	0.337642513251579	nan
sp|Q9GZY8|MFF_HUMAN	metaplastic breast carcinomas-Normal	-0.415943532871703	0.283504124199438	23.9999999995984	0.155317740590007	0.336336266919337	nan
sp|Q9GZY8|MFF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.101160862190734	0.283504124199438	23.9999999998759	0.724342344691268	0.952705022190848	nan
sp|Q9GZY8|MFF_HUMAN	Normal-Triple-negative breast cancer	0.517104395062437	0.33885224010746	23.9999999997298	0.140069919831157	0.301744921269454	nan
sp|Q9GZZ1|NAA50_HUMAN	metaplastic breast carcinomas-Normal	0.589828460474492	0.371653119453052	23.999999999563	0.125592418919896	0.296183334837538	nan
sp|Q9GZZ1|NAA50_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.199215413447638	0.371653119453053	23.9999999996087	0.596874663731255	0.940559810632461	nan
sp|Q9GZZ1|NAA50_HUMAN	Normal-Triple-negative breast cancer	-0.78904387392213	0.444210441118661	23.9999999995368	0.0883669461414952	0.22401788132619	nan
sp|Q9GZZ9|UBA5_HUMAN	metaplastic breast carcinomas-Normal	-0.0340314186896987	0.251986729110234	22.0000000310258	0.893798446540227	0.941974012777335	nan
sp|Q9GZZ9|UBA5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0344876507035648	0.251986729110234	22.0000000307056	0.892383890766766	0.988218752026376	nan
sp|Q9GZZ9|UBA5_HUMAN	Normal-Triple-negative breast cancer	0.0685190693932635	0.301181747805147	22.0000000307632	0.822135332867699	0.898940081069813	nan
sp|Q9H074|PAIP1_HUMAN	metaplastic breast carcinomas-Normal	0.72866904668601	0.396972073810035	22.9999999994625	0.0793857009800717	0.223436130446874	nan
sp|Q9H074|PAIP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.165007750970887	0.396972073810035	22.9999999994625	0.68150709790217	0.946568877415162	nan
sp|Q9H074|PAIP1_HUMAN	Normal-Triple-negative breast cancer	-0.893676797656897	0.469703692064535	22.9999999994233	0.0696807431407575	0.191896263628731	nan
sp|Q9H0A0|NAT10_HUMAN	metaplastic breast carcinomas-Normal	0.300954443155113	0.22595501129821	22.000000025198	0.196520970113959	0.389298210720485	nan
sp|Q9H0A0|NAT10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.755208998731265	0.22595501129821	22.0000000250766	0.002950256465132	0.448717474870704	nan
sp|Q9H0A0|NAT10_HUMAN	Normal-Triple-negative breast cancer	-1.05616344188638	0.270067893926096	22.0000000251736	0.0007496181077212	0.0257262735003663	nan
sp|Q9H0B6|KLC2_HUMAN	metaplastic breast carcinomas-Normal	0.307855882560934	0.377647659756763	14.0000000021936	0.428612462353204	0.626520591408113	nan
sp|Q9H0B6|KLC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.271699325015364	0.377647659756763	14.0000000022186	0.483700223677805	0.913320451076758	nan
sp|Q9H0B6|KLC2_HUMAN	Normal-Triple-negative breast cancer	-0.579555207576298	0.451375287189464	14.000000001938	0.219993415762076	0.403341485931132	nan
sp|Q9H0C8|ILKAP_HUMAN	metaplastic breast carcinomas-Normal	0.502695935773209	0.224405670939535	14.9999999999877	0.0406516776827258	0.149310692394896	nan
sp|Q9H0C8|ILKAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0313873615264945	0.224405670939535	14.9999999999883	0.890624416542894	0.98820634909787	nan
sp|Q9H0C8|ILKAP_HUMAN	Normal-Triple-negative breast cancer	-0.534083297299704	0.268216078003812	15.0000000000079	0.0649896901401481	0.184795320809112	nan
sp|Q9H0D6|XRN2_HUMAN	metaplastic breast carcinomas-Normal	0.419048715025959	0.24556218357772	22.000003126116	0.101995929134244	0.258601320429514	nan
sp|Q9H0D6|XRN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.210671118931912	0.24556218357772	22.0000031251585	0.400190446406848	0.885297496092956	nan
sp|Q9H0D6|XRN2_HUMAN	Normal-Triple-negative breast cancer	-0.629719833957871	0.293502947182715	22.0000031258255	0.0432026514322476	0.14176269828311	nan
sp|Q9H0E3|SP130_HUMAN	metaplastic breast carcinomas-Normal	0.188373193438333	0.224674352335078	21.9999991830833	0.410807968324938	0.613168247288772	nan
sp|Q9H0E3|SP130_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.227280100469787	0.224674352335078	21.9999991838923	0.322727551090133	0.867696529950794	nan
sp|Q9H0E3|SP130_HUMAN	Normal-Triple-negative breast cancer	0.0389069070314534	0.268537213694561	21.999999185225	0.886121139612716	0.933882900466921	nan
sp|Q9H0P0|5NT3A_HUMAN	metaplastic breast carcinomas-Normal	-0.0464365186438932	1.33255704501764	9.99999999999075	0.972886988920228	0.986686483715501	nan
sp|Q9H0P0|5NT3A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.722895940435653	1.33255704501764	9.99999999993032	0.59936305212732	0.940559810632461	nan
sp|Q9H0P0|5NT3A_HUMAN	Normal-Triple-negative breast cancer	0.769332459079546	1.70461269949485	9.99999999995827	0.6613856943818	0.799725735949474	nan
sp|Q9H0U3|MAGT1_HUMAN	metaplastic breast carcinomas-Normal	0.17212455328509	0.185526742552137	23.9999999993188	0.362768440441775	0.573664270232378	nan
sp|Q9H0U3|MAGT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.005197466290087	0.185526742552137	23.9999999990406	0.977882121988457	0.99709406933403	nan
sp|Q9H0U3|MAGT1_HUMAN	Normal-Triple-negative breast cancer	-0.177322019575177	0.221746870494931	23.9999999991606	0.431751994998918	0.617000701365607	nan
sp|Q9H0U4|RAB1B_HUMAN	metaplastic breast carcinomas-Normal	0.249481877497703	0.210404214791083	23.9999999996614	0.247337511052672	0.447023820508909	nan
sp|Q9H0U4|RAB1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.291531263789014	0.210404214791083	23.9999999996614	0.178618602872759	0.843662073010871	nan
sp|Q9H0U4|RAB1B_HUMAN	Normal-Triple-negative breast cancer	-0.541013141286716	0.251481137042842	23.9999999997299	0.0417300550925522	0.13854792318675	nan
sp|Q9H0W8|SMG9_HUMAN	metaplastic breast carcinomas-Normal	0.222373681573459	0.399399970707881	13.9999999999026	0.586475773341296	0.746056437269984	nan
sp|Q9H0W8|SMG9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.161111774622002	0.358947557163277	13.9999999997065	0.660412794167039	0.944434752137403	nan
sp|Q9H0W8|SMG9_HUMAN	Normal-Triple-negative breast cancer	-0.0612619069514573	0.463399303685069	13.9999999998172	0.896706429055251	0.940268823400522	nan
sp|Q9H1B7|I2BPL_HUMAN	metaplastic breast carcinomas-Normal	0.131463353168138	0.304075202221367	14.9999999997701	0.671646496482423	0.808148806621432	nan
sp|Q9H1B7|I2BPL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.617633324601759	0.304075202221367	14.99999999977	0.0603476768528367	0.773787875546141	nan
sp|Q9H1B7|I2BPL_HUMAN	Normal-Triple-negative breast cancer	0.486169971433622	0.363439381084119	14.9999999997907	0.200926335473845	0.38169809305568	nan
sp|Q9H1E3|NUCKS_HUMAN	metaplastic breast carcinomas-Normal	0.827680932869653	0.332350007832428	22.0003512252949	0.02079868401647	0.0983425685216875	nan
sp|Q9H1E3|NUCKS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.165901891979905	0.332350007832428	22.0003512252937	0.622608867020062	0.941374262616245	nan
sp|Q9H1E3|NUCKS_HUMAN	Normal-Triple-negative breast cancer	-0.661779040889748	0.397234237673828	22.0003512996627	0.109896544203283	0.256708441975905	nan
sp|Q9H1E5|TMX4_HUMAN	metaplastic breast carcinomas-Normal	0.131205459602031	0.46530278488954	14.9999999998507	0.781813108785248	0.881827883814783	nan
sp|Q9H1E5|TMX4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0167544988244256	0.46530278488954	14.9999999998501	0.971751014841465	0.99709406933403	nan
sp|Q9H1E5|TMX4_HUMAN	Normal-Triple-negative breast cancer	-0.147959958426457	0.556143200502946	14.9999999998504	0.793825505969638	0.882283347258742	nan
sp|Q9H223|EHD4_HUMAN	metaplastic breast carcinomas-Normal	-0.44399974517087	0.269757739606027	22.0000000324528	0.113993020819299	0.27799912047201	nan
sp|Q9H223|EHD4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0231659810531527	0.269757739606027	22.0000000324527	0.932340989199554	0.995359816653149	nan
sp|Q9H223|EHD4_HUMAN	Normal-Triple-negative breast cancer	0.467165726224022	0.322422167966501	22.0000000320967	0.161463230171798	0.331094248668141	nan
sp|Q9H299|SH3L3_HUMAN	metaplastic breast carcinomas-Normal	0.18391985722115	0.194061541607778	23.9999999992738	0.352707800425212	0.561744479911381	nan
sp|Q9H299|SH3L3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.160848400999677	0.194061541607778	23.9999999995294	0.415355370369939	0.8860071777014	nan
sp|Q9H299|SH3L3_HUMAN	Normal-Triple-negative breast cancer	-0.0230714562214729	0.231947906501153	23.9999999993398	0.921592675432027	0.954322134933351	nan
sp|Q9H2D6|TARA_HUMAN	metaplastic breast carcinomas-Normal	-0.0997993860110255	0.167461641091371	22.0000000360125	0.557288497513863	0.727869141743057	nan
sp|Q9H2D6|TARA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.037241312489187	0.167461641091371	22.0000000361701	0.826064135463938	0.965774701272009	nan
sp|Q9H2D6|TARA_HUMAN	Normal-Triple-negative breast cancer	0.137040698500212	0.200154944398495	22.0000000360542	0.500700433056197	0.676135101017241	nan
sp|Q9H2G2|SLK_HUMAN	metaplastic breast carcinomas-Normal	0.199116219085392	0.126901462532707	23.9999999991435	0.129725249335682	0.300492493931573	nan
sp|Q9H2G2|SLK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0549915582268359	0.126901462532707	23.999999999096	0.668637292048306	0.946277260710207	nan
sp|Q9H2G2|SLK_HUMAN	Normal-Triple-negative breast cancer	-0.144124660858556	0.151676258585468	23.99999999915	0.351475863958005	0.541885793968649	nan
sp|Q9H2M9|RBGPR_HUMAN	metaplastic breast carcinomas-Normal	-0.0222306558810937	0.247195832009959	23.9999999993637	0.929088085980354	0.962083737631992	nan
sp|Q9H2M9|RBGPR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.004913793388575	0.247195832009959	23.9999999993895	0.984304924008278	0.99777413090774	nan
sp|Q9H2M9|RBGPR_HUMAN	Normal-Triple-negative breast cancer	0.0173168624925187	0.295455530526521	23.9999999993582	0.953747457091851	0.976064207935133	nan
sp|Q9H2P0|ADNP_HUMAN	metaplastic breast carcinomas-Normal	0.696240873151262	0.307326317556022	22.0000001261508	0.0336718568547002	0.131226247969629	nan
sp|Q9H2P0|ADNP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.426451585327855	0.307326317556022	22.0000001264529	0.17914927596417	0.843662073010871	nan
sp|Q9H2P0|ADNP_HUMAN	Normal-Triple-negative breast cancer	-1.12269245847912	0.367325207144344	22.0000001259033	0.0057847075020509	0.0481913978366351	nan
sp|Q9H2U1|DHX36_HUMAN	metaplastic breast carcinomas-Normal	-0.456398554300778	0.604818394055498	15.0000000001457	0.462170136909403	0.654925807993489	nan
sp|Q9H2U1|DHX36_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.518011368266718	0.604818394055498	15.000000000145	0.405210728696352	0.885297496092956	nan
sp|Q9H2U1|DHX36_HUMAN	Normal-Triple-negative breast cancer	0.974409922567496	0.722896248026814	15.0000000001432	0.197688035699726	0.3786926489393	nan
sp|Q9H2U2|IPYR2_HUMAN	metaplastic breast carcinomas-Normal	-0.100858714663084	0.297212347960274	22.0000000304992	0.737564906893595	0.854536685435452	nan
sp|Q9H2U2|IPYR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.672896668487128	0.297212347960274	22.0000000304694	0.0337746599433571	0.724424466074313	nan
sp|Q9H2U2|IPYR2_HUMAN	Normal-Triple-negative breast cancer	-0.572037953824044	0.355236701329568	22.0000000304965	0.1215883386866	0.274751623245588	nan
sp|Q9H307|PININ_HUMAN	metaplastic breast carcinomas-Normal	0.829359222523701	0.245040841417056	24.0000000001104	0.0024486425288297	0.0356986305518857	nan
sp|Q9H307|PININ_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.237107225993171	0.245040841417056	24.0000000001104	0.342883107438448	0.870943310236299	nan
sp|Q9H307|PININ_HUMAN	Normal-Triple-negative breast cancer	-1.06646644851687	0.292879824117038	24.0000000001209	0.0012970679348609	0.0266490250684039	nan
sp|Q9H3G5|CPVL_HUMAN	metaplastic breast carcinomas-Normal	0.0530067261076487	0.213305878296832	24.0000000001217	0.805860887059293	0.897982429964831	nan
sp|Q9H3G5|CPVL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.112269781144462	0.213305878296832	24.0000000001217	0.603487938812995	0.940559810632461	nan
sp|Q9H3G5|CPVL_HUMAN	Normal-Triple-negative breast cancer	0.0592630550368133	0.254949288279573	24.0000000001445	0.818159060810682	0.896788728984734	nan
sp|Q9H3K2|GHITM_HUMAN	metaplastic breast carcinomas-Normal	-0.0080040043906124	0.299415721398455	20.9566091311821	0.978926354338999	0.989752057128702	nan
sp|Q9H3K2|GHITM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.117609523062537	0.299415721398455	20.956609130986	0.698436542150382	0.947043345959522	nan
sp|Q9H3K2|GHITM_HUMAN	Normal-Triple-negative breast cancer	0.12561352745315	0.354167768308013	20.9088585981956	0.726387272139049	0.841586368975321	nan
sp|Q9H3N1|TMX1_HUMAN	metaplastic breast carcinomas-Normal	0.600334989514504	0.20855037454596	21.9999999988389	0.0087228693448033	0.061560122509822	nan
sp|Q9H3N1|TMX1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0754824218291254	0.20855037454596	21.9999999996367	0.720851245059864	0.951268548117182	nan
sp|Q9H3N1|TMX1_HUMAN	Normal-Triple-negative breast cancer	-0.524852567685379	0.249265374144735	21.9999999994473	0.0468802834736759	0.148615044380989	nan
sp|Q9H3P2|NELFA_HUMAN	metaplastic breast carcinomas-Normal	0.253962793591698	0.328714908360418	23.9999999993723	0.447305616657342	0.643376836767203	nan
sp|Q9H3P2|NELFA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.462836817536952	0.328714908360418	23.999999999343	0.171947620862394	0.843662073010871	nan
sp|Q9H3P2|NELFA_HUMAN	Normal-Triple-negative breast cancer	-0.71679961112865	0.392889462787105	23.9999999993566	0.0805620825280947	0.211447941800934	nan
sp|Q9H3Q1|BORG4_HUMAN	metaplastic breast carcinomas-Normal	-0.681527289046432	0.303797207505221	23.9999999991064	0.0343706646736746	0.133337659999685	nan
sp|Q9H3Q1|BORG4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.405182739323087	0.303797207505221	23.9999999991064	0.194813254903237	0.843662073010871	nan
sp|Q9H3Q1|BORG4_HUMAN	Normal-Triple-negative breast cancer	1.08671002836952	0.363107113846137	23.999999999122	0.0063126447240918	0.0506841330021288	nan
sp|Q9H3S7|PTN23_HUMAN	metaplastic breast carcinomas-Normal	-0.0450605010590797	0.303611791821445	23.9999999997784	0.883255334491377	0.939478318898811	nan
sp|Q9H3S7|PTN23_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.253731097607775	0.303611791821445	23.9999999997784	0.411561777895757	0.885784822958391	nan
sp|Q9H3S7|PTN23_HUMAN	Normal-Triple-negative breast cancer	0.298791598666855	0.36288549971627	23.9999999997784	0.418400616419293	0.605206113567333	nan
sp|Q9H3U1|UN45A_HUMAN	metaplastic breast carcinomas-Normal	0.155077663250433	0.237073799310128	22.0000000052497	0.519806501213761	0.701232471604927	nan
sp|Q9H3U1|UN45A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0447890855369865	0.237073799310128	22.0000000040842	0.851883889215498	0.976728941945356	nan
sp|Q9H3U1|UN45A_HUMAN	Normal-Triple-negative breast cancer	-0.199866748787419	0.283357387459065	22.0000000040974	0.487992872770365	0.665062857354938	nan
sp|Q9H479|FN3K_HUMAN	metaplastic breast carcinomas-Normal	-0.916124165861012	0.620676702609515	23.9999999996905	0.152942410605842	0.332927683597785	nan
sp|Q9H479|FN3K_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.290700406875425	0.620676702609515	23.9999999996915	0.643752767601043	0.941868024951375	nan
sp|Q9H479|FN3K_HUMAN	Normal-Triple-negative breast cancer	1.20682457273644	0.741850552106227	23.9999999997308	0.116844505659798	0.267302915907205	nan
sp|Q9H488|OFUT1_HUMAN	metaplastic breast carcinomas-Normal	-0.0982301618083938	0.308748580013669	13.2871774516372	0.755312010521568	0.86565366297539	nan
sp|Q9H488|OFUT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.570172601934789	0.276984310285373	12.9999999891602	0.0601666880037877	0.773787875546141	nan
sp|Q9H488|OFUT1_HUMAN	Normal-Triple-negative breast cancer	0.668402763743183	0.35805839987673	13.2172983972166	0.0842754789643313	0.217870762433392	nan
sp|Q9H4A3|WNK1_HUMAN	metaplastic breast carcinomas-Normal	0.249226145280873	0.199745881163387	23.9999999998964	0.224172407658834	0.423620854495716	nan
sp|Q9H4A3|WNK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.107918988716742	0.199745881163387	23.9999999998964	0.593981772195907	0.940559810632461	nan
sp|Q9H4A3|WNK1_HUMAN	Normal-Triple-negative breast cancer	-0.141307156564132	0.238741991763188	23.9999999999445	0.559464354639544	0.722759236230799	nan
sp|Q9H4A4|AMPB_HUMAN	metaplastic breast carcinomas-Normal	-0.195168430099002	0.196468291433047	22.0000000709535	0.331324034013303	0.539838494291648	nan
sp|Q9H4A4|AMPB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.19082406164482	0.196468291433047	22.0000000713147	0.341971466619838	0.870943310236299	nan
sp|Q9H4A4|AMPB_HUMAN	Normal-Triple-negative breast cancer	0.0043443684541817	0.234824522747825	22.0000000709996	0.985406351027658	0.992272254109644	nan
sp|Q9H4A6|GOLP3_HUMAN	metaplastic breast carcinomas-Normal	1.22859451260528	0.398275034149076	22.0000000944838	0.0054141356255357	0.0486241778934414	nan
sp|Q9H4A6|GOLP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.166393803257142	0.398275034149076	22.0000000941056	0.680152938590144	0.946568877415162	nan
sp|Q9H4A6|GOLP3_HUMAN	Normal-Triple-negative breast cancer	-1.06220070934814	0.476029715198608	22.0000000937642	0.0361652931320595	0.126678556343412	nan
sp|Q9H4E7|DEFI6_HUMAN	metaplastic breast carcinomas-Normal	0.0616802591206494	0.31943451215408	14.999999999701	0.849477093138245	0.920659229733136	nan
sp|Q9H4E7|DEFI6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0013007702850362	0.31943451215408	14.9999999997204	0.996804604314524	0.998432050811921	nan
sp|Q9H4E7|DEFI6_HUMAN	Normal-Triple-negative breast cancer	-0.0603794888356131	0.381797267735331	14.9999999997059	0.876451580727733	0.928106102051286	nan
sp|Q9H4F8|SMOC1_HUMAN	metaplastic breast carcinomas-Normal	0.109180866000392	0.248933553947937	14.9999999996864	0.667206689290407	0.805007272305376	nan
sp|Q9H4F8|SMOC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.404214427814141	0.248933553947937	14.9999999996863	0.125245059435443	0.823891816737944	nan
sp|Q9H4F8|SMOC1_HUMAN	Normal-Triple-negative breast cancer	-0.513395293814533	0.297532505501861	14.9999999996653	0.104970634817334	0.250712237131185	nan
sp|Q9H4G0|E41L1_HUMAN	metaplastic breast carcinomas-Normal	-1.09566659060098	0.378343938330628	22.0000001681872	0.0083828711687529	0.0602818106368712	nan
sp|Q9H4G0|E41L1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.62288153941705	0.378343938330628	22.0000001690853	0.113906633062673	0.823891816737944	nan
sp|Q9H4G0|E41L1_HUMAN	Normal-Triple-negative breast cancer	0.472785051183929	0.452207499261014	22.0000001681827	0.307141860953763	0.499236941716532	nan
sp|Q9H4G4|GAPR1_HUMAN	metaplastic breast carcinomas-Normal	-0.500197968896073	0.294789223427146	23.9999999997412	0.102668382339544	0.259126577749919	nan
sp|Q9H4G4|GAPR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0265213669743256	0.294789223427146	23.9999999997424	0.929059884450302	0.995359816653149	nan
sp|Q9H4G4|GAPR1_HUMAN	Normal-Triple-negative breast cancer	0.473676601921748	0.352340513563594	23.9999999997694	0.191398338997463	0.372051508086296	nan
sp|Q9H4M9|EHD1_HUMAN	metaplastic breast carcinomas-Normal	-0.394110013282005	0.250140381167677	23.9999999992339	0.128219737586601	0.299374855792279	nan
sp|Q9H4M9|EHD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.497375926116266	0.250140381167677	23.9999999992843	0.0582888904061968	0.773787875546141	nan
sp|Q9H4M9|EHD1_HUMAN	Normal-Triple-negative breast cancer	-0.10326591283426	0.298974939921417	23.9999999992488	0.732802827091114	0.845776596267661	nan
sp|Q9H4Z3|CAPAM_HUMAN	metaplastic breast carcinomas-Normal	-0.0988796294788705	0.313096165906948	22.0000000054797	0.755121519556512	0.86565366297539	nan
sp|Q9H4Z3|CAPAM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.33883101879534	0.313096165906948	22.0000000056974	0.290885702808428	0.867696529950794	nan
sp|Q9H4Z3|CAPAM_HUMAN	Normal-Triple-negative breast cancer	-0.239951389316469	0.374221494964892	22.0000000056185	0.528015750715128	0.697552699510103	nan
sp|Q9H583|HEAT1_HUMAN	metaplastic breast carcinomas-Normal	0.337089335791211	0.24332131826939	6.0	0.215243853975488	0.411189983111795	nan
sp|Q9H583|HEAT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.23888845237309	0.24332131826939	6.0	0.364122352084922	0.883542279876718	nan
sp|Q9H583|HEAT1_HUMAN	Normal-Triple-negative breast cancer	-0.575977788164301	0.290824600856534	6.0	0.0949582504374894	0.235905249965781	nan
sp|Q9H6F5|CCD86_HUMAN	metaplastic breast carcinomas-Normal	0.607961841812514	0.315695844056109	22.0000000030732	0.0671525191150726	0.200192801379822	nan
sp|Q9H6F5|CCD86_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.362711932451119	0.315695844056109	22.0000000030768	0.262924098661879	0.86431258289795	nan
sp|Q9H6F5|CCD86_HUMAN	Normal-Triple-negative breast cancer	-0.970673774263633	0.377328704663831	22.0000000028935	0.017370637274214	0.0847870753296437	nan
sp|Q9H6R4|NOL6_HUMAN	metaplastic breast carcinomas-Normal	0.266828535456656	0.475048520159448	14.999999999954	0.582625204827836	0.743248857809139	nan
sp|Q9H6R4|NOL6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.471636439184281	0.475048520159448	14.999999999954	0.336545464544642	0.870943310236299	nan
sp|Q9H6R4|NOL6_HUMAN	Normal-Triple-negative breast cancer	0.204807903727625	0.567791582116538	14.9999999999627	0.723345861893743	0.840406027589934	nan
sp|Q9H6S3|ES8L2_HUMAN	metaplastic breast carcinomas-Normal	0.106608766671753	0.374507894335419	22.000000169115	0.778564254057496	0.880254279077251	nan
sp|Q9H6S3|ES8L2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.25160641641208	0.374507894335419	22.0000001696452	0.508684904990641	0.913992324008525	nan
sp|Q9H6S3|ES8L2_HUMAN	Normal-Triple-negative breast cancer	-0.358215183083833	0.447622549731275	22.0000001693579	0.432116435350522	0.617201755042369	nan
sp|Q9H6U8|ALG9_HUMAN	metaplastic breast carcinomas-Normal	0.473427411031134	0.21522913242776	22.0000002104111	0.0386352076689573	0.144403934532856	nan
sp|Q9H6U8|ALG9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.295684836976532	0.21522913242776	22.0000002105106	0.183336892474968	0.843662073010871	nan
sp|Q9H6U8|ALG9_HUMAN	Normal-Triple-negative breast cancer	-0.769112248007666	0.25724801663988	22.0000002104386	0.0067527666242586	0.0524989501286484	nan
sp|Q9H6X2|ANTR1_HUMAN	metaplastic breast carcinomas-Normal	0.513947654509711	0.284198086918912	22.0002145151707	0.0842323854862393	0.231586806746286	nan
sp|Q9H6X2|ANTR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0907420748899057	0.284198086918912	22.0002145175169	0.752517374371993	0.954643368861838	nan
sp|Q9H6X2|ANTR1_HUMAN	Normal-Triple-negative breast cancer	-0.604689729399617	0.339681684203587	22.0002144956542	0.0888659373009413	0.22451925943725	nan
sp|Q9H6Z4|RANB3_HUMAN	metaplastic breast carcinomas-Normal	0.138913108593639	0.218604573949296	23.9999999996291	0.53114531211073	0.708682730508622	nan
sp|Q9H6Z4|RANB3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.553623781063912	0.218604573949296	23.9999999994277	0.0182776224141186	0.674062840112479	nan
sp|Q9H6Z4|RANB3_HUMAN	Normal-Triple-negative breast cancer	-0.692536889657551	0.261282440915555	23.9999999995571	0.0140033800221331	0.0766840777488802	nan
sp|Q9H7B2|RPF2_HUMAN	metaplastic breast carcinomas-Normal	0.296649773056005	0.259090202682675	14.0000000111576	0.271419966244271	0.473099091660176	nan
sp|Q9H7B2|RPF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0974781542339968	0.259090202682675	14.000000011131	0.71238424366288	0.94948208919602	nan
sp|Q9H7B2|RPF2_HUMAN	Normal-Triple-negative breast cancer	-0.199171618822008	0.30967202264458	14.0000000111645	0.530508362633227	0.698656813547087	nan
sp|Q9H7C9|AAMDC_HUMAN	metaplastic breast carcinomas-Normal	-1.02207463169088	0.287212298550682	21.9999999494114	0.0017582831008757	0.0298263306532335	nan
sp|Q9H7C9|AAMDC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.480067683929661	0.287212298550682	21.9999999511451	0.108793586501362	0.823891816737944	nan
sp|Q9H7C9|AAMDC_HUMAN	Normal-Triple-negative breast cancer	0.542006947761216	0.343284356180466	21.9999999499568	0.128633851751348	0.285695054896968	nan
sp|Q9H7N4|SFR19_HUMAN	metaplastic breast carcinomas-Normal	0.777377645343393	0.365366328252238	17.9417696178861	0.0474885723706518	0.164258079667062	nan
sp|Q9H7N4|SFR19_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.305708172153466	0.276736156338493	17.2069172844553	0.284501610084855	0.867696529950794	nan
sp|Q9H7N4|SFR19_HUMAN	Normal-Triple-negative breast cancer	-1.08308581749686	0.403580553315378	17.9561299928107	0.0151895761545945	0.0782793040897244	nan
sp|Q9H7Z7|PGES2_HUMAN	metaplastic breast carcinomas-Normal	-0.0430322958391391	0.250500675127681	23.9999999997284	0.865046721869579	0.92965253911881	nan
sp|Q9H7Z7|PGES2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.323617966518224	0.250500675127681	23.9999999993713	0.208699632780716	0.843662073010871	nan
sp|Q9H7Z7|PGES2_HUMAN	Normal-Triple-negative breast cancer	-0.280585670679085	0.299405573570185	23.9999999995602	0.358020804306245	0.549174505544052	nan
sp|Q9H814|PHAX_HUMAN	metaplastic breast carcinomas-Normal	-0.21278014342902	0.710430628021953	6.0	0.774656239635584	0.878247722709605	nan
sp|Q9H814|PHAX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.215537320809591	0.710430628021953	6.0	0.771837728695424	0.959745866833315	nan
sp|Q9H814|PHAX_HUMAN	Normal-Triple-negative breast cancer	0.428317464238611	0.849127011559238	6.0	0.631950099825982	0.779314007614477	nan
sp|Q9H845|ACAD9_HUMAN	metaplastic breast carcinomas-Normal	-1.24606086823321	0.348203382709376	23.9999999998227	0.0015163735463438	0.0281210167842065	nan
sp|Q9H845|ACAD9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.290158542777434	0.348203382709376	23.9999999998219	0.412891083504706	0.885784822958391	nan
sp|Q9H845|ACAD9_HUMAN	Normal-Triple-negative breast cancer	0.955902325455774	0.416182644881259	23.999999999785	0.0306575395046451	0.116975226402462	nan
sp|Q9H8H0|NOL11_HUMAN	metaplastic breast carcinomas-Normal	1.41056584728661	0.325205751814214	15.0000000001863	0.0005859847719598	0.0205217420849069	nan
sp|Q9H8H0|NOL11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.146830726442672	0.325205751814214	15.0000000000539	0.658087846981745	0.944190045212043	nan
sp|Q9H8H0|NOL11_HUMAN	Normal-Triple-negative breast cancer	-1.55739657372928	0.388695218488449	15.0000000001305	0.0011435585598035	0.026613045414958	nan
sp|Q9H8H2|DDX31_HUMAN	metaplastic breast carcinomas-Normal	0.276732262142927	0.187738188545763	14.0000000751219	0.162601312255107	0.34847631330495	nan
sp|Q9H8H2|DDX31_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.407657031954821	0.187738188545763	14.0000000751895	0.0475783903617433	0.760401133998256	nan
sp|Q9H8H2|DDX31_HUMAN	Normal-Triple-negative breast cancer	-0.684389294097748	0.22439005401451	14.0000000750177	0.0086498269673492	0.0588076066258844	nan
sp|Q9H8H3|MET7A_HUMAN	metaplastic breast carcinomas-Normal	-0.71662530970397	0.274645517953392	24.0000000000028	0.0153784145376958	0.0817474695422512	nan
sp|Q9H8H3|MET7A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.193258225977763	0.274645517953392	24.0000000000041	0.488413150874888	0.913320451076758	nan
sp|Q9H8H3|MET7A_HUMAN	Normal-Triple-negative breast cancer	0.523367083726207	0.328264180483357	23.999999999946	0.123944187152183	0.27776955473837	nan
sp|Q9H8Y8|GORS2_HUMAN	metaplastic breast carcinomas-Normal	0.230978940221564	0.168785247158729	22.0000002785281	0.184976256322057	0.376061820192366	nan
sp|Q9H8Y8|GORS2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.346579504530195	0.168785247158729	22.0000002786297	0.0521133711156614	0.773286317778246	nan
sp|Q9H8Y8|GORS2_HUMAN	Normal-Triple-negative breast cancer	-0.577558444751759	0.201736956237689	22.0000002785198	0.0090415422765327	0.0597496750043638	nan
sp|Q9H910|JUPI2_HUMAN	metaplastic breast carcinomas-Normal	0.80208229328588	0.29166148084521	23.9999999994383	0.0111466635993022	0.0705294023488664	nan
sp|Q9H910|JUPI2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.285486746115356	0.29166148084521	23.999999999212	0.33742885257444	0.870943310236299	nan
sp|Q9H910|JUPI2_HUMAN	Normal-Triple-negative breast cancer	-1.08756903940124	0.34860214614703	23.9999999993379	0.0046605445989763	0.0436121424321106	nan
sp|Q9H9A5|CNO10_HUMAN	metaplastic breast carcinomas-Normal	0.866981534301587	0.191560209813199	23.9999999994408	0.0001386649252889	0.0148684584406619	nan
sp|Q9H9A5|CNO10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.213511654866359	0.191560209813199	23.9999999994394	0.276062466926636	0.867696529950794	nan
sp|Q9H9A5|CNO10_HUMAN	Normal-Triple-negative breast cancer	-0.653469879435228	0.228958243178835	23.9999999994359	0.0087530796073134	0.0588076066258844	nan
sp|Q9H9B4|SFXN1_HUMAN	metaplastic breast carcinomas-Normal	0.719195698300414	0.261482795511561	22.0000000472836	0.0116745708697563	0.0712452568367856	nan
sp|Q9H9B4|SFXN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.293328214395364	0.261482795511561	22.0000000463167	0.274047801715653	0.867696529950794	nan
sp|Q9H9B4|SFXN1_HUMAN	Normal-Triple-negative breast cancer	-1.01252391269578	0.312531718044152	22.0000000465397	0.0037622052627725	0.0400819560687694	nan
sp|Q9H9E3|COG4_HUMAN	metaplastic breast carcinomas-Normal	0.579542429140782	0.552107633172503	13.0190004259644	0.312955935599584	0.520705650113393	nan
sp|Q9H9E3|COG4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.775694811413195	0.552107633172503	13.019000425696	0.183439592090416	0.843662073010871	nan
sp|Q9H9E3|COG4_HUMAN	Normal-Triple-negative breast cancer	-1.35523724055398	0.649244708596488	13.0000000023983	0.0571020323008561	0.17099743726851	nan
sp|Q9H9Q2|CSN7B_HUMAN	metaplastic breast carcinomas-Normal	-0.190050224637355	0.159765254741738	22.0000003830067	0.246899996360246	0.446758621612117	nan
sp|Q9H9Q2|CSN7B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0601371639449221	0.159765254741738	22.0000003823652	0.710218235351256	0.94948208919602	nan
sp|Q9H9Q2|CSN7B_HUMAN	Normal-Triple-negative breast cancer	0.129913060692433	0.190956003244923	22.0000003824411	0.503393077561958	0.677916668869779	nan
sp|Q9HA64|KT3K_HUMAN	metaplastic breast carcinomas-Normal	-0.360917449228715	0.258270026208366	23.9999999998752	0.175066515422496	0.362341903651542	nan
sp|Q9HA64|KT3K_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.259961956530901	0.258270026208366	24.0000000002096	0.324191659751798	0.867696529950794	nan
sp|Q9HA64|KT3K_HUMAN	Normal-Triple-negative breast cancer	0.100955492697814	0.308691724257782	24.0000000000425	0.746470641730472	0.854137147370771	nan
sp|Q9HA65|TBC17_HUMAN	metaplastic breast carcinomas-Normal	-1.05482764459694	0.266747338443676	14.0000000009798	0.0014392440940591	0.0280426514467702	nan
sp|Q9HA65|TBC17_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.343056456048253	0.266747338443676	14.0000000010374	0.219281427489132	0.843662073010871	nan
sp|Q9HA65|TBC17_HUMAN	Normal-Triple-negative breast cancer	0.711771188548687	0.318824050371686	14.0000000010005	0.0424306495185583	0.139903312044452	nan
sp|Q9HAB8|PPCS_HUMAN	metaplastic breast carcinomas-Normal	-0.0765151289435989	0.242662275007221	22.0000000280094	0.755493765430688	0.86565366297539	nan
sp|Q9HAB8|PPCS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.622101561093687	0.242662275007221	22.0000000280995	0.0177124873522015	0.669250232341703	nan
sp|Q9HAB8|PPCS_HUMAN	Normal-Triple-negative breast cancer	-0.545586432150088	0.290036893494801	22.000000028198	0.0732605716042524	0.198081837574995	nan
sp|Q9HAT2|SIAE_HUMAN	metaplastic breast carcinomas-Normal	-0.201466166715341	0.202751487305053	22.0000000388258	0.331192242340214	0.539838494291648	nan
sp|Q9HAT2|SIAE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.211095467142442	0.202751487305053	22.000000038565	0.309111523818562	0.867696529950794	nan
sp|Q9HAT2|SIAE_HUMAN	Normal-Triple-negative breast cancer	-0.0096293004271004	0.242334378212099	22.0000000387123	0.968662320461487	0.984453068852962	nan
sp|Q9HAU0|PKHA5_HUMAN	metaplastic breast carcinomas-Normal	-0.797507884894762	0.472016379023933	14.9999999997505	0.111779935116882	0.274616780730611	nan
sp|Q9HAU0|PKHA5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.80559847985636	0.472016379023933	14.9999999997505	0.10848527930214	0.823891816737944	nan
sp|Q9HAU0|PKHA5_HUMAN	Normal-Triple-negative breast cancer	1.60310636475112	0.564167480283832	14.9999999997215	0.0123763750925986	0.072025433201228	nan
sp|Q9HAV0|GBB4_HUMAN	metaplastic breast carcinomas-Normal	0.153551545860306	0.202730209436488	23.9999999995685	0.456172011689559	0.649830006677249	nan
sp|Q9HAV0|GBB4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.371508071881963	0.202730209436488	23.9999999993355	0.0793101887550881	0.806849600316436	nan
sp|Q9HAV0|GBB4_HUMAN	Normal-Triple-negative breast cancer	0.217956526021657	0.242308946294843	23.9999999994969	0.377324147761142	0.564966426647764	nan
sp|Q9HAV4|XPO5_HUMAN	metaplastic breast carcinomas-Normal	0.50940801731648	0.33730631394115	22.0000000042501	0.145216663643289	0.322445016666863	nan
sp|Q9HAV4|XPO5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.43916464476486	0.33730631394115	22.0000000036999	0.206392441493771	0.843662073010871	nan
sp|Q9HAV4|XPO5_HUMAN	Normal-Triple-negative breast cancer	-0.94857266208134	0.403158156531591	22.0000000038765	0.0279839778227258	0.112205961740339	nan
sp|Q9HB40|RISC_HUMAN	metaplastic breast carcinomas-Normal	0.310980482488258	0.249687390865615	23.9999999994804	0.224978596966221	0.424661474341691	nan
sp|Q9HB40|RISC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.402592165178398	0.249687390865615	23.9999999993269	0.119952174171959	0.823891816737944	nan
sp|Q9HB40|RISC_HUMAN	Normal-Triple-negative breast cancer	-0.713572647666657	0.298433512952642	23.9999999994216	0.0249939132933595	0.10516426302168	nan
sp|Q9HB71|CYBP_HUMAN	metaplastic breast carcinomas-Normal	0.568736846807302	0.194515934964411	22.0000000001049	0.0078623272066836	0.058994075925545	nan
sp|Q9HB71|CYBP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.326276426783871	0.194515934964411	21.9999999998717	0.10762137442854	0.823891816737944	nan
sp|Q9HB71|CYBP_HUMAN	Normal-Triple-negative breast cancer	-0.895013273591173	0.232491010440892	22.0000000002017	0.0008696161325285	0.025773942907156	nan
sp|Q9HB90|RRAGC_HUMAN	metaplastic breast carcinomas-Normal	-0.711806307514559	0.323061864411239	22.0000040251325	0.0383419795294179	0.143798240446479	nan
sp|Q9HB90|RRAGC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.359855333745087	0.323061864411239	22.0000040253401	0.277348548570436	0.867696529950794	nan
sp|Q9HB90|RRAGC_HUMAN	Normal-Triple-negative breast cancer	0.351950973769471	0.386132782929222	22.0000040247651	0.37192417227744	0.561055559292967	nan
sp|Q9HBH5|RDH14_HUMAN	metaplastic breast carcinomas-Normal	0.241775874770262	0.382817469690014	20.3631717247758	0.534694548972694	0.711214358057317	nan
sp|Q9HBH5|RDH14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.491219536471476	0.357280202764595	19.9997974673536	0.184375554694911	0.843662073010871	nan
sp|Q9HBH5|RDH14_HUMAN	Normal-Triple-negative breast cancer	-0.732995411241739	0.444064302475889	20.1629870355019	0.114301026788133	0.263661771716692	nan
sp|Q9HBI0|PARVG_HUMAN	metaplastic breast carcinomas-Normal	0.915263839932759	0.447220709275126	14.0000000125967	0.0599569968485116	0.187838885508438	nan
sp|Q9HBI0|PARVG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.699679871698695	0.447220709275126	14.0000000125743	0.140016035441482	0.823891816737944	nan
sp|Q9HBI0|PARVG_HUMAN	Normal-Triple-negative breast cancer	-0.215583968234064	0.53453098641245	14.0000000126589	0.692809277704083	0.8191222906967	nan
sp|Q9HBL0|TENS1_HUMAN	metaplastic breast carcinomas-Normal	-1.43976258395248	0.35725577791491	22.000003685452	0.000560520641354	0.0205217420849069	nan
sp|Q9HBL0|TENS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.167199147494867	0.35725577791491	22.0000036854018	0.644381012214827	0.941868024951375	nan
sp|Q9HBL0|TENS1_HUMAN	Normal-Triple-negative breast cancer	1.27256343645762	0.427002326613914	22.0000036854325	0.0069035672428363	0.0526317832917153	nan
sp|Q9HBL7|PLRKT_HUMAN	metaplastic breast carcinomas-Normal	-0.0431608052087445	0.316045260226801	13.9999999933872	0.893318833905433	0.941767143641503	nan
sp|Q9HBL7|PLRKT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.538398878919311	0.316045260226801	13.9999999923525	0.110550385831072	0.823891816737944	nan
sp|Q9HBL7|PLRKT_HUMAN	Normal-Triple-negative breast cancer	0.581559684128056	0.377746336867606	13.9999999927804	0.145962624412213	0.310843727714765	nan
sp|Q9HBR0|S38AA_HUMAN	metaplastic breast carcinomas-Normal	-0.749800906788254	0.568030068808845	6.0	0.234957055607649	0.434853704253801	nan
sp|Q9HBR0|S38AA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.03106538757884	0.568030068808845	6.0	0.958161257912768	0.99709406933403	nan
sp|Q9HBR0|S38AA_HUMAN	Normal-Triple-negative breast cancer	0.780866294367094	0.678925789202516	6.0	0.293850896938424	0.486676821835238	nan
sp|Q9HC07|TM165_HUMAN	metaplastic breast carcinomas-Normal	0.514117608978849	0.358086799084021	23.9999999998863	0.163984283907326	0.3500859086114	nan
sp|Q9HC07|TM165_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.245260142596094	0.358086799084022	23.9999999995353	0.499957530184634	0.913320451076758	nan
sp|Q9HC07|TM165_HUMAN	Normal-Triple-negative breast cancer	-0.268857466382755	0.427995586890199	23.9999999996336	0.535819842934355	0.702867070999919	nan
sp|Q9HC35|EMAL4_HUMAN	metaplastic breast carcinomas-Normal	0.537020429934637	0.265312202298943	22.0000000399985	0.055269407850528	0.179470650068388	nan
sp|Q9HC35|EMAL4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.136587038887766	0.265312202298943	22.0000000400358	0.611815261585626	0.94077736515583	nan
sp|Q9HC35|EMAL4_HUMAN	Normal-Triple-negative breast cancer	-0.673607468822404	0.317108734593211	22.0000000402361	0.045131946967008	0.145366852440247	nan
sp|Q9HC36|MRM3_HUMAN	metaplastic breast carcinomas-Normal	0.0690424619596939	0.195207166159516	21.9999920700944	0.726939600117282	0.848436527664973	nan
sp|Q9HC36|MRM3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.019799397630014	0.195207166159516	21.9999920600019	0.920129759449131	0.994508979919649	nan
sp|Q9HC36|MRM3_HUMAN	Normal-Triple-negative breast cancer	-0.0492430643296799	0.233317189740947	21.9999920647135	0.834786098701765	0.906349225873604	nan
sp|Q9HC38|GLOD4_HUMAN	metaplastic breast carcinomas-Normal	-0.509836946939583	0.235286008213249	23.9999999993825	0.0403927900542054	0.149100152809582	nan
sp|Q9HC38|GLOD4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.423558958690347	0.235286008213249	23.9999999993825	0.084414429708213	0.806849600316436	nan
sp|Q9HC38|GLOD4_HUMAN	Normal-Triple-negative breast cancer	0.086277988249236	0.281220568392562	23.9999999994202	0.761642986604266	0.862883874394199	nan
sp|Q9HCB6|SPON1_HUMAN	metaplastic breast carcinomas-Normal	-1.40101731385662	0.443131098566267	23.999999999607	0.0042138835861373	0.042883667309653	nan
sp|Q9HCB6|SPON1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.959760840431686	0.443131098566267	23.999999999607	0.0404791416330739	0.738255867002113	nan
sp|Q9HCB6|SPON1_HUMAN	Normal-Triple-negative breast cancer	2.3607781542883	0.529642966692181	23.9999999995678	0.0001651044748714	0.0227914720285933	nan
sp|Q9HCC0|MCCB_HUMAN	metaplastic breast carcinomas-Normal	-0.380927080483716	0.347088884063214	21.9999999228126	0.284294097527115	0.487612786470656	nan
sp|Q9HCC0|MCCB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.93981566782333	0.347088884063214	21.9999999230086	0.0128541920880356	0.61942302453215	nan
sp|Q9HCC0|MCCB_HUMAN	Normal-Triple-negative breast cancer	-0.558888587339614	0.414850564214302	21.9999999226844	0.191627655205454	0.372062106251712	nan
sp|Q9HCD5|NCOA5_HUMAN	metaplastic breast carcinomas-Normal	-0.105706894366738	0.366372183459257	13.9999999999556	0.777174017339975	0.879280610496282	nan
sp|Q9HCD5|NCOA5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.606922156533601	0.366372183459257	14.0000000000945	0.119838026035501	0.823891816737944	nan
sp|Q9HCD5|NCOA5_HUMAN	Normal-Triple-negative breast cancer	-0.501215262166863	0.431108979853003	14.0000000000345	0.264419901517925	0.455462390739585	nan
sp|Q9HCG8|CWC22_HUMAN	metaplastic breast carcinomas-Normal	0.151723218226952	0.40265014047985	6.0	0.719280314502489	0.843892572513791	nan
sp|Q9HCG8|CWC22_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0124275769624547	0.40265014047985	6.0	0.976378698745202	0.99709406933403	nan
sp|Q9HCG8|CWC22_HUMAN	Normal-Triple-negative breast cancer	-0.139295641264497	0.481258967454029	6.0	0.781985859111479	0.875782006632937	nan
sp|Q9HCM7|FBSL_HUMAN	metaplastic breast carcinomas-Normal	-0.0313156604799493	0.682579245916771	22.9999999992252	0.9638031731133	0.982981891035447	nan
sp|Q9HCM7|FBSL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-2.09002030473834	0.729707907869449	22.9999999990211	0.0087707527478412	0.547668704418496	nan
sp|Q9HCM7|FBSL_HUMAN	Normal-Triple-negative breast cancer	-2.05870464425839	0.855658367784662	22.9999999991509	0.0245634392178511	0.104602334568014	nan
sp|Q9HCN8|SDF2L_HUMAN	metaplastic breast carcinomas-Normal	0.968705283062198	0.276546841102026	22.000000319272	0.0020102505825001	0.0320881648658721	nan
sp|Q9HCN8|SDF2L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.616014623292214	0.276546841102026	22.0000003189554	0.0364572021054761	0.73123935744099	nan
sp|Q9HCN8|SDF2L_HUMAN	Normal-Triple-negative breast cancer	-0.352690659769983	0.330536696306195	22.0000003189383	0.297530775507489	0.489230177230913	nan
sp|Q9HCS7|SYF1_HUMAN	metaplastic breast carcinomas-Normal	0.517522028716743	0.286893943181662	6.0	0.12129898763894	0.289653617034366	nan
sp|Q9HCS7|SYF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.356789786574116	0.286893943181662	6.0	0.260020976628706	0.862813416943474	nan
sp|Q9HCS7|SYF1_HUMAN	Normal-Triple-negative breast cancer	-0.874311815290859	0.342903848735479	6.0	0.0435065133033851	0.142190688240576	nan
sp|Q9HCU5|PREB_HUMAN	metaplastic breast carcinomas-Normal	0.0621952100744143	0.270173999097407	6.0	0.825580927039133	0.907783989903434	nan
sp|Q9HCU5|PREB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.241448587701418	0.270173999097407	6.0	0.405910934439219	0.885297496092956	nan
sp|Q9HCU5|PREB_HUMAN	Normal-Triple-negative breast cancer	0.179253377627003	0.322919693219505	6.0	0.598893786717076	0.752067603720272	nan
sp|Q9HCY8|S10AE_HUMAN	metaplastic breast carcinomas-Normal	0.381835607559204	0.662359588979692	23.9999999996173	0.569659949318748	0.734528007858528	nan
sp|Q9HCY8|S10AE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.416393022054818	0.662359588979692	23.9999999996173	0.535515356094386	0.921388505638487	nan
sp|Q9HCY8|S10AE_HUMAN	Normal-Triple-negative breast cancer	0.0345574144956137	0.791671130415498	23.9999999996256	0.965543571689823	0.982929910189078	nan
sp|Q9HD15|SRA1_HUMAN	metaplastic breast carcinomas-Normal	-0.526221139590481	0.33662181383444	22.0000000208857	0.132267263299137	0.304260472807149	nan
sp|Q9HD15|SRA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.298434590494586	0.33662181383444	22.0000000210166	0.384906247929653	0.885234295852111	nan
sp|Q9HD15|SRA1_HUMAN	Normal-Triple-negative breast cancer	0.824655730085067	0.402340022420959	22.0000000211791	0.0525060906179936	0.161901897230251	nan
sp|Q9HD20|AT131_HUMAN	metaplastic breast carcinomas-Normal	0.613900866878834	0.254397965751922	21.999999998295	0.0245899897365513	0.109714262931941	nan
sp|Q9HD20|AT131_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.211469539693136	0.254397965751922	21.9999999985662	0.414760991213929	0.8860071777014	nan
sp|Q9HD20|AT131_HUMAN	Normal-Triple-negative breast cancer	-0.82537040657197	0.304063726823168	21.9999999988477	0.0126605112157568	0.0726831421091115	nan
sp|Q9HD26|GOPC_HUMAN	metaplastic breast carcinomas-Normal	-0.560814829069496	0.325934429073042	23.9999999997003	0.098186398796165	0.252650653045745	nan
sp|Q9HD26|GOPC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0225519279485084	0.325934429073042	23.9999999995191	0.945410379195476	0.996541950781621	nan
sp|Q9HD26|GOPC_HUMAN	Normal-Triple-negative breast cancer	0.538262901120987	0.389566154395172	23.9999999995689	0.179792091306433	0.356155489572458	nan
sp|Q9HD33|RM47_HUMAN	metaplastic breast carcinomas-Normal	0.69030662544124	0.223685739226109	22.9999999995937	0.0052170482143214	0.0476983941525986	nan
sp|Q9HD33|RM47_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.306349660845356	0.223685739226109	22.9999999995937	0.184050811452073	0.843662073010871	nan
sp|Q9HD33|RM47_HUMAN	Normal-Triple-negative breast cancer	-0.996656286286597	0.264668535920655	22.9999999996198	0.001004820609484	0.0260939352025391	nan
sp|Q9HD45|TM9S3_HUMAN	metaplastic breast carcinomas-Normal	0.387386140617998	0.207164355023648	22.0000000218559	0.074857880710835	0.213769411926818	nan
sp|Q9HD45|TM9S3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.161949313254883	0.207164355023648	22.0000000215968	0.442698070877233	0.89755436380139	nan
sp|Q9HD45|TM9S3_HUMAN	Normal-Triple-negative breast cancer	-0.54933545387288	0.247608763958571	22.0000000213465	0.0371447756252972	0.12835519121726	nan
sp|Q9HDC9|APMAP_HUMAN	metaplastic breast carcinomas-Normal	0.117697187682133	0.318423793951375	23.9999999996647	0.714903872923285	0.839696280422969	nan
sp|Q9HDC9|APMAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.120351647970928	0.318423793951375	23.9999999996335	0.708782137269274	0.94948208919602	nan
sp|Q9HDC9|APMAP_HUMAN	Normal-Triple-negative breast cancer	0.0026544602887952	0.380589228423483	23.9999999996112	0.994492765881436	0.998986312135056	nan
sp|Q9NNX6|CD209_HUMAN	metaplastic breast carcinomas-Normal	-1.67957865372795	0.422860015807432	24.0000000002342	0.0005655943672	0.0205217420849069	nan
sp|Q9NNX6|CD209_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.275794010415223	0.422860015807432	23.9999999999825	0.520463191003087	0.917480869285828	nan
sp|Q9NNX6|CD209_HUMAN	Normal-Triple-negative breast cancer	1.95537266414317	0.505414388636637	24.0000000001442	0.0007334646829092	0.0257262735003663	nan
sp|Q9NP61|ARFG3_HUMAN	metaplastic breast carcinomas-Normal	0.677168996004255	0.242450705322067	23.9999999996291	0.0100914591305345	0.0665555756942394	nan
sp|Q9NP61|ARFG3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.276489823654129	0.242450705322067	23.9999999996291	0.265374339885026	0.865068313840895	nan
sp|Q9NP61|ARFG3_HUMAN	Normal-Triple-negative breast cancer	-0.400679172350126	0.289784019354237	23.9999999995658	0.179493887752194	0.355974449190258	nan
sp|Q9NP72|RAB18_HUMAN	metaplastic breast carcinomas-Normal	-0.137781360292543	0.246899857974869	21.9999999344059	0.582448364467686	0.743248857809139	nan
sp|Q9NP72|RAB18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.396369270287023	0.246899857974869	21.9999999360981	0.122669140012888	0.823891816737944	nan
sp|Q9NP72|RAB18_HUMAN	Normal-Triple-negative breast cancer	-0.25858790999448	0.295101773892163	21.9999999361408	0.390352817527017	0.577965597086773	nan
sp|Q9NP79|VTA1_HUMAN	metaplastic breast carcinomas-Normal	-0.940169479409455	0.59198693148406	14.9999999997563	0.13310188874879	0.305546048481338	nan
sp|Q9NP79|VTA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.249195175762339	0.59198693148406	14.9999999997562	0.679762970943084	0.946568877415162	nan
sp|Q9NP79|VTA1_HUMAN	Normal-Triple-negative breast cancer	0.690974303647115	0.707559716861828	14.9999999997325	0.344274799812165	0.536255592584647	nan
sp|Q9NP81|SYSM_HUMAN	metaplastic breast carcinomas-Normal	0.0795855902219732	0.280425578905755	23.9999999997731	0.778995418405187	0.880388669916456	nan
sp|Q9NP81|SYSM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.360835811214866	0.280425578905755	23.9999999997718	0.210457182863464	0.843662073010871	nan
sp|Q9NP81|SYSM_HUMAN	Normal-Triple-negative breast cancer	-0.440421401436839	0.335172674697318	23.9999999997806	0.201263447360502	0.382067218176076	nan
sp|Q9NPA0|EMC7_HUMAN	metaplastic breast carcinomas-Normal	0.682419405254567	0.453168913718067	10.6606080477119	0.161139192370819	0.346012064238115	nan
sp|Q9NPA0|EMC7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.481623507568496	0.374807207810577	10.071455233551	0.227560414229378	0.843662073010871	nan
sp|Q9NPA0|EMC7_HUMAN	Normal-Triple-negative breast cancer	-0.20079589768607	0.518984710142488	10.3178384805115	0.706689448270479	0.827999903437107	nan
sp|Q9NPF4|OSGEP_HUMAN	metaplastic breast carcinomas-Normal	0.161410741364114	0.194224523058431	20.9929028742716	0.415296684633892	0.616586334382752	nan
sp|Q9NPF4|OSGEP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0323207321942704	0.194224523058431	20.9929028743953	0.869427352977798	0.981157375562638	nan
sp|Q9NPF4|OSGEP_HUMAN	Normal-Triple-negative breast cancer	-0.193731473558384	0.229641086378594	20.9821390314858	0.408393113449217	0.59670272927701	nan
sp|Q9NPH2|INO1_HUMAN	metaplastic breast carcinomas-Normal	0.0039683200603599	0.231984993201748	22.0000000207177	0.986506293783774	0.993572774672199	nan
sp|Q9NPH2|INO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.282042456073581	0.231984993201748	22.000000021017	0.236954574443314	0.84876230490475	nan
sp|Q9NPH2|INO1_HUMAN	Normal-Triple-negative breast cancer	0.278074136013222	0.277275100810974	22.0000000205738	0.326821735089626	0.519290366844129	nan
sp|Q9NPI6|DCP1A_HUMAN	metaplastic breast carcinomas-Normal	0.613012423020963	0.350077451711753	14.9999999996713	0.10034924079325	0.255832857856663	nan
sp|Q9NPI6|DCP1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.183795357328671	0.350077451711753	14.9999999996713	0.607247299273628	0.940559810632461	nan
sp|Q9NPI6|DCP1A_HUMAN	Normal-Triple-negative breast cancer	-0.429217065692292	0.418422585768767	14.9999999996711	0.321245853096964	0.513128887887703	nan
sp|Q9NPJ3|ACO13_HUMAN	metaplastic breast carcinomas-Normal	-0.0139512814295746	0.342831146914931	23.9999999992054	0.967876234271964	0.984461628739293	nan
sp|Q9NPJ3|ACO13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.401551835506384	0.342831146914931	23.9999999992054	0.252983413074465	0.855758210685228	nan
sp|Q9NPJ3|ACO13_HUMAN	Normal-Triple-negative breast cancer	-0.38760055407681	0.409761594963648	23.9999999991973	0.353617774904549	0.543675061879149	nan
sp|Q9NPQ8|RIC8A_HUMAN	metaplastic breast carcinomas-Normal	-0.23646295458262	0.250589400433705	22.0000003951303	0.355608631316278	0.565030157980549	nan
sp|Q9NPQ8|RIC8A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.112169064576223	0.250589400433705	22.0000003958137	0.658803279666749	0.944190045212043	nan
sp|Q9NPQ8|RIC8A_HUMAN	Normal-Triple-negative breast cancer	0.124293890006397	0.299511620594316	22.0000003956625	0.682169409567307	0.813610017008155	nan
sp|Q9NQ55|SSF1_HUMAN	metaplastic breast carcinomas-Normal	-0.516281331899541	0.313827008548048	23.9993516092857	0.112982438536863	0.276345567105617	nan
sp|Q9NQ55|SSF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.159628257609729	0.313827008548048	23.9993509163165	0.615641590091959	0.941374262616245	nan
sp|Q9NQ55|SSF1_HUMAN	Normal-Triple-negative breast cancer	0.356653074289812	0.375095018998456	23.9993515335392	0.351166891139545	0.541660671066287	nan
sp|Q9NQ88|TIGAR_HUMAN	metaplastic breast carcinomas-Normal	0.148466932423074	0.292700594050312	14.9999999999427	0.619367921121475	0.771757642090732	nan
sp|Q9NQ88|TIGAR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0288475960652274	0.292700594050312	14.9999999999197	0.922795273546436	0.994508979919649	nan
sp|Q9NQ88|TIGAR_HUMAN	Normal-Triple-negative breast cancer	-0.177314528488301	0.349844123978106	14.9999999998713	0.61963692991287	0.768821633083382	nan
sp|Q9NQC3|RTN4_HUMAN	metaplastic breast carcinomas-Normal	-0.160440146134456	0.269190034105648	22.0000000021659	0.557251088059221	0.727869141743057	nan
sp|Q9NQC3|RTN4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.130705329086296	0.269190034105648	22.0000000021658	0.63208653430786	0.941868024951375	nan
sp|Q9NQC3|RTN4_HUMAN	Normal-Triple-negative breast cancer	0.291145475220752	0.321743630110771	22.0000000023632	0.375322401702573	0.56312537905329	nan
sp|Q9NQG5|RPR1B_HUMAN	metaplastic breast carcinomas-Normal	0.104820794287556	0.397832120987217	22.0000000039735	0.79463277477771	0.888748096689471	nan
sp|Q9NQG5|RPR1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.38465695026979	0.397832120987217	22.0000000039756	0.344112377823682	0.870943310236299	nan
sp|Q9NQG5|RPR1B_HUMAN	Normal-Triple-negative breast cancer	-0.489477744557346	0.475500332716104	22.0000000043091	0.314479202562998	0.50744119869874	nan
sp|Q9NQR4|NIT2_HUMAN	metaplastic breast carcinomas-Normal	-0.358988880933103	0.234420559881045	22.0000002828397	0.139927685417547	0.314908345516538	nan
sp|Q9NQR4|NIT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.439952453042242	0.234420559881045	22.0000002828389	0.0738771016817774	0.794955867611359	nan
sp|Q9NQR4|NIT2_HUMAN	Normal-Triple-negative breast cancer	-0.0809635721091387	0.280186159786012	22.000000283212	0.775314700157189	0.872176795236645	nan
sp|Q9NQT8|KI13B_HUMAN	metaplastic breast carcinomas-Normal	-0.162605355544829	0.346981100143958	14.000000033156	0.646548327608271	0.790158386910385	nan
sp|Q9NQT8|KI13B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.500826497660305	0.346981100143958	14.0000000326141	0.170914849928146	0.843662073010871	nan
sp|Q9NQT8|KI13B_HUMAN	Normal-Triple-negative breast cancer	-0.338221142115476	0.414721737790381	14.000000032717	0.428422008181353	0.613865389185306	nan
sp|Q9NQW6|ANLN_HUMAN	metaplastic breast carcinomas-Normal	0.146014575588468	0.338175654253335	14.9999999998877	0.672049432407547	0.808148806621432	nan
sp|Q9NQW6|ANLN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.260208553538671	0.338175654253335	14.9999999998877	0.453574384510081	0.908567154037048	nan
sp|Q9NQW6|ANLN_HUMAN	Normal-Triple-negative breast cancer	0.114193977950203	0.404197216943962	14.9999999999349	0.781405611424768	0.875427115731692	nan
sp|Q9NQW7|XPP1_HUMAN	metaplastic breast carcinomas-Normal	0.0906038721585304	0.238169030388553	23.9999999996237	0.706981066413411	0.833630743085555	nan
sp|Q9NQW7|XPP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.19219589811138	0.238169030388553	23.9999999996237	0.427607460681618	0.894058800058913	nan
sp|Q9NQW7|XPP1_HUMAN	Normal-Triple-negative breast cancer	-0.282799770269911	0.284666438977831	23.9999999995899	0.33040548854577	0.522952622863184	nan
sp|Q9NQX3|GEPH_HUMAN	metaplastic breast carcinomas-Normal	-0.116975573255852	0.272942457926208	22.0000000416573	0.672401543877448	0.808148806621432	nan
sp|Q9NQX3|GEPH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0023359961987171	0.272942457926208	22.0000000413729	0.993248471849036	0.998185231446144	nan
sp|Q9NQX3|GEPH_HUMAN	Normal-Triple-negative breast cancer	0.119311569454569	0.326228634415453	22.0000000418179	0.718059735523901	0.836603771777584	nan
sp|Q9NQZ2|SAS10_HUMAN	metaplastic breast carcinomas-Normal	1.23157704406641	0.277321461215422	22.0000000161024	0.00020545727933	0.0157578323963946	nan
sp|Q9NQZ2|SAS10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0800771288541134	0.277321461215422	22.0000000161064	0.775474429442412	0.960657739983943	nan
sp|Q9NQZ2|SAS10_HUMAN	Normal-Triple-negative breast cancer	-1.15149991521229	0.331462544427091	22.0000000163882	0.0021543024868997	0.032066107359435	nan
sp|Q9NR12|PDLI7_HUMAN	metaplastic breast carcinomas-Normal	0.456138271688276	0.246082525033418	22.0000000061662	0.0772552359499559	0.218736289861715	nan
sp|Q9NR12|PDLI7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0983848152389001	0.246082525033418	22.0000000070836	0.693156008254171	0.946568877415162	nan
sp|Q9NR12|PDLI7_HUMAN	Normal-Triple-negative breast cancer	-0.554523086927176	0.294124874177189	22.0000000065749	0.072661032272715	0.197324568034726	nan
sp|Q9NR28|DBLOH_HUMAN	metaplastic breast carcinomas-Normal	0.193980451822318	0.161247942204055	24.000000000024	0.240711867142641	0.44107417536677	nan
sp|Q9NR28|DBLOH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.542857816455226	0.161247942204055	24.000000000024	0.0025590460774508	0.448717474870704	nan
sp|Q9NR28|DBLOH_HUMAN	Normal-Triple-negative breast cancer	-0.736838268277545	0.192728153718585	23.9999999999717	0.0008226851484203	0.0257262735003663	nan
sp|Q9NR30|DDX21_HUMAN	metaplastic breast carcinomas-Normal	0.799221855625492	0.281870214486642	22.0000004371054	0.0096274695533345	0.0650005124722237	nan
sp|Q9NR30|DDX21_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.189162555893444	0.281870214486642	22.0000004373334	0.509143457522914	0.913997266820081	nan
sp|Q9NR30|DDX21_HUMAN	Normal-Triple-negative breast cancer	-0.988384411518936	0.336899344473657	22.0000004371511	0.0076850025727457	0.0555698888938111	nan
sp|Q9NR31|SAR1A_HUMAN	metaplastic breast carcinomas-Normal	0.035232678587009	0.58627060113344	21.9999993809945	0.952621541833664	0.975193989958575	nan
sp|Q9NR31|SAR1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.251608860167819	0.58627060113344	21.999999380962	0.671974169169209	0.946386428913156	nan
sp|Q9NR31|SAR1A_HUMAN	Normal-Triple-negative breast cancer	-0.286841538754828	0.70072739528636	21.9999993818815	0.686242168056394	0.815541282309423	nan
sp|Q9NR45|SIAS_HUMAN	metaplastic breast carcinomas-Normal	0.267651670841442	0.192541711348309	22.0000000241185	0.178405383957526	0.367878099426065	nan
sp|Q9NR45|SIAS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.257764666985528	0.192541711348309	22.0000000241712	0.194323661108509	0.843662073010871	nan
sp|Q9NR45|SIAS_HUMAN	Normal-Triple-negative breast cancer	-0.525416337826971	0.230131361893703	22.0000000241326	0.0324448641252712	0.121245596403811	nan
sp|Q9NR50|EI2BG_HUMAN	metaplastic breast carcinomas-Normal	0.343719822878085	0.297982070844503	21.9999687705245	0.261087044752364	0.463349352246053	nan
sp|Q9NR50|EI2BG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.126260515610335	0.297982070844503	21.9999687671945	0.675885162668343	0.946386428913156	nan
sp|Q9NR50|EI2BG_HUMAN	Normal-Triple-negative breast cancer	-0.21745930726775	0.356156696142058	21.999968772895	0.547739477235903	0.713155512076828	nan
sp|Q9NR99|MXRA5_HUMAN	metaplastic breast carcinomas-Normal	0.632579913692185	0.371464985335883	23.9999999994087	0.101498832184348	0.257740350023507	nan
sp|Q9NR99|MXRA5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0631900287237889	0.371464985335883	23.9999999996877	0.866349231622912	0.980530611231673	nan
sp|Q9NR99|MXRA5_HUMAN	Normal-Triple-negative breast cancer	-0.695769942415974	0.443985577839428	23.9999999995925	0.130182829167644	0.288101014749167	nan
sp|Q9NRD1|FBX6_HUMAN	metaplastic breast carcinomas-Normal	-0.140902132858741	0.386564901668102	14.9999999997147	0.720573594615981	0.843969918429711	nan
sp|Q9NRD1|FBX6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.883002449471877	0.386564901668102	14.9999999996874	0.0373444614122328	0.73123935744099	nan
sp|Q9NRD1|FBX6_HUMAN	Normal-Triple-negative breast cancer	-0.742100316613136	0.462033429838252	14.999999999685	0.129080504769808	0.286190250370801	nan
sp|Q9NRL2|BAZ1A_HUMAN	metaplastic breast carcinomas-Normal	0.333774496763551	0.276401329184559	21.9999998980252	0.24003449655134	0.440571323322282	nan
sp|Q9NRL2|BAZ1A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.15870215922935	0.276401329184559	21.9999998980253	0.571675326857718	0.935631258424823	nan
sp|Q9NRL2|BAZ1A_HUMAN	Normal-Triple-negative breast cancer	-0.175072337534201	0.330362776299438	21.9999998967154	0.601461801531252	0.754242473378804	nan
sp|Q9NRN7|ADPPT_HUMAN	metaplastic breast carcinomas-Normal	0.812246585528728	0.773058927120445	6.0	0.333865175739227	0.542408525981031	nan
sp|Q9NRN7|ADPPT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.693564818731517	0.773058927120445	6.0	0.404188025048971	0.885297496092956	nan
sp|Q9NRN7|ADPPT_HUMAN	Normal-Triple-negative breast cancer	-1.50581140426024	0.923982146395707	6.0	0.154287867252681	0.322548975313151	nan
sp|Q9NRV9|HEBP1_HUMAN	metaplastic breast carcinomas-Normal	-0.251435904946227	0.283983133123787	23.9999999993522	0.384731422430527	0.589602235204736	nan
sp|Q9NRV9|HEBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.545713691871922	0.283983133123787	23.9999999991123	0.0666028738903588	0.774640662531106	nan
sp|Q9NRV9|HEBP1_HUMAN	Normal-Triple-negative breast cancer	0.797149596818149	0.339424765277968	23.9999999992446	0.0274193848746004	0.111013441319332	nan
sp|Q9NRX4|PHP14_HUMAN	metaplastic breast carcinomas-Normal	-0.27424061653701	0.275139800734629	21.9999999058163	0.329732084609512	0.538565069064444	nan
sp|Q9NRX4|PHP14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.240164445413388	0.275139800734629	21.9999999060865	0.392155508162491	0.885234295852111	nan
sp|Q9NRX4|PHP14_HUMAN	Normal-Triple-negative breast cancer	0.514405061950397	0.328854961404593	21.9999999061501	0.132034977477186	0.290907975979388	nan
sp|Q9NRX5|SERC1_HUMAN	metaplastic breast carcinomas-Normal	0.144656635001301	0.312938719218569	21.999999859929	0.648439415798986	0.79096884249651	nan
sp|Q9NRX5|SERC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.35467979546903	0.312938719218569	21.9999998600722	0.269253551960046	0.867507810336388	nan
sp|Q9NRX5|SERC1_HUMAN	Normal-Triple-negative breast cancer	-0.499336430470331	0.374033310178497	21.9999998601983	0.195525937059372	0.376769979585711	nan
sp|Q9NRY4|RHG35_HUMAN	metaplastic breast carcinomas-Normal	0.391891428880045	0.280017936023953	23.9999999999306	0.17444953536688	0.362192539387576	nan
sp|Q9NRY4|RHG35_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.434931865896747	0.280017936023953	23.9999999999306	0.13345724685277	0.823891816737944	nan
sp|Q9NRY4|RHG35_HUMAN	Normal-Triple-negative breast cancer	0.0430404370167021	0.334685448262597	23.9999999999711	0.898746027982325	0.941085638149985	nan
sp|Q9NRY5|F1142_HUMAN	metaplastic breast carcinomas-Normal	-0.0955602444996528	0.189387349583428	6.0	0.631847717572569	0.779421617230991	nan
sp|Q9NRY5|F1142_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.220912448526842	0.189387349583428	6.0	0.287690717713795	0.867696529950794	nan
sp|Q9NRY5|F1142_HUMAN	Normal-Triple-negative breast cancer	-0.125352204027189	0.226361178468127	6.0	0.599749330314667	0.752857543038502	nan
sp|Q9NS69|TOM22_HUMAN	metaplastic breast carcinomas-Normal	-0.267745563571798	0.390917962159853	14.9999999997033	0.503844525703022	0.688770327048361	nan
sp|Q9NS69|TOM22_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.314710903175382	0.390917962159853	14.99999999952	0.43336353488767	0.896102083258464	nan
sp|Q9NS69|TOM22_HUMAN	Normal-Triple-negative breast cancer	-0.0469653396035845	0.467236332276157	14.9999999995921	0.921264852724047	0.954279953398172	nan
sp|Q9NS86|LANC2_HUMAN	metaplastic breast carcinomas-Normal	0.355513346644824	0.307308479047081	23.9999999992929	0.258714292960735	0.460899265381682	nan
sp|Q9NS86|LANC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.157430312884675	0.307308479047081	23.9999999992929	0.613132195576747	0.94077736515583	nan
sp|Q9NS86|LANC2_HUMAN	Normal-Triple-negative breast cancer	-0.198083033760149	0.36730388604811	23.9999999992707	0.594655523115453	0.747835271465998	nan
sp|Q9NSC5|HOME3_HUMAN	metaplastic breast carcinomas-Normal	0.879678479790505	0.265673863612722	14.0000000008356	0.0051471155866519	0.0475250339167534	nan
sp|Q9NSC5|HOME3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.489423297315759	0.265673863612722	14.0000000008356	0.0867252025340148	0.809016644110817	nan
sp|Q9NSC5|HOME3_HUMAN	Normal-Triple-negative breast cancer	-0.390255182474746	0.317541002542329	14.000000000995	0.239332606200346	0.426106900380262	nan
sp|Q9NSD9|SYFB_HUMAN	metaplastic breast carcinomas-Normal	0.245573035179043	0.219366183435875	21.9999999545187	0.275015056630655	0.477548285858522	nan
sp|Q9NSD9|SYFB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.215918569013294	0.219366183435875	21.9999999543081	0.335677838841038	0.870890600099115	nan
sp|Q9NSD9|SYFB_HUMAN	Normal-Triple-negative breast cancer	-0.461491604192337	0.262192738363054	21.9999999544647	0.0922853768041001	0.230817601577749	nan
sp|Q9NSE4|SYIM_HUMAN	metaplastic breast carcinomas-Normal	0.0185412291831715	0.274075092054932	24.0000000000895	0.946624557841838	0.972567428615729	nan
sp|Q9NSE4|SYIM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.563271814815005	0.274075092054932	24.0000000003458	0.0509009617650982	0.772811405794299	nan
sp|Q9NSE4|SYIM_HUMAN	Normal-Triple-negative breast cancer	-0.581813043998177	0.327582391130012	24.0000000001387	0.0884010769345261	0.22401788132619	nan
sp|Q9NSI6|BRWD1_HUMAN	metaplastic breast carcinomas-Normal	0.647917758131871	0.483697541041438	14.0000000152415	0.201745153660557	0.395079844022346	nan
sp|Q9NSI6|BRWD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.193454043726715	0.483697541041438	14.0000000152416	0.69523017165963	0.947043345959522	nan
sp|Q9NSI6|BRWD1_HUMAN	Normal-Triple-negative breast cancer	-0.454463714405156	0.578129139317423	14.0000000152381	0.444914726727638	0.629578712212468	nan
sp|Q9NSK0|KLC4_HUMAN	metaplastic breast carcinomas-Normal	0.388856664179306	0.14021158607347	6.0	0.0322790086453302	0.128806032097332	nan
sp|Q9NSK0|KLC4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0838897365212204	0.14021158607347	6.0	0.571512981368733	0.935631258424823	nan
sp|Q9NSK0|KLC4_HUMAN	Normal-Triple-negative breast cancer	-0.472746400700527	0.167584899035164	6.0	0.0303167839018943	0.116515652166404	nan
sp|Q9NSY1|BMP2K_HUMAN	metaplastic breast carcinomas-Normal	-0.356941882147815	0.407522891854189	14.000000008315	0.395874017640672	0.600135472644601	nan
sp|Q9NSY1|BMP2K_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0023489897018596	0.407522891854189	14.0000000085665	0.995482294836051	0.998185231446144	nan
sp|Q9NSY1|BMP2K_HUMAN	Normal-Triple-negative breast cancer	0.359290871849675	0.487083019302813	14.0000000082114	0.472917736009041	0.651943767896769	nan
sp|Q9NTI5|PDS5B_HUMAN	metaplastic breast carcinomas-Normal	0.247014246392341	0.23887871167072	23.9999999997517	0.311417292038903	0.519654155992627	nan
sp|Q9NTI5|PDS5B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0685312262212193	0.23887871167072	23.9999999997517	0.776661003033063	0.960657739983943	nan
sp|Q9NTI5|PDS5B_HUMAN	Normal-Triple-negative breast cancer	-0.178483020171122	0.285514670349786	23.9999999997518	0.537786487849097	0.704057615443245	nan
sp|Q9NTJ3|SMC4_HUMAN	metaplastic breast carcinomas-Normal	0.233421602754658	0.338805710882588	24.0000000000555	0.497459087719036	0.684418049494237	nan
sp|Q9NTJ3|SMC4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.114342956025788	0.338805710882588	24.0000000000555	0.738682792747755	0.954643368861838	nan
sp|Q9NTJ3|SMC4_HUMAN	Normal-Triple-negative breast cancer	-0.119078646728871	0.404950278652746	23.9999999999913	0.771242190829106	0.869314697292624	nan
sp|Q9NTJ5|SAC1_HUMAN	metaplastic breast carcinomas-Normal	-0.11839991970405	0.153869909133313	21.9999999936886	0.449791395546765	0.644964587635915	nan
sp|Q9NTJ5|SAC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.154496240950663	0.153869909133313	21.9999999964404	0.32626121761202	0.867975899287892	nan
sp|Q9NTJ5|SAC1_HUMAN	Normal-Triple-negative breast cancer	0.272896160654713	0.183909717511819	21.9999999942989	0.152032862823394	0.31972470314917	nan
sp|Q9NTK5|OLA1_HUMAN	metaplastic breast carcinomas-Normal	0.292042030748333	0.19224343214907	22.0000000282305	0.142972326749585	0.319340083250317	nan
sp|Q9NTK5|OLA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.222192810829856	0.19224343214907	22.0000000282258	0.260165807140819	0.862813416943474	nan
sp|Q9NTK5|OLA1_HUMAN	Normal-Triple-negative breast cancer	-0.514234841578189	0.229774850061203	22.0000000275864	0.0356685103069939	0.12639885742052	nan
sp|Q9NTX5|ECHD1_HUMAN	metaplastic breast carcinomas-Normal	-1.59193030135074	0.712211394595169	22.0000000011751	0.0358779464864086	0.137394348065463	nan
sp|Q9NTX5|ECHD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.896188734897706	0.712211394595169	22.0000000015699	0.221467589600233	0.843662073010871	nan
sp|Q9NTX5|ECHD1_HUMAN	Normal-Triple-negative breast cancer	2.48811903624844	0.851255434714093	22.0000000016707	0.0078799924231971	0.0563292361606612	nan
sp|Q9NTZ6|RBM12_HUMAN	metaplastic breast carcinomas-Normal	0.488223887509678	0.228379580863215	22.0000000249377	0.0438960296625021	0.155668104255662	nan
sp|Q9NTZ6|RBM12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.015093600273497	0.228379580863215	22.0000000247685	0.947903115024796	0.996541950781621	nan
sp|Q9NTZ6|RBM12_HUMAN	Normal-Triple-negative breast cancer	-0.473130287236181	0.272965808835513	22.0000000248246	0.0970387359910165	0.23871253280979	nan
sp|Q9NUB1|ACS2L_HUMAN	metaplastic breast carcinomas-Normal	0.917921668396993	0.495843673236157	13.0395797715258	0.0869123636195822	0.236924781788546	nan
sp|Q9NUB1|ACS2L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.379197555356275	0.495843673236157	13.0395797702063	0.458036659898565	0.908567154037048	nan
sp|Q9NUB1|ACS2L_HUMAN	Normal-Triple-negative breast cancer	-0.538724113040718	0.583314953136421	12.9999999882296	0.372542302605439	0.561417010671586	nan
sp|Q9NUJ1|ABHDA_HUMAN	metaplastic breast carcinomas-Normal	0.318552060208837	0.150986843593254	21.999989165851	0.0464804171272856	0.161801372522583	nan
sp|Q9NUJ1|ABHDA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0345443107750024	0.150986843593254	21.9999891658415	0.821145380631984	0.965774701272009	nan
sp|Q9NUJ1|ABHDA_HUMAN	Normal-Triple-negative breast cancer	-0.353096370983839	0.180463795095755	21.9999891658725	0.0632053267824108	0.182057631043963	nan
sp|Q9NUL3|STAU2_HUMAN	metaplastic breast carcinomas-Normal	0.499708022189606	0.280547291331663	22.0000000209285	0.0886943180112407	0.239886015516163	nan
sp|Q9NUL3|STAU2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0077408048799322	0.280547291331663	22.0000000208905	0.97823648564242	0.99709406933403	nan
sp|Q9NUL3|STAU2_HUMAN	Normal-Triple-negative breast cancer	-0.491967217309674	0.335318148870875	22.0000000212174	0.156481992326762	0.325912773022447	nan
sp|Q9NUL5|SHFL_HUMAN	metaplastic breast carcinomas-Normal	-0.1895455922348	0.439568580186752	14.000000014531	0.67288270974053	0.808148806621432	nan
sp|Q9NUL5|SHFL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0128103638673618	0.439568580186752	14.0000000143912	0.977161881614681	0.99709406933403	nan
sp|Q9NUL5|SHFL_HUMAN	Normal-Triple-negative breast cancer	0.176735228367438	0.525384942803706	14.0000000146215	0.741564350056765	0.851557700975204	nan
sp|Q9NUM4|T106B_HUMAN	metaplastic breast carcinomas-Normal	-0.283306429522021	0.274815821673514	14.9999999996177	0.318926430466817	0.526350188622422	nan
sp|Q9NUM4|T106B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.573670294640181	0.274815821673514	14.9999999994575	0.0543195038038513	0.773286317778246	nan
sp|Q9NUM4|T106B_HUMAN	Normal-Triple-negative breast cancer	-0.290363865118159	0.328467732361923	14.9999999995228	0.390648052370211	0.578083962813143	nan
sp|Q9NUQ2|PLCE_HUMAN	metaplastic breast carcinomas-Normal	-0.113151333520196	0.218099721833327	14.0000000016528	0.611999360252401	0.767676061213969	nan
sp|Q9NUQ2|PLCE_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.543903718338057	0.218099721833327	14.0000000016528	0.0257719477858139	0.721684569712558	nan
sp|Q9NUQ2|PLCE_HUMAN	Normal-Triple-negative breast cancer	-0.430752384817861	0.260679027223066	14.0000000016704	0.120689887539475	0.273092706726492	nan
sp|Q9NUQ6|SPS2L_HUMAN	metaplastic breast carcinomas-Normal	0.191078388819018	0.393247214798616	23.9999999991561	0.631445726268332	0.779400517681372	nan
sp|Q9NUQ6|SPS2L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.273994399480491	0.393247214798616	23.9999999994063	0.492654194528817	0.913320451076758	nan
sp|Q9NUQ6|SPS2L_HUMAN	Normal-Triple-negative breast cancer	0.0829160106614732	0.470020321668373	23.9999999992441	0.861452470955349	0.920618363364173	nan
sp|Q9NUQ7|UFSP2_HUMAN	metaplastic breast carcinomas-Normal	0.147263100806855	0.168799817671447	14.0000009334986	0.397699219002699	0.601923998636815	nan
sp|Q9NUQ7|UFSP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.11127911999478	0.168799817671447	14.0000009335601	0.520440351080041	0.917480869285828	nan
sp|Q9NUQ7|UFSP2_HUMAN	Normal-Triple-negative breast cancer	-0.258542220801635	0.201754371331342	14.0000009335634	0.220847031430594	0.404015152710673	nan
sp|Q9NUQ8|ABCF3_HUMAN	metaplastic breast carcinomas-Normal	0.105875660068743	0.303878776989622	14.9999999994204	0.732371014868697	0.851109065467202	nan
sp|Q9NUQ8|ABCF3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0140384496266119	0.303878776989622	14.9999999994203	0.963762253240205	0.99709406933403	nan
sp|Q9NUQ8|ABCF3_HUMAN	Normal-Triple-negative breast cancer	-0.0918372104421312	0.363204608027542	14.9999999994042	0.803814522185397	0.887372790350136	nan
sp|Q9NUQ9|CYRIB_HUMAN	metaplastic breast carcinomas-Normal	-0.23357401707425	0.225708039566066	22.0000000062467	0.311980914107133	0.520333446308134	nan
sp|Q9NUQ9|CYRIB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.230800299384109	0.225708039566066	22.0000000052439	0.317628765181059	0.867696529950794	nan
sp|Q9NUQ9|CYRIB_HUMAN	Normal-Triple-negative breast cancer	0.464374316458359	0.269772706246142	22.0000000060067	0.0992208309400255	0.241796218507804	nan
sp|Q9NUU7|DD19A_HUMAN	metaplastic breast carcinomas-Normal	0.229714177838843	0.258464633228245	22.0000000590261	0.383744656851726	0.589275343425259	nan
sp|Q9NUU7|DD19A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.510607923699678	0.258464633228245	22.0000000588248	0.0608829571333044	0.773787875546141	nan
sp|Q9NUU7|DD19A_HUMAN	Normal-Triple-negative breast cancer	0.280893745860835	0.30892432413552	22.0000000587835	0.37306500790781	0.561474362245857	nan
sp|Q9NV70|EXOC1_HUMAN	metaplastic breast carcinomas-Normal	0.206472793306492	0.314461911695702	13.9996349154421	0.522091330542237	0.702436882783103	nan
sp|Q9NV70|EXOC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0022348048750433	0.314461911695702	13.9996349252279	0.994429953780371	0.998185231446144	nan
sp|Q9NV70|EXOC1_HUMAN	Normal-Triple-negative breast cancer	-0.208707598181535	0.375853873404689	13.9996349113573	0.587460831651042	0.743208813016678	nan
sp|Q9NVA1|UQCC1_HUMAN	metaplastic breast carcinomas-Normal	0.235178231819134	0.165339967834054	22.0000002726241	0.168937131675632	0.357673264770574	nan
sp|Q9NVA1|UQCC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.216907851880944	0.165339967834054	22.000000272761	0.203082490659395	0.843662073010871	nan
sp|Q9NVA1|UQCC1_HUMAN	Normal-Triple-negative breast cancer	-0.452086083700079	0.19761905982169	22.0000002727846	0.0321350744095419	0.120560933789297	nan
sp|Q9NVA2|SEP11_HUMAN	metaplastic breast carcinomas-Normal	-0.0731761898505134	0.197174966880174	22.0000032324538	0.714095736304455	0.839637151565621	nan
sp|Q9NVA2|SEP11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0181567365324462	0.197174966880174	22.0000032322269	0.927464368998835	0.995209711945114	nan
sp|Q9NVA2|SEP11_HUMAN	Normal-Triple-negative breast cancer	0.0550194533180673	0.235669161459746	22.0000032316139	0.817562407360814	0.896594339184211	nan
sp|Q9NVD7|PARVA_HUMAN	metaplastic breast carcinomas-Normal	-0.724931312499841	0.281605263438389	22.0000000021268	0.0173020236915592	0.0885925786057228	nan
sp|Q9NVD7|PARVA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.19923471129782	0.281605263438389	22.0000000020232	0.486685936745538	0.913320451076758	nan
sp|Q9NVD7|PARVA_HUMAN	Normal-Triple-negative breast cancer	0.525696601202021	0.336582667400711	22.0000000015874	0.132591001053105	0.291621375393624	nan
sp|Q9NVI7|ATD3A_HUMAN	metaplastic breast carcinomas-Normal	0.0663877274636828	0.385300219636292	14.9999999994822	0.865503879636532	0.929843211348362	nan
sp|Q9NVI7|ATD3A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.702296404757416	0.385300219636292	14.9999999996443	0.0883381111080491	0.809016644110817	nan
sp|Q9NVI7|ATD3A_HUMAN	Normal-Triple-negative breast cancer	-0.768684132221098	0.460521845692122	14.9999999995794	0.115817726525252	0.26588760329451	nan
sp|Q9NVP1|DDX18_HUMAN	metaplastic breast carcinomas-Normal	0.926558498172505	0.202528852062062	22.0000000011749	0.0001481315144244	0.0153871610608405	nan
sp|Q9NVP1|DDX18_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0316562947754318	0.202528852062062	22.0000000015039	0.87721798587772	0.983181130777328	nan
sp|Q9NVP1|DDX18_HUMAN	Normal-Triple-negative breast cancer	-0.958214792947937	0.242068278200229	22.0000000016019	0.0006674066583196	0.0247210772633291	nan
sp|Q9NVS9|PNPO_HUMAN	metaplastic breast carcinomas-Normal	-0.391327309452581	0.277819016037498	23.9999999996913	0.171786575638857	0.360525616455081	nan
sp|Q9NVS9|PNPO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.274090088475284	0.277819016037498	23.999999999901	0.333692124909049	0.870890600099115	nan
sp|Q9NVS9|PNPO_HUMAN	Normal-Triple-negative breast cancer	0.117237220977297	0.332057236185148	23.9999999998121	0.727123193075893	0.842145468217515	nan
sp|Q9NVV5|AIG1_HUMAN	metaplastic breast carcinomas-Normal	0.222537043557952	0.392012574191778	14.0000000032548	0.5792439470101	0.740541107639066	nan
sp|Q9NVV5|AIG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.17381253310974	0.392012574191778	14.000000002959	0.664262162341233	0.944724271291086	nan
sp|Q9NVV5|AIG1_HUMAN	Normal-Triple-negative breast cancer	-0.396349576667692	0.468544643892834	14.0000000030347	0.411824920898961	0.600159286793477	nan
sp|Q9NVZ3|NECP2_HUMAN	metaplastic breast carcinomas-Normal	0.368133528607431	0.311089082762544	15.0000000000044	0.255078561215139	0.456340762905879	nan
sp|Q9NVZ3|NECP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.115574616858867	0.311089082762544	15.0000000000044	0.715448510860926	0.949812109346858	nan
sp|Q9NVZ3|NECP2_HUMAN	Normal-Triple-negative breast cancer	-0.483708145466299	0.371822571769388	15.0000000000261	0.212919127318948	0.395387250954292	nan
sp|Q9NW08|RPC2_HUMAN	metaplastic breast carcinomas-Normal	0.61937039000173	0.65249315294067	21.9999999997791	0.352812140377848	0.561744479911381	nan
sp|Q9NW08|RPC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.955621406238304	0.696672045286217	21.9999999997903	0.183986659134355	0.843662073010871	nan
sp|Q9NW08|RPC2_HUMAN	Normal-Triple-negative breast cancer	-1.57499179624003	0.809722708423732	21.9999999998021	0.064654091340705	0.184632968217622	nan
sp|Q9NW13|RBM28_HUMAN	metaplastic breast carcinomas-Normal	0.778410717320732	0.300380702857064	21.9999997603974	0.0166592084062063	0.0864692424825917	nan
sp|Q9NW13|RBM28_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.171220802231898	0.300380702857064	21.9999997603964	0.574444654192957	0.935847692353991	nan
sp|Q9NW13|RBM28_HUMAN	Normal-Triple-negative breast cancer	-0.94963151955263	0.359023609746736	21.9999997596946	0.0147890397132754	0.0779324922305247	nan
sp|Q9NW64|RBM22_HUMAN	metaplastic breast carcinomas-Normal	1.1640283203282	0.311738597607263	12.1202270088056	0.0028064442890014	0.0379733940896436	nan
sp|Q9NW64|RBM22_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.161470001975102	0.280802994536188	12.0376700343612	0.575861672599687	0.935847692353991	nan
sp|Q9NW64|RBM22_HUMAN	Normal-Triple-negative breast cancer	-1.3254983223033	0.357396146781455	12.2021115194898	0.0029074530765604	0.0361961574025721	nan
sp|Q9NW68|BSDC1_HUMAN	metaplastic breast carcinomas-Normal	0.361610425000526	0.179670670893685	23.9999999996734	0.0555041601294534	0.179470650068388	nan
sp|Q9NW68|BSDC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.202861693308058	0.179670670893685	23.9999999997223	0.270025786531201	0.867696529950794	nan
sp|Q9NW68|BSDC1_HUMAN	Normal-Triple-negative breast cancer	-0.564472118308584	0.214747526110436	23.9999999997743	0.0147213107296239	0.0779324922305247	nan
sp|Q9NWA0|MED9_HUMAN	metaplastic breast carcinomas-Normal	-1.2813208521859	0.327647523474134	15.0000000000682	0.0013906402531978	0.0276795700696394	nan
sp|Q9NWA0|MED9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.373819313843727	0.327647523474134	15.0000000000492	0.271792384021159	0.867696529950794	nan
sp|Q9NWA0|MED9_HUMAN	Normal-Triple-negative breast cancer	1.65514016602963	0.391613693833847	15.0000000000429	0.0007326988427776	0.0257262735003663	nan
sp|Q9NWH9|SLTM_HUMAN	metaplastic breast carcinomas-Normal	0.760872127077176	0.2214687791323	22.0000000049063	0.0023618339859524	0.0347377706606461	nan
sp|Q9NWH9|SLTM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.157885475504988	0.2214687791323	22.0000000048351	0.48340031738694	0.913320451076758	nan
sp|Q9NWH9|SLTM_HUMAN	Normal-Triple-negative breast cancer	-0.918757602582164	0.264705820893285	22.0000000048958	0.0021705397580845	0.032066107359435	nan
sp|Q9NWU2|GID8_HUMAN	metaplastic breast carcinomas-Normal	0.389914700132929	0.344514553390571	6.0	0.300923095417459	0.50723548132233	nan
sp|Q9NWU2|GID8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0423401364704637	0.344514553390571	6.0	0.906201192477191	0.992888981494585	nan
sp|Q9NWU2|GID8_HUMAN	Normal-Triple-negative breast cancer	-0.347574563662465	0.411773650544471	6.0	0.430980186533132	0.616427771099885	nan
sp|Q9NWU5|RM22_HUMAN	metaplastic breast carcinomas-Normal	0.327677249749688	0.295956145034234	6.0	0.310617117221859	0.518776561749451	nan
sp|Q9NWU5|RM22_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0011867236448232	0.295956145034234	6.0	0.996930649231753	0.998432050811921	nan
sp|Q9NWU5|RM22_HUMAN	Normal-Triple-negative breast cancer	-0.326490526104865	0.353735251653236	6.0	0.39162273226558	0.578814567385855	nan
sp|Q9NWV4|CZIB_HUMAN	metaplastic breast carcinomas-Normal	0.0382002380078735	0.22073993031132	22.0000024471078	0.864190186872712	0.929332960583919	nan
sp|Q9NWV4|CZIB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0208787006030146	0.22073993031132	22.0000024472889	0.925500617857425	0.994822473738689	nan
sp|Q9NWV4|CZIB_HUMAN	Normal-Triple-negative breast cancer	-0.0590789386108881	0.26383467993057	22.0000024476583	0.824882790227789	0.900463183815163	nan
sp|Q9NX00|TM160_HUMAN	metaplastic breast carcinomas-Normal	0.48463345094308	0.314500549922778	14.0000000156894	0.145620687737674	0.322739185525647	nan
sp|Q9NX00|TM160_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.295024312583083	0.314500549922778	14.0000000156909	0.364109781486963	0.883542279876718	nan
sp|Q9NX00|TM160_HUMAN	Normal-Triple-negative breast cancer	-0.189609138359996	0.375900054919104	14.0000000157675	0.621816135843362	0.771237625202737	nan
sp|Q9NX40|OCAD1_HUMAN	metaplastic breast carcinomas-Normal	0.0883446247045034	0.176519725958265	23.9999999993025	0.621295668829318	0.773478203441443	nan
sp|Q9NX40|OCAD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.058754780281429	0.176519725958265	23.9999999992771	0.742136791771703	0.954643368861838	nan
sp|Q9NX40|OCAD1_HUMAN	Normal-Triple-negative breast cancer	-0.147099404985932	0.210981426577185	23.9999999993056	0.492367475303692	0.66910445131213	nan
sp|Q9NX46|ADPRS_HUMAN	metaplastic breast carcinomas-Normal	-0.327496145595489	0.232151479787998	14.9999999996438	0.178734660583771	0.367883501589116	nan
sp|Q9NX46|ADPRS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.255361553922939	0.232151479787998	14.9999999997366	0.288682177905859	0.867696529950794	nan
sp|Q9NX46|ADPRS_HUMAN	Normal-Triple-negative breast cancer	0.0721345916725494	0.27747409034193	14.9999999997004	0.798422406154128	0.884062650918162	nan
sp|Q9NX62|IMPA3_HUMAN	metaplastic breast carcinomas-Normal	0.709016092235369	0.362051115598025	23.9999999994168	0.061912254458016	0.191082946906634	nan
sp|Q9NX62|IMPA3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.42977898468268	0.362051115598025	23.9999999997105	0.246818349341991	0.84964799869723	nan
sp|Q9NX62|IMPA3_HUMAN	Normal-Triple-negative breast cancer	-0.279237107552689	0.432733851404193	23.9999999995781	0.524863354633651	0.695444310582923	nan
sp|Q9NX63|MIC19_HUMAN	metaplastic breast carcinomas-Normal	0.442860329486931	0.18980923819709	23.9999999997347	0.0283462281931032	0.120182222594229	nan
sp|Q9NX63|MIC19_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0679191856176734	0.18980923819709	23.9999999997771	0.723599397400601	0.952670488452066	nan
sp|Q9NX63|MIC19_HUMAN	Normal-Triple-negative breast cancer	-0.510779515104604	0.226865431809128	23.9999999997851	0.0337829425188147	0.123621534315429	nan
sp|Q9NXC5|MIO_HUMAN	metaplastic breast carcinomas-Normal	0.170928234223174	0.31562804127579	6.0	0.607635956182498	0.765068908466145	nan
sp|Q9NXC5|MIO_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.819486492005559	0.31562804127579	6.0	0.0408610086101793	0.738255867002113	nan
sp|Q9NXC5|MIO_HUMAN	Normal-Triple-negative breast cancer	-0.990414726228733	0.377247664841002	6.0	0.0393025016760532	0.132496466096553	nan
sp|Q9NXG2|THUM1_HUMAN	metaplastic breast carcinomas-Normal	-0.0424686686084814	0.299914915628494	21.9999847867678	0.888682774267865	0.940458943542306	nan
sp|Q9NXG2|THUM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.155173482967063	0.299914915628494	21.9999847870826	0.610046186855137	0.940559810632461	nan
sp|Q9NXG2|THUM1_HUMAN	Normal-Triple-negative breast cancer	-0.112704814358582	0.358466887525286	21.9999847874437	0.756173535855296	0.859388505509785	nan
sp|Q9NXH9|TRM1_HUMAN	metaplastic breast carcinomas-Normal	-0.811015376727274	1.11445068954065	6.0	0.494188025208089	0.682459906851553	nan
sp|Q9NXH9|TRM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.380355049870424	1.11445068954065	6.0	0.744517231738905	0.954643368861838	nan
sp|Q9NXH9|TRM1_HUMAN	Normal-Triple-negative breast cancer	1.1913704265977	1.33202334783142	6.0	0.405550992178291	0.594378967372415	nan
sp|Q9NXR1|NDE1_HUMAN	metaplastic breast carcinomas-Normal	-0.681237889386489	0.43034764606806	13.9999999996887	0.135745198530643	0.308708630279932	nan
sp|Q9NXR1|NDE1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0975481891856251	0.386760760180618	13.9999999995441	0.804537379875908	0.965774701272009	nan
sp|Q9NXR1|NDE1_HUMAN	Normal-Triple-negative breast cancer	0.583689700200863	0.499305994382018	13.9999999996012	0.261922628428961	0.452981694535831	nan
sp|Q9NXR7|BABA2_HUMAN	metaplastic breast carcinomas-Normal	0.213869199929781	0.19319394893944	22.0000000212214	0.280243899090538	0.483660810268405	nan
sp|Q9NXR7|BABA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.177359856819271	0.19319394893944	22.0000000216444	0.368553419361961	0.883542279876718	nan
sp|Q9NXR7|BABA2_HUMAN	Normal-Triple-negative breast cancer	-0.0365093431105094	0.230910934922707	22.0000000215269	0.875812374196127	0.928020507436381	nan
sp|Q9NXV6|CARF_HUMAN	metaplastic breast carcinomas-Normal	-0.0072483802008653	0.222386946263841	23.0000000000625	0.97427991518465	0.986747848285733	nan
sp|Q9NXV6|CARF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.329884102453729	0.20802394005255	23.0000000001558	0.126439206247671	0.823891816737944	nan
sp|Q9NXV6|CARF_HUMAN	Normal-Triple-negative breast cancer	-0.322635722252864	0.260771809383731	23.00000000019	0.228483727349814	0.410973977116224	nan
sp|Q9NY15|STAB1_HUMAN	metaplastic breast carcinomas-Normal	-0.77023637654886	0.418980404480118	21.9999999303638	0.0795501558617166	0.223520471753462	nan
sp|Q9NY15|STAB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.924705060886233	0.418980404480118	21.9999999305289	0.0380464387480575	0.73123935744099	nan
sp|Q9NY15|STAB1_HUMAN	Normal-Triple-negative breast cancer	1.69494143743509	0.500777366185134	21.9999999303365	0.0026673970465407	0.0346344835261781	nan
sp|Q9NY27|PP4R2_HUMAN	metaplastic breast carcinomas-Normal	-0.573732458534553	0.43726721981045	22.0000046134863	0.20301727569124	0.396492023735419	nan
sp|Q9NY27|PP4R2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.320385911174601	0.43726721981045	22.0000046129757	0.471476238557477	0.912607574317916	nan
sp|Q9NY27|PP4R2_HUMAN	Normal-Triple-negative breast cancer	0.894118369709155	0.522634291041561	22.0000046130938	0.101185723282265	0.244442821554936	nan
sp|Q9NY33|DPP3_HUMAN	metaplastic breast carcinomas-Normal	0.0865418527092833	0.158574130084525	23.9999999995423	0.590274868800607	0.748883077821839	nan
sp|Q9NY33|DPP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.398633830756083	0.158574130084525	23.9999999995423	0.0190562126227287	0.674062840112479	nan
sp|Q9NY33|DPP3_HUMAN	Normal-Triple-negative breast cancer	-0.485175683465367	0.189532336977338	23.9999999995422	0.017191501389786	0.0846363140557232	nan
sp|Q9NYB0|TE2IP_HUMAN	metaplastic breast carcinomas-Normal	0.243923982075613	0.361599775727171	14.0000000114069	0.510936190941814	0.69433847043769	nan
sp|Q9NYB0|TE2IP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.250217281277874	0.361599775727171	14.0000000109749	0.500270417082075	0.913320451076758	nan
sp|Q9NYB0|TE2IP_HUMAN	Normal-Triple-negative breast cancer	-0.494141263353487	0.432194397078016	14.0000000110099	0.272075888669931	0.463995415682386	nan
sp|Q9NYF8|BCLF1_HUMAN	metaplastic breast carcinomas-Normal	0.663418156708043	0.242164850690776	21.999999992272	0.0119657991279355	0.0719854488165233	nan
sp|Q9NYF8|BCLF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.282283059201385	0.242164850690776	21.9999999934995	0.256232730819042	0.860579626235671	nan
sp|Q9NYF8|BCLF1_HUMAN	Normal-Triple-negative breast cancer	-0.945701215909428	0.289442357720808	21.9999999928819	0.0035247107631566	0.0397157239889247	nan
sp|Q9NYL4|FKB11_HUMAN	metaplastic breast carcinomas-Normal	1.25411719551905	0.320353497583243	22.000000002608	0.0007422510867285	0.0221825773337916	nan
sp|Q9NYL4|FKB11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.627281174603243	0.320353497583244	22.0000000030164	0.0630203530128136	0.773787875546141	nan
sp|Q9NYL4|FKB11_HUMAN	Normal-Triple-negative breast cancer	-0.62683602091581	0.382895665411829	22.0000000028205	0.115837017380874	0.26588760329451	nan
sp|Q9NYL9|TMOD3_HUMAN	metaplastic breast carcinomas-Normal	0.349072933394015	0.348580350835735	15.0000000000384	0.332508915051452	0.540733675944729	nan
sp|Q9NYL9|TMOD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.233530246074855	0.348580350835735	15.0000000000384	0.513073981884225	0.915620969865368	nan
sp|Q9NYL9|TMOD3_HUMAN	Normal-Triple-negative breast cancer	-0.115542687319159	0.416633207970691	15.0000000000186	0.785316279697039	0.877631088368709	nan
sp|Q9NYM9|BET1L_HUMAN	metaplastic breast carcinomas-Normal	-0.139442825599189	0.242369924541853	22.0000000111357	0.57090593919805	0.734890094424702	nan
sp|Q9NYM9|BET1L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0774949993650926	0.242369924541853	22.0000000111348	0.752183160082044	0.954643368861838	nan
sp|Q9NYM9|BET1L_HUMAN	Normal-Triple-negative breast cancer	0.0619478262340963	0.28968746785464	22.0000000109858	0.832638458446829	0.905361542648761	nan
sp|Q9NYU2|UGGG1_HUMAN	metaplastic breast carcinomas-Normal	0.329170408118394	0.171158313800633	22.0000000024401	0.0674940019218067	0.200850548243586	nan
sp|Q9NYU2|UGGG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0576685261161574	0.171158313800633	22.0000000031446	0.739362082788948	0.954643368861838	nan
sp|Q9NYU2|UGGG1_HUMAN	Normal-Triple-negative breast cancer	-0.386838934234551	0.204573313379951	22.0000000028069	0.0718723866321213	0.196144345784213	nan
sp|Q9NZ01|TECR_HUMAN	metaplastic breast carcinomas-Normal	-0.322108895715106	0.192678432055356	22.0000058459695	0.108739710541564	0.269940849768602	nan
sp|Q9NZ01|TECR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.387671152322537	0.192678432055356	22.000005845971	0.0566227772009675	0.773787875546141	nan
sp|Q9NZ01|TECR_HUMAN	Normal-Triple-negative breast cancer	-0.0655622566074309	0.230294774394254	22.0000058458738	0.778545482954977	0.874519294198955	nan
sp|Q9NZ08|ERAP1_HUMAN	metaplastic breast carcinomas-Normal	-0.173463216567061	0.228160641678381	22.0000001655352	0.455165640861293	0.649292975206949	nan
sp|Q9NZ08|ERAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.29968512899906	0.228160641678381	22.0000001653552	0.202554525379274	0.843662073010871	nan
sp|Q9NZ08|ERAP1_HUMAN	Normal-Triple-negative breast cancer	0.473148345566121	0.272704126458094	22.0000001651376	0.0967261222285034	0.238514562527853	nan
sp|Q9NZ32|ARP10_HUMAN	metaplastic breast carcinomas-Normal	0.451413781440332	0.748709126028199	6.0	0.56863350727405	0.734528007858528	nan
sp|Q9NZ32|ARP10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.19997472646265	0.748709126028199	6.0	0.798340939837143	0.965774701272009	nan
sp|Q9NZ32|ARP10_HUMAN	Normal-Triple-negative breast cancer	-0.651388507902982	0.894878567498654	6.0	0.494085224255395	0.670890230974237	nan
sp|Q9NZB2|F120A_HUMAN	metaplastic breast carcinomas-Normal	0.245941579864404	0.119151148709059	23.9999999996557	0.0499779128274404	0.169912927873181	nan
sp|Q9NZB2|F120A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.156462837613275	0.119151148709059	23.9999999996557	0.201551071192716	0.843662073010871	nan
sp|Q9NZB2|F120A_HUMAN	Normal-Triple-negative breast cancer	-0.402404417477679	0.142412861772124	23.9999999997097	0.0093547247714577	0.0614527769571654	nan
sp|Q9NZJ7|MTCH1_HUMAN	metaplastic breast carcinomas-Normal	0.143709044144524	0.206404518419246	22.0000000030618	0.493563543087754	0.682164331485943	nan
sp|Q9NZJ7|MTCH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0449349591674521	0.206404518419246	22.0000000030044	0.829666768938845	0.967605053216998	nan
sp|Q9NZJ7|MTCH1_HUMAN	Normal-Triple-negative breast cancer	-0.188644003311976	0.246700585510571	22.0000000025328	0.452594142051135	0.635313736561643	nan
sp|Q9NZL4|HPBP1_HUMAN	metaplastic breast carcinomas-Normal	0.0496559157955671	0.480314441655222	12.9999999998832	0.919237547804904	0.957866838049963	nan
sp|Q9NZL4|HPBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.375167974672931	0.43294958693344	12.9999999999391	0.401905143328192	0.885297496092956	nan
sp|Q9NZL4|HPBP1_HUMAN	Normal-Triple-negative breast cancer	0.325512058877364	0.550269321566376	12.9999999999178	0.564297292038611	0.726743199820358	nan
sp|Q9NZL9|MAT2B_HUMAN	metaplastic breast carcinomas-Normal	0.163276255772611	0.175976418316901	21.9999999995491	0.363563910017254	0.574375682936005	nan
sp|Q9NZL9|MAT2B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0702134732624672	0.175976418316901	21.9999999993295	0.693744415748275	0.946921257127675	nan
sp|Q9NZL9|MAT2B_HUMAN	Normal-Triple-negative breast cancer	-0.233489729035078	0.210332049740558	21.9999999989331	0.278942425406592	0.470662244696199	nan
sp|Q9NZM1|MYOF_HUMAN	metaplastic breast carcinomas-Normal	-0.159269603470266	0.234449232246821	23.9999999994803	0.503425244915715	0.688636014032855	nan
sp|Q9NZM1|MYOF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.20948338955818	0.234449232246821	23.9999999994812	0.38045534124534	0.885234295852111	nan
sp|Q9NZM1|MYOF_HUMAN	Normal-Triple-negative breast cancer	0.368752993028446	0.280220429817885	23.9999999994576	0.200626221056286	0.381511189239756	nan
sp|Q9NZM3|ITSN2_HUMAN	metaplastic breast carcinomas-Normal	-0.656035956649451	0.337515199990767	14.9999999998276	0.0709332881776152	0.207008121073216	nan
sp|Q9NZM3|ITSN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.35043478775579	0.337515199990766	14.9999999998276	0.315588650641547	0.867696529950794	nan
sp|Q9NZM3|ITSN2_HUMAN	Normal-Triple-negative breast cancer	1.00647074440524	0.403407823114184	14.9999999999157	0.0247526348946969	0.105004359304005	nan
sp|Q9NZN4|EHD2_HUMAN	metaplastic breast carcinomas-Normal	-2.38009361898228	0.589971960330543	21.9999999951709	0.0005548256818954	0.0205217420849069	nan
sp|Q9NZN4|EHD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.177737456528073	0.589971960330543	21.9999999950516	0.766042065913393	0.957818390309474	nan
sp|Q9NZN4|EHD2_HUMAN	Normal-Triple-negative breast cancer	2.55783107551035	0.705151365692161	21.9999999957487	0.0014899112593023	0.0275017792286832	nan
sp|Q9NZN8|CNOT2_HUMAN	metaplastic breast carcinomas-Normal	0.131817514401907	0.233438785265692	23.9999999996106	0.577533720304623	0.739492329080341	nan
sp|Q9NZN8|CNOT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.21428724387273	0.233438785265692	23.9999999996395	0.367773901932503	0.883542279876718	nan
sp|Q9NZN8|CNOT2_HUMAN	Normal-Triple-negative breast cancer	-0.346104758274637	0.279012714677823	23.9999999995883	0.226794882466577	0.409709885499404	nan
sp|Q9NZT1|CALL5_HUMAN	metaplastic breast carcinomas-Normal	-1.38311016543182	0.551844257624842	14.0000000101141	0.0251564889960038	0.111493559230289	nan
sp|Q9NZT1|CALL5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.90821197708089	0.551844257624842	14.0000000099917	0.0038439326146957	0.475304411992737	nan
sp|Q9NZT1|CALL5_HUMAN	Normal-Triple-negative breast cancer	-0.525101811649071	0.659580044610111	14.0000000101792	0.439256495950478	0.624341863388512	nan
sp|Q9NZT2|OGFR_HUMAN	metaplastic breast carcinomas-Normal	0.695807120764693	0.252683102639778	21.9999995205907	0.011589893397111	0.0710789772177067	nan
sp|Q9NZT2|OGFR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.309584072841538	0.252683102639779	21.999999520584	0.233460681588679	0.847998869365766	nan
sp|Q9NZT2|OGFR_HUMAN	Normal-Triple-negative breast cancer	-0.386223047923155	0.302014073370442	21.999999520598	0.214284552400015	0.396459769713563	nan
sp|Q9NZU5|LMCD1_HUMAN	metaplastic breast carcinomas-Normal	0.242126023203304	0.202468087152259	23.999999999591	0.243428363549397	0.44435597373584	nan
sp|Q9NZU5|LMCD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.118041857090507	0.202468087152259	23.9999999997873	0.565321991630016	0.935109025059232	nan
sp|Q9NZU5|LMCD1_HUMAN	Normal-Triple-negative breast cancer	-0.360167880293811	0.241995650241589	23.9999999996867	0.149688582427625	0.316920285343583	nan
sp|Q9P016|THYN1_HUMAN	metaplastic breast carcinomas-Normal	0.0009830456386757	0.287955632964978	20.0159873594062	0.997309920079549	0.998210832383144	nan
sp|Q9P016|THYN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.421378394121962	0.287955632964978	20.015987359418	0.158900513728858	0.843662073010871	nan
sp|Q9P016|THYN1_HUMAN	Normal-Triple-negative breast cancer	-0.422361439760638	0.336566413318463	20.0080475129316	0.223971300038427	0.406820000725537	nan
sp|Q9P035|HACD3_HUMAN	metaplastic breast carcinomas-Normal	0.219810827093542	0.272097619507272	21.9999975343559	0.427832737963746	0.625931347267381	nan
sp|Q9P035|HACD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.649530247989669	0.272097619507272	21.9999975341176	0.0260055691393019	0.721684569712558	nan
sp|Q9P035|HACD3_HUMAN	Normal-Triple-negative breast cancer	-0.869341075083211	0.325218859366875	21.9999975281489	0.0138911409157675	0.0765740504212459	nan
sp|Q9P0J1|PDP1_HUMAN	metaplastic breast carcinomas-Normal	-0.0614959844263369	0.245548122730343	22.0000000055372	0.804568257181556	0.89774584990651	nan
sp|Q9P0J1|PDP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.198120448609759	0.245548122730343	22.0000000056286	0.428390035939972	0.894058800058913	nan
sp|Q9P0J1|PDP1_HUMAN	Normal-Triple-negative breast cancer	0.259616433036096	0.293486141255658	22.0000000058854	0.385940988071891	0.574504184662322	nan
sp|Q9P0K7|RAI14_HUMAN	metaplastic breast carcinomas-Normal	0.780823016993876	0.194647545108731	22.000000021254	0.0005865118826913	0.0205217420849069	nan
sp|Q9P0K7|RAI14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.135216941377957	0.194647545108731	22.0000000217143	0.494530296140998	0.913320451076758	nan
sp|Q9P0K7|RAI14_HUMAN	Normal-Triple-negative breast cancer	-0.645606075615918	0.232648314650662	22.0000000217734	0.0110434699560336	0.0670157251028676	nan
sp|Q9P0L0|VAPA_HUMAN	metaplastic breast carcinomas-Normal	0.411875047248245	0.18088108551569	22.000000003618	0.0328621805515879	0.129407306133986	nan
sp|Q9P0L0|VAPA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.476309468902812	0.18088108551569	22.000000003116	0.0151815973388943	0.656412655960811	nan
sp|Q9P0L0|VAPA_HUMAN	Normal-Triple-negative breast cancer	-0.888184516151057	0.216194248295813	22.0000000030756	0.0004631474874787	0.0237592699893802	nan
sp|Q9P0M6|H2AW_HUMAN	metaplastic breast carcinomas-Normal	0.389931844641021	0.28689089329858	24.0000000000815	0.186730425095959	0.37824005668432	nan
sp|Q9P0M6|H2AW_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.301414934745611	0.28689089329858	24.0000000003153	0.303895073250344	0.867696529950794	nan
sp|Q9P0M6|H2AW_HUMAN	Normal-Triple-negative breast cancer	-0.691346779386632	0.342900203427963	24.0000000001657	0.0551068814519446	0.166865905675252	nan
sp|Q9P0S9|TM14C_HUMAN	metaplastic breast carcinomas-Normal	0.316717010044604	0.359313869202667	19.9525945857628	0.388569818154109	0.592689911608717	nan
sp|Q9P0S9|TM14C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.245867028753619	0.336124063758069	19.9078941644493	0.473010937280283	0.913280230088743	nan
sp|Q9P0S9|TM14C_HUMAN	Normal-Triple-negative breast cancer	-0.562584038798223	0.418232140895657	20.0064225922433	0.193628081294083	0.375069779849379	nan
sp|Q9P0V9|SEP10_HUMAN	metaplastic breast carcinomas-Normal	-0.34265042559568	0.250517811803139	22.000000033479	0.185195119149446	0.376276635729069	nan
sp|Q9P0V9|SEP10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0382200812856139	0.250517811803139	22.0000000340379	0.880132442444522	0.983583849145686	nan
sp|Q9P0V9|SEP10_HUMAN	Normal-Triple-negative breast cancer	0.380870506881294	0.299426055814962	22.0000000338822	0.216654282935435	0.399196535995467	nan
sp|Q9P107|GMIP_HUMAN	metaplastic breast carcinomas-Normal	-0.0191697728660177	0.313349026181572	6.0	0.953205117103604	0.975193989958575	nan
sp|Q9P107|GMIP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.459000857267321	0.313349026181572	6.0	0.193314065470206	0.843662073010871	nan
sp|Q9P107|GMIP_HUMAN	Normal-Triple-negative breast cancer	0.478170630133339	0.374523720799286	6.0	0.248877539457079	0.437476965179974	nan
sp|Q9P1F3|ABRAL_HUMAN	metaplastic breast carcinomas-Normal	-0.276031668737242	0.285604973409392	14.0000000095103	0.350203698980617	0.559652449717101	nan
sp|Q9P1F3|ABRAL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0734296383969813	0.285604973409392	14.000000009648	0.800840082624362	0.965774701272009	nan
sp|Q9P1F3|ABRAL_HUMAN	Normal-Triple-negative breast cancer	0.202602030340261	0.341363235187093	14.0000000095648	0.562307730890211	0.725023621985671	nan
sp|Q9P1Y5|CAMP3_HUMAN	metaplastic breast carcinomas-Normal	0.617039307313907	0.366418545727884	21.9999999994668	0.106323897950972	0.266129997582101	nan
sp|Q9P1Y5|CAMP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.420737133507512	0.314531875143691	21.9999999997349	0.194671929079532	0.843662073010871	nan
sp|Q9P1Y5|CAMP3_HUMAN	Normal-Triple-negative breast cancer	-1.03777644082142	0.420310897859732	21.9999999995418	0.0217870721231752	0.0972951861616619	nan
sp|Q9P206|K1522_HUMAN	metaplastic breast carcinomas-Normal	-1.11549218982025	0.571941570198608	22.000000033107	0.0639880922406454	0.193712585253101	nan
sp|Q9P206|K1522_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.576744748957916	0.571941570198608	22.0000000334439	0.324226431660581	0.867696529950794	nan
sp|Q9P206|K1522_HUMAN	Normal-Triple-negative breast cancer	1.69223693877817	0.683600927569012	22.000000032677	0.0214856329673604	0.0965111405182511	nan
sp|Q9P258|RCC2_HUMAN	metaplastic breast carcinomas-Normal	0.794738555935038	0.33491021407726	21.9999999856735	0.0268053061112131	0.116172877501596	nan
sp|Q9P258|RCC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.26177370075773	0.33491021407726	21.9999999856735	0.442766933160062	0.89755436380139	nan
sp|Q9P258|RCC2_HUMAN	Normal-Triple-negative breast cancer	-1.05651225669277	0.400294269423448	21.9999999861848	0.0149780264235363	0.0781078712931399	nan
sp|Q9P270|SLAI2_HUMAN	metaplastic breast carcinomas-Normal	0.235507924193472	0.264572589497896	22.0000000044977	0.38301928572506	0.589002717867072	nan
sp|Q9P270|SLAI2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0170524731196097	0.264572589497896	22.0000000041633	0.949191675965714	0.996541950781621	nan
sp|Q9P270|SLAI2_HUMAN	Normal-Triple-negative breast cancer	-0.218455451073863	0.31622472821357	22.0000000039485	0.49690145661259	0.673338948952405	nan
sp|Q9P278|FNIP2_HUMAN	metaplastic breast carcinomas-Normal	-0.999144643476923	0.795552973184503	13.9999999998719	0.229703384831354	0.42943422451036	nan
sp|Q9P278|FNIP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.452834603191109	0.795552973184502	13.9999999998719	0.578234038405152	0.936496920456468	nan
sp|Q9P278|FNIP2_HUMAN	Normal-Triple-negative breast cancer	1.45197924666803	0.936124646391816	13.9999999999034	0.143195614060294	0.306570807991482	nan
sp|Q9P2B2|FPRP_HUMAN	metaplastic breast carcinomas-Normal	-0.36838552909962	0.316285358550118	23.9999999998888	0.25557733006704	0.456741422119807	nan
sp|Q9P2B2|FPRP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.221835518101774	0.316285358550118	23.9999999998888	0.489812990227263	0.913320451076758	nan
sp|Q9P2B2|FPRP_HUMAN	Normal-Triple-negative breast cancer	0.590221047201394	0.378033309252688	23.999999999884	0.131545314263701	0.290248221534721	nan
sp|Q9P2D3|HTR5B_HUMAN	metaplastic breast carcinomas-Normal	0.0335030132773191	0.250475186864078	14.0000011041044	0.89549782846234	0.943166914388092	nan
sp|Q9P2D3|HTR5B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.349676463124129	0.250475186864078	14.0000011040018	0.184443696193381	0.843662073010871	nan
sp|Q9P2D3|HTR5B_HUMAN	Normal-Triple-negative breast cancer	-0.383179476401448	0.299375109268324	14.0000011040243	0.221372619359894	0.404309113600159	nan
sp|Q9P2E9|RRBP1_HUMAN	metaplastic breast carcinomas-Normal	1.04531365196141	0.275138545938794	23.999999999143	0.000873737864284	0.0227210419054423	nan
sp|Q9P2E9|RRBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.362271359331523	0.275138545938794	23.9999999991026	0.200379093077805	0.843662073010871	nan
sp|Q9P2E9|RRBP1_HUMAN	Normal-Triple-negative breast cancer	-0.683042292629882	0.328853461636712	23.999999999133	0.0486696897665916	0.152909308869707	nan
sp|Q9P2J5|SYLC_HUMAN	metaplastic breast carcinomas-Normal	0.432356978084624	0.164585838445321	21.9999996265503	0.0153970096506991	0.0817474695422512	nan
sp|Q9P2J5|SYLC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.364739691288381	0.164585838445321	21.9999996218776	0.0373352702724853	0.73123935744099	nan
sp|Q9P2J5|SYLC_HUMAN	Normal-Triple-negative breast cancer	-0.797096669373005	0.196717702801136	21.9999996264694	0.0005313392829026	0.0237592699893802	nan
sp|Q9P2N5|RBM27_HUMAN	metaplastic breast carcinomas-Normal	0.63504659895858	0.269048735115741	14.9999999999208	0.0322235063498868	0.128806032097332	nan
sp|Q9P2N5|RBM27_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.130573935931115	0.269048735115741	14.9999999999199	0.6344633890641	0.941868024951375	nan
sp|Q9P2N5|RBM27_HUMAN	Normal-Triple-negative breast cancer	-0.504472663027464	0.321574745515564	14.9999999998856	0.137555096863617	0.298649994758107	nan
sp|Q9P2R3|ANFY1_HUMAN	metaplastic breast carcinomas-Normal	-0.0197162677811022	0.201547023106841	23.9999999997235	0.922883942992406	0.958645695783362	nan
sp|Q9P2R3|ANFY1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0766400200013678	0.201547023106841	23.9999999999204	0.707097974597103	0.94948208919602	nan
sp|Q9P2R3|ANFY1_HUMAN	Normal-Triple-negative breast cancer	0.09635628778247	0.240894768143476	23.9999999998376	0.69269937560785	0.8191222906967	nan
sp|Q9P2R7|SUCB1_HUMAN	metaplastic breast carcinomas-Normal	-0.680745666395299	0.350844109290316	22.0000000298793	0.0652661366214047	0.196507824392708	nan
sp|Q9P2R7|SUCB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.428223091525117	0.350844109290316	22.0000000305935	0.235177498134658	0.84876230490475	nan
sp|Q9P2R7|SUCB1_HUMAN	Normal-Triple-negative breast cancer	0.252522574870182	0.419338916840228	22.0000000303309	0.553202849905758	0.717458553681911	nan
sp|Q9P2T1|GMPR2_HUMAN	metaplastic breast carcinomas-Normal	-0.331124037343555	0.345918333619379	22.0000000360316	0.348852078619066	0.558631673936437	nan
sp|Q9P2T1|GMPR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.361827841648106	0.345918333619379	22.0000000360282	0.306921759202633	0.867696529950794	nan
sp|Q9P2T1|GMPR2_HUMAN	Normal-Triple-negative breast cancer	-0.030703804304551	0.413451488835162	22.000000036018	0.941472888747233	0.968571922685176	nan
sp|Q9P2X3|IMPCT_HUMAN	metaplastic breast carcinomas-Normal	-0.125576907243798	0.221454619995167	14.0000000127841	0.579656041686788	0.740783038280232	nan
sp|Q9P2X3|IMPCT_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0389962225943948	0.221454619995167	14.0000000127349	0.862744012274615	0.979916450336765	nan
sp|Q9P2X3|IMPCT_HUMAN	Normal-Triple-negative breast cancer	0.0865806846494035	0.2646888974875	14.0000000129747	0.748429040664928	0.855788830811909	nan
sp|Q9UBB4|ATX10_HUMAN	metaplastic breast carcinomas-Normal	0.553753260230074	0.273960419555063	22.0000000155781	0.0555821211072068	0.179548076346312	nan
sp|Q9UBB4|ATX10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0881542834506704	0.273960419555063	22.0000000161346	0.750658733651182	0.954643368861838	nan
sp|Q9UBB4|ATX10_HUMAN	Normal-Triple-negative breast cancer	-0.465598976779404	0.327445331277465	22.0000000157333	0.169074358917257	0.340607981236946	nan
sp|Q9UBB9|TFP11_HUMAN	metaplastic breast carcinomas-Normal	0.697727974010879	0.476463979996367	6.0	0.193428389824658	0.386624153804669	nan
sp|Q9UBB9|TFP11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.205584512052311	0.476463979996367	6.0	0.681192375618244	0.946568877415162	nan
sp|Q9UBB9|TFP11_HUMAN	Normal-Triple-negative breast cancer	-0.492143461958568	0.569483380208988	6.0	0.420682710161339	0.607977968946213	nan
sp|Q9UBC2|EP15R_HUMAN	metaplastic breast carcinomas-Normal	0.388954688545979	0.167115347511833	23.9999999997516	0.0286992516636119	0.120907873928829	nan
sp|Q9UBC2|EP15R_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.113453768733182	0.167115347511833	23.9999999997516	0.503699221720629	0.913320451076758	nan
sp|Q9UBC2|EP15R_HUMAN	Normal-Triple-negative breast cancer	-0.275500919812797	0.199741044405002	23.9999999997543	0.180523620399748	0.356629951661897	nan
sp|Q9UBE0|SAE1_HUMAN	metaplastic breast carcinomas-Normal	0.0285530056123404	0.193356811155119	22.0000000677933	0.883948223170204	0.939636678547413	nan
sp|Q9UBE0|SAE1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.309618829163277	0.193356811155119	22.0000000675602	0.123577213521047	0.823891816737944	nan
sp|Q9UBE0|SAE1_HUMAN	Normal-Triple-negative breast cancer	-0.338171834775617	0.231105592502266	22.0000000678639	0.157532950686312	0.327684310438862	nan
sp|Q9UBF2|COPG2_HUMAN	metaplastic breast carcinomas-Normal	0.133915903724828	0.203343694751215	21.2238647587656	0.51725371389531	0.699492003656636	nan
sp|Q9UBF2|COPG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0997735354854154	0.18953089973838	21.0249897118679	0.604103640009142	0.940559810632461	nan
sp|Q9UBF2|COPG2_HUMAN	Normal-Triple-negative breast cancer	-0.233689439210243	0.238209539581211	21.1706775199427	0.337659439349154	0.52992444589074	nan
sp|Q9UBG0|MRC2_HUMAN	metaplastic breast carcinomas-Normal	-0.0104065779914782	0.265301282092893	22.0000000641635	0.96906438395365	0.985368618006098	nan
sp|Q9UBG0|MRC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.617745605344679	0.265301282092893	22.0000000653909	0.0294754020733181	0.721684569712558	nan
sp|Q9UBG0|MRC2_HUMAN	Normal-Triple-negative breast cancer	0.628152183336158	0.31709568245052	22.0000000646726	0.0602333037510157	0.176722297698278	nan
sp|Q9UBI1|COMD3_HUMAN	metaplastic breast carcinomas-Normal	0.0433346678068778	0.153076746478946	21.999999867135	0.779753662876043	0.880401214470097	nan
sp|Q9UBI1|COMD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.108464138840923	0.153076746478945	21.9999998696296	0.486038097673166	0.913320451076758	nan
sp|Q9UBI1|COMD3_HUMAN	Normal-Triple-negative breast cancer	0.0651294710340456	0.182961706815464	21.9999998687798	0.725251462083198	0.841098345877946	nan
sp|Q9UBI6|GBG12_HUMAN	metaplastic breast carcinomas-Normal	-0.61227570775	0.254259155938362	22.0000000233837	0.0248602262195582	0.110697267540693	nan
sp|Q9UBI6|GBG12_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0414225651304636	0.254259155938362	22.0000000236094	0.872072776318663	0.981704007186169	nan
sp|Q9UBI6|GBG12_HUMAN	Normal-Triple-negative breast cancer	0.570853142619536	0.303897817362745	22.0000000236028	0.0736383437603969	0.198680076834058	nan
sp|Q9UBL3|ASH2L_HUMAN	metaplastic breast carcinomas-Normal	0.52637520370844	0.36829393717228	14.9999999995092	0.173434416910981	0.361439499568716	nan
sp|Q9UBL3|ASH2L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.151819454675881	0.368293937172279	14.9999999996866	0.686006497394574	0.946568877415162	nan
sp|Q9UBL3|ASH2L_HUMAN	Normal-Triple-negative breast cancer	-0.37455574903256	0.440195450352712	14.9999999995657	0.408211435754685	0.59670272927701	nan
sp|Q9UBM7|DHCR7_HUMAN	metaplastic breast carcinomas-Normal	0.360725851620807	0.358255927144755	23.9999999992288	0.324030023512758	0.531364478616876	nan
sp|Q9UBM7|DHCR7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.681854541120169	0.358255927144756	23.9999999992288	0.0690675891109312	0.781899532609971	nan
sp|Q9UBM7|DHCR7_HUMAN	Normal-Triple-negative breast cancer	-1.04258039274098	0.42819773358703	23.9999999992089	0.0227061947701899	0.0998762571754838	nan
sp|Q9UBQ7|GRHPR_HUMAN	metaplastic breast carcinomas-Normal	-0.462234963169196	0.174903950489589	22.0000000173152	0.0148632355840269	0.0800735738756976	nan
sp|Q9UBQ7|GRHPR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.272516595086	0.17490395048959	22.0000000174398	0.133481399879063	0.823891816737944	nan
sp|Q9UBQ7|GRHPR_HUMAN	Normal-Triple-negative breast cancer	0.189718368083196	0.209050205510764	22.0000000177804	0.373963037404455	0.56195892239259	nan
sp|Q9UBR2|CATZ_HUMAN	metaplastic breast carcinomas-Normal	0.310292500323782	0.190664905902867	22.0000000087916	0.117885938517472	0.283305052934023	nan
sp|Q9UBR2|CATZ_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.18680771060598	0.190664905902867	22.0000000087198	0.337852033378249	0.870943310236299	nan
sp|Q9UBR2|CATZ_HUMAN	Normal-Triple-negative breast cancer	-0.123484789717802	0.227888150331156	22.0000000090716	0.593357265366044	0.74652518927961	nan
sp|Q9UBT2|SAE2_HUMAN	metaplastic breast carcinomas-Normal	0.0837761954154079	0.194043524909126	21.9999922560485	0.670132663939655	0.807365340679744	nan
sp|Q9UBT2|SAE2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.379248893162111	0.194043524909126	21.9999922598806	0.0634741613028173	0.773787875546141	nan
sp|Q9UBT2|SAE2_HUMAN	Normal-Triple-negative breast cancer	-0.463025088577519	0.231926372427478	21.9999922597121	0.0584092722970708	0.173156229478903	nan
sp|Q9UBU9|NXF1_HUMAN	metaplastic breast carcinomas-Normal	0.317402242642179	0.180658699303665	22.000000000795	0.092842870735552	0.246642064934824	nan
sp|Q9UBU9|NXF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.235440108962927	0.180658699303665	22.0000000009367	0.205970897679464	0.843662073010871	nan
sp|Q9UBU9|NXF1_HUMAN	Normal-Triple-negative breast cancer	-0.552842351605105	0.21592844593288	22.0000000006985	0.0178436513417525	0.0864610744314653	nan
sp|Q9UBV2|SE1L1_HUMAN	metaplastic breast carcinomas-Normal	0.241669561001628	0.252148124499253	24.0000000001572	0.347395983348514	0.557013864291281	nan
sp|Q9UBV2|SE1L1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.358789726427572	0.252148124499253	24.0000000004118	0.167625201042221	0.843662073010871	nan
sp|Q9UBV2|SE1L1_HUMAN	Normal-Triple-negative breast cancer	0.117120165425945	0.301374652191518	24.0000000002979	0.700983618386524	0.824803379651967	nan
sp|Q9UBV8|PEF1_HUMAN	metaplastic breast carcinomas-Normal	-0.678443800036997	0.21063627698407	23.9999999997048	0.0036508043922147	0.0407324763980233	nan
sp|Q9UBV8|PEF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0956213827327635	0.21063627698407	23.9999999997048	0.653933109726772	0.944190045212043	nan
sp|Q9UBV8|PEF1_HUMAN	Normal-Triple-negative breast cancer	0.582822417304233	0.251758504415044	23.999999999687	0.029481447305522	0.115047565436672	nan
sp|Q9UBW5|BIN2_HUMAN	metaplastic breast carcinomas-Normal	0.324365353326781	0.201028589179057	23.9999999999492	0.119702719793658	0.286459208491087	nan
sp|Q9UBW5|BIN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.316061951131794	0.201028589179058	23.9999999999102	0.128990295174067	0.823891816737944	nan
sp|Q9UBW5|BIN2_HUMAN	Normal-Triple-negative breast cancer	-0.0083034021949874	0.24027512108094	23.9999999999869	0.972718094445113	0.987196656287347	nan
sp|Q9UBW7|ZMYM2_HUMAN	metaplastic breast carcinomas-Normal	1.0608687137481	0.307250509551119	14.9999999998243	0.0035515158016242	0.0407324763980233	nan
sp|Q9UBW7|ZMYM2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.182970657587625	0.307250509551119	14.9999999996969	0.560381147714926	0.933033207887896	nan
sp|Q9UBW7|ZMYM2_HUMAN	Normal-Triple-negative breast cancer	-1.24383937133573	0.367234599248068	14.9999999997576	0.0040644162824312	0.041407627248948	nan
sp|Q9UBX3|DIC_HUMAN	metaplastic breast carcinomas-Normal	-0.277065457883319	0.345297456502285	18.9999855167335	0.432246264548504	0.629065929666913	nan
sp|Q9UBX3|DIC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.156710971989024	0.345297456502285	18.9999855170814	0.655082898463547	0.944190045212043	nan
sp|Q9UBX3|DIC_HUMAN	Normal-Triple-negative breast cancer	0.120354485894295	0.41809737065036	18.9658319952697	0.776574160907642	0.872956547466014	nan
sp|Q9UBX5|FBLN5_HUMAN	metaplastic breast carcinomas-Normal	-0.880898824047587	0.482905499110846	23.9999999997288	0.0806036292109165	0.224816118300932	nan
sp|Q9UBX5|FBLN5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.62941558674505	0.482905499110846	23.9999999997288	0.204806361232873	0.843662073010871	nan
sp|Q9UBX5|FBLN5_HUMAN	Normal-Triple-negative breast cancer	0.251483237302537	0.577182468142188	23.9999999996959	0.666942119135927	0.8042915764791	nan
sp|Q9UD71|PPR1B_HUMAN	metaplastic breast carcinomas-Normal	0.138894208980594	0.926490965003585	11.1209295449746	0.883516613982455	0.939478318898811	nan
sp|Q9UD71|PPR1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.13984801628059	0.926490965003585	11.120929544833	0.88272327404413	0.983927216291227	nan
sp|Q9UD71|PPR1B_HUMAN	Normal-Triple-negative breast cancer	0.0009538072999954	1.13348404503921	10.9999999807114	0.999343660758301	0.999945312570918	nan
sp|Q9UDW1|QCR9_HUMAN	metaplastic breast carcinomas-Normal	-0.154756220819337	0.270881808837431	21.9992286500349	0.573583647029715	0.736604149359617	nan
sp|Q9UDW1|QCR9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.133865981527999	0.270881808837431	21.9992286497582	0.62607341097084	0.941374262616245	nan
sp|Q9UDW1|QCR9_HUMAN	Normal-Triple-negative breast cancer	0.0208902392913378	0.323765687670748	21.9992286499751	0.949136752704465	0.973407457284302	nan
sp|Q9UDY2|ZO2_HUMAN	metaplastic breast carcinomas-Normal	0.167725104275376	0.317563284205205	14.0000002481117	0.605657753920717	0.763445723941018	nan
sp|Q9UDY2|ZO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.461016485953686	0.317563284205205	14.00000024824	0.168616108439588	0.843662073010871	nan
sp|Q9UDY2|ZO2_HUMAN	Normal-Triple-negative breast cancer	-0.628741590229062	0.37956072255625	14.0000002483972	0.11985331208607	0.272358121389775	nan
sp|Q9UDY4|DNJB4_HUMAN	metaplastic breast carcinomas-Normal	0.555575448731119	0.364009863500508	14.0000012927876	0.14921503491868	0.3278194157764	nan
sp|Q9UDY4|DNJB4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.14515856443806	0.364009863500508	14.0000012926898	0.0071488891615875	0.539588996897564	nan
sp|Q9UDY4|DNJB4_HUMAN	Normal-Triple-negative breast cancer	0.589583115706942	0.435075002935714	14.0000012927754	0.196838859364233	0.378641416971476	nan
sp|Q9UEE9|CFDP1_HUMAN	metaplastic breast carcinomas-Normal	0.849115402618056	0.315520218336587	22.0000000025375	0.0133404921649638	0.0771196451414601	nan
sp|Q9UEE9|CFDP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.41442211454234	0.315520218336587	22.0000000027147	0.202563272085729	0.843662073010871	nan
sp|Q9UEE9|CFDP1_HUMAN	Normal-Triple-negative breast cancer	-1.2635375171604	0.377118791779323	22.0000000026452	0.0028932289889422	0.036154485561068	nan
sp|Q9UER7|DAXX_HUMAN	metaplastic breast carcinomas-Normal	0.675639874772481	0.230804065464899	22.0000000083334	0.0077997341621447	0.0587409160179117	nan
sp|Q9UER7|DAXX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0714930963452906	0.230804065464899	22.0000000096783	0.759661012355703	0.955228196959647	nan
sp|Q9UER7|DAXX_HUMAN	Normal-Triple-negative breast cancer	-0.604146778427191	0.275863622194335	22.0000000090925	0.039414063270683	0.132737939525583	nan
sp|Q9UEU0|VTI1B_HUMAN	metaplastic breast carcinomas-Normal	-0.186413415521679	0.210696166623465	22.0000000014944	0.385859341003738	0.590242268521135	nan
sp|Q9UEU0|VTI1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0449166134264343	0.210696166623465	22.000000001463	0.833148200337107	0.9684421207956	nan
sp|Q9UEU0|VTI1B_HUMAN	Normal-Triple-negative breast cancer	0.141496802095245	0.251830086225452	22.0000000013814	0.579881733596292	0.738415621418319	nan
sp|Q9UEW8|STK39_HUMAN	metaplastic breast carcinomas-Normal	-0.390969113821224	0.373438652092565	14.0000000022834	0.312865290360139	0.520705650113393	nan
sp|Q9UEW8|STK39_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.108644730234504	0.373438652092565	14.0000000025829	0.775369927900694	0.960657739983943	nan
sp|Q9UEW8|STK39_HUMAN	Normal-Triple-negative breast cancer	0.282324383586721	0.446344560812307	14.0000000027281	0.537237882392662	0.70361651736533	nan
sp|Q9UEY8|ADDG_HUMAN	metaplastic breast carcinomas-Normal	-1.0273880958172	0.24567390863693	14.9999999997962	0.0008016638777038	0.022622527118123	nan
sp|Q9UEY8|ADDG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0131139789964185	0.24567390863693	14.9999999997962	0.958133884809209	0.99709406933403	nan
sp|Q9UEY8|ADDG_HUMAN	Normal-Triple-negative breast cancer	1.01427411682078	0.293636484169862	14.9999999998093	0.0035413131667702	0.0397679897511631	nan
sp|Q9UFN0|NPS3A_HUMAN	metaplastic breast carcinomas-Normal	0.160513403485093	0.261966014140545	24.0000000000753	0.545820218173128	0.719749780143363	nan
sp|Q9UFN0|NPS3A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.18612831237728	0.261966014140545	24.0000000000753	0.484238406991782	0.913320451076758	nan
sp|Q9UFN0|NPS3A_HUMAN	Normal-Triple-negative breast cancer	-0.346641715862373	0.313109274774077	24.0000000001495	0.279226042191991	0.470901757608411	nan
sp|Q9UFW8|CGBP1_HUMAN	metaplastic breast carcinomas-Normal	0.276792071196598	0.292466313199582	18.9181843822028	0.355873741611579	0.565143201631083	nan
sp|Q9UFW8|CGBP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.062242655904872	0.275332982506458	18.9716598413296	0.82356991473606	0.965774701272009	nan
sp|Q9UFW8|CGBP1_HUMAN	Normal-Triple-negative breast cancer	-0.33903472710147	0.337972297276799	18.9786912605284	0.328410970293738	0.521068288905195	nan
sp|Q9UG63|ABCF2_HUMAN	metaplastic breast carcinomas-Normal	-0.273843242598078	0.265576061740497	22.0000000731187	0.313683518340984	0.520961847459193	nan
sp|Q9UG63|ABCF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.132328227034215	0.265576061740496	22.0000000731565	0.623239469779249	0.941374262616245	nan
sp|Q9UG63|ABCF2_HUMAN	Normal-Triple-negative breast cancer	0.406171469632293	0.317424106946599	22.0000000728431	0.214021338018558	0.396326979149687	nan
sp|Q9UGI8|TES_HUMAN	metaplastic breast carcinomas-Normal	0.403855636504517	0.197286278008271	23.9999999998984	0.0517523231212221	0.172715584392512	nan
sp|Q9UGI8|TES_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.225726150635595	0.197286278008271	24.0000000001456	0.263842788463585	0.86431258289795	nan
sp|Q9UGI8|TES_HUMAN	Normal-Triple-negative breast cancer	-0.629581787140111	0.235802203704584	23.9999999999107	0.0133966007319433	0.0752201027584113	nan
sp|Q9UGM6|SYWM_HUMAN	metaplastic breast carcinomas-Normal	-0.212869341053558	0.274378238037969	14.0000000009916	0.450760470098184	0.645830949399295	nan
sp|Q9UGM6|SYWM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.769672245613415	0.274378238037969	14.0000000003664	0.0140372831974403	0.648249536548459	nan
sp|Q9UGM6|SYWM_HUMAN	Normal-Triple-negative breast cancer	-0.556802904559857	0.327944719881743	14.000000000851	0.111641530266539	0.259389329701293	nan
sp|Q9UGP4|LIMD1_HUMAN	metaplastic breast carcinomas-Normal	-0.0195405065957457	0.262640736288542	22.0000002553991	0.941364363919441	0.9699612974793	nan
sp|Q9UGP4|LIMD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0189265828985557	0.262640736288542	22.0000002543521	0.943203193536198	0.996541950781621	nan
sp|Q9UGP4|LIMD1_HUMAN	Normal-Triple-negative breast cancer	0.0006139236971899	0.313915721988715	22.0000002548797	0.998457207095368	0.999945312570918	nan
sp|Q9UGP8|SEC63_HUMAN	metaplastic breast carcinomas-Normal	0.202128735675791	0.177946221800158	23.9999999999117	0.267215443548161	0.469984569238895	nan
sp|Q9UGP8|SEC63_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0520978248293991	0.177946221800158	23.9999999995563	0.77221212539942	0.959852454935727	nan
sp|Q9UGP8|SEC63_HUMAN	Normal-Triple-negative breast cancer	-0.25422656050519	0.212686415218513	23.9999999997062	0.243643234486819	0.43147049090793	nan
sp|Q9UGT4|SUSD2_HUMAN	metaplastic breast carcinomas-Normal	0.0829801867044732	0.305582918873909	13.0019229375493	0.790233990066997	0.886876704217463	nan
sp|Q9UGT4|SUSD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.280079502707263	0.305582918873909	13.0019229374133	0.376070189930631	0.885234295852111	nan
sp|Q9UGT4|SUSD2_HUMAN	Normal-Triple-negative breast cancer	0.19709931600279	0.35922833999091	13.0000000296525	0.592527788276745	0.746329052001478	nan
sp|Q9UGU5|HMGX4_HUMAN	metaplastic breast carcinomas-Normal	-1.42251849566999	0.58220787590525	22.0000000266374	0.0230388655314557	0.105338636900356	nan
sp|Q9UGU5|HMGX4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.8341014154876	0.58220787590525	22.0000000266374	0.0046448783295025	0.514807348186537	nan
sp|Q9UGU5|HMGX4_HUMAN	Normal-Triple-negative breast cancer	-0.411582919817607	0.695871509861764	22.000000026773	0.560238626902825	0.722916613286098	nan
sp|Q9UH62|ARMX3_HUMAN	metaplastic breast carcinomas-Normal	0.259993427276092	0.34221906960212	23.9999999998055	0.454815631107272	0.649292975206949	nan
sp|Q9UH62|ARMX3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.248995083818133	0.34221906960212	23.9999999998056	0.473903622974577	0.913280230088743	nan
sp|Q9UH62|ARMX3_HUMAN	Normal-Triple-negative breast cancer	-0.508988511094226	0.409030022648252	23.9999999997783	0.225375869231103	0.408196557664373	nan
sp|Q9UH65|SWP70_HUMAN	metaplastic breast carcinomas-Normal	0.25137485121746	0.174831948827933	24.0000000001288	0.163400498228238	0.349738091507189	nan
sp|Q9UH65|SWP70_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.195487103441812	0.174831948827933	24.0000000001029	0.274573732854247	0.867696529950794	nan
sp|Q9UH65|SWP70_HUMAN	Normal-Triple-negative breast cancer	-0.0558877477756472	0.208964147064833	24.0000000000605	0.791406625819952	0.881275822169597	nan
sp|Q9UH99|SUN2_HUMAN	metaplastic breast carcinomas-Normal	0.452296404373943	0.258769100502368	22.0000064181158	0.0944299096644389	0.248130450375174	nan
sp|Q9UH99|SUN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.14981367161269	0.258769100502368	22.0000064175409	0.56850559881309	0.935631258424823	nan
sp|Q9UH99|SUN2_HUMAN	Normal-Triple-negative breast cancer	-0.302482732761253	0.309288232132158	22.0000064178867	0.338708898588325	0.530819603445352	nan
sp|Q9UHB6|LIMA1_HUMAN	metaplastic breast carcinomas-Normal	0.227294981249573	0.283126399897355	23.9999999998841	0.429967001923383	0.626846629119879	nan
sp|Q9UHB6|LIMA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0431267091250452	0.283126399897355	24.0000000001255	0.880205377655906	0.983583849145686	nan
sp|Q9UHB6|LIMA1_HUMAN	Normal-Triple-negative breast cancer	-0.184168272124528	0.338400773215169	24.0000000000047	0.591303297364355	0.74587811099687	nan
sp|Q9UHB9|SRP68_HUMAN	metaplastic breast carcinomas-Normal	0.429126728580795	0.207056479438625	21.999999983341	0.0501380668796744	0.169912927873181	nan
sp|Q9UHB9|SRP68_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.229428021800172	0.207056479438625	21.9999999846501	0.279809582263271	0.867696529950794	nan
sp|Q9UHB9|SRP68_HUMAN	Normal-Triple-negative breast cancer	-0.658554750380967	0.247479827973103	21.9999999831753	0.0142703408456307	0.0772550699851407	nan
sp|Q9UHD1|CHRD1_HUMAN	metaplastic breast carcinomas-Normal	0.691841180757418	0.29697947926022	21.999999493624	0.0294050653965548	0.122637938993912	nan
sp|Q9UHD1|CHRD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.393955576610041	0.29697947926022	21.999999493619	0.198266873497989	0.843662073010871	nan
sp|Q9UHD1|CHRD1_HUMAN	Normal-Triple-negative breast cancer	-1.08579675736746	0.354958369997045	21.9999994917378	0.0057505562013105	0.0481913978366351	nan
sp|Q9UHD2|TBK1_HUMAN	metaplastic breast carcinomas-Normal	-0.267362258106051	0.239762732432842	14.9999999999328	0.282350029959658	0.485732992213569	nan
sp|Q9UHD2|TBK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.232194858352939	0.239762732432842	14.9999999999327	0.348183494531853	0.871876144726181	nan
sp|Q9UHD2|TBK1_HUMAN	Normal-Triple-negative breast cancer	0.0351673997531119	0.28657127725592	14.999999999928	0.903959675022333	0.944064439492456	nan
sp|Q9UHD4|CIDEB_HUMAN	metaplastic breast carcinomas-Normal	0.0254538538899761	0.510934121145963	23.9999999993665	0.960679501328498	0.980742832437324	nan
sp|Q9UHD4|CIDEB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.188420795600252	0.510934121145963	23.999999999663	0.715527164735415	0.949812109346858	nan
sp|Q9UHD4|CIDEB_HUMAN	Normal-Triple-negative breast cancer	0.162966941710276	0.61068307907878	23.9999999994857	0.791856500475258	0.881275822169597	nan
sp|Q9UHD8|SEPT9_HUMAN	metaplastic breast carcinomas-Normal	0.46249214469929	0.140750617480179	21.9999999763762	0.0033729919161495	0.04050243156379	nan
sp|Q9UHD8|SEPT9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.126813097447965	0.140750617480179	21.9999999764464	0.377358259233801	0.885234295852111	nan
sp|Q9UHD8|SEPT9_HUMAN	Normal-Triple-negative breast cancer	-0.335679047251325	0.168229164793792	21.999999977137	0.0585330394823926	0.173156229478903	nan
sp|Q9UHD9|UBQL2_HUMAN	metaplastic breast carcinomas-Normal	-0.0715011699750207	0.37386980555559	24.0000000000762	0.849941442375639	0.920862240696422	nan
sp|Q9UHD9|UBQL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.109915249146825	0.37386980555559	24.0000000000776	0.771290556286011	0.959745866833315	nan
sp|Q9UHD9|UBQL2_HUMAN	Normal-Triple-negative breast cancer	0.181416419121845	0.446859887766328	24.0000000000931	0.688353919888656	0.816882695362332	nan
sp|Q9UHF7|TRPS1_HUMAN	metaplastic breast carcinomas-Normal	0.095027149835812	0.401822305775523	23.9999999999878	0.815058860599999	0.902183034510288	nan
sp|Q9UHF7|TRPS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.79445731208281	0.401822305775523	23.9999999999499	0.0596227715943558	0.773787875546141	nan
sp|Q9UHF7|TRPS1_HUMAN	Normal-Triple-negative breast cancer	0.699430162246998	0.480269515731618	24.0000000000044	0.158260693353449	0.32817126931183	nan
sp|Q9UHG2|PCS1N_HUMAN	metaplastic breast carcinomas-Normal	-0.598008990008951	0.0914649721539669	1.0	0.0966216643758388	0.250914384676006	nan
sp|Q9UHG2|PCS1N_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-5.9981948213439	0.105614652589029	1.0	0.0112082769729013	0.573346475921489	nan
sp|Q9UHG2|PCS1N_HUMAN	Normal-Triple-negative breast cancer	-5.40018583133495	0.0914649721539669	1.0	0.0107816368628206	0.0663669646889177	nan
sp|Q9UHG3|PCYOX_HUMAN	metaplastic breast carcinomas-Normal	-0.729921295939199	0.256194547403612	23.9999999994155	0.0088561924917408	0.061844503870896	nan
sp|Q9UHG3|PCYOX_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.142496399865218	0.256194547403612	23.9999999994155	0.583220613270311	0.937761568355864	nan
sp|Q9UHG3|PCYOX_HUMAN	Normal-Triple-negative breast cancer	0.587424896073981	0.306211052612274	23.9999999993988	0.0670363383817057	0.187093861276901	nan
sp|Q9UHL4|DPP2_HUMAN	metaplastic breast carcinomas-Normal	-0.0602168606991527	0.368551055052791	22.0000000034432	0.871704506606112	0.932886600115491	nan
sp|Q9UHL4|DPP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.48802865634072	0.368551055052791	22.0000000034158	0.199036292636067	0.843662073010871	nan
sp|Q9UHL4|DPP2_HUMAN	Normal-Triple-negative breast cancer	-0.427811795641567	0.440502764999471	22.0000000034318	0.3420112558997	0.533980936876752	nan
sp|Q9UHQ4|BAP29_HUMAN	metaplastic breast carcinomas-Normal	0.178434189976446	0.355910972008709	14.0000000397824	0.623919106934703	0.774713153324972	nan
sp|Q9UHQ4|BAP29_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0463541237982067	0.355910972008709	14.0000000389824	0.898228792275191	0.989671989983163	nan
sp|Q9UHQ4|BAP29_HUMAN	Normal-Triple-negative breast cancer	-0.224788313774653	0.425394976120821	14.0000000394602	0.605482138819548	0.756340710047418	nan
sp|Q9UHQ9|NB5R1_HUMAN	metaplastic breast carcinomas-Normal	-0.262198708599519	0.30493615726887	21.999999831181	0.399146151993214	0.601923998636815	nan
sp|Q9UHQ9|NB5R1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0579483386031101	0.30493615726887	21.9999998319445	0.851024758600302	0.976080483734393	nan
sp|Q9UHQ9|NB5R1_HUMAN	Normal-Triple-negative breast cancer	0.204250369996409	0.364468419188246	21.9999998322064	0.58086510849252	0.738919104718384	nan
sp|Q9UHR5|S30BP_HUMAN	metaplastic breast carcinomas-Normal	0.527306789247323	0.318997633872602	23.9999999996726	0.111352051979305	0.273970555721102	nan
sp|Q9UHR5|S30BP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.145695777240399	0.318997633872602	23.9999999997036	0.651972035607999	0.944190045212043	nan
sp|Q9UHR5|S30BP_HUMAN	Normal-Triple-negative breast cancer	-0.673002566487722	0.381275098314512	23.9999999996675	0.090263802950281	0.227128600307899	nan
sp|Q9UHV9|PFD2_HUMAN	metaplastic breast carcinomas-Normal	0.670619349892193	0.207287233696317	21.9999999954947	0.0038026789962396	0.0413090787271785	nan
sp|Q9UHV9|PFD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.132146965015983	0.207287233696317	21.9999999970351	0.530374446415842	0.920933816822996	nan
sp|Q9UHV9|PFD2_HUMAN	Normal-Triple-negative breast cancer	-0.802766314908176	0.247755632063623	21.9999999950884	0.0037585986251055	0.0400819560687694	nan
sp|Q9UHX1|PUF60_HUMAN	metaplastic breast carcinomas-Normal	0.555750540327834	0.197131772246173	23.9999999999902	0.0094959946823206	0.0646796741313101	nan
sp|Q9UHX1|PUF60_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.17088589932321	0.197131772246173	23.999999999989	0.394602413066944	0.885234295852111	nan
sp|Q9UHX1|PUF60_HUMAN	Normal-Triple-negative breast cancer	-0.384864641004623	0.235617533997418	24.0000000000026	0.115430560947504	0.265530231549829	nan
sp|Q9UI08|EVL_HUMAN	metaplastic breast carcinomas-Normal	0.0633788997547941	0.394779222539532	21.9999999044231	0.873918663602882	0.934053259747903	nan
sp|Q9UI08|EVL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.018156555111189	0.394779222539532	21.9999999044436	0.963731823540286	0.99709406933403	nan
sp|Q9UI08|EVL_HUMAN	Normal-Triple-negative breast cancer	-0.0815354548659831	0.471851421150038	21.9999999045219	0.864389320703567	0.921572024077996	nan
sp|Q9UI09|NDUAC_HUMAN	metaplastic breast carcinomas-Normal	0.768636825737401	0.221809901800437	23.9999999997507	0.0020073296386186	0.0320881648658721	nan
sp|Q9UI09|NDUAC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0114464106504911	0.221809901800437	23.9999999997507	0.959270871691946	0.99709406933403	nan
sp|Q9UI09|NDUAC_HUMAN	Normal-Triple-negative breast cancer	-0.75719041508691	0.265113540465534	23.9999999997506	0.0087122846974032	0.0588076066258844	nan
sp|Q9UI10|EI2BD_HUMAN	metaplastic breast carcinomas-Normal	0.225063082389837	0.19062054129724	21.1886331883977	0.250811968024037	0.451135812614665	nan
sp|Q9UI10|EI2BD_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.125881097617299	0.177548978881581	21.0451970402577	0.486109135704667	0.913320451076758	nan
sp|Q9UI10|EI2BD_HUMAN	Normal-Triple-negative breast cancer	-0.350944180007136	0.22326289918161	21.1501538843512	0.130817505214227	0.28931296562348	nan
sp|Q9UI12|VATH_HUMAN	metaplastic breast carcinomas-Normal	0.260109410696614	0.206221997078494	22.0000000437861	0.22040911714419	0.418773822230466	nan
sp|Q9UI12|VATH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0176802571265849	0.206221997078494	22.0000000437861	0.932453274132985	0.995359816653149	nan
sp|Q9UI12|VATH_HUMAN	Normal-Triple-negative breast cancer	-0.242429153570029	0.24648243078229	22.0000000435606	0.336027945786939	0.528611874962511	nan
sp|Q9UIA9|XPO7_HUMAN	metaplastic breast carcinomas-Normal	0.0387492199466886	0.177293889807518	23.9999999996451	0.828841260241115	0.909492232445857	nan
sp|Q9UIA9|XPO7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.127824479396633	0.177293889807518	23.9999999999514	0.477889677221971	0.913280230088743	nan
sp|Q9UIA9|XPO7_HUMAN	Normal-Triple-negative breast cancer	-0.166573699343322	0.211906729358125	23.9999999998675	0.439518640291552	0.624341863388512	nan
sp|Q9UIG0|BAZ1B_HUMAN	metaplastic breast carcinomas-Normal	0.558906090370752	0.187357161507258	23.9999999998878	0.0064596868741162	0.052627448945006	nan
sp|Q9UIG0|BAZ1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.236425061569546	0.187357161507258	23.9999999996137	0.219112925767912	0.843662073010871	nan
sp|Q9UIG0|BAZ1B_HUMAN	Normal-Triple-negative breast cancer	-0.795331151940298	0.223934639597159	23.9999999998129	0.0016211958313798	0.0283781197026415	nan
sp|Q9UIJ7|KAD3_HUMAN	metaplastic breast carcinomas-Normal	-0.507927631545918	0.25905577608655	23.9999999997051	0.0616211251296259	0.190673136419685	nan
sp|Q9UIJ7|KAD3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.443975214577833	0.25905577608655	23.9999999996566	0.0994506484605225	0.820529543749969	nan
sp|Q9UIJ7|KAD3_HUMAN	Normal-Triple-negative breast cancer	0.0639524169680853	0.309630874991969	23.9999999996089	0.838108198043537	0.908337675349434	nan
sp|Q9UIQ6|LCAP_HUMAN	metaplastic breast carcinomas-Normal	0.394516240221845	0.511611285596634	20.9938549887598	0.449225393292055	0.64474318104611	nan
sp|Q9UIQ6|LCAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.376076399102042	0.511611285596634	20.9938549896176	0.4704219779956	0.91257472394129	nan
sp|Q9UIQ6|LCAP_HUMAN	Normal-Triple-negative breast cancer	-0.0184398411198029	0.604864097170898	20.9884792924605	0.975967558178368	0.988457088173338	nan
sp|Q9UJ68|MSRA_HUMAN	metaplastic breast carcinomas-Normal	-1.19059525560036	0.280536188286019	23.9999999997695	0.0002839519980233	0.0159975668038937	nan
sp|Q9UJ68|MSRA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.141974174254379	0.280536188286019	23.999999999974	0.617416721019733	0.941374262616245	nan
sp|Q9UJ68|MSRA_HUMAN	Normal-Triple-negative breast cancer	1.04862108134598	0.33530487819307	23.9999999998634	0.0045765195609759	0.043471142411956	nan
sp|Q9UJ70|NAGK_HUMAN	metaplastic breast carcinomas-Normal	0.0898876630350633	0.274004458936072	23.999999999809	0.745717312499536	0.859564245547108	nan
sp|Q9UJ70|NAGK_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0169458394970798	0.274004458936072	24.0000000000654	0.951198335981781	0.996541950781621	nan
sp|Q9UJ70|NAGK_HUMAN	Normal-Triple-negative breast cancer	-0.0729418235379834	0.327497968405584	23.9999999999073	0.825634562102097	0.900987946299202	nan
sp|Q9UJ83|HACL1_HUMAN	metaplastic breast carcinomas-Normal	0.405368595699311	0.307642046728951	22.0000054239731	0.201174196325044	0.394515061111768	nan
sp|Q9UJ83|HACL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.521154247996001	0.307642046728951	22.0000054239755	0.104372212719673	0.821630939204717	nan
sp|Q9UJ83|HACL1_HUMAN	Normal-Triple-negative breast cancer	0.115785652296689	0.36770257568463	22.0000054241504	0.755812774263955	0.859388505509785	nan
sp|Q9UJF2|NGAP_HUMAN	metaplastic breast carcinomas-Normal	-0.325000506425186	0.333251786259029	14.0000010685027	0.345992156759072	0.556378306825882	nan
sp|Q9UJF2|NGAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0281280557512186	0.333251786259029	14.0000010683404	0.933929673374023	0.995359816653149	nan
sp|Q9UJF2|NGAP_HUMAN	Normal-Triple-negative breast cancer	0.353128562176405	0.398312069048582	14.0000010685118	0.39028989601679	0.577965597086773	nan
sp|Q9UJS0|S2513_HUMAN	metaplastic breast carcinomas-Normal	0.261417277364237	0.425821455874442	20.9721098411671	0.545875209308489	0.719749780143363	nan
sp|Q9UJS0|S2513_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.541082989481618	0.357003590502177	20.1447197848355	0.145149595315116	0.827647387111815	nan
sp|Q9UJS0|S2513_HUMAN	Normal-Triple-negative breast cancer	-0.802500266845855	0.485742741564113	20.7981230726563	0.113530674676531	0.262248757904647	nan
sp|Q9UJU6|DBNL_HUMAN	metaplastic breast carcinomas-Normal	0.435132737890713	0.268542647006183	23.9999999987399	0.11822400969618	0.283737623270833	nan
sp|Q9UJU6|DBNL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.186539316705455	0.268542647006183	23.9999999990055	0.493954005116427	0.913320451076758	nan
sp|Q9UJU6|DBNL_HUMAN	Normal-Triple-negative breast cancer	-0.621672054596168	0.320969854528177	23.9999999988749	0.0646213582685575	0.184632968217622	nan
sp|Q9UJY4|GGA2_HUMAN	metaplastic breast carcinomas-Normal	0.279957458593508	0.54184715734872	6.0	0.62386901902994	0.774713153324972	nan
sp|Q9UJY4|GGA2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.171895401092503	0.54184715734872	6.0	0.761810766014263	0.955228196959647	nan
sp|Q9UJY4|GGA2_HUMAN	Normal-Triple-negative breast cancer	-0.108062057501005	0.647631224349705	6.0	0.872963554640353	0.926805050561244	nan
sp|Q9UJZ1|STML2_HUMAN	metaplastic breast carcinomas-Normal	0.407474364263516	0.158783395780286	22.0000003582773	0.0176121876221945	0.0895151554375756	nan
sp|Q9UJZ1|STML2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.263582700147837	0.158783395780286	22.0000003582495	0.111099920120143	0.823891816737944	nan
sp|Q9UJZ1|STML2_HUMAN	Normal-Triple-negative breast cancer	-0.671057064411353	0.189782457323864	22.0000003580596	0.0018568067066512	0.0296731994851374	nan
sp|Q9UK22|FBX2_HUMAN	metaplastic breast carcinomas-Normal	-0.344723780978764	0.555498002006045	23.9999999997908	0.540733319067905	0.715851119316988	nan
sp|Q9UK22|FBX2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.230310645846811	0.555498002006045	23.9999999997908	0.682115734179155	0.946568877415162	nan
sp|Q9UK22|FBX2_HUMAN	Normal-Triple-negative breast cancer	0.575034426825574	0.66394710442572	23.9999999997908	0.395019649844472	0.583316444283885	nan
sp|Q9UK45|LSM7_HUMAN	metaplastic breast carcinomas-Normal	0.549313082770883	0.191386640349694	23.9999999992208	0.0084299468604199	0.0602818106368712	nan
sp|Q9UK45|LSM7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.270431974212657	0.191386640349694	23.9999999992208	0.170490148295045	0.843662073010871	nan
sp|Q9UK45|LSM7_HUMAN	Normal-Triple-negative breast cancer	-0.81974505698354	0.228750787990347	23.999999999269	0.0014975397233428	0.0275017792286832	nan
sp|Q9UK59|DBR1_HUMAN	metaplastic breast carcinomas-Normal	1.13008265678478	0.708340435380991	13.0156396860809	0.134608413714927	0.308153145446568	nan
sp|Q9UK59|DBR1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.320201036578577	0.708340435380991	13.0156396857383	0.658678820325627	0.944190045212043	nan
sp|Q9UK59|DBR1_HUMAN	Normal-Triple-negative breast cancer	-1.45028369336335	0.832910739949001	13.0000000012037	0.105240925995975	0.250947516506902	nan
sp|Q9UK76|JUPI1_HUMAN	metaplastic breast carcinomas-Normal	0.492911134552744	0.362570969462716	22.0000000485481	0.187764319697463	0.379640266833557	nan
sp|Q9UK76|JUPI1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.754985979409267	0.362570969462716	22.0000000484758	0.0491524305936739	0.764019040906631	nan
sp|Q9UK76|JUPI1_HUMAN	Normal-Triple-negative breast cancer	-1.24789711396201	0.433355195615945	22.0000000485758	0.0087027497550724	0.0588076066258844	nan
sp|Q9UKD2|MRT4_HUMAN	metaplastic breast carcinomas-Normal	0.628273377556984	0.277110059129021	22.0000013147193	0.0335477811166981	0.131037396512226	nan
sp|Q9UKD2|MRT4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0008446548671847	0.277110059129021	22.0000013145351	0.997595455120532	0.998570872698367	nan
sp|Q9UKD2|MRT4_HUMAN	Normal-Triple-negative breast cancer	-0.629118032424169	0.331209870605352	22.0000013151086	0.0706945203729277	0.193884971715851	nan
sp|Q9UKG1|DP13A_HUMAN	metaplastic breast carcinomas-Normal	-0.0537747115189091	0.158399718296329	22.0000000358159	0.737462081615527	0.854536685435452	nan
sp|Q9UKG1|DP13A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.208654953059504	0.158399718296329	22.0000000364304	0.201304223252276	0.843662073010871	nan
sp|Q9UKG1|DP13A_HUMAN	Normal-Triple-negative breast cancer	0.262429664578413	0.189323875018281	22.000000036134	0.179593607488587	0.355974449190258	nan
sp|Q9UKK9|NUDT5_HUMAN	metaplastic breast carcinomas-Normal	0.272258650654317	0.23895712135081	22.0000000420898	0.26680635530614	0.469737460295343	nan
sp|Q9UKK9|NUDT5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.272437959981091	0.23895712135081	22.0000000428976	0.266500320069476	0.866437412304381	nan
sp|Q9UKK9|NUDT5_HUMAN	Normal-Triple-negative breast cancer	-0.544696610635408	0.285608387842679	22.0000000426623	0.0696433442517725	0.191896263628731	nan
sp|Q9UKM9|RALY_HUMAN	metaplastic breast carcinomas-Normal	0.494256196448941	0.200315615370774	22.0000000059884	0.0218668344130635	0.101374278366838	nan
sp|Q9UKM9|RALY_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.563433647560872	0.200315615370774	22.0000000067651	0.0101380307362087	0.547668704418496	nan
sp|Q9UKM9|RALY_HUMAN	Normal-Triple-negative breast cancer	-1.05768984400981	0.239422954387574	22.0000000061294	0.0002174974614707	0.0227914720285933	nan
sp|Q9UKS6|PACN3_HUMAN	metaplastic breast carcinomas-Normal	-0.0904440333433698	0.377155396393451	23.9999999994994	0.81251716794844	0.900925915386606	nan
sp|Q9UKS6|PACN3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0904151666513002	0.377155396393451	23.9999999995008	0.812575823092811	0.965774701272009	nan
sp|Q9UKS6|PACN3_HUMAN	Normal-Triple-negative breast cancer	2.88666920695707e-05	0.450786919934307	23.9999999994801	0.99994943579539	0.99994943579539	nan
sp|Q9UKV3|ACINU_HUMAN	metaplastic breast carcinomas-Normal	0.642278462483757	0.208253410783888	23.9999999999374	0.0050772062971791	0.0472734838426424	nan
sp|Q9UKV3|ACINU_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.145627572203787	0.208253410783888	24.0000000001582	0.491098947541141	0.913320451076758	nan
sp|Q9UKV3|ACINU_HUMAN	Normal-Triple-negative breast cancer	-0.787906034687545	0.248910434560371	24.000000000035	0.0041755353586721	0.0418056612416451	nan
sp|Q9UKV8|AGO2_HUMAN	metaplastic breast carcinomas-Normal	0.204705855709114	0.334494924057212	14.0000004272912	0.55035807753678	0.722880426895562	nan
sp|Q9UKV8|AGO2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.240853507967484	0.334494924057211	14.0000004276345	0.483342483669497	0.913320451076758	nan
sp|Q9UKV8|AGO2_HUMAN	Normal-Triple-negative breast cancer	-0.445559363676598	0.399797902910315	14.0000004274478	0.283848290408627	0.47648423120551	nan
sp|Q9UKX7|NUP50_HUMAN	metaplastic breast carcinomas-Normal	0.855445833919116	0.344687838583029	21.1881452880625	0.0215285159679172	0.100085016891408	nan
sp|Q9UKX7|NUP50_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0108154757916414	0.321467986313979	20.9325142243221	0.973479772154947	0.99709406933403	nan
sp|Q9UKX7|NUP50_HUMAN	Normal-Triple-negative breast cancer	-0.866261309710758	0.403855161650733	21.1199449319718	0.0437366488163633	0.142578675614312	nan
sp|Q9UKY7|CDV3_HUMAN	metaplastic breast carcinomas-Normal	1.11162801679277	0.475319648731946	23.999999999435	0.0280102036531381	0.119213722078145	nan
sp|Q9UKY7|CDV3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.665037970771794	0.475319648731946	23.999999999435	0.174563350377891	0.843662073010871	nan
sp|Q9UKY7|CDV3_HUMAN	Normal-Triple-negative breast cancer	-1.77666598756456	0.568115642743196	23.9999999994407	0.0045772863550495	0.043471142411956	nan
sp|Q9UKZ9|PCOC2_HUMAN	metaplastic breast carcinomas-Normal	0.652393734541023	1.03445836690289	6.0	0.55151093135654	0.722996021286722	nan
sp|Q9UKZ9|PCOC2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.503054371152028	1.03445836690289	6.0	0.644007094535094	0.941868024951375	nan
sp|Q9UKZ9|PCOC2_HUMAN	Normal-Triple-negative breast cancer	-0.149339363388995	1.23641423528767	6.0	0.907805233891337	0.94682918024939	nan
sp|Q9UL15|BAG5_HUMAN	metaplastic breast carcinomas-Normal	-1.84858131829874	0.617482768207321	23.9999999992388	0.00629873488549	0.0524479728582505	nan
sp|Q9UL15|BAG5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0184753789249711	0.617482768207321	23.9999999990369	0.97637790103826	0.99709406933403	nan
sp|Q9UL15|BAG5_HUMAN	Normal-Triple-negative breast cancer	1.83010593937377	0.738033070332388	23.9999999991092	0.0205608543175633	0.0940086378976347	nan
sp|Q9UL25|RAB21_HUMAN	metaplastic breast carcinomas-Normal	0.0619641586660194	0.400304636268723	13.999999999483	0.879194361383053	0.936980460800664	nan
sp|Q9UL25|RAB21_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.329236731316718	0.359760595513126	13.9999999995907	0.375604017984842	0.885234295852111	nan
sp|Q9UL25|RAB21_HUMAN	Normal-Triple-negative breast cancer	-0.391200889982738	0.464448931681333	13.9999999994984	0.413783402225019	0.60128493320689	nan
sp|Q9UL46|PSME2_HUMAN	metaplastic breast carcinomas-Normal	0.679744823985935	0.366047699526697	23.9999999998802	0.0756286089853569	0.215505801889304	nan
sp|Q9UL46|PSME2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.178182249160187	0.366047699526697	23.9999999995914	0.630834934779181	0.941868024951375	nan
sp|Q9UL46|PSME2_HUMAN	Normal-Triple-negative breast cancer	-0.857927073146122	0.437510682855348	23.9999999996731	0.0615915496928588	0.179116632702592	nan
sp|Q9ULA0|DNPEP_HUMAN	metaplastic breast carcinomas-Normal	-0.125427604547566	0.213104943750723	23.9999999997426	0.561647333649814	0.729834142709922	nan
sp|Q9ULA0|DNPEP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0631807114838608	0.213104943750723	23.9999999995307	0.76941634226849	0.959745866833315	nan
sp|Q9ULA0|DNPEP_HUMAN	Normal-Triple-negative breast cancer	0.188608316031427	0.254709125561461	23.9999999996422	0.46618887443617	0.645671591094096	nan
sp|Q9ULC4|MCTS1_HUMAN	metaplastic breast carcinomas-Normal	0.173183382913332	0.224293820943113	23.9999999996675	0.447576082851775	0.643487413234992	nan
sp|Q9ULC4|MCTS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.257159884597702	0.224293820943113	23.9999999996685	0.262878174311855	0.86431258289795	nan
sp|Q9ULC4|MCTS1_HUMAN	Normal-Triple-negative breast cancer	-0.430343267511034	0.268082391688135	23.9999999996554	0.121514951892493	0.274751623245588	nan
sp|Q9ULH1|ASAP1_HUMAN	metaplastic breast carcinomas-Normal	0.71231296168181	0.208815193013008	22.0000000001217	0.0025034003816045	0.0358739474876542	nan
sp|Q9ULH1|ASAP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.616654999857464	0.195573347018676	22.0000000000756	0.0046143330910296	0.514807348186537	nan
sp|Q9ULH1|ASAP1_HUMAN	Normal-Triple-negative breast cancer	-0.0956579618243457	0.242700141035589	22.0000000001098	0.697271796042012	0.822818207813969	nan
sp|Q9ULT8|HECD1_HUMAN	metaplastic breast carcinomas-Normal	0.678097059991471	0.270168897037223	21.9999828768438	0.0199311978050289	0.0961557351290508	nan
sp|Q9ULT8|HECD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.262329951212585	0.270168897037223	21.9999828688766	0.342110964444591	0.870943310236299	nan
sp|Q9ULT8|HECD1_HUMAN	Normal-Triple-negative breast cancer	-0.415767108778886	0.322913595091207	21.9999828741689	0.211283521072772	0.394285546333942	nan
sp|Q9ULU4|PKCB1_HUMAN	metaplastic breast carcinomas-Normal	0.73943030581571	0.293328941446652	21.1383419708945	0.0198047869988702	0.0959717813406512	nan
sp|Q9ULU4|PKCB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.297733368860997	0.293328941446652	21.1383419703768	0.321576351415974	0.867696529950794	nan
sp|Q9ULU4|PKCB1_HUMAN	Normal-Triple-negative breast cancer	-0.441696936954713	0.346988570262034	21.0898736120543	0.21689198074844	0.399196535995467	nan
sp|Q9ULV4|COR1C_HUMAN	metaplastic breast carcinomas-Normal	0.377486027702065	0.188517235266686	22.0000000357359	0.0577195705127935	0.182897857373237	nan
sp|Q9ULV4|COR1C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.193836303913595	0.188517235266686	22.0000000354882	0.315021402870574	0.867696529950794	nan
sp|Q9ULV4|COR1C_HUMAN	Normal-Triple-negative breast cancer	-0.18364972378847	0.225321192943366	22.0000000354594	0.423775600102991	0.609796577810538	nan
sp|Q9ULX6|AKP8L_HUMAN	metaplastic breast carcinomas-Normal	0.60531215989431	0.208715177793343	22.0000000039572	0.0083019156920797	0.0602818106368712	nan
sp|Q9ULX6|AKP8L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.112141505019784	0.208715177793343	22.0000000039112	0.596457449640497	0.940559810632461	nan
sp|Q9ULX6|AKP8L_HUMAN	Normal-Triple-negative breast cancer	-0.717453664914094	0.249462351700918	22.000000003628	0.0087751422642715	0.0588076066258844	nan
sp|Q9ULZ3|ASC_HUMAN	metaplastic breast carcinomas-Normal	0.182025693732006	0.319909370671723	23.999999999534	0.57464871505144	0.737218189436891	nan
sp|Q9ULZ3|ASC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.472977170236343	0.319909370671723	23.999999999534	0.152286911996434	0.843465960034572	nan
sp|Q9ULZ3|ASC_HUMAN	Normal-Triple-negative breast cancer	0.290951476504337	0.382364832221005	23.9999999995401	0.454112931525753	0.636639133020499	nan
sp|Q9UM47|NOTC3_HUMAN	metaplastic breast carcinomas-Normal	-0.0552605687838088	0.533786393074565	11.6571685873961	0.919305502895918	0.957866838049963	nan
sp|Q9UM47|NOTC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0786508907912323	0.479888894787255	11.1735505659924	0.872741677206421	0.981704007186169	nan
sp|Q9UM47|NOTC3_HUMAN	Normal-Triple-negative breast cancer	0.133911459575041	0.598678641562619	11.1972062102429	0.827036291937218	0.901629594752152	nan
sp|Q9UM54|MYO6_HUMAN	metaplastic breast carcinomas-Normal	0.285146996696214	0.27785192610217	23.9999999990272	0.315004299635739	0.521971232297706	nan
sp|Q9UM54|MYO6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.719815106136521	0.27785192610217	23.9999999990272	0.0160399049217254	0.656412655960811	nan
sp|Q9UM54|MYO6_HUMAN	Normal-Triple-negative breast cancer	-1.00496210283274	0.33209657123598	23.9999999989898	0.0058319123730906	0.0482220814133169	nan
sp|Q9UMD9|COHA1_HUMAN	metaplastic breast carcinomas-Normal	-1.2100165172978	1.05348417054089	13.9999999997689	0.269973697007582	0.472716075635733	nan
sp|Q9UMD9|COHA1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.225649365389858	1.05348417054089	13.9999999997689	0.833484548027915	0.9684421207956	nan
sp|Q9UMD9|COHA1_HUMAN	Normal-Triple-negative breast cancer	1.43566588268766	1.23963146373441	13.9999999997897	0.266183039045947	0.45725706552389	nan
sp|Q9UMS0|NFU1_HUMAN	metaplastic breast carcinomas-Normal	0.27657173840637	0.251498038876291	14.000000009219	0.290014897039127	0.494110465278348	nan
sp|Q9UMS0|NFU1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.209419503507442	0.251498038876291	14.0000000091787	0.418999262559237	0.8860071777014	nan
sp|Q9UMS0|NFU1_HUMAN	Normal-Triple-negative breast cancer	-0.485991241913812	0.300597651256436	14.0000000090933	0.128234919083433	0.285500918307657	nan
sp|Q9UMS4|PRP19_HUMAN	metaplastic breast carcinomas-Normal	0.931677527669701	0.217804554173402	23.9999999997243	0.000260734290554	0.0157578323963946	nan
sp|Q9UMS4|PRP19_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.249269833927902	0.217804554173402	23.9999999997243	0.263716656134305	0.86431258289795	nan
sp|Q9UMS4|PRP19_HUMAN	Normal-Triple-negative breast cancer	-1.1809473615976	0.260326234391372	23.9999999997039	0.0001350034411557	0.0227914720285933	nan
sp|Q9UMS6|SYNP2_HUMAN	metaplastic breast carcinomas-Normal	-0.952797832870738	0.397824968077827	14.9999999997894	0.0301167070960551	0.124822860832029	nan
sp|Q9UMS6|SYNP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0004281275849835	0.397824968077827	14.9999999999414	0.999155522197142	0.999155522197142	nan
sp|Q9UMS6|SYNP2_HUMAN	Normal-Triple-negative breast cancer	0.952369705285754	0.47549178335416	14.9999999998654	0.0636006525579436	0.182879385036855	nan
sp|Q9UMX0|UBQL1_HUMAN	metaplastic breast carcinomas-Normal	0.323978027456397	0.219852318612743	23.9999999996027	0.153581003477789	0.333747236325783	nan
sp|Q9UMX0|UBQL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.156398962581663	0.219852318612743	23.9999999998018	0.483705134346333	0.913320451076758	nan
sp|Q9UMX0|UBQL1_HUMAN	Normal-Triple-negative breast cancer	-0.48037699003806	0.262773781034451	23.9999999997322	0.0799923006240334	0.210464269316822	nan
sp|Q9UMZ2|SYNRG_HUMAN	metaplastic breast carcinomas-Normal	0.45596684061484	0.441512355095735	14.0000000018195	0.319237684082406	0.526362133873966	nan
sp|Q9UMZ2|SYNRG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.622769339557743	0.441512355095734	14.0000000017731	0.180212901958435	0.843662073010871	nan
sp|Q9UMZ2|SYNRG_HUMAN	Normal-Triple-negative breast cancer	-1.07873618017258	0.527708198185028	14.0000000017329	0.0602182805361278	0.176722297698278	nan
sp|Q9UN36|NDRG2_HUMAN	metaplastic breast carcinomas-Normal	-0.741403671582015	0.433124777000504	22.0000000206828	0.101005075319833	0.256896548541066	nan
sp|Q9UN36|NDRG2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.830305717566257	0.433124777000504	22.0000000204938	0.0683147042565986	0.777898601552022	nan
sp|Q9UN36|NDRG2_HUMAN	Normal-Triple-negative breast cancer	-0.0889020459842416	0.517683124882582	22.0000000206554	0.865219170511673	0.921861522788462	nan
sp|Q9UNF0|PACN2_HUMAN	metaplastic breast carcinomas-Normal	0.360758036129156	0.207142291503758	23.9999999997893	0.0943842192289731	0.248130450375174	nan
sp|Q9UNF0|PACN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.107140139107354	0.207142291503758	23.9999999997881	0.609730299081147	0.940559810632461	nan
sp|Q9UNF0|PACN2_HUMAN	Normal-Triple-negative breast cancer	-0.253617897021802	0.247582393008376	23.9999999998595	0.315871784837013	0.508700490696818	nan
sp|Q9UNF1|MAGD2_HUMAN	metaplastic breast carcinomas-Normal	0.851845927665341	0.391131320113131	21.9999968925382	0.0404149331171581	0.149100152809582	nan
sp|Q9UNF1|MAGD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.198224449680113	0.391131320113131	21.9999968925678	0.617338802543363	0.941374262616245	nan
sp|Q9UNF1|MAGD2_HUMAN	Normal-Triple-negative breast cancer	-1.05007037734545	0.467491343805943	21.9999968913082	0.0350627148289724	0.12532092913065	nan
sp|Q9UNH7|SNX6_HUMAN	metaplastic breast carcinomas-Normal	-0.215748144755068	0.173132427958046	22.0000074870448	0.225818154486515	0.425762646348937	nan
sp|Q9UNH7|SNX6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.171996549784569	0.173132427958046	22.0000074878195	0.331297649843856	0.870890600099115	nan
sp|Q9UNH7|SNX6_HUMAN	Normal-Triple-negative breast cancer	0.387744694539637	0.206932831098982	22.0000074873106	0.0743064112728666	0.200157626475696	nan
sp|Q9UNL2|SSRG_HUMAN	metaplastic breast carcinomas-Normal	0.7879087452214	0.328433511450521	23.9999999997009	0.0245641359073681	0.109714262931941	nan
sp|Q9UNL2|SSRG_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.116375632975302	0.328433511450521	23.9999999997009	0.72618188670426	0.953491935272676	nan
sp|Q9UNL2|SSRG_HUMAN	Normal-Triple-negative breast cancer	-0.904284378196702	0.392553129149818	23.9999999996728	0.0302148791348095	0.116487768919398	nan
sp|Q9UNM6|PSD13_HUMAN	metaplastic breast carcinomas-Normal	0.0944925943619424	0.130617228380246	21.9999999615579	0.477037031055621	0.667369987890944	nan
sp|Q9UNM6|PSD13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.120551471949635	0.130617228380246	21.9999999624998	0.366052168500178	0.883542279876718	nan
sp|Q9UNM6|PSD13_HUMAN	Normal-Triple-negative breast cancer	-0.215044066311577	0.156117448232034	21.9999999611784	0.182226299045901	0.358294038729188	nan
sp|Q9UNN5|FAF1_HUMAN	metaplastic breast carcinomas-Normal	0.62707366095277	0.283656579616647	14.0000000013967	0.0442059215833734	0.156153542341268	nan
sp|Q9UNN5|FAF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0969687995096221	0.283656579616647	14.0000000013967	0.73753893709066	0.954643368861838	nan
sp|Q9UNN5|FAF1_HUMAN	Normal-Triple-negative breast cancer	-0.530104861443148	0.339034459183755	14.0000000014096	0.140234965513771	0.30190480917602	nan
sp|Q9UNS2|CSN3_HUMAN	metaplastic breast carcinomas-Normal	-0.0946430625565204	0.197554687473028	23.9999999996776	0.63622312378279	0.782681592692078	nan
sp|Q9UNS2|CSN3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.309915928259631	0.197554687473028	23.9999999997168	0.129795496164865	0.823891816737944	nan
sp|Q9UNS2|CSN3_HUMAN	Normal-Triple-negative breast cancer	-0.215272865703111	0.236123014375878	23.9999999997222	0.3709948890209	0.561055559292967	nan
sp|Q9UNX4|WDR3_HUMAN	metaplastic breast carcinomas-Normal	1.00321371144364	0.322802563887013	14.0000000048919	0.0077115977518994	0.0584743324995458	nan
sp|Q9UNX4|WDR3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.416072073576778	0.322802563887013	14.0000000047123	0.218311631479688	0.843662073010871	nan
sp|Q9UNX4|WDR3_HUMAN	Normal-Triple-negative breast cancer	-1.41928578502041	0.385822859524252	14.0000000047154	0.002480266226936	0.0337628805562287	nan
sp|Q9UNZ2|NSF1C_HUMAN	metaplastic breast carcinomas-Normal	0.16054120034494	0.183275407179292	23.9999999994855	0.389737129085273	0.593171344816596	nan
sp|Q9UNZ2|NSF1C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0918150662662171	0.183275407179292	23.999999999772	0.620957585814847	0.941374262616245	nan
sp|Q9UNZ2|NSF1C_HUMAN	Normal-Triple-negative breast cancer	-0.0687261340787231	0.2190560100481	23.9999999996745	0.756430924127243	0.859388505509785	nan
sp|Q9UP38|FZD1_HUMAN	metaplastic breast carcinomas-Normal	0.880904377716332	0.365134523024702	23.0000000002091	0.0242157249641924	0.10862762453573	nan
sp|Q9UP38|FZD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.420319761316656	0.365134523024702	23.0000000002091	0.261502966424682	0.864311494395694	nan
sp|Q9UP38|FZD1_HUMAN	Normal-Triple-negative breast cancer	-0.460584616399676	0.432032993955632	23.0000000002946	0.297448153389968	0.489230177230913	nan
sp|Q9UP83|COG5_HUMAN	metaplastic breast carcinomas-Normal	0.273027175541344	0.441595413073373	14.9999999998461	0.545668713067945	0.719749780143363	nan
sp|Q9UP83|COG5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.199720468434226	0.441595413073373	14.9999999999891	0.657546109033336	0.944190045212043	nan
sp|Q9UP83|COG5_HUMAN	Normal-Triple-negative breast cancer	-0.47274764397557	0.527807471456135	14.9999999999104	0.384571181606001	0.572721598413238	nan
sp|Q9UPN3|MACF1_HUMAN	metaplastic breast carcinomas-Normal	0.507522524115089	0.134237213109729	22.0000000129967	0.0010278946433689	0.0245807323349512	nan
sp|Q9UPN3|MACF1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0441778647801311	0.134237213109729	22.0000000132415	0.74519036011788	0.954643368861838	nan
sp|Q9UPN3|MACF1_HUMAN	Normal-Triple-negative breast cancer	-0.463344659334958	0.160444157546066	22.000000013148	0.0085393872895261	0.0588076066258844	nan
sp|Q9UPN7|PP6R1_HUMAN	metaplastic breast carcinomas-Normal	-0.0656255335979423	0.247954672869734	22.0000000408918	0.79372947553501	0.888335615043224	nan
sp|Q9UPN7|PP6R1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.128247975912298	0.247954672869734	22.0000000417057	0.610161657604276	0.940559810632461	nan
sp|Q9UPN7|PP6R1_HUMAN	Normal-Triple-negative breast cancer	0.19387350951024	0.296362518832057	22.0000000416941	0.519778407925765	0.692482335849796	nan
sp|Q9UPQ0|LIMC1_HUMAN	metaplastic breast carcinomas-Normal	0.0445954076552908	0.310359008234183	14.0000000007015	0.887793246528438	0.940415790777734	nan
sp|Q9UPQ0|LIMC1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.16290608197036	0.310359008234183	14.0000000011419	0.607868257970613	0.940559810632461	nan
sp|Q9UPQ0|LIMC1_HUMAN	Normal-Triple-negative breast cancer	0.118310674315069	0.370949965806144	14.0000000009623	0.754481054317788	0.858868159093262	nan
sp|Q9UPT5|EXOC7_HUMAN	metaplastic breast carcinomas-Normal	-0.232692630702692	0.245152939294032	22.000000032336	0.352843607303655	0.561744479911381	nan
sp|Q9UPT5|EXOC7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.164651737508355	0.245152939294032	22.000000032336	0.508811967440535	0.913992324008525	nan
sp|Q9UPT5|EXOC7_HUMAN	Normal-Triple-negative breast cancer	0.0680408931943361	0.293013806706645	22.0000000326276	0.818520993893004	0.896788728984734	nan
sp|Q9UPT8|ZC3H4_HUMAN	metaplastic breast carcinomas-Normal	0.547465043300776	0.273238605876683	24.0000000002779	0.0565255434702652	0.180664333168424	nan
sp|Q9UPT8|ZC3H4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0031363951419682	0.273238605876683	24.0000000000188	0.990936493628782	0.998185231446144	nan
sp|Q9UPT8|ZC3H4_HUMAN	Normal-Triple-negative breast cancer	-0.544328648158808	0.326582598918457	24.0000000001703	0.108565168883437	0.255393221067617	nan
sp|Q9UPU5|UBP24_HUMAN	metaplastic breast carcinomas-Normal	-0.234224146081459	0.157259385747692	22.0000000247316	0.150575820757535	0.329502322711024	nan
sp|Q9UPU5|UBP24_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.021906310230103	0.157259385747692	22.0000000250554	0.890480052918179	0.98820634909787	nan
sp|Q9UPU5|UBP24_HUMAN	Normal-Triple-negative breast cancer	0.256130456311562	0.187960916931995	22.0000000249635	0.186770988192896	0.365407159948902	nan
sp|Q9UQ35|SRRM2_HUMAN	metaplastic breast carcinomas-Normal	0.562515770703095	0.181831917845616	23.9999999996203	0.0049630992108882	0.0470009737236255	nan
sp|Q9UQ35|SRRM2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.228278293597523	0.181831917845616	23.9999999993293	0.221406864246247	0.843662073010871	nan
sp|Q9UQ35|SRRM2_HUMAN	Normal-Triple-negative breast cancer	-0.790794064300617	0.217330710299221	23.9999999993682	0.0013056439089222	0.0266490250684039	nan
sp|Q9UQ80|PA2G4_HUMAN	metaplastic breast carcinomas-Normal	0.57473865577326	0.176623582511652	22.0000000021608	0.0036373034891566	0.0407324763980233	nan
sp|Q9UQ80|PA2G4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.216750884473124	0.176623582511652	22.0000000022555	0.232721532636847	0.847998869365766	nan
sp|Q9UQ80|PA2G4_HUMAN	Normal-Triple-negative breast cancer	-0.791489540246384	0.211105558901061	22.0000000021434	0.0011095385940084	0.026613045414958	nan
sp|Q9UQB8|BAIP2_HUMAN	metaplastic breast carcinomas-Normal	0.478485462107639	0.521458872269884	13.999999296605	0.374371063453246	0.581984288538432	nan
sp|Q9UQB8|BAIP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.426333655230336	0.521458872269884	13.9999992972552	0.427293466637277	0.894058800058913	nan
sp|Q9UQB8|BAIP2_HUMAN	Normal-Triple-negative breast cancer	-0.052151806877303	0.623262562728215	13.9999992974954	0.934499134664264	0.963124296633419	nan
sp|Q9UQE7|SMC3_HUMAN	metaplastic breast carcinomas-Normal	0.499529912458064	0.190762097400823	21.9999734364567	0.0156849133170943	0.082757816366911	nan
sp|Q9UQE7|SMC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0184269846626308	0.190762097400823	21.9999734383628	0.923921274878736	0.994508979919649	nan
sp|Q9UQE7|SMC3_HUMAN	Normal-Triple-negative breast cancer	-0.481102927795433	0.228004316390098	21.9999734382399	0.0464557405657209	0.148052619022489	nan
sp|Q9Y216|MTMR7_HUMAN	metaplastic breast carcinomas-Normal	-0.787477236089778	0.406692243420938	22.0000000294209	0.0657822695556247	0.197371926686736	nan
sp|Q9Y216|MTMR7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.274446363236002	0.406692243420938	22.0000000294559	0.506817144279247	0.913864970026299	nan
sp|Q9Y216|MTMR7_HUMAN	Normal-Triple-negative breast cancer	1.06192359932578	0.486090204531092	22.0000000296394	0.0398570628835237	0.133958419640882	nan
sp|Q9Y224|RTRAF_HUMAN	metaplastic breast carcinomas-Normal	0.356264393593649	0.202566453766376	22.000000002586	0.0925232354966408	0.246475010402543	nan
sp|Q9Y224|RTRAF_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.19955815889213	0.202566453766376	22.0000000018307	0.335262138865843	0.870890600099115	nan
sp|Q9Y224|RTRAF_HUMAN	Normal-Triple-negative breast cancer	-0.555822552485779	0.242113220832985	22.0000000017795	0.0315936228052729	0.119609569709256	nan
sp|Q9Y230|RUVB2_HUMAN	metaplastic breast carcinomas-Normal	0.527890203055601	0.199474802748286	22.0000000943205	0.0147442423469706	0.0799508345209304	nan
sp|Q9Y230|RUVB2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.131612763689067	0.199474802748286	22.0000000944294	0.51623297959232	0.915620969865368	nan
sp|Q9Y230|RUVB2_HUMAN	Normal-Triple-negative breast cancer	-0.659502966744668	0.238417991086086	22.0000000943619	0.0112673270867253	0.0674941302089485	nan
sp|Q9Y237|PIN4_HUMAN	metaplastic breast carcinomas-Normal	0.414793717118393	0.302236897620777	21.9999999734445	0.183766396128076	0.374692776303095	nan
sp|Q9Y237|PIN4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.684707451488786	0.302236897620777	21.9999999789641	0.0336726657742994	0.724424466074313	nan
sp|Q9Y237|PIN4_HUMAN	Normal-Triple-negative breast cancer	-1.09950116860718	0.361242186832823	21.9999999769236	0.0059587155392824	0.0487851488979678	nan
sp|Q9Y240|CLC11_HUMAN	metaplastic breast carcinomas-Normal	1.68941063128767	0.961933474369116	23.9999999993757	0.0917980570974386	0.245248171876744	nan
sp|Q9Y240|CLC11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.33783935485063	0.961933474369116	23.9999999993757	0.177053572862707	0.843662073010871	nan
sp|Q9Y240|CLC11_HUMAN	Normal-Triple-negative breast cancer	-0.351571276437039	1.1497304088424	23.9999999994008	0.762404383231202	0.863158096001538	nan
sp|Q9Y250|LZTS1_HUMAN	metaplastic breast carcinomas-Normal	0.417509192840953	0.177445438658679	22.0000000039467	0.0279820212407222	0.119213722078145	nan
sp|Q9Y250|LZTS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.154433410763675	0.177445438658679	22.0000000036063	0.393525805156785	0.885234295852111	nan
sp|Q9Y250|LZTS1_HUMAN	Normal-Triple-negative breast cancer	-0.263075782077278	0.212087864880744	22.0000000039326	0.227890542564016	0.410804747922291	nan
sp|Q9Y262|EIF3L_HUMAN	metaplastic breast carcinomas-Normal	0.334571353336604	0.120099801756653	22.000001588508	0.0107778015533814	0.0691610277286483	nan
sp|Q9Y262|EIF3L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0671100656114	0.120099801756653	22.000001588511	0.581951638598222	0.937040774014086	nan
sp|Q9Y262|EIF3L_HUMAN	Normal-Triple-negative breast cancer	-0.267461287725204	0.143546719034941	22.0000015885631	0.0758340713059917	0.202956886490432	nan
sp|Q9Y263|PLAP_HUMAN	metaplastic breast carcinomas-Normal	-0.0711801242810697	0.331094459161338	22.0000000696822	0.831759945985845	0.910823889104312	nan
sp|Q9Y263|PLAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.555046747226002	0.331094459161338	22.0000000694586	0.107814514422908	0.823891816737944	nan
sp|Q9Y263|PLAP_HUMAN	Normal-Triple-negative breast cancer	-0.483866622944933	0.395733569981729	22.000000069039	0.234377499711009	0.41930614049483	nan
sp|Q9Y265|RUVB1_HUMAN	metaplastic breast carcinomas-Normal	0.679071103456907	0.204141217860589	22.0000008036711	0.0030633304614983	0.0386458689304557	nan
sp|Q9Y265|RUVB1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.168462919596581	0.204141217860589	22.000000803879	0.418101324928109	0.8860071777014	nan
sp|Q9Y265|RUVB1_HUMAN	Normal-Triple-negative breast cancer	-0.847534023053489	0.243995423931341	22.0000008034584	0.0021565325841123	0.032066107359435	nan
sp|Q9Y266|NUDC_HUMAN	metaplastic breast carcinomas-Normal	0.871437983253673	0.234570125997214	23.9999999993295	0.0010789458450636	0.0249056665902193	nan
sp|Q9Y266|NUDC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0663355752205678	0.234570125997214	23.9999999993295	0.779757718286235	0.961606157891275	nan
sp|Q9Y266|NUDC_HUMAN	Normal-Triple-negative breast cancer	-0.805102408033105	0.280364925487044	23.9999999993991	0.0084013913248162	0.0581796349243527	nan
sp|Q9Y277|VDAC3_HUMAN	metaplastic breast carcinomas-Normal	0.758476838918865	0.273119534791346	22.0000001184504	0.0109921378691603	0.0701302615683086	nan
sp|Q9Y277|VDAC3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.024097873084963	0.273119534791346	22.0000001187258	0.9304905549116	0.995359816653149	nan
sp|Q9Y277|VDAC3_HUMAN	Normal-Triple-negative breast cancer	-0.734378965833902	0.326440281750717	22.0000001179155	0.0348083204113076	0.124814301021776	nan
sp|Q9Y279|VSIG4_HUMAN	metaplastic breast carcinomas-Normal	-0.652930622434386	0.450437798974572	13.9999991540668	0.169215078901377	0.357920447257086	nan
sp|Q9Y279|VSIG4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.697004449606109	0.450437798974572	13.9999991542525	0.144071172065263	0.827647387111815	nan
sp|Q9Y279|VSIG4_HUMAN	Normal-Triple-negative breast cancer	1.34993507204049	0.538376144060023	13.9999991544293	0.0251041036111323	0.105455600909054	nan
sp|Q9Y281|COF2_HUMAN	metaplastic breast carcinomas-Normal	-0.907907784719273	0.282530114073176	15.0000000000077	0.0058013631717013	0.0506134676712213	nan
sp|Q9Y281|COF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.249107317372549	0.282530114073176	15.0000000000077	0.391848005205729	0.885234295852111	nan
sp|Q9Y281|COF2_HUMAN	Normal-Triple-negative breast cancer	1.15701510209182	0.33768807533877	15.0000000000167	0.003749978250212	0.0400819560687694	nan
sp|Q9Y285|SYFA_HUMAN	metaplastic breast carcinomas-Normal	0.362932454949358	0.298986456305372	22.0000000046265	0.237666059541089	0.437431883673632	nan
sp|Q9Y285|SYFA_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.424101142678252	0.298986456305371	22.0000000057697	0.170067127085053	0.843662073010871	nan
sp|Q9Y285|SYFA_HUMAN	Normal-Triple-negative breast cancer	-0.78703359762761	0.357357166379688	22.0000000052338	0.0384169289588649	0.131376411377847	nan
sp|Q9Y295|DRG1_HUMAN	metaplastic breast carcinomas-Normal	0.277130585689164	0.225482013264138	21.1087669128766	0.232575443017946	0.432613750750785	nan
sp|Q9Y295|DRG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0066446910079274	0.209902828740107	21.0075067793334	0.97504519383714	0.99709406933403	nan
sp|Q9Y295|DRG1_HUMAN	Normal-Triple-negative breast cancer	-0.270485894681236	0.264054258677167	21.0815332337389	0.317277927626802	0.510470392754835	nan
sp|Q9Y2A7|NCKP1_HUMAN	metaplastic breast carcinomas-Normal	0.0055641137893367	0.103320389784332	22.0000000348994	0.957538322170264	0.978738432624218	nan
sp|Q9Y2A7|NCKP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.194505237580369	0.103320389784332	22.0000000351023	0.0730548144866283	0.78865992911701	nan
sp|Q9Y2A7|NCKP1_HUMAN	Normal-Triple-negative breast cancer	-0.200069351369706	0.123491485797814	22.0000000345306	0.119456334632051	0.271967709806122	nan
sp|Q9Y2B0|CNPY2_HUMAN	metaplastic breast carcinomas-Normal	0.417677906001645	0.196497889712834	23.9999999994114	0.0440236915185199	0.155841054960128	nan
sp|Q9Y2B0|CNPY2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0820269650830033	0.196497889712834	23.9999999994536	0.680064130411892	0.946568877415162	nan
sp|Q9Y2B0|CNPY2_HUMAN	Normal-Triple-negative breast cancer	-0.499704871084648	0.234859899458614	23.9999999994426	0.0438355481259199	0.142589124098468	nan
sp|Q9Y2D5|AKAP2_HUMAN	metaplastic breast carcinomas-Normal	-0.689474121960187	0.30768333842697	22.0000000307544	0.0354556774334122	0.136405870125766	nan
sp|Q9Y2D5|AKAP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0704407717747262	0.30768333842697	22.0000000301819	0.821031025694506	0.965774701272009	nan
sp|Q9Y2D5|AKAP2_HUMAN	Normal-Triple-negative breast cancer	0.759914893734913	0.367751928703431	22.0000000300099	0.0507635911995969	0.15799454789088	nan
sp|Q9Y2G5|OFUT2_HUMAN	metaplastic breast carcinomas-Normal	0.666019587566988	0.361623827456446	14.9999999992646	0.0853714252460658	0.233751744248701	nan
sp|Q9Y2G5|OFUT2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.676438795852715	0.361623827456446	14.9999999992646	0.0810466944538153	0.806849600316436	nan
sp|Q9Y2G5|OFUT2_HUMAN	Normal-Triple-negative breast cancer	0.010419208285727	0.432223144392948	14.9999999992306	0.981085755812416	0.990321607142567	nan
sp|Q9Y2H0|DLGP4_HUMAN	metaplastic breast carcinomas-Normal	0.112531878484435	0.688076346905935	13.9999999999805	0.872426307575312	0.933058251731125	nan
sp|Q9Y2H0|DLGP4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.29948379650113	0.688076346905935	13.9999999998856	0.07984571664976	0.806849600316436	nan
sp|Q9Y2H0|DLGP4_HUMAN	Normal-Triple-negative breast cancer	1.1869519180167	0.809657243011154	13.9999999999759	0.164748641633396	0.334802242417098	nan
sp|Q9Y2H6|FND3A_HUMAN	metaplastic breast carcinomas-Normal	0.161519294937698	0.281387660518848	24.0000000001055	0.57130210530416	0.734910293355661	nan
sp|Q9Y2H6|FND3A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.13242642151565	0.281387660518848	24.0000000000657	0.642161843854372	0.941868024951375	nan
sp|Q9Y2H6|FND3A_HUMAN	Normal-Triple-negative breast cancer	-0.293945716453348	0.336322582165801	24.0000000000873	0.390780584970256	0.578083962813143	nan
sp|Q9Y2I8|WDR37_HUMAN	metaplastic breast carcinomas-Normal	-0.190463585408253	0.226969886589745	23.9999999999375	0.409661782334974	0.612007085160204	nan
sp|Q9Y2I8|WDR37_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.526573301362594	0.226969886589745	23.9999999999375	0.0291646564436226	0.721684569712558	nan
sp|Q9Y2I8|WDR37_HUMAN	Normal-Triple-negative breast cancer	-0.336109715954341	0.271280901909446	23.9999999999205	0.227336184208421	0.410241843815848	nan
sp|Q9Y2J2|E41L3_HUMAN	metaplastic breast carcinomas-Normal	-0.515584089241445	0.324403373120888	22.0000000175296	0.126254759887147	0.296587153261396	nan
sp|Q9Y2J2|E41L3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.475911167361439	0.324403373120888	22.0000000177247	0.15651712811842	0.843465960034572	nan
sp|Q9Y2J2|E41L3_HUMAN	Normal-Triple-negative breast cancer	0.991495256602884	0.387736192518665	22.0000000173087	0.0179684600747437	0.0866867362677038	nan
sp|Q9Y2J8|PADI2_HUMAN	metaplastic breast carcinomas-Normal	0.290216549023309	0.546547804250431	6.0	0.614491144885073	0.768460709404808	nan
sp|Q9Y2J8|PADI2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-1.24222797773486	0.546547804250431	6.0	0.063417995814156	0.773787875546141	nan
sp|Q9Y2J8|PADI2_HUMAN	Normal-Triple-negative breast cancer	-1.53244452675817	0.653249572009009	6.0	0.0573807793368843	0.171407234971458	nan
sp|Q9Y2L1|RRP44_HUMAN	metaplastic breast carcinomas-Normal	-0.23911125251304	0.259501071379648	22.000002678026	0.36682236966352	0.576763772233082	nan
sp|Q9Y2L1|RRP44_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.117999471257997	0.259501071379648	22.0000026774141	0.653768194452673	0.944190045212043	nan
sp|Q9Y2L1|RRP44_HUMAN	Normal-Triple-negative breast cancer	0.121111781255043	0.310163104665881	22.0000026770951	0.699938672812747	0.824399407135586	nan
sp|Q9Y2Q3|GSTK1_HUMAN	metaplastic breast carcinomas-Normal	0.287547095163232	0.293427239330794	23.9999999994285	0.336881490992952	0.545322156772893	nan
sp|Q9Y2Q3|GSTK1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0906170701602416	0.293427239330794	23.9999999993918	0.760121092110816	0.955228196959647	nan
sp|Q9Y2Q3|GSTK1_HUMAN	Normal-Triple-negative breast cancer	-0.378164165323473	0.350712631206176	23.9999999994381	0.291630346984313	0.484689636687928	nan
sp|Q9Y2Q9|RT28_HUMAN	metaplastic breast carcinomas-Normal	0.204217604718968	0.276926099715886	23.9999999995555	0.468001288932462	0.659447343964182	nan
sp|Q9Y2Q9|RT28_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0506847787753481	0.276926099715886	23.9999999997653	0.856314709905174	0.977691255315669	nan
sp|Q9Y2Q9|RT28_HUMAN	Normal-Triple-negative breast cancer	-0.254902383494316	0.330989997051817	23.9999999996688	0.448742695288651	0.632088735336703	nan
sp|Q9Y2R9|RT07_HUMAN	metaplastic breast carcinomas-Normal	-0.518267989589756	0.501660480720841	14.0000000534389	0.319072090876709	0.526350188622422	nan
sp|Q9Y2R9|RT07_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.274103836406258	0.501660480720841	14.0000000531313	0.593397357646285	0.940559810632461	nan
sp|Q9Y2R9|RT07_HUMAN	Normal-Triple-negative breast cancer	0.792371825996014	0.599598958729995	14.0000000532854	0.207523616100832	0.389436459261568	nan
sp|Q9Y2S2|CRYL1_HUMAN	metaplastic breast carcinomas-Normal	-1.15781725594691	0.375343365538523	13.9999999983291	0.0080742273228505	0.0598781084433848	nan
sp|Q9Y2S2|CRYL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.246123053501447	0.375343365538523	13.9999999981689	0.522630031992052	0.917607105199968	nan
sp|Q9Y2S2|CRYL1_HUMAN	Normal-Triple-negative breast cancer	0.911694202445464	0.4486211288155	13.9999999982061	0.0615553326514813	0.179116632702592	nan
sp|Q9Y2T2|AP3M1_HUMAN	metaplastic breast carcinomas-Normal	-0.982866802529575	0.558888709983579	12.9999999998734	0.102145174992228	0.258601320429514	nan
sp|Q9Y2T2|AP3M1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.175666772721463	0.426858303092662	12.9999999998742	0.687385057146142	0.946568877415162	nan
sp|Q9Y2T2|AP3M1_HUMAN	Normal-Triple-negative breast cancer	1.15853357525104	0.624856573690224	12.9999999998737	0.0865497016821077	0.22205871018163	nan
sp|Q9Y2U8|MAN1_HUMAN	metaplastic breast carcinomas-Normal	0.348668460445461	0.246796186112325	13.9999999843784	0.179565122254098	0.369124592685604	nan
sp|Q9Y2U8|MAN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0716165980015635	0.246796186112325	13.9999999846081	0.77592840153407	0.960657739983943	nan
sp|Q9Y2U8|MAN1_HUMAN	Normal-Triple-negative breast cancer	-0.277051862443898	0.294977862316066	13.999999984132	0.363536095211632	0.5541195703899	nan
sp|Q9Y2V2|CHSP1_HUMAN	metaplastic breast carcinomas-Normal	-0.249041566328232	0.239349246632501	23.9999999995619	0.308479334709521	0.516085669093257	nan
sp|Q9Y2V2|CHSP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.188864347632455	0.239349246632501	23.999999999562	0.437794686795443	0.897513075778899	nan
sp|Q9Y2V2|CHSP1_HUMAN	Normal-Triple-negative breast cancer	0.0601772186957774	0.286077067197799	23.9999999995816	0.835167692975283	0.906349225873604	nan
sp|Q9Y2W1|TR150_HUMAN	metaplastic breast carcinomas-Normal	0.858709574139339	0.186852059510573	23.9999999993458	0.0001161105847301	0.0137839851301073	nan
sp|Q9Y2W1|TR150_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.221768152062067	0.186852059510573	23.9999999993458	0.246896621111233	0.84964799869723	nan
sp|Q9Y2W1|TR150_HUMAN	Normal-Triple-negative breast cancer	-1.08047772620141	0.22333092724009	23.9999999993394	6.26996093177016e-05	0.022319699811492	nan
sp|Q9Y2W2|WBP11_HUMAN	metaplastic breast carcinomas-Normal	0.571645000296519	0.262195089924124	24.0000000000744	0.0392777432092653	0.146039394214315	nan
sp|Q9Y2W2|WBP11_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.17626994632656	0.262195089924124	24.000000000073	0.507823190453397	0.913992324008525	nan
sp|Q9Y2W2|WBP11_HUMAN	Normal-Triple-negative breast cancer	-0.747914946623079	0.313383072704317	24.0000000000104	0.0252396131289967	0.105514402071789	nan
sp|Q9Y2W6|TDRKH_HUMAN	metaplastic breast carcinomas-Normal	-1.66899418520557	0.929979343921301	13.9999999996517	0.0943227865978515	0.248130450375174	nan
sp|Q9Y2W6|TDRKH_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.886110856852491	0.835788277904025	13.9999999995716	0.306998292068464	0.867696529950794	nan
sp|Q9Y2W6|TDRKH_HUMAN	Normal-Triple-negative breast cancer	2.55510504205806	1.07899802709255	13.9999999996056	0.0328147731491742	0.121510585324113	nan
sp|Q9Y2X3|NOP58_HUMAN	metaplastic breast carcinomas-Normal	0.8406985725047	0.236391252512344	22.000000004959	0.0017676856614581	0.0298263306532335	nan
sp|Q9Y2X3|NOP58_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.196967078742711	0.236391252512344	22.000000004959	0.413672877544044	0.885784822958391	nan
sp|Q9Y2X3|NOP58_HUMAN	Normal-Triple-negative breast cancer	-1.03766565124741	0.282541587999145	22.0000000050984	0.0013356596644858	0.0266490250684039	nan
sp|Q9Y2Z0|SGT1_HUMAN	metaplastic breast carcinomas-Normal	0.369179862567367	0.256867324095833	22.0000000351354	0.164721400945046	0.350533890359369	nan
sp|Q9Y2Z0|SGT1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0282153691191897	0.256867324095833	22.0000000348076	0.913528829124127	0.99408739879047	nan
sp|Q9Y2Z0|SGT1_HUMAN	Normal-Triple-negative breast cancer	-0.397395231686557	0.30701517456251	22.0000000344377	0.208955540635956	0.390865625815373	nan
sp|Q9Y2Z4|SYYM_HUMAN	metaplastic breast carcinomas-Normal	0.775442646623588	0.332298672325428	23.9999999995304	0.0283226314095881	0.120182222594229	nan
sp|Q9Y2Z4|SYYM_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0479849857845754	0.332298672325428	23.9999999995304	0.886387873942227	0.986358661599032	nan
sp|Q9Y2Z4|SYYM_HUMAN	Normal-Triple-negative breast cancer	-0.727457660839012	0.397172880007187	23.9999999995973	0.0794539481270543	0.2097735691615	nan
sp|Q9Y305|ACOT9_HUMAN	metaplastic breast carcinomas-Normal	0.0093200604390053	0.154369058631529	23.999999999683	0.952356771579214	0.975193989958575	nan
sp|Q9Y305|ACOT9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0665639921161239	0.154369058631529	23.999999999683	0.670171142369893	0.946277260710207	nan
sp|Q9Y305|ACOT9_HUMAN	Normal-Triple-negative breast cancer	0.0572439316771186	0.184506315272422	23.9999999996175	0.759045573745484	0.861703376752045	nan
sp|Q9Y314|NOSIP_HUMAN	metaplastic breast carcinomas-Normal	0.715239856731153	0.390075988326715	14.9999999996187	0.0866324052652546	0.236642800784097	nan
sp|Q9Y314|NOSIP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.065135250154685	0.390075988326715	14.9999999996187	0.869615273919728	0.981157375562638	nan
sp|Q9Y314|NOSIP_HUMAN	Normal-Triple-negative breast cancer	-0.650104606576468	0.466229981062479	14.9999999996396	0.18351148633446	0.360302528396777	nan
sp|Q9Y316|MEMO1_HUMAN	metaplastic breast carcinomas-Normal	0.130703113254579	0.266614140175107	21.9999999885104	0.628822410203416	0.778360007018459	nan
sp|Q9Y316|MEMO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.123948352751344	0.266614140175107	21.9999999862859	0.646573103679752	0.943315325604231	nan
sp|Q9Y316|MEMO1_HUMAN	Normal-Triple-negative breast cancer	-0.0067547605032345	0.318664847990378	21.9999999887877	0.983279533544575	0.991632636378084	nan
sp|Q9Y320|TMX2_HUMAN	metaplastic breast carcinomas-Normal	0.37691343714661	0.142604114928541	22.0000000151658	0.0148538905614057	0.0800735738756976	nan
sp|Q9Y320|TMX2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.1058963372946	0.142604114928541	22.0000000152025	0.465585878217655	0.909423669537079	nan
sp|Q9Y320|TMX2_HUMAN	Normal-Triple-negative breast cancer	-0.48280977444121	0.170444517971402	22.000000015219	0.0096885427981941	0.0620611678009953	nan
sp|Q9Y333|LSM2_HUMAN	metaplastic breast carcinomas-Normal	0.0300345201822425	0.40927330667967	14.000000012232	0.942537939377612	0.97019065827596	nan
sp|Q9Y333|LSM2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.142354280063607	0.40927330667967	14.0000000120742	0.733147967951547	0.954643368861838	nan
sp|Q9Y333|LSM2_HUMAN	Normal-Triple-negative breast cancer	0.112319759881364	0.489175165180431	14.0000000123335	0.821715164106457	0.898940081069813	nan
sp|Q9Y365|STA10_HUMAN	metaplastic breast carcinomas-Normal	-0.512805689349452	0.36912448230342	22.0000000206636	0.178659711483479	0.367883501589116	nan
sp|Q9Y365|STA10_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.880379281576595	0.36912448230342	22.0000000211866	0.0261215955608385	0.721684569712558	nan
sp|Q9Y365|STA10_HUMAN	Normal-Triple-negative breast cancer	-0.367573592227143	0.441188141654795	22.0000000213554	0.413717102995003	0.60128493320689	nan
sp|Q9Y376|CAB39_HUMAN	metaplastic breast carcinomas-Normal	0.144351642291227	0.217315421946118	23.9999999995597	0.512862521459934	0.696102499523405	nan
sp|Q9Y376|CAB39_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0231050565262478	0.217315421946118	23.9999999997635	0.916211881310374	0.99408739879047	nan
sp|Q9Y376|CAB39_HUMAN	Normal-Triple-negative breast cancer	-0.167456698817475	0.259741609559575	23.9999999996683	0.525233492149578	0.695444310582923	nan
sp|Q9Y383|LC7L2_HUMAN	metaplastic breast carcinomas-Normal	1.03966096359941	0.278778090136922	22.0000007754636	0.0011643588704653	0.0258553603828806	nan
sp|Q9Y383|LC7L2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.29296966250808	0.278778090136922	22.000000775696	0.304708919559405	0.867696529950794	nan
sp|Q9Y383|LC7L2_HUMAN	Normal-Triple-negative breast cancer	-1.33263062610749	0.333203548987251	22.0000007757541	0.0006039543959503	0.0238993382397495	nan
sp|Q9Y394|DHRS7_HUMAN	metaplastic breast carcinomas-Normal	-0.340607967142631	0.167427429853641	23.9999999996595	0.0531085255540541	0.175479859782978	nan
sp|Q9Y394|DHRS7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.498282727255761	0.167427429853641	23.9999999996313	0.0065676859123413	0.519941801393686	nan
sp|Q9Y394|DHRS7_HUMAN	Normal-Triple-negative breast cancer	0.838890694398392	0.200114054148399	23.9999999996278	0.0003239645462063	0.0227914720285933	nan
sp|Q9Y3A5|SBDS_HUMAN	metaplastic breast carcinomas-Normal	-0.492747625283811	0.322712948843885	22.0000002336311	0.141037987558496	0.316549811373694	nan
sp|Q9Y3A5|SBDS_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0585736165090378	0.322712948843885	22.0000002337643	0.857634046015743	0.978597530199844	nan
sp|Q9Y3A5|SBDS_HUMAN	Normal-Triple-negative breast cancer	0.434174008774773	0.385715749060878	22.0000002340118	0.272451626612963	0.463995415682386	nan
sp|Q9Y3A6|TMED5_HUMAN	metaplastic breast carcinomas-Normal	1.22179608852737	0.698472845187876	22.0000000409302	0.0941891852187623	0.248130450375174	nan
sp|Q9Y3A6|TMED5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.784048505510008	0.698472845187876	22.000000040927	0.273743997955574	0.867696529950794	nan
sp|Q9Y3A6|TMED5_HUMAN	Normal-Triple-negative breast cancer	-0.437747583017364	0.834834727411743	22.0000000410882	0.605276997172588	0.756340710047418	nan
sp|Q9Y3B3|TMED7_HUMAN	metaplastic breast carcinomas-Normal	0.347961187464869	0.212606863353183	22.0000000024531	0.115932152049035	0.280668953686084	nan
sp|Q9Y3B3|TMED7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.101504005120256	0.212606863353183	22.0000000022392	0.637767898234651	0.941868024951375	nan
sp|Q9Y3B3|TMED7_HUMAN	Normal-Triple-negative breast cancer	-0.449465192585125	0.254113805620572	22.000000002428	0.0907991057424528	0.227935031097777	nan
sp|Q9Y3B8|ORN_HUMAN	metaplastic breast carcinomas-Normal	0.0616726204234902	0.247920876495404	22.0000016250665	0.805854538460677	0.897982429964831	nan
sp|Q9Y3B8|ORN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.519140948206116	0.247920876495404	22.00000162499	0.0480019991540036	0.760401133998256	nan
sp|Q9Y3B8|ORN_HUMAN	Normal-Triple-negative breast cancer	-0.580813568629606	0.296322124438565	22.0000016251079	0.0627740304117695	0.181387677362224	nan
sp|Q9Y3B9|RRP15_HUMAN	metaplastic breast carcinomas-Normal	1.04497541296566	0.351742096618597	21.9999999959546	0.0070547564300999	0.0558333580325056	nan
sp|Q9Y3B9|RRP15_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.26188823711716	0.351742096618597	21.9999999957779	0.464425676558585	0.909423669537079	nan
sp|Q9Y3B9|RRP15_HUMAN	Normal-Triple-negative breast cancer	-1.30686365008282	0.42041221698581	21.9999999955805	0.0051219305715617	0.0454007925863229	nan
sp|Q9Y3C4|TPRKB_HUMAN	metaplastic breast carcinomas-Normal	-0.0829207682078419	0.397695427258051	18.0000000000575	0.837177284575622	0.914223915690573	nan
sp|Q9Y3C4|TPRKB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.030514193149133	0.187475422307366	17.9999999999929	0.872517842024698	0.981704007186169	nan
sp|Q9Y3C4|TPRKB_HUMAN	Normal-Triple-negative breast cancer	0.113434961356975	0.414994537855252	18.0000000000362	0.787702811522281	0.878927205605929	nan
sp|Q9Y3C6|PPIL1_HUMAN	metaplastic breast carcinomas-Normal	0.526875875839592	0.255425373229957	22.0000000143096	0.0511382487479055	0.171354373828667	nan
sp|Q9Y3C6|PPIL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.183177421234963	0.255425373229957	22.0000000133053	0.48082916709643	0.913320451076758	nan
sp|Q9Y3C6|PPIL1_HUMAN	Normal-Triple-negative breast cancer	-0.710053297074554	0.305291713634361	22.0000000137358	0.0296417423467539	0.115508970176565	nan
sp|Q9Y3D6|FIS1_HUMAN	metaplastic breast carcinomas-Normal	-0.0087657054671303	0.264746393147891	22.0000077438686	0.973885575068056	0.986747848285733	nan
sp|Q9Y3D6|FIS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.04653310250299	0.264746393147891	22.0000077433493	0.862086498234451	0.979916450336765	nan
sp|Q9Y3D6|FIS1_HUMAN	Normal-Triple-negative breast cancer	0.0552988079701204	0.31643246330845	22.0000077437118	0.862868836612103	0.921322797184073	nan
sp|Q9Y3D7|TIM16_HUMAN	metaplastic breast carcinomas-Normal	0.60038455305395	0.458745902832483	13.9999999129812	0.211695468963589	0.407455552307452	nan
sp|Q9Y3D7|TIM16_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.412157253397218	0.458745902832483	13.9999999129708	0.384141032037818	0.885234295852111	nan
sp|Q9Y3D7|TIM16_HUMAN	Normal-Triple-negative breast cancer	-1.01254180645117	0.54830622748032	13.999999912639	0.086038797283682	0.221356781866067	nan
sp|Q9Y3E0|GOT1B_HUMAN	metaplastic breast carcinomas-Normal	0.712611592278041	0.352880783104571	13.9999999836437	0.0630146716062535	0.191989705242151	nan
sp|Q9Y3E0|GOT1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.254498088865292	0.352880783104571	13.9999999835649	0.482656580725505	0.913320451076758	nan
sp|Q9Y3E0|GOT1B_HUMAN	Normal-Triple-negative breast cancer	-0.458113503412749	0.421773207650908	13.9999999838269	0.295756286393859	0.487645781732731	nan
sp|Q9Y3E5|PTH2_HUMAN	metaplastic breast carcinomas-Normal	0.528101689594536	0.238789739129688	22.0000003302981	0.0376889536321313	0.14187778241586	nan
sp|Q9Y3E5|PTH2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.561454457984022	0.238789739129688	22.0000003302981	0.0280799333911061	0.721684569712558	nan
sp|Q9Y3E5|PTH2_HUMAN	Normal-Triple-negative breast cancer	-1.08955614757856	0.2854083278233	22.000000330337	0.0009402074229925	0.025828508049811	nan
sp|Q9Y3E7|CHMP3_HUMAN	metaplastic breast carcinomas-Normal	0.690998339934901	0.311616998323922	23.9999999996198	0.0363123987970392	0.13826164215505	nan
sp|Q9Y3E7|CHMP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.250153214757736	0.311616998323922	23.999999999818	0.429992711730291	0.894696975283614	nan
sp|Q9Y3E7|CHMP3_HUMAN	Normal-Triple-negative breast cancer	-0.440845125177165	0.372453551551659	23.9999999997504	0.24815328080771	0.436665698996733	nan
sp|Q9Y3F4|STRAP_HUMAN	metaplastic breast carcinomas-Normal	0.560866276364839	0.165958380844965	22.0000000025631	0.0026997751798959	0.0374448413967682	nan
sp|Q9Y3F4|STRAP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.192043286041191	0.165958380844965	22.0000000025631	0.25961013516083	0.862813416943474	nan
sp|Q9Y3F4|STRAP_HUMAN	Normal-Triple-negative breast cancer	-0.368822990323648	0.198358204744715	22.0000000023847	0.0764000798252407	0.203979008304498	nan
sp|Q9Y3I0|RTCB_HUMAN	metaplastic breast carcinomas-Normal	0.234416798338941	0.116397672761362	21.9999999401867	0.056406113612976	0.180456132482707	nan
sp|Q9Y3I0|RTCB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0454254959458779	0.116397672761362	21.9999999427667	0.700096440240985	0.947423957591076	nan
sp|Q9Y3I0|RTCB_HUMAN	Normal-Triple-negative breast cancer	-0.279842294284819	0.139121828544323	21.9999999378526	0.0566816405149208	0.170198530326646	nan
sp|Q9Y3P9|RBGP1_HUMAN	metaplastic breast carcinomas-Normal	0.145825500938426	0.205419781631583	23.9999999999376	0.484613043440028	0.674279512932043	nan
sp|Q9Y3P9|RBGP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.179327625598046	0.205419781631583	23.9999999997083	0.391324201165649	0.885234295852111	nan
sp|Q9Y3P9|RBGP1_HUMAN	Normal-Triple-negative breast cancer	-0.325153126536473	0.245523599929291	23.9999999998044	0.197869167909942	0.3786926489393	nan
sp|Q9Y3S2|ZN330_HUMAN	metaplastic breast carcinomas-Normal	-1.03022417080432	0.475588349423751	6.0	0.0734449238907002	0.211185923021356	nan
sp|Q9Y3S2|ZN330_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.616809168517704	0.475588349423751	6.0	0.242289946541583	0.84964799869723	nan
sp|Q9Y3S2|ZN330_HUMAN	Normal-Triple-negative breast cancer	0.413415002286617	0.56843680149739	6.0	0.494440019894876	0.671097846521261	nan
sp|Q9Y3T9|NOC2L_HUMAN	metaplastic breast carcinomas-Normal	0.518069487466285	0.199600441101711	14.9999999995367	0.0202784988594164	0.0967083647183645	nan
sp|Q9Y3T9|NOC2L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.324396160720541	0.199600441101711	14.9999999997125	0.124935329607265	0.823891816737944	nan
sp|Q9Y3T9|NOC2L_HUMAN	Normal-Triple-negative breast cancer	-0.842465648186826	0.23856815764053	14.9999999996072	0.0030227554942245	0.0368045394241847	nan
sp|Q9Y3U8|RL36_HUMAN	metaplastic breast carcinomas-Normal	0.070154551130787	0.292628282662636	23.9999999997112	0.812567958582745	0.900925915386606	nan
sp|Q9Y3U8|RL36_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0711368767385736	0.292628282662636	23.9999999997112	0.809996442892676	0.965774701272009	nan
sp|Q9Y3U8|RL36_HUMAN	Normal-Triple-negative breast cancer	0.0009823256077865	0.349757695338775	23.9999999997092	0.997782288445511	0.999945312570918	nan
sp|Q9Y3Y2|CHTOP_HUMAN	metaplastic breast carcinomas-Normal	0.316853406981623	0.322245707800137	22.0000000199137	0.336166964943967	0.54455116543555	nan
sp|Q9Y3Y2|CHTOP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.716681662197872	0.322245707800137	22.0000000206569	0.0367244496354848	0.73123935744099	nan
sp|Q9Y3Y2|CHTOP_HUMAN	Normal-Triple-negative breast cancer	-1.0335350691795	0.385157289197935	22.0000000206164	0.0135741471357548	0.0754897960437323	nan
sp|Q9Y3Z3|SAMH1_HUMAN	metaplastic breast carcinomas-Normal	-0.156987665805016	0.358958420784783	21.9999679330705	0.666126369930946	0.804500152362328	nan
sp|Q9Y3Z3|SAMH1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0493889186907054	0.358958420784783	21.9999679385999	0.891816340806069	0.988218752026376	nan
sp|Q9Y3Z3|SAMH1_HUMAN	Normal-Triple-negative breast cancer	0.206376584495722	0.429037374083466	21.9999679403966	0.635250052964162	0.781906844086648	nan
sp|Q9Y446|PKP3_HUMAN	metaplastic breast carcinomas-Normal	-0.386511914441006	0.599461864160329	23.9999999995934	0.525195350468636	0.703647458668982	nan
sp|Q9Y446|PKP3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.223468559561214	0.599461864160329	23.9999999998077	0.712582766243348	0.94948208919602	nan
sp|Q9Y446|PKP3_HUMAN	Normal-Triple-negative breast cancer	0.163043354879792	0.716493970249353	23.9999999997095	0.821917908923774	0.898940081069813	nan
sp|Q9Y450|HBS1L_HUMAN	metaplastic breast carcinomas-Normal	-0.250151597563592	0.43020703325414	14.0000000016568	0.570169410130146	0.734528007858528	nan
sp|Q9Y450|HBS1L_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.222550312485579	0.43020703325414	14.0000000019182	0.613016040062185	0.94077736515583	nan
sp|Q9Y450|HBS1L_HUMAN	Normal-Triple-negative breast cancer	0.472701910049171	0.514195754082221	14.0000000017818	0.373505151739017	0.56177878931244	nan
sp|Q9Y490|TLN1_HUMAN	metaplastic breast carcinomas-Normal	0.116799365173986	0.19888702129887	22.0000000044482	0.563005063821954	0.731312556523711	nan
sp|Q9Y490|TLN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.177982792819496	0.19888702129887	22.0000000035569	0.380530563518176	0.885234295852111	nan
sp|Q9Y490|TLN1_HUMAN	Normal-Triple-negative breast cancer	0.0611834276455099	0.237715457881708	22.0000000041569	0.799276784072571	0.884713962789619	nan
sp|Q9Y4E6|WDR7_HUMAN	metaplastic breast carcinomas-Normal	2.03988503670071	0.895726011429866	13.9999999997878	0.0389869655047515	0.14528326607376	nan
sp|Q9Y4E6|WDR7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.51646652211653	0.895726011429866	13.9999999998814	0.11257901277517	0.823891816737944	nan
sp|Q9Y4E6|WDR7_HUMAN	Normal-Triple-negative breast cancer	-0.523418514584183	1.0539979410262	13.9999999998192	0.627175514867521	0.775858359292757	nan
sp|Q9Y4F1|FARP1_HUMAN	metaplastic breast carcinomas-Normal	0.0406761899204274	0.229137877106185	23.9999999995026	0.860590952441264	0.927563010997005	nan
sp|Q9Y4F1|FARP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.077670662347622	0.229137877106185	23.9999999995326	0.737580978668616	0.954643368861838	nan
sp|Q9Y4F1|FARP1_HUMAN	Normal-Triple-negative breast cancer	-0.118346852268049	0.27387214619946	23.9999999994731	0.669508689993657	0.806029295740281	nan
sp|Q9Y4F5|C170B_HUMAN	metaplastic breast carcinomas-Normal	-0.969904070407466	0.645679561107381	14.0000000122304	0.155276467427985	0.336336266919337	nan
sp|Q9Y4F5|C170B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.240675485752547	0.645679561107381	14.0000000120974	0.714918900077555	0.949812109346858	nan
sp|Q9Y4F5|C170B_HUMAN	Normal-Triple-negative breast cancer	0.729228584654919	0.771734683898017	14.0000000120589	0.36072255367006	0.55139307856607	nan
sp|Q9Y4G6|TLN2_HUMAN	metaplastic breast carcinomas-Normal	-0.857342391719585	0.318799000414777	22.0000000060848	0.0133965782374619	0.0773094202453531	nan
sp|Q9Y4G6|TLN2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.222181239081004	0.318799000414777	22.0000000067469	0.493144582973983	0.913320451076758	nan
sp|Q9Y4G6|TLN2_HUMAN	Normal-Triple-negative breast cancer	1.07952363080059	0.381037685922949	22.0000000061475	0.0096782924754936	0.0620611678009953	nan
sp|Q9Y4I1|MYO5A_HUMAN	metaplastic breast carcinomas-Normal	0.465959581218866	0.377278561012434	14.9999999996593	0.235806743267059	0.435456452566503	nan
sp|Q9Y4I1|MYO5A_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.168890406261279	0.377278561012434	14.9999999995189	0.66079980356167	0.944434752137403	nan
sp|Q9Y4I1|MYO5A_HUMAN	Normal-Triple-negative breast cancer	-0.297069174957587	0.450934129810572	14.9999999996102	0.520018302349506	0.692524373801986	nan
sp|Q9Y4K0|LOXL2_HUMAN	metaplastic breast carcinomas-Normal	0.682141853436513	0.307960288451227	22.0000040980741	0.0374188700033336	0.141341277148956	nan
sp|Q9Y4K0|LOXL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.256799770285613	0.307960288451227	22.0000040980752	0.413315311664424	0.885784822958391	nan
sp|Q9Y4K0|LOXL2_HUMAN	Normal-Triple-negative breast cancer	-0.425342083150899	0.368082947295779	22.0000040977452	0.260257294416926	0.451040274578656	nan
sp|Q9Y4K1|CRBG1_HUMAN	metaplastic breast carcinomas-Normal	0.0625431688687147	0.343817285594813	16.3416096771712	0.857892140750729	0.926155724538949	nan
sp|Q9Y4K1|CRBG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0629866908473912	0.298571820771033	16.3169504252807	0.835530668333843	0.96926934693647	nan
sp|Q9Y4K1|CRBG1_HUMAN	Normal-Triple-negative breast cancer	0.0004435219786765	0.387359656886158	16.7215711700092	0.999099981273065	0.999945312570918	nan
sp|Q9Y4L1|HYOU1_HUMAN	metaplastic breast carcinomas-Normal	0.924931164361054	0.243385086934154	22.0000000544513	0.0009804237709058	0.0237878001057735	nan
sp|Q9Y4L1|HYOU1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0606441464888963	0.243385086934154	22.0000000544513	0.80554121647228	0.965774701272009	nan
sp|Q9Y4L1|HYOU1_HUMAN	Normal-Triple-negative breast cancer	-0.98557531084995	0.29090081898904	22.0000000547136	0.0026459160665635	0.034490294138263	nan
sp|Q9Y4P3|TBL2_HUMAN	metaplastic breast carcinomas-Normal	0.270732442193875	0.514432204004215	14.9999999995985	0.60639230326466	0.763792351667953	nan
sp|Q9Y4P3|TBL2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0301341422817053	0.514432204004215	14.9999999996274	0.954061903293102	0.996624514121761	nan
sp|Q9Y4P3|TBL2_HUMAN	Normal-Triple-negative breast cancer	-0.30086658447558	0.614864087788785	14.9999999995914	0.631691726843387	0.779314007614477	nan
sp|Q9Y4W6|AFG32_HUMAN	metaplastic breast carcinomas-Normal	-0.476463419032794	0.346232232756211	23.9999999997409	0.181484849767279	0.371920863518149	nan
sp|Q9Y4W6|AFG32_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.494647233934967	0.346232232756211	23.9999999997409	0.165989118060256	0.843662073010871	nan
sp|Q9Y4W6|AFG32_HUMAN	Normal-Triple-negative breast cancer	-0.018183814902173	0.413826670063948	23.9999999997597	0.96531526044312	0.982929910189078	nan
sp|Q9Y4X5|ARI1_HUMAN	metaplastic breast carcinomas-Normal	-0.248027923305007	0.238254647263397	14.9999999995795	0.314355573984765	0.52141613169928	nan
sp|Q9Y4X5|ARI1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.320684206188691	0.238254647263397	14.9999999995794	0.198302646852034	0.843662073010871	nan
sp|Q9Y4X5|ARI1_HUMAN	Normal-Triple-negative breast cancer	0.568712129493697	0.284768770716087	14.9999999996216	0.0642890774336605	0.184221459818524	nan
sp|Q9Y4Z0|LSM4_HUMAN	metaplastic breast carcinomas-Normal	0.0990253384416221	0.224320058833284	13.9999999773868	0.665631221136312	0.804274147239949	nan
sp|Q9Y4Z0|LSM4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.597592863466288	0.224320058833284	13.9999999773901	0.0185150998283003	0.674062840112479	nan
sp|Q9Y4Z0|LSM4_HUMAN	Normal-Triple-negative breast cancer	-0.69661820190791	0.268113751965116	13.9999999773903	0.0210501749961493	0.0953699510109521	nan
sp|Q9Y508|RN114_HUMAN	metaplastic breast carcinomas-Normal	0.473020338467811	0.178206331431778	23.9999999997718	0.0138823528241748	0.0787184055002298	nan
sp|Q9Y508|RN114_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.18958018587411	0.178206331431778	24.0000000000749	0.297995416831312	0.867696529950794	nan
sp|Q9Y508|RN114_HUMAN	Normal-Triple-negative breast cancer	-0.662600524341921	0.212997305691788	23.9999999999868	0.0047619756571316	0.0440913846359484	nan
sp|Q9Y512|SAM50_HUMAN	metaplastic breast carcinomas-Normal	0.457176078034372	0.21306541244124	23.9999999994765	0.0422204837182624	0.152285044160049	nan
sp|Q9Y512|SAM50_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0573348528075338	0.21306541244124	23.9999999996885	0.790156408790424	0.962981271203673	nan
sp|Q9Y512|SAM50_HUMAN	Normal-Triple-negative breast cancer	-0.514510930841906	0.254661876609402	23.9999999995456	0.0546402277353299	0.16598219735594	nan
sp|Q9Y520|PRC2C_HUMAN	metaplastic breast carcinomas-Normal	0.459562263030306	0.238028042319646	23.9999999998643	0.0654158678171918	0.196780402374973	nan
sp|Q9Y520|PRC2C_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0587719101909661	0.238028042319646	23.9999999998643	0.807076409018951	0.965774701272009	nan
sp|Q9Y520|PRC2C_HUMAN	Normal-Triple-negative breast cancer	-0.518334173221272	0.284497926004298	23.9999999998675	0.0809529392292891	0.211879976376502	nan
sp|Q9Y570|PPME1_HUMAN	metaplastic breast carcinomas-Normal	0.225549868654486	0.148205864326801	22.000000733491	0.142286679893415	0.318277876154584	nan
sp|Q9Y570|PPME1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.391044297933262	0.148205864326801	22.0000007331545	0.0150053275267474	0.656412655960811	nan
sp|Q9Y570|PPME1_HUMAN	Normal-Triple-negative breast cancer	-0.616594166587748	0.177139889114524	22.0000007337017	0.0021193054106384	0.032020778113465	nan
sp|Q9Y5A9|YTHD2_HUMAN	metaplastic breast carcinomas-Normal	0.382888380522271	0.312244688161552	14.0000000159572	0.240332634306661	0.440875097370497	nan
sp|Q9Y5A9|YTHD2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0945275887976978	0.312244688161552	14.0000000159135	0.766542777928875	0.957818390309474	nan
sp|Q9Y5A9|YTHD2_HUMAN	Normal-Triple-negative breast cancer	-0.477415969319969	0.373203784403383	14.0000000157525	0.221610019681668	0.40452043131349	nan
sp|Q9Y5B9|SP16H_HUMAN	metaplastic breast carcinomas-Normal	0.638399417650166	0.249275081148869	22.0000000033601	0.0178153567492835	0.0901343163388406	nan
sp|Q9Y5B9|SP16H_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.368784692283895	0.249275081148869	22.0000000028191	0.153203562085084	0.843465960034572	nan
sp|Q9Y5B9|SP16H_HUMAN	Normal-Triple-negative breast cancer	-1.00718410993406	0.29794070858328	22.0000000030946	0.0026938273421855	0.0348415645347272	nan
sp|Q9Y5C1|ANGL3_HUMAN	metaplastic breast carcinomas-Normal	1.01001304750615	0.547858311067782	12.9999999997974	0.0881553968136679	0.238622588769244	nan
sp|Q9Y5C1|ANGL3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.163018052851811	0.418433696763129	12.9999999999431	0.703146425266802	0.94948208919602	nan
sp|Q9Y5C1|ANGL3_HUMAN	Normal-Triple-negative breast cancer	-1.17303110035796	0.612524212792893	12.9999999998483	0.0777439357066317	0.20640642355339	nan
sp|Q9Y5K5|UCHL5_HUMAN	metaplastic breast carcinomas-Normal	0.804815015825788	0.303124660645098	22.000000062663	0.0144621489546064	0.0795450818130059	nan
sp|Q9Y5K5|UCHL5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.099416489802214	0.303124660645098	22.0000000623966	0.746033499951794	0.954643368861838	nan
sp|Q9Y5K5|UCHL5_HUMAN	Normal-Triple-negative breast cancer	-0.904231505628002	0.362303266597801	22.0000000625803	0.0205553767356341	0.0940086378976347	nan
sp|Q9Y5K6|CD2AP_HUMAN	metaplastic breast carcinomas-Normal	0.41757130247532	0.229842293166043	23.9999999995585	0.0817621875264159	0.226670151240873	nan
sp|Q9Y5K6|CD2AP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0550653359396104	0.229842293166043	23.9999999995585	0.812691112711233	0.965774701272009	nan
sp|Q9Y5K6|CD2AP_HUMAN	Normal-Triple-negative breast cancer	-0.472636638414931	0.274714084427077	23.9999999995481	0.09821767704649	0.240367502451312	nan
sp|Q9Y5L0|TNPO3_HUMAN	metaplastic breast carcinomas-Normal	0.822218114209332	0.207385182322801	23.999999999768	0.0005760547505766	0.0205217420849069	nan
sp|Q9Y5L0|TNPO3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0286052302380449	0.207385182322801	23.999999999581	0.891444223950074	0.988218752026376	nan
sp|Q9Y5L0|TNPO3_HUMAN	Normal-Triple-negative breast cancer	-0.793612883971287	0.247872703064241	23.99999999968	0.0038249541413161	0.0403623732245556	nan
sp|Q9Y5L4|TIM13_HUMAN	metaplastic breast carcinomas-Normal	0.199954399252066	0.250079995644745	21.9999998182151	0.432513523396242	0.629179409964599	nan
sp|Q9Y5L4|TIM13_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.171965122888488	0.250079995644745	21.9999998181861	0.49886546958996	0.913320451076758	nan
sp|Q9Y5L4|TIM13_HUMAN	Normal-Triple-negative breast cancer	-0.371919522140554	0.29890276541682	21.9999998182337	0.22648953349533	0.409603487126484	nan
sp|Q9Y5M8|SRPRB_HUMAN	metaplastic breast carcinomas-Normal	0.770292062145176	0.240455575816492	22.0000000284961	0.0040984388580798	0.0428402854221928	nan
sp|Q9Y5M8|SRPRB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0198327648645125	0.240455575816492	22.0000000284961	0.935010903574011	0.995571782532303	nan
sp|Q9Y5M8|SRPRB_HUMAN	Normal-Triple-negative breast cancer	-0.750459297280663	0.287399383489846	22.0000000280182	0.0159444565434975	0.0806335913116407	nan
sp|Q9Y5P6|GMPPB_HUMAN	metaplastic breast carcinomas-Normal	-0.644506517560241	0.380583451371705	6.0	0.141307701136164	0.316727443409717	nan
sp|Q9Y5P6|GMPPB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.493147120340206	0.380583451371705	6.0	0.242668328871355	0.84964799869723	nan
sp|Q9Y5P6|GMPPB_HUMAN	Normal-Triple-negative breast cancer	0.151359397220036	0.454884229318686	6.0	0.750646930187064	0.856556950203158	nan
sp|Q9Y5S2|MRCKB_HUMAN	metaplastic breast carcinomas-Normal	-0.148245627991838	0.162099092935811	23.9999999999524	0.369532019008361	0.578542078903062	nan
sp|Q9Y5S2|MRCKB_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.293644215379591	0.162099092935811	23.9999999999524	0.0825958561989979	0.806849600316436	nan
sp|Q9Y5S2|MRCKB_HUMAN	Normal-Triple-negative breast cancer	-0.145398587387753	0.193745473424037	23.9999999998594	0.460271416620204	0.64148519448451	nan
sp|Q9Y5V3|MAGD1_HUMAN	metaplastic breast carcinomas-Normal	0.331827836175442	0.540254054240639	13.0068660057581	0.549671495258158	0.722880426895562	nan
sp|Q9Y5V3|MAGD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0607365893483339	0.540254054240639	13.0068660059221	0.912205116551757	0.99408739879047	nan
sp|Q9Y5V3|MAGD1_HUMAN	Normal-Triple-negative breast cancer	-0.392564425523776	0.635156720929897	13.0000000169862	0.547212137822248	0.712748098009856	nan
sp|Q9Y5X1|SNX9_HUMAN	metaplastic breast carcinomas-Normal	0.0660732712620468	0.293116041523556	23.9999999997119	0.823563515165511	0.907569094159468	nan
sp|Q9Y5X1|SNX9_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.559808247173883	0.293116041523556	23.9999999997119	0.06817475180971	0.777898601552022	nan
sp|Q9Y5X1|SNX9_HUMAN	Normal-Triple-negative breast cancer	-0.62588151843593	0.350340678683802	23.9999999997137	0.0866596827419931	0.22206387260471	nan
sp|Q9Y5X2|SNX8_HUMAN	metaplastic breast carcinomas-Normal	-0.089432343991119	0.181389054082808	15.0000000001053	0.629122800686805	0.778360007018459	nan
sp|Q9Y5X2|SNX8_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.246743616295031	0.181389054082808	14.9999999999525	0.193828088983998	0.843662073010871	nan
sp|Q9Y5X2|SNX8_HUMAN	Normal-Triple-negative breast cancer	0.33617596028615	0.216801386859876	15.0000000000681	0.141832478660528	0.304375165825092	nan
sp|Q9Y5X3|SNX5_HUMAN	metaplastic breast carcinomas-Normal	-0.3692667270509	0.197940458630446	22.0000000026534	0.0754968953186809	0.215409167415704	nan
sp|Q9Y5X3|SNX5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.36331403705018	0.197940458630446	22.0000000027976	0.0799916086253553	0.806849600316436	nan
sp|Q9Y5X3|SNX5_HUMAN	Normal-Triple-negative breast cancer	0.73258076410108	0.23658409909988	22.0000000029187	0.0052681364217199	0.0460823301731506	nan
sp|Q9Y5Y6|ST14_HUMAN	metaplastic breast carcinomas-Normal	0.0205880879927408	0.48150898129979	13.0687783075639	0.966541270732157	0.983705812588393	nan
sp|Q9Y5Y6|ST14_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.636527804966387	0.430024925210289	13.0000000094392	0.162640441473101	0.843662073010871	nan
sp|Q9Y5Y6|ST14_HUMAN	Normal-Triple-negative breast cancer	-0.657115892959128	0.557766029085529	13.0514388219693	0.259783549984843	0.450924553602934	nan
sp|Q9Y5Z4|HEBP2_HUMAN	metaplastic breast carcinomas-Normal	-0.699044415264726	0.305777218580594	22.0000000682818	0.0322397087750103	0.128806032097332	nan
sp|Q9Y5Z4|HEBP2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.477691928503841	0.305777218580594	22.0000000687715	0.132506898235641	0.823891816737944	nan
sp|Q9Y5Z4|HEBP2_HUMAN	Normal-Triple-negative breast cancer	0.221352486760885	0.365473679730222	22.0000000687269	0.55093897977067	0.71563937817808	nan
sp|Q9Y606|PUS1_HUMAN	metaplastic breast carcinomas-Normal	0.055398010188728	0.260935400312404	14.9999999997774	0.834726768292095	0.912407687537956	nan
sp|Q9Y606|PUS1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.645160853011142	0.260935400312404	14.9999999997484	0.0258712968115816	0.721684569712558	nan
sp|Q9Y606|PUS1_HUMAN	Normal-Triple-negative breast cancer	-0.70055886319987	0.311877455641508	14.9999999997851	0.0401752890001483	0.134755459774463	nan
sp|Q9Y613|FHOD1_HUMAN	metaplastic breast carcinomas-Normal	-0.0496007190326623	0.275113275906039	14.9999999998744	0.859336528043806	0.926760402276236	nan
sp|Q9Y613|FHOD1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.188087299340646	0.275113275906039	14.9999999997416	0.504607122806721	0.913320451076758	nan
sp|Q9Y613|FHOD1_HUMAN	Normal-Triple-negative breast cancer	0.237688018373309	0.328823258170604	14.9999999998133	0.480895288345612	0.659445519167003	nan
sp|Q9Y617|SERC_HUMAN	metaplastic breast carcinomas-Normal	0.453945320960702	0.511412086279044	21.9999999932838	0.384340837709375	0.589275343425259	nan
sp|Q9Y617|SERC_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.198181640121255	0.511412086279044	21.9999999917508	0.702096169614367	0.948971448767387	nan
sp|Q9Y617|SERC_HUMAN	Normal-Triple-negative breast cancer	-0.652126961081957	0.611254356680103	21.9999999912212	0.297600306366097	0.489230177230913	nan
sp|Q9Y618|NCOR2_HUMAN	metaplastic breast carcinomas-Normal	0.411863212438086	0.35465528346131	14.0000000002503	0.264935705291801	0.467931075658845	nan
sp|Q9Y618|NCOR2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0885246136051121	0.35465528346131	14.0000000004984	0.806516048551355	0.965774701272009	nan
sp|Q9Y618|NCOR2_HUMAN	Normal-Triple-negative breast cancer	-0.323338598832974	0.423894141244557	14.0000000006898	0.458254305686378	0.640751778146441	nan
sp|Q9Y624|JAM1_HUMAN	metaplastic breast carcinomas-Normal	-0.0747201018787049	0.470357146578573	6.0	0.878992824164042	0.936980460800664	nan
sp|Q9Y624|JAM1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.568391819126733	0.470357146578573	6.0	0.272343692951944	0.867696529950794	nan
sp|Q9Y624|JAM1_HUMAN	Normal-Triple-negative breast cancer	-0.493671717248028	0.562184318195602	6.0	0.413650330355963	0.60128493320689	nan
sp|Q9Y639|NPTN_HUMAN	metaplastic breast carcinomas-Normal	0.16663155059804	0.159263871344768	22.000000029617	0.306800454764997	0.514273682117424	nan
sp|Q9Y639|NPTN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.372059880188104	0.159263871344768	22.0000000297909	0.0289996085067504	0.721684569712558	nan
sp|Q9Y639|NPTN_HUMAN	Normal-Triple-negative breast cancer	0.205428329590063	0.190356735464619	22.0000000296381	0.29219961689069	0.485150612659667	nan
sp|Q9Y646|CBPQ_HUMAN	metaplastic breast carcinomas-Normal	0.858710654180615	1.36019108205773	5.0	0.555565224571115	0.726597478880195	nan
sp|Q9Y646|CBPQ_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.95543312292564	1.36019108205773	5.0	0.210053272568024	0.843662073010871	nan
sp|Q9Y646|CBPQ_HUMAN	Normal-Triple-negative breast cancer	1.09672246874502	1.57061337475072	5.0	0.516138058945428	0.689290039346968	nan
sp|Q9Y666|S12A7_HUMAN	metaplastic breast carcinomas-Normal	0.0887535127445645	0.382086640696765	14.0000000069647	0.81967687362625	0.905184693665667	nan
sp|Q9Y666|S12A7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.387120127828886	0.382086640696765	14.0000000075197	0.328168217424714	0.867975899287892	nan
sp|Q9Y666|S12A7_HUMAN	Normal-Triple-negative breast cancer	-0.47587364057345	0.456680884205245	14.0000000074126	0.315060386772075	0.508132326846374	nan
sp|Q9Y673|ALG5_HUMAN	metaplastic breast carcinomas-Normal	0.119015870541591	0.353888349012391	14.000000008229	0.741625433415191	0.85741667200675	nan
sp|Q9Y673|ALG5_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.206226621165004	0.353888349012391	14.0000000082272	0.569332916150341	0.935631258424823	nan
sp|Q9Y673|ALG5_HUMAN	Normal-Triple-negative breast cancer	0.087210750623413	0.422977479249725	14.0000000081581	0.839616296798222	0.908491071144951	nan
sp|Q9Y678|COPG1_HUMAN	metaplastic breast carcinomas-Normal	0.627190864129892	0.193749372609391	23.9999999995658	0.0035100728998683	0.0407324763980233	nan
sp|Q9Y678|COPG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.080248191794469	0.193749372609391	23.9999999996078	0.682416610061828	0.946568877415162	nan
sp|Q9Y678|COPG1_HUMAN	Normal-Triple-negative breast cancer	-0.707439055924361	0.231574793183334	23.9999999996227	0.0054447784165437	0.0465451118963115	nan
sp|Q9Y679|AUP1_HUMAN	metaplastic breast carcinomas-Normal	0.218636261391699	0.178732710149741	22.000000002055	0.234173787157399	0.434042408603237	nan
sp|Q9Y679|AUP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.392564780203623	0.178732710149741	22.0000000023315	0.0388978333385774	0.738255867002113	nan
sp|Q9Y679|AUP1_HUMAN	Normal-Triple-negative breast cancer	-0.611201041595322	0.213626448594842	22.0000000022644	0.0090799565665696	0.0598844754509474	nan
sp|Q9Y680|FKBP7_HUMAN	metaplastic breast carcinomas-Normal	-0.120668006158719	0.326416001784041	23.9999999993147	0.714866233507079	0.839696280422969	nan
sp|Q9Y680|FKBP7_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.553785306760351	0.326416001784041	23.9999999993147	0.102713549280011	0.821630939204717	nan
sp|Q9Y680|FKBP7_HUMAN	Normal-Triple-negative breast cancer	0.67445331291907	0.390141743876832	23.999999999352	0.0967013681434418	0.238514562527853	nan
sp|Q9Y696|CLIC4_HUMAN	metaplastic breast carcinomas-Normal	0.562234850703949	0.172959849001632	23.999999999281	0.0033964589600757	0.04050243156379	nan
sp|Q9Y696|CLIC4_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.363717868945184	0.172959849001632	23.999999999281	0.0461439005854626	0.759166737802103	nan
sp|Q9Y696|CLIC4_HUMAN	Normal-Triple-negative breast cancer	-0.198516981758765	0.206726559792908	23.9999999993641	0.346485857461276	0.537822699850043	nan
sp|Q9Y6A4|CFA20_HUMAN	metaplastic breast carcinomas-Normal	0.669515643768248	0.238968571493739	23.9999999997154	0.0098902995290723	0.0662809589407996	nan
sp|Q9Y6A4|CFA20_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0194459449385122	0.238968571493739	23.9999999997154	0.935818963183074	0.995571782532303	nan
sp|Q9Y6A4|CFA20_HUMAN	Normal-Triple-negative breast cancer	-0.68896158870676	0.285622073381088	23.9999999997071	0.0238661672064151	0.102760543774772	nan
sp|Q9Y6B6|SAR1B_HUMAN	metaplastic breast carcinomas-Normal	0.201560301701494	0.303710375254277	22.9999999997586	0.513506199477997	0.696407428423036	nan
sp|Q9Y6B6|SAR1B_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0869593424684318	0.303710375254277	22.9999999997586	0.777193780618588	0.960657739983943	nan
sp|Q9Y6B6|SAR1B_HUMAN	Normal-Triple-negative breast cancer	-0.288519644169926	0.359354962191886	22.9999999997752	0.430262038411032	0.615984668993204	nan
sp|Q9Y6C2|EMIL1_HUMAN	metaplastic breast carcinomas-Normal	0.711985680461653	0.30847813825677	21.999998927205	0.0307793795677926	0.126153237930521	nan
sp|Q9Y6C2|EMIL1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	1.07047977126291	0.30847813825677	21.9999989272039	0.0021740071802129	0.448717474870704	nan
sp|Q9Y6C2|EMIL1_HUMAN	Normal-Triple-negative breast cancer	0.358494090801256	0.368701896198702	21.9999989272299	0.341464207522186	0.533628126847083	nan
sp|Q9Y6C9|MTCH2_HUMAN	metaplastic breast carcinomas-Normal	-0.0500441692949446	0.197704488898177	24.0000000001127	0.802326386609375	0.89584578739992	nan
sp|Q9Y6C9|MTCH2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.705854468167286	0.197704488898177	23.9999999998261	0.0015479369481752	0.448717474870704	nan
sp|Q9Y6C9|MTCH2_HUMAN	Normal-Triple-negative breast cancer	-0.655810298872342	0.236302061324935	23.9999999999811	0.0105144132152144	0.0653269336960234	nan
sp|Q9Y6D6|BIG1_HUMAN	metaplastic breast carcinomas-Normal	0.478931445384288	0.229852056384676	22.0000001777844	0.0490191788110385	0.167461202844699	nan
sp|Q9Y6D6|BIG1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0718984436522586	0.229852056384676	22.0000001777807	0.75737617442808	0.955228196959647	nan
sp|Q9Y6D6|BIG1_HUMAN	Normal-Triple-negative breast cancer	-0.407033001732029	0.274725753705306	22.0000001778436	0.152629576872532	0.320088778248768	nan
sp|Q9Y6E0|STK24_HUMAN	metaplastic breast carcinomas-Normal	-0.870211711303297	0.421776215800179	23.9999999997364	0.0500708709334691	0.169912927873181	nan
sp|Q9Y6E0|STK24_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.209980516484974	0.421776215800179	23.9999999995556	0.623122238853782	0.941374262616245	nan
sp|Q9Y6E0|STK24_HUMAN	Normal-Triple-negative breast cancer	0.660231194818323	0.504118999861171	23.9999999996943	0.202705491392231	0.382901192452517	nan
sp|Q9Y6E2|5MP1_HUMAN	metaplastic breast carcinomas-Normal	0.304214081763902	0.244535331435507	22.0000000587895	0.226573640713576	0.426702992482677	nan
sp|Q9Y6E2|5MP1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0097470618276628	0.244535331435507	22.0000000587895	0.968564636597561	0.99709406933403	nan
sp|Q9Y6E2|5MP1_HUMAN	Normal-Triple-negative breast cancer	-0.313961143591565	0.292275624124786	22.0000000587867	0.2943761829568	0.487061439596019	nan
sp|Q9Y6G9|DC1L1_HUMAN	metaplastic breast carcinomas-Normal	0.528328672031551	0.26046013772468	21.9999999536207	0.0547913520798593	0.178730573418501	nan
sp|Q9Y6G9|DC1L1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.244980098664037	0.26046013772468	21.9999999536194	0.357140691184946	0.882894273747171	nan
sp|Q9Y6G9|DC1L1_HUMAN	Normal-Triple-negative breast cancer	-0.773308770695588	0.311309408199714	21.9999999531829	0.0210881209365372	0.0953699510109521	nan
sp|Q9Y6I3|EPN1_HUMAN	metaplastic breast carcinomas-Normal	0.109862333700672	0.213485112063768	23.9999999995004	0.611529986979666	0.767645648308312	nan
sp|Q9Y6I3|EPN1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0938376377343947	0.213485112063768	23.9999999995015	0.664194738410795	0.944724271291086	nan
sp|Q9Y6I3|EPN1_HUMAN	Normal-Triple-negative breast cancer	-0.203699971435067	0.255163513605574	23.9999999995183	0.432518706347792	0.617201755042369	nan
sp|Q9Y6K5|OAS3_HUMAN	metaplastic breast carcinomas-Normal	0.318650517094967	0.334507685072227	22.0000000041035	0.351144775909684	0.560886705970106	nan
sp|Q9Y6K5|OAS3_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.408560625408823	0.334507685072227	22.0000000041577	0.234870185469588	0.84876230490475	nan
sp|Q9Y6K5|OAS3_HUMAN	Normal-Triple-negative breast cancer	0.0899101083138566	0.399813155240545	22.000000004488	0.824148020430788	0.899956642546629	nan
sp|Q9Y6N5|SQOR_HUMAN	metaplastic breast carcinomas-Normal	0.0822606327722378	0.382691267395397	23.9999999997209	0.831620060589603	0.910823889104312	nan
sp|Q9Y6N5|SQOR_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.103869705296133	0.382691267395397	23.9999999997209	0.788389737945633	0.962981271203673	nan
sp|Q9Y6N5|SQOR_HUMAN	Normal-Triple-negative breast cancer	-0.186130338068371	0.457403551333417	23.9999999997321	0.687667226322467	0.816650896854548	nan
sp|Q9Y6N7|ROBO1_HUMAN	metaplastic breast carcinomas-Normal	-0.817272861432593	0.529105680634826	22.000000000114	0.136699714182866	0.310163720098189	nan
sp|Q9Y6N7|ROBO1_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.296309579632099	0.495552873309853	22.0000000003658	0.555987654077143	0.931642387063667	nan
sp|Q9Y6N7|ROBO1_HUMAN	Normal-Triple-negative breast cancer	1.11358244106469	0.614964943210833	22.0000000002293	0.0838497799760876	0.217577415019918	nan
sp|Q9Y6Q1|CAN6_HUMAN	metaplastic breast carcinomas-Normal	-1.10886342605159	0.631750228931683	14.0000000044603	0.101068102146988	0.256896548541066	nan
sp|Q9Y6Q1|CAN6_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.777116248009645	0.631750228931683	14.0000000046233	0.23892977966642	0.84876230490475	nan
sp|Q9Y6Q1|CAN6_HUMAN	Normal-Triple-negative breast cancer	0.331747178041949	0.755085947572701	14.0000000043661	0.667113250886895	0.8042915764791	nan
sp|Q9Y6Q5|AP1M2_HUMAN	metaplastic breast carcinomas-Normal	0.444480547222409	0.338860846976124	14.9999999998442	0.209346716338059	0.404574700644017	nan
sp|Q9Y6Q5|AP1M2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.600495034557311	0.338860846976124	14.9999999998442	0.0966840404255998	0.814943337126966	nan
sp|Q9Y6Q5|AP1M2_HUMAN	Normal-Triple-negative breast cancer	-1.04497558177972	0.405016178889148	14.9999999998319	0.0209112031728173	0.0952175881458148	nan
sp|Q9Y6R0|NUMBL_HUMAN	metaplastic breast carcinomas-Normal	0.648684403227183	0.184460127280486	22.0000000028458	0.001944742240962	0.0316878588674408	nan
sp|Q9Y6R0|NUMBL_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.0138162931850538	0.184460127280486	22.0000000028457	0.94097020304664	0.996092303447972	nan
sp|Q9Y6R0|NUMBL_HUMAN	Normal-Triple-negative breast cancer	-0.63486811004213	0.2204720214071	22.0000000027389	0.0087033767490939	0.0588076066258844	nan
sp|Q9Y6R7|FCGBP_HUMAN	metaplastic breast carcinomas-Normal	-0.832591361134192	0.456282608026096	23.9999999994304	0.080515901895607	0.224816118300932	nan
sp|Q9Y6R7|FCGBP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.367698759642286	0.456282608026096	23.9999999994304	0.428237868670433	0.894058800058913	nan
sp|Q9Y6R7|FCGBP_HUMAN	Normal-Triple-negative breast cancer	0.464892601491906	0.5453620270545	23.9999999993515	0.402392658504103	0.592624367243082	nan
sp|Q9Y6U3|SCIN_HUMAN	metaplastic breast carcinomas-Normal	-0.51091205472418	0.451433755250113	14.9999999997875	0.275507110068889	0.477718118867495	nan
sp|Q9Y6U3|SCIN_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.783632382553142	0.451433755250113	14.9999999997875	0.103075136176744	0.821630939204717	nan
sp|Q9Y6U3|SCIN_HUMAN	Normal-Triple-negative breast cancer	1.29454443727732	0.539566539494196	14.9999999997689	0.0298698246806388	0.115989833222481	nan
sp|Q9Y6W5|WASF2_HUMAN	metaplastic breast carcinomas-Normal	0.100082768859226	0.180653685675117	24.0000000002207	0.584701983671853	0.744369740990134	nan
sp|Q9Y6W5|WASF2_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	-0.0632752426781669	0.180653685675117	24.0000000001723	0.729201111488331	0.954643368861838	nan
sp|Q9Y6W5|WASF2_HUMAN	Normal-Triple-negative breast cancer	-0.163358011537393	0.215922453500603	24.0000000001969	0.456677320218937	0.638891090113239	nan
sp|Q9Y6Y8|S23IP_HUMAN	metaplastic breast carcinomas-Normal	0.822418041909114	0.175938784665652	23.999999999123	9.50220099292233e-05	0.0136889536397125	nan
sp|Q9Y6Y8|S23IP_HUMAN	metaplastic breast carcinomas-Triple-negative breast cancer	0.180599833764115	0.175938784665653	23.999999999123	0.314894819832903	0.867696529950794	nan
sp|Q9Y6Y8|S23IP_HUMAN	Normal-Triple-negative breast cancer	-0.641818208144999	0.210287068923911	23.9999999991696	0.0054813224466889	0.046717732853318	nan
tr|CONTAMINANT_Q3SX28|CONTAMINANT_TPM2_BOVIN	metaplastic breast carcinomas-Normal	-0.146264685750111	0.403119029637526	22.0000033439819	0.720192689029928	0.843892572513791	nan
tr|CONTAMINANT_Q3SX28|CONTAMINANT_TPM2_BOVIN	metaplastic breast carcinomas-Triple-negative breast cancer	0.179328479329975	0.403119029637526	22.0000033429314	0.660772306641562	0.944434752137403	nan
tr|CONTAMINANT_Q3SX28|CONTAMINANT_TPM2_BOVIN	Normal-Triple-negative breast cancer	0.325593165080086	0.48181939718989	22.0000033432942	0.506236417873844	0.680269546112475	nan
